Citrus Sinensis ID: 002760

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880----
Protein Sequence
MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTDC
Secondary Structure (PSIPRED)
ccccccccEEEccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEEEccccEEcccccccccccccEEEccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHHHHccccEEEccccccEEcccccccccccccEEEccccccccccccccccHHcccccccccEEEcccccccccccHHHHcccccccEEEEcccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccccccccEEccccccccccccccccEEcccccccccccHHHHcccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccEEcccccccccccccHHHccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHccccccccEEEEEEcccccccccEEEEEEcccccccHHHHccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEEcccccccccccccEEEEccccccccccccccccccccccccccccccEEEEcccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEcccccEEEEEEcccccccccccHHHccccHEEEEEcccccccccccHHHHccHcccEEEcccccccccccccHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccccHcccHHccEEEccccccccccccHccccccEEEEEEcccccccccHcHccccccEEEEEccccccccccHHHHcccccccEEEEEcccccccccccHHcccccEEEEcccccccccccHcHccccccEEEEEcccccccccccccccHHHccccccEEEEEEccccccccccccHcccccccEEEEcEEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEEcccccccccccccEEEcccccEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEccccccccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEcccccEEEEccHcHHHHEccccccccccccccEEEEEEcEcEccccccccccEcccccHHHHHHHHHHHHcccccccHHccccccHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
mnlcqwtgvtcgqrhqrvtrldlgnqsirgtlspyvgnlSFLRYINIasngfngeiphQIGRLISLERLilsnnsfsgaipanlsscSNLIElsadsnnlvgeipadigslfklERLSIFqnhitgqlpasignlsslrvidvrenrlwgridslgqlksLTLLSVAFNqfsgmippsifniSSLEVIslsenrftgslpvdtgvnlpslrelrtnannftgfipvslsnassleMIEFSknqfsggvsvdfsrlkNLYWLNLGinnlgtgaanELDFINLLTNCSKLERLYFNrnrfegelphsvaNLSSTIKQIAMgrnrisgtippeirnlaslnwltidtnqltgtippeigeltnlqqldldrnflqgsipsslgnlTLLTYLKLGLnnlegnipsslgnctnllglnishnkligtlprqILRITTLSLYLELGnnllngslppevgnlknlmrldlsgnkfsgeipatlsACANLEYLnisgnafsgsiPLLLDSLQsikeldfssnnlngqipeylenLSFLEFLNLSynhfegevpmkgvfnnktrfsiagngklcggldelrlpscqskgsltiLKVVIPVIVSCLILSVGFTLIYVWRRRSarkasnmlpieQQFLVDSYAELSkatdnfssankigeggsgivykgflgengTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVcsgrdfkgaDFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHhycepsivhgdlkpsnvlldqdlvshvSDFGLAkflsnhnpdtivetrsisigikgtvgyvapeygmgreasmkgdvYSFGILLLELFtrkrptdamfnegltlhdfsrefftrksdtdc
Flexible Loop (DISEMBL)
mnlcqwtgvtcgqrhqrvtrldlgnqsirgtLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITgqlpasignlsslrVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSarkasnmlpIEQQFLVDSYAELSKATDNfssankigeggSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALrnirhrnlikiitvcsgrdfKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKflsnhnpdtivetrsisigikgtVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEgltlhdfsrefftrksdtdc
Low Complexity Region (SEG)
MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSlgnltlltylklglnnlEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTlslylelgnnllngslppeVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPeylenlsfleflnlsynHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTDC
Disordered region (IsUnstruct)
**LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNF**ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFF********
Disordered Region (DISOPRED)
MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGL******************VVIPVIVSCLILSVGFTLIYV********************VDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL****************GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR******
Disordered Region (DISEMBL)
MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFF********
Disordered Region (DISPRO)
*NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSAR*****LPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH********RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFT*******
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTDC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	884	2.2.26 [Sep-21-2011]
C0LGT6	1031	LRR receptor-like serine/	yes	no	0.984	0.843	0.462	0.0
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.978	0.856	0.455	0.0
Q9SD62	1025	Putative receptor-like pr	no	no	0.993	0.856	0.468	0.0
Q9FL28	1173	LRR receptor-like serine/	no	no	0.916	0.690	0.360	1e-135
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.882	0.795	0.378	1e-133
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.908	0.641	0.348	1e-123
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.953	0.841	0.353	1e-123
O49318	1124	Probable leucine-rich rep	no	no	0.969	0.762	0.327	1e-121
O49545	1003	Leucine-rich repeat recep	no	no	0.957	0.843	0.340	1e-121
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.964	0.774	0.327	1e-119

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  749 bits (1934), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/896 (46%), Positives = 580/896 (64%), Gaps = 26/896 (2%)

Query: 3   LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
            C W GVTCG+R +RV  L+LG   + G +SP +GNLSFLR +N+A N F   IP ++GR
Sbjct: 60  FCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGR 119

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
           L  L+ L +S N   G IP++LS+CS L  +   SN+L   +P+++GSL KL  L + +N
Sbjct: 120 LFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKN 179

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
           ++TG  PAS+GNL+SL+ +D   N++ G I D + +L  +    +A N FSG  PP+++N
Sbjct: 180 NLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYN 239

Query: 182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
           ISSLE +SL++N F+G+L  D G  LP+LR L    N FTG IP +L+N SSLE  + S 
Sbjct: 240 ISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISS 299

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
           N  SG + + F +L+NL+WL +  N+LG  +++ L+FI  + NC++LE L    NR  GE
Sbjct: 300 NYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGE 359

Query: 302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
           LP S+ANLS+T+  + +G+N ISGTIP +I NL SL  L+++TN L+G +P   G+L NL
Sbjct: 360 LPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNL 419

Query: 362 QQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG 421
           Q +DL  N + G IPS  GN+T L  L L  N+  G IP SLG C  LL L +  N+L G
Sbjct: 420 QVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNG 479

Query: 422 TLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
           T+P++IL+I +L+ Y++L NN L G  P EVG L+ L+ L  S NK SG++P  +  C +
Sbjct: 480 TIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLS 538

Query: 482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
           +E+L + GN+F G+IP  +  L S+K +DFS+NNL+G+IP YL +L  L  LNLS N FE
Sbjct: 539 MEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFE 597

Query: 542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC------QSKGSLTILKVVIP----V 591
           G VP  GVF N T  S+ GN  +CGG+ E++L  C      + +  L++ K V+      
Sbjct: 598 GRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIG 657

Query: 592 IVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFL-----VDSYAELSKATDNFSSANK 646
           I S L++ +  +L +  +R+    AS+  P +   L       SY EL  AT  FSS N 
Sbjct: 658 IASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNL 717

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           IG G  G V+KG LG     VAVKV+NL + GA+KSF+AEC+  + IRHRNL+K+ITVCS
Sbjct: 718 IGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCS 777

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLH-----HSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             D +G DF+A+VYEFM  GSL+ WL        ND     SL+  ++LNIAIDVASA+E
Sbjct: 778 SLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSR--SLTPAEKLNIAIDVASALE 835

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH +C   + H D+KPSN+LLD DL +HVSDFGLA+ L  ++ ++ +   S S G++GT
Sbjct: 836 YLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFS-SAGVRGT 894

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFT 877
           +GY APEYGMG + S++GDVYSFGILLLE+F+ K+PTD  F     LH +++   +
Sbjct: 895 IGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILS 950

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  738 bits (1906), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/890 (45%), Positives = 583/890 (65%), Gaps = 25/890 (2%)

Query: 3   LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
           LC W GVTCG++++RVT L+LG   + G +SP +GNLSFL  +++  N F G IP ++G+
Sbjct: 53  LCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQ 112

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
           L  LE L +  N   G IP  L +CS L+ L  DSN L G +P+++GSL  L +L+++ N
Sbjct: 113 LSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGN 172

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPSIFN 181
           ++ G+LP S+GNL+ L  + +  N L G I S + QL  +  L +  N FSG+ PP+++N
Sbjct: 173 NMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYN 232

Query: 182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
           +SSL+++ +  N F+G L  D G+ LP+L       N FTG IP +LSN S+LE +  ++
Sbjct: 233 LSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNE 292

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
           N  +G +   F  + NL  L L  N+LG+ ++ +L+F+  LTNC++LE L   RNR  G+
Sbjct: 293 NNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGD 351

Query: 302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
           LP S+ANLS+ +  + +G   ISG+IP +I NL +L  L +D N L+G +P  +G+L NL
Sbjct: 352 LPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNL 411

Query: 362 QQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG 421
           + L L  N L G IP+ +GN+T+L  L L  N  EG +P+SLGNC++LL L I  NKL G
Sbjct: 412 RYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNG 471

Query: 422 TLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
           T+P +I++I  L L L++  N L GSLP ++G L+NL  L L  NK SG++P TL  C  
Sbjct: 472 TIPLEIMKIQQL-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLT 530

Query: 482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
           +E L + GN F G IP  L  L  +KE+D S+N+L+G IPEY  + S LE+LNLS+N+ E
Sbjct: 531 MESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLE 589

Query: 542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQS-------KGSLTILKVVIPVIVS 594
           G+VP+KG+F N T  SI GN  LCGG+   +L  C S       K S  + KVVI V V 
Sbjct: 590 GKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVG 649

Query: 595 CLILSVGF----TLIYVWRRRSARKASNMLPIEQQFLVD--SYAELSKATDNFSSANKIG 648
             +L + F    TLI++ +R+  ++ +N  P   + L +  SY +L  AT+ FSS+N +G
Sbjct: 650 ITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVG 709

Query: 649 EGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGR 708
            G  G VYK  L      VAVKV+N++++GA KSF+AEC++L++IRHRNL+K++T CS  
Sbjct: 710 SGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSI 769

Query: 709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC-----SLSVIQRLNIAIDVASAIEYL 763
           DF+G +F+A++YEFM NGSL+ WLH   +++E       +L++++RLNIAIDVAS ++YL
Sbjct: 770 DFQGNEFRALIYEFMPNGSLDMWLHP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYL 827

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H +C   I H DLKPSNVLLD DL +HVSDFGLA+ L   + ++     S S G++GT+G
Sbjct: 828 HVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLS-SAGVRGTIG 886

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           Y APEYG+G + S+ GDVYSFGILLLE+FT KRPT+ +F    TL+ +++
Sbjct: 887 YAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTK 936

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  724 bits (1869), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/903 (46%), Positives = 600/903 (66%), Gaps = 25/903 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           + LC WTGV CG +H+RVT +DLG   + G +SP+VGNLSFLR +N+A N F+G IP ++
Sbjct: 66  LPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEV 125

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           G L  L+ L +SNN F G IP  LS+CS+L  L   SN+L   +P + GSL KL  LS+ 
Sbjct: 126 GNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLG 185

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSGMIPPSI 179
           +N++TG+ PAS+GNL+SL+++D   N++ G I   + +LK +    +A N+F+G+ PP I
Sbjct: 186 RNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPI 245

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           +N+SSL  +S++ N F+G+L  D G  LP+L+ L    N+FTG IP +LSN SSL  ++ 
Sbjct: 246 YNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDI 305

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
             N  +G + + F RL+NL  L L  N+LG  ++ +LDF+  LTNCS+L+ L    N+  
Sbjct: 306 PSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLG 365

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G+LP  +ANLS+ + ++++G N ISG+IP  I NL SL  L +  N LTG +PP +GEL+
Sbjct: 366 GQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELS 425

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
            L+++ L  N L G IPSSLGN++ LTYL L  N+ EG+IPSSLG+C+ LL LN+  NKL
Sbjct: 426 ELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKL 485

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            G++P +++ + +L + L +  NLL G L  ++G LK L+ LD+S NK SG+IP TL+ C
Sbjct: 486 NGSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANC 544

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
            +LE+L + GN+F G IP  +  L  ++ LD S NNL+G IPEY+ N S L+ LNLS N+
Sbjct: 545 LSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNN 603

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSK--GSLTILKVVIPVIVSCLI 597
           F+G VP +GVF N +  S+ GN  LCGG+  L+L  C  +     + ++ +I + VS ++
Sbjct: 604 FDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVM 663

Query: 598 LSVGFTLI-------YVWRRRSARKASN-----MLPIEQQFLVDSYAELSKATDNFSSAN 645
            ++    +       Y  R +S R  +N       P++  +   SY EL K T  FSS+N
Sbjct: 664 AALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSN 723

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
            IG G  G V+KGFLG     VA+KV+NL ++GA+KSF+AEC+AL  IRHRNL+K++T+C
Sbjct: 724 LIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTIC 783

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC-----SLSVIQRLNIAIDVASAI 760
           S  DF+G DF+A+VYEFM NG+L+ WLH   D++E       +L +  RLNIAIDVASA+
Sbjct: 784 SSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGNPSRTLGLFARLNIAIDVASAL 841

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YLH YC   I H D+KPSN+LLD+DL +HVSDFGLA+ L   + DT    +  S G++G
Sbjct: 842 VYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTF-HIQFSSAGVRG 900

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKS 880
           T+GY APEYGMG   S+ GDVYSFGI+LLE+FT KRPT+ +F +GLTLH F++    ++ 
Sbjct: 901 TIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQ 960

Query: 881 DTD 883
             D
Sbjct: 961 ALD 963

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  484 bits (1246), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 323/895 (36%), Positives = 498/895 (55%), Gaps = 85/895 (9%)

Query: 28   IRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSC 87
            + G++   +G L+ L  ++++ N   G+IP   G L++L+ L+L+ N   G IPA + +C
Sbjct: 204  LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263

Query: 88   SNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENR 147
            S+L++L    N L G+IPA++G+L +L+ L I++N +T  +P+S+  L+ L  + + EN 
Sbjct: 264  SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323

Query: 148  LWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVN 206
            L G I + +G L+SL +L++  N F+G  P SI N+ +L V+++  N  +G LP D G+ 
Sbjct: 324  LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382

Query: 207  LPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGIN 266
            L +LR L  + N  TG IP S+SN + L++++ S NQ +G +   F R+ NL ++++G N
Sbjct: 383  LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRN 441

Query: 267  NLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGT 326
            +  TG   +  F     NCS LE L    N   G L   +  L   ++ + +  N ++G 
Sbjct: 442  HF-TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLTGP 494

Query: 327  IPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL-- 384
            IP EI NL  LN L + +N  TG IP E+  LT LQ L +  N L+G IP  + ++ L  
Sbjct: 495  IPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLS 554

Query: 385  ----------------------LTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGT 422
                                  LTYL L  N   G+IP+SL + + L   +IS N L GT
Sbjct: 555  VLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGT 614

Query: 423  LPRQIL-RITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
            +P ++L  +  + LYL   NNLL G++P E+G L+ +  +DLS N FSG IP +L AC N
Sbjct: 615  IPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKN 674

Query: 482  ---LEY----------------------LNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
               L++                      LN+S N+FSG IP    ++  +  LD SSNNL
Sbjct: 675  VFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNL 734

Query: 517  NGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC 576
             G+IPE L NLS L+ L L+ N+ +G VP  GVF N     + GN  LCG    L+  + 
Sbjct: 735  TGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTI 794

Query: 577  QSKGSLTILKVVIPVIV--------SCLILSVGFTLIYVWRRRSARKASNMLP-IEQQFL 627
            + K S    +  + +I+          L+L +  T      ++    + + LP ++    
Sbjct: 795  KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALK 854

Query: 628  VDSY--AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSF 683
            +  +   EL +ATD+F+SAN IG      VYKG L E+GT +AVKV+NLK+  A   K F
Sbjct: 855  LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWF 913

Query: 684  VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
              E K L  ++HRNL+KI+    G  ++    KA+V  FM+NG+LE+ +H S   +    
Sbjct: 914  YTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG--- 966

Query: 744  LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
             S+++++++ + +AS I+YLH      IVH DLKP+N+LLD D V+HVSDFG A+ L   
Sbjct: 967  -SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFR 1025

Query: 804  NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT 858
               +   + S     +GT+GY+APE+   R+ + K DV+SFGI+++EL T++RPT
Sbjct: 1026 EDGSTTASTS---AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  478 bits (1229), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 317/837 (37%), Positives = 460/837 (54%), Gaps = 57/837 (6%)

Query: 88  SNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL-SSLRVIDVREN 146
           + +IEL     +L GEI   I +L  L  L + +N   G++P  IG+L  +L+ + + EN
Sbjct: 66  TQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSEN 125

Query: 147 RLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIF---NISSLEVISLSENRFTGSLPVD 202
            L G I   LG L  L  L +  N+ +G IP  +F   + SSL+ I LS N  TG +P++
Sbjct: 126 LLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLN 185

Query: 203 TGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGV-SVDFSRLKNLYWL 261
              +L  LR L   +N  TG +P SLSN+++L+ ++   N  SG + S   S++  L +L
Sbjct: 186 YHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFL 245

Query: 262 NLGINNLGT--GAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMG 319
            L  N+  +     N   F   L N S L+ L    N   GE+  SV +LS  + QI + 
Sbjct: 246 YLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLD 305

Query: 320 RNRISGTIPPEIR------------------------NLASLNWLTIDTNQLTGTIPPEI 355
           +NRI G+IPPEI                          L+ L  + +  N LTG IP E+
Sbjct: 306 QNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMEL 365

Query: 356 GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNIS 415
           G++  L  LD+ RN L GSIP S GNL+ L  L L  N+L G +P SLG C NL  L++S
Sbjct: 366 GDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLS 425

Query: 416 HNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA 474
           HN L GT+P +++  +  L LYL L +N L+G +P E+  +  ++ +DLS N+ SG+IP 
Sbjct: 426 HNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPP 485

Query: 475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLN 534
            L +C  LE+LN+S N FS ++P  L  L  +KELD S N L G IP   +  S L+ LN
Sbjct: 486 QLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLN 545

Query: 535 LSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVS 594
            S+N   G V  KG F+  T  S  G+  LCG +  ++    + K    +L V++ +I +
Sbjct: 546 FSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIAT 605

Query: 595 CLILSVGFTLIY---------VWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSAN 645
            ++   G+ L+          V+ +            + ++   SY +L  AT  F++++
Sbjct: 606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASS 665

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITV 704
            IG G  G VYKG L  N T+VAVKV++ K     S SF  EC+ L+  RHRNLI+IIT 
Sbjct: 666 LIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITT 724

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           CS        F A+V   M NGSLE  L+    +    +L +IQ +NI  DVA  I YLH
Sbjct: 725 CS-----KPGFNALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVNICSDVAEGIAYLH 777

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG-----IK 819
           HY    +VH DLKPSN+LLD ++ + V+DFG+++ +     +T+    S+S G     + 
Sbjct: 778 HYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ETVSTDDSVSFGSTDGLLC 836

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFF 876
           G+VGY+APEYGMG+ AS  GDVYSFG+LLLE+ + +RPTD + NEG +LH+F +  +
Sbjct: 837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHY 893

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  444 bits (1142), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 303/870 (34%), Positives = 467/870 (53%), Gaps = 67/870 (7%)

Query: 18   VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
            + +L L    + G +   + N   L+ +++++N   G+IP  + +L+ L  L L+NNS  
Sbjct: 339  LKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLE 398

Query: 78   GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
            G + +++S+ +NL E +   NNL G++P +IG L KLE + +++N  +G++P  IGN + 
Sbjct: 399  GTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTR 458

Query: 138  LRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFT 196
            L+ ID   NRL G I  S+G+LK LT L +  N+  G IP S+ N   + VI L++N+ +
Sbjct: 459  LQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLS 518

Query: 197  GSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLK 256
            GS+P   G  L +L       N+  G +P SL N  +L  I FS N+F+G +S       
Sbjct: 519  GSIPSSFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPL----- 572

Query: 257  NLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQI 316
                          G+++ L F                 N FEG++P  +   S+ + ++
Sbjct: 573  -------------CGSSSYLSF-------------DVTENGFEGDIPLELGK-STNLDRL 605

Query: 317  AMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIP 376
             +G+N+ +G IP     ++ L+ L I  N L+G IP E+G    L  +DL+ N+L G IP
Sbjct: 606  RLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIP 665

Query: 377  SSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLY 436
            + LG L LL  LKL  N   G++P+ + + TN+L L +  N L G++P++I  +  L+  
Sbjct: 666  TWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALN-A 724

Query: 437  LELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLE-YLNISGNAFSGS 495
            L L  N L+G LP  +G L  L  L LS N  +GEIP  +    +L+  L++S N F+G 
Sbjct: 725  LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784

Query: 496  IPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTR 555
            IP  + +L  ++ LD S N L G++P  + ++  L +LNLSYN+ EG+  +K  F+    
Sbjct: 785  IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGK--LKKQFSRWQA 842

Query: 556  FSIAGNGKLCGG-LDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVW------ 608
             +  GN  LCG  L        +++ SL+   VVI   +S L       L+ +       
Sbjct: 843  DAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH 902

Query: 609  ----RRRSARKASNMLPIEQQFLVDS---------YAELSKATDNFSSANKIGEGGSGIV 655
                + R    A +      Q  + S         + ++ +AT   +    IG GGSG V
Sbjct: 903  DLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKV 962

Query: 656  YKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD 714
            YK  L +NG  +AVK I  K    S KSF  E K L  IRHR+L+K++  CS    K   
Sbjct: 963  YKAEL-KNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADG 1018

Query: 715  FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHG 774
               ++YE+M NGS+ +WLH + +  +   L    RL IA+ +A  +EYLH+ C P IVH 
Sbjct: 1019 LNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHR 1078

Query: 775  DLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE 834
            D+K SNVLLD ++ +H+ DFGLAK L+  N DT  E+ ++     G+ GY+APEY    +
Sbjct: 1079 DIKSSNVLLDSNIEAHLGDFGLAKILTG-NYDTNTESNTM---FAGSYGYIAPEYAYSLK 1134

Query: 835  ASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
            A+ K DVYS GI+L+E+ T K PT+AMF+E
Sbjct: 1135 ATEKSDVYSMGIVLMEIVTGKMPTEAMFDE 1164

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  442 bits (1136), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 318/900 (35%), Positives = 465/900 (51%), Gaps = 57/900 (6%)

Query: 3   LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
            C WTGVTC    + VT LDL   ++ GTLS  V +L  L+ +++A+N  +G IP QI  
Sbjct: 56  FCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISN 115

Query: 63  LISLERLILSNNSFSGAIPANLSS-CSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQ 121
           L  L  L LSNN F+G+ P  LSS   NL  L   +NNL G++P  + +L +L  L +  
Sbjct: 116 LYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGG 175

Query: 122 NHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAF-NQFSGMIPPSI 179
           N+ +G++PA+ G    L  + V  N L G+I   +G L +L  L + + N F   +PP I
Sbjct: 176 NYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEI 235

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
            N+S L     +    TG +P + G  L  L  L    N FTG I   L   SSL+ ++ 
Sbjct: 236 GNLSELVRFDAANCGLTGEIPPEIG-KLQKLDTLFLQVNAFTGTITQELGLISSLKSMDL 294

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
           S N F+G +   FS+LKNL  LNL  N L  GA  E      +    +LE L    N F 
Sbjct: 295 SNNMFTGEIPTSFSQLKNLTLLNLFRNKL-YGAIPEF-----IGEMPELEVLQLWENNFT 348

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G +P  +   +  +  + +  N+++GT+PP + +   L  L    N L G+IP  +G+  
Sbjct: 349 GSIPQKLGE-NGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCE 407

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLG-LNISHNK 418
           +L ++ +  NFL GSIP  L  L  L+ ++L  N L G +P S G  +  LG +++S+N+
Sbjct: 408 SLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQ 467

Query: 419 LIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
           L G+LP  I  ++ +   L L  N  +GS+PPE+G L+ L +LD S N FSG I   +S 
Sbjct: 468 LSGSLPAAIGNLSGVQKLL-LDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISR 526

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           C  L ++++S N  SG IP  L  ++ +  L+ S N+L G IP  + ++  L  ++ SYN
Sbjct: 527 CKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYN 586

Query: 539 HFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVIVSC--- 595
           +  G VP  G F+     S  GN  LCG       P     G  T    V P+  +    
Sbjct: 587 NLSGLVPSTGQFSYFNYTSFVGNSHLCG-------PYLGPCGKGTHQSHVKPLSATTKLL 639

Query: 596 -----LILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAEL----SKATDNFSSANK 646
                L  S+ F ++ + + RS R AS      + + + ++  L        D+    N 
Sbjct: 640 LVLGLLFCSMVFAIVAIIKARSLRNASE----AKAWRLTAFQRLDFTCDDVLDSLKEDNI 695

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKIITV 704
           IG+GG+GIVYKG +   G  VAVK +     G+S    F AE + L  IRHR++++++  
Sbjct: 696 IGKGGAGIVYKGTM-PKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 754

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           CS       +   +VYE+M NGSL E LH          L    R  IA++ A  + YLH
Sbjct: 755 CSNH-----ETNLLVYEYMPNGSLGEVLHGKKGG----HLHWNTRYKIALEAAKGLCYLH 805

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
           H C P IVH D+K +N+LLD +  +HV+DFGLAKFL +        T      I G+ GY
Sbjct: 806 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSG------TSECMSAIAGSYGY 859

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTDC 884
           +APEY    +   K DVYSFG++LLEL T K+P    F +G+ +  + R      S+ DC
Sbjct: 860 IAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGDGVDIVQWVRSM--TDSNKDC 916

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  436 bits (1122), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 330/1008 (32%), Positives = 482/1008 (47%), Gaps = 151/1008 (14%)

Query: 4    CQWTGVTCGQRHQR-------VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEI 56
            C W GV C  +          VT LDL + ++ G +SP +G L  L Y+N+A N   G+I
Sbjct: 66   CNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDI 125

Query: 57   PHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLER 116
            P +IG    LE + L+NN F G+IP  ++  S L   +  +N L G +P +IG L+ LE 
Sbjct: 126  PREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEE 185

Query: 117  LSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDS-LGQLKSLTLLSVAFN------ 169
            L  + N++TG LP S+GNL+ L      +N   G I + +G+  +L LL +A N      
Sbjct: 186  LVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGEL 245

Query: 170  ------------------QFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLR 211
                              +FSG IP  I N++SLE ++L  N   G +P + G N+ SL+
Sbjct: 246  PKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIG-NMKSLK 304

Query: 212  ELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTG 271
            +L    N   G IP  L   S +  I+FS+N  SG + V+ S++  L  L L  N L   
Sbjct: 305  KLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGI 364

Query: 272  AANELD----------FINLLT--------NCSKLERLY--------------------- 292
              NEL            IN LT        N + + +L                      
Sbjct: 365  IPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLW 424

Query: 293  ---FNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTG 349
               F+ N+  G++P  +   S+ I  + +G NRI G IPP +    SL  L +  N+LTG
Sbjct: 425  VVDFSENQLSGKIPPFICQQSNLI-LLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTG 483

Query: 350  TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNL 409
              P E+ +L NL  ++LD+N   G +P  +G    L  L L  N    N+P+ +   +NL
Sbjct: 484  QFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNL 543

Query: 410  LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFS 469
            +  N+S N L G +P +I     L   L+L  N   GSLPPE+G+L  L  L LS N+FS
Sbjct: 544  VTFNVSSNSLTGPIPSEIANCKMLQ-RLDLSRNSFIGSLPPELGSLHQLEILRLSENRFS 602

Query: 470  GEIPATLSACANLEYLNISGNAFSGSIPL---LLDSLQSIKEL---DFS----------- 512
            G IP T+    +L  L + GN FSGSIP    LL SLQ    L   DFS           
Sbjct: 603  GNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLH 662

Query: 513  --------SNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKL 564
                    +N+L+G+IP   ENLS L   N SYN+  G++P   +F N T  S  GN  L
Sbjct: 663  LLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGL 722

Query: 565  CGGLDELRLPSCQSKGSLTILK----------------------VVIPVIVSCLILSVGF 602
            CGG      PS  S   ++ LK                      ++I ++V  L   V  
Sbjct: 723  CGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEP 782

Query: 603  TLIYVWRRRSARKASNMLPI-EQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLG 661
            T  YV  +    + S++  + +++F V    E   AT  F  +  +G G  G VYK  + 
Sbjct: 783  TAPYVHDKEPFFQESDIYFVPKERFTVKDILE---ATKGFHDSYIVGRGACGTVYKAVM- 838

Query: 662  ENGTEVAVKVIN-------LKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD 714
             +G  +AVK +                SF AE   L  IRHRN++++ + C     +G++
Sbjct: 839  PSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCY---HQGSN 895

Query: 715  FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHG 774
               ++YE+M  GSL E LH         S+    R  IA+  A  + YLHH C+P I+H 
Sbjct: 896  SNLLLYEYMSRGSLGELLHGGKSH----SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHR 951

Query: 775  DLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE 834
            D+K +N+L+D++  +HV DFGLAK +       +  ++S+S  + G+ GY+APEY    +
Sbjct: 952  DIKSNNILIDENFEAHVGDFGLAKVID------MPLSKSVS-AVAGSYGYIAPEYAYTMK 1004

Query: 835  ASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDT 882
             + K D+YSFG++LLEL T K P   +  +G  L  ++R      S T
Sbjct: 1005 VTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDLATWTRNHIRDHSLT 1051

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 307/901 (34%), Positives = 466/901 (51%), Gaps = 55/901 (6%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG 61
           + C W GVTC    + VT LDL   ++ GTLSP V +L  L+ +++A N  +G IP +I 
Sbjct: 55  SFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEIS 114

Query: 62  RLISLERLILSNNSFSGAIPANLSS-CSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
            L  L  L LSNN F+G+ P  +SS   NL  L   +NNL G++P  + +L +L  L + 
Sbjct: 115 SLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLG 174

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAF-NQFSGMIPPS 178
            N+  G++P S G+   +  + V  N L G+I   +G L +L  L + + N F   +PP 
Sbjct: 175 GNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE 234

Query: 179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
           I N+S L     +    TG +P + G  L  L  L    N F+G +   L   SSL+ ++
Sbjct: 235 IGNLSELVRFDGANCGLTGEIPPEIG-KLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMD 293

Query: 239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
            S N F+G +   F+ LKNL  LNL  N L        +    + +  +LE L    N F
Sbjct: 294 LSNNMFTGEIPASFAELKNLTLLNLFRNKL------HGEIPEFIGDLPELEVLQLWENNF 347

Query: 299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
            G +P  +   +  +  + +  N+++GT+PP + +   L  L    N L G+IP  +G+ 
Sbjct: 348 TGSIPQKLGE-NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKC 406

Query: 359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNK 418
            +L ++ +  NFL GSIP  L  L  LT ++L  N L G +P + G   NL  +++S+N+
Sbjct: 407 ESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQ 466

Query: 419 LIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
           L G LP  I   T +   L L  N   G +P EVG L+ L ++D S N FSG I   +S 
Sbjct: 467 LSGPLPPAIGNFTGVQKLL-LDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISR 525

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           C  L ++++S N  SG IP  + +++ +  L+ S N+L G IP  + ++  L  L+ SYN
Sbjct: 526 CKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYN 585

Query: 539 HFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQ-----------SKGSLTILKV 587
           +  G VP  G F+     S  GN  LCG      L  C+           SKG L+   +
Sbjct: 586 NLSGLVPGTGQFSYFNYTSFLGNPDLCGPY----LGPCKDGVAKGGHQSHSKGPLSA-SM 640

Query: 588 VIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAEL----SKATDNFSS 643
            + +++  L+ S+ F ++ + + RS +KAS      + + + ++  L        D+   
Sbjct: 641 KLLLVLGLLVCSIAFAVVAIIKARSLKKASE----SRAWRLTAFQRLDFTCDDVLDSLKE 696

Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKI 701
            N IG+GG+GIVYKG +  NG  VAVK +    +G+S    F AE + L  IRHR+++++
Sbjct: 697 DNIIGKGGAGIVYKGVM-PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 755

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           +  CS       +   +VYE+M NGSL E LH          L    R  IA++ A  + 
Sbjct: 756 LGFCSNH-----ETNLLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIALEAAKGLC 806

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLHH C P IVH D+K +N+LLD +  +HV+DFGLAKFL +        T      I G+
Sbjct: 807 YLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSG------TSECMSAIAGS 860

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSD 881
            GY+APEY    +   K DVYSFG++LLEL T ++P    F +G+ +  + R+      D
Sbjct: 861 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV-GEFGDGVDIVQWVRKMTDSNKD 919

Query: 882 T 882
           +
Sbjct: 920 S 920

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  431 bits (1108), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 326/995 (32%), Positives = 481/995 (48%), Gaps = 142/995 (14%)

Query: 4    CQWTGVTCG--QRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNG---------- 51
            C WTGV C        V  L+L +  + G LSP +G L  L+ ++++ NG          
Sbjct: 59   CGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIG 118

Query: 52   --------------FNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS 97
                          F+GEIP +IG+L+SLE LI+ NN  SG++P  + +  +L +L   S
Sbjct: 119  NCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYS 178

Query: 98   NNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLG 156
            NN+ G++P  IG+L +L      QN I+G LP+ IG   SL ++ + +N+L G +   +G
Sbjct: 179  NNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIG 238

Query: 157  QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGV----------- 205
             LK L+ + +  N+FSG IP  I N +SLE ++L +N+  G +P + G            
Sbjct: 239  MLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYR 298

Query: 206  ------------NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
                        NL    E+  + N  TG IP+ L N   LE++   +NQ +G + V+ S
Sbjct: 299  NGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELS 358

Query: 254  RLKNLYWLNLGINNL------GTGAANELDFINLLTNC------------SKLERLYFNR 295
             LKNL  L+L IN L      G      L  + L  N             S L  L  + 
Sbjct: 359  TLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSD 418

Query: 296  NRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI 355
            N   G +P S   L S +  + +G N +SG IP  I    +L  L +  N L G  P  +
Sbjct: 419  NHLSGRIP-SYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNL 477

Query: 356  GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNIS 415
             +  N+  ++L +N  +GSIP  +GN + L  L+L  N   G +P  +G  + L  LNIS
Sbjct: 478  CKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNIS 537

Query: 416  HNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPAT 475
             NKL G +P +I     L   L++  N  +G+LP EVG+L  L  L LS N  SG IP  
Sbjct: 538  SNKLTGEVPSEIFNCKMLQ-RLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVA 596

Query: 476  LSACANLEYLNISGNAFSGSIPLLLDSLQSIK-ELDFSSNNLNGQIPEYLENLSFLEF-- 532
            L   + L  L + GN F+GSIP  L SL  ++  L+ S N L G+IP  L NL  LEF  
Sbjct: 597  LGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLL 656

Query: 533  ----------------------LNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGG--- 567
                                   N SYN   G +P+     N +  S  GN  LCG    
Sbjct: 657  LNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLN 713

Query: 568  --LDELRLPSCQSKG------SLTILKVVIPVI--VSCLILSVGFTLIYVWRRRSARKAS 617
              +        QS G      S  I+ +   VI  VS +++++   L+    R  A  A 
Sbjct: 714  QCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQ 773

Query: 618  NMLPIEQQFLVD-------SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVK 670
            +  P E    +        ++ +L  ATDNF  +  +G G  G VYK  L   G  +AVK
Sbjct: 774  DGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVL-PAGYTLAVK 832

Query: 671  VINLKQKGASK-----SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
             +    +G +      SF AE   L NIRHRN++K+   C   + +G++   ++YE+M  
Sbjct: 833  KLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPK 887

Query: 726  GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ 785
            GSL E LH  +     C+L   +R  IA+  A  + YLHH C+P I H D+K +N+LLD 
Sbjct: 888  GSLGEILHDPS-----CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDD 942

Query: 786  DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG 845
               +HV DFGLAK +       +  ++S+S  I G+ GY+APEY    + + K D+YS+G
Sbjct: 943  KFEAHVGDFGLAKVID------MPHSKSMS-AIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995

Query: 846  ILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKS 880
            ++LLEL T K P   + ++G  + ++ R +  R +
Sbjct: 996  VVLLELLTGKAPVQPI-DQGGDVVNWVRSYIRRDA 1029

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	884
359482058	1040	PREDICTED: probable LRR receptor-like se	0.983	0.835	0.509	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.983	0.456	0.509	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.980	0.857	0.505	0.0
224119022	1021	predicted protein [Populus trichocarpa]	0.985	0.853	0.504	0.0
359486510	965	PREDICTED: probable LRR receptor-like se	0.975	0.893	0.510	0.0
255577438	1028	receptor-kinase, putative [Ricinus commu	0.980	0.843	0.496	0.0
255585471	963	serine-threonine protein kinase, plant-t	0.952	0.874	0.508	0.0
224113117	1006	predicted protein [Populus trichocarpa]	0.979	0.860	0.507	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.977	0.845	0.492	0.0
224116466	1008	predicted protein [Populus trichocarpa]	0.983	0.862	0.5	0.0

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  828 bits (2139), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/887 (50%), Positives = 604/887 (68%), Gaps = 18/887 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ C WTGVTCG RHQRV  L+L +  + G+LSP +GNL+FL  +N+  N F+G+IP ++
Sbjct: 66  VHFCNWTGVTCGHRHQRVNTLNLNSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQEL 125

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL  L  L L+NNSFSG IPANLS CSNL+      NNL+G IP+ +GS  K+ R+ + 
Sbjct: 126 GRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLH 185

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
            N++TG +P S+GNL+S++ +    N L G I  +LGQL++L  + +  N FSG+IP S+
Sbjct: 186 YNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSV 245

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           +N+SSLEV SL  N+  GSLP D    LP+L+ L    N+FTG +P SLSNAS+L   + 
Sbjct: 246 YNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDI 305

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
           + + F+G VS+DF  + NL+ L L  N LG G A++L F+N L  C  L+ L  + ++F 
Sbjct: 306 TMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFG 365

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G LP+S+ANLS+ + ++ +  N++SGTIPP I NL +L  L +  N  TG+IP  IG L 
Sbjct: 366 GVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQ 425

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
            L ++DL RN L G IPSSLGN+T L  L L  N+L G IPSS GN   L  L++S+N L
Sbjct: 426 MLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSL 485

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            GT+P +++ + +L++ L L  N L G LP EV  LKNL  LD+S NK SGEIP  L +C
Sbjct: 486 NGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSC 545

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             LE+L++ GN F GSIP    SL+ + +LD S NNL+GQIPE+L+ LS L  LNLS+N+
Sbjct: 546 LTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNN 604

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC-----QSKGSLTILKVVIPVIVS 594
           FEG++P KGVFNN T  S+AGN KLCGG+ EL LP+C     ++  S   LK++I ++  
Sbjct: 605 FEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTG 664

Query: 595 CLILSVGFTLIYVWR-RRSARKASNMLPIEQQFLVD-SYAELSKATDNFSSANKIGEGGS 652
            L L +  +L+ + R RR  R+ S      +  +++ SY  L KAT  FSSAN IG GG 
Sbjct: 665 FLGLVLIMSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGF 724

Query: 653 GIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG 712
           G VYKG LG++ T VAVKVI L Q+GA KSF AEC+ALRNIRHRNL+K++T CS  D++G
Sbjct: 725 GSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQG 784

Query: 713 ADFKAIVYEFMQNGSLEEWLH------HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
            DFKA+VYEFM NGSLE WLH        ND L + SL   QRLNIAIDVASA++YLHH+
Sbjct: 785 NDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLP--QRLNIAIDVASALDYLHHH 842

Query: 767 CEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVA 826
           C   IVH DLKPSN+LLD D+ +HV DFGLA+F+      +   ++S SIG+KGT+GY A
Sbjct: 843 CHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRS-HPSQSSSIGLKGTIGYAA 901

Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           PEYGMG + S  GD YS+GILLLE+FT KRPT++MF++ L LH+F +
Sbjct: 902 PEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVK 948

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  826 bits (2134), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/887 (50%), Positives = 605/887 (68%), Gaps = 18/887 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ C WTGVTCG RHQRV  L+L +  + G+LSP +GNL+FL  +N+  N F+G+IP ++
Sbjct: 97  VHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQEL 156

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL  L  L L+NNSFSG IPANLS CSNL+      NNL+G IP+ +GS  K+ R+ + 
Sbjct: 157 GRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLH 216

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
            N++TG +P S+GNL+S++ +    N L G I  +LGQL++L  + +  N FSG+IP S+
Sbjct: 217 YNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSV 276

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           +N+SSLEV SL  N+  GSLP D    LP+L+ L    N+FTG +P SLSNAS+L   + 
Sbjct: 277 YNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDI 336

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
           + + F+G VS+DF  + NL+ L L  N LG G A++L F+N L  C  L+ L  + ++F 
Sbjct: 337 TMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFG 396

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G LP+S+ANLS+ + ++ +  N++SGTIPP I NL +L  L +  N  TG+IP  IG L 
Sbjct: 397 GVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQ 456

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
            L ++DL RN L G IPSSLGN+T L  L L  N+L G IPSS GN   L  L++S+N L
Sbjct: 457 MLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSL 516

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            GT+P +++ + +L++ L L  N L G LP EV  LKNL  LD+S NK SGEIP  L +C
Sbjct: 517 NGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSC 576

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             LE+L++ GN F GSIP    SL+ + +LD S NNL+GQIPE+L+ LS L  LNLS+N+
Sbjct: 577 LTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNN 635

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC-----QSKGSLTILKVVIPVIVS 594
           FEG++P KGVFNN T  S+AGN KLCGG+ EL LP+C     ++  S   LK++I ++  
Sbjct: 636 FEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTG 695

Query: 595 CLILSVGFTLIYVWR-RRSARKASNMLPIEQQFLVD-SYAELSKATDNFSSANKIGEGGS 652
            L L +  +L+ + R RR  R+ S      +  +++ SY  L KAT  FSSAN IG GG 
Sbjct: 696 FLGLVLIMSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGF 755

Query: 653 GIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG 712
           G VYKG LG++ T VAVKVI L Q+GA KSF AEC+ALRNIRHRNL+K++T CS  D++G
Sbjct: 756 GSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQG 815

Query: 713 ADFKAIVYEFMQNGSLEEWLH------HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
            DFKA+VYEFM NGSLE WLH        ND L +  LS+ QRLNIAIDVASA++YLHH+
Sbjct: 816 NDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHH 873

Query: 767 CEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVA 826
           C   IVH DLKPSN+LLD D+ +HV DFGLA+F+      +   ++S SIG+KGT+GY A
Sbjct: 874 CHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRS-HPSQSSSIGLKGTIGYAA 932

Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           PEYGMG + S  GD YS+GILLLE+FT KRPT++MF++ L LH+F +
Sbjct: 933 PEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVK 979

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  823 bits (2125), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 446/883 (50%), Positives = 598/883 (67%), Gaps = 16/883 (1%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG 61
           + C+W+GV CG RHQR+  L+L +  + G LSP++GNLSFLR +N+  N F+ +IP ++G
Sbjct: 60  HFCKWSGVICGHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELG 119

Query: 62  RLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQ 121
           RL  L+RL+L NN+FSG IP N+SSCSNL+ L   SNNL G+IPA +GSL KL    +  
Sbjct: 120 RLFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFVLQG 179

Query: 122 NHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
           N++ G +P+S GNLSS++     +N L G I +SLG LK L   +VA N  SG IP SI 
Sbjct: 180 NNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSIC 239

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
           NISSL  +SL +N+  GSLP D G+NLP+L  L  N N+  G IP +LSNAS + +++ S
Sbjct: 240 NISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLS 299

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
            N  +G +  D + L +L  L +  N+LG G  ++L F+  L N + LE L  N N F G
Sbjct: 300 YNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGG 358

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
            LP  V+N S+ +K I  GRN+I G+IP EI NL SL+ L+++TNQL G IP  IG+L N
Sbjct: 359 VLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQN 418

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
           L  L L+ N + GSIPSSLGN+T L  +    NNL+G IP+SLGN   LL L++S N L 
Sbjct: 419 LAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLS 478

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACA 480
           G +P+++L I++LS+ L L +N L GSLP EVG L NL  L +S N+ SGEIP +L +C 
Sbjct: 479 GPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCK 538

Query: 481 NLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
           +LE L++ GN F G +P  L SL++++ L  S NNL+GQIP++L++   LE L+LSYN F
Sbjct: 539 SLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDF 597

Query: 541 EGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQS-------KGSLTILKVVIPVIV 593
           EGEVP +GVF N +R S+ GN KLCGG+ +L LP C S         +  IL + IP   
Sbjct: 598 EGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGF 657

Query: 594 SCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSG 653
             ++L   F L Y   R++  + ++    E  F   +Y +L +ATD FSS+N +G G  G
Sbjct: 658 LGIVLMTSFLLFY--SRKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFG 715

Query: 654 IVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA 713
            VY+G L  +G  VAVKV+NL +KGASKSF+AEC AL NIRHRNL+K+IT CS  DF+G 
Sbjct: 716 SVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGN 775

Query: 714 DFKAIVYEFMQNGSLEEWLH--HSND-QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS 770
           DFKA+VYEFM NGSLEEWLH  H +D   E  +L ++QRLNIAIDVASA++YLH++C+  
Sbjct: 776 DFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVP 835

Query: 771 IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYG 830
           +VH DLKPSNVLL  D+ + V DFGLA+FL   + + +    S S+G+KGT+GY APEYG
Sbjct: 836 VVHCDLKPSNVLLGDDMTACVGDFGLARFLPEAS-NQLPADESSSVGLKGTIGYAAPEYG 894

Query: 831 MGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           MG E S  GDVYS+GILLLE+FT +RPTD MF +G  LH++++
Sbjct: 895 MGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAK 937

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  819 bits (2116), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/880 (50%), Positives = 595/880 (67%), Gaps = 9/880 (1%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ CQW GV+CG+RHQRV  L L +  + GT+SP++GNLSFLR +++ +N F  EIP Q+
Sbjct: 56  IHFCQWHGVSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQV 115

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL SL+   L NNS SG IP ++S CSNLI +  + NNL GEIP ++GSL KL+ L++ 
Sbjct: 116 GRLRSLQIFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLE 175

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENR-LWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPS 178
            N +TG +P S+GNLSSL ++ + +N+ L+G + S LG+LK+L +L++  N+ SG+IPPS
Sbjct: 176 VNGLTGTIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPS 235

Query: 179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
           IFN+SSL  + +  N F G+LP D G++LP+L      +N FTG IPVS+SNAS++E+++
Sbjct: 236 IFNLSSLTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQ 295

Query: 239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
            S N  +G V     +L  L +  L  N+LG+G AN+L F++ LTN + LE L   RN F
Sbjct: 296 VSLNNLTGEVPT-LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNF 354

Query: 299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
            GELP  ++NLS+ +  I++  N I G+IP  I  L +L    +  N+++G IP  IGEL
Sbjct: 355 GGELPKQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGEL 414

Query: 359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNK 418
            NL+ L LD N L G IPSS+GNLT L  L LG N+LEG+IPSSLGNC  LL L +  N 
Sbjct: 415 QNLEGLVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNN 474

Query: 419 LIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
           L G +P  +  I +L LY+    N  +GSLP E+G L NL  LD+SGN  SGEIP++L  
Sbjct: 475 LSGDIPPGLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGG 533

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           C +LE L ++ N F GSIP  L SL+ + + +FS NNL+G+IPE+ +  + LE L+LSYN
Sbjct: 534 CISLEDLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYN 593

Query: 539 HFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC---QSKGSLTILKVVIPVIVSC 595
           +FEG +P +G+F N T  S+ GN +LCGG  EL LP C   Q K     LK+ I  I   
Sbjct: 594 NFEGMIPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAITVL 653

Query: 596 LILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIV 655
           L L++  T +++   R  R+   +  +  + L  SY  L KAT+ FSS+N +G G  G V
Sbjct: 654 LALALVVTCLFLCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSV 713

Query: 656 YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF 715
           YKG L +NG  +AVKV+NL ++GAS+SF+AEC+ALRNIRHRNL+K++T CS  D+ G DF
Sbjct: 714 YKGMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDF 773

Query: 716 KAIVYEFMQNGSLEEWLH-HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHG 774
           KAIVYEFM NGSLE+WLH          +L+++QRLNIAIDVA A+EYLHH+CE  I H 
Sbjct: 774 KAIVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHC 833

Query: 775 DLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE 834
           DLKPSNVLLD +L  HV DFGLAKFLS  + D      S SIG++GT+GY  PEYG+G E
Sbjct: 834 DLKPSNVLLDDELTGHVGDFGLAKFLSGASLDYPT-NESTSIGVRGTIGYAPPEYGVGGE 892

Query: 835 ASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSRE 874
            S  GD YS+GILLLE+FT KRPTD MF EG  LH+F + 
Sbjct: 893 VSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKR 932

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  814 bits (2103), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 448/877 (51%), Positives = 600/877 (68%), Gaps = 15/877 (1%)

Query: 8   GVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLE 67
           GV CG+RHQRVT LDL +Q + G++SP++GNLSFLR + +  NGFN EIP +IG L  L+
Sbjct: 1   GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60

Query: 68  RLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQ 127
            L LSNNS SG IPANLSSCS L+ +    N LVG+IPA++GSL KL+ L I  N ++G 
Sbjct: 61  MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120

Query: 128 LPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLE 186
           +P S GNLSSL  +   +N + G I  SL QL +LT +++  N  SG IPPS+ N+SSL 
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180

Query: 187 VISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSG 246
             ++S N   G+LP + G+ LP+L++L  + N FTG IPVSLSNAS+LE    + N  +G
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240

Query: 247 GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSV 306
            V     +L+ L++ ++  NNLG G   +L F++ LTN S LE L  N N F G LP S+
Sbjct: 241 KVP-SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESI 299

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
            N S+ +  + +  N+I G+IP  I NL SL  L +  NQL+G+IP +IG+L NL+ L L
Sbjct: 300 GNWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLML 359

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
            +N L G +PSSLGNL  L  L LG N  +G IPSSLG C NLL L++S N L GT+P Q
Sbjct: 360 IKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQ 419

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN 486
           ++ +++LS+ L++ +N L G+LP EVGNLKNL  LD+S N  SG IP+++ +C +LEYL+
Sbjct: 420 VVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLS 479

Query: 487 ISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPM 546
           + GN F GSIP    SL+ I+ LD S NNL+G+IPE+L+++ F + +NLSYN FEG +P 
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QLVNLSYNDFEGILPT 538

Query: 547 KGVFNNKTRFSIAGNGKLCGGLDELRLPSC-----QSKGSLTILKVVIPVIVSCLILSVG 601
           +GVF N +  SI GN KLCGG+ E +LP C     + +G    LK++I  +   L ++  
Sbjct: 539 EGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCV 598

Query: 602 FT-LIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFL 660
            + LI++W R+   + ++    +    V SY  L +ATD FSS+N IG G  G VYKG L
Sbjct: 599 LSFLIFLWLRKKKGEPASSSSEKSLLKV-SYQSLLRATDGFSSSNLIGVGSFGSVYKGIL 657

Query: 661 GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY 720
             +GT +AVKV+NL +KGASKSF+AEC+ALRNIRHRNL+K++T CSG D++G DFKA+VY
Sbjct: 658 DHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVY 717

Query: 721 EFMQNGSLEEWLHHSNDQLEVCS----LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           EFM NGSLE+WLH +    E  +    L+ +QRLNIAIDVA A++YLHH C+  IVH DL
Sbjct: 718 EFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDL 777

Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
           KPSNVLLD ++  HV DFG+AKFL       + E +S SIGI+GT+GY APEYGMG E S
Sbjct: 778 KPSNVLLDTEMTGHVGDFGIAKFLP-EAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVS 836

Query: 837 MKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
             GDVYSFGILLLE+FT KRPT+ MF + L +H+F +
Sbjct: 837 TSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVK 873

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis]

 Score =  814 bits (2102), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/886 (49%), Positives = 593/886 (66%), Gaps = 19/886 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ C+W+G+TCG RHQRV  +DL +  + G+L+ ++GNLSFLR +N+ +N  +  IP +I
Sbjct: 61  LHFCKWSGITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEI 120

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL  L  LIL  NSFSG IP N+S CSNL+ L    NNL G++PA++ SL KL+     
Sbjct: 121 GRLFRLRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAELKSLSKLQMFEFE 180

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
            N++TG++  S  NLSSL +I    N   G I +S+GQLKSL   S+  + FSG+IPPSI
Sbjct: 181 INYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSI 240

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           FN+SSL ++S+  N+  G+LP D G +LP L  LR  AN F+G IP ++SNAS+L  ++ 
Sbjct: 241 FNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDV 300

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
           S+N F+G V    +RL NL ++ +  NNLG G  ++L F+  L N + LE L    N   
Sbjct: 301 SQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLG 359

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G LP  ++N S+ +  +A GRN+I G IP EI NL  L  L  + N+LTG+IP  +G+L 
Sbjct: 360 GVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLK 419

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           NL +L L+ N + GSIPSSLGN+T L+ + L +NNLEG+IPSSLGNC  +L +++S N L
Sbjct: 420 NLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNL 479

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            GT+P++++ I +LS+ L+L  N   GSLP EVG L NL  LD+S NK SGEIP +L +C
Sbjct: 480 SGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSC 539

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             LE L + GNAF G+IP+ L SL+ I +L+ S NNL GQIP +      LE L+LSYN 
Sbjct: 540 TRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYND 599

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLT---------ILKVVIP 590
           FEGEVP +GVF N + FSI+GN  LCGG+ E+ LP C    S+          I+ V   
Sbjct: 600 FEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACC 659

Query: 591 VIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEG 650
            +V  L+L+       +  R++   + + L I  Q +  SY  L KATD FSSAN IG G
Sbjct: 660 GVVGVLLLTSALLFCCLKMRKNKEASGSSLDIFFQKV--SYQNLLKATDGFSSANLIGAG 717

Query: 651 GSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF 710
             G VYKG L  + T +AVKV+NL+ KGAS+SF+ EC+AL N+RHRNL+K++T CS  DF
Sbjct: 718 SFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDF 777

Query: 711 KGADFKAIVYEFMQNGSLEEWLHHSN--DQLEVCS-LSVIQRLNIAIDVASAIEYLHHYC 767
           +  DFKA+VYE+M NGSLEEWLH +   DQ +    LS+I+RL+I+IDVASA++YLH+ C
Sbjct: 778 EENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQC 837

Query: 768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAP 827
           +  +VH DLKPSN+LLD D+ +HV DFGLA+FL          + S SIGI+GTVGY AP
Sbjct: 838 QVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAA---PHHSSPSSSIGIRGTVGYAAP 894

Query: 828 EYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           EYGMG + S  GDVY++GILLLELFT K+PTDAMF +GL LH  ++
Sbjct: 895 EYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAK 940

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  810 bits (2092), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/885 (50%), Positives = 581/885 (65%), Gaps = 43/885 (4%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ CQW GVTCG  H+RVT LDL +  I G++SPY+GNLSFLR +NI +N F  EIP QI
Sbjct: 66  IHFCQWQGVTCGLLHRRVTVLDLHSLKISGSISPYIGNLSFLRALNIQNNSFGHEIPQQI 125

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           G L  LE L L+NNS  G IP N+S CSNL+ +S   N L G +P ++G L  L+ LSIF
Sbjct: 126 GYLRRLEELRLNNNSVGGKIPTNISRCSNLVFISLGKNKLEGNVPEELGVLSNLQVLSIF 185

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
            N +TG +P S+GNLS L+ + + ENR+ G + +SLG L++LT LS+  N+ SG IP S+
Sbjct: 186 GNKLTGSIPHSLGNLSQLQRLSLAENRMVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSL 245

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           FN+SS+  + + EN F G+LP D G  LP++R    ++N FTG IPVSLSNA++LE +  
Sbjct: 246 FNLSSIRNLDIGENNFHGNLPSDIGFLLPNIRWFAISSNEFTGKIPVSLSNATNLESLLL 305

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
            +N  +G V    ++L  L   +L  NNLGTG A++L F++ LTN + LE L  N N F 
Sbjct: 306 LQNNLTGEVP-SLAKLDRLRVFSLTSNNLGTGKADDLSFLHSLTNTTALEELGVNGNNFG 364

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G LP S+ANLS+T++ + +  NRI G+IP  I NL SL    +  NQL+G IP  IG+L 
Sbjct: 365 GMLPDSIANLSTTLRILLLDNNRIIGSIPSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQ 424

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           NL  L L+ N L G IPSSLGNLT L  L +  NNL G IPS LG C N+LGL++S N  
Sbjct: 425 NLVVLALNSNMLSGHIPSSLGNLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNF 484

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            G++P +++ I++LS+YL+L  N L G+LP EVGNLK+L   D+SGNK SGEIP TL +C
Sbjct: 485 SGSIPPEVISISSLSIYLDLSQNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSC 544

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
            +LE LN++GN F G IP  L SL++++ LD                        LS NH
Sbjct: 545 ISLEILNMAGNNFQGLIPSSLSSLRALQILD------------------------LSNNH 580

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQS----KGSLT-ILKVVIPVI-- 592
             G VP KG+F N +  S+ GN  LCGG+ E +LP C S    K  LT +LK VI  I  
Sbjct: 581 LSGMVPSKGIFKNASATSVEGNNMLCGGIPEFQLPVCNSARHKKNRLTPVLKTVISAISG 640

Query: 593 VSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGS 652
           ++ LIL     L   W R+     +     E++ +  SY  L KATD FSSAN IG G  
Sbjct: 641 MAFLIL----MLYLFWFRQKKVNETTADFSEKKIMELSYQNLHKATDGFSSANIIGMGSF 696

Query: 653 GIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG 712
           G VYKG L   GT +AVKV NL ++G  KSF+AEC+ALRNIRHRNL+K++T CS  D+ G
Sbjct: 697 GSVYKGRLDREGTLIAVKVFNLMRRGGFKSFLAECEALRNIRHRNLLKVLTACSSLDYHG 756

Query: 713 ADFKAIVYEFMQNGSLEEWLH----HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE 768
            DFKA+VYEFM NGSLEEWLH     +  +LE   L+ +QRLNIAIDVASA+ YLHH+CE
Sbjct: 757 NDFKALVYEFMVNGSLEEWLHPPVATNEAELETRKLNFLQRLNIAIDVASALYYLHHHCE 816

Query: 769 PSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE 828
           P IVH DLKPSN+LLD++L  HV DFGLA+FL +   +    T+S SIG++GTVGY  PE
Sbjct: 817 PQIVHCDLKPSNILLDEELTGHVGDFGLARFLLDATQNHY--TQSSSIGVRGTVGYAPPE 874

Query: 829 YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           YGM  E S  GDVYS+GILLLE+FT KRP D MF +G  LH+F +
Sbjct: 875 YGMSSEVSTYGDVYSYGILLLEMFTGKRPMDDMFKDGFNLHNFVK 919

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  809 bits (2090), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 451/888 (50%), Positives = 599/888 (67%), Gaps = 22/888 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ C+W+G  CG+RHQRV  LDL +  + G+LSP++GNLSFLR +++++N F+  IP ++
Sbjct: 42  LHFCEWSGAKCGRRHQRVVELDLHSCKLAGSLSPHIGNLSFLRILDLSNNSFSQNIPQEL 101

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL+ L++L L NN+FSG IPAN+S+CSNL  +    NNL+G+IPA++GSL  L+   + 
Sbjct: 102 GRLLRLQQLNLENNTFSGEIPANISNCSNLQLIDLKGNNLIGKIPAELGSLLNLQACLLV 161

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSGMIPPSI 179
            NH+ G++P S  NLSS+ +I V +N L G I   +G+LK L  LSV  N  SG IPPSI
Sbjct: 162 TNHLVGEIPLSFENLSSVEIIGVGDNHLQGSIPYGIGKLKRLRKLSVPLNNLSGTIPPSI 221

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           +N+SSL + S++ N+F GSLP D G  LPSL  L   AN F G IPV++SNAS+L +I+F
Sbjct: 222 YNLSSLTLFSVAINQFHGSLPSDLGQKLPSLEVLVFYANRFNGPIPVTISNASTLSVIDF 281

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
             N F+G V   F+ L NL +L +  N LG G   +L F+  L N + LE L  + N   
Sbjct: 282 GNNSFTGKVP-PFANLPNLQYLGIDSNELGNGEEGDLSFLQSLANYTNLEELGMSDNNLG 340

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G  P  ++N SS    ++MGRN++ G+IP +I NL SL+ L ++TNQLTG IP  IG+L 
Sbjct: 341 GMFPEIISNFSSQFTTLSMGRNQVRGSIPVDIGNLISLDTLMLETNQLTGVIPTSIGKLK 400

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           NL  L L  N + G+IPSSLGN+T L  L L  NNL+G IPSSL NC NL+ L ++ N L
Sbjct: 401 NLHGLTLVENKISGNIPSSLGNVTSLVELYLSANNLQGGIPSSLANCQNLMSLKLAQNNL 460

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            G L +Q++ + +LS+ L+L +N L G LP EVG L NL  LD+S N+ SGEIP +L +C
Sbjct: 461 SGPLTKQVIGMASLSVSLDLSHNQLIGPLPSEVGRLVNLGYLDVSHNRLSGEIPGSLGSC 520

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             LEYL++ GN   GSIP LL SL++++ L+ S NNL GQIP +L +   L+ L+LS+NH
Sbjct: 521 IMLEYLHLEGNFLQGSIPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQRLDLSFNH 580

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQS------KGSLTILKVV--IPV 591
            EGE+P + VF N +  S+ GN KLCGG+ +L L  C S      K S T LK+V  IP 
Sbjct: 581 LEGEMPTQRVFGNVSAVSVLGNDKLCGGISQLNLSRCTSNELRKPKFS-TKLKLVISIPC 639

Query: 592 IVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGG 651
                +L +   LI+ WR+     AS     E  F   +Y EL +AT  FSS+N IG G 
Sbjct: 640 GFIIALLLISSLLIHSWRKTKNEPASGA-SWEVSFRRVTYEELYQATGGFSSSNFIGGGS 698

Query: 652 SGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK 711
            G VYK  L  +G  VAVKV NL +KGASKS++AEC AL NIRHRNL+KI+T CS  DF+
Sbjct: 699 FGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTACSSLDFR 758

Query: 712 GADFKAIVYEFMQNGSLEEWLH--HSND-QLEVCSLSVIQRLNIAIDVASAIEYLHHYCE 768
           G DFKA+VYEFM NGSLEEWLH  H++D + E  +L++IQRLN+AIDVASA++YLH++C+
Sbjct: 759 GNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQGNLNLIQRLNVAIDVASALDYLHYHCQ 818

Query: 769 PSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS---ISIGIKGTVGYV 825
            ++VH DLKPSNVLLD D+ +HV DFGLA+F     P+  V+  S    SIG+KGTVGY 
Sbjct: 819 MAVVHCDLKPSNVLLDGDMTAHVGDFGLARF----RPEASVQLSSNQNSSIGLKGTVGYA 874

Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           APEYG+G E S  GDVYS+GILLLE+ T K PTD  F EGL LH + +
Sbjct: 875 APEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEGLNLHKYVK 922

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  808 bits (2088), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/883 (49%), Positives = 590/883 (66%), Gaps = 19/883 (2%)

Query: 3   LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
            CQW+GVTCG+RHQRV  LDL +  + G+LSP++GNLSFLR +N+A+N  +  IP ++GR
Sbjct: 63  FCQWSGVTCGRRHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGR 122

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
           L  LE L+L NN+F G IPAN+S C+NL  L     NL G++PA++G L KL+ L+I  N
Sbjct: 123 LFRLEELVLRNNTFDGGIPANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELN 182

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSL-GQLKSLTLLSVAFNQFSGMIPPSIFN 181
           +  G++P S GNLS++  I    N L G I ++ GQLK L +LS+  N  SGMIPPSIFN
Sbjct: 183 NFVGEIPYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFN 242

Query: 182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
           +SSL ++S   N+  GSLP   G+ LP+L+    + N F G IP + SNAS+L   +   
Sbjct: 243 LSSLTLLSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGS 302

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFI-NLLTNCSKLERLYFNRNRFEG 300
           N F+G V    S   +L  L +G NNLG G  N+L+F+  L  N + LE L  + N F G
Sbjct: 303 NNFNGKVP-PLSSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGG 361

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
            LP  V+N S+ + ++   RN+I G+IP +I NL +L  L ++TNQLTG IP  +G+L  
Sbjct: 362 VLPEIVSNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQK 421

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
           L  L L+ N + G IPSS+GN+T L  + + LNNLEG+IP SLGN   LL L +S N L 
Sbjct: 422 LSDLFLNGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLS 481

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACA 480
           G +P++++ I +LS+YL L  N L GSLP E+  L NL  LD+S N+FSGEIP +L +C 
Sbjct: 482 GPIPKELVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCV 541

Query: 481 NLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
           +LE L++  N   G IP+ L SL++I+EL+ S NNL GQIPE+LE+   LE LNLS+N F
Sbjct: 542 SLESLHLEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDF 601

Query: 541 EGEVPMKGVFNNKTRFSIAGNGKLCGGLDEL---RLPSCQSKGSLTILKVVIPVIVSC-- 595
           EGEVP++G F N +  SI GN KLCGG+ +L   R PS +   S +  K++  +   C  
Sbjct: 602 EGEVPVQGAFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGF 661

Query: 596 --LILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSG 653
             +IL + F L Y +R++  + A++   +E  F   +Y +L  ATD FSSAN IGEG  G
Sbjct: 662 LGVILIISFLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFG 721

Query: 654 IVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA 713
            V+KG LG +   VAVKV+NL +KGASKSF+AEC+AL++IRHRNL+K++T CS  DF+G 
Sbjct: 722 SVFKGILGPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGN 781

Query: 714 DFKAIVYEFMQNGSLEEWLHHSNDQLEV---CSLSVIQRLNIAIDVASAIEYLHHYCEPS 770
           DFKA+VYEFM NG+LEEWLH      E     +L ++ RLNIAI +ASA+ YLHH C+  
Sbjct: 782 DFKALVYEFMVNGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMP 841

Query: 771 IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYG 830
           I+H DLKPSN+LLD ++ +HV DFGLA+F S          ++ S+G+KGT+GY APEYG
Sbjct: 842 IIHCDLKPSNILLDTNMTAHVGDFGLARFHSE------ASNQTSSVGLKGTIGYAAPEYG 895

Query: 831 MGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           +G + S  GDVYS+GILLLE+FT KRP D MF +GL LH +++
Sbjct: 896 IGGKVSTYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAK 938

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa]

 Score =  808 bits (2087), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/884 (50%), Positives = 604/884 (68%), Gaps = 15/884 (1%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           ++ CQW+GV CG++HQRV  LDL +  + G+LSP +GNLSFLR +++ +N F   IP +I
Sbjct: 54  LHFCQWSGVKCGRQHQRVIELDLHSSQLVGSLSPSIGNLSFLRLLSLENNSFTNAIPQEI 113

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           GRL+ L+ LIL NNSFSG IP+N+S CSNL++L+ + NNL G +PA +GSL KL+  S  
Sbjct: 114 GRLVRLQTLILGNNSFSGEIPSNISHCSNLLKLNLEGNNLTGNLPAGLGSLSKLQVFSFR 173

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
           +N++ G++P S  NLSS+  ID   N + G I  S+G+LK+L   S+  N  SG IP S+
Sbjct: 174 KNNLDGKIPLSFENLSSIIEIDGTLNNIQGGIPSSIGKLKTLNFFSLGSNNLSGTIPASL 233

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           +NISSL   SL  N+F G+LP + G+ LP+L+ L  + N  +G +P +L NA+    I  
Sbjct: 234 YNISSLIHFSLPYNQFHGTLPPNIGLTLPNLQYLGIHDNRLSGQLPATLINATKFTEIYL 293

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
           S N+F+G V    + + NL  L++  N LG G  ++L F+  L+N SKLE LY + N F 
Sbjct: 294 SYNKFTGKVPT-LAIMPNLRILSMEENGLGKGEDDDLSFLYTLSNSSKLEDLYIDNNNFG 352

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G LP  ++N S+ +KQ+A G N+I GTIP  I NL SL+ L ++ N LTG+IP  IG+L 
Sbjct: 353 GVLPDIISNFSTKLKQMAFGSNQIRGTIPDGIGNLVSLDTLGLEANHLTGSIPSSIGKLQ 412

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           NL    L+ N L GSIPSSLGN+T L  +    NNL+G+IP SLGNC NLL L +S N L
Sbjct: 413 NLADFFLNENKLSGSIPSSLGNITSLMQINFDQNNLQGSIPPSLGNCQNLLVLALSQNNL 472

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            G +P+++L I++LS+YL L  N L GSLP EVG L  L  +D+S N+ SGEIPA+L +C
Sbjct: 473 SGPIPKEVLSISSLSMYLVLSENQLTGSLPFEVGKLVTLGYMDISKNRLSGEIPASLGSC 532

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
            +LE+L + GN   G I   L SL+++++L+ S NNL+GQIP++L +L  L+ L+LS+N 
Sbjct: 533 ESLEHLYLDGNFLQGPISESLRSLRALQDLNLSHNNLSGQIPKFLGDLK-LQSLDLSFND 591

Query: 540 FEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGS--LTILKVVIPVIVSCLI 597
            EGEVPM GVF N +  SIAGN  LCGG+ +L LP+C+SK +   +  K+ + V + C  
Sbjct: 592 LEGEVPMHGVFENTSAVSIAGNKNLCGGILQLNLPTCRSKSTKPKSSTKLTLTVAIPCGF 651

Query: 598 LSVGFTLIYVW---RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGI 654
           + + F   +++    ++S RK  N L  E  F   +Y +L +AT+ FSS N +G G  G 
Sbjct: 652 IGLIFIASFLFLCCLKKSLRKTKNELSCEMPFRTVAYKDLLQATNGFSSGNLVGAGSFGS 711

Query: 655 VYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD 714
           VYKG L  +G  VAVKV NL ++GASKSF+ EC AL NIRHRNL+K++  C+G D +G D
Sbjct: 712 VYKGVLAFDGVTVAVKVFNLLREGASKSFMRECAALLNIRHRNLVKVLFACAGVDVQGND 771

Query: 715 FKAIVYEFMQNGSLEEWLH--HSNDQLEVC---SLSVIQRLNIAIDVASAIEYLHHYCEP 769
           FKA+VYEFM NGSLEEWLH  H+ D LEV    +L++IQRLNIAIDVA+A++YLH+ C+ 
Sbjct: 772 FKALVYEFMINGSLEEWLHPIHTLD-LEVHQPKNLNLIQRLNIAIDVANALDYLHNQCKM 830

Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            IVH DLKPSNVLLD D+ +HV DFGL KFLS  +      +++ S+G+KGTVGY APEY
Sbjct: 831 PIVHCDLKPSNVLLDGDMTAHVGDFGLLKFLSEAS-CQSSSSQTSSVGLKGTVGYAAPEY 889

Query: 830 GMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
           G+G E S  GDV+S+GILLLE+ T KRPTD+MF +GL LH + +
Sbjct: 890 GIGSEVSTFGDVHSYGILLLEMITGKRPTDSMFKDGLELHSYVK 933

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	884
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.989	0.853	0.442	1.1e-197
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.985	0.844	0.434	5.9e-192
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.980	0.858	0.426	2.4e-186
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.981	0.858	0.405	6e-183
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.981	0.860	0.413	1.6e-182
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.976	0.841	0.418	1.3e-173
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.798	0.868	0.391	6.6e-129
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.661	0.468	0.305	3.3e-116
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.921	0.694	0.338	8.4e-113
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.960	0.846	0.328	3.3e-111

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1914 (678.8 bits), Expect = 1.1e-197, P = 1.1e-197
 Identities = 399/902 (44%), Positives = 569/902 (63%)

Query:     3 LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
             LC WTGV CG +H+RVT +DLG   + G +SP+VGNLSFLR +N+A N F+G IP ++G 
Sbjct:    68 LCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGN 127

Query:    63 LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
             L  L+ L +SNN F G IP  LS+CS+L  L   SN+L   +P + GSL KL  LS+ +N
Sbjct:   128 LFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRN 187

Query:   123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPSIFN 181
             ++TG+ PAS+GNL+SL+++D   N++ G I   + +LK +    +A N+F+G+ PP I+N
Sbjct:   188 NLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYN 247

Query:   182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
             +SSL  +S++ N F+G+L  D G  LP+L+ L    N+FTG IP +LSN SSL  ++   
Sbjct:   248 LSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPS 307

Query:   242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
             N  +G + + F RL+NL  L L  N+LG  ++ +LDF+  LTNCS+L+ L    N+  G+
Sbjct:   308 NHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQ 367

Query:   302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
             LP  +ANLS+ + ++++G N ISG+IP  I NL SL  L +  N LTG +PP +GEL+ L
Sbjct:   368 LPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSEL 427

Query:   362 QQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIG 421
             +++ L  N L G IPSS                 EG+IPSSLG+C+ LL LN+  NKL G
Sbjct:   428 RKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNG 487

Query:   422 TLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
             ++P +++ + +                   +G LK L+ LD+S NK SG+IP TL+ C +
Sbjct:   488 SIPHELMELPSLVVLNVSFNLLVGPLRQD-IGKLKFLLALDVSYNKLSGQIPQTLANCLS 546

Query:   482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFE 541
             LE+L + GN+F G IP +   L  ++ LD S NNL+G IP                 +F+
Sbjct:   547 LEFLLLQGNSFVGPIPDIR-GLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFD 605

Query:   542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSK-----GSLT-ILKVVIPVIVSC 595
             G VP +GVF N +  S+ GN  LCGG+  L+L  C  +      S+  I+ + +  +++ 
Sbjct:   606 GAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAA 665

Query:   596 LILSVGFTLIYV-W---RRRSARKASN-----MLPIEQQFLVDSYAELSKATDNFSSANK 646
             L+L +   ++Y+ W   R +S R  +N       P++  +   SY EL K T  FSS+N 
Sbjct:   666 LLL-LCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNL 724

Query:   647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
             IG G  G V+KGFLG     VA+KV+NL ++GA+KSF+AEC+AL  IRHRNL+K++T+CS
Sbjct:   725 IGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICS 784

Query:   707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC-----SLSVIQRLNIAIDVASAIE 761
               DF+G DF+A+VYEFM NG+L+ WLH   D++E       +L +  RLNIAIDVASA+ 
Sbjct:   785 SSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGNPSRTLGLFARLNIAIDVASALV 842

Query:   762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
             YLH YC   I H D+KPSN+LLD+DL +HVSDFGLA+ L   + DT    +  S G++GT
Sbjct:   843 YLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTF-HIQFSSAGVRGT 901

Query:   822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSD 881
             +GY APEYGMG   S+ GDVYSFGI+LLE+FT KRPT+ +F +GLTLH F++    ++  
Sbjct:   902 IGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQA 961

Query:   882 TD 883
              D
Sbjct:   962 LD 963

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1860 (659.8 bits), Expect = 5.9e-192, P = 5.9e-192
 Identities = 388/893 (43%), Positives = 551/893 (61%)

Query:     4 CQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRL 63
             C W GVTCG+R +RV  L+LG   + G +SP +GNLSFLR +N+A N F   IP ++GRL
Sbjct:    61 CNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRL 120

Query:    64 ISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
               L+ L +S N   G IP++LS+CS L  +   SN+L   +P+++GSL KL  L + +N+
Sbjct:   121 FRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNN 180

Query:   124 ITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
             +TG  PAS+GNL+SL+ +D   N++ G I D + +L  +    +A N FSG  PP+++NI
Sbjct:   181 LTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNI 240

Query:   183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKN 242
             SSLE +SL++N F+G+L  D G  LP+LR L    N FTG IP +L+N SSLE  + S N
Sbjct:   241 SSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSN 300

Query:   243 QFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
               SG + + F +L+NL+WL +  N+LG  +++ L+FI  + NC++LE L    NR  GEL
Sbjct:   301 YLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGEL 360

Query:   303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQ 362
             P S+ANLS+T+  + +G+N ISGTIP +I NL SL  L+++TN L+G +P   G+L NLQ
Sbjct:   361 PASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQ 420

Query:   363 QLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGT 422
              +DL  N + G IPS                   G IP SLG C  LL L +  N+L GT
Sbjct:   421 VVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGT 480

Query:   423 LPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSACANL 482
             +P++IL+I +                   VG L+ L+ L  S NK SG++P  +  C ++
Sbjct:   481 IPQEILQIPSLAYIDLSNNFLTGHFPEE-VGKLELLVGLGASYNKLSGKMPQAIGGCLSM 539

Query:   483 EYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFEG 542
             E+L + GN+F G+IP +   L S+K +DFS+NNL+G+IP                  FEG
Sbjct:   540 EFLFMQGNSFDGAIPDI-SRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEG 598

Query:   543 EVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGS------LTILKVVIPVI---- 592
              VP  GVF N T  S+ GN  +CGG+ E++L  C  + S      L++ K V+  I    
Sbjct:   599 RVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGI 658

Query:   593 VSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFL-----VDSYAELSKATDNFSSANKI 647
              S L++ +  +L +  +R+    AS+  P +   L       SY EL  AT  FSS N I
Sbjct:   659 ASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLI 718

Query:   648 GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSG 707
             G G  G V+KG LG     VAVKV+NL + GA+KSF+AEC+  + IRHRNL+K+ITVCS 
Sbjct:   719 GSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSS 778

Query:   708 RDFKGADFKAIVYEFMQNGSLEEWLHHSN-DQLE--VCSLSVIQRLNIAIDVASAIEYLH 764
              D +G DF+A+VYEFM  GSL+ WL   + +++     SL+  ++LNIAIDVASA+EYLH
Sbjct:   779 LDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLH 838

Query:   765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
              +C   + H D+KPSN+LLD DL +HVSDFGLA+ L  ++ ++ +   S S G++GT+GY
Sbjct:   839 VHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFS-SAGVRGTIGY 897

Query:   825 VAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFT 877
              APEYGMG + S++GDVYSFGILLLE+F+ K+PTD  F     LH +++   +
Sbjct:   898 AAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILS 950

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1807 (641.2 bits), Expect = 2.4e-186, P = 2.4e-186
 Identities = 379/888 (42%), Positives = 547/888 (61%)

Query:     3 LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
             LC W GVTCG++++RVT L+LG   + G +SP +GNLSFL  +++  N F G IP ++G+
Sbjct:    53 LCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQ 112

Query:    63 LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
             L  LE L +  N   G IP  L +CS L+ L  DSN L G +P+++GSL  L +L+++ N
Sbjct:   113 LSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGN 172

Query:   123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPSIFN 181
             ++ G+LP S+GNL+ L  + +  N L G I S + QL  +  L +  N FSG+ PP+++N
Sbjct:   173 NMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYN 232

Query:   182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
             +SSL+++ +  N F+G L  D G+ LP+L       N FTG IP +LSN S+LE +  ++
Sbjct:   233 LSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNE 292

Query:   242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
             N  +G +   F  + NL  L L  N+LG+ ++ +L+F+  LTNC++LE L   RNR  G+
Sbjct:   293 NNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGD 351

Query:   302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
             LP S+ANLS+ +  + +G   ISG+IP +I NL +L  L +D N L+G +P  +G+L NL
Sbjct:   352 LPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNL 411

Query:   362 QQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIG 421
             + L L  N L G IP+                  EG +P+SLGNC++LL L I  NKL G
Sbjct:   412 RYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNG 471

Query:   422 TLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
             T+P +I++I                     +G L+NL  L L  NK SG++P TL  C  
Sbjct:   472 TIPLEIMKIQQLLRLDMSGNSLIGSLPQD-IGALQNLGTLSLGDNKLSGKLPQTLGNCLT 530

Query:   482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFE 541
             +E L + GN F G IP L   L  +KE+D S+N+L+G IP                 + E
Sbjct:   531 MESLFLEGNLFYGDIPDL-KGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLE 589

Query:   542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQS-------KGSLTILKVVIPVIVS 594
             G+VP+KG+F N T  SI GN  LCGG+   +L  C S       K S  + KVVI V V 
Sbjct:   590 GKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVG 649

Query:   595 CLILSVGF----TLIYVWRRRSARKASNMLPIEQQFLVD--SYAELSKATDNFSSANKIG 648
               +L + F    TLI++ +R+  ++ +N  P   + L +  SY +L  AT+ FSS+N +G
Sbjct:   650 ITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVG 709

Query:   649 EGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGR 708
              G  G VYK  L      VAVKV+N++++GA KSF+AEC++L++IRHRNL+K++T CS  
Sbjct:   710 SGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSI 769

Query:   709 DFKGADFKAIVYEFMQNGSLEEWLHHSN-DQLEVCS--LSVIQRLNIAIDVASAIEYLHH 765
             DF+G +F+A++YEFM NGSL+ WLH    +++   S  L++++RLNIAIDVAS ++YLH 
Sbjct:   770 DFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV 829

Query:   766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
             +C   I H DLKPSNVLLD DL +HVSDFGLA+ L   + ++     S S G++GT+GY 
Sbjct:   830 HCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLS-SAGVRGTIGYA 888

Query:   826 APEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
             APEYG+G + S+ GDVYSFGILLLE+FT KRPT+ +F    TL+ +++
Sbjct:   889 APEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTK 936

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1775 (629.9 bits), Expect = 6.0e-183, P = 6.0e-183
 Identities = 360/888 (40%), Positives = 549/888 (61%)

Query:     3 LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
             LC W  VTCG++H+RVT L+LG   + G +SP +GN+SFL  ++++ N F G IP ++G 
Sbjct:    53 LCNWKWVTCGRKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGN 112

Query:    63 LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
             L  LE L ++ NS  G IPA LS+CS L+ L   SN L   +P+++GSL KL  L + +N
Sbjct:   113 LFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRN 172

Query:   123 HITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
             ++ G+LP S+GNL+SL+ +   +N + G + D L +L  +  L ++ N+F G+ PP+I+N
Sbjct:   173 NLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYN 232

Query:   182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
             +S+LE + L  + F+GSL  D G  LP++REL    N+  G IP +LSN S+L+    +K
Sbjct:   233 LSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINK 292

Query:   242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
             N  +GG+  +F ++ +L +L+L  N LG+    +L+FI+ LTNC+ L+ L     R  G 
Sbjct:   293 NMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGA 352

Query:   302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
             LP S+AN+S+ +  + +  N   G+IP +I NL  L  L +  N LTG +P  +G+L  L
Sbjct:   353 LPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRL 412

Query:   362 QQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIG 421
               L L  N + G IPS                  EG +P SLG C+++L L I +NKL G
Sbjct:   413 GLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNG 472

Query:   422 TLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
             T+P++I++I T                   +G+L+NL++L L  NKFSG +P TL  C  
Sbjct:   473 TIPKEIMQIPTLVNLSMEGNSLSGSLPND-IGSLQNLVKLSLENNKFSGHLPQTLGNCLA 531

Query:   482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFE 541
             +E L + GN+F G+IP +   L  ++ +D S+N+L+G IP                 +F 
Sbjct:   532 MEQLFLQGNSFDGAIPNIR-GLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFT 590

Query:   542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC-------QSKGSLTILKVVIPVIV- 593
             G+VP KG F N T   + GN  LCGG+ +L+L  C       ++K S  + KV I V + 
Sbjct:   591 GKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIG 650

Query:   594 -SCLILSVGFTLIYVW--RRRSARKASNMLPIEQQFLVD--SYAELSKATDNFSSANKIG 648
              + L+L V  +++  W  +RR  ++ +N++P + +   +  SY +L  AT+ FSS+N +G
Sbjct:   651 IALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVG 710

Query:   649 EGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGR 708
              G  G V+K  L      VAVKV+N++++GA KSF+AEC++L++ RHRNL+K++T C+  
Sbjct:   711 SGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACAST 770

Query:   709 DFKGADFKAIVYEFMQNGSLEEWLHHSN-DQLE--VCSLSVIQRLNIAIDVASAIEYLHH 765
             DF+G +F+A++YE++ NGS++ WLH    +++     +L++++RLNI IDVAS ++YLH 
Sbjct:   771 DFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHV 830

Query:   766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
             +C   I H DLKPSNVLL+ DL +HVSDFGLA+ L   + ++ +   S S G++GT+GY 
Sbjct:   831 HCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLS-SAGVRGTIGYA 889

Query:   826 APEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
             APEYGMG + S+ GDVYSFG+LLLE+FT KRPTD +F   LTLH +++
Sbjct:   890 APEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTK 937

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1771 (628.5 bits), Expect = 1.6e-182, P = 1.6e-182
 Identities = 366/886 (41%), Positives = 539/886 (60%)

Query:     3 LCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
             LC W  V CG++H+RVTRLDLG   + G +SP +GNLSFL Y+++++N F G IP ++G 
Sbjct:    53 LCSWKWVRCGRKHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGN 112

Query:    63 LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
             L  L+ L +  N   G IPA+LS+CS L+ L   SNNL   +P+++GSL KL  L +  N
Sbjct:   113 LFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLN 172

Query:   123 HITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
              + G+ P  I NL+SL V+++  N L G I D +  L  +  L++  N FSG+ PP+ +N
Sbjct:   173 DLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYN 232

Query:   182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
             +SSLE + L  N F+G+L  D G  LP++ EL  + N  TG IP +L+N S+LEM    K
Sbjct:   233 LSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGK 292

Query:   242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
             N+ +G +S +F +L+NL++L L  N+LG+ +  +L F++ LTNCS L  L  + NR  G 
Sbjct:   293 NRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGA 352

Query:   302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
             LP S+ N+S+ +  + +  N I G+IP +I NL  L  L +  N LTG +P  +G L  L
Sbjct:   353 LPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGL 412

Query:   362 QQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIG 421
              +L L  N   G IPS                  EG +P SLG+C+++L L I +NKL G
Sbjct:   413 GELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNG 472

Query:   422 TLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
             T+P++I++I T                   +G L+NL+ L L  N  SG +P TL  C +
Sbjct:   473 TIPKEIMQIPTLVHLNMESNSLSGSLPND-IGRLQNLVELLLGNNNLSGHLPQTLGKCLS 531

Query:   482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFE 541
             +E + +  N F G+IP +   L  +K +D S+NNL+G I                  +FE
Sbjct:   532 MEVIYLQENHFDGTIPDI-KGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFE 590

Query:   542 GEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC-------QSKGSLTILKVVIPVIVS 594
             G VP +G+F N T  S+ GN  LCG + EL+L  C       +++    + KV I V V 
Sbjct:   591 GRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVG 650

Query:   595 CLILSVGFTLIYVW--RRRSARKASNMLPIEQQFLVD--SYAELSKATDNFSSANKIGEG 650
               +L + F +   W  +R++ +K +N  P   +   +  SY +L  ATD FSS+N +G G
Sbjct:   651 IALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSG 710

Query:   651 GSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF 710
               G V+K  L      VAVKV+N++++GA KSF+AEC++L++IRHRNL+K++T C+  DF
Sbjct:   711 SFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDF 770

Query:   711 KGADFKAIVYEFMQNGSLEEWLHHSN-DQLEVCS--LSVIQRLNIAIDVASAIEYLHHYC 767
             +G +F+A++YEFM NGSL++WLH    +++   S  L++++RLNIAIDVAS ++YLH +C
Sbjct:   771 QGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHC 830

Query:   768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAP 827
                I H DLKPSN+LLD DL +HVSDFGLA+ L   + ++     S S G++GT+GY AP
Sbjct:   831 HEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLS-SAGVRGTIGYAAP 889

Query:   828 EYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR 873
             EYGMG + S+ GDVYSFG+L+LE+FT KRPT+ +F    TL+ +++
Sbjct:   890 EYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTK 935

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1687 (598.9 bits), Expect = 1.3e-173, P = 1.3e-173
 Identities = 368/879 (41%), Positives = 518/879 (58%)

Query:     4 CQWTGVTCGQRHQR----VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQ 59
             C W GV CG+R +R    V +L L + ++ G +SP +GNLSFLR +++  N  +GEIP +
Sbjct:    63 CTWVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPE 122

Query:    60 IGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFK-LERLS 118
             + RL  L+ L LS+NS  G+IPA + +C+ L  L    N L G IP +IG+  K L  L 
Sbjct:   123 LSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLY 182

Query:   119 IFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPP 177
             +++N ++G++P+++GNL+SL+  D+  NRL G I  SLGQL SL  +++  N  SGMIP 
Sbjct:   183 LYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPN 242

Query:   178 SIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMI 237
             SI+N+SSL   S+ EN+  G +P +    L  L  +    N F G IP S++NAS L +I
Sbjct:   243 SIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVI 302

Query:   238 EFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNR 297
             +   N FSG ++  F RL+NL  L L  N   T   ++  FI+ LTNCSKL+ L    N 
Sbjct:   303 QIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENN 362

Query:   298 FEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGE 357
               G LP+S +NLS+++  +A+  N+I+G+IP +I NL  L  L +  N   G++P  +G 
Sbjct:   363 LGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGR 422

Query:   358 LTNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHN 417
             L NL  L    N L GSIP +                  G IP +L N TNLL L +S N
Sbjct:   423 LKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTN 482

Query:   418 KLIGTLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLS 477
              L G +P ++  I T                   +G+LKNL+      N+ SG+IP TL 
Sbjct:   483 NLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLG 542

Query:   478 ACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXX 537
              C  L YL +  N  SGSIP  L  L+ ++ LD SSNNL+GQIP                
Sbjct:   543 DCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSF 602

Query:   538 XHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC----QSKGSLTILKVVIPVIV 593
               F GEVP  G F   +  SI GN KLCGG+ +L LP C    +++    +L + + +  
Sbjct:   603 NSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAA 662

Query:   594 SCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSG 653
             +  ILS  + LI  W +R+ + A +   ++   LV SY++L KATD F+  N +G G  G
Sbjct:   663 ALAILSSLYLLI-TWHKRTKKGAPSRTSMKGHPLV-SYSQLVKATDGFAPTNLLGSGSFG 720

Query:   654 IVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA 713
              VYKG L      VAVKV+ L+   A KSF AEC+ALRN+RHRNL+KI+T+CS  D +G 
Sbjct:   721 SVYKGKLNIQD-HVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGN 779

Query:   714 DFKAIVYEFMQNGSLEEWLH-HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIV 772
             DFKAIVY+FM NGSLE+W+H  +NDQ +   L++ +R+ I +DVA A++YLH +    +V
Sbjct:   780 DFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVV 839

Query:   773 HGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG 832
             H D+K SNVLLD D+V+HV DFGLA+ L +    ++++  + S+G  GT+GY APEYG+G
Sbjct:   840 HCDIKSSNVLLDSDMVAHVGDFGLARILVDGT--SLIQQSTSSMGFIGTIGYAAPEYGVG 897

Query:   833 REASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDF 871
               AS  GD+YS+GIL+LE+ T KRPTD+ F   L L  +
Sbjct:   898 LIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQY 936

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1265 (450.4 bits), Expect = 6.6e-129, P = 6.6e-129
 Identities = 281/718 (39%), Positives = 408/718 (56%)

Query:    45 INIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEI 104
             + + S+   G I   +G L  L  L LS+N  SG IP  LS  S L +L  + N+L GEI
Sbjct:    83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142

Query:   105 PADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTL 163
             PA +G+L  L  L +  N ++G +P+S+G L+ L  + + EN L G I  S GQL+ L+ 
Sbjct:   143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202

Query:   164 LSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGF 223
             LS+AFN  SG IP  I+NISSL +  +  N+ +G+LP +   NLPSL+E+    N F G 
Sbjct:   203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGR 262

Query:   224 IPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLT 283
             IP S+ NAS++ +     N FSG V  +  R++NL  L L          N+  F+  LT
Sbjct:   263 IPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALT 322

Query:   284 NCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTID 343
             NCS L+ +     +F G LP SV+NLSS++  +++  N+ISG++P +I NL +L +L++ 
Sbjct:   323 NCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLA 382

Query:   344 TNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSL 403
              N LTG++P    +L NL++L +D N L GS+P +                  G IPS+L
Sbjct:   383 NNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTL 442

Query:   404 GNCTNLLGLNISHNKLIGTLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDL 463
             GN T L  +N+ HN  IG +P +I  I                     +G LKN++    
Sbjct:   443 GNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHA 502

Query:   464 SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXX 523
               NK SGE P+T+  C  L++L +  N  +GSIP+ L  L+ +  LD S NNL+GQIP  
Sbjct:   503 DSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMS 562

Query:   524 XXXXXXXXXXXXXXXHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLT 583
                             F GEVP  GVF N +   I GN  +CGG+ EL LP+C  K    
Sbjct:   563 LGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKK 622

Query:   584 IL-KVVIPVIVSCLILSVG-FTLIYVW---RRRSARKASNMLPIEQQFLVDSYAELSKAT 638
                ++++ V+V CL+ ++  F+L+Y+     +R  ++      ++   ++ +Y +L KAT
Sbjct:   623 KKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGHPMI-TYKQLVKAT 681

Query:   639 DNFSSANKIGEGGSGIVYKG-FLGENG--TE-VAVKVINLKQKGASKSFVAECKALRNIR 694
             D FSS++ +G G  G VYKG F  ++G  T  VAV+V+ L+   A KSF AEC+ LRN R
Sbjct:   682 DGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTR 741

Query:   695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQLEVCSLSVIQRLN 751
             HRNL+KI+T+CS  D +G DFKAIVY+FM NGSLE+WLH  +NDQ E   L++ QR++
Sbjct:   742 HRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 3.3e-116, Sum P(2) = 3.3e-116
 Identities = 184/602 (30%), Positives = 295/602 (49%)

Query:     1 MNLCQWTGVTCGQRHQ-RVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQ 59
             +N C WTGVTC      RV  L+L    + G++SP+ G    L +++++SN   G IP  
Sbjct:    55 INYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTA 114

Query:    60 IGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSI 119
             +  L SLE L L +N  +G IP+ L S  N+  L    N LVG+IP  +G+L  L+ L++
Sbjct:   115 LSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLAL 174

Query:   120 FQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPS 178
                 +TG +P+ +G L  ++ + +++N L G I + LG    LT+ + A N  +G IP  
Sbjct:   175 ASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAE 234

Query:   179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
             +  + +LE+++L+ N  TG +P   G  +  L+ L   AN   G IP SL++  +L+ ++
Sbjct:   235 LGRLENLEILNLANNSLTGEIPSQLG-EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLD 293

Query:   239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
              S N  +G +  +F  +  L  L L  N+L +G+  +    ++ +N + LE+L  +  + 
Sbjct:   294 LSANNLTGEIPEEFWNMSQLLDLVLANNHL-SGSLPK----SICSNNTNLEQLVLSGTQL 348

Query:   299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
              GE+P  ++   S +KQ+ +  N ++G+IP  +  L  L  L +  N L GT+ P I  L
Sbjct:   349 SGEIPVELSKCQS-LKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNL 407

Query:   359 TNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNK 418
             TNLQ L L  N L+G +P                    G IP  +GNCT+L  +++  N 
Sbjct:   408 TNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNH 467

Query:   419 LIGTLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSA 478
               G +P  I R+                     +GN   L  LDL+ N+ SG IP++   
Sbjct:   468 FEGEIPPSIGRLKELNLLHLRQNELVGGLPAS-LGNCHQLNILDLADNQLSGSIPSSFGF 526

Query:   479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXX 538
                LE L +  N+  G++P  L SL+++  ++ S N LNG I                  
Sbjct:   527 LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNG 586

Query:   539 HFEGEVPMK-GVFNNKTRFSIAGN---GKLCGGLDELRLPSCQSKGSLTILKVVIPV-IV 593
              FE E+P++ G   N  R  +  N   GK+   L ++R  S     S   L   IP+ +V
Sbjct:   587 -FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSS-NALTGTIPLQLV 644

Query:   594 SC 595
              C
Sbjct:   645 LC 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
 Identities = 290/856 (33%), Positives = 440/856 (51%)

Query:    21 LDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAI 80
             L L    + G +   +GN S L  + +  N   G+IP ++G L+ L+ L +  N  + +I
Sbjct:   245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304

Query:    81 PANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRV 140
             P++L   + L  L    N+LVG I  +IG L  LE L++  N+ TG+ P SI NL +L V
Sbjct:   305 PSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTV 364

Query:   141 IDVRENRLWGRIDS-LGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSL 199
             + V  N + G + + LG L +L  LS   N  +G IP SI N + L+++ LS N+ TG +
Sbjct:   365 LTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEI 424

Query:   200 PVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLY 259
             P   G    +L  +    N+FTG IP  + N S+LE +  + N  +G +     +L+ L 
Sbjct:   425 P--RGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLR 482

Query:   260 WLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMG 319
              L +  N+L      E+       N   L  LY + N F G +P  ++NL+  ++ + M 
Sbjct:   483 ILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNLT-LLQGLRMY 535

Query:   320 RNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSX 379
              N + G IP E+ ++  L+ L +  N+ +G IP    +L +L  L L  N   GSIP+S 
Sbjct:   536 SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595

Query:   380 XXXXXXXXXXXXXXXXEGNIPSSL-GNCTNL-LGLNISHNKLIGTLPRQILRITTXXXXX 437
                              G IP  L  +  N+ L LN S+N L GT+P+++ ++       
Sbjct:   596 KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEID 655

Query:   438 XXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIP-ATLSACANLEYLNISGNAFSGSI 496
                               KN+  LD S N  SG IP         +  LN+S N+FSG I
Sbjct:   656 LSNNLFSGSIPRSLQA-CKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714

Query:   497 PLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFEGEVPMKGVFNNKTRF 556
             P    ++  +  LD SSNNL G+IP                 + +G VP  GVF N    
Sbjct:   715 PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774

Query:   557 SIAGNGKLCGGLDELRLPSCQSKGSLTILKV-VIPVIV---SCLILSVGFTLIYVWRRRS 612
              + GN  LCG    L+  + + K S    +  VI +I+   + L+L +   LI    ++ 
Sbjct:   775 DLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKK 834

Query:   613 ARKASNM----LP-IEQQFLVDSYA--ELSKATDNFSSANKIGEGGSGIVYKGFLGENGT 665
              +K  N     LP ++    +  +   EL +ATD+F+SAN IG      VYKG L E+GT
Sbjct:   835 EKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGT 893

Query:   666 EVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM 723
              +AVKV+NLK+  A   K F  E K L  ++HRNL+KI+    G  ++    KA+V  FM
Sbjct:   894 VIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFM 949

Query:   724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH-YCEPSIVHGDLKPSNVL 782
             +NG+LE+ +H S   +     S+++++++ + +AS I+YLH  Y  P IVH DLKP+N+L
Sbjct:   950 ENGNLEDTIHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFP-IVHCDLKPANIL 1004

Query:   783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVY 842
             LD D V+HVSDFG A+ L      +   T S S   +GT+GY+APE+   R+ + K DV+
Sbjct:  1005 LDSDRVAHVSDFGTARILGFREDGST--TASTS-AFEGTIGYLAPEFAYMRKVTTKADVF 1061

Query:   843 SFGILLLELFTRKRPT 858
             SFGI+++EL T++RPT
Sbjct:  1062 SFGIIMMELMTKQRPT 1077

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
 Identities = 295/898 (32%), Positives = 444/898 (49%)

Query:     2 NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG 61
             + C W GVTC    + VT LDL   ++ GTLSP V +L  L+ +++A N  +G IP +I 
Sbjct:    55 SFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEIS 114

Query:    62 RLISLERLILSNNSFSGAIPANLSS-CSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
              L  L  L LSNN F+G+ P  +SS   NL  L   +NNL G++P  + +L +L  L + 
Sbjct:   115 SLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLG 174

Query:   121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAF-NQFSGMIPPS 178
              N+  G++P S G+   +  + V  N L G+I   +G L +L  L + + N F   +PP 
Sbjct:   175 GNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE 234

Query:   179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
             I N+S L     +    TG +P + G  L  L  L    N F+G +   L   SSL+ ++
Sbjct:   235 IGNLSELVRFDGANCGLTGEIPPEIG-KLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMD 293

Query:   239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
              S N F+G +   F+ LKNL  LNL  N L  G   E  FI  L    +LE L    N F
Sbjct:   294 LSNNMFTGEIPASFAELKNLTLLNLFRNKLH-GEIPE--FIGDLP---ELEVLQLWENNF 347

Query:   299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
              G +P  +   +  +  + +  N+++GT+PP + +   L  L    N L G+IP  +G+ 
Sbjct:   348 TGSIPQKLGE-NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKC 406

Query:   359 TNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNK 418
              +L ++ +  NFL GSIP                    G +P + G   NL  +++S+N+
Sbjct:   407 ESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQ 466

Query:   419 LIGTLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSA 478
             L G LP  I   T                    VG L+ L ++D S N FSG I   +S 
Sbjct:   467 LSGPLPPAIGNFT-GVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISR 525

Query:   479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXX 538
             C  L ++++S N  SG IP  + +++ +  L+ S N+L G IP                 
Sbjct:   526 CKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYN 585

Query:   539 HFEGEVPMKGVFNNKTRFSIAGNGKLCGGL-----DELRLPSCQS--KGSLTI-LKVVIP 590
             +  G VP  G F+     S  GN  LCG       D +     QS  KG L+  +K+++ 
Sbjct:   586 NLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLL- 644

Query:   591 VIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELS----KATDNFSSANK 646
              ++  L+ S+ F ++ + + RS +KAS      + + + ++  L        D+    N 
Sbjct:   645 -VLGLLVCSIAFAVVAIIKARSLKKASE----SRAWRLTAFQRLDFTCDDVLDSLKEDNI 699

Query:   647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKIITV 704
             IG+GG+GIVYKG +  NG  VAVK +    +G+S    F AE + L  IRHR++++++  
Sbjct:   700 IGKGGAGIVYKGVM-PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 758

Query:   705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
             CS  +        +VYE+M NGSL E LH          L    R  IA++ A  + YLH
Sbjct:   759 CSNHETN-----LLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIALEAAKGLCYLH 809

Query:   765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
             H C P IVH D+K +N+LLD +  +HV+DFGLAKFL +        T      I G+ GY
Sbjct:   810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSG------TSECMSAIAGSYGY 863

Query:   825 VAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDT 882
             +APEY    +   K DVYSFG++LLEL T ++P    F +G+ +  + R+      D+
Sbjct:   864 IAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDS 920

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGT6	EFR_ARATH	2, ., 7, ., 1, 1, ., 1	0.4620	0.9841	0.8438	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	884
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-114
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-36
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
PLN03210	1153	PLN03210, PLN03210, Resistant to P	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-04
COG3173	321	COG3173, COG3173, Predicted aminoglycoside phospho	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	0.003
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.003
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.003
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  372 bits (957), Expect = e-114
 Identities = 280/917 (30%), Positives = 435/917 (47%), Gaps = 146/917 (15%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLS------PYV-------GNLSF------- 41
           ++C W G+TC     RV  +DL  ++I G +S      PY+         LS        
Sbjct: 56  DVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF 114

Query: 42  -----LRYINIASNGF----------------------NGEIPHQIGRLISLERLILSNN 74
                LRY+N+++N F                      +GEIP+ IG   SL+ L L  N
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174

Query: 75  SFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGN 134
              G IP +L++ ++L  L+  SN LVG+IP ++G +  L+ + +  N+++G++P  IG 
Sbjct: 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234

Query: 135 LSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
           L+SL  +D+  N L G I  SLG LK+L  L +  N+ SG IPPSIF++  L  + LS+N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
             +G +P +  + L +L  L   +NNFTG IPV+L++   L++++   N+FSG +  +  
Sbjct: 295 SLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTI 313
           +  NL  L+L  NNL TG   E      L +   L +L    N  EGE+P S+    S +
Sbjct: 354 KHNNLTVLDLSTNNL-TGEIPEG-----LCSSGNLFKLILFSNSLEGEIPKSLGACRS-L 406

Query: 314 KQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG 373
           +++ +  N  SG +P E   L  + +L I  N L G I     ++ +LQ L L RN   G
Sbjct: 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466

Query: 374 SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL 433
            +P S G+                           L  L++S N+  G +PR++      
Sbjct: 467 GLPDSFGS-------------------------KRLENLDLSRNQFSGAVPRKL------ 495

Query: 434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS 493
                              G+L  LM+L LS NK SGEIP  LS+C  L  L++S N  S
Sbjct: 496 -------------------GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536

Query: 494 GSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNK 553
           G IP     +  + +LD S N L+G+IP+ L N+  L  +N+S+NH  G +P  G F   
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596

Query: 554 TRFSIAGNGKLCGGLDELRLPSCQ--SKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRR 611
              ++AGN  LCGG     LP C+   K       +   +    ++  V F  +++  R 
Sbjct: 597 NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656

Query: 612 SA--RKASNMLPIEQQFLVDSYAELSKATDNFSSA----NKIGEGGSGIVYKGFLGENGT 665
           +   ++  N     +    DS    S   ++  S+    N I  G  G  YKG   +NG 
Sbjct: 657 NLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGM 716

Query: 666 EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           +  VK IN        S +A+   +  ++H N++K+I +C  R  KGA    +++E+++ 
Sbjct: 717 QFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLC--RSEKGA---YLIHEYIEG 767

Query: 726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ 785
            +L E L          +LS  +R  IAI +A A+ +LH  C P++V G+L P  +++D 
Sbjct: 768 KNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818

Query: 786 DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG 845
               H+    L   L       I            +  YVAPE    ++ + K D+Y FG
Sbjct: 819 KDEPHLR-LSLPGLLCTDTKCFI------------SSAYVAPETRETKDITEKSDIYGFG 865

Query: 846 ILLLELFTRKRPTDAMF 862
           ++L+EL T K P DA F
Sbjct: 866 LILIELLTGKSPADAEF 882

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  190 bits (483), Expect = 9e-50
 Identities = 126/346 (36%), Positives = 184/346 (53%), Gaps = 19/346 (5%)

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTG----- 271
           + +   +  ++ +N+S +  I+ S    SG +S    RL  +  +NL  N L        
Sbjct: 54  SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI 113

Query: 272 --AANELDFINLLTN----------CSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMG 319
              ++ L ++NL  N             LE L  + N   GE+P+ + + SS +K + +G
Sbjct: 114 FTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSS-LKVLDLG 172

Query: 320 RNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSL 379
            N + G IP  + NL SL +LT+ +NQL G IP E+G++ +L+ + L  N L G IP  +
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232

Query: 380 GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLEL 439
           G LT L +L L  NNL G IPSSLGN  NL  L +  NKL G +P  I  +  L + L+L
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDL 291

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
            +N L+G +P  V  L+NL  L L  N F+G+IP  L++   L+ L +  N FSG IP  
Sbjct: 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVP 545
           L    ++  LD S+NNL G+IPE L +   L  L L  N  EGE+P
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  154 bits (392), Expect = 7e-43
 Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 24/208 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIITVC 705
           +GEGG G VY     + G +VA+K+I  +   +     + E + L+ + H N++K+  V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
               F+  +   +V E+ + GSL++ L  +  +     LS  + L I + +   +EYLH 
Sbjct: 60  ----FEDENHLYLVMEYCEGGSLKDLLKENEGK-----LSEDEILRILLQILEGLEYLHS 110

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                I+H DLKP N+LLD D     ++DFGL+K L++          S+   I GT  Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--------SLLKTIVGTPAY 159

Query: 825 VAPEYGMGR-EASMKGDVYSFGILLLEL 851
           +APE  +G+   S K D++S G++L EL
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  147 bits (374), Expect = 7e-40
 Identities = 72/227 (31%), Positives = 104/227 (45%), Gaps = 26/227 (11%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGASKSFVAECKALRNIRHRNLIKIIT 703
            K+GEG  G VY     + G  VA+KVI   K K   +  + E K L+ ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V     F+  D   +V E+ + G L + L           LS  +       + SA+EYL
Sbjct: 65  V-----FEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYL 113

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-DTIVETRSISIGIKGTV 822
           H      IVH DLKP N+LLD+D    ++DFGLA+ L       T V          GT 
Sbjct: 114 HSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV----------GTP 160

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
            Y+APE  +G+      D++S G++L EL T K P            
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  143 bits (363), Expect = 2e-38
 Identities = 72/217 (33%), Positives = 105/217 (48%), Gaps = 29/217 (13%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIIT 703
           K+G G  G VYK      G  VAVK++  +       ++   E + LR + H N++++I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                D    D   +V E+ + G L ++L           LS  +   IA+ +   +EYL
Sbjct: 66  AF--EDK---DHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYL 114

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL--SNHNPDTIVETRSISIGIKGT 821
           H      I+H DLKP N+LLD++ V  ++DFGLAK L  S+ +  T V          GT
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----------GT 161

Query: 822 VGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
             Y+APE    G     K DV+S G++L EL T K P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  137 bits (348), Expect = 2e-36
 Identities = 70/218 (32%), Positives = 110/218 (50%), Gaps = 33/218 (15%)

Query: 646 KIGEGGSGIVYKGFL----GENGTEVAVKVINL-KQKGASKSFVAECKALRNIRHRNLIK 700
           K+GEG  G VYKG L    G+   EVAVK +     +   + F+ E + +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 701 IITVCSGRD-FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++ VC+  +         IV E+M+ G L  +L  +  +L     S+   L+ A+ +A  
Sbjct: 66  LLGVCTEEEPLY------IVMEYMEGGDLLSYLRKNRPKL-----SLSDLLSFALQIARG 114

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ ++LV  +SDFGL++ L +   D     R   + I+
Sbjct: 115 MEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIR 168

Query: 820 GTVGYVAPE---YGMGREASMKGDVYSFGILLLELFTR 854
               ++APE    G     S   DV+SFG+LL E+FT 
Sbjct: 169 ----WMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  136 bits (346), Expect = 5e-36
 Identities = 70/222 (31%), Positives = 114/222 (51%), Gaps = 31/222 (13%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
            K+GEG  G VYKG L       TEVAVK +   ++ AS+     F+ E + ++ + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57

Query: 698 LIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC---SLSVIQRLNI 752
           +++++ VC+  +  +       +V E+M+ G L ++L  S          +LS+   L+ 
Sbjct: 58  VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           AI +A  +EYL        VH DL   N L+ +DLV  +SDFGL++ + +   D   +  
Sbjct: 111 AIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD--DYYRKKT 165

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
              + I+    ++APE       + K DV+SFG+LL E+FT 
Sbjct: 166 GGKLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (345), Expect = 6e-36
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 32/218 (14%)

Query: 646 KIGEGGSGIVYKGFL----GENGTEVAVKVINL-KQKGASKSFVAECKALRNIRHRNLIK 700
           K+GEG  G VYKG L         EVAVK +     +   + F+ E + +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 701 IITVCSGRD-FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++ VC+  +         IV E+M  G L ++L  +  +     LS+   L+ A+ +A  
Sbjct: 66  LLGVCTEEEPLM------IVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARG 115

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ ++LV  +SDFGL++ L +   D            K
Sbjct: 116 MEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGG-----K 165

Query: 820 GTVGYVAPE---YGMGREASMKGDVYSFGILLLELFTR 854
             + ++APE    G     S   DV+SFG+LL E+FT 
Sbjct: 166 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  135 bits (342), Expect = 1e-35
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 646 KIGEGGSGIVYKGFL----GENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIK 700
           K+GEG  G VYKG L        T+VAVK +     +   + F+ E   ++ + H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 701 IITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++ VC+  +  +       IV E+M  G L ++L    +      L++   L +A+ +A 
Sbjct: 66  LLGVCTQGEPLY-------IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAK 113

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL      + VH DL   N L+ ++LV  +SDFGL++ +   +       R    G 
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGG- 164

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
           K  + ++APE     + + K DV+SFG+LL E+FT 
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 34/231 (14%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F    KIG+GG G VYK      G EVA+KVI L+ K   +  + E + L+  +H N++K
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 701 IIT--VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
                +     +       IV EF   GSL++ L  +N  L    ++ + +     ++  
Sbjct: 62  YYGSYLKKDELW-------IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK-----ELLK 109

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-DTIVETRSISIG 817
            +EYLH      I+H D+K +N+LL  D    + DFGL+  LS+    +T+V        
Sbjct: 110 GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-------- 158

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK------RPTDAMF 862
             GT  ++APE   G+    K D++S GI  +EL   K       P  A+F
Sbjct: 159 --GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  128 bits (323), Expect = 5e-33
 Identities = 75/224 (33%), Positives = 112/224 (50%), Gaps = 22/224 (9%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+   K+G G  G V++G L +N   VA+K++        + F  E +AL+ +RH++LI 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +  VCS       +   I+ E M+ GSL  +L     Q     L V   +++A  VA  +
Sbjct: 67  LFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEGM 117

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YL    E + +H DL   N+L+ +DLV  V+DFGLA+ +     + +  +    I  K 
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKW 170

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
           T    APE       S K DV+SFGILL E+FT  + P   M N
Sbjct: 171 T----APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (318), Expect = 3e-32
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKII 702
             +G G  G VY     + G  +AVK + L        ++   E + L +++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                 +    +   I  E++  GSL   L     +L      VI++      +   + Y
Sbjct: 66  GSERDEEKNTLN---IFLEYVSGGSLSSLLK-KFGKLP---EPVIRKY--TRQILEGLAY 116

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH      IVH D+K +N+L+D D V  ++DFG AK L +      +ET   +  ++GT 
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGTGSVRGTP 167

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++APE   G E     D++S G  ++E+ T K P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 5e-30
 Identities = 74/210 (35%), Positives = 110/210 (52%), Gaps = 26/210 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           IG+G  G V  G     G +VAVK +      A ++F+AE   +  +RH NL++++ V  
Sbjct: 14  IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVV- 69

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
               +G     IV E+M  GSL ++L      +    +++ Q+L  A+DV   +EYL   
Sbjct: 70  ---LQGNPL-YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLE-- 119

Query: 767 CEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVA 826
            E + VH DL   NVL+ +DLV+ VSDFGLAK            ++    G K  V + A
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----------EASQGQDSG-KLPVKWTA 167

Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKR 856
           PE    ++ S K DV+SFGILL E+++  R
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 34/234 (14%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHRN 697
           N+   + IG G  G+VYKG   E G  VA+K I+L   ++ A KS + E   L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE-VCSLSVIQRLNIAIDV 756
           ++K I        + +D   I+ E+ +NGSL + +       E + ++ V Q       V
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSIS 815
              + YLH   E  ++H D+K +N+L  +D V  ++DFG+A K       D  V      
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV----- 160

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK------RPTDAMFN 863
               GT  ++APE      AS   D++S G  ++EL T         P  A+F 
Sbjct: 161 ----GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 79/222 (35%), Positives = 116/222 (52%), Gaps = 28/222 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           K+G G  G V++G L  N T VAVK   LK      K F+AE + ++ +RH  LI++  V
Sbjct: 13  KLGAGQFGEVWEG-LWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL- 763
           C+  +        IV E M+ GSL E+L     +    +L + Q +++A  VAS + YL 
Sbjct: 70  CTLEEPI-----YIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLE 120

Query: 764 -HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
             +Y     +H DL   NVL+ ++ +  V+DFGLA+ +     + I E R    G K  +
Sbjct: 121 AQNY-----IHRDLAARNVLVGENNICKVADFGLARVIK----EDIYEARE---GAKFPI 168

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            + APE  +    S+K DV+SFGILL E+ T  R P   M N
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 24/220 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           K+G G  G V+ G      T+VAVK   LK    S ++F+ E + ++ +RH  L+++  V
Sbjct: 13  KLGAGQFGEVWMG-TWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           CS  +        IV E+M  GSL ++L       E   L + Q +++A  +A  + YL 
Sbjct: 70  CSEEEPI-----YIVTEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + +H DL   N+L+ ++LV  ++DFGLA+ +     D     R    G K  + +
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE----DDEYTARE---GAKFPIKW 170

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (275), Expect = 2e-26
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 23/220 (10%)

Query: 645 NKIGEGGSGIVYKG---FLGEN-GTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLI 699
            ++GEG  G V       LG+N G +VAVK +N   +   +S F  E + LR + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K   VC     +      ++ E++ +GSL ++L    DQ+     ++ + L  +  +   
Sbjct: 70  KYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQI-----NLKRLLLFSSQICKG 121

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS-NHNPDTIVETRSISIGI 818
           ++YL        +H DL   N+L++ + +  +SDFGLAK L  + +   + E     I  
Sbjct: 122 MDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF- 177

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT 858
                + APE     + S   DV+SFG+ L ELFT   P+
Sbjct: 178 -----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 5e-26
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 26/224 (11%)

Query: 647 IGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGASKS----FVAECKALRNIRHRNLIKI 701
           IG G  G V +G L   G  E+ V +  LK  G+S      F+ E   +    H N+I++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             V +    K      I+ E+M+NGSL+++L  ++ +      +V Q + +   +AS ++
Sbjct: 71  EGVVT----KSRPV-MIITEYMENGSLDKFLRENDGKF-----TVGQLVGMLRGIASGMK 120

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        VH DL   N+L++ +LV  VSDFGL++ L   + +    T+   I I+ T
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE--DSEATYTTKGGKIPIRWT 175

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
               APE    R+ +   DV+SFGI++ E+ +  +RP   M N+
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (269), Expect = 6e-26
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 22/210 (10%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIIT 703
           +K+G G  G VY+G   +    VAVK   LK+     + F+ E   ++ I+H NL++++ 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  L +A  ++SA+EYL
Sbjct: 70  VCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSAMEYL 120

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               + + +H DL   N L+ ++ +  V+DFGL++ ++        +T +   G K  + 
Sbjct: 121 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIK 170

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + APE     + S+K DV++FG+LL E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (269), Expect = 9e-26
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 40/222 (18%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
            +G+G SG+VYK      G   A+K I++       K  + E K LR+     ++K    
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---------IAID 755
           C G  +K  +  +IV E+M  GSL                 +++++          IA  
Sbjct: 64  CYGAFYKEGEI-SIVLEYMDGGSLA---------------DLLKKVGKIPEPVLAYIARQ 107

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++YLH   +  I+H D+KPSN+L++      ++DFG++K L N    T+ +  +  
Sbjct: 108 ILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN----TLDQCNTFV 161

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               GTV Y++PE   G   S   D++S G+ LLE    K P
Sbjct: 162 ----GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (267), Expect = 1e-25
 Identities = 77/230 (33%), Positives = 105/230 (45%), Gaps = 33/230 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---ECKALRNIRHRNLIKI 701
           NKIG G  G VY     + G  +AVK I + Q    K+      E K L  ++H NL+K 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 702 ITVCSGRDFKGADFKAIVYEFM---QNGSLEEWLHH-SNDQLEVCSLSVIQRLNIAIDVA 757
             V   R+         VY FM     G+LEE L H       V  +  +Q L       
Sbjct: 65  YGVEVHRE--------KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL------- 109

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + YLH      IVH D+KP+N+ LD + V  + DFG A  L N+   T+ E       
Sbjct: 110 EGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT-TTMGEEVQ---S 162

Query: 818 IKGTVGYVAPEYGMGREASMKG---DVYSFGILLLELFTRKRPTDAMFNE 864
           + GT  Y+APE   G +    G   D++S G ++LE+ T KRP   + NE
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 30/212 (14%)

Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            IGEG  G V +G + G+   +VAVK  N+K    +++F+ E   +  + H+NL++++ V
Sbjct: 13  IIGEGEFGAVLQGEYTGQ---KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
                        IV E M  G+L  +L      L    +SVIQ L  ++DVA  +EYL 
Sbjct: 68  ILHNGLY------IVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE 117

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                 +VH DL   N+L+ +D V+ VSDFGLA+          V +  +    K  V +
Sbjct: 118 ---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR----------VGSMGVD-NSKLPVKW 163

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
            APE    ++ S K DV+S+G+LL E+F+  R
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (261), Expect = 4e-24
 Identities = 74/223 (33%), Positives = 110/223 (49%), Gaps = 24/223 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRH-RNLIKI 701
           K+GEG  G VY   L  +   VA+KV+  K   +    + F+ E + L ++ H  N++K+
Sbjct: 7   KLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                   F+      +V E++  GSLE+ L     +     LS  + L I   + SA+E
Sbjct: 64  YDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALE 115

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           YLH      I+H D+KP N+LLD+D  V  + DFGLAK L +    + +     +    G
Sbjct: 116 YLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVG 170

Query: 821 TVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDA 860
           T GY+APE  +G     AS   D++S GI L EL T   P + 
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  101 bits (254), Expect = 5e-24
 Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 28/211 (13%)

Query: 647 IGEGGSGIVYKGFLGE-NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           IG+G  G V    LG+  G +VAVK I  K    +++F+AE   +  +RH NL++++ V 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + KG  +  IV E+M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 69  V--EEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLE- 119

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + VH DL   NVL+ +D V+ VSDFGL K           E  S     K  V + 
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 166

Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR 856
           APE    ++ S K DV+SFGILL E+++  R
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (254), Expect = 1e-23
 Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 31/247 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKAL-RNIR 694
           D+F     IGEG    V      E   E A+K+++   L ++   K    E + L R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  +IK+        F+  +    V E+  NG L +++          SL        A 
Sbjct: 61  HPGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRK------YGSLDEKCTRFYAA 109

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP---DTIVET 811
           ++  A+EYLH      I+H DLKP N+LLD+D+   ++DFG AK L  ++    +    T
Sbjct: 110 EILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 812 RSISIGIK---------GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF 862
              S   K         GT  YV+PE    + A    D+++ G ++ ++ T K P     
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS- 225

Query: 863 NEGLTLH 869
           NE LT  
Sbjct: 226 NEYLTFQ 232

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 98.6 bits (245), Expect = 7e-23
 Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 27/221 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           K+G+G  G V+ G    NGT  VA+K   LK    S ++F+ E + ++ +RH  L+++  
Sbjct: 13  KLGQGCFGEVWMGTW--NGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+
Sbjct: 69  VVSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 118

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
                 + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + 
Sbjct: 119 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIK 168

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.3 bits (246), Expect = 8e-23
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 24/220 (10%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
            +IG+G  G VY      +G    +K I+L        +  + E K L+ + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+      IV E+   G L + +     + +       Q L+  + +  A++Y
Sbjct: 66  -----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK--PFPEEQILDWFVQLCLALKY 118

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVETRSISIGIKG 820
           LH      I+H D+KP N+ L  + +  + DFG++K LS+      T+V          G
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV----------G 165

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           T  Y++PE    +  + K D++S G +L EL T K P + 
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 8e-23
 Identities = 74/215 (34%), Positives = 106/215 (49%), Gaps = 33/215 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVK------VINLKQKGASKSFVAECKALRNIRHRNLI 699
           KIG+G  G VYKG L +  TEVAVK        +LK+K     F+ E + L+   H N++
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIV 55

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+I VC  +         IV E +  GSL  +L    ++L V  L     L +++D A+ 
Sbjct: 56  KLIGVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAG 105

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ ++ V  +SDFG+++          V      I IK
Sbjct: 106 MEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIK 160

Query: 820 GTVGYVAPE-YGMGREASMKGDVYSFGILLLELFT 853
            T    APE    GR  S + DV+S+GILL E F+
Sbjct: 161 WT----APEALNYGRYTS-ESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 64/253 (25%), Positives = 119/253 (47%), Gaps = 39/253 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            + + +  KIGEG SG VYK      G EVA+K + L+++   +  + E   +++ +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++          +   D   +V E+M  GSL + +  +  ++    ++ + R     +V 
Sbjct: 77  IVDYYD-----SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-----EVL 126

Query: 758 SAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             +EYLH  +     ++H D+K  N+LL +D    ++DFG A  L+          R+  
Sbjct: 127 QGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQLT-----KEKSKRN-- 174

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL------FTRKRPTDAMF---NEGL 866
             + GT  ++APE    ++   K D++S GI+ +E+      + R+ P  A+F    +G+
Sbjct: 175 -SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233

Query: 867 ----TLHDFSREF 875
                   +S EF
Sbjct: 234 PPLKNPEKWSPEF 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 4e-22
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G  G V      + G   A+KV+    + ++   +  + E   L  I H  ++K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
             +   F+  +   +V E+   G L     H + +    S    +    A ++  A+EYL
Sbjct: 59  HYA---FQTEEKLYLVLEYAPGGEL---FSHLS-KEGRFSEERARF--YAAEIVLALEYL 109

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           H      I++ DLKP N+LLD D   H+  +DFGLAK            T +      GT
Sbjct: 110 H---SLGIIYRDLKPENILLDAD--GHIKLTDFGLAK----ELSSEGSRTNTFC----GT 156

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             Y+APE  +G+      D +S G+LL E+ T K P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 642 SSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLI 699
           +   ++G G  G+V+ G       +VA+K+I    +GA     F+ E K +  + H NL+
Sbjct: 7   TFLKELGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLV 62

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  VC+ +      F  IV E+M NG L  +L     +L    L     L++  DV  A
Sbjct: 63  QLYGVCTKQ---RPIF--IVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEA 112

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ +D V  VSDFGLA+++ +       +  + S G K
Sbjct: 113 MEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD-------DQYTSSQGTK 162

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             V +  PE       S K DV+SFG+L+ E+F+
Sbjct: 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 26/220 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHR 696
              +   +IG G  G+V+ G+      +VA+K I   ++GA   + F+ E + +  + H 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L+++  VC     + +    +V+EFM++G L ++L     +    +L     L + +DV
Sbjct: 60  KLVQLYGVC----TERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDV 109

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + YL      +++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S 
Sbjct: 110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-------DQYTSST 159

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           G K  V + +PE     + S K DV+SFG+L+ E+F+  +
Sbjct: 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 71/220 (32%), Positives = 114/220 (51%), Gaps = 25/220 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           K+G G  G V+ G    N T+VAVK   LK    S +SF+ E + ++ +RH  L+++  V
Sbjct: 13  KLGNGQFGEVWMGTWNGN-TKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +    +L +   +++A  VA+ + Y+ 
Sbjct: 70  VSEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + +H DL+ +N+L+   LV  ++DFGLA+ + + N  T  +      G K  + +
Sbjct: 120 RM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQ------GAKFPIKW 169

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 70/226 (30%), Positives = 119/226 (52%), Gaps = 27/226 (11%)

Query: 647 IGEGGSGIVYKGFL---GENGTEVAVKVINL----KQKGASKSFVAECKALRNIRHRNLI 699
           IG G  G V +G L   G+    VA+K +      KQ+   + F++E   +    H N+I
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNII 68

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +  V +      +    I+ EFM+NG+L+ +L  ++ Q      +VIQ + +   +A+ 
Sbjct: 69  HLEGVVTK-----SRPVMIITEFMENGALDSFLRQNDGQF-----TVIQLVGMLRGIAAG 118

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL    E + VH DL   N+L++ +LV  VSDFGL++FL +   D    T + S+G K
Sbjct: 119 MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP---TYTSSLGGK 172

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             + + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.5 bits (232), Expect = 6e-21
 Identities = 70/223 (31%), Positives = 115/223 (51%), Gaps = 23/223 (10%)

Query: 647 IGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIKII 702
           IG G  G V++G L   G  EVAV +  LK     K    F++E   +    H N+I++ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +   FK A    I+ E+M+NG+L+++L   + +      S  Q + +   +A+ ++Y
Sbjct: 73  GVVT--KFKPA---MIITEYMENGALDKYLRDHDGEF-----SSYQLVGMLRGIAAGMKY 122

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    + + VH DL   N+L++ +L   VSDFGL++ L + +P+    T    I I+ T 
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTTSGGKIPIRWT- 177

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
              APE    R+ +   DV+SFGI++ E+ +  +RP   M N 
Sbjct: 178 ---APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.6 bits (230), Expect = 8e-21
 Identities = 68/230 (29%), Positives = 117/230 (50%), Gaps = 31/230 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRN 697
           +      K+G G  G V+ G+     T+VA+K  +LKQ   S   F+AE   ++ ++H  
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPR 62

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           L+++  V +           I+ E+M+NGSL ++L       E   L++ + +++A  +A
Sbjct: 63  LVRLYAVVTQEPI------YIITEYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIA 112

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + ++      + +H DL+ +N+L+ + L   ++DFGLA+ + + N  T  E      G
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTARE------G 162

Query: 818 IKGTVGYVAPE---YGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            K  + + APE   YG     ++K DV+SFGILL E+ T  R P   M N
Sbjct: 163 AKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 92.6 bits (230), Expect = 8e-21
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 31/229 (13%)

Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K +  + H  L+++  
Sbjct: 11  ELGTGQFGVVKYGKWRGQY--DVAIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   +       IV E+M NG L  +L     + +       Q L +  DV   + 
Sbjct: 67  VCTKQRPIY-------IVTEYMSNGCLLNYLREHGKRFQP-----SQLLEMCKDVCEGMA 114

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L+D      VSDFGL++++ +       +  + S+G K  
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD-------DEYTSSVGSKFP 164

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  +  + S K DV++FG+L+ E+++  K P +   N      
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 44/229 (19%)

Query: 647 IGEGGSGIVYKGFL-----GENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNL 698
           +GEG  G V+ G         +   VAVK   LK+     A K F  E + L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQLEVCS-------LSVIQRL 750
           +K   VC+       D   +V+E+M++G L ++L  H  D   + S       L++ Q L
Sbjct: 71  VKFYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 751 NIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            IA+ +AS + YL   H+     VH DL   N L+  DLV  + DFG+++         +
Sbjct: 126 QIAVQIASGMVYLASQHF-----VHRDLATRNCLVGYDLVVKIGDFGMSR--------DV 172

Query: 809 VETRSISIGIKGT----VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             T    +G  G     + ++ PE  M R+ + + DV+SFG++L E+FT
Sbjct: 173 YTTDYYRVG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 25/220 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT +VA+K +        ++F+ E + ++ +RH  L+ +  V
Sbjct: 13  KLGQGCFGEVWMGTW--NGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV EFM  GSL ++L   + +     L + Q +++A  +A  + Y+ 
Sbjct: 70  VSEEPI------YIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE 119

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + +H DL+ +N+L+  +LV  ++DFGLA+ + ++         +   G K  + +
Sbjct: 120 RM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-------YTARQGAKFPIKW 169

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 3e-20
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKII 702
            +IGEG  G VYK    + G  VA+K I ++ +  G   + + E K L+ +RH N++++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            + + +  KG+ +  +V+E+M +  L   L     +      +  Q       +   ++Y
Sbjct: 65  EIVTSKG-KGSIY--MVFEYMDH-DLTGLLDSPEVKF-----TESQIKCYMKQLLEGLQY 115

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH      I+H D+K SN+L++ D V  ++DFGLA+  +  N       R I      T+
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVI------TL 165

Query: 823 GYVAPEYGMGREA-SMKGDVYSFGILLLELFTRK 855
            Y  PE  +G      + D++S G +L ELF  K
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.1 bits (227), Expect = 6e-20
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 32/219 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVA--ECKALRNIRHRNLI 699
            K+GEG   +VYK    E G  VA+K I L ++  +K   +F A  E K L+ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            ++ V     F       +V+EFM+   LE+ +    D+  V + + I+  +  +     
Sbjct: 66  GLLDV-----FGHKSNINLVFEFME-TDLEKVIK---DKSIVLTPADIK--SYMLMTLRG 114

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYLH      I+H DLKP+N+L+  D V  ++DFGLA+     +P+  +  + +     
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVV----- 164

Query: 820 GTVGYVAPEYGMGREASMKG---DVYSFGILLLELFTRK 855
            T  Y APE   G  A   G   D++S G +  EL  R 
Sbjct: 165 -TRWYRAPELLFG--ARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
             IG G + +VY      N  +VA+K I+L++   S      E +A+    H N++K   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--Y 64

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN--DQLEVCSLSVIQRLNIAIDVASAIE 761
             S   F   D   +V  ++  GSL + +  S     L+   ++ + +     +V   +E
Sbjct: 65  YTS---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVLKGLE 116

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH   +   +H D+K  N+LL +D    ++DFG++  L+    D    TR +     GT
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLA----DGGDRTRKVRKTFVGT 169

Query: 822 VGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
             ++APE          K D++SFGI  +EL T   P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 26/219 (11%)

Query: 647 IGEGGSGIVYKGF---LGEN-GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKI 701
           +G G  G VYKG     GE     VA+KV+  +    A+K  + E   + ++ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + +C            ++ + M  G L +++ +  D +    L     LN  + +A  + 
Sbjct: 75  LGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKGMS 123

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH DL   NVL+       ++DFGLAK L     D   E    + G K  
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VD---EKEYHAEGGKVP 174

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
           + ++A E  + R  + K DV+S+G+ + EL T   +P +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIIT 703
           +IGEG  GIV+K    E G  VA+K + L++   G     + E KAL+  +H  ++K++ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V       G+ F  +V E+M    L E L      L     + ++     +     + Y+
Sbjct: 67  VFP----HGSGF-VLVMEYMP-SDLSEVLRDEERPL---PEAQVKSYMRML--LKGVAYM 115

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H      I+H DLKP+N+L+  D V  ++DFGLA+  S   P      R  S  +  T  
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP------RLYSHQV-ATRW 165

Query: 824 YVAPE--YGMGREASMKGDVYSFGILLLELFTRKRP 857
           Y APE  YG  R+     D+++ G +  EL     P
Sbjct: 166 YRAPELLYG-ARKYDPGVDLWAVGCIFAELL-NGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 15/214 (7%)

Query: 647 IGEGGSGIVYKGFLG-ENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRNLIKI 701
           +GEG  G V +G L  ++G+++ V V  +K    + S    F++E   +++  H N++K+
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 702 ITVC-SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           I VC      +      ++  FM++G L  +L +S        L +   L   +D+A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL +    + +H DL   N +L +D+   V+DFGL+K +  ++ D   + R I+   K 
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGR-IA---KM 177

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
            V ++A E    R  + K DV++FG+ + E+ TR
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 72/223 (32%), Positives = 112/223 (50%), Gaps = 23/223 (10%)

Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIKII 702
           IG G  G V  G L   G  E+ V +  LK     K    F++E   +    H N+I + 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +    K      IV E+M+NGSL+ +L   + Q      +VIQ + +   +AS ++Y
Sbjct: 72  GVVT----KSKPV-MIVTEYMENGSLDAFLRKHDGQF-----TVIQLVGMLRGIASGMKY 121

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+    TR   I I+ T 
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWT- 176

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
              APE    R+ +   DV+S+GI++ E+ +  +RP   M N+
Sbjct: 177 ---APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 59/239 (24%), Positives = 115/239 (48%), Gaps = 36/239 (15%)

Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS-FVAE 686
           E+  +   F     +GEG  G VYKG L       + T VA+K +    +   +  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVC-- 742
            + + +++H N++ ++ VC+           +++E++ +G L E+L  +  +  +     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 743 ------SLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
                 SL     L+IAI +A+ +EYL  HH+     VH DL   N L+ + L   +SDF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDF 168

Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           GL++ + + +   +     + +       ++ PE  +  + + + D++SFG++L E+F+
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPV------RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 31/216 (14%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIIT 703
           KIGEG  G+VYK      G  VA+K I L+   +G  K+ + E K L+ + H N+IK++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V     F+      +V+EFM    L + +      L     S+I+  +    +   + + 
Sbjct: 66  V-----FRHKGDLYLVFEFMDT-DLYKLIKDRQRGL---PESLIK--SYLYQLLQGLAFC 114

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHNPDT-IVETRSISIGIKGT 821
           H +    I+H DLKP N+L++ + V  ++DFGLA+ F S   P T  V TR         
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--------- 162

Query: 822 VGYVAPE--YGMGREASMKGDVYSFGILLLELFTRK 855
             Y APE   G  +  S   D++S G +  EL +R+
Sbjct: 163 -WYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 28/222 (12%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK----GASKSFVAECKALRNIRH 695
           +F     IG+G  G V      +     A+K +N KQK    G+ ++ + E + L+ + H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNH 59

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             L+    +     F+  +   +V + +  G L   L     Q    S   + +  I  +
Sbjct: 60  PFLVN---LWY--SFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQV-KFWIC-E 108

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +  A+EYLH      I+H D+KP N+LLD+    H++DF +A         T V   +++
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIA---------TKVTPDTLT 156

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               GT GY+APE    +  S+  D +S G+   E    KRP
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRNLIKIIT 703
            ++G G SG+V K      G  +AVK I L+   A  K  + E   L       ++    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV---- 62

Query: 704 VCSGRDFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
                 F GA +     +I  E+M  GSL++ L     ++    L       IA+ V   
Sbjct: 63  -----GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKG 112

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YLH   +  I+H D+KPSN+L++      + DFG++  L N    T V T S      
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS------ 164

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               Y+APE   G + S+K D++S G+ L+EL T + P
Sbjct: 165 ----YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 85.6 bits (213), Expect = 3e-18
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 27/214 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIIT 703
           K+GEG  G+VYK    + G  VA+K I L  +  G   + + E   L+ ++H N++K++ 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 704 VCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
           V           K  +V+E+     L+++L      L   S ++I+   I   +   + Y
Sbjct: 66  VIHTER------KLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKS--IMYQLLRGLAY 113

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
            H +    I+H DLKP N+L+++D V  ++DFGLA+          +  R+ +  +  T+
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG-------IPLRTYTHEVV-TL 162

Query: 823 GYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            Y APE  +G +  S   D++S G +  E+ T K
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 34/217 (15%)

Query: 646 KIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKI 701
           ++G G  G+V+   LG+     +VA+K IN   +GA   + F+ E K +  + H  L+++
Sbjct: 11  ELGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 702 ITVCSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             VC+ +       K   IV EFM+NG L  +L     +L    L     L++  DV   
Sbjct: 65  YGVCTQQ-------KPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEG 112

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL      S +H DL   N L+    V  VSDFG+ +++ +   D        S G K
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD---DEYTS----SSGAK 162

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
             V +  PE     + S K DV+SFG+L+ E+FT  +
Sbjct: 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 38/231 (16%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRN 697
            +     +G G  GIV+      +   V +K I ++Q  K    +   EC+ L+ + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I+        +F       IV E+   G+L E++               +R N  +D  
Sbjct: 61  IIEYY-----ENFLEDKALMIVMEYAPGGTLAEYIQ--------------KRCNSLLDED 101

Query: 758 SAIEY-------LHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIV 809
           + + +       LHH     I+H DLK  N+LLD+  +V  + DFG++K LS        
Sbjct: 102 TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-------- 153

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            ++S +  + GT  Y++PE   G+  + K D+++ G +L EL + KR  +A
Sbjct: 154 -SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 43/234 (18%)

Query: 646 KIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           ++GEG  G   K FL E        +   VAVK +    + A + F  E + L  ++H++
Sbjct: 12  ELGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSND-------QLEVCS-LSVIQ 748
           +++   VC+           +V+E+M++G L  +L  H  D       +      L++ Q
Sbjct: 69  IVRFYGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 749 RLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            L IA  +AS + YL   H+     VH DL   N L+ Q LV  + DFG+++        
Sbjct: 124 MLAIASQIASGMVYLASLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSR-------- 170

Query: 807 TIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
            I  T    +G +    + ++ PE  + R+ + + D++SFG++L E+FT  K+P
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 36/223 (16%)

Query: 647 IGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
           +G+G  G+VY+G       GE  T VA+K +N   + AS      F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVCSLSVIQR---LNI 752
           +++++ V S     G     +V E M  G L+ +L       +     L        + +
Sbjct: 71  VVRLLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAE-NNPGLGPPTLQKFIQM 124

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++A  + YL        VH DL   N ++ +DL   + DFG+ +         I ET 
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETD 173

Query: 813 SISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
               G KG   V ++APE       + K DV+SFG++L E+ T
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 67/244 (27%), Positives = 122/244 (50%), Gaps = 17/244 (6%)

Query: 647 IGEGGSGIVYKGFLGENGT--EVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKII 702
           +GEG  G V +G L ++ +  +VAVK + +    +   + F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 703 TVC-SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
            VC    + +G     ++  FM++G L  +L +S        L     +    D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL      S +H DL   N +L++++   V+DFGL+K +  +N D   + R   + +K  
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI--YNGDYYRQGRIAKMPVK-- 179

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLHDFSREFFTRKS 880
             ++A E    R  + K DV+SFG+ + E+ TR + P   + N    ++D+ R+    K 
Sbjct: 180 --WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGNRLKQ 235

Query: 881 DTDC 884
             DC
Sbjct: 236 PPDC 239

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 24/227 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRN 697
           ++     K+G G  G V+ G+   N T+VAVK   LK    S ++F+ E   ++ ++H  
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDK 62

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           L+++  V +  +        I+ E+M  GSL ++L       E   + + + ++ +  +A
Sbjct: 63  LVRLYAVVTKEEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIA 113

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + Y+      + +H DL+ +NVL+ + L+  ++DFGLA+ + + N  T  E      G
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTARE------G 163

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
            K  + + APE       ++K DV+SFGILL E+ T  K P   M N
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 43/252 (17%)

Query: 612 SARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKV 671
           S+  AS   P   +    S +EL +        N+IG G  G VYK      G   A+KV
Sbjct: 58  SSSSASGSAPSAAK----SLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 672 INLKQKGASKSFVA-ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEE 730
           I    +   +  +  E + LR++ H N++K    C        + + ++ EFM  GSLE 
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQ-VLLEFMDGGSLEG 161

Query: 731 WLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH 790
              H  D+  +         ++A  + S I YLH      IVH D+KPSN+L++      
Sbjct: 162 --THIADEQFLA--------DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVK 208

Query: 791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE-----YGMGREASMKGDVYSFG 845
           ++DFG+++ L+     T+    S S+   GT+ Y++PE        G      GD++S G
Sbjct: 209 IADFGVSRILAQ----TMDPCNS-SV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260

Query: 846 ILLLELFTRKRP 857
           + +LE +  + P
Sbjct: 261 VSILEFYLGRFP 272

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 645 NKIGEGGSGIVYKG-FLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIK 700
            ++G G  G V KG +L ++G EV V V  LKQ       K F+ E   +  + H  +++
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I VC G          +V E    G L ++L    +      + V     +A  VA  +
Sbjct: 61  LIGVCKGEPL------MLVMELAPLGPLLKYLKKRRE------IPVSDLKELAHQVAMGM 108

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YL        VH DL   NVLL     + +SDFG+++ L   +       R+ + G + 
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD----YYRATTAG-RW 160

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
            + + APE     + S K DV+S+G+ L E F+ 
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 28/211 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           +G+G  G V+KG L ++ T VAVK    +L Q+   K F++E + L+   H N++K+I V
Sbjct: 3   LGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           C+ R         IV E +  G    +L    D+L+   L     +  A+D A+ + YL 
Sbjct: 61  CTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE 110

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI-SIGIKGTVG 823
                + +H DL   N L+ ++ V  +SDFG    +S    D I  +  +  I IK T  
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT-- 161

Query: 824 YVAPE-YGMGREASMKGDVYSFGILLLELFT 853
             APE    GR +S + DV+S+GILL E F+
Sbjct: 162 --APEALNYGRYSS-ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 82.3 bits (203), Expect = 1e-16
 Identities = 90/321 (28%), Positives = 139/321 (43%), Gaps = 21/321 (6%)

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
           +N    +P SLS   SL+++  S      G   +   L  L  L+L +N L         
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE-NLLNLLPLPSLDLNLNRL-------RS 107

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL 337
            I+ L   + L  L  + N    ++P  +  L S +K++ +  N+I  ++P  +RNL +L
Sbjct: 108 NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNL 165

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
             L +  N L+  +P  +  L+NL  LDL  N +   +P  +  L+ L  L L  N++  
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII- 222

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN 457
            + SSL N  NL GL +S+NKL          I  LS    L  +    S    +G+L N
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLEDL----PESIGNLSNLETLDLSNNQISSISSLGSLTN 278

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L  LDLSGN  S  +P        L  L ++      ++ L L+S+     +    +N  
Sbjct: 279 LRELDLSGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNNNIL---SNGE 334

Query: 518 GQIPEYLENLSFLEFLNLSYN 538
              PE L  L  L  L    N
Sbjct: 335 TSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 31/220 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRN 697
           +     +++GEG  G V K  L   G   A+K I         K  + E +  ++ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 698 LIKIITVCSGRDFKGADFK------AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           ++K         + GA          I  E+ + GSL+        +       V+ +  
Sbjct: 61  IVK---------YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-- 109

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YLH      I+H D+KPSN+LL +     + DFG++  L N    T    
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-- 164

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                   GT  Y+APE   G+  S+  DV+S G+ LLE+
Sbjct: 165 --------GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 68/235 (28%), Positives = 112/235 (47%), Gaps = 44/235 (18%)

Query: 646 KIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           ++GEG  G   K FL E        +   VAVK +      A K F  E + L N++H +
Sbjct: 12  ELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQLEVC---------SLSVI 747
           ++K   VC        D   +V+E+M++G L ++L  H  D + +           L + 
Sbjct: 69  IVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 748 QRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           Q L+IA  +AS + YL   H+     VH DL   N L+  +L+  + DFG+++       
Sbjct: 124 QMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSR------- 171

Query: 806 DTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
             +  T    +G      + ++ PE  M R+ + + DV+SFG++L E+FT  K+P
Sbjct: 172 -DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 67/253 (26%), Positives = 120/253 (47%), Gaps = 45/253 (17%)

Query: 639 DNFSSANKIGEGGSGIVYK----GFL-GENGTEVAVKVINLKQKGAS----KSFVAECKA 689
           +N      IG+G  G V++    G L  E  T VAVK++   ++ AS      F  E   
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAAL 61

Query: 690 LRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHH---------SNDQL 739
           +    H N++K++ VC+ G+         +++E+M  G L E+L H         S+   
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPM------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115

Query: 740 EV-------CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS 792
                      LS  ++L IA  VA+ + YL    E   VH DL   N L+ +++V  ++
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIA 172

Query: 793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF 852
           DFGL++ +  ++ D    + + +I I+    ++ PE       + + DV+++G++L E+F
Sbjct: 173 DFGLSRNI--YSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIF 226

Query: 853 TRK-RPTDAMFNE 864
           +   +P   M +E
Sbjct: 227 SYGMQPYYGMAHE 239

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 54/252 (21%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+GEG  G VYK    E G  VA+KV+ +  +   +  + E   L+      ++K     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK----- 62

Query: 706 SGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI---DVAS 758
               + G+ FK     IV E+   GS+       +D +++ + ++ +   IA        
Sbjct: 63  ----YYGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEEE-IAAILYQTLK 110

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD--TIVETRSISI 816
            +EYLH       +H D+K  N+LL+++  + ++DFG++  L++      T++       
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------- 160

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK------RPTDAMF----NEGL 866
              GT  ++APE       + K D++S GI  +E+   K       P  A+F        
Sbjct: 161 ---GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP 217

Query: 867 TL---HDFSREF 875
           TL     +S EF
Sbjct: 218 TLSDPEKWSPEF 229

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVI------NLKQKGASKSFVAECKALRNIRHRNLI 699
           +IG G  G V+ G L  + T VAVK        +LK K     F+ E + L+   H N++
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIV 56

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++I VC+ +         IV E +Q G    +L     +L+V  L     + +  + A+ 
Sbjct: 57  RLIGVCTQKQPI-----YIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAG 106

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ +  V  +SDFG+    S    D +    + + G+K
Sbjct: 107 MEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGM----SREEEDGVY---ASTGGMK 156

Query: 820 GT-VGYVAPE-YGMGREASMKGDVYSFGILLLELFT 853
              V + APE    GR +S + DV+SFGILL E F+
Sbjct: 157 QIPVKWTAPEALNYGRYSS-ESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.3 bits (199), Expect = 4e-16
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHRNLIKIITV 704
           IG G  G+V        G +VA+K I+        +K  + E K LR++RH N+I ++ +
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 705 CSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSND-QLEVCSLSVIQRLNIAIDVASAIE 761
              R     DF    IV E M+   L + +        +     + Q L         ++
Sbjct: 68  L--RPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL-------RGLK 117

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI-----VETRSISI 816
           YLH     +++H DLKPSN+L++ +    + DFGLA+ +     +       V TR    
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW--- 171

Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
                  Y APE  +      K  D++S G +  EL TRK
Sbjct: 172 -------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.8 bits (202), Expect = 6e-16
 Identities = 54/158 (34%), Positives = 78/158 (49%), Gaps = 12/158 (7%)

Query: 461 LDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQI 520
           L L      G IP  +S   +L+ +N+SGN+  G+IP  L S+ S++ LD S N+ NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 521 PEYLENLSFLEFLNLSYNHFEGEVP--MKGVFNNKTRFSIAGNGKLCG--GLDELRLPSC 576
           PE L  L+ L  LNL+ N   G VP  + G   ++  F+   N  LCG  G     L +C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-----LRAC 537

Query: 577 QSKGSLTILKVVIPVIVSC-LILSVGFTLIYVWRRRSA 613
               S+   K+ I   VS   +  V   + + W+RR  
Sbjct: 538 GPHLSVGA-KIGIAFGVSVAFLFLVICAMCW-WKRRQN 573

Length = 623

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 7e-16
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVK--VINLKQKGASKSFVAECKALRNIR---HRNLI 699
            +IGEG  G VYK      G  VA+K   + L ++G   S + E   L+ +    H N++
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ-----LEVCS---LSVIQRLN 751
           +++ VC G          +V+E +             DQ     L  C    L      +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-------------DQDLATYLSKCPKPGLPPETIKD 111

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +   +   +++LH +    IVH DLKP N+L+  D    ++DFGLA+  S     T V  
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                    T+ Y APE  +    +   D++S G +  ELF R+
Sbjct: 169 ---------TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 21/223 (9%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIR 694
             NF    KIG+G   +VYK     +G  VA+K +    +    A +  + E   L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N+IK +       F   +   IV E    G L   + H   Q  +     I +    +
Sbjct: 61  HPNVIKYLA-----SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY--FV 113

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            + SA+E++H      I+H D+KP+NV +    V  + D GL +F S+          S+
Sbjct: 114 QLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT----TAAHSL 166

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                GT  Y++PE       + K D++S G LL E+   + P
Sbjct: 167 V----GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 27/230 (11%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           +F   NKIG+G  G+V+K     +    A+K I+L +      +  + E + L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I+         F       IV E+ +NG L + L     +     L   Q     I + 
Sbjct: 61  IIRYY-----ESFLDKGKLNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQIL 111

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN--PDTIVETRSIS 815
             + +LH      I+H D+K  N+ LD      + D G+AK LS++    +TIV      
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV------ 162

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEG 865
               GT  Y++PE    +  + K DV++ G++L E  T K P DA  N+G
Sbjct: 163 ----GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 26/225 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQKGASKS----FVAECKALRN 692
           D  + ++ + EG  G ++ G L +   G E  V V  +K   AS+      + E   L  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYG 64

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC--SLSVIQRL 750
           + H+N++ I+ VC     +  +   ++Y +M  G+L+ +L            +LS  Q +
Sbjct: 65  LSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK--FLSNHNPDTI 808
           ++AI +A  + YLH      ++H D+   N ++D++L   ++D  L++  F  +++    
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            E R +         ++A E  + +E S   DV+SFG+LL EL T
Sbjct: 178 NENRPVK--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 647 IGEG--GSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHRNLIKI 701
           +GEG  G   +Y      +GT   V V  LK++   +    +  E   L+ + H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
              CS +  KG     ++ E++  GSL ++L           L++ Q L  A  +   + 
Sbjct: 72  KGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMA 121

Query: 762 YLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           YLH  HY     +H DL   NVLLD D +  + DFGLAK      P+     R    G  
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAK----AVPEGHEYYRVREDG-D 171

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             V + A E     + S   DV+SFG+ L EL T 
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 33/224 (14%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRN 697
            F   N+IGEG  GIVY+     +G  VA+K + +  +  G   S + E   L N+RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQN--GSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++++  V  G+     D   +V E+ +    SL +     N        S  Q   + + 
Sbjct: 68  IVELKEVVVGKH---LDSIFLVMEYCEQDLASLLD-----NMP---TPFSESQVKCLMLQ 116

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD---TIVETR 812
           +   ++YLH      I+H DLK SN+LL       ++DFGLA+            +V   
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--- 170

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
                   T+ Y APE  +G        D+++ G +L EL   K
Sbjct: 171 --------TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINL-----KQKGASKSFVAECKALRNIRHRNLIKI 701
           +G G  G VY+G   ++G   AVK ++L       + A K    E   L  ++H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 702 I-TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           + T          D   I  E +  GSL + L       E     VI+       +   +
Sbjct: 68  LGTEREE------DNLYIFLELVPGGSLAKLLKKYGSFPE----PVIR--LYTRQILLGL 115

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYLH   + + VH D+K +N+L+D + V  ++DFG+AK +           +S     KG
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-----EFSFAKS----FKG 163

Query: 821 TVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
           +  ++APE    +    +  D++S G  +LE+ T K P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 35/226 (15%)

Query: 647 IGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS---FVAECKALRNI-RHRN 697
           +GEG  G V K            + VAVK+  LK     K     V+E + ++ I +H+N
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV----IQRL--- 750
           +I ++ VC+    +G  +  +V E+  +G+L ++L       E  S        + L   
Sbjct: 78  IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 751 ---NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
              + A  VA  +E+L        +H DL   NVL+ +D V  ++DFGLA+ +  H+ D 
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHIDY 187

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +T +  + +K    ++APE    R  + + DV+SFG+LL E+FT
Sbjct: 188 YRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 32/233 (13%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRN 692
            +  D F    +IGEG  G VYK    + G  VA+K + L  +++G   + + E K LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 693 IRHRNLIKIITVCSGRDFKGADFKA------IVYEFMQN---GSLEEWLHHSNDQLEVCS 743
           + HRN++ +  + + +     DFK       +V+E+M +   G LE  L H ++   + S
Sbjct: 63  LNHRNIVNLKEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-HIKS 120

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
             + Q L         + Y H   + + +H D+K SN+LL+      ++DFGLA+ L N 
Sbjct: 121 F-MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNS 168

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
                   + I      T+ Y  PE  +G E      DV+S G +L ELFT+K
Sbjct: 169 EESRPYTNKVI------TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 30/203 (14%)

Query: 665 TEVAVKVINLKQKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY 720
           T+VAVK+  LK     K     ++E + ++ I +H+N+I ++  C+    +      IV 
Sbjct: 51  TKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV- 103

Query: 721 EFMQNGSLEEWLH----------HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS 770
           E+   G+L E+L           ++  Q+    LS    ++ A  VA  +EYL       
Sbjct: 104 EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKK 160

Query: 771 IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYG 830
            +H DL   NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE  
Sbjct: 161 CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEAL 214

Query: 831 MGREASMKGDVYSFGILLLELFT 853
             R  + + DV+SFG+LL E+FT
Sbjct: 215 FDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 38/237 (16%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINL----------KQKGASKSFVAECKALRNIRHR 696
           IG+G  G VY       G  +AVK + L          +QK   K+  +E + L+++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N    I    G +    ++ +I  E++  GS+   L       E       ++      V
Sbjct: 69  N----IVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------V 117

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + YLH      I+H DLK  N+L+D D +  +SDFG++K   +      +     ++
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDD------IYDNDQNM 168

Query: 817 GIKGTVGYVAPE--YGMGREASMKGDVYSFGILLLELFTRKRP------TDAMFNEG 865
            ++G+V ++APE  +   +  S K D++S G ++LE+F  +RP        AMF  G
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 20/215 (9%)

Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG+G  G VY G L ++       AVK +N +      + F+ E   +++  H N++ ++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C   +  G+    +V  +M++G L  ++        V  L     +   + VA  +EY
Sbjct: 63  GICLPSE--GSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEY 113

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +    ++        G K  V
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT----GAKLPV 166

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.3 bits (187), Expect = 5e-15
 Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 41/238 (17%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALR 691
           N     ++GEG  G   K FL E        +   VAVK +      A K F  E + L 
Sbjct: 6   NIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT 62

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQLEVC------SL 744
           N++H +++K   VC        D   +V+E+M++G L ++L  H  D + +        L
Sbjct: 63  NLQHEHIVKFYGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117

Query: 745 SVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
           +  Q L+IA  +A+ + YL   H+     VH DL   N L+ ++L+  + DFG+++    
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHF-----VHRDLATRNCLVGENLLVKIGDFGMSR---- 168

Query: 803 HNPDTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
                +  T    +G      + ++ PE  M R+ + + DV+S G++L E+FT  K+P
Sbjct: 169 ----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 26/220 (11%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHRN 697
           NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 698 LIKIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++K++ V         + K  +V+EF+ +  L++++  S   L    L +I+  +    +
Sbjct: 61  IVKLLDVIH------TENKLYLVFEFL-HQDLKKFMDAS--PLSGIPLPLIK--SYLFQL 109

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 110 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 159

Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 160 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 17/210 (8%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           I +G  G V+       G   A+KVI    + +K      + E   L   +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
             S   F+G     +V E++  G L   L +        SL          ++  A+EYL
Sbjct: 59  YYS---FQGKKNLYLVMEYLPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYL 109

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H      I+H DLKP N+L+D +    ++DFGL+K         + +       I GT  
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFT 853
           Y+APE  +G+  S   D +S G +L E   
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 24/213 (11%)

Query: 646 KIGEGGSGIVYKG-FLGENGT--EVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKI 701
           K+G+G  G+V +G +    G    VAVK + + K       F+ E   + ++ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             V             +V E    GSL + L    D L    +S +   + A+ +A+ + 
Sbjct: 62  YGVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTL--CDYAVQIANGMR 111

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS-NHNPDTIVETRSISIGIKG 820
           YL        +H DL   N+LL  D    + DFGL + L  N +   + E   +      
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF---- 164

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
              + APE    R  S   DV+ FG+ L E+FT
Sbjct: 165 --AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 23/217 (10%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           ++   KIG+G SG VY       G EVA+K +NL+Q+   +  + E   +R  +H N++ 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            +       +   D   +V E++  GSL        D +    +   Q   +  +   A+
Sbjct: 81  YLD-----SYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQAL 128

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+     RS  +   G
Sbjct: 129 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSTMV---G 177

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 78.3 bits (193), Expect = 1e-14
 Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 36/235 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKII 702
            IG+GG G VY  +       VA+K I     +     K F+ E K   ++ H  ++ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 703 TVCSGRD--------FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           ++CS  D         +G   K+++    Q  SL + L            SV   L+I  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT--------SVGAFLSIFH 120

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKF----------LSN 802
            + + IEY+H      ++H DLKP N+LL   L   V   D+G A F          +  
Sbjct: 121 KICATIEYVH---SKGVLHRDLKPDNILLG--LFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              +    + +I   I GT  Y+APE  +G  AS   D+Y+ G++L ++ T   P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 46/217 (21%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVK------VINLKQKGASKSFVAECKALRNIRHRNLIK 700
           +G G  G V       +G   A+K      ++ LKQ    +  + E + L++IRH  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI------AI 754
           +        F+      +V E++  G   E   H         L    R         A 
Sbjct: 66  LYGS-----FQDDSNLYLVMEYVPGG---ELFSH---------LRKSGRFPEPVARFYAA 108

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            V  A+EYLH      IV+ DLKP N+LLD D    ++DFG AK +          T ++
Sbjct: 109 QVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYTL 158

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                GT  Y+APE  + +      D ++ GIL+ E+
Sbjct: 159 C----GTPEYLAPEIILSKGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+GG G V    +   G   A K ++   LK++   +  + E K L  +  R       
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V     F+  D   +V   M  G L+  +++  +          + +  A  +   +E+L
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHL 111

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H   +  IV+ DLKP NVLLD      +SD GLA  L                G  GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---------GRAGTPG 159

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           Y+APE   G       D ++ G  L E+   + P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 29/238 (12%)

Query: 627 LVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAE 686
           LV S  +  +  D+F    KIGEG +GIV        G +VAVK ++L+++   +    E
Sbjct: 13  LVVSPGDPREYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNE 69

Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +R+  H N++ +        +   D   +V EF++ G+L + + H+    E      
Sbjct: 70  VVIMRDYHHENVVDMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE------ 118

Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            Q   + + V  A+ YLH+     ++H D+K  ++LL  D    +SDFG    +S   P 
Sbjct: 119 -QIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174

Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
                      + GT  ++APE         + D++S GI+++E+   + P    FNE
Sbjct: 175 --------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 58/232 (25%), Positives = 111/232 (47%), Gaps = 37/232 (15%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
              +  KIGEG +GIV        G +VAVK ++L+++   +    E   +R+ +H N++
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN---DQLEVCSLSVIQRLNIAIDV 756
           ++ +      +   D   +V EF++ G+L + + H+    +Q+    L+V++        
Sbjct: 80  EMYS-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLK-------- 126

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+ +LH      ++H D+K  ++LL  D    +SDFG    +S   P      +S+  
Sbjct: 127 --ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----RRKSLV- 176

Query: 817 GIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLEL------FTRKRPTDAM 861
              GT  ++APE  + R     + D++S GI+++E+      +  + P  AM
Sbjct: 177 ---GTPYWMAPEV-ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 30/203 (14%)

Query: 665 TEVAVKVINLKQKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY 720
             VAVK+  LK     K     V+E + ++ I +H+N+I ++  C+    +      +V 
Sbjct: 45  VTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV- 97

Query: 721 EFMQNGSLEEWLHHS-----NDQLEVC-----SLSVIQRLNIAIDVASAIEYLHHYCEPS 770
           E+   G+L E+L        +   + C      L+    ++ A  VA  +EYL       
Sbjct: 98  EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQK 154

Query: 771 IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYG 830
            +H DL   NVL+ +D V  ++DFGLA+ +  HN D   +T +  + +K    ++APE  
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLARDV--HNIDYYKKTTNGRLPVK----WMAPEAL 208

Query: 831 MGREASMKGDVYSFGILLLELFT 853
             R  + + DV+SFG+LL E+FT
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 68/234 (29%), Positives = 102/234 (43%), Gaps = 37/234 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G+G  GIVY          +A+K I  +     +    E      ++HRN+++ +   S
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
              F    FK I  E +  GSL   L      L+    ++I        +   ++YLH  
Sbjct: 76  ENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QILEGLKYLH-- 125

Query: 767 CEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
            +  IVH D+K  NVL++    V  +SDFG +K L+  NP T  ET        GT+ Y+
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT--ET------FTGTLQYM 176

Query: 826 APEY------GMGREASMKGDVYSFGILLLELFTRK-------RPTDAMFNEGL 866
           APE       G G  A    D++S G  ++E+ T K        P  AMF  G+
Sbjct: 177 APEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 43/227 (18%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS---KSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V +  + ++G ++   +  LK+  +    + F  E + L  +  H N+I ++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS----------NDQLEVCSLSVIQRLNI 752
             C  R +       I  E+   G+L ++L  S           +     +L+  Q L  
Sbjct: 70  GACENRGYL-----YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A DVA+ ++YL    E   +H DL   NVL+ ++L S ++DFGL              +R
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL--------------SR 167

Query: 813 SISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
              + +K T+G + P   M  E+      + K DV+SFG+LL E+ +
Sbjct: 168 GEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 56/217 (25%), Positives = 110/217 (50%), Gaps = 21/217 (9%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKII 702
            KIG+G  G V+K    +    VA+K + ++   +G   + + E K L+ ++H N++ +I
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 703 TVCSGRDFKGADFKA---IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +C  +      +K    +V+EF ++  L   L + N +    +LS I++  +   + + 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF---TLSEIKK--VMKMLLNG 131

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHNPDTIVETRSISIGI 818
           + Y+H      I+H D+K +N+L+ +D +  ++DFGLA+ F  + N      T  +    
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV--- 185

Query: 819 KGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
             T+ Y  PE  +G R+     D++  G ++ E++TR
Sbjct: 186 --TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.0 bits (187), Expect = 4e-14
 Identities = 39/110 (35%), Positives = 60/110 (54%), Gaps = 4/110 (3%)

Query: 6   WTGVTCG----QRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG 61
           W+G  C     +    +  L L NQ +RG +   +  L  L+ IN++ N   G IP  +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 62  RLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSL 111
            + SLE L LS NSF+G+IP +L   ++L  L+ + N+L G +PA +G  
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 29/222 (13%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+G G  G V+     ++ T+VAVK +         +F+AE   ++ ++H  L+K+  V 
Sbjct: 13  KLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV 70

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
           +           I+ EFM  GSL ++L       E     + + ++ +  +A  + ++  
Sbjct: 71  TKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE- 119

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
             + + +H DL+ +N+L+   LV  ++DFGLA+ + + N  T  E      G K  + + 
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTARE------GAKFPIKWT 170

Query: 826 APE---YGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           APE   +G     ++K DV+SFGILL+E+ T  R P   M N
Sbjct: 171 APEAINFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 5e-14
 Identities = 36/80 (45%), Positives = 48/80 (60%)

Query: 325 GTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL 384
           G IP +I  L  L  + +  N + G IPP +G +T+L+ LDL  N   GSIP SLG LT 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 385 LTYLKLGLNNLEGNIPSSLG 404
           L  L L  N+L G +P++LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 62/229 (27%), Positives = 111/229 (48%), Gaps = 35/229 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           DNF    KIGEG +GIV    +  +G  VAVK ++L+++   +    E   +R+ +H N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEVCSLSVIQRLNIAID 755
           +++        +   D   +V EF++ G+L + + H+    +Q+    L+V++ L++   
Sbjct: 80  VEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV--- 131

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
                  LH      ++H D+K  ++LL  D    +SDFG    +S   P      R  S
Sbjct: 132 -------LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKS 175

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
             + GT  ++APE         + D++S GI+++E+   + P    FNE
Sbjct: 176 --LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 30/206 (14%)

Query: 662 ENGTEVAVKVINLKQKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKA 717
           +    VAVK+  LK     K     ++E + ++ I +H+N+I ++ VC+    +G  +  
Sbjct: 42  DQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ---EGPLY-- 94

Query: 718 IVYEFMQNGSLEEWLH--------HSNDQLEVCS--LSVIQRLNIAIDVASAIEYLHHYC 767
           ++ E+   G+L E+L         ++ D  +V    LS    ++ A  VA  +EYL    
Sbjct: 95  VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--- 151

Query: 768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAP 827
               +H DL   NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++AP
Sbjct: 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGV--HDIDYYKKTSNGRLPVK----WMAP 205

Query: 828 EYGMGREASMKGDVYSFGILLLELFT 853
           E    R  + + DV+SFGIL+ E+FT
Sbjct: 206 EALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 37/85 (43%), Positives = 54/85 (63%)

Query: 340 LTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI 399
           L +D   L G IP +I +L +LQ ++L  N ++G+IP SLG++T L  L L  N+  G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 400 PSSLGNCTNLLGLNISHNKLIGTLP 424
           P SLG  T+L  LN++ N L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 18/195 (9%)

Query: 661 GEN-GTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           G+N G +VAVK +  +  G        E + LRN+ H N++K   +C+  +  G   K I
Sbjct: 29  GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIKLI 86

Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           + EF+ +GSL+E+L  + +++     ++ Q+L  A+ +   ++YL        VH DL  
Sbjct: 87  M-EFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKGMDYLG---SRQYVHRDLAA 137

Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            NVL++ +    + DFGL K +     +T  E  ++   +   V + APE  +  +  + 
Sbjct: 138 RNVLVESEHQVKIGDFGLTKAI-----ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA 192

Query: 839 GDVYSFGILLLELFT 853
            DV+SFG+ L EL T
Sbjct: 193 SDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 57/227 (25%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAEC------KALRNI-RHRNL 698
           ++G+G  G VY     E G  VA+K   +K+K  S     EC      K+LR +  H N+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWE---ECMNLREVKSLRKLNEHPNI 60

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K+  V     F+  D    V+E+M+    +             S SVI+  +I   +  
Sbjct: 61  VKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPF---SESVIR--SIIYQILQ 110

Query: 759 AIEYLHHYCEPSIVHG----DLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT-IVETRS 813
            + ++H        HG    DLKP N+L+    V  ++DFGLA+ + +  P T  V TR 
Sbjct: 111 GLAHIHK-------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR- 162

Query: 814 ISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFT 853
                     Y APE       Y      S   D+++ G ++ EL+T
Sbjct: 163 ---------WYRAPEILLRSTSY------SSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNIRHRNLIKIIT 703
            +GEG  G+V K    E G  VA+K    +   K   K  + E + L+ +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V     F+      +V+EF+ +  L++ L    + L+    S +++      +   IE+ 
Sbjct: 68  V-----FRRKKRLYLVFEFVDHTVLDD-LEKYPNGLD---ESRVRK--YLFQILRGIEFC 116

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI--VETRSISIGIKGT 821
           H +   +I+H D+KP N+L+ Q  V  + DFG A+ L+         V TR         
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR--------- 164

Query: 822 VGYVAPEYGMGREASMKG-DVYSFGILLLELFT 853
             Y APE  +G     +  D+++ G L+ E+ T
Sbjct: 165 -WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVK---VINLKQKGASKSFVAECKALRNIRHR 696
           NF    KIG G    VY+     +G  VA+K   + +L    A    + E   L+ + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+IK         F   +   IV E    G L   + H   Q  +     + +    + +
Sbjct: 63  NVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQL 115

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+E++H      ++H D+KP+NV +    V  + D GL +F S+          + + 
Sbjct: 116 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------TAAH 164

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            + GT  Y++PE       + K D++S G LL E+   + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 25/221 (11%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIRHRNLIKI 701
             IG+G  G V K     +G  +  K I   N+ +K   +  V+E   LR ++H N+++ 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNIVRY 64

Query: 702 ITVCSGRDF-KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
                 R   +      IV E+ + G L + +     + +      I    I   +  A+
Sbjct: 65  Y----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI--WRILTQLLLAL 118

Query: 761 EYLHH--YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD--TIVETRSISI 816
              H+      +++H DLKP+N+ LD +    + DFGLAK L + +    T V       
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV------- 171

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y++PE         K D++S G L+ EL     P
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 26/221 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEV----AVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKI 701
           +G G  G VYKG     G  V    A+K++N      A+  F+ E   + ++ H +L+++
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + VC     +      +V + M +G L +++H   D +    L     LN  + +A  + 
Sbjct: 75  LGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMM 123

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH DL   NVL+       ++DFGLA+ L         E    + G K  
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEYNADGGKMP 174

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
           + ++A E    R+ + + DV+S+G+ + EL T   +P D +
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 24/224 (10%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F    K+G+G  G VYK     +    A+K ++L    QK    + V E + L ++ H 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-VNEIRILASVNHP 59

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I          F   +   IV E+   G L + +     + ++     I R  I I +
Sbjct: 60  NII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQL 112

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              ++ LH   E  I+H DLK +N+LL  + +  + D G++K L  +   T +       
Sbjct: 113 LRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI------- 162

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              GT  Y+APE   GR  S K D++S G LL E+ T   P +A
Sbjct: 163 ---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 46/222 (20%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS------KSFVAECKALRNIRHRNLI 699
            +GEG  G+V K      G  VA+K    K K +       K+ + E K LR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 700 KIITVC--SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL--EVCSLSVIQRLNIAID 755
            +       GR +       +V+E+++   LE  L  S   L  +     + Q L     
Sbjct: 64  NLKEAFRRKGRLY-------LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ---- 111

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL---SNHNPDTIVETR 812
              AI Y H +   +I+H D+KP N+L+ +  V  + DFG A+ L           V TR
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFT 853
                      Y APE  +G     K  DV++ G ++ EL  
Sbjct: 166 ----------WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 33/225 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           D +   N+I EG  G+VY+    + G  VA+K + ++++  G   + + E   L  ++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           N++ +  V  G      D   +V E++++   SL E +     Q EV  L ++Q L    
Sbjct: 65  NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQLL---- 116

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDT--IVET 811
              S + +LH      I+H DLK SN+LL+   +  + DFGLA ++ S   P T  +V  
Sbjct: 117 ---SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-- 168

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                    T+ Y APE  +G +E S   D++S G +  EL T+K
Sbjct: 169 ---------TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRNLIKIITVC 705
           +G G  G V K      GT +A KV+++  K +  K  + E + +   R       I   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS----PYIVSF 68

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSND-QLEVCSLSVIQRLNIAIDVASAIEYLH 764
            G  F   +   +  EFM  GSL+          +E+          IA+ V   + YL 
Sbjct: 69  YGA-FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGLTYL- 119

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
            Y    I+H D+KPSN+L++      + DFG++  L N   DT V          GT  Y
Sbjct: 120 -YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----------GTSTY 168

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           ++PE   G + ++K DV+S GI ++EL   K P   
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 3e-13
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 23/217 (10%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            +       +   D   +V E++  GSL + +       E C +   Q   +  +   A+
Sbjct: 82  YLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQAL 129

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+    +  +     G
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMV-----G 178

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 37/225 (16%)

Query: 647 IGEGGSGIVYKGFL------GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHR 696
           +G G  G VY+G        G     VAVK +   +KGA+    K F+ E   + N  H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAID 755
           N++K++ VC   + +      I+ E M+ G L  +L  +  +      L++ + L+I +D
Sbjct: 60  NIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 756 VASAIEYLH--HYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNPDTI 808
           VA    YL   H+     +H DL   N L+     D D V  + DFGLA+ +   +    
Sbjct: 115 VAKGCVYLEQMHF-----IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                +       V ++APE  +  + + + DV+SFG+L+ E+ T
Sbjct: 170 EGEGLLP------VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 26/217 (11%)

Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGA---SKSFVAECKALRNIRHRNLIKI 701
            IGEG  G VY+G ++     ++AV V   K   +    + F+ E   +R   H +++K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I V +       +   IV E    G L  +L  +   L++ SL     +  +  +++A+ 
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASL-----ILYSYQLSTALA 121

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        VH D+   NVL+       + DFGL+++L + +     + +   + IK  
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK---LPIK-- 173

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
             ++APE    R  +   DV+ FG+ + E+     +P
Sbjct: 174 --WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 23/217 (10%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           ++   KIG+G SG VY       G EVA+K +NL+Q+   +  + E   +R  ++ N++ 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            +       +   D   +V E++  GSL + +       E C +   Q   +  +   A+
Sbjct: 81  YLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQAL 128

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           ++LH      ++H D+K  N+LL  D    ++DFG   F +   P+     RS  +   G
Sbjct: 129 DFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSTMV---G 177

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 56/258 (21%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---------SFVAECKALR 691
           F+    IG+G  G VYK         VA+KVI+L++  A            F+++C+   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR--- 57

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
                     IT   G   KG+    I+ E+   GS  + L           ++ I R  
Sbjct: 58  -------SPYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLLKPGKLDETY--IAFILR-- 105

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH--NPDTIV 809
              +V   +EYLH   E   +H D+K +N+LL ++    ++DFG++  L++     +T V
Sbjct: 106 ---EVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK------RPTDAMFN 863
                     GT  ++APE         K D++S GI  +EL   +       P   +F 
Sbjct: 160 ----------GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209

Query: 864 ------EGLTLHDFSREF 875
                   L  + FS+ F
Sbjct: 210 IPKNNPPSLEGNKFSKPF 227

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 32/224 (14%)

Query: 647 IGEGGSGIVYKGFLGENG-TEVAVKVINLK-------QKGASKSF---VAECKALR-NIR 694
           +G G  G VYK     NG   +A+K IN+        ++   KS    V+E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL-NIA 753
           H N+++       + F   D   IV + ++   L E   H N   E       +R+ NI 
Sbjct: 68  HPNIVRYY-----KTFLENDRLYIVMDLIEGAPLGE---HFNSLKEKKQRFTEERIWNIF 119

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           + +  A+ YLH   E  IVH DL P+N++L +D    ++DFGLAK      P++ + +  
Sbjct: 120 VQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTS-- 172

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               + GT+ Y  PE         K DV++FG +L ++ T + P
Sbjct: 173 ----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 57/263 (21%)

Query: 646 KIGEGGSGIVY-------KGFLGENGTE-------VAVKVINLK-QKGASKSFVAECKAL 690
           K+GEG  G V+         FLGE   E       VAVK++     K A   F+ E K +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH---------HSNDQLEV 741
             +++ N+I+++ VC   D    D   ++ E+M+NG L ++L          H+N+   +
Sbjct: 72  SRLKNPNIIRLLGVCV-SD----DPLCMITEYMENGDLNQFLSQREIESTFTHANN---I 123

Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
            S+S+   L +A+ +AS ++YL      + VH DL   N L+       ++DFG+++ L 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG------DVYSFGILLLELFT-- 853
           + +             I+G    V P   M  E+ + G      DV++FG+ L E+FT  
Sbjct: 181 SGD----------YYRIQGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228

Query: 854 RKRPTDAMFNEGLTLHDFSREFF 876
           +++P   + +E +   + + EFF
Sbjct: 229 KEQPYSLLSDEQVI--ENTGEFF 249

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTE----VAVKVINLKQKGASKSFVA---ECKALRNIRHRNLI 699
           +G G  G V+KG     G      VA+K I  + +   ++F        A+ ++ H  ++
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +++ +C G   +      +V +    GSL + +    D     SL   + LN  + +A  
Sbjct: 73  RLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKG 121

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YL  +    +VH +L   N+LL  D +  ++DFG+A  L    PD   + +      K
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY---PD---DKKYFYSEHK 172

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             + ++A E  +    + + DV+S+G+ + E+ +
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 15/220 (6%)

Query: 641 FSSANKIGEGGSGIVYKGFLG-ENGT--EVAVKVINLKQKGAS--KSFVAECKALRNIRH 695
           F+    +G+G  G V +  L  E+G+  +VAVK++      +S  + F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 696 RNLIKIITVCSGRDFKGA-DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
            N+IK+I V      KG      ++  FM++G L  +L  S    E  +L +   +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           D+AS +EYL      + +H DL   N +L++++   V+DFGL+K +  ++ D   +  + 
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDYYRQGCAS 175

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
            + +K    ++A E       +   DV++FG+ + E+ TR
Sbjct: 176 KLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 28/229 (12%)

Query: 637 ATDNFSSANKIGEGGSGIVYKG-FLGENG--TEVAVKVINLKQ--KGASKS-FVAECKAL 690
             D+ +    +G G  G VY+G + G +G   E+ V V  L +      +S F+ E   +
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS-NDQLEVCSLSVIQR 749
               H+N++++I V   R  +      I+ E M  G L+ +L  +        SL++   
Sbjct: 64  SKFNHQNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAKFLSNHNPD 806
           L  A DVA   +YL    E   +H D+   N LL       V+ ++DFG+A+        
Sbjct: 119 LFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-------- 167

Query: 807 TIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            I        G +    + ++ PE  +    + K DV+SFG+LL E+F+
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 53/234 (22%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRN 697
           +++   KIGEG  G+VYKG   + G  VA+K I L+  ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 698 LIKIITVC--SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++ +  V     R +       +++EF+    L+++L    D L              +D
Sbjct: 61  IVCLQDVLMQESRLY-------LIFEFLSM-DLKKYL----DSL---------PKGQYMD 99

Query: 756 VASAIEYLHH------YCEP-SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                 YL+       +C    ++H DLKP N+L+D   V  ++DFGLA           
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA----------- 148

Query: 809 VETRSISIGIKG------TVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRK 855
              R+  I ++       T+ Y APE  +G    S   D++S G +  E+ T+K
Sbjct: 149 ---RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 55/215 (25%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           KIGEG +GIV       +G +VAVK+++L+++   +    E   +R+ +H+N++++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY--- 84

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHH---SNDQLEVCSLSVIQRLNIAIDVASAIEY 762
             + +   +   ++ EF+Q G+L + +     + +Q+     SV+Q          A+ Y
Sbjct: 85  --KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQ----------ALCY 132

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH      ++H D+K  ++LL  D    +SDFG    +S   P    + +S+     GT 
Sbjct: 133 LH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----KRKSLV----GTP 181

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++APE         + D++S GI+++E+   + P
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 36/219 (16%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G GG G V    +       A+K +  +   + G  +   +E + L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHH----SNDQLEVCSLSVIQRLNIAIDVASA 759
               R FK   +  ++ E+   G L   L                 V+           A
Sbjct: 60  ----RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV----------LA 105

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD-TIVETRSISIGI 818
            EYLH+     I++ DLKP N+LLD +    + DFG AK L +     T           
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--------- 153

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            GT  YVAPE  + +      D +S GILL EL T + P
Sbjct: 154 -GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 37/236 (15%)

Query: 639 DNFSSANKIGEGGSG-IVYKGFLG------ENGTEVAVKVINLKQKGASKSF---VAECK 688
           D  +    +GEG  G +V    LG      +    VAVK+  LK     K     V+E +
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEME 72

Query: 689 ALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSNDQL 739
            ++ I +H+N+I ++  C+    +      IV E+   G+L E+L         +S D  
Sbjct: 73  MMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIA 127

Query: 740 EVCS--LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
            V    ++    ++    VA  +EYL        +H DL   NVL+ ++ V  ++DFGLA
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184

Query: 798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +  +N D   +T +  + +K    ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 185 RDV--NNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 43/227 (18%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS---KSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V K  + ++G  +   +  +K+  +    + F  E + L  +  H N+I ++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN----------DQLEVCSLSVIQRLNI 752
             C  R +       +  E+  +G+L ++L  S                 +LS  Q L+ 
Sbjct: 63  GACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A DVA  ++YL    +   +H DL   N+L+ ++ V+ ++DFGL              +R
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL--------------SR 160

Query: 813 SISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
              + +K T+G + P   M  E+      +   DV+S+G+LL E+ +
Sbjct: 161 GQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 22/213 (10%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-ECKALRNIRHRNLIKIITVC 705
           IG G  G VY+G     G  VA+K+INL       S +  E   L  +R       IT  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ-PPNITKY 67

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
            G   KG     I+ E+ + GS+   +      +    +SVI R     +V  A++Y+H 
Sbjct: 68  YGSYLKGPRL-WIIMEYAEGGSVRTLMKAG--PIAEKYISVIIR-----EVLVALKYIHK 119

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
                ++H D+K +N+L+       + DFG+A  L         +  S      GT  ++
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL--------NQNSSKRSTFVGTPYWM 168

Query: 826 APEYGM-GREASMKGDVYSFGILLLELFTRKRP 857
           APE    G+    K D++S GI + E+ T   P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)

Query: 647 IGEGGSGIVYKGFL----GENG-TEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
           +GEG  G V K       G  G T VAVK++   ++ AS S     ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN------------------DQL 739
           +IK+   CS     G     ++ E+ + GSL  +L  S                   D  
Sbjct: 65  VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           +  +L++   ++ A  ++  ++YL    E  +VH DL   NVL+ +     +SDFGL++ 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +  +  D+ V+     I +K    ++A E       + + DV+SFG+LL E+ T
Sbjct: 177 V--YEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 34/222 (15%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGASKSFVAECKALRNIRHRNL 698
           NF    K+GEG    VYKG     G  VA+K I+L  ++G   + + E   ++ ++H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  V         +   +V+E+M    L++++     +    +L      +    +  
Sbjct: 61  VRLHDV-----IHTENKLMLVFEYMDK-DLKKYMDTHGVR---GALDPNTVKSFTYQLLK 111

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            I + H   E  ++H DLKP N+L+++     ++DFGLA              R+  I +
Sbjct: 112 GIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLA--------------RAFGIPV 154

Query: 819 KG------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
                   T+ Y AP+  +G R  S   D++S G ++ E+ T
Sbjct: 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.4 bits (175), Expect = 1e-12
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 25/115 (21%)

Query: 364 LDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
           L LD   L+G IP+ +  L  L  + L  N++ GNIP SLG+ T+L  L++S+N      
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS----- 477

Query: 424 PRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
                                NGS+P  +G L +L  L+L+GN  SG +PA L  
Sbjct: 478 --------------------FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512

Length = 623

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 1e-12
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 23/217 (10%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           ++   KIG+G SG V+       G EVA+K INL+++   +  + E   ++ +++ N++ 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            +       F   D   +V E++  GSL + +       E C +   Q   +  +   A+
Sbjct: 81  FLD-----SFLVGDELFVVMEYLAGGSLTDVV------TETC-MDEAQIAAVCRECLQAL 128

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           E+LH      ++H D+K  NVLL  D    ++DFG   F +   P+     RS  +   G
Sbjct: 129 EFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFG---FCAQITPEQ--SKRSTMV---G 177

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 60/241 (24%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---------ECKA 689
             +     IG G  G+V       +G +VA+K I         +F           E K 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKI 57

Query: 690 LRNIRHRNLIKIITVCSGRDF---KGADFKAI--VYEFMQNGSLEEWLH---HSNDQLE- 740
           LR+ +H N+I I      RD     GADFK +  V + M++      LH   HS+  L  
Sbjct: 58  LRHFKHDNIIAI------RDILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTE 106

Query: 741 --VCS-LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
             +   L  + R          ++Y+H      ++H DLKPSN+L+++D    + DFG+A
Sbjct: 107 EHIRYFLYQLLR---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154

Query: 798 KFLSNHNPD-TIVETRSISIGIKGTVGYVAPE--YGMGREASMKGDVYSFGILLLELFTR 854
           + LS+   +     T  ++     T  Y APE    +  E +   D++S G +  E+  R
Sbjct: 155 RGLSSSPTEHKYFMTEYVA-----TRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGR 208

Query: 855 K 855
           +
Sbjct: 209 R 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 646 KIGEGGSGIVYKGF--LGENGTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKII 702
           ++G G  G V KG   + +   +VA+KV+ N  +K      + E + +  + +  ++++I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            VC       A+   +V E    G L ++L    D++ V ++  +        V+  ++Y
Sbjct: 62  GVCE------AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-----QVSMGMKY 110

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L      + VH DL   NVLL     + +SDFGL+K L     D+  + RS     K  +
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD--DSYYKARS---AGKWPL 162

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + APE    R+ S + DV+S+GI + E F+
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 30/220 (13%)

Query: 647 IGEG--GSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--ECKALRNIRHRNLIKII 702
           +G+G  G   +Y+    E+ + V  K +NL +    +   A  E   L  ++H N+I   
Sbjct: 8   LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F   +   I  E+   G+L + +     QL          L     + SA+ Y
Sbjct: 66  N-----HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL----FEEEMVLWYLFQIVSAVSY 116

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVETRSISIGIKG 820
           +H   +  I+H D+K  N+ L +  +  + DFG++K L +     +T+V          G
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----------G 163

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           T  Y++PE   G + + K D+++ G +L EL T KR  DA
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 41/232 (17%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           F+   +IG G  G VY          VA+K ++   K +++ +   + E + L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI--- 754
            I         ++KG   +    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 77  TI---------EYKGCYLR----EHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICH 122

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH +     +H D+K  N+LL +     ++DFG A  +S  N  + V     
Sbjct: 123 GALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--SFV----- 172

Query: 815 SIGIKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRPTDAMFN 863
                GT  ++APE  +  +      K DV+S GI  +EL  RK P   +FN
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 21/221 (9%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVK---VINLKQKGASKSFVAECKALRNIRHR 696
           NF    KIG G    VY+     +   VA+K   +  +    A +  V E   L+ + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+IK +       F   +   IV E    G L + + +   Q  +     + +    + +
Sbjct: 63  NVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQL 115

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+E++H      ++H D+KP+NV +    V  + D GL +F S+          + + 
Sbjct: 116 CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------TAAH 164

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            + GT  Y++PE       + K D++S G LL E+   + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 17/195 (8%)

Query: 660 LGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           L +N G  VAVK +        + F  E + L++++H N++K   VC      G     +
Sbjct: 28  LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLRL 84

Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V E++  GSL ++L    ++L+   L     L  A  +   +EYL        VH DL  
Sbjct: 85  VMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYLG---SKRYVHRDLAT 136

Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            N+L++ +    + DFGL K L        V     S      + + APE     + S+ 
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-----PIFWYAPESLTESKFSVA 191

Query: 839 GDVYSFGILLLELFT 853
            DV+SFG++L ELFT
Sbjct: 192 SDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 55/229 (24%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           IG G  GIV      E   +VA+K I      +  +K  + E K LR++ H N+I I  +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 705 C---SGRDFKGADFKAIVYEFMQNGSLEEWLHH---SNDQL--EVCSLSVIQRLNIAIDV 756
                   F       IVYE M        LH    S+  L  + C   + Q L      
Sbjct: 73  MPPPHREAFNDV---YIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR----- 119

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE---TRS 813
              ++Y+H     +++H DLKPSN+LL+ +    + DFGLA+  ++   D + E   TR 
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTR- 172

Query: 814 ISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFTRK 855
                     Y APE       Y      ++  DV+S G +  EL  RK
Sbjct: 173 ---------WYRAPELLLNCSEYT----TAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-----KSFVAECKALRNIRHRNLIKI 701
           +G+G  G VY  +  + G E+AVK +              +   E + L+N++H  +++ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
              C   D       +I  E+M  GS+++ L          + +V ++    I     +E
Sbjct: 70  YG-CLRDDET----LSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQI--LEGVE 118

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH      IVH D+K +N+L D      + DFG +K L      TI  + +    + GT
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-----TICSSGTGMKSVTGT 170

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             +++PE   G     K DV+S G  ++E+ T K P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            +IG G  G VYK      G  VA+KVI L+     +    E   L+  RH N++     
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA---- 64

Query: 705 CSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
                + G+  +     IV E+   GSL++    +   L    ++ + R     +    +
Sbjct: 65  -----YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGL 114

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YLH       +H D+K +N+LL +D    ++DFG++  L+     TI + +S  I   G
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----TIAKRKSF-I---G 163

Query: 821 TVGYVAPEYGMGREAS---MKGDVYSFGILLLEL 851
           T  ++APE            K D+++ GI  +EL
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 20/229 (8%)

Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVK-VINLKQK-GASKSFVAECKALRNIR 694
              ++    K+GEG  G VYK    + G  VA+K ++   +K G   + + E K L+ ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVY--EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           H N++ +I +   R  K    +  VY      +  L   L + + +L        Q    
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES-----QIKCY 120

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL-----SNHNPDT 807
            + +   I YLH   E  I+H D+K +N+L+D   +  ++DFGLA+       +      
Sbjct: 121 MLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 808 IVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
               +  ++ +  T  Y  PE  +G R  +   D++  G +  E+FTR+
Sbjct: 178 GGTRKYTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 29/217 (13%)

Query: 654 IVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKA--LRNIRHRNLIKIIT 703
           +V KG  GE        +G +  +K +NL+     +   AE +A  L  ++H N++    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
              G D        IV  F + G L   L     +L    L   Q +   + +A A++YL
Sbjct: 67  SWEGED----GLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H   E  I+H DLK  NV L +  +  V D G+A+ L N           ++  + GT  
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--------DMASTLIGTPY 167

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           Y++PE    +  + K DV++ G  + E+ T K   +A
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G+G  G VYK    E G   A KVI+ K +   + ++ E   L +  H N++K++   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA- 70

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
               F   +   I+ EF   G+++  +      L    + V+ +  +      A+ YLH 
Sbjct: 71  ----FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLH- 120

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
             E  I+H DLK  N+L   D    ++DFG    +S  N  TI    S      GT  ++
Sbjct: 121 --ENKIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFI----GTPYWM 170

Query: 826 APEYGM-----GREASMKGDVYSFGILLLEL 851
           APE  M      R    K DV+S GI L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIR---HRNLIK 700
           +IG G  G VYK     +G  VA+K + ++  + G   S V E   L+ +    H N+++
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           ++ VC+           +V+E +    L  +L    D++    L      ++       +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           ++LH  C   IVH DLKP N+L+       ++DFGLA+  S     T V           
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--------- 169

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 6e-12
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
             + + + IGEG  G+V        G +VA+K I+    Q    ++ + E K LR  +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 697 NLIKIITVCSGRDFKGADFKA--IVYEFMQNGSLEEWLHH-------SNDQLEVCSLSVI 747
           N+I I+ +     F    F    IV E M     E  L+        SND        + 
Sbjct: 64  NIIGILDIIRPPSF--ESFNDVYIVQELM-----ETDLYKLIKTQHLSNDH---IQYFLY 113

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
           Q L         ++Y+H     +++H DLKPSN+LL+ +    + DFGLA+     +  T
Sbjct: 114 QILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163

Query: 808 IVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              T  ++     T  Y APE  +  +  +   D++S G +L E+ + +
Sbjct: 164 GFLTEYVA-----TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 36/222 (16%)

Query: 647 IGEGGSGIVYKGFLGENGTE-----VAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIK 700
           +G G  G V+         E     V VK +   K +     F  E    R + H+N+++
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS---LSVIQRLNIAIDVA 757
           ++ +C  R+   A+   ++ E+   G L+++L  +  + E      LS  Q++ +   +A
Sbjct: 73  LLGLC--RE---AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN----HNPDTIVET 811
             +++L    +     VH DL   N L+       VS   L+K + N       + ++  
Sbjct: 128 LGMDHLSNARF-----VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           R           ++APE     + S K DV+SFG+L+ E+FT
Sbjct: 183 R-----------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 34/230 (14%)

Query: 641 FSSAN-----KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIR 694
           F++ +     +IG G  G V K     +GT +AVK I         K  + +   +  +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 695 HRNLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
             +   I+       F GA F+     I  E M + SL+++  +  + L+      I   
Sbjct: 59  SSDCPYIVK------FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG- 110

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
            IA+    A+ YL    E  I+H D+KPSN+LLD++    + DFG    +S    D+I +
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG----ISGQLVDSIAK 164

Query: 811 TRSISIGIKGTVGYVAPEY--GMGREA-SMKGDVYSFGILLLELFTRKRP 857
           TR       G   Y+APE      R+   ++ DV+S GI L E+ T K P
Sbjct: 165 TRDA-----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 42/222 (18%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIIT 703
           KIGEG  G+VYK      G  VA+K I L+   +G   + + E   L+ + H N+++++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 704 VCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSL--SVIQRLNIAIDVASAI 760
           V        ++ K  +V+EF     L+  L    D   +  L   +I+     +     I
Sbjct: 66  VVH------SENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQL--LQGI 112

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            Y H +    ++H DLKP N+L+D++    ++DFGLA              R+  + ++ 
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA--------------RAFGVPVRT 155

Query: 821 ------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                 T+ Y APE  +G R+ S   D++S G +  E+  R+
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 37/210 (17%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVC 705
           +G G  G VYK +       +AVKVI L       K  ++E + L       +I      
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG----- 63

Query: 706 SGRDFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
               F GA F     +I  EFM  GSL        D        V+ R  IA+ V   + 
Sbjct: 64  ----FYGAFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGR--IAVAVVKGLT 109

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL       I+H D+KPSN+L++      + DFG++  L N          SI+    GT
Sbjct: 110 YLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----------SIAKTYVGT 156

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             Y+APE   G +  +  DV+S GI  +EL
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 33/231 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRN 697
           D+     ++G G  G+V K      GT +AVK I         K  + +     +I  R+
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL----DISMRS 56

Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +    TV     F GA F+     I  E M   SL+++     D+       ++ +  IA
Sbjct: 57  VDCPYTV----TFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGK--IA 109

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           + +  A+EYLH   + S++H D+KPSNVL++++    + DFG    +S +  D++ +T  
Sbjct: 110 VSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKT-- 161

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-----DVYSFGILLLELFTRKRPTD 859
           I  G K    Y+APE  +  E + KG     DV+S GI ++EL T + P D
Sbjct: 162 IDAGCK---PYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 32/93 (34%), Positives = 53/93 (56%)

Query: 41  FLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNL 100
           F+  + + + G  G IP+ I +L  L+ + LS NS  G IP +L S ++L  L    N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 101 VGEIPADIGSLFKLERLSIFQNHITGQLPASIG 133
            G IP  +G L  L  L++  N ++G++PA++G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 2e-11
 Identities = 73/232 (31%), Positives = 109/232 (46%), Gaps = 55/232 (23%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVI-----NLKQKGASKSF--VAECKALRNIRHRN 697
            K+G+G  GIV+K         VA+K I     N     A ++F  +   + L +  H N
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGD--HPN 68

Query: 698 LIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++K++ V      K  + K I  V+E+M     E  LH           +VI R NI  D
Sbjct: 69  IVKLLNV-----IKAENDKDIYLVFEYM-----ETDLH-----------AVI-RANILED 106

Query: 756 V---------ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH--N 804
           V           A++Y+H     +++H DLKPSN+LL+ D    ++DFGLA+ LS    N
Sbjct: 107 VHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
           P+  V T  ++     T  Y APE  +G     KG D++S G +L E+   K
Sbjct: 164 PENPVLTDYVA-----TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 66/256 (25%), Positives = 101/256 (39%), Gaps = 55/256 (21%)

Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI 693
           L   T  F     IGEG  G VYK    + G  VA+K++++  +   +    E   LR  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 694 -RHRNLIKIITVCSGRDFKGADFKA----------IVYEFMQNGS---LEEWLHHSNDQL 739
             H N+           F GA  K           +V E    GS   L + L     +L
Sbjct: 60  SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110

Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLA 797
           +   ++ I R     +    + YLH   E  ++H D+K  N+LL ++  + V   DFG++
Sbjct: 111 KEEWIAYILR-----ETLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVKLVDFGVS 160

Query: 798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPE-----YGMGREASMKGDVYSFGILLLEL- 851
             L     D+ +  R+  I   GT  ++APE              + DV+S GI  +EL 
Sbjct: 161 AQL-----DSTLGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212

Query: 852 -----FTRKRPTDAMF 862
                     P  A+F
Sbjct: 213 DGKPPLCDMHPMRALF 228

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 26/211 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G+G  G VYK    E G   A KVI  K +   + ++ E + L    H  ++K++   
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA- 77

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
               F       I+ EF   G+++  +   +  L    + VI R      +  A++YLH 
Sbjct: 78  ----FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQYLH- 127

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
                I+H DLK  NVLL  D    ++DFG    +S  N  T+    S      GT  ++
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFI----GTPYWM 177

Query: 826 APEYGMGREAS-----MKGDVYSFGILLLEL 851
           APE  M           K D++S GI L+E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54

Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 55  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 109

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 110 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 166 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 25/220 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS---------KSFVAECKALRNIRHRN 697
           IG G  G VY G    +G  +AVK + L    AS          +   E   L+ ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +++ +          AD   I  E++  GS+   L    +       ++++  N    + 
Sbjct: 68  IVQYLGSSLD-----ADHLNIFLEYVPGGSVAALL----NNYGAFEETLVR--NFVRQIL 116

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + YLH+     I+H D+K +N+L+D      +SDFG++K L  ++     +T      
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANS--LSTKTNGARPS 171

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           ++G+V ++APE       + K D++S G L++E+ T K P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 42/230 (18%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVA--VKVINLKQKGASK---SFVAECKALRNIRHRNLIK 700
           ++GE   G +YKG L   G + A  V +  LK     +    F  E   +  + H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWL----HHSN-------DQLEVCSLSVIQR 749
           ++ V +           +++E++  G L E+L     HS+       D     SL     
Sbjct: 72  LLGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 750 LNIAIDVASAIEYL-HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN---- 804
           L+IAI +A+ +EYL  H+     VH DL   N+L+ + L   +SD GL++ + + +    
Sbjct: 127 LHIAIQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 805 -PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            P +++  R           ++ PE  M  + S   D++SFG++L E+F+
Sbjct: 183 QPKSLLPIR-----------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           +HH     ++H D+K +N+LL  + +  + DFG +K  +    D +  T        GT 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
            YVAPE    +  S K D++S G+LL EL T KRP D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 647 IGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRNLI 699
           +G G  G + +G L    +    VA+  +   + G S    + F+AE   L    H N++
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V +    +G     IV E+M NG+L+ +L     QL        Q + +   +AS 
Sbjct: 70  RLEGVIT----RGNTM-MIVTEYMSNGALDSFLRKHEGQL-----VAGQLMGMLPGLASG 119

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL    E   VH  L    VL++ DLV  +S F           +   E    ++  K
Sbjct: 120 MKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSGK 169

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             V + APE       S   DV+SFGI++ E+ +  +RP   M  +
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 36/226 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54

Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 55  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVS 109

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 110 IA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+EL   + P
Sbjct: 166 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 1/87 (1%)

Query: 411 GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG 470
           GL + +  L G +P  I ++  L   + L  N + G++PP +G++ +L  LDLS N F+G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 471 EIPATLSACANLEYLNISGNAFSGSIP 497
            IP +L    +L  LN++GN+ SG +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 26/229 (11%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            D +    ++G+G  G VYK    E G   A K+I ++ +   + F+ E   L   +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ +        +   +   I+ EF   G+L+  +      L    +  + R      + 
Sbjct: 64  IVGLYEA-----YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QML 113

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A+ +LH      ++H DLK  N+LL  D    ++DFG    +S  N  T+ + R   I 
Sbjct: 114 EALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFG----VSAKNKSTL-QKRDTFI- 164

Query: 818 IKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAM 861
             GT  ++APE              K D++S GI L+EL   + P   +
Sbjct: 165 --GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 36/226 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVK------VINLKQKGASKSFVAECKALRN 692
           D+      +G G  G V+      +    A+K      VI LKQ+    +   E + L+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKE 57

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           + H  +I++    +  D     F  ++ E++  G L  +L +S         S    L  
Sbjct: 58  VSHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFY 106

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++  A+EYLH      IV+ DLKP N+LLD++    ++DFG AK           + R
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK-----------KLR 152

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRP 857
             +  + GT  Y+APE  +  +   K  D ++ GIL+ E+     P
Sbjct: 153 DRTWTLCGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 646 KIGEGGSGIVYKG--FLGENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRNLI 699
           +IG G  G V  G    G    +V VK +   +  AS      F+ E +  R+++H NL+
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKEL---RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND-QLEVCSLSVIQRLNIAIDVAS 758
           + +  C+    +   +  +V EF   G L+ +L      +L     + +QR+  A ++A 
Sbjct: 59  QCLGQCT----EVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIAL 111

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + +LH     + +H DL   N LL  DL   + D+GL+   + +  D  V    + + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPL 166

Query: 819 KGTVGYVAPE-----YG--MGREASMKGDVYSFGILLLELF 852
           +    ++APE     +G  +  + + + +V+S G+ + ELF
Sbjct: 167 R----WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 21/214 (9%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+GG G V    +   G   A K +N   LK++   +  + E + L  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                 F+      +V   M  G L    H  N   E       +       + S +E+L
Sbjct: 61  A-----FQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H   +  I++ DLKP NVLLD D    +SD GLA  L         + +S + G  GT G
Sbjct: 114 H---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK--------DGQSKTKGYAGTPG 162

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           ++APE   G E     D ++ G+ L E+   + P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC- 705
           +G G +G+V+     +    VAVK I L    + K  + E K +R + H N++K+  V  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 706 -SGRDFKG-----ADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            SG D         +  +  IV E+M+   L   L       E   L + Q L       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNH 803
             ++Y+H     +++H DLKP+NV ++  DLV  + DFGLA+ +  H
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 5e-11
 Identities = 30/85 (35%), Positives = 51/85 (60%), Gaps = 1/85 (1%)

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
           G +P+ ++ L   ++ I +  N I G IPP + ++ SL  L +  N   G+IP  +G+LT
Sbjct: 432 GFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTL 384
           +L+ L+L+ N L G +P++LG   L
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 43/227 (18%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V K  + ++G  +   +  +K+   K   + F  E + L  +  H N+I ++
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN----------DQLEVCSLSVIQRLNI 752
             C  R   G  + AI  E+  +G+L ++L  S                 +LS  Q L+ 
Sbjct: 75  GACEHR---GYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A DVA  ++YL    +   +H DL   N+L+ ++ V+ ++DFGL              +R
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------------SR 172

Query: 813 SISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
              + +K T+G + P   M  E+      +   DV+S+G+LL E+ +
Sbjct: 173 GQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 6e-11
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKS----------FVA--ECKAL 690
             +GEG  G V K +    G  VA+K + + +     +K           F    E K +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
             I+H N++ ++ V     +   DF  +V + M    L++ +   + ++    L+  Q  
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVV---DRKIR---LTESQVK 122

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
            I + + + +  LH +     +H DL P+N+ ++   +  ++DFGLA+           +
Sbjct: 123 CILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGY---PPYSD 176

Query: 811 TRSISIGIKG---------TVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRK 855
           T S    ++          T+ Y APE  MG E      D++S G +  EL T K
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 647 IGEGGSGIVYKGFL---GEN-GTEVAVKVI--NLKQKGASKSFVAECKALRNIRHRNLIK 700
           +G G  G VYKG     GEN    VA+KV+  N   K A+K  + E   +  +    + +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVCR 73

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           ++ +C     +      +V + M  G L +++  + D++    L     LN  + +A  +
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGM 122

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YL    E  +VH DL   NVL+       ++DFGLA+ L       I ET   + G K 
Sbjct: 123 SYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD------IDETEYHADGGKV 173

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRH 695
           A  ++ +  K+GEG    VYKG    NG  VA+KVI++K ++G   + + E   L+ ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++ +  +   +     +    V+E+M    L +++      L   ++ +         
Sbjct: 63  ANIVLLHDIIHTK-----ETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQ 111

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   + Y+H      I+H DLKP N+L+       ++DFGLA+  +   P     +  + 
Sbjct: 112 LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVV- 165

Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
                T+ Y  P+  +G  + S   D++  G + +E+ 
Sbjct: 166 -----TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.2 bits (153), Expect = 9e-11
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 22/223 (9%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVA-EC--KALRNIR 694
           N+     +G+G  G VY  +  + G E+A K +    +    SK   A EC  + L+N++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  +++       RD +      I  E+M  GS+++ L       E    SV ++    I
Sbjct: 63  HERIVQYYGCL--RD-RAEKTLTIFMEYMPGGSVKDQLKAYGALTE----SVTRKYTRQI 115

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH      IVH D+K +N+L D      + DFG +K L      TI  + + 
Sbjct: 116 --LEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-----TICMSGTG 165

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              + GT  +++PE   G     K DV+S G  ++E+ T K P
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 8/203 (3%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNL-SFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSF 76
           +T LDL N +I   + P +G L S L+ ++++ N     +P  +  L +L+ L LS N  
Sbjct: 118 LTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDL 175

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS 136
           S  +P  LS+ SNL  L   S N + ++P +I  L  LE L +  N I  +L +S+ NL 
Sbjct: 176 S-DLPKLLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232

Query: 137 SLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFT 196
           +L  +++  N+L    +S+G L +L  L ++ NQ       S+ ++++L  + LS N  +
Sbjct: 233 NLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLS 290

Query: 197 GSLPVDTGVNLPSLRELRTNANN 219
            +LP+   + L     L      
Sbjct: 291 NALPLIALLLLLLELLLNLLLTL 313

Length = 394

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 40/223 (17%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           I +G  G VY       G   A+KV+  K    +K+ V   KA R I             
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL---------NIAIDVA 757
              F+  D+  +V E++  G                  S+I+ L             +V 
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIAEVV 107

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             +E LH   +  I+H D+KP N+L+DQ     ++DFGL++          +E +     
Sbjct: 108 LGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--------NGLENKKFV-- 154

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
             GT  Y+APE  +G       D +S G ++ E      P  A
Sbjct: 155 --GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGTE--VAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKI 701
           ++G G  G V KG      +E  VAVK++       +     + E   ++ + +  ++++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +    E     ++ +      V+  ++
Sbjct: 62  IGICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVHQ------VSMGMK 109

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 110 YLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-----KWP 161

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V + APE     + S K DV+SFG+L+ E F+
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 49/243 (20%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
           D +    KIGEG  G+VYK         +A+K I L+Q  +G   + + E   L+ ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 697 NLIKIITV--CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND---QLEVCSLSVIQRLN 751
           N++++  V     R +       +V+E++ +  L++ +  S D      +    + Q L 
Sbjct: 62  NIVRLQDVVHSEKRLY-------LVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL- 112

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVE 810
                   I Y H +    ++H DLKP N+L+D+   +  ++DFGLA             
Sbjct: 113 ------RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA------------- 150

Query: 811 TRSISIGIKG------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKR--PTDAM 861
            R+  I ++       T+ Y APE  +G R  S   D++S G +  E+  +K   P D+ 
Sbjct: 151 -RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209

Query: 862 FNE 864
            +E
Sbjct: 210 IDE 212

Length = 294

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKIITV 704
           IG+G  G+V        G +VA+K IN   +  S +   + E K LR +RH ++++I  +
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 705 C---SGRDFKGADFKAIVYEFMQNGSLEEWLHH---SNDQL--EVCSLSVIQRLNIAIDV 756
               S R+FK      +V+E M     E  LH    +ND L  E     + Q L      
Sbjct: 68  MLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A++Y+H     ++ H DLKP N+L + D    + DFGLA+   N  P  I  T  ++ 
Sbjct: 115 --ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA- 168

Query: 817 GIKGTVGYVAPE-----YGMGREASMKGDVYSFGILLLELFTRK 855
               T  Y APE     +     A    D++S G +  E+ T K
Sbjct: 169 ----TRWYRAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.1 bits (156), Expect = 2e-10
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 28/129 (21%)

Query: 93  LSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI 152
           L  D+  L G IP DI  L  L+ +++  N I G +P S+G+++SL V+D+         
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL--------- 473

Query: 153 DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRE 212
                         ++N F+G IP S+  ++SL +++L+ N  +G +P   G      R 
Sbjct: 474 --------------SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG-----RL 514

Query: 213 LRTNANNFT 221
           L   + NFT
Sbjct: 515 LHRASFNFT 523

Length = 623

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 29/224 (12%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-----KQKGASKSFVAECKALRNIR 694
            +    KIGEG  G +Y      +     +K I+L     K+K ASK    E   L  ++
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMK 57

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N   I+T  +     G  F  IV E+   G L + ++     L     S  Q L+  +
Sbjct: 58  HPN---IVTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVL----FSEDQILSWFV 108

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++  ++++H   +  I+H D+K  N+ L ++ +V+ + DFG+A+ L++        +  
Sbjct: 109 QISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--------SME 157

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           ++    GT  Y++PE    R  + K D++S G +L EL T K P
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 641 FSSANKIGEGGSGIVYKGFL---GEN-GTEVAVKVI-NLKQKGASKSFVAECKALRNIRH 695
           F     +G G  G VYKG     GE     VA+K +       A+K  + E   + ++ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            ++ +++ +C     +      ++ + M  G L +++    D   + S  +   LN  + 
Sbjct: 69  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN--IGSQYL---LNWCVQ 117

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +A  + YL    E  +VH DL   NVL+       ++DFGLAK L     +   E     
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE----- 169

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
            G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 170 -GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 649 EGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS------FVAECKALRNIRHRNLIKII 702
           E G+G   K  LGE    ++   + +K+  AS +      F+ E +  R + H N+++ +
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 703 TVCSGRDFKGADFKAI----VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
             C          ++I    V EF   G L+ +L  +   +   +   +    +A +VAS
Sbjct: 62  GQCI---------ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-QRMACEVAS 111

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + +LH   +   +H DL   N  L  DL   + D+GLA  L  +  D  +     ++ +
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPL 166

Query: 819 KGTVGYVAPEYG---MGREASMKGDVYSFGILLLELFT 853
           +     +    G   + ++ + K +++S G+ + ELFT
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 29/241 (12%)

Query: 637 ATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAECKAL 690
           A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSL----SV 746
           +     ++++++ V S    +G     ++ E M  G L+ +L     ++E   +    S+
Sbjct: 64  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +        
Sbjct: 119 KKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------- 167

Query: 807 TIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN 863
            I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P   M N
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Query: 864 E 864
           E
Sbjct: 228 E 228

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 11/103 (10%)

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++A A+++LH      I++ DLKP N+LLD++    ++DFGL+K   +H      E ++ 
Sbjct: 106 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------EKKAY 156

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           S    GTV Y+APE    R  +   D +SFG+L+ E+ T   P
Sbjct: 157 SFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 42/216 (19%)

Query: 667 VAVKVINL-KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           VAVKV+       A + F+ E K L  +   N+ +++ VC+           ++ E+M+N
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMEN 103

Query: 726 GSLEEWLHH-----SNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSN 780
           G L ++L       S       SLS    L +A  +AS + YL      + VH DL   N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160

Query: 781 VLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG----IKGTVGYVAPEYGMGREA- 835
            L+ ++    ++DFG+              +R++       ++G      P   M  E+ 
Sbjct: 161 CLVGKNYTIKIADFGM--------------SRNLYSSDYYRVQGRA--PLPIRWMAWESV 204

Query: 836 -----SMKGDVYSFGILLLELFT--RKRPTDAMFNE 864
                + K DV++FG+ L E+ T  R++P + + ++
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 32/173 (18%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVK---------VINLKQKGASKSFVAECKA 689
           + +   +KIGEG  G+V+K    E G  VA+K         VI        K  + E + 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-------KIALREIRM 53

Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           L+ ++H NL+ +I V     F+      +V+E+  +  L E   +     E         
Sbjct: 54  LKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH------LI 102

Query: 750 LNIAIDVASAIEYLH-HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             I      A+ + H H C    +H D+KP N+L+ +     + DFG A+ L+
Sbjct: 103 KKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 49/254 (19%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+   +IG+G  G V+KG        VA+K+I+L++        AE   + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 701 IITVCS--------GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +++ C         G   KG     I+ E++  GS       + D L        Q   +
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKL-WIIMEYLGGGS-------ALDLLRAGPFDEFQIATM 106

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
             ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L+    DT ++  
Sbjct: 107 LKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRN 159

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM----------- 861
           +      GT  ++APE         K D++S GI  +EL   + P   M           
Sbjct: 160 TFV----GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215

Query: 862 FNEGLTLHDFSREF 875
            N      +FS+ F
Sbjct: 216 NNPPTLTGEFSKPF 229

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 66/261 (25%), Positives = 112/261 (42%), Gaps = 41/261 (15%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAEC--KALRNIR 694
           N+     +G G  G VY  +  + G E+AVK +      Q+ + +    EC  + L+N+R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  +++       RD +     +I  E+M  GS+++ L       E    +V +R    I
Sbjct: 63  HDRIVQYYGCL--RDPEEKKL-SIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI 115

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH      IVH D+K +N+L D      + DFG +K +      TI  + + 
Sbjct: 116 --LQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ-----TICMSGTG 165

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK-----------------RP 857
              + GT  +++PE   G     K DV+S    ++E+ T K                 +P
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP 225

Query: 858 TDAMFNEGLT--LHDFSREFF 876
           T  M  +G++    DF ++ F
Sbjct: 226 TKPMLPDGVSDACRDFLKQIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ----KGASKSFVAECKALRNIRHR 696
           F     +G+GG G V    +   G   A K +  K+    KG S + + E + L  +  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSR 60

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            ++ +        ++  D   +V   M  G L+  ++H  +          + +  A ++
Sbjct: 61  FVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEI 111

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              +E LH   +  IV+ DLKP N+LLD      +SD GLA     H P    E ++I  
Sbjct: 112 CCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAV----HVP----EGQTIK- 159

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G  GTVGY+APE       +   D ++ G LL E+   + P
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 6e-10
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 22/202 (10%)

Query: 662 ENGTEVAVKVI-NLKQKGAS--KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
             G EVA+K++     +       F  E      + H N++ ++   SG           
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGE--APPGLLFA 56

Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V+E++   +L E L  + D     +L   +   + + V  A+   H      IVH DLKP
Sbjct: 57  VFEYVPGRTLREVL--AADG----ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKP 107

Query: 779 SNVLLDQ-DLVSH--VSDFGLAKFLSN-HNPDTIVETRSISIGIKGTVGYVAPEYGMGRE 834
            N+++ Q  +  H  V DFG+   L    + D    TR+  +   GT  Y APE   G  
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEV--LGTPTYCAPEQLRGEP 165

Query: 835 ASMKGDVYSFGILLLELFTRKR 856
            +   D+Y++G++ LE  T +R
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 664 GTEVAVKVINLKQKGAS------KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA 717
           GT +AVK +   +  +S      ++   E + +  + H ++I+      G   + + F  
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR----MLGATCEDSHFN- 79

Query: 718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK 777
           +  E+M  GS+   L       E   ++  ++      +   + YLH   E  I+H D+K
Sbjct: 80  LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLH---ENQIIHRDVK 130

Query: 778 PSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE 834
            +N+L+D   Q L   ++DFG A  L+                + GT+ ++APE   G +
Sbjct: 131 GANLLIDSTGQRL--RIADFGAAARLAA----KGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 835 ASMKGDVYSFGILLLELFTRKRPTDA 860
                DV+S G +++E+ T K P +A
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 7e-10
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 46/242 (19%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           D+F     IG G  G V+     + G   A+KV+    + ++       AE   L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             ++K+    S   F+  +   +V E+M  G L   L   +   E        R  IA +
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIA-E 109

Query: 756 VASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLA-KFLSNHNPDTIVE 810
           +  A++ +H   +     +H D+KP N+L+D D   H+  +DFGL  K     + +  + 
Sbjct: 110 LVLALDSVHKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLN 162

Query: 811 TRSISIGIK--------------------GTVGYVAPEYGMGREASMKGDVYSFGILLLE 850
                +                       GT  Y+APE   G    ++ D +S G++L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 851 LF 852
           + 
Sbjct: 223 ML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 37/259 (14%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-----FVAECKALRNIR 694
           N+     +G+G  G VY  +  + G E+AVK +    +    S        E + L+N+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  +++       RD       +I  E M  GS+++ L       E    +V ++    I
Sbjct: 63  HERIVQYYGCL--RDPMERTL-SIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQI 115

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH      IVH D+K +N+L D      + DFG +K L      TI  + + 
Sbjct: 116 --LEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ-----TICLSGTG 165

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF------ 862
              + GT  +++PE   G     K D++S G  ++E+ T K P        A+F      
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 225

Query: 863 -NEGLTLH--DFSREFFTR 878
            N  L  H  D  R+F  R
Sbjct: 226 TNPVLPPHVSDHCRDFLKR 244

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGTE-VAVKVINLK--QKGASKSFVAECKALRNIR---HRNLI 699
           +IGEG  G V+K    +NG   VA+K + ++  ++G   S + E   LR++    H N++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  VC+           +V+E +    L  +L    +      +      ++   +   
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP----GVPTETIKDMMFQLLRG 122

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +++LH +    +VH DLKP N+L+       ++DFGLA+  S     T V          
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-------- 171

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            T+ Y APE  +    +   D++S G +  E+F R++P
Sbjct: 172 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 56/216 (25%), Positives = 107/216 (49%), Gaps = 27/216 (12%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIIT 703
           +K+GEG    V+KG        VA+K I L+ ++GA  + + E   L+N++H N++ +  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL-- 68

Query: 704 VCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                D    +    +V+E++ +  L+++L +  + + + ++ +         +   + Y
Sbjct: 69  ----HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM-----FQLLRGLSY 118

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
            H      I+H DLKP N+L+++     ++DFGLA+  S       V T++ S  +  T+
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS-------VPTKTYSNEVV-TL 167

Query: 823 GYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRP 857
            Y  P+  +G  E S   D++  G +L E+ T  RP
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 36/224 (16%)

Query: 667 VAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           VAVK++     K A   F+ E K +  ++  N+I+++ VC       +D   ++ E+M+N
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMEN 103

Query: 726 GSLEEWL-----HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSN 780
           G L ++L       + ++ +V ++S    + +A  +AS ++YL      + VH DL   N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160

Query: 781 VLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA----- 835
            L+ ++    ++DFG+++ L                 I+G    V P   M  E+     
Sbjct: 161 CLVGKNYTIKIADFGMSRNL----------YSGDYYRIQGRA--VLPIRWMSWESILLGK 208

Query: 836 -SMKGDVYSFGILLLELFT--RKRPTDAMFNEGLTLHDFSREFF 876
            +   DV++FG+ L E+ T  +++P   + +E +   + + EFF
Sbjct: 209 FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI--ENTGEFF 250

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 36/224 (16%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+   +IG+G  G VYKG        VA+K+I+L++        AE   + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 701 IITVCSG---RDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +++ C       + G+  K     I+ E++  GS  + L      LE   ++ I R    
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 108

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L+    DT ++  +
Sbjct: 109 -EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRNT 160

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 161 FV----GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 36/226 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F    ++G G  G+V K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL 50

Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            K++  C+      F GA +     +I  E M  GSL++ L  +    E    +++ +++
Sbjct: 51  -KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKIS 105

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 106 IA--VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 161

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   +++ D++S G+ L+E+   + P
Sbjct: 162 RS----------YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 41/232 (17%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           FS   +IG G  G VY      N   VA+K ++   K +++ +   + E + L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I          ++G   +    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 77  TI---------QYRGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTH 122

Query: 758 SAIE---YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            A++   YLH +   +++H D+K  N+LL +  +  + DFG A  ++  N          
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------- 169

Query: 815 SIGIKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRPTDAMFN 863
                GT  ++APE  +  +      K DV+S GI  +EL  RK P   +FN
Sbjct: 170 --XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 41/232 (17%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           F   ++IG G  G VY          VAVK ++   K  ++ +   + E K L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I         ++KG   K    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 83  TI---------EYKGCYLK----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITH 128

Query: 758 SAIE---YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            A++   YLH +    ++H D+K  N+LL +     ++DFG A   S  N          
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---------- 175

Query: 815 SIGIKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRPTDAMFN 863
                GT  ++APE  +  +      K DV+S GI  +EL  RK P   +FN
Sbjct: 176 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 36/239 (15%)

Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGA-SKSFVAE 686
           E++ +T  F    ++GE   G VYKG L     GE    VA+K +  K +G   + F  E
Sbjct: 1   EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL----HHSN------ 736
                 ++H N++ ++ V +          ++++ +  +  L E+L     HS+      
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
           D+    +L     ++I   +A+ +E+L  HH     +VH DL   NVL+   L   +SD 
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDL 168

Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           GL  F   +  D      +  + I+    +++PE  M  + S+  D++S+G++L E+F+
Sbjct: 169 GL--FREVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 35/229 (15%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           F+   +IG G  G VY          VA+K ++   K +++ +   + E K L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I         ++KG   +    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 87  SI---------EYKGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITH 132

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A++ L +    +++H D+K  N+LL +     ++DFG A   S  N             
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------------S 180

Query: 818 IKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRPTDAMFN 863
             GT  ++APE  +  +      K DV+S GI  +EL  RK P   +FN
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+   KIG+G  G V+KG        VA+K+I+L++        AE   + +I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 701 IITVCSG---RDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +++ C       + G+  K     I+ E++  GS       + D LE   L   Q   I 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 107

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L+    DT ++  +
Sbjct: 108 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNT 160

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 161 FV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N S    +G G  G V +     L ++   + V V  LK    S   ++ ++E K + +
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +  H N++ ++  C+     G     ++ E+   G L  +L    +      L++   L+
Sbjct: 95  LGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF----LTLEDLLS 145

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            +  VA  + +L      + +H DL   NVLL    +  + DFGLA+ + N + + +V  
Sbjct: 146 FSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS-NYVV-- 199

Query: 812 RSISIGIKGT----VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                  KG     V ++APE       + + DV+S+GILL E+F+
Sbjct: 200 -------KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIIT--- 703
           IG GG G VY     + G   A+K ++ K+    K    E  AL     R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTGD 55

Query: 704 ----VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               VC    F   D  + + + M  G L    H+   Q  V S + ++    A ++   
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFY--AAEIILG 109

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V          
Sbjct: 110 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---------- 156

Query: 820 GTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
           GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 157 GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 15/110 (13%)

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           + + +  A+ YL    +  ++H D+KPSN+LLD      + DFG++  L     D+  +T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV----DSKAKT 172

Query: 812 RSISIGIKGTVGYVAPEY----GMGREASMKGDVYSFGILLLELFTRKRP 857
           RS      G   Y+APE         +  ++ DV+S GI L+EL T + P
Sbjct: 173 RS-----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 4/128 (3%)

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
           NI  D+ + +EY+H +    I HGD+KP N+++D +   ++ D+G+A     H       
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHD 870
                +  +GT+ Y   +   G   + +GD+ S G  +L+    K P     + G  +H 
Sbjct: 187 KEQKDLH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245

Query: 871 FSREFFTR 878
              +F  R
Sbjct: 246 AKCDFIKR 253

Length = 294

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 34/228 (14%)

Query: 641 FSSANKIGEGGSGIVYKGFL---GENGTEVAVKVINL-----KQKGASKSFVAECKALRN 692
           +    KIGEG  G   K  L    E+G +  +K IN+     K++  S+    E   L N
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSN 55

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N+     V     F+      IV ++ + G L + +   N Q  V      Q L+ 
Sbjct: 56  MKHPNI-----VQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVL-FPEDQILDW 106

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
            + +  A++++H   +  I+H D+K  N+ L +D    + DFG+A+ L++      VE  
Sbjct: 107 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELA 158

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              I   GT  Y++PE    R  + K D+++ G +L E+ T K   +A
Sbjct: 159 RTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 35/235 (14%)

Query: 646 KIGEGGSGIVYKGFL-----GENGTEVAVKVIN----LKQKGASKSFVAECKALRNIRHR 696
           ++G+G  G+VY+G       GE  T VAVK +N    L+++     F+ E   ++     
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCH 69

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VCSLSVIQRLNI 752
           ++++++ V S    KG     +V E M +G L+ +L     + E        ++ + + +
Sbjct: 70  HVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++A  + YL+       VH DL   N ++  D    + DFG+ +         I ET 
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETD 173

Query: 813 SISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNE 864
               G KG   V ++APE       +   D++SFG++L E+ +  ++P   + NE
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKAL-RNIRHRNLIKII 702
           IG+G  G V       +G   AVKV+  K   +K   K  +AE   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+ AD    V +++  G L   L     Q E        R   A ++ASA+ Y
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARF-YAAEIASALGY 111

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     +I++ DLKP N+LLD      ++DFGL K          +E    +    GT 
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCGTP 160

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLEL 851
            Y+APE    +      D +  G +L E+
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           IG G  GIV   F    G  VAVK ++   + +  +K    E   L+ + H+N+I ++ V
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 705 CSGRDFKGADFKAI--VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            + +     +F+ +  V E M + +L + +H   D  E  S  + Q L         I++
Sbjct: 89  FTPQK-SLEEFQDVYLVMELM-DANLCQVIHMELDH-ERMSYLLYQML-------CGIKH 138

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS-NHNPDTIVETRSISIGIKGT 821
           LH      I+H DLKPSN+++  D    + DFGLA+    N      V TR         
Sbjct: 139 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-------- 187

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             Y APE  +G       D++S G ++ EL
Sbjct: 188 --YRAPEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 30/84 (35%), Positives = 48/84 (57%)

Query: 69  LILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQL 128
           L L N    G IP ++S   +L  ++   N++ G IP  +GS+  LE L +  N   G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 129 PASIGNLSSLRVIDVRENRLWGRI 152
           P S+G L+SLR++++  N L GR+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 31/76 (40%), Positives = 48/76 (63%), Gaps = 1/76 (1%)

Query: 153 DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRE 212
           + + +L+ L  ++++ N   G IPPS+ +I+SLEV+ LS N F GS+P   G  L SLR 
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG-QLTSLRI 494

Query: 213 LRTNANNFTGFIPVSL 228
           L  N N+ +G +P +L
Sbjct: 495 LNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKAL-RNIRHRNLIKII 702
           IG+G  G V       +G+  AVKV+  K   +K      +AE   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+ A+    V +++  G L  + H    Q E C L    R   A +VASAI Y
Sbjct: 62  ----HYSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARF-YAAEVASAIGY 111

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     +I++ DLKP N+LLD      ++DFGL K          VE    +    GT 
Sbjct: 112 LHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGTP 160

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            Y+APE           D +  G +L E+ 
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 42/257 (16%)

Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKVIN----LKQKGASKSFVAECKALRNI 693
           ++F+    +G G  G ++   +  E+   VA+K       +KQK     F +E K L  I
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88

Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL--N 751
            H   + +        FK   +  +V EF+  G    +L  +            +R   +
Sbjct: 89  NHPFCVNLYG-----SFKDESYLYLVLEFVIGGEFFTFLRRN------------KRFPND 131

Query: 752 IAIDVASAIEYLHHYCEP-SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
           +    A+ I  +  Y +  +IV+ DLKP N+LLD+D    ++DFG AK         +V+
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVD 182

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHD 870
           TR+ ++   GT  Y+APE  +        D ++ GI + E+     P  A  NE L ++ 
Sbjct: 183 TRTYTLC--GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA--NEPLLIYQ 238

Query: 871 FSRE---FFTRKSDTDC 884
              E   +F +  D +C
Sbjct: 239 KILEGIIYFPKFLDNNC 255

Length = 340

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 33/219 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIIT--- 703
           IG GG G VY     + G   A+K ++ K+    +    E  AL     R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALN---ERIMLSLVSTGD 55

Query: 704 ----VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               VC    F   D    + + M  G L    H+   Q  V S   ++    A ++   
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFY--ATEIILG 109

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V          
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---------- 156

Query: 820 GTVGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT GY+APE    G       D +S G +L +L     P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 5e-09
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 646 KIGEGGSGIVYKGFLGEN--GTEVAVKVI---NLKQKGASKSFVAECKALRNIRHRNLIK 700
            IG G  G VYK        G E A+K       +  G S+S   E   LR ++H N++ 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 701 IITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++ V      + AD    +++++ ++   +    H   +      S+++ L   I   + 
Sbjct: 67  LVEVF----LEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI--LNG 120

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH----VSDFGLAKFLSNHNP-------DTI 808
           + YLH      ++H DLKP+N+L+  +        + D GLA+    + P       D +
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADLDPV 175

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFT 853
           V           T+ Y APE  +G     K  D+++ G +  EL T
Sbjct: 176 VV----------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVA---ECKALRNIR 694
           ++    +G+G  G VY G L   G  +AVK + L       A K +     E   L++++
Sbjct: 2   WTKGEVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N+++ +  C   +       +I  EF+  GS+   L+      E     V  +    I
Sbjct: 61  HVNIVQYLGTCLDDNTI-----SIFMEFVPGGSISSILNRFGPLPEP----VFCKYTKQI 111

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH+ C   +VH D+K +NV+L  + +  + DFG A+ L+           ++
Sbjct: 112 --LDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH--GTHSNM 164

Query: 815 SIGIKGTVGYVAPEY----GMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
              + GT  ++APE     G GR    K D++S G  + E+ T K P  +M
Sbjct: 165 LKSMHGTPYWMAPEVINESGYGR----KSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 11/260 (4%)

Query: 31  TLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNL 90
             S  + NL  L  +++  N     I   +  L +L  L L NN+ +   P      SNL
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142

Query: 91  IELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG 150
            EL    N +   +P+ + +L  L+ L +  N ++  LP  + NLS+L  +D+  N++  
Sbjct: 143 KELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD 200

Query: 151 RIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSL 210
               +  L +L  L ++ N     +  S+ N+ +L  + LS N+           NL +L
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIG--NLSNL 257

Query: 211 RELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGT 270
             L  + N        SL + ++L  ++ S N  S   +        L  L L +N L T
Sbjct: 258 ETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLS---NALPLIALLLLLLELLLNLLLT 312

Query: 271 GAANELDFINLLTNCSKLER 290
             A EL   ++L N + L  
Sbjct: 313 LKALELKLNSILLNNNILSN 332

Length = 394

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 9e-09
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 23/209 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           IG+G  G VY+    +     A+KV++ K+  A K  VA     RNI  R L+       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE-VAHTIGERNILVRTLLDESPFIV 59

Query: 707 GR--DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI-DVASAIEYL 763
           G    F+      +V ++M  G L   L       E        R    I ++  A+E+L
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-------DRAKFYIAELVLALEHL 112

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H Y    IV+ DLKP N+LLD      + DFGL+K  +N   +    T        GT  
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNT------FCGTTE 161

Query: 824 YVAPEYGMGREASMKG-DVYSFGILLLEL 851
           Y+APE  +  +   K  D +S G+L+ E+
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 25/216 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHR 696
           + F     +GEG  G+V K    E    VA+K     ++     ++ + E K LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++++        F+      +V+E+++   LE      N        S I +L  AI  
Sbjct: 61  NIVEL-----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI-- 113

Query: 757 ASAIEYLHHYCEPS-IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
                   H+C  + IVH D+KP N+L+  + V  + DFG A+ LS  +     E  +  
Sbjct: 114 --------HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-- 163

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                T  Y +PE  +G       D++S G +L EL
Sbjct: 164 -----TRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIIT 703
           KIGEG  G V+K    E    VA+K + L    +G   S + E   L+ ++H+N++++  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 704 VCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLE--VCSLSVIQRLNIAIDVASAI 760
           V         D K  +V+E+     L+++    N  ++  +    + Q L         +
Sbjct: 67  VLHS------DKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK-------GL 112

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            + H     +++H DLKP N+L++++    ++DFGLA+          +  R  S  +  
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------IPVRCYSAEVV- 161

Query: 821 TVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
           T+ Y  P+   G +  S   D++S G +  EL    RP
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ----KGASKSFVAECKALRNIRHR 696
           F     +G+GG G V    +   G   A K +  K+    KG S + + E + L  +  +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQ 60

Query: 697 NLIKIITVCSGRD--------FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            ++ +      +D          G D K  +Y     G  EE                 +
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-----------------R 103

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L  A ++   +E LH     + V+ DLKP N+LLD      +SD GLA          I
Sbjct: 104 ALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAV--------KI 152

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            E  SI  G  GTVGY+APE    +  ++  D +  G L+ E+   + P
Sbjct: 153 PEGESIR-GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 28/217 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRN 697
           D++    K+GEG    VYKG    NG  VA+KVI L+ ++G   + + E   L+ ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVCSLSVIQRLNIAID 755
           ++ +  +   +     +   +V+E++    L +++  H      E   L + Q L     
Sbjct: 65  IVLLHDIIHTK-----ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR---- 114

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
               + Y+H   +  I+H DLKP N+L+       ++DFGLA+  S       V + + S
Sbjct: 115 ---GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYS 161

Query: 816 IGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLEL 851
             +  T+ Y  P+  +G  E S   D++  G + +E+
Sbjct: 162 NEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 647 IGEGGSGIVYKGFLGENG-------TEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +G+G    ++KG   E G       TEV +KV++   +  S+SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               VC        D   +V E+++ GSL+ +L  + +      +++  +L +A  +A A
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + +L    +  + HG++   NVLL ++      +    K LS+      V  + I   + 
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEI---LL 165

Query: 820 GTVGYVAPE-YGMGREASMKGDVYSFGILLLELFT 853
             + +V PE     +  S+  D +SFG  L E+F+
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRN 697
           F    ++G+GG G V+     + G  VA+K +    L +    +  + E   L   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           L+K++       F+  ++  +  E++  G     L++         LS         ++ 
Sbjct: 63  LVKLLYA-----FQDDEYLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMF 111

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSIS 815
            A++ LH   E   +H DLKP N L+D     H+  +DFGL+K              + +
Sbjct: 112 EAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK-----------GIVTYA 155

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE 850
             + G+  Y+APE   G+      D +S G +L E
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 13/105 (12%)

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHNPDTIVETRS 813
           ++  A+E+LH      IV+ D+K  N+LLD +    ++DFGL+K FLS        + R+
Sbjct: 113 EIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE------KERT 163

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRP 857
            S    GT+ Y+APE   G+    K  D +S GIL+ EL T   P
Sbjct: 164 YSFC--GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 9/214 (4%)

Query: 350 TIPPEIGELTNLQQLDLD-RNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTN 408
             P    E   + +L L+  +     +PSSL  L  L  L     +       +L N   
Sbjct: 36  NFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLP 94

Query: 409 LLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLK-NLMRLDLSGNK 467
           L  L+++ N+L   +    L   T    L+L NN +   +PP +G LK NL  LDLS NK
Sbjct: 95  LPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL 527
               +P+ L    NL+ L++S N  S  +P LL +L ++  LD S N ++  +P  +E L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208

Query: 528 SFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           S LE L+LS N     +       N +   ++ N
Sbjct: 209 SALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242

Length = 394

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 56/238 (23%)

Query: 667 VAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           VAVK++     K A   F+ E K L  ++  N+I+++ VC        D   ++ E+M+N
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMEN 103

Query: 726 GSLEEWL--HHSND-------------QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS 770
           G L ++L  HH +D              L   S S +  L++A+ +AS ++YL      +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL--LHVALQIASGMKYLSSL---N 158

Query: 771 IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG----IKGTVGYVA 826
            VH DL   N L+ ++L   ++DFG+              +R++  G    I+G    V 
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGM--------------SRNLYAGDYYRIQGRA--VL 202

Query: 827 PEYGMGREASMKG------DVYSFGILLLELFT--RKRPTDAMFNEGLTLHDFSREFF 876
           P   M  E  + G      DV++FG+ L E+    +++P   + +E +   + + EFF
Sbjct: 203 PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI--ENAGEFF 258

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 24/156 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI--KIIT 703
            +  G +  VY   LG    +  +K+   ++KGA      E   L+ +  + L   K++ 
Sbjct: 5   LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLA 60

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                +  G  +  ++ E+++  +L+E             +S  ++ +IA  +A  +  L
Sbjct: 61  SG---ESDGWSY--LLMEWIEGETLDE-------------VSEEEKEDIAEQLAELLAKL 102

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           H      + HGDL P N+L+D   +  + D+  A +
Sbjct: 103 HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 11/105 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++   +++LH   +  I++ DLK  NVLLD+D    ++DFG+ K   N N +    T 
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKAST- 155

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  GT  Y+APE   G++ +   D +SFG+LL E+   + P
Sbjct: 156 -----FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKAL-RNIRHRNLIKII 702
           IG+G  G V            AVKV+  K   +K   K  ++E   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+ AD    V +++  G L    +H   Q E C L    R   A ++ASA+ Y
Sbjct: 62  ----HFSFQTADKLYFVLDYINGGEL---FYHL--QRERCFLEPRARF-YAAEIASALGY 111

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     +IV+ DLKP N+LLD      ++DFGL K   N   +    T        GT 
Sbjct: 112 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTST------FCGTP 160

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            Y+APE    +      D +  G +L E+ 
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 28/222 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           D +    ++G G  G V        G +VA+K +    + +  +K    E + L++++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 697 NLIKIITVCSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           N+I ++ V +  D     F    +V  FM    L + + H     +     V Q L    
Sbjct: 75  NVIGLLDVFTP-DLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLK--- 129

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                ++Y+H      I+H DLKP N+ +++D    + DFGLA+           +T S 
Sbjct: 130 ----GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSE 171

Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
             G   T  Y APE  +     +   D++S G ++ E+ T K
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++  A EYLH      I++ DLKP N+LLD      V+DFG AK          V  R+ 
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------KVPDRTF 173

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           ++   GT  Y+APE    +      D ++ G+LL E 
Sbjct: 174 TLC--GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 646 KIGEGGSGIVYKG--FLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHRNLIK 700
           +IG G  G V     +       V VK   LK   +SK    F+ +    R ++H N+++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVK--ELKANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
               C G+  +   +  +V+E+ + G L+ +L           L ++QR+  A ++A+ +
Sbjct: 60  ----CLGQCVEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGV 112

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            ++H +   + +H DL   N  L  DL   V D+G+    S +  D I       + ++ 
Sbjct: 113 THMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR- 166

Query: 821 TVGYVAPEYGMGR-------EASMKGDVYSFGILLLELF 852
              ++APE            E +   +V++ G+ L ELF
Sbjct: 167 ---WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 11/107 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++  A+ +LH   E  I++ DLK  NVLLD D    ++D+G+ K      P     T 
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTST- 155

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                  GT  Y+APE   G E     D ++ G+L+ E+   + P D
Sbjct: 156 -----FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++   +++LH   E  I++ DLK  NVLLD +    ++DFG+ K          V T 
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGG--VTTS 154

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           +      GT  Y+APE    +      D ++ G+LL E+   + P + 
Sbjct: 155 TFC----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 50/231 (21%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 697 NLIKIITVCS-GRDFK------------GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
           N+I ++ V +  R  +            GAD   IV          +    ++D ++   
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----------KCQKLTDDHVQFLI 126

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
             +++ L          +Y+H      I+H DLKPSN+ +++D    + DFGLA+    H
Sbjct: 127 YQILRGL----------KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----H 169

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
             D +        G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 170 TDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 45/229 (19%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNIRH 695
           T+ +     +G G  G+V        G  VA+K I         +K    E K L+++RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 696 RNLIKI--ITVCSGRD------FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
            N+I +  I +    D        G D   +    + +  LE        Q     L  I
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLE-------KQFIQYFLYQI 117

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
            R          ++Y+H      +VH DLKPSN+L++++    + DFGLA+ + +     
Sbjct: 118 LR---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTG 164

Query: 808 IVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            V TR           Y APE  +  ++  ++ D++S G +  E+   K
Sbjct: 165 YVSTRY----------YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 33/231 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHR 696
           D +    KIGEG  G VYK      G  VA+K   L+  ++G   + + E   L+ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 697 NLI-KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAI 754
             I +++ V    +  G     +V+E++ +  L++++  +            I+     +
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRS 813
               A  + H +    ++H DLKP N+L+D+   +  ++D GL               R+
Sbjct: 120 LKGVA--HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG--------------RA 160

Query: 814 ISIGIKG------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRP 857
            SI +K       T+ Y APE  +G    S   D++S G +  E+ +RK+P
Sbjct: 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM-SRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  +    V EF+  G L   + H  D+       + +    A ++   +++LH     
Sbjct: 65  FQTKEHLFFVMEFLNGGDL---MFHIQDK---GRFDLYRATFYAAEIVCGLQFLH---SK 115

Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            I++ DLK  NV+LD+D    ++DFG+ K       +   + R+ +    GT  Y+APE 
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNRASTFC--GTPDYIAPEI 167

Query: 830 GMGREASMKGDVYSFGILLLELFTRKRP 857
             G + +   D +SFG+LL E+   + P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 47/191 (24%), Positives = 92/191 (48%), Gaps = 19/191 (9%)

Query: 662 ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE 721
           E   +V +KV++   +  S +F      +R + H++++ +  VC  RD +      +V E
Sbjct: 30  EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-RDVE----NIMVEE 84

Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           F++ G L+ ++H  +D      L+   +  +A  +ASA+ YL    +  +VHG++   N+
Sbjct: 85  FVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNI 136

Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE-YGMGREASMKGD 840
           LL ++ +    + G    LS+      V +R   +     + ++APE     +  S+  D
Sbjct: 137 LLAREGID--GECGPFIKLSDPGIPITVLSRQECV---ERIPWIAPECVEDSKNLSIAAD 191

Query: 841 VYSFGILLLEL 851
            +SFG  L E+
Sbjct: 192 KWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 38/249 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++F    +IG G  G VYK      G   A+KVI L+          E   +++ +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +        RD        I  EF   GSL++  H +        LS  Q   ++ +   
Sbjct: 69  VAYFGSYLRRDKLW-----ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQ 117

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + YLH   +   +H D+K +N+LL  +    ++DFG++  ++     TI + +S     
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA----TIAKRKSFI--- 167

Query: 819 KGTVGYVAPEYGMGREASMKG------DVYSFGILLLELFTRKRPTDAMFNEGLTLHDFS 872
            GT  ++APE         KG      D+++ GI  +EL   + P   MF+    LH   
Sbjct: 168 -GTPYWMAPEVA---AVERKGGYNQLCDIWAVGITAIELAELQPP---MFD----LHPMR 216

Query: 873 REFFTRKSD 881
             F   KS+
Sbjct: 217 ALFLMTKSN 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 11/105 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++   +++LH      IV+ DLK  N+LLD D    ++DFG+ K       + + + +
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAK 152

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           + +    GT  Y+APE  +G++ +   D +SFG+LL E+   + P
Sbjct: 153 TCTFC--GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 24/214 (11%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+GG G V    +   G   A K ++   LK+K   K  + E + L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +     F+      +V   M  G L+  +++  ++     L + + ++ +  +   I +L
Sbjct: 58  LAYA--FESKTHLCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHL 111

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H      IV+ D+KP NVLLD      +SD GLA  L +    T    R+      GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT---QRA------GTNG 159

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           Y+APE       S   D ++ G  + E+   + P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVK-VINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           IG G  G+V+      +G  VA+K + N+ Q   S K    E K L   +H N++  + +
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHH--------SNDQLEVCSLSVIQRLNIAIDV 756
                    +   +V E MQ+      LH         S+D ++V    +++ L      
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQILRGL------ 116

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE-TRSIS 815
               +YLH      I+H D+KP N+L++ + V  + DFGLA+      PD     T+ + 
Sbjct: 117 ----KYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                T  Y APE  MG R  +   D++S G +  EL  R+
Sbjct: 167 -----TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 34/213 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           IG G  GIV   +    G  VA+K ++        A +++  E   ++ + H+N+I ++ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82

Query: 704 VCSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           V +       +F+   +V E M + +L + +    D  E  S  + Q L         I+
Sbjct: 83  VFT-PQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH-ERMSYLLYQML-------CGIK 132

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT-IVETRSISIGIKG 820
           +LH      I+H DLKPSN+++  D    + DFGLA+        T  V TR        
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------- 182

Query: 821 TVGYVAPE--YGMGREASMKGDVYSFGILLLEL 851
              Y APE   GMG + ++  D++S G ++ E+
Sbjct: 183 ---YRAPEVILGMGYKENV--DIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 28/147 (19%)

Query: 718 IVYEFMQNGSLEEWLHHSN--DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD 775
           ++ +++  G L   L+      + EV       R+ IA ++  A+++LH      I++ D
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEV-------RVYIA-EIVLALDHLHQL---GIIYRD 130

Query: 776 LKPSNVLLDQDLVSHV--SDFGLAK-FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG 832
           +K  N+LLD +   HV  +DFGL+K FL+        E R+ S    GT+ Y+APE   G
Sbjct: 131 IKLENILLDSE--GHVVLTDFGLSKEFLAEE------EERAYSFC--GTIEYMAPEVIRG 180

Query: 833 REA--SMKGDVYSFGILLLELFTRKRP 857
                    D +S G+L  EL T   P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 44/146 (30%), Positives = 59/146 (40%), Gaps = 29/146 (19%)

Query: 712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSI 771
           G D K  +Y     G  EE                 + +  A ++   +E LH      I
Sbjct: 84  GGDLKFHIYNMGNPGFDEE-----------------RAVFYAAEITCGLEDLH---RERI 123

Query: 772 VHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM 831
           V+ DLKP N+LLD      +SD GLA          I E  +I  G  GTVGY+APE   
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAV--------EIPEGETIR-GRVGTVGYMAPEVVK 174

Query: 832 GREASMKGDVYSFGILLLELFTRKRP 857
               +   D +  G L+ E+   K P
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITV 704
           K+GEG    VYKG     G  VA+K I L+  +GA  + + E   L++++H N   I+T+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTL 68

Query: 705 CSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI---DVASAI 760
               D         +V+E++    L++++              +   N+ +    +   +
Sbjct: 69  ---HDIIHTKKTLTLVFEYLDT-DLKQYMDDCG--------GGLSMHNVRLFLFQLLRGL 116

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            Y H      ++H DLKP N+L+ +     ++DFGLA+  S       V +++ S  +  
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS-------VPSKTYSNEVV- 165

Query: 821 TVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
           T+ Y  P+  +G  E S   D++  G +  E+ T
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 35/224 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHRNLIKI-- 701
           I E     +YKG    N  EV ++      KG          E K LR I   N++KI  
Sbjct: 28  IKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 702 --ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             I +            +++ E+   G L E L    D      LS   +L++AID    
Sbjct: 86  FIIDIVDD-----LPRLSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKG 134

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +  L+ Y   +  + +L   + L+ ++    +   GL K LS+     +           
Sbjct: 135 LYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV----------- 181

Query: 820 GTVGYVAPEY--GMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
             + Y + +    +  E ++K D+YS G++L E+FT K P + +
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIKII 702
           +G+G  G V       +G   A+K++  K+   +K  VA    E + L+N RH  L  + 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+  D    V E++  G L  + H S +++     S  +      ++ SA++Y
Sbjct: 61  ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGAEIVSALDY 110

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH      IV+ DLK  N++LD+D    ++DFGL K       + I +  ++     GT 
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKT-FCGTP 159

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            Y+APE     +     D +  G+++ E+   + P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 32/220 (14%)

Query: 647 IGEGGSGIVYKGFLGENGT--------EVAVKVINLKQKG-ASKSFVAECKALRNIRHRN 697
           +G+G    +YKG L             EV+V +  L      S +F      +  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           L+K+  VC        D   +V E+++ G L+ +LH      E  ++S+  +L++A  +A
Sbjct: 63  LVKLYGVCV------RDENIMVEEYVKFGPLDVFLH-----REKNNVSLHWKLDVAKQLA 111

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           SA+ YL    +  +VHG++   N+L+ +  L      F   K LS+      V +R   +
Sbjct: 112 SALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF--IK-LSDPGIPITVLSREERV 165

Query: 817 GIKGTVGYVAPEYGMGREASMK--GDVYSFGILLLELFTR 854
                + ++APE     +AS+    D +SFG  LLE+ + 
Sbjct: 166 ---ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 25/215 (11%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIIT 703
           +K+GEG    VYKG        VA+K I L+ ++GA  + + E   L++++H N++ +  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +             +V+E++ +  L+++L    +         I   N+ + +   +  L
Sbjct: 72  I-----IHTEKSLTLVFEYL-DKDLKQYLDDCGN--------SINMHNVKLFLFQLLRGL 117

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           ++     ++H DLKP N+L+++     ++DFGLA+  S       + T++ S  +  T+ 
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS-------IPTKTYSNEVV-TLW 169

Query: 824 YVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRP 857
           Y  P+  +G  + S + D++  G +  E+ T  RP
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           VA  +E+L        +H DL   N+LL ++ V  + DFGLA+ +   +PD  V      
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPD-YVRKGDAR 236

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +K    ++APE    +  + + DV+SFG+LL E+F+
Sbjct: 237 LPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 52/216 (24%), Positives = 106/216 (49%), Gaps = 26/216 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRN 697
           + +    K+GEG    V+KG        VA+K I L+ ++GA  + + E   L++++H N
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 698 LIKIITVCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++ +       D    D    +V+E++ +  L++++       + C  +++   N+ I +
Sbjct: 66  IVTL------HDIVHTDKSLTLVFEYL-DKDLKQYM-------DDCG-NIMSMHNVKIFL 110

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              +  L +     ++H DLKP N+L+++     ++DFGLA+  S       V T++ S 
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS-------VPTKTYSN 163

Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLEL 851
            +  T+ Y  P+  +G  E S + D++  G +  E+
Sbjct: 164 EVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 21/194 (10%)

Query: 668 AVKVINL-KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNG 726
           A+K I L K   A +    E   L  ++H N+     V     F+      IV E+   G
Sbjct: 29  AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI-----VAFKESFEADGHLYIVMEYCDGG 83

Query: 727 SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD 786
            L + +     +L          L   + +   ++++H   E  ++H D+K  N+ L Q+
Sbjct: 84  DLMQKIKLQRGKL----FPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQN 136

Query: 787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGI 846
               + DFG A+ L++          + +    GT  YV PE       + K D++S G 
Sbjct: 137 GKVKLGDFGSARLLTS--------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGC 188

Query: 847 LLLELFTRKRPTDA 860
           +L EL T K P  A
Sbjct: 189 ILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 40/123 (32%), Positives = 62/123 (50%), Gaps = 19/123 (15%)

Query: 735 SNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
           S+D  E   L+ +  L+    VA  +E+L      + VH DL   NVLL Q  +  + DF
Sbjct: 227 SDDGSE--GLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDF 281

Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGT----VGYVAPEYGMGREASMKGDVYSFGILLLE 850
           GLA+       D + ++  +S   KG+    V ++APE       +   DV+S+GILL E
Sbjct: 282 GLAR-------DIMHDSNYVS---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331

Query: 851 LFT 853
           +F+
Sbjct: 332 IFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 14/121 (11%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A +V  A+ +LH +    +++ DLK  N+LLD +    ++DFG+ K            T 
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTT- 155

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL---TLH 869
                  GT  Y+APE     E     D ++ G+L+ E+   + P +A   + L    LH
Sbjct: 156 -----FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210

Query: 870 D 870
           D
Sbjct: 211 D 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 48/238 (20%)

Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI 693
           L   TD +     IG+G  G VYK    ++G+  AVK+++       +   AE   L+++
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSL 75

Query: 694 -RHRNLIKIITVCSGRDFKGADFKA---------IVYEFMQNGSLEEWLHHSNDQLEVCS 743
             H N++K         F G  +KA         +V E    GS+ E +      L +C 
Sbjct: 76  PNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICG 122

Query: 744 LSVIQRLN---IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
               QRL+   I+  +  A+  L H     I+H D+K +N+LL  +    + DFG++  L
Sbjct: 123 ----QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLEL 851
           ++         R+ S+   GT  ++APE       Y    +A  + DV+S GI  +EL
Sbjct: 179 TSTR-----LRRNTSV---GTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 11/107 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++A  + +LH      I++ DLK  NV+LD +    ++DFG+ K   N        T 
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRT- 160

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                  GT  Y+APE    +      D ++FG+LL E+   + P D
Sbjct: 161 -----FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 32/245 (13%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           ++    ++G G  G VYK      G   AVK+I L+          E   ++  +H N++
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
                   R+        I  E+   GSL++ ++H    L    ++ + R     +    
Sbjct: 70  AYFGSYLSREKLW-----ICMEYCGGGSLQD-IYHVTGPLSELQIAYVCR-----ETLQG 118

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YLH   +   +H D+K +N+LL  +    ++DFG+A  ++     TI + +S      
Sbjct: 119 LAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA----TIAKRKSFI---- 167

Query: 820 GTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFF 876
           GT  ++APE     +    +   D+++ GI  +EL   + P   MF+    LH     F 
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD----LHPMRALFL 220

Query: 877 TRKSD 881
             KS+
Sbjct: 221 MSKSN 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 14/106 (13%)

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHNPDTIVETRS 813
           ++  A+E+LH      I++ D+K  N+LLD +    ++DFGL+K F  +         R+
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV------ERA 163

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG--DVYSFGILLLELFTRKRP 857
            S    GT+ Y+AP+   G +       D +S G+L+ EL T   P
Sbjct: 164 YSFC--GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 42/126 (33%), Positives = 59/126 (46%), Gaps = 36/126 (28%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFL---------- 800
           A +V  A+EYLH      IV+ DLKP N+LL +    H+  SDF L+K            
Sbjct: 109 AAEVLLALEYLH--LL-GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 801 --------SNHNP--DTIVE---TRSISIGIKGTVGYVAPEY--GMGREASMKGDVYSFG 845
                   S ++   +T  E    RS S    GT  Y+APE   G G  +++  D ++ G
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNS--FVGTEEYIAPEVISGDGHGSAV--DWWTLG 219

Query: 846 ILLLEL 851
           ILL E+
Sbjct: 220 ILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 56/236 (23%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHR 696
           D + + + +G G  G V   F  + G +VA+K ++   + A  +K    E + L+++ H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 697 NLIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN- 751
           N+I ++ V     S  DF+  D   +V   M        L++         +   Q+L+ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQ--DV-YLVTHLMGAD-----LNN---------IVKCQKLSD 117

Query: 752 -----IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
                +   +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+  ++    
Sbjct: 118 DHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMT 173

Query: 807 TIVETRSISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFTRK 855
             V TR           Y APE       Y      +   D++S G ++ EL T K
Sbjct: 174 GYVATR----------WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 57/228 (25%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV---AECKALRNIR-HRNLIK 700
            KIGEG    V K    + G   A+K   +K+   S   V    E +ALR +  H N+++
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 701 IITVC----SGRDFKGADFKAIVYEFMQNGSLEEWL---HHSNDQLEVCSLSVIQRLNIA 753
           +I V     +GR        A+V+E M + +L E +        +  V         +  
Sbjct: 63  LIEVLFDRKTGR-------LALVFELM-DMNLYELIKGRKRPLPEKRV--------KSYM 106

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI-VETR 812
             +  +++++H      I H D+KP N+L+  D++  ++DFG  + + +  P T  + TR
Sbjct: 107 YQLLKSLDHMHRN---GIFHRDIKPENILIKDDILK-LADFGSCRGIYSKPPYTEYISTR 162

Query: 813 SISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFT 853
                      Y APE       YG       K D+++ G +  E+ +
Sbjct: 163 ----------WYRAPECLLTDGYYG------PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 37/224 (16%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           ++S  ++G G  G V        G +VA+K ++   + +  +K    E   L++++H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 699 IKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLHH--SNDQLEVCSLSVIQRLNI 752
           I ++ V     SG +F+  DF  +V  +MQ   L++ + H  S D+++     V Q L  
Sbjct: 77  IGLLDVFTSAVSGDEFQ--DF-YLVMPYMQT-DLQKIMGHPLSEDKVQYL---VYQML-- 127

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
                  ++Y+H      I+H DLKP N+ +++D    + DFGLA+         +V   
Sbjct: 128 -----CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--- 176

Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                   T  Y APE  +     +   D++S G ++ E+ T K
Sbjct: 177 --------TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 29/237 (12%)

Query: 624 QQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF 683
           +  + DS+ + S   D +     IG+G  G V+K    +NG++ AVK+++       +  
Sbjct: 6   KTIIFDSFPDPS---DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEI 61

Query: 684 VAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC 742
            AE   L+ +  H N++K   +   +D K  D   +V E    GS+ +        L   
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--------LVKG 113

Query: 743 SLSVIQRLN---IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            L   +R+    IA  +  A+  L H      +H D+K +N+LL  +    + DFG++  
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173

Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEY-----GMGREASMKGDVYSFGILLLEL 851
           L++         R+ S+   GT  ++APE       +      + DV+S GI  +EL
Sbjct: 174 LTSTR-----LRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           +++G+G  G VYK      G  +A+K I L+   +   F      L +I H+ +   I  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMEL-DILHKAVSPYIV- 62

Query: 705 CSGRDFKGADF-KAIVY---EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
               DF GA F +  VY   E+M  GSL++ L+      E     V++R  I   V   +
Sbjct: 63  ----DFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR--ITYAVVKGL 115

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           ++L    E +I+H D+KP+NVL++ +    + DFG++  L            S++    G
Sbjct: 116 KFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL----------VASLAKTNIG 163

Query: 821 TVGYVAPEY----GMGREA--SMKGDVYSFGILLLEL 851
              Y+APE     G  +    +++ DV+S G+ +LE+
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 40/188 (21%)

Query: 671 VINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA-------DFKAIVYEFM 723
           V+ + QKG +   + E   L+N+ H ++I++          GA        + + +Y ++
Sbjct: 95  VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTL----VSGAITCMVLPHYSSDLYTYL 147

Query: 724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL 783
              S                L + Q L I   +   + YLH      I+H D+K  N+ +
Sbjct: 148 TKRSRP--------------LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFI 190

Query: 784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYS 843
           +      + D G A+F     P          +G+ GTV   APE     + + K D++S
Sbjct: 191 NDVDQVCIGDLGAAQFPVV-APA--------FLGLAGTVETNAPEVLARDKYNSKADIWS 241

Query: 844 FGILLLEL 851
            GI+L E+
Sbjct: 242 AGIVLFEM 249

Length = 357

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 42/147 (28%), Positives = 60/147 (40%), Gaps = 40/147 (27%)

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+E+LH      I++ DLKP N+LLD      ++DFGL K              SI  G 
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-------------ESIHEGT 155

Query: 819 K-----GTVGYVAPEYGMGREASMKG-DVYSFGILLLELFT---------RKRPTDAMFN 863
                 GT+ Y+APE  M R    K  D +S G L+ ++ T         RK+  D +  
Sbjct: 156 VTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214

Query: 864 EGLTL--------HDFSREFFTRKSDT 882
             L L         D  ++   R   +
Sbjct: 215 GKLNLPPYLTPEARDLLKKLLKRNPSS 241

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 17/103 (16%)

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A++ +H      ++H DLK +N+ L    +  + DFG +K  S+          S+S+ +
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD----------SVSLDV 227

Query: 819 K----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                GT  Y+APE    +  S K D++S G++L EL T  RP
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 40/155 (25%), Positives = 61/155 (39%), Gaps = 20/155 (12%)

Query: 646 KIGEG--GSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV---AECKALRNIRHRNLIK 700
            IG+      IV+        T VAVK INL    + +       E    R ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILP 63

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +T      F       +V   M  GS E+ L  H  + L       I    I  DV +A
Sbjct: 64  YVTS-----FIVDSELYVVSPLMAYGSCEDLLKTHFPEGL---PELAIA--FILKDVLNA 113

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
           ++Y+H       +H  +K S++LL  D    +S  
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 52/232 (22%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 86  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 127

Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH---NP 805
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+         P
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184

Query: 806 DTIVETRSISIGIKGTVGYVAPE--YGMGREASMKGDVYSFGILLLELFTRK 855
             +            T  Y APE   GMG + ++  D++S G ++ E+    
Sbjct: 185 YVV------------TRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 28/219 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G  G V    L E+G   AVKV+    + Q    +  + E + L   R+   +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN--DQLEVCSLSVIQRLNIAIDVASAIE 761
            C    F+  D    V EF+  G L   +  S   D+              A ++ SA+ 
Sbjct: 63  CC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--------AAEITSALM 110

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           +LH   +  I++ DLK  NVLLD +    ++DFG+ K       + I   ++ S    GT
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTST-FCGT 159

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
             Y+APE           D ++ G+LL E+     P +A
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
           + E + L+N RH  L  +        F+  D    V E+   G L  + H S +++    
Sbjct: 43  LTENRVLQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV---- 91

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            S  +      ++ SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K     
Sbjct: 92  FSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----- 144

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             + I +  ++     GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 145 --EGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)

Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           +N+I ++ V                 F    SLEE+       +E+   ++ Q + + +D
Sbjct: 76  KNIISLLNV-----------------FTPQKSLEEF-QDVYLVMELMDANLCQVIQMELD 117

Query: 756 ----------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
                     +   I++LH      I+H DLKPSN+++  D    + DFGLA+       
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174

Query: 806 DT-IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            T  V TR           Y APE  +G       D++S G ++ E+   K
Sbjct: 175 MTPYVVTRY----------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 26/107 (24%)

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKF--------LSNHNPDTI 808
           A+EYLH+Y    IVH DLKP N+L+    + H+  +DFGL+K         L   + +  
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIE-- 165

Query: 809 VETRS-ISIGIKGTVGYVAPEY----GMGREASMKGDVYSFGILLLE 850
            +TR  +   + GT  Y+APE     G G+      D ++ GI+L E
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           + +++ A+ +LH   E  I++ DLK  NVLLD +    ++D+G+ K      P     T 
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTST- 155

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                  GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 156 -----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 37/114 (32%), Positives = 49/114 (42%), Gaps = 16/114 (14%)

Query: 751 NIAIDVASAIEYLHHYC-------EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           N   D   AI Y    C          IV+ DLKP N+LLD      +SD GLA      
Sbjct: 96  NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV----- 150

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               I E  ++  G  GTVGY+APE     + +   D +  G L+ E+   + P
Sbjct: 151 ---QIPEGETVR-GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 31/186 (16%)

Query: 671 VINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG---ADFKAIVYEFMQNGS 727
           VI   Q+G +     E   LR I H ++I++    +   F       +K  +Y ++    
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA--- 174

Query: 728 LEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL 787
                  +   + +C +  I+R      V  AI+YLH   E  I+H D+K  N+ ++   
Sbjct: 175 -------AKRNIAICDILAIER-----SVLRAIQYLH---ENRIIHRDIKAENIFINHPG 219

Query: 788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
              + DFG A F     P  I   +    G  GT+   APE           D++S GI+
Sbjct: 220 DVCLGDFGAACF-----PVDINANK--YYGWAGTIATNAPELLARDPYGPAVDIWSAGIV 272

Query: 848 LLELFT 853
           L E+ T
Sbjct: 273 LFEMAT 278

Length = 391

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 9/101 (8%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           +  VA  +E+L        +H DL   N+LL ++ V  + DFGLA+ +   +PD + +  
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGD 240

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 241 A-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 17/136 (12%)

Query: 718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK 777
           +V  F+  G L    HH   Q E        R   A ++  A+E LH +   ++++ DLK
Sbjct: 70  LVLAFINGGEL---FHHL--QREGRFDLSRARFYTA-ELLCALENLHKF---NVIYRDLK 120

Query: 778 PSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASM 837
           P N+LLD      + DFGL K L+  + D    T +      GT  Y+APE  +G   + 
Sbjct: 121 PENILLDYQGHIALCDFGLCK-LNMKDDDK---TNTFC----GTPEYLAPELLLGHGYTK 172

Query: 838 KGDVYSFGILLLELFT 853
             D ++ G+LL E+ T
Sbjct: 173 AVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.6 bits (115), Expect = 7e-06
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 25/219 (11%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLI 699
           F     +G G  G VYKG   + G   A+KV+++      +    E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66

Query: 700 KIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSN-DQLEVCSLSVIQRLNIAIDVA 757
                   ++  G D +  +V EF   GS+ + + ++  + L+   ++ I R     ++ 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 121

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + +LH +    ++H D+K  NVLL ++    + DFG++  L     D  V  R+  I 
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFI- 172

Query: 818 IKGTVGYVAPEYGMGREA-----SMKGDVYSFGILLLEL 851
             GT  ++APE     E        K D++S GI  +E+
Sbjct: 173 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 17/151 (11%)

Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  D    V E++  G L   ++H     +V      Q +  A +++  + +LH     
Sbjct: 70  FQTVDRLYFVMEYVNGGDL---MYHIQ---QVGKFKEPQAVFYAAEISVGLFFLH---RR 120

Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            I++ DLK  NV+LD +    ++DFG+ K    H  D  V TR+      GT  Y+APE 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDG-VTTRTFC----GTPDYIAPEI 172

Query: 830 GMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              +      D +++G+LL E+   + P D 
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 7e-06
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 9/111 (8%)

Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
           +L     L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + +V+  +     +  V ++APE       + + DV+S+GILL E+F+
Sbjct: 267 -DSNYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 13/106 (12%)

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-DTIVETRS 813
           +++ A+ YLH   E  I++ DLK  NVLLD +    ++D+G+ K      P DT      
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT------ 152

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
            +    GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 153 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 9/98 (9%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           VA  +E+L        +H DL   N+LL ++ V  + DFGLA+ +   +PD  V   S  
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPD-YVRKGSAR 237

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +K    ++APE    +  + + DV+SFG+LL E+F+
Sbjct: 238 LPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
           V E + L+N RH  L  +        F+  D    V E+   G L  + H S +++    
Sbjct: 43  VTESRVLQNTRHPFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV---- 91

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            +  +      ++ SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K     
Sbjct: 92  FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----- 143

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             + I +  ++     GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 144 --EGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 17/114 (14%)

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           LS +  +  +  VA+ +E+L      + VH DL   NVL+ +  +  + DFGLA+     
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR----- 287

Query: 804 NPDTIVETRSISIGIKGT----VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             D + ++  IS   KG+    + ++APE       +   DV+SFGILL E+FT
Sbjct: 288 --DIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 1/76 (1%)

Query: 173 GMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNAS 232
           G IP  I  +  L+ I+LS N   G++P   G ++ SL  L  + N+F G IP SL   +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 233 SLEMIEFSKNQFSGGV 248
           SL ++  + N  SG V
Sbjct: 491 SLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 61/235 (25%)

Query: 83  NLSSCSNLIELSADSNNL-------------VGEIPADIG--SLFKL-----ERLSIFQN 122
            LS CS+L+EL +    L             +  +P  I   SL++L      RL  F +
Sbjct: 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPD 722

Query: 123 HITG------------QLPAS--IGNLSSLRVIDVRENRLWGRIDSLGQL-----KSLTL 163
             T             + P++  + NL  L + +++  +LW R+  L  L      SLT 
Sbjct: 723 ISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782

Query: 164 LSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSL--------RELRT 215
           L ++       +P SI N+  LE + +       +LP  TG+NL SL          LRT
Sbjct: 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP--TGINLESLESLDLSGCSRLRT 840

Query: 216 NAN----------NFTGF--IPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNL 258
             +          + TG   +P  +   S+L  ++ +       VS++ S+LK+L
Sbjct: 841 FPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895

syringae 6; Provisional. Length = 1153

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 67/249 (26%), Positives = 98/249 (39%), Gaps = 44/249 (17%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F S   IG G  G V      + G   A+K++  K     K  VA  +A R+I    L
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDI----L 55

Query: 699 IKIITVCSGRDFKGADFKAIVY---EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++       + F     K  +Y   EF+  G +   L   +   E  +   I    +AID
Sbjct: 56  VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL---------AKFLSN--HN 804
              AI  L        +H D+KP N+LLD      +SDFGL          +F  N  HN
Sbjct: 116 ---AIHQL------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 805 PDT-----------IVET-----RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           P +             ET     R ++    GT  Y+APE  M    +   D +S G+++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 849 LELFTRKRP 857
            E+     P
Sbjct: 227 YEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 26/210 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKAL-RNIRHRNLIKII 702
           IG+G  G V       +G   AVKV+  K    +   K  +AE   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  F+  +    V +F+  G L  + H   ++    S    +    A ++ASA+ Y
Sbjct: 62  ----HYSFQTTEKLYFVLDFVNGGEL--FFHLQRER----SFPEPRARFYAAEIASALGY 111

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     +IV+ DLKP N+LLD      ++DFGL K       + I ++ + +    GT 
Sbjct: 112 LHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTT-FCGTP 160

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            Y+APE    +      D +  G +L E+ 
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 22/60 (36%), Positives = 30/60 (50%)

Query: 457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
           NL  LDLS N+ +           NL+ L++SGN  +   P     L S++ LD S NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.0 bits (114), Expect = 2e-05
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 29/133 (21%)

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD--QDLVSHVSDFGLAKFL- 800
           L + Q   +A  + SAI+Y+H   E  I+H D+K  NVL++  +D+   + DFG A F  
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GE-GIIHRDIKTENVLVNGPEDIC--LGDFGAACFAR 311

Query: 801 -SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE-------LF 852
            S   P           GI GTV   APE   G   +   D++S G+++ E       LF
Sbjct: 312 GSWSTP--------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363

Query: 853 T-----RKRPTDA 860
           +      +RP DA
Sbjct: 364 SASRGDERRPYDA 376

Length = 461

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 25/219 (11%)

Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLI 699
           F     +G G  G VYKG   + G   A+KV+++ +    +    E   L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIA 76

Query: 700 KIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSN-DQLEVCSLSVIQRLNIAIDVA 757
                   +   G D +  +V EF   GS+ + + ++  + L+   ++ I R     ++ 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EIL 131

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + +LH +    ++H D+K  NVLL ++    + DFG++  L     D  V  R+  I 
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFI- 182

Query: 818 IKGTVGYVAPEYGMGREA-----SMKGDVYSFGILLLEL 851
             GT  ++APE     E        + D++S GI  +E+
Sbjct: 183 --GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 22/152 (14%)

Query: 718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK 777
           ++ +++++G L + L           LS  +   I   +  A+  LH +   +I+H D+K
Sbjct: 86  LIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIK 136

Query: 778 PSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
             NVL D+     ++ D+GL K         I+ T S      GT+ Y +PE   G    
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCK---------IIGTPSC---YDGTLDYFSPEKIKGHNYD 184

Query: 837 MKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
           +  D ++ G+L  EL T K P     +E L L
Sbjct: 185 VSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 3e-05
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 11/160 (6%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           + F     I  G  G VY G    N    AVKV+  K    +K+ V + +A R+    + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSK 62

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
              I V      + A+   +V E++  G ++  LH      E  ++  I       +VA 
Sbjct: 63  SPFI-VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS------EVAL 115

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
           A++YLH +    I+H DLKP N+L+  +    ++DFGL+K
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 50/225 (22%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           +G G  G V   +      +VAVK ++   +    ++    E + L++++H N+I ++ V
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 705 ----CSGRDFK---------GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
                S  +F          GAD   IV          +    S++ ++     +++ L 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIV----------KCQKLSDEHVQFLIYQLLRGL- 131

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                    +Y+H      I+H DLKPSNV +++D    + DFGLA+           + 
Sbjct: 132 ---------KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QA 168

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                G   T  Y APE  +     +   D++S G ++ EL   K
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 32/179 (17%)

Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
           + E + L+N RH  L  +        F+  D    V E+   G L  + H S +++    
Sbjct: 43  LTESRVLQNTRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV---- 91

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            S  +      ++ SA+ YLH      +V+ DLK  N++LD+D    ++DFGL K     
Sbjct: 92  FSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----- 143

Query: 804 NPDTIVETRSISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                     IS G       GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 144 --------EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 26/226 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F     IG G  G V    +       A+K++N K +   ++  A  +  RN+     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVA 757
            + IT      F+  ++  +V ++   G L   L    D+L E  +   I  + +AI   
Sbjct: 60  CQWITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH-- 116

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            +I  LH+      VH D+KP NVLLD +    ++DFG    +   N D  V++ S+++ 
Sbjct: 117 -SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKM---NQDGTVQS-SVAV- 164

Query: 818 IKGTVGYVAPEY------GMGREASMKGDVYSFGILLLELFTRKRP 857
             GT  Y++PE       GMG+    + D +S G+ + E+   + P
Sbjct: 165 --GTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 9e-05
 Identities = 20/60 (33%), Positives = 26/60 (43%)

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           NL+ LDL  N L      +   L  L  L L  NNL    P +     +L  L++S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 60/249 (24%), Positives = 94/249 (37%), Gaps = 44/249 (17%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++F S   IG G  G V      + G   A+K++  K     K  V   +A R+I    L
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDI----L 55

Query: 699 IKIITVCSGRDFKGADFKAIVY---EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++  ++   + F     K  +Y   EF+  G +   L   +   E  +   I    +AID
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL--------------- 800
               + ++H          D+KP N+LLD      +SDFGL   L               
Sbjct: 116 SIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 801 -------SNHNPDTIVET-----RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                   N N     ET     R ++    GT  Y+APE  M    +   D +S G+++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 849 LELFTRKRP 857
            E+     P
Sbjct: 227 YEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++A  + +LH      I++ DLK  NV+LD +    ++DFG+ K     N    V T+
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTK 159

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           +      GT  Y+APE    +      D ++FG+LL E+   + P + 
Sbjct: 160 TFC----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 54/204 (26%), Positives = 81/204 (39%), Gaps = 42/204 (20%)

Query: 662 ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKII-------TVC-SGRDFKGA 713
           E   +V VK +     G  K+   E   L+ I HR +I +I       TVC     +K  
Sbjct: 117 EQRKKVIVKAVT---GG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVH 773
            F  +  +      LE+ +              IQR      +  A+ YLH      I+H
Sbjct: 172 LFTYV--DRSGPLPLEQAI-------------TIQR-----RLLEALAYLH---GRGIIH 208

Query: 774 GDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR 833
            D+K  N+ LD+   + + DFG A  L  H PDT         G  GT+   +PE     
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAH-PDT-----PQCYGWSGTLETNSPELLALD 262

Query: 834 EASMKGDVYSFGILLLELFTRKRP 857
               K D++S G++L E+  +   
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 22/219 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+G G  G VYK    +   E    +  ++  G S S   E   LR ++H N+I +  V 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 706 SGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL--NIAIDVASAIEY 762
                  +D K  +++++ ++        H   +     + + + +  ++   +   I Y
Sbjct: 68  ----LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 763 LHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           LH      ++H DLKP+N+L+     ++  V  ++D G A+ L N     + +   + + 
Sbjct: 124 LH---ANWVLHRDLKPANILVMGEGPERGRVK-IADMGFAR-LFNSPLKPLADLDPVVV- 177

Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +G     K  D+++ G +  EL T +
Sbjct: 178 ---TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 31/243 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHR 696
            +F   + +G G  G V        G   A+KV+      A +  SF  E + + +I + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
             I  +       F+  D   +V E+   G L   L+   DQ +     + Q       +
Sbjct: 61  PWIPQLQYA----FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYL 108

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           A  +  +H   +   VH D+KP NVL+D+     ++DFG A  L+ +    +     +  
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK--MVNSKLPV-- 164

Query: 817 GIKGTVGYVAPEYGMGREASMKG------DVYSFGILLLELFTRKRPTDAMFNEGLTLHD 870
              GT  Y+APE         KG      D +S G++  E+   + P    F+EG +   
Sbjct: 165 ---GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKT 217

Query: 871 FSR 873
           ++ 
Sbjct: 218 YNN 220

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 45/228 (19%)

Query: 646 KIGEGGSGIV----YKGFLGENGTEVAVK-VINLKQKGAS-KSFVAECKALRNIR-HRNL 698
           ++G+G  GIV               VA+K + N+  K    K  + E K LR+ R H+N+
Sbjct: 7   ELGQGAYGIVCSARNAE--TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI----QRLNIA- 753
             +  +             IV+    N     +L+   ++L    L  I    Q L  A 
Sbjct: 65  TCLYDM------------DIVFPGNFNEL---YLY---EELMEADLHQIIRSGQPLTDAH 106

Query: 754 -----IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   ++Y+H     +++H DLKP N+L++ D    + DFGLA+     + +  
Sbjct: 107 FQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPG 160

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
                ++     T  Y APE  +  ++  K  DV+S G +L EL  RK
Sbjct: 161 ENAGFMT-EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 33/152 (21%)

Query: 701 IIT-VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           IIT  C GRD    D K  + E    G                +LS  Q     I +   
Sbjct: 79  IITEYCEGRDL---DCK--LEELKHTGK---------------TLSENQVCEWFIQLLLG 118

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + Y+H   +  I+H DLK  N+ L  +L+  + DFG+++ L        + +  ++    
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLL--------MGSCDLATTFT 166

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           GT  Y++PE    +    K D++S G +L E+
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 27/174 (15%)

Query: 686 ECKALRNIRHRNLIKIITVCSGRDF-----KGADFKAIVYEFMQNGSLEEWLHHSNDQLE 740
           E  AL  + H N++KI  +           +  DF   +Y FM + + + W         
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-WKD------- 262

Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
                + Q   I   +  A+EY+H   +  ++H D+K  N+ L+ D    + DFG A   
Sbjct: 263 --RPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
                    E  +   G  GTV   +PE   G       D++S G++LL++ + 
Sbjct: 318 EK-------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 26/221 (11%)

Query: 646 KIGEGGSGIVYKGFL--GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           K+G G  G VYK     G++  + A+K I  +  G S S   E   LR ++H N+I +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQK 65

Query: 704 VCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL--NIAIDVASAI 760
           V        AD K  +++++ ++        H   +     + + + +  ++   +   I
Sbjct: 66  VF----LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 761 EYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
            YLH      ++H DLKP+N+L+     ++  V  ++D G A+ L N     + +   + 
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVK-IADMGFAR-LFNSPLKPLADLDPVV 176

Query: 816 IGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
           +    T  Y APE  +G     K  D+++ G +  EL T +
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-04
 Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 37/125 (29%)

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGL----------------AKFL 800
           AI+ +H       +H D+KP N+LLD     H+  SDFGL                +  L
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 801 SNHNPDTIVET--------------RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGI 846
            ++  D I +               R+++    GT  Y+APE  +    + + D +S G+
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 847 LLLEL 851
           ++ E+
Sbjct: 228 IMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 14/86 (16%)

Query: 772 VHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT----VGYVAP 827
           +H D+   NVLL    V+ + DFGLA+ + N +          +  +KG     V ++AP
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS----------NYVVKGNARLPVKWMAP 283

Query: 828 EYGMGREASMKGDVYSFGILLLELFT 853
           E       +++ DV+S+GILL E+F+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 5e-04
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 21/107 (19%)

Query: 759 AIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           AI+ +H   Y     VH D+KP NVLLD++    ++DFG    L     D  V++ ++++
Sbjct: 114 AIDSVHQLGY-----VHRDIKPDNVLLDKNGHIRLADFGSCLRL---LADGTVQS-NVAV 164

Query: 817 GIKGTVGYVAPEY------GMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y++PE       G GR    + D +S G+ + E+   + P
Sbjct: 165 ---GTPDYISPEILQAMEDGKGRYGP-ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 39/144 (27%)

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHN--- 804
           R  IA ++  AIE +H       +H D+KP N+L+D+D    ++DFGL   F   H+   
Sbjct: 104 RFYIA-ELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 805 --------------PDTIVE-----------------TRSISIGIKGTVGYVAPEYGMGR 833
                          +   E                  R ++  + GT  Y+APE  +  
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 834 EASMKGDVYSFGILLLELFTRKRP 857
             +   D +S G++L E+   + P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only]

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 21/97 (21%), Positives = 33/97 (34%), Gaps = 16/97 (16%)

Query: 709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA-IEYLHHYC 767
                D             L  W    +D+           L   I +A   I++L    
Sbjct: 142 AAGLPDPGKPNAYR--GRQLARW----DDEYRRAKKE----LGGRIPLADRLIKWLEANR 191

Query: 768 -----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
                 P +VHGD +P N+++D    + V D+ LA  
Sbjct: 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228

Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 41.7 bits (98), Expect = 0.002
 Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 7/75 (9%)

Query: 197 GSLPVDTGVNLPSLRELRT---NANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
           G +P D    +  LR L++   + N+  G IP SL + +SLE+++ S N F+G +     
Sbjct: 432 GFIPND----ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487

Query: 254 RLKNLYWLNLGINNL 268
           +L +L  LNL  N+L
Sbjct: 488 QLTSLRILNLNGNSL 502

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 22/56 (39%), Positives = 28/56 (50%), Gaps = 2/56 (3%)

Query: 436 YLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGN 490
            L+L NN L   +P      L NL  LDLSGN  +   P   S   +L  L++SGN
Sbjct: 4   SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 26/111 (23%), Positives = 35/111 (31%), Gaps = 19/111 (17%)

Query: 712 GADFKAIVYEFMQNGSLEEW-LHHSNDQLEVCSLS-VIQRLNIAIDVASAIEYLH---HY 766
              F       +      EW +      L +  +     R  +   +   +  L      
Sbjct: 138 LRGFPFERPNAL---RRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194

Query: 767 CEPSIVHGDLKPSNVLLDQD-LVSHVSDFG----------LAKFLSNHNPD 806
               I+HGDL P NVL D D  VS   DF           LA  L+  N D
Sbjct: 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYGWFIYDLAIALNAWNGD 245

Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.003
 Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 40/214 (18%)

Query: 668 AVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA-IVYEFMQNG 726
           A+    LK++  S+  V E   +R ++H+N+++ I     R    A+ K  I+ EF   G
Sbjct: 45  AISYRGLKEREKSQ-LVIEVNVMRELKHKNIVRYID----RFLNKANQKLYILMEFCDAG 99

Query: 727 SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE----PSIVHGDLKPSNVL 782
            L   +              I  ++I   +  A+ Y H+  +      ++H DLKP N+ 
Sbjct: 100 DLSRNIQKCYKMFGKIEEHAI--VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157

Query: 783 LDQDL-----------------VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
           L   +                 ++ + DFGL+K +            S++    GT  Y 
Sbjct: 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---------IESMAHSCVGTPYYW 208

Query: 826 APEYGMGREASM--KGDVYSFGILLLELFTRKRP 857
           +PE  +    S   K D+++ G ++ EL + K P
Sbjct: 209 SPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 24/147 (16%)

Query: 718 IVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           +V ++   G L   L    D+L E  +   +  + IAID   ++  LH+      VH D+
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---SVHQLHY------VHRDI 128

Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY------G 830
           KP N+L+D +    ++DFG    L     D  V++ S+++   GT  Y++PE       G
Sbjct: 129 KPDNILMDMNGHIRLADFGSCLKLME---DGTVQS-SVAV---GTPDYISPEILQAMEDG 181

Query: 831 MGREASMKGDVYSFGILLLELFTRKRP 857
            G+    + D +S G+ + E+   + P
Sbjct: 182 KGKYGP-ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 11/105 (10%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A  V   ++YLH   E  IV+ DLK  N+LLD +    ++DFGL K            T 
Sbjct: 107 AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST- 160

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  GT  ++APE       +   D +  G+L+ E+   + P
Sbjct: 161 -----FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 18/51 (35%), Positives = 28/51 (54%), Gaps = 4/51 (7%)

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           R ++  +V   +  LH   +  IVHGDL  SN++L    + +  DFGL +F
Sbjct: 94  RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140

Length = 204

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 56/237 (23%), Positives = 113/237 (47%), Gaps = 31/237 (13%)

Query: 623 EQQFLVDSYAELSKATD-NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           +++ ++D+  +++++ + ++   N IG G  G+VY+    +   +VA+K +    +  ++
Sbjct: 51  DEEKMIDN--DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR 108

Query: 682 SFVAECKALRNIRHRNLIKI----ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS-N 736
               E   ++N+ H N+I +     T C  ++ K   F  +V EF+     +   H++ N
Sbjct: 109 ----ELLIMKNLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARN 163

Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFG 795
           +     +L +      +  +  A+ Y+H      I H DLKP N+L+D +  +  + DFG
Sbjct: 164 NH----ALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLEL 851
            AK L       +   RS+S     +  Y APE  +G    +   D++S G ++ E+
Sbjct: 217 SAKNL-------LAGQRSVSYIC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	884
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.98
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.98
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.98
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.98
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.98
PTZ00284	467	protein kinase; Provisional	99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.98
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
smart00090	237	RIO RIO-like kinase.	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
PLN03150	623	hypothetical protein; Provisional	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
PLN03150	623	hypothetical protein; Provisional	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.17
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.14
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.1
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.95
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.8
COG4248	637	Uncharacterized protein with protein kinase and he	98.73
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.69
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.66
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.59
PRK09902	216	hypothetical protein; Provisional	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.49
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-106  Score=1000.43  Aligned_cols=831  Identities=32%  Similarity=0.516  Sum_probs=711.6

Q ss_pred             CCceeEeeEEcCCCCeEEEEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCCcCcC-CCCCCCEEEccCCcCcCcC
Q 002760            2 NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG-RLISLERLILSNNSFSGAI   80 (884)
Q Consensus         2 ~~~~w~~v~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~   80 (884)
                      +||.|+||+|+. .++|+.|||+++++++.+|+.+..+++|++|+|++|++.+.+|..+. .+++|++|+|++|++++.+
T Consensus        56 ~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~  134 (968)
T PLN00113         56 DVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI  134 (968)
T ss_pred             CCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCcccccc
Confidence            799999999975 56899999999999999999999999999999999999999998766 8999999999999999888


Q ss_pred             CccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccc-ccccccccc
Q 002760           81 PANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQLK  159 (884)
Q Consensus        81 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~l~~l~  159 (884)
                      |.  +.+++|++|+|++|.+.+.+|..++.+++|++|+|++|.+++.+|..++++++|++|++++|++.. +|..+++++
T Consensus       135 p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~  212 (968)
T PLN00113        135 PR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMK  212 (968)
T ss_pred             Cc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcC
Confidence            85  568999999999999999999999999999999999999998999999999999999999999875 678899999


Q ss_pred             ccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecc
Q 002760          160 SLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF  239 (884)
Q Consensus       160 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L  239 (884)
                      +|++|++++|++++.+|..+.++++|++|+|++|.+.+.+|.. +.++++|++|++++|.+++..|..+.++++|+.|++
T Consensus       213 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  291 (968)
T PLN00113        213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL  291 (968)
T ss_pred             CccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence            9999999999999999999999999999999999999888765 458999999999999999999999999999999999


Q ss_pred             cccccccCcccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhccc
Q 002760          240 SKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMG  319 (884)
Q Consensus       240 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~  319 (884)
                      ++|.+.+..+..+..+++|+.|++++|.+....      +..+..+++|+.|++++|.+.+.+|..+..+. .|+.|+++
T Consensus       292 s~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls  364 (968)
T PLN00113        292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLS  364 (968)
T ss_pred             cCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECC
Confidence            999999999999999999999999999987533      34578899999999999999999998887764 59999999


Q ss_pred             CCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccC
Q 002760          320 RNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI  399 (884)
Q Consensus       320 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  399 (884)
                      +|++++..|..+..+++|+.|++++|++.+..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.+
T Consensus       365 ~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  444 (968)
T PLN00113        365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI  444 (968)
T ss_pred             CCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcCcccccccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcc
Q 002760          400 PSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSAC  479 (884)
Q Consensus       400 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  479 (884)
                      |..+..+++|+.|++++|++.+.+|..+..  ..+..|++++|++++..|..|..+++|+.|+|++|++++.+|..+..+
T Consensus       445 ~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~--~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  522 (968)
T PLN00113        445 NSRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC  522 (968)
T ss_pred             ChhhccCCCCcEEECcCceeeeecCccccc--ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence            999999999999999999999988876532  345579999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcEEeeccCccccCccccceeeccCccccccccccccCCCccceeeccCccCccccCCCCccccccccccc
Q 002760          480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIA  559 (884)
Q Consensus       480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~  559 (884)
                      ++|++|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+++|+.|++++|+++|.+|..+++..+...++.
T Consensus       523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~  602 (968)
T PLN00113        523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA  602 (968)
T ss_pred             cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccCCCCcCC-CCCCCCCCcceeEEEeehhhhhHHHHHHhheeeeeeeecccccccCccccc--cc--cc---cccH
Q 002760          560 GNGKLCGGLDELR-LPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIE--QQ--FL---VDSY  631 (884)
Q Consensus       560 ~n~~~c~~~~~~~-~~c~~~~~~~~~~~i~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~--~~--~~---~~~~  631 (884)
                      ||+.+||+..... .+|....++..++.+++++++++++++++++.++++|+++...........  .+  ..   ....
T Consensus       603 ~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (968)
T PLN00113        603 GNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS  682 (968)
T ss_pred             CCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchh
Confidence            9999999753322 345432222222222332333222222222233333333221111111000  00  00   0011


Q ss_pred             HHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          632 AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       632 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .........|...+.||+|+||.||+|++..+++.||||+++....    ....|++++++++|||||+++++|.     
T Consensus       683 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~-----  753 (968)
T PLN00113        683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCR-----  753 (968)
T ss_pred             hhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEE-----
Confidence            1223334568888999999999999999988999999998863322    1234688999999999999999964     


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      .++..++||||+++|+|.++++         .++|.++.+|+.|+++|++|||+.++++|+||||||+||+++.++.+++
T Consensus       754 ~~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        754 SEKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             cCCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            3456799999999999999996         3678899999999999999999766789999999999999999998887


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCccHHHH
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDF  871 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~~~  871 (884)
                      . ||.+......            ....||+.|+|||+..+..++.++|||||||++|||+||+.||+..........+|
T Consensus       825 ~-~~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  891 (968)
T PLN00113        825 R-LSLPGLLCTD------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW  891 (968)
T ss_pred             E-eccccccccC------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence            6 6655432111            11247899999999999999999999999999999999999997765555566667


Q ss_pred             HHHHh
Q 002760          872 SREFF  876 (884)
Q Consensus       872 ~~~~~  876 (884)
                      ++..+
T Consensus       892 ~~~~~  896 (968)
T PLN00113        892 ARYCY  896 (968)
T ss_pred             HHHhc
Confidence            65543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.8e-60  Score=586.44  Aligned_cols=515  Identities=31%  Similarity=0.506  Sum_probs=476.9

Q ss_pred             CCeEEEEEcCCCCCccccCcCcc-CCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEE
Q 002760           15 HQRVTRLDLGNQSIRGTLSPYVG-NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIEL   93 (884)
Q Consensus        15 ~~~v~~L~l~~~~~~~~~~~~l~-~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L   93 (884)
                      ...++.|||++|.+++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..++++++|++|
T Consensus        92 l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L  169 (968)
T PLN00113         92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVL  169 (968)
T ss_pred             CCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEE
Confidence            45789999999999999998877 999999999999999988886  568999999999999999999999999999999


Q ss_pred             eccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccc-cccccccccccceeeccccccC
Q 002760           94 SADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFS  172 (884)
Q Consensus        94 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~l~~l~~L~~L~L~~n~l~  172 (884)
                      +|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++.. +|..++++++|++|++++|+++
T Consensus       170 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  249 (968)
T PLN00113        170 DLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT  249 (968)
T ss_pred             ECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceec
Confidence            999999999999999999999999999999999999999999999999999999874 6788999999999999999999


Q ss_pred             CCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccccc
Q 002760          173 GMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDF  252 (884)
Q Consensus       173 ~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~  252 (884)
                      +.+|..+.++++|++|+|++|++.+.+|... .++++|++|++++|.+.+.+|..+.++++|+.|++++|.+.+..+..+
T Consensus       250 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~  328 (968)
T PLN00113        250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL  328 (968)
T ss_pred             cccChhHhCCCCCCEEECcCCeeeccCchhH-hhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence            9999999999999999999999998887655 479999999999999999999999999999999999999999999999


Q ss_pred             ccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCcccc
Q 002760          253 SRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR  332 (884)
Q Consensus       253 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  332 (884)
                      ..+++|+.|+++.|++....      +..+..+++|+.|++++|++.+.+|..+.... .++.|++++|.+.+..|..+.
T Consensus       329 ~~l~~L~~L~L~~n~l~~~~------p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-~L~~L~l~~n~l~~~~p~~~~  401 (968)
T PLN00113        329 TSLPRLQVLQLWSNKFSGEI------PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-NLFKLILFSNSLEGEIPKSLG  401 (968)
T ss_pred             hcCCCCCEEECcCCCCcCcC------ChHHhCCCCCcEEECCCCeeEeeCChhHhCcC-CCCEEECcCCEecccCCHHHh
Confidence            99999999999999987432      34578899999999999999999999888764 599999999999999999999


Q ss_pred             CCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCccccccc
Q 002760          333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGL  412 (884)
Q Consensus       333 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  412 (884)
                      .+++|+.|++++|++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|
T Consensus       402 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L  480 (968)
T PLN00113        402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENL  480 (968)
T ss_pred             CCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEE
Confidence            99999999999999999999999999999999999999999999999999999999999999998888766 45899999


Q ss_pred             ccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEE
Q 002760          413 NISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAF  492 (884)
Q Consensus       413 ~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  492 (884)
                      ++++|++.+.+|..+..+..+ ..|++++|.+.+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|++|++
T Consensus       481 ~ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  559 (968)
T PLN00113        481 DLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL  559 (968)
T ss_pred             ECcCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcc
Confidence            999999999999988877665 4799999999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCccccceeeccCccccccccccccCCCccceeeccCccCcc
Q 002760          493 SGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG  542 (884)
Q Consensus       493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  542 (884)
                      ++.+|..+..+++|+.|++++|++++.+|.. ..+..+....+.+|+.-|
T Consensus       560 ~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        560 SGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLC  608 (968)
T ss_pred             cccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCcccc
Confidence            9999999999999999999999999998864 333445556677887555

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=375.89  Aligned_cols=203  Identities=33%  Similarity=0.577  Sum_probs=181.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ..+|...++||+|+||+||+|+++.++.+||||.+..+  .....+-+..|+.+++.++|||||+++++     .+.++.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~-----~~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC-----IEDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE-----EecCCe
Confidence            46799999999999999999999999999999999755  34455678899999999999999999999     456778


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC------Cce
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD------LVS  789 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~------~~~  789 (884)
                      +|+|||||.||+|.+|+++.+      .+++.+++.++.|++.|+++||   +++||||||||.|||++.+      -.+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~L  154 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVL  154 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceE
Confidence            899999999999999999876      6899999999999999999999   8999999999999999864      468


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      ||+|||+|+.+.+..         .....||+|-|||||++....|+.|+|+||+|+++|+|++|+.||++...
T Consensus       155 KIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  155 KIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             EecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            999999999886432         22356899999999999999999999999999999999999999996443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.1e-48  Score=389.31  Aligned_cols=490  Identities=28%  Similarity=0.410  Sum_probs=382.8

Q ss_pred             CCeEEEEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEe
Q 002760           15 HQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELS   94 (884)
Q Consensus        15 ~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~   94 (884)
                      ..++..|++++|.+. .+.+++.++..|.+|++++|++. +.|.+++.+.+++.|+.|+|+++ .+|..++++.+|+.|+
T Consensus        44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~  120 (565)
T KOG0472|consen   44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD  120 (565)
T ss_pred             hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence            346788999999998 78889999999999999999999 99999999999999999999999 8999999999999999


Q ss_pred             ccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCC
Q 002760           95 ADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGM  174 (884)
Q Consensus        95 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~  174 (884)
                      .++|.+. ++|+.++.+..|+.|+..+|+++ ..|+++.++.+|..|++.+|+++.+|+..-+++.|++|++..|-++ .
T Consensus       121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-t  197 (565)
T KOG0472|consen  121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-T  197 (565)
T ss_pred             cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-c
Confidence            9999999 88999999999999999999999 8899999999999999999999999987777999999999999998 7


Q ss_pred             CCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccccccc
Q 002760          175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSR  254 (884)
Q Consensus       175 ~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  254 (884)
                      +|..++.+.+|+.|+|.+|++. .+|  .|.++..|++|+++.|+|..+.....+++++|.+|||++|+++..+. ...-
T Consensus       198 lP~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pd-e~cl  273 (565)
T KOG0472|consen  198 LPPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPD-EICL  273 (565)
T ss_pred             CChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCch-HHHH
Confidence            8999999999999999999998 888  45578899999999999997666667799999999999999997654 4667


Q ss_pred             ccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhc--cchhhhhhcc--cCCcccccCCcc
Q 002760          255 LKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVAN--LSSTIKQIAM--GRNRISGTIPPE  330 (884)
Q Consensus       255 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~~l~~L~l--~~n~l~~~~~~~  330 (884)
                      +++|.+||+|+|.|+..+.       .++++ +|+.|.+.+|.+... -..+-+  ...-+++|.-  ..-.++......
T Consensus       274 LrsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~  344 (565)
T KOG0472|consen  274 LRSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEGGT  344 (565)
T ss_pred             hhhhhhhcccCCccccCCc-------ccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence            8889999999999987654       47788 899999999988632 111111  1112333321  111111000000


Q ss_pred             ccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCcccc---CcEEEcccccccccCCCCCcCcc
Q 002760          331 IRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL---LTYLKLGLNNLEGNIPSSLGNCT  407 (884)
Q Consensus       331 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~  407 (884)
                      -...          -... ........+.+.+.|+++.-+++ .+|+.......   .+..+++.|++. .+|..+..++
T Consensus       345 e~~~----------t~~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lk  411 (565)
T KOG0472|consen  345 ETAM----------TLPS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELK  411 (565)
T ss_pred             cccC----------CCCC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHH
Confidence            0000          0000 01111223445666666666666 44443333333   566666666666 4666665555


Q ss_pred             ccc-ccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhccccccccc
Q 002760          408 NLL-GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN  486 (884)
Q Consensus       408 ~L~-~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  486 (884)
                      .+. .+.+++|.+ +.+|..+..+..+. .|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+.+-
T Consensus       412 elvT~l~lsnn~i-sfv~~~l~~l~kLt-~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtll  487 (565)
T KOG0472|consen  412 ELVTDLVLSNNKI-SFVPLELSQLQKLT-FLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLL  487 (565)
T ss_pred             HHHHHHHhhcCcc-ccchHHHHhhhcce-eeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHH
Confidence            553 334444443 35555555544443 5667766666 78889999999999999999998 8999999999999999


Q ss_pred             ccCcEEeeccCccccCccccceeeccCccccccccccccCCCccceeeccCccCc
Q 002760          487 ISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE  541 (884)
Q Consensus       487 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  541 (884)
                      .++|++..+.|+.+.+|.+|..|||.+|.|. .+|+.++++++|++|++++|+|.
T Consensus       488 as~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  488 ASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            9999999888888999999999999999998 79999999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=353.58  Aligned_cols=203  Identities=31%  Similarity=0.428  Sum_probs=182.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..++|++.++||+|+||+||.++.+.+++.+|+|+++++.   ....+...+|..++.+++||.||++.-.     |++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence            3578999999999999999999999999999999997542   3456778999999999999999999966     8889


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...|+|+||+.||.|..++++.+      .+++..+.-++.+|+.||.|||   ++||||||+||+|||++++|+++|+|
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEec
Confidence            99999999999999999999876      6889999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+++..-...        .....+|||+.|||||++.+..|+..+|.||+|+++|||++|.+||.+.
T Consensus       169 FgL~k~~~~~~--------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  169 FGLCKEDLKDG--------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             cccchhcccCC--------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            99998443221        1233589999999999999999999999999999999999999999873

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=376.66  Aligned_cols=401  Identities=21%  Similarity=0.223  Sum_probs=299.6

Q ss_pred             cceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccc
Q 002760          114 LERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN  193 (884)
Q Consensus       114 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n  193 (884)
                      -+.|++++|+++...+..|.++++|+.+++.+|.++.+|.......+|+.|+|.+|.|+.+-.+.+..++.|+.||||.|
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN  159 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN  159 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence            34577777777766666777777777777777777777766556666777777777777666667777777777777777


Q ss_pred             cccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCC
Q 002760          194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAA  273 (884)
Q Consensus       194 ~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  273 (884)
                      .|+ .+|...|..-.++++|+|++|.|+.+....|.++.+|..|.|++|+|+.++...|+++++|+.|+|..|+|.....
T Consensus       160 ~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~  238 (873)
T KOG4194|consen  160 LIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG  238 (873)
T ss_pred             hhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence            777 7777666666677777777777777777777777777777777777777777777777777777777776654321


Q ss_pred             ChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCc
Q 002760          274 NELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPP  353 (884)
Q Consensus       274 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  353 (884)
                      -      .|.++++                         ++.|.|..|+|+..-...|..+.++++|+|+.|+++..-..
T Consensus       239 l------tFqgL~S-------------------------l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g  287 (873)
T KOG4194|consen  239 L------TFQGLPS-------------------------LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG  287 (873)
T ss_pred             h------hhcCchh-------------------------hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence            1      1233333                         34444444444444556777788888888888888877777


Q ss_pred             ccCCCCCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhcc
Q 002760          354 EIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL  433 (884)
Q Consensus       354 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  433 (884)
                      ++.+++.|+.|+||+|.|+.+.++...-.++|+.|+|++|+|+...+.+|..+..|++|+|++|++.             
T Consensus       288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-------------  354 (873)
T KOG4194|consen  288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-------------  354 (873)
T ss_pred             cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-------------
Confidence            8888888888888888888777777777788888888888888777778888888888888888765             


Q ss_pred             chhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCch---hhhhcccccccccccCcEEeeccCccccCccccceee
Q 002760          434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIP---ATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELD  510 (884)
Q Consensus       434 ~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  510 (884)
                                  ..-..+|..+++|++|||++|.|+..+.   ..|.++++|+.|.|-||+|..+...+|.+++.|+.||
T Consensus       355 ------------~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld  422 (873)
T KOG4194|consen  355 ------------HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD  422 (873)
T ss_pred             ------------HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence                        2233467788999999999999987655   4688899999999999999988888999999999999


Q ss_pred             ccCccccccccccccCCCccceeeccCccCccccCCCCcccccccccccC-CCcccCCCCcCC
Q 002760          511 FSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAG-NGKLCGGLDELR  572 (884)
Q Consensus       511 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~-n~~~c~~~~~~~  572 (884)
                      |.+|.|-.+.|.+|..+ .|+.|-+..-.+-|+|...|..+|+-...+.. -...|+-|+.+.
T Consensus       423 L~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~La  484 (873)
T KOG4194|consen  423 LGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPLA  484 (873)
T ss_pred             CCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccceeeeccCCcccc
Confidence            99999999999999999 89999999999999999877655553322221 124576665443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=375.27  Aligned_cols=395  Identities=23%  Similarity=0.261  Sum_probs=279.5

Q ss_pred             CcEEEccCCcCCCCCCcCcCCC--CCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecc
Q 002760           42 LRYINIASNGFNGEIPHQIGRL--ISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSI  119 (884)
Q Consensus        42 L~~L~l~~n~~~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  119 (884)
                      -+-||.+++++...-...+...  +.-++||+|+|+++..-+..|.++.+|+++++..|.++ .+|.......+|+.|+|
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L  132 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL  132 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence            3456666666652212222222  23345888888887777777778888888888888777 77776666777888888


Q ss_pred             cccccCCCCCcccCCCCCCcEEEeccccccccc-cccccccccceeeccccccCCCCCccccCCCcccEEEecccccccc
Q 002760          120 FQNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGS  198 (884)
Q Consensus       120 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~  198 (884)
                      .+|.|+..-.++++.++.|+.|||+.|.|..++ .+|..-.++++|+|++|.|+......|.++.+|..|.|++|+++ .
T Consensus       133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-t  211 (873)
T KOG4194|consen  133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-T  211 (873)
T ss_pred             eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-c
Confidence            888877666667777777777777777777766 35656666777777777776666666666666666666666666 6


Q ss_pred             CCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhh
Q 002760          199 LPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDF  278 (884)
Q Consensus       199 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  278 (884)
                      +|...|.+||+|+.|+|..|+|.-..-..|.++++|+.|.|..|.|.....+.|-.                        
T Consensus       212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~------------------------  267 (873)
T KOG4194|consen  212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYG------------------------  267 (873)
T ss_pred             cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceee------------------------
Confidence            66666655666666666666555444445555555555555555555544444444                        


Q ss_pred             hhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCC
Q 002760          279 INLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL  358 (884)
Q Consensus       279 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  358 (884)
                            +.++++|+|+.|++..                         .-..++.+|+.|+.|+|++|.|..+-+++..-.
T Consensus       268 ------l~kme~l~L~~N~l~~-------------------------vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft  316 (873)
T KOG4194|consen  268 ------LEKMEHLNLETNRLQA-------------------------VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT  316 (873)
T ss_pred             ------ecccceeecccchhhh-------------------------hhcccccccchhhhhccchhhhheeecchhhhc
Confidence                  4444444444444431                         223456677788888888888887777777777


Q ss_pred             CCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhccchhhh
Q 002760          359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLE  438 (884)
Q Consensus       359 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~  438 (884)
                      ++|++|+|++|+|+...+..|..+..|+.|+|++|.|+..-..+|..+++|+.|||++|.+++.+.+             
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED-------------  383 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED-------------  383 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec-------------
Confidence            8888888888888877777888888888888888888877777888888999999999988755443             


Q ss_pred             cCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccc
Q 002760          439 LGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL  516 (884)
Q Consensus       439 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  516 (884)
                               ....|..|+.|+.|+|.+|+|..+...+|.++++|+.|||.+|.|..+-|.+|..+ .|++|-++.-.+
T Consensus       384 ---------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  384 ---------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             ---------chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence                     22357778899999999999987777899999999999999999998889999988 888888765443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=8.2e-46  Score=370.67  Aligned_cols=483  Identities=28%  Similarity=0.403  Sum_probs=400.1

Q ss_pred             cCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCC
Q 002760           58 HQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS  137 (884)
Q Consensus        58 ~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  137 (884)
                      +.++.-..|+.|++++|.++ .+-..+.++..|.+|++.+|+++ ..|.+++.+.+++.|+.++|+++ .+|+.++.+.+
T Consensus        39 e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~  115 (565)
T KOG0472|consen   39 ENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLIS  115 (565)
T ss_pred             hhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhh
Confidence            34455567888899999888 56667888889999999999988 78888999999999999999998 88889999999


Q ss_pred             CcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCC
Q 002760          138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA  217 (884)
Q Consensus       138 L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~  217 (884)
                      |+.|++++|++..++++++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|.++ .+|.+... ++.|++|++..
T Consensus       116 l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~  192 (565)
T KOG0472|consen  116 LVKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNS  192 (565)
T ss_pred             hhhhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccch
Confidence            99999999999999999999999999999999998 67888888999999999999998 67766653 88999999999


Q ss_pred             CcccccCCcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCc
Q 002760          218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNR  297 (884)
Q Consensus       218 n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~  297 (884)
                      |.++. +|..++.+.+|+.|+|..|+|...+  .|.++..|++++++.|.|...+.      +...+++++..|||..|+
T Consensus       193 N~L~t-lP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpa------e~~~~L~~l~vLDLRdNk  263 (565)
T KOG0472|consen  193 NLLET-LPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPA------EHLKHLNSLLVLDLRDNK  263 (565)
T ss_pred             hhhhc-CChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHH------HHhcccccceeeeccccc
Confidence            88885 5677999999999999999998776  78999999999999999987664      456789999999999999


Q ss_pred             ccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCC--CCCEE-------EccC
Q 002760          298 FEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT--NLQQL-------DLDR  368 (884)
Q Consensus       298 l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L-------~Ls~  368 (884)
                      ++ ++|..++-+. ++.+|++++|.|+ ..|..++++ +|+.|.+.+|.+..+-.+.+..=+  -|++|       -+|.
T Consensus       264 lk-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~  339 (565)
T KOG0472|consen  264 LK-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ  339 (565)
T ss_pred             cc-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence            98 7888877664 4889999999998 678889999 999999999998743222222110  02221       1111


Q ss_pred             CCCC----CC-CC---CccCccccCcEEEcccccccccCCCCCcCccc---ccccccccccccCccchhhhhhhccchhh
Q 002760          369 NFLQ----GS-IP---SSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTN---LLGLNISHNKLIGTLPRQILRITTLSLYL  437 (884)
Q Consensus       369 N~l~----~~-~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L  437 (884)
                      ..=.    .. .+   .....+.+.+.|++++-+++ .+|+......+   .+..+++.|++. ++|..+..+..+...+
T Consensus       340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l  417 (565)
T KOG0472|consen  340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL  417 (565)
T ss_pred             CcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence            1000    01 11   12234567899999999998 56766555444   789999999997 8999999999999899


Q ss_pred             hcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCcccc
Q 002760          438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN  517 (884)
Q Consensus       438 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  517 (884)
                      .+++|.++ -+|..++.+++|+.|+|++|-+. .+|..++.+..|+.||+|.|++. ..|.....+..|+.+-.++|++.
T Consensus       418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~  494 (565)
T KOG0472|consen  418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG  494 (565)
T ss_pred             HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence            99999987 78889999999999999999997 88999999999999999999998 88998888899999999999998


Q ss_pred             ccccccccCCCccceeeccCccCccccCCCCcccccccccccCCCcc
Q 002760          518 GQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKL  564 (884)
Q Consensus       518 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~  564 (884)
                      ...|..+.+|.+|.+|||.+|.+...+|..+....+...-+.|||+.
T Consensus       495 ~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  495 SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            77677799999999999999999998888888999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=349.06  Aligned_cols=206  Identities=27%  Similarity=0.463  Sum_probs=176.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-------cchHHHHHHHHHHHcCCCCCccceeeeeccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-------GASKSFVAECKALRNIRHRNLIKIITVCSGRD  709 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  709 (884)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.....       ......++|+++|++++|||||++.++     
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence            34678899999999999999999999999999999974321       122346799999999999999999999     


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC---
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD---  786 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~---  786 (884)
                      ++.++..|+||||++||+|.+++-..+      .+.+.....+++|++.|+.|||   ++||+||||||+|||+..+   
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcc
Confidence            667778899999999999999998776      4566666889999999999999   8899999999999999765   


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC---CCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE---ASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      ..+||+|||+|+.....         .....+||||.|.|||++.+..   +..++|+||+||++|-+++|.+||.+...
T Consensus       316 ~llKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             eEEEecccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence            89999999999976522         2344679999999999988754   33478999999999999999999987655


Q ss_pred             CC
Q 002760          864 EG  865 (884)
Q Consensus       864 ~~  865 (884)
                      +.
T Consensus       387 ~~  388 (475)
T KOG0615|consen  387 DP  388 (475)
T ss_pred             Cc
Confidence            54

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=341.65  Aligned_cols=200  Identities=30%  Similarity=0.445  Sum_probs=178.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc-cc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD-FK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~  716 (884)
                      .+.+..+.||+|..|+||+++|+.+++.+|+|++... +....+.+.+|+++++..+||+||.++|.+     ...+ ..
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~i  153 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEI  153 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceE
Confidence            3456678999999999999999999999999999543 344567899999999999999999999985     3444 58


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      .++||||++|+|++++...+      .+++....+||.++++||.|||+  +++||||||||+|||++..|+|||||||.
T Consensus       154 sI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence            99999999999999998765      68899999999999999999994  37999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +..+.+.          ....++||..|||||.+.+..|+.++||||||++++|+++|++||...
T Consensus       226 S~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  226 SGILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             cHHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            9877544          233577999999999999999999999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-43  Score=337.38  Aligned_cols=209  Identities=27%  Similarity=0.414  Sum_probs=180.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+|++.++||+|+||+||++.+..+|..||.|.++..  +....+....|+.+|++++|||||++++.-.   .++...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence            4688999999999999999999999999999988743  3344567889999999999999999988421   2334448


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCeeeCCCCceEEecc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS--IVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ++|||||.+|+|...++..+..  ...+++.++|+++.|+++||.++|..- +.  |+||||||.||+++++|.|||+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccc
Confidence            9999999999999999876543  347899999999999999999999421 33  899999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |++++++....        .....+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.
T Consensus       173 GL~r~l~s~~t--------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  173 GLGRFLSSKTT--------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             hhHhHhcchhH--------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            99998875432        233578999999999999999999999999999999999999999884

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-41  Score=357.02  Aligned_cols=201  Identities=26%  Similarity=0.438  Sum_probs=184.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+|..++.||+|||+.||++++..+|+.||+|++..+   .....+.+.+|+++.++++|||||+++++     |++...
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            5799999999999999999999999999999999743   45566889999999999999999999999     788999


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|+|.|+|+.++|..++++.+      ++++.+++.+..||+.|+.|||   +++|+|||||..|++++++.+|||+|||
T Consensus        93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccc
Confidence            999999999999999999655      7999999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|..+.....        .....||||.|.|||++....++..+||||+||++|-|+.|++||+..
T Consensus       164 LAt~le~~~E--------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  164 LATQLEYDGE--------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             eeeeecCccc--------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            9998765432        233578999999999999999999999999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=352.94  Aligned_cols=212  Identities=29%  Similarity=0.440  Sum_probs=186.5

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  711 (884)
                      ....+|.+++.||+|+|++|++|+.+.++++||||++.++   .....+.+.+|-.+|.+| .||.|++++-.     |+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence            4457899999999999999999999999999999998633   233446678899999999 89999999977     78


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      +...+|+|+||+++|+|.++|++.+      .+++...+.+|.+|+.|++|||   ++|||||||||+|||++.||+++|
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikI  215 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKI  215 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEE
Confidence            8889999999999999999999987      7889999999999999999999   899999999999999999999999


Q ss_pred             eccccccccccCCCC-----cccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPD-----TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .|||.|+.+.+....     ...........++||..|.+||++.+...++.+|+|+|||++|+|+.|++||.+.
T Consensus       216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            999999988754433     1111111225689999999999999999999999999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=325.31  Aligned_cols=201  Identities=28%  Similarity=0.388  Sum_probs=182.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|+..+.||.|+||.|..++.+.+|..+|+|++++.+-   ...+...+|..+++.+.||.++++.+.     +.+.+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence            4679999999999999999999999999999999975432   334567889999999999999999988     56778


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||++||.|.+++++.+      ++++..++.+|.||+.|++|||   +.+|++||+||+|||+|.+|++||+||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEec
Confidence            8999999999999999999876      7899999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+|+.....           ....||||.|+|||++..++|..++|.|||||++|||+.|.+||.+..+
T Consensus       189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            999866432           3357899999999999999999999999999999999999999987543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=351.66  Aligned_cols=238  Identities=43%  Similarity=0.722  Sum_probs=199.3

Q ss_pred             ccccccHHHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeee
Q 002760          625 QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV  704 (884)
Q Consensus       625 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  704 (884)
                      .....++.++..++++|.....||+|+||.||+|... +|+.||||++........++|.+|+.++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4455689999999999999999999999999999995 558999998864333214569999999999999999999999


Q ss_pred             eccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC
Q 002760          705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD  784 (884)
Q Consensus       705 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~  784 (884)
                      |.+.+    ...++|+|||++|+|.++++.....    +++|.++++||.++|+||+|||+.+...||||||||+|||+|
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            96332    2579999999999999999976542    689999999999999999999987777899999999999999


Q ss_pred             CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc-c
Q 002760          785 QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF-N  863 (884)
Q Consensus       785 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~-~  863 (884)
                      +++++||+|||+|+.....  ......     ...||.+|+|||+......+.++|||||||++.|++||+.|.+... .
T Consensus       212 ~~~~aKlsDFGLa~~~~~~--~~~~~~-----~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEG--DTSVST-----TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             CCCCEEccCccCcccCCcc--ccceee-----ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            9999999999999644321  111100     0159999999999999999999999999999999999999998765 3


Q ss_pred             CCccHHHHHHHHhcc
Q 002760          864 EGLTLHDFSREFFTR  878 (884)
Q Consensus       864 ~~~~~~~~~~~~~~~  878 (884)
                      .+..+.+|....+.+
T Consensus       285 ~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEE  299 (361)
T ss_pred             ccccHHHHHHHHHHC
Confidence            455588887665554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.8e-40  Score=343.65  Aligned_cols=223  Identities=23%  Similarity=0.377  Sum_probs=188.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||+||.|+-+.+|+.+|+|++++.   ..+..+.+..|-.+|...++|.||+++-.     |++..
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCCC
Confidence            46899999999999999999999999999999999743   34566788999999999999999999966     78899


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      .+|+||||++||++..++.+.+      .+++..+..++.+++.|++.+|   +.|+|||||||+|+|||..|++||+||
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccc
Confidence            9999999999999999999876      7899999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCC-------------------CCccc------cc--------------ceeeeccccccceeCccccCCCCC
Q 002760          795 GLAKFLSNHN-------------------PDTIV------ET--------------RSISIGIKGTVGYVAPEYGMGREA  835 (884)
Q Consensus       795 g~a~~~~~~~-------------------~~~~~------~~--------------~~~~~~~~gt~~y~aPE~~~~~~~  835 (884)
                      |++.-+...+                   +....      ..              +......+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            9985332100                   00000      00              001234569999999999999999


Q ss_pred             CcccceeehhHHHHHHhcCCCCCCccccCCc--cHHHHHHH
Q 002760          836 SMKGDVYSFGILLLELFTRKRPTDAMFNEGL--TLHDFSRE  874 (884)
Q Consensus       836 ~~~~DvwSlG~il~~lltg~~p~~~~~~~~~--~~~~~~~~  874 (884)
                      +..+|.||||||+|||+.|.+||.+....+.  .+..|.+.
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~  406 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET  406 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence            9999999999999999999999998765443  45556544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=346.06  Aligned_cols=203  Identities=35%  Similarity=0.549  Sum_probs=171.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcE-EEEEEeecccccc--hHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTE-VAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ...+.+.+|+|+||+||+|.+  .|+. ||||++.......  .++|.+|+.+|++++|||||+++|+|...    ....
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCce
Confidence            344556799999999999999  4666 9999997443222  46899999999999999999999998432    2267


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCCeeeCCCC-ceEEecc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS-IVHGDLKPSNVLLDQDL-VSHVSDF  794 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-ivH~Dlkp~NiLl~~~~-~~kl~DF  794 (884)
                      ++|||||++|+|.++++...    ...+++..++.+|.|||+||+|||   +++ ||||||||+|||++.++ ++||+||
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCC
Confidence            99999999999999998741    127999999999999999999999   777 99999999999999998 9999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccC--CCCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM--GREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+++.......        ......||+.|||||++.  ...|+.++||||||+++|||+||+.||.....
T Consensus       189 Glsr~~~~~~~--------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  189 GLSREKVISKT--------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             ccceeeccccc--------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            99986654320        112246999999999999  56999999999999999999999999988655

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-40  Score=339.21  Aligned_cols=207  Identities=29%  Similarity=0.433  Sum_probs=181.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+.|+..++||+|+||.||+|++..+|+.||+|.++...  .+......+||.+|++++||||+++.++....   ..+.
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence            356778899999999999999999999999999997654  56677888999999999999999999986432   3568


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|+|+|||++ +|.-++...+.     .+++.++..++.|++.||+|+|   .+||+|||||.+||||+.+|.+||+|||
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecccc
Confidence            8999999977 99998887553     6899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      +|+++.......       .+..+-|.+|+|||.+.| ..|+.++|+||.|||+.||++|++.|.+..+
T Consensus       264 LAr~y~~~~~~~-------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE  325 (560)
T KOG0600|consen  264 LARFYTPSGSAP-------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE  325 (560)
T ss_pred             ceeeccCCCCcc-------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence            999886554332       233456999999999888 5799999999999999999999999998654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-40  Score=320.26  Aligned_cols=203  Identities=26%  Similarity=0.386  Sum_probs=173.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      +.|+...++|+|+||+||+++++.+|+.||||.+....  +...+-..+|++++++++|||+|.++++     |.....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence            56888999999999999999999999999999986332  3334567899999999999999999999     5567788


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|+|||+..-|. -+++...     .++...+..+..|++.|+.|+|   ++++|||||||+|||++.+|.+||||||+
T Consensus        77 hLVFE~~dhTvL~-eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   77 HLVFEYCDHTVLH-ELERYPN-----GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             EEEeeecchHHHH-HHHhccC-----CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchh
Confidence            9999999874444 4444322     5788889999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+.+..+..        ..+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+.++
T Consensus       148 AR~L~~pgd--------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  148 ARTLSAPGD--------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hHhhcCCcc--------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            998874221        1234568999999999887 7899999999999999999999999988654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=339.30  Aligned_cols=199  Identities=33%  Similarity=0.488  Sum_probs=180.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..  .+..+.+.+|+++++.++||||+.+++.     |+...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            57889999999999999999999999999999996433  3345678999999999999999999998     7788899


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|+||+.| +|..++...+      .+++.++..++.|++.|+.|||   +.+|.|||+||.|||++.+|.+|+||||+
T Consensus        77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhh
Confidence            999999976 9999998765      6899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |+..+..        ........|||.|||||+..+.+|+..+|+||+||++||+++|++||.+
T Consensus       147 Ar~m~~~--------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  147 ARAMSTN--------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             hhhcccC--------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence            9976542        2344567799999999999999999999999999999999999999976

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-38  Score=301.45  Aligned_cols=201  Identities=32%  Similarity=0.476  Sum_probs=175.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+|...+++|+|.||.||+|++..+|+.||||.++...  .+......+|++.++.++||||+.++++     |...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            46888899999999999999999999999999997543  2334567899999999999999999998     5567778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      .+|+|||+. +|...++....     .++..++..++.++++|++|+|   .+.|+||||||.|+|++.+|.+||+|||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccc
Confidence            999999965 99999987543     7899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+.+.........        .+-|.+|+|||.+.| +.|+..+||||.|||+.||+-|.+-|.+.
T Consensus       148 Ar~f~~p~~~~~~--------~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~  205 (318)
T KOG0659|consen  148 ARFFGSPNRIQTH--------QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD  205 (318)
T ss_pred             hhccCCCCccccc--------ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence            9988765543322        146889999998877 67999999999999999999998877774

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=309.93  Aligned_cols=206  Identities=26%  Similarity=0.393  Sum_probs=179.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+.|+...+|++|+||.||+|+++.+++.||+|.++.+.  .+..-.-.+||.++.+.+|||||.+-.+..+..   -+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence            456889999999999999999999999999999998553  455667789999999999999999999876544   345


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|+|||||++ +|.+.+...+.     ++...++..++.|+++|++|||   .+.|+|||+||+|+|++..|.+||+|||
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccc
Confidence            8999999977 99999987652     7889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      +|+.++.+...        .+..+-|.+|+|||.+.+ ..|+.++|+||+|||+.||+++++-|.+..+
T Consensus       223 LAR~ygsp~k~--------~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE  283 (419)
T KOG0663|consen  223 LAREYGSPLKP--------YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE  283 (419)
T ss_pred             hhhhhcCCccc--------CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence            99987654211        223456999999999887 5699999999999999999999999988654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=335.76  Aligned_cols=202  Identities=30%  Similarity=0.461  Sum_probs=177.0

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc----cc-cchHHHHHHHHHHHcCC-CCCccceeeeeccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK----QK-GASKSFVAECKALRNIR-HRNLIKIITVCSGRDF  710 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  710 (884)
                      ....|.+++.||+|+||.|+.|++..+++.||+|++..+    .. ...+.+.+|+.++++++ ||||++++++     +
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev-----~   89 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV-----F   89 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----E
Confidence            456899999999999999999999999999999987643    11 23456778999999998 9999999999     4


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-Cce
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVS  789 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-~~~  789 (884)
                      ......++||||+.||+|.+++...+      .+.+.++.+++.|++.|++|+|   ++||+||||||+|||++.+ +++
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCE
Confidence            55666999999999999999999844      6788999999999999999999   8899999999999999999 999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC-CC-cccceeehhHHHHHHhcCCCCCCc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE-AS-MKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ||+|||++.....  .+      .....+|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus       161 Kl~DFG~s~~~~~--~~------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  161 KLSDFGLSAISPG--ED------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             EEeccccccccCC--CC------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            9999999987631  11      1233578999999999999977 75 789999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=330.92  Aligned_cols=200  Identities=26%  Similarity=0.433  Sum_probs=180.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ...|...++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.+     --++..|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeE
Confidence            34688889999999999999999999999999999877777778899999999999999999999874     3347789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|||||+||+|.+.+...       .+++.++..|+.+++.||+|||   .+||+|||||.+|||++.+|.+||+|||++
T Consensus       347 VVMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             EEEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeee
Confidence            999999999999998765       5889999999999999999999   899999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ..+......        ....+|||+|||||+.....|++++||||||++++||+.|++||-.
T Consensus       417 aqi~~~~~K--------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  417 AQISEEQSK--------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             eccccccCc--------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence            877654332        2245799999999999999999999999999999999999999863

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=338.60  Aligned_cols=207  Identities=26%  Similarity=0.365  Sum_probs=180.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  712 (884)
                      ..++|.+.++||+|+||.|++|..+.+++.+|||++++.   +....+....|.+++... +||.++.++..     |+.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            457899999999999999999999999999999999854   345667788899888877 59999999987     788


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ..++|.||||+.||++..+++..       .+++..+..+|..++.||.|||   ++||||||||-+|||+|.+|++||+
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEec
Confidence            99999999999999954443322       6899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      |||+++..-.        ....+..+||||.|||||++.+..|+.++|.|||||++|||+.|+.||.+..+|+.
T Consensus       511 DFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~  576 (694)
T KOG0694|consen  511 DFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV  576 (694)
T ss_pred             ccccccccCC--------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            9999984321        12234578999999999999999999999999999999999999999998655543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=363.55  Aligned_cols=483  Identities=27%  Similarity=0.341  Sum_probs=300.7

Q ss_pred             EEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCC-cCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCc
Q 002760           20 RLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIP-HQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSN   98 (884)
Q Consensus        20 ~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n   98 (884)
                      ++|++++++. -||..+..-..++.|++++|-+- ..| +.+.+..+|+.||+|+|.+. ..|..+..+.+|+.|.++.|
T Consensus         2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n   78 (1081)
T KOG0618|consen    2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN   78 (1081)
T ss_pred             CcccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence            4678888887 78888877777888888888777 444 34455666888999988888 78888888888888888888


Q ss_pred             cccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCcc
Q 002760           99 NLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPS  178 (884)
Q Consensus        99 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  178 (884)
                      .+. ..|...+.+.+|++|+|.+|++. .+|.++..+.+|+.|+++.|++...|..+..++.++.+..++|.....    
T Consensus        79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~----  152 (1081)
T KOG0618|consen   79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQR----  152 (1081)
T ss_pred             hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhh----
Confidence            888 77888888888888888888887 788888888888888888888888888888888888888888832222    


Q ss_pred             ccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccccccccccc
Q 002760          179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNL  258 (884)
Q Consensus       179 l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  258 (884)
                      ++... ++.++|..|.+.+.++.+.. .+..  .|+|..|.+..   ..+..+.+|+.|....|++..+..    ..++|
T Consensus       153 lg~~~-ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~~----~g~~l  221 (1081)
T KOG0618|consen  153 LGQTS-IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELEI----SGPSL  221 (1081)
T ss_pred             hcccc-chhhhhhhhhcccchhcchh-hhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEEe----cCcch
Confidence            22222 77778888877766665542 2222  47777777761   345566677777777777664432    23556


Q ss_pred             ceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCc
Q 002760          259 YWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLN  338 (884)
Q Consensus       259 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~  338 (884)
                      +.|+.++|.+.+...        -....+|+++++++|+++ .+|+++.... +++.+...+|.+. .+|..+....+|+
T Consensus       222 ~~L~a~~n~l~~~~~--------~p~p~nl~~~dis~n~l~-~lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~  290 (1081)
T KOG0618|consen  222 TALYADHNPLTTLDV--------HPVPLNLQYLDISHNNLS-NLPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLV  290 (1081)
T ss_pred             heeeeccCcceeecc--------ccccccceeeecchhhhh-cchHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHH
Confidence            666666666653322        112345666666666666 4454444443 3566666666663 4555555556666


Q ss_pred             EEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCc-cCcccc-CcEEEcccccccccCCC-CCcCcccccccccc
Q 002760          339 WLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSS-LGNLTL-LTYLKLGLNNLEGNIPS-SLGNCTNLLGLNIS  415 (884)
Q Consensus       339 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~-L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls  415 (884)
                      .|.+..|.+. .+|.....++.|++|+|..|+|. ..|+. +.-+.. |..|+.+.|+++. .|. .=..++.|+.|++.
T Consensus       291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~Lyla  367 (1081)
T KOG0618|consen  291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLA  367 (1081)
T ss_pred             HHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHh
Confidence            6666666665 44455555666666666666665 33332 222222 5555555555552 221 11224556666666


Q ss_pred             cccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEeec
Q 002760          416 HNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGS  495 (884)
Q Consensus       416 ~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  495 (884)
                      +|.++...-..+-.... ++.|+|++|++.......+.++..|++|+||+|+++ .+|.++..+..|++|...+|+|. .
T Consensus       368 nN~Ltd~c~p~l~~~~h-LKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~  444 (1081)
T KOG0618|consen  368 NNHLTDSCFPVLVNFKH-LKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-S  444 (1081)
T ss_pred             cCcccccchhhhccccc-eeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-e
Confidence            66655332222222222 235666666665333344555666666666666665 55566666666666666666665 3


Q ss_pred             cCccccCccccceeeccCccccccccccccCCCccceeeccCccC
Q 002760          496 IPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF  540 (884)
Q Consensus       496 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  540 (884)
                      .| .+..++.|+.+|+|.|+|+...-......++|++|||++|..
T Consensus       445 fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  445 FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            44 456666666666666666543222222225666666666653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=316.14  Aligned_cols=200  Identities=28%  Similarity=0.447  Sum_probs=181.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .-+|++.+.||+|.||.|-+|.....|+.||||.+++..   ..+.-.+.+|+++|+.++||||+.++++     |+..+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence            357899999999999999999999999999999997443   3344568899999999999999999999     78899


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ...+||||..+|.|++|+.+.+      .+++.+.+++++||..|+.|+|   .++|||||+|.+|||+|+++++||+||
T Consensus       127 KIvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeecc
Confidence            9999999999999999999776      7999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCC-CcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |++-.+...         .....+||+|-|.+||++.+.+| ++.+|-|||||+||-+..|..||++
T Consensus       198 GLSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  198 GLSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             chhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence            999765432         24456899999999999999988 6789999999999999999999998

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=363.67  Aligned_cols=485  Identities=26%  Similarity=0.335  Sum_probs=390.0

Q ss_pred             eEEEEEcCCCCCccccC-cCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEec
Q 002760           17 RVTRLDLGNQSIRGTLS-PYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSA   95 (884)
Q Consensus        17 ~v~~L~l~~~~~~~~~~-~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L   95 (884)
                      +++.|+++.|.+. ..| +.+....+|+.|||++|.+. ..|..+..+.+|+.|+++.|.|. .+|.+..++++|++|.|
T Consensus        22 ~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL   98 (1081)
T KOG0618|consen   22 ALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL   98 (1081)
T ss_pred             HHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence            3677888887765 433 33445555999999999998 88999999999999999999998 78999999999999999


Q ss_pred             cCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccc-cccccccccccccccceeeccccccCCC
Q 002760           96 DSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVREN-RLWGRIDSLGQLKSLTLLSVAFNQFSGM  174 (884)
Q Consensus        96 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~l~~l~~L~~L~L~~n~l~~~  174 (884)
                      .+|.+. .+|..+..+++|+.|+++.|++. .+|..+..++.+..+..++| ++..+    +... .+.+++..|.+.+.
T Consensus        99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~~-ik~~~l~~n~l~~~  171 (1081)
T KOG0618|consen   99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQTS-IKKLDLRLNVLGGS  171 (1081)
T ss_pred             ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh----cccc-chhhhhhhhhcccc
Confidence            999988 89999999999999999999998 88889999999999999999 33222    2222 88889999999888


Q ss_pred             CCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccccccc
Q 002760          175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSR  254 (884)
Q Consensus       175 ~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  254 (884)
                      ++..+.+++.  .|||++|.+. .+   ....+++|+.|....|++..+.    -..++|+.|+.++|.++....  -..
T Consensus       172 ~~~~i~~l~~--~ldLr~N~~~-~~---dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~  239 (1081)
T KOG0618|consen  172 FLIDIYNLTH--QLDLRYNEME-VL---DLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPV  239 (1081)
T ss_pred             hhcchhhhhe--eeecccchhh-hh---hhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--ccc
Confidence            8888887777  7999999886 22   2346788999999999887542    235679999999999883322  223


Q ss_pred             ccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCC
Q 002760          255 LKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNL  334 (884)
Q Consensus       255 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l  334 (884)
                      -.+|+++++++|+++..       ++++..+.+|+.+...+|+++ .+|..++... .++.|.+..|.++ -+|+....+
T Consensus       240 p~nl~~~dis~n~l~~l-------p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~  309 (1081)
T KOG0618|consen  240 PLNLQYLDISHNNLSNL-------PEWIGACANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGL  309 (1081)
T ss_pred             cccceeeecchhhhhcc-------hHHHHhcccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhh-hCCCccccc
Confidence            46789999999998764       467888999999999999996 7777777664 4899999999998 677788889


Q ss_pred             CCCcEEEeecCCCCccCCcccCCCCC-CCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccc
Q 002760          335 ASLNWLTIDTNQLTGTIPPEIGELTN-LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN  413 (884)
Q Consensus       335 ~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  413 (884)
                      +.|++|+|..|+|....+..|..+.. |+.|+.+.|++....-..=..++.|+.|++.+|.++...-..+.++++|+.|+
T Consensus       310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            99999999999998544444444444 88889999998843322223467899999999999987777889999999999


Q ss_pred             cccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEe
Q 002760          414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS  493 (884)
Q Consensus       414 Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  493 (884)
                      |++|++. .+|....+....++.|+||+|+++ .+|..+..++.|++|...+|++. ..| .+..+++|+.+|+|.|+|+
T Consensus       390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence            9999986 788887777777788999999998 78899999999999999999997 777 8899999999999999998


Q ss_pred             ecc-CccccCccccceeeccCccccccccccccCCCccceeeccCc
Q 002760          494 GSI-PLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN  538 (884)
Q Consensus       494 ~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  538 (884)
                      ... |.... .++|++|||++|.=....-..|..+.++..++++-|
T Consensus       466 ~~~l~~~~p-~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  466 EVTLPEALP-SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             hhhhhhhCC-CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            544 43333 389999999999843345567777888888888877

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=318.39  Aligned_cols=207  Identities=29%  Similarity=0.469  Sum_probs=174.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|..++.||+|+||+||+|...++|+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+   ...++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeE
Confidence            346788899999999999999999899999999987553333567899999999999999999999632221   13689


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEecccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFg~  796 (884)
                      +.|||+++|+|.+++.+.+.     .+++..+.+++.||+.|++|||   ++|||||||||+|||++. ++.+||+|||.
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999998763     5899999999999999999999   899999999999999999 79999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |+.........     .....+.||+.|||||++.+ ....+++||||+||++.||+||+.||..
T Consensus       165 a~~~~~~~~~~-----~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  165 AKKLESKGTKS-----DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccc-----cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            98765311110     11223569999999999995 3344699999999999999999999986

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.4e-39  Score=341.53  Aligned_cols=381  Identities=25%  Similarity=0.389  Sum_probs=269.2

Q ss_pred             EEEccCCcCc-CcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccc
Q 002760           68 RLILSNNSFS-GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVREN  146 (884)
Q Consensus        68 ~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  146 (884)
                      -.|+|+|.++ +..|..+..+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+.+++.+|
T Consensus        11 GvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N   88 (1255)
T KOG0444|consen   11 GVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDN   88 (1255)
T ss_pred             cccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcc
Confidence            3444444444 334444444555555555554444 55566666666666666666655 44455666666666666666


Q ss_pred             ccc--ccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccC
Q 002760          147 RLW--GRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFI  224 (884)
Q Consensus       147 ~l~--~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~  224 (884)
                      +++  ++|+.+.+|..|+.|+|++|++. ..|..+..-+++-.|+||+|+|. ++|...|.+|..|-.|+||+|.+.. .
T Consensus        89 ~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~-L  165 (1255)
T KOG0444|consen   89 NLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM-L  165 (1255)
T ss_pred             ccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh-c
Confidence            654  35666666666666666666666 45666666667777777777776 6776666667777777777777664 4


Q ss_pred             CcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCc
Q 002760          225 PVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH  304 (884)
Q Consensus       225 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~  304 (884)
                      |.....+..|++|+|++|.+....-..+.                              .+++|+.|.+++.+-+     
T Consensus       166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP------------------------------smtsL~vLhms~TqRT-----  210 (1255)
T KOG0444|consen  166 PPQIRRLSMLQTLKLSNNPLNHFQLRQLP------------------------------SMTSLSVLHMSNTQRT-----  210 (1255)
T ss_pred             CHHHHHHhhhhhhhcCCChhhHHHHhcCc------------------------------cchhhhhhhcccccch-----
Confidence            55567777788888888876533322222                              3333444444433221     


Q ss_pred             hhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCcccc
Q 002760          305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL  384 (884)
Q Consensus       305 ~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  384 (884)
                                         -..+|..+..+.+|..+|++.|.+. ..|+.+..+++|+.|+||+|+|+ ...-......+
T Consensus       211 -------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~  269 (1255)
T KOG0444|consen  211 -------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWEN  269 (1255)
T ss_pred             -------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhh
Confidence                               0146777888889999999999998 88999999999999999999998 45555666789


Q ss_pred             CcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecC
Q 002760          385 LTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLS  464 (884)
Q Consensus       385 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls  464 (884)
                      |++|+||.|+++ .+|++++.+++|+.|.+.+|++.                       +. .+|..++.+.+|+.+..+
T Consensus       270 lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~-----------------------Fe-GiPSGIGKL~~Levf~aa  324 (1255)
T KOG0444|consen  270 LETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT-----------------------FE-GIPSGIGKLIQLEVFHAA  324 (1255)
T ss_pred             hhhhccccchhc-cchHHHhhhHHHHHHHhccCccc-----------------------cc-CCccchhhhhhhHHHHhh
Confidence            999999999998 79999999999999999999876                       33 478899999999999999


Q ss_pred             CCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccccccccccccCCCccceeecc
Q 002760          465 GNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS  536 (884)
Q Consensus       465 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  536 (884)
                      +|++. ..|+.++.+..|+.|.|+.|++- ..|+++.-|+.|+.|||..|.=---.|.--..-++|++-++.
T Consensus       325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             ccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence            99997 89999999999999999999997 789999999999999999987543344333333456655554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=323.38  Aligned_cols=205  Identities=27%  Similarity=0.384  Sum_probs=177.4

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchH-HHHHHHHHHHcCC-CCCccceeeeeccCCccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIR-HRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..++|.+.++||.|+||.||+|+...+|+.||||.|+.+-....+ .-.+|+..++++. ||||+++.+++.    +.+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCc
Confidence            467899999999999999999999999999999999755443322 2468999999998 999999999852    2233


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++|||||+. +|++.++..+.     .+++.+++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+||
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccc
Confidence            88999999954 99999987743     7999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+|+......++         +.++.|.+|+|||++.+ ..|+.+.||||+|||++|+.+-++-|.+..+
T Consensus       155 GLARev~SkpPY---------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  155 GLAREVRSKPPY---------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             ccccccccCCCc---------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence            999977654433         35568999999998655 6789999999999999999999999988644

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=324.46  Aligned_cols=203  Identities=34%  Similarity=0.544  Sum_probs=171.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .++..+.||+|-||+||.|++. ....||+|.++.. ....+.|.+|+++|++++|++||+++++|...     +.++||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIV  279 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIV  279 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEE
Confidence            3556789999999999999994 3348999999744 34457888999999999999999999998532     357999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      ||||+.|+|.+|++....    ..+...+.+.+|.|||.||+||+   ++++|||||.++|||++++..+||+|||+|+.
T Consensus       280 tE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             EEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence            999999999999997322    26888999999999999999999   88999999999999999999999999999995


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcccc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~  863 (884)
                      ..+.......       +..-+..|.|||.+....++.++|||||||+||||+| |+.|+.++..
T Consensus       353 ~~d~~Y~~~~-------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn  410 (468)
T KOG0197|consen  353 IGDDEYTASE-------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN  410 (468)
T ss_pred             cCCCceeecC-------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence            4433222111       1223678999999999999999999999999999998 8999888654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-37  Score=326.08  Aligned_cols=200  Identities=27%  Similarity=0.428  Sum_probs=178.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..-|+.++.||.|+-|.|-.|++..||+.+|||++....   ......+.+|+-+|+-+.||||++++++     +++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence            356899999999999999999999999999999996542   2334678899999999999999999999     78889


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ++|+|.||+++|.|++|+-+.+      ++++.++.+++.||+.|+.|+|   ..+|+|||+||+|+|++..+.+||+||
T Consensus        86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeecc
Confidence            9999999999999999999877      7899999999999999999999   779999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCC-CcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |+|..-.+.         ......||+|.|+|||++.|.+| +.++||||+|||+|.++||+.||++
T Consensus       157 GMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  157 GMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             ceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence            999754322         22334689999999999999987 6789999999999999999999985

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-37  Score=340.13  Aligned_cols=214  Identities=29%  Similarity=0.484  Sum_probs=180.9

Q ss_pred             cCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      .+.+..++||+|+||+||+|+...     ....||||.++.+... ..++|++|++++..++|||||+++|+|..     
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence            356777999999999999998632     3356999999866555 67899999999999999999999999863     


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCc--------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQL--------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD  784 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~  784 (884)
                      ++..++|+|||..|||.+|++......        ...+++..+.+.||.|||.||+||-   ++.+|||||.++|+|++
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence            445699999999999999998654322        1334899999999999999999999   88999999999999999


Q ss_pred             CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcccc
Q 002760          785 QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       785 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~  863 (884)
                      ++..|||+|||+++.....+.+.....      -.=..+|||||.+..++++.++||||+||+|||+++ |+.||.+..+
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~------t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGN------TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCC------ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            999999999999997766555442211      123678999999999999999999999999999997 9999998776


Q ss_pred             CCc
Q 002760          864 EGL  866 (884)
Q Consensus       864 ~~~  866 (884)
                      +|.
T Consensus       712 ~EV  714 (774)
T KOG1026|consen  712 QEV  714 (774)
T ss_pred             HHH
Confidence            654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=308.38  Aligned_cols=209  Identities=27%  Similarity=0.371  Sum_probs=183.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+.|++.++||.|..++||+|+....++.||||++..++. ...+.+.+|+..|+.++||||++.+..     |..+...
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence            5689999999999999999999999999999999986544 335889999999999999999999987     5667788


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      |+||.||.+|++.+.++..-..    .+++..+..|.+++++||.|||   .+|-||||||+.||||+.+|.|||+|||.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence            9999999999999999876543    5889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +-.+.......  ..  ....+.||+.|||||++..  ..|+.|+||||||++..|+.+|..||....
T Consensus       173 sa~l~~~G~R~--~~--rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  173 SASLFDSGDRQ--VT--RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             eeeecccCcee--eE--eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            87776644221  11  1256789999999999543  579999999999999999999999998743

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-37  Score=307.90  Aligned_cols=204  Identities=26%  Similarity=0.402  Sum_probs=170.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      -.|+-.+.+|.|+||.||+|....+++.||||....+.+.    --+|.++|+.++|||||++.-++......+.-...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3577789999999999999999999999999987543332    236999999999999999998876554333456778


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-CceEEeccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLA  797 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFg~a  797 (884)
                      |||||+. +|.++++....  ....++...+.-++.||.+|+.|||   ..||+||||||.|+|+|.+ |.+||||||.|
T Consensus       100 VleymP~-tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999965 99999986321  1226777888889999999999999   7899999999999999965 99999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.+....+..         .+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.
T Consensus       174 K~L~~~epni---------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  174 KVLVKGEPNI---------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             eeeccCCCce---------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            9887655442         2345889999999888 57999999999999999999999999883

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=305.10  Aligned_cols=208  Identities=26%  Similarity=0.401  Sum_probs=181.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEee--cccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ...|...+.||+|+||.|+.|.++.+|+.||||.+.  .+.....++..+|+++++.++|+||+.+.++........-..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            456777899999999999999999999999999986  556667789999999999999999999999976544455678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|+|+|+| +.+|...++...      .++...+..++.|+++|+.|+|   +.+|+|||+||+|++++.+...||+|||
T Consensus       101 vYiV~elM-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence            89999999 569999998765      5888999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|+.....      ......+..+.|.+|+|||++.. ..|+.+.||||.|||+.||++|++-|.+.
T Consensus       171 LAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  171 LARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             ceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            99977543      11123345678999999998655 68999999999999999999999999874

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-37  Score=290.32  Aligned_cols=206  Identities=23%  Similarity=0.356  Sum_probs=182.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..++|++++.||+|.||.||.|+.++++-.||+|++.+.   ..+....+.+|+++-+.++||||.+++++     |.+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence            457899999999999999999999999999999999644   33456788999999999999999999999     7788


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ..+|+++||...|++...++..+..    .+++.....+..|+|.|+.|+|   .++||||||||+|+|++..+..||+|
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccC
Confidence            8999999999999999999854432    5777788889999999999999   89999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      ||.+..-..          ......|||..|.+||...+..++..+|+|++|+..||++.|.+||.....+
T Consensus       168 fGwsV~~p~----------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~  228 (281)
T KOG0580|consen  168 FGWSVHAPS----------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS  228 (281)
T ss_pred             CCceeecCC----------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence            999864321          1123468999999999999999999999999999999999999999886633

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=310.66  Aligned_cols=209  Identities=26%  Similarity=0.351  Sum_probs=170.0

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--------------ccchHHHHHHHHHHHcCCCCCcccee
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--------------KGASKSFVAECKALRNIRHRNLIKII  702 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~~~  702 (884)
                      ..+.|++.+.||+|.||.|.+|++..+++.||||++.+..              ....+...+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3578999999999999999999999999999999996321              11225789999999999999999999


Q ss_pred             eeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 002760          703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       703 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiL  782 (884)
                      ++..+   ...+.+|+|+|||..|.+...-...      ..+++.+++.++.++..||+|||   .+|||||||||+|+|
T Consensus       175 EvLDD---P~s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLL  242 (576)
T KOG0585|consen  175 EVLDD---PESDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLL  242 (576)
T ss_pred             EeecC---cccCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheE
Confidence            98643   2356789999999988765321111      12899999999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC----CCcccceeehhHHHHHHhcCCCCC
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE----ASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~~lltg~~p~  858 (884)
                      ++++|+|||+|||.+............   ......+|||.|+|||...+..    .+.+.||||+||+||.|+.|+.||
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d---~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSD---DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccH---HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999999999999999866333111111   1222367999999999987732    366789999999999999999999


Q ss_pred             Cc
Q 002760          859 DA  860 (884)
Q Consensus       859 ~~  860 (884)
                      -+
T Consensus       320 ~~  321 (576)
T KOG0585|consen  320 FD  321 (576)
T ss_pred             cc
Confidence            76

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=323.57  Aligned_cols=211  Identities=29%  Similarity=0.513  Sum_probs=176.5

Q ss_pred             HHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCC
Q 002760          632 AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRD  709 (884)
Q Consensus       632 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  709 (884)
                      .+.....+.+.+++.||+|.||+||+|+|.   -.||||++.....  ...+.|+.|+.++++-+|.||+-+.|+|.   
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~---  458 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM---  458 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc---
Confidence            333444566788999999999999999995   3699999986644  34578999999999999999999999963   


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                        .+.. .||+.+|+|-+|+.+++..+.     .++..+.+.||.||++||.|||   .++|||||+|..||++.+++.|
T Consensus       459 --~p~~-AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  459 --NPPL-AIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             --CCce-eeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcE
Confidence              3333 899999999999999997653     6888999999999999999999   8999999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCC---CCCCcccceeehhHHHHHHhcCCCCCCccccCC
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAMFNEG  865 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~  865 (884)
                      ||+|||+|..-..........      ...|..-|||||+++.   .+|++++||||||+|+|||+||..||...-.|.
T Consensus       528 kIgDFGLatvk~~w~g~~q~~------qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq  600 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLE------QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ  600 (678)
T ss_pred             EEecccceeeeeeeccccccC------CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence            999999997655443332222      2347889999999875   579999999999999999999999998443343

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-36  Score=304.06  Aligned_cols=217  Identities=27%  Similarity=0.339  Sum_probs=185.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+.|+..+.||+|.-|+||+|+.+.++..+|+|++.+.   ......+.+.|.+||+.++||.++.+++.     ++.+.
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence            35688889999999999999999999999999999743   24455678889999999999999999998     77888


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..|+|||||+||+|...++++...    .+++..++.+|.+++.||+|||   ..|||+||+||+|||+.++|++-|+||
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeec
Confidence            899999999999999999877543    7899999999999999999999   779999999999999999999999999


Q ss_pred             ccccccccC-------C------------------------CCc---------------c--cccceeeeccccccceeC
Q 002760          795 GLAKFLSNH-------N------------------------PDT---------------I--VETRSISIGIKGTVGYVA  826 (884)
Q Consensus       795 g~a~~~~~~-------~------------------------~~~---------------~--~~~~~~~~~~~gt~~y~a  826 (884)
                      .++....-.       .                        ...               .  ......+..++||-+|.|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            987433110       0                        000               0  111123567889999999


Q ss_pred             ccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          827 PEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       827 PE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      ||++.+...+.++|+|+||+++|||+.|..||.+...++.
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T  343 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET  343 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence            9999999999999999999999999999999998766554

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.9e-36  Score=302.00  Aligned_cols=212  Identities=27%  Similarity=0.414  Sum_probs=178.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCC-ccceeeeeccCC-ccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRN-LIKIITVCSGRD-FKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-~~~~  713 (884)
                      ...|+..++||+|+||+||+|+.+.+|+.||+|.++...  .+......+|+.+++.++|+| ||++.+++.... +...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456778889999999999999999999999999997543  345667789999999999999 999999975433 2334


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++|+||++ -+|.+|+.......  ..++...+..++.||++|++|||   +++|+||||||.|||++++|.+||+|
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeec
Confidence            57889999995 49999998765321  24666889999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      ||+|+...-+...        ....++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+..+
T Consensus       164 FGlAra~~ip~~~--------yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  164 FGLARAFSIPMRT--------YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             cchHHHhcCCccc--------ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            9999966532211        2234589999999998885 799999999999999999999999988655

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-36  Score=328.35  Aligned_cols=210  Identities=24%  Similarity=0.340  Sum_probs=176.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++.+++||+|+++++.     +.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~-----~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS-----FQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE-----EecCCe
Confidence            46899999999999999999999999999999996432   2234567889999999999999999998     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++.++..++.|++.|++|||   ++||+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeecc
Confidence            899999999999999998654      5889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCccc---------------------------ccceeeeccccccceeCccccCCCCCCcccceeehhHHH
Q 002760          796 LAKFLSNHNPDTIV---------------------------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL  848 (884)
Q Consensus       796 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il  848 (884)
                      +|+...........                           .........+||+.|+|||++.+..++.++||||+||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            99765322110000                           000011245799999999999999999999999999999


Q ss_pred             HHHhcCCCCCCccc
Q 002760          849 LELFTRKRPTDAMF  862 (884)
Q Consensus       849 ~~lltg~~p~~~~~  862 (884)
                      |||++|+.||.+..
T Consensus       227 ~ell~G~~Pf~~~~  240 (363)
T cd05628         227 YEMLIGYPPFCSET  240 (363)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-35  Score=327.43  Aligned_cols=209  Identities=22%  Similarity=0.314  Sum_probs=174.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+.++.||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5889999999999999999999999999999996432   23345788999999999999999999984     456778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++...+      .+++..+..++.|++.|++|||   +.||+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999997654      5788888999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCccc---------------------------------------ccceeeeccccccceeCccccCCCCCCc
Q 002760          797 AKFLSNHNPDTIV---------------------------------------ETRSISIGIKGTVGYVAPEYGMGREASM  837 (884)
Q Consensus       797 a~~~~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~  837 (884)
                      ++...........                                       .........+||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            8644211100000                                       0000112357999999999999989999


Q ss_pred             ccceeehhHHHHHHhcCCCCCCccc
Q 002760          838 KGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       838 ~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ++||||+||++|||++|+.||....
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~  252 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCC
Confidence            9999999999999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=324.99  Aligned_cols=209  Identities=23%  Similarity=0.356  Sum_probs=175.9

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...   ......+.+|+++++.++||||++++++     +..+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS-----FQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCe
Confidence            46899999999999999999999999999999997432   2334567889999999999999999998     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.++|+|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecc
Confidence            899999999999999997654      5889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCccccc------------------------------ceeeeccccccceeCccccCCCCCCcccceeehh
Q 002760          796 LAKFLSNHNPDTIVET------------------------------RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG  845 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  845 (884)
                      ++..............                              .......+||+.|+|||++.+..++.++||||+|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            9875532211000000                              0001124699999999999999999999999999


Q ss_pred             HHHHHHhcCCCCCCcc
Q 002760          846 ILLLELFTRKRPTDAM  861 (884)
Q Consensus       846 ~il~~lltg~~p~~~~  861 (884)
                      |++|||++|..||...
T Consensus       227 ~il~el~~G~~Pf~~~  242 (364)
T cd05599         227 VIMYEMLVGYPPFCSD  242 (364)
T ss_pred             hHHHHhhcCCCCCCCC
Confidence            9999999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=317.98  Aligned_cols=197  Identities=29%  Similarity=0.391  Sum_probs=172.3

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC-C-----CCccceeeeeccCCccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-H-----RNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  713 (884)
                      +|.+.+.||+|+||+|.+|++..+++.||||+++. .......-+.|+.+|..++ |     -|+|+++++     |...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            78999999999999999999999999999999974 3445567778999999996 3     379999999     6677


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC--CCceEE
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ--DLVSHV  791 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~--~~~~kl  791 (884)
                      ++.|+|+|.+ ..+|+++++.....    .++...++.++.||+.||.+||   +.+|||+||||||||+.+  ...|||
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeE
Confidence            8899999999 55999999987654    6889999999999999999999   889999999999999974  349999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|||.|++......           .++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.
T Consensus       333 IDFGSSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             EecccccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            99999987654332           233577899999999999999999999999999999998888774

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=324.85  Aligned_cols=209  Identities=23%  Similarity=0.332  Sum_probs=174.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.++||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++||||++++++     +.+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS-----FQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCe
Confidence            36899999999999999999999999999999986432   2334568889999999999999999998     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .|+||||+++|+|.+++...+      .+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997654      5788889999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcc---------cc------------------------------cceeeeccccccceeCccccCCCCCC
Q 002760          796 LAKFLSNHNPDTI---------VE------------------------------TRSISIGIKGTVGYVAPEYGMGREAS  836 (884)
Q Consensus       796 ~a~~~~~~~~~~~---------~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~  836 (884)
                      +|+..........         ..                              ........+||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            9964322110000         00                              00001124699999999999999999


Q ss_pred             cccceeehhHHHHHHhcCCCCCCcc
Q 002760          837 MKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       837 ~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .++||||+||++|||++|+.||.+.
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCC
Confidence            9999999999999999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.9e-35  Score=325.16  Aligned_cols=208  Identities=21%  Similarity=0.303  Sum_probs=173.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..++||+|+||+||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++.+     .+++..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5889999999999999999999999999999986432   23345788999999999999999999984     456778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++.+.+      .+++..+..++.|++.|++|||   +++|+||||||+|||++.+|.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999997654      5788888999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcc---------------------------------------cccceeeeccccccceeCccccCCCCCCc
Q 002760          797 AKFLSNHNPDTI---------------------------------------VETRSISIGIKGTVGYVAPEYGMGREASM  837 (884)
Q Consensus       797 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  837 (884)
                      |..+........                                       ..........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            864321100000                                       00000112356999999999999999999


Q ss_pred             ccceeehhHHHHHHhcCCCCCCcc
Q 002760          838 KGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       838 ~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++||||+||++|||++|+.||.+.
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCC
Confidence            999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=315.01  Aligned_cols=198  Identities=27%  Similarity=0.388  Sum_probs=174.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ....+.+.+|++++++++||||++++++     +.++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence            36899999999999999999999999999999986432   2234568899999999999999999987     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.++++..+      .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecC
Confidence            899999999999999998654      5788889999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +++......           ...+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  201 (291)
T cd05612         147 FAKKLRDRT-----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD  201 (291)
T ss_pred             cchhccCCc-----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            998653211           1245899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5.9e-38  Score=329.42  Aligned_cols=361  Identities=27%  Similarity=0.410  Sum_probs=186.7

Q ss_pred             eEEEEEcCCCCCc-cccCcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEec
Q 002760           17 RVTRLDLGNQSIR-GTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSA   95 (884)
Q Consensus        17 ~v~~L~l~~~~~~-~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L   95 (884)
                      -|+..|+++|.++ +..|.++..+++++.|-|...++. .+|++++.|.+|++|.+++|++. .+...+..|+.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            4555666666665 345555555556666666555555 55555555555555555555555 44555555555555555


Q ss_pred             cCccccC-CCCcccccccccceecccccccCCCCCcccCCCCCCcEEEecccccccccc-ccccccccceeeccccccCC
Q 002760           96 DSNNLVG-EIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSG  173 (884)
Q Consensus        96 ~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~l~~l~~L~~L~L~~n~l~~  173 (884)
                      ..|++.. -+|..+-.+..|+.|+||+|+++ +.|..+..-+++-.|+||+|+|..+|. -|.+|+.|-.|+|++|++. 
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-  163 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-  163 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence            5555543 34555555555555555555555 455555555555555555555555553 2445555555555555554 


Q ss_pred             CCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceeccccccccc-Cccccc
Q 002760          174 MIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSG-GVSVDF  252 (884)
Q Consensus       174 ~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~~  252 (884)
                      .+|..+..+..|++|+|++|.                         +...--..+..+++|++|.+++.+-+- -.|..+
T Consensus       164 ~LPPQ~RRL~~LqtL~Ls~NP-------------------------L~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl  218 (1255)
T KOG0444|consen  164 MLPPQIRRLSMLQTLKLSNNP-------------------------LNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL  218 (1255)
T ss_pred             hcCHHHHHHhhhhhhhcCCCh-------------------------hhHHHHhcCccchhhhhhhcccccchhhcCCCch
Confidence            445555555555555555554                         433333334456667777776655331 122233


Q ss_pred             ccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCcccc
Q 002760          253 SRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR  332 (884)
Q Consensus       253 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  332 (884)
                      ..+.+|..+|+|.|++...+       +.+-.+++|+.|+||+|+++                          ......+
T Consensus       219 d~l~NL~dvDlS~N~Lp~vP-------ecly~l~~LrrLNLS~N~it--------------------------eL~~~~~  265 (1255)
T KOG0444|consen  219 DDLHNLRDVDLSENNLPIVP-------ECLYKLRNLRRLNLSGNKIT--------------------------ELNMTEG  265 (1255)
T ss_pred             hhhhhhhhccccccCCCcch-------HHHhhhhhhheeccCcCcee--------------------------eeeccHH
Confidence            33334444444333332211       12222333333333333322                          1112223


Q ss_pred             CCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCC-CCCCccCccccCcEEEcccccccccCCCCCcCcccccc
Q 002760          333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG-SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLG  411 (884)
Q Consensus       333 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  411 (884)
                      ...+|++|+++.|+++ .+|++++.+++|+.|.+.+|+++- -+|+.++.+.+|+.+..++|.++ ..|..++.|.+|+.
T Consensus       266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k  343 (1255)
T KOG0444|consen  266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK  343 (1255)
T ss_pred             HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence            3345555566666665 455556666666666666665542 24555555555555555555555 55555555555555


Q ss_pred             cccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCC
Q 002760          412 LNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK  467 (884)
Q Consensus       412 L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  467 (884)
                      |.|++|++.                          .+|+++.-++.|..|||..|.
T Consensus       344 L~L~~NrLi--------------------------TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  344 LKLDHNRLI--------------------------TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             hccccccee--------------------------echhhhhhcCCcceeeccCCc
Confidence            555555543                          455555556666666666664

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-35  Score=317.17  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=175.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..+|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.++++++||||+++++++     ..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            367999999999999999999999999999999996432   23346788999999999999999999984     4567


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|.+++...+      .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeec
Confidence            7899999999999999998654      5778888899999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+++......           ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus       163 g~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        163 GFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             cCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence            9998653221           1246899999999999999999999999999999999999999753

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5e-35  Score=324.58  Aligned_cols=209  Identities=22%  Similarity=0.304  Sum_probs=174.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      +|++.++||+|+||+||+|++..+++.||||++....   ......+.+|++++++++||||+++++.     +.+++..
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS-----FQDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCEE
Confidence            6899999999999999999999999999999986322   2334668899999999999999999988     4566788


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++...+      .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence            99999999999999997654      5778888899999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcc-----------------------------------cccceeeeccccccceeCccccCCCCCCcccce
Q 002760          797 AKFLSNHNPDTI-----------------------------------VETRSISIGIKGTVGYVAPEYGMGREASMKGDV  841 (884)
Q Consensus       797 a~~~~~~~~~~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  841 (884)
                      |..+........                                   ..........+||+.|+|||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            854321100000                                   000001123579999999999999999999999


Q ss_pred             eehhHHHHHHhcCCCCCCccc
Q 002760          842 YSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       842 wSlG~il~~lltg~~p~~~~~  862 (884)
                      ||+||++|||++|+.||.+..
T Consensus       228 wSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             eeccceeeehhhCCCCCCCCC
Confidence            999999999999999997653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=307.06  Aligned_cols=200  Identities=26%  Similarity=0.365  Sum_probs=177.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..|...+.||+|+||.||+|.+..+++.||+|++..... ...+.+++|+.++.+.+++||.+.++.     +-.+..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccHH
Confidence            457888999999999999999999999999999986543 446789999999999999999999987     45667889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      ++||||.||++.+.++...      .+++..+..|+++++.|+.|+|   .++.+|||||+.||++..+|.+|++|||.|
T Consensus        88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEeccee
Confidence            9999999999999998765      3467777789999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ..+.....        ....++|||.|||||++....|+.++||||||++++||++|.+|+..
T Consensus       159 ~ql~~~~~--------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~  213 (467)
T KOG0201|consen  159 GQLTNTVK--------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK  213 (467)
T ss_pred             eeeechhh--------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence            86654322        22467899999999999999999999999999999999999999866

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=318.57  Aligned_cols=198  Identities=24%  Similarity=0.398  Sum_probs=174.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|++++.+++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            36899999999999999999999999999999997432   23345688899999999999999999884     45667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++.++..++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCc
Confidence            899999999999999997654      5788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|.....           ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence            9975533           112346899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.9e-35  Score=315.25  Aligned_cols=195  Identities=26%  Similarity=0.321  Sum_probs=168.8

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.||+|+||.||+|++..+|+.||||+++...   ......+.+|++++++++||||+++.++     +...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEcCCEEEEEEe
Confidence            47999999999999999999999999997432   2334567889999999999999999988     455678899999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++...+      .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999987654      6789999999999999999999   8899999999999999999999999999987432


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         147 SDGA--------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             cCCC--------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence            2111        112356999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-34  Score=308.23  Aligned_cols=202  Identities=25%  Similarity=0.361  Sum_probs=172.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..+.||+|+||+||+|.+..+|+.||||++....   ......+.+|++++++++||+|+++.+++     ...+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            3778899999999999999999999999999986432   22234678899999999999999999884     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++.....    ..+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999988865432    15788999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +........         .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       149 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         149 AVQIPEGET---------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             cEEcCCCCe---------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            976532211         123458999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=309.79  Aligned_cols=185  Identities=33%  Similarity=0.526  Sum_probs=163.6

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      .+-||+|+-|.||+|+.  .++.||||.++.       .-..+|+-|++++||||+.|.|+|..     ...+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeecc
Confidence            47899999999999998  588999998741       12357888999999999999999863     44679999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ..|-|.+.++..+      .+.......+..+||.||.|||   .+.|||||+|.-||||+.+..|||+|||-++...+.
T Consensus       195 a~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             ccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999999999766      5677778889999999999999   779999999999999999999999999999877654


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .+         ...|+||..|||||+++..+.+.|+||||||||||||+||..||..
T Consensus       266 ST---------kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd  313 (904)
T KOG4721|consen  266 ST---------KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD  313 (904)
T ss_pred             hh---------hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence            32         2357899999999999999999999999999999999999999865

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.6e-35  Score=316.43  Aligned_cols=199  Identities=26%  Similarity=0.380  Sum_probs=173.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCC-cEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG-TEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++...   .....+.+.+|+.+++.++||||+++++++     .+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            457999999999999999999876554 68999998643   223446788999999999999999999984     456


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++|+|.+++....      .+++..+..++.|++.|++|||   ++||+||||||+|||++.++.+||+|
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEec
Confidence            67899999999999999998654      5788899999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+|.......           ...+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       175 FG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        175 FGFAKVVDTRT-----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             CCCCeecCCCc-----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence            99998653211           1246999999999999989999999999999999999999999764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=285.97  Aligned_cols=202  Identities=26%  Similarity=0.409  Sum_probs=175.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..+.|++-+.||+|+|+.||++.++.+|+.+|+|++..+  .....+++.+|+++-+.++||||+++.+.     +...+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            356788999999999999999999999999999998633  23356889999999999999999999987     55667


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC---CCCceEE
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHV  791 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl  791 (884)
                      +.|+|+|+|+|++|..-|-..      ..+++..+-+.+.||+.|+.|+|   .++|||||+||+|+++.   ..--+|+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceee
Confidence            789999999999987655433      25788888999999999999999   89999999999999995   3458899


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|||+|......         ....+++|||.|||||+....+|+..+|||+.||++|-++.|..||.+.
T Consensus       155 ~~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~  215 (355)
T KOG0033|consen  155 ADFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  215 (355)
T ss_pred             cccceEEEeCCc---------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence            999999877622         2345778999999999999999999999999999999999999999874

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.6e-35  Score=320.51  Aligned_cols=204  Identities=21%  Similarity=0.296  Sum_probs=173.7

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||++++++     +..
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQD  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEc
Confidence            3456899999999999999999999999999999998632   22334567889999999999999999998     456


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      +...++||||+++|+|.+++...       .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEE
Confidence            67889999999999999999653       4678888999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCC----CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR----EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||+|.........       .....+||+.|+|||++.+.    .++.++||||+||++|||++|+.||.+.
T Consensus       185 DFG~a~~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         185 DFGTCMKMDETGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ecccceecccCCce-------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            99999865432111       11234699999999998764    3788999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-34  Score=318.16  Aligned_cols=209  Identities=21%  Similarity=0.288  Sum_probs=176.1

Q ss_pred             HHHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeecc
Q 002760          631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSG  707 (884)
Q Consensus       631 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  707 (884)
                      ..+.....++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++.   
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~---  111 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA---  111 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE---
Confidence            3444455678999999999999999999999999999999986322   2334567889999999999999999988   


Q ss_pred             CCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC
Q 002760          708 RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~  787 (884)
                        +..+...++||||+++|+|.++++..       .+++..+..++.|++.|++|||   +++|+||||||+||+++.++
T Consensus       112 --~~~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~  179 (371)
T cd05622         112 --FQDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             --EEcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCC
Confidence              45567789999999999999998753       4677888899999999999999   88999999999999999999


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCC----CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR----EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+||+|||+|+........       .....+||+.|+|||++.+.    .++.++||||+||++|||++|+.||.+.
T Consensus       180 ~ikL~DfG~a~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         180 HLKLADFGTCMKMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CEEEEeCCceeEcCcCCcc-------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            9999999999865432111       11234699999999998754    3788999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-34  Score=318.91  Aligned_cols=210  Identities=25%  Similarity=0.345  Sum_probs=176.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++..   .......+.+|+.++.+++||+|+++++.     +.+.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence            3688999999999999999999999999999999643   22344678889999999999999999988     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.++|+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997654      5788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCccc---------------------------ccceeeeccccccceeCccccCCCCCCcccceeehhHHH
Q 002760          796 LAKFLSNHNPDTIV---------------------------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL  848 (884)
Q Consensus       796 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il  848 (884)
                      ++............                           .........+||+.|+|||++.+..++.++||||+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98755321110000                           000011235799999999999999999999999999999


Q ss_pred             HHHhcCCCCCCccc
Q 002760          849 LELFTRKRPTDAMF  862 (884)
Q Consensus       849 ~~lltg~~p~~~~~  862 (884)
                      |||++|+.||.+..
T Consensus       227 yel~tG~~Pf~~~~  240 (360)
T cd05627         227 YEMLIGYPPFCSET  240 (360)
T ss_pred             eecccCCCCCCCCC
Confidence            99999999997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-35  Score=308.91  Aligned_cols=204  Identities=26%  Similarity=0.400  Sum_probs=181.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|..++.+|+|+||.++.++++.+++.||+|.+......  ..+....|+.++++++|||||.+.+.     |..++.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~   77 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQ   77 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCc
Confidence            36799999999999999999999999999999999755432  23356789999999999999999998     556666


Q ss_pred             -ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          716 -KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       716 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                       .+|||+|++||++.+.+.+.+.    ..+++.++..++.|++.|+.|||   +++|+|||||+.||+++.++.|+|+||
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecch
Confidence             9999999999999999988763    27899999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+|+.+.....        ......|||.||+||.+.+.+|..|+|||||||++|||++-+.+|.+.
T Consensus       151 GlaK~l~~~~~--------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~  209 (426)
T KOG0589|consen  151 GLAKILNPEDS--------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS  209 (426)
T ss_pred             hhhhhcCCchh--------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence            99998875431        222457999999999999999999999999999999999999999874

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-34  Score=311.26  Aligned_cols=195  Identities=26%  Similarity=0.337  Sum_probs=168.7

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.||+|+||.||+|++..+|+.||||+++...   ......+.+|+++++.++||||+++.++     +...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS-----FQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCEEEEEEe
Confidence            46999999999999999999999999997432   2334577889999999999999999988     456677899999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999887654      5889999999999999999999   8899999999999999999999999999987532


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ....        .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       147 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         147 TDAA--------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             Cccc--------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            2111        112346999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-34  Score=311.49  Aligned_cols=195  Identities=25%  Similarity=0.321  Sum_probs=168.1

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.||+|+||.||+|++..+|+.||+|+++...   ......+.+|++++++++||||+++.+.+     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            47999999999999999999999999997432   23345677899999999999999999884     45667899999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++...+      .+++..++.++.|++.|++|||   ++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999887654      5789999999999999999999   8899999999999999999999999999987532


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         147 SDGAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             CCCCc--------cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            21111        11346999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=320.66  Aligned_cols=225  Identities=29%  Similarity=0.474  Sum_probs=188.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCc---EEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGT---EVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ...+.++||.|.||+||+|+.+..|+   .||||.++..- .+...+|..|+.||.+++||||+++.|+     .....-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCce
Confidence            45788999999999999999987764   59999998543 3445689999999999999999999999     455566


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ++||+|||++|+|+.|++....     .+.+.+...+.++|+.||.||.   +.++|||||.++|||++.+..+|++|||
T Consensus       705 vMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEecccc
Confidence            7999999999999999998764     5888999999999999999999   7799999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccccCCccHHHHHHH
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNEGLTLHDFSRE  874 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~~~~~~~~~~~~  874 (884)
                      +++.+.+..+.... +    .+-.-..+|.|||.+..++++.++||||+|+++||+++ |..||..+++  .++.+-+++
T Consensus       777 LSRvledd~~~~yt-t----~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~  849 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYT-T----LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQ  849 (996)
T ss_pred             ceeecccCCCcccc-c----cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHh
Confidence            99988655422211 1    12223578999999999999999999999999999886 9999987754  334555666


Q ss_pred             HhccCCCCCC
Q 002760          875 FFTRKSDTDC  884 (884)
Q Consensus       875 ~~~~~~~~~~  884 (884)
                      -+.-..+-||
T Consensus       850 gyRLPpPmDC  859 (996)
T KOG0196|consen  850 GYRLPPPMDC  859 (996)
T ss_pred             ccCCCCCCCC
Confidence            6666666666

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=308.55  Aligned_cols=193  Identities=24%  Similarity=0.336  Sum_probs=167.4

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|+.++++++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            69999999999999999999999998643   223346678899999999999999999884     4567789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            9999999997654      5788899999999999999999   889999999999999999999999999998754222


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         147 DD--------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             CC--------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence            11        112346999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=307.69  Aligned_cols=206  Identities=30%  Similarity=0.419  Sum_probs=181.6

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc---chHHHHHHHHHHHcCC-CCCccceeeeeccCCccC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG---ASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  712 (884)
                      ....|++.+.||+|.||.||+++.+.+|+.+|+|++.++...   ..+.+.+|+.+|+++. |||||.+.+.     ++.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence            356799999999999999999999999999999999755432   3468999999999998 9999999999     667


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC----CCc
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ----DLV  788 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~----~~~  788 (884)
                      ...+++|||+++||.|.+.+...       .+++..+..++.|++.|+.|+|   ..||+|||+||+|+|+..    ++.
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCc
Confidence            77899999999999999999865       2889999999999999999999   889999999999999963    358


Q ss_pred             eEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       789 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      +|++|||+|......         ......+||+.|+|||++....|+..+||||+||++|.|++|..||.+..+++.
T Consensus       178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~  246 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI  246 (382)
T ss_pred             EEEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence            999999999877541         133457899999999999999999999999999999999999999998664443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.2e-34  Score=309.71  Aligned_cols=195  Identities=26%  Similarity=0.325  Sum_probs=167.7

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.||+|+||.||+|++..+|+.||+|+++...   .....++..|+++++.++||||+++.++     +...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~-----~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEcCCEEEEEEe
Confidence            47999999999999999999999999997432   2334567789999999999999999987     455677899999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      |+++|+|.+++...+      .+++.++..++.|++.|++|||   + +||+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999887654      5789999999999999999999   5 69999999999999999999999999998753


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         147 IKDGA--------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             CCCCc--------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            22111        112346999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-34  Score=313.53  Aligned_cols=203  Identities=21%  Similarity=0.300  Sum_probs=172.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.+++.++||||++++++     +.++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecC
Confidence            346799999999999999999999999999999999632   22333557789999999999999999987     4566


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++|+|.+++...       .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence            7889999999999999998753       4677888889999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCC----CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR----EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+.........       .....+||+.|+|||++.+.    .++.++||||+||++|||++|+.||.+.
T Consensus       186 fG~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         186 FGTCMKMDANGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             ccceeeccCCCcc-------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence            9999765432111       11234699999999987653    4788999999999999999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-34  Score=308.96  Aligned_cols=201  Identities=23%  Similarity=0.302  Sum_probs=170.3

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCC-CccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR-NLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  715 (884)
                      +|++.+.||+|+||.||+|++..+++.||||+++..   .....+.+..|++++..+.|+ +|+++.++     +...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----EEcCCE
Confidence            488899999999999999999999999999999743   223446678899999999765 57777776     445667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++....      .+++.+++.++.|++.|++|||   ++||+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            899999999999999987654      5788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ++........        .....+||+.|+|||++.+..++.++||||+||++|+|+||+.||.+..
T Consensus       147 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         147 MCKENIFGGK--------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             cceecCCCCC--------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            9864321111        1123569999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=330.25  Aligned_cols=213  Identities=30%  Similarity=0.452  Sum_probs=176.5

Q ss_pred             CCCccCeeeeccceEEEEEEECCCC-----cEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENG-----TEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..+..+.||+|+||.||+|......     ..||||.++.. +.+...+|.+|+.+|+.++|||||+++|+|.    . .
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l----~-~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL----D-S  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec----C-C
Confidence            4567789999999999999875432     24899988644 3455678999999999999999999999984    3 5


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCC-cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ...++++|||+||+|..|+++.+.. .+...++..+.+.++.|||+|+.||+   ++++|||||.++|+|++....|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence            5679999999999999999986432 23456899999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccccCCc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNEGL  866 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~~~~  866 (884)
                      |||+|+.+.+...+.....      ..=..+|||||.+.+..++.|+|||||||++||++| |..||....+.+.
T Consensus       845 DFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v  913 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV  913 (1025)
T ss_pred             ccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence            9999996655443322111      112468999999999999999999999999999998 8889987655443

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=314.13  Aligned_cols=210  Identities=24%  Similarity=0.359  Sum_probs=177.9

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...   ......+.+|++++..++||||++++++     +.+++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence            36899999999999999999999999999999997432   2445678899999999999999999987     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCC
Confidence            899999999999999998653      6888999999999999999999   7899999999999999999999999999


Q ss_pred             cccccccCCCCccc---------------------ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcC
Q 002760          796 LAKFLSNHNPDTIV---------------------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR  854 (884)
Q Consensus       796 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg  854 (884)
                      ++............                     ..........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            99866543200000                     000112234699999999999999999999999999999999999


Q ss_pred             CCCCCccc
Q 002760          855 KRPTDAMF  862 (884)
Q Consensus       855 ~~p~~~~~  862 (884)
                      +.||....
T Consensus       227 ~~Pf~~~~  234 (350)
T cd05573         227 FPPFYSDT  234 (350)
T ss_pred             CCCCCCCC
Confidence            99997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-34  Score=312.71  Aligned_cols=212  Identities=25%  Similarity=0.406  Sum_probs=171.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.++||+|+||.||+|.+.     .+++.||||+++... ....+.+.+|+.+++++ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT----   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence            467999999999999999999752     345789999986432 23345788999999999 8999999999863    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCc---------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQL---------------------------------------------------  739 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  739 (884)
                      ......++||||+++|+|.+++.......                                                   
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            33456789999999999999997532110                                                   


Q ss_pred             -----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCccccccee
Q 002760          740 -----EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI  814 (884)
Q Consensus       740 -----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~  814 (884)
                           ...++++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+|+.........      .
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh------c
Confidence                 1134778889999999999999999   8899999999999999999999999999998653221110      0


Q ss_pred             eeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       815 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            112236788999999999999999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=308.18  Aligned_cols=203  Identities=26%  Similarity=0.321  Sum_probs=172.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.++..++||+|++++++     +..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYA-----FQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEE-----EecCCe
Confidence            4789999999999999999999999999999998632   22334568889999999999999999988     456678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++.....     .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECC
Confidence            8999999999999999976432     5788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++..........       .....||+.|+|||++..     ..++.++||||+||++|+|++|+.||.+.
T Consensus       148 ~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         148 SCLRLLADGTVQ-------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeecCCCCCcc-------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            987654322111       112358999999999863     45788999999999999999999999763

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=292.28  Aligned_cols=225  Identities=25%  Similarity=0.414  Sum_probs=177.2

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHc--CCCCCccceeeeeccCCccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN--IRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..++.++.+.||+|.||+||+|+|  .|+.||||++...+   .+...+|.++.+.  ++|+||..+++.-.. +-..-.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~T  282 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWT  282 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceE
Confidence            345688899999999999999999  69999999996433   3456677777766  499999999986211 112234


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCCeeeCCCCce
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH-----YCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-----~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                      ..++|++|.+.|||+||+.+.       .++....++++..+|.||++||.     +....|.|||||+.|||+..+|..
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            679999999999999999975       68899999999999999999993     346789999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCC------CCCcccceeehhHHHHHHhcC---------
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR------EASMKGDVYSFGILLLELFTR---------  854 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~~lltg---------  854 (884)
                      .|+|+|+|.........-..    ..+..+||.+|||||++...      +.-..+||||||.|+||++.+         
T Consensus       356 ~IADLGLAv~h~~~t~~idi----~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDI----PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             EEeeceeeEEecccCCcccC----CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            99999999866544322111    23456799999999997652      233469999999999998862         


Q ss_pred             -CCCCCccccCCccHHHHHHHHhcc
Q 002760          855 -KRPTDAMFNEGLTLHDFSREFFTR  878 (884)
Q Consensus       855 -~~p~~~~~~~~~~~~~~~~~~~~~  878 (884)
                       +.||....+....+++..+.++-+
T Consensus       432 y~~Pyyd~Vp~DPs~eeMrkVVCv~  456 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFEEMRKVVCVQ  456 (513)
T ss_pred             hcCCcccCCCCCCCHHHHhcceeec
Confidence             368888877777777766555433

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.3e-34  Score=308.28  Aligned_cols=201  Identities=22%  Similarity=0.282  Sum_probs=170.5

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +|++.+.||+|+||+||+|++..+++.||||+++...   ....+....|..++..+ +||+|+++.+++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4888999999999999999999999999999997432   22334567788888777 588888888874     45567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++.++..++.|++.|++|||   ++||+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCC
Confidence            899999999999999987654      5788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +++.......        .....+||+.|+|||++.+..++.++||||+||++|||+||+.||.+..
T Consensus       147 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         147 MCKENMWDGV--------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             CceecCCCCC--------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            9875332111        1123569999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.6e-34  Score=302.60  Aligned_cols=202  Identities=25%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            357999999999999999999999999999999986432 23345778999999999999999999984     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++ |+|.+++...+.     .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~  149 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGL  149 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence            99999996 599999875432     4788899999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.......        ......|++.|+|||++.+ ..++.++||||+||++|+|+||+.||.+.
T Consensus       150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         150 ARAKSVPTK--------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             eeeccCCCc--------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            975432211        1122358999999998865 56899999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9e-34  Score=306.18  Aligned_cols=195  Identities=26%  Similarity=0.371  Sum_probs=165.4

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|++..+++.||||+++...   ....+....|..++... +||||++++++     +..++..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence            47999999999999999999999999997432   23334556677777654 89999999988     44566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++....      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999987654      5788899999999999999999   889999999999999999999999999999754


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         147 MNGEG--------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             CCCCC--------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            32211        122356999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-33  Score=304.27  Aligned_cols=202  Identities=26%  Similarity=0.425  Sum_probs=170.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||+||+|++..+++.||||+++... ......+.+|+.++++++||||+++.+++     ..+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            468999999999999999999999999999999986432 23345678899999999999999999984     456678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++ +++.+++.....     .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999995 688888875432     5788889999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........        .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       150 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         150 ARAKSVPSHT--------YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             ceeccCCCcc--------CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8754322111        112458999999998865 45888999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=284.29  Aligned_cols=205  Identities=26%  Similarity=0.325  Sum_probs=177.6

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..++|...+.||+|.||.|..++.+.+|+.+|+|++++.   +......-..|-++++..+||.+..+--.     |+..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccC
Confidence            356799999999999999999999999999999999744   23334456779999999999987765432     7888


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ++.|.||||..||.|.-++.+.+      .+++...+.+...|+.||.|||   +++||+||+|.+|.|+|.+|++||.|
T Consensus       241 drlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeee
Confidence            99999999999999998888765      5778888889999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      ||+++.--        ........+||||.|.|||++.+..|+.++|.|.+||++|||++|+.||.....
T Consensus       312 FGLCKE~I--------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  312 FGLCKEEI--------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             cccchhcc--------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence            99987321        222344578999999999999999999999999999999999999999987543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=308.82  Aligned_cols=206  Identities=29%  Similarity=0.457  Sum_probs=172.9

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  718 (884)
                      +...+.||+||||.||+|+++.+|+.||||.++... ....++..+|+++|++++|||||+.+++-.... .--.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            455688999999999999999999999999997433 344577889999999999999999998722111 001345689


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC--CCC--ceEEecc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD--QDL--VSHVSDF  794 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~--~~~--~~kl~DF  794 (884)
                      |||||.||||+..+.+....   ..+++.+.+.+..+++.||.|||   ++|||||||||.||++-  .+|  .-||+||
T Consensus        95 vmEyC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEeecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            99999999999999876543   46999999999999999999999   88999999999999984  334  4599999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.|+.+.+..         ....++||+.|.+||...+ +.|+..+|.|||||++|+++||..||...
T Consensus       169 G~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  169 GAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9999876543         3345789999999999885 88999999999999999999999999764

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-33  Score=307.88  Aligned_cols=203  Identities=24%  Similarity=0.309  Sum_probs=172.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .......+.+|+.++..++||+|+++.++     +.+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~-----~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYA-----FQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence            4789999999999999999999999999999998642   22234557889999999999999999998     455678


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecc
Confidence            8999999999999999986432     5788889999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.........       .....+||+.|+|||++.+     ..++.++||||+||++|+|++|+.||...
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         148 SCLKMNQDGTV-------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeeccCCCce-------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            99765432211       1123469999999998875     46788999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=296.07  Aligned_cols=202  Identities=32%  Similarity=0.421  Sum_probs=165.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHc--CCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN--IRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ....+..+.||+|.||.||+|+.  +++.||||++...   ..+.+++|-++.+-  ++|+||+++++.-...+.. ...
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence            34567789999999999999998  6799999999643   33567777777665  5899999999974333222 457


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCCeeeCCCCce
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY------CEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                      +++|+||.+.|+|.+|++.+       ..+|....+|+..+++||+|||+.      +..+|+|||||++|||+..|++.
T Consensus       283 ywLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            89999999999999999977       689999999999999999999953      36789999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC------CCcccceeehhHHHHHHhcCCCCC
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE------ASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~~lltg~~p~  858 (884)
                      .|+|||+|..+....+...      ..+.+||.+|||||++.+.-      .-.+.||||+|.++|||+++-.-+
T Consensus       356 cIaDFGLAl~~~p~~~~~d------~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGD------THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             EeeccceeEEecCCCCCcc------hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            9999999998875443322      23467999999999987742      223689999999999999865433

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-33  Score=306.68  Aligned_cols=196  Identities=25%  Similarity=0.321  Sum_probs=167.4

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+++.||||+++..   .....+.+..|.+++..+ +||+|++++++     +...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~-----~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC-----FQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCeEEEEE
Confidence            4699999999999999989999999999743   223345677888888866 79999999998     45566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|..++...+      .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++...
T Consensus        76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654      5788899999999999999999   889999999999999999999999999998754


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         147 ILNGV--------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             ccCCc--------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            32211        1123468999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=278.85  Aligned_cols=202  Identities=23%  Similarity=0.369  Sum_probs=173.3

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccceEEEEcc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      +.||+|+||.|-.+....+|.+||||++.+.......++.+|++++.+.+ |+||+.++++     |+++...|+|||-|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEecc
Confidence            68999999999999999999999999998665666788999999999984 9999999999     78888999999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC---ceEEecccccccc
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL---VSHVSDFGLAKFL  800 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~DFg~a~~~  800 (884)
                      .||+|...|+..+      -+.+.++.++..+|+.||.|||   .+||.|||+||+|||-....   -||||||.++.-.
T Consensus       159 ~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  159 RGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             cCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            9999999998765      6889999999999999999999   89999999999999987543   6799999887654


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccC---C--CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGM---G--REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....-.. ...+.....+|+..|||||+..   +  ..|+.++|.||||||+|-|+.|++||.+.
T Consensus       230 k~~~~~sp-astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  230 KLNNDCSP-ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             ccCCCCCC-CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            33332222 2223445678999999999743   2  46899999999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.6e-34  Score=307.46  Aligned_cols=198  Identities=26%  Similarity=0.371  Sum_probs=168.3

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHH---HcCCCCCccceeeeeccCCccCCc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKAL---RNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      |++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|++++   +.++||||++++++     +...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~-----~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC-----FQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE-----EEcCC
Confidence            678899999999999999999999999999997432   23345666776665   46689999999998     45667


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|..+++..       .+++.++..++.|++.|++|||   ++||+||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcc
Confidence            889999999999999888642       5889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+++.......        .....+|++.|+|||.+.+..++.++||||+||++|||++|+.||.+.
T Consensus       146 g~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         146 GLCKEGMGFGD--------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             cCCccCCCCCC--------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            99874322111        122356999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-33  Score=305.65  Aligned_cols=194  Identities=25%  Similarity=0.340  Sum_probs=167.6

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|++..+++.||||+++...   ....+.+.+|..+++++ +||||++++++     +......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~-----~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC-----FQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEE-----EEcCCEEEEEE
Confidence            47999999999999999999999999997432   23345678899999888 79999999998     45567789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++..++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999887654      6889999999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .....        .....+||+.|+|||++.+..++.++|+||+||++|+|++|+.||+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         147 IRPGD--------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCC--------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            21111        11235699999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-33  Score=306.16  Aligned_cols=201  Identities=22%  Similarity=0.299  Sum_probs=170.3

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +|+..+.||+|+||+||+|++..+|+.||+|+++...   ....+.+..|..+++.+. ||+|+++.++     +...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence            4778899999999999999999999999999987432   233456778888988885 5677778877     455667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+      .+++.+++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccc
Confidence            899999999999999987654      5889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +++.......        ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..
T Consensus       147 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         147 MCKEHMVDGV--------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             cccccCCCCc--------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            9875322111        1123468999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-33  Score=309.79  Aligned_cols=207  Identities=25%  Similarity=0.378  Sum_probs=172.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.++||+|+||.||+|++..+|+.||||+++..  ......++.+|++++++++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999999999999999998632  223345688999999999999999999987544333445689


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+ +++|.+++....      .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        81 lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence            999999 469999987653      5789999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........     .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+.
T Consensus       151 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         151 RVAFNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             cccccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            7543322111     11123468999999999866  67899999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-33  Score=305.74  Aligned_cols=195  Identities=28%  Similarity=0.366  Sum_probs=167.4

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|+++.+++.||||+++..   .....+.+..|..++... +||||++++++     +...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~-----~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC-----FQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE-----EEcCCEEEEEE
Confidence            4799999999999999999999999998743   233445677888888876 69999999998     45667789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999987654      5788999999999999999999   889999999999999999999999999998753


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (320)
T cd05590         147 IFNGK--------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE  199 (320)
T ss_pred             CcCCC--------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            22111        112346999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-33  Score=305.22  Aligned_cols=194  Identities=24%  Similarity=0.342  Sum_probs=166.7

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||||++++++     +......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeE-----EEeCCEEEEEE
Confidence            47999999999999999999999999997432   23345677888888776 89999999998     44567889999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|..++...+      .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999999887654      5889999999999999999999   889999999999999999999999999998753


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .....        ......||+.|+|||++.+..++.++||||+||++|||++|+.||+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         147 LRPGD--------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cCCCC--------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            22111        11235699999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-33  Score=303.91  Aligned_cols=196  Identities=26%  Similarity=0.369  Sum_probs=166.0

Q ss_pred             cCeeeeccceEEEEEEEC---CCCcEEEEEEeeccc----ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          644 ANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLKQ----KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+.||+|+||.||+|+..   .+++.||||+++...    ......+.+|++++++++||||+++++++     ..++..
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            368999999999999863   468899999997431    22335677899999999999999999884     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++...+      .+.+..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            99999999999999997654      5678888899999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.......        ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         147 CKESIHEGT--------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             CeecccCCC--------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence            874322211        112346899999999999988999999999999999999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-33  Score=306.49  Aligned_cols=201  Identities=25%  Similarity=0.399  Sum_probs=174.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.+.||+|+||.||+|++..+|..||+|++.... ....+.+.+|++++++++||||+++++++     ..++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence            368999999999999999999999999999999987542 23346789999999999999999999985     445678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++....      .+++..+..++.|++.|+.|||+  ..+|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            99999999999999997654      57888999999999999999993  23699999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.......          .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       151 ~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cccccccc----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            87553221          12345899999999999999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.8e-34  Score=308.55  Aligned_cols=203  Identities=24%  Similarity=0.263  Sum_probs=173.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||+||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||+|+++.+++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            36899999999999999999999999999999997432   23445688899999999999999999874     45667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCC
Confidence            8999999999999999987532     5888999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccC------CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM------GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|.........       ......||+.|+|||++.      +..++.++||||+||++|||++|+.||...
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             CCeECCCCCce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            99866432211       112245899999999976      456789999999999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-33  Score=300.62  Aligned_cols=202  Identities=25%  Similarity=0.344  Sum_probs=171.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...  ....+.+.+|+.++++++||||+++++++     ..++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            36899999999999999999999999999999987432  23346788999999999999999999884     456678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++++.+..+.....      .+++..++.++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999998877665543322      5788899999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       147 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         147 ARNLSEGSNA-------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cccccccccc-------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            9865432211       111345899999999999989999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=271.27  Aligned_cols=225  Identities=20%  Similarity=0.242  Sum_probs=182.7

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..++|++.+.+|+|||+-||.++.-.+++.||+|++.-...+..+...+|++..++++||||+++++++....-+.....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35689999999999999999999999999999999875555667888999999999999999999998765544466778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      |+++.|...|+|.+.++.....  ...+++.++++|+.++++|+++||+. ...++||||||.|||+++++.+++.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999999875432  33789999999999999999999943 23499999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccceeeeccccccceeCccccCC---CCCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          797 AKFLSNHNPDTI-VETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       797 a~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      ++...-...... ...-+.+.....|..|+|||.+.-   ...+.++|||||||++|+|+.|.-||+...+.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            875432211110 000011222336889999998654   45789999999999999999999999875443

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-33  Score=304.32  Aligned_cols=203  Identities=23%  Similarity=0.285  Sum_probs=171.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.++||+|+||+||+|++..+++.||+|++...   .......+..|+.++..++||+|+++.+.+     .+.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            4689999999999999999999999999999998632   222334578899999999999999999884     45677


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecc
Confidence            8999999999999999986432     5788889999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.........       .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         148 SCLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             hheecccCCcc-------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            98754322111       112346999999999876     346889999999999999999999999763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=284.56  Aligned_cols=198  Identities=25%  Similarity=0.380  Sum_probs=175.1

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      -|.++++||+|+||.||+|.++.+|+.||||.+..  ....+++..|+.+|++.+.|+||+++|.|.     .....++|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEee
Confidence            37788999999999999999999999999998854  344678999999999999999999999852     34567999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      ||||..|+..+.++..+.     ++.+.++..+....+.||+|||   ...-||||||+.|||+..+|++|++|||.|..
T Consensus       107 MEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             hhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccch
Confidence            999999999999987654     7999999999999999999999   55779999999999999999999999999987


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +.+.-.+        .+...|||.|||||++..-.|+.++||||+|++..||..|++||..
T Consensus       179 LTDTMAK--------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  179 LTDTMAK--------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             hhhhHHh--------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence            6543322        1245699999999999999999999999999999999999999865

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-33  Score=301.74  Aligned_cols=195  Identities=24%  Similarity=0.364  Sum_probs=165.9

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+++.||||+++...   ....+....|..++... +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999997432   23345566788888764 899999999984     4566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++....      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999997643      5788889999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         147 MLGDA--------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             CCCCC--------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            22111        112346999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-33  Score=303.09  Aligned_cols=195  Identities=25%  Similarity=0.374  Sum_probs=166.2

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|++..+|+.||+|+++...   ....+....|..++... +||+|++++++     +...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE-----EEeCCEEEEEE
Confidence            47999999999999999999999999997432   23345567788888754 89999999998     45567889999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++....      .+++.++..++.|++.|++|||   ++||+||||||+||+++.++.++|+|||+++..
T Consensus        76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999987643      5788899999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ....        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            2111        1122456999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-34  Score=273.31  Aligned_cols=202  Identities=29%  Similarity=0.453  Sum_probs=175.0

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc----cch----HHHHHHHHHHHcC-CCCCccceeeeec
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK----GAS----KSFVAECKALRNI-RHRNLIKIITVCS  706 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~  706 (884)
                      ..-..|...+.+|.|..++|.++.++.+|+++|+|++.....    ...    ++-..|+.+++++ -||+|+.+.++  
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~--   91 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV--   91 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee--
Confidence            345678889999999999999999999999999999974321    112    3456799999998 69999999999  


Q ss_pred             cCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       707 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                         ++.+.+.++|+|.|+.|.|.+|+....      .+++++..+|+.|+..|++|||   .+.|||||+||+|||++++
T Consensus        92 ---yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn  159 (411)
T KOG0599|consen   92 ---YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDN  159 (411)
T ss_pred             ---ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccc
Confidence               567778899999999999999998765      7899999999999999999999   8899999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC------CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG------REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .++||+|||+|+.+.+...         ....||||+|.|||.+.-      ..|+..+|+||+||++|-++.|.+||..
T Consensus       160 ~~i~isDFGFa~~l~~Gek---------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH  230 (411)
T KOG0599|consen  160 MNIKISDFGFACQLEPGEK---------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH  230 (411)
T ss_pred             cceEEeccceeeccCCchh---------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence            9999999999997754432         235689999999998653      3578899999999999999999999875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-33  Score=297.99  Aligned_cols=207  Identities=25%  Similarity=0.415  Sum_probs=171.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECC-CCcEEEEEEeeccc--ccchHHHHHHHHHHHcC---CCCCccceeeeeccCCccC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGE-NGTEVAVKVINLKQ--KGASKSFVAECKALRNI---RHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~  712 (884)
                      ++|++.+.||+|+||+||+|++.. +++.||+|+++...  ......+.+|+.+++.+   +||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368999999999999999999854 46889999986432  22334566787777765   6999999999986544445


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ....++||||+. ++|.+++.....    ..+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence            667899999995 699999876432    25788999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      |||+++......         ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus       153 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         153 DFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             cccceEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            999997654321         1123458999999999988899999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=306.23  Aligned_cols=204  Identities=31%  Similarity=0.479  Sum_probs=171.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCc---E-EEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT---E-VAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      .++....++||+|+||.||+|+.+..+.   . ||||..+..   .....+++.+|+++|++++|||||+++|++.    
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~----  231 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV----  231 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence            3455667999999999999998865432   3 899998742   2455678999999999999999999999965    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                       ....+++|||+|.||+|.+|++..+.     .++..+..+++.+.|.||+|||   ++++|||||.++|+|++.++.+|
T Consensus       232 -~~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  232 -LEEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             -CCCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEE
Confidence             34456999999999999999998764     5889999999999999999999   88999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      |+|||+++......   ...     ....-+.+|+|||.+....|+.++|||||||++||+++ |..||.+..
T Consensus       303 ISDFGLs~~~~~~~---~~~-----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYV---MKK-----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             eCccccccCCccee---ecc-----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence            99999987553111   110     01124678999999999999999999999999999998 888998754

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-33  Score=303.13  Aligned_cols=195  Identities=30%  Similarity=0.373  Sum_probs=164.4

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECK-ALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+|+.||||++....   ....+++..|.. +++.++||||+++++.+     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999996432   222344555554 46788999999999884     4567789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++..+..++.||+.|++|||   ++||+||||||+|||++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999987654      5788899999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  199 (323)
T cd05575         147 IEHSK--------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (323)
T ss_pred             ccCCC--------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence            22111        122346999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-33  Score=302.62  Aligned_cols=195  Identities=25%  Similarity=0.349  Sum_probs=167.9

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|+...+++.||+|+++...   ....+.+.+|+.++.++ +||+|++++++     +......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-----FQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-----EEeCCEEEEEE
Confidence            47999999999999999999999999997432   23345678899999888 69999999998     45567789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999887654      5889999999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||+..
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         147 LGPGD--------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             cCCCC--------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            22111        112356999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-33  Score=304.07  Aligned_cols=195  Identities=30%  Similarity=0.365  Sum_probs=164.6

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECK-ALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||++++++     +..++..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~-----~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEE-----EecCCEEEEEE
Confidence            46999999999999999999999999996432   223344555554 4677899999999988     44567789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|..++...+      .+++.++..++.||+.|++|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999999887654      6889999999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         147 IAQSD--------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             CCCCC--------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            22111        112356999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-33  Score=303.80  Aligned_cols=201  Identities=25%  Similarity=0.350  Sum_probs=169.3

Q ss_pred             CCCccCeeeeccceEEEEEEEC---CCCcEEEEEEeecc----cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLK----QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  711 (884)
                      +|++.+.||+|+||.||+|+..   .+++.||+|+++..    .....+.+..|+.+++.+ +||+|+++.++     +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence            4889999999999999998863   47889999998632    123345678899999999 59999999987     45


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      ..+..++||||+++|+|.+++....      .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEE
Confidence            6677899999999999999987654      5788999999999999999999   889999999999999999999999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|||+++........       .....+||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus       147 ~DfG~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         147 TDFGLSKEFLSEEKE-------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             eeCcCCccccccCCC-------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            999999755332211       11235699999999998875 4788999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=316.86  Aligned_cols=218  Identities=24%  Similarity=0.309  Sum_probs=177.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC-CCCccceeeeeccCC-ccC-Ccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRD-FKG-ADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~-~~~  715 (884)
                      -++++.+.|.+|||+.||.|++...|..||+|++-..+....+.+.+|+++|+.+. |||||.+++...... -.. .-.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            35678899999999999999998777999999987667777788999999999996 999999999432222 222 356


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +++.||||+||.|-+++......    .|++.++++|+.|+++|+++||.. ...|||||||-|||||+.+|+.||||||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            78999999999999999865432    599999999999999999999966 6779999999999999999999999999


Q ss_pred             cccccccCC-CCcccccceeeeccccccceeCccc---cCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHN-PDTIVETRSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .|....... ....+..-.......-|+-|+|||.   ..+.+.++|+|||||||+||.++....||+..
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            997443222 1111100011122336999999996   46788999999999999999999999999875

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=296.36  Aligned_cols=201  Identities=26%  Similarity=0.372  Sum_probs=172.3

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|++.+.||+|+||+||+|.+..+++.||||++....   ......+.+|+.++++++||||+++.+.+     ..++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4788999999999999999998899999999986432   22234567899999999999999999884     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.+++.....    ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999998875432    25889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +........         .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         149 AVEIPEGET---------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             ceecCCCCc---------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence            876532211         11345899999999999989999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.4e-33  Score=302.45  Aligned_cols=195  Identities=30%  Similarity=0.370  Sum_probs=163.1

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECK-ALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||++++++     +...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~-----~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEE-----EEcCCeEEEEE
Confidence            47999999999999999999999999996432   122234444444 5678899999999988     44567789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999997654      5677888889999999999999   889999999999999999999999999998753


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         147 IEHNG--------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             ccCCC--------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence            22111        112356999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=294.10  Aligned_cols=196  Identities=27%  Similarity=0.423  Sum_probs=170.3

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      .+.||+|.||+||-|+++++|+.||||++.+-  .......+.+|+.++++++||.||.+...     ++..+.+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            48999999999999999999999999999632  23445778999999999999999999987     678889999999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC---CceEEecccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD---LVSHVSDFGLAK  798 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFg~a~  798 (884)
                      -+ +|++.+.|-....    ..+++.....+..||+.||.|||   .++|||+|+||+|||+...   -.+||||||+|+
T Consensus       644 Kl-~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KL-HGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hh-cchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccccee
Confidence            99 6688887765432    26888888889999999999999   8899999999999999643   489999999999


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++....         .....+|||.|.|||+++.+.|...-|+||.|||+|.-++|.+||.+.
T Consensus       716 iIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  716 IIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             ecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            886532         223467999999999999999999999999999999999999999763

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3e-33  Score=324.36  Aligned_cols=215  Identities=27%  Similarity=0.387  Sum_probs=175.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.++||+|+||.||+|++..+|+.||||+++...   ....+++.+|++++++++||||+++++++     .+++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            57999999999999999999999999999999986432   22346789999999999999999999985     34567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCC-----cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQ-----LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                      .++||||++||+|.+++......     ......++.+++.++.|++.|++|||   ++||+||||||+||+++.++.++
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence            89999999999999998753211     01124567788999999999999999   88999999999999999999999


Q ss_pred             EeccccccccccCCCCcc----------cccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          791 VSDFGLAKFLSNHNPDTI----------VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |+|||+|+..........          ..........+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986622111000          0000111235699999999999999999999999999999999999999976


Q ss_pred             c
Q 002760          861 M  861 (884)
Q Consensus       861 ~  861 (884)
                      .
T Consensus       234 ~  234 (932)
T PRK13184        234 K  234 (932)
T ss_pred             c
Confidence            3

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.7e-33  Score=301.77  Aligned_cols=195  Identities=29%  Similarity=0.350  Sum_probs=163.6

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECK-ALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     .+.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432   222334555554 57889999999999884     4566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|..++....      .+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999998887543      5778888999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         147 VEPEE--------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             CCCCC--------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            22111        112346899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-33  Score=309.70  Aligned_cols=195  Identities=25%  Similarity=0.346  Sum_probs=168.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|...      .+.+.+|++++++++||||+++++++     ......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeE
Confidence            357999999999999999999999999999999753      23567899999999999999999984     4456789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|||++ +++|.+++....      .+++.+++.++.|++.||+|||   +++||||||||+||+++.++.+||+|||+|
T Consensus       160 lv~e~~-~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             EEEecC-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            999999 478998887643      5788999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +........       .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       230 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        230 CFPVDINAN-------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccccc-------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            754322111       11235699999999999999999999999999999999999988754

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=290.95  Aligned_cols=204  Identities=26%  Similarity=0.389  Sum_probs=179.2

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..+.|+.-++||+|+||.||-++.+.+|+.+|+|.+.++   .+.......+|..+++++..|.||.+--.     ++..
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence            345788889999999999999999999999999988532   33445667889999999999988877643     7889


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      +..++|+..|.||+|.-+|...+..    .+++..+..+|.+|+.||++||   +.+||+||+||+|||+|+.|+++|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~----gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNP----GFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCC----CCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeec
Confidence            9999999999999999988877653    6899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .|+|..+....+.         .+.+||.+|||||++.+..|+...|.||+||++|||+.|+.||...
T Consensus       331 LGLAvei~~g~~~---------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  331 LGLAVEIPEGKPI---------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             cceEEecCCCCcc---------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            9999977554322         2347999999999999999999999999999999999999999763

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=290.41  Aligned_cols=207  Identities=22%  Similarity=0.347  Sum_probs=178.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ..-|...+.||+|.|+.|-.|++.-+|+.||||++.+.+  ......+..|++.|+-++|||||+++++     ......
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence            456889999999999999999999999999999997543  2334568899999999999999999998     667788


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-CCCceEEecc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDF  794 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DF  794 (884)
                      .|+|+|.-++|+|++||-+...     .+.+....+++.||+.|+.|+|   +..|||||+||+||.+- .-|-||+.||
T Consensus        92 lyLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeec
Confidence            9999999999999999987653     5788888999999999999999   66899999999998874 6799999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCC-cccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      |++-.+.+..         .....||+..|.|||++.+..|+ +++||||||||||.+.+|+.||...-+.|.
T Consensus       164 GFSNkf~PG~---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET  227 (864)
T KOG4717|consen  164 GFSNKFQPGK---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET  227 (864)
T ss_pred             cccccCCCcc---------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence            9987654432         22357899999999999998875 578999999999999999999988655443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.2e-33  Score=302.39  Aligned_cols=201  Identities=25%  Similarity=0.411  Sum_probs=174.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||.||+|.+..+++.+|+|+++... ....+.+.+|++++++++||||+++++++     ..++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence            468999999999999999999999999999999987542 23346788999999999999999999985     445678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++|+|.++++..+      .+++..+..++.|++.|+.|||+  ..+|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999997654      57888889999999999999993  24799999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.......          .....|++.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            87553221          11345899999999999989999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=299.39  Aligned_cols=195  Identities=28%  Similarity=0.380  Sum_probs=170.1

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|.-.+.||.|+||.||-|++..+.+.||||.+....   ...+..+..|++.+++++|||++.+-|+|     -.+...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchH
Confidence            4677889999999999999999999999999997432   34567899999999999999999999874     345567


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      |+||||| -|+-.+++.-.+.     ++.+.++..|+.+.+.||+|||   +.+.||||||+.|||+++.|.||++|||.
T Consensus       102 WLVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccc
Confidence            9999999 5688888876554     6888999999999999999999   77999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC---CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |.+..+.            ..|+|||+|||||++..   +.|+-++||||||++..|+..+++|.-.
T Consensus       173 Asi~~PA------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn  227 (948)
T KOG0577|consen  173 ASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  227 (948)
T ss_pred             hhhcCch------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence            9876542            35789999999999764   6799999999999999999999999643

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-33  Score=316.57  Aligned_cols=207  Identities=22%  Similarity=0.321  Sum_probs=176.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCC-CcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++||||+++++++     ..++..+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence            3489999999999999999998777 788999987655444556788899999999999999999984     4567889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.++++....  ...++++.++..++.|++.||.|+|   +++|+||||||+|||++.++.+||+|||+|
T Consensus       142 lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            99999999999998865321  1236889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +........      ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       217 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        217 KQYSDSVSL------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             eecCCcccc------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            866432211      1122456999999999999999999999999999999999999999764

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.1e-33  Score=293.78  Aligned_cols=197  Identities=28%  Similarity=0.410  Sum_probs=166.9

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||+||+|.+..+++.||||++.....   ...+.+..|++++++++||+|+++.++     +......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-----~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEE-----EcCCCeEEEEEeCC
Confidence            6999999999999999999999999864322   223567789999999999999999887     44556789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++|+|.+++.....  ....+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||.+......
T Consensus        76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            99999988864321  1226889999999999999999999   889999999999999999999999999999765432


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ...        .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       151 ~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         151 QSK--------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             Ccc--------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            211        12346899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9e-33  Score=298.84  Aligned_cols=195  Identities=25%  Similarity=0.322  Sum_probs=167.5

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|++..+++.||||+++..   .......+..|.++++.+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            4799999999999999999999999999743   223345677888998887 799999999984     4566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|..++...+      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999987654      5889999999999999999999   889999999999999999999999999998743


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         147 ILGGV--------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             CcCCC--------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            22111        112346899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-33  Score=297.64  Aligned_cols=202  Identities=27%  Similarity=0.424  Sum_probs=179.0

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ....|.+.+.||+|.|+.|..|++..++..||||++++.+-.  ....+.+|+++|..++|||||+++.+     .+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecc
Confidence            356799999999999999999999999999999999755432  23458899999999999999999998     56778


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      .+|+||||+.+|.+++|+.+.+      ...+..+..++.|+.+|++|+|   +++|||||||++|||++.+..+||+||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecc
Confidence            8999999999999999999877      3445778889999999999999   899999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCC-CcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |++.++....         ....+||++.|+|||++.+.+| ++++|+||+|+++|-++.|..||++.
T Consensus       200 gfS~~~~~~~---------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  200 GFSTFFDYGL---------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             ccceeecccc---------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            9998776322         2335789999999999999765 78999999999999999999999974

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=321.27  Aligned_cols=211  Identities=23%  Similarity=0.300  Sum_probs=181.4

Q ss_pred             cHHHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeec---ccccchHHHHHHHHHHHcCCCCCccceeeeec
Q 002760          630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALRNIRHRNLIKIITVCS  706 (884)
Q Consensus       630 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  706 (884)
                      ...++....++|.+++.||+|+||.|..++++.+++.||+|++.+   -......-|..|-.+|..-+.+-|+.+.-.  
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--  143 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--  143 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH--
Confidence            445555567899999999999999999999999999999999964   234556678899999988888888887644  


Q ss_pred             cCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       707 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                         |++..+.|+|||||+||+|-.++.+.+      .+++.-++.++..|+.|+..+|   +-|+|||||||+|||+|..
T Consensus       144 ---FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~  211 (1317)
T KOG0612|consen  144 ---FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKS  211 (1317)
T ss_pred             ---hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEeccc
Confidence               889999999999999999999998875      5788888899999999999999   7799999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |++||+|||.+-.+...+.-       .+...+|||.|.+||++..     +.|++.+|.||+||++|||+.|..||++.
T Consensus       212 GHikLADFGsClkm~~dG~V-------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  212 GHIKLADFGSCLKMDADGTV-------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             CcEeeccchhHHhcCCCCcE-------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            99999999998766543321       2234579999999998653     57899999999999999999999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6e-33  Score=315.47  Aligned_cols=215  Identities=26%  Similarity=0.368  Sum_probs=178.0

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCc---
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDF---  710 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  710 (884)
                      ...++|++.+.||+|+||+||+|++..+|+.||||++....  ......+.+|+.++..++|+|++++.+.+...+.   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999999999999999986442  2334567889999999999999998876543221   


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                      ......++||||+++|+|.++++.....  ...+++..+..++.|++.||.|+|   +++|+||||||+|||++.++.+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence            1122468999999999999999754321  236889999999999999999999   88999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+|||+++.........      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       184 L~DFGls~~~~~~~~~~------~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDD------VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             EEecccCeecccccccc------ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999998654322111      112356999999999999999999999999999999999999999763

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-33  Score=299.99  Aligned_cols=195  Identities=26%  Similarity=0.367  Sum_probs=167.1

Q ss_pred             CeeeeccceEEEEEEE---CCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      +.||+|+||.||+++.   ..+|+.||+|+++....  .....+..|++++++++||||+++++++     ..++..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            6799999999999876   35789999999974322  2335677899999999999999999984     456778999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      |||+++|+|.+++....      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            99999999999987543      5889999999999999999999   88999999999999999999999999999875


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......        ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus       148 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         148 SIDHEK--------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             cCCCCC--------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            433211        112356999999999999988999999999999999999999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-32  Score=290.65  Aligned_cols=203  Identities=27%  Similarity=0.393  Sum_probs=169.1

Q ss_pred             cCCCccCeeeeccceEEEEEEEC---CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+|++.+.||+|+||.||+|++.   ..+..||+|+++.... ...+.+.+|+.++++++||||+++++++     ..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecCC
Confidence            46889999999999999999875   3456899999875422 3345788999999999999999999985     3456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|.+++.....     .+++.+++.++.|++.|++|||   +++++||||||+||+++.++.++++||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCC
Confidence            78999999999999999976432     5789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |.+.........       ......++..|+|||.+.+..++.++||||+||++||+++ |+.||...
T Consensus       152 g~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         152 RRLQEDKSEAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             cccccccccchh-------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            987653221111       0112235678999999999999999999999999999775 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=295.74  Aligned_cols=206  Identities=27%  Similarity=0.447  Sum_probs=173.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ...++++||+|-||+|..+... .+..||||+++..... ...+|.+|+++|.+++||||++++|+|..     ++.+++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePicm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchHH
Confidence            4567899999999999999884 4689999999865543 34789999999999999999999999853     445699


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ++|||++|+|.+|+.+....    ........+|+.||+.||+||.   +-.+||||+.++|+|++.++++||+|||+++
T Consensus       613 I~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccc
Confidence            99999999999999987543    2345566779999999999999   7799999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc--CCCCCCccccC
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT--RKRPTDAMFNE  864 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt--g~~p~~~~~~~  864 (884)
                      -+...+.+. ++.     ..+-..+|||||.+.-.+++.++|||+||+++||+++  ...||....+|
T Consensus       686 ~lysg~yy~-vqg-----r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  686 NLYSGDYYR-VQG-----RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             ccccCCcee-eec-----ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence            765544332 221     2334688999999999999999999999999999875  78899876554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-32  Score=291.22  Aligned_cols=196  Identities=26%  Similarity=0.341  Sum_probs=165.5

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA---SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      ..||+|++|.||+|..  +|+.||||+++......   .+.+.+|+.++++++||||+++++++... .......++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence            6899999999999998  78999999987443322   46778999999999999999999986431 123456789999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++....      .+++.+...++.|++.|+.|||.  ..+++||||||+||+++.++.+||+|||+++...
T Consensus       103 y~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        103 YCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             eCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            999999999998653      57888999999999999999993  2488999999999999999999999999998654


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ....           ...|++.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       175 ~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        175 SPPF-----------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             cccc-----------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            3211           2347899999999876  689999999999999999999999998653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-32  Score=309.25  Aligned_cols=205  Identities=25%  Similarity=0.374  Sum_probs=166.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCcc---CCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK---GAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~~  714 (884)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....    ....+|+.+++.++||||+++.+++....+.   ...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999999899999999885321    2345799999999999999999876433221   223


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-ceEEec
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSD  793 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~D  793 (884)
                      ..++||||++ +++.+++.....  ....+++..++.++.|++.||+|||   +++|+||||||+|||++.++ .+||+|
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence            5679999996 578777764321  1226889999999999999999999   88999999999999999664 799999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+|+.......         .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.
T Consensus       215 FGla~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        215 FGSAKNLLAGQR---------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             cccchhccCCCC---------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999986543211         113458999999999876 46899999999999999999999999764

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-32  Score=290.99  Aligned_cols=205  Identities=26%  Similarity=0.409  Sum_probs=170.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcC---CCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNI---RHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++...  ........+|+.+++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986432  22334566777777665   699999999987554444456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+. ++|.+++.....    ..+++.++..++.|++.|++|||   ++||+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcc
Confidence            7899999996 589998876432    15889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+++........         ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       153 g~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         153 GLARIYSCQMAL---------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             CccccccCcccC---------CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            999865432211         1235899999999999989999999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-32  Score=289.08  Aligned_cols=194  Identities=26%  Similarity=0.372  Sum_probs=165.4

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||+||+|+.+.+|+.||+|.+..+.   ....+....|++++++++||||+++.++     ++.+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~-----~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA-----FESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE-----EecCCeEEEEEecC
Confidence            699999999999999999999999986321   1223445679999999999999999988     44567789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++.....    ..+++..+..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||++......
T Consensus        76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999998865432    25788899999999999999999   889999999999999999999999999998765432


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..         .....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       149 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         149 KT---------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             ce---------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            11         11235899999999999988999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-32  Score=302.01  Aligned_cols=211  Identities=25%  Similarity=0.424  Sum_probs=171.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEE-----CCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.++||+|+||.||+|++     ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            45799999999999999999974     3356789999986432 23446788999999999 899999999985     


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCC----------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ----------------------------------------------------  738 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  738 (884)
                      ...+..++||||+++|+|.++++.....                                                    
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            4556779999999999999999753210                                                    


Q ss_pred             -----------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          739 -----------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       739 -----------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                                       .+...+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             01125788899999999999999999   8899999999999999999999999999998654


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      ......      ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       266 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~  321 (375)
T cd05104         266 NDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP  321 (375)
T ss_pred             Cccccc------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence            322111      1112235678999999999999999999999999999998 899997653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.98  E-value=1.6e-32  Score=302.73  Aligned_cols=213  Identities=25%  Similarity=0.423  Sum_probs=171.6

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRD  709 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  709 (884)
                      ..++|++.+.||+|+||.||+|++...     ++.||||+++... ....+.+.+|+++++.+ +||||+++++.|    
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----  111 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----  111 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence            345799999999999999999986443     3579999996432 23345688999999999 899999999985    


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCC---------------------------------------------------
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQ---------------------------------------------------  738 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  738 (884)
                       ...+..++||||+++|+|.++++.....                                                   
T Consensus       112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence             4456789999999999999998653210                                                   


Q ss_pred             -------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCC
Q 002760          739 -------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP  805 (884)
Q Consensus       739 -------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~  805 (884)
                                   ....++++.++++++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                         01124788899999999999999999   88999999999999999999999999999976533221


Q ss_pred             CcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcccc
Q 002760          806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       806 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~  863 (884)
                      ..      ......+++.|||||++.+..++.++||||+||++|||++ |+.||.....
T Consensus       268 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         268 YV------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             ee------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            10      1112235678999999998899999999999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.9e-34  Score=306.97  Aligned_cols=205  Identities=29%  Similarity=0.455  Sum_probs=175.5

Q ss_pred             CCccCeeeeccceEEEEEEECCCCc----EEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGT----EVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+..++||+|+||+||+|.|...|+    +||+|++... ..+...++.+|+.+|.+++|||+++++|+|....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4556899999999999999977665    5899988643 3456789999999999999999999999985433      


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ..+|++||+.|+|.+|++..+.     .+.....+.|..|||+||.|||   ++++|||||.++|||+....++||.|||
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfg  843 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFG  843 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecc
Confidence            6799999999999999998765     5777888999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccccCC
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNEG  865 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~~~  865 (884)
                      +|+.+...........      ..-.+.|||-|.+....|+.++|||||||++||++| |..|+++..-++
T Consensus       844 la~ll~~d~~ey~~~~------gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e  908 (1177)
T KOG1025|consen  844 LAKLLAPDEKEYSAPG------GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE  908 (1177)
T ss_pred             hhhccCcccccccccc------cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence            9998765543322221      223678999999999999999999999999999998 999999875544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.98  E-value=2.8e-32  Score=301.88  Aligned_cols=205  Identities=25%  Similarity=0.345  Sum_probs=170.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+++++.++||||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999889999999988632  223346788999999999999999999986543322233679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+. ++|.+++....      .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999995 68888886543      6889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........       .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.
T Consensus       151 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         151 RVEEPDESKH-------MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             eecccCcccc-------CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            8654322111       1123578999999998774 5789999999999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.98  E-value=4e-32  Score=289.30  Aligned_cols=201  Identities=25%  Similarity=0.369  Sum_probs=171.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|++++++++|++|+++.+.+     ..++..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            3677889999999999999999999999999986432   22334578899999999999999998874     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++++|.+++...+..    .+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNP----GFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCc
Confidence            9999999999999988754321    5899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +........         .....|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.
T Consensus       149 ~~~~~~~~~---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         149 AVKIPEGES---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             ceecCCCCc---------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            875432211         11235899999999999889999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.98  E-value=5e-32  Score=288.43  Aligned_cols=201  Identities=26%  Similarity=0.400  Sum_probs=171.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..+.||+|+||+||+|.+..+++.||||.+....   ....+.+.+|+.++++++|++++++.+.+     ...+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            3778899999999999999999999999999986432   22234577899999999999999999884     345678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+++++|.+++.....    ..+++.++..++.|++.|+.|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999865432    25888999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +........         .....|++.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       149 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         149 AVHVPEGQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             eeecCCCcc---------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            875432211         11235899999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=3.7e-33  Score=271.15  Aligned_cols=212  Identities=25%  Similarity=0.349  Sum_probs=175.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCC----cEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG----TEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      ...|+..+.||+|.||.||+|....+.    +.+|+|.++..  ..+.+....+|+..++.++|||++.++.++    ..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf----l~   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF----LS   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH----hc
Confidence            457999999999999999999655443    26999998743  345667788999999999999999999885    33


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC----C
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD----L  787 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~----~  787 (884)
                      .+..+++++||.++ +|...|+..+.... ..++...+..|+.||+.|+.|||   ++=|+|||+||.|||+..+    |
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccC
Confidence            37889999999987 99999987654433 47899999999999999999999   8889999999999999877    9


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      .|||+|||+|+.+.++-... .    .....+-|.+|+|||.+.| +.|+++.||||.|||..||+|-++-|.+..+
T Consensus       174 ~VKIaDlGlaR~~~~plkpl-~----s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPL-A----SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             eeEeecccHHHHhhcccccc-c----cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            99999999999886543211 1    1123456899999999888 5689999999999999999999998877533

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.98  E-value=4.1e-32  Score=292.35  Aligned_cols=210  Identities=26%  Similarity=0.413  Sum_probs=169.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC----------------CCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE----------------NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIK  700 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  700 (884)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++..... .....+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998632                334799999864422 23457889999999999999999


Q ss_pred             eeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCc-------------ccccCCHHHHHHHHHHHHHHHHHHhhcC
Q 002760          701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-------------EVCSLSVIQRLNIAIDVASAIEYLHHYC  767 (884)
Q Consensus       701 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~  767 (884)
                      +++++.     ..+..++||||+++|+|.+++.......             ....+++.+++.++.|++.|+.|||   
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---  155 (304)
T cd05096          84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---  155 (304)
T ss_pred             EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence            999853     4456799999999999999986542111             1124678889999999999999999   


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHH
Q 002760          768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL  847 (884)
Q Consensus       768 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~i  847 (884)
                      +.+|+||||||+||+++.++.+||+|||+++........      .......++..|+|||++.+..++.++|||||||+
T Consensus       156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  229 (304)
T cd05096         156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT  229 (304)
T ss_pred             HCCccccCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence            789999999999999999999999999999765432211      11122346788999999988899999999999999


Q ss_pred             HHHHhc--CCCCCCcc
Q 002760          848 LLELFT--RKRPTDAM  861 (884)
Q Consensus       848 l~~llt--g~~p~~~~  861 (884)
                      +|||++  +..||...
T Consensus       230 l~el~~~~~~~p~~~~  245 (304)
T cd05096         230 LWEILMLCKEQPYGEL  245 (304)
T ss_pred             HHHHHHccCCCCCCcC
Confidence            999986  56788754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.98  E-value=5.2e-32  Score=293.05  Aligned_cols=203  Identities=27%  Similarity=0.476  Sum_probs=170.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcE----EEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTE----VAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|+..+.||+|+||+||+|++..+++.    ||+|+++... ....+++.+|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            5699999999999999999998666654    8999986432 3345678899999999999999999998742      


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++|+||+++|+|.+++.....     .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcc
Confidence            245799999999999999986532     5788889999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ||+++..........      .....++..|+|||.+.+..++.++|||||||++||+++ |+.||++.
T Consensus       153 fG~a~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         153 FGLAKLLGADEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             ccccccccCCCccee------ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999987653322110      112234678999999999999999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=4.7e-32  Score=298.78  Aligned_cols=204  Identities=26%  Similarity=0.354  Sum_probs=170.8

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++...  ......++.+|+.+++.++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999999999999998633  2234567889999999999999999999865332 2233


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++ ++.+.+..        .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence            457999999965 67666542        3677888899999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+++......         ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       167 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         167 FGLARTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCCccccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            99997543211         112345899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=2.1e-32  Score=300.61  Aligned_cols=196  Identities=30%  Similarity=0.482  Sum_probs=163.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .+|+..++||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++.++||||++++++     +...+..+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM-----FDHNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeE-----eccCCeEE
Confidence            456778999999999999999999999999999864332 334678899999999999999999998     45567789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.+..          ...+..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999986431          3456677889999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +........        .....||..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       216 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        216 RILAQTMDP--------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             eeccccccc--------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            865432111        113458999999998743     3345689999999999999999999974

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-33  Score=281.77  Aligned_cols=207  Identities=23%  Similarity=0.317  Sum_probs=175.7

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..+|....+||+|+||.|-.|..+.+.+.+|||+++..   +....+--..|-+++.-. +-|.++.+...     |+.-
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence            45788999999999999999999989999999999743   333334445567777655 56777777765     6778


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ++.|.||||+.||+|--.++..+      .+.+..+..+|.+|+-||-+||   ++|||+||+|.+|||++.+|++||+|
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeee
Confidence            89999999999999999998776      5667778889999999999999   99999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      ||+++.-        +........+||||.|+|||++...+|+..+|.||+||+||||+.|++||++..+++.
T Consensus       494 FGmcKEn--------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el  558 (683)
T KOG0696|consen  494 FGMCKEN--------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL  558 (683)
T ss_pred             ccccccc--------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            9998732        1122234568999999999999999999999999999999999999999999766655

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2e-32  Score=298.07  Aligned_cols=193  Identities=27%  Similarity=0.324  Sum_probs=160.9

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcC---CCCCccceeeeeccCCccCCccceEEE
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI---RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      ||+|+||+||+|++..+++.||||++....   .........|..++...   +||+|+++.++     +......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence            799999999999999999999999986432   12223455666776655   69999999988     45667789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++...+      .+++..+..++.||+.|++|||   +++|+||||||+|||++.++.++|+|||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999987654      5788999999999999999999   889999999999999999999999999998753


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         147 LTDNK--------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             CCCCC--------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            22111        11235699999999998764 5899999999999999999999999764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.98  E-value=3.7e-32  Score=293.33  Aligned_cols=201  Identities=23%  Similarity=0.405  Sum_probs=169.9

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.++||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++     ..++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence            57999999999999999999999899999999987443 23345678899999999999999999984     4556789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++ ++.+++...+.     .+++.++..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999964 89888876532     5788889999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....||+.|+|||.+.+ ..++.++||||+||++|+|+||+.||.+.
T Consensus       152 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         152 RAKSVPTKT--------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             eecCCCccc--------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            754322111        112357899999998765 56889999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6e-33  Score=295.02  Aligned_cols=197  Identities=28%  Similarity=0.403  Sum_probs=170.9

Q ss_pred             eeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccCC
Q 002760          646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN  725 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  725 (884)
                      +||+|.||+||.|++..+...+|||.+..+.....+.+..|+...++++|.|||+++|.+     ..+++.-+.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999999888888888999999999999999999999985     345677899999999


Q ss_pred             CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-CCCceEEeccccccccccCC
Q 002760          726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDFGLAKFLSNHN  804 (884)
Q Consensus       726 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFg~a~~~~~~~  804 (884)
                      |+|.++++..=.+.   .-.+.++-.+.+||+.|+.|||   ++.|||||||-+|||++ -.|.+||+|||-++.+..-.
T Consensus       657 GSLSsLLrskWGPl---KDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPL---KDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CcHHHHHHhccCCC---ccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99999998643211   1256677789999999999999   88999999999999996 58999999999998775433


Q ss_pred             CCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          805 PDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       805 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +        ....+.||..|||||++..  +.|+.++|||||||++.||.||++||...
T Consensus       731 P--------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El  781 (1226)
T KOG4279|consen  731 P--------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL  781 (1226)
T ss_pred             c--------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence            2        3335679999999999876  46899999999999999999999999763

>PTZ00284 protein kinase; Provisional

Probab=99.98  E-value=2.7e-32  Score=310.58  Aligned_cols=201  Identities=23%  Similarity=0.328  Sum_probs=165.6

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCC------CccceeeeeccCC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR------NLIKIITVCSGRD  709 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~  709 (884)
                      ...++|++.++||+|+||+||+|++..+++.||||+++.. .........|+.+++.++|.      +++.+++++.   
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~---  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ---  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE---
Confidence            3457899999999999999999999989999999998632 22334566788888777554      5777887753   


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCeeeCCCC-
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGDLKPSNVLLDQDL-  787 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~Dlkp~NiLl~~~~-  787 (884)
                       ....+.++|||++ +++|.+++...+      .+++.++..|+.||+.||+|||   . .|||||||||+|||++.++ 
T Consensus       202 -~~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        202 -NETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             -cCCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCc
Confidence             2345789999998 789999887654      6888999999999999999999   5 5999999999999998765 


Q ss_pred             ---------------ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHh
Q 002760          788 ---------------VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF  852 (884)
Q Consensus       788 ---------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~ll  852 (884)
                                     .+||+|||.+......           ....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence                           4999999987532211           12356999999999999999999999999999999999


Q ss_pred             cCCCCCCccc
Q 002760          853 TRKRPTDAMF  862 (884)
Q Consensus       853 tg~~p~~~~~  862 (884)
                      +|+.||++..
T Consensus       340 tG~~pf~~~~  349 (467)
T PTZ00284        340 TGKLLYDTHD  349 (467)
T ss_pred             hCCCCCCCCC
Confidence            9999998643

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=6.4e-32  Score=298.30  Aligned_cols=204  Identities=24%  Similarity=0.319  Sum_probs=172.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+++.++||||+++++++.... +...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999999999999999998643  2234467889999999999999999998764332 2344


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||++ +++.+++..        .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence            56799999996 477777643        4677888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+|+.......         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus       170 fG~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         170 FGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             CCCccccCCCCc---------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            999975533211         12345899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=8.1e-33  Score=264.15  Aligned_cols=199  Identities=24%  Similarity=0.373  Sum_probs=167.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +.+.+..||.|+.|+||+++.+.+|..+|||.+.... ....+++...++++..-. .|+||+.+|+     |..+..++
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy-----Fi~n~dV~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY-----FITNTDVF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE-----EeeCchHH
Confidence            3456688999999999999999999999999997443 344567788888876664 8999999999     55667788


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +.||.| ......++++...     ++++.-+-++...+..||.||.+  .++|+|||+||+|||+|+.|.+|+||||++
T Consensus       168 IcMelM-s~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  168 ICMELM-STCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             HHHHHH-HHHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccc
Confidence            999999 4477777776543     67888888899999999999986  569999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCC---CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .++.+....         ...+|-+.|||||.+.-   ..|+.++||||||++++|+.||+.||.+
T Consensus       240 GrlvdSkAh---------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  240 GRLVDSKAH---------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             ceeeccccc---------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence            877654432         23469999999998765   3689999999999999999999999987

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.98  E-value=9.3e-32  Score=284.00  Aligned_cols=202  Identities=24%  Similarity=0.347  Sum_probs=172.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++     ..+...+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEE
Confidence            35799999999999999999999889999999999755444556788999999999999999999985     3456789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++...      .+++.++..++.|++.|+.|||   +++|+|||+||+||+++.++.++|+|||++
T Consensus        83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999987543      5788999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|++.|+|||.+.   ...++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         154 AKITATIAK--------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             eeecccccc--------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            865322111        11245889999999874   345788999999999999999999998543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.98  E-value=1e-31  Score=291.17  Aligned_cols=206  Identities=23%  Similarity=0.326  Sum_probs=164.2

Q ss_pred             cCeeeeccceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          644 ANKIGEGGSGIVYKGFLG--ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +++||+|+||+||+|++.  .+++.||+|.++..  .......+|++++++++||||+++++++..   ..+...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            578999999999999965  36788999998533  234567889999999999999999998642   23456799999


Q ss_pred             ccCCCCHHHHhhccCCC---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee----CCCCceEEecc
Q 002760          722 FMQNGSLEEWLHHSNDQ---LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDF  794 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DF  794 (884)
                      |+. ++|.+++......   .....+++..+..++.|++.|++|||   ++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            995 5898887643211   12235889999999999999999999   8899999999999999    46689999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+|+.........     .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....+
T Consensus       157 G~a~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~  221 (317)
T cd07868         157 GFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             CceeccCCCCccc-----cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence            9998664322110     11223568999999999877 4589999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=321.96  Aligned_cols=210  Identities=31%  Similarity=0.408  Sum_probs=180.3

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+-+++-+..||.|.||.||.|....+|+..|+|.++...  ....+...+|..++..++|||+|+.+|+     ....+
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHRE 1307 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHH
Confidence            3457888999999999999999999999999999887432  3345678899999999999999999998     66777


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      .++|.||||++|+|.+.++..+      ..++.-...+..|++.|++|||   +.|||||||||+||+++.+|.+|.+||
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecc
Confidence            8899999999999999998776      4566666778899999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCC---CCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR---EASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      |.|....++.....    .......||+.|||||++.+.   ....++||||+|||+.||+||+.||.....+
T Consensus      1379 Gsa~ki~~~~~~~~----~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMP----GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred             cceeEecCchhcCC----HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence            99998876532221    233467799999999999874   4677899999999999999999999875544

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=5.6e-32  Score=297.81  Aligned_cols=204  Identities=24%  Similarity=0.325  Sum_probs=171.5

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999989999999998643  2233467788999999999999999999864332 2334


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++ ++.+++..        .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence            567999999965 67776643        4678888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+++.......         .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       163 fg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         163 FGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             CcccccCCCccc---------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999975433211         12345899999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=8.5e-32  Score=288.31  Aligned_cols=201  Identities=25%  Similarity=0.432  Sum_probs=175.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+     ..+...+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEEE
Confidence            45799999999999999999999889999999999765555567888999999999999999999985     3456789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++..       .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.++|+|||.+
T Consensus        94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~  163 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (296)
T ss_pred             EeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999998643       4678899999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|++.|+|||...+..++.++|||||||++|+|++|+.||...
T Consensus       164 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         164 AQITPEQSK--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             hhccccccc--------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            754322111        11235889999999999888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=7.4e-32  Score=284.76  Aligned_cols=200  Identities=26%  Similarity=0.351  Sum_probs=172.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++     ..++..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence            4788899999999999999999989999999999765544456788999999999999999999984     45667899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++...+      .+++.+++.++.|++.|+.|||   +.|++|+||||+||+++.++.++|+|||.+.
T Consensus        84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            999999999999987654      5789999999999999999999   7899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .......        ......|++.|+|||++.   ...++.++|+||+||++|+|++|+.||..
T Consensus       155 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         155 QITATIA--------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             EccCccc--------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            6543211        112345899999999874   45688899999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=293.13  Aligned_cols=203  Identities=24%  Similarity=0.358  Sum_probs=170.7

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKG  712 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  712 (884)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++.... ...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999999999999999986432  223456778999999999999999998764321 122


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ....++++|++ +++|.++++..       .+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEc
Confidence            34568999998 78999887643       5888999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |||+++......           ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+
T Consensus       161 Dfg~~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         161 DFGLARQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             CCccceecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999998653221           13458999999999877 5689999999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=242.24  Aligned_cols=200  Identities=25%  Similarity=0.388  Sum_probs=171.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .|...++||+|.||+||+|+.+.+++.||+|..+..  +.+......+|+.+++.++|.|||+++++     .+.+....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence            566778999999999999999999999999998754  34556778899999999999999999998     67788899


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||| ..+|..|...-..     .++...+..++.|+++|+.|+|   ++.+.|||+||.|.+|..+|+.|++|||+|
T Consensus        78 lvfe~c-dqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             EeHHHh-hHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchh
Confidence            999999 4589998876543     5788889999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++-+.        +.....+-|.+|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.
T Consensus       149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            9775432        123344568999999998885 58999999999999999996 55556653

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2.1e-31  Score=283.02  Aligned_cols=195  Identities=29%  Similarity=0.398  Sum_probs=168.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++     ......+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEE
Confidence            36888999999999999999999999999999986442 23345788999999999999999999985     3456678


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|..+.          .+++..+..++.|++.|+.|||   +.||+|+||||+||+++.++.++|+|||++
T Consensus        76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            999999999997652          4577788899999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .......          .....|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...
T Consensus       143 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         143 TQLVNSI----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             eeccccc----------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence            7553221          12346899999999999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.8e-31  Score=287.48  Aligned_cols=199  Identities=26%  Similarity=0.415  Sum_probs=172.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|++++++++||||+++++++     ..++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence            36899999999999999999999999999999986432 22345688999999999999999999985     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++..+      .+++..+..++.|++.|++|||+  ..+++||||||+||+++.++.++|+|||.+
T Consensus        76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence            9999999999999998653      57888899999999999999993  258999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .......          .....|++.|+|||...+..++.++|+||+||++|+|++|+.||..
T Consensus       148 ~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         148 GQLIDSM----------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             ccccccc----------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            7543221          1234689999999999888899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=8.4e-32  Score=313.44  Aligned_cols=211  Identities=23%  Similarity=0.379  Sum_probs=172.4

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ....+|++.+.||+|+||+||+|++..+++.||+|++....  ......+..|+.++++++||||+++++++..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            34568999999999999999999999999999999986432  2334678899999999999999999998532   234


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC----CCCeeecCCCCCCeeeCC----
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC----EPSIVHGDLKPSNVLLDQ----  785 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----~~~ivH~Dlkp~NiLl~~----  785 (884)
                      ..+|+||||+++|+|.+++......  ...+++..++.|+.||+.||+|||...    .++||||||||+|||++.    
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            5789999999999999999753211  126899999999999999999999431    146999999999999964    


Q ss_pred             -------------CCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHH
Q 002760          786 -------------DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLE  850 (884)
Q Consensus       786 -------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~  850 (884)
                                   .+.+||+|||++........         .....||+.|+|||++.+  ..++.++|||||||++||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             cccccccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                         34589999999976543211         123468999999999854  458899999999999999


Q ss_pred             HhcCCCCCCc
Q 002760          851 LFTRKRPTDA  860 (884)
Q Consensus       851 lltg~~p~~~  860 (884)
                      |+||+.||..
T Consensus       236 LLTGk~PF~~  245 (1021)
T PTZ00266        236 LCSGKTPFHK  245 (1021)
T ss_pred             HHHCCCCCCc
Confidence            9999999975

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=1.4e-31  Score=295.92  Aligned_cols=211  Identities=27%  Similarity=0.422  Sum_probs=171.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQK-GASKSFVAECKALRNIR-HRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  710 (884)
                      .++|++++.||+|+||.||+|.+...     +..||||+++.... ...+.+.+|+++++++. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            56899999999999999999987433     34699999864332 33467889999999996 99999999995     


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCc---------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQL---------------------------------------------------  739 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  739 (884)
                      ...+..++||||+++|+|.+++.......                                                   
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            34567899999999999999987532100                                                   


Q ss_pred             ---------------------------------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 002760          740 ---------------------------------------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSN  780 (884)
Q Consensus       740 ---------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~N  780 (884)
                                                             ....+++.++..++.|++.|++|||   +++|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence                                                   0124778888999999999999999   8899999999999


Q ss_pred             eeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCC
Q 002760          781 VLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD  859 (884)
Q Consensus       781 iLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~  859 (884)
                      |+++.++.+||+|||+++.........      ......|++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYV------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             EEEeCCCEEEEEeCCcceecccccccc------ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            999999999999999998654322110      1112346788999999999899999999999999999997 999997


Q ss_pred             ccc
Q 002760          860 AMF  862 (884)
Q Consensus       860 ~~~  862 (884)
                      ...
T Consensus       342 ~~~  344 (400)
T cd05105         342 GMI  344 (400)
T ss_pred             ccc
Confidence            653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=1.3e-31  Score=285.15  Aligned_cols=210  Identities=31%  Similarity=0.499  Sum_probs=173.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|.+.+.||+|+||.||+|++..     +++.||||+++..... ..+.+.+|++++++++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence            3568889999999999999998743     3578999998744333 456889999999999999999999985     3


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCC--------CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSND--------QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl  783 (884)
                      .....++||||+++++|.++++..+.        ......+++.++..++.|++.|+.|||   +++++||||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence            45678999999999999999986542        112235788999999999999999999   8899999999999999


Q ss_pred             CCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       784 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++.++|+|||.+..........      ......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             cCCCeEEECCcccceecccCccee------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999987543221110      1112235788999999999999999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=2.4e-31  Score=280.00  Aligned_cols=203  Identities=30%  Similarity=0.519  Sum_probs=172.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ..|++.++||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|++++++++||||+++++++     ..++..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEE
Confidence            3578889999999999999999989999999998643 33356788999999999999999999985     34556799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++.....    ..+++..++.++.|++.|++|||   +++++||||||+||++++++.+||+|||.+.
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999976432    25788999999999999999999   8899999999999999999999999999998


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .........       .....+++.|+|||...+..++.++|||||||++|||++ |..||.+.
T Consensus       153 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  209 (263)
T cd05052         153 LMTGDTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  209 (263)
T ss_pred             ccccceeec-------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            654322111       111224668999999999999999999999999999998 99998753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1.8e-31  Score=285.99  Aligned_cols=201  Identities=25%  Similarity=0.427  Sum_probs=175.7

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++     ..+...+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence            46799999999999999999999889999999999765555567788999999999999999999984     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++...       .+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||.+
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             EeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence            999999999999998653       4688899999999999999999   789999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|++.|+|||...+..++.++|+||+||++|++++|+.||...
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         163 AQITPEQSK--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             eEccCCccC--------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            765432211        11235889999999999988999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=252.45  Aligned_cols=215  Identities=25%  Similarity=0.345  Sum_probs=171.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+....+..||+|+||.|=+.++..+|+..|+|.++..- .+..++..+|+.+..+- ..|.+|+++|.     ....+.
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regd  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGD  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhcccc
Confidence            344556688999999999999999999999999997442 34456788888876554 79999999996     445677


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +++.||.| ..+|..|-+..-.  .....++.-+-+||..+.+||.|||+  +..|||||+||+|||++.+|+||+||||
T Consensus       120 vwIcME~M-~tSldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccc
Confidence            89999999 4588877554222  12367888888999999999999997  5689999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC----CCCCcccceeehhHHHHHHhcCCCCCCccccCCccHHHH
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG----REASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDF  871 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~~~  871 (884)
                      ++..+.+......         .+|...|||||.+..    ..|+.++||||||+++.||.++++||+.-.-....+.+-
T Consensus       195 IsG~L~dSiAkt~---------daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  195 ISGYLVDSIAKTM---------DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             cceeehhhhHHHH---------hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            9988766543321         247888999998654    479999999999999999999999997643333333333

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=2.1e-31  Score=283.89  Aligned_cols=210  Identities=27%  Similarity=0.482  Sum_probs=172.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCC-----cEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENG-----TEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ++|++.+.||+|+||.||+|.....+     ..||+|.++.... .....+.+|++++++++||||+++++++     ..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence            47899999999999999999876544     6799999864322 3345688999999999999999999985     34


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcc----------cccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLE----------VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiL  782 (884)
                      ....+++|||+++|+|.+++.......+          ...+++.+++.++.|++.|++|||   +++++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence            5567999999999999999976432111          135788999999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++++.++|+|||+++.........      ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYR------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEECCCcceeecccccccc------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999997553322111      1112346889999999988899999999999999999998 99999864


Q ss_pred             c
Q 002760          862 F  862 (884)
Q Consensus       862 ~  862 (884)
                      .
T Consensus       231 ~  231 (283)
T cd05048         231 S  231 (283)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=2.9e-31  Score=278.43  Aligned_cols=203  Identities=29%  Similarity=0.404  Sum_probs=175.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.+|++++++++|||++++++++     ...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            477889999999999999999999999999998643  233456788999999999999999999984     4556789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++....    ..+++.+++.++.|++.|+.|||   ++|++||||||+||+++.++.++|+|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999986422    26889999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .........        .....|++.|+|||+..+..++.++|+|||||++|+|++|+.||....
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         149 KLLSDNTNF--------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             eeccCccch--------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            866432211        112358899999999999899999999999999999999999997543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.4e-31  Score=280.78  Aligned_cols=212  Identities=27%  Similarity=0.417  Sum_probs=171.9

Q ss_pred             CCccCeeeeccceEEEEEEECCC---CcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCc-cCCc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDF-KGAD  714 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  714 (884)
                      |++.+.||+|+||.||+|....+   +..||+|+++....  ...+.+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67889999999999999987653   37899999874322  234578899999999999999999998754332 3334


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|.+++...........+++..+..++.|++.|++|||   +++++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence            57999999999999999866433223346889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |.++..........      .....++..|+|||...+..++.++||||+||++|||++ |..||.+.
T Consensus       158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             cceeeccccccccc------cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99986643322110      111235678999999988899999999999999999999 88998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=1.8e-31  Score=281.79  Aligned_cols=205  Identities=26%  Similarity=0.388  Sum_probs=173.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|++..+++.||||.++..   .......+.+|++++++++||||+++++++     ...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence            5789999999999999999999999999999987532   223345688999999999999999999984     34567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++......  ...+++.++..++.|++.|++|||   +++++||||||+||+++.++.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence            79999999999999988653221  125788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+.........        .....|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         152 LGRFFSSKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cceeccchhHH--------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            98865432211        11235889999999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=1.3e-31  Score=291.48  Aligned_cols=211  Identities=25%  Similarity=0.416  Sum_probs=170.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.+.||+|+||.||+|....     +++.||+|+++... ....+.+..|+.+++++ +||||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            3579999999999999999997533     45789999986332 22335677899999999 8999999999873    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCC----------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ----------------------------------------------------  738 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  738 (884)
                      ..+..++++|||+++++|.+++......                                                    
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            3445778999999999999998643210                                                    


Q ss_pred             ---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceee
Q 002760          739 ---LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS  815 (884)
Q Consensus       739 ---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  815 (884)
                         .....+++.++..++.||+.|++|||   +++|+||||||+||+++.++.++|+|||+++.+.......  .    .
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--~----~  232 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--R----K  232 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--h----c
Confidence               00126789999999999999999999   8899999999999999999999999999998654322111  0    1


Q ss_pred             eccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       816 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ....++..|+|||++.+..++.++||||+||++|||++ |..||.+.
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence            12235778999999999999999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=2.5e-31  Score=278.60  Aligned_cols=202  Identities=25%  Similarity=0.347  Sum_probs=174.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +|++.++||+|+||.||++++..+++.||+|.++.. .....+.+.+|+.++++++||||+++.+.     +.+++..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES-----FEADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEECCEEEE
Confidence            578899999999999999999999999999998643 23345678899999999999999999998     456678899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++|++.+++.....    ..+++..++.++.|++.|+.|||   +++|+|+||||+||++++++.++++|||.+.
T Consensus        76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999999875432    15788899999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .......        ......|++.|+|||+..+..++.++|+||+|+++|+|++|+.||...
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         149 LLTSPGA--------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             eeccccc--------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence            6543221        112345899999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=2.4e-31  Score=284.77  Aligned_cols=200  Identities=26%  Similarity=0.445  Sum_probs=175.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++     ......++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence            4699999999999999999999989999999999765555567889999999999999999999984     45667899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      |+||+++++|.+++...       .+++.++..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||++.
T Consensus        94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999998643       5788999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        .....|++.|+|||.+.+..++.++|||||||++|++++|+.||...
T Consensus       164 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         164 QITPEQSK--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             hccccccc--------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            65432211        11235889999999999888999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=278.04  Aligned_cols=203  Identities=26%  Similarity=0.414  Sum_probs=172.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ++|++.+.||+|+||.||+|....+++.||+|.+.....     ...+.+.+|++++++++||||+++++++     +..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            468999999999999999999988999999999864321     1235688899999999999999999984     455


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++|+||+++++|.+++....      .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence            68899999999999999987654      5778888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ||.++.........     .......|+..|+|||...+..++.++||||+|+++||+++|+.||..
T Consensus       148 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         148 FGASKRLQTICSSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             cccceecccccccc-----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            99987653321110     001234578899999999998999999999999999999999999965

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=3.6e-31  Score=280.37  Aligned_cols=212  Identities=28%  Similarity=0.427  Sum_probs=170.8

Q ss_pred             CCccCeeeeccceEEEEEEECCCCc--EEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCc-cCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGT--EVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDF-KGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  715 (884)
                      |.+++.||+|+||.||+|++..+++  .||+|.++...  ....+.+.+|++++++++||||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577999999999999999877665  69999886432  3345678899999999999999999998753221 22345


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++...+.......+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            7899999999999998864332222335889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++.........      ......+++.|+|||...+..++.++|||||||++|||++ |+.||.+.
T Consensus       158 ~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         158 LSKKIYNGDYYR------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             cccccCccccee------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            998664332110      0111236778999999999999999999999999999999 88998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=3e-31  Score=281.65  Aligned_cols=211  Identities=23%  Similarity=0.419  Sum_probs=170.8

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      ..++|++.+.||+|+||.||+|.+..     +++.||||++.... .....++.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            35679999999999999999998642     35679999985332 22345688999999999999999999985     


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcc----cccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                      ..+...++||||+++|+|.+++........    ...+++.++..++.|++.|++|||   +.+++||||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence            445678999999999999999976432211    234678889999999999999999   7899999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++|+|||+++.........      ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             CCEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999987553322111      0111235788999999998899999999999999999999 78898754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=2.3e-31  Score=281.86  Aligned_cols=208  Identities=24%  Similarity=0.346  Sum_probs=173.6

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc-CCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK-GAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~  714 (884)
                      +...|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++.+++...... ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            3567889999999999999999999999999999986443 3346788999999998 799999999987543322 135


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++.....    ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.++|+||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence            67899999999999999886432    25788999999999999999999   789999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |++.........        .....|++.|+|||++.     +..++.++||||+||++|||++|+.||..
T Consensus       156 g~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         156 GVSAQLDRTVGR--------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             CCceeccccccc--------CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998765332111        12345899999999876     34678899999999999999999999965

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.1e-31  Score=282.47  Aligned_cols=198  Identities=28%  Similarity=0.385  Sum_probs=174.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|++++++++||||+++++++     ..+..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            36889999999999999999999899999999986432   23346788999999999999999999984     45677


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.+++....      .+++..+..++.|++.|++|||   ++|++||||+|+||+++.++.+||+|||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCC
Confidence            899999999999999998654      6889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++......           .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...
T Consensus       147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  201 (290)
T cd05580         147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD  201 (290)
T ss_pred             CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            98865432           11235899999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=3.3e-31  Score=284.88  Aligned_cols=202  Identities=24%  Similarity=0.409  Sum_probs=170.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++     ..+...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            357999999999999999999999899999999986433 33345678899999999999999999984     456678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  150 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGL  150 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcc
Confidence            99999996 599998876432     5788899999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........        .....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         151 ARAKSIPTKT--------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             hhccCCCCCc--------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8754322111        112347889999998765 45788999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=5e-31  Score=278.02  Aligned_cols=205  Identities=25%  Similarity=0.371  Sum_probs=171.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|++.+.||+|+||.||+|++..+++.||||.+.....     ...+.+.+|+.++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            468899999999999999999998999999998863221     223578889999999999999999997532   123


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++++|.+++....      .+++..+..++.|++.|++|||   +++++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECc
Confidence            46789999999999999987653      4678888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ||.+..........     .......|+..|+|||+..+..++.++|||||||++|+|++|+.||..
T Consensus       150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         150 FGASKRLQTICLSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             Cccccccccccccc-----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            99988654321110     011223588999999999888899999999999999999999999965

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=3.5e-31  Score=281.92  Aligned_cols=200  Identities=28%  Similarity=0.407  Sum_probs=170.5

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      |++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++     ..+...++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEEE
Confidence            67889999999999999999989999999998655545567788999999999999999999985     3456789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++++|..++.....     .+++.++..++.|++.||.|||   +.|++||||||+||+++.++.+|++|||++...
T Consensus        82 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          82 EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999998765322     6889999999999999999999   789999999999999999999999999998754


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        ......|++.|+|||++.     +..++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         154 TRTIQ--------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             ccccc--------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence            32211        112345899999999873     456788999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=4.4e-31  Score=286.38  Aligned_cols=206  Identities=24%  Similarity=0.332  Sum_probs=163.7

Q ss_pred             cCeeeeccceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          644 ANKIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.+||+|+||+||+|+...  +++.||+|.++..  .....+.+|++++++++||||+++++++..   ..+...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            3689999999999999753  5678999988532  234567889999999999999999998642   34567799999


Q ss_pred             ccCCCCHHHHhhccCC---CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee----CCCCceEEecc
Q 002760          722 FMQNGSLEEWLHHSND---QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDF  794 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DF  794 (884)
                      |++ +++.+++.....   ......+++..+..++.|++.||.|||   +++|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            995 588888754321   112235888999999999999999999   8899999999999999    56789999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      |+|+.........     .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||....+
T Consensus       157 G~a~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~  221 (317)
T cd07867         157 GFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             cceeccCCCcccc-----cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence            9998664332111     11123468999999999876 4589999999999999999999999976543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=4e-31  Score=281.00  Aligned_cols=204  Identities=26%  Similarity=0.469  Sum_probs=169.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCc----EEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT----EVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ..+|++.++||+|+||+||+|++..+++    .||+|+++... ....+++.+|+.+++.+.||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            3578899999999999999999877776    48999986433 2335678899999999999999999998642     


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                       ...+++|||+++|+|.++++....     .+++.+++.++.|++.|++|||   +++|+||||||+||+++.++.+||+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEEC
Confidence             345799999999999999976432     5888999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |||+++..........      .....+++.|+|||...+..++.++|||||||++||+++ |..||+..
T Consensus       152 dfG~~~~~~~~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         152 DFGLARLLDIDETEYH------ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             CCCceeecccccceee------cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999986643221110      111235678999999998899999999999999999998 89998753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=3.8e-31  Score=282.39  Aligned_cols=209  Identities=28%  Similarity=0.459  Sum_probs=172.5

Q ss_pred             cCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+........+.+.+|++++++++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            57889999999999999999852     345679999986544445667899999999999999999999853     45


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCC-------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQ-------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                      +..++||||+++++|.+++...+..       .....+++.+++.++.|++.|++|||   ++|++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            6789999999999999999754321       11235899999999999999999999   8899999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++|+|||.++........      .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             CcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999755322111      01112235778999999998899999999999999999998 89998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=283.30  Aligned_cols=203  Identities=26%  Similarity=0.385  Sum_probs=174.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||+||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++++     ..+...+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence            45799999999999999999999889999999999765555567788999999999999999999984     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++...+.     .+++.+++.++.|++.|+.|||   +++|+||||||+||+++.++.++|+|||.+
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccc
Confidence            99999999999999876432     5889999999999999999999   889999999999999999999999999988


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        ......|++.|+|||.+.     +..++.++|+||+|+++|+|++|+.||...
T Consensus       151 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         151 AKNKSTLQ--------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             hhhccccc--------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            75432211        112345899999999864     345788999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=5.5e-31  Score=281.92  Aligned_cols=201  Identities=27%  Similarity=0.382  Sum_probs=172.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++.+     ..+...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence            6799999999999999999999989999999999765555567788999999999999999999985     34567899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++++++..++.....     .+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999988765432     5788999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ........        .....|++.|+|||.+.     ...++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         159 KNVKTLQR--------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             eccccccc--------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence            54322111        11234789999999874     34578899999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=5.3e-31  Score=279.79  Aligned_cols=203  Identities=24%  Similarity=0.410  Sum_probs=167.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcE----EEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTE----VAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ++|++.+.||+|+||+||+|.+..+++.    ||+|.+..... ....++..|+.++++++||||+++++++.      +
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            5788999999999999999999777764    67777643222 23356778888999999999999999853      2


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++++||+++|+|.+++.....     .+++..+..++.|++.|++|||   +++++||||||+||++++++.+||+|
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcC
Confidence            346799999999999999976432     5889999999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ||.++.........      ......|+..|+|||...+..++.++|||||||++||+++ |+.||.+.
T Consensus       153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         153 FGVADLLYPDDKKY------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             CccceeccCCCccc------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99998654322111      1112347788999999988899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.5e-31  Score=296.95  Aligned_cols=196  Identities=26%  Similarity=0.330  Sum_probs=167.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++||||+++++++     ..++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence            457999999999999999999999999999999642      23456899999999999999999985     3456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|||++ .++|.+++.....     .+++.+++.++.|++.||.|||   ++|||||||||+|||++.++.+||+|||+|
T Consensus       237 lv~e~~-~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEcc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            999999 5799998875432     6899999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCC
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD  859 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~  859 (884)
                      +........      .......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       308 ~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        308 CFARGSWST------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             eeccccccc------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            865432211      11124569999999999999999999999999999999999887653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=262.97  Aligned_cols=202  Identities=26%  Similarity=0.352  Sum_probs=172.2

Q ss_pred             hcCCCcc-CeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSA-NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +++|++. ++||-|-.|.|..+.++.+|+.+|+|++.     +.....+|++..-.. .|||||.+++++. ..+.+...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVye-Ns~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYE-NSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhh-hhccCcee
Confidence            4556543 68999999999999999999999999985     224556788876555 6999999999863 44667788


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC---CCCceEEe
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVS  792 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~  792 (884)
                      ..+|||.|+||.|...++..+..    .+++.++..|+.||+.|+.|||   ...|.||||||+|+|.+   .+..+||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence            89999999999999999988754    7999999999999999999999   78999999999999996   46689999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||+|+....+..         ....|-||.|.|||++....|+..+|+||+||++|-|++|.+||...
T Consensus       207 DfGFAK~t~~~~~---------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  207 DFGFAKETQEPGD---------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ccccccccCCCcc---------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            9999986543221         12346799999999999999999999999999999999999999864

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=4.6e-31  Score=276.74  Aligned_cols=201  Identities=32%  Similarity=0.485  Sum_probs=168.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+|++.+.||+|+||.||+|+++ ++..+|+|.++.. ....+.+.+|++++++++||||+++++++     ......++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence            45888999999999999999885 5668999987633 33356788999999999999999999985     34566799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++|+|.++++....     .+++..++.++.|++.|++|||   +++|+||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999999999875432     4788899999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ........       ......++..|+|||...+..++.++||||+|+++|||++ |+.||...
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         149 YVLDDEYT-------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             ccCCCcee-------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            65322111       1112235678999999988899999999999999999999 89999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=3.9e-31  Score=278.20  Aligned_cols=203  Identities=28%  Similarity=0.512  Sum_probs=170.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++||||+++++++     ......+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence            467999999999999999999974 6678999987643 22357889999999999999999999884     4556679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.++++....    ..+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999976432    25788889999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .........       ......++..|+|||...+..++.++|||||||++|+|+| |+.||...
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         151 RVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             eecCCCcee-------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            865432111       1112335778999999988889999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2e-31  Score=280.25  Aligned_cols=199  Identities=37%  Similarity=0.594  Sum_probs=171.0

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++++.||+|+||+||+|+...+++.||+|++........  ....+|+.++++++||||+++++++     ......++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence            6788999999999999999999999999999975543222  2345699999999999999999995     34677799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++....      .+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccc------cccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            999999999999998433      6889999999999999999999   7899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccC-CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......        .......|++.|+|||+.. +..++.++||||+|+++|+|++|..||...
T Consensus       147 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  147 KLSENN--------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             ESTSTT--------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccc--------cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            541111        1122345899999999998 888999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=7.7e-31  Score=276.75  Aligned_cols=204  Identities=30%  Similarity=0.473  Sum_probs=170.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCC---CcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ++|++.+.||+|+||+||+|.+..+   ...||||+++... .....++.+|+.++++++||||+++++++     ...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            5689999999999999999998644   4579999986433 23346788999999999999999999984     4456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++.....     .+++.+++.++.|++.|++|||   +++|+||||||+||++++++.++|+||
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECcc
Confidence            67999999999999999976432     5789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |+++.........      ......+++.|+|||...+..++.++||||||+++|+|++ |..||...
T Consensus       151 g~~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~  212 (266)
T cd05033         151 GLSRRLEDSEATY------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             chhhcccccccce------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence            9998764211110      0112235678999999998899999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=6.3e-31  Score=280.37  Aligned_cols=206  Identities=28%  Similarity=0.419  Sum_probs=170.5

Q ss_pred             cCCCccCeeeeccceEEEEEEE----CCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+|++.+.||+|+||+||+|..    ..+++.||+|.++.......+.+.+|++++++++||||+++.+++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            4788999999999999999974    45688999999875555555788999999999999999999998642   2345


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.|++|||   ++||+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCC
Confidence            67999999999999999975432     5789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |++............     .....++..|+|||...+..++.++||||+||++|||++|..|+..
T Consensus       153 g~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         153 GLTKVLPQDKEYYKV-----REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             cccccccCCCcceee-----cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            999866432221111     0112245569999999988999999999999999999998777543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=7.8e-31  Score=276.96  Aligned_cols=206  Identities=27%  Similarity=0.445  Sum_probs=172.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc---------chHHHHHHHHHHHcCCCCCccceeeeeccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG---------ASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+......         ..+.+.+|+.++++++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            478889999999999999999888999999988643222         125678899999999999999999984     


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                      ...+..++||||+++++|.+++...+      .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEE
Confidence            45567899999999999999997654      5788888999999999999999   78999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+|||.++............  .......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...
T Consensus       147 l~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTN--GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ecccCCCcccccccccCCcc--ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            99999998665321111000  1112345889999999999888999999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=4e-31  Score=278.19  Aligned_cols=204  Identities=33%  Similarity=0.536  Sum_probs=174.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.++||.|+||.||+|.+.. ++.+|+|+++.........+.+|+.+++.++||||+++++++     ......+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            4568999999999999999999976 889999999765554567889999999999999999999985     3456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++....    ..+++.+++.++.|++.|+.|||   ++|++||||||+||++++++.+||+|||.+
T Consensus        79 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             EEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccch
Confidence            99999999999999986532    25789999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      ..........        ....++..|+|||...+..++.++||||||+++|+|++ |+.||....
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         152 RLIKEDVYLS--------SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             hhcCCccccc--------cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            7654321110        12235778999999988899999999999999999998 899997643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=5.6e-31  Score=275.44  Aligned_cols=198  Identities=29%  Similarity=0.434  Sum_probs=164.9

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            47999999999999999899999999876332 233467899999999999999999999853     455679999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++...+.     .+++.+++.++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||.+......
T Consensus        76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999975432     5788999999999999999999   889999999999999999999999999998754321


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .....      .....++..|+|||.+.+..++.++||||+||++|||++ |..||...
T Consensus       148 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         148 VYAST------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             ccccc------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            11100      001123567999999988889999999999999999997 88998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=3.7e-31  Score=279.42  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=174.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....   ....+++.+|+.+++.++||||+++++++     ..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            46888999999999999999998899999999876432   22345788999999999999999999984     45567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.+++.....  ....+++.+++.++.|++.|+.|||   ++|++|+||||+||+++.++.++++|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcch
Confidence            8999999999999999875322  1226889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.........        .....|+..|+|||...+..++.++|+||+|+++|+|++|..||.+.
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         152 LGRFFSSKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhhccccCCcc--------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98765432211        11345889999999998889999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.9e-31  Score=295.19  Aligned_cols=198  Identities=25%  Similarity=0.330  Sum_probs=167.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG--ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ..+|++.+.||+|+||.||+|...  .+++.||+|.+...     +...+|++++++++||||+++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            357999999999999999999764  34678999987532     2356899999999999999999884     45567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++|||++. ++|.+++....      .+++.+++.++.|++.|+.|||   ++||+||||||+|||++.++.++|+|||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence            899999995 68999885433      6889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|+.........      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       231 ~a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        231 AACKLDAHPDTP------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccCcccccc------cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            997654332111      112456999999999999999999999999999999999999999764

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-31  Score=276.25  Aligned_cols=202  Identities=28%  Similarity=0.385  Sum_probs=175.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++     ......++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            5789999999999999999999889999999999765555667899999999999999999999984     45667899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      +|||+++++|.+++.....     .+++.++..++.|++.|+.|||   +++++||||+|+||+++.++.++|+|||.+.
T Consensus        78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999876522     5888999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCC---CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR---EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .......        ......|+..|+|||...+.   .++.++|+||+||++|+|++|+.||...
T Consensus       150 ~~~~~~~--------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~  207 (262)
T cd06613         150 QLTATIA--------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL  207 (262)
T ss_pred             hhhhhhh--------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            6543211        11124578899999998776   8899999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=1.1e-30  Score=275.46  Aligned_cols=206  Identities=25%  Similarity=0.381  Sum_probs=172.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|+..+.||+|+||.||+|.+..+++.||+|++.....     ...+.+.+|+.++++++||||+++.+++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            368999999999999999999998999999998863321     233568889999999999999999997532   224


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...+++|||+++++|.+++....      .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.++|+|
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence            56789999999999999997653      4778888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||+++..........     ......|+..|+|||.+.+..++.++||||+||++||+++|+.||...
T Consensus       150 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         150 FGASKRLQTICMSGT-----GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             CCCccccccccccCC-----ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            999876543211100     011234789999999999988999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.1e-30  Score=274.07  Aligned_cols=203  Identities=27%  Similarity=0.393  Sum_probs=173.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+.+|++++++++|||++++.+.+.    ..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4889999999999999999999899999999986432  233456888999999999999999988642    2344678


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccce
Confidence            99999999999999986432    25889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        ......|++.|+|||+..+..++.++||||+|+++|++++|+.||+..
T Consensus       150 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         150 RVLENQCD--------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             EEecccCC--------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            76643221        112345889999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=9e-31  Score=276.74  Aligned_cols=207  Identities=32%  Similarity=0.517  Sum_probs=169.9

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCc---EEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGT---EVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..|++.+.||+|+||.||+|.+..+++   .||||+++.. .....+++..|+.++++++||||+++.+++     ..+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            357889999999999999999876664   5999998643 233456789999999999999999999984     4556


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++|+|.++++....     .+++.+++.++.|++.|++|||   ++|++||||||+||+++.++.++++||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCC
Confidence            77999999999999999976432     5788999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |.+............ .  ......++..|+|||...+..++.++||||+||++||+++ |..||...
T Consensus       151 g~~~~~~~~~~~~~~-~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         151 GLSRFLEDDTSDPTY-T--SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ccccccccCcccccc-c--cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            998765432211100 0  0011112457999999999999999999999999999886 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.8e-31  Score=275.12  Aligned_cols=203  Identities=34%  Similarity=0.541  Sum_probs=170.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|+.++++++||||+++++++     ......+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence            356899999999999999999975 56789999986433 3356788999999999999999999984     4456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|+.|||   ++|++||||||+||++++++.++|+|||++
T Consensus        78 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceE
Confidence            99999999999999976431    25789999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........       ..+..++..|+|||...+..++.++||||||+++|||++ |+.||.+.
T Consensus       151 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         151 RVIKEDIYEA-------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             EEccCCcccc-------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            8765321111       011223467999999999899999999999999999999 99999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=6.4e-31  Score=280.06  Aligned_cols=209  Identities=25%  Similarity=0.408  Sum_probs=170.0

Q ss_pred             cCCCccCeeeeccceEEEEEEEC----CCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG----ENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|++.++||+|+||+||+|.+.    .+++.||+|.++... ......+.+|++++++++||||+++++++     ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            46888999999999999999853    355789999986432 23346788999999999999999999984     445


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCC-----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQ-----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiL  782 (884)
                      ...++||||+++++|.+++......           .....+++.++..++.|++.|++|||   +++++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence            6679999999999999998643210           01125788899999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++++.+||+|||+++.........      ......++..|+|||+..+..++.++|||||||++|||++ |..||.+.
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEeccccccccccCCccee------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999998654322111      1122346778999999988889999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=288.55  Aligned_cols=201  Identities=27%  Similarity=0.390  Sum_probs=174.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +.|.++..||.|+||.||+|..+.++-..|.|+|..+.....+.+.-|++++...+||+||++++.|     ...+..++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEE
Confidence            4467888999999999999999988888999999877777778899999999999999999999974     34567899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      +.|||.||-.+..+-.-+.     .+.+.++.-+++|++.||.|||   ++.|||||+|+.|||++.+|.++|+|||.+.
T Consensus       107 liEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             EEeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccc
Confidence            9999999999888766543     7899999999999999999999   8899999999999999999999999999875


Q ss_pred             ccccCCCCcccccceeeeccccccceeCcccc-----CCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYG-----MGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ....        +......+.|||+|||||+.     .+.+|++++||||||++|.||..+.+|-..
T Consensus       179 Kn~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe  237 (1187)
T KOG0579|consen  179 KNKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE  237 (1187)
T ss_pred             cchh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence            3221        12223357899999999974     457999999999999999999999999644

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.6e-31  Score=275.52  Aligned_cols=201  Identities=32%  Similarity=0.507  Sum_probs=168.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+|++.+.||+|+||.||+|+++ ++..+|+|++... ......+.+|++++++++||||+++++++     ...+..++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence            35889999999999999999985 5678999998532 22345788899999999999999999985     34556799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++.....     .+++..++.++.|++.|++|||   +++++||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccce
Confidence            9999999999999976432     5789999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ...+.....       .....++..|+|||...+..++.++||||||+++|++++ |+.||+..
T Consensus       149 ~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         149 YVLDDQYTS-------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             ecccccccc-------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence            653221110       111124567999999998899999999999999999999 89999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=6e-31  Score=282.77  Aligned_cols=207  Identities=27%  Similarity=0.421  Sum_probs=168.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcE--EEEEEeecc-cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTE--VAVKVINLK-QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.+.||+|+||+||+|.++.++..  +|+|.++.. .....+.+.+|++++.++ +||||+++++++     ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            35788999999999999999998877764  577766532 223345788899999999 899999999985     445


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQL----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl  783 (884)
                      +..++||||+++|+|.++++..+...          ....+++.+++.++.|++.|++|||   ++|++||||||+||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili  157 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV  157 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEe
Confidence            67899999999999999997654211          1125789999999999999999999   8899999999999999


Q ss_pred             CCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       784 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++.+||+|||++.......     .    .....++..|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~-----~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYV-----K----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             cCCCcEEeCccccCcccchhh-----h----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            999999999999986321100     0    001124667999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=1.3e-30  Score=275.21  Aligned_cols=204  Identities=27%  Similarity=0.429  Sum_probs=174.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|....+|+.||+|.++..   .....+.+.+|++++++++|++++++++++     ...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence            5799999999999999999999989999999988632   223356788999999999999999999984     44567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++|+|.+++.....  ....+++.+++.++.|++.|+.|||   +.|++||||+|+||+++.++.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccc
Confidence            7999999999999999875422  1235789999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .+.........        .....|++.|+|||...+..++.++|+||+||++|+|++|+.||..
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         152 LGRFFSSKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             eeeeccCCCcc--------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            98765432211        1123488899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=7.4e-31  Score=274.99  Aligned_cols=201  Identities=29%  Similarity=0.496  Sum_probs=168.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.+.||+|+||+||.|++. .+..||||.++.. ....+.+.+|+.++++++||||+++++++.     .....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence            46888999999999999999875 4557999988633 233467899999999999999999999863     3456799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++|+|.+++.....     .+++.+++.++.|++.|++|||   +++++|+||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccce
Confidence            9999999999999976432     5789999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ........       ......++..|+|||...+..++.++|||||||++|+|++ |+.||...
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         149 YVLDDEYT-------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             ecCCCcee-------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            65332111       1112235678999999988889999999999999999998 99998753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=7.8e-31  Score=286.79  Aligned_cols=211  Identities=25%  Similarity=0.424  Sum_probs=169.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEE-----CCCCcEEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQK-GASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.... .....+.+|+.++.++ +||||+++++++.    
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence            35799999999999999999984     24678899999964332 2345688999999999 6899999999863    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCc---------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQL---------------------------------------------------  739 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  739 (884)
                      ..+...++||||+++|+|.+++.......                                                   
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            33456789999999999999987532100                                                   


Q ss_pred             ----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCccc
Q 002760          740 ----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV  809 (884)
Q Consensus       740 ----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~  809 (884)
                                ....+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++..........  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--  236 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--  236 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh--
Confidence                      0124678888999999999999999   8899999999999999999999999999997653221110  


Q ss_pred             ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       810 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                          ......+++.|+|||...+..++.++||||||+++|+|++ |..||...
T Consensus       237 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         237 ----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             ----hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence                0111235678999999988899999999999999999997 99998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.4e-32  Score=287.63  Aligned_cols=199  Identities=25%  Similarity=0.438  Sum_probs=170.4

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeec----ccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL----KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+..++||+|+|-+||+|.+..+|.+||=-.++.    +.+...++|..|+++|+.++||||++++.+....   .....
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~i  118 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTI  118 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCcee
Confidence            4667899999999999999998998887543331    2344558899999999999999999999984321   22457


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-CCCceEEeccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFg  795 (884)
                      -+|+|.+..|+|..|+++.+      ......+..|++||++||.|||++ ...|||||||-+||+|+ ..|.|||+|.|
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             eeeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence            78999999999999999887      567788899999999999999987 78999999999999997 56999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +|..........          ..|||.|||||... ..|+..+||||||+++.||+|+.+||..
T Consensus       192 LAtl~r~s~aks----------vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE  245 (632)
T KOG0584|consen  192 LATLLRKSHAKS----------VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE  245 (632)
T ss_pred             HHHHhhccccce----------eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence            999876554332          46999999999877 7899999999999999999999999865

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.2e-30  Score=278.61  Aligned_cols=214  Identities=24%  Similarity=0.328  Sum_probs=176.7

Q ss_pred             HHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccC
Q 002760          634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       634 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  712 (884)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|+.+.. ......+.+|+.+++++ +||||+++++++.......
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            344567899999999999999999999999999999987532 22345678899999999 6999999999876555556


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      +...++||||+++++|.+++......  ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEc
Confidence            67889999999999999988643211  125788899999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||.+.........        .....|++.|+|||++..     ..++.++||||+||++|||++|+.||...
T Consensus       167 dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         167 DFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             cCCceeecccCCCc--------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99998765432111        112358999999998753     45788999999999999999999998754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.9e-31  Score=283.38  Aligned_cols=211  Identities=28%  Similarity=0.359  Sum_probs=175.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|+..+.||+|+||+||+|....+++.||+|.+.....   ...+.+..|+++++.++||+|+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            368899999999999999999998899999999874432   2446788999999999999999999984     45667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.+++.....    ..+++..+..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecc
Confidence            8999999999999999875432    26888999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCccc---------------------ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcC
Q 002760          796 LAKFLSNHNPDTIV---------------------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR  854 (884)
Q Consensus       796 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg  854 (884)
                      ++............                     ..........|+..|+|||+..+..++.++||||+|+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98755322111000                     000111234689999999999998899999999999999999999


Q ss_pred             CCCCCcc
Q 002760          855 KRPTDAM  861 (884)
Q Consensus       855 ~~p~~~~  861 (884)
                      +.||.+.
T Consensus       229 ~~pf~~~  235 (316)
T cd05574         229 TTPFKGS  235 (316)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=8.2e-31  Score=275.69  Aligned_cols=202  Identities=32%  Similarity=0.530  Sum_probs=168.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.++||+|+||.||+|++..+ ..||+|+++... ...+.+.+|++++++++||||+++++++.      ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence            35699999999999999999988644 569999986432 23467899999999999999999998742      24468


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.+++.....    ..+++.++..++.|++.|++|+|   +++++||||||+||++++++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCce
Confidence            99999999999999976432    15788899999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.........       .....++..|+|||...+..++.++||||+||++|+++| |..||.+.
T Consensus       150 ~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         150 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             eecccccccc-------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            7654322111       112236778999999988899999999999999999999 88898764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=271.54  Aligned_cols=212  Identities=26%  Similarity=0.416  Sum_probs=179.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-------cccchHHHHHHHHHHHcCCCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-------QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      .++|-....||+|||+.||+|.+....++||||+....       .....+...+|.++.+.++||-||++++|+.    
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----  537 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----  537 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence            35688889999999999999999888999999998532       2234456778999999999999999999974    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC---CCC
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDL  787 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~---~~~  787 (884)
                      -+.+..|-|+|||+|.+|+-|++..+      .+++.+++.|+.||+.||.||.+. ...|||-|+||.|||+.   .-|
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            34566789999999999999999776      688999999999999999999976 78899999999999995   568


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCC----CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR----EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+||.|||+++++.+...+. +..-......+||.+|.+||.+.-.    ..+.++||||.|||+|+++.|+.||...
T Consensus       611 eIKITDFGLSKIMdddSy~~-vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNS-VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             eeEeeecchhhhccCCccCc-ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            99999999999987655442 2222345678899999999986532    4688999999999999999999999764

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=1.1e-30  Score=278.82  Aligned_cols=202  Identities=27%  Similarity=0.412  Sum_probs=169.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|+.++++++||||+++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            4888999999999999999999899999999986432  23346788999999999999999999984     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||++ ++|.+++.....   ...+++.+++.++.|++.||+|||   +++++||||||+||+++.++.++|+|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 689998875432   126889999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        ......|++.|+|||++.+. .++.++||||+||++|+|+||+.||.+.
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         149 RAFGIPVR--------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             eecCCCcc--------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            75432211        11123478899999987654 5788999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.3e-30  Score=277.79  Aligned_cols=203  Identities=29%  Similarity=0.398  Sum_probs=167.7

Q ss_pred             CCccCeeeeccceEEEEEE----ECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGF----LGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      |++.+.||+|+||+||++.    ...+++.||+|+++.... ...+.+.+|++++++++||||+++++++.   ......
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCS---EQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCCCce
Confidence            4889999999999998765    334678999999864432 34567889999999999999999999864   223456


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.+++...       .+++.+++.++.|++.|+.|||   +++|+||||||+||+++.++.++|+|||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecc
Confidence            78999999999999999753       5889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +++..........     ......++..|+|||...+..++.++||||||+++|||+||..||...
T Consensus       153 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         153 LAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             cccccCCcchhhc-----cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            9986543221110     011123567799999998888999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.9e-31  Score=288.49  Aligned_cols=192  Identities=22%  Similarity=0.356  Sum_probs=163.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|++.+.||+|+||.||+|++..+++.||+|+....      ....|+.++++++||||+++++++     ......+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~  133 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAITC  133 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheE-----EeCCeeE
Confidence            45799999999999999999999989999999985321      234689999999999999999985     3456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+ .++|.+++.....     .+++.+++.++.|++.||.|||   +++||||||||+||+++.++.+||+|||.+
T Consensus       134 lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  204 (357)
T PHA03209        134 MVLPHY-SSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA  204 (357)
T ss_pred             EEEEcc-CCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccc
Confidence            999999 5689998875432     6889999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCC
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~  858 (884)
                      +......         ......||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus       205 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        205 QFPVVAP---------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccCc---------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            7432211         112346899999999999999999999999999999999865554

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=9.3e-31  Score=280.30  Aligned_cols=198  Identities=27%  Similarity=0.435  Sum_probs=170.5

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      |.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++     ..+...++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence            44556899999999999999889999999999765555567788999999999999999999984     4566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++++|.+++...       .+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999999999987542       5788999999999999999999   889999999999999999999999999998754


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......        .....|++.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus       168 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  220 (297)
T cd06659         168 SKDVPK--------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD  220 (297)
T ss_pred             cccccc--------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            332211        11245899999999999889999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=8.2e-31  Score=285.02  Aligned_cols=207  Identities=22%  Similarity=0.234  Sum_probs=166.9

Q ss_pred             ccCeeeec--cceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          643 SANKIGEG--GSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       643 ~~~~lg~G--~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +.++||+|  +|++||+++.+.+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++     ..++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence            56789999  78999999999999999999986442  23345678899999999999999999985     45567899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++|+|.+++......    .+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.++++||+.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999999999754321    5788999999999999999999   8899999999999999999999999998764


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ........... .........++..|+|||++.+  ..++.++||||+||++|||++|+.||....
T Consensus       150 ~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         150 SMINHGQRLRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             ccccccccccc-cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            33221111000 0001112346788999999876  468999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.7e-31  Score=277.33  Aligned_cols=199  Identities=27%  Similarity=0.353  Sum_probs=174.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|||++++.+++     .++...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence            36888999999999999999999999999999987543 33446788999999999999999999984     4557789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||+++++|.+++...       .+++.+++.++.|++.|+.|||   +++++||||+|+||++++++.++|+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999998754       5788999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +........        .....|++.|+|||...+..++.++||||+||++|+|+||+.||..
T Consensus       146 ~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         146 GQLTSTMSK--------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             eeecccccc--------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            876543211        1124588899999999988899999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=273.43  Aligned_cols=206  Identities=25%  Similarity=0.368  Sum_probs=172.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-----KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+.+|++++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            46899999999999999999999899999999875321     2234578899999999999999999998532   123


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++++|.+++....      .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECc
Confidence            56789999999999999987653      4778888999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.++.........     .......|+..|+|||.+.+..++.++|+|||||++|++++|+.||...
T Consensus       150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         150 FGASKRIQTICMSG-----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccccccccccC-----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            99998653221110     0112345899999999999888999999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.9e-30  Score=271.90  Aligned_cols=197  Identities=28%  Similarity=0.473  Sum_probs=161.9

Q ss_pred             eeeeccceEEEEEEEC--CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEc
Q 002760          646 KIGEGGSGIVYKGFLG--ENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEF  722 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  722 (884)
                      .||+|+||.||+|.++  ..+..||+|++..... ...+++.+|+.++++++||||+++++++.      ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            4899999999999775  3456799999864432 33467889999999999999999999863      2356899999


Q ss_pred             cCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          723 MQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       723 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      +++|+|.+++.....     .+++.+++.++.|++.|++|||   ++|++||||||+||+++.++.+||+|||.+.....
T Consensus        76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999875432     5889999999999999999999   88999999999999999999999999999975543


Q ss_pred             CCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       803 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ......     ......+++.|+|||...+..++.++|||||||++||+++ |..||...
T Consensus       148 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         148 DDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             Ccccee-----ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            221110     0111224678999999888889999999999999999996 99999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=1.5e-30  Score=277.95  Aligned_cols=202  Identities=26%  Similarity=0.390  Sum_probs=171.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++....  ....+.+.+|+.++++++|||++++++++     ..+...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            46889999999999999999999899999999986432  22345678999999999999999999984     456678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++++.+..++....      .+++.++..++.|++.|++|||   +++++||||||+||+++.++.++|+|||+
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccc
Confidence            99999999988888766443      5789999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +.........        .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+..
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         147 ARILTGPGDD--------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             ceecCCCccc--------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            9866443211        112347889999999876 557889999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=278.33  Aligned_cols=216  Identities=24%  Similarity=0.318  Sum_probs=161.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC---CcEEEEEEeecccccch-----------HHHHHHHHHHHcCCCCCccceee
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQKGAS-----------KSFVAECKALRNIRHRNLIKIIT  703 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  703 (884)
                      .++|++.+.||+|+||+||+|.+..+   +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46799999999999999999998777   66788886543322111           11223334456678999999998


Q ss_pred             eeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee
Q 002760          704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       704 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl  783 (884)
                      .+.... ......++++|++ ..++.+.+....      ..++..+..++.|++.|++|||   +++|+||||||+|||+
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV  159 (294)
T ss_pred             eeeEec-CCceEEEEEEehh-ccCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            653221 1122446788877 447777765432      3567788899999999999999   8899999999999999


Q ss_pred             CCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       784 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      +.++.++|+|||+|+.......... ..........||+.|+|||+..+..++.++||||+||++|||++|+.||.+...
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999986643221111 011112234699999999999999999999999999999999999999987644


Q ss_pred             CC
Q 002760          864 EG  865 (884)
Q Consensus       864 ~~  865 (884)
                      ..
T Consensus       239 ~~  240 (294)
T PHA02882        239 NG  240 (294)
T ss_pred             ch
Confidence            33

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.4e-30  Score=279.42  Aligned_cols=206  Identities=28%  Similarity=0.446  Sum_probs=167.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCc--EEEEEEeecc-cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGT--EVAVKVINLK-QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ++|++.+.||+|+||.||+|+...++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++     ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            468899999999999999999877765  4788887632 233446788999999999 799999999985     3456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQL----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD  784 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~  784 (884)
                      ..++||||+++|+|.++++......          ....+++.+++.++.|++.|++|||   ++||+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence            7899999999999999997643211          1125888999999999999999999   88999999999999999


Q ss_pred             CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          785 QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       785 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++.+||+|||++.........         .....+..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVKK---------TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             CCCeEEECCcCCCccccceecc---------CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999998633211000         01123557999999998889999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=1.2e-30  Score=278.92  Aligned_cols=208  Identities=26%  Similarity=0.391  Sum_probs=168.7

Q ss_pred             CCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+..... ...+.+.+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998743     235789998864322 23467889999999999999999999853     45


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCc------------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQL------------------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD  775 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~D  775 (884)
                      +..++||||+.+|+|.+++.......                  ....+++.+++.++.|++.|++|||   +++++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence            56799999999999999987532211                  1235789999999999999999999   88999999


Q ss_pred             CCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-C
Q 002760          776 LKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-R  854 (884)
Q Consensus       776 lkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g  854 (884)
                      |||+||++++++.+||+|||+++.........      ......++..|+|||...+..++.++||||||+++|||++ |
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchh------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            99999999999999999999997653322110      0112335778999999988899999999999999999998 9


Q ss_pred             CCCCCcc
Q 002760          855 KRPTDAM  861 (884)
Q Consensus       855 ~~p~~~~  861 (884)
                      ..||.+.
T Consensus       227 ~~p~~~~  233 (290)
T cd05045         227 GNPYPGI  233 (290)
T ss_pred             CCCCCCC
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=1.5e-30  Score=274.66  Aligned_cols=205  Identities=31%  Similarity=0.488  Sum_probs=169.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCC---cEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENG---TEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+|++.+.||+|+||.||+|++..++   ..||+|.++... ....+.+.+|+.++++++||||+++.+++     ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            57889999999999999999886444   379999886432 22346788999999999999999999985     4556


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++.....     .+++.+++.++.|++.|++|||   +++++||||||+||+++.++.++++||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCC
Confidence            78999999999999999976532     5788999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |.+...........     ......++..|+|||.+.+..++.++|+|||||++||+++ |+.||...
T Consensus       151 g~~~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         151 GLSRVLEDDPEAAY-----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             Ccccccccccceee-----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            99986643321110     0111224568999999998899999999999999999886 99999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=3.8e-31  Score=277.40  Aligned_cols=201  Identities=37%  Similarity=0.586  Sum_probs=163.6

Q ss_pred             ccCeeeeccceEEEEEEEC----CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          643 SANKIGEGGSGIVYKGFLG----ENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +.+.||.|+||.||+|.+.    ..+..||||+++.... ...+.+.+|++.+++++||||++++|+|.     ..+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            4578999999999999987    3456899999964332 23678999999999999999999999975     344479


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.++++....    ..+++.+++.|+.|++.||.|||   +++++|+||+++||+++.++.+||+|||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             cccccccccccccccccccc----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            99999999999999998722    26899999999999999999999   779999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .........      .......+...|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus       151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             ccccccccc------cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            866322111      11112336788999999998889999999999999999999 78998764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1.5e-30  Score=273.35  Aligned_cols=200  Identities=28%  Similarity=0.409  Sum_probs=175.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||++++++     +.++...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            4889999999999999999999899999999997432   2345788999999999999999999987     4566788


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|+||+++++|.+++....      .+++.++..++.|++.|+.|||   +++++|+||+|+||++++++.++|+|||.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999997653      6888999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +........         .....|+..|+|||...+..++.++|+||+|+++|+|++|+.||....
T Consensus       147 ~~~~~~~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         147 ATKVTPDTL---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ccccCCCcc---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            876543321         112358889999999988889999999999999999999999998654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=8.7e-31  Score=279.32  Aligned_cols=199  Identities=25%  Similarity=0.400  Sum_probs=167.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||++++++     +.+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence            4888999999999999999999999999999986432  2234567889999999999999999998     45667889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||++ ++|.+++.....     .+++..++.++.||+.|+.|||   +++++||||||+||+++.++.++|+|||++
T Consensus        76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence            9999996 588888765432     5889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +........        .....+++.|+|||.+.+. .++.++||||+||++|+|+||..||..
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         147 RAFGIPVRC--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             hccCCCCCC--------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            755322111        1123478899999988764 478999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3.3e-30  Score=271.59  Aligned_cols=209  Identities=25%  Similarity=0.336  Sum_probs=170.1

Q ss_pred             HHHHHHhcCCCccCee--eeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccC
Q 002760          632 AELSKATDNFSSANKI--GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGR  708 (884)
Q Consensus       632 ~~~~~~~~~y~~~~~l--g~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  708 (884)
                      .+.....++|++.+.+  |+|+||.||+++.+.+++.+|+|++........     |+.....+ +|||++++++.+   
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~---   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV---   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE---
Confidence            3444455678887777  999999999999999999999999864322211     22222222 699999999985   


Q ss_pred             CccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-
Q 002760          709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-  787 (884)
Q Consensus       709 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-  787 (884)
                        ...+..++||||+++++|.+++....      .+++.++..++.|+++|+.|||   +.+++||||||+||+++.++ 
T Consensus        79 --~~~~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         79 --TTLKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             --ecCCeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCC
Confidence              34567899999999999999998654      6889999999999999999999   88999999999999999988 


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLT  867 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~  867 (884)
                      .++|+|||.+.......            ...|+..|+|||++.+..++.++||||+|+++|+|++|+.||....+++..
T Consensus       148 ~~~l~dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T PHA03390        148 RIYLCDYGLCKIIGTPS------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD  215 (267)
T ss_pred             eEEEecCccceecCCCc------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence            99999999987553221            134889999999999989999999999999999999999999865554443


Q ss_pred             HHHH
Q 002760          868 LHDF  871 (884)
Q Consensus       868 ~~~~  871 (884)
                      ..++
T Consensus       216 ~~~~  219 (267)
T PHA03390        216 LESL  219 (267)
T ss_pred             HHHH
Confidence            4444

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=1.4e-30  Score=278.71  Aligned_cols=214  Identities=26%  Similarity=0.293  Sum_probs=175.6

Q ss_pred             HHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccC
Q 002760          634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       634 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  712 (884)
                      +....++|++.+.||+|+||.||+|....+++.+|+|++... ......+.+|+.+++++ +|||++++++++...+...
T Consensus        17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            334567899999999999999999999989999999998632 22346678899999998 8999999999976444334


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ....++||||+++|+|.++++.....  ...+++..++.++.|++.|++|||   +++++||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence            46789999999999999998753211  125788999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCC-----CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-----EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||.+.........        .....|+..|+|||.+...     .++.++||||+||++|||++|+.||...
T Consensus       171 dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         171 DFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             ecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            99998765432211        1123588999999987543     3688999999999999999999999764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-30  Score=277.50  Aligned_cols=210  Identities=23%  Similarity=0.417  Sum_probs=172.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            35789999999999999999988643     3789999986332 23345688999999999999999999984     4


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCc----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQL----EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~  787 (884)
                      .....++||||+++|+|.+++.......    ....+++..++.++.|++.|+.|||   +++++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence            5577899999999999999997643221    1224788899999999999999999   88999999999999999999


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .+||+|||+++.........      ......++..|+|||...+..++.++|||||||++||+++ |..||.+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  225 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL  225 (277)
T ss_pred             CEEECCcccchhhccCcccc------cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence            99999999997654332111      1112346788999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=1e-30  Score=277.46  Aligned_cols=211  Identities=27%  Similarity=0.383  Sum_probs=171.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+..... .....+.+|+.++++++||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            4578999999999999999999976     678899998864332 23456889999999999999999999853     


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCc-ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC---
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL---  787 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~---  787 (884)
                      +....++||||+++++|.+++...+... ....+++.+++.++.||+.|++|||   +++++||||||+||+++.++   
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCc
Confidence            4456699999999999999998754321 2235889999999999999999999   88999999999999998654   


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      .+||+|||+++.........      ......++..|+|||++.+..++.++|||||||++|||++ |..||+...
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         157 VAKIADFGMARDIYRASYYR------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             ceEeccCccccccCCcccee------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            69999999998653221110      0011123568999999998899999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=2.4e-30  Score=278.63  Aligned_cols=209  Identities=24%  Similarity=0.319  Sum_probs=172.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+     ..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            36889999999999999999999999999999986432   23345778999999999999999999884     45667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.++++..+      .+++..+..++.|++.|++|||   +++++||||||+||+++.++.++++|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCC
Confidence            899999999999999997654      5788889999999999999999   7899999999999999999999999999


Q ss_pred             cccccccCCCCccc-------ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIV-------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .++...........       ..........|+..|+|||.+.+..++.++|+|||||++||+++|+.||.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            98742111100000       0000111245788999999998889999999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.5e-30  Score=278.24  Aligned_cols=209  Identities=29%  Similarity=0.459  Sum_probs=172.0

Q ss_pred             cCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ++|.+.+.||+|+||.||+|++.     .++..+|+|.++.......+.+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence            46888899999999999999853     24566999998654444456789999999999999999999985     345


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCC----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl  783 (884)
                      ...++||||+++++|.+++......          .....+++.+++.++.|++.|++|||   +++|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            6679999999999999999764321          01124789999999999999999999   8899999999999999


Q ss_pred             CCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       784 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++.++|+|||++.........      .......|+..|+|||.+.+..++.++||||+||++|||+| |+.||...
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             ccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999755332111      11112346788999999999999999999999999999999 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=284.93  Aligned_cols=208  Identities=26%  Similarity=0.382  Sum_probs=174.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++... ......++.+|+.++++++||||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999999999999998632 23345678889999999999999999998766555556678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|+||++ +++.+++...       .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence            99999995 5888877643       5888999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +...........     ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       153 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         153 ARIADPEHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             eeeccccccccC-----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            976543222111     1123468999999998654 56899999999999999999999999653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=6.9e-31  Score=280.59  Aligned_cols=199  Identities=28%  Similarity=0.448  Sum_probs=170.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .|.....||+|+||.||+|....+++.||||.+........+.+.+|+.+++.++|||++++++.+     ..++..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEE
Confidence            455567899999999999999889999999998755555566788999999999999999999884     456678999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      |||+++++|.+++...       .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||++..
T Consensus        98 ~e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          98 MEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EeCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            9999999999988643       4778899999999999999999   78999999999999999999999999999875


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .......        .....|++.|+|||...+..++.++||||+|+++|||++|+.||...
T Consensus       168 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  221 (292)
T cd06658         168 VSKEVPK--------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE  221 (292)
T ss_pred             ccccccc--------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            4322211        11235899999999998888999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=281.13  Aligned_cols=200  Identities=26%  Similarity=0.374  Sum_probs=177.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .+++.+..||-|+||.|=.++.......+|+|+++++   +....+.+..|-.+|...+.|.||+++-.     |.+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence            4567788999999999999988666566899988744   34455778899999999999999999976     678888


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|+.||-|-||.++..++..+      .++..+...++..++.|++|||   ++|||+||+||+|.+++.+|.+||.|||
T Consensus       495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehh
Confidence            999999999999999999876      6778888889999999999999   8999999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|+.+....         .+..+||||+|.|||++.++..+.++|.||||+++||+++|.+||.+.
T Consensus       566 FAKki~~g~---------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  566 FAKKIGSGR---------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             hHHHhccCC---------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            999775432         345689999999999999999999999999999999999999999885

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.5e-30  Score=277.28  Aligned_cols=201  Identities=27%  Similarity=0.384  Sum_probs=173.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++     ......+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence            57889999999999999999999899999999886443 33457789999999999999999999985     3456789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++...+      .+++..+..++.+++.|+.|||+  ..+++||||||+||+++.++.++|+|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            9999999999999987643      57889999999999999999994  258999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ........          ....|+..|+|||++.+..++.++|+||+||++|++++|+.||+...
T Consensus       152 ~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         152 GELINSIA----------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             cchhhhcc----------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            65432211          12358999999999988899999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=1.7e-30  Score=274.68  Aligned_cols=203  Identities=24%  Similarity=0.389  Sum_probs=172.5

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc------cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK------GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      +|+..+.||+|+||.||+|....+++.||+|++.....      ...+.+.+|+.++++++|||++++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            47889999999999999999999999999999864321      1346788999999999999999999984     456


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-ceEEe
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVS  792 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~  792 (884)
                      +..++||||+++++|.+++...+      ++++..+..++.|++.|+.|||   ++|++||||+|+||+++.++ .++|+
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            67899999999999999997654      5788899999999999999999   88999999999999998776 69999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |||.+...........    .......|+..|+|||.+.+..++.++|+||+|+++|++++|+.||..
T Consensus       147 dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         147 DFGAAARLAAKGTGAG----EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccccccccccccCC----ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            9999976654321111    111234588999999999888899999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=2.4e-30  Score=271.38  Aligned_cols=202  Identities=25%  Similarity=0.376  Sum_probs=174.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|+..+.||+|+||.||.++...+++.||+|.+....  ....+.+.+|++++++++||||+++++++     .+.+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            5889999999999999999999999999999986432  33456788999999999999999999995     4556789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.+++.....    ..+++.++..++.|++.|+.|||   +.+++||||+|+||++++++.+||+|||.+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999986532    26789999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        ......|++.|+|||...+..++.++||||+|+++|+|++|+.||...
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08221         149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT  204 (256)
T ss_pred             EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence            76543321        112345899999999998888999999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.6e-30  Score=272.75  Aligned_cols=200  Identities=27%  Similarity=0.407  Sum_probs=174.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++....  .+.+.+|++++++++||||+++++++     ......++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEE
Confidence            579999999999999999999988899999999864432  67899999999999999999999984     45577899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ++||+++++|.+++...+.     .+++..++.++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.+.
T Consensus        76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999975432     6889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        ....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...
T Consensus       148 ~~~~~~~~~--------~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         148 QLTDTMAKR--------NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             hcccCcccc--------ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            665432111        1234788999999999889999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2.6e-30  Score=271.00  Aligned_cols=198  Identities=35%  Similarity=0.510  Sum_probs=168.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|..  .|+.||+|.++.  ....+.+.+|+.++++++||+++++++++    +..+...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC--CchHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceE
Confidence            35789999999999999999987  588899999853  23356788999999999999999999875    33456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++.....    .+++..++.++.|++.|++|||   ++|++||||||+||+++.++.+|++|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccc
Confidence            999999999999999865432    5788999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ........           ...++..|+|||+..+..++.++||||+||++|+|++ |+.||...
T Consensus       150 ~~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~  203 (256)
T cd05082         150 KEASSTQD-----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             eeccccCC-----------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            75432211           1224668999999998899999999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.5e-30  Score=277.82  Aligned_cols=202  Identities=23%  Similarity=0.348  Sum_probs=169.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            36889999999999999999999899999999886432 23346788999999999999999999974     4567889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|+.|||+  +.+|+||||||+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999999999999876421   1257899999999999999999993  259999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC------CCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ........          ....|++.|+|||.+.+.      .++.++|+||+||++|+|++|+.||..
T Consensus       151 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         151 GNLVASLA----------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             ccccCCcc----------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            75532211          123478899999987553      358899999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.5e-30  Score=276.51  Aligned_cols=209  Identities=27%  Similarity=0.447  Sum_probs=171.8

Q ss_pred             cCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ++|+..++||+|+||.||+|...     .++..+|+|.++.......+.+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence            56888999999999999999742     34668999988755555567899999999999999999999985     345


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCC---------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQ---------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD  784 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~  784 (884)
                      ...++||||+++|+|.+++......         .....+++.+++.++.|++.|++|||   +++++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence            6679999999999999999865321         01125788999999999999999999   88999999999999999


Q ss_pred             CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          785 QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       785 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++.+||+|||++.........      .......+++.|+|||...+..++.++|||||||++|||++ |+.||...
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            9999999999998755322110      11112235788999999999999999999999999999998 89998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=277.83  Aligned_cols=202  Identities=25%  Similarity=0.419  Sum_probs=169.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.+.||+|+||.||+|+.+.+++.||||.+.... ......+.+|++++++++||||+++++++     ..+...
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            367999999999999999999998899999999986432 22335577899999999999999999984     456678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+. ++|.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||.
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  149 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGL  149 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccc
Confidence            99999997 599999876542     5788899999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++........        .....++..|+|||+..+ ..++.++||||+|+++|+|++|+.||...
T Consensus       150 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         150 ARAKSVPSKT--------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccccCCCCcc--------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8754321111        111236888999998865 45889999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2.2e-30  Score=277.11  Aligned_cols=203  Identities=25%  Similarity=0.411  Sum_probs=168.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..+|++.+.||+|+||.||+|....+|+.||+|+++... ......+.+|++++++++|+||+++.+++     ..+...
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence            467999999999999999999999899999999986443 23345678899999999999999999984     455678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+. +++.+++.....     .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccc
Confidence            99999995 688877754322     4677888899999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ++........        .....+++.|+|||.+.+. .++.++||||+||++|+|++|+.||++..
T Consensus       150 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         150 ARAKSIPSQT--------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccccCCCCCC--------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            8754322111        1123478899999998764 57889999999999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=2e-30  Score=273.96  Aligned_cols=205  Identities=29%  Similarity=0.504  Sum_probs=169.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCc---EEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGT---EVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+|+..+.||+|+||.||+|+...+++   .+|+|.++... ....+.+..|++++++++|||++++.+++     ...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence            468889999999999999999876554   79999886442 23346788999999999999999999985     4456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++.....     .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCC
Confidence            77999999999999999976432     5788999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |++............     .....+++.|+|||++.+..++.++||||+||++||+++ |+.||...
T Consensus       152 g~~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         152 GLSRVLEDDPEGTYT-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             ccceeccccccccee-----ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            999766432211110     011123567999999988889999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=262.03  Aligned_cols=202  Identities=27%  Similarity=0.359  Sum_probs=161.2

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+-...||.|+||+|++..++.+|+..|||.++.... ...+++..|.++..+- +.||||+++|.+    |. ++..|+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~----F~-EGdcWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL----FS-EGDCWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh----hc-CCceee
Confidence            3445779999999999999999999999999975433 5567888888865554 799999999986    33 445689


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      .||.| ..++..+-+.... .+...+++.-+-+|+.-...||.||.+  ...|||||+||+|||++..|.+||||||++.
T Consensus       141 CMELM-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchH
Confidence            99999 4577665432111 112267787778888889999999986  5689999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .+.+.....         .-+|-..|||||.+..  ..|+.++||||||+++||+.||.+|+.+
T Consensus       217 qLv~SiAkT---------~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  217 QLVDSIAKT---------VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             hHHHHHHhh---------hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence            665433221         2358889999998765  4589999999999999999999999876

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=279.24  Aligned_cols=203  Identities=30%  Similarity=0.526  Sum_probs=175.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+.....+||-|.||.||.|.|++-.-.||||.++ .+....++|..|+.+|+.++|||+|+++|+|...     ...||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYI  340 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYI  340 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEE
Confidence            35566789999999999999999888999999997 3455678999999999999999999999999633     34599


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      |+|||..|+|.+|+++....    .++..-.+.+|.||..||+||.   .+.+||||+.++|+|++++..||++|||+++
T Consensus       341 iTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999986543    5677778899999999999999   8899999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ++.........       +..-...|.|||.+....++.++|||+|||+|||+.| |..||.+.
T Consensus       414 lMtgDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  414 LMTGDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             hhcCCceeccc-------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            88654332211       1112567999999999999999999999999999997 89998873

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.1e-30  Score=276.10  Aligned_cols=204  Identities=27%  Similarity=0.462  Sum_probs=169.4

Q ss_pred             cCCCccCeeeeccceEEEEEEE----CCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      +.|++.+.||+|+||.||.|+.    ..+++.||+|.++... ....+.+.+|++++++++|||++++.+++..   .++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            4578999999999999999974    4567899999986442 3344678999999999999999999998642   224


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++++|.+++.....     .+++.++..++.|++.|++|||   ++|++||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECC
Confidence            567999999999999999975432     5788999999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCC
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~  858 (884)
                      ||+++.........     .......|+..|+|||...+..++.++||||+||++||++|+..|+
T Consensus       153 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         153 FGLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             CccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            99998664332211     0111244777899999998889999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1.4e-30  Score=279.60  Aligned_cols=206  Identities=25%  Similarity=0.446  Sum_probs=170.7

Q ss_pred             hcCCCccCeeeeccceEEEEEEE-----CCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.+.||+|+||.||+|.+     ..++..||||+++... ....+.+.+|+.+++++ +||||+++++++.    
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence            45799999999999999999975     2345689999986432 23346788999999999 7999999999853    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                       ..+..++||||+++|+|.++++.....    .+++.++..++.|++.|++|||   +++|+|+||||+||+++.++.++
T Consensus       110 -~~~~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         110 -IGGPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             -cCCceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEE
Confidence             445679999999999999999764321    4789999999999999999999   88999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ++|||.++.........      ......++..|+|||.+.+..++.++||||+||++|||++ |..||...
T Consensus       182 l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         182 ICDFGLARDIMNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             ECCCcccccccCCCcee------ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            99999998654322110      1112336788999999999899999999999999999998 99998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.9e-31  Score=277.22  Aligned_cols=201  Identities=24%  Similarity=0.324  Sum_probs=164.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeec--ccccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  714 (884)
                      ...|++.++||+||.+.||++... +.+.||+|.+..  .+......+.+|+..|.+++ |.+|+++++|     ...++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCc
Confidence            456999999999999999999885 345566665542  23455678999999999994 9999999999     66789


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..|+||||= .-+|..+++.....     .+-..++.+..||+.|+.++|   ..||||.|+||.|+|+- .|.+||+||
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDF  503 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDF  503 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeee
Confidence            999999987 45999999876542     332367889999999999999   78999999999999984 679999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCC-----------CCcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE-----------ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |+|..+..+.+.-      .....+||+.||+||.+....           .++++||||+|||||+|+.|++||..
T Consensus       504 GIA~aI~~DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  504 GIANAIQPDTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             chhcccCccccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            9998776554432      223467999999999876532           46789999999999999999999865

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=2.6e-30  Score=273.07  Aligned_cols=204  Identities=27%  Similarity=0.372  Sum_probs=169.8

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      +.+.+.....||+|+||.||+|++..+++.||+|.+........+.+.+|+.++++++||||+++++++     ..++..
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~   80 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFF   80 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEE
Confidence            344555667899999999999999889999999998755555567889999999999999999999985     345678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEec
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSL--SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSD  793 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~D  793 (884)
                      ++|+||+++++|.+++.....     .+  ++..+..++.|++.|++|||   +++|+||||||+||+++. ++.++|+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEec
Confidence            999999999999999986422     23  77888899999999999999   889999999999999976 77999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCC--CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR--EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+.........        .....|++.|+|||...+.  .++.++||||+|+++|+|++|+.||...
T Consensus       153 fg~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         153 FGTSKRLAGINPC--------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             chhheecccCCCc--------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            9998755322211        1123478999999997654  4788999999999999999999999653

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.2e-30  Score=281.04  Aligned_cols=211  Identities=26%  Similarity=0.420  Sum_probs=171.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEEC-------CCCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeecc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLG-------ENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSG  707 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  707 (884)
                      ..++|++.+.||+|+||.||+|++.       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++  
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence            3567899999999999999999752       234579999886432 23346788999999999 899999999985  


Q ss_pred             CCccCCccceEEEEccCCCCHHHHhhccCCCc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 002760          708 RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK  777 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlk  777 (884)
                         ......++||||+++|+|.+++.......          ....+++.+++.++.|++.|++|||   ++|++|||||
T Consensus        91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlk  164 (304)
T cd05101          91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLA  164 (304)
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence               34567799999999999999998643211          1235788899999999999999999   8899999999


Q ss_pred             CCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCC
Q 002760          778 PSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKR  856 (884)
Q Consensus       778 p~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~  856 (884)
                      |+||+++.++.+||+|||.++.........      ......+++.|+|||+..+..++.++||||||+++|++++ |..
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  238 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  238 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999998664322111      1112235678999999988889999999999999999998 788


Q ss_pred             CCCcc
Q 002760          857 PTDAM  861 (884)
Q Consensus       857 p~~~~  861 (884)
                      ||.+.
T Consensus       239 p~~~~  243 (304)
T cd05101         239 PYPGI  243 (304)
T ss_pred             CcccC
Confidence            88654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.3e-32  Score=259.60  Aligned_cols=212  Identities=25%  Similarity=0.406  Sum_probs=177.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeec--ccccchHHHHHHHHHHHcCCCCCccceeeeeccCCcc---CC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK---GA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~  713 (884)
                      ..|+-..+||+|.||+||+|+.+.+|+.||+|++-.  +..+......+|++++..++|+|++.++++|...+..   ..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            457777899999999999999999999999986643  4567778888999999999999999999999765422   23


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...|+||++|++ +|...+.....     .++..++.+++.++..|+.|+|   +..|+|||+||+|+||+.+|.+||+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeec
Confidence            457999999976 89888876532     6888899999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcccc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      ||+|+.++........    ...+.+-|.+|++||.+.+ +.|+++.|||+.|||+.||+||.+-+.+..+
T Consensus       168 FGlar~fs~~~n~~kp----rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKP----RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             cccccceecccccCCC----CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence            9999877644332211    1334456999999998776 6899999999999999999999999887544

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.4e-30  Score=277.44  Aligned_cols=209  Identities=23%  Similarity=0.361  Sum_probs=169.0

Q ss_pred             cCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      .+|++.++||+|+||.||+|++..+     ++.||+|+++.... ...+.+.+|+.++++++||||+++++++     ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence            4578889999999999999987533     57899999874432 2245688999999999999999999985     34


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCC----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiL  782 (884)
                      ....++++||+.+++|.+++......          .....+++..+..++.|++.|++|+|   ++||+||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil  156 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence            45679999999999999998632210          11235788889999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +++++.+||+|||+++.........      ......+++.|+|||.+.+..++.++||||+||++|||++ |..||.+.
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYK------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             ecCCCceEecccccccccccchhee------eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999988654322111      1112346789999999988889999999999999999998 88888763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=3e-30  Score=272.10  Aligned_cols=205  Identities=25%  Similarity=0.423  Sum_probs=171.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc------cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK------GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      +|++.+.||+|+||+||+|.. .+++.+|+|.++....      ...+.+.+|++++++++||||+++++++     .+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            478899999999999999987 4788999998864321      1234688899999999999999999985     345


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      +..++||||+++++|.+++.+..      .+++..+..++.|++.|++|||   +.+|+|+||+|+||+++.++.++|+|
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEecc
Confidence            67899999999999999997653      5788889999999999999999   78999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+...........  .........|+..|+|||...+..++.++||||+||++|+|++|+.||...
T Consensus       146 fg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         146 FGCARRLAWVGLHGT--HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             chhhHhhhhcccccc--ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence            999876532111110  011122345899999999999988999999999999999999999999753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.7e-30  Score=271.64  Aligned_cols=202  Identities=31%  Similarity=0.552  Sum_probs=168.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||+++++++++.      ....+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence            357899999999999999999875 667799999864333 3467899999999999999999998742      24468


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++....    ..+++.+++.++.|++.|++|||   +++++||||||+||++++++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceee
Confidence            99999999999999976432    25789999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........       .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+.
T Consensus       150 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         150 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             eeccCccccc-------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            7654322111       112235678999999988889999999999999999999 89999763

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=2.8e-30  Score=271.43  Aligned_cols=202  Identities=28%  Similarity=0.532  Sum_probs=170.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++      ..+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence            467999999999999999999875 67889999986433 3356788999999999999999999874      234579


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcce
Confidence            99999999999999875432    26788999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........       .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.+.
T Consensus       150 ~~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         150 RLIEDNEYTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             eecCCCCccc-------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            7654221110       112235678999999988889999999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=1.8e-30  Score=275.69  Aligned_cols=200  Identities=26%  Similarity=0.390  Sum_probs=172.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..|+..++||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.+++++.||||+++++++     .++...+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence            45788899999999999999998899999999987443 23456788999999999999999999985     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++|+|.+++...       .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||.+
T Consensus        79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence            999999999999998743       4778889999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         149 GQLTDTQIK--------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             eeccCCccc--------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            765432211        11235788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=9.5e-31  Score=277.82  Aligned_cols=199  Identities=26%  Similarity=0.388  Sum_probs=171.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++     ..+...++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence            4677789999999999999998889999999986433 33446788999999999999999999984     45667899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|||   +++++|+||+|+||++++++.++++|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccc
Confidence            99999999999998642       5788899999999999999999   8899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         150 QLTDTQIK--------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             cccCcchh--------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            65432211        11235788999999999989999999999999999999999998653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=2e-30  Score=286.61  Aligned_cols=210  Identities=26%  Similarity=0.427  Sum_probs=170.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCccceeeeeccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQK-GASKSFVAECKALRNIR-HRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  710 (884)
                      .++|.+.++||+|+||.||+|++.     .+++.||+|+++.... ...+.+.+|++++.++. ||||+++++++.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            456889999999999999999864     3456899999974322 22356889999999997 999999999863    


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCC----------------------------------------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ----------------------------------------------------  738 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  738 (884)
                       ..+..++||||+++|+|.++++..+..                                                    
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             445689999999999999999764310                                                    


Q ss_pred             ----------------------------------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 002760          739 ----------------------------------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       739 ----------------------------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp  778 (884)
                                                              .....+++.++..++.|++.|++|||   +++++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                    01124677888999999999999999   88999999999


Q ss_pred             CCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCC
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP  857 (884)
Q Consensus       779 ~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p  857 (884)
                      +||+++.++.+||+|||+++.........      ......|++.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYI------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccc------cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999997653221110      0112346889999999998889999999999999999998 8999


Q ss_pred             CCcc
Q 002760          858 TDAM  861 (884)
Q Consensus       858 ~~~~  861 (884)
                      |...
T Consensus       342 ~~~~  345 (401)
T cd05107         342 YPEL  345 (401)
T ss_pred             CCCC
Confidence            8754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=277.69  Aligned_cols=203  Identities=29%  Similarity=0.465  Sum_probs=174.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCC--C--cEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGEN--G--TEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .....++||.|-||.||+|....-  |  -.||||+.+.. .....+.|..|+.+|++++||||++++|+|..      .
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~  463 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q  463 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence            345668899999999999986432  2  24999998753 44567889999999999999999999999852      3


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++|||.++-|.|..|++....     .++..+...++.||+.||+|||   ++.+|||||..+|||+.....||++||
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeeccc
Confidence            46999999999999999998765     7889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcccc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~  863 (884)
                      |+++.+.+...+....       ..-...|||||.+.-+.++.++|||.|||++||++. |..||.+..+
T Consensus       536 GLSR~~ed~~yYkaS~-------~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN  598 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASR-------GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN  598 (974)
T ss_pred             chhhhccccchhhccc-------cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence            9999988766543221       123678999999999999999999999999999886 9999988644

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=2.3e-30  Score=276.76  Aligned_cols=201  Identities=26%  Similarity=0.438  Sum_probs=174.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||+++.+++     ......+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence            36899999999999999999999888999999998755445557788999999999999999999985     3456779


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||+++++|.+++...       .+++.++..++.|++.|+.|||   ++|++|||+||+||+++.++.++|+|||++
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            999999999999998753       4678889999999999999999   889999999999999999999999999988


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|++.|+|||.+.+..++.++|+||+||++|++++|+.||...
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         163 AQITPEQSK--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             ecccccccc--------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            755432211        12235889999999998888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.7e-31  Score=278.26  Aligned_cols=220  Identities=21%  Similarity=0.270  Sum_probs=180.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .-|..++.||-|+||+|.+++...+...||.|.+++++   +......+.|-+||...+.+-||+++-.     |++++.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            35888899999999999999988888899999987543   3344668889999999999999999865     788899


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      +|.||||++||++-+++-+.+      .+++..++.++.++..|+++.|   ..|+|||||||+|||||.+|++||.|||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecc
Confidence            999999999999999988766      6788888889999999999999   8899999999999999999999999999


Q ss_pred             ccccccc---CCCCc---cccc----------------------------ceeeeccccccceeCccccCCCCCCcccce
Q 002760          796 LAKFLSN---HNPDT---IVET----------------------------RSISIGIKGTVGYVAPEYGMGREASMKGDV  841 (884)
Q Consensus       796 ~a~~~~~---~~~~~---~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  841 (884)
                      ++.-+.=   ...+.   ....                            +......+||+.|+|||++....|+.-+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            9853321   00000   0000                            001123459999999999999999999999


Q ss_pred             eehhHHHHHHhcCCCCCCccccCC--ccHHHHH
Q 002760          842 YSFGILLLELFTRKRPTDAMFNEG--LTLHDFS  872 (884)
Q Consensus       842 wSlG~il~~lltg~~p~~~~~~~~--~~~~~~~  872 (884)
                      ||.|||||||+.|+.||-+...-+  ..+..|.
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWR  887 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence            999999999999999998765543  3445554

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.7e-30  Score=269.26  Aligned_cols=197  Identities=28%  Similarity=0.439  Sum_probs=163.8

Q ss_pred             CeeeeccceEEEEEEECCCC---cEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENG---TEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      ++||+|+||.||+|.+...+   ..||+|.+..... ...+++.+|+++++++.||||+++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            57999999999999875554   7899999874432 34567889999999999999999999853      23568999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++....      .+++..++.++.|++.|++|||   ..+++||||||+||+++.++.+||+|||.++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999998654      5789999999999999999999   789999999999999999999999999999866


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ........     ......++..|+|||...+..++.++|||||||++|+|++ |+.||...
T Consensus       146 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         146 GAGSDYYR-----ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             ecCCcccc-----cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence            43321110     0111124568999999998899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=3.1e-30  Score=274.65  Aligned_cols=211  Identities=24%  Similarity=0.344  Sum_probs=174.1

Q ss_pred             HHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc-cC
Q 002760          635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF-KG  712 (884)
Q Consensus       635 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~  712 (884)
                      ......|++.+.||+|+||+||+|++..+++.||+|++.... .....+..|+.+++++ +||||+++++++..... ..
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            345578999999999999999999999999999999986432 2345688899999998 69999999998643221 23


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ....++||||+++|+|.+++......    .+++..++.++.|++.|++|||   +++|+||||||+||++++++.++|+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence            56789999999999999999765432    5778888999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||.+........        ......|++.|+|||.+.     +..++.++||||+||++|||++|+.||...
T Consensus       164 dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         164 DFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             eCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            9999875532211        112345899999999875     356788999999999999999999999654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=4.3e-30  Score=272.64  Aligned_cols=192  Identities=27%  Similarity=0.358  Sum_probs=157.5

Q ss_pred             eeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHc---CCCCCccceeeeeccCCccCCccceEE
Q 002760          646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRN---IRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .||+|+||.||+|.+..+++.||+|.+.....   .....+.+|..+++.   .+||+|+.+.+++     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            48999999999999998999999998864321   112334445444333   4799999998874     445678999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      |||+++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+||++++++.++++|||++..
T Consensus        76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999987654      5899999999999999999999   88999999999999999999999999999875


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccC-CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......          ....|++.|+|||... +..++.++||||+||++|+|++|..||...
T Consensus       147 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         147 FSKKKP----------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             ccccCc----------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            432211          1235899999999876 456899999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.5e-30  Score=273.73  Aligned_cols=204  Identities=27%  Similarity=0.485  Sum_probs=170.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCc----EEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT----EVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ..+|++.+.||+|+||+||+|.++.+|+    .||+|.++.... ....++.+|+.++++++|||++++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3578899999999999999999876665    589998764432 334678899999999999999999998742     


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                       ...++||||+++|+|.+++.....     .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEEC
Confidence             567999999999999999986543     5889999999999999999999   7899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |||.++..........      .....++..|+|||.+....++.++|+||+|+++||+++ |+.||++.
T Consensus       152 dfg~~~~~~~~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         152 DFGLAKLLDVDEKEYH------AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             CCcccccccCccccee------cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999986653221110      011224678999999988899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=3.9e-30  Score=269.86  Aligned_cols=197  Identities=28%  Similarity=0.465  Sum_probs=162.8

Q ss_pred             CeeeeccceEEEEEEE--CCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFL--GENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      ++||+|+||.||+|.+  ..+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++.      ....++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~   74 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVM   74 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEE
Confidence            3689999999999965  45678899999864332  23467889999999999999999999853      23568999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++....      .+++..+..++.|++.|++|+|   +++|+||||||+||+++.++.+||+|||.++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            9999999999997543      5788899999999999999999   889999999999999999999999999999865


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .......     .......++..|+|||.+....++.++|+|||||++|||++ |+.||...
T Consensus       146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         146 GADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             CCCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4322110     00112234678999999988889999999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=2.2e-30  Score=277.71  Aligned_cols=209  Identities=26%  Similarity=0.424  Sum_probs=168.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECC----------------CCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGE----------------NGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKI  701 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  701 (884)
                      ++|++.++||+|+||.||+|.+..                ++..||+|+++... ......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            569999999999999999986432                34469999986432 2334678899999999999999999


Q ss_pred             eeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCc-----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 002760          702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-----EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL  776 (884)
Q Consensus       702 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dl  776 (884)
                      ++++     ...+..++||||+++|+|.+++.......     ....+++.++..++.|++.|++|||   +.+++||||
T Consensus        85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl  156 (296)
T cd05095          85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL  156 (296)
T ss_pred             EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence            9985     34556799999999999999997643221     1235778899999999999999999   889999999


Q ss_pred             CCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc--C
Q 002760          777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT--R  854 (884)
Q Consensus       777 kp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt--g  854 (884)
                      ||+||+++.++.++|+|||+++.........      ......+++.|+|||...+..++.++|||||||++|||++  |
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            9999999999999999999997653322111      1111234678999999888889999999999999999998  7


Q ss_pred             CCCCCcc
Q 002760          855 KRPTDAM  861 (884)
Q Consensus       855 ~~p~~~~  861 (884)
                      ..||...
T Consensus       231 ~~p~~~~  237 (296)
T cd05095         231 EQPYSQL  237 (296)
T ss_pred             CCCcccc
Confidence            7888654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=2.5e-30  Score=277.10  Aligned_cols=211  Identities=28%  Similarity=0.436  Sum_probs=171.4

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRD  709 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  709 (884)
                      ..++|++.+.||+|+||.||+|.+...     ...||+|++.... .....++.+|+++++++ +||||+++++++    
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            345789999999999999999987643     3689999986432 22335688999999999 899999999985    


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCC----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPS  779 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~  779 (884)
                       ..++..++||||+++|+|.++++.....          .....+++..++.++.|++.|++|||   +++|+||||||+
T Consensus        86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~  161 (293)
T cd05053          86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAAR  161 (293)
T ss_pred             -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccccee
Confidence             3455679999999999999999754311          12236889999999999999999999   889999999999


Q ss_pred             CeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCC
Q 002760          780 NVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPT  858 (884)
Q Consensus       780 NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~  858 (884)
                      ||+++.++.+||+|||.++.........      ......++..|+|||+..+..++.++|||||||++||+++ |..||
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYR------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             eEEEcCCCeEEeCcccccccccccccee------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            9999999999999999998654322111      0111235678999999988899999999999999999997 99998


Q ss_pred             Ccc
Q 002760          859 DAM  861 (884)
Q Consensus       859 ~~~  861 (884)
                      .+.
T Consensus       236 ~~~  238 (293)
T cd05053         236 PGI  238 (293)
T ss_pred             CCC
Confidence            764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.4e-30  Score=270.75  Aligned_cols=192  Identities=25%  Similarity=0.472  Sum_probs=158.6

Q ss_pred             CeeeeccceEEEEEEECCC------------CcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          645 NKIGEGGSGIVYKGFLGEN------------GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      +.||+|+||.||+|+....            ...||+|++..........+.+|+.+++.++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            4689999999999985322            2358999887555555668889999999999999999999964     3


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCc----
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV----  788 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~----  788 (884)
                      ....++||||+++|+|..++.....     .+++..++.++.|++.|++|||   +++|+||||||+||+++.++.    
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCC
Confidence            4566999999999999999875432     5788899999999999999999   889999999999999987664    


Q ss_pred             ---eEEeccccccccccCCCCcccccceeeeccccccceeCccccC-CCCCCcccceeehhHHHHHHh-cCCCCCCcc
Q 002760          789 ---SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELF-TRKRPTDAM  861 (884)
Q Consensus       789 ---~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~~ll-tg~~p~~~~  861 (884)
                         ++++|||.+.......            ...|+..|+|||.+. +..++.++|||||||++|||+ +|..||...
T Consensus       148 ~~~~~l~d~g~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         148 GPFIKLSDPGIPITVLSRQ------------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             CceeEeCCCCCCccccCcc------------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence               8999999986543211            234788899999876 467899999999999999998 688888754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=277.37  Aligned_cols=210  Identities=27%  Similarity=0.422  Sum_probs=168.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC--------------CcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCcccee
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN--------------GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKII  702 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~  702 (884)
                      .++|++.++||+|+||.||+|++...              ...||+|+++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35799999999999999999987532              2358999986432 22345688999999999999999999


Q ss_pred             eeeccCCccCCccceEEEEccCCCCHHHHhhccCCC------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 002760          703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL  776 (884)
Q Consensus       703 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dl  776 (884)
                      +++     ......++||||+++++|.+++......      .....+++.+++.++.|++.|++|||   +++++||||
T Consensus        84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl  155 (295)
T cd05097          84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL  155 (295)
T ss_pred             EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence            985     3456779999999999999998653211      11224788899999999999999999   889999999


Q ss_pred             CCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc--C
Q 002760          777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT--R  854 (884)
Q Consensus       777 kp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt--g  854 (884)
                      ||+||+++.++.+||+|||++.........      .......+++.|+|||...+..++.++|||||||++|+|++  |
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~  229 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK  229 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence            999999999999999999999765332211      11112235778999999988889999999999999999988  6


Q ss_pred             CCCCCcc
Q 002760          855 KRPTDAM  861 (884)
Q Consensus       855 ~~p~~~~  861 (884)
                      ..||...
T Consensus       230 ~~p~~~~  236 (295)
T cd05097         230 EQPYSLL  236 (295)
T ss_pred             CCCCccc
Confidence            6788754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=2.4e-30  Score=276.26  Aligned_cols=211  Identities=21%  Similarity=0.400  Sum_probs=168.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECC-----CCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      ..++|++.++||+|+||.||+|..+.     .+..||+|.++.... .....+.+|+.++++++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            35689999999999999999997642     345799998763322 2334678899999999999999999985     


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCc----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQL----EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                      ......++||||+++|+|.++++......    .....++..+..++.|++.|+.|||   +++|+||||||+||+++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence            34456799999999999999997643211    1234567788899999999999999   8899999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.++|+|||+++.........      ......++..|+|||...+..++.++||||+||++|||++ |..||.+.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             CcEEECcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999987553322110      0111235678999999998899999999999999999998 78898653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=2.9e-30  Score=278.30  Aligned_cols=210  Identities=28%  Similarity=0.422  Sum_probs=169.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC-------CCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-------NGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGR  708 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  708 (884)
                      .++|.+.+.||+|+||.||+|++..       +...||+|.++... ......+.+|+.+++++ +||||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            3579999999999999999998643       23469999987432 23345688899999999 7999999999863  


Q ss_pred             CccCCccceEEEEccCCCCHHHHhhccCCCc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 002760          709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQL----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       709 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp  778 (884)
                         ..+..++||||+++|+|.+++.......          ....+++.+++.++.|++.|++|||   ++|++||||||
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  168 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  168 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence               4456799999999999999998653211          1235888999999999999999999   88999999999


Q ss_pred             CCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCC
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP  857 (884)
Q Consensus       779 ~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p  857 (884)
                      +||+++.++.+||+|||.++.........      ......+++.|+|||...+..++.++||||+||++|||++ |..|
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhh------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999987553221110      0111224578999999998899999999999999999998 8888


Q ss_pred             CCcc
Q 002760          858 TDAM  861 (884)
Q Consensus       858 ~~~~  861 (884)
                      |.+.
T Consensus       243 ~~~~  246 (307)
T cd05098         243 YPGV  246 (307)
T ss_pred             CCcC
Confidence            8653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=4.6e-30  Score=273.65  Aligned_cols=202  Identities=28%  Similarity=0.394  Sum_probs=164.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHH-HHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKA-LRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++     ..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence            468899999999999999999999999999999864322 223455556665 5667899999999985     345668


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCCeeeCCCCceEEeccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP-SIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ++||||++ |+|.+++......  ...+++.+++.++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999996 6898888653221  136899999999999999999999   65 99999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC----CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG----REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .+........         .....|+..|+|||.+.+    ..++.++|+||+||++|+|++|+.||..
T Consensus       150 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         150 ISGYLVDSVA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             cccccccccc---------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            9876532211         112347889999998765    4568899999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=3.1e-30  Score=272.13  Aligned_cols=201  Identities=30%  Similarity=0.439  Sum_probs=173.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|+..+.||+|+||.||+|.++.+++.||+|++.... ....+++.+|++++++++||||+++++++     ......+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            35788899999999999999999899999999986543 23446788999999999999999999985     3457789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      +|+||+++++|.+++....     ..+++..+..++.|++.|++|+|   + .+++||||||+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999998653     26888999999999999999999   7 8999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      +.........          ...|+..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus       148 ~~~~~~~~~~----------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  203 (265)
T cd06605         148 SGQLVNSLAK----------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN  203 (265)
T ss_pred             chhhHHHHhh----------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence            8755322111          1458889999999999899999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=5.7e-30  Score=268.93  Aligned_cols=199  Identities=28%  Similarity=0.435  Sum_probs=171.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|+..+.||+|+||+||+|....+++.||+|.+.....     ...+.+.+|+.++++++||||+++.+++     ..+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            47888999999999999999988999999999864331     2346788999999999999999999984     4556


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++....      .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence            7899999999999999997653      5788889999999999999999   789999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCC-CCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.+.......         ......|++.|+|||.+.... ++.++|+||+||++|++++|+.||...
T Consensus       147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            9987654322         111345889999999987766 899999999999999999999999664

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=4.5e-30  Score=274.22  Aligned_cols=201  Identities=29%  Similarity=0.443  Sum_probs=171.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|+.++++++|||++++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            5889999999999999999998899999999987543  33456789999999999999999999984     4467789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+ +++|.+++.....     .+++.+++.++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 9999999876442     6889999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........       ......|+..|+|||.+.+. .++.++||||+||++|||++|.+||.+.
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         147 RLFSEEEPR-------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             ccccCCCCC-------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            866433211       11123589999999987654 4689999999999999999998888653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=5.2e-30  Score=269.41  Aligned_cols=201  Identities=31%  Similarity=0.538  Sum_probs=167.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.++||+|+||.||+|.+..+ ..||+|.+... ....+.+.+|++++++++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            5688999999999999999988644 56999987533 233467889999999999999999998742      345689


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++|+|.++++....    ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.++|+|||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999999999976432    25788999999999999999999   8899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .........       .....++..|+|||...+..++.++||||+|+++|+|+| |+.||.+.
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         151 LIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             EccCCcccc-------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            654322111       112235778999999988899999999999999999999 89999764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=8.8e-30  Score=270.17  Aligned_cols=192  Identities=27%  Similarity=0.359  Sum_probs=157.8

Q ss_pred             eeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHH---HHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECK---ALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .||+|+||.||+|++..+++.||+|.+..+..   .....+..|..   .++...||+|+++.++     +...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence            48999999999999988999999999864321   11222334443   3444579999999987     4456678999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      |||+++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999887543      6889999999999999999999   78999999999999999999999999999875


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......          ....|+..|+|||.+.+. .++.++||||+||++|+|++|+.||...
T Consensus       147 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         147 FSKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCccCC----------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            532211          123589999999998754 6899999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=4e-30  Score=271.92  Aligned_cols=204  Identities=25%  Similarity=0.391  Sum_probs=169.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC---CcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..+|++.+.||+|+||.||+|.+...   ...||||...... ....+.+.+|+.++++++||||+++++++.      .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------E   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------C
Confidence            34688999999999999999987543   3469999886543 344567899999999999999999999863      2


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++|+|.+++.....     .+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d  150 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGD  150 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEcc
Confidence            346899999999999999976432     5789999999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      ||+++.........       .....++..|+|||.+....++.++||||||+++||+++ |..||.+..
T Consensus       151 ~g~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         151 FGLSRYLEDESYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             Cceeeeccccccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99997654332111       011234578999999988889999999999999999986 999997654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=5.6e-30  Score=270.63  Aligned_cols=203  Identities=24%  Similarity=0.385  Sum_probs=160.6

Q ss_pred             CeeeeccceEEEEEEEC--CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLG--ENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.||+|+||.||+|.+.  .++..+|+|.++.... .....+.+|+.++++++||||+++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            46999999999999864  2456799998864432 23357888999999999999999999853     4456799999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++...... .....++..+..++.|++.|++|||   +++++||||||+||+++.++.++|+|||.+....
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999764321 1224567778889999999999999   8899999999999999999999999999986433


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCC-------CCCcccceeehhHHHHHHhc-CCCCCCccc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-------EASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~~llt-g~~p~~~~~  862 (884)
                      .....      .......|++.|+|||++.+.       .++.++|+||+||++|||++ |+.||....
T Consensus       152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  214 (269)
T cd05087         152 KEDYY------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS  214 (269)
T ss_pred             Cccee------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            22111      011234578899999987642       35789999999999999996 999997643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=5.4e-30  Score=272.53  Aligned_cols=210  Identities=26%  Similarity=0.419  Sum_probs=172.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC----CCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE----NGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      .++|++.+.||+|+||.||+|.+..    ++..||+|+++... ....+.+.+|+.++++++||||+++++++.    ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            4679999999999999999999865    25789999886332 233566889999999999999999999873    33


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCC--cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQ--LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                      +...++++||+++|+|.+++......  .....+++.+++.++.|++.|++|||   +++++||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEE
Confidence            56779999999999999998764321  11236889999999999999999999   88999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDA  860 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~  860 (884)
                      |+|||+++.+.......      ......++..|+|||++.+..++.++||||+||++||+++ |+.||..
T Consensus       158 l~d~g~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         158 ITDNALSRDLFPMDYHC------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             ECCCCCcccccCCceEE------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence            99999998654322110      0112235778999999998899999999999999999999 9999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=7.9e-30  Score=272.10  Aligned_cols=205  Identities=27%  Similarity=0.387  Sum_probs=173.6

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|+..++||.|++|.||+|.+..+++.||+|++..... ....++.+|++++++++||||+++++++..   ...+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            367888999999999999999988999999999874322 345678999999999999999999998642   2345689


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....  ....++...+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            99999999999998765322  1225788899999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........          ...++..|+|||...+..++.++||||+||++|+|++|+.||+..
T Consensus       153 ~~~~~~~~~----------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         153 GELVNSLAG----------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccccccccc----------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            754322111          234788999999999889999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-30  Score=270.56  Aligned_cols=203  Identities=31%  Similarity=0.540  Sum_probs=171.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||.||+|... +++.||||.+.... ...+++.+|+.++++++|||++++++++     ......+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence            467999999999999999999975 56789999986432 3456789999999999999999999984     4456679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|+.|||   +++++||||||+||+++.++.++++|||.+
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccc
Confidence            99999999999999976432    25889999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........       .....++..|+|||.+.+..++.++|+||+||++|++++ |+.||.+.
T Consensus       151 ~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         151 RLIEDDEYTA-------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             eeccchhhhh-------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7654321110       011224678999999998899999999999999999998 99999664

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-31  Score=256.80  Aligned_cols=215  Identities=23%  Similarity=0.326  Sum_probs=183.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|...++||+|+|+.|..++++++.+.+|+|++++.   .....+-.+.|-.+..+. +||.+|.+...     |+..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            46799999999999999999999999999999999743   344556678888888776 79999988876     7788


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...+.|.||+.||+|--++++.+      .+++..++.+..+|+.|+.|||   ++|||+||+|.+|+|++..|++|+.|
T Consensus       324 srlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecc
Confidence            89999999999999988777765      6899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc--ccCCccHHHH
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM--FNEGLTLHDF  871 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~--~~~~~~~~~~  871 (884)
                      +|+++.--.+        ......+||||.|.|||++++.+|+..+|.|++||+++||+.|+.||+-.  .+.+..-++|
T Consensus       395 ygmcke~l~~--------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy  466 (593)
T KOG0695|consen  395 YGMCKEGLGP--------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY  466 (593)
T ss_pred             cchhhcCCCC--------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH
Confidence            9998743221        22345689999999999999999999999999999999999999999753  3334444555


Q ss_pred             HHH
Q 002760          872 SRE  874 (884)
Q Consensus       872 ~~~  874 (884)
                      .-+
T Consensus       467 lfq  469 (593)
T KOG0695|consen  467 LFQ  469 (593)
T ss_pred             HHH
Confidence            433

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=5.3e-30  Score=275.29  Aligned_cols=200  Identities=31%  Similarity=0.435  Sum_probs=168.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-----ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|++.+.||+|+||.||+|.+..+++.||||.++.....     ....+..|++++++++||||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            478889999999999999999889999999999744322     335577899999999999999999985     3466


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+ +|+|.+++....     ..+++..++.++.|++.|+.|||   ++|++||||||+||+++.++.++|+||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccc
Confidence            789999999 899999997653     15889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |++.........        .....+++.|+|||.+.+ ..++.++||||+||++|||++|..||.+.
T Consensus       147 g~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         147 GLARSFGSPNRK--------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             eeeeeccCCCcc--------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence            999866433211        112246788999998754 56789999999999999999998887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=5.2e-30  Score=279.62  Aligned_cols=210  Identities=28%  Similarity=0.422  Sum_probs=169.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC-------CcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN-------GTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGR  708 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  708 (884)
                      ..+|++.+.||+|+||.||+|++...       +..||+|+++... ....+.+.+|+++++++ +||||+++++++.  
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            35799999999999999999986432       2368999886432 23346788999999999 7999999999863  


Q ss_pred             CccCCccceEEEEccCCCCHHHHhhccCCC----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 002760          709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       709 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp  778 (884)
                         ..+..++||||+++|+|.+++......          .....+++.+++.++.|++.|++|||   ++|++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  162 (334)
T cd05100          89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA  162 (334)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence               445679999999999999999764321          11235788899999999999999999   88999999999


Q ss_pred             CCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCC
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP  857 (884)
Q Consensus       779 ~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p  857 (884)
                      +||+++.++.+||+|||+++.........      ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999998654322111      0111224578999999999999999999999999999998 8889


Q ss_pred             CCcc
Q 002760          858 TDAM  861 (884)
Q Consensus       858 ~~~~  861 (884)
                      |.+.
T Consensus       237 ~~~~  240 (334)
T cd05100         237 YPGI  240 (334)
T ss_pred             CCCC
Confidence            8764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=6.7e-30  Score=268.00  Aligned_cols=201  Identities=25%  Similarity=0.393  Sum_probs=172.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||.++...+|+.||+|.+....  ....+++.+|++++++++||||+++.++     +...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence            5889999999999999999999999999999986432  2334678899999999999999999998     45567889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|+.|||   +++++|+||+|+||+++.++.++++|||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999876432    15788899999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .........        .....|++.|+|||+..+..++.++|+||+||++|+|++|+.||..
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         149 RVLNSTVEL--------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             eecCcchhh--------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            765432111        1123478899999999888899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=6.6e-30  Score=274.31  Aligned_cols=210  Identities=27%  Similarity=0.411  Sum_probs=171.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCC----------------cEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG----------------TEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIK  700 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  700 (884)
                      ..+|++.++||+|+||.||+|++...+                ..||+|++..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876533                4689999864432 34567889999999999999999


Q ss_pred             eeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCc-----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 002760          701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-----EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD  775 (884)
Q Consensus       701 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~D  775 (884)
                      +++++.     .++..++||||+++++|.+++.......     ....+++..++.++.|++.|++|||   +.+|+|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence            999853     4467899999999999999997654211     1125889999999999999999999   78999999


Q ss_pred             CCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc--
Q 002760          776 LKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT--  853 (884)
Q Consensus       776 lkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt--  853 (884)
                      |||+||+++.++.++|+|||.++.........      ......+++.|+|||...+..++.++|||||||++|||++  
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence            99999999999999999999987654322111      1112346788999999988889999999999999999998  


Q ss_pred             CCCCCCcc
Q 002760          854 RKRPTDAM  861 (884)
Q Consensus       854 g~~p~~~~  861 (884)
                      |..||...
T Consensus       230 ~~~p~~~~  237 (296)
T cd05051         230 REQPYEHL  237 (296)
T ss_pred             CCCCCCCc
Confidence            77788653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=8.1e-30  Score=268.74  Aligned_cols=204  Identities=32%  Similarity=0.471  Sum_probs=174.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|....+++.||+|+++.....  ..+.+.+|++++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            588899999999999999999889999999998754432  567889999999999999999999984     4556789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||+++++|.+++....      .+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.+||+|||.+
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999998643      4678888999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCC---CCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE---ASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ............    ......|++.|+|||.+.+..   ++.++||||+|+++|++++|+.||...
T Consensus       147 ~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         147 VKLKNNTTTMGE----EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccCCCCCcccc----cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            876543322111    011345789999999988766   889999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=4.1e-30  Score=277.96  Aligned_cols=210  Identities=28%  Similarity=0.432  Sum_probs=169.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECC-------CCcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-------NGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGR  708 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  708 (884)
                      .++|.+.++||+|+||.||+|++..       ....||+|.++... ......+..|+++++++ +||||+++++++.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            4578899999999999999998632       34579999986432 23345688999999999 6999999999863  


Q ss_pred             CccCCccceEEEEccCCCCHHHHhhccCCC----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 002760          709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       709 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp  778 (884)
                         ..+..++||||+++|+|.+++......          .....+++.++..++.|++.|+.|||   ++|++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  162 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA  162 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               445679999999999999999764321          01235888999999999999999999   88999999999


Q ss_pred             CCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCC
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP  857 (884)
Q Consensus       779 ~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p  857 (884)
                      +||+++.++.+||+|||.++...........      ....+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKT------SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             eeEEEcCCCcEEEcccccccccccccccccc------ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence            9999999999999999999865432211100      11124567999999998899999999999999999999 8889


Q ss_pred             CCcc
Q 002760          858 TDAM  861 (884)
Q Consensus       858 ~~~~  861 (884)
                      |.+.
T Consensus       237 ~~~~  240 (314)
T cd05099         237 YPGI  240 (314)
T ss_pred             CCCC
Confidence            8764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=4.2e-30  Score=271.63  Aligned_cols=202  Identities=24%  Similarity=0.362  Sum_probs=158.0

Q ss_pred             CeeeeccceEEEEEEECC--CCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      ++||+|+||+||+|....  ....+|+|.+..... .....+.+|+++++.++||||+++++.+     ......++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence            469999999999997532  335688887753322 2345678899999999999999999985     34566799999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.+++....... ....++.....++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence            999999999998754321 123567788899999999999999   8899999999999999999999999999986433


Q ss_pred             cCCCCcccccceeeeccccccceeCccccC-------CCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGM-------GREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ......      ......+++.|+|||+..       ...++.++||||+||++|||++ |..||...
T Consensus       152 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         152 PEDYYI------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             cchhee------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            221100      011234677899999864       3457889999999999999999 78888754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1e-29  Score=267.52  Aligned_cols=203  Identities=35%  Similarity=0.561  Sum_probs=170.4

Q ss_pred             CeeeeccceEEEEEEECCC---CcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|.+...   +..||+|+++..... ..+.+.+|+++++.++|||++++++++     ......++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence            4799999999999999765   889999999754333 257889999999999999999999985     3467789999


Q ss_pred             EccCCCCHHHHhhccCCC---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQ---LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      ||+++++|.+++......   .....+++.+++.++.|++.|++|||   +++++||||||+||+++.++.++|+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999875210   01126899999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........      ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...
T Consensus       153 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         153 RDVYDDDYYR------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             cccccccccc------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            8665432111      1123447889999999988899999999999999999999 69999765

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=7.9e-30  Score=270.69  Aligned_cols=194  Identities=27%  Similarity=0.387  Sum_probs=165.7

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||+||+|.+..+|+.||+|++....   ......+..|++++++++||||+++.+++     ...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999899999999986432   22334567899999999999999999884     4556789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++.....    ..+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999976543    25889999999999999999999   889999999999999999999999999998765431


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..         .....|+..|+|||...+..++.++||||+||++|+|++|+.||...
T Consensus       149 ~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         149 KK---------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             Cc---------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            11         11234788999999998888999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1.7e-29  Score=266.22  Aligned_cols=201  Identities=30%  Similarity=0.426  Sum_probs=175.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +|++.+.||+|++|.||+|++..+++.||||++..... ...+.+.+|+.++.+++|||++++++++     ..+...++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence            68889999999999999999998999999999875433 4457889999999999999999999984     45577899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      ||||+++++|.+++....      .+++..++.++.|++.|++|||   + .+++||||+|+||+++.++.++|+|||.+
T Consensus        77 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          77 VLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             EEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence            999999999999998653      6889999999999999999999   7 89999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ..........        ....|+..|+|||...+..++.++|+||||+++|+|++|+.||....
T Consensus       148 ~~~~~~~~~~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         148 KVLENTLDQC--------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             eecccCCCcc--------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            8664322211        12347889999999999899999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=3.6e-30  Score=272.39  Aligned_cols=192  Identities=25%  Similarity=0.412  Sum_probs=156.3

Q ss_pred             eeeeccceEEEEEEECCC------------------------CcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccce
Q 002760          646 KIGEGGSGIVYKGFLGEN------------------------GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKI  701 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  701 (884)
                      .||+|+||.||+|....+                        ...||+|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999975321                        13589998865444445678889999999999999999


Q ss_pred             eeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCe
Q 002760          702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV  781 (884)
Q Consensus       702 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~Ni  781 (884)
                      +++|.     .....++||||+++|+|..++.....     .+++..+..++.|+++|++|||   +++|+||||||+||
T Consensus        82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNI  148 (274)
T ss_pred             EEEEE-----eCCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccE
Confidence            99964     34567999999999999999875432     5788889999999999999999   88999999999999


Q ss_pred             eeCCCC-------ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHh-
Q 002760          782 LLDQDL-------VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF-  852 (884)
Q Consensus       782 Ll~~~~-------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~ll-  852 (884)
                      +++..+       .++++|||.+.......            ...|+..|+|||.+.+ ..++.++|||||||++||++ 
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~------------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSRE------------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             EEeccCcccCccceeeecCCcccccccccc------------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            997644       47999999876432211            1236788999998865 56899999999999999985 


Q ss_pred             cCCCCCCccc
Q 002760          853 TRKRPTDAMF  862 (884)
Q Consensus       853 tg~~p~~~~~  862 (884)
                      +|+.||....
T Consensus       217 ~g~~p~~~~~  226 (274)
T cd05076         217 DGEVPLKERT  226 (274)
T ss_pred             CCCCCccccC
Confidence            7999997643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=6.9e-30  Score=274.66  Aligned_cols=204  Identities=28%  Similarity=0.500  Sum_probs=168.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCc----EEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT----EVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ..+|+..+.||+|+||.||+|.+..+|+    .||+|.+..... ....++.+|+.++++++||||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            3568889999999999999999877776    468888754322 233468899999999999999999998642     


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                       ...++++||+++|+|.+++.....     .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEc
Confidence             235799999999999999876432     5788899999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |||+++.........      ......++..|+|||...+..++.++|||||||++||+++ |+.||.+.
T Consensus       152 Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         152 DFGLARLLEGDEKEY------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             cccccccccCccccc------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998654322110      0112235778999999998999999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=9.7e-30  Score=269.38  Aligned_cols=201  Identities=27%  Similarity=0.454  Sum_probs=168.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc----------cchHHHHHHHHHHHcCCCCCccceeeeeccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK----------GASKSFVAECKALRNIRHRNLIKIITVCSGRD  709 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  709 (884)
                      +|...+.||+|+||.||+|....+|+.||+|.++....          ...+.+.+|+.++++++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            57888999999999999999988999999998853211          1124678899999999999999999985    


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                       ......++||||+++++|.++++..+      .+++..+..++.|++.|+.|||   +++++||||+|+||+++.++.+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeE
Confidence             45567899999999999999998653      5788889999999999999999   7899999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC--CCcccceeehhHHHHHHhcCCCCCCc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE--ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +++|||.+..........      ......|+..|+|||......  ++.++|+||+|+++|++++|..||..
T Consensus       148 ~l~d~~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         148 KISDFGISKKSDDIYDND------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             EEeecccccccccccccc------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            999999987543221110      112345889999999987654  78999999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.1e-29  Score=266.53  Aligned_cols=201  Identities=29%  Similarity=0.470  Sum_probs=172.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|+..+.||+|+||.||+|....+++.+|+|++....  ....+.+.+|++++++++|||++++++.     +..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-----FLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-----EecCCEEE
Confidence            5888999999999999999999899999999986432  2335678899999999999999999987     44567789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-CceEEecccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFg~  796 (884)
                      +||||+++++|.+++.....    ..+++..++.++.|++.|++|||   +++++||||+|+||+++.+ +.++++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999976432    25789999999999999999999   8899999999999999854 4689999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +........         .....|++.|+|||...+..++.++||||+|+++|+|++|+.||+..
T Consensus       149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         149 SKILSSKSK---------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             ceecCCCcc---------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence            986643221         11235888999999999888999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-30  Score=270.26  Aligned_cols=210  Identities=26%  Similarity=0.344  Sum_probs=174.8

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCc-cCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF-KGAD  714 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  714 (884)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            45789999999999999999999988899999999874433 346788999999999 79999999998754432 3456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++......  ...+++..++.++.|++.|+.|||   +.+++||||+|+||++++++.++|+||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence            789999999999999998764311  126789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |.+.........        .....|++.|+|||.+..     ..++.++||||+||++|+|++|+.||..
T Consensus       158 ~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         158 GVSAQLDSTLGR--------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             ccceecccchhh--------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            998765432211        112458999999998653     3567899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=6.4e-30  Score=268.32  Aligned_cols=199  Identities=28%  Similarity=0.442  Sum_probs=167.2

Q ss_pred             CeeeeccceEEEEEEECC-CCc--EEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGE-NGT--EVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|.+.. .++  .||||.+..... ...+.+.+|+.++++++||||+++++++.     + ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            478999999999999865 333  699999975544 45678899999999999999999999853     3 6779999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|+|.+++.....    ..+++..++.++.|++.|++|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999987542    26889999999999999999999   889999999999999999999999999999876


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .........     .....++..|+|||...+..++.++||||+||++|+|++ |+.||...
T Consensus       148 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         148 PQNEDHYVM-----EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             cccccceec-----ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            442211111     112347789999999988899999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-29  Score=266.54  Aligned_cols=198  Identities=37%  Similarity=0.562  Sum_probs=170.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|..  .|+.||+|.++.... ..+++.+|+.++++++||||+++++++.     .....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence            45789999999999999999987  588999999974433 4578899999999999999999999853     456779


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.++++.....    .+++..+..++.|++.|+.|||   +++++||||||+||+++.++.++|+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccc
Confidence            999999999999999765421    5889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.......           ...++..|+|||.+.+..++.++||||+|+++|++++ |..||...
T Consensus       150 ~~~~~~~~-----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         150 KEASQGQD-----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             cccccccc-----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            86532211           1124567999999988889999999999999999997 99998654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=9.1e-30  Score=269.10  Aligned_cols=200  Identities=28%  Similarity=0.437  Sum_probs=162.2

Q ss_pred             CeeeeccceEEEEEEECCCCc--EEEEEEeecc-cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGT--EVAVKVINLK-QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|++..++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++.     ..+..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            468999999999999987775  4688887632 233446788999999999 7999999999853     455679999


Q ss_pred             EccCCCCHHHHhhccCCCc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceE
Q 002760          721 EFMQNGSLEEWLHHSNDQL----------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~k  790 (884)
                      ||+++|+|.+++...+...          ....+++.+++.++.|++.|++|||   +++++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence            9999999999997643211          1124788999999999999999999   78999999999999999999999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ++|||++........         ......+..|+|||+.....++.++|||||||++|||++ |..||...
T Consensus       153 l~dfgl~~~~~~~~~---------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         153 IADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             ECCCCCccccchhhh---------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            999999853211100         001124567999999988889999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1e-29  Score=269.87  Aligned_cols=198  Identities=27%  Similarity=0.383  Sum_probs=170.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      -|+..++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++     ..+...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4778899999999999999998899999999986432 23346788999999999999999999984     45667899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|||   +++++|+||+|+||+++.++.++++|||++.
T Consensus        80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccce
Confidence            99999999999998643       5788999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ........        .....|+..|+|||...+..++.++|+||+||++|+|++|..||..
T Consensus       150 ~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         150 QLTDTQIK--------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             ecccchhh--------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            65432211        1123578899999999888899999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.4e-30  Score=270.65  Aligned_cols=199  Identities=26%  Similarity=0.397  Sum_probs=170.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-cccchHHHHHHHHHHHcCC---CCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIR---HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .|+..+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|+.++++++   |||++++++++     ..+..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            478889999999999999999989999999998644 2334567889999999996   99999999985     35567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+++++|.++++..       .+++..++.++.|++.|+.|||   +.|++||||+|+||+++.++.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence            89999999999999998653       5788999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+.........        .....|+..|+|||...+ ..++.++|+||+||++|+|++|+.||.+.
T Consensus       147 ~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         147 VAALLNQNSSK--------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             ceeecCCCccc--------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence            99866543211        112358999999998765 45789999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.1e-29  Score=266.86  Aligned_cols=190  Identities=26%  Similarity=0.490  Sum_probs=160.1

Q ss_pred             CeeeeccceEEEEEEECCCC----------cEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          645 NKIGEGGSGIVYKGFLGENG----------TEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +.||+|+||.||+|.+..++          ..||+|++...... ...+.+|+.++++++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            47999999999999997666          35788877544333 6788999999999999999999998642      4


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-------
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-------  787 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-------  787 (884)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.|++|||   +++|+||||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCce
Confidence            46899999999999999987542     5788889999999999999999   88999999999999999887       


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCC--CCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR--EASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .+|++|||++.......            ...++..|+|||++.+.  .++.++||||+||++|++++ |..||...
T Consensus       146 ~~kl~Dfg~a~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         146 FIKLSDPGIPITVLSRE------------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             eEEeCCCCccccccccc------------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            79999999998653311            12367789999998876  78999999999999999999 57787664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=8.4e-30  Score=268.28  Aligned_cols=200  Identities=29%  Similarity=0.483  Sum_probs=159.5

Q ss_pred             CeeeeccceEEEEEEECC---CCcEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGE---NGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||+||+|.+..   .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.    ..++..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence            468999999999998643   3457999988532 2234567889999999999999999999763    3345678999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+.+|+|.+++.....     ..++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999976432     3567778899999999999999   889999999999999999999999999999755


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcC-CCCCCc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDA  860 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg-~~p~~~  860 (884)
                      .........    ......++..|+|||...+..++.++|||||||++|||++| ..||..
T Consensus       149 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         149 YDKEYYSVH----NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             cCCcceeec----ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            332111100    01123467789999999888999999999999999999995 555653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.1e-29  Score=270.52  Aligned_cols=198  Identities=27%  Similarity=0.445  Sum_probs=170.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++     ...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence            355568999999999999999889999999998755444556788999999999999999999984     456678999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      +||+++++|.+++...       .+++.+++.++.|++.|++|||   ++|++||||+|+||+++.++.++|+|||.+..
T Consensus        95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            9999999999998762       5788899999999999999999   88999999999999999999999999998875


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .......        .....|++.|+|||...+..++.++||||+||++|+|++|+.||..
T Consensus       165 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         165 VSKEVPR--------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             hccCCcc--------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            4332111        1124589999999999988899999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=278.66  Aligned_cols=204  Identities=27%  Similarity=0.419  Sum_probs=171.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCC-Cc--EEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGEN-GT--EVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~-~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .....++||+|.||.|++|.|... |+  .||||.++..... ....|.+|+.+|.+++|||+++++|+.     - +..
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV-----l-~qp  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV-----L-DQP  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee-----c-cch
Confidence            345668999999999999998653 33  5999999755444 567899999999999999999999984     2 256


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ..+|||.++.|+|.+.++...    ...+.......++.|||.||.||.   .++.||||+..+|+++-..-.|||+|||
T Consensus       185 ~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccc
Confidence            689999999999999998722    126888889999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +.+-+...+....+. ..    ..-...|+|||.+....++.++|||+|||++|||+| |+.||-+-
T Consensus       258 LmRaLg~ned~Yvm~-p~----rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~  319 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMA-PQ----RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC  319 (1039)
T ss_pred             ceeccCCCCcceEec-CC----CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence            999887554433221 11    123567999999999999999999999999999998 78899773

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1.2e-29  Score=266.70  Aligned_cols=202  Identities=28%  Similarity=0.500  Sum_probs=168.7

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||.||+|.+. .+..+|+|.++.. ....+.+.+|++++++++|+||+++.+++.     . ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence            468999999999999999999864 5667999988633 223467889999999999999999998853     2 4579


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      ++|||+++++|.+++.....    ..+++.+++.++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcce
Confidence            99999999999999976432    25788889999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ..........       .....++..|+|||.+.+..++.++|+|||||++|++++ |+.||.+.
T Consensus       150 ~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         150 RVIEDNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             eeccCCCccc-------ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            7654322110       112235678999999988889999999999999999998 99999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.6e-30  Score=274.11  Aligned_cols=200  Identities=27%  Similarity=0.411  Sum_probs=169.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.++||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++     ..+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            368899999999999999999988899999998864322  2346688999999999999999999984     566778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++++++.++.....      .+++.++..++.|++.|++|||   +.+++|||++|+||++++++.++|+|||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeee
Confidence            99999999998888766432      4789999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +.........        .....|+..|+|||...+ ..++.++||||+|+++|||++|+.||..
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         147 ARTLAAPGEV--------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             eeeccCCccc--------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            8765432211        112347889999998775 4578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.4e-30  Score=271.56  Aligned_cols=191  Identities=27%  Similarity=0.470  Sum_probs=158.6

Q ss_pred             CeeeeccceEEEEEEECCCCc-------EEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          645 NKIGEGGSGIVYKGFLGENGT-------EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +.||+|+||+||+|.+...+.       .||+|..........+++.+|+.+++.++||||+++++++     ..+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVC-----VCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEE-----EeCCCcE
Confidence            469999999999998865443       4888887654445567788999999999999999999985     3455679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCc--------e
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV--------S  789 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~--------~  789 (884)
                      +||||+++|+|.++++..+.     .+++..++.++.|++.|++|||   +++|+||||||+||+++.++.        +
T Consensus        76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceE
Confidence            99999999999999986542     5788889999999999999999   889999999999999987765        6


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCC-CCCCc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK-RPTDA  860 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~-~p~~~  860 (884)
                      +++|||.+.......            ...|++.|+|||++.+ ..++.++||||+||++|||++|. .||..
T Consensus       148 ~l~d~g~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         148 KLSDPGISITVLPKE------------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             EecccccccccCCch------------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            999999886443211            2347889999999887 45789999999999999999995 56544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=9e-30  Score=277.74  Aligned_cols=209  Identities=25%  Similarity=0.391  Sum_probs=173.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||.||+|....+|+.||+|++....  ....+.+.+|+.++++++||||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368999999999999999999999999999999986432  234567788999999999999999998764332 34457


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+. ++|.+++....      .+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence            899999995 68999887543      5889999999999999999999   7899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.........    .........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            99765432211    1111123468999999998765 56889999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=5.4e-30  Score=273.68  Aligned_cols=210  Identities=28%  Similarity=0.479  Sum_probs=170.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEEC-----CCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|+++.... ...+.+.+|+.++++++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            357999999999999999999874     3578899999864332 23466889999999999999999999853     


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCC----------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQ----------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD  775 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~D  775 (884)
                      .+...++||||+++|+|.+++......                .....+++.+++.++.|++.|++|||   +++++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence            455679999999999999999753221                11235788899999999999999999   88999999


Q ss_pred             CCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-C
Q 002760          776 LKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-R  854 (884)
Q Consensus       776 lkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g  854 (884)
                      |||+||+++.++.++|+|||.+..........      ......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcccc------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            99999999999999999999987543222110      0111224677999999998899999999999999999997 8


Q ss_pred             CCCCCcc
Q 002760          855 KRPTDAM  861 (884)
Q Consensus       855 ~~p~~~~  861 (884)
                      ..||.+.
T Consensus       230 ~~p~~~~  236 (288)
T cd05050         230 MQPYYGM  236 (288)
T ss_pred             CCCCCCC
Confidence            8898654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=8.1e-30  Score=271.83  Aligned_cols=201  Identities=27%  Similarity=0.432  Sum_probs=168.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|+..+.||+|+||.||+|++..+|+.||||+++...  ....+.+.+|++++++++||||+++++++     .+++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4888999999999999999999899999999886432  22335788999999999999999999984     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+. ++|.+++.....    ..+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||.+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999995 689998876432    26889999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....+++.|+|||...+. .++.++|||||||++|+|+||+.||.+.
T Consensus       148 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         148 RAFGVPVRT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             hhcccCccc--------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            755322111        1122468899999987764 4688999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.3e-29  Score=264.67  Aligned_cols=196  Identities=31%  Similarity=0.453  Sum_probs=162.7

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      +.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.     ..+..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            47999999999999864 788999999864332 23346889999999999999999999863     445679999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++.....     .+++.+++.++.|++.|+.|+|   ++|++||||||+||+++.++.+|++|||++......
T Consensus        75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999875432     4788999999999999999999   889999999999999999999999999998754322


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ....       .....+++.|+|||+..+..++.++||||+|+++|++++ |..||...
T Consensus       147 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         147 IYSS-------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             cccc-------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            1110       001124678999999988889999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1e-29  Score=268.15  Aligned_cols=209  Identities=25%  Similarity=0.358  Sum_probs=175.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||.|+||.||+|.+..+++.||+|+++...  ....+++..|++++++++||||+++++++.   ...+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII---DRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeee---cCCCCEEE
Confidence            4888999999999999999999999999999986432  233457888999999999999999998753   23345679


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC--EPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ++|||+++++|.+++.....  ....+++.+++.++.|++.|+.|||..+  +.+++|+||||+||+++.++.+|++|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            99999999999999976422  1236889999999999999999999543  5689999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+.........        .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         156 LAKILGHDSSF--------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             ccccccCCccc--------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            99866432210        11235899999999999988999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=1.4e-29  Score=267.53  Aligned_cols=208  Identities=28%  Similarity=0.418  Sum_probs=175.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|||++++++.+     ..+...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            46899999999999999999998899999999986432 23457789999999999999999999884     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|||++++++|.++++....   ...+++..+..++.|++.|++|||   +.|++||||+|+||++++++.++|+|||++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            99999999999999986432   125788999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..........    ........|+..|+|||.+... .++.++|+||+||++|+|++|+.||...
T Consensus       150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            7665432211    0112234589999999998776 7899999999999999999999999764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.3e-29  Score=273.53  Aligned_cols=204  Identities=30%  Similarity=0.422  Sum_probs=169.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++....  .....+.+|+.++++++|||++++++++..   ...+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            4679999999999999999999999999999999874322  223456789999999999999999998642   22346


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||++ ++|.+++....     ..+++.++..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccc
Confidence            799999996 58988887643     26889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+..........        ....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       154 ~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         154 LARTYGLPAKPM--------TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             eeeecCCccCCC--------CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998664322111        11235788999998765 56789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-29  Score=275.34  Aligned_cols=212  Identities=23%  Similarity=0.356  Sum_probs=172.7

Q ss_pred             CCCccCeeeeccceEEEEEEECC--CCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|++.++||+|+||.||+|.+..  +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            47889999999999999999988  78999999997532   44456788999999999999999999996422   236


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC----CCceE
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ----DLVSH  790 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~----~~~~k  790 (884)
                      ..++||||++ +++.+++...... ....+++..++.++.|++.|++|||   +++|+||||||+||+++.    ++.+|
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEE
Confidence            7899999996 4787777543321 1136888999999999999999999   889999999999999999    99999


Q ss_pred             EeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       791 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      |+|||++..........     .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.....+
T Consensus       153 l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         153 IGDLGLARLFNAPLKPL-----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             ECCCccccccCCCcccc-----cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence            99999998664432210     11123458899999998766 45789999999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.7e-29  Score=270.91  Aligned_cols=210  Identities=23%  Similarity=0.339  Sum_probs=170.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.+++++. ||||+++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36889999999999999999999999999999886432  223467888999999995 699999999875443333345


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEecc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDF  794 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DF  794 (884)
                      .++||||+++ ++.+++...... ....+++..++.++.||+.|+.|||   +++|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence            7999999975 899988754321 1235799999999999999999999   889999999999999998 899999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.+.........        .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.
T Consensus       156 g~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         156 GLGRAFSIPVKS--------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ccceecCCCccc--------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            998755332111        112246889999998765 45789999999999999999999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.4e-29  Score=278.32  Aligned_cols=204  Identities=24%  Similarity=0.328  Sum_probs=171.4

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .....+++.+|+.++++++||||+++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998532  2233456778999999999999999999864322 2334


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+. ++|.+++..        .++..++..++.|++.|++|||   .+||+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence            56799999995 588887753        2677888899999999999999   78999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.++.......         .....|++.|+|||.+.+..++.++||||+||++|+|++|+.||.+.
T Consensus       162 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         162 FGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             CccceeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            999986543211         11235789999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2e-29  Score=265.42  Aligned_cols=193  Identities=28%  Similarity=0.392  Sum_probs=168.0

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||.|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++     .++...++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            699999999999998889999999986432   23456789999999999999999999984     4567789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++....      .+++.++..++.|++.|++|+|   +++++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999998653      4788899999999999999999   889999999999999999999999999999866432


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ..         .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus       147 ~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         147 QK---------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             cc---------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            10         112357899999999988889999999999999999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=9e-30  Score=272.15  Aligned_cols=202  Identities=25%  Similarity=0.370  Sum_probs=171.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|++++++++||||+++++++     ..++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence            36889999999999999999999899999999986432  33446789999999999999999999985     346678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++++.+..+.....      .+++.++..++.|++.|++|||   +++++|||++|+||++++++.+||+|||.
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeec
Confidence            99999998877766554432      5788999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........       ......|+..|+|||+..+. .++.++||||+|+++|+|++|+.||.+.
T Consensus       147 ~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         147 ARALRARPAS-------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccccCCCccc-------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9866543220       11124578899999999887 8899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.2e-29  Score=271.71  Aligned_cols=203  Identities=27%  Similarity=0.406  Sum_probs=170.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+.++++++||||+++.+++...   .....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            57899999999999999999999899999999997433  22334567899999999999999999986422   23678


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++ ++|.+++.....     .+++.+++.++.|++.||+|||   +++++||||||+||+++.++.++|+|||.
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence            99999996 599998876432     5889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........        .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.
T Consensus       153 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         153 AREYGSPLKP--------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             eeeccCCccc--------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9866543211        1123478899999988764 4688999999999999999999999764

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=2e-29  Score=267.13  Aligned_cols=212  Identities=27%  Similarity=0.420  Sum_probs=168.4

Q ss_pred             CCccCeeeeccceEEEEEEECC---CCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccC-Cc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGE---NGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG-AD  714 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~-~~  714 (884)
                      |++.+.||+|+||.||+|.+..   +++.||||+++...  ....+++.+|++++++++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6778999999999999998643   56889999986432  233567889999999999999999999864322111 12


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++++||+++|+|.+++...........+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            34789999999999998764332222335788999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      |.++.........      ......+++.|++||......++.++|||||||++|+|++ |+.||.+.
T Consensus       158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         158 GLSKKIYSGDYYR------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             cccccccCCccee------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            9998654322110      1112235678999999988889999999999999999999 88998754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2.5e-29  Score=268.16  Aligned_cols=207  Identities=28%  Similarity=0.460  Sum_probs=172.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECC----CCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGE----NGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      +.|++.+.||+|+||.||+|++..    +++.||||+++..... ..+.+.+|+++++++.||||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            467888999999999999998643    4789999999754443 45789999999999999999999998642   235


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+++++|.+++.....     .+++.+++.++.|++.|++|||   ++|++||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence            567999999999999999986542     5889999999999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+...........     ......++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus       153 fg~~~~~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         153 FGLAKVLPEDKDYYY-----VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cccccccccCCccee-----ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            999986653221110     011123566799999998889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=1.7e-29  Score=264.53  Aligned_cols=195  Identities=36%  Similarity=0.543  Sum_probs=165.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ++|++.+.||+|+||.||+|..  +++.||+|.++..  ...+.+.+|+.++++++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            5689999999999999999975  7889999998532  234678899999999999999999998532      23689


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++.....    ..+++.+++.++.|++.|+.|||   +.|++||||||+||+++.++.++|+|||.+.
T Consensus        76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence            9999999999999976532    25788899999999999999999   8899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .......           ....+..|+|||.+.+..++.++|+||+||++|+|++ |+.||...
T Consensus       149 ~~~~~~~-----------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         149 VGSMGVD-----------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             eccccCC-----------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            5432111           1124567999999988899999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=1.4e-29  Score=265.51  Aligned_cols=201  Identities=29%  Similarity=0.539  Sum_probs=168.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+|++.+.||+|+||.||+|.+. +++.+|+|.++.. ......+.+|++++++++||+++++++++     ......++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence            46888999999999999999885 5778999988633 23346788999999999999999999984     44556799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++++|.+++.....     .+++..++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+.
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCccee
Confidence            9999999999999875432     5788899999999999999999   7899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ........       ......++..|+|||...+..++.++||||+|+++|||++ |+.||...
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  205 (256)
T cd05112         149 FVLDDQYT-------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR  205 (256)
T ss_pred             ecccCccc-------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            55322111       0112235678999999988889999999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=261.20  Aligned_cols=200  Identities=27%  Similarity=0.387  Sum_probs=168.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC--CCC----ccceeeeeccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR--HRN----LIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~n----iv~~~~~~~~~~~~  711 (884)
                      ..+|.+.+.+|+|+||.|.++.+..++..||||+++.- ....+.-.-|+++++++.  .|+    +|.+.++     |+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            67899999999999999999999999999999999632 234456677999999993  232    4555555     56


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-------
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-------  784 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-------  784 (884)
                      -.++.++|+|.+ |-++.+++..+...    +++..++..|+.|++++++|||   +.+++|.|+||+|||+.       
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEE
Confidence            678899999999 77999999987643    8999999999999999999999   88999999999999982       


Q ss_pred             -------------CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHH
Q 002760          785 -------------QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL  851 (884)
Q Consensus       785 -------------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~l  851 (884)
                                   .+..|+++|||.|++-....           ...+.|-.|+|||++.+-.++.++||||+||||+|+
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                         14578999999998655433           123468899999999999999999999999999999


Q ss_pred             hcCCCCCCccc
Q 002760          852 FTRKRPTDAMF  862 (884)
Q Consensus       852 ltg~~p~~~~~  862 (884)
                      .||...|..-.
T Consensus       303 ytG~~LFqtHe  313 (415)
T KOG0671|consen  303 YTGETLFQTHE  313 (415)
T ss_pred             eccceecccCC
Confidence            99999998754

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=1.9e-29  Score=267.61  Aligned_cols=207  Identities=25%  Similarity=0.374  Sum_probs=170.2

Q ss_pred             cCCCccCeeeeccceEEEEEEECCC-----CcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGEN-----GTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ++|++.+.||+|+||.||+|+.+.+     .+.||+|.+...... ..+++.+|++++++++||||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            5788999999999999999997543     467999988643333 456789999999999999999999985     34


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCc---ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQL---EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                      ....++||||+++|+|.++++......   ....+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence            456799999999999999998654211   1225899999999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDA  860 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~  860 (884)
                      +++|||++.........       ......+++.|+|||.+.+..++.++||||+|+++|++++ |..||..
T Consensus       157 ~l~~~~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         157 KVSLLSLSKDVYNSEYY-------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             EEcccccccccCccccc-------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99999998754322111       1112346788999999888889999999999999999998 7889865

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=4e-29  Score=267.23  Aligned_cols=200  Identities=24%  Similarity=0.361  Sum_probs=167.3

Q ss_pred             CCCccCeeeeccceEEEEEEEC---CCCcEEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLKQ----KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  711 (884)
                      +|++.+.||+|+||.||+|+..   .+|+.||+|+++...    ....+.+.+|+++++++ +||+|+++.+.     ++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----ee
Confidence            4788999999999999999874   478999999986422    23346778899999999 59999999887     44


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      .+...++||||+++++|.+++....      .+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEE
Confidence            5567899999999999999997653      5778889999999999999999   889999999999999999999999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCC--CCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR--EASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +|||++..........       .....|+..|+|||...+.  .++.++||||+|+++|+|++|+.||..
T Consensus       147 ~dfg~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         147 TDFGLSKEFHEDEVER-------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             eeCccceecccccccc-------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            9999997654322111       1124588999999998753  467899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=2.8e-29  Score=263.64  Aligned_cols=201  Identities=34%  Similarity=0.571  Sum_probs=170.3

Q ss_pred             CCccCeeeeccceEEEEEEECCCC----cEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENG----TEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +++.+.||+|+||.||+|++..++    ..||+|+++..... ..+.+..|+++++.++||||+++++++     ...+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence            467799999999999999998766    88999999654332 457889999999999999999999985     34467


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .+++|||+++++|.+++......    .+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++|+|||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccC
Confidence            89999999999999999865421    2899999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~  860 (884)
                      .+............       ...+++.|+|||...+..++.++||||+|+++|+|++ |..||..
T Consensus       149 ~~~~~~~~~~~~~~-------~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      149 LSRDLYDDDYYKKK-------GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             Cceecccccccccc-------cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            99866543211100       1226789999999988889999999999999999998 7888875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.3e-29  Score=270.65  Aligned_cols=197  Identities=27%  Similarity=0.433  Sum_probs=168.9

Q ss_pred             CccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          642 SSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       642 ~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      ....+||+|+||.||+|....+++.||||++........+.+.+|+.+++.++|||++++++++     ..++..++|||
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   97 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVME   97 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEe
Confidence            3447899999999999999999999999998654444556788999999999999999999984     45677899999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++++|.+++...       .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.++|+|||.+....
T Consensus        98 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657          98 FLEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             cCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            99999999987543       4678889999999999999999   7899999999999999999999999999987554


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .....        .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.
T Consensus       168 ~~~~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         168 KEVPR--------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             ccccc--------ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            32111        11235889999999998888999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=1.8e-29  Score=269.13  Aligned_cols=203  Identities=26%  Similarity=0.417  Sum_probs=169.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +|++.++||+|++|.||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++     ...+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence            58899999999999999999998999999999875432 3345677899999999999999999985     44567799


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++ ++|.+++.....   ...+++.++..++.|++.|++|||   +.+++||||||+||++++++.++++|||.+.
T Consensus        76 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMD-KDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCC-ccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            999997 489998876442   125899999999999999999999   7899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .......        ......+++.|+|||.+.+ ..++.++||||+||++|++++|+.||.+..
T Consensus       149 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         149 AFGIPVN--------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             hhcCCcc--------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5533211        0112347889999998765 457889999999999999999999997653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-29  Score=262.91  Aligned_cols=197  Identities=32%  Similarity=0.477  Sum_probs=164.3

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ++||+|+||.||+|.+.. ++.||+|.++..... ..+.+.+|++++++++||||+++++++     ......++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            479999999999999976 999999998654333 456789999999999999999999985     4456779999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++.....     .+++..+..++.+++.|++|||   +++++||||||+||+++.++.++|+|||.+......
T Consensus        75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999999976432     5788899999999999999999   889999999999999999999999999998755321


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      ....      ......++..|+|||.+.+..++.++|+|||||++|||+| |..||...
T Consensus       147 ~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         147 IYTV------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             ccee------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence            1100      0011224567999999988899999999999999999999 88888653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=1.4e-29  Score=270.15  Aligned_cols=203  Identities=28%  Similarity=0.450  Sum_probs=175.4

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..+.|+..+.||+|+||.||+|.+..+++.||+|+++.... ..+.+.+|++++++++|||++++++.+     ......
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-----LVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCEE
Confidence            45678999999999999999999988899999999975433 456788999999999999999999984     445778


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|+||+++++|.+++....     ..+++.++..++.|++.|++|||   ..|++|+|++|+||+++.++.++|+|||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999999998754     26889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........        .....|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...
T Consensus       163 ~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         163 AAQLTKEKSK--------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             hhhhccchhh--------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            8755432111        11234788999999998888999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3.1e-29  Score=271.06  Aligned_cols=212  Identities=23%  Similarity=0.380  Sum_probs=171.7

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCc---c
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDF---K  711 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  711 (884)
                      ..++|++.++||+|+||.||+|.+..+++.||||.+....  ......+.+|++++++++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999999999999999886432  2233456789999999999999999998754332   1


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      .....++||||+. +++.+++.....     .+++.+++.++.|++.|++|||   +++++|+||||+||+++.++.+||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEE
Confidence            2345699999995 588888765432     5789999999999999999999   789999999999999999999999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|||.+..........    ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||.+.
T Consensus       161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             CcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999998664432211    0111234578899999987664 4788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=278.49  Aligned_cols=210  Identities=24%  Similarity=0.340  Sum_probs=182.8

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCc
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ..++.|++.+.||+|.+|.||+++.+++++.+|+|++..... ..+++..|.++++.. .|||++.++|++...+.-.++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            346779999999999999999999999999999999875433 346777888888887 799999999999877777889


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      .+|+|||||.+|+..|+++...    ...+.|..+..|++.+++|+.+||   ...++|||||-.|||++.++.||++||
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence            9999999999999999998776    337899999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-----CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.+..++..        +.....+.|||.|||||++.-     ..|+.++|+||||++..||..|.+|+-.+
T Consensus       168 GvSaQldsT--------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  168 GVSAQLDST--------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             eeeeeeecc--------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence            998765432        233345679999999999764     35788999999999999999999997653

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=1.4e-29  Score=267.08  Aligned_cols=201  Identities=27%  Similarity=0.395  Sum_probs=167.9

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||.||+|++..+|+.||+|++.....   ...+.+.+|++++++++||||+++++.     +..+...++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence            6899999999999998899999999864432   345678899999999999999999887     45567789999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++.+.+      .+++..+..++.|++.|++|||   +++++||||+|+||++++++.++|+|||++......
T Consensus        76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999998654      5788999999999999999999   889999999999999999999999999998754332


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ................++..|+|||...+..++.++||||+|+++|++++|+.||...
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            1110000011122345788999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=2e-29  Score=275.31  Aligned_cols=206  Identities=29%  Similarity=0.388  Sum_probs=171.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||+||+|++..+++.||||.++..  ......++.+|+.+++.++||||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999999999999998632  2333456778999999999999999999865433333356


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+. ++|.+++...+      .+++..+..++.|++.|+.|||   +++++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence            799999995 78999887543      6889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++........        ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       154 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         154 LARTTSEKGD--------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             cccccCCCcc--------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            9976543211        1112357889999998765 46889999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=3.8e-29  Score=269.60  Aligned_cols=197  Identities=28%  Similarity=0.384  Sum_probs=166.4

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ..|+..+.||+|+||+||+|.+..+++.||+|++.....   ...+++.+|+++++.++||||+++.+++.     ....
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence            468999999999999999999988999999999864322   22356889999999999999999999963     4556


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+. |++.+++.....     .+++.++..++.|++.|+.|||   +.+|+||||+|+||+++.++.++|+|||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecC
Confidence            799999996 678777764332     5789999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++.......            ...|++.|+|||++.   ...++.++||||||+++|||+||+.||...
T Consensus       161 ~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~  217 (307)
T cd06607         161 SASLVSPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (307)
T ss_pred             cceecCCCC------------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence            987543221            234788999999874   356889999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=1.4e-29  Score=267.70  Aligned_cols=203  Identities=29%  Similarity=0.444  Sum_probs=164.4

Q ss_pred             CeeeeccceEEEEEEECCCC------cEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          645 NKIGEGGSGIVYKGFLGENG------TEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +.||+|+||.||+|++....      +.||+|.+.... ......+.+|+.++++++||||+++++++     ......+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence            46999999999999876433      679999875332 23456788999999999999999999985     3455679


Q ss_pred             EEEEccCCCCHHHHhhccCCCc-ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-----ceEE
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-----VSHV  791 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-----~~kl  791 (884)
                      +||||+++++|.+++....... ....+++.+++.++.|++.|++|||   +.+++|+||||+||+++.++     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997643221 2235788999999999999999999   88999999999999999877     8999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      +|||++..........      ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       153 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         153 GDFGLARDIYKSDYYR------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             CCcccccccccccccc------cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            9999997554322111      0112235788999999999999999999999999999998 99998653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=5e-29  Score=263.05  Aligned_cols=201  Identities=21%  Similarity=0.351  Sum_probs=156.2

Q ss_pred             CeeeeccceEEEEEEECCCC--cEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENG--TEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      ++||+|+||.||+|+....+  ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            36999999999999754322  346667665332 234568899999999999999999999854     4456799999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      |+++|+|.++++.....  ....++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccC
Confidence            99999999999865322  124667778899999999999999   7899999999999999999999999999986432


Q ss_pred             cCCCCcccccceeeeccccccceeCccccCC-------CCCCcccceeehhHHHHHHhc-CCCCCCcc
Q 002760          802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMG-------REASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~~llt-g~~p~~~~  861 (884)
                      .....      .......|+..|+|||+...       ..++.++|||||||++|||++ |..||...
T Consensus       151 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         151 KEDYI------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             cchhh------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            11100      01123457899999998743       345789999999999999997 56788653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=5e-30  Score=291.03  Aligned_cols=210  Identities=26%  Similarity=0.380  Sum_probs=162.9

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCccceeeeeccC------
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGR------  708 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  708 (884)
                      +...+|+..+.||+||||.||+++.+-+|++||||+|.... ......+.+|+..+++++|||||+++......      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888899999999999999999999999999997553 33346788999999999999999875421000      


Q ss_pred             ------------------------------------------------C-------------------------------
Q 002760          709 ------------------------------------------------D-------------------------------  709 (884)
Q Consensus       709 ------------------------------------------------~-------------------------------  709 (884)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ccC-----------------------------CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHH
Q 002760          710 FKG-----------------------------ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI  760 (884)
Q Consensus       710 ~~~-----------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al  760 (884)
                      .++                             ....||-||||+...+++++++....     -.....++++++|+.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence            000                             02467889999988888888776421     13567789999999999


Q ss_pred             HHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccc----cCCC------CcccccceeeeccccccceeCcccc
Q 002760          761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS----NHNP------DTIVETRSISIGIKGTVGYVAPEYG  830 (884)
Q Consensus       761 ~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~----~~~~------~~~~~~~~~~~~~~gt~~y~aPE~~  830 (884)
                      .|+|   ++|||||||||.||+++++..|||+|||+|....    ....      ...-......+..+||.-|+|||++
T Consensus       711 aYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            9999   8899999999999999999999999999998721    1000      0000111134567899999999998


Q ss_pred             CCCC---CCcccceeehhHHHHHHhc
Q 002760          831 MGRE---ASMKGDVYSFGILLLELFT  853 (884)
Q Consensus       831 ~~~~---~~~~~DvwSlG~il~~llt  853 (884)
                      .+..   |+.|+|+||+|+|++||+.
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc
Confidence            8754   9999999999999999985

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=3.5e-29  Score=268.29  Aligned_cols=202  Identities=27%  Similarity=0.417  Sum_probs=166.5

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|++|+||+|.+..+|+.||+|.+....  ....+.+.+|++++++++||||+++++++     ..+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            46899999999999999999999899999999886432  23346788999999999999999999984     456688


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEeccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFg  795 (884)
                      ++||||++ +++.+++.....    ...++..+..++.|++.|++|||   +++++||||+|+||+++. ++.+||+|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999995 588888765432    14578888899999999999999   889999999999999985 5679999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ++........        ......|++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        149 LARAFGIPVR--------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cccccCCCcc--------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9975432211        0112347889999998766 45789999999999999999999999754

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=3.8e-29  Score=266.51  Aligned_cols=200  Identities=28%  Similarity=0.432  Sum_probs=168.3

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++.+.||.|++|.||+|.+..+|+.||+|++....  ....+.+.+|++++++++|||++++++++     .+++..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            678899999999999999999899999999987443  23346788999999999999999999985     45578899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++ ++|.+++.....    ..+++.+++.++.|++.|++|||   +++++||||+|+||+++.++.++|+|||.+.
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999994 699999876542    25889999999999999999999   7899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        .....+++.|+|||++.+. .++.++|+||+|+++|+|++|+.||...
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         148 AFGVPVRT--------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             ccCCCccc--------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            54322111        1122468899999987664 5788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=8.5e-30  Score=290.78  Aligned_cols=205  Identities=20%  Similarity=0.281  Sum_probs=158.3

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCc-EEEEEEe--------------ec---ccccchHHHHHHHHHHHcCCCCCc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGT-EVAVKVI--------------NL---KQKGASKSFVAECKALRNIRHRNL  698 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~-~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ni  698 (884)
                      ..++|++.++||+|+||+||+|..+.... .+++|.+              ..   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999987654322 2222211              00   111234567899999999999999


Q ss_pred             cceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 002760          699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       699 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp  778 (884)
                      +++++++     ...+..++|+|++ ++++.+++........ ......++..++.|++.||+|||   +++||||||||
T Consensus       226 v~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP  295 (501)
T PHA03210        226 LKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKL  295 (501)
T ss_pred             CcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            9999994     4556679999999 5688888765432111 12345667789999999999999   88999999999


Q ss_pred             CCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCC
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       779 ~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~  858 (884)
                      +|||++.++.+||+|||+|+.+......       ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCccccc-------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999866432211       112356999999999999999999999999999999999987643

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.6e-29  Score=260.16  Aligned_cols=200  Identities=33%  Similarity=0.499  Sum_probs=174.5

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            47889999999999999999988999999999975433  3456789999999999999999999984     3456789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++....      .+++..+..++.|++.|+.|||   +.|++||||+|+||+++.++.++|+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccc
Confidence            9999999999999987653      6889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........        .....|+..|+|||...+..++.++||||+|+++|+|++|+.||...
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         147 TKLNDVSKD--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             eecCCCccc--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence            876543321        11235789999999988888899999999999999999999999753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=9.8e-29  Score=258.49  Aligned_cols=200  Identities=35%  Similarity=0.508  Sum_probs=175.0

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      +|+..+.||+|++|.||+|.+..+++.||+|++........+.+.+|++++++++||+++++++++     ..+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence            478889999999999999999888999999999755444567899999999999999999999984     445678999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      +||+++++|.+++....     ..+++..+..++.|++.|+.|||   +++++||||+|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            99999999999987653     26889999999999999999999   88999999999999999999999999999876


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ......         .....|+..|+|||...+..++.++|+||+|+++|+|++|+.||...
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            654321         11235889999999998888999999999999999999999999764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=269.32  Aligned_cols=198  Identities=26%  Similarity=0.395  Sum_probs=170.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--------cchHHHHHHHHHHHcCC---CCCccceeeeecc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--------GASKSFVAECKALRNIR---HRNLIKIITVCSG  707 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  707 (884)
                      .+|...+++|+|+||.|+.|.++.+..+|+||.+.+..-        ...-.+-.|+.+|..++   |+||++++++   
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf---  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF---  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe---
Confidence            469999999999999999999999999999999863311        11123557999999997   9999999999   


Q ss_pred             CCccCCccceEEEEccC-CCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          708 RDFKGADFKAIVYEFMQ-NGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                        |++++++|++||... |-+|.+||....      .+++.++..|++|++.|+++||   ++||||||||-+|+.++.+
T Consensus       638 --FEddd~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  638 --FEDDDYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             --eecCCeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecC
Confidence              788899999999873 458999998765      6889999999999999999999   8899999999999999999


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCC-CcccceeehhHHHHHHhcCCCCCCc
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |-+||+|||.|.......          ...++||..|+|||++.|.+| +..-|||++|+++|-+.....||..
T Consensus       707 g~~klidfgsaa~~ksgp----------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSGP----------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CeEEEeeccchhhhcCCC----------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999997654322          224679999999999999887 5668999999999999999999863

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=3.1e-29  Score=263.11  Aligned_cols=202  Identities=25%  Similarity=0.402  Sum_probs=171.8

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|....+|..||+|.+....  ....+.+.+|++++++++||||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            5788999999999999999999999999999986432  23345778999999999999999999984     4566789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-ceEEecccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFg~  796 (884)
                      +|+||+++++|.+++......    .+++..+..++.|++.|+.|||   +.+++|+||||+||++++++ .++++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence            999999999999999764322    5789999999999999999999   78999999999999999876 569999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.........        .....|++.|+|||...+..++.++|+||+|+++|+|++|+.||...
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         149 ARQLNDSMEL--------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             chhccCCccc--------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            8765432211        11234889999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.9e-29  Score=262.05  Aligned_cols=191  Identities=25%  Similarity=0.346  Sum_probs=160.1

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHH-HcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKAL-RNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|+||.||+|.+..+|+.||||+++....   .....+..|..++ ...+|||++++++++     ..++..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            579999999999999998999999999864321   1123344555444 445899999999984     4556789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||.+...
T Consensus        77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999997654      5788899999999999999999   789999999999999999999999999998754


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ...            ....|++.|+|||...+..++.++||||+|+++|+|++|..||...
T Consensus       148 ~~~------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         148 LEN------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             ccc------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            321            1234788999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=3.6e-29  Score=273.49  Aligned_cols=208  Identities=26%  Similarity=0.404  Sum_probs=170.7

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++++ +||||+++++++..   ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            456899999999999999999999888999999988532  223345677899999999 99999999998642   234


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||++ ++|.+++...       .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence            46799999996 5999988653       4678888899999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+..........   .........|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.
T Consensus       151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            99998664332110   0112223568999999998765 56788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6.6e-29  Score=271.81  Aligned_cols=209  Identities=23%  Similarity=0.365  Sum_probs=172.9

Q ss_pred             HHHHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccC
Q 002760          631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGR  708 (884)
Q Consensus       631 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  708 (884)
                      ..++....++|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+.++++++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3455667789999999999999999999998899999999986422  22345678899999999999999999986432


Q ss_pred             C-ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC
Q 002760          709 D-FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       709 ~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~  787 (884)
                      . +......+++++++ +++|.++++..       .+++..++.++.|++.|++|||   +++|+||||||+||++++++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCC
Confidence            2 22334567888887 78998887643       4788899999999999999999   88999999999999999999


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .+||+|||++......           .....|++.|+|||...+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       158 ~~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         158 ELKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             CEEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998754321           112357899999998766 56888999999999999999999999653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=3.4e-29  Score=266.56  Aligned_cols=209  Identities=29%  Similarity=0.456  Sum_probs=176.3

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  714 (884)
                      ++|++.+.||+|+||.||+|....+++.||+|++...   .....+.+.+|++++++++ ||||++++++     +..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence            3688999999999999999999999999999998642   2233466888999999998 9999999988     45667


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++...+      .+++.+++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++++||
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCC
Confidence            8899999999999999998654      6899999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCccc------------ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIV------------ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.+............            ..........|+..|+|||+..+..++.++|+||+|+++|++++|+.||...
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            999866543321100            0011223445889999999988888999999999999999999999999764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=4.9e-29  Score=269.69  Aligned_cols=215  Identities=27%  Similarity=0.399  Sum_probs=171.3

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCc---cC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDF---KG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  712 (884)
                      .++|++.++||+|+||.||+|.+..+++.||||++.....  .....+.+|++++++++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999999999999998864322  223467789999999999999999987543221   23


Q ss_pred             CccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~  792 (884)
                      ....++||||+. +++.+.+.....     .+++.++..++.|++.|++|||   ++||+||||||+||++++++.++|+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence            446799999995 477777765322     6889999999999999999999   8899999999999999999999999


Q ss_pred             ccccccccccCCCCcccc---cceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          793 DFGLAKFLSNHNPDTIVE---TRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |||++.............   .........|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            999997654332211100   1111233457889999998765 45889999999999999999999999753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=9.4e-29  Score=267.59  Aligned_cols=196  Identities=29%  Similarity=0.385  Sum_probs=165.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++|||++++++++     ..+...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence            37788999999999999999988999999999863322   2335688899999999999999999985     345567


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+. |++.+++.....     .+++.++..++.|++.|+.|||   +++|+||||+|+||+++.++.++|+|||+
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCC
Confidence            99999996 588887764432     5889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.......            ...|++.|+|||.+.   ...++.++||||+||++|||++|+.||...
T Consensus       172 ~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         172 ASIASPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             ccccCCcc------------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            86543211            234888999999874   456889999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=4e-29  Score=273.35  Aligned_cols=208  Identities=25%  Similarity=0.391  Sum_probs=169.6

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCC--------
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRD--------  709 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  709 (884)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999999999999987665555677889999999999999999998754321        


Q ss_pred             -ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-CCC
Q 002760          710 -FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDL  787 (884)
Q Consensus       710 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-~~~  787 (884)
                       .......++||||++ ++|.+++...       .+++..++.++.|++.|+.|||   +.||+||||||+||+++ +++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence             112245789999996 5898887542       5788899999999999999999   78999999999999997 566


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .++++|||.++.........     .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHK-----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             eEEECCcccceecCCccccc-----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            88999999997653321111     01112347889999997654 56888999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=5.1e-29  Score=271.73  Aligned_cols=207  Identities=26%  Similarity=0.370  Sum_probs=173.9

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999998889999999986432  34457889999999999999999999986543322334779


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||++ ++|.+++....      .+++..++.++.|++.|++|||   ++||+||||||+||+++.++.++|+|||.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999996 58998887543      6889999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..........     .......|++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.
T Consensus       151 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         151 RGVDPDEDEK-----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             Eeeccccccc-----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            8765432110     011223578899999999887 8899999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.8e-28  Score=257.42  Aligned_cols=204  Identities=28%  Similarity=0.451  Sum_probs=175.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|++++++++|||++++.+.+     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            58889999999999999999988899999999975433  4556788999999999999999999984     3447789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||+++++|.+++.....  ....+++.++..++.+++.|+.|||   +.|++|+||+|+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccce
Confidence            99999999999999987531  1136899999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        ......|++.|+|||...+..++.++|+||+|+++|+|++|+.||+..
T Consensus       151 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         151 KVLSSTVD--------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             eecccCcc--------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence            76544321        112235889999999998888999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.5e-29  Score=271.14  Aligned_cols=207  Identities=24%  Similarity=0.363  Sum_probs=171.3

Q ss_pred             HHHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCC-
Q 002760          633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRD-  709 (884)
Q Consensus       633 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  709 (884)
                      .+....++|++.+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++.... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            33445778999999999999999999999999999999985322  223456889999999999999999999864321 


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                      .......++||||+ +++|.+++...       .+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            11223468999999 77999888642       5788999999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +++|||++.......           ....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||...
T Consensus       158 kl~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         158 KILDFGLARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             EEeecccccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999987543211           12347889999998876 45888999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1.1e-28  Score=265.68  Aligned_cols=209  Identities=29%  Similarity=0.423  Sum_probs=171.1

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCC----
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRD----  709 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  709 (884)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|+++...  ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999999899999999987432  233456788999999999999999999864332    


Q ss_pred             -ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCc
Q 002760          710 -FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV  788 (884)
Q Consensus       710 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~  788 (884)
                       ..+....++|+||+++ ++.+++....     ..+++.+++.++.|++.|++|||   +.+|+||||||+||++++++.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence             1233478999999975 7777776542     15889999999999999999999   889999999999999999999


Q ss_pred             eEEeccccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       789 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +||+|||.+.........       ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||..
T Consensus       155 ~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         155 IKLADFGLARLYNSEESR-------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             EEeCcccccccccCCccc-------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999866443211       0112235788999998765 4578899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=1.2e-28  Score=260.47  Aligned_cols=203  Identities=27%  Similarity=0.436  Sum_probs=167.8

Q ss_pred             CCCccCeeeeccceEEEEEEECC-CCcEEEEEEeeccc----------ccchHHHHHHHHHHHc-CCCCCccceeeeecc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGE-NGTEVAVKVINLKQ----------KGASKSFVAECKALRN-IRHRNLIKIITVCSG  707 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  707 (884)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            47889999999999999999977 67889999885321          1123456778888865 7999999999985  


Q ss_pred             CCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC
Q 002760          708 RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~  787 (884)
                         ..++..++||||+++++|.+++......  ...+++.+++.++.|++.|+.|||+  ..+++||||+|+||+++.++
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCC
Confidence               4566789999999999999988643211  2268889999999999999999993  26899999999999999999


Q ss_pred             ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       788 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .++|+|||.+.......         ......|+..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus       152 ~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         152 KVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            99999999997654322         11234588999999999988899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.1e-28  Score=262.84  Aligned_cols=199  Identities=24%  Similarity=0.330  Sum_probs=163.6

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++.++||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |||++++++++...   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999899999999986432 222234457888898885 99999999986422   2267899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++ |++.+++.....     .+++.+++.++.|++.|++|||   +.+++||||||+||+++. +.+||+|||.+.
T Consensus        78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999996 588888875432     5889999999999999999999   889999999999999999 999999999998


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccC-CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........         ....+++.|+|||... +..++.++||||+||++|||++|+.||.+.
T Consensus       148 ~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         148 GIYSKPPY---------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             ccccCCCc---------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            65432211         1234788999999764 456788999999999999999999999764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.3e-31  Score=249.91  Aligned_cols=204  Identities=25%  Similarity=0.361  Sum_probs=166.9

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .+..+.||.|+||.||.+.+..+|+.||.|.+...  .-...+++.+|+.++...+|.||...+++.......--...|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568999999999999999999999999988532  2245688999999999999999999988754332222345688


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ++|.| ..+|.+.|-...      .++...+.-+..||++|+.|||   ..+|.||||||.|.|++.+...||||||+|+
T Consensus       135 ~TELm-QSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHH-HhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence            99999 458888776543      6777788889999999999999   8899999999999999999999999999998


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      .........+.       ..+-|-+|+|||++.+ +.|+.+.||||.|||+.|++.++..|.+.
T Consensus       205 vee~d~~~hMT-------qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  205 TWDQRDRLNMT-------HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             ccchhhhhhhH-------HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            65543322211       1235789999999888 57999999999999999999999999774

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=262.77  Aligned_cols=205  Identities=27%  Similarity=0.418  Sum_probs=169.1

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCccceeeeeccCCccCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNI---RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      |++.+.||+|+||.||+|+++.+++.||+|+++....  .....+.+|+.+++++   +|||++++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999988899999999974322  2234566788777666   5999999999976544333445


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .+++|||+. ++|.+++.....    ..+++.+++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccC
Confidence            899999996 589998876432    15889999999999999999999   7899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .+.........         ....+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+..
T Consensus       153 ~~~~~~~~~~~---------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         153 LARIYSFEMAL---------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             cceeccCCccc---------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            98765432211         12347889999999999899999999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=8.5e-29  Score=264.47  Aligned_cols=202  Identities=29%  Similarity=0.441  Sum_probs=169.5

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++.++||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++|||++++++++...   ..+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            678899999999999999999889999999997552  34456788999999999999999999986422   1367899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++ ++|.+++....     ..+++.+++.++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.
T Consensus        78 v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eecccc-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence            999996 48998887543     26889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~  205 (287)
T cd07840         149 PYTKRNSA-------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS  205 (287)
T ss_pred             eccCCCcc-------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            66543211       1112346788999997765 45789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=4.7e-29  Score=266.46  Aligned_cols=204  Identities=26%  Similarity=0.329  Sum_probs=163.7

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++     ..+...
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcE
Confidence            35667789999999999999999999999999986432 234457889999999996 99999999985     345667


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      +++|||+. +++.++...... .....+++..+..++.|++.|++|||+  ..+++||||||+||+++.++.++|+|||+
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecch
Confidence            89999985 466554332100 011268899999999999999999993  35999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCC---CCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR---EASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ++........         ....|++.|+|||++.+.   .++.++||||+||++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         155 SGQLVDSIAK---------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             hHHhccCCcc---------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            9765432211         122478899999998776   689999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=7.5e-29  Score=269.76  Aligned_cols=205  Identities=24%  Similarity=0.309  Sum_probs=163.2

Q ss_pred             Ceeeec--cceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          645 NKIGEG--GSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G--~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.||+|  +||+||+|++..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++     ..++..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            456666  99999999999999999999986432  22346788999999999999999999995     4566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+.++++.+++......    .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++||+.+...
T Consensus        79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999999998875432    5788999999999999999999   889999999999999999999999999865433


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCCC--CCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR--EASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ........... .......++..|+|||++.+.  .++.++||||+||++|+|++|+.||....
T Consensus       152 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         152 VRNGQKAKVVY-DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             hccCccccccc-cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence            22111110000 000112356779999998763  47899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=6.6e-29  Score=260.50  Aligned_cols=202  Identities=29%  Similarity=0.401  Sum_probs=173.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|++.++||+|+||.||+|.+..+++.+|+|.+....  .....++.+|++++++++||||+++.+++     .+....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            4788999999999999999999999999999987432  23345678899999999999999999884     4557889


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+++++|.+++.....  ....+++..++.++.|++.|++|||   +.|++||||+|+||+++.++.+|++|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccch
Confidence            99999999999999876321  1236888999999999999999999   889999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........          ....|++.|+|||...+..++.++|+||+|+++|++++|+.||...
T Consensus       151 ~~~~~~~~----------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         151 KVLKKNMA----------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             hhhccCCc----------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            76644311          1124788999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=1.1e-28  Score=268.89  Aligned_cols=207  Identities=25%  Similarity=0.343  Sum_probs=168.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCC--CcEEEEEEeecc--cccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGEN--GTEVAVKVINLK--QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|++.+.||+|+||.||+|++..+  ++.||+|++...  .....+.+.+|+++++++ .||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            478889999999999999999877  889999998632  222346678899999999 599999999875321 12334


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++++||+. ++|.+++....      .+++.+++.++.|++.||+|||   ++||+||||||+||+++.++.++|+||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence            5788999985 69999887543      5889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |.+..........    ........||+.|+|||...+ ..++.++|+||+||++|++++|+.||...
T Consensus       150 g~a~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         150 GLARGFSENPGEN----AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             CCceecccccccc----cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            9998654322111    111223568999999998765 56899999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=2e-28  Score=257.34  Aligned_cols=205  Identities=26%  Similarity=0.410  Sum_probs=175.5

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      +|+..+.||+|++|.||+|.+..+++.|++|++.....  ...+.+.+|++++++++||||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47888999999999999999988999999999875432  34578899999999999999999999853221   26789


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +|+||+++++|.+++....      .+++.+++.++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999999998654      6889999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ..........      ......++..|+|||...+..++.++||||+|+++|++++|+.||....
T Consensus       149 ~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         149 KRLGDIETGE------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             Eecccccccc------cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8765443210      0112347889999999988889999999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=1.3e-28  Score=268.90  Aligned_cols=209  Identities=24%  Similarity=0.377  Sum_probs=167.4

Q ss_pred             hcCCC-ccCeeeeccceEEEEEEECCCCcEEEEEEeecccccc--------------hHHHHHHHHHHHcCCCCCcccee
Q 002760          638 TDNFS-SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--------------SKSFVAECKALRNIRHRNLIKII  702 (884)
Q Consensus       638 ~~~y~-~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  702 (884)
                      .++|. +.+.||+|+||+||+|.+..+++.||||+++......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 4577999999999999999899999999986332111              12577899999999999999999


Q ss_pred             eeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 002760          703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       703 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiL  782 (884)
                      +++     ......++||||++ |+|.+++....      .+++..+..++.|++.|++|||   +.||+||||+|+||+
T Consensus        87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nil  151 (335)
T PTZ00024         87 DVY-----VEGDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIF  151 (335)
T ss_pred             EEE-----ecCCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeE
Confidence            985     45567899999996 69999987543      5788899999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccccccccccCCCCc------ccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCC
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDT------IVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRK  855 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~~~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~  855 (884)
                      ++.++.++|+|||.+..........      ............+++.|+|||.+.+. .++.++||||+||++|+|++|+
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999997654211100      00011112233478899999988764 4689999999999999999999


Q ss_pred             CCCCcc
Q 002760          856 RPTDAM  861 (884)
Q Consensus       856 ~p~~~~  861 (884)
                      .||.+.
T Consensus       232 ~p~~~~  237 (335)
T PTZ00024        232 PLFPGE  237 (335)
T ss_pred             CCCCCC
Confidence            999764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.7e-28  Score=266.38  Aligned_cols=200  Identities=25%  Similarity=0.362  Sum_probs=168.3

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|++++++++||||+++.+++.    ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~   82 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SPL   82 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cCC
Confidence            3567899999999999999999999999999999987532  2234467889999999999999999999852    234


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++||||+ +++|.++++..       .+++..+..++.|++.|+.|||   +++|+||||+|+||+++.++.++|+|
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCc
Confidence            5678999999 67899888643       4677788889999999999999   88999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+.......           ....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus       152 fg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         152 FGLARIQDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cccccccCCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987442211           12347889999998765 57899999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=3.7e-28  Score=262.33  Aligned_cols=194  Identities=28%  Similarity=0.374  Sum_probs=164.0

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      |...++||+|+||+||+|++..+++.||+|++.....   ...+.+.+|++++++++|||++++++++     .+....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence            6777889999999999999988999999999864322   2335678899999999999999999985     3456779


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||+. |++.+++.....     .+++.+++.++.|++.|+.|||   ++|++||||+|+||+++.++.++|+|||.+
T Consensus        98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999995 588888765432     5789999999999999999999   889999999999999999999999999988


Q ss_pred             cccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ......            ....|+..|+|||.+.   ...++.++||||+||++|+|++|..||..
T Consensus       169 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         169 SKSSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             cccCCC------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            643211            1235889999999874   45688899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=2.1e-28  Score=262.38  Aligned_cols=201  Identities=25%  Similarity=0.374  Sum_probs=164.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCcc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||+||+|.+..+++.||||.++... .....++..|+.++.+.. ||||+++++++     ..+..
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence            357899999999999999999998889999999986432 223455667777776664 99999999985     34567


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .++||||+. +++.+++.....     .+++.++..++.|++.|++|||+  ..+|+||||+|+||+++.++.+||+|||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccc
Confidence            899999984 578877765332     68889999999999999999993  2599999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCC----CCcccceeehhHHHHHHhcCCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE----ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .+.........         ....|++.|+|||.+.+..    ++.++||||||+++|+|++|+.||..
T Consensus       161 ~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         161 ISGRLVDSKAK---------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             cchhccCCCcc---------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            98765432211         1224788999999987654    78899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.8e-28  Score=266.60  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=166.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  714 (884)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||+++...  ......+.+|+.++++++||||+++++++.... .....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999998899999999986432  223456789999999999999999999864322 12234


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++|+||+. .++..+...        .+++..+..++.|++.|++|||   +++++||||||+||+++.++.++|+||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence            5689999995 477766421        4778889999999999999999   789999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+++......           ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       162 g~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         162 GLARHADAEM-----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCCcCCCCCC-----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9987542211           12357889999999876 46889999999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=2.3e-28  Score=287.64  Aligned_cols=148  Identities=28%  Similarity=0.414  Sum_probs=130.8

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.++||+|+||+||+|++..+++.||||+++...   ......+.+|+.+++.++||||+++++++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            467999999999999999999999899999999996432   22346788899999999999999999874     4566


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..|+||||+.+++|.+++...+      .+++..++.++.||+.||+|||   .++||||||||+|||++.++.+||+||
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence            7899999999999999997654      4778888999999999999999   789999999999999999999999999


Q ss_pred             ccccc
Q 002760          795 GLAKF  799 (884)
Q Consensus       795 g~a~~  799 (884)
                      |+++.
T Consensus       149 Gls~~  153 (669)
T cd05610         149 GLSKV  153 (669)
T ss_pred             CCCcc
Confidence            99863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=2.1e-28  Score=261.43  Aligned_cols=200  Identities=24%  Similarity=0.349  Sum_probs=166.8

Q ss_pred             CCCccCeeeeccceEEEEEEEC---CCCcEEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLKQ----KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  711 (884)
                      +|++.+.||+|+||.||+|+..   .+++.||||+++...    ....+.+.+|+++++++ +||+|+++.+.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            4788899999999999999863   467889999986322    22345678899999999 59999999987     45


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEE
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl  791 (884)
                      .+...++||||+++|+|.+++....      .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence            5667899999999999999987543      5788899999999999999999   789999999999999999999999


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCC--CCcccceeehhHHHHHHhcCCCCCCc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE--ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +|||+++........       ......|+..|+|||...+..  ++.++||||+|+++|+|++|..||..
T Consensus       147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         147 TDFGLSKEFLAEEEE-------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             EECcccccccccccc-------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            999998765433211       112345889999999987654  78899999999999999999999953

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8e-29  Score=265.90  Aligned_cols=197  Identities=27%  Similarity=0.335  Sum_probs=166.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+.|.....+|.|+|+.|-.+.+..+++..|||++.....    .-.+|+.++... .||||+++.+.     +.++...
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecce-----ecCCcee
Confidence            4678888889999999999999999999999999975422    233567666555 79999999998     5677788


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee-CCCCceEEeccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl-~~~~~~kl~DFg  795 (884)
                      |+|||.+.|+-+.+.+....      ... .++..|+.+|+.|+.|||   ++||||||+||+|||+ ++.|+++|+|||
T Consensus       392 ~~v~e~l~g~ell~ri~~~~------~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP------EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             eeeehhccccHHHHHHHhcc------hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEec
Confidence            99999999998888777553      222 667789999999999999   8899999999999999 699999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      .++...+.           ....|=|..|.|||+....+|++++|+||||++||+|++|+.||.....+
T Consensus       462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence            99866543           11224588899999999999999999999999999999999999876544

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=2.7e-28  Score=264.09  Aligned_cols=204  Identities=25%  Similarity=0.272  Sum_probs=160.5

Q ss_pred             ccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEE
Q 002760          643 SANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +++.+|.|  |.||.++...+++.||||++...  .....+.+.+|++++++++||||++++++     +......+++|
T Consensus         6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~-----~~~~~~~~~~~   78 (314)
T cd08216           6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVS   78 (314)
T ss_pred             hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhe-----eecCCeEEEEE
Confidence            33444444  45555555668999999998754  23445689999999999999999999998     44566789999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      ||+++|++.+++......    .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+|++|||.+...
T Consensus        79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          79 PLMAYGSCEDLLKTHFPE----GLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             eccCCCCHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            999999999999864322    5788889999999999999999   889999999999999999999999999988755


Q ss_pred             ccCCCCcccccceeeeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ....... ...........++..|+|||++..  ..++.++|+||+||++|||++|+.||...
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         152 IKHGKRQ-RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccc-cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            3221110 000111123457889999999876  35889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=3.1e-28  Score=262.38  Aligned_cols=196  Identities=28%  Similarity=0.397  Sum_probs=164.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .|+..+.||+|+||.||+|++..+++.||+|.+...   .....+++.+|+++++.++|||++++.+++.     .....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCee
Confidence            477789999999999999999989999999988632   2223456788999999999999999999853     45677


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||+. |++.+++.....     .+++.++..++.|++.|+.|||   +++++||||+|+||+++.++.++|+|||+
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccc
Confidence            99999996 688887764332     5788999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccC---CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM---GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +.......            ...|++.|+|||.+.   ...++.++||||+||++|+|++|+.||...
T Consensus       162 ~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         162 ASIMAPAN------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             ceeecCcc------------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence            87553211            234788999999874   356788999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-28  Score=259.52  Aligned_cols=200  Identities=30%  Similarity=0.425  Sum_probs=169.5

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++.+.||+|++|.||+|.+..+++.+|+|+++....  .....+.+|++++++++||+|+++++++     ..+...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            6778999999999999999988999999999864432  3456788899999999999999999984     45577899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+++ ++.+++....     ..+++.+++.++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999965 8888887643     26889999999999999999999   8899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .......        ......++..|+|||...+. .++.++|+||+|+++|+|+||+.||.+..
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         147 SFGSPVR--------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             ecCCCcc--------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            6644320        11123478899999998776 78999999999999999999999996643

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.8e-28  Score=258.71  Aligned_cols=199  Identities=29%  Similarity=0.433  Sum_probs=169.8

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |+..+.||+|+||.||+|+...+++.||+|++....  ....+.+..|+.++++++|||++++.+++     .+.+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            567789999999999999999899999999997542  34456788899999999999999999984     45578899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||++ ++|.+++....     ..+++.++..++.|++.|++|||   +++|+||||+|+||++++++.++|+|||.+.
T Consensus        76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 59999998653     26889999999999999999999   7899999999999999999999999999987


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........        .....++..|+|||.+.+. .++.++||||+||++||+++|+.||...
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         147 AFGIPLRT--------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             ccCCCccc--------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            65432211        1122357789999998776 7899999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=6.6e-28  Score=256.99  Aligned_cols=199  Identities=27%  Similarity=0.393  Sum_probs=166.7

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |++.+.||+|+||+||+|+...+++.||||.+..... .......+|+..+++++ |||++++++++     ..++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            6788999999999999999988899999999864322 22234567899999998 99999999984     44677899


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ||||+ +|++.+++.....    ..+++.++..++.|++.|+.|||   +++++|+||+|+||++++++.++|+|||.+.
T Consensus        76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 8899998876542    26789999999999999999999   7899999999999999999999999999997


Q ss_pred             ccccCCCCcccccceeeeccccccceeCccccC-CCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ........         ....|+..|+|||+.. ...++.++|+||||+++|+|++|+.||...
T Consensus       148 ~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         148 EIRSRPPY---------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             eccCCCCc---------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            65432211         1234788999999875 456789999999999999999999999654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.1e-28  Score=252.16  Aligned_cols=193  Identities=32%  Similarity=0.423  Sum_probs=167.2

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEcc
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFM  723 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  723 (884)
                      ||+|+||.||+|.+..+++.||+|++.....   ...+.+..|++++++++|||++++++.     ++.+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence            6999999999999988899999999864322   244678899999999999999999987     45677889999999


Q ss_pred             CCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccC
Q 002760          724 QNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH  803 (884)
Q Consensus       724 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~  803 (884)
                      ++++|.+++....      .+++..+..++.|++.|+.|+|   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999998654      5788999999999999999999   789999999999999999999999999998765432


Q ss_pred             CCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       804 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ..        ......|+..|+|||...+..++.++|+||||+++|++++|+.||...
T Consensus       147 ~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  196 (250)
T cd05123         147 GS--------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE  196 (250)
T ss_pred             CC--------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            21        112345788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.2e-28  Score=267.62  Aligned_cols=203  Identities=25%  Similarity=0.383  Sum_probs=169.5

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cccchHHHHHHHHHHHcCCCCCccceeeeeccCCc-cCC
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF-KGA  713 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~  713 (884)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            467899999999999999999999989999999988632  22334567789999999999999999887533222 223


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEec
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D  793 (884)
                      ...++|+||+ +++|.+++...       .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.++|+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcc
Confidence            4579999999 67999998752       5888999999999999999999   78999999999999999999999999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      ||.+......           .....++..|+|||...+ ..++.++||||+||++|++++|+.||.+.
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999765322           112347889999998765 46788999999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=5.1e-28  Score=250.08  Aligned_cols=181  Identities=21%  Similarity=0.196  Sum_probs=153.1

Q ss_pred             ccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccCCCCHH
Q 002760          650 GGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLE  729 (884)
Q Consensus       650 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  729 (884)
                      |.||.||+|++..+++.||+|+++...     ....|...+....|||++++++++     .+....++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986432     233455555556799999999984     4567789999999999999


Q ss_pred             HHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCccc
Q 002760          730 EWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV  809 (884)
Q Consensus       730 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~  809 (884)
                      +++....      .+++..+..++.|++.|++|+|   +++|+||||||+||+++.++.++++|||.+.......     
T Consensus        74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----  139 (237)
T cd05576          74 SHISKFL------NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----  139 (237)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence            9987653      4789999999999999999999   8899999999999999999999999999876543321     


Q ss_pred             ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       810 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                            ....++..|+|||...+..++.++|+||+|+++|||++|+.|++.
T Consensus       140 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         140 ------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence                  122357789999999888899999999999999999999988764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=5.6e-28  Score=254.03  Aligned_cols=202  Identities=22%  Similarity=0.316  Sum_probs=166.4

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc-----cccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      +|.+.++||+|+||.||+|.+...+..+++|+.+..     .......+..|+.++++++||||+++++++     .+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            588999999999999999999877777777776531     122334567899999999999999999884     4456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++||||+++++|.+++......  ...+++.+++.++.|++.|+.|||   +.|++|+|+||+||+++. +.++|+||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeeccc
Confidence            689999999999999998753221  226889999999999999999999   889999999999999975 57999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      |.+.........        .....|++.|+|||...+..++.++|+||+|+++|+|++|..||..
T Consensus       150 g~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         150 GVSRLLMGSCDL--------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CceeecCCCccc--------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            998765432211        1123478899999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.8e-28  Score=247.75  Aligned_cols=136  Identities=26%  Similarity=0.437  Sum_probs=118.1

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC-----C---CCccceeeeeccCCc
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-----H---RNLIKIITVCSGRDF  710 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~~~  710 (884)
                      .+|.+.++||=|.|++||+|++....+.||+|+.+. .....+.-..||++|++++     |   ..||++++.+.... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence            679999999999999999999999999999999874 3446677889999999983     3   36899999875443 


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeee
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl  783 (884)
                      ..+.++++|+|++ |-+|..+|......    -++...+..|++|++.||.|||..|  ||||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            4578999999999 77999999887654    6888999999999999999999854  99999999999999

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=274.75  Aligned_cols=208  Identities=30%  Similarity=0.477  Sum_probs=170.4

Q ss_pred             cCCCccCeeeeccceEEEEEEEC---CC----CcEEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCccceeeeeccCC
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLG---EN----GTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRD  709 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~---~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  709 (884)
                      ++..+.+.+|+|+||+|++|...   ..    ...||||..+... ....+.+..|+++|+.+ +||||+.++|.|..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            34466779999999999999743   11    4569999987433 34567899999999999 69999999999864  


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccC---------CCccc-ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSN---------DQLEV-CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPS  779 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~  779 (884)
                         .+..++|+||++.|+|.+|++..+         ..... ..++..+.+.++.|||.||+||+   ++++||||+.++
T Consensus       374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR  447 (609)
T KOG0200|consen  374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR  447 (609)
T ss_pred             ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence               567799999999999999999876         11111 24899999999999999999999   889999999999


Q ss_pred             CeeeCCCCceEEeccccccccccCCCCcccccceeeecccc--ccceeCccccCCCCCCcccceeehhHHHHHHhc-CCC
Q 002760          780 NVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKR  856 (884)
Q Consensus       780 NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~  856 (884)
                      |||++.+..+||+|||+|+...+........       -.|  ...|||||.+....|+.++||||||+++||++| |..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-------~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~  520 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-------SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT  520 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecC-------CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence            9999999999999999999655443332111       112  346999999999999999999999999999998 788


Q ss_pred             CCCcc
Q 002760          857 PTDAM  861 (884)
Q Consensus       857 p~~~~  861 (884)
                      ||.+.
T Consensus       521 PYp~~  525 (609)
T KOG0200|consen  521 PYPGI  525 (609)
T ss_pred             CCCCC
Confidence            99873

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=3e-28  Score=226.99  Aligned_cols=206  Identities=22%  Similarity=0.354  Sum_probs=168.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCcc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ..++|++.+++|+|.|++||.|....+.+.++||+++.   ...+.+.+|+.+++.+. ||||++++++..+.   ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence            35789999999999999999999988999999999963   34467899999999997 99999999985432   2456


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEecc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDF  794 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DF  794 (884)
                      ..+|+||+.+.+....-.         .++...+..++.+++.||.|+|   +.||+|||+||.|++|+. .-..+|+||
T Consensus       110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeec
Confidence            689999998887766543         5677788899999999999999   889999999999999995 568899999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCC-CCCCcccceeehhHHHHHHhcCCCCCCccccCCccHH
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH  869 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~  869 (884)
                      |+|.+.-+....         +-.+.+..|.-||.+-+ ..|+..-|+|||||++..|+..+.||-...+...++.
T Consensus       178 GLAEFYHp~~eY---------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV  244 (338)
T KOG0668|consen  178 GLAEFYHPGKEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  244 (338)
T ss_pred             chHhhcCCCcee---------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence            999987543322         12235778899998776 5689999999999999999999999865544333333

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.6e-27  Score=259.89  Aligned_cols=214  Identities=20%  Similarity=0.278  Sum_probs=155.1

Q ss_pred             HhcCCCccCeeeeccceEEEEEEEC----------------CCCcEEEEEEeecccccchH--------------HHHHH
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLG----------------ENGTEVAVKVINLKQKGASK--------------SFVAE  686 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e  686 (884)
                      ..++|++.++||+|+||+||+|...                ..++.||||.+........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                24567999998643322222              23346


Q ss_pred             HHHHHcCCCCCc-----cceeeeeccCC---ccCCccceEEEEccCCCCHHHHhhccCCCc------------------c
Q 002760          687 CKALRNIRHRNL-----IKIITVCSGRD---FKGADFKAIVYEFMQNGSLEEWLHHSNDQL------------------E  740 (884)
Q Consensus       687 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~  740 (884)
                      +.++.+++|.++     ++++++|....   ....+..++||||+++|+|.++++......                  .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766544     67777764321   122456799999999999999987532110                  1


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeecccc
Q 002760          741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG  820 (884)
Q Consensus       741 ~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~g  820 (884)
                      ...+++..+..++.|++.|+.|+|   +++|+||||||+||+++.++.+||+|||++..........       .....+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-------PLYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------ccccCC
Confidence            123567788899999999999999   7899999999999999999999999999997543221110       011235


Q ss_pred             ccceeCccccCCCC--------------------C--CcccceeehhHHHHHHhcCCC-CCCc
Q 002760          821 TVGYVAPEYGMGRE--------------------A--SMKGDVYSFGILLLELFTRKR-PTDA  860 (884)
Q Consensus       821 t~~y~aPE~~~~~~--------------------~--~~~~DvwSlG~il~~lltg~~-p~~~  860 (884)
                      |+.|+|||.+....                    +  ..+.||||+||++|+|++|.. ||..
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            88999999875422                    1  124699999999999999976 6653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.5e-26  Score=237.39  Aligned_cols=212  Identities=31%  Similarity=0.471  Sum_probs=176.4

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      |.+.+.||+|++|+||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++     ......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence            56788999999999999999888999999999755444 567889999999999999999999985     344677999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      +||+++++|.+++.....     .+++..+..++.+++.++.|||   +.+++|+|++|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            999999999999986542     1788899999999999999999   77999999999999999999999999999986


Q ss_pred             cccCCCCcccccceeeeccccccceeCcccc-CCCCCCcccceeehhHHHHHHhcCCCCCCc-cccCCccHHHHH
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYG-MGREASMKGDVYSFGILLLELFTRKRPTDA-MFNEGLTLHDFS  872 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~~lltg~~p~~~-~~~~~~~~~~~~  872 (884)
                      .......       ......++..|++||.. ....++.++|+|++|+++|+|++|+.||+. ....+.....|.
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      148 IHRDLAA-------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             ecCcccc-------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            6443210       11123578889999998 667788899999999999999999999976 333334444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=238.02  Aligned_cols=217  Identities=24%  Similarity=0.340  Sum_probs=176.3

Q ss_pred             HHHHhcCCCccCeeeeccceEEEEEEECCCC-----cEEEEEEeecc-cccchHHHHHHHHHHHcCCCCCccceeeeecc
Q 002760          634 LSKATDNFSSANKIGEGGSGIVYKGFLGENG-----TEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSG  707 (884)
Q Consensus       634 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  707 (884)
                      +.....+++....+-+|.||.||.|.|+...     +.|-||..+.. .+-....+..|.-.+..+.|||+.++.+++  
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~--  356 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS--  356 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE--
Confidence            3444456888888999999999999886543     34667776532 223346788899999999999999999998  


Q ss_pred             CCccCCccceEEEEccCCCCHHHHhhc--cCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC
Q 002760          708 RDFKGADFKAIVYEFMQNGSLEEWLHH--SNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ  785 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~  785 (884)
                        .++....++++.++.-|+|..|+..  ..+......++..+...+|.|++.|++|||   ++||||.||.++|.+|++
T Consensus       357 --ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  357 --IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             --eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence              4566778999999999999999983  223334557889999999999999999999   889999999999999999


Q ss_pred             CCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc-CCCCCCcccc
Q 002760          786 DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       786 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt-g~~p~~~~~~  863 (884)
                      ..+|||+|=.+++.+.+.+..-.-+.      ...+..||+||.+....|+.++|||||||++|||+| |+.|+.+..+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDn------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDN------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCC------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence            99999999999998766554322221      124678999999999999999999999999999998 8999876543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=1.2e-26  Score=265.90  Aligned_cols=210  Identities=21%  Similarity=0.242  Sum_probs=145.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCC----CcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeecc-CCcc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGEN----GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSG-RDFK  711 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  711 (884)
                      ..++|++.++||+|+||.||+|++..+    +..||||++.....  .+....|  .++...+.++..++..+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    89999998753221  1111111  1122223333322221111 1113


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCc--------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQL--------------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK  777 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlk  777 (884)
                      .+...++||||+.+++|.+++.......              .........+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5567899999999999999987543110              0011223446679999999999999   8899999999


Q ss_pred             CCCeeeCC-CCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCC----------------------C
Q 002760          778 PSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR----------------------E  834 (884)
Q Consensus       778 p~NiLl~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~  834 (884)
                      |+|||++. ++.+||+|||+|+........       ....+.|++.|||||.+...                      .
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-------CCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999985 689999999999865432211       12245689999999965322                      2


Q ss_pred             CCcccceeehhHHHHHHhcCCCCCCc
Q 002760          835 ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       835 ~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      ++.++||||+||++|||+++..|++.
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~  381 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCch
Confidence            34467999999999999998877654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=8e-29  Score=248.97  Aligned_cols=440  Identities=21%  Similarity=0.254  Sum_probs=203.5

Q ss_pred             EEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccc-cc
Q 002760           45 INIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQ-NH  123 (884)
Q Consensus        45 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~  123 (884)
                      .+-++-+++ ++|..+-  ..-..++|..|+|+..-|.+|+.+++|++|||++|+|+.+-|+.|.++.+|..|-+.+ |+
T Consensus        51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk  127 (498)
T KOG4237|consen   51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK  127 (498)
T ss_pred             EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence            344444555 5554432  2445566666666644444556666666666666666655566666666555554444 55


Q ss_pred             cCCCCCcccCCCCCCcEEEeccccccccc-cccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCC
Q 002760          124 ITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVD  202 (884)
Q Consensus       124 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~  202 (884)
                      |+....+.|++|.+|+.|.+.-|++..++ +.|..|++|..|.+-.|.+..+-...|..+.+++.+.+..|.+..     
T Consensus       128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----  202 (498)
T KOG4237|consen  128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----  202 (498)
T ss_pred             hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence            65433345556666666655555555544 345555555555555555542222255555555555555554320     


Q ss_pred             CCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCcccccccc-cccceeeccccccCCCCCChhhhhhh
Q 002760          203 TGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL-KNLYWLNLGINNLGTGAANELDFINL  281 (884)
Q Consensus       203 ~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~  281 (884)
                       ..+++.+..       +....|..++...-..-..+.++++..+.+..|..- ..+..=-.+.+.......     ..-
T Consensus       203 -dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP-----~~c  269 (498)
T KOG4237|consen  203 -DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP-----AKC  269 (498)
T ss_pred             -ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh-----HHH
Confidence             011111111       222344555555556666666666666655554322 222111111221111111     112


Q ss_pred             hcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCCCC
Q 002760          282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNL  361 (884)
Q Consensus       282 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  361 (884)
                      |..+++|+.|+|++|+++.+-+.+|.... .+++|.|..|+|.......|.++..|+.|+|.+|+|+...|.+|..+..|
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l  348 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL  348 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence            45555666666666655544343333332 35555555555544444445555555555555555554445555555555


Q ss_pred             CEEEccCCCCCCC-CCCccCccccCcEEEcccccccccCCCCCcCcccccccccccccccC---ccchhhhhhhccchhh
Q 002760          362 QQLDLDRNFLQGS-IPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG---TLPRQILRITTLSLYL  437 (884)
Q Consensus       362 ~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~~~~~~~~L  437 (884)
                      .+|+|-.|.+.-. --.|++.       -|..+.-.| .|. -+.-..++.+.++++.+..   ..|+...-        
T Consensus       349 ~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~-~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~--------  411 (498)
T KOG4237|consen  349 STLNLLSNPFNCNCRLAWLGE-------WLRKKSVVG-NPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGC--------  411 (498)
T ss_pred             eeeehccCcccCccchHHHHH-------HHhhCCCCC-CCC-CCCCchhccccchhccccccccCCccccCC--------
Confidence            5555544444310 0000000       000111000 111 1112234444444443321   01110000        


Q ss_pred             hcCCccCCCCCCccccCCCccCEE-ecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccc
Q 002760          438 ELGNNLLNGSLPPEVGNLKNLMRL-DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL  516 (884)
Q Consensus       438 ~l~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  516 (884)
                           .-+   +..-...+-+.+. .-|++.++ .+|..+.  ..-.+|++.+|.++ .+|..  .+.+| .+|+|+|++
T Consensus       412 -----~~s---~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i  476 (498)
T KOG4237|consen  412 -----LTS---SPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRI  476 (498)
T ss_pred             -----CCC---CCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCce
Confidence                 000   0011112222222 23333333 4444332  34566777777776 45544  45566 677777777


Q ss_pred             cccccccccCCCccceeeccCc
Q 002760          517 NGQIPEYLENLSFLEFLNLSYN  538 (884)
Q Consensus       517 ~~~~p~~~~~l~~L~~L~ls~N  538 (884)
                      +...-..|.+++.|.+|-||+|
T Consensus       477 ~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  477 SSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             ehhhcccccchhhhheeEEecC
Confidence            7666667777777777777766

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=228.13  Aligned_cols=208  Identities=23%  Similarity=0.338  Sum_probs=166.7

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+.|.+.+.+|+|.||.+-.|+++.+.+.+|+|.+.. .....++|.+|..---.+ .|.||+..+++.    |+..+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence            4678999999999999999999999999999998863 233457888888765455 599999988775    7778899


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC--CCCceEEecc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD--QDLVSHVSDF  794 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DF  794 (884)
                      +.++||++.|+|.+-+...       .+.+.-..+++.|+++|++|||   ++.+||||||.+||||-  +...||+|||
T Consensus        98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeec
Confidence            9999999999999877654       3566677889999999999999   89999999999999994  3459999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCC-----CCCcccceeehhHHHHHHhcCCCCCCccccCCccHH
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-----EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH  869 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~  869 (884)
                      |..+..+.....           ..-+..|.|||.....     ...+.+|+|.||+++|.++||.+||...+-....+.
T Consensus       168 G~t~k~g~tV~~-----------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~  236 (378)
T KOG1345|consen  168 GLTRKVGTTVKY-----------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW  236 (378)
T ss_pred             ccccccCceehh-----------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence            998754322111           1124568999975432     357789999999999999999999997766555555


Q ss_pred             HH
Q 002760          870 DF  871 (884)
Q Consensus       870 ~~  871 (884)
                      +|
T Consensus       237 ~~  238 (378)
T KOG1345|consen  237 EW  238 (378)
T ss_pred             HH
Confidence            44

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1e-28  Score=248.17  Aligned_cols=389  Identities=20%  Similarity=0.212  Sum_probs=247.4

Q ss_pred             CcEEEecccccccccc-ccccccccceeeccccccCCCCCccccCCCcccEEEecc-ccccccCCCCCCCCCCCCceEec
Q 002760          138 LRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSE-NRFTGSLPVDTGVNLPSLRELRT  215 (884)
Q Consensus       138 L~~L~l~~n~l~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~-n~l~~~l~~~~~~~l~~L~~L~L  215 (884)
                      -..++|..|+|+.+|+ +|+.+++|+.|+|++|+|+.+-|++|..+.+|..|-+-+ |+|+ .+|...|.+|.+|+.|.+
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhc
Confidence            4455566666666553 466666666666666666666666777766665554444 6666 677777777777777777


Q ss_pred             CCCcccccCCcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCC------ChhhhhhhhcCCCCCc
Q 002760          216 NANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAA------NELDFINLLTNCSKLE  289 (884)
Q Consensus       216 ~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------~~~~~~~~l~~l~~L~  289 (884)
                      .-|++..+...+|..+++|..|.+-+|.+..+....|..+..++.+.+..|..-...-      .....+-.++..+-..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            7777776666777777777777777777777766677777777777776666321110      0000011122333333


Q ss_pred             EEEccCCcccCCCCchhhccchhhhhhcccCCcccccCC-ccccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccC
Q 002760          290 RLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIP-PEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDR  368 (884)
Q Consensus       290 ~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  368 (884)
                      ...+.++++..+-+..+..-...+..-..+.+...++.| ..|..+++|++|+|++|+|+++-+.+|.++..+++|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            334444444433333333222222222223333333444 6799999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhccchhhhcCCccCCCCC
Q 002760          369 NFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSL  448 (884)
Q Consensus       369 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~  448 (884)
                      |+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.-.     .++..+..+|  ..+.-.| .
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn-----C~l~wl~~Wl--r~~~~~~-~  379 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN-----CRLAWLGEWL--RKKSVVG-N  379 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc-----cchHHHHHHH--hhCCCCC-C
Confidence            999977778899999999999999999999999999999999999999976411     1111222222  2222222 2


Q ss_pred             CccccCCCccCEEecCCCCCCC---Cchhhhhc---------ccccc-cccccCcEEeeccCccccCccccceeeccCcc
Q 002760          449 PPEVGNLKNLMRLDLSGNKFSG---EIPATLSA---------CANLE-YLNISGNAFSGSIPLLLDSLQSIKELDFSSNN  515 (884)
Q Consensus       449 ~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~---------l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  515 (884)
                      |.. +.-..++.+.++.+.+..   ..|++.+.         ++-+. +..-|++.++ .+|..+-  ..-.+|++.+|.
T Consensus       380 ~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~  455 (498)
T KOG4237|consen  380 PRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNA  455 (498)
T ss_pred             CCC-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccch
Confidence            222 223356677777776532   23333321         22343 3445555555 4443222  245789999999


Q ss_pred             ccccccccccCCCccceeeccCccCccc
Q 002760          516 LNGQIPEYLENLSFLEFLNLSYNHFEGE  543 (884)
Q Consensus       516 l~~~~p~~~~~l~~L~~L~ls~N~l~~~  543 (884)
                      ++ .+|..  .+.+| .+|+|+|+|+-.
T Consensus       456 ~~-~vp~~--~~~~l-~~dls~n~i~~L  479 (498)
T KOG4237|consen  456 IT-SVPDE--LLRSL-LLDLSNNRISSL  479 (498)
T ss_pred             hc-ccCHH--HHhhh-hcccccCceehh
Confidence            98 66766  66778 899999999764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.4e-27  Score=247.10  Aligned_cols=206  Identities=24%  Similarity=0.319  Sum_probs=171.5

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC------CCCccceeeeeccCC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR------HRNLIKIITVCSGRD  709 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~  709 (884)
                      ....+|.+....|+|-|++|.+|.+...|..||||+|..... -.+.=+.|+++|+++.      --++++++-.     
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----  502 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----  502 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----
Confidence            345689999999999999999999999999999999974322 2344567999999994      2356777655     


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-Cc
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LV  788 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-~~  788 (884)
                      |...+++|+|+|.+ ..+|.+.++..+..   ..+....+..++.|+.-||..|.   .-||+|.||||.|||+.+. ..
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence            67788999999998 55999999987753   25778889999999999999999   7799999999999999865 57


Q ss_pred             eEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccC
Q 002760          789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       789 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~  864 (884)
                      .||||||.|.+.........          .-+-.|.|||++.|.+|+...|+||.||+|||+.||+..|.+..+.
T Consensus       576 LKLCDfGSA~~~~eneitPY----------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITPY----------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             eeeccCccccccccccccHH----------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            79999999987765443221          1345699999999999999999999999999999999999987654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=6.5e-27  Score=229.69  Aligned_cols=210  Identities=24%  Similarity=0.339  Sum_probs=174.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeec--ccccchHHHHHHHHHHHcCCCCCccceeeeeccCC-ccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  714 (884)
                      ..+|.-.+.+|.|+- .|..|.+...+++||+|....  .....+++..+|...+..+.|+||++++.++.... .+.-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357888899999998 888999988999999997742  23345678889999999999999999999876543 23345


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..|+|||+| ..+|...+..        .++-.++..|..|++.|+.|||   +.||+|||+||+||++..++..||.||
T Consensus        95 e~y~v~e~m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM--------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccc
Confidence            679999999 5599988873        4677888999999999999999   889999999999999999999999999


Q ss_pred             ccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCccHHHHHH
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSR  873 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~~~~~  873 (884)
                      |+|+.-...         ...+.++.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+    +..+++|-+
T Consensus       163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~k  228 (369)
T KOG0665|consen  163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNK  228 (369)
T ss_pred             hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHH
Confidence            999844322         112245678899999999999999999999999999999999999986    355666643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2.1e-26  Score=235.16  Aligned_cols=222  Identities=27%  Similarity=0.366  Sum_probs=177.5

Q ss_pred             HHHHhcCCCccCeeeeccceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCC
Q 002760          634 LSKATDNFSSANKIGEGGSGIVYKGFLGE---NGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRD  709 (884)
Q Consensus       634 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  709 (884)
                      .......|..+++||+|+|++||+|.+..   .++.||+|.+.  ......++.+|+++|..+ -+.||+++.+.     
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~--~ts~p~ri~~El~~L~~~gG~~ni~~~~~~-----  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIY--RTSSPSRILNELEMLYRLGGSDNIIKLNGC-----  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecc--cccCchHHHHHHHHHHHhccchhhhcchhh-----
Confidence            44455679999999999999999999877   67899999885  344567899999999999 48999999987     


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC-CCCc
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLV  788 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~-~~~~  788 (884)
                      +...+.+.+|+||+++....++..         .++..++..+++.+..||.++|   .+|||||||||+|++.+ ..+.
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCC
Confidence            677888999999999999888876         4667788899999999999999   89999999999999998 5678


Q ss_pred             eEEeccccccccccCC-------------CC------------------c--c---cccceeeeccccccceeCccccCC
Q 002760          789 SHVSDFGLAKFLSNHN-------------PD------------------T--I---VETRSISIGIKGTVGYVAPEYGMG  832 (884)
Q Consensus       789 ~kl~DFg~a~~~~~~~-------------~~------------------~--~---~~~~~~~~~~~gt~~y~aPE~~~~  832 (884)
                      -.|+|||+|.......             ..                  .  .   ...+...-..+||++|+|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            8999999997221100             00                  0  0   000111224459999999999776


Q ss_pred             -CCCCcccceeehhHHHHHHhcCCCCCCccccCCccHHHHHHH
Q 002760          833 -REASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSRE  874 (884)
Q Consensus       833 -~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~~~~~~~  874 (884)
                       ...++++||||.|||+..+++++.||-...+|-..+..-+..
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ti  294 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATI  294 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHH
Confidence             457889999999999999999999998776666555554443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-27  Score=252.39  Aligned_cols=198  Identities=26%  Similarity=0.391  Sum_probs=174.5

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|+...++|.|+||.||+|+++.+++.+|||+++.........++.|+-+++..+|||||.++|.+     -..+..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence            46799999999999999999999999999999999988887778889999999999999999999984     3456779


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      ++||||.+|+|++.-+-.+      ++++.++...++..++|++|||   ++|-+|||||-.||++++.|++|++|||.+
T Consensus        89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCch
Confidence            9999999999999877665      7899999999999999999999   889999999999999999999999999998


Q ss_pred             cccccCCCCcccccceeeeccccccceeCcccc---CCCCCCcccceeehhHHHHHHhcCCCC
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYG---MGREASMKGDVYSFGILLLELFTRKRP  857 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~~lltg~~p  857 (884)
                      ..+.....+        ...+.|||+|||||+.   +...|...+|||++|+...|+-.-+.|
T Consensus       160 aqitati~K--------rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  160 AQITATIAK--------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             hhhhhhhhh--------hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence            765443222        2356799999999973   446789999999999999998887776

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=4.6e-27  Score=257.70  Aligned_cols=202  Identities=31%  Similarity=0.429  Sum_probs=161.8

Q ss_pred             CCccCeeeeccceE-EEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGI-VYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      |...+.+|.|+-|+ ||+|..  .|++||||.+-   .+.....++|+..++.- +|||||++++.     ..+.++.|+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence            44457789999975 799998  78999999874   23345667999999888 69999999987     677888999


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC---C--CceEEec
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---D--LVSHVSD  793 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~---~--~~~kl~D  793 (884)
                      +.|.|.. +|.++++..+..  .........+....|++.|+++||   .-+|||||+||.||||+.   +  ..++|+|
T Consensus       581 alELC~~-sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EehHhhh-hHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecc
Confidence            9999954 999999875211  111222455678899999999999   779999999999999975   3  5889999


Q ss_pred             cccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcC-CCCCCcccc
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN  863 (884)
Q Consensus       794 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg-~~p~~~~~~  863 (884)
                      ||+++.+......-     +...+..||-+|+|||++.....+.++||+|+||++|+.++| .+||....+
T Consensus       655 fglsKkl~~~~sS~-----~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~  720 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSF-----SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE  720 (903)
T ss_pred             cccccccCCCcchh-----hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence            99999876443221     124466799999999999998888899999999999999996 999987543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-25  Score=218.19  Aligned_cols=207  Identities=24%  Similarity=0.389  Sum_probs=179.1

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCccCCccc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .-.|+++++||+|+||+++.|+..-++++||||.-..+.  ....+..|.+..+.+ ..++|..++-|     -.++.+-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~N   99 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYN   99 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchh
Confidence            357999999999999999999999999999999865433  335677888888887 46888887755     3456666


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-----ceEE
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-----VSHV  791 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-----~~kl  791 (884)
                      .+|+|.+ |.+|.|+..-.+.     .++.+++..+|.|++.-++|+|   ++.+|.|||||+|+||+..+     .+.+
T Consensus       100 iLVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEE
Confidence            8999999 8899988776543     6899999999999999999999   88999999999999997543     6789


Q ss_pred             eccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       792 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      +|||+|+.+.++.+....+.+ ......||.+||+-..+.+++.+.+.|+-|+|-++.+.+.|..||.+-
T Consensus       171 iDFGmAK~YrDp~TkqHIPYr-E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYR-EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             EeccchhhhcCccccccCccc-cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            999999999999988887764 455677999999999999999999999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1e-25  Score=211.94  Aligned_cols=209  Identities=25%  Similarity=0.365  Sum_probs=175.9

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCC-CCccceeeeeccCCccCCcc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH-RNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~  715 (884)
                      ...+|+++++||+|+||.+|.|....+|++||||+-..+.  ....+..|.++.+.+++ ..|..+..+.     .+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc-----ccccc
Confidence            3578999999999999999999999999999999975332  23567789999999974 5677776663     44555


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC---CCceEEe
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVS  792 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~  792 (884)
                      -.+|||.+ |.+|.+...-...     .++.++++..|-|++.-++|+|   .+++|||||||+|+|++-   ...+.++
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEE
Confidence            68999999 8899888764322     6888999999999999999999   889999999999999974   3577899


Q ss_pred             ccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      |||+|+.+.+..+....+.+ ......||.+|++-..+.+.+.+.+.|+-|+|.++.++..|..||.+..
T Consensus       157 DFGLaKky~d~~t~~HIpyr-e~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYR-EDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             eccchhhhccccccccCccc-cCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            99999988887777666554 3446779999999999999999999999999999999999999998853

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=3.5e-25  Score=229.99  Aligned_cols=187  Identities=34%  Similarity=0.499  Sum_probs=162.7

Q ss_pred             cceEEEEEEECCCCcEEEEEEeecccccc-hHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccCCCCHH
Q 002760          651 GSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLE  729 (884)
Q Consensus       651 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  729 (884)
                      +||.||+|.+..+|+.||+|++....... .+.+.+|++.+++++|++++++++++.     .....++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999998889999999997554433 678999999999999999999999853     446779999999999999


Q ss_pred             HHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCccc
Q 002760          730 EWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV  809 (884)
Q Consensus       730 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~  809 (884)
                      +++....      .+++.+++.++.+++.++.|||   +.+++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----  141 (244)
T smart00220       76 DLLKKRG------RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----  141 (244)
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence            9987653      3788899999999999999999   7899999999999999999999999999998665432     


Q ss_pred             ccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       810 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                          ......|+..|+|||...+..++.++||||+|+++|++++|..||..
T Consensus       142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                11123478899999999888899999999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03210 Resistant to P

Probab=99.92  E-value=7.2e-24  Score=263.77  Aligned_cols=181  Identities=19%  Similarity=0.204  Sum_probs=112.1

Q ss_pred             cCcCCCCCCCEEEccCCc------CcCcCCccccCC-CCCcEEeccCccccCCCCcccccccccceecccccccCCCCCc
Q 002760           58 HQIGRLISLERLILSNNS------FSGAIPANLSSC-SNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPA  130 (884)
Q Consensus        58 ~~~~~l~~L~~L~Ls~n~------l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~  130 (884)
                      .+|.+|.+|+.|.+..+.      +...+|..+..+ .+|+.|++.++.+. .+|..| ...+|++|++++|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            455666677776665443      222355555554 35777777777666 566665 3567777777777776 5666


Q ss_pred             ccCCCCCCcEEEecccc-ccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCC
Q 002760          131 SIGNLSSLRVIDVRENR-LWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPS  209 (884)
Q Consensus       131 ~l~~l~~L~~L~l~~n~-l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~  209 (884)
                      .+..+++|+.|+|+++. ++.+| .++.+++|+.|++++|.....+|..+.++++|+.|++++|...+.+|...  ++++
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~s  705 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKS  705 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCC
Confidence            66777777777777654 44444 46667777777777765545667777777777777777765434666543  5667


Q ss_pred             CceEecCCCcccccCCcccccCCCcceecccccccccC
Q 002760          210 LRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGG  247 (884)
Q Consensus       210 L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~  247 (884)
                      |+.|++++|......|..   .++|+.|++++|.+..+
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l  740 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF  740 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccccc
Confidence            777777766544333322   24566666666665543

syringae 6; Provisional

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.7e-24  Score=227.49  Aligned_cols=183  Identities=20%  Similarity=0.197  Sum_probs=137.3

Q ss_pred             HHhcCCCccCeeeeccceEEEEEEECC-CCcEEEEEEeecc-----cccchHHHHHHHHHHHcCCCCCccceeeeeccCC
Q 002760          636 KATDNFSSANKIGEGGSGIVYKGFLGE-NGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLIKIITVCSGRD  709 (884)
Q Consensus       636 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  709 (884)
                      ....+|++.+.||+|+||+||+|++.. +++.||||++...     .....+.+.+|++++++++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            346789999999999999999999876 6788899987522     112345689999999999999998644221    


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCeeeCCCCc
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL-KPSNVLLDQDLV  788 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dl-kp~NiLl~~~~~  788 (884)
                          +..++||||++|++|... ...         .   ...++.|++.|++|+|   ++||+|||| ||+|||++.++.
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~~---------~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RPH---------G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Ccc---------c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCC
Confidence                246999999999999632 110         1   1357889999999999   889999999 999999999999


Q ss_pred             eEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCC------CCccccee
Q 002760          789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE------ASMKGDVY  842 (884)
Q Consensus       789 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  842 (884)
                      +||+|||+|+.+...................|++.|+|||.+....      .+..+|-|
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9999999999876554333321112223566889999999876532      33446666

>PLN03210 Resistant to P

Probab=99.91  E-value=2.3e-23  Score=259.28  Aligned_cols=315  Identities=21%  Similarity=0.275  Sum_probs=169.5

Q ss_pred             CCcccCCCC-CCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCC
Q 002760          128 LPASIGNLS-SLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVN  206 (884)
Q Consensus       128 ~~~~l~~l~-~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~  206 (884)
                      +|+.|..++ +|+.|++.++.++.+|..+ .+.+|+.|++.+|++. .++..+..+++|+.|+|++|...+.+|.  +..
T Consensus       580 lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~  655 (1153)
T PLN03210        580 LPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSM  655 (1153)
T ss_pred             cCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc--ccc
Confidence            344444442 4555666555555555544 3455666666666555 3455555566666666665543334553  334


Q ss_pred             CCCCceEecCCCcccccCCcccccCCCcceecccccc-cccCcccccccccccceeeccccccCCCCCChhhhhhhhcCC
Q 002760          207 LPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ-FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNC  285 (884)
Q Consensus       207 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  285 (884)
                      +++|++|++++|.....+|..+.++++|+.|++++|. ++.++. .+ .+++|+.|++++|.....      ++   ...
T Consensus       656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-~i-~l~sL~~L~Lsgc~~L~~------~p---~~~  724 (1153)
T PLN03210        656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-GI-NLKSLYRLNLSGCSRLKS------FP---DIS  724 (1153)
T ss_pred             CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-cC-CCCCCCEEeCCCCCCccc------cc---ccc
Confidence            5666666666655555556666666666666666643 332222 11 344555555544422110      00   012


Q ss_pred             CCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCC-------CccCCcccCCC
Q 002760          286 SKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQL-------TGTIPPEIGEL  358 (884)
Q Consensus       286 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-------~~~~~~~~~~l  358 (884)
                      ++|+.|++++|.+. .+|                         ..+ .+++|++|.+.++..       ....+..+...
T Consensus       725 ~nL~~L~L~~n~i~-~lP-------------------------~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~  777 (1153)
T PLN03210        725 TNISWLDLDETAIE-EFP-------------------------SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS  777 (1153)
T ss_pred             CCcCeeecCCCccc-ccc-------------------------ccc-cccccccccccccchhhccccccccchhhhhcc
Confidence            34444444444443 222                         221 234444444443221       11112222234


Q ss_pred             CCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhccchhhh
Q 002760          359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLE  438 (884)
Q Consensus       359 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~  438 (884)
                      ++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|++++|....                 
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~-----------------  839 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLR-----------------  839 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccc-----------------
Confidence            567777777776655667777777777777777664333556554 56777777777764221                 


Q ss_pred             cCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccC-cEEeeccCccccCccccceeeccCcc
Q 002760          439 LGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISG-NAFSGSIPLLLDSLQSIKELDFSSNN  515 (884)
Q Consensus       439 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~  515 (884)
                              .+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus       840 --------~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        840 --------TFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             --------ccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence                    12211   246777777777776 6677777777777777777 3455 455566677777777777663

syringae 6; Provisional

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=226.14  Aligned_cols=211  Identities=27%  Similarity=0.357  Sum_probs=170.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHcCCC----CCccceeeeeccCCccCCc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGASKSFVAECKALRNIRH----RNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~  714 (884)
                      +|.+.++||+|+||.||.|.+..++ +.+|+|+...........+..|+.++..+..    +++..+++...    ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987664 6789998865433333378889999988863    57888887732    3556


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-----Cce
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-----LVS  789 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-----~~~  789 (884)
                      ..++||+.+ |.+|.++.+....    ..++..++.+|+.|++.||+++|   +.|++||||||+|++++..     ..+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceE
Confidence            779999988 8899998866542    27899999999999999999999   8899999999999999865     468


Q ss_pred             EEeccccccccc--cCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          790 HVSDFGLAKFLS--NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       790 kl~DFg~a~~~~--~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      ++.|||+|+...  ..........+.....+.||..|++++++.+.+.+++.|+||++.++.++..|..||....
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            999999998433  2222111122222345779999999999999999999999999999999999999997643

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.8e-23  Score=240.53  Aligned_cols=267  Identities=25%  Similarity=0.268  Sum_probs=144.1

Q ss_pred             CCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEec
Q 002760           65 SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVR  144 (884)
Q Consensus        65 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  144 (884)
                      .-..|+|++|.++ .+|..+.  .+|+.|++++|+++ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls  270 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF  270 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence            3455666666665 4555554  25666666666655 34432   345556666666555 33432   2455555555


Q ss_pred             cccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccC
Q 002760          145 ENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFI  224 (884)
Q Consensus       145 ~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~  224 (884)
                      +|.+..+|..+   ++|+.|++++|+++ .+|..   .++|+.|+|++|+++ .+|..                      
T Consensus       271 ~N~L~~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~l----------------------  320 (788)
T PRK15387        271 SNPLTHLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPAL----------------------  320 (788)
T ss_pred             CCchhhhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccc-cCCCC----------------------
Confidence            55555544322   33445555555554 23321   234555555555554 33321                      


Q ss_pred             CcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCc
Q 002760          225 PVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH  304 (884)
Q Consensus       225 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~  304 (884)
                            ..+|+.|++++|.++.++.    ...+|+.|+|++|+|+.++.          ..++|+.|++++|++.     
T Consensus       321 ------p~~L~~L~Ls~N~L~~LP~----lp~~Lq~LdLS~N~Ls~LP~----------lp~~L~~L~Ls~N~L~-----  375 (788)
T PRK15387        321 ------PSELCKLWAYNNQLTSLPT----LPSGLQELSVSDNQLASLPT----------LPSELYKLWAYNNRLT-----  375 (788)
T ss_pred             ------cccccccccccCccccccc----cccccceEecCCCccCCCCC----------CCcccceehhhccccc-----
Confidence                  1234444555555544331    01234444444444433221          0123334444444443     


Q ss_pred             hhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCcccc
Q 002760          305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL  384 (884)
Q Consensus       305 ~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  384 (884)
                                          . +|..   ..+|+.|++++|+|++ +|..   .++|+.|++++|+|+ .+|...   .+
T Consensus       376 --------------------~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~  423 (788)
T PRK15387        376 --------------------S-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SG  423 (788)
T ss_pred             --------------------c-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hh
Confidence                                1 2221   2357777777777774 4432   256888888888887 456432   46


Q ss_pred             CcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhh
Q 002760          385 LTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRI  430 (884)
Q Consensus       385 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  430 (884)
                      |+.|++++|+|+ .+|..+..+++|+.|+|++|++++..|..+..+
T Consensus       424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            778888888887 578888888888888888888887777665443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.7e-23  Score=237.94  Aligned_cols=261  Identities=27%  Similarity=0.312  Sum_probs=125.9

Q ss_pred             EEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccc
Q 002760           44 YINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH  123 (884)
Q Consensus        44 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~  123 (884)
                      .|+|++++++ .+|+.+.  .+|+.|++++|+++ .+|..   +++|++|++++|+++ .+|..   .++|+.|++++|.
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~  273 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP  273 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence            3444444444 3444332  23444444444444 23321   234444444444444 33321   1344444555554


Q ss_pred             cCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCC
Q 002760          124 ITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDT  203 (884)
Q Consensus       124 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~  203 (884)
                      ++ .+|..   .++|+.|++++|++..+|..   +++|+.|++++|++++ +|...   .+|+.|++++|+++ .+|.. 
T Consensus       274 L~-~Lp~l---p~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l-  340 (788)
T PRK15387        274 LT-HLPAL---PSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL-  340 (788)
T ss_pred             hh-hhhhc---hhhcCEEECcCCcccccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc-
Confidence            44 23321   13344455555555444432   2445555555555552 23211   23455555555554 34421 


Q ss_pred             CCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhhhhhhc
Q 002760          204 GVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLT  283 (884)
Q Consensus       204 ~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  283 (884)
                         ..+|+.|+|++|+++.+ |..   .++|+.|++++|+|+.++..    ..+|+.|++++|++...+.          
T Consensus       341 ---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~LP~l----~~~L~~LdLs~N~Lt~LP~----------  399 (788)
T PRK15387        341 ---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSLPAL----PSGLKELIVSGNRLTSLPV----------  399 (788)
T ss_pred             ---ccccceEecCCCccCCC-CCC---CcccceehhhccccccCccc----ccccceEEecCCcccCCCC----------
Confidence               12455555555555542 221   23455555666655543321    1344455555554443221          


Q ss_pred             CCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCcccCCCCCCCE
Q 002760          284 NCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ  363 (884)
Q Consensus       284 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  363 (884)
                      ..++|+.|++++|+++                         + +|...   .+|+.|++++|+|+ .+|..+..+++|+.
T Consensus       400 l~s~L~~LdLS~N~Ls-------------------------s-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~  449 (788)
T PRK15387        400 LPSELKELMVSGNRLT-------------------------S-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETT  449 (788)
T ss_pred             cccCCCEEEccCCcCC-------------------------C-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCe
Confidence            0134455555555544                         2 33221   35667778888887 56777888888888


Q ss_pred             EEccCCCCCCCCCCcc
Q 002760          364 LDLDRNFLQGSIPSSL  379 (884)
Q Consensus       364 L~Ls~N~l~~~~~~~~  379 (884)
                      |+|++|+|++..+..+
T Consensus       450 LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        450 VNLEGNPLSERTLQAL  465 (788)
T ss_pred             EECCCCCCCchHHHHH
Confidence            8888888887666554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=2.4e-22  Score=203.74  Aligned_cols=184  Identities=35%  Similarity=0.604  Sum_probs=156.5

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeeccccc-chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccCC
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN  725 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  725 (884)
                      ||+|++|.||++....+++++++|++...... ..+.+.+|++.++.++|++++++++++     ......+++|||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence            68999999999999877999999998744332 346789999999999999999999985     344677999999999


Q ss_pred             CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-CCceEEeccccccccccCC
Q 002760          726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHN  804 (884)
Q Consensus       726 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFg~a~~~~~~~  804 (884)
                      ++|.+++....     ..+++..+..++.++++++.|||   +++++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            99999988653     25788999999999999999999   789999999999999999 8999999999998664432


Q ss_pred             CCcccccceeeeccccccceeCccccCCC-CCCcccceeehhHHHHHH
Q 002760          805 PDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLEL  851 (884)
Q Consensus       805 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~~l  851 (884)
                      .        ......+...|++||..... .++.++|+|++|++++++
T Consensus       148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            1        01123467889999998877 888999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=1.4e-22  Score=235.12  Aligned_cols=213  Identities=23%  Similarity=0.411  Sum_probs=154.4

Q ss_pred             EeeEEcCCCCeEEEEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccC
Q 002760            7 TGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSS   86 (884)
Q Consensus         7 ~~v~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~   86 (884)
                      +-..|..  ...+.|++++++++ .+|..+.  +.|+.|+|++|+++ .+|..+.  .+|++|+|++|+++ .+|..+. 
T Consensus       171 r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~-  240 (754)
T PRK15370        171 RMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP-  240 (754)
T ss_pred             HHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh-
Confidence            3345643  35688999999998 7887764  57999999999998 7887665  58999999999988 6777654 


Q ss_pred             CCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeec
Q 002760           87 CSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSV  166 (884)
Q Consensus        87 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L  166 (884)
                       .+|+.|+|++|++. .+|..+.  .+|+.|++++|+++ .+|..+.  ++|+.|++++|+++.+|..+.  ++|+.|++
T Consensus       241 -~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~L  311 (754)
T PRK15370        241 -DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNV  311 (754)
T ss_pred             -ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHh
Confidence             47899999999988 7777665  47899999999888 5676654  478888888888888776543  46788888


Q ss_pred             cccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceeccccccccc
Q 002760          167 AFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSG  246 (884)
Q Consensus       167 ~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~  246 (884)
                      ++|+++. +|..+.  ++|+.|++++|.++ .+|....   ++|+.|++++|+++. +|..+  .++|+.|+|++|+++.
T Consensus       312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~  381 (754)
T PRK15370        312 QSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTN  381 (754)
T ss_pred             cCCcccc-CCcccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCC
Confidence            8888873 555443  57788888888776 5664432   567777777777664 34333  2456666666666654


Q ss_pred             Cc
Q 002760          247 GV  248 (884)
Q Consensus       247 ~~  248 (884)
                      ++
T Consensus       382 LP  383 (754)
T PRK15370        382 LP  383 (754)
T ss_pred             CC
Confidence            43

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.1e-21  Score=225.27  Aligned_cols=246  Identities=20%  Similarity=0.353  Sum_probs=135.0

Q ss_pred             CCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEec
Q 002760           65 SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVR  144 (884)
Q Consensus        65 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  144 (884)
                      +.+.|++++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  .+|++|++++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            3455555555555 3454442  34555555555555 4444333  35555555555555 3444332  245566666


Q ss_pred             cccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccC
Q 002760          145 ENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFI  224 (884)
Q Consensus       145 ~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~  224 (884)
                      +|++..+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|+++ .+|....   ++|+.|++++|.++.+ 
T Consensus       250 ~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~L-  319 (754)
T PRK15370        250 INRITELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTAL-  319 (754)
T ss_pred             CCccCcCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCccccC-
Confidence            666555554432  35666666666665 3454443  35666666666665 4553322   3566666666666643 


Q ss_pred             CcccccCCCcceecccccccccCcccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCc
Q 002760          225 PVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH  304 (884)
Q Consensus       225 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~  304 (884)
                      |..+  .++|+.|++++|.++.++.. +  .++|+.|++++|++..++.       .+  .++|+.|++++|+++ .+|.
T Consensus       320 P~~l--~~sL~~L~Ls~N~Lt~LP~~-l--~~sL~~L~Ls~N~L~~LP~-------~l--p~~L~~LdLs~N~Lt-~LP~  384 (754)
T PRK15370        320 PETL--PPGLKTLEAGENALTSLPAS-L--PPELQVLDVSKNQITVLPE-------TL--PPTITTLDVSRNALT-NLPE  384 (754)
T ss_pred             Cccc--cccceeccccCCccccCChh-h--cCcccEEECCCCCCCcCCh-------hh--cCCcCEEECCCCcCC-CCCH
Confidence            3222  24677777777777665432 2  2567777777777765432       11  257788888888877 4555


Q ss_pred             hhhccchhhhhhcccCCcccccCCccc----cCCCCCcEEEeecCCCC
Q 002760          305 SVANLSSTIKQIAMGRNRISGTIPPEI----RNLASLNWLTIDTNQLT  348 (884)
Q Consensus       305 ~~~~l~~~l~~L~l~~n~l~~~~~~~~----~~l~~L~~L~L~~N~l~  348 (884)
                      .+.   ..++.|++++|+++ .+|..+    ..++++..|++.+|.+.
T Consensus       385 ~l~---~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        385 NLP---AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hHH---HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            432   34677777777766 334322    22345555555555554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=5.7e-21  Score=187.76  Aligned_cols=140  Identities=19%  Similarity=0.180  Sum_probs=107.9

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeeccccc--c-------hH-----------------HHHHHHHHHHcCCCCC
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--A-------SK-----------------SFVAECKALRNIRHRN  697 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h~n  697 (884)
                      .+.||+|+||+||+|.+. +|++||||+++.....  .       ..                 ....|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            478999999999999996 8999999999743211  0       01                 2234999999998887


Q ss_pred             ccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCC
Q 002760          698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL-HHYCEPSIVHGDL  776 (884)
Q Consensus       698 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ivH~Dl  776 (884)
                      +.....+.    .   ...++||||++++++........      .++..++..++.|++.++.|+ |   +.||+||||
T Consensus        81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDl  144 (190)
T cd05147          81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQ---DCRLVHADL  144 (190)
T ss_pred             CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            74433321    1   12389999998877665432222      578889999999999999999 6   679999999


Q ss_pred             CCCCeeeCCCCceEEeccccccccc
Q 002760          777 KPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       777 kp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      ||+||+++ ++.++|+|||+|....
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccCC
Confidence            99999998 5789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=4.5e-21  Score=189.45  Aligned_cols=176  Identities=15%  Similarity=0.185  Sum_probs=133.8

Q ss_pred             HhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHH---------HHHHHHHHHcCCCCCccceeeeecc
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS---------FVAECKALRNIRHRNLIKIITVCSG  707 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~  707 (884)
                      ...+|+..+.+|.|+||.||.+..  ++..+|||+++.........         +.+|++.+.+++||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999766  57789999997543332222         6789999999999999999887542


Q ss_pred             CC---ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC
Q 002760          708 RD---FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD  784 (884)
Q Consensus       708 ~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~  784 (884)
                      ..   +...+..++||||++|.+|.++..          .+.    ....+++.++..+|   +.|++|||+||+||+++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~  169 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVS  169 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEe
Confidence            21   112456799999999999988732          222    24569999999999   88999999999999999


Q ss_pred             CCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHh
Q 002760          785 QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF  852 (884)
Q Consensus       785 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~ll  852 (884)
                      .+| ++++|||...........                    ......+.+..++|+||||+++....
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~--------------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAK--------------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhH--------------------HHHHHHhHhcccccccceeEeehHHH
Confidence            988 999999987644221110                    01334456778999999999887654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.83  E-value=2.9e-21  Score=233.79  Aligned_cols=160  Identities=18%  Similarity=0.281  Sum_probs=115.1

Q ss_pred             cCCC-CCccceeeeeccCCc--cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 002760          692 NIRH-RNLIKIITVCSGRDF--KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE  768 (884)
Q Consensus       692 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~  768 (884)
                      .++| +||+++++++.....  ......+.+|||+ +++|.+++....     ..+++.+++.++.||++||+|||   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAH---S   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHH---h
Confidence            3455 578888887533221  2234567889988 669999997532     25899999999999999999999   8


Q ss_pred             CCeeecCCCCCCeeeCCCCc-------------------eEEeccccccccccCCCCcc--c------ccceeeeccccc
Q 002760          769 PSIVHGDLKPSNVLLDQDLV-------------------SHVSDFGLAKFLSNHNPDTI--V------ETRSISIGIKGT  821 (884)
Q Consensus       769 ~~ivH~Dlkp~NiLl~~~~~-------------------~kl~DFg~a~~~~~~~~~~~--~------~~~~~~~~~~gt  821 (884)
                      +|||||||||+|||++..+.                   +|++|||+++..........  .      ..........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            89999999999999965444                   45555555543211000000  0      000001124589


Q ss_pred             cceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       822 ~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      +.|||||++.+..++.++|||||||++|||++|..|+..
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            999999999999999999999999999999999998764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=7.1e-20  Score=181.09  Aligned_cols=141  Identities=21%  Similarity=0.228  Sum_probs=110.2

Q ss_pred             ccCeeeeccceEEEEEEECCCCcEEEEEEeecccccc--------------------------hHHHHHHHHHHHcCCCC
Q 002760          643 SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--------------------------SKSFVAECKALRNIRHR  696 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~  696 (884)
                      +.+.||+|+||+||+|++. +|+.||||+++......                          ...+..|.+.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 89999999987432110                          12245789999999999


Q ss_pred             CccceeeeeccCCccCCccceEEEEccCCCCHHHH-hhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeec
Q 002760          697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW-LHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHG  774 (884)
Q Consensus       697 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~  774 (884)
                      ++.....+..       ...++||||++|+++... +...       .++..+...++.|++.++.++|   . .||+||
T Consensus        80 ~i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH---~~~givHr  142 (190)
T cd05145          80 GVPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLY---QEAGLVHG  142 (190)
T ss_pred             CCCCceEEEe-------cCCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHH---HhCCEecC
Confidence            8754444321       123899999988755433 3221       4667788999999999999999   6 899999


Q ss_pred             CCCCCCeeeCCCCceEEecccccccccc
Q 002760          775 DLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       775 Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      ||||+||+++ ++.++|+|||+|.....
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEcccceecCC
Confidence            9999999998 89999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=1.9e-19  Score=197.45  Aligned_cols=206  Identities=35%  Similarity=0.529  Sum_probs=168.2

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc---chHHHHHHHHHHHcCCCC-CccceeeeeccCCccCCccc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG---ASKSFVAECKALRNIRHR-NLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  716 (884)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+++     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            678889999999999999986   78999998754332   367899999999999988 799999985     334447


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-ceEEeccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFg  795 (884)
                      +++++++.++++.+++......   ..+.......++.|++.+++|+|   ..+++|||+||+||+++..+ .++++|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999999999777755321   25788889999999999999999   78999999999999999988 79999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC---CCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                      .++............  .......||..|+|||...+   ..+....|+||+|++++++++|..||....
T Consensus       148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            998554332211100  12235679999999999887   578899999999999999999999976654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=9.3e-20  Score=175.65  Aligned_cols=194  Identities=14%  Similarity=0.054  Sum_probs=139.2

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc----cchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCcc
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK----GASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +.+...|++|+||+||.+..  .++.++.+.+.....    -....+.+|+++|+++. |+++++++++         ..
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DG   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cC
Confidence            34668899999999997765  677888777653322    11235789999999995 5789988875         12


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCeeeCCCCceEEecc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL-KPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dl-kp~NiLl~~~~~~kl~DF  794 (884)
                      .+++|||++|.+|.+....             ....++.|++.+++++|   ++||+|||| ||+|||++.++.++|+||
T Consensus        73 ~~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDF  136 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDF  136 (218)
T ss_pred             EEEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence            4899999999988654321             01246789999999999   889999999 799999999999999999


Q ss_pred             ccccccccCCCC----ccccccee-eeccccccceeCccccCC--CCCCcccceeehhHHHHHHhcCCCCCCcc
Q 002760          795 GLAKFLSNHNPD----TIVETRSI-SIGIKGTVGYVAPEYGMG--REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~----~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~~lltg~~p~~~~  861 (884)
                      |+|.........    ...+.+.. ......++.|++|+...-  ..--.+.+.++-|+-+|.++||..|+.+.
T Consensus       137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            999855432210    00000000 111226788888875322  23335678999999999999999987653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=3.1e-21  Score=172.38  Aligned_cols=159  Identities=26%  Similarity=0.470  Sum_probs=100.7

Q ss_pred             eEEEEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEecc
Q 002760           17 RVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSAD   96 (884)
Q Consensus        17 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~   96 (884)
                      +++.|-||+|+++ .+||.++++.+|++|++++|++. ++|.+++.+++|+.|+++-|++. .+|..|+.++.|+.|||+
T Consensus        34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence            4566666666666 66666666666666666666666 66666666666666666666665 566666666666666666


Q ss_pred             CccccC-CCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCC
Q 002760           97 SNNLVG-EIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMI  175 (884)
Q Consensus        97 ~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~  175 (884)
                      +|++.. .+|..|..+..|+.|+|++|.+. .+|..+++|++|+.|.+.+|.+-++|..++.++.|++|.+.+|+++ .+
T Consensus       111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vl  188 (264)
T KOG0617|consen  111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VL  188 (264)
T ss_pred             ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ec
Confidence            666554 45666666666666666666665 5666666666666666666666666666666666666666666665 44


Q ss_pred             Ccccc
Q 002760          176 PPSIF  180 (884)
Q Consensus       176 ~~~l~  180 (884)
                      |..++
T Consensus       189 ppel~  193 (264)
T KOG0617|consen  189 PPELA  193 (264)
T ss_pred             Chhhh
Confidence            54443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.79  E-value=2.8e-19  Score=175.51  Aligned_cols=108  Identities=25%  Similarity=0.317  Sum_probs=94.1

Q ss_pred             CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCCC
Q 002760          726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP  805 (884)
Q Consensus       726 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~  805 (884)
                      |+|.++++..+.     .+++.+++.++.|++.|++|||   +++      ||+||+++.++.+++  ||.+....... 
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-
Confidence            689999986432     6899999999999999999999   555      999999999999999  99987654321 


Q ss_pred             CcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccc
Q 002760          806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       806 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~  862 (884)
                                  ..||+.|||||++.+..++.++||||+||++|||+||+.||....
T Consensus        64 ------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       64 ------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             ------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence                        148999999999999999999999999999999999999997643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=2.6e-21  Score=172.84  Aligned_cols=185  Identities=30%  Similarity=0.525  Sum_probs=119.3

Q ss_pred             ccCCCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCccccc
Q 002760          331 IRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL  410 (884)
Q Consensus       331 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  410 (884)
                      +.++.+.+.|.|++|+++ .+|..+..+.+|+.|++++|+|. ..|..+..+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            345566777777777777 56666777788888888888887 67777778888888888888877 6788888888888


Q ss_pred             ccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCc
Q 002760          411 GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGN  490 (884)
Q Consensus       411 ~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  490 (884)
                      .|||+.|.+..                        ..+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|
T Consensus       106 vldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen  106 VLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             hhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence            88888877641                        134445555555555566666554 55555566666666666655


Q ss_pred             EEeeccCccccCccccceeeccCccccccccccccCCCc---cceeeccCccCccccC
Q 002760          491 AFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSF---LEFLNLSYNHFEGEVP  545 (884)
Q Consensus       491 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~ls~N~l~~~~p  545 (884)
                      .+- ..|..++.++.|++|.+.+|+++ .+|+.++++.-   -+.+.+.+|+|-..+.
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa  216 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA  216 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence            554 45555566666666666666665 45555544322   2345566677755443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.2e-19  Score=207.09  Aligned_cols=206  Identities=20%  Similarity=0.264  Sum_probs=161.8

Q ss_pred             CccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cc----cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          642 SSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QK----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       642 ~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ...+.+|.|++|.|+.+......+.++.|..+.+  ..    .....+..|..+-..+.|||++..+..+..     ...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence            4678999999998888887766666666654321  11    112235667777788899999888877432     222


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      ..-+|||+++ +|..++...+      .+...++-.++.|++.|+.|+|   ..||.|||+|++|++++.+|.+||+|||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecC
Confidence            2344999999 9999998763      4677788889999999999999   8899999999999999999999999999


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCCCCCCcc-cceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK-GDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      .+..+.......    -....+++|+..|+|||++.+.+|+++ .||||.|++++.|.+|+.||.....+..
T Consensus       466 ~~~vf~~~~e~~----~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  466 AASVFRYPWEKN----IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN  533 (601)
T ss_pred             cceeeccCcchh----hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence            998665443321    123457889999999999999999775 7999999999999999999977654433

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=2.7e-20  Score=201.99  Aligned_cols=270  Identities=24%  Similarity=0.291  Sum_probs=158.1

Q ss_pred             cccCCCcceecccccccccCc----ccccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCC
Q 002760          228 LSNASSLEMIEFSKNQFSGGV----SVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP  303 (884)
Q Consensus       228 l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p  303 (884)
                      +..+.+|+.|++++|.++...    ...+...++|+.++++.+.+.............+..+++|+.|++++|.+.+..+
T Consensus        19 ~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~   98 (319)
T cd00116          19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC   98 (319)
T ss_pred             HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence            344445555666555553321    1223344455566665555542111112233445567777777777777664333


Q ss_pred             chhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCc----cCCcccCCC-CCCCEEEccCCCCCCC----
Q 002760          304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTG----TIPPEIGEL-TNLQQLDLDRNFLQGS----  374 (884)
Q Consensus       304 ~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~----  374 (884)
                      ..+..+.                     .. ++|+.|++++|++++    .+...+..+ ++|++|++++|.+++.    
T Consensus        99 ~~~~~l~---------------------~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  156 (319)
T cd00116          99 GVLESLL---------------------RS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA  156 (319)
T ss_pred             HHHHHHh---------------------cc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence            3222111                     11 347777777777662    222334455 6777777777777632    


Q ss_pred             CCCccCccccCcEEEccccccccc----CCCCCcCcccccccccccccccCccchhhhhhhccchhhhcCCccCCCCCCc
Q 002760          375 IPSSLGNLTLLTYLKLGLNNLEGN----IPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPP  450 (884)
Q Consensus       375 ~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~  450 (884)
                      ++..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.+.+.....                     ++.
T Consensus       157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~---------------------l~~  215 (319)
T cd00116         157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA---------------------LAE  215 (319)
T ss_pred             HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH---------------------HHH
Confidence            233455566777777777777632    2333444567777777777765221111                     122


Q ss_pred             cccCCCccCEEecCCCCCCCCchhhhhc-----ccccccccccCcEEee----ccCccccCccccceeeccCcccccc--
Q 002760          451 EVGNLKNLMRLDLSGNKFSGEIPATLSA-----CANLEYLNISGNAFSG----SIPLLLDSLQSIKELDFSSNNLNGQ--  519 (884)
Q Consensus       451 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~--  519 (884)
                      .+..+++|++|++++|++++.....+..     .+.|+.|++++|.++.    .+...+..+++|+++++++|.++..  
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~  295 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA  295 (319)
T ss_pred             HhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH
Confidence            3455678888888888887644444432     2688888888888862    2344556667888899999988854  


Q ss_pred             --ccccccCC-CccceeeccCccC
Q 002760          520 --IPEYLENL-SFLEFLNLSYNHF  540 (884)
Q Consensus       520 --~p~~~~~l-~~L~~L~ls~N~l  540 (884)
                        ....+... +.|+.+++.+|+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         296 QLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHHhhcCCchhhcccCCCCC
Confidence              44455555 6788888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=5.2e-18  Score=167.89  Aligned_cols=140  Identities=19%  Similarity=0.329  Sum_probs=106.6

Q ss_pred             CccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-----CCCCccceeeeeccCCccCCccc
Q 002760          642 SSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-----RHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       642 ~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .-.+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||++++|++....  +.+.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence            4457899999999995  6656655 69988765455567899999999999     5799999999863221  12343


Q ss_pred             e-EEEEc--cCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCeeeCC----CCc
Q 002760          717 A-IVYEF--MQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI-EYLHHYCEPSIVHGDLKPSNVLLDQ----DLV  788 (884)
Q Consensus       717 ~-lv~e~--~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~~ivH~Dlkp~NiLl~~----~~~  788 (884)
                      + +|+||  +.+|+|.++++...       +++.  ..++.|++.++ +|||   +++||||||||+|||++.    ++.
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCc
Confidence            3 78999  55799999997532       3333  34677888887 9999   889999999999999974    348


Q ss_pred             eEEec-ccccc
Q 002760          789 SHVSD-FGLAK  798 (884)
Q Consensus       789 ~kl~D-Fg~a~  798 (884)
                      ++|+| ||.+.
T Consensus       148 ~~LiDg~G~~~  158 (210)
T PRK10345        148 PVVCDNIGEST  158 (210)
T ss_pred             EEEEECCCCcc
Confidence            99999 55444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=8.1e-19  Score=203.14  Aligned_cols=198  Identities=20%  Similarity=0.264  Sum_probs=155.2

Q ss_pred             HHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCC---CCCccceeeeeccCCcc
Q 002760          635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR---HRNLIKIITVCSGRDFK  711 (884)
Q Consensus       635 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~  711 (884)
                      ......|.|.+.||+|+||+||+|.+.. |+.||+|+-+....   -+|.--.+++.+++   -+.|..+...     ..
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a-----~~  764 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSA-----HV  764 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHH-----Hc
Confidence            3445689999999999999999999975 99999999753322   23334455566665   2333333333     22


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC------
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ------  785 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~------  785 (884)
                      ..+.-++|+||.+.|+|.+++...+      .+++.-++.++.|+++.+++||   ..+|||+||||+|+||..      
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             cCCcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCC
Confidence            3345589999999999999998554      5788889999999999999999   889999999999999952      


Q ss_pred             -CCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCC
Q 002760          786 -DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR  856 (884)
Q Consensus       786 -~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~  856 (884)
                       ..-++|+|||.|..+.--...      ....+.++|-.+-.+|...|+++++++|.|.++.+++-|+.|++
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDG------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceEEEecccceeeeEcCCC------cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence             457899999999765432211      23456778999999999999999999999999999999999976

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=2.4e-20  Score=202.40  Aligned_cols=280  Identities=21%  Similarity=0.283  Sum_probs=157.8

Q ss_pred             EEEcCCCCCcc-ccCcCccCCCCCcEEEccCCcCCC----CCCcCcCCCCCCCEEEccCCcCcC------cCCccccCCC
Q 002760           20 RLDLGNQSIRG-TLSPYVGNLSFLRYINIASNGFNG----EIPHQIGRLISLERLILSNNSFSG------AIPANLSSCS   88 (884)
Q Consensus        20 ~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~l~~l~   88 (884)
                      .|+|+++.+++ ..+..+..+..|++|+++++.+++    .++..+...++|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            46777777773 345556677778888888888853    355666777788888888887762      2344566677


Q ss_pred             CCcEEeccCccccCCCCcccccccc---cceecccccccCC----CCCcccCCC-CCCcEEEeccccccc-----ccccc
Q 002760           89 NLIELSADSNNLVGEIPADIGSLFK---LERLSIFQNHITG----QLPASIGNL-SSLRVIDVRENRLWG-----RIDSL  155 (884)
Q Consensus        89 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~n~l~~----~~~~~l~~l-~~L~~L~l~~n~l~~-----~~~~l  155 (884)
                      +|++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+..     ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            8888888888777555555655555   7777777777762    122334555 677777777777662     22345


Q ss_pred             ccccccceeeccccccCCC----CCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccC
Q 002760          156 GQLKSLTLLSVAFNQFSGM----IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNA  231 (884)
Q Consensus       156 ~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l  231 (884)
                      ..+++|++|++++|.+++.    ++..+..+++|++|+|++|.+++.-..                     ..+..+..+
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------------~l~~~~~~~  220 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS---------------------ALAETLASL  220 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH---------------------HHHHHhccc
Confidence            5566677777777766532    222334445666666666665411100                     111223334


Q ss_pred             CCcceecccccccccCcccccc-----cccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCC----C
Q 002760          232 SSLEMIEFSKNQFSGGVSVDFS-----RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE----L  302 (884)
Q Consensus       232 ~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~----~  302 (884)
                      ++|++|++++|.+++.....+.     ..+.|+.|++++|.++...  ...+...+..+++|+++++++|.+...    +
T Consensus       221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~--~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~  298 (319)
T cd00116         221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDG--AKDLAEVLAEKESLLELDLRGNKFGEEGAQLL  298 (319)
T ss_pred             CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHH--HHHHHHHHhcCCCccEEECCCCCCcHHHHHHH
Confidence            4455555555544432221111     1245555555555554222  112333445556666666666666533    2


Q ss_pred             CchhhccchhhhhhcccCCc
Q 002760          303 PHSVANLSSTIKQIAMGRNR  322 (884)
Q Consensus       303 p~~~~~l~~~l~~L~l~~n~  322 (884)
                      ...+....+.++.+++.+|.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         299 AESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHhhcCCchhhcccCCCC
Confidence            22222332455666665553

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=7.8e-18  Score=171.29  Aligned_cols=146  Identities=20%  Similarity=0.196  Sum_probs=112.3

Q ss_pred             hcCCCccCeeeeccceEEEEEE-ECCCCcEEEEEEeeccccc------------------------chHHHHHHHHHHHc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGF-LGENGTEVAVKVINLKQKG------------------------ASKSFVAECKALRN  692 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~  692 (884)
                      ..-|++.+.||+|+||.||+|. +..+|+.||||+++.....                        ....+..|++++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458899999999999999998 6678999999998743210                        01235689999999


Q ss_pred             CCCCC--ccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 002760          693 IRHRN--LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS  770 (884)
Q Consensus       693 l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~  770 (884)
                      +.+..  +.+++++         ...++||||++++++..+.....      .....+...++.|++.++++||   ..|
T Consensus       107 L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH---~~g  168 (237)
T smart00090      107 LYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLY---KEG  168 (237)
T ss_pred             HHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHH---hcC
Confidence            97543  3333432         12489999999988776542221      3455667789999999999999   788


Q ss_pred             -eeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          771 -IVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       771 -ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                       |+||||||+||+++ ++.++++|||.|.....
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence             99999999999999 88999999999875543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.73  E-value=3.3e-18  Score=174.39  Aligned_cols=208  Identities=23%  Similarity=0.306  Sum_probs=132.6

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc---cchHHHHHHHHHHHcCCC----------CCccceeeeec
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRH----------RNLIKIITVCS  706 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~  706 (884)
                      .+..++.||.|+++.||.+++..+|+++|||+......   ...+.+++|......+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45567899999999999999999999999998864332   234566666644444322          11111112111


Q ss_pred             c---CCcc-CC---c-----cceEEEEccCCCCHHHHhhc---cCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002760          707 G---RDFK-GA---D-----FKAIVYEFMQNGSLEEWLHH---SNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSI  771 (884)
Q Consensus       707 ~---~~~~-~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i  771 (884)
                      .   ..+. ..   .     ..+++|+-+ .++|.+++..   ....  ...+...-++.+..|+++.+++||   ..|+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh---~~Gl  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLH---SYGL  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHh---hcce
Confidence            0   0000 01   1     235677777 5688887653   2111  123444555677799999999999   7899


Q ss_pred             eecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCC--------CCCCcccceee
Q 002760          772 VHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG--------REASMKGDVYS  843 (884)
Q Consensus       772 vH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS  843 (884)
                      ||+||+|+|++++++|.++|+||+.....+.....           ...+..|.+||....        ..++.+.|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence            99999999999999999999999987654321110           124567999997533        35788999999


Q ss_pred             hhHHHHHHhcCCCCCCccccC
Q 002760          844 FGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       844 lG~il~~lltg~~p~~~~~~~  864 (884)
                      +|+++|.+++|..||+....+
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~  256 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPE  256 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGG
T ss_pred             HHHHHHHHHHccCCCCCCCcc
Confidence            999999999999999876443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.4e-19  Score=190.08  Aligned_cols=187  Identities=26%  Similarity=0.295  Sum_probs=153.9

Q ss_pred             eeeeccceEEEEEEE---CCCCcEEEEEEeecccc--cchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCCccceEE
Q 002760          646 KIGEGGSGIVYKGFL---GENGTEVAVKVINLKQK--GASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAIV  719 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  719 (884)
                      .+|+|+||.|+.++.   ...|+-+|.|+.++...  +.......|..++...+ ||.+|++.-.     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            379999999987543   23567799998864322  11125566888888886 9999988765     6778889999


Q ss_pred             EEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          720 YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       720 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      ++|..||.+...+....      .+.+.....+...++-|++++|   +.+|+|||+|++||+++.+|++++.|||.++.
T Consensus        76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhH
Confidence            99999999988877654      5667777788889999999999   88999999999999999999999999999986


Q ss_pred             cccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCc
Q 002760          800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                      .-....            .|||..|||||++.  ....++|.||+|++++||+||..||..
T Consensus       147 ~v~~~~------------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  147 AVKEKI------------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hHhhhh------------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            643221            27999999999988  677899999999999999999999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2e-18  Score=165.55  Aligned_cols=196  Identities=28%  Similarity=0.459  Sum_probs=154.8

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceE
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      .....+|.+...|+.|+|+|  .|..+++|++...+  ....+.|..|.-.++...||||.+++|.|.     .+....+
T Consensus       192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~  264 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVI  264 (448)
T ss_pred             hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceE
Confidence            44567899999999999999  46677778876443  334567889999999999999999999974     4467789


Q ss_pred             EEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEe--cccc
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGL  796 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~--DFg~  796 (884)
                      +.+||+.|+|+..++.....    ..+..++.++|.++++|++|||+. +.-|----+.+..+++|++.+.+|+  |--+
T Consensus       265 isq~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             eeeeccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccccee
Confidence            99999999999999986543    567788999999999999999987 5555555789999999999888773  3322


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccCCCCCC---cccceeehhHHHHHHhcCCCCCCcccc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS---MKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~~lltg~~p~~~~~~  863 (884)
                      +..    ..           +..-+|.||+||.+..++-+   .++|+|||++++||+-|+..||..-.+
T Consensus       340 sfq----e~-----------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp  394 (448)
T KOG0195|consen  340 SFQ----EV-----------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP  394 (448)
T ss_pred             eee----cc-----------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence            210    00           11236889999998886643   468999999999999999999987544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=7.4e-18  Score=170.30  Aligned_cols=213  Identities=24%  Similarity=0.349  Sum_probs=145.7

Q ss_pred             HHHhcCCCccCeeeeccceEEEEEEECCCCc-----------------------------------EEEEEEeeccc-cc
Q 002760          635 SKATDNFSSANKIGEGGSGIVYKGFLGENGT-----------------------------------EVAVKVINLKQ-KG  678 (884)
Q Consensus       635 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~-----------------------------------~vavK~~~~~~-~~  678 (884)
                      ....++|++++.||+|.-+.||.|+...+|.                                   +.|+|++-... ..
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            3345789999999999999999997653221                                   34666653211 11


Q ss_pred             chHHHH----HH------------H--HHHHc--------CCCCCccceeeeeccC----------------------Cc
Q 002760          679 ASKSFV----AE------------C--KALRN--------IRHRNLIKIITVCSGR----------------------DF  710 (884)
Q Consensus       679 ~~~~~~----~e------------~--~~l~~--------l~h~niv~~~~~~~~~----------------------~~  710 (884)
                      ....+.    +|            .  ...+.        -+|||||++.+++.+.                      ..
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            111111    11            0  00111        2599999998765321                      11


Q ss_pred             cCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeC--CCC-
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD--QDL-  787 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~--~~~-  787 (884)
                      -.+...|+||...+. +|.+|+....       .+.....-|..|+++|+.|||   ++||.|||+|++|||+.  +|+ 
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~  381 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEI  381 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCC
Confidence            224577899988854 8999987653       455566778999999999999   88999999999999984  444 


Q ss_pred             -ceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCC------CcccceeehhHHHHHHhcCCCCCCc
Q 002760          788 -VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       788 -~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlG~il~~lltg~~p~~~  860 (884)
                       ...++|||++-....+.  ...+..+.....-|...-||||+....+-      ..++|.|+.|.+.||+++...||.+
T Consensus       382 P~LVvaDFGCcLAd~~hG--lqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  382 PQLVVADFGCCLADDNHG--LQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             cEEEEcccceeeeccccc--cccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence             45789999875433221  22223333334457888999998765432      3479999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.7e-16  Score=158.59  Aligned_cols=144  Identities=24%  Similarity=0.231  Sum_probs=110.3

Q ss_pred             HHHHhcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc----------------------chHHHHHHHHHHH
Q 002760          634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG----------------------ASKSFVAECKALR  691 (884)
Q Consensus       634 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~  691 (884)
                      +......|.+.+.||+|+||.||+|... +|+.||||+++.....                      .......|..++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3334445888999999999999999885 8999999987643211                      0123567888888


Q ss_pred             cCCCCC--ccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 002760          692 NIRHRN--LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP  769 (884)
Q Consensus       692 ~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~  769 (884)
                      .+.|++  ++..++.         ...++||||++|++|.+....            .....++.+++.++.++|   +.
T Consensus        89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh---~~  144 (198)
T cd05144          89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAY---KH  144 (198)
T ss_pred             HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHH---HC
Confidence            887774  3444332         234899999999998765321            123568899999999999   78


Q ss_pred             CeeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       770 ~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      ||+||||||+||++++++.++|+|||.|.....
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.1e-16  Score=160.04  Aligned_cols=134  Identities=22%  Similarity=0.356  Sum_probs=110.1

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccccc--------chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--------ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      +.||+|++|.||+|.+  .|..|++|+.......        ...++.+|++++..++|++++....++.     .....
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence            6799999999999988  7788999986532211        1245778999999999998876666532     33456


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++||||++|++|.+++....         . ++..++.+++.++.++|   ..+++|||++|+||+++ ++.++++|||.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999986432         1 67789999999999999   88999999999999999 88999999999


Q ss_pred             ccc
Q 002760          797 AKF  799 (884)
Q Consensus       797 a~~  799 (884)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=2.1e-17  Score=186.95  Aligned_cols=178  Identities=29%  Similarity=0.358  Sum_probs=129.4

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+|..++.|..|+||.||..+++.+.+.+|+|+-+   ..         .|++     ||.++.+.           .+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q~---------lilR-----nilt~a~n-----------pf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---QN---------LILR-----NILTFAGN-----------PF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc---cc---------hhhh-----ccccccCC-----------cc
Confidence            357889999999999999999999999999996532   10         1111     23332221           12


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      .|      |+-.+.++..+      +++.        +++.|++|+|   ..||+|||+||+|.+|+.-|++|+.|||++
T Consensus       134 vv------gDc~tllk~~g------~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG------PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ee------chhhhhcccCC------CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhh
Confidence            33      34444444433      2222        3478999999   889999999999999999999999999998


Q ss_pred             cccccCCCCc-------ccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCCccccCCc
Q 002760          798 KFLSNHNPDT-------IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       798 ~~~~~~~~~~-------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~  866 (884)
                      +.........       .....-.....||||.|.|||++....|+..+|+|++|+|+||.+.|..||.+...|+.
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence            6543211110       00111123456899999999999999999999999999999999999999999866654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.67  E-value=2.9e-17  Score=185.86  Aligned_cols=202  Identities=20%  Similarity=0.221  Sum_probs=148.2

Q ss_pred             CCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccccc-chHHHH---HHHHHHHcCCCCCccceeeeeccCCccCCcc
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFV---AECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .|...+.+|++.|=.|.+|+++ .|. |+||++-...+. ..+.+.   .|++ ..-++|||++++.-+     .+.+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence            5778899999999999999985 444 899998654432 223333   3444 455689999998765     456667


Q ss_pred             ceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccc
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg  795 (884)
                      .|+|-+|..+ +|+|.+....      .+...+.+.||.|++.|+.-+|   ..||+|||||.+|||++.=.-+.|+||.
T Consensus        96 AylvRqyvkh-nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   96 AYLVRQYVKH-NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHHHHHHHhh-hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhccc
Confidence            7899999965 8999887543      5777888999999999999999   8899999999999999999999999998


Q ss_pred             cccccccCCCCcccccceeeeccccccceeCccccCC----------CC-CCcccceeehhHHHHHHhc-CCCCCCc
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG----------RE-ASMKGDVYSFGILLLELFT-RKRPTDA  860 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwSlG~il~~llt-g~~p~~~  860 (884)
                      .-+-..-++.+. .+..-....-..-..|.|||.+-.          .+ .+++-||||+||+++|+++ |++||.-
T Consensus       166 sFKPtYLPeDNP-adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  166 SFKPTYLPEDNP-ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             ccCCccCCCCCc-ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            654222111110 011111111123346999997543          12 5778999999999999997 7888865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=1.8e-16  Score=158.92  Aligned_cols=131  Identities=26%  Similarity=0.398  Sum_probs=103.8

Q ss_pred             eeeeccceEEEEEEECCCCcEEEEEEeeccccc--------chHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccce
Q 002760          646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--------ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       646 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .||+|+||.||+|.+  +|..|++|+.......        ...++.+|+++++.++|+++.....++.     .....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            389999999999986  6788999986432111        1255778999999998887554444321     234458


Q ss_pred             EEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccc
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a  797 (884)
                      +||||++|++|.+++....      .       .++.+++.++.++|   +.|++|||++|+||+++ ++.++++|||.+
T Consensus        74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999999999998875431      0       68899999999999   88999999999999999 899999999998


Q ss_pred             ccc
Q 002760          798 KFL  800 (884)
Q Consensus       798 ~~~  800 (884)
                      ...
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=4.7e-16  Score=179.23  Aligned_cols=138  Identities=25%  Similarity=0.335  Sum_probs=109.0

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecc--cc------cchHHHHHHHHHHHcCCCCCccceeeeeccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QK------GASKSFVAECKALRNIRHRNLIKIITVCSGRD  709 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  709 (884)
                      ...|...+.||+|+||+||+|.+.  ++.+++|+...+  ..      ...+++.+|++++++++|++++....++.   
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~---  406 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV---  406 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE---
Confidence            345677899999999999999884  444455443211  11      12356889999999999999988766643   


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                        .....++||||+++++|.+++.              ....++.|++.++.|||   +.+++|||+||+||++ .++.+
T Consensus       407 --~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        407 --DPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             --eCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcE
Confidence              2334589999999999998875              23568899999999999   8899999999999999 68899


Q ss_pred             EEecccccccc
Q 002760          790 HVSDFGLAKFL  800 (884)
Q Consensus       790 kl~DFg~a~~~  800 (884)
                      +|+|||+|+..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=4.5e-17  Score=172.55  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=137.7

Q ss_pred             CCCccCeeeeccceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceee-------eeccCC
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIIT-------VCSGRD  709 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-------~~~~~~  709 (884)
                      .+.+.+..++.+++.++.++-...   .+.++.+..+...........+++-.+.-..|.+..-+.+       ......
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            355566677777777766554322   2334444333222122233334444443333333222222       111111


Q ss_pred             ccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCce
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~  789 (884)
                      .....+.|+.|++|+-.+|.+++.+.+..   ...++.....++.|++.|++|      ++.+|||+||.||+...+..+
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhh
Confidence            12234678999999999999999765432   256777888999999999999      489999999999999999999


Q ss_pred             EEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhc
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT  853 (884)
Q Consensus       790 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~llt  853 (884)
                      ||.|||+.........  ..+.........||..||+||.+.+..|+.++||||||++++|+++
T Consensus       396 kIgDFgl~ts~~~~~~--~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDET--VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhheeecccCCc--ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9999999876654431  1122223446679999999999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=6.6e-15  Score=145.95  Aligned_cols=137  Identities=24%  Similarity=0.318  Sum_probs=96.7

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeecccccc--hHH----------------------HHHHHHHHHcCCCCC--
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKS----------------------FVAECKALRNIRHRN--  697 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--  697 (884)
                      .+.||+|+||+||+|.+. +|++||||+++......  ...                      ...|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 89999999986432211  111                      134555555554332  


Q ss_pred             ccceeeeeccCCccCCccceEEEEccCCCCHHH-HhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecC
Q 002760          698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEE-WLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGD  775 (884)
Q Consensus       698 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~D  775 (884)
                      +.+.++.         ...++||||++++.+.. .+...       ... .+...++.+++.++.++|   . ++|+|||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~D  140 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLY---REAGLVHGD  140 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCC
Confidence            3334432         23489999999854321 11111       011 456789999999999999   6 8999999


Q ss_pred             CCCCCeeeCCCCceEEecccccccccc
Q 002760          776 LKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       776 lkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      +||+||+++ ++.++++|||.|.....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccccC
Confidence            999999999 99999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=1.9e-14  Score=137.41  Aligned_cols=135  Identities=21%  Similarity=0.298  Sum_probs=109.8

Q ss_pred             ccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCC--CCccceeeeeccCCccCCccceEEE
Q 002760          643 SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH--RNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      +.+.||+|.++.||++...  ++.+++|.......  ...+.+|+.+++.++|  +.+++++++.     ...+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence            4578999999999999984  47899999854332  4678899999999976  5888888773     3346779999


Q ss_pred             EccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccc
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~  799 (884)
                      ||++++.+..+             +......++.+++.+++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99988766543             3445667889999999999965446899999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=2.7e-14  Score=145.70  Aligned_cols=140  Identities=21%  Similarity=0.201  Sum_probs=105.2

Q ss_pred             cCeee-eccceEEEEEEECCCCcEEEEEEeeccc-------------ccchHHHHHHHHHHHcCCCCCc--cceeeeecc
Q 002760          644 ANKIG-EGGSGIVYKGFLGENGTEVAVKVINLKQ-------------KGASKSFVAECKALRNIRHRNL--IKIITVCSG  707 (884)
Q Consensus       644 ~~~lg-~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~  707 (884)
                      ...|| .|+.|+||.+..  .+..+|||.+....             .....++.+|++++.+++|+++  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45687 889999999887  47889999885211             1223567889999999998875  566665432


Q ss_pred             CCccCCccceEEEEccCC-CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC
Q 002760          708 RDFKGADFKAIVYEFMQN-GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~  786 (884)
                      .. ......++|||+++| .+|.+++...       .++..    .+.+++.++.+||   ++||+||||||+|||++.+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPD  178 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCC
Confidence            11 111123599999997 6999888643       23333    3568999999999   8899999999999999999


Q ss_pred             CceEEecccccccc
Q 002760          787 LVSHVSDFGLAKFL  800 (884)
Q Consensus       787 ~~~kl~DFg~a~~~  800 (884)
                      +.++|+|||.+...
T Consensus       179 ~~v~LIDfg~~~~~  192 (239)
T PRK01723        179 GKFWLIDFDRGELR  192 (239)
T ss_pred             CCEEEEECCCcccC
Confidence            99999999998754

>PLN03150 hypothetical protein; Provisional

Probab=99.54  E-value=1.1e-14  Score=169.42  Aligned_cols=134  Identities=32%  Similarity=0.476  Sum_probs=107.5

Q ss_pred             ccCEEecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccccccccccccCCCccceeecc
Q 002760          457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS  536 (884)
Q Consensus       457 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  536 (884)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCccccCCC--CcccccccccccCCCcccCCCCcCCCCCCCCCCcceeEEEeehhh
Q 002760          537 YNHFEGEVPMK--GVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKGSLTILKVVIPVI  592 (884)
Q Consensus       537 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~~~~~~~~~~i~~~~~  592 (884)
                      +|+++|.+|..  ........+.+.+|+.+|+.|..  ..|........++.++++++
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~~~~~~~~~i~~~~~~~  554 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPHLSVGAKIGIAFGVS  554 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCcccCCCceEEEEEhHHH
Confidence            99999999863  22234456778999999997642  24543223333344444444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2.8e-15  Score=171.41  Aligned_cols=219  Identities=23%  Similarity=0.312  Sum_probs=170.2

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCC-CcEEEEEEeeccc--ccchHHHHHHHHHHHcCC-CCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN-GTEVAVKVINLKQ--KGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  713 (884)
                      ...|.+.+.||+|+|+.|-.+....+ ...+|+|.+....  ....+....|..+-..+. |+|++++++.     ....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence            45688889999999999988876433 3457777665332  334455556777777775 9999999987     5567


Q ss_pred             ccceEEEEccCCCCHHHHh-hccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC-ceEE
Q 002760          714 DFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHV  791 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl  791 (884)
                      ...++.++|..|+++.+-+ .....     ..+....-.+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..++
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             cccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccC
Confidence            7789999999999998887 33221     23444556688999999999995  56899999999999999999 9999


Q ss_pred             ecccccccccc-CCCCcccccceeeecccc-ccceeCccccCCC-CCCcccceeehhHHHHHHhcCCCCCCccccCCccH
Q 002760          792 SDFGLAKFLSN-HNPDTIVETRSISIGIKG-TVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL  868 (884)
Q Consensus       792 ~DFg~a~~~~~-~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlG~il~~lltg~~p~~~~~~~~~~~  868 (884)
                      +|||+|..+.. ....      ......+| ++.|+|||...+. ...+..|+||.|+++..+++|..||+........+
T Consensus       167 ~df~~At~~~~~~g~~------~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~  240 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAE------RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY  240 (601)
T ss_pred             CCchhhccccccCCcc------eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence            99999987766 2222      22334568 9999999998884 56788999999999999999999999887776666


Q ss_pred             HHHHHH
Q 002760          869 HDFSRE  874 (884)
Q Consensus       869 ~~~~~~  874 (884)
                      ..|...
T Consensus       241 ~~~~~~  246 (601)
T KOG0590|consen  241 SSWKSN  246 (601)
T ss_pred             eeeccc
Confidence            666554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=1.2e-15  Score=161.60  Aligned_cols=175  Identities=33%  Similarity=0.524  Sum_probs=102.8

Q ss_pred             CCCCcEEEeecCCCCccCCcccCCCCCCCEEEccCCCCCCCCCCccCccccCcEEEcccccccccCCCCCcCcccccccc
Q 002760          334 LASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN  413 (884)
Q Consensus       334 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  413 (884)
                      +..-...+|+.|++. .+|..+..+-.|+.+.|+.|.|. .+|..++++..|++|||+.|+++ ..|..++.++ |+.|-
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            444455566666665 55666666666666666666666 55666666666666666666666 4555555554 56666


Q ss_pred             cccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEe
Q 002760          414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS  493 (884)
Q Consensus       414 Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  493 (884)
                      +++|+++                          .+|+.++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++.
T Consensus       150 ~sNNkl~--------------------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~  202 (722)
T KOG0532|consen  150 VSNNKLT--------------------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE  202 (722)
T ss_pred             EecCccc--------------------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence            6666654                          44555555555666666666664 45555566666666666666655


Q ss_pred             eccCccccCccccceeeccCccccccccccccCCCccceeeccCccCcc
Q 002760          494 GSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG  542 (884)
Q Consensus       494 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  542 (884)
                       ..|..+..| .|..||+|+|+++ .+|-.|..|..|++|-|.+|+|..
T Consensus       203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence             344444433 3555666666665 456666666666666666666654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=1.1e-15  Score=161.65  Aligned_cols=212  Identities=27%  Similarity=0.413  Sum_probs=153.0

Q ss_pred             EEcCCCCCccccCcCc--cCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCc
Q 002760           21 LDLGNQSIRGTLSPYV--GNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSN   98 (884)
Q Consensus        21 L~l~~~~~~~~~~~~l--~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n   98 (884)
                      |.|++-.++ ..|..-  -.+.--...||+.|++. ++|.+++.+..|+.|.|+.|.+. .+|..++++..|++|||+.|
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            455555555 343211  24555667778888887 78888888888888888888877 67888888888888888888


Q ss_pred             cccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCcc
Q 002760           99 NLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPS  178 (884)
Q Consensus        99 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  178 (884)
                      ++. .+|..++.| -|+.|.+++|+++ .+|+.++.+..|..||.+.|.+..+|..++++.+|+.|++..|++. .+|..
T Consensus       132 qlS-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEE  207 (722)
T ss_pred             hhh-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence            887 777777766 4788888888887 7778888778888888888888888888888888888888888877 56777


Q ss_pred             ccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccC---CCcceecccccc
Q 002760          179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNA---SSLEMIEFSKNQ  243 (884)
Q Consensus       179 l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l---~~L~~L~Ls~N~  243 (884)
                      +..| .|..||+|.|++. .+|..+. +|+.|++|-|.+|.++. +|..++-.   .=.++|+..-++
T Consensus       208 l~~L-pLi~lDfScNkis-~iPv~fr-~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  208 LCSL-PLIRLDFSCNKIS-YLPVDFR-KMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             HhCC-ceeeeecccCcee-ecchhhh-hhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence            7643 5777888888887 7776643 78888888888888874 34444322   224566666664

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=9.6e-14  Score=154.95  Aligned_cols=198  Identities=25%  Similarity=0.381  Sum_probs=114.4

Q ss_pred             EEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCC-CCcEEeccCccccCCCCcccccccccceeccccc
Q 002760           44 YINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCS-NLIELSADSNNLVGEIPADIGSLFKLERLSIFQN  122 (884)
Q Consensus        44 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n  122 (884)
                      .|+++.+.+. ..+..+..++.++.|++.+|.++ .+|.....++ +|++|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4555555553 23333444556666666666666 4555555553 6666666666666 45555666666666666666


Q ss_pred             ccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCC
Q 002760          123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVD  202 (884)
Q Consensus       123 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~  202 (884)
                      +++ .+|...+.+++|+.|++++|++..+|..+..+..|++|.+++|++. ..+..+.++.++..|.+.+|++. .++ .
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~-~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP-E  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc-c
Confidence            666 4454444566666666666666666655555555666666666433 24455666666666666666654 222 2


Q ss_pred             CCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccc
Q 002760          203 TGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSV  250 (884)
Q Consensus       203 ~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~  250 (884)
                      ....+++++.|++++|.++.+.+  +..+.+++.|++++|.+....+.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            22355556666666666665433  66666666666666666555443

>PLN03150 hypothetical protein; Provisional

Probab=99.43  E-value=2.5e-13  Score=158.13  Aligned_cols=120  Identities=33%  Similarity=0.573  Sum_probs=101.6

Q ss_pred             eeEeeEEcCC--C--CeEEEEEcCCCCCccccCcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcC
Q 002760            5 QWTGVTCGQR--H--QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAI   80 (884)
Q Consensus         5 ~w~~v~c~~~--~--~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~   80 (884)
                      .|.||+|...  .  ..|+.|+|+++++.+.+|+.++.+++|+.|+|++|.+.+.+|..++.+++|++|+|++|++++.+
T Consensus       403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i  482 (623)
T PLN03150        403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI  482 (623)
T ss_pred             ccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence            7999999532  2  25899999999999999999999999999999999999899999999999999999999999888


Q ss_pred             CccccCCCCCcEEeccCccccCCCCcccccc-cccceeccccccc
Q 002760           81 PANLSSCSNLIELSADSNNLVGEIPADIGSL-FKLERLSIFQNHI  124 (884)
Q Consensus        81 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~n~l  124 (884)
                      |..++++++|++|+|++|++++.+|..++.+ .++..+++.+|..
T Consensus       483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~  527 (623)
T PLN03150        483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG  527 (623)
T ss_pred             chHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCcc
Confidence            9889999999999999998888888877653 3566677766653

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=3.2e-13  Score=150.75  Aligned_cols=199  Identities=29%  Similarity=0.395  Sum_probs=102.4

Q ss_pred             EEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCC-CCcEEEeccccccccccccccccccceeeccccc
Q 002760           92 ELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS-SLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQ  170 (884)
Q Consensus        92 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~  170 (884)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|++..++..+..+++|+.|++++|+
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCch
Confidence            3444444443 22233334444555555555555 4444444442 5555555555555555455555555555555555


Q ss_pred             cCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCccc
Q 002760          171 FSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSV  250 (884)
Q Consensus       171 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~  250 (884)
                      ++ .+|.....+++|+.|++++|++. .+|... ..+..|++|.+++|.+. ..+..+.++.++..+.+.+|++... +.
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~  249 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE  249 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCccc-cCchhh-hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence            55 33433334555555555555554 444322 01223555555555322 1334455566666666666665543 33


Q ss_pred             ccccccccceeeccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCch
Q 002760          251 DFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS  305 (884)
Q Consensus       251 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~  305 (884)
                      .+..+.++++|+++.|.++....        +..+.+++.|++++|.+....|..
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--------~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--------LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hhccccccceecccccccccccc--------ccccCccCEEeccCccccccchhh
Confidence            45555666666666666655432        556667777777777776554443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=9.4e-13  Score=146.34  Aligned_cols=143  Identities=20%  Similarity=0.266  Sum_probs=99.3

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeecccccc--------------------------h--------------HHH
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--------------------------S--------------KSF  683 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~  683 (884)
                      .+.||.|++|+||+|+.+ +|+.||||+.+..-...                          .              -.+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            478999999999999985 89999999985321000                          0              024


Q ss_pred             HHHHHHHHcCC----CCCccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHH-
Q 002760          684 VAECKALRNIR----HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS-  758 (884)
Q Consensus       684 ~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-  758 (884)
                      .+|++.+.+++    |.+-+.+-.++    .+.....++||||++|+++.++......     ..   ....++.+++. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~----~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVY----WDRTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS  268 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEe----hhhcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence            45666665552    33333333333    2223446899999999999887653211     11   12346666665 


Q ss_pred             HHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       759 al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      .+..+|   ..|++|+|++|.||+++.++.++++|||++..+..
T Consensus       269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            367778   78999999999999999999999999999986653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.40  E-value=6.8e-13  Score=144.37  Aligned_cols=157  Identities=32%  Similarity=0.502  Sum_probs=124.1

Q ss_pred             HHcCCCCCccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 002760          690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP  769 (884)
Q Consensus       690 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~  769 (884)
                      |+.+.|.|+.+++|.+.     ++...+.|.+|+..|+|.+.+....     ..+++.-...+.++|+.||+|+|.  +.
T Consensus         1 l~~l~h~n~~~f~g~~~-----~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~--s~   68 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASV-----DGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN--SP   68 (484)
T ss_pred             CcccchhhhhhheeeEe-----cCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc--Cc
Confidence            35688999999999974     3367799999999999999998733     368888889999999999999995  23


Q ss_pred             CeeecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCC-------CCCccccee
Q 002760          770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-------EASMKGDVY  842 (884)
Q Consensus       770 ~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvw  842 (884)
                      ...|+.+++.|.+++....+|++|||+............      .....-..-|.|||.++..       ..+.+.|+|
T Consensus        69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~------~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiY  142 (484)
T KOG1023|consen   69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEA------HHPIRKALLWTAPELLRGALSQSLESALTQKGDIY  142 (484)
T ss_pred             ceeeeeeccccceeeeeEEEEechhhhcccccccccccc------cchhHHHHhccCHHHhcccccccccccccccCCee
Confidence            339999999999999999999999999887643100000      0011134569999998774       146679999


Q ss_pred             ehhHHHHHHhcCCCCCCccccC
Q 002760          843 SFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       843 SlG~il~~lltg~~p~~~~~~~  864 (884)
                      |+|++++|+++.+.||+.....
T Consensus       143 s~~ii~~ei~~r~~~~~~~~~~  164 (484)
T KOG1023|consen  143 SFGIIMYEILFRSGPFDLRNLV  164 (484)
T ss_pred             hHHHHHHHHHhccCcccccccc
Confidence            9999999999999999885443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=2.4e-12  Score=144.26  Aligned_cols=147  Identities=20%  Similarity=0.256  Sum_probs=94.8

Q ss_pred             cCCCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc----------------------------------cchH---
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK----------------------------------GASK---  681 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------------------------------~~~~---  681 (884)
                      ..|+. +.||+|++|+||+|+.+.+|+.||||+.+....                                  ...+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 899999999999999987799999999963210                                  0011   


Q ss_pred             ---HHHHHHHHHHcCC----CCCccceeeeeccCCccCCccceEEEEccCCCCHHHHh--hccCCCcccccCCHHHHHHH
Q 002760          682 ---SFVAECKALRNIR----HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVCSLSVIQRLNI  752 (884)
Q Consensus       682 ---~~~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~l~~~~~~~i  752 (884)
                         .+.+|+..+.+++    +...+.+-.++    ++-....++||||++|+++.++-  ...+.  ....+....+..+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g~--d~~~la~~~v~~~  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAGT--DMKLLAERGVEVF  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcCC--CHHHHHHHHHHHH
Confidence               1344555555542    33334333332    22234568999999999998753  22211  0011222222222


Q ss_pred             HHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC----ceEEecccccccccc
Q 002760          753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL----VSHVSDFGLAKFLSN  802 (884)
Q Consensus       753 ~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFg~a~~~~~  802 (884)
                      +.|+       .   ..|++|+|+||.||+++.+|    .++++|||++..++.
T Consensus       273 ~~Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2222       2   56999999999999999888    999999999876643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=3.9e-11  Score=116.44  Aligned_cols=138  Identities=21%  Similarity=0.231  Sum_probs=98.7

Q ss_pred             cCeeeeccceEEEEEEECC------CCcEEEEEEeecc-------------c---------ccchHHHH----HHHHHHH
Q 002760          644 ANKIGEGGSGIVYKGFLGE------NGTEVAVKVINLK-------------Q---------KGASKSFV----AECKALR  691 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~------~~~~vavK~~~~~-------------~---------~~~~~~~~----~e~~~l~  691 (884)
                      ...||.|.-+.||.|....      .+..+|||+++..             +         ....+.+.    +|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998643      3579999998621             0         01122333    7999999


Q ss_pred             cCCC--CCccceeeeeccCCccCCccceEEEEccCCCCHHH-HhhccCCCcccccCCHHHHHHHHHHHHHHHHHH-hhcC
Q 002760          692 NIRH--RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEE-WLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL-HHYC  767 (884)
Q Consensus       692 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~  767 (884)
                      ++..  -+++..+++         ...++||||+.++.+.. .++.       ..++..+...+..+++.++.++ |   
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H---  142 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYK---  142 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHH---
Confidence            9853  455666654         23489999997643321 1221       1344455667889999999999 7   


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEeccccccccc
Q 002760          768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       768 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~  801 (884)
                      ..|+||||+++.||+++ ++.++++|||.|....
T Consensus       143 ~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         143 ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            77999999999999997 5789999999887554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=4.4e-11  Score=131.12  Aligned_cols=181  Identities=18%  Similarity=0.234  Sum_probs=134.5

Q ss_pred             eeeeccceEEE-EEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccC
Q 002760          646 KIGEGGSGIVY-KGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQ  724 (884)
Q Consensus       646 ~lg~G~~g~V~-~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~  724 (884)
                      ..+-++.+ +| .|..+.++.+|.|.+++...........+-++.++.++||+|++++..     ++.++..|+|+|.+.
T Consensus        19 ~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~   92 (690)
T KOG1243|consen   19 ETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR   92 (690)
T ss_pred             cccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc
Confidence            33333443 34 466677899999999986655445667788899999999999999987     667778999999984


Q ss_pred             CCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEeccccccccccCC
Q 002760          725 NGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN  804 (884)
Q Consensus       725 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~  804 (884)
                        .|..++++.+         ...+...+.||+.||.|||+  +.+++|++|.-.-|++++.|+.||++|.++.......
T Consensus        93 --Pl~~~lk~l~---------~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   93 --PLETVLKELG---------KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN  159 (690)
T ss_pred             --cHHHHHHHhH---------HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence              7888887543         45667788999999999986  6689999999999999999999999999886443322


Q ss_pred             CCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCC
Q 002760          805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK  855 (884)
Q Consensus       805 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~  855 (884)
                      ...  +.      ..---.|..|+.+....  -..|.|.|||+++|++.|.
T Consensus       160 ~~~--~~------~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  160 APA--KS------LYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccc--cc------chhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            100  00      00112355665433322  3469999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=8.2e-12  Score=135.89  Aligned_cols=203  Identities=28%  Similarity=0.372  Sum_probs=161.0

Q ss_pred             cCCCccCeeee--ccceEEEEEEE--CCCCcEEEEEEee--cccccchHHHHHHHHHHHcC-CCCCccceeeeeccCCcc
Q 002760          639 DNFSSANKIGE--GGSGIVYKGFL--GENGTEVAVKVIN--LKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       639 ~~y~~~~~lg~--G~~g~V~~a~~--~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  711 (884)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+  ...+....+-.+|+....++ .|++.++....     ++
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence            45677889999  99999999998  8899999999843  33334445566777777777 49999885544     77


Q ss_pred             CCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCeeeCCC-
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS----AIEYLHHYCEPSIVHGDLKPSNVLLDQD-  786 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----al~~LH~~~~~~ivH~Dlkp~NiLl~~~-  786 (884)
                      +.+..++-+|++ +.++.++.+....     .++...++.+..+...    |+.++|   ...++|-|+||+||++..+ 
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccc
Confidence            888999999999 5799999886553     4677778888888888    999999   8899999999999999999 


Q ss_pred             CceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCCCCC
Q 002760          787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD  859 (884)
Q Consensus       787 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p~~  859 (884)
                      ...+++|||+...+.+..-....   .......|...|++||...+ -++...|++|+|-+..+..++..+..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~---~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVF---KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ceeecCCcceeEEccCCccccce---eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence            89999999999877665422211   12222347788999998655 67889999999999999998876543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.23  E-value=1.4e-12  Score=127.71  Aligned_cols=133  Identities=30%  Similarity=0.304  Sum_probs=104.3

Q ss_pred             cccCcEEEcccccccccCCCCCcCcccccccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEE
Q 002760          382 LTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRL  461 (884)
Q Consensus       382 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L  461 (884)
                      ...|+.+|||+|.|+ .+..+..-.++++.|++|+|.+.                           .-+.+..+++|+.|
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~---------------------------~v~nLa~L~~L~~L  334 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR---------------------------TVQNLAELPQLQLL  334 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee---------------------------eehhhhhcccceEe
Confidence            345777777777777 45666666777777777777764                           11236778999999


Q ss_pred             ecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccccccc-cccccCCCccceeeccCccC
Q 002760          462 DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQI-PEYLENLSFLEFLNLSYNHF  540 (884)
Q Consensus       462 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l  540 (884)
                      |||+|.++ .+..+=..+-+.+.|.|++|.|..  -..++.|-+|..||+++|+|.... -..++++|-|+.+.|.+||+
T Consensus       335 DLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  335 DLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             ecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            99999998 667777788999999999999863  334778889999999999997432 35688999999999999999


Q ss_pred             ccccC
Q 002760          541 EGEVP  545 (884)
Q Consensus       541 ~~~~p  545 (884)
                      .+.+.
T Consensus       412 ~~~vd  416 (490)
T KOG1259|consen  412 AGSVD  416 (490)
T ss_pred             cccch
Confidence            98544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=2.8e-11  Score=117.84  Aligned_cols=130  Identities=17%  Similarity=0.152  Sum_probs=93.9

Q ss_pred             cCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCcc-ceeeeeccCCccCCccceEEEEc
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI-KIITVCSGRDFKGADFKAIVYEF  722 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  722 (884)
                      .+.++.|.++.||+++.  .++.|++|+...... ....+..|+.+++.+.+.+++ +++.+.       ....++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence            36789999999999987  478899999753322 123467899999988655544 444432       1234799999


Q ss_pred             cCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCeeeCCCCceEEecccccc
Q 002760          723 MQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC--EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       723 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~  798 (884)
                      ++|.++.+.    .      .    ....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.|.
T Consensus        73 i~G~~l~~~----~------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE----D------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc----c------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999877542    0      0    11235678999999999331  12259999999999999 6789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=5.7e-12  Score=123.41  Aligned_cols=207  Identities=20%  Similarity=0.245  Sum_probs=98.9

Q ss_pred             CcCccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccC-ccccCCCCcccccc
Q 002760           33 SPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS-NNLVGEIPADIGSL  111 (884)
Q Consensus        33 ~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l  111 (884)
                      |-.+..+++|..+.+|.+.-. .|-+-...-+.|+++-..+..++ ..|. +-..+.+..+.-+. .-..|..-..+...
T Consensus       207 ~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTW  283 (490)
T KOG1259|consen  207 SFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSADTW  283 (490)
T ss_pred             ccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEecchH
Confidence            334455566666666665433 22221222245555555554443 1111 11111121111111 11112222233344


Q ss_pred             cccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEec
Q 002760          112 FKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLS  191 (884)
Q Consensus       112 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls  191 (884)
                      +.|++|+|++|.|+ .+.+++.-++.++.|++++|.|..+.. +..|.+|+.|+|++|.++ .+..+-..+.+++.|.|+
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            55666666666666 555666666666666666666654433 555666666666666665 334444455566666666


Q ss_pred             cccccccCCCCCCCCCCCCceEecCCCccccc-CCcccccCCCcceecccccccccCc
Q 002760          192 ENRFTGSLPVDTGVNLPSLRELRTNANNFTGF-IPVSLSNASSLEMIEFSKNQFSGGV  248 (884)
Q Consensus       192 ~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~  248 (884)
                      .|.|. ++.  -...+-+|..|++++|+|... ....+++++.|+.+.|.+|.+..+.
T Consensus       361 ~N~iE-~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  361 QNKIE-TLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhHh-hhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            66554 221  112334445555555555432 1234455555555555555555443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.6e-10  Score=107.30  Aligned_cols=132  Identities=27%  Similarity=0.330  Sum_probs=96.8

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccc--------cchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--------GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..+++|+-+.+|.+.+  -|..+.+|.=..+.-        -..++-.+|++++.+++--.|....-+     ..+++..
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~-----dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY-----DVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE-----EEcCCCC
Confidence            4688999999999977  355566664322211        112456789999998865544433333     2345566


Q ss_pred             eEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      .++|||++|..|.+++....             ..++..+-.-+.-||   ..||||+|+.++||++..+. +.++|||+
T Consensus        75 ~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          75 LIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             EEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCc
Confidence            89999999999998887541             236677788888999   88999999999999997665 99999999


Q ss_pred             cccc
Q 002760          797 AKFL  800 (884)
Q Consensus       797 a~~~  800 (884)
                      +.+-
T Consensus       138 g~~s  141 (204)
T COG3642         138 GEFS  141 (204)
T ss_pred             cccc
Confidence            9743

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.17  E-value=2.1e-11  Score=115.87  Aligned_cols=125  Identities=27%  Similarity=0.372  Sum_probs=35.5

Q ss_pred             ccCCCCCcEEEccCCcCCCCCCcCcC-CCCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCccc-ccccc
Q 002760           36 VGNLSFLRYINIASNGFNGEIPHQIG-RLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFK  113 (884)
Q Consensus        36 l~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~  113 (884)
                      +.+...+++|+|++|.|+ .+ +.++ .+.+|+.|+||+|.|+ .++ .+..+++|++|++++|+|+ .+++.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            444555677777777666 33 2344 4666777777777766 232 4566666666666666666 343333 34666


Q ss_pred             cceecccccccCCCC-CcccCCCCCCcEEEecccccccccc----ccccccccceee
Q 002760          114 LERLSIFQNHITGQL-PASIGNLSSLRVIDVRENRLWGRID----SLGQLKSLTLLS  165 (884)
Q Consensus       114 L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~----~l~~l~~L~~L~  165 (884)
                      |++|+|++|+|...- -..++.+++|+.|+|.+|.+...+.    .+..+++|+.||
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            666666666665221 1234555666666666666554332    244445555544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.15  E-value=1.5e-11  Score=116.81  Aligned_cols=108  Identities=24%  Similarity=0.363  Sum_probs=32.2

Q ss_pred             cCCCCCCCEEEccCCcCcCcCCcccc-CCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCccc-CCCCC
Q 002760           60 IGRLISLERLILSNNSFSGAIPANLS-SCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASI-GNLSS  137 (884)
Q Consensus        60 ~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~  137 (884)
                      +.+..++++|+|++|.|+ .+ +.++ .+.+|+.|+|++|.|+ .++ .+..+++|++|++++|+|+ .+++.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            445556777777777777 23 3454 4677777777777777 332 4666777777777777776 344334 34677


Q ss_pred             CcEEEeccccccccc--cccccccccceeeccccccC
Q 002760          138 LRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQFS  172 (884)
Q Consensus       138 L~~L~l~~n~l~~~~--~~l~~l~~L~~L~L~~n~l~  172 (884)
                      |++|++++|+|..+.  ..+..+++|+.|+|.+|.+.
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            777777777766543  34555666666666666665

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=9.7e-13  Score=132.30  Aligned_cols=37  Identities=24%  Similarity=0.367  Sum_probs=20.7

Q ss_pred             cccceeeccCccccc----cccccccCCCccceeeccCccC
Q 002760          504 QSIKELDFSSNNLNG----QIPEYLENLSFLEFLNLSYNHF  540 (884)
Q Consensus       504 ~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l  540 (884)
                      ++|+.|.|.+|.++.    .+...+...+.|..|+|++|.+
T Consensus       270 p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  270 PSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             CCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            455555555555542    2233444566666677777766

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=9.4e-13  Score=132.38  Aligned_cols=248  Identities=19%  Similarity=0.250  Sum_probs=161.1

Q ss_pred             ccccCCCcceecccccccccCcc----cccccccccceeeccccccCCCCC----ChhhhhhhhcCCCCCcEEEccCCcc
Q 002760          227 SLSNASSLEMIEFSKNQFSGGVS----VDFSRLKNLYWLNLGINNLGTGAA----NELDFINLLTNCSKLERLYFNRNRF  298 (884)
Q Consensus       227 ~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~l~~l~~L~~L~L~~N~l  298 (884)
                      .+..+..++.++|++|.+..-..    ..+...++|+..+++.=..+....    .-..+...+..+++|++|+||.|.|
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            34566788899999998875433    334566778877776433322111    1112334566777888888888877


Q ss_pred             cCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEeecCCCCccCCc-------------ccCCCCCCCEEE
Q 002760          299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPP-------------EIGELTNLQQLD  365 (884)
Q Consensus       299 ~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~l~~L~~L~  365 (884)
                      ....++.+..                     .+.++..|+.|+|.+|.+...--.             ....-++|++++
T Consensus       105 G~~g~~~l~~---------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i  163 (382)
T KOG1909|consen  105 GPKGIRGLEE---------------------LLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFI  163 (382)
T ss_pred             CccchHHHHH---------------------HHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEE
Confidence            6444443332                     234467888888888887632211             123346788888


Q ss_pred             ccCCCCCCC----CCCccCccccCcEEEcccccccc----cCCCCCcCcccccccccccccccCccchhhhhhhccchhh
Q 002760          366 LDRNFLQGS----IPSSLGNLTLLTYLKLGLNNLEG----NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYL  437 (884)
Q Consensus       366 Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L  437 (884)
                      ..+|++...    +...|...+.|+.+.++.|.|..    .....|..+++|+.|||.+|.++.....            
T Consensus       164 ~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~------------  231 (382)
T KOG1909|consen  164 CGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV------------  231 (382)
T ss_pred             eeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH------------
Confidence            888888642    22345566788888888888762    2334567788888888888876522111            


Q ss_pred             hcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhh-----cccccccccccCcEEeec----cCccccCccccce
Q 002760          438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLS-----ACANLEYLNISGNAFSGS----IPLLLDSLQSIKE  508 (884)
Q Consensus       438 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~  508 (884)
                               .+...+..+++|++|+++++.++.....+|.     ..++|++|.|.+|.|+..    +.......+.|+.
T Consensus       232 ---------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~k  302 (382)
T KOG1909|consen  232 ---------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEK  302 (382)
T ss_pred             ---------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHH
Confidence                     2334566677889999999888766555443     357889999999988732    3344556788899


Q ss_pred             eeccCccc
Q 002760          509 LDFSSNNL  516 (884)
Q Consensus       509 L~Ls~N~l  516 (884)
                      |+|++|++
T Consensus       303 LnLngN~l  310 (382)
T KOG1909|consen  303 LNLNGNRL  310 (382)
T ss_pred             hcCCcccc
Confidence            99999988

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=7.6e-12  Score=139.63  Aligned_cols=131  Identities=25%  Similarity=0.342  Sum_probs=77.6

Q ss_pred             ccccccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEE
Q 002760          109 GSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVI  188 (884)
Q Consensus       109 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  188 (884)
                      ..+..++.+++..|.++ .+-..++.+++|+.|++.+|+|..+...+..+++|++|++++|+|+..  ..+..++.|+.|
T Consensus        69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            34556666667777766 333446667777777777777766655566677777777777777643  345566667777


Q ss_pred             EeccccccccCCCCCCCCCCCCceEecCCCcccccCC-cccccCCCcceeccccccccc
Q 002760          189 SLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIP-VSLSNASSLEMIEFSKNQFSG  246 (884)
Q Consensus       189 ~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~-~~l~~l~~L~~L~Ls~N~l~~  246 (884)
                      ++++|.|+ .++..  ..++.|+.+++++|.+..+.+ . ...+.+++.+++.+|.+..
T Consensus       146 ~l~~N~i~-~~~~~--~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~  200 (414)
T KOG0531|consen  146 NLSGNLIS-DISGL--ESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE  200 (414)
T ss_pred             eeccCcch-hccCC--ccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence            77777766 33321  125555555555555554433 1 3444555555555555543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.14  E-value=4.4e-12  Score=131.02  Aligned_cols=210  Identities=20%  Similarity=0.185  Sum_probs=125.2

Q ss_pred             CccCCCCCcEEEccCCcCCCCCC--cCcCCCCCCCEEEccCCcCcCc--CCccccCCCCCcEEeccCccccCCCCccc-c
Q 002760           35 YVGNLSFLRYINIASNGFNGEIP--HQIGRLISLERLILSNNSFSGA--IPANLSSCSNLIELSADSNNLVGEIPADI-G  109 (884)
Q Consensus        35 ~l~~l~~L~~L~l~~n~~~~~~p--~~~~~l~~L~~L~Ls~n~l~~~--~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~  109 (884)
                      .-.++++|+...|.++.+. ..+  .....|++++.||||+|-+..-  +-.-...|++|+.|+|+.|++........ .
T Consensus       116 kQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~  194 (505)
T KOG3207|consen  116 KQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL  194 (505)
T ss_pred             HhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh
Confidence            3446777777777777665 333  2455677777777777766522  22334567777777777777764322211 2


Q ss_pred             cccccceecccccccCCCCC-cccCCCCCCcEEEecccc-ccccccccccccccceeeccccccCCCCC--ccccCCCcc
Q 002760          110 SLFKLERLSIFQNHITGQLP-ASIGNLSSLRVIDVRENR-LWGRIDSLGQLKSLTLLSVAFNQFSGMIP--PSIFNISSL  185 (884)
Q Consensus       110 ~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~l~~n~-l~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~l~~l~~L  185 (884)
                      .++.|+.|.|+.|.++-..- .-+..+++|+.|+|..|. +........-+..|+.|+|++|++-. .+  ...+.++.|
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L  273 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGL  273 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccch
Confidence            45667777777777762111 113456777777777774 22222334446667777777777652 23  345567777


Q ss_pred             cEEEeccccccccCCCCC------CCCCCCCceEecCCCccccc-CCcccccCCCcceecccccccccC
Q 002760          186 EVISLSENRFTGSLPVDT------GVNLPSLRELRTNANNFTGF-IPVSLSNASSLEMIEFSKNQFSGG  247 (884)
Q Consensus       186 ~~L~Ls~n~l~~~l~~~~------~~~l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~Ls~N~l~~~  247 (884)
                      +.|+++.+.+. ++..-.      ...+++|++|+++.|+|... .-..+..+.+|+.|.+..|.+...
T Consensus       274 ~~Lnls~tgi~-si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  274 NQLNLSSTGIA-SIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             hhhhccccCcc-hhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            77777777765 332211      24567788888888887432 113345567778888888887643

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=6.2e-12  Score=140.36  Aligned_cols=128  Identities=28%  Similarity=0.352  Sum_probs=56.3

Q ss_pred             CCCCCEEEccCCcCcCcCCccccCCCCCcEEeccCccccCCCCcccccccccceecccccccCCCCCcccCCCCCCcEEE
Q 002760           63 LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVID  142 (884)
Q Consensus        63 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~  142 (884)
                      +..++.+.+..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|++++|+|+..  ..+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence            344444445455444 22233444455555555555554 2222244445555555555555422  2244444455555


Q ss_pred             eccccccccccccccccccceeeccccccCCCCC-ccccCCCcccEEEecccccc
Q 002760          143 VRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIP-PSIFNISSLEVISLSENRFT  196 (884)
Q Consensus       143 l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~n~l~  196 (884)
                      +++|.|..+. .+..+++|+.+++++|++..+.+ . ...+.+++.+++.+|.+.
T Consensus       147 l~~N~i~~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  147 LSGNLISDIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             eccCcchhcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            5555544332 12224444555555555443222 1 234444444444444443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.11  E-value=9.3e-10  Score=101.46  Aligned_cols=143  Identities=24%  Similarity=0.318  Sum_probs=102.4

Q ss_pred             ccCeeeeccceEEEEEEECCCCcEEEEEEeeccc--------ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          643 SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--------KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ....+-||+-+.|+++.+  .|+.+.||.-..+.        .-..++..+|++.+.+.+--.|.-..-+     +-+..
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence            568899999999999998  78888888532221        1123567889999988764343222222     22333


Q ss_pred             cceEEEEccCC-CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCC---ceE
Q 002760          715 FKAIVYEFMQN-GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL---VSH  790 (884)
Q Consensus       715 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~---~~k  790 (884)
                      .-.++|||++| .++.+|+......    ..........+.+|-+.+.-||   ..++||+|+..+||++..++   .+.
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceE
Confidence            44799999976 4788998876532    2222223568889999999999   88999999999999997554   558


Q ss_pred             Eeccccccc
Q 002760          791 VSDFGLAKF  799 (884)
Q Consensus       791 l~DFg~a~~  799 (884)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999863

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.10  E-value=1.6e-11  Score=126.95  Aligned_cols=215  Identities=22%  Similarity=0.222  Sum_probs=117.1

Q ss_pred             cccccceecccccccCCCCC--cccCCCCCCcEEEeccccccc---cccccccccccceeeccccccCCCCCccc-cCCC
Q 002760          110 SLFKLERLSIFQNHITGQLP--ASIGNLSSLRVIDVRENRLWG---RIDSLGQLKSLTLLSVAFNQFSGMIPPSI-FNIS  183 (884)
Q Consensus       110 ~l~~L~~L~L~~n~l~~~~~--~~l~~l~~L~~L~l~~n~l~~---~~~~l~~l~~L~~L~L~~n~l~~~~~~~l-~~l~  183 (884)
                      ++.+|++..|.++... ..+  +....|++++.|||++|-+..   +..-..+|++|+.|+++.|++........ ..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4555666666666654 222  245566677777777765544   22345566777777777776652211111 1345


Q ss_pred             cccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCcccccCCCcceecccccccccCcc-cccccccccceee
Q 002760          184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVS-VDFSRLKNLYWLN  262 (884)
Q Consensus       184 ~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~  262 (884)
                      .|+.|.|+.|.++-.--......+|+|+.|+|..|....+.......+..|+.|||++|.+-.... .....++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            666666666665411111122345666666666665433444445556667777777766654332 2345566666667


Q ss_pred             ccccccCCCCCChhhhhhhhcCCCCCcEEEccCCcccCCCCchhhccchhhhhhcccCCcccccCCccccCCCCCcEEEe
Q 002760          263 LGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTI  342 (884)
Q Consensus       263 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  342 (884)
                      ++.+.+..+.....+-.+.....++|++|+++.|++...                        ..-..+..+.+|+.|.+
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w------------------------~sl~~l~~l~nlk~l~~  333 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW------------------------RSLNHLRTLENLKHLRI  333 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccc------------------------cccchhhccchhhhhhc
Confidence            766666665544333333344555666666666655311                        11123445667777777


Q ss_pred             ecCCCCc
Q 002760          343 DTNQLTG  349 (884)
Q Consensus       343 ~~N~l~~  349 (884)
                      ..|.+..
T Consensus       334 ~~n~ln~  340 (505)
T KOG3207|consen  334 TLNYLNK  340 (505)
T ss_pred             ccccccc
Confidence            7777763

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.9e-10  Score=114.72  Aligned_cols=163  Identities=20%  Similarity=0.374  Sum_probs=124.5

Q ss_pred             HHHHcCCCCCccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcC
Q 002760          688 KALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC  767 (884)
Q Consensus       688 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~  767 (884)
                      ..+-++.|.|+|++..|..+..+++......+.|||+.|++..++++.+..  ...+......+++.||+.|+.|||+. 
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            345556799999999998877777778889999999999999999986542  22577788889999999999999976 


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEeccccccccccCCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHH
Q 002760          768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL  847 (884)
Q Consensus       768 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~i  847 (884)
                      +..|+|+++.-+-|++..+|-+|+.--.-..  .......  ........-.|-++|.|||.-.....+.++|||+||..
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s--~h~s~~~--~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS--THPSVNS--TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccc--cchhhhh--hhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            8899999999999999999999984321110  0000000  00011112236789999998877778889999999999


Q ss_pred             HHHHhcCCCC
Q 002760          848 LLELFTRKRP  857 (884)
Q Consensus       848 l~~lltg~~p  857 (884)
                      ..+|.-|..-
T Consensus       272 AlemailEiq  281 (458)
T KOG1266|consen  272 ALEMAILEIQ  281 (458)
T ss_pred             HHHHHHheec
Confidence            9999988763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=5.2e-11  Score=136.00  Aligned_cols=213  Identities=22%  Similarity=0.287  Sum_probs=148.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEECCCCcEEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCc
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .+.+.+.+.+-+|+++.++.+.-..+|...+.|+.....   ....+....+-.+.-..++|-+++..--     +....
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCCC
Confidence            345777888999999999999888788777777654221   1112222233333333345665554432     34456


Q ss_pred             cceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecc
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF  794 (884)
                      ..++|++|..++++...++..+..      +..-.......+..+.+|||   ...++|||++|.|.++..+|+.++.||
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~------saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~  948 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCL------SAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDF  948 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCc------ccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcc
Confidence            678999999999999998876632      22222334556788899999   666899999999999999999999999


Q ss_pred             ccccccccC---------------------CCCcccccc--eeeeccccccceeCccccCCCCCCcccceeehhHHHHHH
Q 002760          795 GLAKFLSNH---------------------NPDTIVETR--SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL  851 (884)
Q Consensus       795 g~a~~~~~~---------------------~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~l  851 (884)
                      |........                     .........  +......||+.|.|||...+......+|.|+.|++++|.
T Consensus       949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen  949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred             ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence            844322111                     000000110  223456699999999999999999999999999999999


Q ss_pred             hcCCCCCCccccC
Q 002760          852 FTRKRPTDAMFNE  864 (884)
Q Consensus       852 ltg~~p~~~~~~~  864 (884)
                      ++|..||.....+
T Consensus      1029 l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQ 1041 (1205)
T ss_pred             hcCCCCCCCcchh
Confidence            9999999875443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=2.1e-10  Score=136.23  Aligned_cols=176  Identities=22%  Similarity=0.321  Sum_probs=93.4

Q ss_pred             eEEEEEcCCCC--CccccCc-CccCCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCcCcCcCCccccCCCCCcEE
Q 002760           17 RVTRLDLGNQS--IRGTLSP-YVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIEL   93 (884)
Q Consensus        17 ~v~~L~l~~~~--~~~~~~~-~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L   93 (884)
                      .+++|-+..+.  +. .++. .+..++.|++|||++|.--+++|.+++.|.+||+|+|+++.++ .+|..+++|+.|.+|
T Consensus       546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L  623 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL  623 (889)
T ss_pred             ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence            35555565554  33 3333 2455777777777766555567777777777777777777776 667777777777777


Q ss_pred             eccCccccCCCCcccccccccceecccccccC--CCCCcccCCCCCCcEEEeccccccccccccccccccc----eeecc
Q 002760           94 SADSNNLVGEIPADIGSLFKLERLSIFQNHIT--GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLT----LLSVA  167 (884)
Q Consensus        94 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~----~L~L~  167 (884)
                      ++..+.-...+|..+..+.+|++|.+..-...  ...-..+.+|.+|+.+....... .+...+..++.|.    .+.+.
T Consensus       624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~  702 (889)
T KOG4658|consen  624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSLSIE  702 (889)
T ss_pred             ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhhhhc
Confidence            77766555455555666777777766554321  11122333444444444432222 1111111111111    22222


Q ss_pred             ccccCCCCCccccCCCcccEEEecccccc
Q 002760          168 FNQFSGMIPPSIFNISSLEVISLSENRFT  196 (884)
Q Consensus       168 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~  196 (884)
                      ++... ..+..+..+.+|+.|.+.++.+.
T Consensus       703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  703 GCSKR-TLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             ccccc-eeecccccccCcceEEEEcCCCc
Confidence            22222 33445666677777777776664

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=1.8e-10  Score=136.79  Aligned_cols=129  Identities=23%  Similarity=0.307  Sum_probs=69.5

Q ss_pred             CCCCCcEEEccCCcCCCCCCcCcCCCCCCCEEEccCCc--CcCcCCccccCCCCCcEEeccCccccCCCCcccccccccc
Q 002760           38 NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS--FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLE  115 (884)
Q Consensus        38 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  115 (884)
                      +....|...+-+|.+. .++.+... ++|++|-+.+|.  +....+..|..++.|+.|||++|.--+.+|..++.|.+|+
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            3455566666666555 44443332 256666666664  3322233355566666666665555455666666666666


Q ss_pred             eecccccccCCCCCcccCCCCCCcEEEeccccc-cccccccccccccceeecccc
Q 002760          116 RLSIFQNHITGQLPASIGNLSSLRVIDVRENRL-WGRIDSLGQLKSLTLLSVAFN  169 (884)
Q Consensus       116 ~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l-~~~~~~l~~l~~L~~L~L~~n  169 (884)
                      +|+|++..++ .+|..+++|..|.+|++..+.- ...+.....|++|++|.+...
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            6666666665 5566666666666666665532 222333444555655555443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=4.4e-09  Score=107.43  Aligned_cols=144  Identities=24%  Similarity=0.330  Sum_probs=104.4

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHcCCCC--CccceeeeeccCCccCCccceEEEE
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHR--NLIKIITVCSGRDFKGADFKAIVYE  721 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e  721 (884)
                      +.|+.|..+.||++... +|+.+++|+...... .....+..|+++++.+++.  .+.+++.+.....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            67899999999999874 468899998753322 1345788999999999753  4566777643221  1235689999


Q ss_pred             ccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------
Q 002760          722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY-----------------------------------  766 (884)
Q Consensus       722 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----------------------------------  766 (884)
                      |++|.++.+.+..       ..++..+...++.++++++.+||+.                                   
T Consensus        81 ~i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            9999877654321       1355566666777777777777732                                   


Q ss_pred             ------------------CCCCeeecCCCCCCeeeCC--CCceEEecccccc
Q 002760          767 ------------------CEPSIVHGDLKPSNVLLDQ--DLVSHVSDFGLAK  798 (884)
Q Consensus       767 ------------------~~~~ivH~Dlkp~NiLl~~--~~~~kl~DFg~a~  798 (884)
                                        ....++|+|+.|.||+++.  ++.+.++||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                              1356799999999999998  6778999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.95  E-value=5.4e-10  Score=121.90  Aligned_cols=195  Identities=22%  Similarity=0.196  Sum_probs=142.9

Q ss_pred             hcCCCccCeeeeccceEEEEEEEC-CCCcEEEEEEeecccccchHH--HHHHHHHHHcC-CCCCccceeeeeccCCccCC
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLKQKGASKS--FVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      ..+|..+..||.|.|+.|+....+ .++..||+|...........+  -..|+.+...+ .|.++++....     |...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence            457889999999999999998765 567889999775433332222  23455555555 47777775554     4455


Q ss_pred             ccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCC-CceEEe
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVS  792 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~  792 (884)
                      ...|+--||+++++....+.-.      ..+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcc
Confidence            5667999999999887766321      25667778889999999999999   8899999999999999886 888999


Q ss_pred             ccccccccccCCCCcccccceeeecccccccee--CccccCCCCCCcccceeehhHHHHHHhcCCCC
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV--APEYGMGREASMKGDVYSFGILLLELFTRKRP  857 (884)
Q Consensus       793 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlG~il~~lltg~~p  857 (884)
                      |||.+..+.-....           ..+.-+++  +|+......+..++|++|||..+++..+|..-
T Consensus       410 ~~~~~t~~~~~~~~-----------~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  410 DFGCWTRLAFSSGV-----------FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccccccccceeccc-----------ccccccccccchhhccccccccccccccccccccccccCccc
Confidence            99998642211111           11233344  56666677889999999999999999998763

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=5.3e-10  Score=87.31  Aligned_cols=59  Identities=39%  Similarity=0.541  Sum_probs=30.5

Q ss_pred             ccCEEecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCcc
Q 002760          457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN  515 (884)
Q Consensus       457 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  515 (884)
                      +|++|++++|+|+...++.|.++++|++|++++|+|+...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45555555555554444455555555555555555554444555555555555555554

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=8.6e-09  Score=99.90  Aligned_cols=126  Identities=27%  Similarity=0.301  Sum_probs=81.1

Q ss_pred             EEEEEEECCCCcEEEEEEeecccc-------------c-------------chHHHHHHHHHHHcCCCC--Cccceeeee
Q 002760          654 IVYKGFLGENGTEVAVKVINLKQK-------------G-------------ASKSFVAECKALRNIRHR--NLIKIITVC  705 (884)
Q Consensus       654 ~V~~a~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~~~~~~  705 (884)
                      .||.|... +|.++|||+.+....             .             ......+|.+.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999884 788999999862110             0             013467899999999765  456666541


Q ss_pred             ccCCccCCccceEEEEccC--CCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCCee
Q 002760          706 SGRDFKGADFKAIVYEFMQ--NGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY-LHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       706 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~-LH~~~~~~ivH~Dlkp~NiL  782 (884)
                               ..++||||++  |..+..+....        ++......++.+++..+.. +|   ..|+||+|+.+.||+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIl  139 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNIL  139 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEE
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEE
Confidence                     2379999998  55554433221        1122334567788885555 57   789999999999999


Q ss_pred             eCCCCceEEeccccccccc
Q 002760          783 LDQDLVSHVSDFGLAKFLS  801 (884)
Q Consensus       783 l~~~~~~kl~DFg~a~~~~  801 (884)
                      ++++ .+.++|||.|....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9887 99999999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=7.9e-10  Score=86.33  Aligned_cols=61  Identities=36%  Similarity=0.554  Sum_probs=58.0

Q ss_pred             cccccccccCcEEeeccCccccCccccceeeccCccccccccccccCCCccceeeccCccC
Q 002760          480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF  540 (884)
Q Consensus       480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  540 (884)
                      ++|++|++++|+|+...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999988889999999999999999999988899999999999999999986

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=1e-08  Score=101.25  Aligned_cols=136  Identities=27%  Similarity=0.283  Sum_probs=97.4

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccc-----------------c-----chHHHHHHHHHHHcCCCC--
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----------------G-----ASKSFVAECKALRNIRHR--  696 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----------------~-----~~~~~~~e~~~l~~l~h~--  696 (884)
                      +.++.+||.|.-|.||.|... .|.++|||..+....                 .     .....++|.++|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567899999999999999985 799999998752110                 0     012357899999998655  


Q ss_pred             CccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 002760          697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL  776 (884)
Q Consensus       697 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dl  776 (884)
                      .|.+.+++         +...+||||++|-.|...-           ++....-.++..|+.-+.-.-   ..|+||+|+
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~---~~GiVHGDl  228 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAY---RRGIVHGDL  228 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHH---HcCccccCC
Confidence            56666654         3458999999986665432           112222334455555554443   469999999


Q ss_pred             CCCCeeeCCCCceEEecccccccc
Q 002760          777 KPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       777 kp~NiLl~~~~~~kl~DFg~a~~~  800 (884)
                      .+-||+++++|.+.++||--+...
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             chheEEEecCCCEEEEeCcccccC
Confidence            999999999999999999877544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.80  E-value=6.7e-08  Score=99.71  Aligned_cols=146  Identities=16%  Similarity=0.074  Sum_probs=99.5

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeecccc-----------cchHHHHHHHHHHHcCCCCCc--cceeeeeccCCcc
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----------GASKSFVAECKALRNIRHRNL--IKIITVCSGRDFK  711 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~  711 (884)
                      +.+-......|++...  .|+.|.||.......           .......+|.+.+.++...+|  ++.+++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4444444445777766  678899997642211           011147789988888854443  3445553221111


Q ss_pred             CCccceEEEEccCCC-CHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCC-----
Q 002760          712 GADFKAIVYEFMQNG-SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----  785 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~-----  785 (884)
                      .....++|||++++. +|.+++.....    .+.+......++.+++..+.-||   ..||+|+|++++|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCC
Confidence            123468999999875 79999864221    13445666789999999999999   889999999999999975     


Q ss_pred             --CCceEEeccccccc
Q 002760          786 --DLVSHVSDFGLAKF  799 (884)
Q Consensus       786 --~~~~kl~DFg~a~~  799 (884)
                        ++.+.++||+.++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46889999998863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.73  E-value=1.2e-07  Score=98.44  Aligned_cols=203  Identities=16%  Similarity=0.195  Sum_probs=130.2

Q ss_pred             CCccCeeeeccceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcC-CCCCccceeeeecc--CCccCCccce
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSG--RDFKGADFKA  717 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~  717 (884)
                      ...++.||+|+-+.+|..-.  -+.. +-|++..........   .+..|... .||-+-.-+.+-..  ..........
T Consensus        13 i~~gr~LgqGgea~ly~l~e--~~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE--VRDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecch--hhch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            45678999999999996532  2223 347775333222111   22233333 56644331111000  0011223356


Q ss_pred             EEEEccCCC-CHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccc
Q 002760          718 IVYEFMQNG-SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~  796 (884)
                      ++|..+++. ....+..............|.-.++.++.++.|.+.||   +.|.+-+|+.++|+|+++++.|.+.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence            777777664 23333332221112235778889999999999999999   78999999999999999999999988543


Q ss_pred             ccccccCCCCcccccceeeeccccccceeCccccC-----CCCCCcccceeehhHHHHHHhcC-CCCCCcc
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTR-KRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~~lltg-~~p~~~~  861 (884)
                      -....+         ....-..+|.++|.+||...     +.+-+...|-|.+|+++++++.| ++||.+.
T Consensus       164 fqi~~n---------g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         164 FQINAN---------GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eeeccC---------CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            222211         11223456999999999754     45667889999999999999886 9999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.69  E-value=1.4e-07  Score=100.63  Aligned_cols=175  Identities=16%  Similarity=0.217  Sum_probs=131.6

Q ss_pred             eEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHcCCCCCccceeeeeccCCccCCccceEEEEccCC-CCHHHH
Q 002760          653 GIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN-GSLEEW  731 (884)
Q Consensus       653 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~  731 (884)
                      .+.|+|....+|..|++|++.............-+++.+++.|+|||++.+++....| ++...++|++|.++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHH
Confidence            5789999999999999999954433333334456788999999999999998654433 46678899999986 577776


Q ss_pred             hhccCC---------CcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          732 LHHSND---------QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       732 l~~~~~---------~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      -.....         ..+....++..+|.++.|+..||.++|   +.|..-+-+.|.+|+++.+.+++|+..|+......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            433221         123346788999999999999999999   78999999999999999999999988887654432


Q ss_pred             CCCCcccccceeeeccccccceeCccccCCCCCCcccceeehhHHHHHHhcCCC
Q 002760          803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR  856 (884)
Q Consensus       803 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~~lltg~~  856 (884)
                      ...                      |.+.   --.+-|.-.||.++..+.||..
T Consensus       446 d~~----------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DPT----------------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC----------------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            210                      1111   1235688889999999999954

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.66  E-value=1.6e-09  Score=94.32  Aligned_cols=93  Identities=24%  Similarity=0.296  Sum_probs=71.3

Q ss_pred             CCCccCEEecCCCCCCCCchhhhhcccccccccccCcEEeeccCccccCccccceeeccCccccccccccccCCCcccee
Q 002760          454 NLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFL  533 (884)
Q Consensus       454 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  533 (884)
                      .++.++.|+|++|+|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.+|-.||..+|.+. .+|..+..-......
T Consensus        75 kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~  151 (177)
T KOG4579|consen   75 KFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALI  151 (177)
T ss_pred             ccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHH
Confidence            3457888888888887 67777888888999999988887 66777777888888888888886 455544433445566


Q ss_pred             eccCccCccccCCCCc
Q 002760          534 NLSYNHFEGEVPMKGV  549 (884)
Q Consensus       534 ~ls~N~l~~~~p~~~~  549 (884)
                      ++.+++|.+.+|.+.+
T Consensus       152 ~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  152 KLGNEPLGDETKKKLQ  167 (177)
T ss_pred             HhcCCcccccCccccc
Confidence            7788999998887643

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=1.7e-10  Score=125.99  Aligned_cols=128  Identities=23%  Similarity=0.250  Sum_probs=66.8

Q ss_pred             ccceecccccccCCCCCcccCCCCCCcEEEeccccccccccccccccccceeeccccccCCCCCccccCCCcccEEEecc
Q 002760          113 KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSE  192 (884)
Q Consensus       113 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~  192 (884)
                      +|.+-+.++|.+. .+..++.-++.|+.|+|++|++..+. .+..|++|++|+|++|.+. .+|..=..-..|..|.+++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrn  241 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRN  241 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeecc
Confidence            3555555666655 44455555566666666666655543 5555566666666666655 2332111112366666666


Q ss_pred             ccccccCCCCCCCCCCCCceEecCCCcccccCC-cccccCCCcceeccccccccc
Q 002760          193 NRFTGSLPVDTGVNLPSLRELRTNANNFTGFIP-VSLSNASSLEMIEFSKNQFSG  246 (884)
Q Consensus       193 n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~-~~l~~l~~L~~L~Ls~N~l~~  246 (884)
                      |.++ .+-.  ..+|++|+.|++++|-|.+.-. .-+..+..|+.|.|.+|.+-.
T Consensus       242 N~l~-tL~g--ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  242 NALT-TLRG--IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             cHHH-hhhh--HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            6554 2221  1245566666666665543211 123445566677777776643

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.59  E-value=1.2e-09  Score=119.67  Aligned_cols=181  Identities=24%  Similarity=0.250  Sum_probs=120.2

Q ss_pred             CccccCCCCCcEEeccCccccCCCCccccccc-ccceecccccccC---CCCCc---ccCC---CCCCcEEEeccccccc
Q 002760           81 PANLSSCSNLIELSADSNNLVGEIPADIGSLF-KLERLSIFQNHIT---GQLPA---SIGN---LSSLRVIDVRENRLWG  150 (884)
Q Consensus        81 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~---~~~~~---~l~~---l~~L~~L~l~~n~l~~  150 (884)
                      |-.+..+++|++|.|.++.+..  -..+..+. .|++|..++ .++   ..+..   .+.+   --.|...+.+.|++..
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh
Confidence            5556667777777777777663  12222222 456655432 221   00000   1111   1247777888888888


Q ss_pred             cccccccccccceeeccccccCCCCCccccCCCcccEEEeccccccccCCCCCCCCCCCCceEecCCCcccccCCccccc
Q 002760          151 RIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN  230 (884)
Q Consensus       151 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~  230 (884)
                      +..++.-++.|+.|+|++|+++..  +.+..+++|++|||++|.+. .+|.....++. |+.|.+++|.++..  ..+.+
T Consensus       179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~  252 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN  252 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence            778888888999999999998743  37888889999999999987 77766555555 88888888888764  45677


Q ss_pred             CCCcceecccccccccCccc-ccccccccceeeccccccCC
Q 002760          231 ASSLEMIEFSKNQFSGGVSV-DFSRLKNLYWLNLGINNLGT  270 (884)
Q Consensus       231 l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~  270 (884)
                      +.+|+.||+++|-|.+-..- .+..+..|+.|.|.+|.+--
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            88888888888887654322 23456667777777777643

>PRK09902 hypothetical protein; Provisional

Probab=98.57  E-value=9.5e-07  Score=85.92  Aligned_cols=142  Identities=18%  Similarity=0.157  Sum_probs=103.0

Q ss_pred             eeeccceEEEEEEECCCCcEEEEEEeecc------cccchHHHHHHHHHHHcCCCCC--ccceeeeeccCCccCCccceE
Q 002760          647 IGEGGSGIVYKGFLGENGTEVAVKVINLK------QKGASKSFVAECKALRNIRHRN--LIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       647 lg~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~l  718 (884)
                      -|+||-+.|++...  .|+.+-+|.....      -+-....|.+|...+.++...+  +.+.+ ++...........++
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46799999999876  4557888876411      1234578999999999985333  44444 332111122345689


Q ss_pred             EEEccCC-CCHHHHhhccCCCcccccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeeCCCCc--eEEeccc
Q 002760          719 VYEFMQN-GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV--SHVSDFG  795 (884)
Q Consensus       719 v~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~~--~kl~DFg  795 (884)
                      |+|-+.+ .+|.+++......    +.+..+...+..+++.++.-||   +.|+.|+|+.+.||+++.+|.  ++++||.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            9997753 5899888654321    4566777789999999999999   889999999999999986666  9999998


Q ss_pred             ccc
Q 002760          796 LAK  798 (884)
Q Consensus       796 ~a~  798 (884)
                      -++
T Consensus       176 k~r  178 (216)
T PRK09902        176 KSR  178 (216)
T ss_pred             ccc
Confidence            765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=3.6e-07  Score=102.11  Aligned_cols=142  Identities=20%  Similarity=0.260  Sum_probs=92.1

Q ss_pred             CeeeeccceEEEEEEECCCCcEEEEEEeeccc----------------------cc----ch--------H------HHH
Q 002760          645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ----------------------KG----AS--------K------SFV  684 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------------~~----~~--------~------~~~  684 (884)
                      +.|+.++-|+||+|+.+ +|+.||||+.+..-                      +.    ..        +      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            78999999999999996 69999999975210                      00    00        1      134


Q ss_pred             HHHHHHHcCC-----CCCccceeeeeccCCccCCccceEEEEccCCCCHHHHhhccCCCcccccCCHHHHHHHHHHHHHH
Q 002760          685 AECKALRNIR-----HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA  759 (884)
Q Consensus       685 ~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~a  759 (884)
                      +|+..+.+++     .|.+ .+-.++    ++-.....++|||++|-.+.+.......     ..+...   ++..++++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~~-----g~d~k~---ia~~~~~~  276 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKSA-----GIDRKE---LAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceee----hhccCCcEEEEEeeCCEecccHHHHHhc-----CCCHHH---HHHHHHHH
Confidence            5666665552     3433 232332    3334556899999999888887432211     233222   33333333


Q ss_pred             HHHHhhcCCCCeeecCCCCCCeeeCCCCceEEecccccccccc
Q 002760          760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN  802 (884)
Q Consensus       760 l~~LH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFg~a~~~~~  802 (884)
                      .-.  +....|+.|+|..|.||+++.+|.+.+.|||+...+.+
T Consensus       277 f~~--q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 FLR--QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHH--HHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            211  11134999999999999999999999999999876543

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.51  E-value=7.1e-10  Score=109.07  Aligned_cols=23  Identities=17%  Similarity=0.283  Sum_probs=15.0

Q ss_pred             eeEeeEEcCCCCeEEEEEcCCCCCc
Q 002760            5 QWTGVTCGQRHQRVTRLDLGNQSIR   29 (884)
Q Consensus         5 ~w~~v~c~~~~~~v~~L~l~~~~~~   29 (884)
                      +|.|..-+  ..-=+.||+.+..|.
T Consensus       127 Rfyr~~~d--e~lW~~lDl~~r~i~  149 (419)
T KOG2120|consen  127 RFYRLASD--ESLWQTLDLTGRNIH  149 (419)
T ss_pred             HHhhcccc--ccceeeeccCCCccC
Confidence            67776554  334577888777665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=1.2e-06  Score=87.63  Aligned_cols=111  Identities=24%  Similarity=0.303  Sum_probs=83.3

Q ss_pred             hHHHHHHHHHHHcCCCCC--ccceeeeeccCCccCCccceEEEEccCCC-CHHHHhhccCCCcccccCCHHHHHHHHHHH
Q 002760          680 SKSFVAECKALRNIRHRN--LIKIITVCSGRDFKGADFKAIVYEFMQNG-SLEEWLHHSNDQLEVCSLSVIQRLNIAIDV  756 (884)
Q Consensus       680 ~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i  756 (884)
                      ..+..+|...+..+..-+  +++.+++...+..- ....++|+|++++. +|.+++....      ..+......++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l  127 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRAL  127 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHH
Confidence            346778888888775333  45566654432211 14458999999874 7999988633      13445567789999


Q ss_pred             HHHHHHHhhcCCCCeeecCCCCCCeeeCCCC---ceEEecccccccc
Q 002760          757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL---VSHVSDFGLAKFL  800 (884)
Q Consensus       757 ~~al~~LH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~DFg~a~~~  800 (884)
                      +..+.-||   +.||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       128 ~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  128 ARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999   88999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=1.6e-08  Score=88.27  Aligned_cols=115  Identities=21%  Similarity=0.278  Sum_probs=75.5

Q ss_pred             ccccccccccccCccchhhhhhhccchhhhcCCccCCCCCCccccCCCccCEEecCCCCCCCCchhhhhccccccccccc
Q 002760          409 LLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNIS  488 (884)
Q Consensus       409 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  488 (884)
                      |+..+|++|.+. .+|..+....+....++|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..+.+|..|+..
T Consensus        55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~  131 (177)
T KOG4579|consen   55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP  131 (177)
T ss_pred             EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence            333444444443 334333333333334555555555 67888999999999999999998 788888889999999999


Q ss_pred             CcEEeeccCccccCccccceeeccCccccccccccccCC
Q 002760          489 GNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL  527 (884)
Q Consensus       489 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  527 (884)
                      +|.+. .+|..+-.-...-..++.++.+.+.-+.-++.+
T Consensus       132 ~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~  169 (177)
T KOG4579|consen  132 ENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL  169 (177)
T ss_pred             CCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence            99987 454433222233344567788887766655544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	884
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-42
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-32
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		7e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		7e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		3e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		4e-09
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		9e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-09
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		7e-09
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-04
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		5e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-07
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-06
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		5e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-05
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		9e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		1e-04
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		1e-04
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		1e-04
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-04
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-04
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		4e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  171 bits (433), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 176/628 (28%), Positives = 272/628 (43%), Gaps = 81/628 (12%)
Query: 9   VTCGQRHQRVTRLDLGNQSIRGT------LSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
           V+ G +   +  LDL   SI G       LS   G L   +++ I+ N  +G++   + R
Sbjct: 141 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL---KHLAISGNKISGDV--DVSR 195
Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
            ++LE L +S+N+FS  IP  L  CS L  L    N L G+    I +  +L+ L+I  N
Sbjct: 196 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 254
Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSL--GQLKSLTLLSVAFNQFSGMIPPSIF 180
              G +P     L SL+ + + EN+  G I     G   +LT L ++ N F G +PP   
Sbjct: 255 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 312
Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN-ASSLEMIEF 239
           + S LE ++LS N F+G LP+DT + +  L+ L  + N F+G +P SL+N ++SL  ++ 
Sbjct: 313 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 372
Query: 240 SKNQFSGGVSVDFSR-----LKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           S N FSG +  +  +     L+ LY  N G     TG          L+NCS+L  L+ +
Sbjct: 373 SSNNFSGPILPNLCQNPKNTLQELYLQNNGF----TGKIPP-----TLSNCSELVSLHLS 423
Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
            N   G +P S+ +LS  ++ + +  N + G IP E+  + +L  L +D N LTG IP  
Sbjct: 424 FNYLSGTIPSSLGSLSK-LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 482
Query: 355 IGELTNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNI 414
           +   TNL  + L  N L G IP                    GNIP+ LG+C +L+ L++
Sbjct: 483 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 542
Query: 415 SHNKLIGTLPRQILRITTXXXX-------XXXXXXXXXXXXXXXVGNL--------KNLM 459
           + N   GT+P  + + +                            GNL        + L 
Sbjct: 543 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 602
Query: 460 RL------DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS----------- 502
           RL      +++   + G    T     ++ +L++S N  SG IP  + S           
Sbjct: 603 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 662
Query: 503 -------------LQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFEGEVPMKGV 549
                        L+ +  LD SSN L+G+IP                 +  G +P  G 
Sbjct: 663 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 722
Query: 550 FNNKTRFSIAGNGKLCGGLDELRLPSCQ 577
           F          N  LCG      LP C 
Sbjct: 723 FETFPPAKFLNNPGLCG----YPLPRCD 746

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  170 bits (431), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 176/628 (28%), Positives = 272/628 (43%), Gaps = 81/628 (12%)
Query: 9   VTCGQRHQRVTRLDLGNQSIRGT------LSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
           V+ G +   +  LDL   SI G       LS   G L   +++ I+ N  +G++   + R
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL---KHLAISGNKISGDV--DVSR 198
Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
            ++LE L +S+N+FS  IP  L  CS L  L    N L G+    I +  +L+ L+I  N
Sbjct: 199 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSL--GQLKSLTLLSVAFNQFSGMIPPSIF 180
              G +P     L SL+ + + EN+  G I     G   +LT L ++ N F G +PP   
Sbjct: 258 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN-ASSLEMIEF 239
           + S LE ++LS N F+G LP+DT + +  L+ L  + N F+G +P SL+N ++SL  ++ 
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 240 SKNQFSGGVSVDFSR-----LKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           S N FSG +  +  +     L+ LY  N G     TG          L+NCS+L  L+ +
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGF----TGKIPP-----TLSNCSELVSLHLS 426
Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
            N   G +P S+ +LS  ++ + +  N + G IP E+  + +L  L +D N LTG IP  
Sbjct: 427 FNYLSGTIPSSLGSLSK-LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
Query: 355 IGELTNLQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNI 414
           +   TNL  + L  N L G IP                    GNIP+ LG+C +L+ L++
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545
Query: 415 SHNKLIGTLPRQILRITTXXXX-------XXXXXXXXXXXXXXXVGNL--------KNLM 459
           + N   GT+P  + + +                            GNL        + L 
Sbjct: 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605
Query: 460 RL------DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS----------- 502
           RL      +++   + G    T     ++ +L++S N  SG IP  + S           
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 503 -------------LQSIKELDFSSNNLNGQIPXXXXXXXXXXXXXXXXXHFEGEVPMKGV 549
                        L+ +  LD SSN L+G+IP                 +  G +P  G 
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
Query: 550 FNNKTRFSIAGNGKLCGGLDELRLPSCQ 577
           F          N  LCG      LP C 
Sbjct: 726 FETFPPAKFLNNPGLCG----YPLPRCD 749

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/231 (35%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECK 688
           S  EL  A+DNFS+ N +G GG G VYKG L  +GT VAVK +  ++ +G    F  E +
Sbjct: 29  SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            +    HRNL+++   C          + +VY +M NGS+   L    +      L   +
Sbjct: 88  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWPK 140
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
           R  IA+  A  + YLH +C+P I+H D+K +N+LLD++  + V DFGLAK +   +    
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---- 196
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                +   ++GT+G++APEY    ++S K DV+ +G++LLEL T +R  D
Sbjct: 197 ---XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  132 bits (333), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 125/231 (54%), Gaps = 16/231 (6%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECK 688
           S  EL  A+DNF + N +G GG G VYKG L  +G  VAVK +  ++ +G    F  E +
Sbjct: 21  SLRELQVASDNFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            +    HRNL+++   C          + +VY +M NGS+   L    +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWPK 132
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
           R  IA+  A  + YLH +C+P I+H D+K +N+LLD++  + V DFGLAK +   +    
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---- 188
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                +   ++G +G++APEY    ++S K DV+ +G++LLEL T +R  D
Sbjct: 189 ---XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 140/263 (53%), Gaps = 20/263 (7%)
Query: 613 ARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI 672
           A  +S ++P E   +     +L +AT+NF     IG G  G VYKG L  +G +VA+K  
Sbjct: 15  ALSSSYLVPFESYRV--PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRR 71
Query: 673 NLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
             +     + F  E + L   RH +L+ +I  C  R+        ++Y++M+NG+L+  L
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHL 126
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS 792
           + S+  L   S+S  QRL I I  A  + YLH     +I+H D+K  N+LLD++ V  ++
Sbjct: 127 YGSD--LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181
Query: 793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE-L 851
           DFG++K        T ++   +   +KGT+GY+ PEY +    + K DVYSFG++L E L
Sbjct: 182 DFGISK------KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 852 FTRKRPTDAMFNEGLTLHDFSRE 874
             R     ++  E + L +++ E
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVE 258

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 139/263 (52%), Gaps = 20/263 (7%)
Query: 613 ARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI 672
           A  +S ++P E   +     +L +AT+NF     IG G  G VYKG L  +G +VA+K  
Sbjct: 15  ALSSSYLVPFESYRV--PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRR 71
Query: 673 NLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
             +     + F  E + L   RH +L+ +I  C  R+        ++Y++M+NG+L+  L
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHL 126
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS 792
           + S+  L   S+S  QRL I I  A  + YLH     +I+H D+K  N+LLD++ V  ++
Sbjct: 127 YGSD--LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181
Query: 793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE-L 851
           DFG++K        T +    +   +KGT+GY+ PEY +    + K DVYSFG++L E L
Sbjct: 182 DFGISK------KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 852 FTRKRPTDAMFNEGLTLHDFSRE 874
             R     ++  E + L +++ E
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVE 258

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (289), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 85/234 (36%), Positives = 126/234 (53%), Gaps = 30/234 (12%)
Query: 630 SYAELSKATDNFSS------ANKIGEGGSGIVYKGFLGENGTEVAVK----VINLKQKGA 679
           S+ EL   T+NF         NK+GEGG G+VYKG++  N T VAVK    ++++  +  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73
Query: 680 SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
            + F  E K +   +H NL++++   S     G D   +VY +M NGSL + L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSCLDG-- 126
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS   R  IA   A+ I +LH   E   +H D+K +N+LLD+   + +SDFGLA+ 
Sbjct: 127 -TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR- 181
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            S     T++ +R     I GT  Y+APE   G E + K D+YSFG++LLE+ T
Sbjct: 182 ASEKFAQTVMXSR-----IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/234 (36%), Positives = 125/234 (53%), Gaps = 30/234 (12%)
Query: 630 SYAELSKATDNFSS------ANKIGEGGSGIVYKGFLGENGTEVAVK----VINLKQKGA 679
           S+ EL   T+NF         NK+GEGG G+VYKG++  N T VAVK    ++++  +  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73
Query: 680 SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
            + F  E K +   +H NL++++   S     G D   +VY +M NGSL + L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSCLDG-- 126
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS   R  IA   A+ I +LH   E   +H D+K +N+LLD+   + +SDFGLA+ 
Sbjct: 127 -TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR- 181
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            S     T++  R     I GT  Y+APE   G E + K D+YSFG++LLE+ T
Sbjct: 182 ASEKFAQTVMXXR-----IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 124/234 (52%), Gaps = 30/234 (12%)
Query: 630 SYAELSKATDNFSS------ANKIGEGGSGIVYKGFLGENGTEVAVK----VINLKQKGA 679
           S+ EL   T+NF         NK+GEGG G+VYKG++  N T VAVK    ++++  +  
Sbjct: 10  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 67
Query: 680 SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
            + F  E K +   +H NL++++   S     G D   +VY +M NGSL + L   +   
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSCLDG-- 120
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS   R  IA   A+ I +LH   E   +H D+K +N+LLD+   + +SDFGLA+ 
Sbjct: 121 -TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR- 175
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            S      ++  R     I GT  Y+APE   G E + K D+YSFG++LLE+ T
Sbjct: 176 ASEKFAQXVMXXR-----IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/234 (35%), Positives = 120/234 (51%), Gaps = 30/234 (12%)
Query: 630 SYAELSKATDNFSS------ANKIGEGGSGIVYKGFLGENGTEVAVK----VINLKQKGA 679
           S+ EL   T+NF         NK GEGG G+VYKG++  N T VAVK    ++++  +  
Sbjct: 7   SFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 64
Query: 680 SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
            + F  E K     +H NL++++   S     G D   +VY +  NGSL + L   +   
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSS----DGDDL-CLVYVYXPNGSLLDRLSCLDG-- 117
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS   R  IA   A+ I +LH   E   +H D+K +N+LLD+   + +SDFGLA+ 
Sbjct: 118 -TPPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR- 172
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            S      +  +R     I GT  Y APE   G E + K D+YSFG++LLE+ T
Sbjct: 173 ASEKFAQXVXXSR-----IVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIIT 220

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 118/218 (54%), Gaps = 29/218 (13%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKIIT 703
           KIG G  G V++     +G++VAVK++  +   A +   F+ E   ++ +RH N++    
Sbjct: 44  KIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL--- 98
Query: 704 VCSGRDFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
                 F GA  +    +IV E++  GSL   LH S  + +   L   +RL++A DVA  
Sbjct: 99  ------FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKG 149
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YLH+   P IVH +LK  N+L+D+     V DFGL++  ++    T + ++S +    
Sbjct: 150 MNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAA---- 200
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE      ++ K DVYSFG++L EL T ++P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 116/218 (53%), Gaps = 29/218 (13%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKIIT 703
           KIG G  G V++     +G++VAVK++  +   A +   F+ E   ++ +RH N++    
Sbjct: 44  KIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL--- 98
Query: 704 VCSGRDFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
                 F GA  +    +IV E++  GSL   LH S  + +   L   +RL++A DVA  
Sbjct: 99  ------FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKG 149
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YLH+   P IVH DLK  N+L+D+     V DFGL++  ++      + ++  +    
Sbjct: 150 MNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS----XFLXSKXAA---- 200
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE      ++ K DVYSFG++L EL T ++P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 248 VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 297
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 347
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 274 KLGQGCFGEVWMGTW--NGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 331 VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 380
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 430
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 248 VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 297
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 347
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 248 VSEEPI------YIVGEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 297
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 347
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL 690
           Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   +
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 76
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           + I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  L
Sbjct: 77  KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVLL 127
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
            +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        +
Sbjct: 128 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------D 177
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 178 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 114/214 (53%), Gaps = 20/214 (9%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  L +A  ++SA
Sbjct: 71  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        +T +   G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTXTAHAGAK 171
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             + + APE     + S+K DV++FG+LL E+ T
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 118
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 168
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 114/214 (53%), Gaps = 20/214 (9%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  L +A  ++SA
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        +T +   G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTXTAHAGAK 171
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             + + APE     + S+K DV++FG+LL E+ T
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL 690
           Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 270
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           + I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  L
Sbjct: 271 KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLL 321
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
            +A  ++SA+EYL    + + +H +L   N L+ ++ +  V+DFGL++ ++        +
Sbjct: 322 YMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------D 371
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 15  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 72  VSEEPI------XIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 121
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 122 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------XTARQGAKFPIKW 171
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 192 KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 249 VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 298
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGL + + ++         +   G K  + +
Sbjct: 299 RM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE-------YTARQGAKFPIKW 348
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 388

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 114/214 (53%), Gaps = 20/214 (9%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +++ VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  L +A  ++SA
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        +T +   G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTFTAHAGAK 171
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             + + APE     + S+K DV++FG+LL E+ T
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 64  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNAVVL 114
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 164
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 165 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ IRH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 168
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 169 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 18  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 75  VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 124
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 125 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 174
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 214

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 168
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 64  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 114
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 164
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 165 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 165
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 166 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 168
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 168
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 67  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 117
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 167
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 163
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 165
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 117/224 (52%), Gaps = 20/224 (8%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 165
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------XTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL 690
           Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 309
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           + I+H NL++++ VC+    +   F  I+ EFM  G+L ++L   N Q     ++ +  L
Sbjct: 310 KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVLL 360
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
            +A  ++SA+EYL    + + +H +L   N L+ ++ +  V+DFGL++ ++        +
Sbjct: 361 YMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------D 410
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           T +   G K  + + APE     + S+K DV++FG+LL E+ T
Sbjct: 411 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 14  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 71  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 120
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 121 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 170
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 16  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 73  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 122
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 123 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 172
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 212

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 67/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q ++++  +AS + Y+ 
Sbjct: 79  VSEEPI------YIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVE 128
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 178
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVCEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 67/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q ++++  +AS + Y+ 
Sbjct: 79  VSEEPI------YIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVE 128
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------WTARQGAKFPIKW 178
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 28/211 (13%)
Query: 647 IGEGGSGIVYKGFLGE-NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           IG+G  G V    LG+  G +VAVK I  K    +++F+AE   +  +RH NL++++ V 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + KG  +  IV E+M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 69  V--EEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEG 120
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + VH DL   NVL+ +D V+ VSDFGL K           E  S     K  V + 
Sbjct: 121 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 166
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR 856
           APE    ++ S K DV+SFGILL E+++  R
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 28/211 (13%)
Query: 647 IGEGGSGIVYKGFLGE-NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           IG+G  G V    LG+  G +VAVK I  K    +++F+AE   +  +RH NL++++ V 
Sbjct: 29  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + KG  +  IV E+M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 84  V--EEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEG 135
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + VH DL   NVL+ +D V+ VSDFGL K           E  S     K  V + 
Sbjct: 136 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 181
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR 856
           APE    ++ S K DV+SFGILL E+++  R
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL  +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  G L ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVMEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
           K+G+G  G V+ G    NGT  VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  G L ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 82  VSEEPI------YIVTEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 131
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G K  + +
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 181
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 21/225 (9%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRNLIKII 702
           IG G  G V +G L   G + +   I   + G +    + F++E   +    H N+I++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +      +    I+ EFM+NG+L+ +L  ++ Q      +VIQ + +   +AS + Y
Sbjct: 84  GVVTN-----SMPVMILTEFMENGALDSFLRLNDGQF-----TVIQLVGMLRGIASGMRY 133
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    E S VH DL   N+L++ +LV  VSDFGL++FL  ++ D    T + S+G K  +
Sbjct: 134 L---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP---TETSSLGGKIPI 187
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNEGL 866
            + APE    R+ +   D +S+GI++ E+ +  +RP   M N+ +
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKII 702
            +IG G  G VYKG   +   +VAVK++N+      +  +F  E   LR  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              +          AIV ++ +  SL   LH    + E+  L     ++IA   A  ++Y
Sbjct: 71  GYSTAPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDY 119
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     SI+H DLK +N+ L +DL   + DFGLA   S  +     E  S      G++
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSI 170
Query: 823 GYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
            ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 175
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 29  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 85  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 134
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 135 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 184
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 28  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 84  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 133
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 134 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 183
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 224

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 26  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 82  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 131
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 132 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 181
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 175
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 28/211 (13%)
Query: 647 IGEGGSGIVYKGFLGE-NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           IG+G  G V    LG+  G +VAVK I  K    +++F+AE   +  +RH NL++++ V 
Sbjct: 201 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + KG  +  IV E+M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 256 V--EEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEG 307
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + VH DL   NVL+ +D V+ VSDFGL K           E  S     K  V + 
Sbjct: 308 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 353
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR 856
           APE    ++ S K DV+SFGILL E+++  R
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 21  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 77  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 126
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 127 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 176
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/211 (35%), Positives = 106/211 (50%), Gaps = 28/211 (13%)
Query: 647 IGEGGSGIVYKGFLGE-NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           IG+G  G V    LG+  G +VAVK I  K    +++F+AE   +  +RH NL++++ V 
Sbjct: 20  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + KG  +  IV E+M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 75  V--EEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEG 126
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + VH DL   NVL+ +D V+ VSDFGL K           E  S     K  V + 
Sbjct: 127 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 172
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR 856
           APE       S K DV+SFGILL E+++  R
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 22  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 78  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 127
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 128 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTARE------GAKFPIK 177
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 21/225 (9%)
Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G V  G L   G  E+ V +  LK    +   + F++E   +    H N+I + 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +      +    I+ EFM+NGSL+ +L  ++ Q      +VIQ + +   +A+ ++Y
Sbjct: 101 GVVTK-----STPVMIITEFMENGSLDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKY 150
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    + + VH DL   N+L++ +LV  VSDFGL++FL +   DT   T + ++G K  +
Sbjct: 151 L---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSALGGKIPI 204
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGL 866
            + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+ +
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 59
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 111
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 112 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 166 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 21/225 (9%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRNLIKII 702
           IG G  G V +G L   G + +   I   + G +    + F++E   +    H N+I++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +      +    I+ EFM+NG+L+ +L  ++ Q      +VIQ + +   +AS + Y
Sbjct: 82  GVVTN-----SMPVMILTEFMENGALDSFLRLNDGQF-----TVIQLVGMLRGIASGMRY 131
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    E S VH DL   N+L++ +LV  VSDFGL++FL  ++ D    T + S+G K  +
Sbjct: 132 L---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP---TYTSSLGGKIPI 185
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNEGL 866
            + APE    R+ +   D +S+GI++ E+ +  +RP   M N+ +
Sbjct: 186 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 230

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G +G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQAGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ +     D     R    G K  + 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE----DAEXTARE---GAKFPIK 175
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 59
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 111
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 112 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 166 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 28/223 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRN 697
             +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++  +   +          AIV ++ +  SL   LH    + E+  L     ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +     E  S    
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---- 167
Query: 818 IKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
             G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 168 --GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 24/217 (11%)
Query: 647 IGEGGSGIVYKGFLGENG--TEVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIKI 701
           IG G  G VYKG L  +    EV V +  LK     K    F+ E   +    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             V S   +K      I+ E+M+NG+L+++L   + +      SV+Q + +   +A+ ++
Sbjct: 112 EGVIS--KYKPM---MIITEYMENGALDKFLREKDGEF-----SVLQLVGMLRGIAAGMK 161
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL +    + VH DL   N+L++ +LV  VSDFGL++ L + +P+    T    I I+ T
Sbjct: 162 YLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWT 217
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
               APE    R+ +   DV+SFGI++ E+ T  +RP
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 82
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 134
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 135 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 188
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 189 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 81
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 82  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 133
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 134 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 187
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 188 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKII 702
            +IG G  G VYKG   +   +VAVK++N+      +  +F  E   LR  RH N++  +
Sbjct: 16  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              +          AIV ++ +  SL   LH    + E+  L     ++IA   A  ++Y
Sbjct: 73  GYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDY 121
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     SI+H DLK +N+ L +DL   + DFGLA   S  +     E  S      G++
Sbjct: 122 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSI 172
Query: 823 GYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
            ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 26  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 82  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 131
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 132 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 181
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 30  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 86  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 135
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 136 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 185
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 175
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 15  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 71  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 120
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 121 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 170
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 25  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 81  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 130
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H DL+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 131 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 180
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 221

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           + +  +K+G G  G VY G   +    VAVK +  +     + F+ E   ++ I+H NL+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 91
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +++ VC+        F  IV E+M  G+L ++L   N +     ++ +  L +A  ++SA
Sbjct: 92  QLLGVCTLE----PPF-YIVTEYMPYGNLLDYLRECNRE----EVTAVVLLYMATQISSA 142
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL    + + +H DL   N L+ ++ V  V+DFGL++ ++        +T +   G K
Sbjct: 143 MEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG-------DTYTAHAGAK 192
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             + + APE       S+K DV++FG+LL E+ T
Sbjct: 193 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 125/258 (48%), Gaps = 36/258 (13%)
Query: 623 EQQFLVD--SYAELSKATDNFS---SANKI------GEGGSGIVYKGFL---GENGTEVA 668
           E QF  +  +Y E  +A  +F+    A++I      G G SG V  G L   G+    VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 669 VKVINL-KQKGASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNG 726
           +K +     +   + F++E   +    H N+I++  V + GR         IV E+M+NG
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR------LAMIVTEYMENG 135
Query: 727 SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD 786
           SL+ +L   + Q      +++Q + +   V + + YL    +   VH DL   NVL+D +
Sbjct: 136 SLDTFLRTHDGQF-----TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSN 187
Query: 787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGI 846
           LV  VSDFGL++ L + +PD    T    I I+    + APE    R  S   DV+SFG+
Sbjct: 188 LVCKVSDFGLSRVLED-DPDAAXTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGV 242
Query: 847 LLLELFTR-KRPTDAMFN 863
           ++ E+    +RP   M N
Sbjct: 243 VMWEVLAYGERPYWNMTN 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 125/258 (48%), Gaps = 36/258 (13%)
Query: 623 EQQFLVD--SYAELSKATDNFS---SANKI------GEGGSGIVYKGFL---GENGTEVA 668
           E QF  +  +Y E  +A  +F+    A++I      G G SG V  G L   G+    VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 669 VKVINL-KQKGASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNG 726
           +K +     +   + F++E   +    H N+I++  V + GR         IV E+M+NG
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR------LAMIVTEYMENG 135
Query: 727 SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD 786
           SL+ +L   + Q      +++Q + +   V + + YL    +   VH DL   NVL+D +
Sbjct: 136 SLDTFLRTHDGQF-----TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSN 187
Query: 787 LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGI 846
           LV  VSDFGL++ L + +PD    T    I I+ T    APE    R  S   DV+SFG+
Sbjct: 188 LVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGV 242
Query: 847 LLLELFTR-KRPTDAMFN 863
           ++ E+    +RP   M N
Sbjct: 243 VMWEVLAYGERPYWNMTN 260

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 58
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH S  + E+  L  
Sbjct: 59  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-- 110
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +D    + DFGLA   S  +  
Sbjct: 111 ---IDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGS 164
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E       + G++ ++APE    +++   S + DVY+FGI+L EL T + P
Sbjct: 165 HQFEQ------LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 74
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 75  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 126
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 127 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 180
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 181 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 82
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH    + E+  L  
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-- 134
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +  
Sbjct: 135 ---IDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 188
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E  S      G++ ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 189 HQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKI 701
             +IG G  G VYKG   +   +VAVK++N+      +  +F  E   LR  RH N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           +   +          AIV ++ +  SL   LH    + E+  L     ++IA   A  ++
Sbjct: 70  MGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMD 118
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +     E  S      G+
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS------GS 169
Query: 822 VGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
           + ++APE    ++    S + DVY+FGI+L EL T + P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGLA+ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIIT 703
           +IG G  G+V+ G+   N  +VA+K I   ++GA   + F+ E + +  + H  L+++  
Sbjct: 14  EIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC     + A    +V+EFM++G L ++L          +L     L + +DV   + YL
Sbjct: 70  VC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E S++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V 
Sbjct: 120 E---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 169
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           + +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G G  G V+ G    N T+VA+K +      + +SF+ E + ++ ++H  L+++  V 
Sbjct: 16  RLGNGQFGEVWMGTWNGN-TKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
           S           IV E+M  GSL ++L     +    +L +   +++A  VA+ + Y+  
Sbjct: 74  SEEPI------YIVTEYMNKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIER 123
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
               + +H DL+ +N+L+   L+  ++DFGLA+ + ++         +   G K  + + 
Sbjct: 124 M---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNE-------XTARQGAKFPIKWT 173
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           APE  +    ++K DV+SFGILL EL T+ R P   M N
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKI 701
             +IG G  G VYKG   +   +VAVK++N+      +  +F  E   LR  RH N++  
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           +   +          AIV ++ +  SL   LH S  + E+  L     ++IA   A  ++
Sbjct: 86  MGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMD 134
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH     SI+H DLK +N+ L +D    + DFGLA   S  +     E       + G+
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGS 185
Query: 822 VGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
           + ++APE    +++   S + DVY+FGI+L EL T + P
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAE 686
           DS  +        +   +IG G  G VYKG   +   +VAVK++N+      +  +F  E
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNE 70
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              LR  RH N++  +   +          AIV ++ +  SL   LH S  + E+  L  
Sbjct: 71  VGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-- 122
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
              ++IA   A  ++YLH     SI+H DLK +N+ L +D    + DFGLA   S  +  
Sbjct: 123 ---IDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
              E       + G++ ++APE    +++   S + DVY+FGI+L EL T + P
Sbjct: 177 HQFEQ------LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+    + +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIIT 703
           +IG G  G+V+ G+   N  +VA+K I   ++GA   + F+ E + +  + H  L+++  
Sbjct: 12  EIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC     + A    +V+EFM++G L ++L          +L     L + +DV   + YL
Sbjct: 68  VC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 117
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
              C   ++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V 
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 167
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           + +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIIT 703
           +IG G  G+V+ G+   N  +VA+K I   ++GA   + F+ E + +  + H  L+++  
Sbjct: 17  EIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC     + A    +V+EFM++G L ++L          +L     L + +DV   + YL
Sbjct: 73  VC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 122
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
              C   ++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V 
Sbjct: 123 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 172
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           + +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIIT 703
           +IG G  G+V+ G+   N  +VA+K I   ++GA   + F+ E + +  + H  L+++  
Sbjct: 14  EIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC     + A    +V+EFM++G L ++L          +L     L + +DV   + YL
Sbjct: 70  VC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
              C   ++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V 
Sbjct: 120 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 169
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           + +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 27/221 (12%)
Query: 646 KIGEGGSGIVYKGFLGENG-TEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G V+ G+   NG T+VAVK  +LKQ   S  +F+AE   ++ ++H+ L+++  
Sbjct: 16  RLGAGQFGEVWMGYY--NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 72  VVTQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 121
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               E + +H +L+ +N+L+   L   ++DFGLA+ + + N  T  E      G K  + 
Sbjct: 122 E---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIED-NEYTARE------GAKFPIK 171
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           + APE       ++K DV+SFGILL E+ T  R P   M N
Sbjct: 172 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 25  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 134
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 135 IQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 190
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 191 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 246
Query: 866 L 866
           +
Sbjct: 247 V 247

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 117
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 118 IQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 173
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 174 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 229
Query: 866 L 866
           +
Sbjct: 230 V 230

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 35  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 95  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 144
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 145 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 200
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 201 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 256
Query: 866 L 866
           +
Sbjct: 257 V 257

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 21/225 (9%)
Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G V  G L   G  E+ V +  LK    +   + F++E   +    H N+I + 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +      +    I+ EFM+NGSL+ +L  ++ Q      +VIQ + +   +A+ ++Y
Sbjct: 75  GVVTK-----STPVMIITEFMENGSLDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKY 124
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L    + + VH  L   N+L++ +LV  VSDFGL++FL +   DT   T + ++G K  +
Sbjct: 125 L---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSALGGKIPI 178
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGL 866
            + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+ +
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 223

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G G  G+V K        +VA+K   ++ +   K+F+ E + L  + H N++K+   C 
Sbjct: 17  VGRGAFGVVCKAKW--RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
                  +   +V E+ + GSL   LH +     +   +    ++  +  +  + YLH  
Sbjct: 72  ------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 767 CEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
              +++H DLKP N+LL     V  + DFG A  +  H  +            KG+  ++
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----------KGSAAWM 171
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
           APE   G   S K DV+S+GI+L E+ TR++P D +
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G G  G+V K        +VA+K   ++ +   K+F+ E + L  + H N++K+   C 
Sbjct: 16  VGRGAFGVVCKAKW--RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
                  +   +V E+ + GSL   LH +     +   +    ++  +  +  + YLH  
Sbjct: 71  ------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 767 CEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
              +++H DLKP N+LL     V  + DFG A  +  H  +            KG+  ++
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----------KGSAAWM 170
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
           APE   G   S K DV+S+GI+L E+ TR++P D +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKIITV 704
           +IG G  G+V+ G+   N  +VA+K I  K+   S+  F+ E + +  + H  L+++  V
Sbjct: 34  EIGSGQFGLVHLGYW-LNKDKVAIKTI--KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           C     + A    +V+EFM++G L ++L          +L     L + +DV   + YL 
Sbjct: 91  C----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLE 140
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
             C   ++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V +
Sbjct: 141 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKW 190
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
            +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E+M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL + L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+    + +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKIIT 703
           +IG G  G+V+ G+   N  +VA+K I   ++GA   + F+ E + +  + H  L+++  
Sbjct: 15  EIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC     + A    +V EFM++G L ++L          +L     L + +DV   + YL
Sbjct: 71  VC----LEQAPI-CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 120
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
              C   ++H DL   N L+ ++ V  VSDFG+ +F+ +       +  + S G K  V 
Sbjct: 121 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 170
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           + +PE       S K DV+SFG+L+ E+F+  +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 647 IGEGGSGIVYKGFLG-ENGTEVAVKVINLKQKGASK----SFVAECKALRNIRHRNLIKI 701
           +GEG  G V +G L  E+GT + V V  +K   +S+     F++E   +++  H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + VC     +G     ++  FM+ G L  +L +S  +     + +   L   +D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL +    + +H DL   N +L  D+   V+DFGL+K +  ++ D   + R   + +K  
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVK-- 214
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             ++A E    R  + K DV++FG+ + E+ TR
Sbjct: 215 --WIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 28/219 (12%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRHRNLIKI 701
           + +IG G  G VYKG   +   +VAVK++ +      +  +F  E   LR  RH N++  
Sbjct: 41  STRIGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF 97
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           +       +   D  AIV ++ +  SL + LH     ++     + Q ++IA   A  ++
Sbjct: 98  M------GYMTKDNLAIVTQWCEGSSLYKHLH-----VQETKFQMFQLIDIARQTAQGMD 146
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH     +I+H D+K +N+ L + L   + DFGLA   S  +    VE  +      G+
Sbjct: 147 YLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT------GS 197
Query: 822 VGYVAPEYGMGRE---ASMKGDVYSFGILLLELFTRKRP 857
           V ++APE    ++    S + DVYS+GI+L EL T + P
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E M+NGSL+ +L   + Q      +V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQF-----TV 117
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 118 IQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 173
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 174 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 229
Query: 866 L 866
           +
Sbjct: 230 V 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 633 ELSKATD--NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLK---QKGASKSFVAE 686
           E +K  D  N S    +G G  G V  G L   +  E++V +  LK    +   + F+ E
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
              +    H N+I++  V +      +    IV E M+NGSL+ +L   + Q      +V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQF-----TV 146
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
           IQ + +   +AS ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+
Sbjct: 147 IQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPE 202
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEG 865
               TR   I I+    + +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+ 
Sbjct: 203 AAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 866 L 866
           +
Sbjct: 259 V 259

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 39/266 (14%)
Query: 103 EIPADIGSLFKLERLSIFQ-NHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKS 160
            IP+ + +L  L  L I   N++ G +P +I  L+ L  + +    + G I D L Q+K+
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 161 LTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNF 220
           L  L  ++N  SG +PPSI ++ +L  I+   NR +G++P   G        +  + N  
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 221 TGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFIN 280
           TG IP + +N + L  ++ S+N   G  SV F   KN   ++L  N+L            
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA----------- 234
Query: 281 LLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWL 340
                       F+  +           LS  +  + +  NRI GT+P  +  L  L+ L
Sbjct: 235 ------------FDLGK---------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 341 TIDTNQLTGTIPPEIGELTNLQQLDL 366
            +  N L G IP    +  NLQ+ D+
Sbjct: 274 NVSFNNLCGEIP----QGGNLQRFDV 295

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 4/222 (1%)
Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
            +P S+ANL         G N + G IPP I  L  L++L I    ++G IP  + ++  
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 361 LQQLDLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLL-GLNISHNKL 419
           L  LD   N L G++P S                  G IP S G+ + L   + IS N+L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 420 IGTLPRQILRITTXXXXXXXXXXXXXXXXXXXVGNLKNLMRLDLSGNKFSGEIPATLSAC 479
            G +P     +                      G+ KN  ++ L+ N  + ++   +   
Sbjct: 187 TGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLS 243
Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP 521
            NL  L++  N   G++P  L  L+ +  L+ S NNL G+IP
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 116/243 (47%), Gaps = 37/243 (15%)
Query: 632 AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALR 691
           +E S   DN      IG G  G VYKG L E    VAVKV +   +   ++F+ E    R
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNIYR 60
Query: 692 N--IRHRNLIKIITVCSGRDFKGADFKA---IVYEFMQNGSLEEWLH-HSNDQLEVCSLS 745
              + H N+ + I    G +   AD +    +V E+  NGSL ++L  H++D +  C L 
Sbjct: 61  VPLMEHDNIARFIV---GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL- 116
Query: 746 VIQRLNIAIDVASAIEYLH-------HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
                  A  V   + YLH       HY +P+I H DL   NVL+  D    +SDFGL+ 
Sbjct: 117 -------AHSVTRGLAYLHTELPRGDHY-KPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG------REASMKG-DVYSFGILLLEL 851
            L+ +      E  + +I   GT+ Y+APE   G       E+++K  D+Y+ G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 852 FTR 854
           F R
Sbjct: 229 FMR 231

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG-ASKSFVAECKALRNIRHRNL 698
           +F     +G GG G+V++     +    A+K I L  +  A +  + E KAL  + H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 699 IKIITVC----SGRDFKGADFKAIVYEFMQ---NGSLEEWLHHSNDQLEVCSLSVIQR-- 749
           ++         +    + +  K  +Y  MQ     +L++W++        C++   +R  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR------CTIEERERSV 119
Query: 750 -LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+I + +A A+E+LH      ++H DLKPSN+    D V  V DFGL   +     +  
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 809 VET----RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           V T     +   G  GT  Y++PE   G   S K D++S G++L EL
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 27/226 (11%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V  G + G+   +VAVK+I  K+   S+  F  E + +  + H  L+K   
Sbjct: 15  ELGSGQFGVVKLGKWKGQ--YDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VCS +++       IV E++ NG L  +L      LE   L     L +  DV   + +L
Sbjct: 71  VCS-KEYP----IYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFL 120
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
             +     +H DL   N L+D+DL   VSDFG+ +++ +   D  V     S+G K  V 
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVS----SVGTKFPVK 170
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTL 868
           + APE     + S K DV++FGIL+ E+F+  K P D   N  + L
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 29/228 (12%)
Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIK-- 700
           IG G  G V  G L   G  E+ V +  LK     K    F++E   +    H N+I   
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 701 -IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            ++T C            I+ E+M+NGSL+ +L  ++ +      +VIQ + +   + S 
Sbjct: 97  GVVTKCKP--------VMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSG 143
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL      S VH DL   N+L++ +LV  VSDFG+++ L + +P+    TR   I I+
Sbjct: 144 MKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIR 199
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGL 866
            T    APE    R+ +   DV+S+GI++ E+ +  +RP   M N+ +
Sbjct: 200 WT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHR 696
           N+     +GEG  G V   +    G +VA+K+IN K    S        E   LR +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++IK+  V      K  D   +V E+  N  L +++   +   E  +    Q+      +
Sbjct: 69  HIIKLYDV-----IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------I 116
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EY H +    IVH DLKP N+LLD+ L   ++DFGL+  +++ N    ++T     
Sbjct: 117 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSC--- 167
Query: 817 GIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
              G+  Y APE   G+  A  + DV+S G++L  +  R+ P D
Sbjct: 168 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHR 696
           N+     +GEG  G V   +    G +VA+K+IN K    S        E   LR +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++IK+  V      K  D   +V E+  N  L +++   +   E  +    Q+      +
Sbjct: 65  HIIKLYDV-----IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------I 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EY H +    IVH DLKP N+LLD+ L   ++DFGL+  +++ N    ++T     
Sbjct: 113 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSC--- 163
Query: 817 GIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
              G+  Y APE   G+  A  + DV+S G++L  +  R+ P D
Sbjct: 164 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 122/246 (49%), Gaps = 31/246 (12%)
Query: 647 IGEGGSGIVYKGFL---GENGTEVAVKVINL----KQKGASKSFVAECKALRNIRHRNLI 699
           IG G  G V  G L   G+    VA+K + +    KQ+   + F+ E   +    H N+I
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 86
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +  V +      +    IV E+M+NGSL+ +L  ++ Q      +VIQ + +   +++ 
Sbjct: 87  HLEGVVTK-----SKPVMIVTEYMENGSLDTFLKKNDGQF-----TVIQLVGMLRGISAG 136
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL    +   VH DL   N+L++ +LV  VSDFGL++ L + +P+    TR   I I+
Sbjct: 137 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIR 192
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLHDFSREFFTR 878
            T    APE    R+ +   DV+S+GI++ E+ +  +RP   M N+ +       E +  
Sbjct: 193 WT----APEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI--KAVEEGYRL 246
Query: 879 KSDTDC 884
            S  DC
Sbjct: 247 PSPMDC 252

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIK-- 700
           IG G  G V  G L   G  E+ V +  LK     K    F++E   +    H N+I   
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 701 -IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            ++T C            I+ E+M+NGSL+ +L  ++ +      +VIQ + +   + S 
Sbjct: 76  GVVTKCKP--------VMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSG 122
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL    + S VH DL   N+L++ +LV  VSDFG+++ L + +P+    TR   I I+
Sbjct: 123 MKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIR 178
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
               + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+
Sbjct: 179 ----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 647 IGEGGSGIVYKGFLGENGT-EVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIK-- 700
           IG G  G V  G L   G  E+ V +  LK     K    F++E   +    H N+I   
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 701 -IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            ++T C            I+ E+M+NGSL+ +L  ++ +      +VIQ + +   + S 
Sbjct: 82  GVVTKCKP--------VMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSG 128
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++YL    + S VH DL   N+L++ +LV  VSDFG+++ L + +P+    TR   I I+
Sbjct: 129 MKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIR 184
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
               + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+
Sbjct: 185 ----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 226

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHR 696
           N+     +GEG  G V   +    G +VA+K+IN K    S        E   LR +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++IK+  V      K  D   +V E+  N  L +++   +   E  +    Q+      +
Sbjct: 74  HIIKLYDV-----IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------I 121
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EY H +    IVH DLKP N+LLD+ L   ++DFGL+  +++ N    ++T     
Sbjct: 122 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSC--- 172
Query: 817 GIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
              G+  Y APE   G+  A  + DV+S G++L  +  R+ P D
Sbjct: 173 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHR 696
           N+     +GEG  G V   +    G +VA+K+IN K    S        E   LR +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++IK+  V      K  D   +V E+  N  L +++   +   E  +    Q+      +
Sbjct: 75  HIIKLYDV-----IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------I 122
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EY H +    IVH DLKP N+LLD+ L   ++DFGL+  +++ N    ++T     
Sbjct: 123 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSC--- 173
Query: 817 GIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
              G+  Y APE   G+  A  + DV+S G++L  +  R+ P D
Sbjct: 174 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 31  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 87  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 134
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEETSSVGSKFP 184
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRN 697
           +    ++G GG G V +    + G +VA+K    +Q+ + K+   +  E + ++ + H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 698 LIKIITVCSG-RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++    V  G +     D   +  E+ + G L ++L+   +    C L       +  D+
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDI 130
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           +SA+ YLH   E  I+H DLKP N++L    Q L+  + D G AK L             
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---------E 178
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +     GT+ Y+APE    ++ ++  D +SFG L  E  T  RP
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRN 697
           +    ++G GG G V +    + G +VA+K    +Q+ + K+   +  E + ++ + H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 698 LIKIITVCSG-RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++    V  G +     D   +  E+ + G L ++L+   +    C L       +  D+
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDI 131
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           +SA+ YLH   E  I+H DLKP N++L    Q L+  + D G AK L             
Sbjct: 132 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---------E 179
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +     GT+ Y+APE    ++ ++  D +SFG L  E  T  RP
Sbjct: 180 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 22  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 78  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 125
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 126 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFP 175
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 15  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 71  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 118
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 119 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFP 168
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 217

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 16  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 72  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 119
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFP 169
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 31  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 87  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 134
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFP 184
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 11  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 67  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 114
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +       +  + S+G K  
Sbjct: 115 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFP 164
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 116/228 (50%), Gaps = 29/228 (12%)
Query: 647 IGEGGSGIVYKGFL---GENGTEVAVKVINL----KQKGASKSFVAECKALRNIRHRNLI 699
           IG G  G V  G L   G+    VA+K + +    KQ+   + F+ E   +    H N++
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR---RDFLCEASIMGQFDHPNVV 107
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +  V +    +G     IV EFM+NG+L+ +L   + Q      +VIQ + +   +A+ 
Sbjct: 108 HLEGVVT----RGKPV-MIVIEFMENGALDAFLRKHDGQF-----TVIQLVGMLRGIAAG 157
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + YL    +   VH DL   N+L++ +LV  VSDFGL++ + + +P+ +  T     G K
Sbjct: 158 MRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED-DPEAVYTT----TGGK 209
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGL 866
             V + APE    R+ +   DV+S+GI++ E+ +  +RP   M N+ +
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 257

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 157 GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 207
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 260
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 116 GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 166
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 213
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 214 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 148
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 201
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 146
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 199
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 149
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 202
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 117 GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 167
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 214
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 215 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 103 GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 153
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 206
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 148
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPV 201
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 147
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +    ++        G K  V
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHN----KTGAKLPV 200
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 148
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 195
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 90  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 140
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 187
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 188 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  +++
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKF 149
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH DL   N +LD+     V+DFGLA+ + +   D++        G K  V
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHN----KTGAKLPV 202
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 146
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 193
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 194 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 95  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 145
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 192
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 147
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 194
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 93  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 143
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 190
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 647 IGEGGSGIVYKGFLGENG---TEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKII 702
           IG G  G VY G L +N       AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +C     +      +V  +M++G L  ++ +     E  + +V   +   + VA  ++Y
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKY 148
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK------FLSNHNPDTIVETRSISI 816
           L        VH DL   N +LD+     V+DFGLA+      + S HN            
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----------KT 195
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 645 NKIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHR 696
            ++GEG  G   K FL E        +   VAVK +      A K F  E + L N++H 
Sbjct: 21  RELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQLEVC---------SLSV 746
           +++K   VC        D   +V+E+M++G L ++L  H  D + +           L +
Sbjct: 78  HIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            Q L+IA  +AS + YL        VH DL   N L+  +L+  + DFG+++        
Sbjct: 133 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------- 181
Query: 807 TIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRP 857
            +  T    +G      + ++ PE  M R+ + + DV+SFG++L E+FT  K+P
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 31/229 (13%)
Query: 646 KIGEGGSGIV-YKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V Y  + G+   +VA+K+I  K+   S+  F+ E K + N+ H  L+++  
Sbjct: 16  ELGTGQFGVVKYGKWRGQ--YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VC+ +   F       I+ E+M NG L  +L     + +   L     L +  DV  A+E
Sbjct: 72  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAME 119
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N L++   V  VSDFGL++++ +   D    +R    G K  
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSR----GSKFP 169
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNEGLTLH 869
           V +  PE  M  + S K D+++FG+L+ E+++  K P +   N     H
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVI------NLKQKGASKSFVAECKALRNIRHRNL 698
            +IG G  G V+ G L  + T VAVK        +LK K     F+ E + L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++I VC+ +         IV E +Q G    +L     +L V +L     L +  D A+
Sbjct: 175 VRLIGVCTQKQPI-----YIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL   C    +H DL   N L+ +  V  +SDFG+    S    D +    + S G+
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM----SREEADGVX---AASGGL 274
Query: 819 KGT-VGYVAPE-YGMGREASMKGDVYSFGILLLELFT 853
           +   V + APE    GR +S + DV+SFGILL E F+
Sbjct: 275 RQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVI------NLKQKGASKSFVAECKALRNIRHRNL 698
            +IG G  G V+ G L  + T VAVK        +LK K     F+ E + L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++I VC+ +         IV E +Q G    +L     +L V +L     L +  D A+
Sbjct: 175 VRLIGVCTQKQPI-----YIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL   C    +H DL   N L+ +  V  +SDFG+    S    D +    + S G+
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM----SREEADGVY---AASGGL 274
Query: 819 KGT-VGYVAPE-YGMGREASMKGDVYSFGILLLELFT 853
           +   V + APE    GR +S + DV+SFGILL E F+
Sbjct: 275 RQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFS 310

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 647 IGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKI 701
           +GEG  G V    Y       G +VAVK +  +  G        E + LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             +C+     G +   ++ EF+ +GSL+E+L  + +++     ++ Q+L  A+ +   ++
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKI-----NLKQQLKYAVQICKGMD 140
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        VH DL   NVL++ +    + DFGL K +     +T  E  ++       
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-----ETDKEXXTVKDDRDSP 192
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V + APE  M  +  +  DV+SFG+ L EL T
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 647 IGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKI 701
           +GEG  G V    Y       G +VAVK +  +  G        E + LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             +C+     G +   ++ EF+ +GSL+E+L  + +++     ++ Q+L  A+ +   ++
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKI-----NLKQQLKYAVQICKGMD 128
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        VH DL   NVL++ +    + DFGL K +     +T  E  ++       
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-----ETDKEXXTVKDDRDSP 180
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V + APE  M  +  +  DV+SFG+ L EL T
Sbjct: 181 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 38/248 (15%)
Query: 628 VDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGA 679
           +D++ +  K   N     ++GEG  G   K FL E        +   VAVK +      A
Sbjct: 3   MDTFVQHIK-RHNIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDASDNA 58
Query: 680 SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-HSNDQ 738
            K F  E + L N++H +++K   VC        D   +V+E+M++G L ++L  H  D 
Sbjct: 59  RKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDA 113
Query: 739 LEVC------SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS 792
           + +        L+  Q L+IA  +A+ + YL        VH DL   N L+ ++L+  + 
Sbjct: 114 VLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIG 170
Query: 793 DFGLAKFLSNHNPDTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLE 850
           DFG+++         +  T    +G      + ++ PE  M R+ + + DV+S G++L E
Sbjct: 171 DFGMSR--------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 222
Query: 851 LFTR-KRP 857
           +FT  K+P
Sbjct: 223 IFTYGKQP 230

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            K+G G  G V+     ++ T+VAVK +        ++F+AE   ++ ++H  L+K+  V
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAV 251
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            +           I+ EFM  GSL ++L       E     + + ++ +  +A  + ++ 
Sbjct: 252 VTKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
              + + +H DL+ +N+L+   LV  ++DFGLA+ + + N  T  E      G K  + +
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTARE------GAKFPIKW 351
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE       ++K DV+SFGILL+E+ T  R P   M N
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVINL---KQKGASKSFVAECKALRN 692
           + +   +K+G GG   VY   L E+     +VA+K I +   +++   K F  E      
Sbjct: 11  ERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           + H+N++ +I V      +  D   +V E+++  +L E++           LSV   +N 
Sbjct: 68  LSHQNIVSMIDVD-----EEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINF 116
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   I++ H   +  IVH D+KP N+L+D +    + DFG+AK LS     ++ +T 
Sbjct: 117 TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---TSLTQTN 170
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            +     GTV Y +PE   G       D+YS GI+L E+   + P
Sbjct: 171 HVL----GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+G G  G V+     ++ T+VAVK +      + ++F+AE   ++ ++H  L+K+  V 
Sbjct: 22  KLGAGQFGEVWMATYNKH-TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
           +           I+ EFM  GSL ++L       E     + + ++ +  +A  + ++  
Sbjct: 80  TKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE- 128
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
             + + +H DL+ +N+L+   LV  ++DFGLA+ + + N  T  E      G K  + + 
Sbjct: 129 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTARE------GAKFPIKWT 179
Query: 826 APEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
           APE       ++K DV+SFGILL+E+ T  R P   M N
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G+G  G   K    E G  + +K +    +   ++F+ E K +R + H N++K I V  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL- 76
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
              +K      I  E+++ G+L   +   + Q         QR++ A D+AS + YLH  
Sbjct: 77  ---YKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPWS-----QRVSFAKDIASGMAYLHSM 127
Query: 767 CEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH--NPDTI----VETRSISIGIKG 820
              +I+H DL   N L+ ++    V+DFGLA+ + +    P+ +       R     + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
              ++APE   GR    K DV+SFGI+L E+  R
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 39/252 (15%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 14  EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 69
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 124
Query: 732 LHHSNDQ-LEVC---------SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           L       LE C          LS    ++ A  VA  +EYL        +H DL   NV
Sbjct: 125 LQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 181
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           L+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  + + DV
Sbjct: 182 LVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDV 235
Query: 842 YSFGILLLELFT 853
           +SFG+LL E+FT
Sbjct: 236 WSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 118/246 (47%), Gaps = 39/246 (15%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLKQKGASK 681
           D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK     K
Sbjct: 5   DPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEK 60
Query: 682 SF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND 737
                ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+L     
Sbjct: 61  DLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRP 115
Query: 738 Q-LEVC---------SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL 787
             LE C          LS    ++ A  VA  +EYL        +H DL   NVL+ +D 
Sbjct: 116 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDN 172
Query: 788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
           V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  + + DV+SFG+L
Sbjct: 173 VMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVL 226
Query: 848 LLELFT 853
           L E+FT
Sbjct: 227 LWEIFT 232

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRN 697
           D++     IG G + +V   +      +VA+K INL++ + +    + E +A+    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-------HHSNDQLEVCSLSVIQRL 750
           ++   T      F   D   +V + +  GS+ + +        H +  L+  +++ I R 
Sbjct: 70  IVSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR- 123
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
               +V   +EYLH   +   +H D+K  N+LL +D    ++DFG++ FL+     T  +
Sbjct: 124 ----EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 811 TRSISIGIKGTVGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
            R   +   GT  ++APE     R    K D++SFGI  +EL T   P
Sbjct: 177 VRKTFV---GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 643 SANKIGEGGSGIVYKGFL---GENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNL 698
           S   IG+G  G+VY G      +N  + A+K ++ + +    ++F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           + +I +             ++  +M +G L +++        V  L     ++  + VA 
Sbjct: 85  LALIGIM----LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL    E   VH DL   N +LD+     V+DFGLA+ + +    ++ + R   + +
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           K T    A E       + K DV+SFG+LL EL TR  P
Sbjct: 193 KWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           KIGEG +GIV        G +VAVK ++L+++   +    E   +R+  H N++ + +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-- 109
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEVCSLSVIQRLNIAIDVASAIEY 762
               +   D   +V EF++ G+L + + H+    +Q+    LSV++          A+ Y
Sbjct: 110 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----------ALSY 156
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH+     ++H D+K  ++LL  D    +SDFG    +S   P            + GT 
Sbjct: 157 LHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--------RKXLVGTP 205
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
            ++APE         + D++S GI+++E+   + P    FNE
Sbjct: 206 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNE 244

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             +       +   D   +V E++  GSL + +       E C +   Q   +  +   A
Sbjct: 81  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 128
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+     RS  +   
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSTMV--- 177
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             +       +   D   +V E++  GSL + +       E C +   Q   +  +   A
Sbjct: 81  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 128
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+     RS  +   
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSXMV--- 177
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             +       +   D   +V E++  GSL + +       E C +   Q   +  +   A
Sbjct: 82  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 129
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+     RS  +   
Sbjct: 130 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSXMV--- 178
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRN 697
           D++     IG G + +V   +      +VA+K INL++ + +    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI--- 754
           ++   T      F   D   +V + +  GS+ + + H   + E  S  V+    IA    
Sbjct: 75  IVSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS-GVLDESTIATILR 128
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           +V   +EYLH   +   +H D+K  N+LL +D    ++DFG++ FL+     T  + R  
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 815 SIGIKGTVGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
            +   GT  ++APE     R    K D++SFGI  +EL T   P
Sbjct: 186 FV---GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             +       +   D   +V E++  GSL + +       E C +   Q   +  +   A
Sbjct: 81  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 128
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E+LH      ++H D+K  N+LL  D    ++DFG   F +   P+    +  +     
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSEMV----- 177
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 36/243 (14%)
Query: 625 QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV 684
           Q +VD   +     DNF    KIGEG +GIV    +  +G  VAVK ++L+++   +   
Sbjct: 21  QLVVDP-GDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 76
Query: 685 AECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEV 741
            E   +R+ +H N++++        +   D   +V EF++ G+L + + H+    +Q+  
Sbjct: 77  NEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA 131
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L+V+Q L++          LH      ++H D+K  ++LL  D    +SDFG    +S
Sbjct: 132 VCLAVLQALSV----------LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 178
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
              P      R   +   GT  ++APE         + D++S GI+++E+   + P    
Sbjct: 179 KEVP-----RRKXLV---GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---Y 227
Query: 862 FNE 864
           FNE
Sbjct: 228 FNE 230

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 36/243 (14%)
Query: 625 QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV 684
           Q +VD   +     DNF    KIGEG +GIV    +  +G  VAVK ++L+++   +   
Sbjct: 19  QLVVDP-GDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 74
Query: 685 AECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEV 741
            E   +R+ +H N++++        +   D   +V EF++ G+L + + H+    +Q+  
Sbjct: 75  NEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA 129
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L+V+Q L++          LH      ++H D+K  ++LL  D    +SDFG    +S
Sbjct: 130 VCLAVLQALSV----------LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 176
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
              P      R   +   GT  ++APE         + D++S GI+++E+   + P    
Sbjct: 177 KEVP-----RRKXLV---GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---Y 225
Query: 862 FNE 864
           FNE
Sbjct: 226 FNE 228

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            K+G G  G V+     ++ T+VAVK +        ++F+AE   ++ ++H  L+K+  V
Sbjct: 188 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAV 245
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            +           I+ EFM  GSL ++L       E     + + ++ +  +A  + ++ 
Sbjct: 246 VTKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
              + + +H DL+ +N+L+   LV  ++DFGLA+                 +G K  + +
Sbjct: 296 ---QRNYIHRDLRAANILVSASLVCKIADFGLAR-----------------VGAKFPIKW 335
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTRKR-PTDAMFN 863
            APE       ++K DV+SFGILL+E+ T  R P   M N
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 375

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 14  EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 69
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 124
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 125 LQARRPPGLEFSFNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDI--HHIDXXKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 41/262 (15%)
Query: 611 RSARKASNMLPIEQ-----QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGT 665
           RS ++    +  EQ     Q +VD   +     DNF    KIGEG +GIV    +  +G 
Sbjct: 122 RSPQREPQRVSHEQFRAALQLVVDP-GDPRSYLDNFI---KIGEGSTGIVCIATVRSSGK 177
Query: 666 EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
            VAVK ++L+++   +    E   +R+ +H N++++        +   D   +V EF++ 
Sbjct: 178 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEFLEG 232
Query: 726 GSLEEWLHHS---NDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL 782
           G+L + + H+    +Q+    L+V+Q L++          LH      ++H D+K  ++L
Sbjct: 233 GALTDIVTHTRMNEEQIAAVCLAVLQALSV----------LHAQ---GVIHRDIKSDSIL 279
Query: 783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVY 842
           L  D    +SDFG    +S   P            + GT  ++APE         + D++
Sbjct: 280 LTHDGRVKLSDFGFCAQVSKEVPRRKX--------LVGTPYWMAPELISRLPYGPEVDIW 331
Query: 843 SFGILLLELFTRKRPTDAMFNE 864
           S GI+++E+   + P    FNE
Sbjct: 332 SLGIMVIEMVDGEPP---YFNE 350

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 36/243 (14%)
Query: 625 QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV 684
           Q +VD   +     DNF    KIGEG +GIV    +  +G  VAVK ++L+++   +   
Sbjct: 14  QLVVDP-GDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF 69
Query: 685 AECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEV 741
            E   +R+ +H N++++        +   D   +V EF++ G+L + + H+    +Q+  
Sbjct: 70  NEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA 124
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L+V+Q L++          LH      ++H D+K  ++LL  D    +SDFG    +S
Sbjct: 125 VCLAVLQALSV----------LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 171
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
              P      R   +   GT  ++APE         + D++S GI+++E+   + P    
Sbjct: 172 KEVP-----RRKXLV---GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---Y 220
Query: 862 FNE 864
           FNE
Sbjct: 221 FNE 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 27/247 (10%)
Query: 645 NKIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNL 698
            K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           I++  V      K      +V E    GSL + L        + +LS       A+ VA 
Sbjct: 78  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAE 126
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++       
Sbjct: 127 GMGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHYVMQEHR---- 178
Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFT 877
            K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E   
Sbjct: 179 -KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 237
Query: 878 RKSDTDC 884
                DC
Sbjct: 238 LPRPEDC 244

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 23/209 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           K+G G  G V+ G+   N T+VAVK   LK    S ++F+ E   ++ ++H  L+++  V
Sbjct: 19  KLGAGQFGEVWMGYY-NNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            +  +        I+ EFM  GSL ++L       E   + + + ++ +  +A  + Y+ 
Sbjct: 76  VTKEEPI-----YIITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + +H DL+ +NVL+ + L+  ++DFGLA+ + + N  T  E      G K  + +
Sbjct: 127 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTARE------GAKFPIKW 176
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFT 853
            APE       ++K +V+SFGILL E+ T
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 55  EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 110
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 111 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 165
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 217
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 218 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 271
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 272 HQSDVWSFGVLLWEIFT 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 41/262 (15%)
Query: 611 RSARKASNMLPIEQ-----QFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGT 665
           RS ++    +  EQ     Q +VD   +     DNF    KIGEG +GIV    +  +G 
Sbjct: 45  RSPQREPQRVSHEQFRAALQLVVDP-GDPRSYLDNFI---KIGEGSTGIVCIATVRSSGK 100
Query: 666 EVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
            VAVK ++L+++   +    E   +R+ +H N++++        +   D   +V EF++ 
Sbjct: 101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEFLEG 155
Query: 726 GSLEEWLHHS---NDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL 782
           G+L + + H+    +Q+    L+V+Q L++          LH      ++H D+K  ++L
Sbjct: 156 GALTDIVTHTRMNEEQIAAVCLAVLQALSV----------LHAQ---GVIHRDIKSDSIL 202
Query: 783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVY 842
           L  D    +SDFG    +S   P            + GT  ++APE         + D++
Sbjct: 203 LTHDGRVKLSDFGFCAQVSKEVPRRKX--------LVGTPYWMAPELISRLPYGPEVDIW 254
Query: 843 SFGILLLELFTRKRPTDAMFNE 864
           S GI+++E+   + P    FNE
Sbjct: 255 SLGIMVIEMVDGEPP---YFNE 273

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ          K  D +    ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQ----------KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V   R     D   ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR----TDV-VLILELVSGGELFDFL 106
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSH 790
                  E  + S I++      +   + YLH      I H DLKP N+ LLD+++ + H
Sbjct: 107 AQKESLSEEEATSFIKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 791 VS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           +   DFGLA     H  +  VE ++I     GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLA-----HEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 849 LELFTRKRP------TDAMFNEGLTLHDFSREFFTRKSD 881
             L +   P       + + N     +DF  EFF+  S+
Sbjct: 209 YILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 646 KIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKI 701
           ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             VC      G     ++ EF+  GSL E+L    ++++   L     L     +   +E
Sbjct: 80  KGVCYS---AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGME 131
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL        +H DL   N+L++ +    + DFGL K L         E   +    +  
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGESP 183
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + + APE     + S+  DV+SFG++L ELFT
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 45/241 (18%)
Query: 646 KIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           ++GEG  G V   FL E        +   VAVK +    + A + F  E + L  ++H++
Sbjct: 48  ELGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 698 LIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLH-HSND--------QLEVCSLSVI 747
           +++   VC+ GR         +V+E+M++G L  +L  H  D         +    L + 
Sbjct: 105 IVRFFGVCTEGRPL------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 748 QRLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           Q L +A  VA+ + YL   H+     VH DL   N L+ Q LV  + DFG+++       
Sbjct: 159 QLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSR------- 206
Query: 806 DTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMF 862
             I  T    +G +    + ++ PE  + R+ + + DV+SFG++L E+FT  K+P   + 
Sbjct: 207 -DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 863 N 863
           N
Sbjct: 266 N 266

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGAS------KSFVAECKA 689
           A +      +IG+GG G+V+KG L ++ + VA+K + L   +G +      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           + N+ H N++K+  +         +   +V EF+  G L    H   D+      SV  +
Sbjct: 77  MSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHN 804
           L + +D+A  IEY+ +   P IVH DL+  N+ L     +  + + V+DFGL++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------ 177
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASM--KGDVYSFGILLLELFTRKRPTD 859
                   S+S G+ G   ++APE     E S   K D YSF ++L  + T + P D
Sbjct: 178 ----QSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 7   EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 62
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 63  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 117
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 118 LQARRPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 169
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 170 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 223
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 224 HQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 3   EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 58
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 59  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 113
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 114 LQARRPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 165
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 166 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 219
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 220 HQSDVWSFGVLLWEIFT 236

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 44/230 (19%)
Query: 646 KIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           ++GEG  G   K FL E        +   VAVK +    + A + F  E + L  ++H++
Sbjct: 25  ELGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 698 LIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS---------LSVI 747
           +++   VC+ GR         +V+E+M++G L  +L       ++ +         L + 
Sbjct: 82  IVRFFGVCTEGRPL------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 748 QRLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           Q L +A  VA+ + YL   H+     VH DL   N L+ Q LV  + DFG+++       
Sbjct: 136 QLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSR------- 183
Query: 806 DTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             I  T    +G +    + ++ PE  + R+ + + DV+SFG++L E+FT
Sbjct: 184 -DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 23/209 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNIRHRNLIKIITV 704
           ++G G  G V+ G+   N T+VAVK   LK    S ++F+ E   ++ ++H  L+++  V
Sbjct: 20  RLGAGQFGEVWMGYY-NNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            +  +        I+ E+M  GSL ++L       E   + + + ++ +  +A  + Y+ 
Sbjct: 77  VTREEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + +H DL+ +NVL+ + L+  ++DFGLA+ + + N  T  E      G K  + +
Sbjct: 128 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTARE------GAKFPIKW 177
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFT 853
            APE       ++K DV+SFGILL E+ T
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 14  EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 69
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 124
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 125 LQARRPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 6   EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 61
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 62  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 116
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 117 LQARRPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 168
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 169 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 222
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 223 HQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 49/257 (19%)
Query: 623 EQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGENG------TEVAVKVINLK 675
           E +   D   EL +  D       +GEG  G +V    +G +       T+VAVK+  LK
Sbjct: 14  EYELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LK 69
Query: 676 QKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEW 731
                K     ++E + ++ I +H+N+I ++  C+     G  +  ++ E+   G+L E+
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREY 124
Query: 732 L---------------HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           L               H+  +QL    L     ++ A  VA  +EYL        +H DL
Sbjct: 125 LQAREPPGLEYSYNPSHNPEEQLSSKDL-----VSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              NVL+ +D V  ++DFGLA+ +  H+ D   +T +  + +K    ++APE    R  +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 45/241 (18%)
Query: 646 KIGEGGSGIVYKGFLGE--------NGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           ++GEG  G V   FL E        +   VAVK +    + A + F  E + L  ++H++
Sbjct: 19  ELGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 698 LIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS---------LSVI 747
           +++   VC+ GR         +V+E+M++G L  +L       ++ +         L + 
Sbjct: 76  IVRFFGVCTEGRPL------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 748 QRLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           Q L +A  VA+ + YL   H+     VH DL   N L+ Q LV  + DFG+++       
Sbjct: 130 QLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSR------- 177
Query: 806 DTIVETRSISIGIKGT--VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMF 862
             I  T    +G +    + ++ PE  + R+ + + DV+SFG++L E+FT  K+P   + 
Sbjct: 178 -DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 236
Query: 863 N 863
           N
Sbjct: 237 N 237

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIKII 702
           IG GG G VY+ F    G EVAVK             +     E K    ++H N+I + 
Sbjct: 15  IGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            VC     K  +   +V EF + G L   L       ++        +N A+ +A  + Y
Sbjct: 73  GVC----LKEPNL-CLVMEFARGGPLNRVLSGKRIPPDIL-------VNWAVQIARGMNY 120
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDL--------VSHVSDFGLAKFLSNHNPDTIVETRSI 814
           LH      I+H DLK SN+L+ Q +        +  ++DFGLA+             R+ 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----------RTT 170
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            +   G   ++APE       S   DV+S+G+LL EL T + P
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 70  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 119
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 120 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 169
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 170 EVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 70  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 119
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 120 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 169
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 170 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N++
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
             +       +   D   +V E++  GSL + +       E C +   Q   +  +   A
Sbjct: 82  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 129
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +E+LH      ++H ++K  N+LL  D    ++DFG   F +   P+     RS  +   
Sbjct: 130 LEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG---FCAQITPEQ--SKRSTMV--- 178
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           DNF    KIGEG +GIV    +  +G  VAVK ++L+++   +    E   +R+ +H N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS---NDQLEVCSLSVIQRLNIAID 755
           +++        +   D   +V EF++ G+L + + H+    +Q+    L+V+Q L++   
Sbjct: 80  VEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV--- 131
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
                  LH      ++H D+K  ++LL  D    +SDFG    +S   P      R   
Sbjct: 132 -------LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-----RRKXL 176
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
           +   GT  ++APE         + D++S GI+++E+   + P    FNE
Sbjct: 177 V---GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNE 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 647 IGEGGSGIVYKGFLGENGT----EVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLIKI 701
           +G G  G VYKG     G      VA+K++N      A+  F+ E   + ++ H +L+++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + VC     +      +V + M +G L E++H   D +    L     LN  + +A  + 
Sbjct: 106 LGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMM 154
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH DL   NVL+       ++DFGLA+ L         E    + G K  
Sbjct: 155 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEYNADGGKMP 205
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + ++A E    R+ + + DV+S+G+ + EL T
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 647 IGEGGSGIVYKGFLGENGT----EVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKI 701
           +G G  G VYKG     G      VA+K++N      A+  F+ E   + ++ H +L+++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + VC     +      +V + M +G L E++H   D +    L     LN  + +A  + 
Sbjct: 83  LGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMM 131
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH DL   NVL+       ++DFGLA+ L         E    + G K  
Sbjct: 132 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEYNADGGKMP 182
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + ++A E    R+ + + DV+S+G+ + EL T
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 67  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 116
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 166
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 167 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 62  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 111
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 161
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLI 699
            + +G G  G V  G     G +VAVK++N +QK  S   V     E + L+  RH ++I
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+  V S       DF  +V E++  G L +++       E+ +  + Q+      + SA
Sbjct: 75  KLYQVIS----TPTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------ILSA 123
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           ++Y H +    +VH DLKP NVLLD  + + ++DFGL+  +S+      + T        
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSC------ 171
Query: 820 GTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
           G+  Y APE   GR  A  + D++S G++L  L     P D
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 63  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 113 LQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 162
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 62  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 111
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 161
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           +  +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 49/279 (17%)
Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ          K  D +    ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQ----------KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V   R     D   ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR----TDV-VLILELVSGGELFDFL 106
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSH 790
                  E  + S I++      +   + YLH      I H DLKP N+ LLD+++ + H
Sbjct: 107 AQKESLSEEEATSFIKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 791 VS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           +   DFGLA     H  +  VE ++I     GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLA-----HEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 849 LELFTRKRP------TDAMFNEGLTLHDFSREFFTRKSD 881
             L +   P       + + N     +DF  EFF++ S+
Sbjct: 209 YILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 63  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 162
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 62  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 111
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 161
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 63  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 162
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 63  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 162
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 EVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 49/279 (17%)
Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ          K  D +    ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQ----------KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V   R     D   ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR----TDV-VLILELVSGGELFDFL 106
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSH 790
                  E  + S I++      +   + YLH      I H DLKP N+ LLD+++ + H
Sbjct: 107 AQKESLSEEEATSFIKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 791 VS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           +   DFGLA     H  +  VE ++I     GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLA-----HEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 849 LELFTRKRP------TDAMFNEGLTLHDFSREFFTRKSD 881
             L +   P       + + N     +DF  EFF++ S+
Sbjct: 209 YILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 61  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKDFMDAS--ALTGIPLPLIK--SYLF 110
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-------VPVRTY 160
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 65  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 114
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 115 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 164
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 165 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 63  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 112
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 162
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 63  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 112
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 162
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 62  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 111
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 161
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 63  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 112
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-------VPVRTY 162
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 61  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 110
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 160
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 61  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 110
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 160
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 62  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 111
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+   
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYXH 161
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 61  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 110
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 160
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 80  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 131
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 132 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 183
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 62  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 111
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+   
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYXH 161
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 107 YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 158
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 210
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 62  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 111
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-------VPVRTY 161
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ          K  D +    ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQ----------KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V   R     D   ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR----TDV-VLILELVSGGELFDFL 106
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSH 790
                  E  + S I++      +   + YLH      I H DLKP N+ LLD+++ + H
Sbjct: 107 AQKESLSEEEATSFIKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 791 VS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           +   DFGLA     H  +  VE ++I     GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLA-----HEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 849 LELFTRKRP------TDAMFNEGLTLHDFSREFFTRKSD 881
             L +   P       + + N     +DF  EFF+  S+
Sbjct: 209 YILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 44/237 (18%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +F     IG GG G V+K     +G    ++ +    + A +    E KAL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 700 KIITVCSGRDF---------KGADFKA---------------IVYEFMQNGSLEEWLHHS 735
                  G D+         + +D+                 I  EF   G+LE+W+   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 736 NDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
             +     L  +  L +   +   ++Y+H      ++H DLKPSN+ L       + DFG
Sbjct: 129 RGE----KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF 852
           L   L N        TRS     KGT+ Y++PE    ++   + D+Y+ G++L EL 
Sbjct: 182 LVTSLKNDGK----RTRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 76  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 179
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ          K  D +    ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQ----------KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V   R     D   ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR----TDV-VLILELVSGGELFDFL 106
Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSH 790
                  E  + S I++      +   + YLH      I H DLKP N+ LLD+++ + H
Sbjct: 107 AQKESLSEEEATSFIKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 791 VS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           +   DFGLA     H  +  VE ++I     GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLA-----HEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 849 LELFTRKRP------TDAMFNEGLTLHDFSREFFTRKSD 881
             L +   P       + + N     +DF  EFF+  S+
Sbjct: 209 YILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 83  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 134
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 135 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 186
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 76  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 179
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+ +  L++++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTE-----NKLYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 23/167 (13%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDAMFNEGLTL-------HDFSREFFTRKSD 881
           ++ G ++ +L     P  A  NEGL         +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFPEKFFPKARD 263

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 79  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 130
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 182
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 94  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 145
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 197
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 64  NIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 113
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+   
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYXH 163
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 38/232 (16%)
Query: 650 GGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRD 709
           G  G V+K  L  +   VAVK+  L+ K + +S   E  +   ++H NL++ I      +
Sbjct: 26  GRFGCVWKAQLMNDF--VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA----E 78
Query: 710 FKGADFKA---IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH- 765
            +G++ +    ++  F   GSL        D L+   ++  +  ++A  ++  + YLH  
Sbjct: 79  KRGSNLEVELWLITAFHDKGSL-------TDYLKGNIITWNELCHVAETMSRGLSYLHED 131
Query: 766 --YC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISIG 817
             +C     +PSI H D K  NVLL  DL + ++DFGLA +F     P         + G
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD-------THG 184
Query: 818 IKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
             GT  Y+APE   G     R+A ++ D+Y+ G++L EL +R +  D   +E
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGAS------KSFVAECKA 689
           A +      +IG+GG G+V+KG L ++ + VA+K + L   +G +      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           + N+ H N++K+  +         +   +V EF+  G L    H   D+      SV  +
Sbjct: 77  MSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHN 804
           L + +D+A  IEY+ +   P IVH DL+  N+ L     +  + + V+DFG ++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------ 177
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASM--KGDVYSFGILLLELFTRKRPTD 859
                   S+S G+ G   ++APE     E S   K D YSF ++L  + T + P D
Sbjct: 178 ----QSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 23/167 (13%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSAXKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDAMFNEGLTL-------HDFSREFFTRKSD 881
           ++ G ++ +L     P  A  NEGL         +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFPEKFFPKARD 263

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 81  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 132
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 133 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 184
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLI 699
            + +G G  G V  G     G +VAVK++N +QK  S   V     E + L+  RH ++I
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+  V S       DF  +V E++  G L +++       E+ +  + Q+      + SA
Sbjct: 75  KLYQVIS----TPTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------ILSA 123
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN--PDTIVETRSISIG 817
           ++Y H +    +VH DLKP NVLLD  + + ++DFGL+  +S+     D+          
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC--------- 171
Query: 818 IKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
             G+  Y APE   GR  A  + D++S G++L  L     P D
Sbjct: 172 --GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 82  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 133
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 134 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 185
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 186 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L+ ++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTE-----NKLYLVFEFLHQ-DLKTFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+ +  L++++  S   L    L +I+  +   
Sbjct: 63  HPNIVKLLDVIHTE-----NKLYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLF 112
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 162
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 94  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 145
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 197
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGAS------KSFVAECKA 689
           A +      +IG+GG G+V+KG L ++ + VA+K + L   +G +      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           + N+ H N++K+  +         +   +V EF+  G L    H   D+      SV  +
Sbjct: 77  MSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHN 804
           L + +D+A  IEY+ +   P IVH DL+  N+ L     +  + + V+DF L++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------ 177
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASM--KGDVYSFGILLLELFTRKRPTD 859
                   S+S G+ G   ++APE     E S   K D YSF ++L  + T + P D
Sbjct: 178 ----QSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+ +  L++++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTE-----NKLYLVFEFL-SMDLKKFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 85  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 133
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHXVMQEHR----- 184
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 879 KSDTDC 884
               DC
Sbjct: 245 PRPEDC 250

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 75  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHXVMQEHR----- 174
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 879 KSDTDC 884
               DC
Sbjct: 235 PRPEDC 240

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           + +    K+GEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++ +I V             +V+EFM+   L++ L  +   L        Q   I I +
Sbjct: 80  NIVSLIDV-----IHSERCLTLVFEFMEK-DLKKVLDENKTGL--------QDSQIKIYL 125
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              +  + H  +  I+H DLKP N+L++ D    ++DFGLA+          +  RS + 
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG-------IPVRSYTH 178
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y AP+  MG ++ S   D++S G +  E+ T K
Sbjct: 179 EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           + +    K+GEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++ +I V             +V+EFM+   L++ L  +   L        Q   I I +
Sbjct: 80  NIVSLIDV-----IHSERCLTLVFEFMEK-DLKKVLDENKTGL--------QDSQIKIYL 125
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              +  + H  +  I+H DLKP N+L++ D    ++DFGLA+          +  RS + 
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG-------IPVRSYTH 178
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y AP+  MG ++ S   D++S G +  E+ T K
Sbjct: 179 EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGCLLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + AS   D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANSFVGTAQYVSPELLTEKSASKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+ +  L++++  S   L    L +I+  +   
Sbjct: 62  HPNIVKLLDVIHTE-----NKLYLVFEFL-SMDLKKFMDAS--ALTGIPLPLIK--SYLF 111
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-------VPVRTY 161
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 114/263 (43%), Gaps = 39/263 (14%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECK 688
            K  D +    ++G G   IV K      G E A K I  +Q  AS+  V       E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            LR + H N+I +  V   R     D   ++ E +  G L ++L       E  + S I+
Sbjct: 68  ILRQVLHPNIITLHDVYENR----TDV-VLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDL-VSHVS--DFGLAKFLSNHN 804
           +      +   + YLH      I H DLKP N+ LLD+++ + H+   DFGLA     H 
Sbjct: 123 Q------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HE 168
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------T 858
            +  VE ++I     GT  +VAPE        ++ D++S G++   L +   P       
Sbjct: 169 IEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 859 DAMFNEGLTLHDFSREFFTRKSD 881
           + + N     +DF  EFF++ S+
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSE 247

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIR 694
           AT  +    +IG G  G VYK     +G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 695 ---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
              H N+++++ VC+           +V+E + +  L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-DTIVE 810
           +       +++LH  C   IVH DLKP N+L+       ++DFGLA+  S     D +V 
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                     T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 174 ----------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 79  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 127
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 128 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHYVMQEHR----- 178
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238
Query: 879 KSDTDC 884
               DC
Sbjct: 239 PRPEDC 244

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 75  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHYVMQEHR----- 174
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 879 KSDTDC 884
               DC
Sbjct: 235 PRPEDC 240

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 85  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 133
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHYVMQEHR----- 184
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 879 KSDTDC 884
               DC
Sbjct: 245 PRPEDC 250

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 27/246 (10%)
Query: 646 KIGEGGSGIVYKG-FLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G +   +G  V+V V  LK     Q  A   F+ E  A+ ++ HRNLI
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L        + +LS       A+ VA  
Sbjct: 75  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + YL        +H DL   N+LL  +DLV  + DFGL + L  ++   +++        
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVK-IGDFGLMRALPQNDDHYVMQEHR----- 174
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTR 878
           K    + APE    R  S   D + FG+ L E+FT  +      N    LH   +E    
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 879 KSDTDC 884
               DC
Sbjct: 235 PRPEDC 240

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 26/233 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V         +   +V+EF+    L++++  S   L    L +I+  +   
Sbjct: 61  HPNIVKLLDV-----IHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLF 110
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 160
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKR--PTDAMFNE 864
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+   P D+  ++
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 95  YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 145
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 146 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 199
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 200 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 88  YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 138
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 139 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 192
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 193 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 90  YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 140
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 141 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 194
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 195 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 240

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 91  YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 141
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 142 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 195
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 196 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 241

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 89  YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 139
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 140 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 193
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 194 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+  I L  + +G   + + E   L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V    +        +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 162
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+  I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V    +        +V+EF+    L++++  S   L    L +I+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIK--SYLFQL 111
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ + 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTH 161
Query: 817 GIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 79  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGM 130
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPGES 182
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVK---VINLKQKGASKSFVAECKALRNIRHR 696
           NF    KIG G    VY+     +G  VA+K   + +L    A    + E   L+ + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+IK         F   +   IV E    G L   + H   Q  +     + +    + +
Sbjct: 93  NVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY--FVQL 145
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+E++H      ++H D+KP+NV +    V  + D GL +F S+          + + 
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------TAAH 194
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            + GT  Y++PE       + K D++S G LL E+   + P
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIR 694
           AT  +    +IG G  G VYK     +G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 695 ---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
              H N+++++ VC+           +V+E + +  L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +       +++LH  C   IVH DLKP N+L+       ++DFGLA+  S          
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---------Y 164
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           +     +  T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 76  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGES 179
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 161
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 162 LLNEDMHIQITDFGTAKVLS---PES---KQARANAFVGTAQYVSPELLTEKSACKSSDL 215
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
             S  KIGEG +GIV       +G +VAVK+++L+++   +    E   +R+ +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +      + +   +   ++ EF+Q G+L        D +    L+  Q   +   V  A+
Sbjct: 107 MY-----KSYLVGEELWVLMEFLQGGAL-------TDIVSQVRLNEEQIATVCEAVLQAL 154
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YLH      ++H D+K  ++LL  D    +SDFG    +S   P            + G
Sbjct: 155 AYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--------RKXLVG 203
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  ++APE       + + D++S GI+++E+   + P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIR 694
           AT  +    +IG G  G VYK     +G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 695 ---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
              H N+++++ VC+           +V+E + +  L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +       +++LH  C   IVH DLKP N+L+       ++DFGLA+  S       V  
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV 173
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                    T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 174 ---------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 114 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 164
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 165 LLNEDMHIQITDFGTAKVLS---PES---KQARANSFVGTAQYVSPELLTEKSACKSSDL 218
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 219 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 110 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 160
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 161 LLNEDMHIQITDFGTAKVLS---PES---KQARANSFVGTAQYVSPELLTEKSACKSSDL 214
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 215 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +F     IG GG G V+K     +G    +K +    + A +    E KAL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 700 KIITVCSGRDFKGADFKA-----------IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
                  G D+                  I  EF   G+LE+W+     +     L  + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVL 123
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L +   +   ++Y+H      +++ DLKPSN+ L       + DFGL   L N      
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF 852
              RS     KGT+ Y++PE    ++   + D+Y+ G++L EL 
Sbjct: 178 -RXRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 114 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 164
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 165 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 218
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 219 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 161
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 162 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 215
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 161
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 162 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 215
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 646 KIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKI 701
           ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 702 ITVCSG---RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
             VC     R+ K      ++ E++  GSL ++L    ++++      I+ L     +  
Sbjct: 76  KGVCYSAGRRNLK------LIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICK 124
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL        +H DL   N+L++ +    + DFGL K L         E   +    
Sbjct: 125 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPG 176
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +  + + APE     + S+  DV+SFG++L ELFT
Sbjct: 177 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 646 KIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKI 701
           ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 702 ITVCSG---RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
             VC     R+ K      ++ E++  GSL ++L    ++++      I+ L     +  
Sbjct: 75  KGVCYSAGRRNLK------LIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICK 123
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +EYL        +H DL   N+L++ +    + DFGL K L         E   +    
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EXXKVKEPG 175
Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +  + + APE     + S+  DV+SFG++L ELFT
Sbjct: 176 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 163
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 164 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 217
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 218 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 118 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 168
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 169 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 222
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 223 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 268

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 161
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 162 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 215
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 110 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 160
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 161 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 214
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF  +FF +  D
Sbjct: 215 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 645 NKIGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V    Y       G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC      G     ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 77  YKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 128
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H +L   N+L++ +    + DFGL K L         E   +    + 
Sbjct: 129 EYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGES 180
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + + APE     + S+  DV+SFG++L ELFT
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 116/243 (47%), Gaps = 46/243 (18%)
Query: 639 DNFSSANKIGEGGSGIVYK----GFLG-ENGTEVAVKVINLKQKGAS---KSFVAECKAL 690
           +N      IGEG  G V++    G L  E  T VAVK+  LK++ ++     F  E   +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALM 104
Query: 691 RNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS---- 745
               + N++K++ VC+ G+         +++E+M  G L E+L  S     VCSLS    
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPM------CLLFEYMAYGDLNEFLR-SMSPHTVCSLSHSDL 157
Query: 746 ---------------VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH 790
                            ++L IA  VA+ + YL    E   VH DL   N L+ +++V  
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 214
Query: 791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE 850
           ++DFGL++ +  ++ D      + +I I+    ++ PE       + + DV+++G++L E
Sbjct: 215 IADFGLSRNI--YSADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 851 LFT 853
           +F+
Sbjct: 269 IFS 271

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHR 696
           + +F   + +GEG  G+V        G  VA+K I    K   +   + E K L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I I  +     F+  +   I+ E MQ         H     ++ S   IQ        
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYF--IYQT 121
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET--RSI 814
             A++ LH     +++H DLKPSN+L++ +    V DFGLA+ +     D    T  +S 
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 815 SIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRK 855
            +    T  Y APE  +   + S   DV+S G +L ELF R+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-----SFVAECKA 689
           S AT  +    +IG G  G VYK     +G  VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 690 LRNIR---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
           LR +    H N+++++ VC+           +V+E + +  L  +L    D+     L  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPA 119
Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
               ++       +++LH  C   IVH DLKP N+L+       ++DFGLA+  S     
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           T V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 177 TPVVV---------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 697 NLIKIITVCSGRDFKGADFKAI---VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           N++K++ V    +     F+ +   +  FM   +L      +   L +    + Q L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASAL------TGIPLPLIKSYLFQLLQ-- 113
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
                 + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+
Sbjct: 114 -----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRT 158
Query: 814 ISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 159 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIR 694
           + +NF    KIGEG  G+VYK      G  VA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K++ V    +     F+ +      +  L++++  S   L    L +I+  +   
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV------DQDLKKFMDAS--ALTGIPLPLIK--SYLF 113
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +   + + H +    ++H DLKP N+L++ +    ++DFGLA+          V  R+ 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTY 163
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
              +  T+ Y APE  +G +  S   D++S G +  E+ TR+
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 46/246 (18%)
Query: 631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA- 689
           +A   +    +   + IG G S +V +      G E AVK++ +  +  S   + E +  
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 690 -------LRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
                  LR +  H ++I +I       ++ + F  +V++ M+ G L ++L       E 
Sbjct: 146 TRRETHILRQVAGHPHIITLID-----SYESSSFMFLVFDLMRKGELFDYL------TEK 194
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
            +LS  +  +I   +  A+ +LH     +IVH DLKP N+LLD ++   +SDFG +  L 
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL- 250
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEY----------GMGREASMKGDVYSFGILLLEL 851
              P   +        + GT GY+APE           G G+E     D+++ G++L  L
Sbjct: 251 --EPGEKLRE------LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTL 298
Query: 852 FTRKRP 857
                P
Sbjct: 299 LAGSPP 304

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 647 IGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKI 701
           +GEG  G V    Y       G  VAVK +        +S +  E   LR + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
              C      GA    +V E++  GSL ++L          S+ + Q L  A  +   + 
Sbjct: 99  KGCCED---AGAASLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMA 148
Query: 762 YLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           YLH  HY     +H DL   NVLLD D +  + DFGLAK +   +     E   +     
Sbjct: 149 YLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EXYRVREDGD 198
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             V + APE     +     DV+SFG+ L EL T 
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 21/166 (12%)
Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
           + +NG L +++       E C+     R   A ++ SA+EYLH      I+H DLKP N+
Sbjct: 116 YAKNGELLKYIRKIGSFDETCT-----RFYTA-EIVSALEYLHG---KGIIHRDLKPENI 166
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           LL++D+   ++DFG AK LS   P++    ++ +    GT  YV+PE    + A    D+
Sbjct: 167 LLNEDMHIQITDFGTAKVLS---PES---KQARANXFVGTAQYVSPELLTEKSACKSSDL 220
Query: 842 YSFGILLLELFTRKRPTDA-----MFNEGLTL-HDFSREFFTRKSD 881
           ++ G ++ +L     P  A     +F + + L +DF   FF +  D
Sbjct: 221 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARD 266

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRH 695
           ++  F    K+G G    VYKG     G  VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++  V    +        +V+EFM N  L++++    D   V +      LN+   
Sbjct: 63  ENIVRLYDVIHTENKL-----TLVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVKY 112
Query: 756 VASAIEYLHHYC-EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
               +     +C E  I+H DLKP N+L+++     + DFGLA+          V T S 
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-----IPVNTFSS 167
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +    T+ Y AP+  MG R  S   D++S G +L E+ T K
Sbjct: 168 EV---VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNI 693
           ++ + + +   +GEG  G+V K    + G  VA+K    +   K   K  + E K L+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV----CSLSVIQR 749
           RH NL+ ++ VC     K      +V+EF+ +  L        D LE+        V+Q+
Sbjct: 82  RHENLVNLLEVC-----KKKKRWYLVFEFVDHTIL--------DDLELFPNGLDYQVVQK 128
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
                 + + I + H +   +I+H D+KP N+L+ Q  V  + DFG A+ L+   P  + 
Sbjct: 129 Y--LFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVY 181
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELF 852
           +          T  Y APE  +G     K  DV++ G L+ E+F
Sbjct: 182 DDEV------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 171
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 172 ----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 227
Query: 860 AMFNE 864
            + NE
Sbjct: 228 GLSNE 232

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTE-VAVKVINLK--QKGASKSFVAECKAL 690
           L +A   +    +IGEG  G V+K    +NG   VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 691 RNIR---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           R++    H N++++  VC+           +V+E + +  L  +L    D++    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
              ++   +   +++LH +    +VH DLKP N+L+       ++DFGLA+  S     T
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 178 SVVV---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 180
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 181 ----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 860 AMFNE 864
            + NE
Sbjct: 237 GLSNE 241

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 173
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 174 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 229
Query: 860 AMFNE 864
            + NE
Sbjct: 230 GLSNE 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 186
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 860 AMFNE 864
            + NE
Sbjct: 243 GLSNE 247

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 179
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 180 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 860 AMFNE 864
            + NE
Sbjct: 236 GLSNE 240

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 15/222 (6%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHR 696
           + +F   + +GEG  G+V        G  VA+K I    K   +   + E K L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I I  +     F+  +   I+ E MQ         H     ++ S   IQ        
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYF--IYQT 121
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET--RSI 814
             A++ LH     +++H DLKPSN+L++ +    V DFGLA+ +     D    T  +S 
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 815 SIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +   + S   DV+S G +L ELF R+
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 177
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 178 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 233
Query: 860 AMFNE 864
            + NE
Sbjct: 234 GLSNE 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKI 701
             +IG+G  G V+ G     G +VAVKV    ++    S+  E +  + +  RH N++  
Sbjct: 42  VKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGF 96
Query: 702 ITVCSGRDFKGADFKAIVY---EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           I      D KG      +Y   ++ +NGSL        D L+  +L     L +A    S
Sbjct: 97  IAA----DIKGTGSWTQLYLITDYHENGSL-------YDYLKSTTLDAKSMLKLAYSSVS 145
Query: 759 AIEYLHHYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETR 812
            + +LH        +P+I H DLK  N+L+ ++    ++D GLA KF+S+ N   I    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 813 SISIGIKGTVGYVAPEY---GMGR---EASMKGDVYSFGILLLELFTR 854
            +     GT  Y+ PE     + R   ++ +  D+YSFG++L E+  R
Sbjct: 206 RV-----GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHR 696
           + +F   + +GEG  G+V        G  VA+K I    K   +   + E K L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH-------SNDQLEVCSLSVIQR 749
           N+I I  +     F+  +   I+ E MQ       LH        S+D ++      ++ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
                    A++ LH     +++H DLKPSN+L++ +    V DFGLA+ +     D   
Sbjct: 124 ---------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 810 ET--RSISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRK 855
            T  +S       T  Y APE  +   + S   DV+S G +L ELF R+
Sbjct: 172 PTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTE-VAVKVINLK--QKGASKSFVAECKAL 690
           L +A   +    +IGEG  G V+K    +NG   VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 691 RNIR---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           R++    H N++++  VC+           +V+E + +  L  +L    D++    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
              ++   +   +++LH +    +VH DLKP N+L+       ++DFGLA+  S     T
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 178 SVVV---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 180
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 181 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 860 AMFNE 864
            + NE
Sbjct: 237 GLSNE 241

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 208
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 209 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 264
Query: 860 AMFNE 864
            + NE
Sbjct: 265 GLSNE 269

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 97/364 (26%), Positives = 172/364 (47%), Gaps = 59/364 (16%)
Query: 5   QWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLI 64
           Q T +T  +   ++  + + N  I   ++P + NL+ L  + + +N      P  +  L 
Sbjct: 74  QLTDITPLKNLTKLVDILMNNNQI-ADITP-LANLTNLTGLTLFNNQITDIDP--LKNLT 129
Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
           +L RL LS+N+ S    + LS  ++L +LS  SN +    P  + +L  LERL I  N +
Sbjct: 130 NLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKV 185
Query: 125 TG-QLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS 183
           +   + A + NL SL    +  N     I  LG L +L  LS+  NQ   +   ++ +++
Sbjct: 186 SDISVLAKLTNLESL----IATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLT 239
Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           +L  + L+ N+ +   P+     L  L EL+  AN  +   P  L+  ++L  +E ++NQ
Sbjct: 240 NLTDLDLANNQISNLAPLS---GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 294
Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
                 +  S LKNL +L L  NN+          I+ +++ +KL+RL+F+ N+      
Sbjct: 295 LEDISPI--SNLKNLTYLTLYFNNISD--------ISPVSSLTKLQRLFFSNNK------ 338
Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
             V+++SS                   + NL ++NWL+   NQ++   P  +  LT + Q
Sbjct: 339 --VSDVSS-------------------LANLTNINWLSAGHNQISDLTP--LANLTRITQ 375
Query: 364 LDLD 367
           L L+
Sbjct: 376 LGLN 379

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 159/368 (43%), Gaps = 60/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 65  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 120
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  LS + NQ + + P  + N+++L
Sbjct: 121 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFSSNQVTDLKP--LANLTTL 175
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 176 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 230
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 231 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 278
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 279 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 332
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 333 FFSNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 366
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 367 LANLTRIT 374

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 136
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 191
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 192 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 189
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 190 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTE-VAVKVINLK--QKGASKSFVAECKAL 690
           L +A   +    +IGEG  G V+K    +NG   VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 691 RNIR---HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           R++    H N++++  VC+           +V+E + +  L  +L    D++    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
              ++   +   +++LH +    +VH DLKP N+L+       ++DFGLA+  S     T
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 178 SVVV---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 142
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 143 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 197
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 198 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 189
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 190 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 179
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 180 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 860 AMFNE 864
            + NE
Sbjct: 236 GLSNE 240

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 154
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 155 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 209
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 210 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-- 189
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 190 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRH 695
           +   + +GEG    VYK         VA+K I L  +     G +++ + E K L+ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N+I ++       F      ++V++FM+   LE  +  ++  L    +     + +   
Sbjct: 72  PNIIGLLDA-----FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL--- 122
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
               +EYLH +    I+H DLKP+N+LLD++ V  ++DFGLAK  S  +P+     + + 
Sbjct: 123 --QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYXHQVV- 174
Query: 816 IGIKGTVGYVAPEYGMGREASMKG---DVYSFGILLLELFTR 854
                T  Y APE   G  A M G   D+++ G +L EL  R
Sbjct: 175 -----TRWYRAPELLFG--ARMYGVGVDMWAVGCILAELLLR 209

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-- 189
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 190 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA-- 189
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 190 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 132
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 187
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 188 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 139
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 140 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 194
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 195 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 140
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 141 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 195
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 196 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 131
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 132 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 186
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 187 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH----------HSNDQL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L           +  +++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 36/230 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 58
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 59  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 113
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   +  V T
Sbjct: 114 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGT 169
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
           RS          Y++PE   G   S++ D++S G+ L+E+   + P   M
Sbjct: 170 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 132
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 187
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 188 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIK 700
           + +G G  G V  G     G +VAVK++N +QK  S   V     E + L+  RH ++IK
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +  V S      +D   +V E++  G L +++  +    E  S  + Q+      + S +
Sbjct: 81  LYQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ------ILSGV 129
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +Y H +    +VH DLKP NVLLD  + + ++DFGL+  +S+       E    S    G
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRXSC---G 177
Query: 821 TVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTD 859
           +  Y APE   GR  A  + D++S G++L  L     P D
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 136
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 191
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 192 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 626 FLVDSYAELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGAS 680
           F+ D + E+S+  +  +   ++G+G  G+VY+G       GE  T VAVK +N       
Sbjct: 7   FVPDEW-EVSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 681 K-SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
           +  F+ E   ++     ++++++ V S    KG     +V E M +G L+ +L     + 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEA 118
Query: 740 E----VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
           E        ++ + + +A ++A  + YL+       VH DL   N ++  D    + DFG
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 796 LAKFLSNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +         I ET     G KG   V ++APE       +   D++SFG++L E+ +
Sbjct: 176 MTR--------DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 854 -RKRPTDAMFNE 864
             ++P   + NE
Sbjct: 228 LAEQPYQGLSNE 239

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 626 FLVDSYAELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGAS 680
           F+ D + E+S+  +  +   ++G+G  G+VY+G       GE  T VAVK +N       
Sbjct: 4   FVPDEW-EVSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 681 K-SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
           +  F+ E   ++     ++++++ V S    KG     +V E M +G L+ +L     + 
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEA 115
Query: 740 E----VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
           E        ++ + + +A ++A  + YL+       VH DL   N ++  D    + DFG
Sbjct: 116 ENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 172
Query: 796 LAKFLSNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +         I ET     G KG   V ++APE       +   D++SFG++L E+ +
Sbjct: 173 MTR--------DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224
Query: 854 -RKRPTDAMFNE 864
             ++P   + NE
Sbjct: 225 LAEQPYQGLSNE 236

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKAL 690
           + +  ++F   N +G+G    VY+      G EVA+K+I+ K   + G  +    E K  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
             ++H +++++        F+ +++  +V E   NG +  +L     +  V   S  +  
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEAR 115
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
           +    + + + YLH +    I+H DL  SN+LL +++   ++DFGLA  L          
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK--------M 164
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                  + GT  Y++PE        ++ DV+S G +   L   + P D 
Sbjct: 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 97/364 (26%), Positives = 171/364 (46%), Gaps = 59/364 (16%)
Query: 5   QWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLI 64
           Q T +T  +   ++  + + N  I   ++P + NL+ L  + + +N      P  +  L 
Sbjct: 74  QLTDITPLKNLTKLVDILMNNNQI-ADITP-LANLTNLTGLTLFNNQITDIDP--LKNLT 129
Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
           +L RL LS+N+ S    + LS  ++L +LS  SN +    P  + +L  LERL I  N +
Sbjct: 130 NLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKV 185
Query: 125 TG-QLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS 183
           +   + A + NL SL    +  N     I  LG L +L  LS+  NQ   +   ++ +++
Sbjct: 186 SDISVLAKLTNLESL----IATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLT 239
Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           +L  + L+ N+ +   P+     L  L EL+  AN  +   P  L+  ++L  +E ++NQ
Sbjct: 240 NLTDLDLANNQISNLAPLS---GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 294
Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
                 +  S LKNL +L L  NN+          I+ +++ +KL+RL+F  N+      
Sbjct: 295 LEDISPI--SNLKNLTYLTLYFNNISD--------ISPVSSLTKLQRLFFYNNK------ 338
Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
             V+++SS                   + NL ++NWL+   NQ++   P  +  LT + Q
Sbjct: 339 --VSDVSS-------------------LANLTNINWLSAGHNQISDLTP--LANLTRITQ 375
Query: 364 LDLD 367
           L L+
Sbjct: 376 LGLN 379

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 159/368 (43%), Gaps = 60/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 65  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 120
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  LS + NQ + + P  + N+++L
Sbjct: 121 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFSSNQVTDLKP--LANLTTL 175
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 176 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 230
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 231 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 278
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 279 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 332
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 333 FFYNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 366
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 367 LANLTRIT 374

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 39/232 (16%)
Query: 650 GGSGIVYKG-FLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGR 708
           G  G V+K   L E    VAVK+  ++ K + ++   E  +L  ++H N+++ I    G 
Sbjct: 35  GRFGCVWKAQLLNEY---VAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFI----GA 86
Query: 709 DFKGADFKA---IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
           + +G        ++  F + GSL       +D L+   +S  +  +IA  +A  + YLH 
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSL-------SDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 766 YC-------EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISIG 817
                    +P+I H D+K  NVLL  +L + ++DFGLA KF +        ++   + G
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG-------KSAGDTHG 192
Query: 818 IKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
             GT  Y+APE   G     R+A ++ D+Y+ G++L EL +R    D   +E
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGASK-SFVAE 686
           E   + +  +   ++G+G  G+VY+G       GE  T VAVK +N       +  F+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S    KG     +V E M +G L+ +L     + E      
Sbjct: 71  ASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             ++ + + +A ++A  + YL+       VH DL   N ++  D    + DFG+ +    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V ++APE       +   D++SFG++L E+ +  ++P  
Sbjct: 179 ----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 234
Query: 860 AMFNE 864
            + NE
Sbjct: 235 GLSNE 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 716 KAIVYEFMQ---NGSLEEWLHHSNDQLEVCSLSVIQR---LNIAIDVASAIEYLHHYCEP 769
           K  +Y  MQ     +L++W++        CSL   +    L+I I +A A+E+LH     
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRR------CSLEDREHGVCLHIFIQIAEAVEFLH---SK 183
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET----RSISIGIKGTVGYV 825
            ++H DLKPSN+    D V  V DFGL   +     +  V T     +   G  GT  Y+
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYM 243
Query: 826 APEYGMGREASMKGDVYSFGILLLELF 852
           +PE   G   S K D++S G++L EL 
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D +    ++G+G  G VYK    E     A KVI+ K +   + ++ E   L +  H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K++       F   +   I+ EF   G+++  +      L    + V+ +  +      
Sbjct: 97  VKLLDA-----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----D 146
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+ YLH   +  I+H DLK  N+L   D    ++DFG    +S  N  TI    S     
Sbjct: 147 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFI--- 196
Query: 819 KGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRP 857
            GT  ++APE  M      R    K DV+S GI L+E+   + P
Sbjct: 197 -GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 604 LIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSG-IVYKGFLGE 662
           L+ +  R S+   + ML    ++ +    +     D  +    +GEG  G +V    +G 
Sbjct: 46  LVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGI 105
Query: 663 NGTE----VAVKVINLKQKGASKSF---VAECKALRNI-RHRNLIKIITVCSGRDFKGAD 714
           +  +    V V V  LK     K     V+E + ++ I +H+N+I ++  C+     G  
Sbjct: 106 DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPL 162
Query: 715 FKAIVYEFMQNGSLEEWL--------HHSND--QLEVCSLSVIQRLNIAIDVASAIEYLH 764
           +  ++ E+   G+L E+L         +S D  ++    ++    ++    +A  +EYL 
Sbjct: 163 Y--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL- 219
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                  +H DL   NVL+ ++ V  ++DFGLA+ ++N      ++    +   +  V +
Sbjct: 220 --ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN------IDYYKKTTNGRLPVKW 271
Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFT 853
           +APE    R  + + DV+SFG+L+ E+FT
Sbjct: 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGASKSFVAECKALRNIRHRN 697
           D F    K+G G  G V+      +G E  +K IN  + +   +   AE + L+++ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +IKI  V     F+      IV E  + G L E +  +  + +  S   +  L     + 
Sbjct: 82  IIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--MKQMM 134
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH----VSDFGLAKFLSNHNPDTIVETRS 813
           +A+ Y H      +VH DLKP N+L  QD   H    + DFGLA+   +    T      
Sbjct: 135 NALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHST------ 184
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                 GT  Y+APE    R+ + K D++S G+++  L T
Sbjct: 185 ---NAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 626 FLVDSYAELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGAS 680
           F+ D + E+S+  +  +   ++G+G  G+VY+G       GE  T VAVK +N       
Sbjct: 7   FVPDEW-EVSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 681 K-SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
           +  F+ E   ++     ++++++ V S    KG     +V E M +G L+ +L     + 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEA 118
Query: 740 E----VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
           E        ++ + + +A ++A  + YL+       VH DL   N ++  D    + DFG
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 796 LAKFLSNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +         I ET     G KG   V ++APE       +   D++SFG++L E+ +
Sbjct: 176 MTR--------DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 854 -RKRPTDAMFNE 864
             ++P   + NE
Sbjct: 228 LAEQPYQGLSNE 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 626 FLVDSYAELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGAS 680
           F+ D + E+S+  +  +   ++G+G  G+VY+G       GE  T VAVK +N       
Sbjct: 7   FVPDEW-EVSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 681 K-SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
           +  F+ E   ++     ++++++ V S    KG     +V E M +G L+ +L     + 
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEA 118
Query: 740 E----VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
           E        ++ + + +A ++A  + YL+       VH DL   N ++  D    + DFG
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 796 LAKFLSNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + +         I ET     G KG   V ++APE       +   D++SFG++L E+ +
Sbjct: 176 MTR--------DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 854 -RKRPTDAMFNE 864
             ++P   + NE
Sbjct: 228 LAEQPYQGLSNE 239

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S           ++ E M  G L+ +L     ++E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             S+ + + +A ++A  + YL+       VH DL   N  + +D    + DFG+ +    
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR---- 173
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P  
Sbjct: 174 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 229
Query: 860 AMFNE 864
            + NE
Sbjct: 230 GLSNE 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 74
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 75  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 129
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 130 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 185
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 186 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-----KSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V  ++ + A+     K  + E   + ++ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 110 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 158
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 159 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 211
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 212 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA++ I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 55
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 110
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 111 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 167 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 55
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 110
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 111 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 167 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 55
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 110
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 111 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 167 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 55
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 110
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 111 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 167 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 45/228 (19%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V K  + ++G  +   +  +K+   K   + F  E + L  +  H N+I ++
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE-----------VCSLSVIQRLN 751
             C  R   G  + AI  E+  +G+L ++L  S   LE             +LS  Q L+
Sbjct: 83  GACEHR---GYLYLAI--EYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLH 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A DVA  ++YL    +   +H DL   N+L+ ++ V+ ++DFGL              +
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------------S 179
Query: 812 RSISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
           R   + +K T+G + P   M  E+      +   DV+S+G+LL E+ +
Sbjct: 180 RGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 55
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 110
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 111 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 167 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 117
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 118 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 172
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 173 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 228
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 229 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 136
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++  
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA-- 191
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 192 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 82  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 194 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 45/228 (19%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V K  + ++G  +   +  +K+   K   + F  E + L  +  H N+I ++
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE-----------VCSLSVIQRLN 751
             C  R   G  + AI  E+  +G+L ++L  S   LE             +LS  Q L+
Sbjct: 93  GACEHR---GYLYLAI--EYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLH 146
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A DVA  ++YL    +   +H DL   N+L+ ++ V+ ++DFGL              +
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------------S 189
Query: 812 RSISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
           R   + +K T+G + P   M  E+      +   DV+S+G+LL E+ +
Sbjct: 190 RGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 29/232 (12%)
Query: 646 KIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRNLI 699
           ++G+G  G+VY+G       GE  T VAVK +N       +  F+ E   ++     +++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VCSLSVIQRLNIAID 755
           +++ V S    KG     +V E M +G L+ +L     + E        ++ + + +A +
Sbjct: 83  RLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +A  + YL+       VH DL   N ++  D    + DFG+ +         I ET    
Sbjct: 138 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYR 186
Query: 816 IGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFNE 864
            G KG   V ++APE       +   D++SFG++L E+ +  ++P   + NE
Sbjct: 187 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 238

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 647 IGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKI 701
           +GEG  G V    Y       G  VAVK +        +S +  E   LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
              C     +G     +V E++  GSL ++L          S+ + Q L  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMA 131
Query: 762 YLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           YLH  HY     +H +L   NVLLD D +  + DFGLAK +   +     E   +     
Sbjct: 132 YLHSQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGD 181
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             V + APE     +     DV+SFG+ L EL T 
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V+K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL 82
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 83  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 137
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 138 IA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 193
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 194 RS----------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 84  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 196 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 87  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 199 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 647 IGEGGSGIV----YKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKI 701
           +GEG  G V    Y       G  VAVK +        +S +  E   LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
              C     +G     +V E++  GSL ++L          S+ + Q L  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMA 131
Query: 762 YLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           YLH  HY     +H +L   NVLLD D +  + DFGLAK +   +     E   +     
Sbjct: 132 YLHAQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGD 181
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             V + APE     +     DV+SFG+ L EL T 
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKIIT 703
           K+ E  SG ++KG     G ++ VKV+ ++     KS  F  EC  LR   H N++ ++ 
Sbjct: 17  KLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
            C       A    ++  +M  GSL   LH   + +    +   Q +  A+D+A  + +L
Sbjct: 75  ACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDMARGMAFL 127
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H   EP I    L   +V++D+D+ + +S     KF S  +P           G      
Sbjct: 128 HTL-EPLIPRHALNSRSVMIDEDMTARIS-MADVKF-SFQSP-----------GRMYAPA 173
Query: 824 YVAPEYGMGREASMK---GDVYSFGILLLELFTRKRP 857
           +VAPE    +         D++SF +LL EL TR+ P
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 45/238 (18%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G+G  GIVY G    N   +A+K I  +    S+    E    ++++H+N+++ +    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 86
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHS----NDQLEVCSLSVIQRLNIAIDVASAIEY 762
              F    F  I  E +  GSL   L        D  +       Q       +   ++Y
Sbjct: 87  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLKY 137
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           LH   +  IVH D+K  NVL++    V  +SDFG +K L+  NP T   T        GT
Sbjct: 138 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------GT 186
Query: 822 VGYVAPEY------GMGREASMKGDVYSFGILLLELFTRK-------RPTDAMFNEGL 866
           + Y+APE       G G+ A    D++S G  ++E+ T K        P  AMF  G+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 114
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SCHAPSSRRTT- 166
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 167 -----LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR-------ELQKLSKFDEQRTATY 114
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +  +T 
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDT- 166
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 167 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 32/247 (12%)
Query: 636 KATDNFSSANKIGEG--GSGIVYKGFLGENGTEVAVKVINL-----KQKGASKSFVAECK 688
           ++ + +    KIGEG  G  I+ K    E+G +  +K IN+     K++  S+  VA   
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKS--TEDGRQYVIKEINISRMSSKEREESRREVA--- 75
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            L N++H N+++         F+      IV ++ + G L + ++     L        Q
Sbjct: 76  VLANMKHPNIVQY-----RESFEENGSLYIVMDYCEGGDLFKRINAQKGVL----FQEDQ 126
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+  + +  A++++H   +  I+H D+K  N+ L +D    + DFG+A+ L     ++ 
Sbjct: 127 ILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NST 178
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
           VE     I   GT  Y++PE    +  + K D+++ G +L EL T K   +A   + L L
Sbjct: 179 VELARACI---GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
Query: 869 HDFSREF 875
              S  F
Sbjct: 236 KIISGSF 242

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 45/238 (18%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G+G  GIVY G    N   +A+K I  +    S+    E    ++++H+N+++ +    
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 72
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHS----NDQLEVCSLSVIQRLNIAIDVASAIEY 762
              F    F  I  E +  GSL   L        D  +       Q       +   ++Y
Sbjct: 73  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLKY 123
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           LH   +  IVH D+K  NVL++    V  +SDFG +K L+  NP T   T        GT
Sbjct: 124 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------GT 172
Query: 822 VGYVAPEY------GMGREASMKGDVYSFGILLLELFTRK-------RPTDAMFNEGL 866
           + Y+APE       G G+ A    D++S G  ++E+ T K        P  AMF  G+
Sbjct: 173 LQYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 226

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +D F   +++G G + IVY+    + GT+    +  LK+    K    E   L  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYR--CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +IK+  +     F+     ++V E +  G L + +       E  +   +++      + 
Sbjct: 110 IIKLKEI-----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------IL 158
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            A+ YLH   E  IVH DLKP N+L      D    ++DFGL+K         IVE + +
Sbjct: 159 EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---------IVEHQVL 206
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL------LELFTRKRPTDAMFN 863
              + GT GY APE   G     + D++S GI+        E F  +R    MF 
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR 261

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 109/234 (46%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSGIVYK----GFLGENGTEVAVKVINLKQKGASKS----FVAECKAL 690
           D  +    +GEG  G V      G   +   E     + + +  A++      V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++ E+   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 44/231 (19%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGA-----------SKS 682
           K  +++    K+G G  G V         +E A+KVI   Q  KG             + 
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 683 FVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLE 740
              E   L+++ H N+IK+  V     F+   +  +V EF + G L E +   H  D+ +
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD---LVSHVSDFGLA 797
                     NI   + S I YLH +   +IVH D+KP N+LL+     L   + DFGL+
Sbjct: 148 AA--------NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
            F S    D  +  R       GT  Y+APE  + ++ + K DV+S G+++
Sbjct: 197 SFFS---KDYKLRDRL------GTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 138
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T      ++  
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA-- 193
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 194 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +  H SND   +C             + 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICYF--------LYQIL 139
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T      ++  
Sbjct: 140 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA-- 194
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 195 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 96/364 (26%), Positives = 171/364 (46%), Gaps = 59/364 (16%)
Query: 5   QWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLI 64
           Q T +T  +   ++  + + N  I   ++P + NL+ L  + + +N      P  +  L 
Sbjct: 74  QLTDITPLKNLTKLVDILMNNNQI-ADITP-LANLTNLTGLTLFNNQITDIDP--LKNLT 129
Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
           +L RL LS+N+ S    + LS  ++L +L+  SN +    P  + +L  LERL I  N +
Sbjct: 130 NLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 185
Query: 125 TG-QLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS 183
           +   + A + NL SL    +  N     I  LG L +L  LS+  NQ   +   ++ +++
Sbjct: 186 SDISVLAKLTNLESL----IATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLT 239
Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           +L  + L+ N+ +   P+     L  L EL+  AN  +   P  L+  ++L  +E ++NQ
Sbjct: 240 NLTDLDLANNQISNLAPLS---GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 294
Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
                 +  S LKNL +L L  NN+          I+ +++ +KL+RL+F  N+      
Sbjct: 295 LEDISPI--SNLKNLTYLTLYFNNISD--------ISPVSSLTKLQRLFFYNNK------ 338
Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
             V+++SS                   + NL ++NWL+   NQ++   P  +  LT + Q
Sbjct: 339 --VSDVSS-------------------LANLTNINWLSAGHNQISDLTP--LANLTRITQ 375
Query: 364 LDLD 367
           L L+
Sbjct: 376 LGLN 379

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 87/368 (23%), Positives = 159/368 (43%), Gaps = 60/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 65  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 120
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  L+ + NQ + + P  + N+++L
Sbjct: 121 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTL 175
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 176 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 230
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 231 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 278
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 279 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 332
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 333 FFYNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 366
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 367 LANLTRIT 374

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D+F   +++G G  G+V K     +G  +A K+I+L+ K           A+RN   R L
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIK----------PAIRNQIIREL 65
Query: 699 IKIITVCSGR---DFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            +++  C+      F GA +     +I  E M  GSL++ L  +    E     ++ +++
Sbjct: 66  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVS 120
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           IA  V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V T
Sbjct: 121 IA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           RS          Y+APE   G   S++ D++S G+ L+EL   + P
Sbjct: 177 RS----------YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 116
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 117 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 163
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 164 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 115/227 (50%), Gaps = 31/227 (13%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRN 697
            +    KIG+G  G V+K    + G +VA+K + ++  ++G   + + E K L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 698 LIKIITVCSGRDFKGADFKA---IVYEFMQN---GSLEEWLHHSNDQLEVCSLSVIQRLN 751
           ++ +I +C  +       KA   +V++F ++   G L       ++ L   +LS I+R+ 
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLL-------SNVLVKFTLSEIKRVM 131
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS---NHNPDTI 808
             +   + + Y+H      I+H D+K +NVL+ +D V  ++DFGLA+  S   N  P+  
Sbjct: 132 QML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 809 VETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
              R +      T+ Y  PE  +G R+     D++  G ++ E++TR
Sbjct: 187 X-NRVV------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D +    ++G+G  G VYK    E     A KVI+ K +   + ++ E   L +  H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K++       F   +   I+ EF   G+++  +      L    + V+ +  +      
Sbjct: 97  VKLLDA-----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----D 146
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+ YLH   +  I+H DLK  N+L   D    ++DFG    +S  N   I + R   I  
Sbjct: 147 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRXI-QRRDXFI-- 196
Query: 819 KGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRP 857
            GT  ++APE  M      R    K DV+S GI L+E+   + P
Sbjct: 197 -GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR-------ELQKLSKFDEQRTATY 113
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT- 165
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 166 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+VYK      G   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIAI 754
           N++K+  V   +       K +V  F      E         L+VC   L  +   +  +
Sbjct: 61  NIVKLYDVIHTK-------KRLVLVF------EHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            + + I Y H   +  ++H DLKP N+L++++    ++DFGLA+          +  R  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG-------IPVRKY 157
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLEL 851
           +  I  T+ Y AP+  MG ++ S   D++S G +  E+
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH------SNDQLE 740
              ++     ++++++ V S           ++ E M  G L+ +L        +N  L 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
             SLS  + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +  
Sbjct: 134 PPSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-- 186
Query: 801 SNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP 857
                  I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P
Sbjct: 187 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
Query: 858 TDAMFNE 864
              + NE
Sbjct: 241 YQGLSNE 247

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 117/229 (51%), Gaps = 35/229 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRN 697
            +    KIG+G  G V+K    + G +VA+K + ++  ++G   + + E K L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 698 LIKIITVCSGR-----DFKGADFKAIVYEFMQN---GSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ +I +C  +       KG+ +  +V++F ++   G L       ++ L   +LS I+R
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLL-------SNVLVKFTLSEIKR 129
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS---NHNPD 806
             +   + + + Y+H      I+H D+K +NVL+ +D V  ++DFGLA+  S   N  P+
Sbjct: 130 --VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
                R +      T+ Y  PE  +G R+     D++  G ++ E++TR
Sbjct: 185 RYX-NRVV------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 116
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 117 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT- 168
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 169 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 128
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 129 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 182 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 179
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 180 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D +    ++G+G  G VYK    E     A KVI+ K +   + ++ E   L +  H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K++       F   +   I+ EF   G+++  +      L    + V+ +  +      
Sbjct: 97  VKLLDA-----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----D 146
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+ YLH   +  I+H DLK  N+L   D    ++DFG    +S  N   I    S     
Sbjct: 147 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRXIQRRDSFI--- 196
Query: 819 KGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRP 857
            GT  ++APE  M      R    K DV+S GI L+E+   + P
Sbjct: 197 -GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 125
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 178
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 179 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 180
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 181 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWCV 125
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 178
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 179 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--------ECKAL 690
           D +  +  +G G  G V   F  +   +VA+K+I+ ++     +  A        E + L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQLEVCSLSVIQR 749
           + + H  +IKI      ++F  A+   IV E M+ G L ++ + +   +   C L   Q 
Sbjct: 70  KKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
           L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L      
Sbjct: 124 L-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169
Query: 807 TIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
                 S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASK-SFVAE 686
           E   A +  + + ++G+G  G+VY+G        E  T VA+K +N       +  F+ E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH------SNDQLE 740
              ++     ++++++ V S           ++ E M  G L+ +L        +N  L 
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
             SLS  + + +A ++A  + YL+       VH DL   N ++ +D    + DFG+ +  
Sbjct: 124 PPSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-- 176
Query: 801 SNHNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP 857
                  I ET     G KG   V +++PE       +   DV+SFG++L E+ T  ++P
Sbjct: 177 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 230
Query: 858 TDAMFNE 864
              + NE
Sbjct: 231 YQGLSNE 237

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--------ECKAL 690
           D +  +  +G G  G V   F  +   +VA+K+I+ ++     +  A        E + L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQLEVCSLSVIQR 749
           + + H  +IKI      ++F  A+   IV E M+ G L ++ + +   +   C L   Q 
Sbjct: 69  KKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
           L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L      
Sbjct: 123 L-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 168
Query: 807 TIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
                 S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 169 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 118
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT- 170
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 171 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--------ECKAL 690
           D +  +  +G G  G V   F  +   +VA+K+I+ ++     +  A        E + L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQLEVCSLSVIQR 749
           + + H  +IKI      ++F  A+   IV E M+ G L ++ + +   +   C L   Q 
Sbjct: 70  KKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
           L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L      
Sbjct: 124 L-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169
Query: 807 TIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
                 S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 32/246 (13%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 139
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 140 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT- 191
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA-MFNEGLTLHDF 871
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A  + E  T    
Sbjct: 192 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRI 244
Query: 872 SREFFT 877
           SR  FT
Sbjct: 245 SRVEFT 250

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGASK-SFVAE 686
           E   + +  +   ++G+G  G+VY+G       GE  T VAVK +N       +  F+ E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S    KG     +V E M +G L+ +L     + E      
Sbjct: 72  ASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             ++ + + +A ++A  + YL+       VH +L   N ++  D    + DFG+ +    
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR---- 179
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V ++APE       +   D++SFG++L E+ +  ++P  
Sbjct: 180 ----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 235
Query: 860 AMFNE 864
            + NE
Sbjct: 236 GLSNE 240

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGASK-SFVAE 686
           E   + +  +   ++G+G  G+VY+G       GE  T VAVK +N       +  F+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VC 742
              ++     ++++++ V S    KG     +V E M +G L+ +L     + E      
Sbjct: 71  ASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
             ++ + + +A ++A  + YL+       VH +L   N ++  D    + DFG+ +    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 803 HNPDTIVETRSISIGIKG--TVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTD 859
                I ET     G KG   V ++APE       +   D++SFG++L E+ +  ++P  
Sbjct: 179 ----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 234
Query: 860 AMFNE 864
            + NE
Sbjct: 235 GLSNE 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 180
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 181 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR-------ELQKLSKFDEQRTATY 118
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 165
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 166 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++  +   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 117/229 (51%), Gaps = 35/229 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRN 697
            +    KIG+G  G V+K    + G +VA+K + ++  ++G   + + E K L+ ++H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 698 LIKIITVCSGR-----DFKGADFKAIVYEFMQN---GSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ +I +C  +       KG+ +  +V++F ++   G L       ++ L   +LS I+R
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLL-------SNVLVKFTLSEIKR 128
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS---NHNPD 806
             +   + + + Y+H      I+H D+K +NVL+ +D V  ++DFGLA+  S   N  P+
Sbjct: 129 --VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
                R +      T+ Y  PE  +G R+     D++  G ++ E++TR
Sbjct: 184 RYX-NRVV------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR-------ELQKLSKFDEQRTATY 114
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 161
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 73  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 121
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 122 QIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 174
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 175 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 113
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 160
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 161 SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 628 VDSYAELSKA-TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA- 685
           VD  +   KA  D +  +  +G G  G V   F  +   +VA+++I+ ++     +  A 
Sbjct: 137 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 196
Query: 686 -------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSND 737
                  E + L+ + H  +IKI      ++F  A+   IV E M+ G L ++ + +   
Sbjct: 197 PALNVETEIEILKKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRL 250
Query: 738 QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDF 794
           +   C L   Q L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DF
Sbjct: 251 KEATCKLYFYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 300
Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
           G +K L         ET S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 301 GHSKILG--------ET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 185 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--------ECKAL 690
           D +  +  +G G  G V   F  +   +VA+K+I+ ++     +  A        E + L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQLEVCSLSVIQR 749
           + + H  +IKI      ++F  A+   IV E M+ G L ++ + +   +   C L   Q 
Sbjct: 76  KKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
           L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L      
Sbjct: 130 L-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 175
Query: 807 TIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
                 S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 176 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 180
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 181 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +GEG  G V      +   +VA+K I+   LK+         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +       D   +V E+   G L +++       E       Q+      +  AIEY 
Sbjct: 77  VITT----PTDI-VMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQ------IICAIEYC 124
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H +    IVH DLKP N+LLD +L   ++DFGL+  +++ N    ++T        G+  
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSC------GSPN 172
Query: 824 YVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMF 862
           Y APE   G+  A  + DV+S GI+L  +   + P D  F
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 179
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 180 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 86  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 134
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 135 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 187
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 188 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 180
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 181 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 130
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T 
Sbjct: 131 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT- 182
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 183 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 117/229 (51%), Gaps = 35/229 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRN 697
            +    KIG+G  G V+K    + G +VA+K + ++  ++G   + + E K L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 698 LIKIITVCSGR-----DFKGADFKAIVYEFMQN---GSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ +I +C  +       KG+ +  +V++F ++   G L       ++ L   +LS I+R
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLL-------SNVLVKFTLSEIKR 129
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS---NHNPD 806
           +   +   + + Y+H      I+H D+K +NVL+ +D V  ++DFGLA+  S   N  P+
Sbjct: 130 VMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
                R +      T+ Y  PE  +G R+     D++  G ++ E++TR
Sbjct: 185 RYX-NRVV------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--------ECKAL 690
           D +  +  +G G  G V   F  +   +VA+K+I+ ++     +  A        E + L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQLEVCSLSVIQR 749
           + + H  +IKI      ++F  A+   IV E M+ G L ++ + +   +   C L   Q 
Sbjct: 70  KKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
           L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L      
Sbjct: 124 L-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169
Query: 807 TIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
                 S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+VYK      G   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIAI 754
           N++K+  V   +       K +V  F      E         L+VC   L  +   +  +
Sbjct: 61  NIVKLYDVIHTK-------KRLVLVF------EHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            + + I Y H   +  ++H DLKP N+L++++    ++DFGLA+          +  R  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG-------IPVRKY 157
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLEL 851
           +  +  T+ Y AP+  MG ++ S   D++S G +  E+
Sbjct: 158 THEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 70  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 118
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 171
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 172 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 101 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 149
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 150 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 202
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 203 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 248

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 45/228 (19%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-RHRNLIKII 702
           IGEG  G V K  + ++G  +   +  +K+   K   + F  E + L  +  H N+I ++
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE-----------VCSLSVIQRLN 751
             C  R   G  + AI  E+  +G+L ++L  S   LE             +LS  Q L+
Sbjct: 90  GACEHR---GYLYLAI--EYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLH 143
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A DVA  ++YL    +   +H +L   N+L+ ++ V+ ++DFGL              +
Sbjct: 144 FAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGL--------------S 186
Query: 812 RSISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFT 853
           R   + +K T+G + P   M  E+      +   DV+S+G+LL E+ +
Sbjct: 187 RGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+VYK      G   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIAI 754
           N++K+  V   +       K +V  F      E         L+VC   L  +   +  +
Sbjct: 61  NIVKLYDVIHTK-------KRLVLVF------EHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            + + I Y H   +  ++H DLKP N+L++++    ++DFGLA+          +  R  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG-------IPVRKY 157
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLEL 851
           +  +  T+ Y AP+  MG ++ S   D++S G +  E+
Sbjct: 158 THEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAVK+I+  Q  +S  +    E + ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  DT         
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTD 859
              G+  Y APE   G++    + DV+S G++L  L +   P D
Sbjct: 174 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 82  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 130
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 131 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 183
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 184 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAVK+I+  Q  +S  +    E + ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  DT         
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
              G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 174 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 115
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 116 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 162
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 163 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 628 VDSYAELSKA-TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA- 685
           VD  +   KA  D +  +  +G G  G V   F  +   +VA+++I+ ++     +  A 
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182
Query: 686 -------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSND 737
                  E + L+ + H  +IKI      ++F  A+   IV E M+ G L ++ + +   
Sbjct: 183 PALNVETEIEILKKLNHPCIIKI------KNFFDAEDYYIVLELMEGGELFDKVVGNKRL 236
Query: 738 QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDF 794
           +   C L   Q L        A++YLH   E  I+H DLKP NVLL   ++D +  ++DF
Sbjct: 237 KEATCKLYFYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE--YGMGREASMKG-DVYSFGILLL 849
           G +K L         ET S+   + GT  Y+APE    +G     +  D +S G++L 
Sbjct: 287 GHSKILG--------ET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+      +  +VAVKV+     +       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 123
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++   +++ +T
Sbjct: 124 ---DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 177 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+      +  +VAVKV+     +       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 123
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+L+       V DFG+A+ +++   +++ +T
Sbjct: 124 ---DACQALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSG-NSVXQT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 177 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+      +  +VAVKV+     +       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 123
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++   +++ +T
Sbjct: 124 ---DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 177 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTE----VAVKVINLKQKGASKSF---VAECKAL 690
           D  +    +GEG  G +V    +G +  +    V V V  LK     K     V+E + +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL--------HHSND--QL 739
           + I +H+N+I ++  C+     G  +  ++  +   G+L E+L         +S D  ++
Sbjct: 95  KMIGKHKNIINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               ++    ++    +A  +EYL        +H DL   NVL+ ++ V  ++DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++N      ++    +   +  V ++APE    R  + + DV+SFG+L+ E+FT
Sbjct: 207 INN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIR 694
           +D +     +G+G  G V        G E AVKVI+   +KQK   +S + E + L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K+        F+   +  +V E    G L + +       EV +  +I++     
Sbjct: 85  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ----- 134
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFL--SNHNPDTIV 809
            V S I Y+H   +  IVH DLKP N+LL+   +D    + DFGL+     S    D I 
Sbjct: 135 -VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                     GT  Y+APE   G     K DV+S G++L  L +
Sbjct: 190 ----------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIR 694
           +D +     +G+G  G V        G E AVKVI+   +KQK   +S + E + L+ + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K+        F+   +  +V E    G L + +       EV +  +I++     
Sbjct: 91  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ----- 140
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFL--SNHNPDTIV 809
            V S I Y+H   +  IVH DLKP N+LL+   +D    + DFGL+     S    D I 
Sbjct: 141 -VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 195
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                     GT  Y+APE   G     K DV+S G++L  L +
Sbjct: 196 ----------GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALR 691
           +K +D F     IG+G  G V            AVKV+  K   +K   K  ++E    R
Sbjct: 35  AKPSD-FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----R 89
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           N+  +N+     V     F+ AD    V +++  G L   L     Q E C L    R  
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARF- 143
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A ++ASA+ YLH     +IV+ DLKP N+LLD      ++DFGL K    HN       
Sbjct: 144 YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN------- 193
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
            S +    GT  Y+APE    +      D +  G +L E+
Sbjct: 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 620 LPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINL 674
           +P+  Q       E+S +   F    ++GE   G VYKG L     GE    VA+K +  
Sbjct: 9   MPLINQHKQAKLKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 675 KQKGA-SKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL- 732
           K +G   + F  E      ++H N++ ++ V +    K     ++++ +  +G L E+L 
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLV 121
Query: 733 ---HHSN------DQLEVCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNV 781
               HS+      D+    +L     +++   +A+ +EYL  HH     +VH DL   NV
Sbjct: 122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNV 176
Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDV 841
           L+   L   +SD GL + +   +   ++    + I       ++APE  M  + S+  D+
Sbjct: 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDI 230
Query: 842 YSFGILLLELFT 853
           +S+G++L E+F+
Sbjct: 231 WSYGVVLWEVFS 242

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAVK+I+  Q  +S  +    E + ++ + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 68  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------IV 116
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  DT         
Sbjct: 117 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------- 166
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
              G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 167 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 42/219 (19%)
Query: 651 GSGIVYKGFLGE--------NGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLI 699
           G  ++ KG  GE         G E AVKVI+   +KQK   +S + E + L+ + H N++
Sbjct: 53  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 112
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+        F+   +  +V E    G L + +       EV +  +I++      V S 
Sbjct: 113 KLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 161
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFL--SNHNPDTIVETRSI 814
           I Y+H   +  IVH DLKP N+LL+   +D    + DFGL+     S    D I      
Sbjct: 162 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI------ 212
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                GT  Y+APE   G     K DV+S G++L  L +
Sbjct: 213 -----GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 245

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH N+I
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL---HHSNDQLEVCSLSVIQRLNIAIDV 756
            I  +      +      +V   M    L + L   H SND   +C             +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDH--ICYF--------LYQI 153
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  ++ 
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA- 209
Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
               T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 210 ----TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 45/239 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR------ 694
           +    K+G+G  GIV+K      G  VAVK I         +F     A R  R      
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILT 63
Query: 695 ----HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
               H N++ ++ V    + +      +V+++M+       LH     +    L  + + 
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDV---YLVFDYMETD-----LHAV---IRANILEPVHKQ 112
Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLS-------- 801
            +   +   I+YLH      ++H D+KPSN+LL+ +    V+DFGL++ F++        
Sbjct: 113 YVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 802 ----NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
               N N +   + + I      T  Y APE  +G     KG D++S G +L E+   K
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 32/246 (13%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 139
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       
Sbjct: 140 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------ 186
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA-MFNEGLTLHDF 871
           S    + GT+ Y+ PE   GR    K D++S G+L  E    K P +A  + E  T    
Sbjct: 187 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRI 244
Query: 872 SREFFT 877
           SR  FT
Sbjct: 245 SRVEFT 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 92  -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 143
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 198
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 105 -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 211
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 42/219 (19%)
Query: 651 GSGIVYKGFLGE--------NGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLI 699
           G  ++ KG  GE         G E AVKVI+   +KQK   +S + E + L+ + H N++
Sbjct: 54  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 113
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+        F+   +  +V E    G L + +       EV +  +I++      V S 
Sbjct: 114 KLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 162
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFL--SNHNPDTIVETRSI 814
           I Y+H   +  IVH DLKP N+LL+   +D    + DFGL+     S    D I      
Sbjct: 163 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI------ 213
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                GT  Y+APE   G     K DV+S G++L  L +
Sbjct: 214 -----GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 246

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAV++I+  Q  +S  +    E + ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  DT         
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
              G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 174 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 67  -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 118
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 173
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 44/229 (19%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNL 698
           +F     +G G  G V+      NG   A+KV+        K  V   K + +    R +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLM 59
Query: 699 IKIIT----VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN--- 751
           + I+T    +     F+ A    ++ ++++ G L   L  S            QR     
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS------------QRFPNPV 107
Query: 752 ---IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
               A +V  A+EYLH      I++ DLKP N+LLD++    ++DFG AK++    PD  
Sbjct: 108 AKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PD-- 158
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                ++  + GT  Y+APE    +  +   D +SFGIL+ E+     P
Sbjct: 159 -----VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G + + L   +   E  + + I  L   
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--- 122
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 123 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 166
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 167 RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G + + L   +   E  + + I  L   
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--- 122
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 123 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 170
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 171 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 72  -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 123
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 178
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 634 LSKATD------NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVA 685
           ++ ATD      N+     IG+G    V        G EVAVK+I+  Q   +  +    
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 686 ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
           E + ++ + H N++K+  V      +      +V E+   G + ++L       E  + +
Sbjct: 64  EVRIMKILNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHN 804
             ++      + SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   + 
Sbjct: 119 KFRQ------IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK 169
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
            DT            G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 170 LDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 660 LGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           LG+N G  VAVK +        + F  E + L+ +    ++K   V  G    G     +
Sbjct: 35  LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRL 91
Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V E++ +G L ++L     +L+   L     L  +  +   +EYL        VH DL  
Sbjct: 92  VMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR---RCVHRDLAA 143
Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            N+L++ +    ++DFGLAK L       +V     S      + + APE       S +
Sbjct: 144 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-----PIFWYAPESLSDNIFSRQ 198
Query: 839 GDVYSFGILLLELFT 853
            DV+SFG++L ELFT
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 69  -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 120
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 175
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           IG+G  G V++G     G EVAVK+ + +++   +S+  E +  + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
              +D        +V ++ ++GSL        D L   +++V   + +A+  AS + +LH
Sbjct: 66  -DNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 765 HYC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                   +P+I H DLK  N+L+ ++    ++D GLA        D+  +T  I+   +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-----RHDSATDTIDIAPNHR 172
Query: 820 -GTVGYVAPEY-----GMGR-EASMKGDVYSFGILLLELFTR 854
            GT  Y+APE       M   E+  + D+Y+ G++  E+  R
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 660 LGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           LG+N G  VAVK +        + F  E + L+ +    ++K   V  G    G     +
Sbjct: 34  LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRL 90
Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V E++ +G L ++L     +L+   L     L  +  +   +EYL        VH DL  
Sbjct: 91  VMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR---RCVHRDLAA 142
Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            N+L++ +    ++DFGLAK L       +V     S      + + APE       S +
Sbjct: 143 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-----PIFWYAPESLSDNIFSRQ 197
Query: 839 GDVYSFGILLLELFT 853
            DV+SFG++L ELFT
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 22/219 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHRNLI 699
           ++    IGEG  G+V   +     T VA+K I+  + +   +  + E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I  +      +      IV + M+     L +    SND   +C             + 
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH--ICYF--------LYQIL 154
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             ++Y+H     +++H DLKPSN+L++      + DFGLA+     +  T   T  ++  
Sbjct: 155 RGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA-- 209
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
              T  Y APE  +  +   K  D++S G +L E+ + +
Sbjct: 210 ---TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 660 LGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           LG+N G  VAVK +        + F  E + L+ +    ++K   V  G    G     +
Sbjct: 47  LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRL 103
Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V E++ +G L ++L     +L+   L     L  +  +   +EYL        VH DL  
Sbjct: 104 VMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLG---SRRCVHRDLAA 155
Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            N+L++ +    ++DFGLAK L       +V     S      + + APE       S +
Sbjct: 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-----PIFWYAPESLSDNIFSRQ 210
Query: 839 GDVYSFGILLLELFT 853
            DV+SFG++L ELFT
Sbjct: 211 SDVWSFGVVLYELFT 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS----KSFVAECKALR 691
           D       +G G  G V +     + +  T   V V  LK+ GA+    ++ ++E K L 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRALMSELKILI 87
Query: 692 NI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLE--------EWLHHSNDQLEVC 742
           +I  H N++ ++  C+     G     IV EF + G+L         E++ +  + L   
Sbjct: 88  HIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
            L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +  
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 201 -DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS----KSFVAECKALR 691
           D  +    +G G  G V +     + +  T   V V  LK+ GA+    ++ ++E K L 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRALMSELKILI 85
Query: 692 NI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ------LEVCSL 744
           +I  H N++ ++  C+     G     IV EF + G+L  +L    ++      L    L
Sbjct: 86  HIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 745 SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
           ++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   +
Sbjct: 142 TLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK-D 197
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 198 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 122
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 123 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 170
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 171 ----LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 101/386 (26%), Positives = 173/386 (44%), Gaps = 99/386 (25%)
Query: 23  LGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIP- 81
           LG +SI G    Y+ NL+    IN ++N      P  +  L  L  ++++NN  +   P 
Sbjct: 56  LGIKSIDGV--EYLNNLT---QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL 108
Query: 82  ANLSSCS---------------------NLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           ANL++ +                     N +ELS+   N + +I A +  L  L++LS F
Sbjct: 109 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS---NTISDISA-LSGLTSLQQLS-F 163
Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
            N +T   P  + NL++L  +D+  N++   I  L +L +L  L    NQ S + P  I 
Sbjct: 164 GNQVTDLKP--LANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPLGI- 219
Query: 181 NISSLEVISLSENRFT--GSLPVDTGVN-----------------LPSLRELRTNANNFT 221
            +++L+ +SL+ N+    G+L   T +                  L  L EL+  AN  +
Sbjct: 220 -LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278
Query: 222 GFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINL 281
              P  L+  ++L  +E ++NQ      +  S LKNL +L L  NN+          I+ 
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISD--------ISP 326
Query: 282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT 341
           +++ +KL+RL+F  N+        V+++SS                   + NL ++NWL+
Sbjct: 327 VSSLTKLQRLFFYNNK--------VSDVSS-------------------LANLTNINWLS 359
Query: 342 IDTNQLTGTIPPEIGELTNLQQLDLD 367
              NQ++   P  +  LT + QL L+
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLN 383

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 158/368 (42%), Gaps = 61/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 70  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 125
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  LS   NQ + + P  + N+++L
Sbjct: 126 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTL 179
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 180 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 234
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 235 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 282
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 283 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 337 FFYNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 370
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 371 LANLTRIT 378

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++         +L+  S    QR    
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATY 115
Query: 754 I-DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           I ++A+A+ Y H      ++H D+KP N+LL       +++FG     S H P +   T 
Sbjct: 116 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTT- 167
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 168 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 179
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 180 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 128
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 129 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 182 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 153/329 (46%), Gaps = 74/329 (22%)
Query: 60  IGRLISLERLILSNNSFSGAIPANLSSCSNL--IELSADSNNLVGEIPADIGSLFKLERL 117
           +  L +L  L L NN  +   P  L + +NL  +ELS+   N + +I A +  L  L++L
Sbjct: 107 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS---NTISDISA-LSGLTSLQQL 160
Query: 118 SIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPP 177
           S F N +T   P  + NL++L  +D+  N++   I  L +L +L  L    NQ S + P 
Sbjct: 161 S-FGNQVTDLKP--LANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPL 216
Query: 178 SIFNISSLEVISLSENRFT--GSLPVDTGVN-----------------LPSLRELRTNAN 218
            I  +++L+ +SL+ N+    G+L   T +                  L  L EL+  AN
Sbjct: 217 GI--LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGAN 274
Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDF 278
             +   P  L+  ++L  +E ++NQ      +  S LKNL +L L  NN+          
Sbjct: 275 QISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISD-------- 322
Query: 279 INLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLN 338
           I+ +++ +KL+RL+F  N+        V+++SS                   + NL ++N
Sbjct: 323 ISPVSSLTKLQRLFFANNK--------VSDVSS-------------------LANLTNIN 355
Query: 339 WLTIDTNQLTGTIPPEIGELTNLQQLDLD 367
           WL+   NQ++   P  +  LT + QL L+
Sbjct: 356 WLSAGHNQISDLTP--LANLTRITQLGLN 382

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 158/368 (42%), Gaps = 61/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 69  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 124
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  LS   NQ + + P  + N+++L
Sbjct: 125 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTL 178
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 179 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 233
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 234 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 281
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 282 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 335
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 336 FFANNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 369
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 370 LANLTRIT 377

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +  G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 185 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++FS    IG GG G VY     + G   A+K ++ K+    +    E  AL     R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNE---RIM 242
Query: 699 IKIIT-------VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           + +++       VC    F   D  + + + M  G L    H+   Q  V S + ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMR--F 296
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A ++   +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V  
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 812 RSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
                   GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++FS    IG GG G VY     + G   A+K ++ K+    +    E  AL     R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNE---RIM 242
Query: 699 IKIIT-------VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           + +++       VC    F   D  + + + M  G L    H+   Q  V S + ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMR--F 296
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A ++   +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V  
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 812 RSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
                   GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++FS    IG GG G VY     + G   A+K ++ K+    +    E  AL     R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNE---RIM 242
Query: 699 IKIIT-------VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           + +++       VC    F   D  + + + M  G L    H+   Q  V S + ++   
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMR--F 296
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A ++   +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V  
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 812 RSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
                   GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 179
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 180 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 39/263 (14%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECK 688
           S   D++    ++G G   IV K      G E A K I  ++  +S+  V+      E  
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            LR IRH N+I +  +     F+      ++ E +  G L ++L       E  SL+  +
Sbjct: 61  ILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDE 109
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHN 804
                  +   + YLH      I H DLKP N+ LLD+++ +    + DFG+A     H 
Sbjct: 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HK 161
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------T 858
            +   E ++I     GT  +VAPE        ++ D++S G++   L +   P       
Sbjct: 162 IEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217
Query: 859 DAMFNEGLTLHDFSREFFTRKSD 881
           + + N     +DF  E+F+  S+
Sbjct: 218 ETLTNISAVNYDFDEEYFSNTSE 240

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRN 692
           +K +DN+    ++G+G   +V +      G E A K+IN K+  A   +    E +  R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N++++         +   F  +V++ +  G L E +       E  +   IQ+   
Sbjct: 85  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 136
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIV 809
              +  +I Y H      IVH +LKP N+LL    +     ++DFGLA           V
Sbjct: 137 ---ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 181
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  G  GT GY++PE       S   D+++ G++L  L     P
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+         +VAVKV+     +       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 68  ALNHPAIVAVYATGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 123
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++   +++ +T
Sbjct: 124 ---DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 177 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++FS    IG GG G VY     + G   A+K ++ K+    +    E  AL     R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNE---RIM 241
Query: 699 IKIIT-------VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           + +++       VC    F   D  + + + M  G L    H+   Q  V S + ++   
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMR--F 295
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            A ++   +E++H+     +V+ DLKP+N+LLD+     +SD GLA   S   P   V  
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 350
Query: 812 RSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
                   GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 351 --------GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 389

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 179
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 180 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 39/263 (14%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECK 688
           S   D++    ++G G   IV K      G E A K I  ++  +S+  V+      E  
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            LR IRH N+I +  +     F+      ++ E +  G L ++L       E  SL+  +
Sbjct: 82  ILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDE 130
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHN 804
                  +   + YLH      I H DLKP N+ LLD+++ +    + DFG+A     H 
Sbjct: 131 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HK 182
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------T 858
            +   E ++I     GT  +VAPE        ++ D++S G++   L +   P       
Sbjct: 183 IEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 238
Query: 859 DAMFNEGLTLHDFSREFFTRKSD 881
           + + N     +DF  E+F+  S+
Sbjct: 239 ETLTNISAVNYDFDEEYFSNTSE 261

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS----KSFVAECKALR 691
           D  +    +G G  G V +     + +  T   V V  LK+ GA+    ++ ++E K L 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKE-GATHSEHRALMSELKILI 85
Query: 692 NI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ------LEVCSL 744
           +I  H N++ ++  C+     G     IV EF + G+L  +L    ++      L    L
Sbjct: 86  HIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 745 SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
           ++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   +
Sbjct: 142 TLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK-D 197
Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 198 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 121
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 122 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 169
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 170 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 116
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 117 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 164
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 165 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 121 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 168
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 169 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 185 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +  G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM 861
             G K  + ++A E  + R  + + DV+S+G+ + EL T   +P D +
Sbjct: 185 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQK---GASKSFVAECKALRNIR 694
            F     +G G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFG AK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 47/239 (19%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA---------SKSFVAECKA 689
           +N+     +G G S +V +        E AVK+I++   G+          ++ + E   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 690 LRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
           LR +  H N+I++        ++   F  +V++ M+ G L ++L       E  +LS  +
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKE 125
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
              I   +   I  LH     +IVH DLKP N+LLD D+   ++DFG +  L     D  
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPG 177
Query: 809 VETRSISIGIKGTVGYVAPEY----------GMGREASMKGDVYSFGILLLELFTRKRP 857
            + RS+     GT  Y+APE           G G+E     D++S G+++  L     P
Sbjct: 178 EKLRSVC----GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 110/231 (47%), Gaps = 29/231 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D  +    +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL---------HHSNDQLEVC 742
           I  H N++ ++  C+     G     IV EF + G+L  +L         + + + L   
Sbjct: 88  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD 143
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
            L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 201 -DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVA+K+I+  Q   +  +    E + ++ + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      ++ E+   G + ++L       E  + S  ++      + 
Sbjct: 73  IVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IV 121
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F      DT         
Sbjct: 122 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC------- 171
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
              G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 172 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQ---KGASKSFVAECKALRNIR 694
            F     +  G  G VYKG     G +V + V    L++     A+K  + E   + ++ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           + ++ +++ +C     +      ++ + M  G L +++    D +    L     LN  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +A  + YL    +  +VH DL   NVL+       ++DFGLAK L     +   E    
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             G K  + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 178 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 100/386 (25%), Positives = 174/386 (45%), Gaps = 99/386 (25%)
Query: 23  LGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIP- 81
           LG +SI G    Y+ NL+    IN ++N      P  +  L  L  ++++NN  +   P 
Sbjct: 51  LGIKSIDGV--EYLNNLT---QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL 103
Query: 82  ANLSSCS---------------------NLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           ANL++ +                     N +ELS+   N + +I A +  L  L++L+ F
Sbjct: 104 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS---NTISDISA-LSGLTSLQQLN-F 158
Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
            N +T   P  + NL++L  +D+  N++   I  L +L +L  L    NQ S + P  I 
Sbjct: 159 GNQVTDLKP--LANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPLGI- 214
Query: 181 NISSLEVISLSENRFT--GSLPVDTGVN-----------------LPSLRELRTNANNFT 221
            +++L+ +SL+ N+    G+L   T +                  L  L EL+  AN  +
Sbjct: 215 -LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 273
Query: 222 GFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINL 281
              P  L+  ++L  +E ++NQ      +  S LKNL +L L  NN+          I+ 
Sbjct: 274 NISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISD--------ISP 321
Query: 282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT 341
           +++ +KL+RL+F+ N+        V+++SS                   + NL ++NWL+
Sbjct: 322 VSSLTKLQRLFFSNNK--------VSDVSS-------------------LANLTNINWLS 354
Query: 342 IDTNQLTGTIPPEIGELTNLQQLDLD 367
              NQ++   P  +  LT + QL L+
Sbjct: 355 AGHNQISDLTP--LANLTRITQLGLN 378

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 87/368 (23%), Positives = 158/368 (42%), Gaps = 61/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 65  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 120
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  L+   NQ + + P  + N+++L
Sbjct: 121 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLNFG-NQVTDLKP--LANLTTL 174
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 175 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 229
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 230 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 277
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 278 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 331
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
               N +                             SSL N TN+  L+  HN++    P
Sbjct: 332 FFSNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP 365
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 366 LANLTRIT 373

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+         +VAVKV+     +       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 123
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++   +++ +T
Sbjct: 124 ---DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQT 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 177 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRN 692
           +K +DN+    ++G+G   +V +      G E A K+IN K+  A   +    E +  R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N++++         +   F  +V++ +  G L E +       E  +   IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIV 809
              +  +I Y H      IVH +LKP N+LL    +     ++DFGLA           V
Sbjct: 114 ---ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  G  GT GY++PE       S   D+++ G++L  L     P
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRN 692
           +K +DN+    ++G+G   +V +      G E A K+IN K+  A   +    E +  R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N++++         +   F  +V++ +  G L E +       E  +   IQ+   
Sbjct: 61  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 112
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIV 809
              +  +I Y H      IVH +LKP N+LL    +     ++DFGLA           V
Sbjct: 113 ---ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 157
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  G  GT GY++PE       S   D+++ G++L  L     P
Sbjct: 158 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRN 692
           +K +DN+    ++G+G   +V +      G E A K+IN K+  A   +    E +  R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N++++         +   F  +V++ +  G L E +       E  +   IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIV 809
              +  +I Y H      IVH +LKP N+LL    +     ++DFGLA           V
Sbjct: 114 ---ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  G  GT GY++PE       S   D+++ G++L  L     P
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAVK+I+  Q  +S  +    E + ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V             +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  D          
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTD 859
              G   Y APE   G++    + DV+S G++L  L +   P D
Sbjct: 174 ---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 31/241 (12%)
Query: 621 PIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI----NLKQ 676
           P  Q   +D  +   +  + F    K+GEG  G VYK    E G  VA+K +    +L++
Sbjct: 11  PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE 70
Query: 677 KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN 736
                S + +C +   +++           G  FK  D   IV E+   GS+ + +   N
Sbjct: 71  IIKEISIMQQCDSPHVVKY----------YGSYFKNTDL-WIVMEYCGAGSVSDIIRLRN 119
Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL 796
             L    ++ I +  +       +EYLH   +   +H D+K  N+LL+ +  + ++DFG+
Sbjct: 120 KTLTEDEIATILQSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGV 171
Query: 797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           A  L++      +  R+  I   GT  ++APE       +   D++S GI  +E+   K 
Sbjct: 172 AGQLTD-----XMAKRNXVI---GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
Query: 857 P 857
           P
Sbjct: 224 P 224

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     +    +A+KV+    L++ G       E +   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 114
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +   T  
Sbjct: 115 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTT-- 162
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 163 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL---KQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+         +VAVKV+     +       F  E +   
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H         ++ VI    
Sbjct: 85  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--- 140
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
              D   A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++   +++ +T
Sbjct: 141 ---DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQT 193
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            +    + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 194 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 47/257 (18%)
Query: 628 VDSYAELSKATDNFSSAN-----KIGEGGSGIVYKG----FLGENG-TEVAVKVINLKQK 677
           VD++  L      F   N      +GEG  G V K       G  G T VAVK+  LK+ 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKEN 64
Query: 678 GAS---KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH 734
            +    +  ++E   L+ + H ++IK+   CS    +      IV E+ + GSL  +L  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRE 119
Query: 735 SN------------------DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           S                   D  +  +L++   ++ A  ++  ++YL    E S+VH DL
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              N+L+ +     +SDFGL++    +  D+ V+     I +K    ++A E       +
Sbjct: 177 AARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVK----WMAIESLFDHIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+ T
Sbjct: 231 TQSDVWSFGVLLWEIVT 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 15/221 (6%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-ENGTEVAVKVINLKQKGASKS----FVAECKALRNIR 694
            F+    +G+G  G V +  L  E+G+ V V V  LK    + S    F+ E   ++   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 695 HRNLIKIITVCSGRDFKGA-DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           H ++ K++ V      KG      ++  FM++G L  +L  S       +L +   +   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           +D+A  +EYL      + +H DL   N +L +D+   V+DFGL++ +  ++ D   +  +
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCA 198
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             + +K    ++A E       ++  DV++FG+ + E+ TR
Sbjct: 199 SKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 112/259 (43%), Gaps = 39/259 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D++    ++G G   IV K      G E A K I  ++  +S+  V+      E   LR 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           IRH N+I +  +     F+      ++ E +  G L ++L       E  SL+  +    
Sbjct: 72  IRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQF 120
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              +   + YLH      I H DLKP N+ LLD+++ +    + DFG+A     H  +  
Sbjct: 121 LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAG 172
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 173 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 228
Query: 863 NEGLTLHDFSREFFTRKSD 881
           N     +DF  E+F+  S+
Sbjct: 229 NISAVNYDFDEEYFSNTSE 247

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 45/247 (18%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIIT 703
           +G+G  G V++G + GEN   VAVK+ + + +   KS+  E +    +  RH N++  I 
Sbjct: 45  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 98
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                         I + + + GSL        D L++ +L  +  L I + +AS + +L
Sbjct: 99  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 150
Query: 764 H-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           H        +P+I H DLK  N+L+ ++    ++D GLA   S         T  + +G 
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ-------STNQLDVGN 203
Query: 819 KGTVG---YVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
              VG   Y+APE           ++  + D+++FG++L E+  R      M + G+ + 
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGI-VE 256
Query: 870 DFSREFF 876
           D+   F+
Sbjct: 257 DYKPPFY 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           FS   +IG G  G VY      N   VA+K ++   K +++ +   + E + L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I+         ++G   +    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 116 TIQ---------YRGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTH 161
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A++ L +    +++H D+K  N+LL +  +  + DFG A  ++  N             
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------X 209
Query: 818 IKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRP 857
             GT  ++APE  +  +      K DV+S GI  +EL  RK P
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 660 LGEN-GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           LG+N G  VAVK +        + F  E + L+ +    ++K   V  G    G     +
Sbjct: 31  LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRPELRL 87
Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL-HHYCEPSIVHGDLK 777
           V E++ +G L ++L     +L+   L     L  +  +   +EYL    C    VH DL 
Sbjct: 88  VMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSRRC----VHRDLA 138
Query: 778 PSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASM 837
             N+L++ +    ++DFGLAK L       +V     S      + + APE       S 
Sbjct: 139 ARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS-----PIFWYAPESLSDNIFSR 193
Query: 838 KGDVYSFGILLLELFT 853
           + DV+SFG++L ELFT
Sbjct: 194 QSDVWSFGVVLYELFT 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 651 GSGIVYKGFLGE--------NGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLI 699
           G  ++ KG  GE         G E AVKVI+   +KQK   +S + E + L+ + H N+ 
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           K+        F+   +  +V E    G L + +       EV +  +I++      V S 
Sbjct: 90  KLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 138
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFL--SNHNPDTIVETRSI 814
           I Y H   +  IVH DLKP N+LL+   +D    + DFGL+     S    D I      
Sbjct: 139 ITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI------ 189
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                GT  Y+APE   G     K DV+S G++L  L +
Sbjct: 190 -----GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 45/247 (18%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIIT 703
           +G+G  G V++G + GEN   VAVK+ + + +   KS+  E +    +  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                         I + + + GSL        D L++ +L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 764 H-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           H        +P+I H DLK  N+L+ ++    ++D GLA   S         T  + +G 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ-------STNQLDVGN 174
Query: 819 KGTVG---YVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
              VG   Y+APE           ++  + D+++FG++L E+  R      M + G+ + 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGI-VE 227
Query: 870 DFSREFF 876
           D+   F+
Sbjct: 228 DYKPPFY 234

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 45/247 (18%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIIT 703
           +G+G  G V++G + GEN   VAVK+ + + +   KS+  E +    +  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                         I + + + GSL        D L++ +L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 764 H-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           H        +P+I H DLK  N+L+ ++    ++D GLA   S         T  + +G 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ-------STNQLDVGN 174
Query: 819 KGTVG---YVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
              VG   Y+APE           ++  + D+++FG++L E+  R      M + G+ + 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGI-VE 227
Query: 870 DFSREFF 876
           D+   F+
Sbjct: 228 DYKPPFY 234

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 121 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 164
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 165 RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 100/386 (25%), Positives = 173/386 (44%), Gaps = 99/386 (25%)
Query: 23  LGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIP- 81
           LG +SI G    Y+ NL+    IN ++N      P  +  L  L  ++++NN  +   P 
Sbjct: 51  LGIKSIDGV--EYLNNLT---QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL 103
Query: 82  ANLSSCS---------------------NLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           ANL++ +                     N +ELS+   N + +I A +  L  L++L+ F
Sbjct: 104 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS---NTISDISA-LSGLTSLQQLN-F 158
Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
            N +T   P  + NL++L  +D+  N++   I  L +L +L  L    NQ S + P  I 
Sbjct: 159 GNQVTDLKP--LANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPLGI- 214
Query: 181 NISSLEVISLSENRFT--GSLPVDTGVN-----------------LPSLRELRTNANNFT 221
            +++L+ +SL+ N+    G+L   T +                  L  L EL+  AN  +
Sbjct: 215 -LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 273
Query: 222 GFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINL 281
              P  L+  ++L  +E ++NQ      +  S LKNL +L L  NN+          I+ 
Sbjct: 274 NISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISD--------ISP 321
Query: 282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT 341
           +++ +KL+RL+F  N+        V+++SS                   + NL ++NWL+
Sbjct: 322 VSSLTKLQRLFFYNNK--------VSDVSS-------------------LANLTNINWLS 354
Query: 342 IDTNQLTGTIPPEIGELTNLQQLDLD 367
              NQ++   P  +  LT + QL L+
Sbjct: 355 AGHNQISDLTP--LANLTRITQLGLN 378

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 159/368 (43%), Gaps = 61/368 (16%)
Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
           L ++  SNN  +   P  L + + L+++  ++N +    P  + +L  L  L++F N IT
Sbjct: 65  LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 120
Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
              P  + NL++L  +++  N +   I +L  L SL  L+   NQ + + P  + N+++L
Sbjct: 121 DIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLNFG-NQVTDLKP--LANLTTL 174
Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + +S N+ +    +     L +L  L    N  +   P+ +   ++L+ +  + NQ  
Sbjct: 175 ERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 229
Query: 246 G-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
             G     + L +L   N  I+NL             L+  +KL  L    N+     P 
Sbjct: 230 DIGTLASLTNLTDLDLANNQISNLAP-----------LSGLTKLTELKLGANQISNISP- 277
Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
            +A L++ +  + +  N++    P  I NL +L +LT+  N ++   P  +  LT LQ+L
Sbjct: 278 -LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 331
Query: 365 DLDRNFLQGSIPSSXXXXXXXXXXXXXXXXXEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
                F   +  S                       SSL N TN+  L+  HN++    P
Sbjct: 332 -----FFYNNKVSDV---------------------SSLANLTNINWLSAGHNQISDLTP 365
Query: 425 -RQILRIT 431
              + RIT
Sbjct: 366 LANLTRIT 373

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF---VAECKALRNIRHRN 697
           FS   +IG G  G VY      N   VA+K ++   K +++ +   + E + L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
            I+         ++G   +    E      +E  L  ++D LEV     +Q + IA    
Sbjct: 77  TIQ---------YRGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTH 122
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A++ L +    +++H D+K  N+LL +  +  + DFG A  ++  N             
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------X 170
Query: 818 IKGTVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRP 857
             GT  ++APE  +  +      K DV+S GI  +EL  RK P
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAV++I+  Q  +S  +    E + ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F   +  D          
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDA 860
              G+  Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 174 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAEC 687
           S A  + + D +    K+GEG  G VYK         VA+K I L  +++G   + + E 
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 688 KALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
             L+ ++HRN+I++ +V             +++E+ +N  L++++  + D     S+ VI
Sbjct: 85  SLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAEN-DLKKYMDKNPD----VSMRVI 134
Query: 748 QRLNIAIDVASAIEYLH-HYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLS 801
           +  +    + + + + H   C    +H DLKP N+LL      +  V  + DFGLA+   
Sbjct: 135 K--SFLYQLINGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTR 854
                  +  R  +  I  T+ Y  PE  +G R  S   D++S   +  E+  +
Sbjct: 189 -------IPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 59/226 (26%), Positives = 109/226 (48%), Gaps = 34/226 (15%)
Query: 646 KIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHRNLI 699
           ++GE   G VYKG L     GE    VA+K +  K +G   + F  E      ++H N++
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL----HHSN------DQLEVCSLSVIQR 749
            ++ V + +D       ++++ +  +G L E+L     HS+      D+    +L     
Sbjct: 76  CLLGVVT-KD----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 750 LNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
           +++   +A+ +EYL  HH     +VH DL   NVL+   L   +SD GL + +   +   
Sbjct: 131 VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           ++    + I       ++APE  M  + S+  D++S+G++L E+F+
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 630 SYAELSK---ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSF 683
           + AE+ K     D+F     +G+G  G VY     +N   +A+KV+    L+++G     
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 62
Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
             E +   ++RH N++++        F       ++ EF   G L + L       E  S
Sbjct: 63  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 117
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            + ++ L      A A+ Y H   E  ++H D+KP N+L+       ++DFG     S H
Sbjct: 118 ATFMEEL------ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVH 164
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            P   +  R +     GT+ Y+ PE   G+    K D++  G+L  E      P D+
Sbjct: 165 APS--LRRRXMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L    ++          L  
Sbjct: 78  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 191 K-DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +  +
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 92  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 147 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 192
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P +  +   
Sbjct: 121 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDD-- 168
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 169 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 639 DNFSSAN-KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIR 694
           DN   A+ ++G G  G V +G       ++ V +  LKQ   K  ++  + E + +  + 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           +  ++++I VC       A+   +V E    G L ++L    +++ V +++ +       
Sbjct: 69  NPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH----- 117
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            V+  ++YL    E + VH DL   NVLL     + +SDFGL+K L     D+    RS 
Sbjct: 118 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSA 172
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
               K  + + APE    R+ S + DV+S+G+ + E  +  ++P   M
Sbjct: 173 G---KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 630 SYAELSK---ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSF 683
           + AE+ K     D+F     +G+G  G VY     +N   +A+KV+    L+++G     
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
             E +   ++RH N++++        F       ++ EF   G L + L       E  S
Sbjct: 62  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            + ++ L      A A+ Y H   E  ++H D+KP N+L+       ++DFG     S H
Sbjct: 117 ATFMEEL------ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVH 163
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            P   +  R +     GT+ Y+ PE   G+    K D++  G+L  E      P D+
Sbjct: 164 APS--LRRRXMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIK 700
            ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  +++
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  +
Sbjct: 435 MIGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGM 482
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K 
Sbjct: 483 KYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KW 534
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
            V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           D +     IG G  G+V        G +VA+K I         +K  + E K L++ +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 697 NLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLHHSND-QLEVCSLSVIQRLNIA 753
           N+I I  +       G +FK++  V + M++  L + +H S    LE     + Q L   
Sbjct: 115 NIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR-- 170
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
                 ++Y+H      ++H DLKPSN+L++++    + DFG+A+ L      +  E + 
Sbjct: 171 -----GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT----SPAEHQY 218
Query: 814 ISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKR 856
                  T  Y APE  +   E +   D++S G +  E+  R++
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + S +E+LH   + +I++ DLKP NVLLD D    +SD GLA  L      T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-------- 346
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G  GT G++APE  +G E     D ++ G+ L E+   + P  A
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + S +E+LH   + +I++ DLKP NVLLD D    +SD GLA  L      T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-------- 346
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G  GT G++APE  +G E     D ++ G+ L E+   + P  A
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 40/240 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V       + + G  + V V  LK+K  S   ++ ++E K +  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH-----HSNDQLEVCSLSV 746
           +  H N++ ++  C+     G  +  +++E+   G L  +L       S D++E  +   
Sbjct: 105 LGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 747 IQR------------LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
           ++             L  A  VA  +E+L      S VH DL   NVL+    V  + DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 795 GLAKFLSNHNPDTIVETRSISIG-IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           GLA+       D + ++  +  G  +  V ++APE       ++K DV+S+GILL E+F+
Sbjct: 217 GLAR-------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + S +E+LH   + +I++ DLKP NVLLD D    +SD GLA  L      T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-------- 346
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G  GT G++APE  +G E     D ++ G+ L E+   + P  A
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 47/239 (19%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA---------SKSFVAECKA 689
           +N+     +G G S +V +        E AVK+I++   G+          ++ + E   
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 690 LRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
           LR +  H N+I++        ++   F  +V++ M+ G L ++L       E  +LS  +
Sbjct: 64  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKE 112
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
              I   +   I  LH     +IVH DLKP N+LLD D+   ++DFG +  L     D  
Sbjct: 113 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPG 164
Query: 809 VETRSISIGIKGTVGYVAPEY----------GMGREASMKGDVYSFGILLLELFTRKRP 857
            + R +     GT  Y+APE           G G+E     D++S G+++  L     P
Sbjct: 165 EKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + S +E+LH   + +I++ DLKP NVLLD D    +SD GLA  L      T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-------- 346
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G  GT G++APE  +G E     D ++ G+ L E+   + P  A
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +  +
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 106 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 161 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 206
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L    ++          L  
Sbjct: 87  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 200 K-DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 47/239 (19%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA---------SKSFVAECKA 689
           +N+     +G G S +V +        E AVK+I++   G+          ++ + E   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 690 LRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
           LR +  H N+I++        ++   F  +V++ M+ G L ++L       E  +LS  +
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKE 125
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
              I   +   I  LH     +IVH DLKP N+LLD D+   ++DFG +  L     D  
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPG 177
Query: 809 VETRSISIGIKGTVGYVAPEY----------GMGREASMKGDVYSFGILLLELFTRKRP 857
            + R +     GT  Y+APE           G G+E     D++S G+++  L     P
Sbjct: 178 EKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIK 700
            ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  +++
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  +
Sbjct: 93  MIGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGM 140
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K 
Sbjct: 141 KYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KW 192
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
            V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L    ++          L  
Sbjct: 124 IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 237 K-DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+    K      ++ EF + G+L  +L    ++          L  
Sbjct: 78  IGHHLNVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 191 K-DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIK 700
            ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  +++
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  +
Sbjct: 436 MIGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGM 483
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K 
Sbjct: 484 KYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KW 535
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
            V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 577

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 106 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 161 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 206
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNIRHR 696
           D +     IG G  G+V        G +VA+K I         +K  + E K L++ +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 697 NLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLHHSND-QLEVCSLSVIQRLNIA 753
           N+I I  +       G +FK++  V + M++  L + +H S    LE     + Q L   
Sbjct: 114 NIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR-- 169
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
                 ++Y+H      ++H DLKPSN+L++++    + DFG+A+ L      +  E + 
Sbjct: 170 -----GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT----SPAEHQY 217
Query: 814 ISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKR 856
                  T  Y APE  +   E +   D++S G +  E+  R++
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 647 IGEGGSGIVYKGFL---GEN-GTEVAVKVI--NLKQKGASKSFVAECKALRNIRHRNLIK 700
           +G G  G VYKG     GEN    VA+KV+  N   K A+K  + E   +  +    + +
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVSR 83
Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           ++ +C     +      +V + M  G L + +  +  +L    L     LN  + +A  +
Sbjct: 84  LLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNWCMQIAKGM 132
Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
            YL    +  +VH DL   NVL+       ++DFGLA+ L       I ET   + G K 
Sbjct: 133 SYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD------IDETEYHADGGKV 183
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            + ++A E  + R  + + DV+S+G+ + EL T
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L    ++          L  
Sbjct: 87  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 200 K-DPDXVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++A A+++LH      I++ DLKP N+LLD++    ++DFGL+K   +H      E ++ 
Sbjct: 135 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------EKKAY 185
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           S    GTV Y+APE    R  +   D +SFG+L+ E+ T   P
Sbjct: 186 SFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 92  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 147 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 192
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  A    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       +++FG     S H P +   T  
Sbjct: 121 ---ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTT-- 168
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 169 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++A A+++LH      I++ DLKP N+LLD++    ++DFGL+K   +H      E ++ 
Sbjct: 134 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------EKKAY 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           S    GTV Y+APE    R  +   D +SFG+L+ E+ T   P
Sbjct: 185 SFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 27/231 (11%)
Query: 632 AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKA 689
           A  ++ TD++    ++G+G   +V +        E A K+IN K+  A   +    E + 
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
            R ++H N++++    S   F       +V++ +  G L E         ++ +      
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFH-----YLVFDLVTGGELFE---------DIVAREYYSE 129
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPD 806
            + +  +   +E ++H  +  IVH DLKP N+LL    +     ++DFGLA  +      
Sbjct: 130 ADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG---- 185
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                +    G  GT GY++PE           D+++ G++L  L     P
Sbjct: 186 ----EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 98  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 153 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 198
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 199 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 108 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 163 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 208
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 209 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++A A+++LH      I++ DLKP N+LLD++    ++DFGL+K   +H      E ++ 
Sbjct: 134 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------EKKAY 184
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           S    GTV Y+APE    R  +   D +SFG+L+ E+ T   P
Sbjct: 185 SFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 47/257 (18%)
Query: 628 VDSYAELSKATDNFSSAN-----KIGEGGSGIVYKG----FLGENG-TEVAVKVINLKQK 677
           VD++  L      F   N      +GEG  G V K       G  G T VAVK+  LK+ 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKEN 64
Query: 678 GAS---KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH 734
            +    +  ++E   L+ + H ++IK+   CS    +      IV E+ + GSL  +L  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRE 119
Query: 735 SN------------------DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           S                   D  +  +L++   ++ A  ++  ++YL    E  +VH DL
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              N+L+ +     +SDFGL++    +  D+ V+     I +K    ++A E       +
Sbjct: 177 AARNILVAEGRKMKISDFGLSR--DVYEEDSYVKRSQGRIPVK----WMAIESLFDHIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+ T
Sbjct: 231 TQSDVWSFGVLLWEIVT 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 91  NHQNIVR----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 146 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 191
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L    ++          L  
Sbjct: 87  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 200 K-DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 47/257 (18%)
Query: 628 VDSYAELSKATDNFSSAN-----KIGEGGSGIVYKG----FLGENG-TEVAVKVINLKQK 677
           VD++  L      F   N      +GEG  G V K       G  G T VAVK+  LK+ 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKEN 64
Query: 678 GAS---KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHH 734
            +    +  ++E   L+ + H ++IK+   CS    +      IV E+ + GSL  +L  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRE 119
Query: 735 SN------------------DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDL 776
           S                   D  +  +L++   ++ A  ++  ++YL    E  +VH DL
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDL 176
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
              N+L+ +     +SDFGL++    +  D+ V+     I +K    ++A E       +
Sbjct: 177 AARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVK----WMAIESLFDHIYT 230
Query: 837 MKGDVYSFGILLLELFT 853
            + DV+SFG+LL E+ T
Sbjct: 231 TQSDVWSFGVLLWEIVT 247

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHR 696
           + +    KIGEG  G+V+K    + G  VA+K     +      K  + E + L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL--NIAI 754
           NL+ ++ V     F+      +V+E+  +  L E        L+     V + L  +I  
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITW 109
Query: 755 DVASAIEYLH-HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL---SNHNPDTIVE 810
               A+ + H H C    +H D+KP N+L+ +  V  + DFG A+ L   S++  D +  
Sbjct: 110 QTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-- 163
Query: 811 TRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
                     T  Y +PE  +G  +     DV++ G +  EL +
Sbjct: 164 ---------ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/243 (25%), Positives = 107/243 (44%), Gaps = 30/243 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIRH 695
           ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++        F  A    ++ E+   G++   L   +   E  + + I  L     
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL----- 121
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
            A+A+ Y H      ++H D+KP N+LL  +    ++DFG     S H P +  +T    
Sbjct: 122 -ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDT---- 169
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA-MFNEGLTLHDFSRE 874
             + GT+ Y+ PE   GR    K D++S G+L  E      P +A  + E  T    SR 
Sbjct: 170 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE--TYRRISRV 225
Query: 875 FFT 877
            FT
Sbjct: 226 EFT 228

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNI 693
           A ++F     +G+G  G VY      +   +A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N++++        F  +    ++ E+   G++   L   +   E  + + I  L   
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
              A+A+ Y H      ++H D+KP N+LL       ++DFG     S H P       S
Sbjct: 118 ---ANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGW----SVHAPS------S 161
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
               + GT+ Y+ PE   GR    K D++S G+L  E    K P +A
Sbjct: 162 RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 78  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 125
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 126 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-----KWP 177
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 83  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 138 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 183
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 184 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 106 NHQNIVR----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 161 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 206
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH----------HSNDQLEV 741
           I  H N++ ++  C+     G     IV EF + G+L  +L            + + L  
Sbjct: 89  IGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 202 K-DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 91  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 146 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 191
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 92  NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 147 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----------- 192
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVA+K+I+  Q   +  +    E + ++ + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      ++ E+   G + ++L       E  + S  ++      + 
Sbjct: 76  IVKLFEV-----IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IV 124
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D+   ++DFG + +F      D          
Sbjct: 125 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC------- 174
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTD 859
              G   Y APE   G++    + DV+S G++L  L +   P D
Sbjct: 175 ---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 639 DNFSSAN-KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIR 694
           DN   A+ ++G G  G V +G       ++ V +  LKQ   K  ++  + E + +  + 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           +  ++++I VC       A+   +V E    G L ++L    +++ V +++      +  
Sbjct: 395 NPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLH 443
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            V+  ++YL    E + VH +L   NVLL     + +SDFGL+K L     D+    RS 
Sbjct: 444 QVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSA 498
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
               K  + + APE    R+ S + DV+S+G+ + E  +  ++P   M
Sbjct: 499 G---KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D++    ++G G  G+V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           + +        F+  +   ++YEFM  G L E +   ++++                   
Sbjct: 217 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS---------------EDE 256
Query: 759 AIEYLHHYC-------EPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIV 809
           A+EY+   C       E + VH DLKP N++      + +   DFGL   L   +P   V
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSV 313
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
           +  +      GT  + APE   G+      D++S G+L
Sbjct: 314 KVTT------GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 18/145 (12%)
Query: 718 IVYEFMQNGSLEEWLHHSN--DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD 775
           I+YE+M+N S+ ++  +    D+   C + +     I   V ++  Y+H+  E +I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRD 177
Query: 776 LKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA 835
           +KPSN+L+D++    +SDFG ++++ +         + I  G +GT  ++ PE+    E+
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVD---------KKIK-GSRGTYEFMPPEF-FSNES 226
Query: 836 SMKG---DVYSFGILLLELFTRKRP 857
           S  G   D++S GI L  +F    P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 118 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+           
Sbjct: 173 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----------- 218
Query: 810 ETRSISIGIKG-----TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +    S   KG      V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 219 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 77
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 134
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 135 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 182
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 81
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 138
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 139 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 186
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+    K      ++ EF + G+L  +L    ++          L  
Sbjct: 78  IGHHLNVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 191 K-DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 639 DNFSSANKIGEGGSG-IVYKGFLGENGTEVAVKV-INLKQKGAS----KSFVAECKALRN 692
           D       +G G  G ++     G + T     V + + ++GA+    ++ ++E K L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEV 741
           I  H N++ ++  C+    K      ++ EF + G+L  +L    ++          L  
Sbjct: 78  IGHHLNVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
             L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ + 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 191 K-DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D++    ++G G  G+V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           + +        F+  +   ++YEFM  G L E +   ++++                   
Sbjct: 111 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS---------------EDE 150
Query: 759 AIEYLHHYC-------EPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIV 809
           A+EY+   C       E + VH DLKP N++      + +   DFGL   L   +P   V
Sbjct: 151 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSV 207
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
           +  +      GT  + APE   G+      D++S G+L
Sbjct: 208 KVTT------GTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 89
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 146
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 147 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 194
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 195 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 80
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 137
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 138 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 185
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 95
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 152
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 153 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 200
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 145
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 193
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 104
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 161
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 162 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 209
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 167
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 215
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 84
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 141
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 142 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 189
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 167
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 215
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 31/232 (13%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHR 696
            D+     ++G G  G+V K     +G  +AVK I         K  + +     +I  R
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DISMR 105
Query: 697 NLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            +    TV     F GA F+     I  E M + SL+++     D+ +     ++ +  I
Sbjct: 106 TVDCPFTVT----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--I 158
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A+ +  A+E+LH     S++H D+KPSNVL++      + DFG++ +L     D++ +T 
Sbjct: 159 AVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV----DSVAKT- 211
Query: 813 SISIGIKGTVGYVAPEY---GMGREA-SMKGDVYSFGILLLELFTRKRPTDA 860
            I  G K    Y+APE     + ++  S+K D++S GI ++EL   + P D+
Sbjct: 212 -IDAGCK---PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 259

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 84  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 131
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 132 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 183
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 94  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 141
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 142 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 193
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 145
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 193
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 72  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 119
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 120 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 171
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 172 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 78  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 125
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 126 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 177
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 74  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 121
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 122 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 173
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 112
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 169
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 170 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 217
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 218 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF----VAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         V V  LK +    +     +AE   ++ + +  ++++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +     V   ++I+ ++    V+  ++
Sbjct: 92  IGICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMK 139
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E + VH DL   NVLL     + +SDFGL+K L         +T       K  
Sbjct: 140 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWP 191
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAM 861
           V + APE     + S K DV+SFG+L+ E F+  ++P   M
Sbjct: 192 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 114
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 171
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 172 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 219
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           +     IG G  GIV   F    G  VAVK ++   + +  +K    E   L+ + H+N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +H   D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIHMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK-FLSNHNPDTIVETRS 813
                I++LH      I+H DLKPSN+++  D    + DFGLA+   +N      V TR 
Sbjct: 137 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY 190
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                     Y APE  +G   +   D++S G ++ EL
Sbjct: 191 ----------YRAPEVILGMGYAANVDIWSVGCIMGEL 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G+G  G VYK    E G   A KVI  K +   + ++ E + L    H  ++K++   
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL--- 82
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
            G  +       I+ EF   G+++  +   +  L    + V+ R      +  A+ +LH 
Sbjct: 83  -GAYYHDGKL-WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNFLH- 134
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
                I+H DLK  NVL+  +    ++DFG    +S  N  T+ +  S      GT  ++
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFI----GTPYWM 184
Query: 826 APEYGMGREAS-----MKGDVYSFGILLLELFTRKRP 857
           APE  M           K D++S GI L+E+   + P
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N++
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 155
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 212
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 213 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 260
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 261 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIRH 695
           ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++        F  A    ++ E+   G++   L   +   E  + + I  L     
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL----- 121
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
            A+A+ Y H      ++H D+KP N+LL  +    ++DFG     S H P +   T    
Sbjct: 122 -ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGW----SVHAPSSRRTT---- 169
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA-MFNEGLTLHDFSRE 874
             + GT+ Y+ PE   GR    K D++S G+L  E      P +A  + E  T    SR 
Sbjct: 170 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE--TYRRISRV 225
Query: 875 FFT 877
            FT
Sbjct: 226 EFT 228

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K   + Q  A K+   E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-------SFVAECKALRNI 693
           F+   KIG+G  G V+KG        VA+K+I+L++            + +++C +    
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 64
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
                   +T   G   K      I+ E++  GS       + D LE   L   Q   I 
Sbjct: 65  ------PYVTKYYGSYLKDTKL-WIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH   +   +H D+K +NVLL +     ++DFG+A  L+    DT ++  +
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNT 163
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 164 FV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 30/247 (12%)
Query: 615 KASNMLPIEQQFLVDSYAELSK----ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVK 670
           + S+ML + Q+       EL+K      + + + + +G G  G V   F  + G  VAVK
Sbjct: 17  RGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 76
Query: 671 VINLKQKG--ASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGS 727
            ++   +    +K    E + L++++H N+I ++ V +  R  +  +   +V   M    
Sbjct: 77  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD 135
Query: 728 LEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL 787
           L       N+ ++   L+      +   +   ++Y+H      I+H DLKPSN+ +++D 
Sbjct: 136 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 185
Query: 788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGI 846
              + DFGLA+    H  D +        G   T  Y APE  +     +   D++S G 
Sbjct: 186 ELKILDFGLAR----HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 234
Query: 847 LLLELFT 853
           ++ EL T
Sbjct: 235 IMAELLT 241

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K   + Q  A K+   E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK--SFVAECKALRNIRH 695
           ++ +    K+G G  G V          E A+K+I       S     + E   L+ + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++K+        F+      +V E  + G L + + H     EV +  +I++      
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ------ 144
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           V S + YLH +   +IVH DLKP N+LL   ++D +  + DFGL+    N      ++ R
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKER 198
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  GT  Y+APE  + ++   K DV+S G++L  L     P
Sbjct: 199 L------GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 667 VAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           VA+K I  +  +G   S   E   L  I+H N++ +  +     ++      ++ + +  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSG 100
Query: 726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL--- 782
           G L + +       E  +  +I        V  A++YLH   +  IVH DLKP N+L   
Sbjct: 101 GELFDRIVEKGFYTERDASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYS 151
Query: 783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVY 842
           LD+D    +SDFGL+K     +P +++ T        GT GYVAPE    +  S   D +
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVAPEVLAQKPYSKAVDCW 202
Query: 843 SFGIL 847
           S G++
Sbjct: 203 SIGVI 207

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-------SFVAECKALRNI 693
           F+   +IG+G  G V+KG        VA+K+I+L++            + +++C +    
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 80
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
                   +T   G   KG+    I+ E++  GS       + D L        Q   + 
Sbjct: 81  ------SYVTKYYGSYLKGSKL-WIIMEYLGGGS-------ALDLLRAGPFDEFQIATML 126
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH   +   +H D+K +NVLL +     ++DFG+A  L+    DT ++  +
Sbjct: 127 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRNT 179
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
                 GT  ++APE         K D++S GI  +EL   + P   M
Sbjct: 180 FV----GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           +     IG G  GIV   F    G  VAVK ++   + +  +K    E   L+ + H+N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +H   D  E  S  + Q L    
Sbjct: 84  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIHMELDH-ERMSYLLYQML---- 134
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS-NHNPDTIVETRS 813
                I++LH      I+H DLKPSN+++  D    + DFGLA+  S N      V TR 
Sbjct: 135 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY 188
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                     Y APE  +G       D++S G ++ EL
Sbjct: 189 ----------YRAPEVILGMGYKENVDIWSVGCIMGEL 216

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 132 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+ +         
Sbjct: 187 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             R     +   V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 239 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRN 697
           N+     IG+G    V        G EVAVK+I+  Q  +S  +    E +  + + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K+  V      +      +V E+   G + ++L       E  + +  ++      + 
Sbjct: 75  IVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ------IV 123
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISI 816
           SA++Y H   +  IVH DLK  N+LLD D    ++DFG + +F   +  D          
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC------- 173
Query: 817 GIKGTVGYVAPEYGMGREAS-MKGDVYSFGILLLELFTRKRPTDAM 861
              G   Y APE   G++    + DV+S G++L  L +   P D  
Sbjct: 174 ---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +++    IG G  G+VY+  L ++G  VA+K   + Q  A K+   E + +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 700 KI-ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++     S  + K   +  +V +++         H+S  +    +L VI        +  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++ Y+H +    I H D+KP N+LLD D  V  + DFG AK L    P+         + 
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VS 181
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
              +  Y APE   G  + +   DV+S G +L EL 
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 617 SNMLPIEQQFLVDSYAELSK----ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI 672
           S+ML + Q+       EL+K      + + + + +G G  G V   F  + G  VAVK +
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 60
Query: 673 N--LKQKGASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLE 729
           +   +    +K    E + L++++H N+I ++ V +  R  +  +   +V   M    L 
Sbjct: 61  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL- 118
Query: 730 EWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS 789
                 N+ ++   L+      +   +   ++Y+H      I+H DLKPSN+ +++D   
Sbjct: 119 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 169
Query: 790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILL 848
            + DFGLA+    H  D +        G   T  Y APE  +     +   D++S G ++
Sbjct: 170 KILDFGLAR----HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 218
Query: 849 LELFT 853
            EL T
Sbjct: 219 AELLT 223

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 120
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 121 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQ---PDTTSVVKDSQV 173
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 174 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 230
Query: 866 LTLH 869
             LH
Sbjct: 231 SKLH 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 640 NFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVI-NLKQKGASKSFVAECKALRNI 693
           N +    +G G  G VY+G +       +  +VAVK +  +  +     F+ E   +   
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNI 752
            H+N+++    C G   +    + I+ E M  G L+ +L  +  +  +  SL+++  L++
Sbjct: 109 NHQNIVR----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           A D+A   +YL    E   +H D+   N LL       V+ + DFG+A+ +         
Sbjct: 164 ARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 215
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             R     +   V ++ PE  M    + K D +SFG+LL E+F+
Sbjct: 216 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKGFL--GEN-GTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G     EN    VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 126
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 177
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 617 SNMLPIEQQFLVDSYAELSK----ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI 672
           S+ML + Q+       EL+K      + + + + +G G  G V   F  + G  VAVK +
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 673 N--LKQKGASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLE 729
           +   +    +K    E + L++++H N+I ++ V +  R  +  +   +V   M    L 
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL- 119
Query: 730 EWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS 789
                 N+ ++   L+      +   +   ++Y+H      I+H DLKPSN+ +++D   
Sbjct: 120 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 170
Query: 790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILL 848
            + DFGLA+    H  D +        G   T  Y APE  +     +   D++S G ++
Sbjct: 171 KILDFGLAR----HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 849 LELFT 853
            EL T
Sbjct: 220 AELLT 224

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-------SFVAECKALRNI 693
           F+   KIG+G  G V+KG        VA+K+I+L++            + +++C +    
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
                   +T   G   K      I+ E++  GS       + D LE   L   Q   I 
Sbjct: 80  ------PYVTKYYGSYLKDTKL-WIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 125
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH   +   +H D+K +NVLL +     ++DFG+A  L+    DT ++   
Sbjct: 126 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNX 178
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 179 FV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G ++      +AV +   K        + F+ E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 106 GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 154
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 155 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 205
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 206 -WMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRH 695
           TD +     IG+G   +V +      G E A K+IN K+  A   +    E +  R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++    S   F       +V++ +  G L E         ++ +       + +  
Sbjct: 63  SNIVRLHDSISEEGFH-----YLVFDLVTGGELFE---------DIVAREYYSEADASHC 108
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           +   +E + H  +  +VH DLKP N+LL    +     ++DFGLA  +           +
Sbjct: 109 IQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--------DQ 160
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRP 857
               G  GT GY++PE  + +EA  K  D+++ G++L  L     P
Sbjct: 161 QAWFGFAGTPGYLSPEV-LRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-------SFVAECKALRNI 693
           F+   KIG+G  G V+KG        VA+K+I+L++            + +++C +    
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 64
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
                   +T   G   K      I+ E++  GS       + D LE   L   Q   I 
Sbjct: 65  ------PYVTKYYGSYLKDTKL-WIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH   +   +H D+K +NVLL +     ++DFG+A  L+    DT ++   
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNX 163
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 164 FV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKGFL--GEN-GTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G     EN    VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 126
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STXXKASKGKLPIK--- 177
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV-AECKALRNIR-HRNLIKIITV 704
           +GEG    V      +NG E AVK+I  KQ G S+S V  E + L   + ++N++++I  
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIE-KQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
                F+      +V+E +Q GS+   L H   Q      +  +   +  DVA+A+++LH
Sbjct: 80  -----FEDDTRFYLVFEKLQGGSI---LAHIQKQKH---FNEREASRVVRDVAAALDFLH 128
Query: 765 HYCEPSIVHGDLKPSNVLLDQ-DLVSHVS--DFGLAKFLSNHNPDTIVETRSISIGIKGT 821
                 I H DLKP N+L +  + VS V   DF L   +  +N  T + T  ++    G+
Sbjct: 129 ---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC-GS 184
Query: 822 VGYVAPEY-----GMGREASMKGDVYSFGILLLELFTRKRP 857
             Y+APE              + D++S G++L  + +   P
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 25/241 (10%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G G  G V++    + G + AVK + L+   A +  +  C  L + R   L   +   
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAV--- 154
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
                +   +  I  E ++ GSL + +    +Q  +     +  L  A++    +EYLH 
Sbjct: 155 -----REGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALE---GLEYLHS 203
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
                I+HGD+K  NVLL  D  SH +  DFG A  L    PD + ++      I GT  
Sbjct: 204 R---RILHGDVKADNVLLSSD-GSHAALCDFGHAVCL---QPDGLGKSLLTGDYIPGTET 256
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTD 883
           ++APE  +GR    K DV+S   ++L +     P    F   L L   S     R+    
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 316
Query: 884 C 884
           C
Sbjct: 317 C 317

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRH 695
           TD +    ++G+G   +V +      G E A K+IN K+  A   +    E +  R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++    S        F  +V++ +  G L E         ++ +       + +  
Sbjct: 63  PNIVRLHDSISEE-----GFHYLVFDLVTGGELFE---------DIVAREYYSEADASHC 108
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           +   +E ++H     IVH DLKP N+LL    +     ++DFGLA  +           +
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--------DQ 160
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               G  GT GY++PE           D+++ G++L  L     P
Sbjct: 161 QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV----AECKALRNIR 694
           D+F     IG+G  G V      +     A+K +N KQK   ++ V     E + ++ + 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLE 73
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  L+ +        F+  +   +V + +  G L    +H    +     +V  +L I  
Sbjct: 74  HPFLVNL-----WYSFQDEEDMFMVVDLLLGGDLR---YHLQQNVHFKEETV--KLFIC- 122
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++  A++YL +     I+H D+KP N+LLD+    H++DF +A  L         ET+  
Sbjct: 123 ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-------ETQIT 172
Query: 815 SIGIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRP 857
           ++   GT  Y+APE    R+    S   D +S G+   EL   +RP
Sbjct: 173 TMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G+G  G VYK    E G   A KVI  K +   + ++ E + L    H  ++K++   
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL--- 74
Query: 706 SGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                 GA +      I+ EF   G+++  +   +  L    + V+ R      +  A+ 
Sbjct: 75  ------GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALN 123
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           +LH      I+H DLK  NVL+  +    ++DFG    +S  N  T+ +  S      GT
Sbjct: 124 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFI----GT 172
Query: 822 VGYVAPEYGMGREAS-----MKGDVYSFGILLLELFTRKRP 857
             ++APE  M           K D++S GI L+E+   + P
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 628 VDSYAELSKATDNFSSANK---------------IGEGGSGIVYKGFL--GEN-GTEVAV 669
            D YAE+    D ++  +                IGEG  G V++G     EN    VA+
Sbjct: 364 TDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAI 423
Query: 670 KVI-NLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL 728
           K   N       + F+ E   +R   H +++K+I V +           I+ E    G L
Sbjct: 424 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGEL 477
Query: 729 EEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV 788
             +L      L++ SL +      A  +++A+ YL        VH D+   NVL+  +  
Sbjct: 478 RSFLQVRKFSLDLASLILY-----AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC 529
Query: 789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             + DFGL++++ +    T  +     + IK    ++APE    R  +   DV+ FG+ +
Sbjct: 530 VKLGDFGLSRYMED---STYYKASKGKLPIK----WMAPESINFRRFTSASDVWMFGVCM 582
Query: 849 LELF 852
            E+ 
Sbjct: 583 WEIL 586

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS--FVAECKALRNIRHRNLIKIIT 703
           K+ E  SG ++KG     G ++ VKV+ ++     KS  F  EC  LR   H N++ ++ 
Sbjct: 17  KLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
            C       A    ++  +   GSL   LH   + +    +   Q +  A+D A    +L
Sbjct: 75  ACQS---PPAPHPTLITHWXPYGSLYNVLHEGTNFV----VDQSQAVKFALDXARGXAFL 127
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
           H   EP I    L   +V +D+D  + +S   + KF S  +P           G      
Sbjct: 128 HTL-EPLIPRHALNSRSVXIDEDXTARISXADV-KF-SFQSP-----------GRXYAPA 173
Query: 824 YVAPEYGMGREASMK---GDVYSFGILLLELFTRKRP 857
           +VAPE    +         D +SF +LL EL TR+ P
Sbjct: 174 WVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRH 695
           TD +    ++G+G   +V +      G E A K+IN K+  A   +    E +  R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++    S        F  +V++ +  G L E         ++ +       + +  
Sbjct: 63  PNIVRLHDSISEE-----GFHYLVFDLVTGGELFE---------DIVAREYYSEADASHC 108
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           +   +E ++H     IVH DLKP N+LL    +     ++DFGLA  +           +
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--------DQ 160
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               G  GT GY++PE           D+++ G++L  L     P
Sbjct: 161 QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+   KIG+G  G V+KG        VA+K+I+L++                   +  I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-----------DIQQEIT 77
Query: 701 IITVCSG---RDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +++ C       + G+  K     I+ E++  GS       + D LE   L   Q   I 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 130
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L+    DT ++  +
Sbjct: 131 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNT 183
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 184 FV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 137 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 189
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 190 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 866 LTLH 869
             LH
Sbjct: 247 SKLH 250

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 116
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 117 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 169
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 170 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 226
Query: 866 LTLH 869
             LH
Sbjct: 227 SKLH 230

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 67  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 115
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 166
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G ++      +AV +   K        + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 126
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 177
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKGFL--GEN-GTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G     EN    VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 83  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 131
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 182
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 183 -WMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 683 FVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC 742
            V+E   LR ++H N+++       R         IV E+ + G L   +     + +  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEP--SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
               +  L +   +  A++  H   +   +++H DLKP+NV LD      + DFGLA+ L
Sbjct: 109 DEEFV--LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            NH+ D   E         GT  Y++PE       + K D++S G LL EL     P  A
Sbjct: 167 -NHDEDFAKE-------FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218
Query: 861 MFNEGL 866
              + L
Sbjct: 219 FSQKEL 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHR 696
            +++     +GEG  G V           VAVK++++K+     ++   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K      G   +G + + +  E+   G L + +       E  +     +L      
Sbjct: 66  NVVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++       
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 166
Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
            + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 -MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHR 696
            +++     +GEG  G V           VAVK++++K+     ++   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K      G   +G + + +  E+   G L + +       E  +     +L      
Sbjct: 66  NVVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++       
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 166
Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
            + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 -MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHR 696
            +++     +GEG  G V           VAVK++++K+     ++   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K      G   +G + + +  E+   G L + +       E  +     +L      
Sbjct: 66  NVVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++       
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 166
Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
            + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 -MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G ++      +AV +   K        + F+ E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 80  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 128
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 129 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 179
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 180 -WMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 164
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 217
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 218 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 866 LTLH 869
             LH
Sbjct: 275 SKLH 278

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 69  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 117
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 118 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 170
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 171 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 866 LTLH 869
             LH
Sbjct: 228 SKLH 231

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G ++      +AV +   K        + F+ E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 75  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 123
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 174
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 175 -WMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHR 696
            +++     +GEG  G V           VAVK++++K+     ++   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K      G   +G + + +  E+   G L + +       E  +     +L      
Sbjct: 65  NVVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 113
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++       
Sbjct: 114 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 165
Query: 817 GIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
            + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 -MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 667 VAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQN 725
           VA+K I  K  +G   S   E   L  I+H N++ +  +     ++      ++ + +  
Sbjct: 46  VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSG 100
Query: 726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL--- 782
           G L + +       E  +  +I        V  A++YLH   +  IVH DLKP N+L   
Sbjct: 101 GELFDRIVEKGFYTERDASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYS 151
Query: 783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVY 842
           LD+D    +SDFGL+K     +P +++ T        GT GYVAPE    +  S   D +
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVAPEVLAQKPYSKAVDCW 202
Query: 843 SFGIL 847
           S G++
Sbjct: 203 SIGVI 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G ++      +AV +   K        + F+ E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL     +  A  +++A+ Y
Sbjct: 81  GVITENPV------WIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAY 129
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+  +    + DFGL++++ +    T  +     + IK   
Sbjct: 130 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 180
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 181 -WMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 617 SNMLPIEQQFLVDSYAELSK----ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI 672
           S+ML + Q+       EL+K      + + + + +G G  G V   F  + G  VAVK +
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 673 N--LKQKGASKSFVAECKALRNIRHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLE 729
           +   +    +K    E + L++++H N+I ++ V +  R  +  +   +V   M    L 
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL- 119
Query: 730 EWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS 789
                 N+ ++   L+      +   +   ++Y+H      I+H DLKPSN+ +++D   
Sbjct: 120 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSEL 170
Query: 790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILL 848
            + DFGLA+    H  D +        G   T  Y APE  +     +   D++S G ++
Sbjct: 171 KILDFGLAR----HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 849 LELFT 853
            EL T
Sbjct: 220 AELLT 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   +  ++G ++AVK ++   +    +K    E + L+++
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------- 745
           +H N+I ++ V                 F    SLEE+    ND   V  L         
Sbjct: 108 KHENVIGLLDV-----------------FTPATSLEEF----NDVYLVTHLMGADLNNIV 146
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
             Q+L       +   +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+ 
Sbjct: 147 KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR- 202
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
              H  D +        G   T  Y APE  +     +M  D++S G ++ EL T
Sbjct: 203 ---HTDDEMT-------GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIIT 703
           +IG G    VYKG   E   EVA   +  ++  K   + F  E + L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                  KG     +V E   +G+L+ +L     + +V  + V++  +    +   +++L
Sbjct: 93  SWES-TVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLR--SWCRQILKGLQFL 145
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           H    P I+H DLK  N+ +     S  + D GLA           ++  S +  + GT 
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----------LKRASFAKAVIGTP 194
Query: 823 GYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
            + APE Y    + S+  DVY+FG   LE  T + P
Sbjct: 195 EFXAPEXYEEKYDESV--DVYAFGXCXLEXATSEYP 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 40/244 (16%)
Query: 628 VDSYAELSKATDNFSSANK---------------IGEGGSGIVYKGFL--GEN-GTEVAV 669
            D YAE+    D ++  +                IGEG  G V++G     EN    VA+
Sbjct: 364 TDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAI 423
Query: 670 KVI-NLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL 728
           K   N       + F+ E   +R   H +++K+I V +           I+ E    G L
Sbjct: 424 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGEL 477
Query: 729 EEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV 788
             +L      L++ SL +      A  +++A+ YL        VH D+   NVL+     
Sbjct: 478 RSFLQVRKFSLDLASLILY-----AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDC 529
Query: 789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             + DFGL++++ +    T  +     + IK    ++APE    R  +   DV+ FG+ +
Sbjct: 530 VKLGDFGLSRYMED---STYYKASKGKLPIK----WMAPESINFRRFTSASDVWMFGVCM 582
Query: 849 LELF 852
            E+ 
Sbjct: 583 WEIL 586

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 647 IGEGGSGIVYKGFLGENG-------TEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +G+G    ++KG   E G       TEV +KV++   +  S+SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               VC        D   +V EF++ GSL+ +L  + +      ++++ +L +A  +A+A
Sbjct: 76  LNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAA 125
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + +L    E +++HG++   N+LL   +       G   F+   +P   +      I ++
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILL---IREEDRKTGNPPFIKLSDPGISITVLPKDI-LQ 178
Query: 820 GTVGYVAPE-YGMGREASMKGDVYSFGILLLEL 851
             + +V PE     +  ++  D +SFG  L E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 647 IGEGGSGIVYKGFL--GEN-GTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLIKII 702
           IGEG  G V++G     EN    VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E    G L  +L      L++ SL +      A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 126
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L        VH D+   NVL+       + DFGL++++ +    T  +     + IK   
Sbjct: 127 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED---STYYKASKGKLPIK--- 177
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELF 852
            ++APE    R  +   DV+ FG+ + E+ 
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 651 GSGIVYKGFLGEN---GTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSG 707
           GSG   + FL +    G   A+K I         S   E   L+ I+H N++ +  +   
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI--- 74
Query: 708 RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC 767
             ++      +V + +  G L + +       E  +  VIQ+      V SA++YLH   
Sbjct: 75  --YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH--- 123
Query: 768 EPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
           E  IVH DLKP N+L    +++    ++DFGL+K          +E   I     GT GY
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----------MEQNGIMSTACGTPGY 173
Query: 825 VAPEYGMGREASMKGDVYSFGIL 847
           VAPE    +  S   D +S G++
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 164
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 217
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 218 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 866 LTLH 869
             LH
Sbjct: 275 SKLH 278

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G  G V K        E AVKVIN    K K  S + + E + L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +        + F  IV E    G L + +       E  +  +I++      V S I Y+
Sbjct: 89  ILED----SSSF-YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ------VFSGITYM 137
Query: 764 HHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           H +   +IVH DLKP N+LL   ++D    + DFGL+   +    +T ++ R       G
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRI------G 185
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  Y+APE   G     K DV+S G++L  L +   P
Sbjct: 186 TAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG +G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 647 IGEGGSGIVYKGFLGENG-------TEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           +G+G    ++KG   E G       TEV +KV++   +  S+SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               VC    F G D   +V EF++ GSL+ +L  + +      ++++ +L +A  +A A
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAWA 125
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + +L    E +++HG++   N+LL   +       G   F+   +P   +      I ++
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILL---IREEDRKTGNPPFIKLSDPGISITVLPKDI-LQ 178
Query: 820 GTVGYVAPE-YGMGREASMKGDVYSFGILLLEL 851
             + +V PE     +  ++  D +SFG  L E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           +     +G GG+G+V+     +    VA+K I L    + K  + E K +R + H N++K
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 701 IITVCSGRDFKGADFKA---------IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +  +      +  D            IV E+M+   L   L       E   L + Q L 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR 131
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDFGLAKFLSNH 803
                   ++Y+H     +++H DLKP+N+ ++ +DLV  + DFGLA+ +  H
Sbjct: 132 -------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 683 FVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC 742
            V+E   LR ++H N+++       R         IV E+ + G L   +     + +  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEP--SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
               +  L +   +  A++  H   +   +++H DLKP+NV LD      + DFGLA+ L
Sbjct: 109 DEEFV--LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              N DT     S +    GT  Y++PE       + K D++S G LL EL     P  A
Sbjct: 167 ---NHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218
Query: 861 MFNEGL 866
              + L
Sbjct: 219 FSQKEL 224

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 34/230 (14%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           DNF     +G+G  G V    + E G   AVKV+    + Q    +  + E + L   R+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
              +  +  C    F+  D    V EF+  G L   +  S            +    A +
Sbjct: 83  HPFLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAE 132
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + SA+ +LH   +  I++ DLK  NVLLD +    ++DFG+ K               I 
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------------EGIC 176
Query: 816 IGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G+      GT  Y+APE           D ++ G+LL E+     P +A
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 52/235 (22%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSL------SVI 747
           +H N+I ++ V                 F    SLEE+    ND   V  L      +++
Sbjct: 79  KHENVIGLLDV-----------------FTPARSLEEF----NDVYLVTHLMGADLNNIV 117
Query: 748 QRLNIAID--------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           +   +  D        +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+ 
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
              H  D +        G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 174 ---HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 697 NLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCAKLTDDHVQFLIYQ 129
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +       
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT------ 176
Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
            G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 177 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + IG G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 135
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMT--- 185
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           F+  ++IG+G  G VYKG        VA+K+I+L++                   +  I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIE-----------DIQQEIT 69
Query: 701 IITVCSG---RDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +++ C       + G+  K+    I+ E++  GS  + L      LE   ++ I R    
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 123
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L+    DT ++   
Sbjct: 124 -EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRNX 175
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  ++APE         K D++S GI  +EL   + P
Sbjct: 176 FV----GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 52/235 (22%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSL------SVI 747
           +H N+I ++ V                 F    SLEE+    ND   V  L      +++
Sbjct: 79  KHENVIGLLDV-----------------FTPARSLEEF----NDVYLVTHLMGADLNNIV 117
Query: 748 QRLNIAID--------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           +   +  D        +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+ 
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR- 173
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
              H  D +        G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 174 ---HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 25/241 (10%)
Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           ++G G  G V++    + G + AVK + L+   A +  +  C  L + R   L   +   
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAV--- 135
Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
                +   +  I  E ++ GSL + +    +Q  +     +  L  A++    +EYLH 
Sbjct: 136 -----REGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALE---GLEYLHS 184
Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
                I+HGD+K  NVLL  D  SH +  DFG A  L    PD + +       I GT  
Sbjct: 185 R---RILHGDVKADNVLLSSD-GSHAALCDFGHAVCL---QPDGLGKDLLTGDYIPGTET 237
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTD 883
           ++APE  +GR    K DV+S   ++L +     P    F   L L   S     R+    
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 297
Query: 884 C 884
           C
Sbjct: 298 C 298

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNL 698
           +    KIGEG  G V+K    E    VA+K + L    +G   S + E   L+ ++H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 699 IKIITVCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQL--EVCSLSVIQRLNIAID 755
           +++       D   +D K  +V+EF     L+++    N  L  E+    + Q L     
Sbjct: 64  VRL------HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK---- 112
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
               + + H     +++H DLKP N+L++++    ++DFGLA+          +  R  S
Sbjct: 113 ---GLGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFG-------IPVRCYS 159
Query: 816 IGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
             +  T+ Y  P+   G +  S   D++S G +  EL    RP
Sbjct: 160 AEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           TD +     IG G   +  +        E AVK+I+  ++  ++        LR  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I +  V     +    +  +V E M+ G L + +      L     S  +   +   + 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTIT 126
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS----HVSDFGLAKFLSNHNPDTIVETRS 813
             +EYLH      +VH DLKPSN+L   +  +     + DFG AK L   N         
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--------G 175
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           + +    T  +VAPE    +      D++S G+LL  + T   P
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIRH 695
           D+F     +G+G  G VY     ++   VA+KV+    ++++G       E +   ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++        F       ++ E+   G L + L  S      C+    +   I  +
Sbjct: 83  PNILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKS------CTFDEQRTATIMEE 131
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +A A+ Y H      ++H D+KP N+LL       ++DFG     S H P    +T    
Sbjct: 132 LADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGW----SVHAPSLRRKT---- 180
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
             + GT+ Y+ PE   GR  + K D++  G+L  EL     P ++
Sbjct: 181 --MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIR 694
           +D +    K+G G  G V        G E A+K+I   ++     S + + E   L+ + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K+        F+      +V E  + G L + +       EV +  ++++     
Sbjct: 80  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ----- 129
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVET 811
            V S   YLH +   +IVH DLKP N+LL+   +D +  + DFG    LS H        
Sbjct: 130 -VLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFG----LSAH-------- 173
Query: 812 RSISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               +G K     GT  Y+APE  + ++   K DV+S G++L  L     P
Sbjct: 174 --FEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           ++  D   +V   M  G L+  ++H             + +  A ++   +E LH     
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQA----GFPEARAVFYAAEICCGLEDLHR---E 305
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            IV+ DLKP N+LLD      +SD GLA     H P    E ++I  G  GTVGY+APE 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA----VHVP----EGQTIK-GRVGTVGYMAPEV 356
Query: 830 GMGREASMKGDVYSFGILLLELFTRKRP 857
                 +   D ++ G LL E+   + P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 697 NLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFLIYQ 140
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +       
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMT------ 187
Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
            G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMA--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 651 GSGIVYKGFLGEN---GTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCS 706
           G+G   +  L E    G   AVK I  K  KG   S   E   LR I+H N++ +  +  
Sbjct: 31  GTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDI-- 88
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
              ++  +   +V + +  G L + +       E  + ++I++      V  A+ YLH  
Sbjct: 89  ---YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAVYYLHRM 139
Query: 767 CEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               IVH DLKP N+L    D++    +SDFGL+K     +   ++ T        GT G
Sbjct: 140 ---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTAC------GTPG 187
Query: 824 YVAPEYGMGREASMKGDVYSFGIL 847
           YVAPE    +  S   D +S G++
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 697 NLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFLIYQ 140
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +       
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMT------ 187
Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
            G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           ++  D   +V   M  G L+  ++H             + +  A ++   +E LH     
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---E 305
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            IV+ DLKP N+LLD      +SD GLA     H P    E ++I  G  GTVGY+APE 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA----VHVP----EGQTIK-GRVGTVGYMAPEV 356
Query: 830 GMGREASMKGDVYSFGILLLELFTRKRP 857
                 +   D ++ G LL E+   + P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 697 NLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFLIYQ 140
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +       
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMT------ 187
Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
            G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 686 ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
           E + LR + H +++K    C  +  K      +V E++  GSL ++L           + 
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQ---LVMEYVPLGSLRDYLPRH-------CVG 109
Query: 746 VIQRLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           + Q L  A  +   + YLH  HY     +H  L   NVLLD D +  + DFGLAK +   
Sbjct: 110 LAQLLLFAQQICEGMAYLHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEG 164
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +     E   +       V + APE     +     DV+SFG+ L EL T
Sbjct: 165 H-----EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 686 ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
           E + LR + H +++K    C  +  K      +V E++  GSL ++L           + 
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQ---LVMEYVPLGSLRDYLPRH-------CVG 110
Query: 746 VIQRLNIAIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           + Q L  A  +   + YLH  HY     +H  L   NVLLD D +  + DFGLAK +   
Sbjct: 111 LAQLLLFAQQICEGMAYLHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEG 165
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +     E   +       V + APE     +     DV+SFG+ L EL T
Sbjct: 166 H-----EYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMA--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 132
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 182
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 128
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 129 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 178
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 179 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 126
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMA--- 176
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 177 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 132
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 182
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 142
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 192
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 126
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 176
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 142
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 192
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 683 FVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC 742
            V+E   LR ++H N+++       R         IV E+ + G L   +     + +  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEP--SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
               +  L +   +  A++  H   +   +++H DLKP+NV LD      + DFGLA+ L
Sbjct: 109 DEEFV--LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              N DT     S +    GT  Y++PE       + K D++S G LL EL     P  A
Sbjct: 167 ---NHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218
Query: 861 MFNEGL 866
              + L
Sbjct: 219 FSQKEL 224

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 35/240 (14%)
Query: 637 ATDNFS---------SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV-AE 686
           +TD+FS           + +GEG    V          E AVK+I  KQ G  +S V  E
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFRE 60
Query: 687 CKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
            + L   + HRN++++I       F+  D   +V+E M+ GS+   +H      E+ +  
Sbjct: 61  VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVS--DFGLAKFLSN 802
           V+Q      DVASA+++LH+     I H DLKP N+L +  + VS V   DFGL   +  
Sbjct: 116 VVQ------DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKL 166
Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEY--GMGREASM---KGDVYSFGILLLELFTRKRP 857
           +   + + T  + +   G+  Y+APE       EAS+   + D++S G++L  L +   P
Sbjct: 167 NGDCSPISTPEL-LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 137
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 187
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 188 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 132
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 182
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 135
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 185
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 127
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 177
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 178 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 129
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 130 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 179
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 180 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 150
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 200
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 201 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 127
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 177
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 178 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 135
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMT--- 185
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 149
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 199
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 200 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 142
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 192
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 126
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 176
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 15/95 (15%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVL---LDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           V  A++YLH   +  IVH DLKP N+L   LD+D    +SDFGL+K     +P +++ T 
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
                  GT GYVAPE    +  S   D +S G++
Sbjct: 179 C------GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G  G V K        E AVKVIN    K K  S + + E + L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +      + +    IV E    G L + +       E  +  +I++      V S I Y+
Sbjct: 89  I-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ------VFSGITYM 137
Query: 764 HHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           H +   +IVH DLKP N+LL   ++D    + DFGL+        +T ++ R       G
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRI------G 185
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  Y+APE   G     K DV+S G++L  L +   P
Sbjct: 186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G  G V K        E AVKVIN    K K  S + + E + L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +      + +    IV E    G L + +       E  +  +I++      V S I Y+
Sbjct: 89  I-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ------VFSGITYM 137
Query: 764 HHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           H +   +IVH DLKP N+LL   ++D    + DFGL+        +T ++ R       G
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRI------G 185
Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           T  Y+APE   G     K DV+S G++L  L +   P
Sbjct: 186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 150
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 200
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 201 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++A  +++LH      I++ DLKP N+LLD++    ++DFGL+K   +H      E ++ 
Sbjct: 138 ELALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH------EKKAY 188
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           S    GTV Y+APE    +  S   D +S+G+L+ E+ T   P
Sbjct: 189 SFC--GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVA---ECKALRNIRHRNLIKI 701
           +G G  G V+KG     G  + + V    ++ K   +SF A      A+ ++ H +++++
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + +C G   +      +V +++  GSL   L H           ++  LN  + +A  + 
Sbjct: 99  LGLCPGSSLQ------LVTQYLPLGSL---LDHVRQHRGALGPQLL--LNWGVQIAKGMY 147
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH +L   NVLL       V+DFG+A  L    PD   + + +    K  
Sbjct: 148 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---PD---DKQLLYSEAKTP 198
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + ++A E     + + + DV+S+G+ + EL T
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 136
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 186
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 141
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 142 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 191
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 192 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 33/232 (14%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRN 697
           D+     ++G G  G+V K     +G  +AVK I         K  + +     +I  R 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DISMRT 62
Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +    TV     F GA F+     I  E M + SL+++     D+ +     ++ +  IA
Sbjct: 63  VDCPFTVT----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           + +  A+E+LH   + S++H D+KPSNVL++      + DFG++ +L +         + 
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------VAKD 167
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-----DVYSFGILLLELFTRKRPTDA 860
           I  G K    Y+APE  +  E + KG     D++S GI ++EL   + P D+
Sbjct: 168 IDAGCK---PYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 149
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 199
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 200 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PD     +   +
Sbjct: 137 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQ---PDXXXVVKDSQV 189
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              GTV Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 190 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 866 LTLH 869
             LH
Sbjct: 247 SKLH 250

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 67  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 115
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 166
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 65  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 113
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 114 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 164
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 67  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 115
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 166
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 66  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 114
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 115 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 165
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 67  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 115
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 166
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHR 696
           + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 697 NLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +   
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFLIYQ 144
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +       
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMT------ 191
Query: 816 IGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
            G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 192 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 136
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 186
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 153
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 154 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMX--- 203
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 204 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 15/95 (15%)
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVL---LDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           V  A++YLH   +  IVH DLKP N+L   LD+D    +SDFGL+K     +P +++ T 
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
                  GT GYVAPE    +  S   D +S G++
Sbjct: 179 C------GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVA---ECKALRNIRHRNLIKI 701
           +G G  G V+KG     G  + + V    ++ K   +SF A      A+ ++ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           + +C G   +      +V +++  GSL   L H           ++  LN  + +A  + 
Sbjct: 81  LGLCPGSSLQ------LVTQYLPLGSL---LDHVRQHRGALGPQLL--LNWGVQIAKGMY 129
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YL    E  +VH +L   NVLL       V+DFG+A  L    PD   + + +    K  
Sbjct: 130 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---PD---DKQLLYSEAKTP 180
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + ++A E     + + + DV+S+G+ + EL T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRN 697
            +    KIGEG  G V+K    E    VA+K + L    +G   S + E   L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 698 LIKIITVCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++++       D   +D K  +V+EF  +  L+++    N  L+     +++  +    +
Sbjct: 63  IVRL------HDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDP---EIVK--SFLFQL 110
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H     +++H DLKP N+L++++    +++FGLA+          +  R  S 
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-------IPVRCYSA 160
Query: 817 GIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRP 857
            +  T+ Y  P+   G +  S   D++S G +  EL    RP
Sbjct: 161 EV-VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 150
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMX--- 200
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 201 ----GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D +    ++G G  G+V++      G     K IN        +   E   +  + H  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           I +        F+      ++ EF+  G L + +  + +  ++    VI  +        
Sbjct: 111 INLHDA-----FEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMR------Q 157
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIVETRSISI 816
           A E L H  E SIVH D+KP N++ +    S V   DFGLA  L   NPD IV+  +   
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTT--- 211
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
               T  + APE           D+++ G+L
Sbjct: 212 ---ATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI---NLKQKGASKSFVAECKALRNIR 694
           +D +    K+G G  G V        G E A+K+I   ++     S + + E   L+ + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K+        F+      +V E  + G L + +       EV +  ++++     
Sbjct: 63  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ----- 112
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIVET 811
            V S   YLH +   +IVH DLKP N+LL+   +D +  + DFG    LS H        
Sbjct: 113 -VLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFG----LSAH-------- 156
Query: 812 RSISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILL 848
               +G K     GT  Y+APE  + ++   K DV+S G++L
Sbjct: 157 --FEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHRN 697
           + +   +K+GEG    VYKG        VA+K I L+ ++GA  + + E   L++++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ +  +             +V+E++ +  L+++L       + C  ++I   N+ + + 
Sbjct: 62  IVTLHDIIHTEKSL-----TLVFEYL-DKDLKQYL-------DDCG-NIINMHNVKLFLF 107
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             +  L +     ++H DLKP N+L+++     ++DFGLA+  S       + T++    
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS-------IPTKTYDNE 160
Query: 818 IKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
           +  T+ Y  P+  +G  + S + D++  G +  E+ T
Sbjct: 161 V-VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V +     LG+    + V V  LK    +   ++ ++E K + +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV--------CS 743
           + +H N++ ++  C+     G     ++ E+   G L  +L   +  LE          +
Sbjct: 106 LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           LS    L+ +  VA  + +L      + +H D+   NVLL    V+ + DFGLA+ + N 
Sbjct: 161 LSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN- 216
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + + IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 217 DSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 70  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 118
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 170
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 171 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 227 NVSAVNYEFEDEYFSNTS 244

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 48/211 (22%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGA---SKSFVAECKALRNIRHRNLIKII 702
           +GEG  G VY+G +    G ++ V V   K+       + F++E   ++N+ H +++K+I
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +         +   I+ E    G L  +L  + + L+V +L +      ++ +  A+ Y
Sbjct: 92  GIIE------EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKAMAY 140
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L      + VH D+   N+L+       + DFGL++++ + +      TR   + IK   
Sbjct: 141 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR---LPIK--- 191
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +++PE    R  +   DV+ F + + E+ +
Sbjct: 192 -WMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 48/211 (22%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGA---SKSFVAECKALRNIRHRNLIKII 702
           +GEG  G VY+G +    G ++ V V   K+       + F++E   ++N+ H +++K+I
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +         +   I+ E    G L  +L  + + L+V +L +      ++ +  A+ Y
Sbjct: 76  GIIE------EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKAMAY 124
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L      + VH D+   N+L+       + DFGL++++ + +      TR   + IK   
Sbjct: 125 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR---LPIK--- 175
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +++PE    R  +   DV+ F + + E+ +
Sbjct: 176 -WMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 48/211 (22%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 647 IGEGGSGIVYKG-FLGENGTEVAVKVINLKQKGA---SKSFVAECKALRNIRHRNLIKII 702
           +GEG  G VY+G +    G ++ V V   K+       + F++E   ++N+ H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +         +   I+ E    G L  +L  + + L+V +L +      ++ +  A+ Y
Sbjct: 80  GIIE------EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKAMAY 128
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           L      + VH D+   N+L+       + DFGL++++ + +      TR   + IK   
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR---LPIK--- 179
Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +++PE    R  +   DV+ F + + E+ +
Sbjct: 180 -WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 70  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 118
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 170
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 171 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 227 NVSAVNYEFEDEYFSNTS 244

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 132
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMT--- 182
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + +   +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 140
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+    H  D +    
Sbjct: 141 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--- 190
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 191 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 38/244 (15%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL 698
           +S   +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLE--EWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            KII +    D++  D    +Y  M+ G+++   WL          S+   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 164
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+  +H +    IVH DLKP+N L+   ++  + DFG+A  +    PDT    +   +
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV 217
Query: 817 GIKGTVGYVAPEYGMGREASMKG-----------DVYSFGILLLELFTRKRPTDAMFNEG 865
              G V Y+ PE      +S +            DV+S G +L  +   K P   + N+ 
Sbjct: 218 ---GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 866 LTLH 869
             LH
Sbjct: 275 SKLH 278

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + D+GLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +  + +    KIG G  G +Y G     G EVA+K+  +K K        E K  + ++ 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQG 63
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIA 753
              I  I  C        D+  +V E +   SLE       D    CS   S+   L +A
Sbjct: 64  GVGIPTIRWCGAE----GDYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLA 111
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVE 810
             + S IEY+H     + +H D+KP N L+    +  + ++ DFGLAK   +      + 
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
            R  +  + GT  Y +    +G E S + D+ S G +L+
Sbjct: 169 YRE-NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +   +F     +G+G  G V K     +    A+K I   ++  S + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNH 61
Query: 696 RNLIKIITV-CSGRDF-------KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           + +++        R+F       K      I  E+ +NG+L + +H  N   +      +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
            R      +  A+ Y+H      I+H DLKP N+ +D+     + DFGLAK  + H    
Sbjct: 122 FR-----QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK--NVHRSLD 171
Query: 808 IVETRSISI--------GIKGTVGYVAPEY--GMGREASMKGDVYSFGILLLEL 851
           I++  S ++           GT  YVA E   G G   + K D+YS GI+  E+
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEM 224

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +  + +    KIG G  G +Y G     G EVA+K+  +K K        E K  + ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQG 61
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIA 753
              I  I  C        D+  +V E +   SLE       D    CS   S+   L +A
Sbjct: 62  GVGIPTIRWCGAE----GDYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLA 109
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVE 810
             + S IEY+H     + +H D+KP N L+    +  + ++ DFGLAK   +      + 
Sbjct: 110 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
            R  +  + GT  Y +    +G E S + D+ S G +L+
Sbjct: 167 YRE-NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           +     +G G  G V     G  G +VA+K +    + +  +K    E + L+++RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V +      DF   DF  +V  FM    L + + H     +     V Q L    
Sbjct: 87  IGLLDVFTPDETLDDF--TDF-YLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLK--- 139
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + Y+H      I+H DLKP N+ +++D    + DFGLA+           +  S 
Sbjct: 140 ----GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QADSE 181
Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
             G   T  Y APE  +     +   D++S G ++ E+ T K
Sbjct: 182 MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   Y F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILILELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +  + +    KIG G  G +Y G    +G EVA+K+  +K K        E K  + ++ 
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTK--HPQLHIESKFYKMMQG 63
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIA 753
              I  I  C        D+  +V E +   SLE       D    CS   S+   L +A
Sbjct: 64  GVGIPSIKWCGAE----GDYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLA 111
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVE 810
             + S IEY+H     + +H D+KP N L+    +  + ++ DFGLAK   +      + 
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
            R  +  + GT  Y +    +G E S + D+ S G +L+
Sbjct: 169 YRE-NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK--------- 688
           +  +S+ + +G G  G V+     E   EV VK I  K+K     ++ + K         
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIA 81
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            L  + H N+IK++ +     F+   F  +V E   +G         + +L+    S I 
Sbjct: 82  ILSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
           R      + SA+ YL       I+H D+K  N+++ +D    + DFG A +L        
Sbjct: 137 R-----QLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-------- 180
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKG---DVYSFGILLLELFTRKRP 857
            E   +     GT+ Y APE  MG     +G   +++S G+ L  L   + P
Sbjct: 181 -ERGKLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 59/222 (26%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---------------------- 676
           + ++  ++IG+G  G+V   +   + T  A+KV++ K+                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 677 ----KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
               +G  +    E   L+ + H N++K++ V    D    D   +V+E +  G +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPV---- 125
Query: 733 HHSNDQLEVCSLSVIQRLNIAI---DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS 789
                 +EV +L  +          D+   IEYLH+     I+H D+KPSN+L+ +D   
Sbjct: 126 ------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHI 176
Query: 790 HVSDFGLA-------KFLSN-------HNPDTIVETRSISIG 817
            ++DFG++         LSN         P+++ ETR I  G
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSG 218

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   Y F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   Y F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E      + H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K      G   +G + + +  E+   G L + +       E  +     +L       
Sbjct: 67  VVKFY----GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------M 115
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 166
Query: 818 IKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTD 859
           + GT+ YVAPE    RE   +  DV+S GI+L  +   + P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +     D   ++ E +  G L ++L       E  SL+  +    
Sbjct: 71  IQHPNVITLHEVYENK----TDV-ILIGELVAGGELFDFL------AEKESLTEEEATEF 119
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNV-LLDQDLVS---HVSDFGLAKFLSNHNPDTI 808
              + + + YLH      I H DLKP N+ LLD+++      + DFGLA     H  D  
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFG 171
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP------TDAMF 862
            E ++I     GT  +VAPE        ++ D++S G++   L +   P       + + 
Sbjct: 172 NEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 863 NEGLTLHDFSREFFTRKS 880
           N     ++F  E+F+  S
Sbjct: 228 NVSAVNYEFEDEYFSNTS 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 24  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 74
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 75  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 126
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 127 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 182
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 183 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 52/235 (22%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSL------SVI 747
           +H N+I ++ V                 F    SLEE+    ND   V  L      +++
Sbjct: 79  KHENVIGLLDV-----------------FTPARSLEEF----NDVYLVTHLMGADLNNIV 117
Query: 748 QRLNIAID--------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           +   +  D        +   ++Y+H      I+H DLKPSN+ +++D    + DFGL + 
Sbjct: 118 KSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR- 173
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
              H  D +        G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 174 ---HTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKEIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + ++        L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFGLAK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 108
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 109 ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 164
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 165 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 210
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 211 RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 24  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 74
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 75  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 126
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R         A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 127 RIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 182
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 183 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 52  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQK---------VV 101
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 102 KLKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 154
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 155 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 210
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 211 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAEC----KALRNIR 694
           ++F     +G+G  G V+     +     A+K   LK+         EC    K + ++ 
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI-A 753
             +       C+   F+  +    V E++  G L   ++H    ++ C    + R    A
Sbjct: 76  WEHPFLTHMFCT---FQTKENLFFVMEYLNGGDL---MYH----IQSCHKFDLSRATFYA 125
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
            ++   +++LH      IV+ DLK  N+LLD+D    ++DFG+ K     N     +T  
Sbjct: 126 AEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNE 178
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  Y+APE  +G++ +   D +SFG+LL E+   + P
Sbjct: 179 FC----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKEIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + ++        L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFGLAK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 32  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 82
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 83  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 134
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 190
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 32  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 82
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 83  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 134
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 190
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 32  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 82
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + +         L 
Sbjct: 83  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR 134
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK- 190
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 73
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 74  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 129
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK          V
Sbjct: 130 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---------RV 177
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           + R+ ++   GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 178 KGRTWTLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 32  ESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 82
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   + ++        L 
Sbjct: 83  -LKQIEH-------TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR 134
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK- 190
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 35/240 (14%)
Query: 637 ATDNFS---------SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV-AE 686
           +TD+FS           + +GEG    V          E AVK+I  KQ G  +S V  E
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFRE 60
Query: 687 CKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
            + L   + HRN++++I       F+  D   +V+E M+ GS+   +H      E+ +  
Sbjct: 61  VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVS--DFGLAKFLSN 802
           V+Q      DVASA+++LH+     I H DLKP N+L +  + VS V   DF L   +  
Sbjct: 116 VVQ------DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEY--GMGREASM---KGDVYSFGILLLELFTRKRP 857
           +   + + T  + +   G+  Y+APE       EAS+   + D++S G++L  L +   P
Sbjct: 167 NGDCSPISTPEL-LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 89  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 19/141 (13%)
Query: 718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI-AIDVASAIEYLHHYCEPSIVHGDL 776
            V E++  G L   ++H    ++ C    + R    A ++   +++LH      IV+ DL
Sbjct: 95  FVMEYLNGGDL---MYH----IQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDL 144
Query: 777 KPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREAS 836
           K  N+LLD+D    ++DFG+ K     N     +T        GT  Y+APE  +G++ +
Sbjct: 145 KLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNXFC----GTPDYIAPEILLGQKYN 196
Query: 837 MKGDVYSFGILLLELFTRKRP 857
              D +SFG+LL E+   + P
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSP 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 647 IGEGGSGIVY--KGFLGEN-GTEVAVKVINLKQKGASKSFVAECKALRNI----RHRNLI 699
           +G+GG G V+  +   G N G   A+KV+       +    A  KA RNI    +H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +I       F+      ++ E++  G L   L      +E  +   +  +++A      
Sbjct: 85  DLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA------ 133
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
              L H  +  I++ DLKP N++L+      ++DFGL K          +   +++    
Sbjct: 134 ---LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--------ESIHDGTVTHXFC 182
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT+ Y+APE  M    +   D +S G L+ ++ T   P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 40/232 (17%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK 688
           +S A+ +   D F     +G G  G V      E G   A+K+++ KQK           
Sbjct: 32  ESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILD-KQKVVK-------- 82
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLS 745
            L+ I H       T+   R  +  +F  +V   + F  N +L   L ++        L 
Sbjct: 83  -LKQIEH-------TLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR 134
Query: 746 VIQRLN------IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
            I R +       A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK- 190
Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                       +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V +     LG+    + V V  LK    +   ++ ++E K + +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV--------CS 743
           + +H N++ ++  C+     G     ++ E+   G L  +L   +  LE          +
Sbjct: 106 LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
            S    L+ +  VA  + +L      + +H D+   NVLL    V+ + DFGLA+ + N 
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN- 216
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           + + IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 217 DSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 647 IGEGGSGIVY--KGFLGEN-GTEVAVKVINLKQKGASKSFVAECKALRNI----RHRNLI 699
           +G+GG G V+  +   G N G   A+KV+       +    A  KA RNI    +H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            +I       F+      ++ E++  G L   L      +E  +   +  +++A      
Sbjct: 85  DLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA------ 133
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
              L H  +  I++ DLKP N++L+      ++DFGL K          +   +++    
Sbjct: 134 ---LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--------ESIHDGTVTHTFC 182
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT+ Y+APE  M    +   D +S G L+ ++ T   P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 82
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 83  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 138
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 139 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 184
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 185 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           ++ +  VA  +E+L        +H DL   N+LL ++ V  + DFGLA+ +   NPD + 
Sbjct: 202 ISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK-NPDYVR 257
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +  +     +  + ++APE    +  S K DV+S+G+LL E+F+
Sbjct: 258 KGDT-----RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIIT 703
             KIG GG G++Y  F      + A  V+ ++ +     F +E K  + +  ++ IK   
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWI 100
Query: 704 VCSGRDFKG---------ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
                D+ G          +FK   Y FM    L   L   + Q      S +  L + I
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV--LQLGI 158
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLA-KFLSNHNPDTIVE 810
            +   +EY+H   E   VHGD+K +N+LL   + D V +++D+GL+ ++  N N     E
Sbjct: 159 RMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQYQE 214
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
             +   G  GT+ + + +   G   S + DV   G  +L     K P +
Sbjct: 215 --NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQK---------VVKLKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 89  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK          V
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---------RV 192
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           + R+ ++   GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 193 KGRTWTLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     IG G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI--RHRNLIKIITV 704
           +G+G  G V++G    +G  VAVK+ + + +   +S+  E +    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGLW--HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA- 69
Query: 705 CSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
            S    + +  +  ++  + ++GSL ++L          +L     L +A+  A  + +L
Sbjct: 70  -SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ-------TLEPHLALRLAVSAACGLAHL 121
Query: 764 H-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           H        +P+I H D K  NVL+  +L   ++D GLA  + +   D +    +  +G 
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGT 180
Query: 819 KGTVGYVAPEYGMGR------EASMKGDVYSFGILLLELFTR 854
           K    Y+APE    +      E+    D+++FG++L E+  R
Sbjct: 181 K---RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + ++        L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + DF    +L+ H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF----YLARHTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 89  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    +  FGLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     IG G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 108
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 109 ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 164
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 165 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 210
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 211 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 23/237 (9%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN 692
           E  +     +   ++G G  G V++    + G + AVK + L+     +  +  C  L +
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSS 109
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            R   L   +        +   +  I  E ++ GSL + +       ++  L   + L  
Sbjct: 110 PRIVPLYGAV--------REGPWVNIFMELLEGGSLGQLIK------QMGCLPEDRALYY 155
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVET 811
                  +EYLH      I+HGD+K  NVLL  D   + + DFG A  L    PD + ++
Sbjct: 156 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKS 209
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
                 I GT  ++APE  MG+    K D++S   ++L +     P    F   L L
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     IG G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V +     LG+    + V V  LK    +   ++ ++E K + +
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN----DQLEVCSLSVI 747
           + +H N++ ++  C+     G     ++ E+   G L  +L        D+ +   L + 
Sbjct: 98  LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 152
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
             L+ +  VA  + +L      + +H D+   NVLL    V+ + DFGLA+ + N + + 
Sbjct: 153 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNY 208
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 209 IVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 9/110 (8%)
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 245
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 246 DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 9/110 (8%)
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 243
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 244 DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 74
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 75  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 130
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+D+     V+DFG AK           
Sbjct: 131 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAK----------- 176
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 177 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 218

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + ++        L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + D GLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + D GLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 23/237 (9%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN 692
           E  +     +   ++G G  G V++    + G + AVK + L +    +  VA C  L +
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-EVFRVEELVA-CAGLSS 125
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            R   L   +        +   +  I  E ++ GSL + +       ++  L   + L  
Sbjct: 126 PRIVPLYGAV--------REGPWVNIFMELLEGGSLGQLIK------QMGCLPEDRALYY 171
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVET 811
                  +EYLH      I+HGD+K  NVLL  D   + + DFG A  L    PD + ++
Sbjct: 172 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKS 225
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
                 I GT  ++APE  MG+    K D++S   ++L +     P    F   L L
Sbjct: 226 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 9/110 (8%)
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 250
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 251 DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 29/224 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           TD +     IG G   +  +        E AVK+I+  ++  ++        LR  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I +  V     +    +  +V E  + G L + +      L     S  +   +   + 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELXKGGELLDKI------LRQKFFSEREASAVLFTIT 126
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS----HVSDFGLAKFLSNHNPDTIVETRS 813
             +EYLH      +VH DLKPSN+L   +  +     + DFG AK L   N   ++ T  
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLXTPC 181
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  T  +VAPE    +      D++S G+LL    T   P
Sbjct: 182 Y------TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 639 DNFSSANKIGEGGSGIVYK----GFLGENGT-EVAVKVINLKQKGASK-SFVAECKALRN 692
           +N      +G G  G V +    G   E+   +VAVK++        K + ++E K + +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN----DQLEVCSLSVI 747
           + +H N++ ++  C+     G     ++ E+   G L  +L        D+ +   L + 
Sbjct: 106 LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 160
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
             L+ +  VA  + +L      + +H D+   NVLL    V+ + DFGLA+ + N + + 
Sbjct: 161 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNY 216
Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 217 IVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 23/237 (9%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN 692
           E  +     +   ++G G  G V++    + G + AVK + L+     +  +  C  L +
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSS 123
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            R   L   +        +   +  I  E ++ GSL + +       ++  L   + L  
Sbjct: 124 PRIVPLYGAV--------REGPWVNIFMELLEGGSLGQLIK------QMGCLPEDRALYY 169
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVET 811
                  +EYLH      I+HGD+K  NVLL  D   + + DFG A  L    PD + ++
Sbjct: 170 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKS 223
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
                 I GT  ++APE  MG+    K D++S   ++L +     P    F   L L
Sbjct: 224 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 9/110 (8%)
Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +   
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 252
Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +PD + +  +     +  + ++APE    R  +++ DV+SFG+LL E+F+
Sbjct: 253 DPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLXQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 89  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLXQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + ++        L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R      
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRNIRHR 696
            D+     ++G G  G+V K     +G   AVK I         K  + +     +I  R
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDL----DISXR 88
Query: 697 NLIKIITVCSGRDFKGADFK---AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
            +    TV     F GA F+     +   + + SL+++     D+ +     ++ +  IA
Sbjct: 89  TVDCPFTVT----FYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK--IA 142
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           + +  A+E+LH     S++H D+KPSNVL++        DFG++ +L +         + 
Sbjct: 143 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV------AKD 194
Query: 814 ISIGIKGTVGYVAPEY---GMGREA-SMKGDVYSFGILLLELFTRKRPTDA 860
           I  G K    Y APE     + ++  S+K D++S GI  +EL   + P D+
Sbjct: 195 IDAGCK---PYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS 242

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 30/234 (12%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +   +F     +G+G  G V K     +    A+K I   ++  S + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNH 61
Query: 696 RNLIKIITV-CSGRDF-------KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           + +++        R+F       K      I  E+ +N +L + +H  N   +      +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
            R      +  A+ Y+H      I+H DLKP N+ +D+     + DFGLAK  + H    
Sbjct: 122 FR-----QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK--NVHRSLD 171
Query: 808 IVETRSISI--------GIKGTVGYVAPEY--GMGREASMKGDVYSFGILLLEL 851
           I++  S ++           GT  YVA E   G G   + K D+YS GI+  E+
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEM 224

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ ++
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQM 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVK---------LKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEM 231

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHR 696
           DN+   + IG G  G VY  +       VA+K +N   +     K  + E   L  ++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            +I++  +    D    D   IV E + +  L++             L+      I  ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTP------IFLTEEHIKTILYNL 138
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV------- 809
                ++H   E  I+H DLKP+N LL+QD    V DFGLA+ +++     IV       
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 810 ----ETRSISIGIKGTV---GYVAPEYGMGREASMKG-DVYSFGILLLELF 852
                 +++   +   V    Y APE  + +E   K  D++S G +  EL 
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           +  + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L+++
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 694 RHRNLIKIITVCS-GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           +H N+I ++ V +  R  +  +   +V   M    L       N+ ++   L+      +
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQFL 130
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
              +   ++Y+H      I+H DLKPSN+ +++D    + D GLA+    H  D +    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMT--- 180
Query: 813 SISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFT 853
               G   T  Y APE  +     +   D++S G ++ EL T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 79  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLXQVIQMELDH-ERMSYLLYQML---- 129
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 130 ---XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---------TAGTSFM 174
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVC 705
           + EGG   VY+     +G E A+K +   ++  +++ + E   ++ +  H N+++  +  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 706 S-GR---DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           S G+   D   A+F  ++   +  G L E+L     +     LS    L I      A++
Sbjct: 96  SIGKEESDTGQAEF--LLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQ 150
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT--IVETRSI---SI 816
           ++H   +P I+H DLK  N+LL       + DFG A  +S H PD     + R++    I
Sbjct: 151 HMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS-HYPDYSWSAQRRALVEEEI 208
Query: 817 GIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
               T  Y  PE       + +G     K D+++ G +L  L  R+ P    F +G  L 
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGE----KQDIWALGCILYLLCFRQHP----FEDGAKLR 260
Query: 870 DFSREFFTRKSDTD 883
             + ++     DT 
Sbjct: 261 IVNGKYSIPPHDTQ 274

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLXQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 91/400 (22%), Positives = 158/400 (39%), Gaps = 54/400 (13%)
Query: 16  QRVTRLDLGNQSIRG-TLSPYVGNLSFLRYINIASNGFNGEIPHQIGRL--ISLERLILS 72
           + +TRLDL    IR   L P  G L+ L+ I+ +SN       H++  L   +L    L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 73  NNSFSGAIPANLSSCSN------LIELSADSNNLVGEIPADIG-SLFKLERLS-IFQNHI 124
            NS    +  +   C N      L  L    N    +I  +   ++ K +  S I  +HI
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 125 TGQLPASIG---------------NLSSLRVIDVRENRLWGRIDSLGQ-----LKSLTLL 164
            G   A  G                 SS+R +D+      G + SL       LK L +L
Sbjct: 243 MG---AGFGFHNIKDPDQNTFAGLARSSVRHLDLSH----GFVFSLNSRVFETLKDLKVL 295
Query: 165 SVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFI 224
           ++A+N+ + +   + + + +L+V++LS N   G L       LP +  +    N+     
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYN-LLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354
Query: 225 PVSLSNASSLEMIEFSKNQFSG--------GVSVDFSRLKNLYWLNLGIN--NLGTGAAN 274
             +      L+ ++   N  +          + +  ++L  L  +NL  N  +L      
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
Query: 275 ELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI--- 331
            LD +  L     L+ L  N+NRF         + + +++Q+ +G N +      E+   
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 332 --RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRN 369
               L+ L  L ++ N L    P     LT L+ L L+ N
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIR 694
           + F     +G+G  G V        G   A+K++  K+   +K  VA    E + L+N R
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSR 206
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  L  +        F+  D    V E+   G L  + H S +++     S  +      
Sbjct: 207 HPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGA 255
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++ SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K       + I +  ++
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATM 306
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 307 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 148
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA  +         E + +
Sbjct: 149 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKV 200
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              + GT  Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 201 ---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 635 SKATDN-FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKA 689
           S+ T N F     +G+G  G V        G   A+K++  K+   +K  VA    E + 
Sbjct: 3   SRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRV 61
Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           L+N RH  L  +        F+  D    V E+   G L  + H S +++     S  + 
Sbjct: 62  LQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRA 110
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
                ++ SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K       + I 
Sbjct: 111 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK 161
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +  ++     GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 162 DGATMKX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 64/151 (42%), Gaps = 23/151 (15%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  DF  +V E  +  SL E LH     +         R  I       ++YLH+    
Sbjct: 95  FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 145
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLA---KFLSNHNPDTIVETRSISIGIKGTVGYVA 826
            ++H DLK  N+ L+ D+   + DFGLA   +F      D           + GT  Y+A
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD-----------LCGTPNYIA 194
Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           PE    +  S + D++S G +L  L   K P
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 93  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 146
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA  +         E + +
Sbjct: 147 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKV 198
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              + GT  Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 199 ---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 80  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 130
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 131 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 175
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIR 694
           + F     +G+G  G V        G   A+K++  K+   +K  VA    E + L+N R
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSR 209
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  L  +        F+  D    V E+   G L  + H S +++     S  +      
Sbjct: 210 HPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGA 258
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++ SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K       + I +  ++
Sbjct: 259 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATM 309
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 310 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +    + F  N +L   + ++        L  I R +    
Sbjct: 89  ----TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +    + F  N +L   + ++        L  I R +    
Sbjct: 89  ----TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 79  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 129
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 130 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 174
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 80  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 130
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 131 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 175
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 634 LSKATDN-FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECK 688
           +++ T N F     +G+G  G V        G   A+K++  K+   +K  VA    E +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENR 61
Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            L+N RH  L  +        F+  D    V E+   G L  + H S +++     S  +
Sbjct: 62  VLQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDR 110
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                 ++ SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K       + I
Sbjct: 111 ARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGI 161
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            +  ++     GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 162 KDGATMKX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRH 695
            F     +G+G  G V        G   A+K++  K+   +K  VA    E + L+N RH
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             L  +        F+  D    V E+   G L  + H S +++     S  +      +
Sbjct: 70  PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 118
Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + SA++YLH   E ++V+ DLK  N++LD+D    ++DFGL K       + I +  ++ 
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMK 169
Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 170 X-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 696 RNLIKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +N+I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   I++LH      I+H DLKPSN+++  D    + DFGLA+            T
Sbjct: 137 ------VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGT 178
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +      T  Y APE  +G       D++S G+++ E+
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 87  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 137
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 138 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 182
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 64/151 (42%), Gaps = 23/151 (15%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  DF  +V E  +  SL E LH     +         R  I       ++YLH+    
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLA---KFLSNHNPDTIVETRSISIGIKGTVGYVA 826
            ++H DLK  N+ L+ D+   + DFGLA   +F      D           + GT  Y+A
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD-----------LCGTPNYIA 210
Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           PE    +  S + D++S G +L  L   K P
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L    
Sbjct: 86  IGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                 T  Y APE  +G       D++S G+++ E+
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKII 702
            ++G+G   +V +      G E A K+IN K+  A   +    E +  R ++H N++++ 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              S    +G  +  ++++ +  G L E         ++ +       + +  +   +E 
Sbjct: 88  DSISE---EGHHY--LIFDLVTGGELFE---------DIVAREYYSEADASHCIQQILEA 133
Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDL---VSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           + H  +  +VH DLKP N+LL   L      ++DFGLA  +           +    G  
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG--------EQQAWFGFA 185
Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT GY++PE           D+++ G++L  L     P
Sbjct: 186 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 17/166 (10%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 122
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA  +         E + +
Sbjct: 123 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKV 174
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              + GT  Y+APE    +  S + DV+S G ++  L   K P + 
Sbjct: 175 ---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+AP   + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 66  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K       + I +  ++  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKT 164
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    +LEE+       +E+   ++ Q + + +D   
Sbjct: 124 ISLLNV-----------------FTPQKTLEEF-QDVYLVMELMDANLCQVIQMELDHER 165
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 166 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 213
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
             T  +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 638 TDNFS-SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR 696
           TD++  S   +G G +G V + F    G + A+K++               KA + + H 
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----------YDSPKARQEVDHH 75
Query: 697 -------NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
                  +++ I+ V       G     I+ E M+ G L   +    DQ    + +  + 
Sbjct: 76  WQASGGPHIVCILDVYENM-HHGKRCLLIIMECMEGGELFSRIQERGDQ----AFTEREA 130
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
             I  D+ +AI++LH +   +I H D+KP N+L    ++D V  ++DFG AK  + +   
Sbjct: 131 AEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           T   T            YVAPE     +     D++S G+++
Sbjct: 188 TPCYTPY----------YVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 85  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 135
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 136 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 180
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 86  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 136
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 137 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 181
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE---T 811
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA         T VE    
Sbjct: 125 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGE 172
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           R  ++   GT  Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 173 RKKTLC--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 69  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 117
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K       + I +  ++  
Sbjct: 118 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKT 167
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 168 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 66  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K               IS 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISD 158
Query: 817 GIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G       GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 75  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 128
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE---T 811
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA         T VE    
Sbjct: 129 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGE 176
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           R  ++   GT  Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 177 RKKTLC--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 699 IKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           I ++ V + +    +F+      +V E M + +L + +    D  E  S  + Q L    
Sbjct: 87  ISLLNVFTPQKTLEEFQDV---YLVMELM-DANLCQVIQMELDH-ERMSYLLYQML---- 137
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                I++LH      I+H DLKPSN+++  D    + DFGLA+            T  +
Sbjct: 138 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM 182
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
                 T  Y APE  +G       D++S G ++ E+   K
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           HR+L     V     F+  DF  +V E  +  SL E LH     L         R     
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR----- 124
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE---T 811
            +    +YLH      ++H DLK  N+ L++DL   + DFGLA         T VE    
Sbjct: 125 QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGE 172
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           R  ++   GT  Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 173 RKKTLC--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 66  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K               IS 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISD 158
Query: 817 GIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G       GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 86  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 127
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+         +
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFM 181
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           +E   +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MEPEVV------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 66  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K       + I +  ++  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKT 164
Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E G   A+K+++ KQK            L+ I H   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-KQKVVK---------LKQIEH--- 88
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +    + F  N +L   + ++        L  I R      
Sbjct: 89  ----TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA 144
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+++DQ     V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 190
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT  Y+APE  + +  +   D ++ G+L+ E+
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 19/174 (10%)
Query: 686 ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
           E + LR +RH+N+I+++ V    + +      +V E+   G ++E L    D +      
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCG-MQEML----DSVPEKRFP 107
Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           V Q       +   +EYLH      IVH D+KP N+LL       +S  G+A+ L     
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGRE--ASMKGDVYSFGILLLELFTRKRP 857
           D    T       +G+  +  PE   G +  +  K D++S G+ L  + T   P
Sbjct: 165 DDTCRTS------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 66  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 114
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K               IS 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISD 158
Query: 817 GIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G       GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 159 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 638 TDNFS-SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR 696
           TD++  S   +G G +G V + F    G           QK A K      KA + + H 
Sbjct: 8   TDDYQLSKQVLGLGVNGKVLECFHRRTG-----------QKCALKLLYDSPKARQEVDHH 56
Query: 697 -------NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
                  +++ I+ V       G     I+ E M+ G L   +    DQ    + +  + 
Sbjct: 57  WQASGGPHIVCILDVYENM-HHGKRCLLIIMECMEGGELFSRIQERGDQ----AFTEREA 111
Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD 806
             I  D+ +AI++LH +   +I H D+KP N+L    ++D V  ++DFG AK  + +   
Sbjct: 112 AEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 168
Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
           T   T            YVAPE     +     D++S G+++
Sbjct: 169 TPCYTPY----------YVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 48/226 (21%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           +N+I ++ V                 F    SLEE+       +E+   ++ Q + + +D
Sbjct: 85  KNIIGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELD 126
Query: 756 ----------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
                     +   I++LH      I+H DLKPSN+++  D    + DFGLA+       
Sbjct: 127 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------- 176
Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                T  + +    T  Y APE  +G       D++S G ++ E+
Sbjct: 177 --TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHR 696
           +F     +G+G  G V        G   A+K++  +    K      V E + L+N RH 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
            L  +        F+  D    V E+   G L  + H S +++     +  +      ++
Sbjct: 71  FLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEI 119
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            SA+EYLH      +V+ D+K  N++LD+D    ++DFGL K               IS 
Sbjct: 120 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISD 163
Query: 817 GIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           G       GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 164 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  D    V E++  G L   ++H     +V      Q +  A +++  + +LH   + 
Sbjct: 89  FQTVDRLYFVMEYVNGGDL---MYHIQ---QVGKFKEPQAVFYAAEISIGLFFLH---KR 139
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            I++ DLK  NV+LD +    ++DFG+ K    H  D +  TR       GT  Y+APE 
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVT-TREFC----GTPDYIAPEI 191
Query: 830 GMGREASMKGDVYSFGILLLELFTRKRPTDA 860
              +      D +++G+LL E+   + P D 
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    +LEE+       +E+   ++ Q + + +D   
Sbjct: 124 ISLLNV-----------------FTPQKTLEEF-QDVYLVMELMDANLCQVIQMELDHER 165
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 166 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 213
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
             T  +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRN 697
            + S   +G G  G V       +G +VA+K ++   + +  +K    E   L++++H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 698 LIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +I ++ V     S R+F   DF  +V  FMQ   L++ +     + ++  L V Q L   
Sbjct: 103 VIGLLDVFTPASSLRNF--YDF-YLVMPFMQT-DLQKIMGMEFSEEKIQYL-VYQMLK-- 155
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
                 ++Y+H      +VH DLKP N+ +++D    + DFGLA+         +V    
Sbjct: 156 -----GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---- 203
Query: 814 ISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                  T  Y APE  +     +   D++S G ++ E+ T K
Sbjct: 204 -------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 23/151 (15%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  DF  +V E  +  SL E LH     +         R  I       ++YLH+    
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE---TRSISIGIKGTVGYVA 826
            ++H DLK  N+ L+ D+   + DFGLA         T +E    R  ++   GT  Y+A
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA---------TKIEFDGERKKTLC--GTPNYIA 210
Query: 827 PEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           PE    +  S + D++S G +L  L   K P
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNI 693
           K  DN+   + IG G  G VY  +       VA+K +N   +     K  + E   L  +
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +   +I++  +    D    D   IV E + +  L++             L+      I 
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTP------IFLTEQHVKTIL 137
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
            ++    +++H   E  I+H DLKP+N LL+QD    + DFGLA+
Sbjct: 138 YNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 41/237 (17%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V +     LG+    + V V  LK    +   ++ ++E K + +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL---------------HHSN 736
           + +H N++ ++  C+     G     ++ E+   G L  +L               H+  
Sbjct: 106 LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPE 160
Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL 796
           +QL    L     L+ +  VA  + +L      + +H D+   NVLL    V+ + DFGL
Sbjct: 161 EQLSSRDL-----LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           A+ + N + + IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 213 ARDIMN-DSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 39/253 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--NLKQKGASKSFVAECKALRNIRHR 696
           D +   + IG G  G V + +       VA+K I    +     K  + E   L  + H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           +++K++ +   +D +  D   +V E + +   ++             L+ +    +  ++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTP------VYLTELHIKTLLYNL 165
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL---------------- 800
              ++Y+H      I+H DLKP+N L++QD    V DFGLA+ +                
Sbjct: 166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 801 SNHNPDTIVETRSISIGIKGTV---GYVAPEYGMGREASMKG-DVYSFGILLLELFTRKR 856
            + N  T   T+++   + G V    Y APE  + +E   +  DV+S G +  EL     
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN--- 279
Query: 857 PTDAMFNEGLTLH 869
               M  E +  H
Sbjct: 280 ----MIKENVAYH 288

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 36/233 (15%)
Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR 696
             ++     +IG G  G V K     +G  +AVK I        +S V E +  + +   
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--------RSTVDEKEQKQLLMDL 71
Query: 697 NLIKIITVCSG-RDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLE-VCSLSVIQRL 750
           +++   + C     F GA F+     I  E M   S +++  +    L+ V    ++ ++
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 751 NIAIDVASAIEYLHHYCEP-SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
            +A      ++ L+H  E   I+H D+KPSN+LLD+     + DFG++  L     D+I 
Sbjct: 131 TLA-----TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV----DSIA 181
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKG-----DVYSFGILLLELFTRKRP 857
           +TR       G   Y+APE  +   AS +G     DV+S GI L EL T + P
Sbjct: 182 KTRD-----AGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +D +     IG G      +        E AVKVI+  ++  S+        LR  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I +  V     +       +V E M+ G L + +      L     S  +   +   + 
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGELLDKI------LRQKFFSEREASFVLHTIG 131
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVL-LDQD---LVSHVSDFGLAKFLSNHNPDTIVETRS 813
             +EYLH      +VH DLKPSN+L +D+        + DFG AK L   N         
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN--------G 180
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTDAMFNEGLTLHDFS 872
           + +    T  +VAPE  + R+   +G D++S GILL  +     P    F  G +  D  
Sbjct: 181 LLMTPCYTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYTP----FANGPS--DTP 233
Query: 873 REFFTR 878
            E  TR
Sbjct: 234 EEILTR 239

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D++    K+G G    V++     N  +V VK++   +K   K    E K L N+R    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLR--GG 91
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
             IIT+        +   A+V+E + N   +        QL         R  +  ++  
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFK--------QLYQTLTDYDIRFYM-YEILK 142
Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVETRSISIG 817
           A++Y H      I+H D+KP NV++D +     + D+GLA+F   ++P      R  S  
Sbjct: 143 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRY 196
Query: 818 IKGT---VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            KG    V Y   +Y +        D++S G +L  +  RK P
Sbjct: 197 FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP 231

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           + +++ A+ YLH   E  I++ DLK  NVLLD +    ++D+G+ K      P     T 
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTST- 212
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
                  GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 213 -----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 37/225 (16%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRN 697
            + S   +G G  G V       +G +VA+K ++   + +  +K    E   L++++H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 698 LIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEW--LHHSNDQLEVCSLSVIQRLN 751
           +I ++ V     S R+F   DF  +V  FMQ   L++   L  S ++++     +++   
Sbjct: 85  VIGLLDVFTPASSLRNF--YDF-YLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--- 137
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   ++Y+H      +VH DLKP N+ +++D    + DFGLA+         +V  
Sbjct: 138 -------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 185
Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                    T  Y APE  +     +   D++S G ++ E+ T K
Sbjct: 186 ---------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 91  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 132
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 133 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 180
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
             T  +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 181 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 86  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 127
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+         +
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFM 181
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           +E   +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 182 MEPEVV------TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLI 699
           F     +G G  G VYKG   + G   A+KV+++      +    E   L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 700 KIITVCSGRDFKGADFK-AIVYEFMQNGSLEEWLHHSN-DQLEVCSLSVIQRLNIAIDVA 757
                   ++  G D +  +V EF   GS+ + + ++  + L+   ++ I R     ++ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 139
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
             + +LH +    ++H D+K  NVLL ++    + DFG++  L     D  V  R+  I 
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFI- 190
Query: 818 IKGTVGYVAPEYGMGRE-----ASMKGDVYSFGILLLEL 851
             GT  ++APE     E        K D++S GI  +E+
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRN 692
           ++ T+ +    ++G+G   +V +      G E A  +IN K+  A   +    E +  R 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N++++    S    +G  +  ++++ +  G L E         ++ +       + 
Sbjct: 67  LKHPNIVRLHDSISE---EGHHY--LIFDLVTGGELFE---------DIVAREYYSEADA 112
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL---VSHVSDFGLAKFLSNHNPDTIV 809
           +  +   +E + H  +  +VH +LKP N+LL   L      ++DFGLA  +         
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG------- 165
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             +    G  GT GY++PE           D+++ G++L  L     P
Sbjct: 166 -EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 696 RNLIKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +N+I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   I++LH      I+H DLKPSN+++  D    + DFGLA+            T
Sbjct: 137 ------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGT 178
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +      T  Y APE  +G       D++S G ++ E+
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +D +     IG G      +        E AVKVI+  ++  S+        LR  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I +  V     +       +V E M+ G L + +      L     S  +   +   + 
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGELLDKI------LRQKFFSEREASFVLHTIG 131
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVL-LDQD---LVSHVSDFGLAKFLSNHNPDTIVETRS 813
             +EYLH      +VH DLKPSN+L +D+        + DFG AK L   N         
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN--------G 180
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRKRPTDAMFNEGLTLHDFS 872
           + +    T  +VAPE  + R+   +G D++S GILL  +     P    F  G +  D  
Sbjct: 181 LLMTPCYTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYTP----FANGPS--DTP 233
Query: 873 REFFTR 878
            E  TR
Sbjct: 234 EEILTR 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 64/148 (43%), Gaps = 17/148 (11%)
Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEP 769
           F+  DF  +V E  +  SL E LH     +         R  I       ++YLH+    
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 770 SIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
            ++H DLK  N+ L+ D+   + DFGLA  +         E +     + GT  Y+APE 
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-----ERKKX---LCGTPNYIAPEV 213
Query: 830 GMGREASMKGDVYSFGILLLELFTRKRP 857
              +  S + D++S G +L  L   K P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 80  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 121
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 122 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 169
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
             T  +      T  Y APE  +G       D++S G ++ E+   K
Sbjct: 170 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR---NLIKIIT 703
           IG+G  G V K +  +    VA+K++   +K   +    E + L ++R +   N + +I 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +     F+  +   + +E + + +L E +    ++ +  SL ++++   A  +   ++ L
Sbjct: 164 MLENFTFR--NHICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVS--HVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           H   +  I+H DLKP N+LL Q   S   V DFG           +  E + +   I+  
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRVYTXIQSR 263
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             Y APE  +G    M  D++S G +L EL T
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR---NLIKIIT 703
           IG+G  G V K +  +    VA+K++   +K   +    E + L ++R +   N + +I 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +     F+  +   + +E + + +L E +    ++ +  SL ++++   A  +   ++ L
Sbjct: 164 MLENFTFR--NHICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVS--HVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           H   +  I+H DLKP N+LL Q   S   V DFG           +  E + +   I+  
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRVYTXIQSR 263
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             Y APE  +G    M  D++S G +L EL T
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D F     +G G  G V      E+G   A+K+++ KQK            L+ I H   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQK---------VVKLKQIEH--- 87
Query: 699 IKIITVCSGRDFKGADFKAIV---YEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN---- 751
               T+   R  +  +F  +V   + F  N +L   + +         L  I R +    
Sbjct: 88  ----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 752 --IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
              A  +    EYLH      +++ DLKP N+L+DQ     V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +  +  + GT   +APE  + +  +   D ++ G+L+ E+
Sbjct: 190 RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 86  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 127
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH---NP 805
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+         P
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
           + +            T  Y APE  +G       D++S G ++ E+
Sbjct: 185 EVV------------TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 696 RNLIKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +N+I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   I++LH      I+H DLKPSN+++  D    + DFGLA+            T
Sbjct: 137 ------CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGT 178
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +      T  Y APE  +G       D++S G ++ E+
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           + F    KIG G  G +Y G   +   EVA+K+ N+K K      + E K  R ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--LSVIQRLNIAIDV 756
           I  +           D+  +V + +   SLE       D    CS  LS+   L +A  +
Sbjct: 65  IPNVRWFGVE----GDYNVLVMDLL-GPSLE-------DLFNFCSRKLSLKTVLMLADQM 112
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS---HVSDFGLAKFLSNHNPDTIVETRS 813
            + +E++H     S +H D+KP N L+     +   ++ DFGLAK   + +    +  R 
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
            +  + GT  Y +    +G E S + D+ S G +L+
Sbjct: 170 -NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 640 NFSSANKIGEGGSG-IVYKGFLGENGTEVAVKVINLKQKGASKSFV-AECKALR-NIRHR 696
           +F   + +G G  G IVY+G    +  +VAVK I         SF   E + LR +  H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRI----LPECFSFADREVQLLRESDEHP 78
Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I+    C+ +D +   F+ I  E     +L+E++    +Q +   L  ++ + +    
Sbjct: 79  NVIRYF--CTEKDRQ---FQYIAIELCA-ATLQEYV----EQKDFAHLG-LEPITLLQQT 127
Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----DLVSHVSDFGLAKFLSNHNPDTIVET 811
            S + +LH     +IVH DLKP N+L+        + + +SDFGL K L+       V  
Sbjct: 128 TSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-------VGR 177
Query: 812 RSIS--IGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
            S S   G+ GT G++APE  M  E   +   Y+  I 
Sbjct: 178 HSFSRRSGVPGTEGWIAPE--MLSEDCKENPTYTVDIF 213

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 696 RNLIKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +N+I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   I++LH      I+H DLKPSN+++  D    + DFGLA+            T
Sbjct: 137 ------CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGT 178
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +      T  Y APE  +G       D++S G ++ E+
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIITV 704
           IG+G  G VY G       EVA+++I++++      K+F  E  A R  RH N++  +  
Sbjct: 41  IGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
           C           AI+    +  +L     +S  +     L V +   IA ++   + YLH
Sbjct: 98  CM-----SPPHLAIITSLCKGRTL-----YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET--RSISIGIK-GT 821
                 I+H DLK  NV  D   V  ++DFGL           +++   R   + I+ G 
Sbjct: 148 ---AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSI------SGVLQAGRREDKLRIQNGW 197
Query: 822 VGYVAPEYGMGREA-----------SMKGDVYSFGILLLELFTRKRP 857
           + ++APE  + R+            S   DV++ G +  EL  R+ P
Sbjct: 198 LCHLAPE--IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 107/239 (44%), Gaps = 38/239 (15%)
Query: 639 DNFSSANKIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS---KSFVAECKALRN 692
           +N      +G G  G V +     LG+    + V V  LK    +   ++ ++E K + +
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR-- 749
           + +H N++ ++  C+     G     ++ E+   G L  +L    + +   SL+  Q   
Sbjct: 91  LGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE 145
Query: 750 ---------------LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF 794
                          L+ +  VA  + +L      + +H D+   NVLL    V+ + DF
Sbjct: 146 GLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           GLA+ + N + + IV+  +     +  V ++APE       +++ DV+S+GILL E+F+
Sbjct: 203 GLARDIMN-DSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNI-RHRNLIKI 701
           A   G+      Y     +    VAVK++        + + ++E K L  +  H N++ +
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------------VIQ 748
           +  C+     G     ++ E+   G L  +L    D   +CS +             +  
Sbjct: 116 LGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELALDLED 169
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N + + +
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN-DSNYV 225
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V+  +     +  V ++APE       + + DV+S+GI L ELF+
Sbjct: 226 VKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 80/337 (23%), Positives = 140/337 (41%), Gaps = 49/337 (14%)
Query: 67  ERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITG 126
           +R +L +     A+P  + + + L++L  +    + +   +  S   LE L + +N ++ 
Sbjct: 13  DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ--DEFASFPHLEELELNENIVSA 70
Query: 127 QLPASIGNLSSLRVIDVRENRLWGRIDSLGQ---LKSLTLLSVAFNQFSGMIP---PSIF 180
             P +  NL +LR + +R NRL  ++  LG    L +LT L ++ N+   ++      ++
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRL--KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 181 NISSLEV-----ISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLE 235
           N+ SLEV     + +S   F+G         L SL +L     N T     +LS+   L 
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSG---------LNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 236 MIEFSKNQFSGGVSVDFSRLKNLYWLNLG-INNLGTGAANELDFINL----LTNCS---- 286
           ++       +      F RL  L  L +     L T   N L  +NL    +T+C+    
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239
Query: 287 ---KLERLYFNR---------NRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNL 334
               +  L + R         +  EG + H +  L    ++I +   +++   P   R L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL----QEIQLVGGQLAVVEPYAFRGL 295
Query: 335 ASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFL 371
             L  L +  NQLT         + NL+ L LD N L
Sbjct: 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 696 RNLIKIITVCSGR----DFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +N+I ++ V + +    +F+      IV E M + +L + +    D  E  S  + Q L 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDH-ERMSYLLYQML- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   I++LH      I+H DLKPSN+++  D    + DFGLA+            T
Sbjct: 137 ------VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGT 178
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             +      T  Y APE  +G       D++S G ++ E+
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH 695
           +   +F     +G+G  G V K     +    A+K I   ++  S + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLNH 61
Query: 696 RNLIKIITVC-SGRDF-------KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           + +++        R+F       K      I  E+ +N +L + +H  N   +      +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
            R      +  A+ Y+H      I+H +LKP N+ +D+     + DFGLAK +  H    
Sbjct: 122 FR-----QILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV--HRSLD 171
Query: 808 IVETRSISI--------GIKGTVGYVAPEY--GMGREASMKGDVYSFGILLLE 850
           I++  S ++           GT  YVA E   G G   + K D YS GI+  E
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTG-HYNEKIDXYSLGIIFFE 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 86  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 127
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 175
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             T  +      T  Y APE  +G       D++S G ++ E+
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR---NLIKIIT 703
           IG+G  G V K +  +    VA+K++   +K   +    E + L ++R +   N + +I 
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           +     F+  +   + +E + + +L E +    ++ +  SL ++++   A  +   ++ L
Sbjct: 164 MLENFTFR--NHICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVS--HVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           H   +  I+H DLKP N+LL Q   S   V DFG           +  E + +   I+  
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRVYXXIQSR 263
Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             Y APE  +G    M  D++S G +L EL T
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNI-RHRNLIKI 701
           A   G+      Y     +    VAVK++        + + ++E K L  +  H N++ +
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------------VIQ 748
           +  C+     G     ++ E+   G L  +L    D   +CS +             +  
Sbjct: 93  LGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELALDLED 146
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N + + +
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYV 202
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V+  +     +  V ++APE       + + DV+S+GI L ELF+
Sbjct: 203 VKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNL 698
           + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID--- 755
           I ++ V                 F    SLEE+       +E+   ++ Q + + +D   
Sbjct: 87  IGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHER 128
Query: 756 -------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
                  +   I++LH      I+H DLKPSN+++  D    + DFGLA+          
Sbjct: 129 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 176
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             T  +      T  Y APE  +G       D++S G ++ E+
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           + +++ A+ YLH   E  I++ DLK  NVLLD +    ++D+G+ K          +   
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPG 175
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
             +    GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 176 DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNI-RHRNLIKI 701
           A   G+      Y     +    VAVK++        + + ++E K L  +  H N++ +
Sbjct: 49  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 108
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------------VIQ 748
           +  C+     G     ++ E+   G L  +L    D   +CS +             +  
Sbjct: 109 LGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELALDLED 162
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N + + +
Sbjct: 163 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYV 218
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V+  +     +  V ++APE       + + DV+S+GI L ELF+
Sbjct: 219 VKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 18/117 (15%)
Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           ++ ++ +AI    A+ YL    +  ++H D+KPSN+LLD+     + DFG++  L     
Sbjct: 125 ILGKMTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV---- 176
Query: 806 DTIVETRSISIGIKGTVGYVAPEY-----GMGREASMKGDVYSFGILLLELFTRKRP 857
           D   + RS      G   Y+APE          +  ++ DV+S GI L+EL T + P
Sbjct: 177 DDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 48/226 (21%)
Query: 641 FSSANKIGEGGSGIV---YKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
           + +   IG G  GIV   Y   L  N   VA+K ++   + +  +K    E   ++ + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           +N+I ++ V                 F    SLEE+       +E+   ++ Q + + +D
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELD 124
Query: 756 ----------VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
                     +   I++LH      I+H DLKPSN+++  D    + DFGLA+       
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------- 174
Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                T  +      T  Y APE  +G       D++S G ++ E+
Sbjct: 175 --TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNI-RHRNLIKI 701
           A   G+      Y     +    VAVK++        + + ++E K L  +  H N++ +
Sbjct: 51  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 110
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------------VIQ 748
           +  C+     G     ++ E+   G L  +L    D   +CS +             +  
Sbjct: 111 LGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELALDLED 164
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N + + +
Sbjct: 165 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYV 220
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V+  +     +  V ++APE       + + DV+S+GI L ELF+
Sbjct: 221 VKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 11/105 (10%)
Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           +++ A+ YLH   E  I++ DLK  NVLLD +    ++D+G+ K          +     
Sbjct: 114 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDT 162
Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
           +    GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 163 TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNI-RHRNLIKI 701
           A   G+      Y     +    VAVK++        + + ++E K L  +  H N++ +
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS-------------VIQ 748
           +  C+     G     ++ E+   G L  +L    D   +CS +             +  
Sbjct: 116 LGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELALDLED 169
Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ + N + + +
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYV 225
Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           V+  +     +  V ++APE       + + DV+S+GI L ELF+
Sbjct: 226 VKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           + +++ A+ YLH   E  I++ DLK  NVLLD +    ++D+G+ K          +   
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPG 164
Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
             +    GT  Y+APE   G +     D ++ G+L+ E+   + P D
Sbjct: 165 DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
           +++   IG G  G+V++  L E+  EVA+K +   ++  ++    E + +R ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVD 96
Query: 701 IITV-CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           +     S  D K   F  +V E++         H++  +L+     ++ +L +   +  +
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA--KLKQTMPMLLIKLYM-YQLLRS 153
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           + Y+H      I H D+KP N+LLD    V  + DFG AK L    P+         +  
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---------VSX 201
Query: 819 KGTVGYVAPEYGMG-REASMKGDVYSFGILLLELF 852
             +  Y APE   G    +   D++S G ++ EL 
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 31/239 (12%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVK-VINLKQKGASKSFVAE- 686
           D  AEL      ++    I  G  G V  G   E G  VA+K V N    G + + +++ 
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 687 --CK-ALRNIR------HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND 737
             CK  LR IR      H N++ +  +    +        +V E M+   L + +H   D
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---D 126
Query: 738 QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
           Q  V S   IQ     I +      LH   E  +VH DL P N+LL  +    + DF LA
Sbjct: 127 QRIVISPQHIQYFMYHILLG-----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK-GDVYSFGILLLELFTRK 855
           +       DT    ++  +  +    Y APE  M  +   K  D++S G ++ E+F RK
Sbjct: 182 R------EDTADANKTHYVTHR---WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN 692
           E+    ++F     IG G  G V    +       A+K++N K +   ++  A  +  R+
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREERD 126
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLN 751
           +      + IT      F+  +   +V ++   G L   L    D+L E  +   I  + 
Sbjct: 127 VLVNGDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +AID   +I  LH+      VH D+KP NVLLD +    ++DFG    +   N D  V++
Sbjct: 186 LAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKM---NDDGTVQS 233
Query: 812 RSISIGIKGTVGYVAPEY------GMGREASMKGDVYSFGILLLELFTRKRP 857
            S+++   GT  Y++PE       GMG+    + D +S G+ + E+   + P
Sbjct: 234 -SVAV---GTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETP 280

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 31/239 (12%)
Query: 629 DSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVK-VINLKQKGASKSFVAE- 686
           D  AEL      ++    I  G  G V  G   E G  VA+K V N    G + + +++ 
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 687 --CK-ALRNIR------HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND 737
             CK  LR IR      H N++ +  +    +        +V E M+   L + +H   D
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---D 126
Query: 738 QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
           Q  V S   IQ     I +      LH   E  +VH DL P N+LL  +    + DF LA
Sbjct: 127 QRIVISPQHIQYFMYHILLG-----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK-GDVYSFGILLLELFTRK 855
           +       DT    ++  +  +    Y APE  M  +   K  D++S G ++ E+F RK
Sbjct: 182 R------EDTADANKTHYVTHR---WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +GEG   I  K    ++    AVK+I+ + +  ++  +   K      H N++K+  V  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEV-- 74
Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
              F       +V E +  G L E +       E  +  ++++L       SA+ ++H  
Sbjct: 75  ---FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------VSAVSHMH-- 123
Query: 767 CEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
            +  +VH DLKP N+L    + +L   + DFG A+     N    ++T         T+ 
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF------TLH 174
Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           Y APE           D++S G++L  + + + P
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 61/121 (50%), Gaps = 11/121 (9%)
Query: 736 NDQLEVC--SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLV 788
            D  ++C  + ++   L IAI + S +EY+H     ++++ D+KP N L+      ++ V
Sbjct: 84  EDLFDLCDRTFTLKTVLMIAIQLLSRMEYVH---SKNLIYRDVKPENFLIGRQGNKKEHV 140
Query: 789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
            H+ DFGLAK   +      +  R     + GT  Y++    +G+E S + D+ + G + 
Sbjct: 141 IHIIDFGLAKEYIDPETKKHIPYREHK-SLTGTARYMSINTHLGKEQSRRDDLEALGHMF 199
Query: 849 L 849
           +
Sbjct: 200 M 200

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-----KSFVAECKALRNI 693
           D +     IG+G   +V +    E G + AVK++++ +  +S     +    E      +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +H ++++++       +       +V+EFM    L   +    D   V S +V    +  
Sbjct: 84  KHPHIVELLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS--HYM 136
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVE 810
             +  A+ Y H   + +I+H D+KP NVLL   +      + DFG+A  L         E
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--------E 185
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +  ++ G  GT  ++APE           DV+  G++L  L +
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRN 692
           E+    ++F     IG G  G V    +       A+K++N K +   ++  A  +  R+
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREERD 142
Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLN 751
           +      + IT      F+  +   +V ++   G L   L    D+L E  +   I  + 
Sbjct: 143 VLVNGDCQWITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +AID   +I  LH+      VH D+KP NVLLD +    ++DFG    +   N D  V++
Sbjct: 202 LAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKM---NDDGTVQS 249
Query: 812 RSISIGIKGTVGYVAPEY------GMGREASMKGDVYSFGILLLELFTRKRP 857
            S+++   GT  Y++PE       GMG+    + D +S G+ + E+   + P
Sbjct: 250 -SVAV---GTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETP 296

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 29/224 (12%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +D +     IG G  G+       +    VAVK I   +K   ++   E    R++RH N
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEK-IDENVKREIINHRSLRHPN 76
Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +++   V            AIV E+   G L E + ++    E  +    Q+L   +  A
Sbjct: 77  IVRFKEVILT-----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH--VSDFGLAKFLSNHN-PDTIVETRSI 814
            A++         + H DLK  N LLD        ++DFG +K    H+ P + V     
Sbjct: 132 HAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV----- 177
Query: 815 SIGIKGTVGYVAPEYGMGREASMK-GDVYSFGILLLELFTRKRP 857
                GT  Y+APE  + +E   K  DV+S G+ L  +     P
Sbjct: 178 -----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 736 NDQLEVC--SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----DLV 788
            D  ++C  + S+   L IAI + S +EY+H     ++++ D+KP N L+ +       V
Sbjct: 92  EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQV 148
Query: 789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
            H+ DFGLAK   +      +  R     + GT  Y++    +G+E S + D+ + G + 
Sbjct: 149 IHIIDFGLAKEYIDPETKKHIPYREHK-SLTGTARYMSINTHLGKEQSRRDDLEALGHMF 207
Query: 849 L 849
           +
Sbjct: 208 M 208

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 86/373 (23%), Positives = 146/373 (39%), Gaps = 82/373 (21%)
Query: 7   TGVTCGQRHQRVTRLDLGNQ---SIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRL 63
           T V   +  + +T+L +  +   SI+G     +  L+ L Y+N+  N      P  +  L
Sbjct: 35  TDVVTQEELESITKLVVAGEKVASIQG-----IEYLTNLEYLNLNGNQITDISP--LSNL 87
Query: 64  ISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
           + L  L +  N  +    + L + +NL EL  + +N+    P  + +L K   L++  NH
Sbjct: 88  VKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKXYSLNLGANH 143
Query: 124 ITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS 183
               L + + N + L  + V E+++   +  +  L  L  LS+ +NQ   + P  + +++
Sbjct: 144 NLSDL-SPLSNXTGLNYLTVTESKV-KDVTPIANLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           SL   +   N+ T   PV    N   L  L+   N  T   P                  
Sbjct: 200 SLHYFTAYVNQITDITPV---ANXTRLNSLKIGNNKITDLSP------------------ 238
Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
                    + L  L WL +G         N++  IN + + +KL               
Sbjct: 239 --------LANLSQLTWLEIG--------TNQISDINAVKDLTKL--------------- 267
Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
                     K + +G N+IS      + NL+ LN L ++ NQL       IG LTNL  
Sbjct: 268 ----------KXLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTT 315
Query: 364 LDLDRNFLQGSIP 376
           L L +N +    P
Sbjct: 316 LFLSQNHITDIRP 328

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           ++    +IGEG  G++++G    N  +VA+K    +         ++   LR+       
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR---------SDAPQLRD--EYRTY 59
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS----------NDQLEVC--SLSVI 747
           K++  C+G           VY F Q G     LH+            D L++C    SV 
Sbjct: 60  KLLAGCTG--------IPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVK 106
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL------DQDLVSHVSDFGLAKFLS 801
                A  + + ++ +H   E S+V+ D+KP N L+      + +++ +V DFG+ KF  
Sbjct: 107 TVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYR 162
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
           +      +  R     + GT  Y++    +GRE S + D+ + G + +
Sbjct: 163 DPVTKQHIPYRE-KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM 209

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
           ++    +IGEG  G++++G    N  +VA+K    +         ++   LR+       
Sbjct: 10  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR---------SDAPQLRD--EYRTY 58
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS----------NDQLEVC--SLSVI 747
           K++  C+G           VY F Q G     LH+            D L++C    SV 
Sbjct: 59  KLLAGCTG--------IPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVK 105
Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL------DQDLVSHVSDFGLAKFLS 801
                A  + + ++ +H   E S+V+ D+KP N L+      + +++ +V DFG+ KF  
Sbjct: 106 TVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYR 161
Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL 849
           +      +  R     + GT  Y++    +GRE S + D+ + G + +
Sbjct: 162 DPVTKQHIPYRE-KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM 208

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 645 NKIGEGGSGIV--YKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKII 702
            K+GEGG   V   +G    +G   A+K I   ++   +    E    R   H N+++++
Sbjct: 35  QKLGEGGFSYVDLVEGL--HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 703 TVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
             C     +GA  +A ++  F + G+L   +    D+     L+  Q L + + +   +E
Sbjct: 93  AYCLRE--RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLE 148
Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG- 820
            +H        H DLKP+N+LL  +    + D G       H     VE    ++ ++  
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH-----VEGSRQALTLQDW 200
Query: 821 -----TVGYVAPEYGMGREASM---KGDVYSFGILLLELFTRKRPTDAMFNEG 865
                T+ Y APE    +   +   + DV+S G +L  +   + P D +F +G
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI- 693
            K  D +   + IG+G  G V K +       VA+K+I  K+   +++ + E + L  + 
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMN 108
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +H   +K   V   R F   +   +V+E M + +L + L ++N      SL++ ++   A
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRKF--A 163
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL--DQDLVSHVSDFGLAKFLSNHNPDTIVET 811
             + +A+ +L    E SI+H DLKP N+LL   +     + DFG +  L       I ++
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXI-QS 221
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           R           Y +PE  +G    +  D++S G +L+E+ T
Sbjct: 222 RF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 47/239 (19%)
Query: 641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVI-NLKQKGASKSFVAECKALRNIRHRNLI 699
           F    K+G+G  G V      +N    AVKV+ N+K+   ++S   E   L+ I++ ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDIN 94
Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
               V     F   D   +++E +     E    ++ +   +  + +       I++  A
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY-----CIEILKA 149
Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDL-------VSHVS------------------DF 794
           + YL    + S+ H DLKP N+LLD          V  V+                  DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           G A F S+++  +I+ TR           Y APE  +     +  D++SFG +L EL+T
Sbjct: 207 GCATFKSDYH-GSIINTRQ----------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 8/191 (4%)
Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASI-GNLSS 137
           AIP+N+ + +  ++L +   N +  +P+         RL    ++    LPA I   L +
Sbjct: 30  AIPSNIPADTKKLDLQS---NKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 138 LRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN-ISSLEVISLSENRF 195
           L  + V +N+L    I    QL +L  L +  NQ   + PP +F+ ++ L  +SL  N  
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNEL 145
Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL 255
             SLP      L SL+ELR   N        +    + L+ ++   NQ        F  L
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 256 KNLYWLNLGIN 266
           + L  L L  N
Sbjct: 205 EKLKMLQLQEN 215

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 108/257 (42%), Gaps = 53/257 (20%)
Query: 631 YAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL 690
           Y  + + ++ F   +KIGEG    VY           A   +  ++K A K  +     +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLA--------TAQLQVGPEEKIALKHLIPTSHPI 64
Query: 691 RNIRHRNLIKIITVCSGRD--------FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC 742
           R       ++ +TV  G+D        F+  D   I   ++++ S  + L+         
Sbjct: 65  RIAAE---LQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN--------- 112
Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH-VSDFGLA---- 797
           SLS  +     +++  A++ +H +    IVH D+KPSN L ++ L  + + DFGLA    
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169
Query: 798 -------KFLS--------NHNPDTIVETRSISIGIK-GTVGYVAPEY-GMGREASMKGD 840
                  KF+         + N  +I  +R   +  + GT G+ APE        +   D
Sbjct: 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229
Query: 841 VYSFGILLLELFTRKRP 857
           ++S G++ L L + + P
Sbjct: 230 MWSAGVIFLSLLSGRYP 246

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI- 693
            K  D +   + IG+G  G V K +       VA+K+I  K+   +++ + E + L  + 
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMN 108
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +H   +K   V   R F   +   +V+E M + +L + L ++N      SL++ ++   A
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRKF--A 163
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIVET 811
             + +A+ +L    E SI+H DLKP N+LL     S +   DFG +  L       I ++
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI-QS 221
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           R           Y +PE  +G    +  D++S G +L+E+ T
Sbjct: 222 RF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTE--VAVKVINLKQKGAS--KSFVAECKALRNI 693
           +D +     IG G  G+     + +  T+  VAVK I   ++GA+  ++   E    R++
Sbjct: 19  SDRYDFVKDIGSGNFGVA--RLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSL 73
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           RH N+++   V            AI+ E+   G L E + ++    E  +    Q+L   
Sbjct: 74  RHPNIVRFKEV-----ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--- 125
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH--VSDFGLAKFLSNHN-PDTIVE 810
               S + Y H      I H DLK  N LLD        + DFG +K    H+ P + V 
Sbjct: 126 ---LSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV- 178
Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMK-GDVYSFGILLLELFTRKRP 857
                    GT  Y+APE  + +E   K  DV+S G+ L  +     P
Sbjct: 179 ---------GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 50/225 (22%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITV 704
           +G G  G V   +      +VAVK ++   +    ++    E + L++++H N+I ++ V
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 705 ----CSGRDFK---------GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
                S  DF          GAD   IV                  + +  S   +Q L 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIV------------------KCQALSDEHVQFL- 128
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
               +   ++Y+H      I+H DLKPSNV +++D    + DFGLA+           + 
Sbjct: 129 -VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QA 173
Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                G   T  Y APE  +     +   D++S G ++ EL   K
Sbjct: 174 DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 625 QFLVDSYAELSKAT--DNFSSANKI-GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           QF V S  ++ K    D++   +++ G G +G V + F      + A+K++    K   +
Sbjct: 5   QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 64
Query: 682 SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
             +      R  +  ++++I+ V     + G     IV E +  G L   +    DQ   
Sbjct: 65  VELH----WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ--- 116
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAK 798
            + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 117 -AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             ++HN        S++     T  YVAPE     +     D++S G+++
Sbjct: 173 ETTSHN--------SLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 625 QFLVDSYAELSKAT--DNFSSANKI-GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           QF V S  ++ K    D++   +++ G G +G V + F      + A+K++    K   +
Sbjct: 6   QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 65
Query: 682 SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
             +      R  +  ++++I+ V     + G     IV E +  G L   +    DQ   
Sbjct: 66  VELH----WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ--- 117
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAK 798
            + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 118 -AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             ++HN        S++     T  YVAPE     +     D++S G+++
Sbjct: 174 ETTSHN--------SLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 625 QFLVDSYAELSKAT--DNFSSANKI-GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           QF V S  ++ K    D++   +++ G G +G V + F      + A+K++    K   +
Sbjct: 7   QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 66
Query: 682 SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
             +      R  +  ++++I+ V     + G     IV E +  G L   +    DQ   
Sbjct: 67  VELH----WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ--- 118
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAK 798
            + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 119 -AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             ++HN        S++     T  YVAPE     +     D++S G+++
Sbjct: 175 ETTSHN--------SLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI- 693
            K  D +   + IG+G  G V K +       VA+K+I  K+   +++ + E + L  + 
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMN 89
Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +H   +K   V   R F   +   +V+E M + +L + L ++N      SL++ ++   A
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRKF--A 144
Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--DFGLAKFLSNHNPDTIVET 811
             + +A+ +L    E SI+H DLKP N+LL     S +   DFG +  L       I ++
Sbjct: 145 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI-QS 202
Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           R           Y +PE  +G    +  D++S G +L+E+ T
Sbjct: 203 RF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 31/202 (15%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN----LKQKGASKSFVAECKALRNIRHRNLIKII 702
           +G+G +  V++G   + G   A+KV N    L+        + E + L+ + H+N++K+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKLF 73
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +    +      K ++ EF   GSL   L   ++      L   + L +  DV      
Sbjct: 74  AI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGG--- 124
Query: 763 LHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           ++H  E  IVH ++KP N++     D   V  ++DFG A+ L         E     + +
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDDEQFVSL 175
Query: 819 KGTVGYVAPEYGMGREASMKGD 840
            GT  Y+ P+  M   A ++ D
Sbjct: 176 YGTEEYLHPD--MYERAVLRKD 195

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 50/225 (22%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITV 704
           +G G  G V   +      +VAVK ++   +    ++    E + L++++H N+I ++ V
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 705 ----CSGRDFK---------GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
                S  DF          GAD   IV    ++ +L +         E     V Q L 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSD---------EHVQFLVYQLLR 142
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   ++Y+H      I+H DLKPSNV +++D    + DFGLA+           + 
Sbjct: 143 -------GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----------QA 181
Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                G   T  Y APE  +     +   D++S G ++ EL   K
Sbjct: 182 DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 625 QFLVDSYAELSKAT--DNFSSANKI-GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           QF V S  ++ K    D++   +++ G G +G V + F      + A+K++    K   +
Sbjct: 15  QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 74
Query: 682 SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
             +      R  +  ++++I+ V     + G     IV E +  G L   +    DQ   
Sbjct: 75  VELH----WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ--- 126
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAK 798
            + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 127 -AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILL 848
             ++HN        S++     T  YVAPE  +G E   K  D++S G+++
Sbjct: 183 ETTSHN--------SLTTPCY-TPYYVAPEV-LGPEKYDKSCDMWSLGVIM 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 625 QFLVDSYAELSKAT--DNFSSANKI-GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK 681
           QF V S  ++ K    D++   +++ G G +G V + F      + A+K++    K   +
Sbjct: 1   QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE 60
Query: 682 SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV 741
             +      R  +  ++++I+ V     + G     IV E +  G L   +    DQ   
Sbjct: 61  VELH----WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ--- 112
Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAK 798
            + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 113 -AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             ++HN        S++     T  YVAPE     +     D++S G+++
Sbjct: 169 ETTSHN--------SLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 50/225 (22%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNLIKIITV 704
           +G G  G V   +      +VAVK ++   +    ++    E + L++++H N+I ++ V
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 705 ----CSGRDFK---------GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
                S  DF          GAD   IV                  + +  S   +Q L 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIV------------------KCQALSDEHVQFL- 136
Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
               +   ++Y+H      I+H DLKPSNV +++D    + DFGLA+           + 
Sbjct: 137 -VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----------QA 181
Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                G   T  Y APE  +     +   D++S G ++ EL   K
Sbjct: 182 DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 31/202 (15%)
Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN----LKQKGASKSFVAECKALRNIRHRNLIKII 702
           +G+G +  V++G   + G   A+KV N    L+        + E + L+ + H+N++K+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKLF 73
Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            +    +      K ++ EF   GSL   L   ++      L   + L +  DV   + +
Sbjct: 74  AI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNH 127
Query: 763 LHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           L    E  IVH ++KP N++     D   V  ++DFG A+ L         E     + +
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDDEQFVXL 175
Query: 819 KGTVGYVAPEYGMGREASMKGD 840
            GT  Y+ P+  M   A ++ D
Sbjct: 176 YGTEEYLHPD--MYERAVLRKD 195

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 11/121 (9%)
Query: 736 NDQLEVC--SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----DLV 788
            D  ++C  + S+   L IAI + S +EY+H     ++++ D+KP N L+ +       V
Sbjct: 113 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQV 169
Query: 789 SHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
            H+ DF LAK   +      +  R     + GT  Y++    +G+E S + D+ + G + 
Sbjct: 170 IHIIDFALAKEYIDPETKKHIPYREHK-SLTGTARYMSINTHLGKEQSRRDDLEALGHMF 228
Query: 849 L 849
           +
Sbjct: 229 M 229

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 660 LGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR-------NLIKIITVCSGRDFKG 712
           LG NG  + +     ++K A K      KA R +          ++++I+ V     + G
Sbjct: 27  LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAG 85
Query: 713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIV 772
                IV E +  G L   +    DQ    + +  +   I   +  AI+YLH     +I 
Sbjct: 86  RKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIA 138
Query: 773 HGDLKPSNVLLDQ---DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
           H D+KP N+L      + +  ++DFG AK  ++HN        S++     T  YVAPE 
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--------SLTTPCY-TPYYVAPEV 189
Query: 830 GMGREASMKGDVYSFGILL 848
               +     D++S G+++
Sbjct: 190 LGPEKYDKSCDMWSLGVIM 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 660 LGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR-------NLIKIITVCSGRDFKG 712
           LG NG  + +     ++K A K      KA R +          ++++I+ V     + G
Sbjct: 26  LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAG 84
Query: 713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIV 772
                IV E +  G L   +    DQ    + +  +   I   +  AI+YLH     +I 
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIA 137
Query: 773 HGDLKPSNVLLDQ---DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
           H D+KP N+L      + +  ++DFG AK  ++HN        S++     T  YVAPE 
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--------SLTTPCY-TPYYVAPEV 188
Query: 830 GMGREASMKGDVYSFGILL 848
               +     D++S G+++
Sbjct: 189 LGPEKYDKSCDMWSLGVIM 207
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	884
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-166
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-147
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-100
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-98
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-65
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-92
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-88
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-92
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-75
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-75
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-84
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-78
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-65
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-33
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-71
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-75
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-66
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-75
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-70
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-57
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-22
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-48
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-48
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-42
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-32
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-10
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-08
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-16
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-06
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-12
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	9e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-04
4fev_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	2e-04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	4e-04
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	5e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	9e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  500 bits (1291), Expect = e-166
 Identities = 172/570 (30%), Positives = 275/570 (48%), Gaps = 26/570 (4%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             LD+ + +    + P++G+ S L++++I+ N  +G+    I     L+ L +S+N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASIGNLSS 137
            IP       +L  LS   N   GEIP  + G+   L  L +  NH  G +P   G+ S 
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319

Query: 138 LRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS-SLEVISLSENR 194
           L  + +  N   G +  D+L +++ L +L ++FN+FSG +P S+ N+S SL  + LS N 
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379

Query: 195 FTGSLPVDTGVN-LPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
           F+G +  +   N   +L+EL    N FTG IP +LSN S L  +  S N  SG +     
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTI 313
            L  L  L L +N L  G     +    L     LE L  + N   GE+P  ++N ++ +
Sbjct: 440 SLSKLRDLKLWLNML-EG-----EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-L 492

Query: 314 KQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG 373
             I++  NR++G IP  I  L +L  L +  N  +G IP E+G+  +L  LDL+ N   G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552

Query: 374 SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHN--KLIGTLPRQILRIT 431
           +IP+++   +      +  N + G     + N       + + N  +  G    Q+ R++
Sbjct: 553 TIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608

Query: 432 TLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNA 491
           T +    + + +  G   P   N  ++M LD+S N  SG IP  + +   L  LN+  N 
Sbjct: 609 TRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667

Query: 492 FSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFN 551
            SGSIP  +  L+ +  LD SSN L+G+IP+ +  L+ L  ++LS N+  G +P  G F 
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727

Query: 552 NKTRFSIAGNGKLCGGLDELRLPSCQSKGS 581
                    N  LCG      LP C    +
Sbjct: 728 TFPPAKFLNNPGLCGYP----LPRCDPSNA 753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  451 bits (1163), Expect = e-147
 Identities = 170/598 (28%), Positives = 268/598 (44%), Gaps = 55/598 (9%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLS--------------------------PY 35
           N C + GVTC  R  +VT +DL ++ +    S                            
Sbjct: 38  NPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG 95

Query: 36  VGNLSFLRYINIASNGFNGEIP--HQIGRLISLERLILSNNSFSGAIPA-NLSSCSNLIE 92
               + L  ++++ N  +G +     +G    L+ L +S+N+             ++L  
Sbjct: 96  FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155

Query: 93  LSADSNNLVGEIPADI---GSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLW 149
           L   +N++ G             +L+ L+I  N I+G +   +    +L  +DV  N   
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213

Query: 150 GRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPS 209
             I  LG   +L  L ++ N+ SG    +I   + L+++++S N+F G +P      L S
Sbjct: 214 TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKS 270

Query: 210 LRELRTNANNFTGFIPVSLS-NASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNL 268
           L+ L    N FTG IP  LS    +L  ++ S N F G V   F     L  L L  NN 
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 269 GTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIP 328
            +G        + L     L+ L  + N F GELP S+ NLS+++  + +  N  SG I 
Sbjct: 331 -SGELPM----DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385

Query: 329 PEIRN--LASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLT 386
           P +      +L  L +  N  TG IPP +   + L  L L  N+L G+IPSSLG+L+ L 
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445

Query: 387 YLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG 446
            LKL LN LEG IP  L     L  L +  N L G +P  +   T L+ ++ L NN L G
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN-WISLSNNRLTG 504

Query: 447 SLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSI 506
            +P  +G L+NL  L LS N FSG IPA L  C +L +L+++ N F+G+IP  +      
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS-- 562

Query: 507 KELDFSSNNLNGQIPEYLENLSFLEFLNLSYN--HFEGEVPMK-GVFNNKTRFSIAGN 561
                ++N + G+   Y++N    +  + + N   F+G    +    + +   +I   
Sbjct: 563 --GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 98.1 bits (245), Expect = 5e-21
 Identities = 31/112 (27%), Positives = 55/112 (49%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
               ++ ++   G  SP   N   + +++++ N  +G IP +IG +  L  L L +N  S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLP 129
           G+IP  +     L  L   SN L G IP  + +L  L  + +  N+++G +P
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 77.3 bits (191), Expect = 1e-14
 Identities = 29/90 (32%), Positives = 48/90 (53%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
             +  LD+    + G +   +G++ +L  +N+  N  +G IP ++G L  L  L LS+N 
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIP 105
             G IP  +S+ + L E+   +NNL G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 44.1 bits (105), Expect = 2e-04
 Identities = 24/89 (26%), Positives = 36/89 (40%), Gaps = 9/89 (10%)

Query: 502 SLQSIKELDFSSNNLN---GQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSI 558
               +  +D SS  LN     +   L +L+ LE L LS +H  G V       + T   +
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107

Query: 559 AGNGKLCGGLDELRLPSCQSKGSLTILKV 587
           + N  L G      + +  S GS + LK 
Sbjct: 108 SRNS-LSG-----PVTTLTSLGSCSGLKF 130

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  325 bits (835), Expect = e-100
 Identities = 92/576 (15%), Positives = 180/576 (31%), Gaps = 59/576 (10%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNG----EIP 57
                 GV+    + RVT L L      G +   +G L+ L  + + S+G         P
Sbjct: 68  MWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 58  HQIGRLISLERLILSNNSFSGAIPANLS--SCSNLIELSADSNNLVGEIPADIGSLFKLE 115
             I   +S E+       +             S+LI+   +S+     I        K  
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 116 RLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMI 175
           ++    N+IT  +  ++  L+ LR   +  +            ++    +  + Q     
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQYKTE 241

Query: 176 PPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGF--------IPVS 227
                N+  L  + +        LP      LP ++ +    N                 
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 228 LSNASSLEMIEFSKNQFSGG-VSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCS 286
                 +++I    N      V     ++K L  L    N L  G       +    +  
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL-EG------KLPAFGSEI 353

Query: 287 KLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPP--EIRNLASLNWLTIDT 344
           KL  L    N+    +P +    +  ++ ++   N++   IP   + ++++ ++ +    
Sbjct: 354 KLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411

Query: 345 NQLTG-------TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
           N++          + P   +  N+  ++L  N +           + L+ + L  N L  
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 398 -------NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLP 449
                  +   +  N   L  +++  NKL   L       T   L  ++L  N  +   P
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FP 529

Query: 450 PEVGNLKNLMRL------DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSL 503
            +  N   L         D  GN+   E P  ++ C +L  L I  N        +  ++
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNI 589

Query: 504 QSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
                LD   N        Y+          L Y+ 
Sbjct: 590 SV---LDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  257 bits (658), Expect = 3e-75
 Identities = 90/551 (16%), Positives = 166/551 (30%), Gaps = 55/551 (9%)

Query: 33  SPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIE 92
           + Y+ +   L+ I  A NG N        +  +        + +      +L+S   +  
Sbjct: 26  AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTG 85

Query: 93  LSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQ----LPASIGNLSSLRVIDVRENRL 148
           LS +     G +P  IG L +LE L++  +          P  I    S           
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 149 WGRI---DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGV 205
                  D       L    +  +     I  S         I    N  T  +      
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVM- 203

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
            L  LR+     + F            + E       Q      + +  LK+L  + +  
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYN 258

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG--ELPHSVANLSST-----IKQIAM 318
               T           L    +++ +    NR     +L      L+       I+ I +
Sbjct: 259 CPNLTKLPTF------LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312

Query: 319 GRNRI-SGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS 377
           G N + +  +   ++ +  L  L    NQL G   P  G    L  L+L  N +     +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPAN 371

Query: 378 SLGNLTLLTYLKLGLNNLEGNIPSSL--GNCTNLLGLNISHNKL-------IGTLPRQIL 428
             G    +  L    N L+  IP+     + + +  ++ S+N++          L     
Sbjct: 372 FCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430

Query: 429 RITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG-------EIPATLSACAN 481
           +   +S  + L NN ++            L  ++L GN  +        +          
Sbjct: 431 KGINVS-SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489

Query: 482 LEYLNISGNAFSGSIP-LLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFL------N 534
           L  +++  N  +         +L  +  +D S N+ +   P    N S L+        +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548

Query: 535 LSYNHFEGEVP 545
              N    E P
Sbjct: 549 AQGNRTLREWP 559

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (277), Expect = 4e-25
 Identities = 23/232 (9%), Positives = 61/232 (26%), Gaps = 49/232 (21%)

Query: 378 SLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG----TLPRQILRITTL 433
           SL +   +T L L      G +P ++G  T L  L +  +          P+ I    + 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 434 SLYLELGNNLLN-------------------------GSLPPEVGNLKNLMRLDLSGNKF 468
               ++  +                             S+           ++    N  
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 469 SGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSI-------------------KEL 509
           +  +   +     L    +  + F           ++                     ++
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254

Query: 510 DFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           +  +     ++P +L+ L  ++ +N++ N       +K  +       +   
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  307 bits (790), Expect = 6e-98
 Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 14/308 (4%)

Query: 276 LDFINLLTNCSKL----ERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGT--IPP 329
           L     L N + L             + G L  +       +  + +    +     IP 
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPS 70

Query: 330 EIRNLASLNWLTI-DTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYL 388
            + NL  LN+L I   N L G IPP I +LT L  L +    + G+IP  L  +  L  L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 389 KLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSL 448
               N L G +P S+ +  NL+G+    N++ G +P      + L   + +  N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 449 PPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKE 508
           PP   NL NL  +DLS N   G+      +  N + ++++ N+ +  +   +   +++  
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248

Query: 509 LDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGL 568
           LD  +N + G +P+ L  L FL  LN+S+N+  GE+P  G        + A N  LCG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307

Query: 569 DELRLPSC 576
               LP+C
Sbjct: 308 ---PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  231 bits (591), Expect = 3e-69
 Identities = 72/271 (26%), Positives = 110/271 (40%), Gaps = 11/271 (4%)

Query: 4   CQWTGVTCGQRHQ--RVTRLDLGNQSIRGT--LSPYVGNLSFLRYINIAS-NGFNGEIPH 58
             W GV C    Q  RV  LDL   ++     +   + NL +L ++ I   N   G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 59  QIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLS 118
            I +L  L  L +++ + SGAIP  LS    L+ L    N L G +P  I SL  L  ++
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 119 IFQNHITGQLPASIGNLSSL-RVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIP 176
              N I+G +P S G+ S L   + +  NRL G+I  +   L +L  + ++ N   G   
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214

Query: 177 PSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEM 236
               +  + + I L++N     L         +L  L    N   G +P  L+    L  
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG--KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 237 IEFSKNQFSGGVSVDFSRLKNLYWLNLGINN 267
           +  S N   G +      L+         N 
Sbjct: 273 LNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  219 bits (561), Expect = 6e-65
 Identities = 82/335 (24%), Positives = 128/335 (38%), Gaps = 47/335 (14%)

Query: 127 QLPASIGNLSSLR----VIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSG--MIPPSI 179
           Q+   +GN ++L       D       G + D+  Q   +  L ++         IP S+
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 180 FNISSLEVISLS-ENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
            N+  L  + +   N   G +P      L  L  L     N +G IP  LS   +L  ++
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131

Query: 239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
           FS N  SG +                                 +++   L  + F+ NR 
Sbjct: 132 FSYNALSGTLPPS------------------------------ISSLPNLVGITFDGNRI 161

Query: 299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
            G +P S  + S     + + RNR++G IPP   NL +L ++ +  N L G      G  
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSD 220

Query: 359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNK 418
            N Q++ L +N L   +   +G    L  L L  N + G +P  L     L  LN+S N 
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279

Query: 419 LIGTLPR--QILRITTLSLYLELGNNLLNGS-LPP 450
           L G +P+   + R    +      N  L GS LP 
Sbjct: 280 LCGEIPQGGNLQRFDVSAY---ANNKCLCGSPLPA 311

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  208 bits (531), Expect = 9e-61
 Identities = 81/342 (23%), Positives = 133/342 (38%), Gaps = 66/342 (19%)

Query: 71  LSNNSFSGAIPANLSSCSNLIELSADSNNLVGE--IPADIGSLFKLERLSIF-QNHITGQ 127
             N ++ G +    +    +  L     NL     IP+ + +L  L  L I   N++ G 
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92

Query: 128 LPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLE 186
           +P +I  L+ L  + +    + G I D L Q+K+L  L  ++N  SG +PPSI ++ +L 
Sbjct: 93  IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 187 VISLSENRFTGSLPVDTGVNLPSLRE-LRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
            I+   NR +G++P   G +   L   +  + N  TG IP + +N  +L  ++ S+N   
Sbjct: 153 GITFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210

Query: 246 GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
           G  SV F   KN   ++L                               +N    +L   
Sbjct: 211 GDASVLFGSDKNTQKIHLA------------------------------KNSLAFDL--- 237

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLD 365
                                   ++    +LN L +  N++ GT+P  + +L  L  L+
Sbjct: 238 -----------------------GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 366 LDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCT 407
           +  N L G IP   GNL          N      P  L  CT
Sbjct: 275 VSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP--LPACT 313

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  304 bits (780), Expect = 5e-92
 Identities = 104/549 (18%), Positives = 189/549 (34%), Gaps = 43/549 (7%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
           +T L+L +  +R   +      S L  +++  N  +   P    +L  L+ L L +N  S
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
                  + C+NL EL   SN++             L  L +  N ++     +   L +
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 138 LRVIDVRENRLWGRID---SLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENR 194
           L+ + +  N++         +    SL  L ++ NQ     P     I  L  + L+  +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 195 FTGSLPVDTGV--NLPSLRELRTNANNFTGFIPVSLSN--ASSLEMIEFSKNQFSGGVSV 250
              SL     +     S+R L  + +  +     +      ++L M++ S N  +   + 
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266

Query: 251 DFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLS 310
            F+ L  L +  L  NN+    ++       L     +  L   R+  +  +        
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHS------LHGLFNVRYLNLKRSFTKQSISL------ 314

Query: 311 STIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNF 370
                       +        + L  L  L ++ N + G        L NL+ L L  +F
Sbjct: 315 ----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 371 LQGSIPSSLG----NLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
                 ++        + L  L L  N +      +     +L  L++  N++   L  Q
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG--EIPATLSACANLEY 484
             R       + L  N            + +L RL L           P+      NL  
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484

Query: 485 LNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN--------GQIPEYLENLSFLEFLNLS 536
           L++S N  +     +L+ L+ ++ LD   NNL         G    +L+ LS L  LNL 
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544

Query: 537 YNHFEGEVP 545
            N F+    
Sbjct: 545 SNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  293 bits (752), Expect = 5e-88
 Identities = 108/555 (19%), Positives = 199/555 (35%), Gaps = 42/555 (7%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
           T L L + SI+   +        L  ++++ NG +        +L +L+ L+LSNN    
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 79  AIPANLSSCSN--LIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIG--- 133
                L   +N  L +L   SN +    P    ++ +L  L +    +   L   +    
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219

Query: 134 NLSSLRVIDVRENRLWGRIDSLG---QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISL 190
             +S+R + +  ++L    ++     +  +LT+L +++N  + +   S   +  LE   L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 191 SENRFTGSLPVDTGVNLPSLRELR---------TNANNFTGFIPVSLSNASSLEMIEFSK 241
             N         +   L ++R L           +  +       S      LE +    
Sbjct: 280 EYNNIQHLFS-HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
           N   G  S  F+ L NL +L+L  +           F++L    S L  L   +N+    
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKI 396

Query: 302 LPHSVANLSSTIKQIAMGRNRISGTIPP-EIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
              + + L   ++ + +G N I   +   E R L ++  + +  N+           + +
Sbjct: 397 ESDAFSWLGH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 361 LQQLDLDRNFLQG--SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNK 418
           LQ+L L R  L+   S PS    L  LT L L  NN+       L     L  L++ HN 
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 419 LIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
           L                   L  +   G     +  L +L  L+L  N F          
Sbjct: 516 L-----------------ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLE-NLSFLEFLNLSY 537
              L+ +++  N  +     + ++  S+K L+   N +     +        L  L++ +
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 538 NHFEGEVPMKGVFNN 552
           N F+        F N
Sbjct: 619 NPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  282 bits (723), Expect = 8e-84
 Identities = 102/498 (20%), Positives = 183/498 (36%), Gaps = 26/498 (5%)

Query: 64  ISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
           +S E    S+   +  +P +L   +N+  L+   N L     A+     +L  L +  N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 124 ITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
           I+   P     L  L+V++++ N L      +     +LT L +  N    +        
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNA--SSLEMIEFS 240
            +L  + LS N  + S  + T V L +L+EL  + N         L     SSL+ +E S
Sbjct: 121 KNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
            NQ        F  +  L+ L L    L   +  E   + L    + +  L  + ++   
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQL-GPSLTEKLCLEL--ANTSIRNLSLSNSQLST 236

Query: 301 ELPHSVANLSST-IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
               +   L  T +  + +  N ++         L  L +  ++ N +       +  L 
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 360 NLQQLDLDRNFLQGSI---------PSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL 410
           N++ L+L R+F + SI           S   L  L +L +  N++ G   +      NL 
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 411 GLNISHNKL-IGTLPRQILRITTLSL--YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
            L++S++   + TL  +       S    L L  N ++         L +L  LDL  N+
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 468 FSGEIPA-TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG--QIPEYL 524
              E+         N+  + +S N +          + S++ L      L      P   
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 525 ENLSFLEFLNLSYNHFEG 542
           + L  L  L+LS N+   
Sbjct: 477 QPLRNLTILDLSNNNIAN 494

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  175 bits (445), Expect = 6e-46
 Identities = 81/461 (17%), Positives = 145/461 (31%), Gaps = 78/461 (16%)

Query: 17  RVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSF 76
           ++    L   +I+   S  +  L  +RY+N+  +                 +  +S  S 
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASL 317

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS 136
                 +                              LE L++  N I G        L 
Sbjct: 318 PKIDDFSFQWLKC------------------------LEHLNMEDNDIPGIKSNMFTGLI 353

Query: 137 SLRVIDVRENRLWGRIDSLGQLKSLTL-----LSVAFNQFSGMIPPSIFNISSLEVISLS 191
           +L+ + +  +    R  +     SL       L++  N+ S +   +   +  LEV+ L 
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 192 ENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD 251
            N     L       L ++ E+  + N +      S +   SL+ +   +       S  
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473

Query: 252 --FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANL 309
             F  L+NL  L+L  NN+           ++L    KLE L    N             
Sbjct: 474 SPFQPLRNLTILDLSNNNIANIND------DMLEGLEKLEILDLQHNNLA---------- 517

Query: 310 SSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRN 369
                   + ++   G     ++ L+ L+ L +++N           +L  L+ +DL  N
Sbjct: 518 -------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570

Query: 370 FLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG-NCTNLLGLNISHNKLIGTLP---- 424
            L     S   N   L  L L  N +        G    NL  L++  N    T      
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630

Query: 425 -RQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLS 464
               +  T  ++  EL ++ L  + P   G    +   D S
Sbjct: 631 FVNWINETHTNI-PELSSHYLCNTPPHYHG--FPVRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  132 bits (333), Expect = 7e-32
 Identities = 53/304 (17%), Positives = 103/304 (33%), Gaps = 20/304 (6%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG----RLISLERLIL 71
           + +  L++ +  I G  S     L  L+Y++++++  +                L  L L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 72  SNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPAD-IGSLFKLERLSIFQNHITGQLPA 130
           + N  S       S   +L  L    N +  E+       L  +  + +  N        
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448

Query: 131 SIGNLSSLRVIDVRENRLWGRIDS---LGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEV 187
           S   + SL+ + +R   L     S      L++LT+L ++ N  + +    +  +  LE+
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508

Query: 188 ISLSENRFT-------GSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
           + L  N             P+     L  L  L   +N F         +   L++I+  
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
            N  +   +  F+   +L  LNL  N + +     ++          L  L    N F+ 
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITS-----VEKKVFGPAFRNLTELDMRFNPFDC 623

Query: 301 ELPH 304
               
Sbjct: 624 TCES 627

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  301 bits (774), Expect = 6e-92
 Identities = 121/550 (22%), Positives = 206/550 (37%), Gaps = 37/550 (6%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
              LDL    +R   S    +   L+ ++++              L  L  LIL+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITG-QLPASIGNLS 136
                  S  S+L +L A   NL       IG L  L+ L++  N I   +LP    NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 137 SLRVIDVRENRLWGRI-DSLGQLKSLTL----LSVAFNQFSGMIPPSIFNISSLEVISLS 191
           +L  +D+  N++       L  L  + L    L ++ N  +  I P  F    L  ++L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208

Query: 192 ENRFTGSLPVDTGVNLPSLRELR------TNANNFTGFIPVSLSNASSLEMIEFSKNQ-- 243
            N  + ++       L  L   R       N  N   F   +L    +L + EF      
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 244 -FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
            +   +   F+ L N+   +L    +          +   +     + L     +F    
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFP 320

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLT--GTIPPEIGELTN 360
              + +L               G       +L SL +L +  N L+  G         T+
Sbjct: 321 TLKLKSLKRLT------FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSS-LGNCTNLLGLNISHNKL 419
           L+ LDL  N +   + S+   L  L +L    +NL+     S   +  NL+ L+ISH   
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSA 478
                     +++L   L++  N    +  P++   L+NL  LDLS  +     P   ++
Sbjct: 434 RVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL-SFLEFLNLSY 537
            ++L+ LN+S N F          L S++ LD+S N++     + L++  S L FLNL+ 
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552

Query: 538 NHFEGEVPMK 547
           N F      +
Sbjct: 553 NDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  258 bits (660), Expect = 1e-75
 Identities = 97/542 (17%), Positives = 179/542 (33%), Gaps = 39/542 (7%)

Query: 13  QRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILS 72
           Q    ++ L L    I+         LS L+ +              IG L +L+ L ++
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 73  NNSF-SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLE----RLSIFQNHITGQ 127
           +N   S  +P   S+ +NL  L   SN +      D+  L ++      L +  N +   
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF- 191

Query: 128 LPASIGNLSSLRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
           +         L  + +R N     +    +  L  L +  +   +F        F+ S+L
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 186 E--------VISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMI 237
           E           L+   +     +D    L ++      +           S     + +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHL 309

Query: 238 EFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLY--FNR 295
           E    +F    ++    LK L + +    N  +             +   LE L    N 
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----------EVDLPSLEFLDLSRNG 358

Query: 296 NRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI 355
             F+G    S    +S +K + +  N +  T+      L  L  L    + L       +
Sbjct: 359 LSFKGCCSQSDFGTTS-LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 356 -GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI-PSSLGNCTNLLGLN 413
              L NL  LD+     + +       L+ L  LK+  N+ + N  P       NL  L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIP 473
           +S  +L    P     +++L   L + +N            L +L  LD S N       
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

Query: 474 ATLSACA-NLEYLNISGNAFSGSIPL--LLDSLQSIKELDFSSNNLNGQIPEYLENLSFL 530
             L     +L +LN++ N F+ +      L  ++  ++L      +    P   + +  L
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL 595

Query: 531 EF 532
             
Sbjct: 596 SL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  257 bits (659), Expect = 1e-75
 Identities = 108/515 (20%), Positives = 177/515 (34%), Gaps = 30/515 (5%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKL 114
           +IP  +    S + L LS N        +  S   L  L      +         SL  L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 115 ERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSG 173
             L +  N I      +   LSSL+ +   E  L       +G LK+L  L+VA N    
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 174 MIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLR----ELRTNANNFTGFIPVSL 228
              P  F N+++LE + LS N+       D    L  +      L  + N      P + 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 229 SNASSLEMIEFSKNQFSGGV-SVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSK 287
                L  +    N  S  V       L  L    L +         E    + L     
Sbjct: 198 KE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 288 LERLYFNRNR---FEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDT 344
           L    F       +  ++      L++ +   ++    I      +         L +  
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIER--VKDFSYNFGWQHLELVN 313

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL--EGNIPSS 402
            +           L       L     +G    S  +L  L +L L  N L  +G    S
Sbjct: 314 CKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 403 LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRL 461
               T+L  L++S N +I T+    L +  L  +L+  ++ L       V  +L+NL+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 462 DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSI-PLLLDSLQSIKELDFSSNNLNGQI 520
           D+S            +  ++LE L ++GN+F  +  P +   L+++  LD S   L    
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 521 PEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTR 555
           P    +LS L+ LN+S+N+F         +     
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNS 519

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (250), Expect = 6e-22
 Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 5/138 (3%)

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLS 464
              N+             +P  +   T     L+L  N L         +   L  LDLS
Sbjct: 6   VVPNIT-YQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 465 GNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYL 524
             +          + ++L  L ++GN            L S+++L     NL       +
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 525 ENLSFLEFLNLSYNHFEG 542
            +L  L+ LN+++N  + 
Sbjct: 121 GHLKTLKELNVAHNLIQS 138

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  270 bits (694), Expect = 9e-84
 Identities = 90/254 (35%), Positives = 137/254 (53%), Gaps = 19/254 (7%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECK 688
           S  EL  A+DNFS+ N +G GG G VYKG L  +GT VAVK +  +  +G    F  E +
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            +    HRNL+++   C          + +VY +M NGS+   L    +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWPK 132

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
           R  IA+  A  + YLH +C+P I+H D+K +N+LLD++  + V DFGLAK +     DT 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTH 190

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF---NEG 865
           V T      ++GT+G++APEY    ++S K DV+ +G++LLEL T +R  D      ++ 
Sbjct: 191 VTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 866 LTLHDFSREFFTRK 879
           + L D+ +     K
Sbjct: 246 VMLLDWVKGLLKEK 259

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  270 bits (692), Expect = 5e-78
 Identities = 86/580 (14%), Positives = 174/580 (30%), Gaps = 64/580 (11%)

Query: 1   MNLCQWTGVTCGQRHQ--RVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPH 58
             L  W            RVT L L     +G +   +G L+ L+ ++  ++        
Sbjct: 306 KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL 365

Query: 59  QIGRLISLERLILSNNSFSGAIPANLSS------CSNLIELSADSNNLVGEIPADIGSLF 112
                ++ +      +                   S+L++ + + N  +  I  D     
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISL 425

Query: 113 KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFS 172
           K  ++    N IT  +  +I  L+ L++I    +                  +  + +  
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPF----TYDNIAVDWEDANSDYAKQY 480

Query: 173 GMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGF--------- 223
                S  N+  L  + L        LP     +LP L+ L    N              
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTR 539

Query: 224 IPVSLSNASSLEMIEFSKNQFSG-GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLL 282
           +         +++     N       S    ++  L  L+   N +          +   
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--------LEAF 591

Query: 283 TNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPP--EIRNLASLNWL 340
               KL  L  + N+ E E+P      +  ++ +    N++   IP     +++  +  +
Sbjct: 592 GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649

Query: 341 TIDTNQLTGTIPPEIG------ELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN 394
               N++       I       +  N   + L  N +Q          + ++ + L  N 
Sbjct: 650 DFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 395 LE-------GNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNG 446
           +             +  N   L  +++  NKL  +L       T   L  +++  N  + 
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFS- 766

Query: 447 SLPPEVGNLKNLMRLDL------SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLL 500
           S P +  N   L    +       GN+   + P  ++ C +L  L I  N        L 
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT 826

Query: 501 DSLQSIKELDFSSNNL-NGQIPEYLENLSFLEFLNLSYNH 539
             L     LD + N   +  +      +       L Y+ 
Sbjct: 827 PQLY---ILDIADNPNISIDVTSVCPYIE-AGMYVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  234 bits (599), Expect = 3e-65
 Identities = 68/522 (13%), Positives = 149/522 (28%), Gaps = 73/522 (13%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNG------EIPHQIGRLISLERL 69
           QR+   DL   +I    +P +  +     I++              I   I RL  L+ +
Sbjct: 396 QRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQII 453

Query: 70  ILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLP 129
             +N+ F+           +  + ++D             +L  L  + ++      QLP
Sbjct: 454 YFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508

Query: 130 ASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVIS 189
             + +L  L+ +++  NR                           +         +++  
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTR--------------LADDEDTGPKIQIFY 554

Query: 190 LSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVS 249
           +  N         +   +  L  L    N     +  +      L  ++   NQ      
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE 612

Query: 250 VDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANL 309
              +    +  L    N L       +  I    +   +  + F+ N+   E  +   ++
Sbjct: 613 DFCAFTDQVEGLGFSHNKL-----KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667

Query: 310 SS----TIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLT-------GTIPPEIGEL 358
                     + +  N I           + ++ + +  N +T                 
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727

Query: 359 TNLQQLDLDRNFLQGSIPSSL--GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
             L  +DL  N L  S+        L  L+ + +  N      P+   N + L    I H
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785

Query: 417 NKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATL 476
                                +   N +    P  +    +L++L +  N    ++   L
Sbjct: 786 Q-------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

Query: 477 SACANLEYLNISGNAF-SGSIPLLLDSLQS-IKELDFSSNNL 516
                L  L+I+ N   S  +  +   +++ +  L +     
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  181 bits (460), Expect = 2e-47
 Identities = 81/542 (14%), Positives = 159/542 (29%), Gaps = 65/542 (11%)

Query: 38  NLSFLRYINI-ASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSAD 96
             S +RY+++   N FN            L+ + ++    S       ++    +++   
Sbjct: 151 LFSNIRYVDVTVMNSFNRV-------TTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVA 203

Query: 97  SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLG 156
           + +    +PA     +++   + +      +      ++       V +N          
Sbjct: 204 TCDSAVWLPAGT---YQVVAYTTYSQSGIKRSELETQSVRGE-SFTVIDN---------- 249

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN 216
           +L     + +   + +  I       +  E +     R+      +T             
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTI--HSLNWNFNKE 307

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNL-GTGAANE 275
            + +     V L N   +  +  +     G V     +L  L  L+ G ++   +G    
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA 335
            + +    +  +  R+  +  +   +    +         I   RN     I  + R   
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN--RNPEMKPIKKDSRISL 425

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG-------------------SIP 376
               +   TN++T  I   I  LT LQ +    +                       +  
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484

Query: 377 SSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG---------TLPRQI 427
            S  NL  LT ++L        +P  L +   L  LNI+ N+ I           L    
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544

Query: 428 LRITTLSLYLELGNNLLNGSLPPEV--GNLKNLMRLDLSGNKFSGEIPATLSACANLEYL 485
                +     +G N L    P       +  L  LD   NK    + A       L  L
Sbjct: 545 DTGPKIQ-IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDL 600

Query: 486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLE--NLSFLEFLNLSYNHFEGE 543
            +  N               ++ L FS N L   IP      ++  +  ++ SYN    E
Sbjct: 601 KLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 544 VP 545
             
Sbjct: 660 GR 661

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  137 bits (346), Expect = 3e-33
 Identities = 55/403 (13%), Positives = 121/403 (30%), Gaps = 37/403 (9%)

Query: 156 GQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRT 215
                L  + V + + S               I ++       LP  T      +    T
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTY----QVVAYTT 223

Query: 216 NANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANE 275
            + +      +   +    E      N+ +   +V                 L   A   
Sbjct: 224 YSQSGIKRSELETQSVRG-ESFTVIDNKLTKDANVP--------------IQLKETAEYI 268

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA 335
            D+  L    +  E L     R+     ++  +  +         +        ++ N  
Sbjct: 269 KDYKALK---AIWEALDGKNWRYYSGTINNTIHSLNW--NFNKELDMWGDQPGVDLDNNG 323

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
            +  L++      G +P  IG+LT L+ L    +    S              +   + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383

Query: 396 EGNIPSSLG------NCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLP 449
             +            N ++LL   I+ N  +  + +        +    L N +    + 
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFIS 441

Query: 450 PEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKEL 509
             +  L  L  +  + + F+ +  A     AN +Y     N       L   +L+ + ++
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN-----EELSWSNLKDLTDV 496

Query: 510 DFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
           +  +     Q+P++L +L  L+ LN++ N       +K  +  
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 18/129 (13%), Positives = 41/129 (31%), Gaps = 1/129 (0%)

Query: 461 LDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQI 520
           LD    ++            N    N   + +     + LD+   +  L  +     G++
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 521 PEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQSKG 580
           P+ +  L+ L+ L+   +       + G        S     ++     ++ L   Q   
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 581 SLTILKVVI 589
              +L+  I
Sbjct: 400 LSDLLQDAI 408

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  258 bits (662), Expect = 7e-76
 Identities = 103/538 (19%), Positives = 187/538 (34%), Gaps = 24/538 (4%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
              L+     +    +     L  L ++++                  L+ L+L+ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
                 LS    L  L      +       + +   LE L +  NHI+            
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 138 LRVIDVRENRLWG-RIDSLGQLKSLTL--LSVAFNQFSGMIPPSIFNISSLEVISLSENR 194
           L+V+D + N +     + +  L+  T   L++  N  +G I P  F+ +  + ++    +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213

Query: 195 FTG-SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN--ASSLEMIEFSKNQFSGGVSVD 251
                        + SL        +     P         S+E I   K+ F    S  
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

Query: 252 FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSS 311
           F     L  L+L   +L           + L   S L++L  + N+FE     S +N  S
Sbjct: 274 FHCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326

Query: 312 TIKQIAMGRNRISGTIPPE-IRNLASLNWLTIDTNQLT--GTIPPEIGELTNLQQLDLDR 368
            +  +++  N     +    + NL +L  L +  + +        ++  L++LQ L+L  
Sbjct: 327 -LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385

Query: 369 NFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIP-SSLGNCTNLLGLNISHNKLIGTLPRQI 427
           N        +      L  L L    L+     S   N   L  LN+SH+ L  +  +  
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445

Query: 428 LRITTLSLYLELGNNLL---NGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEY 484
             +  L  +L L  N     N      +  L  L  L LS    S       ++   + +
Sbjct: 446 DGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504

Query: 485 LNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG 542
           +++S N  + S    L  L+ I  L+ +SN+++  +P  L  LS    +NL  N  + 
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  246 bits (629), Expect = 3e-71
 Identities = 105/519 (20%), Positives = 177/519 (34%), Gaps = 22/519 (4%)

Query: 39  LSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSN 98
            +    +  + N           RLI+L  L L+             S   L  L   +N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 99  NLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQ 157
            L+      +     L+ L   Q  I+      + N  +L  + +  N +   ++     
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENR-FTGSLPVDTGVNLPSLRELRTN 216
            + L +L    N    +    + ++     +SL+ N      +      +    + L   
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFG 210

Query: 217 ANNFTGFIPVSLSNAS--SLEMIEFSKNQFSGGVSVDFSRLKNLY--WLNLGINNLGTGA 272
                  I   L N++  SL +  F            F  L  +    +NL  +      
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-- 268

Query: 273 ANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR 332
                  N     S L+ L         ELP  +  LS+ +K++ +  N+          
Sbjct: 269 ----ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLST-LKKLVLSANKFENLCQISAS 322

Query: 333 NLASLNWLTIDTNQLTGTIPPE-IGELTNLQQLDLDRNFLQGS--IPSSLGNLTLLTYLK 389
           N  SL  L+I  N     +    +  L NL++LDL  + ++ S      L NL+ L  L 
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382

Query: 390 LGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLP 449
           L  N        +   C  L  L+++  +L     +   +   L   L L ++LL+ S  
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442

Query: 450 PEVGNLKNLMRLDLSGNKFSGEI---PATLSACANLEYLNISGNAFSGSIPLLLDSLQSI 506
                L  L  L+L GN F         +L     LE L +S    S        SL+ +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502

Query: 507 KELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVP 545
             +D S N L     E L +L  + +LNL+ NH    +P
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (553), Expect = 8e-61
 Identities = 91/551 (16%), Positives = 174/551 (31%), Gaps = 46/551 (8%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
           T LDL    I         +   L  + + +N         +    +L+ L       S 
Sbjct: 60  TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL 138
                L +   L  L   SN++            KL+ L    N I       + +L   
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 139 RVI--DVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN--ISSLEVISLSENR 194
             +  ++  N + G             L+    Q   +I   + N  I SL + +  +  
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239

Query: 195 FTG-------------------------SLPVDTGVNLPSLRELRTNANNFTGFIPVSLS 229
                                       ++  +T      L+EL   A + +  +P  L 
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLV 298

Query: 230 NASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLE 289
             S+L+ +  S N+F     +  S   +L  L++  N               L N   L 
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT-----GCLENLENLR 353

Query: 290 RLYFNRNRFE--GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQL 347
            L  + +  E        + NLS  ++ + +  N          +    L  L +   +L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSH-LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412

Query: 348 TGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI---PSSL 403
                      L  L+ L+L  + L  S       L  L +L L  N+         +SL
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDL 463
                L  L +S    + ++ +       +  +++L +N L  S    + +LK +  L+L
Sbjct: 473 QTLGRLEILVLSFCD-LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530

Query: 464 SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPL--LLDSLQSIKELDFSSNNLNGQIP 521
           + N  S  +P+ L   +    +N+  N    +      L+  +   +    + +   + P
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENP 590

Query: 522 EYLENLSFLEF 532
             L  +   + 
Sbjct: 591 PLLRGVRLSDV 601

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (321), Expect = 1e-30
 Identities = 41/264 (15%), Positives = 74/264 (28%), Gaps = 30/264 (11%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
             L ++ + +    N +          L +L +L +   Q+             L  L L
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPR- 425
             N L     ++L     L +L      +       L N   L  L +  N +       
Sbjct: 89  TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

Query: 426 -------QIL-----RITTLS------------LYLELGNNLLNGSLPPEVGNLKNLMRL 461
                  ++L      I  LS            L L L  N +   + P   +      L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSL 207

Query: 462 DLSGNKFSGEIPATLSACA--NLEYLNISGNAFSGSIPLLLDSLQ--SIKELDFSSNNLN 517
           +  G +    I   L      +L              P + + L   S++ ++   +   
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

Query: 518 GQIPEYLENLSFLEFLNLSYNHFE 541
                     S L+ L+L+  H  
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS 291

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.9 bits (221), Expect = 2e-18
 Identities = 30/131 (22%), Positives = 45/131 (34%), Gaps = 4/131 (3%)

Query: 412 LNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE 471
            N  +  L   +P  +   T     LE   N+L          L NL  LDL+  +    
Sbjct: 17  YNCENLGL-NEIPGTLPNSTE---CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 472 IPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLE 531
              T  +   L+ L ++ N         L   +++K L F    ++      L N   LE
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 532 FLNLSYNHFEG 542
            L L  NH   
Sbjct: 133 SLYLGSNHISS 143

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.5 bits (220), Expect = 3e-18
 Identities = 42/232 (18%), Positives = 78/232 (33%), Gaps = 11/232 (4%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPH-QIGRLISLERLILSNNSFS 77
             L+L         +        L  +++A      +        L  L+ L LS++   
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGS---LFKLERLSIFQNHITGQLPASIGN 134
            +          L  L+   N+          S   L +LE L +    ++     +  +
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498

Query: 135 LSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
           L  +  +D+  NRL    I++L  LK + L ++A N  S ++P  +  +S    I+L +N
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQN 557

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
               +       N+  L   + N             N   L  +  S    S
Sbjct: 558 PLDCTCS-----NIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  258 bits (660), Expect = 1e-75
 Identities = 112/541 (20%), Positives = 194/541 (35%), Gaps = 35/541 (6%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
              +DL    ++   S    N S L++++++              L  L  LIL+ N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITG-QLPASIGNLS 136
              P + S  ++L  L A    L       IG L  L++L++  N I   +LPA   NL+
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 137 SLRVIDVRENRLWG-RIDSLGQLKSLTL----LSVAFNQFSGMIPPSIFNISSLEVISLS 191
           +L  +D+  N +    ++ L  L+        L ++ N     I    F    L  ++L 
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212

Query: 192 ENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLE--------MIEFSKNQ 243
            N  + ++      NL  L   R     F     + +   S +E            +   
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
                 V F  L N+  ++L   ++          +  +    K + L   R + +    
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFPT 324

Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIP--PEIGELTNL 361
             +  L    K + +  N+ S  I  +   L SL++L +  N L+ +           +L
Sbjct: 325 LDLPFL----KSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378

Query: 362 QQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIP-SSLGNCTNLLGLNISHNKLI 420
           + LDL  N     + ++   L  L +L    + L+     S+  +   LL L+IS+    
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSAC 479
                  L +T+L+  L++  N    +    V  N  NL  LDLS  +            
Sbjct: 438 IDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             L+ LN+S N          + L S+  LD S N +             L F NL+ N 
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556

Query: 540 F 540
            
Sbjct: 557 V 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  232 bits (594), Expect = 2e-66
 Identities = 104/519 (20%), Positives = 175/519 (33%), Gaps = 39/519 (7%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKL 114
           ++P  I    S + + LS N        + S+ S L  L      +          L  L
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 115 ERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSG 173
             L +  N I    P S   L+SL  +   E +L       +GQL +L  L+VA N    
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

Query: 174 MIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN---ANNFTGFIPVSLS 229
              P+ F N+++L  + LS N    ++ V+    L    ++  +   + N   FI     
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201

Query: 230 NASSLEMIEFSKNQFSGGV-SVDFSRLKNLYWLNLGINNLGTG---AANELDFINLLTNC 285
               L  +    N  S  +       L  L+   L +            E   +  L + 
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261

Query: 286 SKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTN 345
           +  E           +       L++ +  +++    I      ++        L+I   
Sbjct: 262 TIDE-FRLTYTNDFSDDIVKFHCLAN-VSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRC 317

Query: 346 QLT-------------------GTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTL-- 384
           QL                    G+I  +   L +L  LDL RN L  S   S  +L    
Sbjct: 318 QLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377

Query: 385 LTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLL 444
           L +L L  N     + ++      L  L+  H+ L               LYL++     
Sbjct: 378 LRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 445 NGSLPPEVGNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPLLLDSL 503
                     L +L  L ++GN F     +   +   NL +L++S          + D+L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 504 QSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG 542
             ++ L+ S NNL      +   L  L  L+ S+N  E 
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  220 bits (562), Expect = 5e-62
 Identities = 97/545 (17%), Positives = 168/545 (30%), Gaps = 35/545 (6%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             LDL    I          L  L  + +  N      P     L SLE L+      + 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 79  AIPANLSSCSNLIELSADSNNLVG-EIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
                +     L +L+   N +   ++PA   +L  L  + +  N+I       +  L  
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 138 LR----VIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSE 192
                  +D+  N +    D   Q   L  L++  N  S  I  +   N++ L V  L  
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238

Query: 193 NRFTG-----SLPVDTGVNLPSLR--ELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
             F                L  +   E R    N      V     +++  +  +     
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298

Query: 246 GGVSVDF-SRLKNLYWLNLGINNLGTG----------AANELDFINLLTNCSKLERLYFN 294
               V    + ++L  +   +    T             N+            L  L  +
Sbjct: 299 YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLS 358

Query: 295 RNRFEGELPHSVANLSST-IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPP 353
           RN        S ++L +  ++ + +  N     +      L  L  L    + L      
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 354 E-IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSS-LGNCTNLLG 411
                L  L  LD+     +         LT L  LK+  N+ + N  S+   N TNL  
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477

Query: 412 LNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSG 470
           L++S  + +  +   +         L + +N L   L       L +L  LD S N+   
Sbjct: 478 LDLSKCQ-LEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSFNRIET 535

Query: 471 EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG---QIPEYLENL 527
                     +L + N++ N+ +  I      LQ +KE      N+       P  +   
Sbjct: 536 SKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTS 594

Query: 528 SFLEF 532
             L+F
Sbjct: 595 LVLDF 599

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  118 bits (298), Expect = 9e-28
 Identities = 55/312 (17%), Positives = 101/312 (32%), Gaps = 19/312 (6%)

Query: 17  RVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSF 76
            +    L   +           L+ +  +++A           + +    + L +     
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL- 135
                 +L     L  L+   N     I     +L  L  L + +N ++     S  +L 
Sbjct: 320 KQFPTLDL---PFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374

Query: 136 -SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSEN 193
            +SLR +D+  N       +   L+ L  L    +    +   S F ++  L  + +S  
Sbjct: 375 TNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVS-LSNASSLEMIEFSKNQFSGGVSVDF 252
                      + L SL  L+   N+F      +  +N ++L  ++ SK Q        F
Sbjct: 435 NTK-IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493

Query: 253 SRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSST 312
             L  L  LN+  NNL       LD  +       L  L  + NR E           S 
Sbjct: 494 DTLHRLQLLNMSHNNL-----LFLDS-SHYNQLYSLSTLDCSFNRIETSKGILQHFPKS- 546

Query: 313 IKQIAMGRNRIS 324
           +    +  N ++
Sbjct: 547 LAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.7 bits (236), Expect = 3e-20
 Identities = 32/156 (20%), Positives = 52/156 (33%), Gaps = 6/156 (3%)

Query: 397 GNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLK 456
           G++   +    N+        KL   +P  I   T     ++L  N L         N  
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKL-SKVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFS 56

Query: 457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
            L  LDLS  +             +L  L ++GN      P     L S++ L      L
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 517 NGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
                  +  L  L+ LN+++N       +   F+N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  246 bits (630), Expect = 9e-75
 Identities = 77/230 (33%), Positives = 123/230 (53%), Gaps = 17/230 (7%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
              +L +AT+NF     IG G  G VYKG L  +G +VA+K    +     + F  E + 
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           L   RH +L+ +I  C  R+        ++Y++M+NG+L+  L+ S+      S+S  QR
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLYGSDLP--TMSMSWEQR 141

Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L I I  A  + YLH     +I+H D+K  N+LLD++ V  ++DFG++K  +  +  T +
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHL 197

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
            T      +KGT+GY+ PEY +    + K DVYSFG++L E+   +    
Sbjct: 198 STV-----VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  233 bits (597), Expect = 3e-70
 Identities = 87/260 (33%), Positives = 126/260 (48%), Gaps = 31/260 (11%)

Query: 630 SYAELSKATDNFSS------ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--- 680
           S+ EL   T+NF         NK+GEGG G+VYKG++  N T VAVK +       +   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 681 -KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL 739
            + F  E K +   +H NL++++   S  D        +VY +M NGSL + L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMPNGSLLDRLSCLDGTP 128

Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS   R  IA   A+ I +LH   E   +H D+K +N+LLD+   + +SDFGLA+ 
Sbjct: 129 ---PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR- 181

Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
            S     T++ +R     I GT  Y+APE   G   + K D+YSFG++LLE+ T     D
Sbjct: 182 ASEKFAQTVMTSR-----IVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 860 AMFNEGLTLHDFSREFFTRK 879
                   L D   E    +
Sbjct: 236 EHREPQ-LLLDIKEEIEDEE 254

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  211 bits (539), Expect = 8e-62
 Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 29/247 (11%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
               L   +           G  G V+K  L      VAVK+    Q   S     E  +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP-IQDKQSWQNEYEVYS 71

Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           L  ++H N+++ I     R         ++  F + GSL ++L  +        +S  + 
Sbjct: 72  LPGMKHENILQFIGAEK-RGTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNEL 123

Query: 750 LNIAIDVASAIEYLHH-------YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
            +IA  +A  + YLH          +P+I H D+K  NVLL  +L + ++DFGLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMG-----REASMKGDVYSFGILLLELFTRKRP 857
                   +   + G  GT  Y+APE   G     R+A ++ D+Y+ G++L EL +R   
Sbjct: 184 GK------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 858 TDAMFNE 864
            D   +E
Sbjct: 238 ADGPVDE 244

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  205 bits (524), Expect = 3e-57
 Identities = 119/568 (20%), Positives = 195/568 (34%), Gaps = 45/568 (7%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
              LDL    +R   S    +   L+ ++++              L  L  LIL+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT-GQLPASIGNLS 136
                  S  S+L +L A   NL       IG L  L+ L++  N I   +LP    NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 137 SLRVIDVRENRLW----GRIDSLGQLKSLTL-LSVAFNQFSGMIPPSIFNISSLEVISLS 191
           +L  +D+  N++       +  L Q+  L L L ++ N  +  I P  F    L  ++L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208

Query: 192 ENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD 251
            N  + ++       L  L   R     F                              D
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE------------------GNLE---KFD 247

Query: 252 FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSS 311
            S L+ L  L +    L        D I+L    + +          E     S      
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307

Query: 312 TIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFL 371
            ++ +     +           L SL  LT  +N+       E+  L +L+ LDL RN L
Sbjct: 308 HLELVNCKFGQFPTL------KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGL 359

Query: 372 Q--GSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
              G    S    T L YL L  N +   + S+      L  L+  H+ L       +  
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 430 ITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNI 487
                +YL++ +          +   L +L  L ++GN F         +   NL +L++
Sbjct: 419 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 488 SGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMK 547
           S        P   +SL S++ L+ +SN L        + L+ L+ + L  N ++   P  
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

Query: 548 GVFN---NKTRFSIAGNGKLCGGLDELR 572
              +   NK      G+ K  G    +R
Sbjct: 538 DYLSRWLNKNSQKEQGSAKCSGSGKPVR 565

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (257), Expect = 6e-23
 Identities = 48/251 (19%), Positives = 83/251 (33%), Gaps = 30/251 (11%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
            NL  + K + +  N +         +   L  L +   ++          L++L  L L
Sbjct: 24  DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
             N +Q     +   L+ L  L     NL       +G+   L  LN++HN         
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL-------- 135

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEY-- 484
                           + +  LP    NL NL  LDLS NK        L     +    
Sbjct: 136 ----------------IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 485 --LNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE-YLENLSFLEFLNLSYNHFE 541
             L++S N  +  I         + +L   +N  +  + +  ++ L+ LE   L    F 
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

Query: 542 GEVPMKGVFNN 552
            E  ++    +
Sbjct: 239 NEGNLEKFDKS 249

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.6 bits (181), Expect = 1e-13
 Identities = 27/138 (19%), Positives = 49/138 (35%), Gaps = 5/138 (3%)

Query: 415 SHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA 474
                   +P  +   T     L+L  N L         +   L  LDLS  +       
Sbjct: 15  MELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLN 534
              + ++L  L ++GN            L S+++L     NL       + +L  L+ LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 535 LSYNHFEGEVPMKGVFNN 552
           +++N  +    +   F+N
Sbjct: 131 VAHNLIQ-SFKLPEYFSN 147

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  195 bits (498), Expect = 3e-56
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 30/216 (13%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
             +G G  G+V K        +VA+K   ++ +   K+F+ E + L  + H N++K    
Sbjct: 14  EVVGRGAFGVVCKAKW--RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK---- 65

Query: 705 CSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                  GA      +V E+ + GSL   LH +         +    ++  +  +  + Y
Sbjct: 66  -----LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQCSQGVAY 117

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           LH     +++H DLKP N+LL     V  + DFG A  +  H               KG+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----------MTNNKGS 166

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             ++APE   G   S K DV+S+GI+L E+ TR++P
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  193 bits (493), Expect = 2e-55
 Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 27/241 (11%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK- 688
           + +E S   DN      IG G  G VYKG L  +   VAVKV +   +   ++F+ E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNI 58

Query: 689 -ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
             +  + H N+ + I         G     +V E+  NGSL ++L          +   +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111

Query: 748 QRLNIAIDVASAIEYLH------HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
               +A  V   + YLH       + +P+I H DL   NVL+  D    +SDFGL+  L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMG-------REASMKGDVYSFGILLLELFTR 854
            +      E  + +I   GT+ Y+APE   G         A  + D+Y+ G++  E+F R
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 855 K 855
            
Sbjct: 232 C 232

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (491), Expect = 3e-55
 Identities = 69/215 (32%), Positives = 113/215 (52%), Gaps = 21/215 (9%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
            KIG G  G V++     +G++VAVK++  +   A     F+ E   ++ +RH N++  +
Sbjct: 43  EKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              +    +  +  +IV E++  GSL   LH S  + +   L   +RL++A DVA  + Y
Sbjct: 101 GAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNY 152

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH+   P IVH +LK  N+L+D+     V DFGL++  ++        T   S    GT 
Sbjct: 153 LHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTP 203

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++APE      ++ K DVYSFG++L EL T ++P
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  195 bits (497), Expect = 2e-54
 Identities = 111/484 (22%), Positives = 201/484 (41%), Gaps = 46/484 (9%)

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
           L    + +L   + +  +    +    +  L AD   +  +    +  L  L +++   N
Sbjct: 23  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
            +T   P  + NL+ L  I +  N++   I  L  L +LT L++  NQ + + P  + N+
Sbjct: 79  QLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDP--LKNL 133

Query: 183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKN 242
           ++L  + LS N  +    +     L SL++L    N  T   P  L+N ++LE ++ S N
Sbjct: 134 TNLNRLELSSNTISD---ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSN 187

Query: 243 QFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
           + S       ++L NL  L    N +          I  L   + L+ L  N N+ +   
Sbjct: 188 KVSDISV--LAKLTNLESLIATNNQISD--------ITPLGILTNLDELSLNGNQLKD-- 235

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQ 362
             ++A+L++ +  + +  N+IS   P  +  L  L  L +  NQ++   P  +  LT L 
Sbjct: 236 IGTLASLTN-LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290

Query: 363 QLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGT 422
            L+L+ N L+   P  + NL  LTYL L  NN+    P  + + T L  L   +NK+  +
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--S 344

Query: 423 LPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANL 482
               +  +T ++ +L  G+N ++      + NL  + +L L+   ++       +   N+
Sbjct: 345 DVSSLANLTNIN-WLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKA---NV 398

Query: 483 EYLNISGNAFSGSI-PLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
              N   N     I P  +    S  E D + N  +    E     S    +      F 
Sbjct: 399 SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFS 457

Query: 542 GEVP 545
           G V 
Sbjct: 458 GTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  192 bits (491), Expect = 1e-53
 Identities = 99/478 (20%), Positives = 189/478 (39%), Gaps = 47/478 (9%)

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
           G L S    I  +   +       ++ +  ++      N+   +      L ++  L   
Sbjct: 1   GPLGSA--TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
           +  I       +  L++L  I+   N+L   I  L  L  L  + +  NQ + + P  + 
Sbjct: 55  RLGIKS--IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LA 109

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
           N+++L  ++L  N+ T   P+    NL +L  L  ++N  +      LS  +SL+ + F 
Sbjct: 110 NLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG 164

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
                       + L  L  L++  N +          I++L   + LE L    N+   
Sbjct: 165 NQVTD---LKPLANLTTLERLDISSNKVSD--------ISVLAKLTNLESLIATNNQISD 213

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
             P  +  L++ + ++++  N++       + +L +L  L +  NQ++   P  +  LT 
Sbjct: 214 ITP--LGILTN-LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
           L +L L  N +    P  L  LT LT L+L  N LE   P  + N  NL  L +  N + 
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS 322

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACA 480
              P  +  +T L   L   NN ++      + NL N+  L    N+ S   P  L+   
Sbjct: 323 DISP--VSSLTKLQ-RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLT 375

Query: 481 NLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
            +  L ++  A++ + P+   +  SI     +        P  + +       ++++N
Sbjct: 376 RITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWN 431

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  167 bits (425), Expect = 9e-45
 Identities = 99/460 (21%), Positives = 184/460 (40%), Gaps = 64/460 (13%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
           T+++  N  +   ++P + NL+ L  I + +N      P  +  L +L  L L NN  + 
Sbjct: 71  TQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL 138
             P  L + +NL  L   SN +     + +  L  L++LS   N +T   P  + NL++L
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTL 179

Query: 139 RVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGS 198
             +D+  N++   I  L +L +L  L    NQ S + P  +  +++L+ +SL+ N+    
Sbjct: 180 ERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235

Query: 199 LPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNL 258
             + T  +L +L +L    N  +   P  LS  + L  ++   NQ S       + L  L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 289

Query: 259 YWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAM 318
             L L  N L          I+ ++N   L  L    N      P  V++L+  ++++  
Sbjct: 290 TNLELNENQLED--------ISPISNLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFF 338

Query: 319 GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSS 378
             N++S      + NL ++NWL+   NQ++   P  +  LT + QL L+      +  + 
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394

Query: 379 LGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLE 438
             N+++   +K     L    P+++ +  +    +I+ N                     
Sbjct: 395 KANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLP------------------- 433

Query: 439 LGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
                               + +      FSG +   L A
Sbjct: 434 -------SYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  101 bits (255), Expect = 7e-23
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 36/232 (15%)

Query: 331 IRNLASLNWLTIDTNQLTGTIP--------------------PEIGELTNLQQLDLDRNF 370
              LA      +    +T T+                       +  L NL Q++   N 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ 79

Query: 371 LQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRI 430
           L    P  L NLT L  + +  N +     + L N TNL GL + +N++    P  +  +
Sbjct: 80  LTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNL 133

Query: 431 TTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGN 490
           T L+  LEL +N ++      +  L +L +L    N+ +   P  L+    LE L+IS N
Sbjct: 134 TNLN-RLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSN 187

Query: 491 AFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG 542
             S      L  L +++ L  ++N ++   P  L  L+ L+ L+L+ N  + 
Sbjct: 188 KVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 95.0 bits (237), Expect = 1e-20
 Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 17/207 (8%)

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
            L   TI  +     I      L    +  L +  +  ++     +L  +T L+     +
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 396 EGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNL 455
                  +    NL  +N S+N+L    P  +  +T L   + + NN +       + NL
Sbjct: 59  --KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV-DILMNNNQIAD--ITPLANL 111

Query: 456 KNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN 515
            NL  L L  N+ +   P  L    NL  L +S N  S      L  L S+++L F  N 
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQ 166

Query: 516 LNGQIPEYLENLSFLEFLNLSYNHFEG 542
           +    P  L NL+ LE L++S N    
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSD 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  200 bits (510), Expect = 9e-54
 Identities = 109/550 (19%), Positives = 196/550 (35%), Gaps = 54/550 (9%)

Query: 46  NIASNGFNG--EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGE 103
            IA   F    ++P     L + ERL+LS N       ++      L  L   S      
Sbjct: 7   RIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 104 IPADI-GSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI---DSLGQLK 159
           I  +   +L  L  L +  + I    P +   L  L  + +    L   +        LK
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 160 SLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDT--GVNLPSLRELRTN 216
           +LT L ++ NQ   +     F  ++SL+ I  S N+    +       +   +L      
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLA 182

Query: 217 ANNFTGFIPVSLSNAS------SLEMIEFSKNQFSGGVSVDFSR------------LKNL 258
           AN+    + V             LE+++ S N ++  ++ +FS               ++
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242

Query: 259 YWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAM 318
                G +N+     ++  F  L    S +  L  +              L   +K + +
Sbjct: 243 MGAGFGFHNIKD--PDQNTFAGL--ARSSVRHLDLSHGFVFSLNSRVFETLKD-LKVLNL 297

Query: 319 GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPS 377
             N+I+         L +L  L +  N L   +       L  +  +DL +N +      
Sbjct: 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356

Query: 378 SLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYL 437
           +   L  L  L L  N L     +++    ++  + +S NKL+ TLP+  L    + L  
Sbjct: 357 TFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHL-- 408

Query: 438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG-EIPATLSACANLEYLNISGNAFSGSI 496
              N L N  +   +  + +L  L L+ N+FS      T S   +LE L +  N    + 
Sbjct: 409 -SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467

Query: 497 -----PLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFN 551
                  + + L  ++ L  + N LN   P    +L+ L  L+L+ N     +    +  
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526

Query: 552 NKTRFSIAGN 561
           N     I+ N
Sbjct: 527 NLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  169 bits (431), Expect = 1e-43
 Identities = 122/628 (19%), Positives = 208/628 (33%), Gaps = 71/628 (11%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
             L+LG+Q    T+      NL  LR +++ S+      P     L  L  L L     S
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 78  GAI--PANLSSCSNLIELSADSNNLVG-EIPADIGSLFKLERLSIFQNHITGQLPASIGN 134
            A+       +   L  L    N +    +    G L  L+ +    N I       +  
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170

Query: 135 LS--SLRVIDVRENRL-------WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN---- 181
           L   +L    +  N L       WG+  +  +   L +L V+ N ++  I  +  N    
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230

Query: 182 --------ISSLEVISLSENRFTGSLPVDT--GVNLPSLRELRTNANNFTGFIPVSLSNA 231
                      +       +        +T  G+   S+R L  +               
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
             L+++  + N+ +      F  L NL  LNL  N LG        + +      K+  +
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE------LYSSNFYGLPKVAYI 343

Query: 292 YFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTI 351
              +N        +   L   ++ + +  N ++      I  + S+  + +  N+L  T+
Sbjct: 344 DLQKNHIAIIQDQTFKFLEK-LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TL 396

Query: 352 PPEIGELTNLQQLDLDRNFLQG-SIPSSLGNLTLLTYLKLGLNNLEG-NIPSSLGNCTNL 409
           P           + L  N L+   I   L  +  L  L L  N     +   +     +L
Sbjct: 397 PKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453

Query: 410 LGLNISHNKLIGTLPRQILRITTLSL----YLELGNNLLNGSLPPEV-GNLKNLMRLDLS 464
             L +  N L      ++       L     L L +N LN SLPP V  +L  L  L L+
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLN 512

Query: 465 GNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYL 524
            N+ +      L A  NLE L+IS N      P   D   S+  LD + N    +     
Sbjct: 513 SNRLTVLSHNDLPA--NLEILDISRNQLLAPNP---DVFVSLSVLDITHNKFICEC---- 563

Query: 525 ENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCG-GLDELRLPSCQSKGSLT 583
           E  +F+ +LN +            +                G  L  L    C  +  L 
Sbjct: 564 ELSTFINWLNHTNVT---------IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLK 614

Query: 584 ILKVVIPVIVSCLILSVGFTLIYVWRRR 611
            LK  + ++ +  +     T++ V + R
Sbjct: 615 SLKFSLFIVCTVTLTLFLMTILTVTKFR 642

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  102 bits (256), Expect = 2e-22
 Identities = 83/442 (18%), Positives = 164/442 (37%), Gaps = 47/442 (10%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNL--SFLRYINIASNGFNGEIPHQ 59
           N    +          +     G  +I+         L  S +R+++++           
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285

Query: 60  IGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLS 118
              L  L+ L L+ N  +           NL  L+  S NL+GE+ +     L K+  + 
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL-SYNLLGELYSSNFYGLPKVAYID 344

Query: 119 IFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPS 178
           + +NHI      +   L  L+ +D+R+N     + ++  + S+  + ++ N+   +   +
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDN----ALTTIHFIPSIPDIFLSGNKLVTLPKIN 400

Query: 179 IFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIE 238
           +    +  +I LSENR      +   + +P L+ L  N N F+                 
Sbjct: 401 L----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT---------- 446

Query: 239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRF 298
                         S   +L  L LG N L      EL + ++    S L+ LY N N  
Sbjct: 447 -------------PSENPSLEQLFLGENMLQLAWETELCW-DVFEGLSHLQVLYLNHNYL 492

Query: 299 EGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
               P   ++L++ ++ +++  NR++  +       A+L  L I  NQL     P++   
Sbjct: 493 NSLPPGVFSHLTA-LRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDV--F 546

Query: 359 TNLQQLDLDRNFLQGSIP-SSLGNLTLLTYLKLG--LNNLEGNIPSSLGN--CTNLLGLN 413
            +L  LD+  N        S+  N    T + +     ++    P S       +L    
Sbjct: 547 VSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEG 606

Query: 414 ISHNKLIGTLPRQILRITTLSL 435
               +++ +L   +  + T++L
Sbjct: 607 CDEEEVLKSLKFSLFIVCTVTL 628

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (477), Expect = 1e-53
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 42/229 (18%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-------KSFVAECKALRNIRHRN 697
            +IG+GG G+V+KG L ++ + VA+K + L             + F  E   + N+ H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 698 LIKIITVCSGRDFKGADFKA--IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           ++K           G       +V EF+  G L   L           +    +L + +D
Sbjct: 85  IVK---------LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLMLD 130

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----DLVSHVSDFGLAKFLSNHNPDTIVE 810
           +A  IEY+ +   P IVH DL+  N+ L        + + V+DFGL++   +        
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-------- 181

Query: 811 TRSISIGIKGTVGYVAPE--YGMGREASMKGDVYSFGILLLELFTRKRP 857
                 G+ G   ++APE         + K D YSF ++L  + T + P
Sbjct: 182 ---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (472), Expect = 3e-53
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA--SKSFVAECKALRNIRHRNLIKII 702
            K+ E  SG ++KG     G ++ VKV+ ++      S+ F  EC  LR   H N++ ++
Sbjct: 16  TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
             C       A    ++  +M  GSL   LH   +      +   Q +  A+D+A  + +
Sbjct: 74  GACQSPP---APHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAF 126

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH   EP I    L   +V++D+D+ + +S   +                  S G     
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------------SPGRMYAP 172

Query: 823 GYVAPE------YGMGREASMKGDVYSFGILLLELFTRKRP 857
            +VAPE          R ++   D++SF +LL EL TR+ P
Sbjct: 173 AWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (458), Expect = 3e-51
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK----QKGASKSFVAECKALRNIRHRNLIK 700
             IG GG G VY+ F    G EVAVK              ++   E K    ++H N+I 
Sbjct: 13  EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +  VC     K  +   +V EF + G L   L           +     +N A+ +A  +
Sbjct: 71  LRGVCL----KEPNL-CLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIARGM 118

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSH--------VSDFGLAKFLSNHNPDTIVETR 812
            YLH      I+H DLK SN+L+ Q + +         ++DFGLA+              
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---------- 168

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +  +   G   ++APE       S   DV+S+G+LL EL T + P
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (450), Expect = 9e-50
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 19/223 (8%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
             +G+G  G   K    E G  + +K +    +   ++F+ E K +R + H N++K I V
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
                 K       + E+++ G+L   +   + Q         QR++ A D+AS + YLH
Sbjct: 76  LY----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLH 125

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT------IVETRSISIGI 818
                +I+H DL   N L+ ++    V+DFGLA+ + +               R     +
Sbjct: 126 ---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
            G   ++APE   GR    K DV+SFGI+L E+  R       
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  175 bits (447), Expect = 1e-49
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 28/218 (12%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
            +IG G  G VYKG    +G +VAVK++N+        ++F  E   LR  RH N++  +
Sbjct: 30  QRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              +          AIV ++ +  SL   LH S  +       + + ++IA   A  ++Y
Sbjct: 87  GYSTAPQL------AIVTQWCEGSSLYHHLHASETKF-----EMKKLIDIARQTARGMDY 135

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH     SI+H DLK +N+ L +D    + DFGLA   S  +     E         G++
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSI 186

Query: 823 GYVAPE---YGMGREASMKGDVYSFGILLLELFTRKRP 857
            ++APE          S + DVY+FGI+L EL T + P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  173 bits (441), Expect = 1e-48
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 30/228 (13%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK--ALRNIRHRNLIKII 702
             +G+G  G V++G     G  VAVK+ + + +   KS+  E +      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                          ++  + + GSL ++L  +       +L  +  L I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120

Query: 763 LH-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           LH        +P+I H DLK  N+L+ ++    ++D GLA   S     +  +    +  
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNP 176

Query: 818 IKGTVGYVAPE------YGMGREASMKGDVYSFGILLLELFTRKRPTD 859
             GT  Y+APE           ++  + D+++FG++L E+  R     
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  179 bits (455), Expect = 4e-48
 Identities = 97/508 (19%), Positives = 179/508 (35%), Gaps = 39/508 (7%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFK 113
            IP  +    +++ L LS N  +     +L +C+NL  L   S+ +   I  D   SL  
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGS 75

Query: 114 LERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLW--GRIDSLGQLKSLTLLSVAFNQF 171
           LE L +  NH++    +  G LSSL+ +++  N     G       L +L  L +   + 
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 172 SGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN 230
              I    F  ++SL  + +       +    +  ++  +  L  + +     + +    
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 231 ASSLEMIEFSKNQ---FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSK 287
            SS+  +E        F             +  L    + L   + NEL  + LL    +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL--LKLLRYILE 252

Query: 288 LERLYFNRNRFEG------ELPHSVANLSS----TIKQIAMGRNRISGTIPPEIRNLASL 337
           L  + F+     G           V+ L      TI+++ + +  +   +      L  +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI---PSSLGNLTLLTYLKLGLNN 394
             +T++ +++          L +L+ LDL  N +        +  G    L  L L  N+
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372

Query: 395 LE--GNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           L         L    NL  L+IS N     +P        +  +L L +  +   +    
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNT-FHPMPDSCQWPEKM-RFLNLSSTGIR-VVKT-- 427

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
              + L  LD+S N         L     L+ L IS N    ++P        +  +  S
Sbjct: 428 CIPQTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLK-TLPDAS-LFPVLLVMKIS 481

Query: 513 SNNLNGQIPEYLENLSFLEFLNLSYNHF 540
            N L        + L+ L+ + L  N +
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  161 bits (409), Expect = 4e-42
 Identities = 90/476 (18%), Positives = 178/476 (37%), Gaps = 34/476 (7%)

Query: 86  SCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRE 145
           SC         S +    IP+ +     ++ L +  N IT      +   ++L+V+ ++ 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 146 NRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDT 203
           +R+     D+   L SL  L ++ N  S  +  S F  +SSL+ ++L  N +        
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 204 GVNLPSLRELR-TNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLN 262
             NL +L+ LR  N   F+    +  +  +SL  +E          S     +++++ L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 263 LGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE----GELPHSVANLSSTIKQIAM 318
           L ++          D ++ +    +L      R +F      E+   +  L+     +  
Sbjct: 179 LHLSESAFLLEIFADILSSVR-YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 319 GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIG--------ELTNLQQLDLDRNF 370
                   +   I  L+ + +     N L    P E          E   +++L + + +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297

Query: 371 LQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRI 430
           L   + +    L  +  + +  + +     S   +  +L  L++S N ++    +     
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 431 TTLS--LYLELGNNLLNGSLPPEVG---NLKNLMRLDLSGNKFSGEIPATLSACANLEYL 485
                   L L  N L  S+         LKNL  LD+S N F   +P +      + +L
Sbjct: 358 GAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415

Query: 486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
           N+S       +       Q+++ LD S+NNL+     +L     L+ L +S N  +
Sbjct: 416 NLSSTGIR-VVK--TCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  130 bits (328), Expect = 8e-32
 Identities = 64/398 (16%), Positives = 120/398 (30%), Gaps = 52/398 (13%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           IP  +   ++++ + LS N+ T  +         +L+ L   ++        +  +  SL
Sbjct: 20  IPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           E ++ S N  S   S  F  L +L +LNL  N         L   +L  N + L+ L   
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY-----QTLGVTSLFPNLTNLQTLRIG 131

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
                                        S     +   L SLN L I    L       
Sbjct: 132 NV------------------------ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNI 414
           +  + ++  L L  +     +      L+ + YL+L   NL     S L        +  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 415 SHNKL----------IGTLPRQILRITTLSLY-------LELGNNLLNGSLPPEVGNLKN 457
              +           +  L R IL ++ +           +   +  +            
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           + RL +       ++    S    ++ + +  +            L+S++ LD S N + 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 518 GQI---PEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
            +             L+ L LS NH         +   
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  128 bits (323), Expect = 4e-31
 Identities = 63/453 (13%), Positives = 129/453 (28%), Gaps = 72/453 (15%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
             L +GN      +       L+ L  + I +          +  +  +  L L  +  +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
             +       S++  L     NL     + +        +       +     S   L  
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTG 197
           L             +  + +L  +       N      P     +S L            
Sbjct: 246 L-------------LRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL------------ 280

Query: 198 SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKN 257
                  V   ++R L          +    S    ++ I    ++           LK+
Sbjct: 281 -----GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335

Query: 258 LYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE--GELPHSVANLSSTIKQ 315
           L +L+L  N +               +   L+ L  ++N      +    +  L + +  
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPS---LQTLVLSQNHLRSMQKTGEILLTLKN-LTS 391

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI 375
           + + RN     +P   +    + +L + +  +   +   I     L+ LD+  N L  S 
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SF 446

Query: 376 PSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL 435
              L     L  L +  N L+  +P +      LL + IS N+ + ++P  I        
Sbjct: 447 SLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQ-LKSVPDGIFD------ 494

Query: 436 YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKF 468
                              L +L ++ L  N +
Sbjct: 495 ------------------RLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 33/116 (28%), Positives = 54/116 (46%), Gaps = 5/116 (4%)

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
             +    S+P  +     +  LDLS NK +      L ACANL+ L +  +  +      
Sbjct: 14  SRSF--TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTR 555
             SL S++ LD S N+L+     +   LS L++LNL  N ++  + +  +F N T 
Sbjct: 70  FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  172 bits (438), Expect = 5e-48
 Identities = 65/265 (24%), Positives = 104/265 (39%), Gaps = 39/265 (14%)

Query: 604 LIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGEN 663
           L  +  R   RKAS      Q++ +  + +L            IG+G  G VY G    +
Sbjct: 6   LSLLSARSFPRKASQTSIFLQEWDIP-FEQLEIG-------ELIGKGRFGQVYHGRW--H 55

Query: 664 GTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYE 721
           G EVA+++I++++      K+F  E  A R  RH N++  +  C           AI+  
Sbjct: 56  G-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM----SPPHL-AIITS 109

Query: 722 FMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNV 781
             +  +L   +  +   L      V +   IA ++   + YLH      I+H DLK  NV
Sbjct: 110 LCKGRTLYSVVRDAKIVL-----DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNV 161

Query: 782 LLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE---------YGMG 832
             D   V  ++DFGL             +   I  G    + ++APE             
Sbjct: 162 FYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG---WLCHLAPEIIRQLSPDTEEDK 217

Query: 833 REASMKGDVYSFGILLLELFTRKRP 857
              S   DV++ G +  EL  R+ P
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWP 242

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (431), Expect = 7e-47
 Identities = 54/231 (23%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECK--ALRNIRHRNLIKII 702
             IG+G  G V++G     G EVAVK+ + +++   +S+  E +      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
              +  +        +V ++ ++GSL ++L+         +++V   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154

Query: 763 LH-----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN-HNPDTIVETRSISI 816
           LH        +P+I H DLK  N+L+ ++    ++D GLA    +  +   I        
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN----- 209

Query: 817 GIKGTVGYVAPE------YGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
              GT  Y+APE           E+  + D+Y+ G++  E+  R       
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (429), Expect = 1e-46
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 28/227 (12%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            +IG+G  G V+ G     G +VAVKV    ++ AS     E      +RH N++  I  
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAA 99

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
                        ++ ++ +NGSL ++L  +       +L     L +A    S + +LH
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLH 151

Query: 765 -----HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA-KFLSNHNPDTIVETRSISIGI 818
                   +P+I H DLK  N+L+ ++    ++D GLA KF+S+ N   I          
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN-----TR 206

Query: 819 KGTVGYVAPE------YGMGREASMKGDVYSFGILLLELFTRKRPTD 859
            GT  Y+ PE           ++ +  D+YSFG++L E+  R     
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  171 bits (436), Expect = 3e-46
 Identities = 95/485 (19%), Positives = 179/485 (36%), Gaps = 80/485 (16%)

Query: 57  PHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLER 116
           P  +     L+  +  +++ +  +P    +  +  E     +      P   G   ++  
Sbjct: 5   PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 117 LSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIP 176
             +                     +++    L    +    L+SL     + N  +  +P
Sbjct: 63  SRLRDCLDR-----------QAHELELNNLGLSSLPELPPHLESLVA---SCNSLT-ELP 107

Query: 177 PSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEM 236
               ++ SL V + +    +           P L  L  + N     +P  L N+S L++
Sbjct: 108 ELPQSLKSLLVDNNNLKALSD--------LPPLLEYLGVSNNQLE-KLP-ELQNSSFLKI 157

Query: 237 IEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRN 296
           I+   N       +      +L ++  G         N+L+ +  L N   L  +Y + N
Sbjct: 158 IDVDNNSLK---KL-PDLPPSLEFIAAG--------NNQLEELPELQNLPFLTAIYADNN 205

Query: 297 RFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIG 356
             + +LP    +L    + I  G N +     PE++NL  L  +  D N L  T+P    
Sbjct: 206 SLK-KLPDLPLSL----ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP 257

Query: 357 ELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
              +L+ L++  N+L   +P    +LT L   +   + L    P       NL  LN S 
Sbjct: 258 ---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASS 306

Query: 417 NKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATL 476
           N+ I +L      +  L+    + NN L   LP     L+   RL  S N  + E+P   
Sbjct: 307 NE-IRSLCDLPPSLEELN----VSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELP 356

Query: 477 SACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS 536
               NL+ L++  N      P + +S++ ++      N+   ++PE  +N   L+ L++ 
Sbjct: 357 Q---NLKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVE 404

Query: 537 YNHFE 541
            N   
Sbjct: 405 TNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  171 bits (435), Expect = 3e-46
 Identities = 96/513 (18%), Positives = 174/513 (33%), Gaps = 89/513 (17%)

Query: 32  LSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSS----- 86
           ++P   + +FL+     S+    E+P +   + S      + + +    P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 87  --------CSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL 138
                        EL  ++  L   +P     L   E L    N +T +LP    +L SL
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSL 116

Query: 139 RVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGS 198
            V +     L      L        L V+ NQ   +  P + N S L++I +  N     
Sbjct: 117 LVDNNNLKALSDLPPLL------EYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-K 167

Query: 199 LPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNL 258
           LP       PSL  +    N     +P  L N   L  I    N              +L
Sbjct: 168 LPD----LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK----KLPDLPLSL 217

Query: 259 YWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAM 318
             +  G         N L+ +  L N   L  +Y + N  +  LP    +L    + + +
Sbjct: 218 ESIVAG--------NNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSL----EALNV 264

Query: 319 GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL--------------TNLQQL 364
             N ++  +P   ++L  L+      + L+  +PP +  L               +L++L
Sbjct: 265 RDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEEL 322

Query: 365 DLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
           ++  N L   +P+    L  L       N+L   +P    N   L   ++ +N L    P
Sbjct: 323 NVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFP 373

Query: 425 RQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEY 484
                +  L +     N+ L   +P    NLK   +L +  N    E P       ++E 
Sbjct: 374 DIPESVEDLRM-----NSHLA-EVPELPQNLK---QLHVETNPLR-EFPDIPE---SVED 420

Query: 485 LNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L ++            ++   +++  F  ++ +
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  142 bits (359), Expect = 3e-36
 Identities = 80/440 (18%), Positives = 148/440 (33%), Gaps = 63/440 (14%)

Query: 14  RHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSN 73
             ++   L+L N  +  +L     +L     +  + N    E+P     L SL     + 
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 74  NSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIG 133
            + S   P        L  L   +N L  ++P ++ +   L+ + +  N +  +LP    
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173

Query: 134 NLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
           +L  +       N+L   +  L  L  LT +    N     +P    +   LE I    N
Sbjct: 174 SLEFI---AAGNNQL-EELPELQNLPFLTAIYADNNSLKK-LPDLPLS---LESIVAGNN 225

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
                LP     NLP L  +  + N     +P    +   LE +    N  +  +     
Sbjct: 226 ILE-ELPELQ--NLPFLTTIYADNNLLKT-LPDLPPS---LEALNVRDNYLTD-LPELPQ 277

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTN--------CSKLERLYFNRNRFEGELPHS 305
            L  L       + L     N L ++N  +N           LE L  + N+   ELP  
Sbjct: 278 SLTFLDVSENIFSGLSELPPN-LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 335

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLD 365
              L    +++    N ++  +P   +NL  L+   ++ N L    P     + +L+   
Sbjct: 336 PPRL----ERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM-- 384

Query: 366 LDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPR 425
              N     +P    NL     L +  N L    P    +  +L    ++  +++     
Sbjct: 385 ---NSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEF 434

Query: 426 QILRITTLSLYLELGNNLLN 445
                  L   +   ++  +
Sbjct: 435 AHETTDKLEDDV-FEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  125 bits (315), Expect = 2e-30
 Identities = 75/371 (20%), Positives = 127/371 (34%), Gaps = 76/371 (20%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           I P   + + L+      +  T  +PV+   N+ S  E     + +    P        +
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
            +                   +  + L L    L +          L      LE L  +
Sbjct: 61  AVSRLRDC-----------LDRQAHELELNNLGLSS----------LPELPPHLESLVAS 99

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
            N    ELP    +L S +         +S   P        L +L +  NQL   +P E
Sbjct: 100 CNSLT-ELPELPQSLKS-LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-E 148

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNI 414
           +   + L+ +D+D N L+  +P    +L    ++  G N LE  +P  L N   L  +  
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELPE-LQNLPFLTAIYA 202

Query: 415 SHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA 474
            +N L   LP   L + ++      GNN+L     PE+ NL  L  +    N        
Sbjct: 203 DNNSLK-KLPDLPLSLESIVA----GNNIL--EELPELQNLPFLTTIYADNNLLK----- 250

Query: 475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLN 534
                               ++P L  SL++   L+   N L   +PE  ++L+FL+   
Sbjct: 251 --------------------TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSE 286

Query: 535 LSYNHFEGEVP 545
             ++      P
Sbjct: 287 NIFSGLSELPP 297

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  166 bits (422), Expect = 2e-45
 Identities = 92/420 (21%), Positives = 168/420 (40%), Gaps = 82/420 (19%)

Query: 97  SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLG 156
               + +I  D   L +  R  + +  +T     +   L S+  + V   ++   I  + 
Sbjct: 8   LPAPINQIFPD-ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV-ASIQGIE 63

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN 216
            L +L  L++  NQ + + P  + N+  L  + +  N+ T    +    NL +LREL  N
Sbjct: 64  YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ---NLTNLRELYLN 118

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANEL 276
            +N +   P                           + L  +Y LNLG N+  +      
Sbjct: 119 EDNISDISP--------------------------LANLTKMYSLNLGANHNLS------ 146

Query: 277 DFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLAS 336
             ++ L+N + L  L    ++ +   P  +ANL+  +  +++  N+I    P  + +L S
Sbjct: 147 -DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLTS 200

Query: 337 LNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLE 396
           L++ T   NQ+T   P  +  +T L  L +  N +    P  L NL+ LT+L++G N + 
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 397 GNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLK 456
               +++ + T L  LN+  N+           I+ +S                 + NL 
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQ-----------ISDIS----------------VLNNLS 287

Query: 457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
            L  L L+ N+   E    +    NL  L +S N  +   P  L SL  +   DF++  +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (419), Expect = 5e-45
 Identities = 75/404 (18%), Positives = 150/404 (37%), Gaps = 59/404 (14%)

Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
              L       +   P   +  +  I       ++   +      L  + +L +    + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
                 I  L++L  +++  N++   I  L  L  LT L +  N+ +     ++ N+++L
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNL 112

Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
             + L+E+  +   P+    NL  +  L   AN+    +   LSN + L  +  ++++  
Sbjct: 113 RELYLNEDNISDISPLA---NLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168

Query: 246 GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
                  + L +LY L+L  N +          I+ L + + L                 
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIED--------ISPLASLTSLHYFT------------- 205

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLD 365
                          N+I+   P  + N+  LN L I  N++T   P  +  L+ L  L+
Sbjct: 206 ------------AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249

Query: 366 LDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPR 425
           +  N +     +++ +LT L  L +G N +     S L N + L  L +++N+L      
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 426 QILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFS 469
            I  +T L+  L L  N +       + +L  +   D +     
Sbjct: 306 VIGGLTNLT-TLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  154 bits (391), Expect = 2e-41
 Identities = 79/381 (20%), Positives = 144/381 (37%), Gaps = 56/381 (14%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
               R  L   S+          L  +  + +A       I   I  L +LE L L+ N 
Sbjct: 22  AEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQ 77

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
            +   P  LS+   L  L   +N +     + + +L  L  L + +++I+    + + NL
Sbjct: 78  ITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANL 131

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
           + +  +++  N     +  L  +  L  L+V  ++   + P  I N++ L  +SL+ N+ 
Sbjct: 132 TKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189

Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL 255
               P+    +L SL       N  T   P  ++N + L  ++   N+ +       + L
Sbjct: 190 EDISPLA---SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANL 242

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQ 315
             L WL +G N +          IN + + +KL+ L    N+                  
Sbjct: 243 SQLTWLEIGTNQISD--------INAVKDLTKLKMLNVGSNQI----------------- 277

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI 375
                     +    + NL+ LN L ++ NQL       IG LTNL  L L +N +    
Sbjct: 278 ----------SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327

Query: 376 PSSLGNLTLLTYLKLGLNNLE 396
           P  L +L+ +         ++
Sbjct: 328 P--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  148 bits (377), Expect = 2e-39
 Identities = 81/391 (20%), Positives = 140/391 (35%), Gaps = 61/391 (15%)

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
             +L  L    NQ          +++      L +   T  +  +    L S+ +L    
Sbjct: 2   AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAG 53

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                     +   ++LE +  + NQ +       S L  L  L +G         N++ 
Sbjct: 54  EKVASIQG--IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIG--------TNKIT 101

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL 337
            I+ L N + L  LY N +                                  + NL  +
Sbjct: 102 DISALQNLTNLRELYLNEDNISD---------------------------ISPLANLTKM 134

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
             L +  N    +    +  +T L  L +  + ++   P  + NLT L  L L  N +E 
Sbjct: 135 YSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN 457
             P  L + T+L       N++    P  +  +T L+  L++GNN +       + NL  
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN-SLKIGNNKITDL--SPLANLSQ 244

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L  L++  N+ S  I A +     L+ LN+  N  S    L  ++L  +  L  ++N L 
Sbjct: 245 LTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLG 300

Query: 518 GQIPEYLENLSFLEFLNLSYNHFEGEVPMKG 548
            +  E +  L+ L  L LS NH     P+  
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  160 bits (407), Expect = 9e-44
 Identities = 57/322 (17%), Positives = 115/322 (35%), Gaps = 27/322 (8%)

Query: 227 SLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCS 286
              ++S  E + F  +          S+ +  Y  +           N         N +
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR----------NRWHSAWRQANSN 56

Query: 287 KLERLYFNRNRFEGELPHSVANLSST-IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTN 345
             +         +      + + +      + +    +    P +   L+ L  +TID  
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 346 QLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGN 405
            L   +P  + +   L+ L L RN L+ ++P+S+ +L  L  L +        +P  L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 406 C---------TNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLK 456
                      NL  L +    +  +LP  I  +  L   L++ N+ L+ +L P + +L 
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-ALGPAIHHLP 229

Query: 457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
            L  LDL G       P      A L+ L +   +   ++PL +  L  +++LD      
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289

Query: 517 NGQIPEYLENLSFLEFLNLSYN 538
             ++P  +  L     + +  +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  155 bits (394), Expect = 6e-42
 Identities = 56/302 (18%), Positives = 99/302 (32%), Gaps = 29/302 (9%)

Query: 255 LKNLYWLNL-GINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTI 313
                 L   G   L         + ++L+   +      NR        +S        
Sbjct: 11  SSGRENLYFQGSTALRP-------YHDVLSQWQRHYNADRNRWHSAWRQANS------NN 57

Query: 314 KQIAMGRNRISGTIPPEIRNLASLN--WLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFL 371
            QI     R        + +        L + +  L    P +   L++LQ + +D   L
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

Query: 372 QGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRIT 431
              +P ++     L  L L  N L   +P+S+ +   L  L+I     +  LP  +    
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174

Query: 432 TLSL--------YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLE 483
                        L L    +  SLP  + NL+NL  L +  +  S  +   +     LE
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 484 YLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGE 543
            L++ G     + P +      +K L     +    +P  +  L+ LE L+L        
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292

Query: 544 VP 545
           +P
Sbjct: 293 LP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  150 bits (380), Expect = 4e-40
 Identities = 54/377 (14%), Positives = 109/377 (28%), Gaps = 63/377 (16%)

Query: 131 SIGNLSSLRVIDVRE-NRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVIS 189
              + S    +  +    L    D L Q +            +        N ++ ++ +
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62

Query: 190 LSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVS 249
            +      +  +      P    L   +       P      S L+ +          + 
Sbjct: 63  RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LP 120

Query: 250 VDFSRLKNLYWLNLGINNLGTGAANELDFINL---LTNCSKLERLYFNRNRFEGELPHSV 306
               +   L  L L  N L            L   + + ++L  L         ELP  +
Sbjct: 121 DTMQQFAGLETLTLARNPLRA----------LPASIASLNRLRELSIRACPELTELPEPL 170

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
           A+  +                  E + L +L  L ++   +  ++P  I  L NL+ L +
Sbjct: 171 ASTDA----------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
             + L  ++  ++ +L  L  L L       N P   G    L  L +            
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC--------- 263

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN 486
                         +NL   +LP ++  L  L +LDL G      +P+ ++       + 
Sbjct: 264 --------------SNL--LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307

Query: 487 ISGNAFSGSIPLLLDSL 503
           +  +  +        + 
Sbjct: 308 VPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  142 bits (360), Expect = 2e-37
 Identities = 61/396 (15%), Positives = 112/396 (28%), Gaps = 85/396 (21%)

Query: 57  PHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLER 116
            H        E L    ++        LS          +  +          +    + 
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60

Query: 117 LSIFQNHITGQLPASIGNLSS--LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGM 174
            +     +       + + +      +++R   L    D   +L  L  +++        
Sbjct: 61  ETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           +P ++   + LE ++L+ N    +LP     +L  LREL   A      +P  L++  + 
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
                               L NL  L L                      + +  L   
Sbjct: 177 GEH---------------QGLVNLQSLRL--------------------EWTGIRSL--- 198

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
                                            P  I NL +L  L I  + L+  + P 
Sbjct: 199 ---------------------------------PASIANLQNLKSLKIRNSPLS-ALGPA 224

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL-GLNNLEGNIPSSLGNCTNLLGLN 413
           I  L  L++LDL       + P   G    L  L L   +NL   +P  +   T L  L+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLD 283

Query: 414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLP 449
           +     +  LP  I ++      + +  +L      
Sbjct: 284 LRGCVNLSRLPSLIAQLPANC-IILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  118 bits (299), Expect = 2e-29
 Identities = 43/262 (16%), Positives = 97/262 (37%), Gaps = 19/262 (7%)

Query: 21  LDLGNQSIRGTLSPYVGNLSF--LRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
                ++++   +  + + +      + + S     + P Q  RL  L+ + +       
Sbjct: 61  ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGN---- 134
            +P  +   + L  L+   N L   +PA I SL +L  LSI       +LP  + +    
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 135 -----LSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVIS 189
                L +L+ + +    +     S+  L++L  L +  +  S  + P+I ++  LE + 
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235

Query: 190 LSENRFTGSLPVDTGVNLPSLRELR-TNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGV 248
           L       + P   G     L+ L   + +N    +P+ +   + LE ++         +
Sbjct: 236 LRGCTALRNYPPIFG-GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 249 SVDFSRLKNLYWLNLGINNLGT 270
               ++L     + +  +    
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQ 315

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  112 bits (282), Expect = 4e-27
 Identities = 40/211 (18%), Positives = 72/211 (34%), Gaps = 17/211 (8%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             + +    +   L   +   + L  + +A N     +P  I  L  L  L +       
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164

Query: 79  AIPANLSSCS---------NLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLP 129
            +P  L+S           NL  L  +   +   +PA I +L  L+ L I  + ++  L 
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222

Query: 130 ASIGNLSSLRVIDVRENRLWGRI-DSLGQLKSLTLLSVA-FNQFSGMIPPSIFNISSLEV 187
            +I +L  L  +D+R            G    L  L +   +     +P  I  ++ LE 
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281

Query: 188 ISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
           + L        LP      LP+   +    +
Sbjct: 282 LDLRGCVNLSRLPSLIA-QLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  107 bits (269), Expect = 2e-25
 Identities = 32/203 (15%), Positives = 62/203 (30%), Gaps = 18/203 (8%)

Query: 349 GTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTN 408
           G+        +  + L    +         L              +      +S     N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56

Query: 409 LLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
              +     + +      +   T      LEL +  L    P +   L +L  + +    
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL 527
              E+P T+   A LE L ++ N    ++P  + SL  ++EL   +     ++PE L + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 528 SF---------LEFLNLSYNHFE 541
                      L+ L L +    
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR 196

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 2/154 (1%)

Query: 2   NLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIG 61
            L         Q    +  L L    IR +L   + NL  L+ + I ++  +  +   I 
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 62  RLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQ 121
            L  LE L L   +     P      + L  L     + +  +P DI  L +LE+L +  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 122 NHITGQLPASIGNLSSLRVIDVRENRLWGRIDSL 155
                +LP+ I  L +  +I V  +         
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  156 bits (395), Expect = 9e-41
 Identities = 77/488 (15%), Positives = 139/488 (28%), Gaps = 71/488 (14%)

Query: 56  IPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLE 115
           I          +   ++++S   A+ +   S  N+ EL    N L     AD+    KLE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 116 RLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMI 175
            L++  N +       + +LS+LR +D+  N     +  L    S+  L  A N  S  +
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNN----YVQELLVGPSIETLHAANNNIS-RV 114

Query: 176 PPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLE 235
             S       + I L+ N+ T  L          ++ L    N         L       
Sbjct: 115 SCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL------- 164

Query: 236 MIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNR 295
                            +    L  LNL  N +          +      +KL+ L  + 
Sbjct: 165 ----------------AASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTLDLSS 200

Query: 296 NRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI 355
           N+                             + PE ++ A + W+++  N+L   I   +
Sbjct: 201 NKLA--------------------------FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 356 GELTNLQQLDLDRNFLQ-GSIPSSLGNLTLLTYLKL-GLNNLEGNIPSSLGNCTNLLGLN 413
               NL+  DL  N    G++         +  +    +  L G         T      
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

Query: 414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIP 473
                L      +++ +      L  G       L  E  N      +D    ++   I 
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVID 353

Query: 474 ATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFL 533
                      L     A    +     +   +      +     ++    E  S L+ L
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLL 412

Query: 534 NLSYNHFE 541
                 +E
Sbjct: 413 RAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  142 bits (360), Expect = 3e-36
 Identities = 56/486 (11%), Positives = 132/486 (27%), Gaps = 52/486 (10%)

Query: 37  GNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSAD 96
            N +  +   +  +     +        +++ L LS N  S    A+L+  + L  L+  
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 97  SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLG 156
           SN L      D+ SL  L  L +  N++       +    S+  +    N +  R+    
Sbjct: 67  SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSC-S 117

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN 216
           + +    + +A N+ + +        S ++ + L  N        +   +  +L  L   
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANEL 276
            N     +   +                             L  L+L  N L        
Sbjct: 178 YNFIYD-VKGQVV-------------------------FAKLKTLDLSSNKLAFMGPE-- 209

Query: 277 DFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLAS 336
                  + + +  +    N+    +  ++    + ++   +  N        +     +
Sbjct: 210 -----FQSAAGVTWISLRNNKLV-LIEKALRFSQN-LEHFDLRGNGFHCGTLRDFF-SKN 261

Query: 337 LNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLE 396
               T+    +         E T            +         L  L   +  L + +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321

Query: 397 GN----IPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           G+    +     N      ++    +   T+  Q+       + LE     L+  +    
Sbjct: 322 GSETERLECERENQARQREIDALKEQ-YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS-GSIPLLLDSLQSIKELDF 511
                L            E+       + L+ L      +    +        +I++ D 
Sbjct: 381 RAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439

Query: 512 SSNNLN 517
             +   
Sbjct: 440 YQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  138 bits (349), Expect = 8e-35
 Identities = 64/458 (13%), Positives = 141/458 (30%), Gaps = 30/458 (6%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
            R     + + S++  L+    +   ++ ++++ N  +      +     LE L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
               +   L S S L  L  ++N +      ++     +E L    N+I+ ++  S    
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--G 119

Query: 136 SSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSEN 193
              + I +  N++   R    G    +  L +  N+   +    +  +  +LE ++L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
                  V   V    L+ L  ++N    F+     +A+ +  I    N+    +     
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTI 313
             +NL   +L  N    G        +  +   +++ +     +   +L        +  
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLR-----DFFSKNQRVQTVAKQTVK---KLTGQNEEECTVP 286

Query: 314 KQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTG----TIPPEIGELTNLQQLDLDRN 369
                G         P    L +L           G     +  E       +++D  + 
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 370 FLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
             +  I            L+     L+  + +       L G        I  L      
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEE 405

Query: 430 ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
            + L L   +        +  +      +   D+  +K
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  121 bits (306), Expect = 3e-29
 Identities = 48/282 (17%), Positives = 104/282 (36%), Gaps = 17/282 (6%)

Query: 281 LLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWL 340
           +  N ++ +      +  +  L     +  + +K++ +  N +S     ++     L  L
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 341 TIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIP 400
            + +N L      ++  L+ L+ LDL+ N++       L     +  L    NN+   + 
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115

Query: 401 SSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG-SLPPEVGNLKNLM 459
            S G       + +++NK+           + +  YL+L  N ++  +      +   L 
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLE 172

Query: 460 RLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQ 519
            L+L  N    ++   +   A L+ L++S N  +  +     S   +  +   +N L   
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 520 IPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           I + L     LE  +L  N F           N+   ++A  
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 93.0 bits (231), Expect = 6e-20
 Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 12/179 (6%)

Query: 374 SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL 433
           +I     N       K+  ++L+  + S   +  N+  L++S N L       +   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS 493
              L L +N+L      ++ +L  L  LDL+ N         L    ++E L+ + N  S
Sbjct: 61  -ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 494 GSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
             +       Q  K +  ++N +           S +++L+L  N  +  V    +  +
Sbjct: 113 -RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (372), Expect = 2e-38
 Identities = 76/449 (16%), Positives = 145/449 (32%), Gaps = 80/449 (17%)

Query: 80  IPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLR 139
           I +NL       ++  D          +  +L   + ++   + +     A + +   + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 140 VIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTG 197
           ++++ + ++      +     ++  L + FN     +PP +F N+  L V+ L  N  + 
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 198 SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKN 257
           SLP     N P L  L  + NN       +    +SL+ ++ S N+ +    VD S + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPS 187

Query: 258 LYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIA 317
           L+  N+  N L T           L     +E L  + N                     
Sbjct: 188 LFHANVSYNLLST-----------LAIPIAVEELDASHNSIN------------------ 218

Query: 318 MGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS 377
                    +   +     L  L +  N LT      +     L ++DL  N L+  +  
Sbjct: 219 --------VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 266

Query: 378 SLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYL 437
               +  L  L +  N L   +         L  L++SHN L                  
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL------------------ 307

Query: 438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIP 497
                     +         L  L L  N     +   LS    L+ L +S N +  +  
Sbjct: 308 --------LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSL 356

Query: 498 LLLDSLQSIKELDFSSNNLNGQIPEYLEN 526
             L   +++        + + +I   LE+
Sbjct: 357 RAL--FRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 5e-35
 Identities = 74/397 (18%), Positives = 141/397 (35%), Gaps = 37/397 (9%)

Query: 38  NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS 97
                  ++I     +     +   L + + +   N++      A L S   +  L+ + 
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78

Query: 98  NNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASI-GNLSSLRVIDVRENRLWGRIDS- 154
             +  EI          +++L +  N I   LP  +  N+  L V+ +  N L   +   
Sbjct: 79  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 135

Query: 155 -LGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRE 212
                  LT LS++ N     I    F   +SL+ + LS NR T  + +     +PSL  
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFH 190

Query: 213 LRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGA 272
              + N  +     +L+   ++E ++ S N  +    V       L  L L  NNL    
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD-- 240

Query: 273 ANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR 332
                    L N   L  +  + N  E  + H    +   ++++ +  NR+   +    +
Sbjct: 241 ------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLYGQ 292

Query: 333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGL 392
            + +L  L +  N L   +     +   L+ L LD N +  ++   L     L  L L  
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348

Query: 393 NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
           N+ + N   +L    N+    +        +  Q+  
Sbjct: 349 NDWDCNSLRALF--RNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  136 bits (344), Expect = 8e-35
 Identities = 72/359 (20%), Positives = 131/359 (36%), Gaps = 31/359 (8%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
                 ++  +      +        ++ +++ F  +      +      + +  LNL  
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISG 325
             +      E+D          +++LY   N      PH   N+   +  + + RN +S 
Sbjct: 79  LQI-----EEID-TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDLS- 130

Query: 326 TIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLT 383
           ++P  I  N   L  L++  N L   I  +     T+LQ L L  N L   +   L  + 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186

Query: 384 LLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR-ITTLSLYLELGNN 442
            L +  +  N L     S+L     +  L+ SHN  I  +   +   +T L L     NN
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNS-INVVRGPVNVELTILKLQ---HNN 237

Query: 443 LLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS 502
           L +      + N   L+ +DLS N+    +         LE L IS N    ++ L    
Sbjct: 238 LTD---TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293

Query: 503 LQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           + ++K LD S N+L   +         LE L L +N     + +    +     +++ N
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (312), Expect = 1e-30
 Identities = 69/326 (21%), Positives = 124/326 (38%), Gaps = 26/326 (7%)

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                 I  +L        +             +   L N   +    + +      +L 
Sbjct: 7   QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-----RKLP 61

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLAS 336
              LL +  ++E L  N  + E E+       + TI+++ MG N I   +PP + +N+  
Sbjct: 62  A-ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118

Query: 337 LNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
           L  L ++ N L+ ++P  I      L  L +  N L+     +    T L  L+L  N L
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177

Query: 396 EGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNL 455
             ++   L    +L   N+S+N  + TL   I  +  L       +N +N  +   V   
Sbjct: 178 T-HVD--LSLIPSLFHANVSYNL-LSTLAIPI-AVEELDAS----HNSIN-VVRGPV--N 225

Query: 456 KNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN 515
             L  L L  N  + +    L     L  +++S N     +      +Q ++ L  S+N 
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 516 LNGQIPEYLENLSFLEFLNLSYNHFE 541
           L   +  Y + +  L+ L+LS+NH  
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  100 bits (252), Expect = 6e-23
 Identities = 48/237 (20%), Positives = 80/237 (33%), Gaps = 13/237 (5%)

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLL 385
            I   ++       + ID          E   L N + +    + ++    + L +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 386 TYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLN 445
             L L    +E     +      +  L +  N  I  LP  + +   L   L L  N L+
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 446 GSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQ 504
            SLP  +  N   L  L +S N        T  A  +L+ L +S N  +  +   L  + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186

Query: 505 SIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           S+   + S N L       L     +E L+ S+N     V    V    T   +  N
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 236

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  143 bits (363), Expect = 2e-36
 Identities = 86/469 (18%), Positives = 163/469 (34%), Gaps = 25/469 (5%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
               L +S N  S    +++ S S L  L    N +   +   +     +LE L +  N 
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNK 80

Query: 124 ITGQLPASIGNLSSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
           +      S     +L+ +D+  N           G +  L  L ++           I +
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 182 ISSLEVISLSENRFTGSLPVDTGVNLP--SLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
           ++  +V+ +    +      +   +    SL  +      F   + VS+   ++LE+   
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 240 SKNQFSGGVSVDFSRL----KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNR 295
                    S   S L     N    NL +NN+ T   N    I  L   + +     + 
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET-TWNSFIRILQLVWHTTVWYFSISN 256

Query: 296 NRFEGELPHSVANLSST----IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTI 351
            + +G+L     + S T    +    +  +             +++N      +      
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316

Query: 352 PPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLE--GNIPSSLGNCTNL 409
                +++    LD   N L  ++  + G+LT L  L L +N L+    I        +L
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376

Query: 410 LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFS 469
             L+IS N +     +     T   L L + +N+L             +  LDL  NK  
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-DTIFRCL-PPRIKVLDLHSNKIK 434

Query: 470 GEIPATLSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLN 517
             IP  +     L+ LN++ N    S+P  + D L S++++   +N  +
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  113 bits (285), Expect = 2e-26
 Identities = 79/483 (16%), Positives = 137/483 (28%), Gaps = 77/483 (15%)

Query: 71  LSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPA 130
            S N     +P +LS       L+   N +     +DI SL KL  L I  N I     +
Sbjct: 7   RSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 131 SIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVIS 189
                  L  +D+  N+L     S     +L  L ++FN F  +     F N+S L+ + 
Sbjct: 64  VFKFNQELEYLDLSHNKL--VKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 190 LSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFI-PVSLSN--ASSLEMIEFSKNQFSG 246
           LS         V    +L   + L      +     P  L +    SL ++  +  +F  
Sbjct: 122 LSTTHLE-KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180

Query: 247 GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSV 306
            + V    + NL   N+         +  L  +  L    KL  L  N           +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
             L                     +    S++ + +               L  L    +
Sbjct: 241 LQLVWHT----------------TVWYF-SISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
             +             + +      ++             +  L L+ S+N L       
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT------ 337

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACANLEYL 485
                                   E  G+L  L  L L  N+              L+ L
Sbjct: 338 --------------------DTVFENCGHLTELETLILQMNQ--------------LKEL 363

Query: 486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP-EYLENLSFLEFLNLSYNHFEGEV 544
           +                ++S+++LD S N+++             L  LN+S N     +
Sbjct: 364 SKIAEMT--------TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 545 PMK 547
              
Sbjct: 416 FRC 418

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  103 bits (259), Expect = 3e-23
 Identities = 70/461 (15%), Positives = 142/461 (30%), Gaps = 84/461 (18%)

Query: 19  TRLDL-GNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
             LDL  N      +    GN+S L+++                         LS     
Sbjct: 93  KHLDLSFNAFDALPICKEFGNMSQLKFLG------------------------LSTTHLE 128

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
            +    ++  +    L         +   D   L      S+     T +    I ++S 
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTG 197
             V ++  +        +  +      S   +  + +      +  +L  I  + N F  
Sbjct: 187 KTVANLELSN-------IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239

Query: 198 SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNAS-----SLEMIEFSKNQFSGGVSVDF 252
            L +   V   ++     +     G +     + S     +L + +   + F    S  +
Sbjct: 240 ILQL---VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296

Query: 253 SRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSST 312
               N+   N  ++                   S    L F+                  
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPS------KISPFLHLDFS------------------ 332

Query: 313 IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIG---ELTNLQQLDLDRN 369
                   N ++ T+     +L  L  L +  NQL   +        ++ +LQQLD+ +N
Sbjct: 333 -------NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQN 384

Query: 370 FLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQIL 428
            +              L  L +  N L   I   L     +  L++  NK+  ++P+Q++
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI-KSIPKQVV 441

Query: 429 RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKF 468
           ++  L   L + +N L  S+P  +   L +L ++ L  N +
Sbjct: 442 KLEALQ-ELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 93.0 bits (231), Expect = 8e-20
 Identities = 64/395 (16%), Positives = 128/395 (32%), Gaps = 44/395 (11%)

Query: 159 KSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
           +  T+L+++ N  S +    I ++S L ++ +S NR    L +        L  L  + N
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQF-SGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                  +S     +L+ ++ S N F +  +  +F  +  L +L L   +L   +   + 
Sbjct: 80  KLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL 337
            +N+         L       E E P  + + ++    I       +      I +++  
Sbjct: 137 HLNISKV-----LLVLGETYGEKEDPEGLQDFNTESLHI----VFPTNKEFHFILDVSVK 187

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
               ++ + +             L+           +   +   L+ LT   +       
Sbjct: 188 TVANLELSNIKC----------VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN 457
                L   T +   +IS+ KL G L  +    +  SL                    K 
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL--------------------KA 277

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L    +  + F           +N+   N + +       L    +     LDFS+N L 
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

Query: 518 GQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
             + E   +L+ LE L L  N  +    +  +   
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 37/182 (20%), Positives = 73/182 (40%), Gaps = 7/182 (3%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
           +   +      R         +S   +++ ++N     +    G L  LE LIL  N   
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

Query: 78  --GAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASIGN 134
               I    +   +L +L    N++  +           L  L++  N +T  +   +  
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419

Query: 135 LSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSEN 193
              ++V+D+  N++      + +L++L  L+VA NQ    +P  IF  ++SL+ I L  N
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

Query: 194 RF 195
            +
Sbjct: 479 PW 480

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (349), Expect = 3e-36
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 22/219 (10%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
             +GEG  G V +G L        +VAVK   +K   +S+     F++E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I+++ VC     +G     ++  FM+ G L  +L +S  +     + +   L   +D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             +EYL   ++     +H DL   N +L  D+   V+DFGL+K +  ++ D   + R   
Sbjct: 158 LGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAK 210

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
           + +K      A E    R  + K DV++FG+ + E+ TR
Sbjct: 211 MPVKWI----AIESLADRVYTSKSDVWAFGVTMWEIATR 245

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (346), Expect = 4e-36
 Identities = 71/250 (28%), Positives = 115/250 (46%), Gaps = 34/250 (13%)

Query: 618 NMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK 677
             +  + +F    +  L+           IG+G  G V  G     G +VAVK   +K  
Sbjct: 3   GSVAAQDEFYRSGW-ALNM--KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC--IKND 55

Query: 678 GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSND 737
             +++F+AE   +  +RH NL++++ V      +      IV E+M  GSL ++L     
Sbjct: 56  ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR 111

Query: 738 QLEVCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
                 L     L  ++DV  A+EYL  +++     VH DL   NVL+ +D V+ VSDFG
Sbjct: 112 S----VLGGDCLLKFSLDVCEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFG 162

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR- 854
           L K       +      +  + +K T    APE    ++ S K DV+SFGILL E+++  
Sbjct: 163 LTK-------EASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFG 211

Query: 855 KRPTDAMFNE 864
           + P   +  +
Sbjct: 212 RVPYPRIPLK 221

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (358), Expect = 8e-36
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 23/222 (10%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKIIT 703
           +K+G G  G VY+G   +    VAVK   LK+       F+ E   ++ I+H NL++++ 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           VC+    +   F  I+ EFM  G+L ++L   N Q     +S +  L +A  ++SA+EYL
Sbjct: 284 VCT----REPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYL 334

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               + + +H +L   N L+ ++ +  V+DFGL++ ++    DT          IK T  
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT-- 386

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             APE     + S+K DV++FG+LL E+ T    P   +   
Sbjct: 387 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  140 bits (354), Expect = 1e-35
 Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 31/223 (13%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
             IG+G  G V  G     G +VAVK   +K    +++F+AE   +  +RH NL++++ V
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL- 763
                 +      IV E+M  GSL ++L           L     L  ++DV  A+EYL 
Sbjct: 255 IV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLE 306

Query: 764 -HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
            +++     VH DL   NVL+ +D V+ VSDFGL K       +      +  + +K T 
Sbjct: 307 GNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT- 353

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
              APE    ++ S K DV+SFGILL E+++  + P   +  +
Sbjct: 354 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  137 bits (348), Expect = 2e-35
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRNLIKI 701
           +IG G  G V+ G L  + T VAVK      +         F+ E + L+   H N++++
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 702 ITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           I VC+ +   +       IV E +Q G    +L  +        L V   L +  D A+ 
Sbjct: 178 IGVCTQKQPIY-------IVMELVQGGDFLTFL-RTEGA----RLRVKTLLQMVGDAAAG 225

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYL        +H DL   N L+ +  V  +SDFG+++  ++             + +K
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVK 280

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            T    APE       S + DV+SFGILL E F+    P   + N+
Sbjct: 281 WT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  142 bits (359), Expect = 2e-35
 Identities = 82/421 (19%), Positives = 144/421 (34%), Gaps = 57/421 (13%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
               L +  +  +  +P  L   +++  L    NNL   +PA      +L  L +  N +
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQL 93

Query: 125 TGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISS 184
           T  LP     L  L +       L         L  L +     NQ +  +P     +  
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHL---PALPSGLCKLWIFG---NQLTS-LPVLPPGLQE 145

Query: 185 LEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQF 244
           L   S+S+N+   SLP         L +L    N  T  +P+  S    L+ +  S NQ 
Sbjct: 146 L---SVSDNQLA-SLPA----LPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQL 193

Query: 245 SGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPH 304
           +  +    S L  L+  N  + +L                 S L+ L  + NR    LP 
Sbjct: 194 AS-LPTLPSELYKLWAYNNRLTSL-------------PALPSGLKELIVSGNRLT-SLPV 238

Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
             + L    K++ +  NR++ ++P     L SL+   +  NQLT  +P  +  L++   +
Sbjct: 239 LPSEL----KELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTV 289

Query: 365 DLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
           +L+ N L      +L  +T        +   +    S+      L             +P
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA-----ADWLVP 344

Query: 425 RQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEY 484
            +         +   G      +    +  L       +    F  +I + L+  A  E 
Sbjct: 345 AREGEPAPADRWHMFGQEDNADAFSLFLDRLSETEN-FIKDAGFKAQISSWLAQLAEDEA 403

Query: 485 L 485
           L
Sbjct: 404 L 404

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  132 bits (334), Expect = 3e-32
 Identities = 71/355 (20%), Positives = 124/355 (34%), Gaps = 58/355 (16%)

Query: 183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKN 242
           +   V+++ E+  T +LP     ++     L    NN T  +P        L  +E S N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCLPAHI---TTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 243 QFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
           Q +  + V    L  L   +  + +L            L +    L +L+   N+    L
Sbjct: 92  QLTS-LPVLPPGLLELSIFSNPLTHLPA----------LPSG---LCKLWIFGNQLT-SL 136

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQ 362
           P     L    +++++  N+++ ++P     L  L       NQLT ++P        LQ
Sbjct: 137 PVLPPGL----QELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPS---GLQ 184

Query: 363 QLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPS----SLGN---------CTNL 409
           +L +  N L  S+P+    L  L      L +L           +            + L
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSEL 243

Query: 410 LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFS 469
             L +S N+L  +LP     + +LS+Y     N L   LP  + +L +   ++L GN  S
Sbjct: 244 KELMVSGNRLT-SLPMLPSGLLSLSVY----RNQLT-RLPESLIHLSSETTVNLEGNPLS 297

Query: 470 GEIPATLSACANLEYLN---ISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP 521
                 L    +    +   I  +    S P    +L                 P
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  104 bits (261), Expect = 2e-23
 Identities = 73/414 (17%), Positives = 119/414 (28%), Gaps = 103/414 (24%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
             +T L + + ++  +L      L   R + ++ N     +P     L+ L         
Sbjct: 61  AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
                    +  S L +L    N L   +P        L+ LS+  N +   LPA    L
Sbjct: 116 LP-------ALPSGLCKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-SLPALPSEL 163

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
             L       N+L         L+ L++   + NQ +  +P     +  L       NR 
Sbjct: 164 CKL---WAYNNQLTSLPMLPSGLQELSV---SDNQLA-SLPTLPSELYKLW---AYNNRL 213

Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL 255
           T SLP         L+EL  + N  T  +PV  S                          
Sbjct: 214 T-SLP----ALPSGLKELIVSGNRLTS-LPVLPS-------------------------- 241

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQ 315
             L  L +  N L +          L    S L  L   RN+                  
Sbjct: 242 -ELKELMVSGNRLTS----------LPMLPSGLLSLSVYRNQLT---------------- 274

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRN---FLQ 372
                      +P  + +L+S   + ++ N L+      + E+T+               
Sbjct: 275 ----------RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324

Query: 373 GSIPSSLGNLTLLTYLKLGLNNLEGNIP----SSLGNCTNLLGLNISHNKLIGT 422
            S P     L L     L         P       G   N    ++  ++L  T
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 55.3 bits (133), Expect = 6e-08
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 8/87 (9%)

Query: 455 LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSN 514
                 L++  +  +  +P  L   A++  L I  N  + S+P L   L++   L+ S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91

Query: 515 NLNGQIPEYLENLSFLEFLNLSYNHFE 541
            L   +P     L  L   +    H  
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP 117

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (341), Expect = 3e-35
 Identities = 61/227 (26%), Positives = 89/227 (39%), Gaps = 30/227 (13%)

Query: 646 KIGEGGSGIVYKGFL---GENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLI 699
           K+G+G  G+V +G           VAVK +    L Q  A   F+ E  A+ ++ HRNLI
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
           ++  V      K      +V E    GSL + L             +      A+ VA  
Sbjct: 85  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEG 133

Query: 760 IEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + YL    +     +H DL   N+LL    +  + DFGL + L   N D  V      + 
Sbjct: 134 MGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRKVP 187

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
                   APE    R  S   D + FG+ L E+FT  + P   +  
Sbjct: 188 FAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  140 bits (355), Expect = 5e-35
 Identities = 86/510 (16%), Positives = 172/510 (33%), Gaps = 56/510 (10%)

Query: 38  NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS 97
                  ++I     +     +   L + + +   N++      A L S   +  L+ + 
Sbjct: 25  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84

Query: 98  NNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASI-GNLSSLRVIDVRENRLWGRIDS- 154
             +  EI          +++L +  N I   LP  +  N+  L V+ +  N L   +   
Sbjct: 85  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 141

Query: 155 -LGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRE 212
                  LT LS++ N     I    F   +SL+ + LS NR T  + +     +PSL  
Sbjct: 142 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFH 196

Query: 213 LRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGA 272
              + N  +     +L+   ++E ++ S N  +    V       L  L L  NNL    
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD-- 246

Query: 273 ANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR 332
                    L N   L  +  + N  E  + H    +   ++++ +  NR+   +    +
Sbjct: 247 ------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLYGQ 298

Query: 333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGL 392
            + +L  L +  N L   +     +   L+ L LD N +  ++   L     L  L L  
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 354

Query: 393 NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           N+ + N   +L    N+    +        +  Q            L + L         
Sbjct: 355 NDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQ------------LEHGLCCKESDKPY 400

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
            +        ++      ++      C+  + +N   +            LQ  ++L+  
Sbjct: 401 LDRLL---QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAE 457

Query: 513 SNNLNGQI----PEYLENLSFLEFLNLSYN 538
            N L  ++     E ++    L+ L+   +
Sbjct: 458 VNELRAEVQQLTNEQIQQEQLLQGLHAEID 487

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  137 bits (347), Expect = 5e-34
 Identities = 71/426 (16%), Positives = 128/426 (30%), Gaps = 56/426 (13%)

Query: 103 EIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQLKSL 161
            I +++        + I               L++ +++  + + +       L   + +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 162 TLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNF 220
            LL++   Q    I    F    +++ + +  N     LP     N+P L  L    N+ 
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135

Query: 221 TGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFIN 280
           +        N   L  +  S N         F    +L  L L  N L       +D   
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSL 190

Query: 281 LLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWL 340
           +      L     + N                                  +    ++  L
Sbjct: 191 I----PSLFHANVSYNLLS------------------------------TLAIPIAVEEL 216

Query: 341 TIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIP 400
               N +   +   +     L  L L  N L  +  + L N   L  + L  N LE  + 
Sbjct: 217 DASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMY 271

Query: 401 SSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMR 460
                   L  L IS+N+ +  L      I TL   L+L +N L   +         L  
Sbjct: 272 HPFVKMQRLERLYISNNR-LVALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 461 LDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQI 520
           L L  N     +   LS    L+ L +S N +  +    L   +++        + + +I
Sbjct: 329 LYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKI 383

Query: 521 PEYLEN 526
              LE+
Sbjct: 384 DYQLEH 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  133 bits (335), Expect = 2e-32
 Identities = 66/419 (15%), Positives = 144/419 (34%), Gaps = 55/419 (13%)

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
              + +     + + G        +++ ++++   +     LP     +   +  L  N 
Sbjct: 29  FYDVHIDMQTQDVYFG---FEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 84

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                    + + A +++ +    N         F  +  L  L L  N+L     + L 
Sbjct: 85  LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-----SSLP 139

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL 337
              +  N  KL  L  + N  E     +    +S ++ + +  NR++  +      + SL
Sbjct: 140 -RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRLT-HVDL--SLIPSL 194

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
               +  N L+      +     +++LD   N +   +   +     LT LKL  NNL  
Sbjct: 195 FHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 246

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN 457
              + L N   L+ +++S+N+ +  +                               ++ 
Sbjct: 247 --TAWLLNYPGLVEVDLSYNE-LEKIMYHPFV------------------------KMQR 279

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L RL +S N+    +         L+ L++S N     +         ++ L    N++ 
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

Query: 518 GQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSC 576
             +   L     L+ L LS+N ++    ++ +F N  R ++    + C    +L    C
Sbjct: 338 -TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 392

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  130 bits (329), Expect = 8e-32
 Identities = 72/359 (20%), Positives = 131/359 (36%), Gaps = 31/359 (8%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
                 ++  +      +        ++ +++ F  +      +      + +  LNL  
Sbjct: 25  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISG 325
             +      E+D          +++LY   N      PH   N+   +  + + RN +S 
Sbjct: 85  LQI-----EEID-TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDLS- 136

Query: 326 TIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLT 383
           ++P  I  N   L  L++  N L   I  +     T+LQ L L  N L   +   L  + 
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 192

Query: 384 LLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR-ITTLSLYLELGNN 442
            L +  +  N L     S+L     +  L+ SHN  I  +   +   +T L L     NN
Sbjct: 193 SLFHANVSYNLL-----STLAIPIAVEELDASHNS-INVVRGPVNVELTILKLQ---HNN 243

Query: 443 LLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS 502
           L +      + N   L+ +DLS N+    +         LE L IS N    ++ L    
Sbjct: 244 LTD---TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299

Query: 503 LQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           + ++K LD S N+L   +         LE L L +N     + +    +     +++ N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  122 bits (307), Expect = 5e-29
 Identities = 56/311 (18%), Positives = 116/311 (37%), Gaps = 32/311 (10%)

Query: 249 SVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVAN 308
            +D +   +  + ++ I+          + I L    +  + + F  +         + +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITL----NNQKIVTFKNSTMRKLPAALLDS 73

Query: 309 LSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDL 366
               ++ + +   +I   I         ++  L +  N +   +PP +   +  L  L L
Sbjct: 74  FRQ-VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 130

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
           +RN L         N   LT L +  NNLE     +    T+L  L +S N+ +  +   
Sbjct: 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR-LTHVDLS 189

Query: 427 IL-----------RITTLSL-----YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG 470
           ++            ++TL++      L+  +N +N  +   V     L  L L  N  + 
Sbjct: 190 LIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT- 245

Query: 471 EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFL 530
           +    L     L  +++S N     +      +Q ++ L  S+N L   +  Y + +  L
Sbjct: 246 DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303

Query: 531 EFLNLSYNHFE 541
           + L+LS+NH  
Sbjct: 304 KVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 97.7 bits (243), Expect = 4e-21
 Identities = 48/237 (20%), Positives = 80/237 (33%), Gaps = 13/237 (5%)

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLL 385
            I   ++       + ID          E   L N + +    + ++    + L +   +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 386 TYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLN 445
             L L    +E     +      +  L +  N  I  LP  + +   L   L L  N L+
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 446 GSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQ 504
            SLP  +  N   L  L +S N        T  A  +L+ L +S N  +  +   L  + 
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 192

Query: 505 SIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           S+   + S N L       L     +E L+ S+N     V    V    T   +  N
Sbjct: 193 SLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 242

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (342), Expect = 1e-34
 Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 31/229 (13%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRNL 698
             +G G  G V  G L    +    VA+K   LK     K    F+ E   +    H N+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           I++  V +    K      IV E+M+NGSL+ +L   + Q      +VIQ + +   +AS
Sbjct: 109 IRLEGVVT----KSKPV-MIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIAS 158

Query: 759 AIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            ++YL    Y     VH DL   N+L++ +LV  VSDFGL + L + +P+    TR   I
Sbjct: 159 GMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKI 212

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            I+ T    +PE    R+ +   DV+S+GI+L E+ +  +RP   M N+
Sbjct: 213 PIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (335), Expect = 2e-34
 Identities = 65/227 (28%), Positives = 111/227 (48%), Gaps = 33/227 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
           +K+G G  G VY+G   +    VAVK +    +     + F+ E   ++ I+H NL++++
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 703 TVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            VC+     +       I+ EFM  G+L ++L   N Q     +S +  L +A  ++SA+
Sbjct: 76  GVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAM 124

Query: 761 EYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           EYL   ++     +H DL   N L+ ++ +  V+DFGL++ ++    DT          I
Sbjct: 125 EYLEKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPI 176

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           K T    APE     + S+K DV++FG+LL E+ T    P   +   
Sbjct: 177 KWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  137 bits (346), Expect = 2e-34
 Identities = 77/354 (21%), Positives = 137/354 (38%), Gaps = 20/354 (5%)

Query: 224 IPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLT 283
           +P  +   +   +++  KN+       +F+   +L  L L  N +               
Sbjct: 26  VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AFN 77

Query: 284 NCSKLERLYFNRNRFEGELPHSV-ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLT 341
           N   L  L    NR +  +P  V   LS+ + ++ +  N+I   +   + ++L +L  L 
Sbjct: 78  NLFNLRTLGLRSNRLK-LIPLGVFTGLSN-LTKLDISENKIV-ILLDYMFQDLYNLKSLE 134

Query: 342 IDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNI 399
           +  N L   I       L +L+QL L++  L  SIP+ +L +L  L  L+L   N+    
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIR 192

Query: 400 PSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNL 458
             S      L  L ISH   + T+    L    L+  L + +  L  ++P     +L  L
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYL 250

Query: 459 MRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG 518
             L+LS N  S    + L     L+ + + G   +   P     L  ++ L+ S N L  
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310

Query: 519 QIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELR 572
                  ++  LE L L  N    +  +  VF  + R +       C   + ++
Sbjct: 311 LEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQ 364

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  123 bits (310), Expect = 7e-30
 Identities = 72/325 (22%), Positives = 126/325 (38%), Gaps = 23/325 (7%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFK 113
            +P  I        L L  N          +S  +L EL  + N +   +      +LF 
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFN 81

Query: 114 LERLSIFQNHITGQLPASI-GNLSSLRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQ 170
           L  L +  N +   +P  +   LS+L  +D+ EN++   +       L +L  L V  N 
Sbjct: 82  LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDND 139

Query: 171 FSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLS 229
               I    F  ++SLE ++L +   T S+P +   +L  L  LR    N       S  
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197

Query: 230 NASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLE 289
               L+++E S   +   ++ +     NL  L++   NL       + +   + +   L 
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-----TAVPY-LAVRHLVYLR 251

Query: 290 RLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLT 348
            L  + N         +  L   +++I +   +++  + P   R L  L  L +  NQLT
Sbjct: 252 FLNLSYNPISTIEGSMLHELLR-LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309

Query: 349 GTIPPEI-GELTNLQQLDLDRNFLQ 372
            T+   +   + NL+ L LD N L 
Sbjct: 310 -TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 87.9 bits (218), Expect = 3e-18
 Identities = 37/206 (17%), Positives = 80/206 (38%), Gaps = 8/206 (3%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNSF 76
             L++G+  +   +S      L+ L  + +        IP +    L  L  L L + + 
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNI 188

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS 136
           +     +      L  L       +  +  +      L  LSI   ++T     ++ +L 
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248

Query: 137 SLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENR 194
            LR +++  N +       L +L  L  + +   Q + ++ P  F  ++ L V+++S N+
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307

Query: 195 FTGSLPVDTGVNLPSLRELRTNANNF 220
            T +L      ++ +L  L  ++N  
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPL 332

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (337), Expect = 2e-34
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 34/230 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENG----TEVAVKVINLK---QKGASKSFVAECKALRNIRHRN 697
             +G G  G VYKG     G      VA+K   L+      A+K  + E   + ++ + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           + +++ +C     +      ++ + M  G L +++    D +    L     LN  + +A
Sbjct: 79  VCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIA 127

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             + YL          VH DL   NVL+       ++DFGLAK L     +         
Sbjct: 128 KGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGGK 180

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + IK      A E  + R  + + DV+S+G+ + EL T   +P D +   
Sbjct: 181 VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (336), Expect = 2e-34
 Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 37/232 (15%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRN 697
             IG G SG V  G L   G+    VA+K +     G +    + F++E   +    H N
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPN 111

Query: 698 LIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           +I++  V +             IV E+M+NGSL+ +L   + Q      +++Q + +   
Sbjct: 112 IIRLEGVVTRGRLAM-------IVTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRG 159

Query: 756 VASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           V + + YL    Y     VH DL   NVL+D +LV  VSDFGL++ L + +PD    T  
Sbjct: 160 VGAGMRYLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTG 213

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             I I+ T    APE    R  S   DV+SFG+++ E+    +RP   M N 
Sbjct: 214 GKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (334), Expect = 3e-34
 Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 31/230 (13%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
             IG G  G VY G L          AVK +N   +         F+ E   +++  H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ ++ +C     +G+    +V  +M++G L  ++ +          +V   +   + VA
Sbjct: 88  VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHNP-----TVKDLIGFGLQVA 138

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             ++YL    +     VH DL   N +LD+     V+DFGLA+ + +    ++       
Sbjct: 139 KGMKYLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + +K      A E    ++ + K DV+SFG+LL EL TR   P   +   
Sbjct: 194 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (332), Expect = 4e-34
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 646 KIGEGGSGIVYKGFL--GENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIK 700
           ++G G  G V +G     +   +VA+KV  LK   +K  ++  + E + +  + +  +++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I VC            +V E    G L ++L    +++      V     +   V+  +
Sbjct: 75  LIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGM 123

Query: 761 EYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           +YL   ++     VH DL   NVLL     + +SDFGL+K L   +        +    +
Sbjct: 124 KYLEEKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPL 177

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
           K      APE    R+ S + DV+S+G+ + E  +  ++P   M  
Sbjct: 178 KWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 4e-34
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 23/227 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++     K+G+G  G V+ G      T VA+K +      + ++F+ E + ++ +RH  L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  V S           IV E+M  GSL ++L     +     L + Q +++A  +AS
Sbjct: 242 VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIAS 291

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + Y+      + VH DL+ +N+L+ ++LV  V+DFGLA+ + +   +     +     I
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPI 345

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           K T    APE  +    ++K DV+SFGILL EL T+ + P   M N 
Sbjct: 346 KWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 5e-34
 Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
             +G+G  G V +  L     +  +VAVK+  LK    + S    F+ E   ++   H +
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 698 LIKIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           + K++ V      KG      ++  FM++G L  +L  S       +L +   +   +D+
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 757 ASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           A  +EYL   ++     +H DL   N +L +D+   V+DFGL++ +  ++ D   +  + 
Sbjct: 147 ACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCAS 199

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
            + +K      A E       ++  DV++FG+ + E+ TR
Sbjct: 200 KLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  131 bits (331), Expect = 6e-34
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 24/216 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIIT 703
           +IG G    VYKG   E   EVA   +  ++   S  + F  E + L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
                  KG     +V E M +G+L+ +L           + +    +    +   +++L
Sbjct: 93  SWESTV-KGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFL 145

Query: 764 HHYCEPSIVHGDLKPSNVLLD--QDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           H    P I+H DLK  N+ +      V  + D GLA          ++          GT
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVK-IGDLGLATLKRASFAKAVI----------GT 193

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             ++APE     +     DVY+FG+ +LE+ T + P
Sbjct: 194 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 6e-34
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRN 697
             IG G  G VY G L          AVK +N   +         F+ E   +++  H N
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ ++ +C     +G+    +V  +M++G L  ++ +          +V   +   + VA
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHNP-----TVKDLIGFGLQVA 202

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             +++L    +     VH DL   N +LD+     V+DFGLA+ + +   D++       
Sbjct: 203 KGMKFLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + +K      A E    ++ + K DV+SFG+LL EL TR   P   +   
Sbjct: 258 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (329), Expect = 9e-34
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 33/226 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
            ++G G  G V+ G+     T+VAVK +    +G+    +F+AE   ++ ++H+ L+++ 
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A  + +
Sbjct: 75  AVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAF 124

Query: 763 L--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS-IGIK 819
           +   +Y     +H DL+ +N+L+   L   ++DFGLA+ +     D     R  +   IK
Sbjct: 125 IEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIK 175

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            T    APE       ++K DV+SFGILL E+ T  + P   M N 
Sbjct: 176 WT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 1e-33
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 31/230 (13%)

Query: 645 NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRN 697
             IG+G  G+VY G      +N  + A+K ++   +       ++F+ E   +R + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ +I +    +  G     ++  +M +G L +++        V  L     ++  + VA
Sbjct: 84  VLALIGIMLPPE--GLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVA 134

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             +EYL    +     VH DL   N +LD+     V+DFGLA+ + +    ++ + R   
Sbjct: 135 RGMEYLAEQKF-----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + +K T    A E       + K DV+SFG+LL EL TR   P   +   
Sbjct: 190 LPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (329), Expect = 1e-33
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 29/225 (12%)

Query: 646 KIGEGGSGIVYKGFLGENG--TEVAVKVI--NLKQKGASKSFVAECKALRNIRHRNLIKI 701
           ++G G  G V KG+         VAVK++             +AE   ++ + +  ++++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           I +C    +       +V E  + G L ++L  +        +     + +   V+  ++
Sbjct: 84  IGICEAESWM------LVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMK 131

Query: 762 YL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           YL   ++     VH DL   NVLL     + +SDFGL+K L   + +           +K
Sbjct: 132 YLEESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVK 185

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
                 APE     + S K DV+SFG+L+ E F+  ++P   M  
Sbjct: 186 WY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  131 bits (331), Expect = 1e-33
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 34/230 (14%)

Query: 645 NKIGEGGSGIVYKGFLGENG----TEVAVKVINLKQKGASKS---FVAECKALRNIRHRN 697
             +G G  G V+KG     G      V +KV  ++ K   +S         A+ ++ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +++++ +C G   +      +V +++  GSL + +      L          LN  + +A
Sbjct: 77  IVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGAL-----GPQLLLNWGVQIA 125

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             + YL  H       VH +L   NVLL       V+DFG+A  L     D  +      
Sbjct: 126 KGMYYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLL--PPDDKQLLYSEAK 178

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             IK      A E     + + + DV+S+G+ + EL T    P   +   
Sbjct: 179 TPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (327), Expect = 1e-33
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 35/227 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKII 702
            +IG G  G+V+ G+   N  +VA+K I    +GA   + F+ E + +  + H  L+++ 
Sbjct: 14  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 703 TVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            VC  +           +V EFM++G L ++L            +    L + +DV   +
Sbjct: 70  GVCLEQAPIC-------LVTEFMEHGCLSDYLRTQRGLF-----AAETLLGMCLDVCEGM 117

Query: 761 EYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            YL          +H DL   N L+ ++ V  VSDFG+ +F+ +   D    +      +
Sbjct: 118 AYLEEACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPV 169

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           K      +PE       S K DV+SFG+L+ E+F+  K P +   N 
Sbjct: 170 KWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (331), Expect = 1e-33
 Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 38/232 (16%)

Query: 646 KIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRN 697
            IG G  G VYKG L    G+    VA+K +     G +      F+ E   +    H N
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 698 LIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           +I++  V S             I+ E+M+NG+L+++L   + +      SV+Q + +   
Sbjct: 108 IIRLEGVISKYKPMM-------IITEYMENGALDKFLREKDGEF-----SVLQLVGMLRG 155

Query: 756 VASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           +A+ ++YL   +Y     VH DL   N+L++ +LV  VSDFGL++ L + +P+    T  
Sbjct: 156 IAAGMKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSG 209

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
             I I+ T    APE    R+ +   DV+SFGI++ E+ T  +RP   + N 
Sbjct: 210 GKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (340), Expect = 2e-33
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 23/221 (10%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITV 704
            K+G+G  G V+ G      T VA+K +      + ++F+ E + ++ +RH  L+++  V
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
            S           IV E+M  GSL ++L     +     L + Q +++A  +AS + Y+ 
Sbjct: 331 VSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVE 380

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGY 824
                + VH DL+ +N+L+ ++LV  V+DFGLA+ + +   +     +     IK T   
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWT--- 431

Query: 825 VAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            APE  +    ++K DV+SFGILL EL T+ + P   M N 
Sbjct: 432 -APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 4e-33
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 25/222 (11%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRNLIKIIT 703
            K+G G  G V+        T+VAVK   +K    S   F+AE   ++ ++H  L+K+  
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYL 763
           V +           I+ EFM  GSL ++L             + + ++ +  +A  + ++
Sbjct: 251 VVTKEPI------YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFI 300

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
               + + +H DL+ +N+L+   LV  ++DFGLA+ +     D     R    G K  + 
Sbjct: 301 E---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE----DNEYTARE---GAKFPIK 350

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + APE       ++K DV+SFGILL+E+ T  + P   M N 
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (323), Expect = 5e-33
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 35/233 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHR 696
            + +   ++G G  G+V  G       +VA+K+I    +G+     F+ E K + N+ H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
            L+++  VC+ +   F       I+ E+M NG L  +L     +         Q L +  
Sbjct: 80  KLVQLYGVCTKQRPIF-------IITEYMANGCLLNYLREMRHRF-----QTQQLLEMCK 127

Query: 755 DVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           DV  A+EYL    +     +H DL   N L++   V  VSDFGL++++ +   D    + 
Sbjct: 128 DVCEAMEYLESKQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSV 179

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
                ++ +     PE  M  + S K D+++FG+L+ E+++  K P +   N 
Sbjct: 180 GSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (323), Expect = 8e-33
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 18/227 (7%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK-SFVAECKALRNIRHRN 697
            +F     +G GG G+V++     +    A+K I L  +  ++   + E KAL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 698 LIKIITVCSGRDFKGADFKA-------IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           +++       ++       +       I  +  +  +L++W++      E         L
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE---RERSVCL 121

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
           +I + +A A+E+LH      ++H DLKPSN+    D V  V DFGL   +     +  V 
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 811 TRSISIGIK----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           T   +        GT  Y++PE   G   S K D++S G++L EL  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 9e-33
 Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 35/226 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNLIKIIT 703
           ++G G  G+V  G       +VAVK+I    +G+     F  E + +  + H  L+K   
Sbjct: 15  ELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
           VCS     +       IV E++ NG L  +L  S+ +     L   Q L +  DV   + 
Sbjct: 71  VCSKEYPIY-------IVTEYISNGCLLNYLR-SHGK----GLEPSQLLEMCYDVCEGMA 118

Query: 762 YL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +L  H +     +H DL   N L+D+DL   VSDFG+ +++ +   D  V +      +K
Sbjct: 119 FLESHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVK 170

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            +    APE     + S K DV++FGIL+ E+F+  K P D   N 
Sbjct: 171 WS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  128 bits (323), Expect = 1e-32
 Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 34/230 (14%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRN 697
             +G G  G VYKG       +    VA+K   L+      A+K  + E   + ++ + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           + +++ +C     +      ++ + M  G L +++    D +    L     LN  + +A
Sbjct: 79  VCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIA 127

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             + YL          VH DL   NVL+       ++DFGLAK L     +         
Sbjct: 128 KGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGGK 180

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           + IK      A E  + R  + + DV+S+G+ + EL T   +P D +   
Sbjct: 181 VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  127 bits (320), Expect = 2e-32
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 24/215 (11%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V            G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC     +      ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127

Query: 761 EYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           EYL    Y     +H DL   N+L++ +    + DFGL K L   + +           I
Sbjct: 128 EYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPI 181

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                  APE     + S+  DV+SFG++L ELFT
Sbjct: 182 FWY----APESLTESKFSVASDVWSFGVVLYELFT 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (320), Expect = 2e-32
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRN 697
             +GEG  G V            G +VAVK   LK +           E + LRN+ H N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K   +C+     G +   ++ EF+ +GSL+E+L  + +++ +        L  A+ + 
Sbjct: 85  IVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQIC 136

Query: 758 SAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             ++YL    Y     VH DL   NVL++ +    + DFGL K +   + +         
Sbjct: 137 KGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDRD 190

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +       APE  M  +  +  DV+SFG+ L EL T
Sbjct: 191 SPVFWY----APECLMQSKFYIASDVWSFGVTLHELLT 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (318), Expect = 2e-32
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 36/229 (15%)

Query: 646 KIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGAS----KSFVAECKALRNIRHRNL 698
            IGEG  G V++G           VA+K         S    + F+ E   +R   H ++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K+I V +           I+ E    G L  +L      L      +   +  A  +++
Sbjct: 79  VKLIGVITENPVW------IIMELCTLGELRSFLQVRKYSL-----DLASLILYAYQLST 127

Query: 759 AIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           A+ YL    +     VH D+   NVL+  +    + DFGL++++ +    T  +     +
Sbjct: 128 ALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKL 179

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            IK      APE    R  +   DV+ FG+ + E+     +P   + N 
Sbjct: 180 PIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (319), Expect = 3e-32
 Identities = 58/363 (15%), Positives = 113/363 (31%), Gaps = 50/363 (13%)

Query: 104 IPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWG-RIDSLGQLKSLT 162
           I     +  + +   +  + +   L +   +  +++ +D+  N L       L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 163 LLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTG 222
           LL+++ N         + ++S+L  + L+ N     L        PS+  L    NN + 
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR 113

Query: 223 FIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLL 282
              VS S     + I  + N+ +    +D      + +L+L +N +     + ++F  L 
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELA 165

Query: 283 TNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTI 342
            +   LE L    N                              +  ++   A L  L +
Sbjct: 166 ASSDTLEHLNLQYNFIY--------------------------DVKGQV-VFAKLKTLDL 198

Query: 343 DTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLE-GNIPS 401
            +N+L   + PE      +  + L  N L   I  +L     L +  L  N    G +  
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 402 SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRL 461
                  +  +     K +     +   + TL      G         P    L  L   
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL---GHYGAYCCEDLPAPFADRLIALGHH 313

Query: 462 DLS 464
              
Sbjct: 314 HHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (319), Expect = 4e-32
 Identities = 48/282 (17%), Positives = 104/282 (36%), Gaps = 17/282 (6%)

Query: 281 LLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWL 340
           +  N ++ +      +  +  L     +  + +K++ +  N +S     ++     L  L
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 341 TIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIP 400
            + +N L      ++  L+ L+ LDL+ N++       L     +  L    NN+   + 
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115

Query: 401 SSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG-SLPPEVGNLKNLM 459
            S G       + +++NK+           + +  YL+L  N ++  +      +   L 
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLE 172

Query: 460 RLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQ 519
            L+L  N    ++   +   A L+ L++S N  +  +     S   +  +   +N L   
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 520 IPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           I + L     LE  +L  N F           N+   ++A  
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (318), Expect = 5e-32
 Identities = 59/352 (16%), Positives = 107/352 (30%), Gaps = 69/352 (19%)

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
               +   ++++S   A+ +   S  N+ EL    N L     AD+    KLE L++  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
            +       + +LS+LR +D+  N     +  L    S+  L  A N  S  +  S    
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNN----YVQELLVGPSIETLHAANNNIS-RVSCSRG-- 119

Query: 183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKN 242
              + I L+ N+ T  L          ++ L    N              ++   E    
Sbjct: 120 QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-----------TVNFAEL--- 164

Query: 243 QFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
                     +    L  LNL          N +  +      +KL+ L  + N+     
Sbjct: 165 ---------AASSDTLEHLNL--------QYNFIYDVKGQVVFAKLKTLDLSSNKLA--- 204

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQ 362
                                   + PE ++ A + W+++  N+L   I   +    NL+
Sbjct: 205 -----------------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 363 QLDLDRNFLQ-GSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN 413
             DL  N    G++         +  +                    L    
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  101 bits (254), Expect = 1e-23
 Identities = 40/192 (20%), Positives = 70/192 (36%), Gaps = 16/192 (8%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL 410
           I          +   +  + L+ ++ S   +   +  L L  N L     + L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 411 GLNISHNKLIGTLPRQILRITTLS--LYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKF 468
            LN+S N L      + L + +LS    L+L NN +      E+    ++  L  + N  
Sbjct: 62  LLNLSSNVL-----YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111

Query: 469 SGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG-QIPEYLENL 527
           S  +    S     + + ++ N  +    L       ++ LD   N ++     E   + 
Sbjct: 112 S-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 528 SFLEFLNLSYNH 539
             LE LNL YN 
Sbjct: 169 DTLEHLNLQYNF 180

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 45/290 (15%), Positives = 102/290 (35%), Gaps = 22/290 (7%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
            R     + + S++  L+    +   ++ ++++ N  +      +     LE L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
                  +L S S L  L  ++N +      ++     +E L    N+I+ ++  S    
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--G 119

Query: 136 SSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSEN 193
              + I +  N++   R    G    +  L +  N+   +    +  +  +LE ++L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
                  V   V    L+ L  ++N    F+     +A+ +  I    N+    +     
Sbjct: 180 FIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
             +NL   +L  N    G   +       +   +++ +     +      
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRD-----FFSKNQRVQTVAKQTVKKLTGQN 279

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 12/179 (6%)

Query: 374 SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL 433
           +I     N       K+  ++L+  + S   +  N+  L++S N L       +   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS 493
              L L +N+L      ++ +L  L  LDL+ N         L    ++E L+ + N  S
Sbjct: 61  -ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 494 GSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
             +       Q  K +  ++N +           S +++L+L  N  +  V    +  +
Sbjct: 113 -RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (318), Expect = 4e-32
 Identities = 52/238 (21%), Positives = 94/238 (39%), Gaps = 36/238 (15%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR 694
            +   +F     +G+G  G V K     +    A+K I    +    + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60

Query: 695 HRNLIKIITVCSGRDFKGADFKA--------IVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
           H+ +++       R        A        I  E+ +NG+L + +H  N      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQR 115

Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            +   +   +  A+ Y+H      I+H DLKP N+ +D+     + DFGLAK +      
Sbjct: 116 DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 807 TIVETRSISIGIK------GTVGYVAPE-------YGMGREASMKGDVYSFGILLLEL 851
             ++++++           GT  YVA E       Y        K D+YS GI+  E+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFEM 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  126 bits (319), Expect = 5e-32
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKG--ASKSFVAECKALRNIRHRNL 698
           +++G+G  G V            G  VAVK   L+  G    + F  E + L+ +    +
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K   V  G    G     +V E++ +G L ++L     +L+   L     L  +  +  
Sbjct: 87  VKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICK 138

Query: 759 AIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            +EYL          VH DL   N+L++ +    ++DFGLAK L   + D  V       
Sbjct: 139 GMEYLGSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQS 192

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            I       APE       S + DV+SFG++L ELFT
Sbjct: 193 PIFWY----APESLSDNIFSRQSDVWSFGVVLYELFT 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  126 bits (318), Expect = 5e-32
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIK 700
            ++G+G  G V            G  VAVK +    +   + F  E + L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
              VC     +      ++ E++  GSL ++L    ++++   L     L     +   +
Sbjct: 107 YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 158

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           EYL        +H DL   N+L++ +    + DFGL K L   + +           I  
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFW 214

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                APE     + S+  DV+SFG++L ELFT
Sbjct: 215 Y----APESLTESKFSVASDVWSFGVVLYELFT 243

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (326), Expect = 5e-32
 Identities = 75/472 (15%), Positives = 149/472 (31%), Gaps = 97/472 (20%)

Query: 66  LERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHIT 125
               + +          +    + L  L   ++++  ++   I  L  L +L    N+IT
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 126 GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
             L   +   ++L  +    N+L      +  L  LT L+   N+ + +    +     L
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKL--TNLDVTPLTKLTYLNCDTNKLTKL---DVSQNPLL 129

Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
             ++ + N  T  + V    +   L EL  + N     +   ++  + L  ++ S N+ +
Sbjct: 130 TYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 246 GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
               +D S+ K L  LN   NN+      +LD         +L  L  + N+        
Sbjct: 184 ---ELDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSSNK-------- 223

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLD 365
                  + +I             ++  L  L +     N LT  +   +  L+ L  L 
Sbjct: 224 -------LTEI-------------DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLH 260

Query: 366 LDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPR 425
             +  L   I   L + T L Y +         +   + + T L  L+            
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAG------- 308

Query: 426 QILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYL 485
               IT L L                      L+ L L+  + + E+   +S    L+ L
Sbjct: 309 ----ITELDL-----------------SQNPKLVYLYLNNTELT-ELD--VSHNTKLKSL 344

Query: 486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSY 537
           +             +  + ++     +         E L N S    ++   
Sbjct: 345 SCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  126 bits (319), Expect = 4e-31
 Identities = 90/492 (18%), Positives = 179/492 (36%), Gaps = 76/492 (15%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
             +T LD  N SI  T    +  L+ L  +   SN     +   + +  +L  L   +N 
Sbjct: 42  ATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
            +     +++  + L  L+ D+N L      D+     L  L+  +N +T ++   + + 
Sbjct: 97  LTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID--VSHN 147

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
           + L  +D   N+   ++D +     LT L  +FN+ + +    +     L  ++   N  
Sbjct: 148 TQLTELDCHLNKKITKLD-VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI 203

Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL 255
           T  L ++       L  L  ++N  T      ++  + L   + S N  +    +D S L
Sbjct: 204 T-KLDLN---QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTL 253

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQ 315
             L  L+    +L      E+D    LT+ ++L        R   EL             
Sbjct: 254 SKLTTLHCIQTDL-----LEID----LTHNTQLIYFQAEGCRKIKEL------------- 291

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI 375
                         ++ +   L  L      +T  +   + +   L  L L+   L   +
Sbjct: 292 --------------DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333

Query: 376 PSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL 435
              + + T L  L     +++ +   S+G    L     +  + I T+P++ L  T  SL
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETL--TNNSL 386

Query: 436 YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGS 495
            + +  +LL+    P      +    D + N  + E  +T +      + +    A  G+
Sbjct: 387 TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS-ENGAIVGT 445

Query: 496 IPLLLDSLQSIK 507
           +    ++ Q IK
Sbjct: 446 VTTPFEAPQPIK 457

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  118 bits (298), Expect = 2e-28
 Identities = 77/447 (17%), Positives = 139/447 (31%), Gaps = 98/447 (21%)

Query: 98  NNLVGEIPADIGSLFK---LERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDS 154
           N L           F              +      S   L++L  +D   + +   +  
Sbjct: 1   NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMTG 59

Query: 155 LGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELR 214
           + +L  LT L    N  + +    +   ++L  ++   N+ T +L V     L  L  L 
Sbjct: 60  IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLN 112

Query: 215 TNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAAN 274
            + N  T    + +S    L  +  ++N  +    +D S    L  L+  +N   T    
Sbjct: 113 CDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT---- 162

Query: 275 ELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNL 334
                  +T  ++L  L  + N+             + +                ++   
Sbjct: 163 ----KLDVTPQTQLTTLDCSFNKI------------TEL----------------DVSQN 190

Query: 335 ASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN 394
             LN L  DTN +T     ++ +   L  LD   N L   I   +  LT LTY    +N 
Sbjct: 191 KLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNP 244

Query: 395 LEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGN 454
           L   +  S    + L  L+     L        + +T  +  +             +V +
Sbjct: 245 LT-ELDVS--TLSKLTTLHCIQTDL------LEIDLTHNTQLIYFQAEGCRKIKELDVTH 295

Query: 455 LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSN 514
              L  LD      + E+   LS    L YL ++                 + ELD S  
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT--------------ELTELDVS-- 336

Query: 515 NLNGQIPEYLENLSFLEFLNLSYNHFE 541
                      + + L+ L+    H +
Sbjct: 337 -----------HNTKLKSLSCVNAHIQ 352

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (315), Expect = 6e-32
 Identities = 49/229 (21%), Positives = 95/229 (41%), Gaps = 36/229 (15%)

Query: 646 KIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRNL 698
            +GEG  G VY+G           VAVK      K  +      F++E   ++N+ H ++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K+I +             I+ E    G L  +L  + + L      V+  +  ++ +  
Sbjct: 76  VKLIGIIEEEPTW------IIMELYPYGELGHYLERNKNSL-----KVLTLVLYSLQICK 124

Query: 759 AIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           A+ YL   +      VH D+   N+L+       + DFGL++++ +   +   +     +
Sbjct: 125 AMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRL 176

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            IK      +PE    R  +   DV+ F + + E+ +  K+P   + N+
Sbjct: 177 PIKWM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (313), Expect = 1e-31
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 31/234 (13%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR 694
            +   +F     IG GG G V+K     +G    +K +    + A +    E KAL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 695 HRNLIKIITVCSGRDFKGADFKA-----------IVYEFMQNGSLEEWLHHSNDQLEVCS 743
           H N++       G D+                  I  EF   G+LE+W+     +     
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---- 118

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           L  +  L +   +   ++Y+H      +++ DLKPSN+ L       + DFGL   L N 
Sbjct: 119 LDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              T           KGT+ Y++PE    ++   + D+Y+ G++L EL      
Sbjct: 176 GKRTRS---------KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (328), Expect = 1e-31
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 646 KIGEGGSGIVYKGFL-GENG-TEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIK 700
           ++G G  G V +G         +VA+KV  LK   +K  ++  + E + +  + +  +++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I VC            +V E    G L ++L    +++      V     +   V+  +
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGM 449

Query: 761 EYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           +YL   ++     VH +L   NVLL     + +SDFGL+K L   +        +    +
Sbjct: 450 KYLEEKNF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPL 503

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFN 863
           K      APE    R+ S + DV+S+G+ + E  +  ++P   M  
Sbjct: 504 KWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  129 bits (327), Expect = 1e-31
 Identities = 83/488 (17%), Positives = 160/488 (32%), Gaps = 43/488 (8%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
             + L LS NS S     ++S  S L  L    N +   +   +      LE L +  N 
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111

Query: 124 ITGQLPASIGNLSSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
           +   +      ++SLR +D+  N           G L  LT L ++  +F   +      
Sbjct: 112 LQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA 167

Query: 182 ISSLEVISLSENRFT---GSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEM-- 236
              L  I L    +    G        N   L  +    + F+  + +S++    L++  
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 237 IEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRN 296
           I+ +       ++      +    LN+ + ++ T     +           +E L     
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNL 286

Query: 297 RFEGELPHSVANLSSTIKQIAM----GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIP 352
                +       S T  +  M           +        A +N   +  +       
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346

Query: 353 PEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGL 412
                 ++   L+  +N    S+      L  L  L L  N L+ N         N+  L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405

Query: 413 NISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEI 472
                 L                     N+L + +        ++++ L+LS N  +G +
Sbjct: 406 ETLDVSL---------------------NSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444

Query: 473 PATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEF 532
              L     ++ L++  N    SIP  +  LQ+++EL+ +SN L        + L+ L++
Sbjct: 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY 501

Query: 533 LNLSYNHF 540
           + L  N +
Sbjct: 502 IWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  101 bits (253), Expect = 2e-22
 Identities = 83/479 (17%), Positives = 161/479 (33%), Gaps = 61/479 (12%)

Query: 71  LSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPA 130
            SN + +  +P +L   +  + LS   N++      DI  L +L  L +  N I   L  
Sbjct: 38  YSNRNLT-HVPKDLPPRTKALSLS--QNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93

Query: 131 SI-GNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVI 188
            +      L  +DV  NRL     S   + SL  L ++FN F  +     F N++ L  +
Sbjct: 94  HVFLFNQDLEYLDVSHNRLQN--ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151

Query: 189 SLSENRFTGSLPVDTGVNL---PSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
            LS  +F   L +    +L     L +L +          + + N + L ++    + FS
Sbjct: 152 GLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210

Query: 246 GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
             V++  + L +L   N+ +N+        + F++ LT    L  +         +    
Sbjct: 211 VQVNMSVNALGHLQLSNIKLND--ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268

Query: 306 VANL--SSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
           +        ++ + +    I+  I  E    +                      L +L  
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA-------------------LKSLMI 309

Query: 364 LDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
             +       S  +       +    L +++          + ++   LN + N    ++
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369

Query: 424 PRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLE 483
            +    +  L   +   N L   +        KN+  L+                     
Sbjct: 370 FQGCSTLKRLQTLILQRNGL--KNFFKVALMTKNMSSLET-------------------- 407

Query: 484 YLNISGNAF-SGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
            L++S N+  S +        +SI  L+ SSN L G +   L     ++ L+L  N   
Sbjct: 408 -LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 96.1 bits (239), Expect = 9e-21
 Identities = 63/466 (13%), Positives = 136/466 (29%), Gaps = 75/466 (16%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPH--QIGRLISLERLILSNNSF 76
             LD+ +  ++  +S     ++ LR+++++ N F+  +P   + G L  L  L LS   F
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS 136
                  ++       L    +  +     +   +     L +  +  +        +++
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218

Query: 137 SLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS----SLEVISLSE 192
           +L  +               QL ++ L      +    +       +    +L+ I  + 
Sbjct: 219 ALGHL---------------QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263

Query: 193 NRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF-----SKNQFSGG 247
                            +  L       T  I       S   +            F   
Sbjct: 264 KCSVKLFQF---FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320

Query: 248 VSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVA 307
               +S    +    L I++                + S    L F              
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPP------SPSSFTFLNFT------------- 361

Query: 308 NLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLD 367
                       +N  + ++      L  L  L +  N L            N+  L+  
Sbjct: 362 ------------QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408

Query: 368 RNFLQ----GSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
              L      +   +      +  L L  N L G++   L     +  L++ +N++  ++
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI-MSI 465

Query: 424 PRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKF 468
           P+ +  +  L   L + +N L  S+P  V   L +L  + L  N +
Sbjct: 466 PKDVTHLQALQ-ELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.4 bits (206), Expect = 9e-17
 Identities = 69/436 (15%), Positives = 116/436 (26%), Gaps = 65/436 (14%)

Query: 160 SLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
               LS++ N  S  +       +S L V+ LS NR   SL     +    L  L  + N
Sbjct: 53  RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQF-SGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                  +S    +SL  ++ S N F    V  +F  L  L +L L            + 
Sbjct: 111 RLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL 337
            ++L      L   +                                     E   + + 
Sbjct: 168 HLHLSCILLDLVSYHIKGG-------------------------------ETESLQIPNT 196

Query: 338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG 397
             L +  +  +         +  L  L L    L       L            L N+  
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGN--- 454
               +   C+  L        +                YL + N  +   +  E      
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPV---------------EYLNIYNLTITERIDREEFTYSE 301

Query: 455 --LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
             LK+LM   +    F     A  S  A +    +S +       +   S  S   L+F+
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

Query: 513 SNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLC---GGLD 569
            N     + +    L  L+ L L  N  +    +  +  N +                 D
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421

Query: 570 ELRLPSCQSKGSLTIL 585
                 C    S+ +L
Sbjct: 422 RT----CAWAESILVL 433

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 23/224 (10%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG 404
             LT  +P ++      + L L +N +       +  L+ L  L+L  N +         
Sbjct: 41  RNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL 97

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPP--EVGNLKNLMRL 461
              +L  L++SHN+L   +    +     SL +L+L  N  +  LP   E GNL  L  L
Sbjct: 98  FNQDLEYLDVSHNRL-QNISCCPMA----SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151

Query: 462 DLSGNKFSGEIPATLS------ACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN 515
            LS  KF       ++         +L   +I G             L     L F  N+
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH----LVFHPNS 207

Query: 516 L-NGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSI 558
           L + Q+   +  L  L+  N+  N    +  M  +       ++
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (309), Expect = 4e-31
 Identities = 48/240 (20%), Positives = 103/240 (42%), Gaps = 50/240 (20%)

Query: 646 KIGEGGSGIVYKGFL-------GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
            +G+G    ++KG           + TEV +KV++   +  S+SF      +  + H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 699 IKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           +    VC   D          +V EF++ GSL+ +L  + +      ++++ +L +A  +
Sbjct: 75  VLNYGVCVCGDENI-------LVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQL 122

Query: 757 ASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSH--------VSDFGLAKFLSNHNPD 806
           A+A+ +L  +       +HG++   N+LL ++            +SD G++         
Sbjct: 123 AAAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------- 170

Query: 807 TIVETRSISIGIKGTVGYVAPE-YGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            ++    +   I        PE     +  ++  D +SFG  L E+ +   +P  A+ ++
Sbjct: 171 -VLPKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  126 bits (318), Expect = 5e-31
 Identities = 85/430 (19%), Positives = 155/430 (36%), Gaps = 59/430 (13%)

Query: 101 VGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI--DSLGQL 158
           V E+PA +        + +  N I      S   L  L+ + V +      I  ++   L
Sbjct: 25  VPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78

Query: 159 KSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGS-LPVDTGVNLPSLRELRTN 216
            SL +L + +NQF   +    F  +++LEV++L++    G+ L  +    L SL  L   
Sbjct: 79  SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 217 ANNFTGFIPVSL-SNASSLEMIEFSKNQFSGGVSVDFSRL--KNLYWLNLGINNLGTGAA 273
            NN     P S   N     +++ + N+       D      K+   L L    L     
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197

Query: 274 NELDFI--NLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI 331
             L +         + +  L  + N F+  +     +  +  K  ++  +          
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN----MG 253

Query: 332 RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSL-GNLTLLTYLKL 390
            +    N+   D     G       E + ++  DL ++ +  ++  S+  + T L  L L
Sbjct: 254 SSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTL 306

Query: 391 GLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPP 450
             N +     ++    T+LL LN+S N L                          GS+  
Sbjct: 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFL--------------------------GSIDS 340

Query: 451 EV-GNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPL-LLDSLQSIK 507
            +  NL  L  LDLS N     +   +     NL+ L +  N    S+P  + D L S++
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398

Query: 508 ELDFSSNNLN 517
           ++   +N  +
Sbjct: 399 KIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  125 bits (316), Expect = 9e-31
 Identities = 81/398 (20%), Positives = 147/398 (36%), Gaps = 43/398 (10%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
            +  + LS NS +     + S   +L  L  +       I  +    L  L  L +  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 124 ITGQLPASI-GNLSSLRVIDVRENRLWGRI---DSLGQLKSLTLLSVAFNQFSGMIPPSI 179
              QL       L++L V+ + +  L G +   +    L SL +L +  N    + P S 
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 180 F-NISSLEVISLSENRFTGSLPVDTGVNLPS--LRELRTNANNFTGFIPVSLSNASSLEM 236
           F N+    V+ L+ N+   S+  +  +N        LR ++                   
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ--------------- 193

Query: 237 IEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGT-------GAANELDFINLLTNCSKLE 289
            + ++         +  +  ++  L+L  N            A       +L+ + S   
Sbjct: 194 -DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 290 RLYFNRNRFEGELPHSVANLSST-IKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQL 347
              F    F+     +   L ++ +K   + +++I   +   +  +   L  LT+  N++
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311

Query: 348 TGTIPPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPSSLGN 405
              I       LT+L +L+L +NFL  SI S    NL  L  L L  N++      S   
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369

Query: 406 CTNLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNN 442
             NL  L +  N+L  ++P  I  R+T+L   + L  N
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQ-KIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (296), Expect = 3e-28
 Identities = 64/395 (16%), Positives = 133/395 (33%), Gaps = 32/395 (8%)

Query: 160 SLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
            +  + ++ N  +  +  + F  +  L+ + + +      +  +T   L SL  L+ + N
Sbjct: 31  HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD--FSRLKNLYWLNLGINNLGTGAANEL 276
            F      + +  ++LE++  ++    G V     F  L +L  L L  NN+       +
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-----I 144

Query: 277 DFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQI---------AMGRNRISGTI 327
              +   N  +   L    N+ +      + N       +          M    +    
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 328 PPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTY 387
                   S+  L +  N    ++     +     ++         ++ SS G+      
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 388 LKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGS 447
                  LE          + +   ++S +K I  L + +    T    L L  N +N  
Sbjct: 265 DNFTFKGLE---------ASGVKTCDLSKSK-IFALLKSVFSHFTDLEQLTLAQNEIN-K 313

Query: 448 LPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPL-LLDSLQS 505
           +       L +L++L+LS N               LE L++S N    ++       L +
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPN 372

Query: 506 IKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
           +KEL   +N L        + L+ L+ + L  N +
Sbjct: 373 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  110 bits (278), Expect = 8e-26
 Identities = 79/425 (18%), Positives = 149/425 (35%), Gaps = 60/425 (14%)

Query: 4   CQWTGVTC-GQRHQRV-------TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNG 54
                  C  +   +V         +DL   SI   L+      L  L+++ +       
Sbjct: 10  VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGL 68

Query: 55  EIPHQI-GRLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNL-VGEIPADI-GS 110
            I +     L SL  L L  N F   +     +  +NL  L+    NL    +  +    
Sbjct: 69  VIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127

Query: 111 LFKLERLSIFQNHITGQLPASI-GNLSSLRVIDVRENRLW----GRIDSLGQ-------L 158
           L  LE L +  N+I    PAS   N+    V+D+  N++       + +          L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187

Query: 159 KSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLP--VDTGVNLPSLRELRTN 216
            S+TL  +           + F  +S+  + LS N F  S+       +    ++ L  +
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLK--NLYWLNLGINNLGTGAAN 274
            +                    F    F    +  F  L+   +   +L  + +      
Sbjct: 248 NSY--------------NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK- 292

Query: 275 ELDFINLLTNCSKLERLYFNRNRFEGELPHSV-ANLSSTIKQIAMGRNRISGTIPPEI-R 332
                ++ ++ + LE+L   +N    ++  +    L+  + ++ + +N +  +I   +  
Sbjct: 293 -----SVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH-LLKLNLSQNFLG-SIDSRMFE 344

Query: 333 NLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSS-LGNLTLLTYLKL 390
           NL  L  L +  N +   +  +    L NL++L LD N L+ S+P      LT L  + L
Sbjct: 345 NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402

Query: 391 GLNNL 395
             N  
Sbjct: 403 HTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  106 bits (267), Expect = 2e-24
 Identities = 65/378 (17%), Positives = 131/378 (34%), Gaps = 47/378 (12%)

Query: 208 PSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD-FSRLKNLYWLNLGIN 266
             +  +  + N+       S S    L+ ++  +      +  + F  L +L  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 267 NLGTGAANELDFINLLTNCSKLERLYFNRNRF-EGELPHSV-ANLSSTIKQIAMGRNRIS 324
                     +        + LE L   +       L  +    L+S ++ + +  N I 
Sbjct: 90  QFLQLETGAFN------GLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIK 142

Query: 325 GTIPPEI--RNLASLNWLTIDTNQLTGTIPPEI-----------GELTNLQQLDLDRNFL 371
             I P     N+   + L +  N++  +I  E              L+++   D++  +L
Sbjct: 143 -KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 372 QGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSL-----GNCTNLLGLNISHNKLIGTLPRQ 426
                 +    T +T L L  N  + ++         G     L L+ S+N         
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 427 ILRITTLSL---------YLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPA-T 475
                  +            +L  + +  +L   V  +  +L +L L+ N+ + +I    
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318

Query: 476 LSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYL-ENLSFLEFLN 534
                +L  LN+S N        + ++L  ++ LD S N++   + +     L  L+ L 
Sbjct: 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELA 377

Query: 535 LSYNHFEGEVPMKGVFNN 552
           L  N  +  VP  G+F+ 
Sbjct: 378 LDTNQLK-SVP-DGIFDR 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 49/280 (17%), Positives = 88/280 (31%), Gaps = 30/280 (10%)

Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPE-IRNLASLNWLTIDTNQLTGTIPPEI-GELTNL 361
           H V  L + +  + +  N I+  +       L  L +L ++       I       L++L
Sbjct: 23  HQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 362 QQLDLDRNFLQGSIPSS-LGNLTLLTYLKLGLNNLEGNI--PSSLGNCTNLLGLNISHNK 418
             L LD N     + +     L  L  L L   NL+G +   +     T+L  L +  N 
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 419 LIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV---GNLKNLMRLDLSGNKFSGEIPA 474
           +    P      +      L+L  N +  S+  E       K+   L LS          
Sbjct: 141 IKKIQPASFFLNMRRFH-VLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSIT------- 191

Query: 475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE-YLENLSFLEFL 533
                      +++                SI  LD S N     + + + + ++  +  
Sbjct: 192 ---------LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242

Query: 534 NLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRL 573
           +L  ++        G  N K   +    G    G+    L
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDL 282

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (310), Expect = 6e-31
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 35/229 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIRH 695
            NF    KIG G    VY+     +G  VA+K + +     +K     + E   L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 696 RNLIKIITVCSGRDFKGADFKA-----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
            N+IK         +  + F       IV E    G L   + H   Q  +     +   
Sbjct: 92  PNVIK---------YYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV--W 139

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN--PDTI 808
              + + SA+E++H      ++H D+KP+NV +    V  + D GL +F S+      ++
Sbjct: 140 KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           V          GT  Y++PE       + K D++S G LL E+   + P
Sbjct: 197 V----------GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  124 bits (312), Expect = 6e-31
 Identities = 33/271 (12%), Positives = 69/271 (25%), Gaps = 44/271 (16%)

Query: 614 RKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN 673
              + + P   +  VDS   LS+          +  G   +V+     E   + A+KV  
Sbjct: 39  AVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFT 96

Query: 674 LKQKGAS---KSFVAECKALRNIRHRNLI---------------------KIITVCSGRD 709
           +  + +    +       A   +   +                           +  G+D
Sbjct: 97  MGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD 156

Query: 710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV-CSLSVIQRLNIAIDVASAIEYLHHYCE 768
                   ++        LE      +          ++    +   +      L     
Sbjct: 157 DYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213

Query: 769 PSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE 828
             +VHG   P N+ +  D    + D             T     S        V Y   E
Sbjct: 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSAL-----WKVGTRGPASS------VPVTYAPRE 261

Query: 829 YGMGREASM--KGDVYSFGILLLELFTRKRP 857
           +     A+     + +  G+ +  ++    P
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 7e-31
 Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 31/219 (14%)

Query: 646 KIGEGGSGIVYKGF-LGENGTEVAVKVINLKQKG---ASKSFVAECKALRNIRHRNLIKI 701
            I  GG G +Y       NG  V +K   L   G   A    +AE + L  + H ++++I
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                  D  G     IV E++   SL+              L V + +   +++  A+ 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLEILPALS 196

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH      +V+ DLKP N++L ++ +  + D G    +++               + GT
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRINSFGY------------LYGT 240

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
            G+ APE       ++  D+Y+ G  L  L       + 
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (305), Expect = 3e-30
 Identities = 61/218 (27%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 645 NKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRN 697
             +GEG  G V            G  VAVK   LK     +    +  E   LR + H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +IK    C            +V E++  GSL ++L          S+ + Q L  A  + 
Sbjct: 95  IIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQIC 144

Query: 758 SAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
             + YLH  HY     +H DL   NVLLD D +  + DFGLAK +     +         
Sbjct: 145 EGMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 198

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +       APE     +     DV+SFG+ L EL T
Sbjct: 199 SPVFWY----APECLKEYKFYYASDVWSFGVTLYELLT 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 3e-30
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 26/223 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHR 696
           + +    KIGEG  G        E+G +  +K IN+ +  +   +    E   L N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+++         F+      IV ++ + G L + ++     L        Q L+  + +
Sbjct: 84  NIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVL----FQEDQILDWFVQI 134

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVETRSI 814
             A++++H   +  I+H D+K  N+ L +D    + DFG+A+ L++        +     
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----- 186

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                GT  Y++PE    +  + K D+++ G +L EL T K  
Sbjct: 187 -----GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 5e-30
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVA----ECKALRNIRHRNLIK 700
           K+G GG   VY         +VA+K   +       +  +     E      + H+N++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKA--IFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I V    +     +  +V E+++  +L E++           LSV   +N    +   I
Sbjct: 76  MIDV--DEE-DDCYY--LVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGI 124

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           ++ H      IVH D+KP N+L+D +    + DFG+AK LS     ++ +T  +     G
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---TSLTQTNHVL----G 174

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           TV Y +PE   G       D+YS GI+L E+   + P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (316), Expect = 6e-30
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 20/234 (8%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-ECKALRNI 693
           ++    +    ++G GG G V +    + G +VA+K    +    ++     E + ++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 694 RHRNLIKIITVC-SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            H N++    V    +     D   +  E+ + G L ++L   N     C L       +
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTL 126

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
             D++SA+ YLH   E  I+H DLKP N++L    Q L+  + D G AK L   +   + 
Sbjct: 127 LSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELC 180

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN 863
                     GT+ Y+APE    ++ ++  D +SFG L  E  T  RP    + 
Sbjct: 181 TEF------VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (302), Expect = 6e-30
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 38/240 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNL--IK 700
            +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  +   I+
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +             +  +V E   N  L  WL          S+   +R +   ++  A+
Sbjct: 93  LYDY-----EITDQYIYMVMECG-NIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 140

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
             +H +    IVH DLKP+N L+   ++  + DFG+A  +       + ++        G
Sbjct: 141 HTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 190

Query: 821 TVGYVAPE-----------YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
           TV Y+ PE                + S K DV+S G +L  +   K P   + N+   LH
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (314), Expect = 1e-29
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 36/229 (15%)

Query: 646 KIGEGGSGIVYKGFL---GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRHRNL 698
            IGEG  G V++G           VA+K    K    S S    F+ E   +R   H ++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKN-CTSDSVREKFLQEALTMRQFDHPHI 453

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +K+I V +           I+ E    G L  +L      L++ SL     +  A  +++
Sbjct: 454 VKLIGVITENPV------WIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLST 502

Query: 759 AIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           A+ YL    +     VH D+   NVL+  +    + DFGL++++ +    T  +     +
Sbjct: 503 ALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKL 554

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
            IK      APE    R  +   DV+ FG+ + E+     +P   + N 
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  119 bits (301), Expect = 1e-29
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 35/236 (14%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
             +G G  G VY+G +       +  +VAVK +    +  S+     F+ E   +    H
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNH 92

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAI 754
           +N+++ I V      +      I+ E M  G L+ +L        +  SL+++  L++A 
Sbjct: 93  QNIVRCIGVSL----QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 755 DVASAIEYL--HHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           D+A   +YL  +H+     +H D+   N LL       V+ + DFG+A+ +  +      
Sbjct: 148 DIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR 200

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           +     + +K       PE  M    + K D +SFG+LL E+F+    P  +  N+
Sbjct: 201 KGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 1e-29
 Identities = 57/250 (22%), Positives = 89/250 (35%), Gaps = 23/250 (9%)

Query: 609 RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVA 668
           +R       N   +  + L     E  +     +   ++G G  G V++    + G + A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 669 VKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSL 728
           VK + L+          E  A   +        I    G   +G     I  E ++ GSL
Sbjct: 88  VKKVRLEVFRVE-----ELVACAGLSSPR----IVPLYGAVREGPWVN-IFMELLEGGSL 137

Query: 729 EEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLV 788
            + +       E                   +EYLH      I+HGD+K  NVLL  D  
Sbjct: 138 GQLIKQMGCLPE----DRAL--YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGS 188

Query: 789 S-HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGIL 847
              + DFG A  L        + T      I GT  ++APE  MG+    K D++S   +
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGD---YIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 848 LLELFTRKRP 857
           +L +     P
Sbjct: 246 MLHMLNGCHP 255

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (296), Expect = 2e-29
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 21/228 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHR 696
           +++     IG G  G   K     +G  +  K ++      +  +  V+E   LR ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+++        D        IV E+ + G L   +     + +      +  L +   +
Sbjct: 66  NIVRYYD--RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQL 120

Query: 757 ASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVETR 812
             A++  H       +++H DLKP+NV LD      + DFGLA+ L++      T V   
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--- 177

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
                  GT  Y++PE       + K D++S G LL EL     P  A
Sbjct: 178 -------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 3e-29
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 38/240 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL--IK 700
            +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  +   I+
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +             +  +V E   N  L  WL          S+   +R +   ++  A+
Sbjct: 121 LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 168

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
             +H +    IVH DLKP+N L+   ++  + DFG+A  +       + ++        G
Sbjct: 169 HTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 218

Query: 821 TVGYVAPE-----------YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
            V Y+ PE                + S K DV+S G +L  +   K P   + N+   LH
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (299), Expect = 3e-29
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 38/240 (15%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHRNL--IK 700
            +IG GGS  V++  L E     A+K +NL++       S+  E   L  ++  +   I+
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +             +  +V E   N  L  WL          S+   +R +   ++  A+
Sbjct: 74  LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 121

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
             +H +    IVH DLKP+N L+   ++  + DFG+A  +       + ++        G
Sbjct: 122 HTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 171

Query: 821 TVGYVAPE-----------YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
           TV Y+ PE                + S K DV+S G +L  +   K P   + N+   LH
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  118 bits (297), Expect = 3e-29
 Identities = 51/236 (21%), Positives = 95/236 (40%), Gaps = 31/236 (13%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNI 693
           S +   +  ++ +G+G +  V++G   + G   A+KV N           + E + L+ +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
            H+N++K+  +    +      K ++ EF   GSL   L    +      L   + L + 
Sbjct: 65  NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVL 118

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDFGLAKFLSNHNPDTIV 809
            DV   + +L    E  IVH ++KP N++     D   V  ++DFG A+ L     D   
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQF 172

Query: 810 ETRSISIGIKGTVGYVAPE--------YGMGREASMKGDVYSFGILLLELFTRKRP 857
            +      + GT  Y+ P+            ++     D++S G+      T   P
Sbjct: 173 VS------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 3e-29
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           +G+G  GIVY G    N   +A+K I  +    S+    E    ++++H+N    I    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----IVQYL 85

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
           G   +    K I  E +  GSL   L      L+  +   I        +   ++YLH  
Sbjct: 86  GSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKD-NEQTIG--FYTKQILEGLKYLH-- 139

Query: 767 CEPSIVHGDLKPSNVLLDQDL-VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
            +  IVH D+K  NVL++    V  +SDFG +K L+  N          +    GT+ Y+
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--------PCTETFTGTLQYM 190

Query: 826 APE--YGMGREASMKGDVYSFGILLLELFTRKRP 857
           APE      R      D++S G  ++E+ T K P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (295), Expect = 1e-28
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 35/236 (14%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
             +G G  G VY+G +       +  +VAVK +    +  S+     F+ E   +    H
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNH 133

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAI 754
           +N+++ I V      +      I+ E M  G L+ +L        +  SL+++  L++A 
Sbjct: 134 QNIVRCIGVSL----QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 755 DVASAIEYL--HHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFGLAKFLSNHNPDTIV 809
           D+A   +YL  +H+     +H D+   N LL       V+ + DFG+A+ +  +      
Sbjct: 189 DIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR 241

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDAMFNE 864
           +     + +K       PE  M    + K D +SFG+LL E+F+    P  +  N+
Sbjct: 242 KGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (292), Expect = 1e-28
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 646 KIGEGGSGIVYKG---FLGENGTEVAVKVINLKQKGAS-KSFVA----ECKALRNIRHRN 697
            +G GG   V+            +VAVKV  L+   A   SF      E +    + H  
Sbjct: 19  ILGFGGMSEVHLARDLRDHR---DVAVKV--LRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 698 LIKIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++ +     G     A     IV E++   +L + +H          ++  + + +  D 
Sbjct: 74  IVAVYDT--GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADA 125

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+ + H   +  I+H D+KP+N+++       V DFG+A+ +++ + +++ +T ++  
Sbjct: 126 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVI- 180

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 181 ---GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (291), Expect = 2e-28
 Identities = 48/230 (20%), Positives = 93/230 (40%), Gaps = 16/230 (6%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+GEGG   V       +G   A+K I   ++   +    E    R   H N+++++  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
                   +   ++  F + G+L   +    D+     L+  Q L + + +   +E +H 
Sbjct: 96  LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS--IGIKGTVG 823
                  H DLKP+N+LL  +    + D G        + +   +  ++      + T+ 
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTIS 208

Query: 824 YVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
           Y APE  +           + DV+S G +L  +   + P D +F +G ++
Sbjct: 209 YRAPE--LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (289), Expect = 2e-28
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 44/232 (18%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
            ++GE   G VYKG L     GE    VA+K   LK   A       F  E      ++H
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LK-DKAEGPLREEFRHEAMLRARLQH 71

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLEVCS 743
            N++ ++ V +             +++ +  +G L E+L             +D+    +
Sbjct: 72  PNVVCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 744 LSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
           L     +++   +A+ +EYL  HH      VH DL   NVL+   L   +SD GL + + 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREV- 178

Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +  D      +  + I+      APE  M  + S+  D++S+G++L E+F+
Sbjct: 179 -YAADYYKLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  115 bits (291), Expect = 2e-28
 Identities = 48/227 (21%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
            ++G+G  G+VY+G        E  T VA+K +N   + AS      F+ E   ++    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNC 87

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----HHSNDQLEVCSLSVIQR 749
            ++++++ V S             ++ E M  G L+ +L        +   +   S+ + 
Sbjct: 88  HHVVRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 750 LNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
           + +A ++A  + YL  + +     VH DL   N ++ +D    + DFG+ + +  +  D 
Sbjct: 141 IQMAGEIADGMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDY 193

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR 854
             +     + ++      +PE       +   DV+SFG++L E+ T 
Sbjct: 194 YRKGGKGLLPVRWM----SPESLKDGVFTTYSDVWSFGVVLWEIATL 236

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (294), Expect = 3e-28
 Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 31/236 (13%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNI 693
           S +   +  ++ +G+G +  V++G   + G   A+KV N +         + E + L+ +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
            H+N++K+  +    +      K ++ EF   GSL   L    +      L   + L + 
Sbjct: 65  NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVL 118

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLL----DQDLVSHVSDFGLAKFLSNHNPDTIV 809
            DV   + +L    E  IVH ++KP N++     D   V  ++DFG A+ L     D   
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQF 172

Query: 810 ETRSISIGIKGTVGYVAPE--------YGMGREASMKGDVYSFGILLLELFTRKRP 857
            +      + GT  Y+ P+            ++     D++S G+      T   P
Sbjct: 173 VS------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (288), Expect = 5e-28
 Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 63/280 (22%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKALRNI 693
           S+   +F     +G GG G+V++     +    A+K I L  +  + +  + E KAL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 694 RHRNLIKIITVCSGRDFKGADFKA------------------------------------ 717
            H  +++          +    +                                     
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 718 ----------------IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                           I  +  +  +L++W++      +         L+I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC---LHIFIQIAEAVE 178

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK-- 819
           +LH      ++H DLKPSN+    D V  V DFGL   +     +  V T   +      
Sbjct: 179 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 820 --GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             GT  Y++PE   G   S K D++S G++L EL      
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (286), Expect = 6e-28
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 45/232 (19%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
            ++GEG  G V+          ++   VAVK +    K  + +    F  E + L N++H
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQH 76

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLEVCS 743
            +++K   VC   D          +V+E+M++G L ++L               +     
Sbjct: 77  EHIVKFYGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 744 LSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
           L + Q L+IA  +AS + YL   H+     VH DL   N L+  +L+  + DFG+++ + 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDV- 183

Query: 802 NHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            ++ D         + I+       PE  M R+ + + DV+SFG++L E+FT
Sbjct: 184 -YSTDYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  114 bits (288), Expect = 7e-28
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 36/227 (15%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
            ++GEG  G V+          ++   VAVK +    + A + F  E + L  ++H++++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 700 KIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL---------HHSNDQLEVCSLSVIQ 748
           +   VC+             +V+E+M++G L  +L             + +    L + Q
Sbjct: 107 RFFGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 749 RLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD 806
            L +A  VA+ + YL   H+     VH DL   N L+ Q LV  + DFG+++ +  ++ D
Sbjct: 160 LLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTD 212

Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                    + I+       PE  + R+ + + DV+SFG++L E+FT
Sbjct: 213 YYRVGGRTMLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  114 bits (287), Expect = 9e-28
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 45/230 (19%)

Query: 645 NKIGEGGSGIVYKGFLGENG--TEVAVKVINLKQKGASKS----FVAECKALRNI-RHRN 697
           + IGEG  G V K  + ++G   + A+K   +K + ASK     F  E + L  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MK-EYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 698 LIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLEVCSLS 745
           +I ++  C  R   +       +  E+  +G+L ++L            +       +LS
Sbjct: 88  IINLLGACEHRGYLY-------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 746 VIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
             Q L+ A DVA  ++YL    +     +H DL   N+L+ ++ V+ ++DFGL++     
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGLSR----- 190

Query: 804 NPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             +  V+     + ++      A E       +   DV+S+G+LL E+ +
Sbjct: 191 GQEVYVKKTMGRLPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (286), Expect = 1e-27
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 22/235 (9%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITV 704
            + EGG   VY+     +G E A+K +   ++  +++ + E   ++ +  H N+++  + 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 705 CSGRDFKGADFKAIVYEFMQ--NGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            S    +    +A      +   G L   +           LS    L I      A+++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQL---VEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS-----IG 817
           +H   +P I+H DLK  N+LL       + DFG A  +S H PD     +  +     I 
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS-HYPDYSWSAQRRALVEEEIT 209

Query: 818 IKGTVGYVAPE----YGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
              T  Y  PE    Y        K D+++ G +L  L  R+ P    F +G  L
Sbjct: 210 RNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (282), Expect = 3e-27
 Identities = 54/260 (20%), Positives = 89/260 (34%), Gaps = 38/260 (14%)

Query: 608 WRRRSARKASNMLPIEQQFLVDSYAELSKAT---DNFSSANKIGEGGSGIVYKGFLGENG 664
             +   R+ S      +      Y      +    +F   +++G G  G V+K    E+G
Sbjct: 23  MHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDG 82

Query: 665 TEVAVKVINLKQKGAS--KSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKA---- 717
              AVK      +G       +AE  +   + +H   ++          + A  +     
Sbjct: 83  RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---------LEQAWEEGGILY 133

Query: 718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLK 777
           +  E     SL++            SL   Q      D   A+ +LH      +VH D+K
Sbjct: 134 LQTELCG-PSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVK 184

Query: 778 PSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASM 837
           P+N+ L       + DFGL   L       + E         G   Y+APE   G     
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---------GDPRYMAPELLQGS-YGT 234

Query: 838 KGDVYSFGILLLELFTRKRP 857
             DV+S G+ +LE+      
Sbjct: 235 AADVFSLGLTILEVACNMEL 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (282), Expect = 4e-27
 Identities = 55/235 (23%), Positives = 106/235 (45%), Gaps = 47/235 (20%)

Query: 645 NKIGEGGSGIVYKGFL-------GENGTEVAVKVINLKQKGASKS----FVAECKALRNI 693
             +GEG  G V             +    VAVK++      A++      V+E + ++ I
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMI 97

Query: 694 -RHRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLE 740
            +H+N+I ++  C+     +       ++ E+   G+L E+L           +  +++ 
Sbjct: 98  GKHKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 741 VCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
              ++    ++    +A  +EYL          +H DL   NVL+ ++ V  ++DFGLA+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 205

Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +  +N D   +T +  + +K      APE    R  + + DV+SFG+L+ E+FT
Sbjct: 206 DI--NNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (285), Expect = 5e-27
 Identities = 45/280 (16%), Positives = 83/280 (29%), Gaps = 44/280 (15%)

Query: 609 RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVA 668
               +  ++++    Q F V+S  EL +          +G+       +    E G    
Sbjct: 50  SAADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107

Query: 669 VKVINLKQKGAS---KSFVAECKALRNIR----------------------HRNLIKIIT 703
           V V    ++  S   K    E   LR +R                           K+I 
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVC-SLSVIQRLNIAIDVASAIEY 762
           V           +  +Y  MQ  +L+ +            SL    RL + + V   +  
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LHHY    +VH  L+P +++LDQ     ++ F             +              
Sbjct: 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GASAVSPIGRGF----APP 276

Query: 823 GYVAPEYGMGREA-----SMKGDVYSFGILLLELFTRKRP 857
              A       +      +   D ++ G+ +  ++    P
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  113 bits (285), Expect = 6e-27
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 36/229 (15%)

Query: 640 NFSSANKIGEGGSG-IVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHR 696
           +F   + +G G  G IVY+G    +  +VAVK I  +    A +    E + LR    H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR----EVQLLRESDEHP 78

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I+          K   F+ I  E     +L+E++   +      +   ++ + +    
Sbjct: 79  NVIRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQT 127

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            S + +LH     +IVH DLKP N+L+        + + +SDFGL K L+         +
Sbjct: 128 TSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-----HS 179

Query: 812 RSISIGIKGTVGYVAPEY---GMGREASMKGDVYSFGILLLELFTRKRP 857
            S   G+ GT G++APE          +   D++S G +   + +    
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (278), Expect = 9e-27
 Identities = 50/233 (21%), Positives = 93/233 (39%), Gaps = 43/233 (18%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNI-R 694
             +G G  G V +         +    VAVK++      A  +     ++E K L  +  
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGN 85

Query: 695 HRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL------------HHSNDQLE 740
           H N++ ++  C+             ++ E+   G L  +L              +  + +
Sbjct: 86  HMNIVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
             +L +   L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
              N    V   +  + +K      APE       + + DV+S+GI L ELF+
Sbjct: 196 --KNDSNYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (278), Expect = 1e-26
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNI-R 694
             +G G  G V +              VAVK++    +GA+ S     ++E K L +I  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 89

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLEVCSL 744
           H N++ ++  C+           ++ EF + G+L  +L            + + L    L
Sbjct: 90  HLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 745 SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
           ++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +  + 
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YK 200

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
               V      + +K      APE    R  +++ DV+SFG+LL E+F+
Sbjct: 201 DPDYVRKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  113 bits (284), Expect = 1e-26
 Identities = 63/257 (24%), Positives = 108/257 (42%), Gaps = 14/257 (5%)

Query: 286 SKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDT 344
           ++  ++   R     E+P     + S  + + +  N I   I  +  R+L  L  L +  
Sbjct: 54  NQFSKVVCTRRGLS-EVP---QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGR 108

Query: 345 NQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPS- 401
           N +   I       L +L  L+L  N+L   IPS +   L+ L  L L  N +E +IPS 
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

Query: 402 SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRL 461
           +     +L+ L++   K +  +            YL LG   +     P +  L  L  L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEEL 223

Query: 462 DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP 521
           ++SGN F    P +    ++L+ L +  +  S       D L S+ EL+ + NNL+    
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283

Query: 522 EYLENLSFLEFLNLSYN 538
           +    L +L  L+L +N
Sbjct: 284 DLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (268), Expect = 1e-24
 Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 15/236 (6%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQ 346
              L    N  +     +  +L   ++ + +GRN I   I       LASLN L +  N 
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHH-LEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134

Query: 347 LTGTIPPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPS-SL 403
           LT  IP      L+ L++L L  N ++ SIPS +   +  L  L LG       I   + 
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLD 462
               NL  LN+    +       +  +  L   LE+  N     + P     L +L +L 
Sbjct: 193 EGLFNLKYLNLGMCNI--KDMPNLTPLVGLE-ELEMSGNHFP-EIRPGSFHGLSSLKKLW 248

Query: 463 LSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLN 517
           +  ++ S          A+L  LN++ N  S S+P  L   L+ + EL    N  N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 58/310 (18%), Positives = 99/310 (31%), Gaps = 69/310 (22%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
              +++ +    S  +P  + S  N   L+   NN+          L  LE L + +N I
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 125 TGQLPASIGNLSSLRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQFSGMIPPSIF-N 181
                 +   L+SL  +++ +N L   I   +   L  L  L +  N     IP   F  
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169

Query: 182 ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
           + SL  + L E +    +       L +L+ L     N    +P                
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP---------------- 212

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE 301
                    + + L  L  L +  N+          F  L    S L++L+   ++    
Sbjct: 213 ---------NLTPLVGLEELEMSGNHFPEIRPG--SFHGL----SSLKKLWVMNSQVS-- 255

Query: 302 LPHSVANLSSTIKQIAMGRNRISGTIPPE-IRNLASLNWLTIDTNQLTGTIPPEI-GELT 359
                                    I       LASL  L +  N L+ ++P ++   L 
Sbjct: 256 ------------------------LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290

Query: 360 NLQQLDLDRN 369
            L +L L  N
Sbjct: 291 YLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 13/210 (6%)

Query: 17  RVTRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNN 74
            +  L LG  SIR  +       L+ L  + +  N     IP      L  L  L L NN
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNN 157

Query: 75  SFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASI 132
               +IP+   +   +L+ L       +  I       LF L+ L++   +I   +P  +
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-L 214

Query: 133 GNLSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISL 190
             L  L  +++  N     R  S   L SL  L V  +Q S +I  + F  ++SL  ++L
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNL 273

Query: 191 SENRFTGSLPVDTGVNLPSLRELRTNANNF 220
           + N  + SLP D    L  L EL  + N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 46/211 (21%), Positives = 75/211 (35%), Gaps = 37/211 (17%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG 404
             L+  +P  I   +N + L+L  N +Q     +  +L  L  L+LG N++      +  
Sbjct: 64  RGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDL 463
              +L  L +  N L                            +P      L  L  L L
Sbjct: 121 GLASLNTLELFDNWL--------------------------TVIPSGAFEYLSKLRELWL 154

Query: 464 SGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLNGQIP 521
             N     IP+   +   +L  L++        I     + L ++K L+    N+   +P
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212

Query: 522 EYLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
             L  L  LE L +S NHF  E+   G F+ 
Sbjct: 213 N-LTPLVGLEELEMSGNHFP-EIR-PGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 52/258 (20%), Positives = 95/258 (36%), Gaps = 24/258 (9%)

Query: 4   CQWTG--VTCGQRH---------QRVTRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNG 51
           C      V C +R               L+L   +I+  +      +L  L  + +  N 
Sbjct: 52  CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 52  FNGEIPHQI-GRLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADI- 108
              +I       L SL  L L +N  +  IP+      S L EL   +N +   IP+   
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 109 GSLFKLERLSIFQ-NHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVA 167
             +  L RL + +   +      +   L +L+ +++    +   + +L  L  L  L ++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMPNLTPLVGLEELEMS 226

Query: 168 FNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPV 226
            N F   I P  F  +SSL+ + +  ++ +  +  +    L SL EL    NN +     
Sbjct: 227 GNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHD 284

Query: 227 SLSNASSLEMIEFSKNQF 244
             +    L  +    N +
Sbjct: 285 LFTPLRYLVELHLHHNPW 302

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 1e-26
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 43/233 (18%)

Query: 645 NKIGEGGSGIVYKGFL-------GENGTEVAVKVINLKQKGASKS----FVAECKALRNI 693
             +GEG  G V                T+VAVK++      A++      ++E + ++ I
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131

Query: 694 -RHRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLE 740
            +H+N+I ++  C+     +       ++ E+   G+L E+L           ++     
Sbjct: 132 GKHKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
              LS    ++ A  VA  +EYL        +H DL   NVL+ +D V  ++DFGLA+ +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
             H+ D   +T +  + +K      APE    R  + + DV+SFG+LL E+FT
Sbjct: 242 --HHIDYYKKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (276), Expect = 2e-26
 Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 34/220 (15%)

Query: 646 KIGEGGSGIVYKGF---LGENGTEVAVKVINLKQKGAS-KSFVA----ECKALRNIRHRN 697
            +G GG G VY+            VA+K+  + +  +S   F      E +    ++  +
Sbjct: 41  LVGRGGMGDVYEAEDTVRER---IVALKL--MSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ I     G    G  +  +    +    L   L           L+  + + I   + 
Sbjct: 96  VVPIHDF--GEI-DGQLY--VDMRLINGVDLAAMLR------RQGPLAPPRAVAIVRQIG 144

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           SA++  H        H D+KP N+L+  D  +++ DFG+A   ++     + +  +    
Sbjct: 145 SALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE---KLTQLGNTV-- 196

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             GT+ Y+APE      A+ + D+Y+   +L E  T   P
Sbjct: 197 --GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 2e-26
 Identities = 48/286 (16%), Positives = 91/286 (31%), Gaps = 57/286 (19%)

Query: 610 RRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAV 669
              +  ++++    Q F V+S  EL +          +G+       +    E G    V
Sbjct: 46  AADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEV 103

Query: 670 KVINLKQKGAS------KSFVAECKALRNIRHRNLI-------------------KIITV 704
            V    ++  S      K  V   + LR I+++                      K+I V
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163

Query: 705 CSGRDFKGADFKAIVYEFMQ--NGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                      +  +Y  MQ    +  E L   +   +  SL    RL + + V   +  
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLLAS 221

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LHHY    +VH  L+P +++LDQ     ++ F            +             + 
Sbjct: 222 LHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS------------VSR 266

Query: 823 GYVAPEY-----------GMGREASMKGDVYSFGILLLELFTRKRP 857
           G+  PE                  +   D ++ G+++  ++    P
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  109 bits (275), Expect = 2e-26
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 52/240 (21%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
             +GEG  G V K            T VAVK+  LK + AS S     ++E   L+ + H
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNH 85

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL------------------HHS 735
            ++IK+   CS             ++ E+ + GSL  +L                    S
Sbjct: 86  PHVIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 736 NDQLEVCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSD 793
            D  +  +L++   ++ A  ++  ++YL          VH DL   N+L+ +     +SD
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKISD 193

Query: 794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           FGL++ +  +  D+ V+     I +K      A E       + + DV+SFG+LL E+ T
Sbjct: 194 FGLSRDV--YEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (278), Expect = 3e-26
 Identities = 57/235 (24%), Positives = 107/235 (45%), Gaps = 47/235 (20%)

Query: 645 NKIGEGGSGIVYKGFL-------GENGTEVAVKVINLKQKGASKS----FVAECKALRNI 693
             +GEG  G V             +    VAVK+  LK   A++      V+E + ++ I
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMI 143

Query: 694 -RHRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL----------HHSNDQLE 740
            +H+N+I ++  C+     +       ++ E+   G+L E+L           +  +++ 
Sbjct: 144 GKHKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 741 VCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
              ++    ++    +A  +EYL          +H DL   NVL+ ++ V  ++DFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 251

Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            +  +N D   +T +  + +K      APE    R  + + DV+SFG+L+ E+FT
Sbjct: 252 DI--NNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (276), Expect = 3e-26
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 39/229 (17%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNI-R 694
             +G G  G V +         +   +VAVK+  LK   A        ++E K + ++ +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQ 108

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV--------CSLSV 746
           H N++ ++  C+     G     ++ E+   G L  +L   +  LE          + S 
Sbjct: 109 HENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 747 IQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
              L+ +  VA  + +L   +      +H D+   NVLL    V+ + DFGLA+ +   N
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDI--MN 216

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
               +   +  + +K      APE       +++ DV+S+GILL E+F+
Sbjct: 217 DSNYIVKGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  109 bits (275), Expect = 3e-26
 Identities = 58/263 (22%), Positives = 100/263 (38%), Gaps = 23/263 (8%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQ 346
              L    N+          NL + +  + +  N+IS  I P     L  L  L +  NQ
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 347 LTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL-EGNIPS-SLG 404
           L   +P ++     LQ+L +  N +     S    L  +  ++LG N L    I + +  
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPPEV-GNLKNLMRLD 462
               L  + I+    I T+P+ +      SL  L L  N +   +       L NL +L 
Sbjct: 169 GMKKLSYIRIADTN-ITTIPQGLPP----SLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222

Query: 463 LSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG---- 518
           LS N  S     +L+   +L  L+++ N     +P  L   + I+ +   +NN++     
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 519 --QIPEYLENLSFLEFLNLSYNH 539
               P Y    +    ++L  N 
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  109 bits (275), Expect = 3e-26
 Identities = 69/360 (19%), Positives = 113/360 (31%), Gaps = 67/360 (18%)

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
            L V+  S+      +P D     P    L    N  T        N  +L  +    N+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
            S      F+ L  L  L L  N L            +      L+ L  + N       
Sbjct: 88  ISKISPGAFAPLVKLERLYLSKNQLKELPEK------MPKT---LQELRVHENEITKVRK 138

Query: 304 HSVANLSSTIKQIAMGRNRI-SGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEIGELTNL 361
                L+  +  + +G N + S  I     + +  L+++ I    +T TIP   G   +L
Sbjct: 139 SVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSL 194

Query: 362 QQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
            +L LD N +   + + SL  L  L  L L  N++      SL N  +L  L++++NKL+
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACA 480
                                      +P  + + K +  + L  N  S           
Sbjct: 254 --------------------------KVPGGLADHKYIQVVYLHNNNIS----------- 276

Query: 481 NLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN-GQIPEYL-ENLSFLEFLNLSYN 538
                 I  N F    P       S   +   SN +   +I       +     + L   
Sbjct: 277 -----AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 7e-26
 Identities = 55/303 (18%), Positives = 100/303 (33%), Gaps = 28/303 (9%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           +P  +       ++ L  N+ T  +      NL +L  L    N  +   P + +    L
Sbjct: 46  VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           E +  SKNQ      +     K L  L +  N +     +      +    +++  +   
Sbjct: 103 ERLYLSKNQLK---ELPEKMPKTLQELRVHENEITKVRKS------VFNGLNQMIVVELG 153

Query: 295 RNRF-EGELPHSV-ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIP 352
            N      + +     +   +  I +    I+ TIP  +    SL  L +D N++T  + 
Sbjct: 154 TNPLKSSGIENGAFQGMKK-LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVD 208

Query: 353 PEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLG 411
                 L NL +L L  N +      SL N   L  L L  N L   +P  L +   +  
Sbjct: 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267

Query: 412 LNISHNKL----IGTLPRQILRITTLSL-YLEL-GNNLLNGSLPPEV-GNLKNLMRLDLS 464
           + + +N +                  S   + L  N +    + P     +     + L 
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327

Query: 465 GNK 467
             K
Sbjct: 328 NYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 53/260 (20%), Positives = 98/260 (37%), Gaps = 13/260 (5%)

Query: 42  LRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLV 101
              +++ +N            L +L  LIL NN  S   P   +    L  L    N L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 102 GEIPADIGSLFK-LERLSIFQNHITGQLPASIGNLSSLRVIDVRENRL---WGRIDSLGQ 157
            E+P     + K L+ L + +N IT    +    L+ + V+++  N L        +   
Sbjct: 114 -ELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
           +K L+ + +A    +  IP  +    SL  + L  N+ T  +   +   L +L +L  + 
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSF 225

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
           N+ +     SL+N   L  +  + N+    V    +  K +  + L  NN+    +N+  
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284

Query: 278 FINLLTNCSKLERLYFNRNR 297
                T  +    +    N 
Sbjct: 285 PPGYNTKKASYSGVSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 16/208 (7%)

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
            L  +      L   +P ++    +   LDL  N +         NL  L  L L  N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 396 EGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPPEV-G 453
               P +      L  L +S N+L   LP ++ +    +L  L +  N +   +   V  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQL-KELPEKMPK----TLQELRVHENEIT-KVRKSVFN 142

Query: 454 NLKNLMRLDLSGNKF-SGEIPA-TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDF 511
            L  ++ ++L  N   S  I          L Y+ I+    + +IP       S+ EL  
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHL 199

Query: 512 SSNNLNGQIPEYLENLSFLEFLNLSYNH 539
             N +       L+ L+ L  L LS+N 
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNS 227

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 28/136 (20%), Positives = 51/136 (37%), Gaps = 22/136 (16%)

Query: 62  RLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
            L +L +L LS NS S A+    L++  +L EL  ++N LV ++P  +     ++ + + 
Sbjct: 214 GLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFS-GMIPPSI 179
            N+I+               I   +    G          ++L     N      I PS 
Sbjct: 272 NNNIS--------------AIGSNDFCPPGYNTKKASYSGVSL---FSNPVQYWEIQPST 314

Query: 180 F-NISSLEVISLSENR 194
           F  +     + L   +
Sbjct: 315 FRCVYVRAAVQLGNYK 330

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (272), Expect = 5e-26
 Identities = 53/284 (18%), Positives = 87/284 (30%), Gaps = 43/284 (15%)

Query: 216 NANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANE 275
           N+   T  +P  +   SS   +E   N+        F +L  L  L+L  N L       
Sbjct: 15  NSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA 335
                     + L+ L  + N                             T+      L 
Sbjct: 72  QSDFGT----TSLKYLDLSFNGVI--------------------------TMSSNFLGLE 101

Query: 336 SLNWLTIDTNQLTGTIPPE--IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
            L  L    + L   +        L NL  LD+     + +       L+ L  LK+  N
Sbjct: 102 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160

Query: 394 NLEGNIPS-SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           + + N          NL  L++S  + +  L        +    L + +N    SL    
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP 218

Query: 453 -GNLKNLMRLDLSGNKFSGEIPATL--SACANLEYLNISGNAFS 493
              L +L  LD S N               ++L +LN++ N F+
Sbjct: 219 YKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (268), Expect = 2e-25
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 10/221 (4%)

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFL--QGSIPSSLGNL 382
           ++P  I   +S   L +++N+L  ++P  +  +LT L +L L  N L  +G    S    
Sbjct: 21  SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 383 TLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNN 442
           T L YL L  N +   + S+      L  L+  H+ L       +       +YL++ + 
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136

Query: 443 LLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPLLL 500
                    +   L +L  L ++GN F         +   NL +L++S        P   
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 501 DSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
           +SL S++ L+ S NN         + L+ L+ L+ S NH  
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 16/250 (6%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNL-VGEIPADIGS-LF 112
            +P  I    S  RL L +N             + L +LS  SN L      +       
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 113 KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLG---QLKSLTLLSVAFN 169
            L+ L +  N +   + ++   L  L  +D + + L  ++        L++L  L ++  
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHT 136

Query: 170 QFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSL 228
               +    IF  +SSLEV+ ++ N F  +   D    L +L  L  +        P + 
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 229 SNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKL 288
           ++ SSL+++  S N F    +  +  L +L  L+  +N++ T  + + +  +  ++   L
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT--SKKQELQHFPSS---L 250

Query: 289 ERLYFNRNRF 298
             L   +N F
Sbjct: 251 AFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 8/233 (3%)

Query: 42  LRYINIASNGFNGEIPHQIGRLISLERLILSNN--SFSGAIPANLSSCSNLIELSADSNN 99
              + + SN           +L  L +L LS+N  SF G    +    ++L  L    N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 100 LVGEIPADIGSLFKLERLSIFQNHITGQLPASI-GNLSSLRVIDVRENRLWG-RIDSLGQ 157
           ++  + ++   L +LE L    +++      S+  +L +L  +D+               
Sbjct: 90  VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148

Query: 158 LKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN 216
           L SL +L +A N F     P IF  + +L  + LS+ +    L      +L SL+ L  +
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL-KNLYWLNLGINNL 268
            NNF           +SL+++++S N        +      +L +LNL  N+ 
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  108 bits (273), Expect = 5e-26
 Identities = 51/304 (16%), Positives = 99/304 (32%), Gaps = 31/304 (10%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           +P  I       ++ L  N  +  L  D    L  L  L    N  +     + S    L
Sbjct: 48  VPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           + +  SKN       +  +   +L  L +  N +            + +    +  +   
Sbjct: 105 QKLYISKNHLV---EIPPNLPSSLVELRIHDNRIRKVPKG------VFSGLRNMNCIEMG 155

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
            N  E       A     +  + +   +++  IP ++    +LN L +D N++   I  E
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELE 211

Query: 355 I-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN 413
                + L +L L  N ++     SL  L  L  L L  N L   +P+ L +   L  + 
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270

Query: 414 ISHNKL---------IGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDL 463
           +  N +               +      +SL+    N +    + P     + + + +  
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLF---NNPVPYWEVQPATFRCVTDRLAIQF 327

Query: 464 SGNK 467
              K
Sbjct: 328 GNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (265), Expect = 7e-25
 Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 15/239 (6%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPE-IRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
             +S     + +  N IS  +  +  + L  L  L +  N+++  I  +    L  LQ+L
Sbjct: 50  KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKL 107

Query: 365 DLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL-IGTL 423
            + +N L   IP +L   + L  L++  N +            N+  + +  N L     
Sbjct: 108 YISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164

Query: 424 PRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA-TLSACANL 482
                    L+ YL +    L   +P      + L  L L  NK    I    L   + L
Sbjct: 165 EPGAFDGLKLN-YLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219

Query: 483 EYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
             L +  N         L  L +++EL   +N L+ ++P  L +L  L+ + L  N+  
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (263), Expect = 1e-24
 Identities = 54/276 (19%), Positives = 97/276 (35%), Gaps = 24/276 (8%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQ 346
              L    N            L   +  + +  N+IS  I  +    L  L  L I  N 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 347 LTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL-EGNIPSSLGN 405
           L   IPP +   ++L +L +  N ++         L  +  +++G N L          +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 406 CTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPPEV-GNLKNLMRLDL 463
              L  L IS  KL   +P+ +      +L  L L +N +  ++  E       L RL L
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLPE----TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224

Query: 464 SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE- 522
             N+       +LS    L  L++  N  S  +P  L  L+ ++ +   +NN+  ++   
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 523 ------YLENLSFLEFLNLSYNHFEGEVPMKGVFNN 552
                 +    ++   ++L  N           F  
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 60/328 (18%), Positives = 117/328 (35%), Gaps = 57/328 (17%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFK 113
            +P +I        L L NN  S     +     +L  L   +N +  +I       L K
Sbjct: 47  AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103

Query: 114 LERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQF 171
           L++L I +NH+  ++P ++   SSL  + + +NR+  ++       L+++  + +  N  
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVPKGVFSGLRNMNCIEMGGNPL 159

Query: 172 -SGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSN 230
            +    P  F+   L  + +SE + T  +P D      +L EL  + N     I +    
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL---PETLNELHLDHNKIQ-AIELE--- 211

Query: 231 ASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLER 290
                               D  R   LY L LG N +             L+    L  
Sbjct: 212 --------------------DLLRYSKLYRLGLGHNQIRMIEN------GSLSFLPTLRE 245

Query: 291 LYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-------RNLASLNWLTID 343
           L+ + N+    +P  + +L   ++ + +  N I+  +              A  N +++ 
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKL-LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302

Query: 344 TNQLT-GTIPPEIGE-LTNLQQLDLDRN 369
            N +    + P     +T+   +     
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 49/207 (23%), Positives = 74/207 (35%), Gaps = 15/207 (7%)

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
            L  +      L   +P EI    +   LDL  N +          L  L  L L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 396 EGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLELGNNLLNGSLPPEV-G 453
                 +      L  L IS N L+  +P  +      SL  L + +N +   +P  V  
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS----SLVELRIHDNRIR-KVPKGVFS 144

Query: 454 NLKNLMRLDLSGNKF-SGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
            L+N+  +++ GN   +            L YL IS    +  IP   D  +++ EL   
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP--KDLPETLNELHLD 201

Query: 513 SNNLNGQIPEYLENLSFLEFLNLSYNH 539
            N +     E L   S L  L L +N 
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQ 228

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 38/284 (13%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
             L L N  I   +       L  L+ + I+ N    EIP       SL  L + +N   
Sbjct: 81  YALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIP--PNLPSSLVELRIHDNRIR 136

Query: 78  GAIPAN-LSSCSNLIELSADSNNL-VGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
             +P    S   N+  +    N L             KL  L I +  +T  +P      
Sbjct: 137 -KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLP 192

Query: 136 SSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSEN 193
            +L  + +  N++    ++ L +   L  L +  NQ   MI       + +L  + L  N
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNN 251

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFS 253
           + +  +P     +L  L+ +  + NN T                +   N F         
Sbjct: 252 KLS-RVPAGLP-DLKLLQVVYLHTNNIT----------------KVGVNDFCP--VGFGV 291

Query: 254 RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNR 297
           +      ++L  N +         F  +    +    + F   +
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCV----TDRLAIQFGNYK 331

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 9e-26
 Identities = 36/241 (14%), Positives = 75/241 (31%), Gaps = 31/241 (12%)

Query: 633 ELSKATDNFSSANKIGEGGSGIVYKG-----FLGENGTEVAVKVINLKQKGASKSFVAEC 687
           E    +      + +GEG    VY+         +N  +  +KV                
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 688 KALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           + L+       +K  +          +   +V E    G+L   ++   +  E   +   
Sbjct: 119 ERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV-MPQG 172

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH-----------VSDFGL 796
             ++ A+ +   IE +H   +  I+HGD+KP N +L    +             + D G 
Sbjct: 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           +  +      TI   +        T G+   E    +  + + D +     +  +     
Sbjct: 230 SIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 857 P 857
            
Sbjct: 284 M 284

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (271), Expect = 1e-25
 Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 32/239 (13%)

Query: 624 QQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KS 682
           + FL           D+F   +++G G  G+V+K     +G  +A K+I+L+ K A    
Sbjct: 18  EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77

Query: 683 FVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQ 738
            + E + L       ++          F GA +      I  E M  GSL++ L  +   
Sbjct: 78  IIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 128

Query: 739 LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK 798
            E     ++ +  ++I V   + YL    +  I+H D+KPSN+L++      + DFG++ 
Sbjct: 129 PE----QILGK--VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            L +   ++ V          GT  Y++PE   G   S++ D++S G+ L+E+   + P
Sbjct: 181 QLIDSMANSFV----------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (270), Expect = 2e-25
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 48/238 (20%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGAS----KSFVAECKALRNI-R 694
             +G G  G V               +VAVK+  LK + A     ++ ++E K +  +  
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGS 107

Query: 695 HRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWL-----------------HHS 735
           H N++ ++  C+     +       +++E+   G L  +L                    
Sbjct: 108 HENIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 736 NDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG 795
            ++ ++  L+    L  A  VA  +E+L      S VH DL   NVL+    V  + DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           LA+ +   +    V   +  + +K      APE       ++K DV+S+GILL E+F+
Sbjct: 218 LARDI--MSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (270), Expect = 2e-25
 Identities = 46/242 (19%), Positives = 93/242 (38%), Gaps = 46/242 (19%)

Query: 646 KIGEGGSGIVYKGFLG-ENGTEVAVKVINLKQKGASKSFVA-----------------EC 687
            + +G    +    L  ++    A+K          + F                   E 
Sbjct: 38  TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 688 KALRNIRHRNLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWL--HHSNDQLEVCS 743
           + + +I++   +    +         ++  +  +YE+M+N S+ ++       D+   C 
Sbjct: 95  QIITDIKNEYCLTCEGII-------TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           + +     I   V ++  Y+H+  E +I H D+KPSN+L+D++    +SDFG     S +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFG----ESEY 201

Query: 804 NPDTIVETRSISIGIKGTVGYVAPE--YGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
             D  ++        +GT  ++ PE           K D++S GI L  +F    P    
Sbjct: 202 MVDKKIKG------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

Query: 862 FN 863
            +
Sbjct: 256 IS 257

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (275), Expect = 4e-25
 Identities = 63/292 (21%), Positives = 105/292 (35%), Gaps = 42/292 (14%)

Query: 263 LGINNLGTGAANEL---------DFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTI 313
           L INN  + + N           D+ +      K      NRN     L      L +  
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQF 61

Query: 314 KQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG 373
            ++ + R  +S ++P  +     +  L I  N L  ++P       +L+ LD   N L  
Sbjct: 62  SELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS- 113

Query: 374 SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL 433
           ++P    +L    +L +  N L   +P        L  +N  +N+L   LP     +  L
Sbjct: 114 TLPELPASLK---HLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELPTSLEVL 165

Query: 434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLE----YLNISG 489
           S+     NN L   LP    +L+    LD+S N     +PA      + E    +     
Sbjct: 166 SVR----NNQLT-FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216

Query: 490 NAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
           N  +  IP  + SL     +    N L+ +I E L   +     +    +F 
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  106 bits (265), Expect = 6e-24
 Identities = 76/493 (15%), Positives = 138/493 (27%), Gaps = 124/493 (25%)

Query: 56  IPHQIGRLISLERLILSNNSFSGAIPANLSSC----SNLIELSADSNNLVGEIPADIGSL 111
           I   I    SL +    N        A+  S             + N  V  +      +
Sbjct: 3   IMLPINNNFSLSQNSFYNTISG--TYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58

Query: 112 FKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQF 171
            +   L + + +++  LP ++     + V+++ +N L                       
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL----------------------- 92

Query: 172 SGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNA 231
              +P      +SLE +   +NR + +LP        SL+ L  + N  T  +P   +  
Sbjct: 93  -ISLPELP---ASLEYLDACDNRLS-TLPEL----PASLKHLDVDNNQLT-MLPELPAL- 141

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
                                     L ++N   N L            L    + LE L
Sbjct: 142 --------------------------LEYINADNNQLTM----------LPELPTSLEVL 165

Query: 292 YFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASL----NWLTIDTNQL 347
               N+    LP    +L    + + +  N +  ++P              +     N++
Sbjct: 166 SVRNNQLT-FLPELPESL----EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219

Query: 348 TGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCT 407
           T  IP  I  L     + L+ N L   I  SL   T                        
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ---------------------P 257

Query: 408 NLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
           +  G  I  +   G        +       +        +   +V  + +    +   N 
Sbjct: 258 DYHGPRIYFSMSDGQQNTLHRPLA------DAVTAWFPENKQSDVSQIWHAFEHEEHANT 311

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL 527
           FS      LS   +      + + F   +   L+ L +  EL   S  +     E  E+ 
Sbjct: 312 FS-AFLDRLSDTVSAR----NTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDR 366

Query: 528 SFLEFLNLSYNHF 540
             L + NL     
Sbjct: 367 VALTWNNLRKTLL 379

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (264), Expect = 1e-24
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 52/240 (21%)

Query: 645 NKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQKGASKS----FVAECKALRNIRH 695
             IGEG  G V++         E  T VAVK+  LK + AS      F  E   +    +
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LK-EEASADMQADFQREAALMAEFDN 109

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHS------------------ 735
            N++K++ VC+             +++E+M  G L E+L                     
Sbjct: 110 PNIVKLLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 736 NDQLEVCSLSVIQRLNIAIDVASAIEYL--HHYCEPSIVHGDLKPSNVLLDQDLVSHVSD 793
                   LS  ++L IA  VA+ + YL    +     VH DL   N L+ +++V  ++D
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIAD 217

Query: 794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           FGL++ +  ++ D      + +I I+       PE       + + DV+++G++L E+F+
Sbjct: 218 FGLSRNI--YSADYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 2e-24
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
                S  KIGEG +GIV       +G +VAVK+++L+++   +    E   +R+ +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           +++            +        ++ EF+Q G+L        D +    L+  Q   + 
Sbjct: 104 VVE---------MYKSYLVGEELWVLMEFLQGGAL-------TDIVSQVRLNEEQIATVC 147

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVET 811
             V  A+ YLH      ++H D+K  ++LL  D    +SDFG    +S   P   ++V  
Sbjct: 148 EAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-- 202

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                   GT  ++APE       + + D++S GI+++E+
Sbjct: 203 --------GTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (259), Expect = 2e-24
 Identities = 43/250 (17%), Positives = 91/250 (36%), Gaps = 53/250 (21%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRN 692
           S+ T  F    KIG G  G V+K     +G   A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 693 I-RHRNLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           + +H ++++         +  A  +     I  E+   GSL + +  +   +     + +
Sbjct: 67  LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS--------------- 792
           +  ++ + V   + Y+H     S+VH D+KPSN+ + +  + + +               
Sbjct: 118 K--DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 793 ----DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGIL 847
               D G    +S  +P              G   ++A E          K D+++  + 
Sbjct: 173 FKIGDLGHVTRIS--SPQVEE----------GDSRFLANEVLQENYTHLPKADIFALALT 220

Query: 848 LLELFTRKRP 857
           ++     +  
Sbjct: 221 VVCAAGAEPL 230

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  102 bits (256), Expect = 4e-24
 Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 12/217 (5%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
             + +  ++I +  NRIS  +P    R   +L  L + +N L   I       L  L+QL
Sbjct: 28  VGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQL 85

Query: 365 DLDRNFLQGSIPSS-LGNLTLLTYLKLGLNNLEGNIPS-SLGNCTNLLGLNISHNKLIGT 422
           DL  N    S+  +    L  L  L L    L+  +          L  L +  N  +  
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQA 143

Query: 423 LPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACAN 481
           LP    R      +L L  N ++ S+P      L +L RL L  N+ +   P        
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 482 LEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLN 517
           L  L +  N  S ++P   L  L++++ L  + N   
Sbjct: 203 LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 45/196 (22%), Positives = 64/196 (32%), Gaps = 7/196 (3%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG 404
             L   +P  I      Q++ L  N +     +S      LT L L  N L     ++  
Sbjct: 21  QGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDL 463
               L  L++S N  + ++             L L    L   L P +   L  L  L L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 464 SGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE 522
             N     +P  T     NL +L + GN  S         L S+  L    N +    P 
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 523 YLENLSFLEFLNLSYN 538
              +L  L  L L  N
Sbjct: 196 AFRDLGRLMTLYLFAN 211

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 58/289 (20%), Positives = 100/289 (34%), Gaps = 65/289 (22%)

Query: 86  SCSNLIELSAD-SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVR 144
            C N  +++       +  +P  I +    +R+ +  N I+  +PA              
Sbjct: 7   VCYNEPKVTTSCPQQGLQAVPVGIPA--ASQRIFLHGNRIS-HVPA-------------- 49

Query: 145 ENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDT 203
                    S    ++LT+L +  N  +  I  + F  ++ LE + LS+N    S+   T
Sbjct: 50  --------ASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100

Query: 204 GVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNL 263
              L  L  L  +           L                       F  L  L +L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQ-----ELGPGL-------------------FRGLAALQYLYL 136

Query: 264 GINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSV-ANLSSTIKQIAMGRNR 322
             N L           +   +   L  L+ + NR    +P      L S + ++ + +NR
Sbjct: 137 QDNALQALPD------DTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS-LDRLLLHQNR 188

Query: 323 ISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRN 369
           ++  + P   R+L  L  L +  N L+  +P E    L  LQ L L+ N
Sbjct: 189 VA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 48/209 (22%), Positives = 77/209 (36%), Gaps = 9/209 (4%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
           + +R+ L  N  S    A+  +C NL  L   SN L   I A     L  LE+L +  N 
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNA 91

Query: 124 ITGQLPASI-GNLSSLRVIDVRENRLWGRI--DSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
               +  +    L  L  + +    L   +       L +L  L +  N     +P   F
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149

Query: 181 -NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
            ++ +L  + L  NR + S+P      L SL  L  + N      P +  +   L  +  
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 240 SKNQFSGGVSVDFSRLKNLYWLNLGINNL 268
             N  S   +   + L+ L +L L  N  
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 8/132 (6%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNSF 76
             L L    ++  L P +   L+ L+Y+ +  N     +P      L +L  L L  N  
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165

Query: 77  SGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASI-GN 134
           S           +L  L    N +   +       L +L  L +F N+++  LP      
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAP 223

Query: 135 LSSLRVIDVREN 146
           L +L+ + + +N
Sbjct: 224 LRALQYLRLNDN 235

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (257), Expect = 4e-24
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 29/219 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+GG    ++    +     A K++    L +    +    E    R++ H++++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                 F+  DF  +V E  +  SL E      +  + E      ++++          +
Sbjct: 83  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQI------VLGCQ 129

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH      ++H DLK  N+ L++DL   + DFGLA  +         +       + GT
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LCGT 178

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
             Y+APE    +  S + DV+S G ++  L   K P + 
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  102 bits (256), Expect = 6e-24
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 35/220 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
              ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           ++          +  +        +V E++  GSL        D +    +   Q   + 
Sbjct: 79  IVN---------YLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVC 122

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVET 811
            +   A+E+LH      ++H D+K  N+LL  D    ++DFG    ++       T+V  
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-- 177

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                   GT  ++APE    +    K D++S GI+ +E+
Sbjct: 178 --------GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (262), Expect = 6e-24
 Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 13/235 (5%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQ 346
              L  + N+ +    +S  +L   ++ + + RN I  TI       LA+LN L +  N+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRH-LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123

Query: 347 LTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPS-SL 403
           LT TIP      L+ L++L L  N ++ SIPS     +  L  L LG       I   + 
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLD 462
              +NL  LN++   L   +P  +  +  L   L+L  N L+ ++ P     L +L +L 
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLD-ELDLSGNHLS-AIRPGSFQGLMHLQKLW 237

Query: 463 LSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           +  ++             +L  +N++ N  +     L   L  ++ +    N  N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  102 bits (257), Expect = 2e-23
 Identities = 55/236 (23%), Positives = 92/236 (38%), Gaps = 34/236 (14%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
             +S+  + + +  N+I   I     ++L  L  L +  N +  TI       L NL  L
Sbjct: 60  DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTL 117

Query: 365 DLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPSSL-GNCTNLLGLNISHNKLIGT 422
           +L  N L  +IP+ +   L+ L  L L  N +E +IPS       +L  L++   K +  
Sbjct: 118 ELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSY 175

Query: 423 LPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANL 482
           +                               L NL  L+L+      EIP  L+    L
Sbjct: 176 ISEGAFE------------------------GLSNLRYLNLAMCNLR-EIP-NLTPLIKL 209

Query: 483 EYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           + L++SGN  S   P     L  +++L    + +        +NL  L  +NL++N
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.8 bits (236), Expect = 1e-20
 Identities = 52/269 (19%), Positives = 98/269 (36%), Gaps = 38/269 (14%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           +P  I   ++  +++L EN+    + V++  +L  L  L+ + N+       + +  ++L
Sbjct: 58  VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
             +E   N+ +   +  F  L  L  L L  N + +  +              L RL   
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY------AFNRIPSLRRLDLG 168

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPP 353
                                      R+S  I       L++L +L +    L     P
Sbjct: 169 EL------------------------KRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IP 201

Query: 354 EIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN 413
            +  L  L +LDL  N L    P S   L  L  L +  + ++    ++  N  +L+ +N
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261

Query: 414 ISHNKLIGTLPRQILRITTLSLYLELGNN 442
           ++HN L   LP  +         + L +N
Sbjct: 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 92.9 bits (231), Expect = 5e-20
 Identities = 71/308 (23%), Positives = 114/308 (37%), Gaps = 65/308 (21%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
              ++I    +    +P  +S+  N   L+   N +          L  LE L + +NHI
Sbjct: 44  QFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 125 TGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NIS 183
                 +   L++L  +++ +NRL                          IP   F  +S
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRL------------------------TTIPNGAFVYLS 136

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
            L+ + L  N    S+P      +PSLR L              L     L  I  S+  
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLD-------------LGELKRLSYI--SEGA 180

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
           F G        L NL +LNL + N        L  I  LT   KL+ L  + N      P
Sbjct: 181 FEG--------LSNLRYLNLAMCN--------LREIPNLTPLIKLDELDLSGNHLSAIRP 224

Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPE-IRNLASLNWLTIDTNQLTGTIPPEI-GELTNL 361
            S   L   ++++ M +++I   I      NL SL  + +  N LT  +P ++   L +L
Sbjct: 225 GSFQGLMH-LQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHL 281

Query: 362 QQLDLDRN 369
           +++ L  N
Sbjct: 282 ERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 9/197 (4%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG 404
             L   +P  I   TN + L+L  N +Q    +S  +L  L  L+L  N++      +  
Sbjct: 53  KNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFN 109

Query: 405 NCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDL 463
              NL  L +  N+ + T+P       +    L L NN +  S+P      + +L RLDL
Sbjct: 110 GLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167

Query: 464 SGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE 522
              K    I        +NL YLN++       IP  L  L  + ELD S N+L+   P 
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPG 225

Query: 523 YLENLSFLEFLNLSYNH 539
             + L  L+ L +  + 
Sbjct: 226 SFQGLMHLQKLWMIQSQ 242

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.5 bits (217), Expect = 3e-18
 Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 9/231 (3%)

Query: 42  LRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNL 100
            R +N+  N       +    L  LE L LS N     I     +  +NL  L    N L
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124

Query: 101 VGEIPADI-GSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRI--DSLGQ 157
              IP      L KL+ L +  N I      +   + SLR +D+ E +    I   +   
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
           L +L  L++A      +  P++  +  L+ + LS N  + ++   +   L  L++L    
Sbjct: 184 LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQ 240

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNL 268
           +        +  N  SL  I  + N  +      F+ L +L  ++L  N  
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 13/208 (6%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNSF 76
             L L    IR T+       L+ L  + +  N     IP+     L  L+ L L NN  
Sbjct: 91  EILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148

Query: 77  SGAIPANL-SSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASIGN 134
             +IP+   +   +L  L       +  I       L  L  L++   ++  ++P  +  
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTP 205

Query: 135 LSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSE 192
           L  L  +D+  N L   R  S   L  L  L +  +Q   +I  + F N+ SL  I+L+ 
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264

Query: 193 NRFTGSLPVDTGVNLPSLRELRTNANNF 220
           N  T  LP D    L  L  +  + N +
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (255), Expect = 7e-24
 Identities = 62/260 (23%), Positives = 110/260 (42%), Gaps = 46/260 (17%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECK-ALRNIRHR 696
           D+     ++G G  G+V K     +G  +AVK I         K  + +   ++R +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 697 NLIKIITVCSGRDFKGADFK----AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
             +          F GA F+     I  E M + SL+++     D+ +     ++ +  I
Sbjct: 67  FTVT---------FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--I 114

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A+ +  A+E+LH   + S++H D+KPSNVL++      + DFG++ +L +     + +  
Sbjct: 115 AVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDI 168

Query: 813 SISIGIKGTVGYVAPE--YGMGREA--SMKGDVYSFGILLLELFTRKRPTDAMFNE---- 864
                  G   Y+APE       +   S+K D++S GI ++EL   + P D+        
Sbjct: 169 DA-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223

Query: 865 ---------GLTLHDFSREF 875
                     L    FS EF
Sbjct: 224 KQVVEEPSPQLPADKFSAEF 243

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (257), Expect = 7e-24
 Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 29/216 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+GG    ++    +     A K++    L +    +    E    R++ H++++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWL--HHSNDQLEVCSLSVIQRLNIAIDVASAIE 761
                 F+  DF  +V E  +  SL E      +  + E      ++++          +
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQI------VLGCQ 155

Query: 762 YLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           YLH      ++H DLK  N+ L++DL   + DFGLA  +         +       + GT
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LCGT 204

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             Y+APE    +  S + DV+S G ++  L   K P
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (261), Expect = 7e-24
 Identities = 52/241 (21%), Positives = 86/241 (35%), Gaps = 39/241 (16%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALR-NIRHRN 697
           +   S   +G G SG V        G  VAVK +           + E K L  +  H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPN 70

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNIAIDV 756
           +I+              F  I  E   N +L++ +   +     +        +++   +
Sbjct: 71  VIRYYCS-----ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH-------------VSDFGLAKFLSNH 803
           AS + +LH      I+H DLKP N+L+                    +SDFGL K L + 
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 804 NPDTIVETRSISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFTRKR 856
                    + S    GT G+ APE           R  +   D++S G +   + ++ +
Sbjct: 182 QSSFRTNLNNPS----GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 857 P 857
            
Sbjct: 238 H 238

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  101 bits (253), Expect = 1e-23
 Identities = 60/280 (21%), Positives = 98/280 (35%), Gaps = 21/280 (7%)

Query: 279 INLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPP---EIRNLA 335
           + L      LE L    +        +    S ++K++ +   RI   I      +  ++
Sbjct: 36  VELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS 95

Query: 336 SLNWLTIDTNQLTGTIPPEIGELT--NLQQLDLDRNFLQG--SIPSSLGNLTL--LTYLK 389
            L  LT++  ++TGT PP + E T  +L  L+L         +  + L       L  L 
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 390 LGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG--TLPRQILRITTLSL-YLELGNNLLN- 445
           +   +        +     L  L++S N  +G   L   +  +   +L  L L N  +  
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 446 --GSLPPEVGNLKNLMRLDLSGNKFSGEIPATL-SACANLEYLNISGNAFSGSIPLLLDS 502
             G           L  LDLS N       A      + L  LN+S       +P  L  
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272

Query: 503 LQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG 542
              +  LD S N L+   P   + L  +  L+L  N F  
Sbjct: 273 PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =   99 bits (249), Expect = 5e-23
 Identities = 53/302 (17%), Positives = 89/302 (29%), Gaps = 18/302 (5%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
           N    +   ++A N  G   V L            +      +      +K+L    L +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSST-IKQIAMGRNRIS 324
                 +      + +L   S L+ L        G  P  +   +   +  + +     +
Sbjct: 76  RAARIPSRILFGALRVL-GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

Query: 325 G--TIPPEIRNL--ASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI----- 375
                  E++      L  L+I           ++     L  LDL  N   G       
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 376 --PSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTL 433
             P     L +L     G+    G   +       L GL++SHN L            + 
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 434 SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS 493
              L L    L   +P  +     L  LDLS N+     P+       +  L++ GN F 
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFL 309

Query: 494 GS 495
            S
Sbjct: 310 DS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.6 bits (209), Expect = 8e-18
 Identities = 46/245 (18%), Positives = 80/245 (32%), Gaps = 24/245 (9%)

Query: 42  LRYINIASNGFNGEIPHQIGRLIS---LERLILSNNSFSGAIPANLSSCS--NLIELSAD 96
           L+ + + +      I     R++    L+ L L N   +G  P  L   +  +L  L+  
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL- 128

Query: 97  SNNLVGEIPADIGSLF-----KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGR 151
            N       A +  L       L+ LSI Q H        +    +L  +D+ +N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 152 I--------DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDT 203
                         L+ L L +      SG+          L+ + LS N    +    +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 204 GVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNL 263
                 L  L  +       +P  L   + L +++ S N+     S     L  +  L+L
Sbjct: 249 CDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDRNPS--PDELPQVGNLSL 303

Query: 264 GINNL 268
             N  
Sbjct: 304 KGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 12/197 (6%)

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
           L+++D + +  Q +      +L  LT     + +        +   + L  L + + ++ 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 421 GTLPRQILRITTLSL-YLELGNNLLNG--SLPPEVGNL--KNLMRLDLSGNKFSGEIPAT 475
           GT P  +L  T   L  L L N       +   E+       L  L ++           
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 476 LSACANLEYLNISGNAFSGSIPLL----LDSLQSIKELDFSSNNLN---GQIPEYLENLS 528
           +     L  L++S N   G   L+         +++ L   +  +    G          
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 529 FLEFLNLSYNHFEGEVP 545
            L+ L+LS+N       
Sbjct: 229 QLQGLDLSHNSLRDAAG 245

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 41/251 (16%), Positives = 72/251 (28%), Gaps = 41/251 (16%)

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVN---------- 206
            LK LT+ +             +  IS L+ ++L     TG+ P                
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 207 -------------------LPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGG 247
                               P L+ L     +   F    +    +L  ++ S N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 248 VSVDFS----RLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
             +  +    +   L  L L    + T          L     +L+ L  + N       
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMET---PSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
               +  S +  + +    +   +P  +   A L+ L +  N+L     P   EL  +  
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGN 300

Query: 364 LDLDRNFLQGS 374
           L L  N    S
Sbjct: 301 LSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 35/167 (20%), Positives = 60/167 (35%), Gaps = 12/167 (7%)

Query: 15  HQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI----GRLISLERLI 70
              +  L +            V     L  ++++ N   GE          +  +L+ L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 71  LSNN---SFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLF-KLERLSIFQNHITG 126
           L N    + SG   A  ++   L  L    N+L     A       +L  L++    +  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 127 QLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSG 173
           Q+P  +   + L V+D+  NRL  R  S  +L  +  LS+  N F  
Sbjct: 267 QVPKGL--PAKLSVLDLSYNRL-DRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 37/197 (18%), Positives = 67/197 (34%), Gaps = 16/197 (8%)

Query: 14  RHQRVTRLDLGNQSIRGTLSPYVGNLSF----LRYINIASNGFNGEIPHQIGRLISLERL 69
               +  L+L N S     +       +    L+ ++IA          Q+    +L  L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178

Query: 70  ILSNNSFSGAIPANLSSC----SNLIELSADSNN---LVGEIPADIGSLFKLERLSIFQN 122
            LS+N   G      + C      L  L+  +       G   A   +  +L+ L +  N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238

Query: 123 HITGQLPASI-GNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFN 181
            +     A      S L  +++    L      L     L++L +++N+      PS   
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLDLSYNRLDRN--PSPDE 294

Query: 182 ISSLEVISLSENRFTGS 198
           +  +  +SL  N F  S
Sbjct: 295 LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 29/173 (16%), Positives = 55/173 (31%), Gaps = 28/173 (16%)

Query: 380 GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLS--LYL 437
           G  +L   LK      +    + +    +L  L +   ++   +    LR+  +S    L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIP 497
            L N  + G+ PP +                            +L  LN+   +++    
Sbjct: 101 TLENLEVTGTAPPPLLEATGP----------------------DLNILNLRNVSWATRDA 138

Query: 498 LLLD----SLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPM 546
            L +        +K L  +  +      E +     L  L+LS N   GE  +
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (256), Expect = 1e-23
 Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 20/259 (7%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
           + L+  +K + +  NRI+  I     +   +L  L + +N +  TI  +    L +L+ L
Sbjct: 48  SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHL 105

Query: 365 DLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSL-GNCTNLLGLNISHNKLIGT 422
           DL  N+L  ++ SS    L+ LT+L L  N  +    +SL  + T L  L + +      
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164

Query: 423 LPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSACAN 481
           + R+     T    LE+  + L  S  P+   +++N+  L L   +    +   +   ++
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223

Query: 482 LEYLNISGN--------AFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFL 533
           +E L +             S      L    + + +  +  +L  Q+ + L  +S L  L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282

Query: 534 NLSYNHFEGEVPMKGVFNN 552
             S N  +  VP  G+F+ 
Sbjct: 283 EFSRNQLKS-VP-DGIFDR 299

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 3e-23
 Identities = 58/306 (18%), Positives = 112/306 (36%), Gaps = 39/306 (12%)

Query: 71  LSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPA 130
            S+ S + +IP+ L+    +  L   +N +     +D+     L+ L +  N I   +  
Sbjct: 38  GSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE 93

Query: 131 SI-GNLSSLRVIDVRENRLWGRIDS--LGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLE 186
               +L SL  +D+  N L   + S     L SLT L++  N +  +   S+F +++ L+
Sbjct: 94  DSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152

Query: 187 VISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSG 246
           ++ +        +       L  L EL  +A++   + P SL +  ++  +     Q   
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212

Query: 247 GVSVDFSRLKNLYWLNLGINNLGTGAANELDFI--NLLTNCSKLERLYFNRNRFEGELPH 304
            + +      ++  L L   +L T   +EL     N L        +             
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF----- 267

Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQ 363
                                 +   +  ++ L  L    NQL  ++P  I   LT+LQ+
Sbjct: 268 ---------------------QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQK 305

Query: 364 LDLDRN 369
           + L  N
Sbjct: 306 IWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 57/339 (16%), Positives = 115/339 (33%), Gaps = 49/339 (14%)

Query: 69  LILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQL 128
            ++ + S   +      SC         S +L   IP+ +     ++ L +  N IT  +
Sbjct: 12  GVIISLSKEESSNQASLSCDRNGICKGSSGSL-NSIPSGLTE--AVKSLDLSNNRIT-YI 67

Query: 129 PASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEV 187
                                     L +  +L  L +  N  +  I    F ++ SLE 
Sbjct: 68  SN----------------------SDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEH 104

Query: 188 ISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSL-SNASSLEMIEFSKNQFSG 246
           + LS N  + +L       L SL  L    N +      SL S+ + L+++         
Sbjct: 105 LDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 247 GVSVD-FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
            +    F+ L  L  L +  ++L +           L +   +  L  +  +    L   
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPK------SLKSIQNVSHLILHMKQHI-LLLEI 216

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEI--------RNLASLNWLTIDTNQLTGTIPPEIGE 357
             +++S+++ + +    +      E+            +   + I    L   +   + +
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275

Query: 358 LTNLQQLDLDRNFLQGSIPSS-LGNLTLLTYLKLGLNNL 395
           ++ L +L+  RN L+ S+P      LT L  + L  N  
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 33/291 (11%)

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
            +++ ++ S N+ +   + D  R  NL  L L  N + T   +        ++   LE L
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED------SFSSLGSLEHL 105

Query: 292 YFNRNRFEGELPHSV-ANLSSTIKQIAMGRNRISGTIPPEI--RNLASLNWLTIDTNQLT 348
             + N     L  S    LSS +  + +  N    T+       +L  L  L +      
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSS-LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162

Query: 349 GTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCT 407
             I  +    LT L++L++D + LQ   P SL ++  +++L L +      +   +   +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

Query: 408 NLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
           ++  L +    L      ++    T SL                         + ++   
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSL-----------------IKKFTFRNVKITDES 265

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIP-LLLDSLQSIKELDFSSNNLN 517
              ++   L+  + L  L  S N    S+P  + D L S++++   +N  +
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 56/265 (21%), Positives = 100/265 (37%), Gaps = 19/265 (7%)

Query: 18  VTRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNS 75
           V  LDL N  I   +S         L+ + + SNG N  I       L SLE L LS N 
Sbjct: 54  VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 76  FSGAIPANL-SSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASI- 132
            S  + ++     S+L  L+   N         +   L KL+ L +       ++     
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 133 GNLSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISL 190
             L+ L  +++  + L      SL  +++++ L +   Q   ++        SS+E + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229

Query: 191 SENRFTG-------SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
            +            +   ++ +   + R ++    +    +   L+  S L  +EFS+NQ
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQ 288

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNL 268
                   F RL +L  + L  N  
Sbjct: 289 LKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 34/207 (16%), Positives = 70/207 (33%), Gaps = 23/207 (11%)

Query: 19  TRLDLGNQSIRGTLSPYV--GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNS 75
           T L+L     + TL       +L+ L+ + + +     +I  +    L  LE L +  + 
Sbjct: 127 TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASIGN 134
                P +L S  N+  L       +  +          +E L +    +         +
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF------H 238

Query: 135 LSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENR 194
            S L   +          +SL +  +   + +        +   +  IS L  +  S N+
Sbjct: 239 FSELSTGE---------TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288

Query: 195 FTGSLPVDTGVNLPSLRELRTNANNFT 221
              S+P      L SL+++  + N + 
Sbjct: 289 LK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  100 bits (252), Expect = 1e-23
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           +G+G    VY+      G EVA+K+I+   + + G  +    E K    ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVASAIEY 762
                 F+ +++  +V E   NG +  +L +      E  +   + ++       + + Y
Sbjct: 79  Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLY 127

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH +    I+H DL  SN+LL +++   ++DFGLA  L    P     T      + GT 
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEKHYT------LCGTP 176

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            Y++PE        ++ DV+S G +   L   + P
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 31/218 (14%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
              F     +G G    V+       G   A+K I         S   E   L+ I+H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++ +  +     ++      +V + +  G L + +       E  +  VIQ       V 
Sbjct: 68  IVTLEDI-----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ------QVL 116

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           SA++YLH   E  IVH DLKP N+L    +++    ++DFGL+K   N    T       
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----- 168

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
                GT GYVAPE    +  S   D +S G    ILL
Sbjct: 169 -----GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (251), Expect = 2e-23
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHRN 697
           D++     IG G + +V   +      +VA+K INL++   S    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI--- 754
           ++      S   F   D   +V + +  GS+ + + H   + E     V+    IA    
Sbjct: 75  IVSYY--TS---FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILR 128

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           +V   +EYLH   +   +H D+K  N+LL +D    ++DFG++ FL+     T  + R  
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 815 SIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLEL 851
            +   GT  ++APE       Y        K D++SFGI  +EL
Sbjct: 186 FV---GTPCWMAPEVMEQVRGYD------FKADIWSFGITAIEL 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 26/220 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECK-ALRNIRHR 696
           ++     +IG G  G V K     +G  +AVK I         K  + +    +R+    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAID 755
                I    G  F+  D   I  E M + S +++  +    L +V    ++ +  I + 
Sbjct: 82  Y----IVQFYGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLA 133

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
              A+ +L       I+H D+KPSN+LLD+     + DFG++  L +    +I +TR   
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDA- 186

Query: 816 IGIKGTVGYVAPE----YGMGREASMKGDVYSFGILLLEL 851
               G   Y+APE        +   ++ DV+S GI L EL
Sbjct: 187 ----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =   99 bits (249), Expect = 9e-23
 Identities = 52/263 (19%), Positives = 87/263 (33%), Gaps = 55/263 (20%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-----KGASKSFVAECKALRN 692
              +     IG+G  G+V      +     A+K++N  +         +    E + ++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL-- 750
           + H N+ ++  V     ++   +  +V E    G L + L+   D         + +   
Sbjct: 85  LHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 751 --------------------------------NIAIDVASAIEYLHHYCEPSIVHGDLKP 778
                                           NI   + SA+ YLH      I H D+KP
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKP 196

Query: 779 SNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPE--YGMGRE 834
            N L   +    +   DFGL+K     N        + +    GT  +VAPE        
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA----GTPYFVAPEVLNTTNES 252

Query: 835 ASMKGDVYSFGILLLELFTRKRP 857
              K D +S G+LL  L     P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 35/220 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            + F    K+GEG  G VYK    E G  VA+K + ++     +  + E   ++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           ++K         + G+ FK     IV E+   GS+ + +   N  L    ++ I +    
Sbjct: 86  VVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ---- 132

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVET 811
                 +EYLH       +H D+K  N+LL+ +  + ++DFG+A  L++     +T++  
Sbjct: 133 -STLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-- 186

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                   GT  ++APE       +   D++S GI  +E+
Sbjct: 187 --------GTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 27/216 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++        F  A    ++ E+   G++   L   +   E  + + I  L     
Sbjct: 69  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 118

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
            A+A+ Y H      ++H D+KP N+LL       ++DFG +    +     +       
Sbjct: 119 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------ 168

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
               GT+ Y+ PE   GR    K D++S G+L  E 
Sbjct: 169 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 29/220 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS-KSFVAECKAL-RNIRHR 696
           ++  +  ++G G  G V+K    + G  +AVK +         K  + +   + ++    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
                I  C G      D   I  E M     E+        +    L       + + +
Sbjct: 85  Y----IVQCFGTFITNTDVF-IAMELM-GTCAEKLKKRMQGPIPERILGK-----MTVAI 133

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
             A+ YL    +  ++H D+KPSN+LLD+     + DFG++  L     D   + RS   
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSA-- 185

Query: 817 GIKGTVGYVAPE-----YGMGREASMKGDVYSFGILLLEL 851
              G   Y+APE          +  ++ DV+S GI L+EL
Sbjct: 186 ---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 41/228 (17%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---------KGASKSFVAECK 688
            +N+     +G G S +V +        E AVK+I++           +   ++ + E  
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 689 ALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
            LR +  H N+I++        ++   F  +V++ M+ G L ++L       E  +LS  
Sbjct: 76  ILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEK 124

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-D 806
           +   I   +   I  LH   + +IVH DLKP N+LLD D+   ++DFG +  L       
Sbjct: 125 ETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 807 TIVETRSISIGIKGTVGYVAPE------YGMGREASMKGDVYSFGILL 848
            +           GT  Y+APE               + D++S G+++
Sbjct: 182 EVC----------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.4 bits (245), Expect = 5e-22
 Identities = 48/235 (20%), Positives = 84/235 (35%), Gaps = 37/235 (15%)

Query: 638 TDNFSSANKIGEGGS--GIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNI 693
              +     IG+G      V        G  V V+ INL+            E    +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL-HHSNDQLEVCSLSVIQRLNI 752
            H N++          F   +   +V  FM  GS ++ +  H  D +   +++ I +   
Sbjct: 84  NHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ--- 135

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVE 810
              V  A++Y+HH      VH  +K S++L+  D   ++S       + +H      + +
Sbjct: 136 --GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 811 TRSISIGIKGTVGYVAPE--------YGMGREASMKGDVYSFGILLLELFTRKRP 857
               S+     + +++PE        Y        K D+YS GI   EL     P
Sbjct: 191 FPKYSV---KVLPWLSPEVLQQNLQGYD------AKSDIYSVGITACELANGHVP 236

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.0 bits (247), Expect = 7e-22
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 33/245 (13%)

Query: 622 IEQQFLVDSYAELSKATDNFSSA----NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ- 676
            +          ++    + S       K+G G  G V          E A+K+I     
Sbjct: 16  FQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV 75

Query: 677 -KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHS 735
              ++   + E   L+ + H N++K+        F+      +V E  + G L + + H 
Sbjct: 76  STSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHR 130

Query: 736 NDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVS 792
               EV +  +I+       V S + YLH +   +IVH DLKP N+LL   ++D +  + 
Sbjct: 131 MKFNEVDAAVIIK------QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

Query: 793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF 852
           DFGL+    N                 GT  Y+APE  + ++   K DV+S G++L  L 
Sbjct: 182 DFGLSAVFENQKKMK---------ERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILL 231

Query: 853 TRKRP 857
               P
Sbjct: 232 AGYPP 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 51/262 (19%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            + +    ++G+G  G VYK    E G   A KVI  K +   + ++ E + L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 698 LIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           ++K           GA +      I+ EF   G+++  +   +  L    + V+ R    
Sbjct: 78  IVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR---- 124

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVET 811
             +  A+ +LH      I+H DLK  NVL+  +    ++DFG++          D+ +  
Sbjct: 125 -QMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178

Query: 812 RSISIGIKGTVGYVAPEYGMGREAS-----MKGDVYSFGILLLELFTRK------RPTDA 860
                   GT  ++APE  M           K D++S GI L+E+   +       P   
Sbjct: 179 --------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230

Query: 861 MF----NEGLTL---HDFSREF 875
           +     ++  TL     +S EF
Sbjct: 231 LLKIAKSDPPTLLTPSKWSVEF 252

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 34/247 (13%)

Query: 621 PIEQQFLVDSYAELSKATDNFSSA----NKIGEGGSGIVYKGFLGENGTEVAVKVIN--- 673
            +           +  +T  FS        +G+G  G V        G E AVKVI+   
Sbjct: 4   SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63

Query: 674 LKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH 733
           +KQK   +S + E + L+ + H N++K+        F+   +  +V E    G L + + 
Sbjct: 64  VKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEII 118

Query: 734 HSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSH 790
                 EV +  +I++      V S I Y+H      IVH DLKP N+LL    +D    
Sbjct: 119 SRKRFSEVDAARIIRQ------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169

Query: 791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLE 850
           + DFGL+                      GT  Y+APE  +      K DV+S G++L  
Sbjct: 170 IIDFGLSTHFEASKKMK---------DKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYI 219

Query: 851 LFTRKRP 857
           L +   P
Sbjct: 220 LLSGCPP 226

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.9 bits (239), Expect = 3e-21
 Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 48/264 (18%)

Query: 609 RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSA----NKIGEGGSGIVYKGFLGENG 664
           +   A+         Q    +       A   F       + IG G S +V +      G
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119

Query: 665 TEVAVKVINLKQKGASKSFVA--------ECKALRNIR-HRNLIKIITVCSGRDFKGADF 715
            E AVK++ +  +  S   +         E   LR +  H ++I +I       ++ + F
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSF 174

Query: 716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD 775
             +V++ M+ G L ++L       E  +LS  +  +I   +  A+ +LH     +IVH D
Sbjct: 175 MFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRD 225

Query: 776 LKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-DTIVETRSISIGIKGTVGYVAPE------ 828
           LKP N+LLD ++   +SDFG +  L        +           GT GY+APE      
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----------GTPGYLAPEILKCSM 275

Query: 829 YGMGREASMKGDVYSFG----ILL 848
                    + D+++ G     LL
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLL 299

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 39/227 (17%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVA-ECKALRNIRHRNLIKII 702
           +GEG  G V +    E     AVK++    L++    ++ V  E + LR +RH+N+I+++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA----- 757
            V    + K   +  +V E+   G  E  +  S            +R  +    A     
Sbjct: 73  DVLYNEE-KQKMY--MVMEYCVCGMQE--MLDS---------VPEKRFPV--CQAHGYFC 116

Query: 758 ---SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                +EYLH      IVH D+KP N+LL       +S  G+A+ L     D    T   
Sbjct: 117 QLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ- 172

Query: 815 SIGIKGTVGYVAPEYGMGRE--ASMKGDVYSFGILLLELFTRKRPTD 859
                G+  +  PE   G +  +  K D++S G+ L  + T   P +
Sbjct: 173 -----GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 51/226 (22%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRN 697
           + +   +K+GEG    VYKG        VA+K I L+ + GA  + + E   L++++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 698 LIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQL---EVCSLSVIQRLNI 752
           ++ +  +               +V+E++    L+++L    + +    V    + Q L  
Sbjct: 62  IVTLHDIIHTEKSLT-------LVFEYLDK-DLKQYLDDCGNIINMHNVKLF-LFQLL-- 110

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD--TIVE 810
                  + Y H      ++H DLKP N+L+++     ++DFGLA+  S         V 
Sbjct: 111 -----RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 811 TRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           T            Y  P+  +G  + S + D++  G +  E+ T +
Sbjct: 163 TL----------WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 97.9 bits (243), Expect = 3e-21
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 42/265 (15%)

Query: 274 NELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRN 333
             +  I      ++  +    +      +      L+S I QI    + I  ++   I+ 
Sbjct: 9   TPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDIK-SVQG-IQY 63

Query: 334 LASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
           L ++  L ++ N+LT  I P +  L NL  L LD N ++  + SSL +L  L  L L  N
Sbjct: 64  LPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHN 119

Query: 394 NLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVG 453
            +  +I + L +   L  L + +N        +I  IT LS                   
Sbjct: 120 GIS-DI-NGLVHLPQLESLYLGNN--------KITDITVLS------------------- 150

Query: 454 NLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSS 513
            L  L  L L  N+ S +I   L+    L+ L +S N  S    L    L+++  L+  S
Sbjct: 151 RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRAL--AGLKNLDVLELFS 206

Query: 514 NNLNGQIPEYLENLSFLEFLNLSYN 538
                +   +  NL     +  +  
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDG 231

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.8 bits (235), Expect = 3e-20
 Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 29/224 (12%)

Query: 321 NRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLG 380
             I   I P     A      +    +T  +     EL ++ Q+  + + ++ S+   + 
Sbjct: 9   TPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQ 62

Query: 381 NLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL----- 435
            L  +T L L  N L  +I   L N  NL  L +  N        +I  +++L       
Sbjct: 63  YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN--------KIKDLSSLKDLKKLK 112

Query: 436 YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGS 495
            L L +N ++  +   + +L  L  L L  NK + +I   LS    L+ L++  N  S  
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-D 167

Query: 496 IPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
           I  L   L  ++ L  S N++       L  L  L+ L L    
Sbjct: 168 IVPL-AGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQE 208

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.1 bits (215), Expect = 7e-18
 Identities = 50/322 (15%), Positives = 102/322 (31%), Gaps = 76/322 (23%)

Query: 97  SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLG 156
            +  + +I  D  +  +  + ++ +  +T     +   L+S+  I    + +   +  + 
Sbjct: 7   VSTPIKQIFPD-DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSVQGIQ 62

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTN 216
            L ++T L +  N+        + +I  L                    NL +L  L  +
Sbjct: 63  YLPNVTKLFLNGNK--------LTDIKPLT-------------------NLKNLGWLFLD 95

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD-FSRLKNLYWLNLGINNLGTGAANE 275
            N         L +   L+ +    N  S    ++    L  L  L LG N +       
Sbjct: 96  ENKIKDLSS--LKDLKKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITD----- 145

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA 335
              I +L+  +KL+ L    N+               I  I              +  L 
Sbjct: 146 ---ITVLSRLTKLDTLSLEDNQ---------------ISDI------------VPLAGLT 175

Query: 336 SLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL 395
            L  L +  N ++  +   +  L NL  L+L          +   NL +   +K    +L
Sbjct: 176 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

Query: 396 EGNIPSSLGNCTNLLGLNISHN 417
               P  + +  +    N+  +
Sbjct: 234 --VTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 3e-17
 Identities = 54/324 (16%), Positives = 111/324 (34%), Gaps = 32/324 (9%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD-FSRLKNLYWLNLG 264
                 +      + T  +    +  +S++ I  + +      SV     L N+  L L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---SVQGIQYLPNVTKLFLN 73

Query: 265 INNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSS--TIKQIAMGRNR 322
            N L          I  LTN   L  L+ + N+ +      +++L     +K +++  N 
Sbjct: 74  GNKLTD--------IKPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNG 120

Query: 323 ISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNL 382
           IS  I   + +L  L  L +  N++T  I   +  LT L  L L+ N +   I   L  L
Sbjct: 121 IS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGL 174

Query: 383 TLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNN 442
           T L  L L  N++  ++  +L    NL  L +   + +    + I   + L +   + N 
Sbjct: 175 TKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLN---KPINHQSNLVVPNTVKNT 229

Query: 443 LLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS 502
             +   P  + +  +  + ++  +        +      +                L + 
Sbjct: 230 DGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEV 289

Query: 503 LQSIKELDFSSNNLNGQIPEYLEN 526
                ++D +      +    +  
Sbjct: 290 YTVSYDVDGTVIKTKVEAGTRITA 313

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 80.9 bits (199), Expect = 6e-16
 Identities = 47/268 (17%), Positives = 108/268 (40%), Gaps = 24/268 (8%)

Query: 38  NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS 97
             +     N+        +      L S++++I +N+    ++   +    N+ +L  + 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74

Query: 98  NNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQ 157
           N L  +I   + +L  L  L + +N I   L  S+ +L  L+ + +  N +   I+ L  
Sbjct: 75  NKLT-DIK-PLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI-SDINGLVH 129

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
           L  L  L +  N+ + +    +  ++ L+ +SL +N+ +  +P+     L  L+ L  + 
Sbjct: 130 LPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLSK 184

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
           N+ +      L+   +L+++E    +    ++   +   NL   N   N  G+     L 
Sbjct: 185 NHISDLRA--LAGLKNLDVLELFSQEC---LNKPINHQSNLVVPNTVKNTDGS-----LV 234

Query: 278 FINLLTNCSKLERLYFNRNRFEGELPHS 305
              ++++    E+     +  E     S
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVS 262

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 13/176 (7%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             L L    I+  LS  + +L  L+ +++  NG + +I   +  L  LE L L NN  + 
Sbjct: 90  GWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT- 144

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL 138
                LS  + L  LS + N +  +I   +  L KL+ L + +NHI+  L A +  L +L
Sbjct: 145 -DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNL 199

Query: 139 RVIDVRENRL-WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
            V+++         I+    L     +         + P  I +    E  ++  +
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 47/256 (18%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS-FVAECKALRNIRHR 696
            + F+   KIG+G  G V+KG        VA+K+I+L++          E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 697 NLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
            + K         + G+  K     I+ E++  GS  + L      L+   ++ I R   
Sbjct: 81  YVTK---------YYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR--- 126

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP--DTIVE 810
             ++   ++YLH       +H D+K +NVLL +     ++DFG+A  L++     +T V 
Sbjct: 127 --EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 180

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK------RPTDAMF-- 862
                    GT  ++APE         K D++S GI  +EL   +       P   +F  
Sbjct: 181 ---------GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231

Query: 863 --NEGLTLHD-FSREF 875
             N   TL   +S+  
Sbjct: 232 PKNNPPTLEGNYSKPL 247

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 53/240 (22%)

Query: 637 ATDNFSS---------ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-E 686
           +TD+FS           + +GEG    V          E AVK+I  KQ G  +S V  E
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFRE 60

Query: 687 CKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
            + L   + HRN++++I       F+  D   +V+E M+ GS+               LS
Sbjct: 61  VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI---------------LS 100

Query: 746 VIQRL---------NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSD 793
            I +           +  DVASA+++LH      I H DLKP N+L    +Q     + D
Sbjct: 101 HIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICD 157

Query: 794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG-----DVYSFGILL 848
           F L   +  +   + + T  +     G+  Y+APE                D++S G++L
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 50/231 (21%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---------ECK 688
            D +  +  +G G  G V   F  +   +VA+K+I+ K+K A  S            E +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67

Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            L+ + H  +IKI       D+       IV E M+ G L + +  +    E        
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP 805
                  +  A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L   + 
Sbjct: 122 ------QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 806 -DTIVETRSISIGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILL 848
             T+           GT  Y+APE        G  R      D +S G++L
Sbjct: 173 MRTLC----------GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 94.5 bits (235), Expect = 5e-21
 Identities = 51/239 (21%), Positives = 93/239 (38%), Gaps = 15/239 (6%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
           ++L     ++     ++   I          L  + I  N +   I  ++   L  L ++
Sbjct: 26  SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84

Query: 365 DLDR-NFLQGSIPSS-LGNLTLLTYLKLGLNNLEGNIPS-SLGNCTNLLGLNISHNKLIG 421
            +++ N L   I      NL  L YL +    ++ ++P     +    + L+I  N  I 
Sbjct: 85  RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH 142

Query: 422 TLPRQILR-ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA-TLSAC 479
           T+ R     ++  S+ L L  N +   +     N   L  L+LS N    E+P       
Sbjct: 143 TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201

Query: 480 ANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           +    L+IS      S+P     L+++K+L   S     ++P  LE L  L   +L+Y 
Sbjct: 202 SGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.0 bits (218), Expect = 8e-19
 Identities = 45/240 (18%), Positives = 82/240 (34%), Gaps = 24/240 (10%)

Query: 159 KSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELR-TN 216
           ++   L     +   +I    F     LE I +S+N     +  D   NLP L E+R   
Sbjct: 30  RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 217 ANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINN----LGTGA 272
           ANN     P +  N  +L+ +  S         V          L++  N     +   +
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 273 ANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI- 331
                F+ L     +   L+ N+N  + E+ +S  N +   +      N +   +P ++ 
Sbjct: 149 -----FVGL---SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVF 198

Query: 332 RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL 390
              +    L I   ++  ++P      L  L+            +P +L  L  L    L
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 33/202 (16%), Positives = 66/202 (32%), Gaps = 10/202 (4%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSS-L 403
           +++T  IP ++    N  +L      L+     +      L  +++  N++   I +   
Sbjct: 19  SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLD 462
            N   L  + I     +  +  +  +      YL + N  +   LP     +    + LD
Sbjct: 76  SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 463 LSGNKFSGEIPATLSA--CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQI 520
           +  N     I              L ++ N     I     +   + EL+ S NN   ++
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 521 PEY-LENLSFLEFLNLSYNHFE 541
           P       S    L++S     
Sbjct: 194 PNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 9e-14
 Identities = 54/258 (20%), Positives = 87/258 (33%), Gaps = 20/258 (7%)

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           S  V    E++ T  +P D      +  ELR            + S    LE IE S+N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 244 FSGGVSVD-FSRLKNLYWLNLGINNLGTGAANELDFI--NLLTNCSKLERLYFNRNRFEG 300
               +  D FS L  L+ + +         AN L +I      N   L+ L  +    + 
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIE-------KANNLLYINPEAFQNLPNLQYLLISNTGIK- 117

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPE-IRNLAS-LNWLTIDTNQLTGTIPPEIGEL 358
            LP      S     + +  N    TI       L+     L ++ N +   I       
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG 176

Query: 359 TNLQQLDL-DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHN 417
           T L +L+L D N L+          +    L +    +       L N   L   +  + 
Sbjct: 177 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236

Query: 418 KLIGTLPRQILRITTLSL 435
           K + TL  +++ +   SL
Sbjct: 237 KKLPTL-EKLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 40/218 (18%), Positives = 70/218 (32%), Gaps = 16/218 (7%)

Query: 57  PHQIGRLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADI-GSLFKL 114
                    LE++ +S N     I A+  S+   L E+  +  N +  I  +   +L  L
Sbjct: 47  KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106

Query: 115 ERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSL------GQLKSLTLLSVAF 168
           + L I    I         +     ++D+++N     I ++      G      +L +  
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI---NIHTIERNSFVGLSFESVILWLNK 163

Query: 169 NQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSL 228
           N     I  S FN + L+ ++LS+N     LP D          L  +           L
Sbjct: 164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222

Query: 229 SNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGIN 266
            N   L        +          +L  L   +L   
Sbjct: 223 ENLKKLRARSTYNLKKLP----TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 39/239 (16%), Positives = 75/239 (31%), Gaps = 17/239 (7%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
           S    +   +  +  IP++L    N IEL      L   I          LE++ I QN 
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 124 ITGQLPASI-GNLSSLRVIDVRENRLWGRIDS--LGQLKSLTLLSVAFNQFSGMIPPSIF 180
           +   + A +  NL  L  I + +      I+      L +L  L ++       +P    
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124

Query: 181 -NISSLEVISLSENRFTGSLPVDTGVNLPS-LRELRTNANNFTGFIPVSLSNASSLEMIE 238
            +     ++ + +N    ++  ++ V L      L  N N        + +     E+  
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184

Query: 239 FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNR 297
              N      +  F        L++    + +  +        L N  KL        +
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS------YGLENLKKLRARSTYNLK 237

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 47/227 (20%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASK---SFVAECKALRNIR 694
            + ++    +G+G  G V K        E AVKVIN K    +K   + + E + L+ + 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++K+  +      + +    IV E    G L + +      ++    S      I  
Sbjct: 80  HPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIK 128

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVE 810
            V S I Y+H   + +IVH DLKP N+LL   ++D    + DFGL+     +      + 
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI- 184

Query: 811 TRSISIGIKGTVGYVAPE-----YGMGREASMKGDVYSFG----ILL 848
                    GT  Y+APE     Y        K DV+S G    ILL
Sbjct: 185 ---------GTAYYIAPEVLRGTYD------EKCDVWSAGVILYILL 216

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 26/216 (12%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHR 696
            D F    K+G G  G V+      +G E  +K IN  + +   +   AE + L+++ H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+IKI  V     F+      IV E  + G L E +  +  + +  +LS      +   +
Sbjct: 81  NIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQM 133

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVETR 812
            +A+ Y H      +VH DLKP N+L           + DFGLA+   +           
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--- 187

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                  GT  Y+APE    R+ + K D++S G+++
Sbjct: 188 -------GTALYMAPEV-FKRDVTFKCDIWSAGVVM 215

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 7e-21
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 42/227 (18%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---------ECK 688
            D +  +  +G G  G V   F  +   +VA+++I+ K+K A  S            E +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIE 192

Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            L+ + H  +IKI       D+       IV E M+ G L + +  +    E        
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP 805
                  +  A++YLH   E  I+H DLKP NVLL   ++D +  ++DFG +K L   + 
Sbjct: 247 ------QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

Query: 806 -DTIVETRSISIGIKGTVGYVAPE---YGMGREASMKGDVYSFGILL 848
             T+           GT  Y+APE          +   D +S G++L
Sbjct: 298 MRTLC----------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 92.6 bits (231), Expect = 8e-21
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 22/204 (10%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-ECKALRNIRHRNLIKIITVC 705
           +GEG  G V           VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
              + +      +  E+   G L + +       E  +     +L       + + YLH 
Sbjct: 75  REGNIQ-----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYV 825
                I H D+KP N+LLD+     +SDFGLA     +N + ++          GT+ YV
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYV 174

Query: 826 APEYGMGRE-ASMKGDVYSFGILL 848
           APE    RE  +   DV+S GI+L
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 27/222 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           D+F     +G+G  G VY     +N   +A+KV+    L+++G       E +   ++RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++        F       ++ EF   G L + L       E  S + ++ L     
Sbjct: 74  PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----- 123

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
            A A+ Y H      ++H D+KP N+L+       ++DFG     S H P     T    
Sbjct: 124 -ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRT---- 171

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             + GT+ Y+ PE   G+    K D++  G+L  E      P
Sbjct: 172 --MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.1 bits (239), Expect = 1e-20
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-ECKALRNIRHR 696
            D++    ++G G  G+V++      G   A K +      + K  V  E + +  +RH 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAID 755
            L+ +        F+  +   ++YEFM  G L E +   ++++ E  ++  ++       
Sbjct: 215 TLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR------Q 263

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           V   + ++H   E + VH DLKP N++      + +   DFGL   L   +P   V+   
Sbjct: 264 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKV-- 315

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                 GT  + APE   G+      D++S G+L 
Sbjct: 316 ----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 26/214 (12%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            D +    ++G G  G+V++      G     K IN        +   E   +  + H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDV 756
           LI +        F+      ++ EF+  G L + +   + ++ E   ++ ++        
Sbjct: 110 LINLHDA-----FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR------QA 158

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSI 814
              ++++H   E SIVH D+KP N++ +    S V   DFGLA  L   NPD IV+    
Sbjct: 159 CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKV--- 209

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                 T  + APE           D+++ G+L 
Sbjct: 210 ---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.8 bits (236), Expect = 2e-20
 Identities = 62/254 (24%), Positives = 106/254 (41%), Gaps = 44/254 (17%)

Query: 624 QQFLVDSYAELSKATDNFSSA----NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--- 676
           Q   ++    + K       +     K+G G  G V         +E A+KVI   Q   
Sbjct: 17  QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76

Query: 677 ----------KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNG 726
                     +   +    E   L+++ H N+IK+  V     F+   +  +V EF + G
Sbjct: 77  GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGG 131

Query: 727 SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL--- 783
            L E + + +   E  + +++++      + S I YLH +   +IVH D+KP N+LL   
Sbjct: 132 ELFEQIINRHKFDECDAANIMKQ------ILSGICYLHKH---NIVHRDIKPENILLENK 182

Query: 784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYS 843
           +  L   + DFGL+ F S                  GT  Y+APE  + ++ + K DV+S
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLR---------DRLGTAYYIAPEV-LKKKYNEKCDVWS 232

Query: 844 FGILLLELFTRKRP 857
            G+++  L     P
Sbjct: 233 CGVIMYILLCGYPP 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 38/212 (17%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-ECKALRNIRHRNLIKIITVC 705
           +GEG  G V           VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA-------- 757
              + +      +  E+   G L + +                 +      A        
Sbjct: 75  REGNIQ-----YLFLEYCSGGELFDRIEPD------------IGMPE--PDAQRFFHQLM 115

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168

Query: 818 IKGTVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
             GT+ YVAPE    RE  +   DV+S GI+L
Sbjct: 169 --GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL-KQKGASKSF-------VAE 686
           S AT  +    +IG G  G VYK     +G  VA+K + +    G            VA 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL----EVC 742
            + L    H N+++++ VC+           +V+E +    L  +L  +         + 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
            L + Q L         +++LH  C   IVH DLKP N+L+       ++DFGLA+  S 
Sbjct: 124 DL-MRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

Query: 803 HNPDT--IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
               T  +V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 173 QMALTPVVV-----------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 56/253 (22%), Positives = 105/253 (41%), Gaps = 20/253 (7%)

Query: 282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT 341
               +   ++   ++     +    A+L   I  ++     ++ TI   ++ L +L  L 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVT-TIEG-VQYLNNLIGLE 69

Query: 342 IDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPS 401
           +  NQ+T  + P +  LT + +L+L  N L     S++  L  +  L L    +    P 
Sbjct: 70  LKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP- 124

Query: 402 SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRL 461
            L   +NL  L +  N++    P  +  +T L  YL +GN  ++  L P + NL  L  L
Sbjct: 125 -LAGLSNLQVLYLDLNQITNISP--LAGLTNLQ-YLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 462 DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP 521
               NK S +I   L++  NL  +++  N  S   PL   +  ++  +  ++  +  Q  
Sbjct: 179 KADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTITNQPV 234

Query: 522 EYLENLSFLEFLN 534
            Y  NL     + 
Sbjct: 235 FYNNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 53/315 (16%), Positives = 115/315 (36%), Gaps = 55/315 (17%)

Query: 110 SLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFN 169
           +L    +++  ++++T     +  +L  +  +      +   I+ +  L +L  L +  N
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEGVQYLNNLIGLELKDN 73

Query: 170 QFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLS 229
           Q + + P  + N++ +  + LS N       +     L S++ L   +   T   P  L+
Sbjct: 74  QITDLAP--LKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQITDVTP--LA 126

Query: 230 NASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLE 289
             S+L+++    NQ +       + L NL +L++G   +          +  L N SKL 
Sbjct: 127 GLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQVSD--------LTPLANLSKLT 176

Query: 290 RLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTG 349
            L  + N+               I  I              + +L +L  + +  NQ++ 
Sbjct: 177 TLKADDNK---------------ISDI------------SPLASLPNLIEVHLKNNQIS- 208

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI--PSSLGNCT 407
            + P +   +NL  + L    +         NL +   +K       G    P+++ +  
Sbjct: 209 DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK----GPSGAPIAPATISDNG 263

Query: 408 NLLGLNISHNKLIGT 422
                N++ N     
Sbjct: 264 TYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 55/316 (17%), Positives = 119/316 (37%), Gaps = 30/316 (9%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
            +++   I+  ++  T ++      +L  +  L       T      +   ++L  +E  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
            NQ +         L  +  L L  N L          ++ +     ++ L     +   
Sbjct: 72  DNQIT--DLAPLKNLTKITELELSGNPLKN--------VSAIAGLQSIKTLDLTSTQITD 121

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
             P  +A LS+ ++ + +  N+I+  I P +  L +L +L+I   Q++  + P +  L+ 
Sbjct: 122 VTP--LAGLSN-LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSK 174

Query: 361 LQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLI 420
           L  L  D N +   I S L +L  L  + L  N +     S L N +NL  + +++  + 
Sbjct: 175 LTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT 230

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACA 480
                 +     L +   +         P  + +       +L+ N  S     + +   
Sbjct: 231 NQ---PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287

Query: 481 NLEYLNISGNAFSGSI 496
           ++ + N +   FSG++
Sbjct: 288 SVTFKNTTVP-FSGTV 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 56/297 (18%), Positives = 110/297 (37%), Gaps = 32/297 (10%)

Query: 63  LISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQN 122
           L +  ++    ++ +  +    +    +  LSA     V  I   +  L  L  L +  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSA-FGTGVTTIEG-VQYLNNLIGLELKDN 73

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
            IT   P  + NL+ +  +++  N L   + ++  L+S+  L +   Q + + P  +  +
Sbjct: 74  QITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128

Query: 183 SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKN 242
           S+L+V+ L  N+ T   P+     L +L+ L       +   P  L+N S L  ++   N
Sbjct: 129 SNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183

Query: 243 QFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL 302
           + S       + L NL  ++L  N +          ++ L N S L  +           
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISD--------VSPLANTSNLFIVTLTNQT----- 228

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
              + N         +  N + G     I      +  T  +  LT  +   I  ++
Sbjct: 229 ---ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 56/242 (23%), Positives = 104/242 (42%), Gaps = 18/242 (7%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             L+L +  I   L+P + NL+ +  + ++ N         I  L S++ L L++   + 
Sbjct: 66  IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD 121

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL 138
             P  L+  SNL  L  D N +   I   +  L  L+ LSI    ++  L   + NLS L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKL 175

Query: 139 RVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGS 198
             +   +N++   I  L  L +L  + +  NQ S + P  + N S+L +++L+    T +
Sbjct: 176 TTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-N 231

Query: 199 LPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLE--MIEFSKNQFSGGVSVDFSRLK 256
            PV    NL     ++  +       P ++S+  +     + ++   F   VS  F++  
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTSFINNVSYTFNQSV 289

Query: 257 NL 258
             
Sbjct: 290 TF 291

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 36/222 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---ECKALRNIR 694
           +DN+    ++G+G   +V +      G E A K+IN  +K +++ F     E +  R ++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++++         +   F  +V++ +  G L E +       E  +   IQ      
Sbjct: 64  HPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVE 810
            +  +I Y H      IVH +LKP N+LL    +     ++DFGLA  +++         
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 168

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
                    GT GY++PE       S   D+++ G    ILL
Sbjct: 169 ---------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 6e-20
 Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 55/223 (24%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---------ECKALRNIRHRN 697
           +G G  G V+     E   EV VK I  K+K     ++          E   L  + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 698 LIKIITVCSGRDF---------KGAD-FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           +IK++ +   + F          G D F  I     ++  L+E          + S    
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFID----RHPRLDE---------PLASYIFR 137

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP-D 806
           Q       + SA+ YL       I+H D+K  N+++ +D    + DFG A +L       
Sbjct: 138 Q-------LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187

Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
           T            GT+ Y APE  MG      + +++S G+ L
Sbjct: 188 TFC----------GTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.9 bits (224), Expect = 7e-20
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 41/230 (17%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
             +    KIGEG  G V+K    E    VA+K + L     G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQL---EVCSLSVIQRLN 751
           N++++  V               +V+EF     L+++    N  L    V S  + Q L 
Sbjct: 62  NIVRLHDVLHSDKKLT-------LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF-LFQLL- 111

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD---TI 808
                   + + H      ++H DLKP N+L++++    +++FGLA+            +
Sbjct: 112 ------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 809 VETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRP 857
           V           T+ Y  P+   G +  S   D++S G +  EL    RP
Sbjct: 163 V-----------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.3 bits (227), Expect = 7e-20
 Identities = 62/260 (23%), Positives = 105/260 (40%), Gaps = 52/260 (20%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS---KSFVAECKALRNIR 694
              FS   +IG G  G VY      N   VA+K ++   K ++   +  + E + L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 695 HRNLIKIITVCSGRDFKGADFKA----IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           H N I+         ++G   +     +V E+   GS  + L      L+   ++ +   
Sbjct: 113 HPNTIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH- 161

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
                    + YLH     +++H D+K  N+LL +  +  + DFG A  ++  N  + V 
Sbjct: 162 ----GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--SFV- 211

Query: 811 TRSISIGIKGTVGYVAPEYGMGREAS---MKGDVYSFGILLLELFTRK------RPTDAM 861
                    GT  ++APE  +  +      K DV+S GI  +EL  RK          A+
Sbjct: 212 ---------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

Query: 862 F----NEGLTLHD--FSREF 875
           +    NE   L    +S  F
Sbjct: 263 YHIAQNESPALQSGHWSEYF 282

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 92.8 bits (231), Expect = 8e-20
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 39/230 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRH 695
            + ++    +G+G  G V K        E AVKVIN        + + + E + L+ + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++K+  +      + +    IV E    G L + +       E  +  +I+       
Sbjct: 81  PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------Q 129

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           V S I Y+H +   +IVH DLKP N+LL   ++D    + DFGL+     +         
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK----- 181

Query: 813 SISIGIKGTVGYVAPE-----YGMGREASMKGDVYSFGILLLELFTRKRP 857
                  GT  Y+APE     Y        K DV+S G++L  L +   P
Sbjct: 182 ----DRIGTAYYIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPP 221

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 8e-20
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 29/206 (14%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCS 706
           IG G  G+            VAVK I  +     ++   E    R++RH N+++   V  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 707 GRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY 766
                     AI+ E+   G L E + ++    E  +    Q+L       S + Y H  
Sbjct: 87  TP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCHSM 135

Query: 767 CEPSIVHGDLKPSNVLLDQDLVSH--VSDFGLAKFLSNHN-PDTIVETRSISIGIKGTVG 823
               I H DLK  N LLD        + DFG +K    H+ P + V          GT  
Sbjct: 136 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----------GTPA 182

Query: 824 YVAPEYGMGRE-ASMKGDVYSFGILL 848
           Y+APE  + +E      DV+S G+ L
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTL 208

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 53/216 (24%), Positives = 75/216 (34%), Gaps = 43/216 (19%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
            IG G  G V            A K I          F  E + ++++ H N+I++    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
               F+      +V E    G L E +      +            I  DV SA+ Y H 
Sbjct: 75  ----FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCH- 123

Query: 766 YCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVETRSISIGIKGT 821
             + ++ H DLKP N L      D    + DFGLA          T V          GT
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----------GT 171

Query: 822 VGYVAPE-----YGMGREASMKGDVYSFG----ILL 848
             YV+P+     YG       + D +S G    +LL
Sbjct: 172 PYYVSPQVLEGLYG------PECDEWSAGVMMYVLL 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 35/229 (15%)

Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-GASKSFVAECKALRNIRH 695
           ++  F    K+G G    VYKG     G  VA+K + L  + G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 696 RNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
            N++++  V    +          +V+EFM N  L++++           L +       
Sbjct: 63  ENIVRLYDVIHTENKLT-------LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
             +   + + H      I+H DLKP N+L+++     + DFGLA              R+
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA--------------RA 157

Query: 814 ISIGIKG------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
             I +        T+ Y AP+  MG R  S   D++S G +L E+ T K
Sbjct: 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 27/214 (12%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            + +  A  +G G  GIV++     +      K +   +         E   L   RHRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDV 756
           ++ +        F+  +   +++EF+    + E ++ S  +L E   +S +        V
Sbjct: 63  ILHLHES-----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------QV 111

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSI 814
             A+++LH     +I H D++P N++      S +   +FG A+ L    P         
Sbjct: 112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRL--- 162

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
              +     Y APE       S   D++S G L+
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 38/217 (17%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALRNIRHRNLI 699
            IG+G   +V +    E G + AVK+++   K  S   ++      E      ++H +++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSL-EEWLHHSNDQL----EVCSLSVIQRLNIAI 754
           +++       +       +V+EFM    L  E +  ++        V S  + Q      
Sbjct: 90  ELLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ------ 138

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVET 811
            +  A+ Y H   + +I+H D+KP  VLL   +      +  FG+A  L         E+
Sbjct: 139 -ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ES 186

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             ++ G  GT  ++APE           DV+  G++L
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 30/216 (13%)

Query: 640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI 699
             S    +G G  G V+K      G ++A K+I  +     +    E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL-EVCSLSVIQRLNIAIDVAS 758
           ++        F+  +   +V E++  G L + +   +  L E+ ++  ++       +  
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK------QICE 198

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISI 816
            I ++H   +  I+H DLKP N+L        +   DFGLA+      P   ++      
Sbjct: 199 GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKV----- 247

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
              GT  ++APE       S   D++S G    +LL
Sbjct: 248 -NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 21/220 (9%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
            NL  + K + +  N +   +      +   L  L +   ++  TI       L++L  L
Sbjct: 24  DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81

Query: 365 DLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSL-GNCTNLLGLNISHNKLIGT 422
            L  N +Q S+       L+ L  L     NL  ++ +   G+   L  LN++HN  I +
Sbjct: 82  ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL-IQS 138

Query: 423 LPRQIL--RITTLSLYLELGNNLLNGSLPPEV-GNLKNL----MRLDLSGNKFSGEIPAT 475
                    +T L  +L+L +N +  S+       L  +    + LDLS N  +  I   
Sbjct: 139 FKLPEYFSNLTNLE-HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195

Query: 476 LSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSN 514
                 L+ L +  N    S+P  + D L S++++   +N
Sbjct: 196 AFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 53/248 (21%), Positives = 85/248 (34%), Gaps = 54/248 (21%)

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGT---GAANELDFINLLTNCSKL 288
            S + ++ S N      S  F     L  L+L    + T   GA     + +L    S L
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-----YQSL----SHL 78

Query: 289 ERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQL 347
             L    N            + S               +       L+SL  L      L
Sbjct: 79  STLILTGNP-----------IQS---------------LALGAFSGLSSLQKLVAVETNL 112

Query: 348 TGTIPPEI-GELTNLQQLDLDRNFLQGSIPSS--LGNLTLLTYLKLGLNNLEGNIPS-SL 403
             ++     G L  L++L++  N +Q S        NLT L +L L  N ++ +I    L
Sbjct: 113 A-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169

Query: 404 GNCTNL----LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNL 458
                +    L L++S N  +  +     +   L   L L  N L  S+P  +   L +L
Sbjct: 170 RVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLK-ELALDTNQLK-SVPDGIFDRLTSL 226

Query: 459 MRLDLSGN 466
            ++ L  N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 49/196 (25%), Positives = 76/196 (38%), Gaps = 15/196 (7%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSL-GNCTNL 409
           IP  +    + + LDL  N L+     S  +   L  L L    ++  I      + ++L
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 410 LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKF 468
             L ++ N +  +L        +    L      L  SL     G+LK L  L+++ N  
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 469 -SGEIPATLSACANLEYLNISGNAFSGSIPL-LLDSLQSIK----ELDFSSNNLNGQIPE 522
            S ++P   S   NLE+L++S N    SI    L  L  +      LD S N +N  I  
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194

Query: 523 YLENLSFLEFLNLSYN 538
                  L+ L L  N
Sbjct: 195 GAFKEIRLKELALDTN 210

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 48/241 (19%), Positives = 80/241 (33%), Gaps = 42/241 (17%)

Query: 160 SLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
           S   L ++FN     +    F +   L+V+ LS      ++      +L  L  L    N
Sbjct: 29  STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDF 278
                   + S  SSL+ +   +   +   +     LK L  LN+  N +          
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI-----QSFKL 141

Query: 279 INLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASL 337
               +N + LE L  + N+ +                          +I     R L  +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQ--------------------------SIYCTDLRVLHQM 175

Query: 338 NW----LTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGL 392
                 L +  N +   I P   +   L++L LD N L+ S+P      LT L  + L  
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHT 233

Query: 393 N 393
           N
Sbjct: 234 N 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 36/193 (18%), Positives = 66/193 (34%), Gaps = 20/193 (10%)

Query: 62  RLISLERLILSNNSFSGAIPANL-SSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSI 119
               L+ L LS       I      S S+L  L    N +   +       L  L++L  
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107

Query: 120 FQNHITGQLPASIGNLSSLRVIDVRENRL-----WGRIDSLGQLKSLTLLSVAFNQFSGM 174
            + ++       IG+L +L+ ++V  N +          +L  L+ L L   + N+    
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL---SSNKIQ-S 163

Query: 175 IPPSIF-NISSLEVI----SLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLS 229
           I  +    +  + ++     LS N     +       +  L+EL  + N           
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLKELALDTNQLKSVPDGIFD 221

Query: 230 NASSLEMIEFSKN 242
             +SL+ I    N
Sbjct: 222 RLTSLQKIWLHTN 234

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 61/271 (22%), Positives = 103/271 (38%), Gaps = 63/271 (23%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHR 696
              F     +G G  G VYKG   + G   A+KV+++      +    E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81

Query: 697 NLIKIITVCSGRDFKGADFKA----------IVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
           N+           + GA  K           +V EF   GS+        D ++    + 
Sbjct: 82  NIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNT 125

Query: 747 IQRLNIAI---DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNH 803
           ++   IA    ++   + +LH   +  ++H D+K  NVLL ++    + DFG++  L   
Sbjct: 126 LKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

Query: 804 NP--DTIVETRSISIGIKGTVGYVAPEYGMGREAS-----MKGDVYSFGILLLELFTRK- 855
               +T +          GT  ++APE     E        K D++S GI  +E+     
Sbjct: 183 VGRRNTFI----------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

Query: 856 -----RPTDAMF----NEGLTLHD--FSREF 875
                 P  A+F    N    L    +S++F
Sbjct: 233 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 263

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 50/231 (21%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN----LKQKGASKSFVA----------------- 685
           IG+G  G+V   +   + T  A+KV++    ++Q G  +                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 686 -----ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE 740
                E   L+ + H N++K++ V    D    D   +V+E +  G + E          
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPVMEVPTLK----- 132

Query: 741 VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
              LS  Q      D+   IEYLH+     I+H D+KPSN+L+ +D    ++DFG++   
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG---DVYSFGILL 848
                D ++          GT  ++APE          G   DV++ G+ L
Sbjct: 188 --KGSDALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 33/209 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIKII 702
           +G G  G V  G     G +VAVK++N +QK  S   V     E + L+  RH ++IK+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 703 TVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            V S     F       +V E++  G L +++       E+ +  + Q++       SA+
Sbjct: 78  QVISTPTDFF-------MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAV 124

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +Y H +    +VH DLKP NVLLD  + + ++DFGL+  +S       + T        G
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSC------G 172

Query: 821 TVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
           +  Y APE   GR  A  + D++S G++L
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 36/222 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA---ECKALRNIR 694
           +DN+    ++G+G   +V +      G E A K+IN  +K +++ F     E +  R ++
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N++++         +   F  +V++ +  G L E +      +     S     +   
Sbjct: 87  HPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQ 135

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVE 810
            +  +I Y H      IVH +LKP N+LL    +     ++DFGLA  +++         
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 191

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
                    GT GY++PE       S   D+++ G    ILL
Sbjct: 192 ---------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 35/211 (16%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL-RNIRHRNLIKIITV 704
            +G G +G V + F    G + A+K++      A +    E     +     +++ I+ V
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 705 CSGRDFKGADFKAIVYEFMQNGSL----EEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
                        I+ E M+ G L    +E    +  + E           I  D+ +AI
Sbjct: 91  YENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAA--------EIMRDIGTAI 141

Query: 761 EYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           ++LH     +I H D+KP N+L    ++D V  ++DFG AK  + +   T          
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-------- 190

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
              T  YVAPE     +     D++S G+++
Sbjct: 191 --YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 49/217 (22%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
            +GEG   I  K    ++    AVK+I+ + +  ++  +   K      H N++K+  V 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEV- 74

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL---------NIAIDV 756
               F       +V E +  G L                  I++           I   +
Sbjct: 75  ----FHDQLHTFLVMELLNGGEL---------------FERIKKKKHFSETEASYIMRKL 115

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD--TIVET 811
            SA+ ++H   +  +VH DLKP N+L    + +L   + DFG A+     N    T    
Sbjct: 116 VSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-- 170

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                    T+ Y APE           D++S G++L
Sbjct: 171 --------FTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 44/226 (19%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
           IG+G    V        G EVA+K+I+   L      K F  E + ++ + H N++K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 704 VCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN------IAID 755
           V       +       ++ E+   G + ++L                R+           
Sbjct: 82  VIETEKTLY-------LIMEYASGGEVFDYLVAH------------GRMKEKEARSKFRQ 122

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + SA++Y H      IVH DLK  N+LLD D+   ++DFG +   +       ++     
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFC-- 174

Query: 816 IGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTDA 860
               G   Y APE   G++    + DV+S G++L  L +   P D 
Sbjct: 175 ----GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 9e-19
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 37/219 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKAL-RNIRHR 696
           TD +     IG G   +  +        E AVK+I+  ++  ++    E + L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I +  V     +    +  +V E M+ G L + +       E  + +V+        +
Sbjct: 77  NIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF------TI 125

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNP--DTIV 809
              +EYLH      +VH DLKPSN+L      + + +  + DFG AK L   N    T  
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR-ICDFGFAKQLRAENGLLMTPC 181

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
                      T  +VAPE    +      D++S G+LL
Sbjct: 182 ----------YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 14/210 (6%)

Query: 332 RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLG 391
             +AS   +  D   LT  +PP++    +   L L  N L     ++L   T LT L L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 392 LNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPE 451
              L   +    G    L  L++SHN+L  +LP     +  L+  L++  N L  SLP  
Sbjct: 64  RAELT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALT-VLDVSFNRLT-SLPLG 118

Query: 452 V-GNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPL-LLDSLQSIKE 508
               L  L  L L GN+    +P   L+    LE L+++ N  +  +P  LL+ L+++  
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 509 LDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           L    N+L   IP+       L F  L  N
Sbjct: 177 LLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 44/181 (24%), Positives = 66/181 (36%), Gaps = 10/181 (5%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQL 347
              L+ + N        +     + + Q+ + R  +  T       L  L  L +  NQL
Sbjct: 33  TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQL 89

Query: 348 TGTIPPEIGELTNLQQLDLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSL-GN 405
             ++P     L  L  LD+  N L  S+P      L  L  L L  N L+  +P  L   
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146

Query: 406 CTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSG 465
              L  L++++N L   LP  +L        L L  N L  ++P        L    L G
Sbjct: 147 TPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 466 N 466
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 51/183 (27%), Positives = 72/183 (39%), Gaps = 14/183 (7%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
               L LS N       A L   + L +L+ D   L  ++  D G+L  L  L +  N +
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQL 89

Query: 125 TGQLPASIGNLSSLRVIDVRENRL----WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
              LP     L +L V+DV  NRL     G +  LG+L+ L L     N+    +PP + 
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL---KGNELK-TLPPGLL 144

Query: 181 -NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEF 239
                LE +SL+ N  T  LP      L +L  L    N+    IP     +  L     
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFL 202

Query: 240 SKN 242
             N
Sbjct: 203 HGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 51/245 (20%), Positives = 80/245 (32%), Gaps = 43/245 (17%)

Query: 200 PVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLY 259
           P+     + S  E+  +  N T  +P  L       ++  S+N               L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 260 WLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMG 319
            LNL    L          + +      L  L  + N+ +                    
Sbjct: 59  QLNLDRAELTK--------LQVDGTLPVLGTLDLSHNQLQ-------------------- 90

Query: 320 RNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSS 378
                 ++P   + L +L  L +  N+LT ++P      L  LQ+L L  N L+ ++P  
Sbjct: 91  ------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPG 142

Query: 379 L-GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYL 437
           L      L  L L  NNL       L    NL  L +  N L  T+P+       L  + 
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLP-FA 200

Query: 438 ELGNN 442
            L  N
Sbjct: 201 FLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 44/203 (21%), Positives = 79/203 (38%), Gaps = 9/203 (4%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHI 124
           S   +     + + A+P +L    +   L    N L     A +    +L +L++ +  +
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 125 TGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NIS 183
           T +L    G L  L  +D+  N+L         L +LT+L V+FN+ +  +P      + 
Sbjct: 68  T-KLQVD-GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
            L+ + L  N    +LP       P L +L    NN T      L+   +L+ +   +N 
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 244 FSGGVSVDFSRLKNLYWLNLGIN 266
               +   F     L +  L  N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 50/199 (25%), Positives = 75/199 (37%), Gaps = 35/199 (17%)

Query: 358 LTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHN 417
           + +  +++ D+  L  ++P  L      T L L  N L     ++L   T L  LN+   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 418 KLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLS 477
           +L           T L                   G L  L  LDLS N+    +P    
Sbjct: 66  EL-----------TKL----------------QVDGTLPVLGTLDLSHNQLQ-SLPLLGQ 97

Query: 478 ACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS 536
               L  L++S N  + S+PL  L  L  ++EL    N L    P  L     LE L+L+
Sbjct: 98  TLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156

Query: 537 YNHFEGEVPMKGVFNNKTR 555
            N+   E+P  G+ N    
Sbjct: 157 NNNLT-ELP-AGLLNGLEN 173

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 42/177 (23%), Positives = 66/177 (37%), Gaps = 31/177 (17%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
           T+L+L    +  T     G L  L  ++++ N     +P     L +L  L +S N  + 
Sbjct: 58  TQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113

Query: 79  AIPANL-SSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHITGQLPASIGNLS 136
           ++P         L EL    N L   +P  +     KLE+LS+  N++T +LPA +    
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL---- 167

Query: 137 SLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
                          ++ L  L +L L     N     IP   F    L    L  N
Sbjct: 168 ---------------LNGLENLDTLLLQE---NSLY-TIPKGFFGSHLLPFAFLHGN 205

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 39/229 (17%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           D +    K+GEG  G VYK         VA+K I L+ +  G   + + E   L+ ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSN--DQLEVCSLSVIQRLNI 752
           N+I++ +V               +++E+ +N  L++++  +       + S  + Q +  
Sbjct: 94  NIIELKSVIHHNHRLH-------LIFEYAEN-DLKKYMDKNPDVSMRVIKSF-LYQLI-- 142

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH-----VSDFGLAKFLSNHNPDT 807
                + + + H       +H DLKP N+LL     S      + DFGLA+         
Sbjct: 143 -----NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG------ 188

Query: 808 IVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            +  R  +  I  T+ Y  PE  +G R  S   D++S   +  E+  + 
Sbjct: 189 -IPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 33/232 (14%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGF-LGENGTEVAVKVINLKQK--GASKSFVAECKALR 691
            +A   +    +IGEG  G V+K   L   G  VA+K + ++    G   S + E   LR
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 692 NIR---HRNLIKIITVCSGRDFKGADFKAIVYEFMQN---GSLEEWLHHSNDQLEVCSLS 745
           ++    H N++++  VC+           +V+E +       L++          +  + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 125

Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
           + Q L         +++LH +    +VH DLKP N+L+       ++DFGLA+  S    
Sbjct: 126 MFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 806 DT--IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            T  +V           T+ Y APE  +    +   D++S G +  E+F RK
Sbjct: 176 LTSVVV-----------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 37/225 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALR 691
            D++    ++G G   IV K      G E A K I  ++  +S+  V+      E   LR
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            IRH N+I +  +     F+      ++ E +  G L ++L       E  +   ++   
Sbjct: 64  EIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--- 115

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSH---VSDFGLAKFLSNHNPDT 807
               +   + YLH      I H DLKP N++L D+++ +    + DFG+A  +       
Sbjct: 116 ---QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGN 166

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
             +       I GT  +VAPE        ++ D++S G    ILL
Sbjct: 167 EFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 30/185 (16%), Positives = 64/185 (34%), Gaps = 15/185 (8%)

Query: 357 ELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
                    L ++       + + +LT +T   + + +L G     +    N+  L I++
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75

Query: 417 NKLIGTLPRQILRITTLSL--YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA 474
                        I+ LS    L +    +     P +  L +L  LD+S +     I  
Sbjct: 76  IHA-----TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLN 534
            ++    +  +++S N     I  L  +L  +K L+   + ++      +E+   L  L 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187

Query: 535 LSYNH 539
                
Sbjct: 188 AFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.9 bits (203), Expect = 6e-18
 Identities = 30/190 (15%), Positives = 63/190 (33%), Gaps = 33/190 (17%)

Query: 305 SVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQL 364
           + A ++S +  I +    ++      I    ++  LTI+    T   P  I  L+NL++L
Sbjct: 39  TEAQMNS-LTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93

Query: 365 DLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLP 424
            +    +      +L  LT LT L +  +  + +I + +     +  +++S+N  I  + 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152

Query: 425 RQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEY 484
                                      +  L  L  L++  +         +     L  
Sbjct: 153 -------------------------MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185

Query: 485 LNISGNAFSG 494
           L        G
Sbjct: 186 LYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 34/222 (15%), Positives = 63/222 (28%), Gaps = 63/222 (28%)

Query: 250 VDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANL 309
           +  +++ +L ++ L   N+      +L  I    N   ++ L  N               
Sbjct: 38  ITEAQMNSLTYITLANINV-----TDLTGIEYAHN---IKDLTINNIH------------ 77

Query: 310 SSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRN 369
                                I  L++L  L I    +T    P +  LT+L  LD+  +
Sbjct: 78  ---ATNYN------------PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122

Query: 370 FLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
               SI + +  L  +  + L  N    +I   L     L  LNI  +            
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG----------- 170

Query: 430 ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE 471
           +                     + +   L +L        G+
Sbjct: 171 VHDYR----------------GIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 34/182 (18%), Positives = 61/182 (33%), Gaps = 9/182 (4%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
           +      LG  S     +     ++ L YI +A+          I    +++ L ++N  
Sbjct: 23  KAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
            +   P  +S  SNL  L     ++  +   ++  L  L  L I  +     +   I  L
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
             +  ID+  N     I  L  L  L  L++ F+         I +   L  +       
Sbjct: 136 PKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

Query: 196 TG 197
            G
Sbjct: 194 GG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 21/182 (11%), Positives = 53/182 (29%), Gaps = 7/182 (3%)

Query: 88  SNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENR 147
           S                      +  L  +++   ++T      I    +++ + +    
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77

Query: 148 LWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNL 207
                + +  L +L  L +     +    P++  ++SL ++ +S +    S  +     L
Sbjct: 78  A-TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS-ILTKINTL 135

Query: 208 PSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINN 267
           P +  +  + N     I   L     L+ +    +               L  L      
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQT 192

Query: 268 LG 269
           +G
Sbjct: 193 IG 194

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 27/206 (13%), Positives = 62/206 (30%), Gaps = 40/206 (19%)

Query: 92  ELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGR 151
           +    ++     IP    +        + Q+        +   ++SL  I +    +   
Sbjct: 5   QTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TD 58

Query: 152 IDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLR 211
           +  +    ++  L++                ++   IS                 L +L 
Sbjct: 59  LTGIEYAHNIKDLTINNIH-----------ATNYNPIS----------------GLSNLE 91

Query: 212 ELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTG 271
            LR    + T     +LS  +SL +++ S +     +    + L  +  ++L  N   T 
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 272 AANELDFINLLTNCSKLERLYFNRNR 297
                  I  L    +L+ L    + 
Sbjct: 152 -------IMPLKTLPELKSLNIQFDG 170

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 45/236 (19%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--ECKALRNIRHR 696
             +    KIG+G  G V+K    + G +VA+K + ++ +       A  E K L+ ++H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 697 NLIKIITVCSGRDFKGADFKAIVY---EFMQNGSLEEWLHHSNDQL---EVCSLSVIQRL 750
           N++ +I +C  +       K  +Y   +F ++  L   L +   +    E+  + +   L
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-MQMLL 134

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
                  + + Y+H      I+H D+K +NVL+ +D V  ++DFGLA             
Sbjct: 135 -------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA------------- 171

Query: 811 TRSISIGIKGTVG----------YVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            R+ S+                 Y  PE  +G R+     D++  G ++ E++TR 
Sbjct: 172 -RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           + +    K+GEG  G+VYK      G  VA+K I L  +  G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQL---EVCSLSVIQRLN 751
           N++ +I V               +V+EFM+   L++ L  +   L   ++    + Q L 
Sbjct: 80  NIVSLIDVIHSERCLT-------LVFEFMEK-DLKKVLDENKTGLQDSQIKIY-LYQLL- 129

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD---TI 808
                   + + H +    I+H DLKP N+L++ D    ++DFGLA+            +
Sbjct: 130 ------RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180

Query: 809 VETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           V           T+ Y AP+  MG ++ S   D++S G +  E+ T K
Sbjct: 181 V-----------TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 43/240 (17%)

Query: 619 MLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKG 678
           M P +QQ + D Y ++ +         ++G G   IV K      G E A K I  +Q  
Sbjct: 2   MEPFKQQKVEDFY-DIGE---------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51

Query: 679 ASKSFVA------ECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWL 732
           AS+  V+      E   LR + H N+I +  V     ++      ++ E +  G L ++L
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL 106

Query: 733 HHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSH- 790
                  E  + S I+       +   + YLH      I H DLKP N++L D+++    
Sbjct: 107 AQKESLSEEEATSFIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157

Query: 791 --VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             + DFGLA  +         +       I GT  +VAPE        ++ D++S G++ 
Sbjct: 158 IKLIDFGLAHEI---EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 29/222 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
           + + +   +GEG  G+V K    + G  VA+K        K   K  + E K L+ +RH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           NL+ ++ VC     K   +  +V+EF+ + ++ + L    + L      V+Q       +
Sbjct: 85  NLVNLLEVCKK---KKRWY--LVFEFVDH-TILDDLELFPNGL---DYQVVQ--KYLFQI 133

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPD--TIVETRSI 814
            + I + H +   +I+H D+KP N+L+ Q  V  + DFG A+ L+         V TR  
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-- 188

Query: 815 SIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                    Y APE  +G  +     DV++ G L+ E+F  +
Sbjct: 189 --------WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 44/222 (19%), Positives = 85/222 (38%), Gaps = 35/222 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRH 695
           T+ +    ++G+G   +V +      G E A  +IN K+      +    E +  R ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++                ++++ +  G L E +      +     S     +    
Sbjct: 70  PNIVRLHDS-----ISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQ 118

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPD--TIVE 810
           +  A+ + H   +  +VH +LKP N+LL    +     ++DFGLA  +            
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
                    GT GY++PE           D+++ G    ILL
Sbjct: 175 ---------GTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 35/226 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR--------HRN 697
           K+G G    V+      N T VA+K++   +     +   E K L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMG 84

Query: 698 LIKIITVCSGRDFKGADFK--AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
              I+ +    + KG +     +V+E +   +L   +     +     L  +++  I+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQ--ISKQ 139

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH------VSDFGLAKFLSNHNPDTIV 809
           +   ++Y+H  C   I+H D+KP NVL++            ++D G A +   H  ++I 
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            TR           Y +PE  +G       D++S   L+ EL T  
Sbjct: 198 -TRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALR 691
            D + +  ++G G   +V K      G + A K I  ++  +S+  V+      E   L+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            I+H N+I +  V     ++      ++ E +  G L ++L       E  SL+  +   
Sbjct: 70  EIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFL------AEKESLTEEEATE 118

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSH---VSDFGLAKFLSNHNPDT 807
               + + + YLH      I H DLKP N++L D+++      + DFGLA  +   +   
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGN 172

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             +       I GT  +VAPE        ++ D++S G++ 
Sbjct: 173 EFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 33/221 (14%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA------ECKALR 691
            D +    ++G G   IV K      G E A K I  +Q  AS+  V       E   LR
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H N+I +  V     ++      ++ E +  G L ++L       E  + S I+   
Sbjct: 71  QVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--- 122

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL-DQDLVSH---VSDFGLAKFLSNHNPDT 807
               +   + YLH      I H DLKP N++L D+++      + DFGLA  +       
Sbjct: 123 ---QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGV 173

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILL 848
             +       I GT  +VAPE        ++ D++S G++ 
Sbjct: 174 EFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 7e-18
 Identities = 48/225 (21%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+V+K    + G  VA+K     +      K  + E + L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           NL+ ++ V   +           +V+E+  + ++   L      +      +++  +I  
Sbjct: 63  NLVNLLEVFRRKRRLH-------LVFEYCDH-TVLHELDRYQRGV---PEHLVK--SITW 109

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP---DTIVET 811
               A+ + H +   + +H D+KP N+L+ +  V  + DFG A+ L+  +    D +   
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-- 164

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
                    T  Y +PE  +G  +     DV++ G +  EL +  
Sbjct: 165 ---------TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 38/227 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HR 696
            D++    K+G G    V++     N  +V VK++   +K   K    E K L N+R   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91

Query: 697 NLIKII-TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           N+I +   V            A+V+E + N   ++      D  ++    + + L     
Sbjct: 92  NIITLADIVKDPVSRT----PALVFEHVNNTDFKQLYQTLTDY-DIRFY-MYEILK---- 141

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAKFLSNHNPDTI-VET 811
              A++Y H      I+H D+KP NV++D     L   + D+GLA+F        + V +
Sbjct: 142 ---ALDYCHSM---GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEYNVRVAS 193

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRP 857
           R           +  PE  +  +      D++S G +L  +  RK P
Sbjct: 194 RY----------FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 34/272 (12%)

Query: 274 NELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRN 333
             +  I      ++  +    +      +      L+S I QI    + I  ++   I+ 
Sbjct: 12  TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDIK-SVQG-IQY 66

Query: 334 LASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
           L ++  L ++ N+LT  I P +  L NL  L LD N ++  + SSL +L  L  L L  N
Sbjct: 67  LPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHN 122

Query: 394 NLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-----YLELGNNLLNGSL 448
            +  +I + L +   L  L + +N        +I  IT LS       L L +N ++  +
Sbjct: 123 GIS-DI-NGLVHLPQLESLYLGNN--------KITDITVLSRLTKLDTLSLEDNQIS-DI 171

Query: 449 PPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKE 508
            P +  L  L  L LS N  S ++ A L+   NL+ L +              +L     
Sbjct: 172 VP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228

Query: 509 LDFSSNNLNGQI--PEYLENLSFLEFLNLSYN 538
           +     N +G +  PE + +    E  N+ ++
Sbjct: 229 V----KNTDGSLVTPEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 46/209 (22%), Positives = 76/209 (36%), Gaps = 39/209 (18%)

Query: 331 IRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL 390
               A      +    +T  +     EL ++ Q+  + + ++ S+   +  L  +T L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75

Query: 391 GLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPP 450
             N L  +I   L N  NL  L +  N        ++  +++L                 
Sbjct: 76  NGNKLT-DI-KPLANLKNLGWLFLDEN--------KVKDLSSLK---------------- 109

Query: 451 EVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELD 510
              +LK L  L L  N  S +I   L     LE L +  N  +    L    L  +  L 
Sbjct: 110 ---DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVL--SRLTKLDTLS 162

Query: 511 FSSNNLNGQIPEYLENLSFLEFLNLSYNH 539
              N ++  +P  L  L+ L+ L LS NH
Sbjct: 163 LEDNQISDIVP--LAGLTKLQNLYLSKNH 189

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 50/268 (18%), Positives = 99/268 (36%), Gaps = 26/268 (9%)

Query: 152 IDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLR 211
           I S          ++     +  +  +   ++S++ I  + +       +     LP++ 
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVT 71

Query: 212 ELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTG 271
           +L  N N  T   P  L+N  +L  +   +N+           LK L  L+L  N +   
Sbjct: 72  KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD- 126

Query: 272 AANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI 331
                  IN L +  +LE LY   N+        ++ L+  +  +++  N+IS  I P +
Sbjct: 127 -------INGLVHLPQLESLYLGNNKITD--ITVLSRLTK-LDTLSLEDNQIS-DIVP-L 174

Query: 332 RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLG 391
             L  L  L +  N ++  +   +  L NL  L+L          +   NL +   +K  
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232

Query: 392 LNNLEGNIPSSLGNCTNLLGLNISHNKL 419
             +L    P  + +  +    N+  +  
Sbjct: 233 DGSLVT--PEIISDDGDYEKPNVKWHLP 258

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 48/277 (17%), Positives = 100/277 (36%), Gaps = 36/277 (12%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
             +     +L +   T ++  +    L S+ ++  N ++        +    ++  +  +
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEG 300
            N+ +       + LKNL WL L  N +          ++ L +  KL+ L    N    
Sbjct: 77  GNKLT--DIKPLANLKNLGWLFLDENKVKD--------LSSLKDLKKLKSLSLEHNGIS- 125

Query: 301 ELPHSVANLS--STIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL 358
                +  L     ++ + +G N+I+  I   +  L  L+ L+++ NQ++  I P +  L
Sbjct: 126 ----DINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGL 177

Query: 359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNK 418
           T LQ L L +N +   +  +L  L  L  L+L          +   N      +  +   
Sbjct: 178 TKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 419 LIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNL 455
           L+            +S   +     +   LP     +
Sbjct: 236 LVT--------PEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 44/241 (18%), Positives = 95/241 (39%), Gaps = 14/241 (5%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
           + ++   N  I+ ++   +  L  +  + +  N    +I   +  L +L  L L  N   
Sbjct: 48  IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK 103

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
               ++L     L  LS + N +  +I   +  L +LE L +  N IT      +  L+ 
Sbjct: 104 DL--SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTK 157

Query: 138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTG 197
           L  + + +N++   I  L  L  L  L ++ N  S +   ++  + +L+V+ L       
Sbjct: 158 LDTLSLEDNQI-SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL- 213

Query: 198 SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKN 257
           + P++   NL     ++    +      +S         +++   +F+  VS  F +   
Sbjct: 214 NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 273

Query: 258 L 258
           +
Sbjct: 274 I 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 41/233 (17%), Positives = 95/233 (40%), Gaps = 19/233 (8%)

Query: 38  NLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADS 97
             +     N+        +      L S++++I +N+         +    N+ +L   +
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL-N 76

Query: 98  NNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQ 157
            N + +I   + +L  L  L + +N +   L  S+ +L  L+ + +  N +   I+ L  
Sbjct: 77  GNKLTDIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI-SDINGLVH 132

Query: 158 LKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
           L  L  L +  N+ + +    +  ++ L+ +SL +N+ +  +P+     L  L+ L  + 
Sbjct: 133 LPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLSK 187

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGT 270
           N+ +      L+   +L+++E    +     +   +   NL   N   N  G+
Sbjct: 188 NHISDLRA--LAGLKNLDVLELFSQECL---NKPINHQSNLVVPNTVKNTDGS 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 85.0 bits (211), Expect = 9e-18
 Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 42/237 (17%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR 694
            K  D F      G+G  G V  G     G  VA+K +    +  ++  +   + L  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 695 HRNLIKIITV--CSGRDFKGADFKAIVYEFMQNGSLEEWLH-------HSNDQLEV--CS 743
           H N++++ +     G   +   +  +V E++      + LH                   
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIK 132

Query: 744 LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDFGLAKFL 800
           + + Q +        +I  LH     ++ H D+KP NVL+++    L   + DFG AK L
Sbjct: 133 VFLFQLI-------RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKL 182

Query: 801 SNHNPDTI-VETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           S   P+   + +R           Y APE   G +  +   D++S G +  E+   +
Sbjct: 183 SPSEPNVAYICSRY----------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 9e-18
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 33/209 (15%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIKII 702
           +G G  G V  G     G +VAVK++N +QK  S   V     E + L+  RH ++IK+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 703 TVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
            V S     F       +V E++  G L +++  +    E  S  + Q++       S +
Sbjct: 83  QVISTPSDIF-------MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGV 129

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +Y H +    +VH DLKP NVLLD  + + ++DFGL+  +S       + T        G
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSC------G 177

Query: 821 TVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
           +  Y APE   GR  A  + D++S G++L
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 20/211 (9%)

Query: 321 NRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLG 380
             I+   P     LA+     +    +T  +     EL+ +Q  + D + +Q S+ + + 
Sbjct: 7   TPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQ 60

Query: 381 NLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSL-YLEL 439
             T L  L L  N +  ++ S L + T L  L+++ N+L     + +  I +  L  L L
Sbjct: 61  FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFL 113

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
            NN L       + +LKNL  L +  NK    I   L   + LE L++ GN  + +  L 
Sbjct: 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGL- 168

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFL 530
              L+ +  +D +      +  +Y   L   
Sbjct: 169 -TRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 15/241 (6%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
             + +LG QS+   L      LS ++  N  ++     +   +    +L+ L LS+N  S
Sbjct: 21  AVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
             +   L   + L ELS + N L   +         L RL +  N +      S+ +L +
Sbjct: 77  -DLS-PLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIHLKN 129

Query: 138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTG 197
           L ++ +R N+L   I  LG L  L +L +  N+ +      +  +  +  I L+  +   
Sbjct: 130 LEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV- 185

Query: 198 SLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKN 257
           + PV     L     ++     +     +S   +     + +    ++  VS  FS   N
Sbjct: 186 NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYIN 245

Query: 258 L 258
           +
Sbjct: 246 V 246

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 38/245 (15%), Positives = 87/245 (35%), Gaps = 31/245 (12%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
            +++    +L +   T  +       L  ++    + +N        +   ++L+ +  S
Sbjct: 17  GLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71

Query: 241 KNQFSGGVSVD-FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
            NQ S    +     L  L  L++  N L       L+ I        L RL+ + N   
Sbjct: 72  HNQIS---DLSPLKDLTKLEELSVNRNRL-----KNLNGIPSAC----LSRLFLDNNELR 119

Query: 300 GELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELT 359
                S+ +L + ++ +++  N++  +I   +  L+ L  L +  N++T      +  L 
Sbjct: 120 D--TDSLIHLKN-LEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLK 172

Query: 360 NLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI--PSSLGNCTNLLGLNISHN 417
            +  +DL               L +   +K    + +G    P  + N  + +   +   
Sbjct: 173 KVNWIDLTGQKCVNEPVKYQPELYITNTVK----DPDGRWISPYYISNGGSYVDGCVLWE 228

Query: 418 KLIGT 422
             + T
Sbjct: 229 LPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 32/216 (14%), Positives = 76/216 (35%), Gaps = 17/216 (7%)

Query: 69  LILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQL 128
            I      +   P      +N ++ +    ++   +      L  ++  +   ++I    
Sbjct: 2   SIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS-- 55

Query: 129 PASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVI 188
            A +   ++L+ + +  N++   +  L  L  L  LSV  N+   +   +    + L  +
Sbjct: 56  LAGMQFFTNLKELHLSHNQI-SDLSPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRL 111

Query: 189 SLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGV 248
            L  N    +  +    +L +L  L    N     +   L   S LE+++   N+ +   
Sbjct: 112 FLDNNELRDTDSLI---HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT--N 164

Query: 249 SVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTN 284
           +   +RLK + W++L               + +   
Sbjct: 165 TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 1e-17
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 48/231 (20%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+VYK      G   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 697 NLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQL---EVCSLSVIQRLN 751
           N++K+  V   +           +V+E +    L++ L      L      S  ++Q L 
Sbjct: 61  NIVKLYDVIHTKKRLV-------LVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL- 110

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                 + I Y H      ++H DLKP N+L++++    ++DFGLA              
Sbjct: 111 ------NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA-------------- 147

Query: 812 RSISIGIKG------TVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           R+  I ++       T+ Y AP+  MG ++ S   D++S G +  E+    
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)

Query: 633 ELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-----EC 687
           ++      +   + +GEG    VYK         VA+K I L  +  +K  +      E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 688 KALRNIRHRNLIKIITVCSGRD--FKGADFKAIVYEFMQNGSLEEWLHHSNDQL---EVC 742
           K L+ + H N+I ++     +           +V++FM+   LE  +  ++  L    + 
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNIS-------LVFDFMET-DLEVIIKDNSLVLTPSHIK 115

Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
           +  ++  L         +EYLH +    I+H DLKP+N+LLD++ V  ++DFGLAK   +
Sbjct: 116 AY-MLMTL-------QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

Query: 803 HNPD--TIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
            N      V TR           Y APE   G R   +  D+++ G +L EL  R 
Sbjct: 165 PNRAYTHQVVTR----------WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 29/248 (11%)

Query: 621 PIEQQFLVDSYAELSKATDNFSSAN-KIGEGGSGIVYKG--FLGENGTEVAVKVINLKQK 677
            ++  F V   +E  +  D F     K+G G  G VYK     G++  + A+K I  +  
Sbjct: 2   KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGT 59

Query: 678 GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA-IVYEFMQNGSLEEWLHHSN 736
           G S S   E   LR ++H N+I +  V        AD K  +++++ ++  L   +    
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSH----ADRKVWLLFDYAEH-DLWHIIKFHR 114

Query: 737 DQLEVCSLSVIQRLNI---AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH--- 790
                     + R  +      +   I YLH      ++H DLKP+N+L+  +       
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171

Query: 791 -VSDFGLA-KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGIL 847
            ++D G A  F S   P   ++   +      T  Y APE  +G R  +   D+++ G +
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVV------TFWYRAPELLLGARHYTKAIDIWAIGCI 225

Query: 848 LLELFTRK 855
             EL T +
Sbjct: 226 FAELLTSE 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA----ECKALRNIRHRNLIKII 702
           +GEG  G V      +   +VA+K I+ +Q             E   L+ +RH ++IK+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 703 TVCSGRDF--------KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
            V +             G  F  IV    +   + E         E       Q++    
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV----EKKRMTED--------EGRRF--FQQI---- 117

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
               AIEY H +    IVH DLKP N+LLD +L   ++DFGL+  ++       ++T   
Sbjct: 118 --ICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSC- 168

Query: 815 SIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTD 859
                G+  Y APE   G+  A  + DV+S GI+L  +   + P D
Sbjct: 169 -----GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 46/225 (20%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +D F   +++G G + IVY+          A+KV+        K    E   L  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +IK+  +     F+     ++V E +  G L + +       E  +   ++       + 
Sbjct: 110 IIKLKEI-----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK------QIL 158

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLL-----DQDLVSHVSDFGLAKFLSNHNP-DTIVET 811
            A+ YLH   E  IVH DLKP N+L      D  L   ++DFGL+K + +     T+   
Sbjct: 159 EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK--IADFGLSKIVEHQVLMKTVC-- 211

Query: 812 RSISIGIKGTVGYVAPE----YGMGREASMKGDVYSFG----ILL 848
                   GT GY APE       G E     D++S G    ILL
Sbjct: 212 --------GTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
             +++    IG G  G+VY+  L ++G  VA+K +   ++  ++    E + +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 698 LIKIITV-CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++++     S  + K   +  +V +++   ++     H +   +   +  ++       +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK--LYMYQL 165

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV---SDFGLAKFLSNHNPDT--IVET 811
             ++ Y+H +    I H D+KP N+LLD D  + V    DFG AK L    P+   I  +
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYIC-S 219

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           R           Y APE   G  + +   DV+S G +L EL   +
Sbjct: 220 RY----------YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 49/225 (21%), Positives = 81/225 (36%), Gaps = 57/225 (25%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-------ECKALRNIR----H 695
           +G+GG G V+ G    +  +VA+KVI  + +    S ++       E   L  +     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 696 RNLIKIITVCSGRD---------FKGAD-FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
             +I+++     ++             D F  I     + G L E               
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGE---------GPSRCF 144

Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHN 804
             Q       V +AI++ H      +VH D+K  N+L+D     + + DFG         
Sbjct: 145 FGQ-------VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG----SGALL 190

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
            D             GT  Y  PE+    +  ++   V+S GILL
Sbjct: 191 HDEPYTDFD------GTRVYSPPEWISRHQYHALPATVWSLGILL 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 54/257 (21%), Positives = 96/257 (37%), Gaps = 61/257 (23%)

Query: 609 RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVA 668
           ++       + L I++  ++D Y   S+          +G G +G V + F      + A
Sbjct: 41  QQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFA 91

Query: 669 VKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKA-IVYEFMQNG 726
           +K++      A +    E +      +  ++++I+ V    +         IV E +  G
Sbjct: 92  LKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY--ENLYAGRKCLLIVMECLDGG 144

Query: 727 SLEEWLHHSNDQLEVCSLSVIQRL-----------NIAIDVASAIEYLHHYCEPSIVHGD 775
            L                S IQ              I   +  AI+YLH     +I H D
Sbjct: 145 EL---------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRD 186

Query: 776 LKPSNVLL---DQDLVSHVSDFGLAKFLSNHNP-DTIVETRSISIGIKGTVGYVAPEYGM 831
           +KP N+L      + +  ++DFG AK  ++HN   T             T  YVAPE   
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----------YTPYYVAPEVLG 236

Query: 832 GREASMKGDVYSFGILL 848
             +     D++S G+++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 28/218 (12%), Positives = 58/218 (26%), Gaps = 54/218 (24%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKS---FVAECKALRNIRHRNLIKII 702
             G       ++        +VA+  ++ +           ++    L  I    + +++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
            V             +V E+++ GSL+E    S         S +  +     +A+A + 
Sbjct: 98  DV--VHT---RAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADA 144

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
            H      +      PS V +  D        G                           
Sbjct: 145 AH---RAGVALSIDHPSRVRVSID--------GDVVL--------------------AYP 173

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA 860
             +         A+ + D+   G  L  L   + P   
Sbjct: 174 ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPE 204

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 57/224 (25%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-------ECKALRNIRHR--N 697
           +G GG G VY G    +   VA+K +  K + +    +        E   L+ +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 698 LIKIITVCSGRDFKGADFKAIVYEF-----------MQNGSLEEWLHHSNDQLEVCSLSV 746
           +I+++       F+  D   ++ E             + G+L+E         E+     
Sbjct: 110 VIRLLDW-----FERPDSFVLILERPEPVQDLFDFITERGALQE---------ELARSFF 155

Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNP 805
            Q       V  A+ + H+     ++H D+K  N+L+D +     + DFG          
Sbjct: 156 WQ-------VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG----SGALLK 201

Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILL 848
           DT+           GT  Y  PE+            V+S GILL
Sbjct: 202 DTVYTDFD------GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 36/227 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
              + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 696 RNLIKIITV-CSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLEVCSLSVIQR 749
           +N+I ++ V    +  +  +F+ +  V E M     +  L          E  S  + Q 
Sbjct: 84  KNIIGLLNVFTPQKSLE--EFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQM 136

Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI- 808
           L         I++LH      I+H DLKPSN+++  D    + DFGLA+        T  
Sbjct: 137 LC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
           V TR           Y APE  +G       D++S G ++ E+    
Sbjct: 187 VVTRY----------YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 84.0 bits (207), Expect = 7e-17
 Identities = 44/219 (20%), Positives = 78/219 (35%), Gaps = 25/219 (11%)

Query: 328 PPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTY 387
             +      L    +   + T  +  E+     LQ+L+ +  +   +I   +  L  L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 388 LKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLY-------LELG 440
            K  L                L  ++      +  L  + L   ++          L L 
Sbjct: 401 EKETLQYFS-----------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449

Query: 441 NNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLL 500
           +  L  ++   +  L  +  LDLS N+    +P  L+A   LE L  S NA   ++  + 
Sbjct: 450 HKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGV- 504

Query: 501 DSLQSIKELDFSSNNLNG-QIPEYLENLSFLEFLNLSYN 538
            +L  ++EL   +N L      + L +   L  LNL  N
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.1 bits (176), Expect = 3e-13
 Identities = 34/216 (15%), Positives = 71/216 (32%), Gaps = 19/216 (8%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
               L     +    T  +   L +   L+ +E         + +    L  L +    +
Sbjct: 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISG 325
                   + L  ++ +      +                     + ++ + +    +  
Sbjct: 406 QYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDL-- 453

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLL 385
           T+   +  L  +  L +  N+L   +PP +  L  L+ L    N L+ ++   + NL  L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 510

Query: 386 TYLKLGLNNLEGNIPS--SLGNCTNLLGLNISHNKL 419
             L L  N L+    +   L +C  L+ LN+  N L
Sbjct: 511 QELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 7e-13
 Identities = 40/265 (15%), Positives = 78/265 (29%), Gaps = 33/265 (12%)

Query: 303 PHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT------IDTNQLTGTIPPEIG 356
           P +V +   T+  +            P+ RN  S  WL       ++      T      
Sbjct: 264 PLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWT 323

Query: 357 ELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
              + ++  L                  L   +L +      + S L +C  L  L   +
Sbjct: 324 GSDSQKECVLL-KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPEN 381

Query: 417 NKLIGTLPRQILRITTLSLYLELGNNLLN--------------------GSLPPEVGNLK 456
              + T+   +  +  L    E                                      
Sbjct: 382 KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL 516
           ++  L L+    +  +   L     + +L++S N    ++P  L +L+ ++ L  S N L
Sbjct: 442 DVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498

Query: 517 NGQIPEYLENLSFLEFLNLSYNHFE 541
              +   + NL  L+ L L  N  +
Sbjct: 499 E-NVDG-VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.5 bits (138), Expect = 1e-08
 Identities = 26/121 (21%), Positives = 54/121 (44%), Gaps = 8/121 (6%)

Query: 43  RYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVG 102
           R +++A       + H + +L+ +  L LS+N    A+P  L++   L  L A  N L  
Sbjct: 444 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499

Query: 103 EIPADIGSLFKLERLSIFQNHITGQLPA--SIGNLSSLRVIDVRENRLWGRIDSLGQLKS 160
            +   + +L +L+ L +  N +  Q  A   + +   L +++++ N L        +L  
Sbjct: 500 NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 557

Query: 161 L 161
           +
Sbjct: 558 M 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.1 bits (137), Expect = 2e-08
 Identities = 27/148 (18%), Positives = 57/148 (38%), Gaps = 13/148 (8%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
            +            +  V  L L ++ +  T+  ++  L  + +++++ N     +P  +
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPAL 482

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPA--DIGSLFKLERLS 118
             L  LE L  S+N+    +   +++   L EL    NN + +  A   + S  +L  L+
Sbjct: 483 AALRCLEVLQASDNALE-NVD-GVANLPRLQELLL-CNNRLQQSAAIQPLVSCPRLVLLN 539

Query: 119 IFQNHITGQLPASIGN----LSSLRVID 142
           +  N +  Q           L S+  I 
Sbjct: 540 LQGNSLC-QEEGIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.8 bits (118), Expect = 3e-06
 Identities = 30/173 (17%), Positives = 58/173 (33%), Gaps = 13/173 (7%)

Query: 57  PHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIEL--------SADSNNLVGEIPADI 108
           P     L+++  L++            L   S L  +            +  + E     
Sbjct: 379 PENKWCLLTII-LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437

Query: 109 GSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAF 168
                +  L +    +T  +   +  L  +  +D+  NRL     +L  L+ L +L  + 
Sbjct: 438 MEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASD 495

Query: 169 NQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFT 221
           N    +    + N+  L+ + L  NR   S  +   V+ P L  L    N+  
Sbjct: 496 NALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 43/215 (20%), Positives = 84/215 (39%), Gaps = 35/215 (16%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHR-NLIKII 702
           ++G G   +V +      G E A K +  +++G       + E   L   +    +I + 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL--EVCSLSVIQRLNIAIDVASAI 760
            V     ++      ++ E+   G +         ++  E   + +I+       +   +
Sbjct: 96  EV-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK------QILEGV 144

Query: 761 EYLHHYCEPSIVHGDLKPSNVLL-DQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISIG 817
            YLH   + +IVH DLKP N+LL     +  +   DFG+++ +        +        
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELRE------ 192

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFG----ILL 848
           I GT  Y+APE       +   D+++ G    +LL
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 42/232 (18%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHR 696
              +++ + IGEG  G+V   +   N   VA+K I+  +     +  + E K L   RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 697 NLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLEV-CSLSVIQRL 750
           N+I I  +      +    K +  V + M     E  L+    +           + Q L
Sbjct: 86  NIIGINDIIRAPTIE--QMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL 138

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
                    ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   
Sbjct: 139 R-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 811 TRSISIGIKGTVGYV------APEYGMGREASMKG-DVYSFGILLLELFTRK 855
           T            YV      APE  +  +   K  D++S G +L E+ + +
Sbjct: 189 T-----------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 31/225 (13%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
              +++   IG G  G+V++  L E+  EVA+K +   ++  ++    E + +R ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKHPN 93

Query: 698 LIKIITV-CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           ++ +     S  D K   F  +V E++   ++     H     +   + +I+       +
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK--LYMYQL 150

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV---SDFGLAKFLSNHNPDT--IVET 811
             ++ Y+H      I H D+KP N+LLD    S V    DFG AK L    P+   I  +
Sbjct: 151 LRSLAYIHSI---GICHRDIKPQNLLLDPP--SGVLKLIDFGSAKILIAGEPNVSYIC-S 204

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           R           Y APE   G    +   D++S G ++ EL   +
Sbjct: 205 RY----------YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 29/221 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV----AECKALRNIR 694
           ++F     +GEG    V          E A+K++  K+    ++ V     E   +  + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLD 88

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H   +K+    +   F+  +       + +NG L +++       E C+     R   A 
Sbjct: 89  HPFFVKLY--FT---FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFYTA- 137

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETR 812
           ++ SA+EYLH      I+H DLKP N+LL++D   H+  +DFG AK LS  +        
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQA--RAN 190

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           S      GT  YV+PE    + A    D+++ G ++ +L  
Sbjct: 191 SFV----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 47/239 (19%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
              +     +G GG+G+V+     +    VA+K I L    + K  + E K +R + H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 698 LIKIITV-------CSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLEV-CSL 744
           ++K+  +        +       +  ++  V E+M     E  L         LE    L
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARL 124

Query: 745 SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDFGLAKFLSNH 803
            + Q L         ++Y+H     +++H DLKP+N+ ++ +DLV  + DFGLA+ +  H
Sbjct: 125 FMYQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 804 NPDTIVETRSISIGIKGTVGYV------APEYGMG-REASMKGDVYSFGILLLELFTRK 855
                  +             +      +P   +     +   D+++ G +  E+ T K
Sbjct: 175 YSHKGHLS-----------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.0 bits (200), Expect = 4e-16
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
              + +   IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 696 RNLIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLH---HSNDQLEVCSLSVIQ 748
           +N+I ++ V     +  +F+  D   +V E M     +  L          E  S  + Q
Sbjct: 121 KNIISLLNVFTPQKTLEEFQ--DV-YLVMELM-----DANLCQVIQMELDHERMSYLLYQ 172

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT- 807
            L         I++LH      I+H DLKPSN+++  D    + DFGLA+        T 
Sbjct: 173 MLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            V TR           Y APE  +G       D++S G ++ E+   K
Sbjct: 223 YVVTRY----------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.9 bits (197), Expect = 9e-16
 Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 57/290 (19%)

Query: 609 RRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVA 668
           +  S++  ++M      + +          D +   + IG G  G V + +       VA
Sbjct: 32  QHHSSKPTASMPRPHSDWQIP---------DRYEIRHLIGTGSYGHVCEAYDKLEKRVVA 82

Query: 669 VKVINL--KQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI--VYEFMQ 724
           +K I    +     K  + E   L  + H +++K++ +   +D +   F  +  V E   
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE--KFDELYVVLEIA- 139

Query: 725 NGSLEEWLH---HSNDQLE---VCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
               +        +   L    + +L +   L         ++Y+H      I+H DLKP
Sbjct: 140 ----DSDFKKLFRTPVYLTELHIKTL-LYNLLV-------GVKYVH---SAGILHRDLKP 184

Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV-------------GYV 825
           +N L++QD    V DFGLA+ +            S        V             G+V
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244

Query: 826 ------APEYGMGREASMKG-DVYSFGILLLELFTRKRPTDAMFNEGLTL 868
                 APE  + +E   +  DV+S G +  EL    +   A   +   L
Sbjct: 245 VTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 43/236 (18%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA-----------E 686
              ++    I  G  G V  G +   G  VA+K +           +            E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 687 CKALRNIRHRNLIK---IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEV-- 741
            + L +  H N++    I                +V E M+   L + +H     +    
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKL---YLVTELMRT-DLAQVIHDQRIVISPQH 135

Query: 742 CSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLS 801
               +   L         +  LH   E  +VH DL P N+LL  +    + DF LA+  +
Sbjct: 136 IQYFMYHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 802 NHNPDTI-VETRSISIGIKGTVGYVAPEYGMGREASMKG-DVYSFGILLLELFTRK 855
                T  V  R           Y APE  M  +   K  D++S G ++ E+F RK
Sbjct: 186 ADANKTHYVTHRW----------YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 37/233 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA-SKSFVAECKALRNIRHR 696
           + +F   + +GEG  G+V        G  VA+K I    K   +   + E K L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69

Query: 697 NLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLHH--SNDQLE---VCSLSVIQR 749
           N+I I  +     F+  +F  +  + E M     +  LH   S   L    +    + Q 
Sbjct: 70  NIITIFNIQRPDSFE--NFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYF-IYQT 121

Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L        A++ LH     +++H DLKPSN+L++ +    V DFGLA+ +     D   
Sbjct: 122 LR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 810 ETRSISIGIKGTVGYV------APEYGMGREASMKG-DVYSFGILLLELFTRK 855
            T   S      V +V      APE  +      +  DV+S G +L ELF R+
Sbjct: 172 PTGQQSG----MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 23/109 (21%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +  A++YL +     I+H D+KP N+LLD+    H++DF +A  L            +++
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-----ITTMA 175

Query: 816 IGIKGTVGYVAPE-------YGMGREASMKGDVYSFGILLLELFTRKRP 857
               GT  Y+APE        G         D +S G+   EL   +RP
Sbjct: 176 ----GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 35/226 (15%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
              + S   +G G  G V       +G +VA+K ++   + +  +K    E   L++++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 696 RNLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLEVCSLSVIQRL 750
            N+I ++ V +       +F     V  FM     +  L          E     V Q L
Sbjct: 83  ENVIGLLDVFT-PASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQML 136

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
                    ++Y+H      +VH DLKP N+ +++D    + DFGLA+          V 
Sbjct: 137 K-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-YVV 185

Query: 811 TRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           TR           Y APE  +     +   D++S G ++ E+ T K
Sbjct: 186 TRW----------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 57/200 (28%), Positives = 78/200 (39%), Gaps = 16/200 (8%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN---NLEGNIPS 401
            +LT  IP  I    + ++LDL  N L      +   LT L  L L  N    L   I  
Sbjct: 26  KKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK 82

Query: 402 SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMR 460
            L    NL  L ++ NKL   LP  +         L L  N L  SLPP V  +L  L  
Sbjct: 83  EL---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137

Query: 461 LDLSGNKFSGEIPATL-SACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLNG 518
           L L  N+    +P  +     +L+ L +  N     +P    D L  +K L   +N L  
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 519 QIPEYLENLSFLEFLNLSYN 538
                 ++L  L+ L L  N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 15/191 (7%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
           +N+ +  K++ +  N++S ++P +    L  L  L ++ N+L  T+P  I  EL NL+ L
Sbjct: 33  SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90

Query: 365 DLDRNFLQGSIPSSL-GNLTLLTYLKLGLN---NLEGNIPSSLGNCTNLLGLNISHNKLI 420
            +  N LQ ++P  +   L  L  L+L  N   +L   +  SL   T L  L++ +N+L 
Sbjct: 91  WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL---TKLTYLSLGYNEL- 145

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEIPATLSAC 479
            +LP+ +    T    L L NN L   +P      L  L  L L  N+          + 
Sbjct: 146 QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204

Query: 480 ANLEYLNISGN 490
             L+ L +  N
Sbjct: 205 EKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 14/185 (7%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNH 123
             ++L L +N  S          + L  L  + N L   +PA I   L  LE L +  N 
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96

Query: 124 ITGQLPASI-GNLSSLRVIDVRENRL----WGRIDSLGQLKSLTLLSVAFNQFSGMIPPS 178
           +   LP  +   L +L  + +  N+L        DSL +L  L+L     N+    +P  
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY---NELQ-SLPKG 151

Query: 179 IF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMI 237
           +F  ++SL+ + L  N+    +P      L  L+ L+ + N        +  +   L+M+
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210

Query: 238 EFSKN 242
           +  +N
Sbjct: 211 QLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 54/239 (22%), Positives = 80/239 (33%), Gaps = 84/239 (35%)

Query: 157 QLKSLTLLSVAFNQFSGMIPPSIFN-ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRT 215
           +L  L LL +  N+    +P  IF  + +LE + +++N+   +LP+     L +L ELR 
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 216 NANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANE 275
           + N        SL                   V   F  L  L +L+LG N L +     
Sbjct: 117 DRNQLK-----SLPP----------------RV---FDSLTKLTYLSLGYNELQS----- 147

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA 335
                                     LP  V                           L 
Sbjct: 148 --------------------------LPKGV------------------------FDKLT 157

Query: 336 SLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
           SL  L +  NQL   +P     +LT L+ L LD N L+     +  +L  L  L+L  N
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 40/229 (17%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
              +     +G G  G V     G  G +VA+K +    + +  +K    E + L+++RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 696 RNLIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLHH--SNDQL--EVCSLSVI 747
            N+I ++ V     +  DF   DF  +V  FM        L     +++L  +     V 
Sbjct: 84  ENVIGLLDVFTPDETLDDFT--DF-YLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVY 135

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
           Q L         + Y+H      I+H DLKP N+ +++D    + DFGLA+   +     
Sbjct: 136 QMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185

Query: 808 IVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           +V TR           Y APE  +     +   D++S G ++ E+ T K
Sbjct: 186 VV-TRW----------YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 647 IGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR---NLIKIIT 703
           IG+G  G V K +  +    VA+K++  +++   ++   E + L ++R +   N + +I 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVIH 163

Query: 704 VCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAIDVASAIEY 762
           +     F+      + +E +   +L E +  +  Q     SL ++++   A  +   ++ 
Sbjct: 164 MLENFTFRN--HICMTFELLSM-NLYELIKKNKFQGF---SLPLVRK--FAHSILQCLDA 215

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSH--VSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           LH   +  I+H DLKP N+LL Q   S   V DFG + +  +    T +++R        
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYTYIQSRF------- 264

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
              Y APE  +G    M  D++S G +L EL T
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.5 bits (186), Expect = 9e-15
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 23/218 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI-KIITV 704
           KIG G  G +  G        VA+K+     K  +     E +  + +   + I ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY-- 71

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
             G       + A+V E +   SLE+     +      SL  +  L IAI + S +EY+H
Sbjct: 72  YFGPC---GKYNAMVLE-LLGPSLEDLFDLCDRTF---SLKTV--LMIAIQLISRMEYVH 122

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVS-----HVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                ++++ D+KP N L+ +         H+ DF LAK   +      +  R     + 
Sbjct: 123 SK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE-HKSLT 178

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  Y++    +G+E S + D+ + G + +       P
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 37/212 (17%), Positives = 75/212 (35%), Gaps = 17/212 (8%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQ 346
            + L            H+ +NL + I +I +  +     +      NL+ +  + I   +
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPN-ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 347 LTGTIPPEI-GELTNLQQLDLDRNFLQGSIP--SSLGNLTLLTYLKLGLNNLEGNIPS-S 402
               I P+   EL  L+ L +    L+   P  + + +  +   L++  N    +IP  +
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 403 LGNCTNLLG-LNISHNKLIGTLPRQILRITTL-SLYLELGNNLLNGSLPPEV--GNLKNL 458
                N    L + +N    ++       T L ++YL   N  L   +  +   G     
Sbjct: 151 FQGLCNETLTLKLYNNG-FTSVQGYAFNGTKLDAVYL-NKNKYLT-VIDKDAFGGVYSGP 207

Query: 459 MRLDLSGNKFSGEIPATLSACANLEYLNISGN 490
             LD+S    +  +P+      +L+ L     
Sbjct: 208 SLLDVSQTSVT-ALPS--KGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 36/208 (17%), Positives = 76/208 (36%), Gaps = 17/208 (8%)

Query: 340 LTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGN 398
             +    +   IP       + Q L L    L+ +IPS +  NL  ++ + + ++     
Sbjct: 16  FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70

Query: 399 IPS-SLGNCTNLLGLNISHNKLIGTLPRQILR-ITTLSLYLELGNNLLNGSLPPE--VGN 454
           + S S  N + +  + I + + +  +    L+ +  L  +L + N  L    P    V +
Sbjct: 71  LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK-FLGIFNTGLK-MFPDLTKVYS 128

Query: 455 LKNLMRLDLSGNKFSGEIPATL--SACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
                 L+++ N +   IP       C     L +  N F+ S+     +   +  +  +
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187

Query: 513 SNNLNGQIPEY-LENL-SFLEFLNLSYN 538
            N     I +     + S    L++S  
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQT 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 31/180 (17%), Positives = 71/180 (39%), Gaps = 10/180 (5%)

Query: 63  LISLERLILSNNSFSGAIPANL-SSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIF 120
           L ++ R+ +S +     + ++   + S +  +   +   +  I  D    L  L+ L IF
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 121 QNHITGQLPA--SIGNLSSLRVIDVRENRLWGRI--DSLGQLKSLTL-LSVAFNQFSGMI 175
              +    P    + +     ++++ +N     I  ++   L + TL L +  N F+  +
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SV 171

Query: 176 PPSIFNISSLEVISLSENRFTGSLPVDTGVNLPS-LRELRTNANNFTGFIPVSLSNASSL 234
               FN + L+ + L++N++   +  D    + S    L  +  + T      L +   L
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 36/309 (11%), Positives = 83/309 (26%), Gaps = 89/309 (28%)

Query: 86  SCSNLIELSADSNNL--VGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDV 143
            C    +      ++  +  +P         + L + + H+      +  NL ++  I V
Sbjct: 9   ECHQEEDFRVTCKDIQRIPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYV 62

Query: 144 RENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVD 202
             +           L+               +    F N+S +  I +   R    +  D
Sbjct: 63  SID---------VTLQQ--------------LESHSFYNLSKVTHIEIRNTRNLTYIDPD 99

Query: 203 TGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLN 262
               LP L+ L         F  ++                               + L 
Sbjct: 100 ALKELPLLKFLGIFNTGLKMFPDLTK-----------------------VYSTDIFFILE 136

Query: 263 LGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNR 322
           +  N                     +  +            ++   L +    + +  N 
Sbjct: 137 ITDNP-------------------YMTSIP----------VNAFQGLCNETLTLKLYNNG 167

Query: 323 ISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI--GELTNLQQLDLDRNFLQGSIPS-SL 379
            + ++     N   L+ + ++ N+    I  +   G  +    LD+ +  +  ++PS  L
Sbjct: 168 FT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGL 225

Query: 380 GNLTLLTYL 388
            +L  L   
Sbjct: 226 EHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 38/202 (18%), Positives = 59/202 (29%), Gaps = 42/202 (20%)

Query: 359 TNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPS-SLGNCTNLLGLNISHN 417
              +   +    +Q  IPS   +      LKL   +L   IPS +  N  N+  + +S +
Sbjct: 11  HQEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 418 KLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA-TL 476
             +  L                              NL  +  +++   +    I    L
Sbjct: 66  VTLQQLESHSFY------------------------NLSKVTHIEIRNTRNLTYIDPDAL 101

Query: 477 SACANLEYLNISGNAFSGSIPLL--LDSLQSIKELDFSSNNLNGQIPE----YLENLSFL 530
                L++L I         P L  + S      L+ + N     IP      L N    
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--T 158

Query: 531 EFLNLSYNHFEGEVPMKGVFNN 552
             L L  N F   V     FN 
Sbjct: 159 LTLKLYNNGFT-SVQ-GYAFNG 178

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 21/216 (9%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI-KIITV 704
           KIG G  G +Y G     G EVA+K+  +K K        E K  + ++    I  I   
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIR-- 71

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
             G +    D+  +V E +   SLE+  +  + +    SL  +  L +A  + S IEY+H
Sbjct: 72  WCGAE---GDYNVMVME-LLGPSLEDLFNFCSRKF---SLKTV--LLLADQMISRIEYIH 122

Query: 765 HYCEPSIVHGDLKPSNVLLDQDL---VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
                + +H D+KP N L+       + ++ DFGLAK   +      +  R  +  + GT
Sbjct: 123 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE-NKNLTGT 178

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             Y +    +G E S + D+ S G +L+       P
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 32/224 (14%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           KIG GG G++Y  F      + A  V+ ++ +     F  E K  + +  ++ IK     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102

Query: 706 SGRDFKG--------------ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
              D+ G                ++ +V E      L++ +   N        S +  L 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQK-ISGQNGTF---KKSTV--LQ 155

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAK-FLSNHNPDT 807
           + I +   +EY+H   E   VHGD+K +N+LL   + D V +++D+GL+  +  N N   
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQ 211

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
             E         GT+ + + +   G   S + DV   G  +L  
Sbjct: 212 YQENPRKG--HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 55/241 (22%), Positives = 91/241 (37%), Gaps = 43/241 (17%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
            DN+   + IG G  G VY  +       VA+K +N   +     K  + E   L  ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 696 RNLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLE---VCSLSVI 747
             +I++  +    D     F  +  V E       +  L     +   L    + ++ + 
Sbjct: 85  DYIIRLYDLIIPDDLL--KFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTI-LY 136

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
             L           ++H   E  I+H DLKP+N LL+QD    V DFGLA+ +++     
Sbjct: 137 NLLL-------GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 808 IVETRSISIGIKGTV--------GYV------APEYGMGREASMKG-DVYSFGILLLELF 852
           IV     +                +V      APE  + +E   K  D++S G +  EL 
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 853 T 853
            
Sbjct: 247 N 247

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINL--KQKGASKSFVAECKALRNIRH 695
            + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 696 RNLIKIITV----CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            N+I ++ V     S  +F   D   +V   M    L   +       +     + Q L 
Sbjct: 88  ENVIGLLDVFTPARSLEEFN--DV-YLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR 143

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
                   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+  ++     +  T
Sbjct: 144 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-T 192

Query: 812 RSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRK 855
           R           Y APE  +     +   D++S G ++ EL T +
Sbjct: 193 RW----------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 53/359 (14%), Positives = 110/359 (30%), Gaps = 52/359 (14%)

Query: 232 SSLEMIEFSKNQFS-GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLER 290
             ++ ++    + S    +     L+    + L    L      ++   + L     L  
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAE 60

Query: 291 LYFNRNRFEGE----LPHSVANLSSTIKQIAMGRNRISGT----IPPEIRNLASLNWLTI 342
           L    N         +   +   S  I+++++    ++G     +   +R L +L  L +
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 343 DTNQLTGTIPPEIGEL-----TNLQQLDLDRNFLQ----GSIPSSLGNLTLLTYLKLGLN 393
             N L       + E        L++L L+   L       + S L        L +  N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 394 NLEG----NIPSSLGNCT-NLLGLNISHNKL-------IGTLPRQILRITTLSLYLELGN 441
           ++       +   L +    L  L +    +       +  +      +  L+L     N
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG---SN 237

Query: 442 NLLNGSLPPEVGNLKN----LMRLDLSGNKFSGE----IPATLSACANLEYLNISGNAFS 493
            L +  +      L +    L  L +     + +    +   L A  +L+ L+++GN   
Sbjct: 238 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297

Query: 494 GS-----IPLLLDSLQSIKELDFSSNNLNGQ----IPEYLENLSFLEFLNLSYNHFEGE 543
                     LL+    ++ L   S +            L    FL  L +S N  E  
Sbjct: 298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 75.4 bits (186), Expect = 3e-14
 Identities = 70/456 (15%), Positives = 140/456 (30%), Gaps = 97/456 (21%)

Query: 136 SSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFNQFSGM----IPPSIFNISSLEVIS 189
             ++ +D++   L      + L  L+   ++ +     +      I  ++    +L  ++
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 190 LSENRFTGSLPVDTGVNL---------PSLRELRTNANNFT----GFIPVSLSNASSLEM 236
           L  N        D GV+            +++L       T    G +  +L    +L+ 
Sbjct: 63  LRSNELG-----DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117

Query: 237 IEFSKNQFS-GGVSVDFSRLKN----LYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
           +  S N     G+ +    L +    L  L L   +L   +   L   ++L      + L
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL--ASVLRAKPDFKEL 175

Query: 292 YFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTI 351
             + N         V  L   +K                  +   L  L +++  +T   
Sbjct: 176 TVSNNDINEA---GVRVLCQGLKD-----------------SPCQLEALKLESCGVTSDN 215

Query: 352 PPEIGEL----TNLQQLDLDRNFLQGS-----IPSSLGNLTLLTYLKLGLNNLE----GN 398
             ++  +     +L++L L  N L         P  L   + L  L +    +     G+
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275

Query: 399 IPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNL 458
           +   L    +L  L+++ N+L                   L   LL             L
Sbjct: 276 LCRVLRAKESLKELSLAGNEL------------GDEGARLLCETLLE--------PGCQL 315

Query: 459 MRLDLSGNKFSGE----IPATLSACANLEYLNISGNAFSGS-IPLLLDSLQS----IKEL 509
             L +    F+        + L+    L  L IS N    + +  L   L      ++ L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 510 DFSSNNLNGQ----IPEYLENLSFLEFLNLSYNHFE 541
             +  +++      +   L     L  L+LS N   
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.8 bits (174), Expect = 8e-13
 Identities = 82/538 (15%), Positives = 163/538 (30%), Gaps = 126/538 (23%)

Query: 42  LRYINIASNGFNGE-IPHQIGRLISLERLILSNNSFS----GAIPANLSSCSNLIELSAD 96
           ++ ++I     +       +  L   + + L +   +      I + L     L EL+  
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 97  SNNLVGEIPADIGSLFK-----LERLSIFQNHITGQ----LPASIGNLSSLRVIDVRENR 147
           SN L       +    +     +++LS+    +TG     L +++  L +L+ + + +N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 148 LWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNL 207
           L            L LL                    LE + L     +           
Sbjct: 125 L--------GDAGLQLLCEGLLD----------PQCRLEKLQLEYCSLS-----AASC-- 159

Query: 208 PSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSG-GVSVDFSRLK----NLYWLN 262
                           +   L      + +  S N  +  GV V    LK     L  L 
Sbjct: 160 --------------EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 263 LGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE----LPHSVANLSSTIKQIAM 318
           L    + +    +L    ++ + + L  L    N+        L   + + SS ++ + +
Sbjct: 206 LESCGVTSDNCRDL--CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 319 GRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSS 378
               I+        +L  +                 +    +L++L L  N L       
Sbjct: 264 WECGIT---AKGCGDLCRV-----------------LRAKESLKELSLAGNELGDEGARL 303

Query: 379 LGNL-----TLLTYLKLGLNNLEG----NIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
           L          L  L +   +       +  S L     LL L IS+N+L      +   
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL------EDAG 357

Query: 430 ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE----IPATLSACANLEYL 485
           +  L   L                    L  L L+    S      + ATL A  +L  L
Sbjct: 358 VRELCQGLGQPG--------------SVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403

Query: 486 NISGNAFSGS-IPLLLDSLQS----IKELDFSSNNLNGQ----IPEYLENLSFLEFLN 534
           ++S N    + I  L++S++     +++L       + +    +    ++   L  ++
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR---NLIKI 701
           + IG+G  G V K +       VA+K+I  K+   +++ + E + L  +          I
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAIDVASAI 760
           + +     F+      +V+E +   +L + L ++N + +   SL++ ++   A  + +A+
Sbjct: 119 VHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFRGV---SLNLTRK--FAQQMCTAL 170

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSH--VSDFGLAKFLSNHNPDTIVETRSISIGI 818
            +L    E SI+H DLKP N+LL     S   + DFG +  L        +++R      
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQSRF----- 223

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
                Y +PE  +G    +  D++S G +L+E+ T
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 75.6 bits (186), Expect = 3e-14
 Identities = 63/271 (23%), Positives = 103/271 (38%), Gaps = 40/271 (14%)

Query: 623 EQQFLVDSYAELSKAT-DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKG 678
             +FL   + E      D F     +G GG G V+   +   G   A K +N   LK++ 
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227

Query: 679 ASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ 738
             +  + E K L  +  R +     V     F+      +V   M  G +   +++ ++ 
Sbjct: 228 GYQGAMVEKKILAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282

Query: 739 LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGL 796
                         A  + S +E+LH   + +I++ DLKP NVLLD D   +V  SD GL
Sbjct: 283 NPGFQEPRA-IFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGL 335

Query: 797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT--- 853
           A         T  +  +      GT G++APE  +G E     D ++ G+ L E+     
Sbjct: 336 AV--ELKAGQTKTKGYA------GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

Query: 854 ------RKRPTDAMFNEGLTLHD---FSREF 875
                  K     +      L     +  +F
Sbjct: 388 PFRARGEKVENKELKQ--RVLEQAVTYPDKF 416

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 43/229 (18%), Positives = 82/229 (35%), Gaps = 37/229 (16%)

Query: 645 NKIGEGGSGIVYKGF--------LGENGTEVAVKV----------INLKQKGASKSFVAE 686
           +       GI+Y+           G    + ++K+           N  Q+ A    V +
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 687 CKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSV 746
            K L +     +   +    G       ++ +V       SL+  L  S        LS 
Sbjct: 108 WKKLYSTPLLAIPTCM--GFGVH--QDKYRFLVLP-SLGRSLQSALDVSPKH----VLSE 158

Query: 747 IQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAK-FLSN 802
              L +A  +  A+E+LH       VHG++   N+ +   DQ  V  ++ +G A  +  +
Sbjct: 159 RSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPS 214

Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
                 VE        +G + +++ +   G   S + D+ S G  +L+ 
Sbjct: 215 GKHVAYVEGSRSP--HEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 45/218 (20%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI-KIITV 704
           +IGEG  G++++G    N  +VA+K    +    +     E +  + +     I  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVY-- 72

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
             G++        +V + +   SLE+ L     +    S+  +     A  + + ++ +H
Sbjct: 73  YFGQE---GLHNVLVID-LLGPSLEDLLDLCGRKF---SVKTV--AMAAKQMLARVQSIH 123

Query: 765 HYCEPSIVHGDLKPSNVLLDQDL-----VSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
                S+V+ D+KP N L+ +       + +V DFG+ KF  +      +  R     + 
Sbjct: 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE-KKNLS 179

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           GT  Y++    +GRE S + D+ + G + +       P
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.1 bits (182), Expect = 8e-14
 Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 29/239 (12%)

Query: 621 PIEQQFLVDSYAELSKAT-DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQ 676
               +FL   + E    T + F     +G+GG G V    +   G   A K +    +K+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224

Query: 677 KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN 736
           +      + E + L  +  R +     V     ++  D   +V   M  G L+  ++H  
Sbjct: 225 RKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279

Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDF 794
                      + +  A ++   +E LH      IV+ DLKP N+LLD     H+  SD 
Sbjct: 280 QAG----FPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDL 330

Query: 795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           GLA  +           +       GTVGY+APE       +   D ++ G LL E+  
Sbjct: 331 GLAVHVPEGQT-----IKGRV----GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 10/150 (6%)

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHS-NDQLEVCSLSVIQRLNIAIDVASAIEYL 763
               D   +   +    F++  SL +       + L    L++   +  +  VA  +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 764 HHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVG 823
                   +H DL   N+LL +  V  + DFGLA+ +  +     V      + +K    
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLKWM-- 262

Query: 824 YVAPEYGMGREASMKGDVYSFGILLLELFT 853
             APE    R  +++ DV+SFG+LL E+F+
Sbjct: 263 --APETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 54/264 (20%), Positives = 95/264 (35%), Gaps = 76/264 (28%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
           +  +S    +G G  GIV + F  E+G   A+K +    +  ++    E   ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 698 LIKIITV-------------------------------CSGRDFKGADFKA--IVYEFMQ 724
           +IK++                                         +  K   ++ E++ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120

Query: 725 NGSLEEWLH-------HSNDQL--EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGD 775
                + LH        S   +   + S+ + Q          A+ ++H      I H D
Sbjct: 121 ----PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSL---GICHRD 166

Query: 776 LKPSNVLLD-QDLVSHVSDFGLAKFLSNHNPDT--IVETRSISIGIKGTVGYVAPEYGMG 832
           +KP N+L++ +D    + DFG AK L    P    I  +R           Y APE  +G
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRF----------YRAPELMLG 215

Query: 833 -REASMKGDVYSFGILLLELFTRK 855
             E +   D++S G +  EL   K
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILGK 239

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 2e-13
 Identities = 37/204 (18%), Positives = 60/204 (29%), Gaps = 53/204 (25%)

Query: 637 ATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI--------NLKQKGASKSFVAECK 688
            T+      KIGEG  G V++     + T VA+K+I        N   +   +  + E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 689 ALRNI---------RHRNLIKI--ITVCSGR-----------------------DFKGAD 714
             + +         R    I +  +    G                        DF   D
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHG 774
              IV EF   G   E +            S+    +I   + +++            H 
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL-------SSLATAKSILHQLTASLAVAEASLR--FEHR 186

Query: 775 DLKPSNVLLDQDLVSHVSDFGLAK 798
           DL   NVLL +  +  +      K
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 2e-13
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 22/107 (20%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +   +E++H      +V+ DLKP+N+LLD+    HV  SD GLA   S   P   V    
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV---- 351

Query: 814 ISIGIKGTVGYVAPE---YGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT GY+APE    G+  ++S   D +S G +L +L     P
Sbjct: 352 ------GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 49/233 (21%), Positives = 92/233 (39%), Gaps = 35/233 (15%)

Query: 646 KIGEGGSGIVYKGFL-----GENGTEVAVKV-----------INLKQKGASKSFVAECKA 689
            IG+GG G +Y   +       +     VKV           +   Q+ A    + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 690 LRNIRHRNLIKIITVCSGR-DFKGADFKAIVYEFMQNG-SLEEWLHHSNDQLEVCSLSVI 747
            R +++  + K     SG  D  G  ++ ++ +    G  L++    +  +    S   +
Sbjct: 102 TRKLKYLGVPKYW--GSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRF---SRKTV 154

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHN 804
             L +++ +   +EY+H   E   VHGD+K SN+LL   + D V ++ D+GLA       
Sbjct: 155 --LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEG 208

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                          GT+ + + +   G   S +GD+   G  +++  T   P
Sbjct: 209 VHKAYAADP-KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 59/249 (23%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSF--VAECK-ALRNIR 694
              +    K+G+G  GIV+K      G  VAVK I         +F    + +   R I 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIM 60

Query: 695 -------HRNLIKIITVCSGRDFKGADFKAI--VYEFMQNGSLEEWLH---HSNDQLEVC 742
                  H N++ ++ V      +  + + +  V+++M     E  LH    +N      
Sbjct: 61  ILTELSGHENIVNLLNV-----LRADNDRDVYLVFDYM-----ETDLHAVIRANI----- 105

Query: 743 SLSVIQRLNIAIDVASAIEYLHHYCEPS--IVHGDLKPSNVLLDQDLVSHVSDFGLAKFL 800
            L  + +  +   +   I+YLH     S  ++H D+KPSN+LL+ +    V+DFGL++  
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 801 SNHNPDTIVETRSISIGIKGTV-------GYV------APEYGMGREASMKG-DVYSFGI 846
            N    T     SI+   +           YV      APE  +G     KG D++S G 
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219

Query: 847 LLLELFTRK 855
           +L E+   K
Sbjct: 220 ILGEILCGK 228

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 41/193 (21%), Positives = 68/193 (35%), Gaps = 33/193 (17%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI--RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQ 363
            +L S    + +  N +S  +  E     L +L+ L +  N L   I  E    + NL+ 
Sbjct: 35  QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY 92

Query: 364 LDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPS-SLGNCTNLLGLNISHNKLIG 421
           LDL  N L  ++      +L  L  L L  N++   +   +  +   L  L +S N++  
Sbjct: 93  LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS- 149

Query: 422 TLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
             P ++++                     +   L  LM LDLS NK        L     
Sbjct: 150 RFPVELIK---------------------DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188

Query: 482 L--EYLNISGNAF 492
                L +  N  
Sbjct: 189 WVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 42/181 (23%), Positives = 69/181 (38%), Gaps = 25/181 (13%)

Query: 224 IPVSLSNASSLEMIEFSKNQFSG-GVSVDFSRLKNLYWLNLGINNLGT---GAANELDFI 279
           +P SL   S   +++ S N  S        +RL NL+ L L  N+L      A       
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA------- 83

Query: 280 NLLTNCSKLERLYFNRNRFEGELPHSV-ANLSSTIKQIAMGRNRISGTIPPEI-RNLASL 337
                   L  L  + N     L   + ++L + ++ + +  N I   +      ++A L
Sbjct: 84  --FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA-LEVLLLYNNHIV-VVDRNAFEDMAQL 138

Query: 338 NWLTIDTNQLTGTIPPEI----GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
             L +  NQ++   P E+     +L  L  LDL  N L+    + L  L       L L+
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

Query: 394 N 394
           N
Sbjct: 198 N 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 32/166 (19%), Positives = 60/166 (36%), Gaps = 19/166 (11%)

Query: 261 LNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSV-ANLSSTIKQIAMG 319
           L+L  NNL +    E     L    + L  L  + N     +       + + ++ + + 
Sbjct: 44  LDLSHNNL-SRLRAEWTPTRL----TNLHSLLLSHNHLN-FISSEAFVPVPN-LRYLDLS 96

Query: 320 RNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIP- 376
            N +  T+   +  +L +L  L +  N +   +      ++  LQ+L L +N +    P 
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153

Query: 377 ---SSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNL--LGLNISHN 417
                   L  L  L L  N L+    + L         GL + +N
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 12/144 (8%)

Query: 62  RLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSI 119
           RL +L  L+LS+N  +  I +       NL  L   SN+L   +   +   L  LE L +
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 120 FQNHITGQLPASI-GNLSSLRVIDVRENRL----WGRIDSLGQLKSLTLLSVAFNQFSGM 174
           + NHI   +  +   +++ L+ + + +N++       I    +L  L LL ++ N+   +
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178

Query: 175 IPPSIFNISSL--EVISLSENRFT 196
               +  + +     + L  N   
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 38/159 (23%), Positives = 59/159 (37%), Gaps = 17/159 (10%)

Query: 390 LGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLP 449
             L N+  ++PS          L++SHN L            T    L L +N LN  + 
Sbjct: 28  QQLPNVPQSLPSYTAL------LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80

Query: 450 PEV-GNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPL-LLDSLQSI 506
            E    + NL  LDLS N     +     S    LE L +  N     +     + +  +
Sbjct: 81  SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138

Query: 507 KELDFSSNNLNGQIPE----YLENLSFLEFLNLSYNHFE 541
           ++L  S N ++ + P         L  L  L+LS N  +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 26/133 (19%), Positives = 50/133 (37%), Gaps = 11/133 (8%)

Query: 19  TRLDLGNQSIRGTLSPYV-GNLSFLRYINIASNGFNGEIPHQI-GRLISLERLILSNNSF 76
             L L +  +   +S      +  LRY++++SN  +  +   +   L +LE L+L NN  
Sbjct: 67  HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI 124

Query: 77  SGAIPAN-LSSCSNLIELSADSNNLVGEIPADI----GSLFKLERLSIFQNHITGQLPAS 131
              +  N     + L +L    N +    P ++      L KL  L +  N +       
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182

Query: 132 IGNLSSLRVIDVR 144
           +  L +     + 
Sbjct: 183 LQKLPAWVKNGLY 195

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.0 bits (176), Expect = 3e-13
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLI-KIITV 704
           KIG G  G +Y G   +   EVA+K+ N+K K      + E K  R ++    I  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVR-- 69

Query: 705 CSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLH 764
             G +    D+  +V + +   SLE+  +  + +L   SL  +  L +A  + + +E++H
Sbjct: 70  WFGVE---GDYNVLVMD-LLGPSLEDLFNFCSRKL---SLKTV--LMLADQMINRVEFVH 120

Query: 765 HYCEPSIVHGDLKPSNVLLDQDLVSH---VSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
                S +H D+KP N L+     ++   + DFGLAK   + +    +  R  +  + GT
Sbjct: 121 SK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE-NKNLTGT 176

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             Y +    +G E S + D+ S G +L+       P
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 70.7 bits (173), Expect = 6e-13
 Identities = 58/312 (18%), Positives = 107/312 (34%), Gaps = 97/312 (31%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-----HRNLIK 700
           K+G G    V+  +  +    VA+KV+   +     + + E + L+++R       N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 701 IITVCSGRDFKGADFK--AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++ +       G +     +V+E + +  L +W+  SN Q     L  +++  I   V  
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG--LPLPCVKK--IIQQVLQ 157

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSH------------------------- 790
            ++YLH  C   I+H D+KP N+LL   +Q +                            
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 791 ---------------------VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEY 829
                                ++D G A ++  H  + I            T  Y + E 
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----------TRQYRSLEV 264

Query: 830 GMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHD------------------- 870
            +G   +   D++S   +  EL T     +    E  T  +                   
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 871 ---FSREFFTRK 879
              +S+EFFT+K
Sbjct: 325 AGKYSKEFFTKK 336

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.5 bits (173), Expect = 7e-13
 Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 34/227 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           D+F     IG G    V    + + G   A+K++N   + ++G    F  E   L N   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           R + ++    +   F+  ++  +V E+   G L   L    +++       + R  +A +
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDLLTLLSKFGERIPA----EMARFYLA-E 170

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +  AI+ +H       VH D+KP N+LLD+    H+  +DFG    L     D  V +  
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDRC--GHIRLADFGSCLKL---RADGTVRSLV 222

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVY-------SFGILLLELFT 853
                 GT  Y++PE             Y       + G+   E+F 
Sbjct: 223 AV----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 46/231 (19%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFV----AECKALRNIR 694
           D F     +G G  G V      E+G   A+K+++ KQK      +     E + L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN--- 751
              L+K+        FK      +V E++  G +  + H          L  I R +   
Sbjct: 100 FPFLVKLE-----FSFKDNSNLYMVMEYVAGGEM--FSH----------LRRIGRFSEPH 142

Query: 752 ---IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPD 806
               A  +    EYLH      +++ DLKP N+L+DQ    ++  +DFG AK +      
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRVKGR--- 194

Query: 807 TIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               T ++     GT   +APE  + +  +   D ++ G+L+ E+     P
Sbjct: 195 ----TWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 36/139 (25%), Positives = 56/139 (40%), Gaps = 7/139 (5%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
            NL  TI +I + +N I   IPP        L  + +  NQ++  + P+    L +L  L
Sbjct: 28  TNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL 85

Query: 365 DLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
            L  N +   +P SL   L  L  L L  N +      +  +  NL  L++  NKL  T+
Sbjct: 86  VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL-QTI 143

Query: 424 PRQILRITTLSLYLELGNN 442
            +           + L  N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 31/144 (21%), Positives = 57/144 (39%), Gaps = 5/144 (3%)

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNL 409
            IP  +     + ++ L++N ++   P +      L  + L  N +    P +     +L
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 410 LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKF 468
             L +  NK+   LP+ +         L L  N +N  L  +   +L NL  L L  NK 
Sbjct: 83  NSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140

Query: 469 SGEIPATLSACANLEYLNISGNAF 492
                 T S    ++ ++++ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 16/146 (10%)

Query: 104 IPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLW----GRIDSLGQLK 159
           +P  I        + + QN I    P +      LR ID+  N++          L  L 
Sbjct: 30  LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83

Query: 160 SLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
           SL L     N+ +  +P S+F  + SL+++ L+ N+    L VD   +L +L  L    N
Sbjct: 84  SLVLYG---NKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQF 244
                   + S   +++ +  ++N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 30/164 (18%), Positives = 52/164 (31%), Gaps = 35/164 (21%)

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
            ++  I   +N         FS  K L  ++L  N +   A +       L +   L  L
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---GLRS---LNSL 85

Query: 292 YFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGT 350
               N            ++                +P  +   L SL  L ++ N++   
Sbjct: 86  VLYGN-----------KITE---------------LPKSLFEGLFSLQLLLLNANKIN-C 118

Query: 351 IPPEI-GELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN 393
           +  +   +L NL  L L  N LQ     +   L  +  + L  N
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)

Query: 65  SLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQN 122
           ++  + L  N+    IP    S    L  +   +N +  E+  D    L  L  L ++ N
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 123 HITGQLPASI-GNLSSLRVIDVRENRLWG-RIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
            IT +LP S+   L SL+++ +  N++   R+D+   L +L LLS+  N+    I    F
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148

Query: 181 -NISSLEVISLSEN 193
             + +++ + L++N
Sbjct: 149 SPLRAIQTMHLAQN 162

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 32/225 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           ++F     IG G  G V    L       A+K++N   + ++  +  F  E   L N   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
           + +  +    +   F+  +   +V ++   G L   L     + E      + R  +A +
Sbjct: 134 KWITTLH--YA---FQDDNNLYLVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLA-E 183

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +  AI+ +H       VH D+KP N+L+D +   H+  +DFG          D  V++  
Sbjct: 184 MVIAIDSVHQL---HYVHRDIKPDNILMDMN--GHIRLADFGSCL---KLMEDGTVQSSV 235

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKG-----DVYSFGILLLELFT 853
                 GT  Y++PE     E          D +S G+ + E+  
Sbjct: 236 AV----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 24/106 (22%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +  A+E+LH   +  I++ D+K  N+LLD +   HV  +DFGL+K       +       
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER---AYD 219

Query: 814 ISIGIKGTVGYVAPE------YGMGREASMKGDVYSFGILLLELFT 853
                 GT+ Y+AP+       G  +      D +S G+L+ EL T
Sbjct: 220 FC----GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLT 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 36/161 (22%), Positives = 66/161 (40%), Gaps = 25/161 (15%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITV 704
            +G G +G V + F      + A+K++      A +    E +      +  ++++I+ V
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 79

Query: 705 CSGRDFKGADFKAIVYEFMQNGSL----EEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
                + G     IV E +  G L    ++    +  + E           I   +  AI
Sbjct: 80  YEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAI 130

Query: 761 EYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAK 798
           +YLH     +I H D+KP N+L      + +  ++DFG AK
Sbjct: 131 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 55/324 (16%), Positives = 98/324 (30%), Gaps = 79/324 (24%)

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRN---RFEGELPHSVANLSST 312
            ++  + L  N +GT AA  L     + +   LE   F+     R + E+P ++  L   
Sbjct: 32  DSVKEIVLSGNTIGTEAARWL--SENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89

Query: 313 IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL----TNLQQLDLDR 368
           +                       L+ + +  N    T    + +     T L+ L L  
Sbjct: 90  LL------------------KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 131

Query: 369 NFL-------------QGSIPSSLGNLTLLTYLKLGLNNLEGN----IPSSLGNCTNLLG 411
           N L             + ++     N   L  +  G N LE         +  +   L  
Sbjct: 132 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191

Query: 412 LNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE 471
           + +  N            I    +   L   L            + L  LDL  N F+  
Sbjct: 192 VKMVQN-----------GIRPEGIEHLLLEGL---------AYCQELKVLDLQDNTFTHL 231

Query: 472 ----IPATLSACANLEYLNISGNAFSGS-IPLLLDSLQ-----SIKELDFSSNNLNGQ-- 519
               +   L +  NL  L ++    S      ++D+        ++ L    N +     
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291

Query: 520 --IPEYL-ENLSFLEFLNLSYNHF 540
             +   + E +  L FL L+ N F
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 48/291 (16%), Positives = 94/291 (32%), Gaps = 55/291 (18%)

Query: 306 VANLSSTIKQIAMGRNRISG----TIPPEIRNLASLNWLTIDTNQLTGT----IPPEIGE 357
           +A  S  I+  ++  + I+     ++   +    S+  + +  N +       +   I  
Sbjct: 1   MARFS--IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58

Query: 358 LTNLQQLDLDRNFLQ----------GSIPSSLGNLTLLTYLKLGLNNLEGN----IPSSL 403
             +L+  +    F              +  +L     L  ++L  N         +   L
Sbjct: 59  KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118

Query: 404 GNCTNLLGLNISHNKL-----------IGTLPRQILRITTLSL-YLELGNNLLNG----S 447
              T L  L + +N L           +  L           L  +  G N L       
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178

Query: 448 LPPEVGNLKNLMRLDLSGNKFSGE-----IPATLSACANLEYLNISGNAFS--GSIPL-- 498
                 + + L  + +  N    E     +   L+ C  L+ L++  N F+  GS  L  
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238

Query: 499 LLDSLQSIKELDFSSNNLNGQ----IPEYLENLSF--LEFLNLSYNHFEGE 543
            L S  +++EL  +   L+ +    + +    L    L+ L L YN  E +
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 44/294 (14%), Positives = 92/294 (31%), Gaps = 55/294 (18%)

Query: 227 SLSNASSLEMIEFSKNQFS-GGVSV------DFSRLKNLYWLNLGINNLGTGAANELDFI 279
            L    S++ I  S N                   L+   + ++    +       L  +
Sbjct: 27  VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86

Query: 280 -NLLTNCSKLERLYFNRNRFEGELPHSVANL---SSTIKQIAMGRNRIS----------- 324
              L  C KL  +  + N F       + +     + ++ + +  N +            
Sbjct: 87  LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146

Query: 325 --GTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL----TNLQQLDLDRNFL-----QG 373
               +  + +N   L  +    N+L      E  +       L  + + +N +     + 
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206

Query: 374 SIPSSLGNLTLLTYLKLGLNNL--EG--NIPSSLGNCTNLLGLNISHNKL-------IGT 422
            +   L     L  L L  N     G   +  +L +  NL  L ++   L       +  
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266

Query: 423 LPRQILRITTLSLYLELGNNL-------LNGSLPPEVGNLKNLMRLDLSGNKFS 469
              ++  I   +L L+  N +       L   +      + +L+ L+L+GN+FS
Sbjct: 267 AFSKLENIGLQTLRLQ-YNEIELDAVRTLKTVI---DEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 58/369 (15%), Positives = 114/369 (30%), Gaps = 64/369 (17%)

Query: 36  VGNLSFLRYINIASNGFNGEIPHQIGRLI----SLERLILSNNSFSG----AIPANLSSC 87
           +   S +   ++  +    E    +  ++    S++ ++LS N+        +  N++S 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 88  SNLIELSADSN---NLVGEIPADIGSLFK-------LERLSIFQNHITGQ----LPASIG 133
            +L            +  EIP  +  L +       L  + +  N         L   + 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 134 NLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
             + L  + +  N L       G   +  L  +A N+ +        N   L  I    N
Sbjct: 120 KHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAK-------NAPPLRSIICGRN 169

Query: 194 RFTGSLPVDTGV--------NLPSLRELRTNANNFT-----GFIPVSLSNASSLEMIEFS 240
           R       +  +        +   L  ++   N          +   L+    L++++  
Sbjct: 170 RLE-----NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 241 KNQFSGGVSVDFSR----LKNLYWLNLGINNLGTGAANEL-DFINLLTNCSKLERLYFNR 295
            N F+   S   +       NL  L L    L    A  + D  + L N   L+ L    
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQY 283

Query: 296 NRFEGE----LPHSVANLSSTIKQIAMGRNRIS--GTIPPEIRN-LASLNWLTIDTNQLT 348
           N  E +    L   +      +  + +  NR S    +  EIR   ++     +D     
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343

Query: 349 GTIPPEIGE 357
             +  E  E
Sbjct: 344 EELTDEEEE 352

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 31/224 (13%), Positives = 62/224 (27%), Gaps = 51/224 (22%)

Query: 379 LGNLTLLTYLKLGLNNL--EG--NIPSSLGNCTNLLGLNISHNKL----IGTLPRQILRI 430
           +   ++     L L+ +  E   ++ + L    ++  + +S N +       L   I   
Sbjct: 1   MARFSIEG-KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 431 TTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGN 490
             L    E  +             L+ L++               L  C  L  + +S N
Sbjct: 60  KDLE-IAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDN 104

Query: 491 AFS--GSIPL--LLDSLQSIKELDFSSNNL-------------NGQIPEYLENLSFLEFL 533
           AF      PL   L     ++ L   +N L                + +  +N   L  +
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164

Query: 534 NLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRLPSCQ 577
               N  E       +         A   +    L  +++    
Sbjct: 165 ICGRNRLENG----SM------KEWAKTFQSHRLLHTVKMVQNG 198

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 37/268 (13%), Positives = 69/268 (25%), Gaps = 67/268 (25%)

Query: 13  QRHQRVTRLDLGNQSIR----------GTLSPYVGNLSFLRYINIASNGFNGEIPHQIGR 62
              + +   +  +                L   +     L  + ++ N F       +  
Sbjct: 57  ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116

Query: 63  LI----SLERLILSNNSFS-------------GAIPANLSSCSNLIELSADSNNLVGEIP 105
            +     LE L L NN                 A+     +   L  +    N L     
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176

Query: 106 ADIGSLFK----LERLSIFQNHITGQ-----LPASIGNLSSLRVIDVRENRLWGRI---- 152
            +    F+    L  + + QN I  +     L   +     L+V+D+++N     +    
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSSA 235

Query: 153 --DSLGQLKSLTLLSVAFNQ--------FSGMIPPSIFNISSLEVISLSENRFTGSLPVD 202
              +L    +L  L +                          L+ + L  N         
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN--IGLQTLRLQYNEIE-----L 288

Query: 203 TGV---------NLPSLRELRTNANNFT 221
             V          +P L  L  N N F+
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 44/232 (18%), Positives = 89/232 (38%), Gaps = 49/232 (21%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           +++     IG G  G V            A+K+++   + ++  S  F  E   +     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             ++++    +   F+   +  +V E+M  G L               ++++   ++   
Sbjct: 129 PWVVQL--FYA---FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPEK 168

Query: 756 VA--------SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNP 805
            A         A++ +H       +H D+KP N+LLD+    H+  +DFG    +   N 
Sbjct: 169 WARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKM---NK 220

Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGREASMK-G---DVYSFGILLLELFT 853
           + +V   +      GT  Y++PE    +      G   D +S G+ L E+  
Sbjct: 221 EGMVRCDTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 13/162 (8%)

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           E ++      +      F  L  L WLNL  N L T +A   D    LT    L  L   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD---DLTE---LGTLGLA 91

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPP 353
            N+    LP  V +  + + ++ +G N++  ++P  +   L  L  L ++TNQL  +IP 
Sbjct: 92  NNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148

Query: 354 EI-GELTNLQQLDLDRNFLQGSIP-SSLGNLTLLTYLKLGLN 393
               +LTNLQ L L  N LQ S+P  +   L  L  + L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 13/166 (7%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLD 365
           + + +  +++ +    ++       R L  L WL +D NQL  T+   +  +LT L  L 
Sbjct: 31  SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89

Query: 366 LDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPS----SLGNCTNLLGLNISHNKLI 420
           L  N L  S+P  +  +LT L  L LG N L+  +PS     L   T L  L ++ N+L 
Sbjct: 90  LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRL---TKLKELRLNTNQL- 143

Query: 421 GTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGN 466
            ++P       T    L L  N L          L  L  + L GN
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL---EGNIPSSLGNC 406
           ++P  I    + ++LDL    L     ++   LT LT+L L  N L      +   L   
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL--- 82

Query: 407 TNLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLS 464
           T L  L +++N+L  +LP  +   +T L   L LG N L  SLP  V   L  L  L L+
Sbjct: 83  TELGTLGLANNQL-ASLPLGVFDHLTQLD-KLYLGGNQLK-SLPSGVFDRLTKLKELRLN 139

Query: 465 GNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLN 517
            N+    IPA       NL+ L++S N    S+P    D L  ++ +    N  +
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 14/161 (8%)

Query: 67  ERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADI-GSLFKLERLSIFQNHIT 125
           E+L L +   +    A     + L  L+ D N L   + A +   L +L  L +  N + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 126 GQLPASI-GNLSSLRVIDVRENRL----WGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
             LP  +  +L+ L  + +  N+L     G  D L +LK L L +   NQ    IP   F
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT---NQLQS-IPAGAF 151

Query: 181 N-ISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNF 220
           + +++L+ +SLS N+   S+P      L  L+ +    N F
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.3 bits (155), Expect = 7e-11
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 20/115 (17%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +A A+++LH      I++ DLKP N+LLD++   H+  +DFGL+K  S  +        S
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEKK---AYS 185

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
                 GTV Y+APE    R  +   D +SFG+L+ E+ T   P           
Sbjct: 186 FC----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 1e-10
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 18/100 (18%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           V  A+EYLH      I++ DLKP N+LLD++   H+  +DFG AK    + PD    T +
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK----YVPDV---TYT 162

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
           +     GT  Y+APE    +  +   D +SFGIL+ E+  
Sbjct: 163 LC----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 19/115 (16%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           + SA++YLH   E ++V+ DLK  N++LD+D   H+  +DFGL K     +  T    ++
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKD--GHIKITDFGLCK-EGIKDGAT---MKT 308

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
                 GT  Y+APE     +     D +  G+++ E+   + P      + +F 
Sbjct: 309 FC----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.0 bits (154), Expect = 2e-10
 Identities = 36/120 (30%), Positives = 51/120 (42%), Gaps = 30/120 (25%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +ASA+ YLH     +IV+ DLKP N+LLD     H+  +DFGL K              +
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK-------------EN 189

Query: 814 ISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
           I          GT  Y+APE    +      D +  G +L E+     P     T  M++
Sbjct: 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 20/115 (17%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           ++ A+ +LH   +  I++ DLKP N++L+     HV  +DFGL K  S H+      T +
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK-ESIHDGTV---THT 180

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
                 GT+ Y+APE  M    +   D +S G L+ ++ T   P          +
Sbjct: 181 FC----GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 45/222 (20%), Positives = 82/222 (36%), Gaps = 33/222 (14%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
            P   F  +     +L +   T        +N         +       I   L N   L
Sbjct: 13  FPDDAF--AETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQGIQ-YLPNVRYL 68

Query: 235 EMIEFSKNQFSG-GVSVDFSRLKNLYWLNLGINNLGT---GAANELDFINLLTNCSKLER 290
            +     N+            L NL +L L  N L +   G  ++L         + L+ 
Sbjct: 69  AL---GGNKLHDISA---LKELTNLTYLILTGNQLQSLPNGVFDKL---------TNLKE 113

Query: 291 LYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTG 349
           L    N+ +  LP  V +  + +  + +  N++  ++P  +   L +L  L +  NQL  
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ- 170

Query: 350 TIPPEI-GELTNLQQLDLDRNFLQGSIPS----SLGNLTLLT 386
           ++P  +  +LT L+ L L +N L+ S+P      L +L  + 
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIW 211

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 17/148 (11%)

Query: 252 FSRLKNLYWLNLGINNLGT-GAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLS 310
              L N+ +L LG N L    A  EL         + L  L    N+ +  LP+ V +  
Sbjct: 59  IQYLPNVRYLALGGNKLHDISALKEL---------TNLTYLILTGNQLQ-SLPNGVFDKL 108

Query: 311 STIKQIAMGRNRISGTIPPEIRN-LASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDR 368
           + +K++ +  N++  ++P  + + L +L +L +  NQL  ++P  +  +LTNL +LDL  
Sbjct: 109 TNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSY 166

Query: 369 NFLQGSIPSSL-GNLTLLTYLKLGLNNL 395
           N LQ S+P  +   LT L  L+L  N L
Sbjct: 167 NQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 25/147 (17%), Positives = 54/147 (36%), Gaps = 10/147 (6%)

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSS--LGNLTLLTYLKLGLNNLEGNIPSSLGNCT 407
            IP  I       +L L+ N     + ++     L  L  +    N +      +    +
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81

Query: 408 NLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSG 465
            +  + ++ N+L   +  ++   + +L   L L +N +   +  +    L ++  L L  
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLK-TLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138

Query: 466 NKFSGEIPATLSACANLEYLNISGNAF 492
           N+ +   P       +L  LN+  N F
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 21/138 (15%), Positives = 52/138 (37%), Gaps = 12/138 (8%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPE--IRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQ 363
            ++     ++ +  N  +  +      + L  L  +    N++T  I        + + +
Sbjct: 28  EHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNE 85

Query: 364 LDLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGT 422
           + L  N L+ ++   +   L  L  L L  N +      S    +++  L++  N++  T
Sbjct: 86  ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TT 143

Query: 423 LPRQIL----RITTLSLY 436
           +          ++TL+L 
Sbjct: 144 VAPGAFDTLHSLSTLNLL 161

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 28/121 (23%), Positives = 51/121 (42%), Gaps = 13/121 (10%)

Query: 252 FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSV-ANLS 310
           F +L  L  +N   N +        +     +    +  +    NR E  + H +   L 
Sbjct: 53  FKKLPQLRKINFSNNKITDIEEGAFE---GASG---VNEILLTSNRLE-NVQHKMFKGLE 105

Query: 311 STIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDR 368
           S +K + +  NRI+  +  +    L+S+  L++  NQ+T T+ P     L +L  L+L  
Sbjct: 106 S-LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162

Query: 369 N 369
           N
Sbjct: 163 N 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 32/147 (21%), Positives = 51/147 (34%), Gaps = 17/147 (11%)

Query: 104 IPADIGSLFKLERLSIFQNHITGQLP-ASIGNLSSLRVIDVRENRLW----GRIDSLGQL 158
           IP           L +  N  T          L  LR I+   N++     G  +    +
Sbjct: 30  IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 159 KSLTLLSVAFNQFSGMIPPSIF-NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
             + L     N+    +   +F  + SL+ + L  NR T  +  D+ + L S+R L    
Sbjct: 84  NEILL---TSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQF 244
           N  T   P +     SL  +    N F
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 3/97 (3%)

Query: 460 RLDLSGNKFSG-EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNG 518
            L L+ N+F+  E          L  +N S N  +       +    + E+  +SN L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 519 QIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTR 555
              +  + L  L+ L L  N     V     F   + 
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVG-NDSFIGLSS 130

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 57/242 (23%), Positives = 93/242 (38%), Gaps = 63/242 (26%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR-----NLIK 700
           K+G+G  G V      +N    AVKV+   +K    + + E   L+ I++      N++K
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-EADILKKIQNDDINNNNIVK 100

Query: 701 IITVCSGRDFKGADFKA---IVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAIDV 756
                    F    +     +++E +   SL E +  +N        +  I+     I++
Sbjct: 101 YH-----GKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGF---HIEDIKL--YCIEI 146

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS------------------------ 792
             A+ YL    + S+ H DLKP N+LLD                                
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 793 -DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLEL 851
            DFG A F  +    +I+ TR           Y APE  +     +  D++SFG +L EL
Sbjct: 204 IDFGCATF-KSDYHGSIINTRQ----------YRAPEVILNLGWDVSSDMWSFGCVLAEL 252

Query: 852 FT 853
           +T
Sbjct: 253 YT 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 59/238 (24%)

Query: 646 KIGEGGSGIVYKGF-LGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR------NL 698
            +GEG  G V +        ++VA+K+I    K    + + E   L+ I+ +        
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLC 84

Query: 699 IKIITVCSGRDFKGADFKA---IVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAI 754
           + +        F   +F     I +E +   +  E+L  +N Q      L  ++   +A 
Sbjct: 85  VLMS-----DWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPY---PLPHVRH--MAY 130

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH-------------------VSDFG 795
            +  A+ +LH   E  + H DLKP N+L                           V+DFG
Sbjct: 131 QLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            A F  + +  TIV TR           Y  PE  +    +   DV+S G +L E + 
Sbjct: 188 SATF-DHEHHTTIVATRH----------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 5/115 (4%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLD 365
           A + +  + + +  N+I+   P    +L +L  L + +NQL   +P  +   LT L  LD
Sbjct: 36  AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94

Query: 366 LDRNFLQGSIPSSL-GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
           L  N L   +PS++   L  L  L +  N L   +P  +   T+L  L +  N+L
Sbjct: 95  LGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 50/146 (34%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 327 IPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSL-GNLTLL 385
           +P  I    +   L +  NQ+T   P     L NL++L L  N L  ++P  +  +LT L
Sbjct: 34  VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 386 TYLKLGLNNLEGNIPS----SLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGN 441
           T L LG N L   +PS     L    +L  L +  NKL   LPR I R+T L+ +L L  
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRL---VHLKELFMCCNKL-TELPRGIERLTHLT-HLALDQ 144

Query: 442 NLLNGSLPPEV-GNLKNLMRLDLSGN 466
           N L  S+P      L +L    L GN
Sbjct: 145 NQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 37/121 (30%), Positives = 50/121 (41%), Gaps = 12/121 (9%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNL---EGNIPSSLGNCT 407
           +P  I   TN Q L L  N +    P    +L  L  L LG N L      +  SL   T
Sbjct: 34  VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL---T 88

Query: 408 NLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGN 466
            L  L++  N+L   LP  +  R+  L   L +  N L   LP  +  L +L  L L  N
Sbjct: 89  QLTVLDLGTNQL-TVLPSAVFDRLVHLK-ELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

Query: 467 K 467
           +
Sbjct: 146 Q 146

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 42/160 (26%), Positives = 58/160 (36%), Gaps = 33/160 (20%)

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           +++    NQ +      F  L NL  L LG N LG       D    LT    L  L   
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVLDLG 96

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
            N+    LP +V +                         L  L  L +  N+LT  +P  
Sbjct: 97  TNQLT-VLPSAVFD------------------------RLVHLKELFMCCNKLT-ELPRG 130

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN 394
           I  LT+L  L LD+N L+     +   L+ LT+  L   N
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL-FGN 169

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.1 bits (149), Expect = 5e-10
 Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 30/120 (25%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           + SA+EYLH      +V+ D+K  N++LD+D   H+  +DFGL K               
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK-------------EG 155

Query: 814 ISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
           IS G       GT  Y+APE     +     D +  G+++ E+   + P      + +F 
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 62.0 bits (150), Expect = 6e-10
 Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 20/118 (16%)

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVE 810
           A ++A  + +L       I++ DLK  NV+LD +   H+  +DFG+ K  +  +  T   
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVT--- 498

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
           T++      GT  Y+APE    +      D ++FG+LL E+   + P      D +F 
Sbjct: 499 TKTFC----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.3 bits (147), Expect = 9e-10
 Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 30/120 (25%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +   +++LH      IV+ DLK  N+LLD+D   H+  +DFG+ K              +
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK-------------EN 168

Query: 814 ISIGIK-----GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
           +    K     GT  Y+APE  +G++ +   D +SFG+LL E+   + P      + +F+
Sbjct: 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 60.3 bits (147), Expect = 1e-09
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 20/115 (17%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           +A  + +L       I++ DLK  NV+LD +   H+  +DFG+ K  +  +  T   T++
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVT---TKT 180

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
                 GT  Y+APE    +      D ++FG+LL E+   + P      D +F 
Sbjct: 181 FC----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 34/153 (22%)

Query: 388 LKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGS 447
           L   +  +E  + ++L        L +S N         I +I++LS             
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNN--------IEKISSLS------------- 67

Query: 448 LPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIK 507
                  ++NL  L L  N    +I    +    LE L IS N  + S+   ++ L +++
Sbjct: 68  ------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLR 118

Query: 508 ELDFSSNNLN--GQIPEYLENLSFLEFLNLSYN 538
            L  S+N +   G+I + L  L  LE L L+ N
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 43/172 (25%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL 410
           +   +  L   + L L  N ++  I SSL  +  L  L LG N ++  I +       L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 411 GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFS- 469
            L IS+N           +I +LS                 +  L NL  L +S NK + 
Sbjct: 97  ELWISYN-----------QIASLS----------------GIEKLVNLRVLYMSNNKITN 129

Query: 470 -GEIPATLSACANLEYLNISGNAFSGSIPL----------LLDSLQSIKELD 510
            GEI   L+A   LE L ++GN                  ++  L ++K+LD
Sbjct: 130 WGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 7/126 (5%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKL 114
           ++   +  L + + L LS N+    I ++LS   NL  LS   N +  +I         L
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95

Query: 115 ERLSIFQNHITGQLPASIGNLSSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFNQFS 172
           E L I  N I   L + I  L +LRV+ +  N++  WG ID L  L  L  L +A N   
Sbjct: 96  EELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153

Query: 173 GMIPPS 178
                +
Sbjct: 154 NDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 27/139 (19%), Positives = 58/139 (41%), Gaps = 9/139 (6%)

Query: 110 SLFKLERLSIFQNH--ITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVA 167
              + E++ +      I   + A++  L + + + +  N +  +I SL  +++L +LS+ 
Sbjct: 21  VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKISSLSGMENLRILSLG 78

Query: 168 FNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVS 227
            N     I        +LE + +S N+      ++    L +LR L  + N  T +  + 
Sbjct: 79  RNLIKK-IENLDAVADTLEELWISYNQIASLSGIE---KLVNLRVLYMSNNKITNWGEID 134

Query: 228 -LSNASSLEMIEFSKNQFS 245
            L+    LE +  + N   
Sbjct: 135 KLAALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 10/87 (11%)

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS---GSIPLLLDSLQSIKELDFSSN 514
            + L         ++ ATLS     ++L +S N            L  +++++ L    N
Sbjct: 27  KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRN 80

Query: 515 NLNGQIPEYLENLSFLEFLNLSYNHFE 541
            +  +I         LE L +SYN   
Sbjct: 81  LIK-KIENLDAVADTLEELWISYNQIA 106

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 72/514 (14%), Positives = 150/514 (29%), Gaps = 75/514 (14%)

Query: 62  RLISLERLILSNNSFSGAIPANLSS-CSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
            +    R  +   +     PA +      +  +            AD   +        +
Sbjct: 39  EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHF----ADFNLV-----PDGW 89

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGR-----IDSLGQLKSLTLLSVAFNQFSGMI 175
             ++   + A   + + L  I ++   +          S    K L L S     FS   
Sbjct: 90  GGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC--EGFSTDG 147

Query: 176 PPSIF-NISSLEVISLSENRF---TGSLPVDTGVNLPSLRELRTNANNFTGFIPVS---- 227
             +I     +L+ + L E+     +G           SL  L  N +     +  S    
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL--NISCLASEVSFSALER 205

Query: 228 -LSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCS 286
            ++   +L+ ++ ++      ++    R   L  L  G                 L+ C 
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265

Query: 287 KLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQ 346
           +L  L    +     LP   +  S                    +  L +L++ T+ +  
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSR-------------------LTTL-NLSYATVQSYD 305

Query: 347 LTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSS---- 402
           L       + +   LQ+L +        +         L  L++  +      P+     
Sbjct: 306 LVKL----LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE 361

Query: 403 ------LGNCTNLLGLNISHNKL----IGTLPRQILRITTLSLYL-------ELGNNLLN 445
                    C  L  +     ++    + T+ R    +T   L +        L    L+
Sbjct: 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421

Query: 446 GSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSG-SIPLLLDSLQ 504
                 V + K+L RL LSG           +    +E L+++    S   +  +L    
Sbjct: 422 IGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCD 481

Query: 505 SIKELDFSS-NNLNGQIPEYLENLSFLEFLNLSY 537
           S+++L+       +  +      L  +  L +S 
Sbjct: 482 SLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 39/229 (17%), Positives = 68/229 (29%), Gaps = 20/229 (8%)

Query: 358 LTNLQQLDLDRNFLQGSIPSSLGNLT-LLTYLK-LGLNNLEGNIPSS-----LGNCTNLL 410
             NL++LDL  + +       L +     T L  L ++ L   +  S     +  C NL 
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214

Query: 411 GLNISHNKLIGTLPRQILRITTL-----SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSG 465
            L ++    +  L   + R   L       Y       +   L   +   K L  L    
Sbjct: 215 SLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFW 274

Query: 466 NKFSGEIPATLSACANLEYLNISGNAFSG-SIPLLLDSLQSIKELDFSSNNLNGQIPEYL 524
           +     +PA  S C+ L  LN+S        +  LL     ++ L       +  +    
Sbjct: 275 DAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA 334

Query: 525 ENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRL 573
                L  L +  +                  +  G   +  G  +L  
Sbjct: 335 STCKDLRELRVFPSEPFVM-------EPNVALTEQGLVSVSMGCPKLES 376

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 15/104 (14%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           ++ A+ YLH   E  I++ DLK  NVLLD +   H+  +D+G+ K       DT   T +
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDT---TST 212

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  Y+APE   G +     D ++ G+L+ E+   + P
Sbjct: 213 FC----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.4 bits (142), Expect = 4e-09
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 15/104 (14%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           ++ A+ YLH   E  I++ DLK  NVLLD +   H+  +D+G+ K       DT   T +
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDT---TST 169

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 GT  Y+APE   G +     D ++ G+L+ E+   + P
Sbjct: 170 FC----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.4 bits (142), Expect = 4e-09
 Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 59/238 (24%)

Query: 646 KIGEGGSGIVYKGF-LGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHR------NL 698
            +GEG  G V +       G  VAVK++    +    +   E + L ++           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRC 79

Query: 699 IKIITVCSGRDFKGADFKA---IVYEFMQNGSLEEWLHHSNDQ-LEVCSLSVIQRLNIAI 754
           ++++       F   +      IV+E +   S  +++  +         L  I++  +A 
Sbjct: 80  VQML-----EWF---EHHGHICIVFELL-GLSTYDFIKENGFLPF---RLDHIRK--MAY 125

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS-------------------DFG 795
            +  ++ +LH      + H DLKP N+L  Q   +                      DFG
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT 853
            A +   H+  T+V TR           Y APE  +    S   DV+S G +L+E + 
Sbjct: 183 SATYDDEHHS-TLVSTRH----------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 5e-09
 Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 20/115 (17%)

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRS 813
           + SA+ +LH   +  I++ DLK  NVLLD +   H   +DFG+ K     N  T   T +
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK-EGICNGVT---TAT 183

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP-----TDAMFN 863
                 GT  Y+APE           D ++ G+LL E+     P      D +F 
Sbjct: 184 FC----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.7 bits (141), Expect = 7e-09
 Identities = 68/482 (14%), Positives = 133/482 (27%), Gaps = 152/482 (31%)

Query: 21  LDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGE-IPHQIG-------RLISLER---- 68
           L+L N +   T+   +  L +    N  S   +   I  +I        RL+  +     
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 69  -LILSN-------NSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
            L+L N       N+F+        SC  L+  +            D             
Sbjct: 247 LLVLLNVQNAKAWNAFNL-------SCKILL-TTRFKQV------TDF------------ 280

Query: 121 QNHITGQLPASIGNLSSLRVIDVR-ENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSI 179
                         LS+     +  ++        L   +  +LL    +     +P  +
Sbjct: 281 --------------LSAATTTHISLDHHSMT----LTPDEVKSLLLKYLDCRPQDLPREV 322

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLPSLRE--LRTNANNFTGFIPVSLSNASSLEMI 237
              +    +S+       S+      +  +  +     N +  T  I  SL+     E  
Sbjct: 323 LTTNPR-RLSI----IAESIR-----DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 238 E-------FSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLER 290
           +       F  +       +    L  L W ++  +       + +  +N L   S +E+
Sbjct: 373 KMFDRLSVFPPS-----AHIPTILLS-LIWFDVIKS-------DVMVVVNKLHKYSLVEK 419

Query: 291 LYFNRNRFEGELPHSVANLSSTIKQIAMGRNRI------------SGTIPPEIRN----- 333
                      +P     L   ++        I               IPP +       
Sbjct: 420 ---QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476

Query: 334 LA--------------------SLNWLTIDTNQL--TGTIPPEIGELTN-LQQLDLDRNF 370
           +                        +L     ++    T     G + N LQQL   + +
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFLDFRFL---EQKIRHDSTAWNASGSILNTLQQLKFYKPY 533

Query: 371 LQGSIPSSLGNL-TLLTYLKLGLNNLEGNIPSSLGNCTNLL--GLNISHNKLIGTLPRQI 427
           +  + P     +  +L +L      +E N+  S    T+LL   L      +     +Q+
Sbjct: 534 ICDNDPKYERLVNAILDFLP----KIEENLICS--KYTDLLRIALMAEDEAIFEEAHKQV 587

Query: 428 LR 429
            R
Sbjct: 588 QR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 7e-08
 Identities = 84/597 (14%), Positives = 177/597 (29%), Gaps = 219/597 (36%)

Query: 54  GEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIEL------SADSNNLVGEIPAD 107
           GE  +Q   ++S+         F  A   N   C ++ ++        + ++++    A 
Sbjct: 12  GEHQYQYKDILSV---------FEDAFVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAV 61

Query: 108 IGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDV-RENR--LWGRIDSLGQLKSLTLL 164
            G+L     L   Q  +  +            V +V R N   L   I +  + +  +++
Sbjct: 62  SGTLRLFWTLLSKQEEMVQKF-----------VEEVLRINYKFLMSPIKT--EQRQPSMM 108

Query: 165 SVAFNQ-----FSGMIPPSIFNISSLE-VISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
           +  + +     ++     + +N+S L+  + L +                +L ELR   N
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ----------------ALLELRPAKN 152

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLK----NLYWLNLG---------- 264
                  V +       ++   K   +  V + +         ++WLNL           
Sbjct: 153 -------VLIDG-----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200

Query: 265 -INNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGEL---------PHS--------- 305
            +  L      ++D  N  +       +    +  + EL          +          
Sbjct: 201 MLQKL----LYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255

Query: 306 ---------------------VANL--SSTIKQIAMGRNRISGTIPPEIRNLASLNWLTI 342
                                V +   ++T   I++  + ++ T P E+++L  L +L  
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT-PDEVKSL-LLKYLDC 313

Query: 343 DTNQLTGTIPPE-----------IGEL--------TNLQQLDLDRNFLQGSIPSSLGNLT 383
               L    P E           I E          N + ++ D+  L   I SSL  L 
Sbjct: 314 RPQDL----PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLE 367

Query: 384 LLT----YLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLEL 439
                  + +L +     +IP+ L        L++    +I +    ++           
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTIL--------LSLIWFDVIKSDVMVVV----------- 408

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA----TLSACANLEYLNISGNAFSGS 495
            N L   SL            ++    + +  IP+          N   L+ S       
Sbjct: 409 -NKLHKYSL------------VEKQPKESTISIPSIYLELKVKLENEYALHRS------- 448

Query: 496 IPLLLDSLQSIKEL---DFSSNNLNGQIPEYL----------ENLSFLE--FLNLSY 537
              ++D     K     D     L+     ++          E ++     FL+  +
Sbjct: 449 ---IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF 502

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 3e-07
 Identities = 75/535 (14%), Positives = 156/535 (29%), Gaps = 162/535 (30%)

Query: 420 IGTLPRQILRITTLSLYLELGNNLLNG---------SLPPEVGNLKN-LMRLDLSGNKFS 469
           I T  RQ   +T +  Y+E  + L N          S       L+  L+ L        
Sbjct: 98  IKTEQRQPSMMTRM--YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR------- 148

Query: 470 GEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSF 529
              PA        + + I G   SG   + LD   S K        ++ +I         
Sbjct: 149 ---PA--------KNVLIDGVLGSGKTWVALDVCLSYKVQC----KMDFKI--------- 184

Query: 530 LEF-LNLSYNHFEGEVPMKGVFNNKTRFSIAGNGK-LCGGLDELRLPSCQSKGSLTILKV 587
             F LNL   +    V        K  + I  N          ++L     +  L  L +
Sbjct: 185 --FWLNLKNCNSPETVLEM---LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-L 238

Query: 588 VIPVIVSCLILSVGFTLIYVWRRRSARKASNMLPIEQQFLVDSYAELSKATDNFSSANKI 647
                 +CL++     L+ V   ++     N   +  + L+         T      + +
Sbjct: 239 KSKPYENCLLV-----LLNVQNAKAW----NAFNLSCKILL--------TTRFKQVTDFL 281

Query: 648 GEGGSGIVY-----KGFLGENGTEVAVKVINLKQKGASKSFVAECKAL-RNIRHRNLIKI 701
               +  +           +    + +K ++ +            + L R +   N  ++
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR-----------PQDLPREVLTTNPRRL 330

Query: 702 ITVCSGRDFKGADFKAIVYEFMQNG--SLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
                          +I+ E +++G  + + W H + D+L     ++I+    +++V   
Sbjct: 331 ---------------SIIAESIRDGLATWDNWKHVNCDKLT----TIIE---SSLNVLEP 368

Query: 760 IEYLHHYCEPSIVHGDLK-PSNVL----------LDQDLVSHVSDFGLAK---------- 798
            EY   +   S+       P+ +L              +V+ +  + L +          
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428

Query: 799 -----FLSNHNPD------TIVETRSI-------SIGIKGTVGYVAPEYGMG---REASM 837
                 L     +      +IV+  +I        +       Y    + +G   +    
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY-SH-IGHHLKNIEH 486

Query: 838 KGDVYSFGILLLEL-FTRK--RPTDAMFNEGL----TLHDFS--REFFTRKSDTD 883
              +  F ++ L+  F  +  R     +N       TL      + +        
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 5e-05
 Identities = 51/430 (11%), Positives = 114/430 (26%), Gaps = 139/430 (32%)

Query: 506 IKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLC 565
             E  +   ++   +  + +   F++  N      +     K + + +            
Sbjct: 11  TGEHQYQYKDI---LSVFEDA--FVD--NFDCKDVQDM--PKSILSKEE----------- 50

Query: 566 GGLDELRLPSCQSKGSLTILKVVIPVIVSCLILSVGFTLIYVWRRRSARKA-SNMLPIEQ 624
             +D              I+     V  +  +    F  +   +    +K    +L I  
Sbjct: 51  --IDH-------------IIMSKDAVSGTLRL----FWTLLSKQEEMVQKFVEEVLRINY 91

Query: 625 QFLVDSYAELSKA----TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS 680
           +FL+       +     T  +          + +  K  +           + L+     
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV-----SRLQPYLKLR----- 141

Query: 681 KSFVAECKALRNIR-HRNLI--------K---IITVCSGRDFK---GADFKAIVYEFMQN 725
                  +AL  +R  +N++        K    + VC    +K     DFK  ++     
Sbjct: 142 -------QALLELRPAKNVLIDGVLGSGKTWVALDVC--LSYKVQCKMDFK--IF----- 185

Query: 726 GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPS------ 779
                WL+  N       L ++Q+L   ID  +      H     +    ++        
Sbjct: 186 -----WLNLKNCNSPETVLEMLQKLLYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLK 239

Query: 780 -----NVLLDQDLVSHVSDFGLAK-FLSNHNPDTIVETRSISI------GIKGTVGYVAP 827
                N LL      +V +      F  N +   ++ TR   +           +     
Sbjct: 240 SKPYENCLLVLL---NVQNAKAWNAF--NLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 828 EYGMGREASMKGDVYSFGILLLELFTRKRPTD-------------AMFNEGLTLHDF-SR 873
              +  +             LL  +   RP D             ++     ++ D  + 
Sbjct: 295 SMTLTPDEVKS---------LLLKYLDCRPQDLPREVLTTNPRRLSII--AESIRDGLAT 343

Query: 874 EFFTRKSDTD 883
               +  + D
Sbjct: 344 WDNWKHVNCD 353

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 73/499 (14%), Positives = 153/499 (30%), Gaps = 56/499 (11%)

Query: 62  RLISLERLILSN--NSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLF--KLERL 117
              ++  LI  N     +  +    ++   L  +      +       +       LE L
Sbjct: 84  PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143

Query: 118 SIFQ-NHITGQLPASIG-NLSSLRVIDVRENRLWGRID-SLGQL----KSLTLLSVAFNQ 170
            + + +  T     SI  +   ++ + + E+    +    L +L     SL +L+    +
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203

Query: 171 FSGMIPPSIFNI----SSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPV 226
           F+ + P  +  I     SL  + + +      +         +L E    + N    +P 
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELVGF--FKAAANLEEFCGGSLNEDIGMPE 261

Query: 227 SLSNASSLEMIEFSKNQFSG--GVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTN 284
              N      +      + G   + + F     +  L+L    L T      D   L+  
Sbjct: 262 KYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE-----DHCTLIQK 316

Query: 285 CSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDT 344
           C  LE L   RN         +A     +K++ + R      +  E   ++    + +  
Sbjct: 317 CPNLEVLET-RNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375

Query: 345 NQLTGTIPPEIGELTNLQQLDLD-RNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSL 403
                           L+ + +   +    S+ S    L  L   +L            L
Sbjct: 376 G------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRL----------VLL 413

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDL 463
                +  L + +   + +L     ++   + YL     L +  L        N+  + L
Sbjct: 414 DREERITDLPLDN--GVRSLLIGCKKLRRFAFYL-RQGGLTDLGLSYIGQYSPNVRWMLL 470

Query: 464 SGNKFSGE-IPATLSACANLEYLNISGNAFS-GSIPLLLDSLQSIKELDFSSNNLNGQIP 521
                S E +      C NL+ L + G  FS  +I   +  L S++ L       +    
Sbjct: 471 GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQ 530

Query: 522 EYLE---NLSFLEFLNLSY 537
           + ++       +E +    
Sbjct: 531 DLMQMARPYWNIELIPSRR 549

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 36/256 (14%), Positives = 78/256 (30%), Gaps = 25/256 (9%)

Query: 358 LTNLQQLDLDRNFL--QGSIPSSLGNLTLLTYLKL-GLNNLEGNIPSSLG-NCTNLLGLN 413
           L  L+ +   R  +        +      L  LKL   +    +   S+  +C  +  L 
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLL 170

Query: 414 ISHNKL-------IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGN 466
           +  +         +  L +    +  L+ Y+     +    L     N ++L+ + +   
Sbjct: 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF 230

Query: 467 KFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQ--IPEYL 524
           +   E+     A ANLE            +P    +L   ++L     +  G   +P   
Sbjct: 231 EIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILF 289

Query: 525 ENLSFLEFLNLSYNHFEGEVPMKGVFNNK-----------TRFSIAGNGKLCGGLDELRL 573
              + +  L+L Y   E E     +                   +    + C  L  LR+
Sbjct: 290 PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRI 349

Query: 574 PSCQSKGSLTILKVVI 589
                +  +   + ++
Sbjct: 350 ERGADEQGMEDEEGLV 365

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 6/110 (5%)

Query: 430 ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISG 489
           +  L L     +    G L       + L  L       +  I A L     L+ L +S 
Sbjct: 19  VKELVL---DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73

Query: 490 NAFSGSIPLLLDSLQSIKELDFSSNNLNG-QIPEYLENLSFLEFLNLSYN 538
           N  SG + +L +   ++  L+ S N +      E L+ L  L+ L+L   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 24/108 (22%), Positives = 49/108 (45%), Gaps = 5/108 (4%)

Query: 65  SLERLILSNNSFS-GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
            ++ L+L N+  + G +         L  LS   N  +  I A++  L KL++L +  N 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSI-ANLPKLNKLKKLELSDNR 75

Query: 124 ITGQLPASIGNLSSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFN 169
           ++G L        +L  +++  N++     I+ L +L++L  L +   
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 6e-06
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 3/89 (3%)

Query: 454 NLKNLMRLDLSGNKFS-GEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
              ++  L L  ++ + G++         LE+L+      + SI  L   L  +K+L+ S
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL-PKLNKLKKLELS 72

Query: 513 SNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
            N ++G +    E    L  LNLS N  +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 33/136 (24%), Positives = 50/136 (36%), Gaps = 27/136 (19%)

Query: 332 RNLASLNWLTIDTNQLT-GTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL 390
           R  + +  L +D ++   G +     E   L+ L      L  SI ++L  L  L  L+L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71

Query: 391 GLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPP 450
             N + G +      C NL  LN+S NK+     + +  I  L                 
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLK---------------- 110

Query: 451 EVGNLKNLMRLDLSGN 466
               L+NL  LDL   
Sbjct: 111 ---KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 20/105 (19%), Positives = 41/105 (39%), Gaps = 2/105 (1%)

Query: 110 SLFKLERLSIFQNHIT-GQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAF 168
           +   ++ L +  +    G+L         L  +      L   I +L +L  L  L ++ 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIANLPKLNKLKKLELSD 73

Query: 169 NQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLREL 213
           N+ SG +        +L  ++LS N+      ++    L +L+ L
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 28/119 (23%), Positives = 42/119 (35%), Gaps = 13/119 (10%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASS---LEMI 237
             S ++ + L  +R               L  L T     T     S++N      L+ +
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69

Query: 238 EFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRN 296
           E S N+ SGG+ V   +  NL  LNL  N +      +L  I  L     L+ L     
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 48/329 (14%), Positives = 104/329 (31%), Gaps = 63/329 (19%)

Query: 229 SNASSLEMIEFSKNQFSGGVSVDFSRL-----KNLYWLNLGINNLGTGAANELDFINLLT 283
           +  +S+  +  S N      S +  ++      N+  LNL  N L   +++EL    L  
Sbjct: 48  NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT-LAA 106

Query: 284 NCSKLERLYFNRNRFEGE----LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLA---- 335
               +  L    N F  +       + +NL ++I  + +  N +          L     
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQILA 163

Query: 336 ----SLNWLTIDTNQLTGTIPPEIGEL-----TNLQQLDLDRNFLQGSIPSSLG-----N 381
               ++N L +  N L      E+ +       ++  LDL  N L     + L       
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223

Query: 382 LTLLTYLKLGLNNLEG----NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYL 437
              +  L L LN L G    N+     +  +L  + + ++ +     + + +    +L  
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-----KNMSKEQCKALGA 278

Query: 438 ELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA-----CANLEYLNISGNAF 492
              N              + ++ +D +G +        +S          +  ++     
Sbjct: 279 AFPNI-------------QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCL 325

Query: 493 S-----GSIPLLLDSLQSIKELDFSSNNL 516
                  +    L+    ++E   +   L
Sbjct: 326 IFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 49/321 (15%), Positives = 95/321 (29%), Gaps = 76/321 (23%)

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQ 315
             +  L+L +NNL + +  EL         + +  L  + N    +   +   L   +  
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQA-FANTPASVTSLNLSGNSLGFK---NSDELVQILA- 76

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGEL-----TNLQQLDLDRNF 370
                              A++  L +  N L+     E+ +        +  LDL  N 
Sbjct: 77  ----------------AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120

Query: 371 LQGSIPSSLGNL-----TLLTYLKLGLNNLEGN----IPSSLGNC-TNLLGLNISHNKL- 419
                 S            +T L L  N+L       +   L     N+  LN+  N L 
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180

Query: 420 -IGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE----IPA 474
                         L+ +L                   ++  LDLS N    +    +  
Sbjct: 181 SKN--------CAELAKFLASIP--------------ASVTSLDLSANLLGLKSYAELAY 218

Query: 475 TLSAC-ANLEYLNISGNAFSGS----IPLLLDSLQSIKELDFSSNNLNGQ-------IPE 522
             S+   ++  LN+  N   G     + LL DSL+ ++ +    + +          +  
Sbjct: 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278

Query: 523 YLENLSFLEFLNLSYNHFEGE 543
              N+  +  ++ +       
Sbjct: 279 AFPNIQKIILVDKNGKEIHPS 299

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 46/331 (13%), Positives = 98/331 (29%), Gaps = 70/331 (21%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGV---------NLPSLRELRTNANNFTGFIPVSLSNA 231
             +S+  ++LS N                        ++  L  + N  +      L   
Sbjct: 49  TPASVTSLNLSGNSLG-----FKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103

Query: 232 -----SSLEMIEFSKNQFS-GGVSVDFSRLKN----LYWLNLGINNLGTGAANELDFINL 281
                 ++ +++   N FS    S       N    +  LNL  N+LG  +++EL    L
Sbjct: 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL-IQIL 162

Query: 282 LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLT 341
               + +  L    N    +   + A L+  +  I                  AS+  L 
Sbjct: 163 AAIPANVNSLNLRGNNLASK---NCAELAKFLASIP-----------------ASVTSLD 202

Query: 342 IDTNQLTGTIPPEIGEL-----TNLQQLDLDRNFLQGS----IPSSLGNLTLLTYLKLGL 392
           +  N L      E+  +      ++  L+L  N L G     +     +L  L  + L  
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262

Query: 393 NNLEG-------NIPSSLGNCTNLLGLNISHNK--------LIGTLPRQILRITTLSLYL 437
           + ++         + ++  N   ++ ++ +  +        +   +     +    SL  
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322

Query: 438 ELGNNLLNGSLPPEVGNL-KNLMRLDLSGNK 467
           +            E  N+   L     +   
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 22/108 (20%), Positives = 42/108 (38%), Gaps = 6/108 (5%)

Query: 289 ERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQL 347
             L  N N         +      + ++ + RN+++  I P      + +  L +  N++
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 348 TGTIPPEI-GELTNLQQLDLDRNFLQGSIP-SSLGNLTLLTYLKLGLN 393
              I  ++   L  L+ L+L  N +   +   S  +L  LT L L  N
Sbjct: 91  K-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 7/93 (7%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPE--IRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQ 363
            ++     ++ +  N +   I  +     L  L  L +  NQLT  I P      +++Q+
Sbjct: 25  RDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQE 82

Query: 364 LDLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNL 395
           L L  N ++  I + +   L  L  L L  N +
Sbjct: 83  LQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 8/108 (7%)

Query: 289 ERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQL 347
             LY + N+F   +P  ++N    +  I +  NRIS T+  +   N+  L  L +  N+L
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKH-LTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90

Query: 348 TGTIPPEI-GELTNLQQLDLDRNFLQGSIP-SSLGNLTLLTYLKLGLN 393
              IPP     L +L+ L L  N +   +P  +  +L+ L++L +G N
Sbjct: 91  R-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 5/91 (5%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLD 365
             +   + ++ +  N+ +  +P E+ N   L  + +  N+++ T+  +    +T L  L 
Sbjct: 27  KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLI 84

Query: 366 LDRNFLQGSIPSSL-GNLTLLTYLKLGLNNL 395
           L  N L+  IP      L  L  L L  N++
Sbjct: 85  LSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 8/125 (6%)

Query: 416 HNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPAT 475
            NK +  LP+ I R  T    L L  N     +P E+ N K+L  +DLS N+ S     +
Sbjct: 18  SNKGLKVLPKGIPRDVT---ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS 73

Query: 476 LSACANLEYLNISGNAFSGSIPL-LLDSLQSIKELDFSSNNLNGQIPE-YLENLSFLEFL 533
            S    L  L +S N     IP    D L+S++ L    N+++  +PE    +LS L  L
Sbjct: 74  FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131

Query: 534 NLSYN 538
            +  N
Sbjct: 132 AIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 33/119 (27%), Positives = 44/119 (36%), Gaps = 32/119 (26%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL 410
           +P  I    ++ +L LD N     +P  L N   LT + L                    
Sbjct: 25  LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDL-------------------- 61

Query: 411 GLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNK 467
               S+N+ I TL  Q    +T L   L L  N L   +PP     LK+L  L L GN 
Sbjct: 62  ----SNNR-ISTLSNQSFSNMTQLL-TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGND 113

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 26/108 (24%), Positives = 50/108 (46%), Gaps = 5/108 (4%)

Query: 65  SLERLILSNNSFS-GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
           ++  L+L N   + G I    +   NL  LS   N  +  + +++  L KL++L + +N 
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISV-SNLPKLPKLKKLELSENR 82

Query: 124 ITGQLPASIGNLSSLRVIDVRENRL--WGRIDSLGQLKSLTLLSVAFN 169
           I G L      L +L  +++  N+L     ++ L +L+ L  L +   
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 33/171 (19%), Positives = 56/171 (32%), Gaps = 55/171 (32%)

Query: 368 RNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQI 427
              L+   P+++  L L         + +G I        NL  L++ +          +
Sbjct: 15  HLELRNRTPAAVRELVLD-----NCKSNDGKIEGLTAEFVNLEFLSLINV--------GL 61

Query: 428 LRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNI 487
           + ++ L                     L  L +L+LS N+  G +        NL +LN+
Sbjct: 62  ISVSNLP-------------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102

Query: 488 SGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
           SGN            L+ I  L            E L+ L  L+ L+L   
Sbjct: 103 SGN-----------KLKDISTL------------EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 3/89 (3%)

Query: 454 NLKNLMRLDLSGNKFS-GEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
               +  L L   K + G+I    +   NLE+L++       S+  L   L  +K+L+ S
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNL-PKLPKLKKLELS 79

Query: 513 SNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
            N + G +    E L  L  LNLS N  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 17/97 (17%), Positives = 40/97 (41%), Gaps = 2/97 (2%)

Query: 117 LSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIP 176
           L   +++  G++        +L  + +    L   + +L +L  L  L ++ N+  G + 
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGL-ISVSNLPKLPKLKKLELSENRIFGGLD 88

Query: 177 PSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLREL 213
                + +L  ++LS N+      ++    L  L+ L
Sbjct: 89  MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 7/116 (6%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
             +++  + L   +              +L  L              L     L+ +E S
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELS 79

Query: 241 KNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRN 296
           +N+  GG+ +   +L NL  LNL  N L      ++  +  L     L+ L     
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 25/120 (20%), Positives = 37/120 (30%), Gaps = 25/120 (20%)

Query: 398 NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN 457
           +    L    NL  L I + + +  L  + LR                         L  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLR------------------------GLGE 57

Query: 458 LMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
           L  L +  +      P        L  LN+S NA        +  L S++EL  S N L+
Sbjct: 58  LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 7e-07
 Identities = 19/101 (18%), Positives = 31/101 (30%), Gaps = 2/101 (1%)

Query: 441 NNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA-TLSACANLEYLNISGNAFSGSIPLL 499
                      +   +NL  L +   +    +    L     L  L I  +      P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
                 +  L+ S N L     + ++ LS L+ L LS N  
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 8e-07
 Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 3/103 (2%)

Query: 344 TNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLNNLEGNIPSS 402
           T          +    NL +L ++       +    L  L  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 403 LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLN 445
                 L  LN+S N L  +L  + ++  +L   L L  N L+
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 20/100 (20%), Positives = 37/100 (37%), Gaps = 2/100 (2%)

Query: 321 NRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE-IGELTNLQQLDLDRNFLQGSIPSSL 379
              +      +    +L  L I+  Q    +    +  L  L+ L + ++ L+   P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 380 GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL 419
                L+ L L  N LE ++        +L  L +S N L
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 19/119 (15%), Positives = 37/119 (31%), Gaps = 25/119 (21%)

Query: 79  AIPANLSSCSNLIELSADSNNLVGEIPA-DIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
               +L    NL EL  ++   +  +   D+  L +L  L+I ++ +    P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFT 196
           L  +++  N L                          +        SL+ + LS N   
Sbjct: 82  LSRLNLSFNALE------------------------SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 4/96 (4%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPAN-LSSCSNLIELSADSNNLVGEIPADIGS-LF 112
           +  H +    +L  L + N      +    L     L  L+   + L   +  D      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 113 KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRL 148
           +L RL++  N +   L        SL+ + +  N L
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 30/184 (16%), Positives = 61/184 (33%), Gaps = 8/184 (4%)

Query: 364 LDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
               R+F+   +        +              +   L  C+ L  L++   +L   +
Sbjct: 75  FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPI 134

Query: 424 PRQILRITTL-SLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKF---SGEIPATLSAC 479
              + + + L  L L   +     +L   + +   L  L+LS            A     
Sbjct: 135 VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194

Query: 480 ANLEYLNISGNAFS---GSIPLLLDSLQSIKELDFSS-NNLNGQIPEYLENLSFLEFLNL 535
             +  LN+SG   +     +  L+    ++  LD S    L     +    L++L+ L+L
Sbjct: 195 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 254

Query: 536 SYNH 539
           S  +
Sbjct: 255 SRCY 258

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 36/185 (19%), Positives = 62/185 (33%), Gaps = 17/185 (9%)

Query: 400 PSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGN-NLLNGSLPPEVGNLKNL 458
           P   G   +   +     +     P           +++L N  +   +L   +     L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 459 MRLDLSGNKFSGEIPATLSACANLEYLNISGNAF--SGSIPLLLDSLQSIKELDFSS-NN 515
             L L G + S  I  TL+  +NL  LN+SG +     ++  LL S   + EL+ S   +
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180

Query: 516 LNGQIPEYL--ENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELRL 573
              +  +         +  LNLS           G   N  +  ++   + C  L  L L
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLS-----------GYRKNLQKSDLSTLVRRCPNLVHLDL 229

Query: 574 PSCQS 578
                
Sbjct: 230 SDSVM 234

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQL 364
             + S+  ++ +  N++  ++P  +   L  L  L++  NQ+  ++P  +  +LT L  L
Sbjct: 24  TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTIL 81

Query: 365 DLDRNFLQGSIPSSL-GNLTLLTYLKLGLNNL 395
            L  N LQ S+P+ +   LT L  L L  N L
Sbjct: 82  YLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 15/122 (12%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPS----SLGNC 406
           +P  I   ++  +L+L+ N LQ         LT LT L L  N ++ ++P      L   
Sbjct: 22  VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL--- 75

Query: 407 TNLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLS 464
           T L  L +  NKL  +LP  +  ++T L   L L  N L  S+P  +   L +L ++ L 
Sbjct: 76  TKLTILYLHENKL-QSLPNGVFDKLTQLK-ELALDTNQLK-SVPDGIFDRLTSLQKIWLH 132

Query: 465 GN 466
            N
Sbjct: 133 TN 134

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.9 bits (117), Expect = 8e-07
 Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 9/107 (8%)

Query: 437 LELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSI 496
           ++L   L+  +   +  N      LDL G K    I    +     + ++ S N     I
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EI 54

Query: 497 PLL--LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFE 541
             L     L+ +K L  ++N +        + L  L  L L+ N   
Sbjct: 55  RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 27/155 (17%), Positives = 49/155 (31%), Gaps = 37/155 (23%)

Query: 388 LKLGLNNLEGNIPSSLGNCTNLLGLNISHNKL--IGTLPRQILRITTLSLYLELGNNLLN 445
           +KL    +E        N      L++   K+  I  L   + +   +       +N + 
Sbjct: 2   VKLTAELIE-QAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDF----SDNEIR 55

Query: 446 --GSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSL 503
                P     L+ L  L ++ N+          A  +L  L ++ N           SL
Sbjct: 56  KLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-----------SL 100

Query: 504 QSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
             + +LD             L +L  L +L +  N
Sbjct: 101 VELGDLD------------PLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 23/121 (19%), Positives = 42/121 (34%), Gaps = 11/121 (9%)

Query: 97  SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS----LRVIDVRENRLWGRI 152
           +  L+ +      +  +   L +    I       I NL +       ID  +N +  ++
Sbjct: 5   TAELIEQAA-QYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEI-RKL 57

Query: 153 DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRE 212
           D    L+ L  L V  N+   +       +  L  + L+ N       +D   +L SL  
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117

Query: 213 L 213
           L
Sbjct: 118 L 118

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 20/138 (14%), Positives = 38/138 (27%), Gaps = 27/138 (19%)

Query: 329 PEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYL 388
            +  N      L +   ++   I      L     +D   N ++  +      L  L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69

Query: 389 KLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSL 448
            +  N +            +L  L +++N            +  L     L         
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNS-----------LVELGDLDPL--------- 109

Query: 449 PPEVGNLKNLMRLDLSGN 466
                +LK+L  L +  N
Sbjct: 110 ----ASLKSLTYLCILRN 123

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 35/164 (21%)

Query: 232 SSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
           +    ++   N      +  F  L +L  L LG N L +      +    LT+   L  L
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN---KLTS---LTYL 81

Query: 292 YFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTI 351
             + N+ +  LP+ V +                         L  L  L ++TNQL  ++
Sbjct: 82  NLSTNQLQ-SLPNGVFD------------------------KLTQLKELALNTNQLQ-SL 115

Query: 352 PPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLN 393
           P  +  +LT L+ L L +N L+ S+P      LT L Y+ L  N
Sbjct: 116 PDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 41/122 (33%), Positives = 55/122 (45%), Gaps = 13/122 (10%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLN---NLEGNIPSSLGNCT 407
           +P  I        LDL+ N L+         LT LT L LG N   +L   + + L   T
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL---T 76

Query: 408 NLLGLNISHNKLIGTLPRQIL-RITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSG 465
           +L  LN+S N+L  +LP  +  ++T L   L L  N L  SLP  V   L  L  L L  
Sbjct: 77  SLTYLNLSTNQL-QSLPNGVFDKLTQLK-ELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133

Query: 466 NK 467
           N+
Sbjct: 134 NQ 135

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 17/147 (11%)

Query: 327 IPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGN-LTLL 385
           +P  I   A   +L ++TN L         ELT+L QL L  N LQ S+P+ + N LT L
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 386 TYLKLGLNNLEGNIPS----SLGNCTNLLGLNISHNKLIGTLPRQIL-RITTLSLYLELG 440
           TYL L  N L+ ++P+     L   T L  L ++ N+L  +LP  +  ++T L   L L 
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKL---TQLKELALNTNQL-QSLPDGVFDKLTQLK-DLRLY 132

Query: 441 NNLLNGSLPPEV-GNLKNLMRLDLSGN 466
            N L  S+P  V   L +L  + L  N
Sbjct: 133 QNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 7e-06
 Identities = 35/215 (16%), Positives = 73/215 (33%), Gaps = 29/215 (13%)

Query: 343 DTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSS 402
           D + +   I     +  + + L       +    S +  + L   L   +  L       
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLD-AMPLLNNL---K 178

Query: 403 LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLD 462
           +    NL         L      + L I +  L   +  ++L   LP    NL+ L  L 
Sbjct: 179 IKGTNNLSIGKKPRPNL------KSLEIISGGLPDSVVEDILGSDLP----NLEKL-VLY 227

Query: 463 LSGNKFSGEIPATL-------SACANLEYLNISGNAFSGSIPLLL---DSLQSIKELDFS 512
           +    +  +    +           NL++L I        +  +    D L  ++ +D S
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 513 SNNLNG----QIPEYLENLSFLEFLNLSYNHFEGE 543
           +  L       + ++++ +  L+F+N+ YN+   E
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 2e-04
 Identities = 36/302 (11%), Positives = 76/302 (25%), Gaps = 23/302 (7%)

Query: 141 IDVRENRL---WGRIDSLGQLKSLTLLSVAF------NQFSGMIPPSIFNISSLEVISLS 191
           IDVR   +   +G++ + GQ +     S            +                 + 
Sbjct: 18  IDVRGTDVIVNYGKLGTDGQTQVKNFSSAGEAEKAAGKLIAEKTKKGYVETLEEVAKEMK 77

Query: 192 ENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD 251
                 +L  D      +L +             +++                       
Sbjct: 78  VEAKKYALSYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEK 137

Query: 252 FSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSS 311
           F+  + L+W ++           ++D   +L     L  L                NL S
Sbjct: 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS 197

Query: 312 -TIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEI------GELTNLQQL 364
             I    +  + +   +  ++ NL  L       +                    NL+ L
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257

Query: 365 DLDRNFLQGSIPSSLGN---LTLLTYLKLGLNNLEGN----IPSSLGNCTNLLGLNISHN 417
            +     Q  +         L  L  + +    L       +   +    +L  +N+ +N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317

Query: 418 KL 419
            L
Sbjct: 318 YL 319

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 25/71 (35%), Positives = 35/71 (49%), Gaps = 6/71 (8%)

Query: 327 IPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSL-GNLTL 384
           +P  I    +   L +  NQ+T  + P +   LT L +LDLD N L   +P+ +   LT 
Sbjct: 24  VPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 385 LTYLKLGLNNL 395
           LT L L  N L
Sbjct: 80  LTQLSLNDNQL 90

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 305 SV-ANLSSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEI-GELTNL 361
           SV   + +T + + +  N+I+  + P +   L  L  L +D NQLT  +P  +  +LT L
Sbjct: 23  SVPTGIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 362 QQLDLDRNFLQGSIPS-SLGNLTLLTYLKLGLN 393
            QL L+ N L+ SIP  +  NL  LT++ L  N
Sbjct: 81  TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 25/71 (35%), Positives = 36/71 (50%), Gaps = 6/71 (8%)

Query: 327 IPPEIRNLASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPSSL-GNLTL 384
           +P  I        L ++ NQ+T  + P +   L NLQQL  + N L  +IP+ +   LT 
Sbjct: 27  VPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 385 LTYLKLGLNNL 395
           LT L L  N+L
Sbjct: 83  LTQLDLNDNHL 93

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 5/63 (7%)

Query: 334 LASLNWLTIDTNQLTGTIPPEI-GELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTYLKLG 391
           L +L  L  ++N+LT  IP  +  +LT L QLDL+ N L+ SIP  +  NL  LT++ L 
Sbjct: 56  LVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYL- 112

Query: 392 LNN 394
            NN
Sbjct: 113 YNN 115

>4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 7/30 (23%), Positives = 13/30 (43%)

Query: 768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
           +  + HGD    N++ D+  +    D G  
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A Length = 304

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 9/32 (28%), Positives = 16/32 (50%), Gaps = 2/32 (6%)

Query: 768 EPSIVHGDLKPSNVLLDQDL--VSHVSDFGLA 797
            P ++H D    ++L D +   +  + DFG A
Sbjct: 190 YPCLIHNDFSSDHILFDTEKNTICGIIDFGDA 221

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 7/30 (23%), Positives = 13/30 (43%)

Query: 768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
           +  + HGD    N++++    S   D G  
Sbjct: 183 DLVVTHGDACLPNIMVENGRFSGFIDCGRL 212

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 41.2 bits (96), Expect = 9e-04
 Identities = 11/30 (36%), Positives = 14/30 (46%)

Query: 768 EPSIVHGDLKPSNVLLDQDLVSHVSDFGLA 797
           E    HGDL  SN+ +    VS   D G +
Sbjct: 182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	884
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-49
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-29
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-22
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-56
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 28/231 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS--KSFVAECKALRNIRHR 696
              +   +IG G  G VYKG       +VAVK++N+        ++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++  +   +          AIV ++ +  SL   LH    +       +I+ ++IA   
Sbjct: 65  NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKF-----EMIKLIDIARQT 113

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
           A  ++YLH     SI+H DLK +N+ L +DL   + DFGLA   S  +     E      
Sbjct: 114 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ----- 165

Query: 817 GIKGTVGYVAPEYGMGREA---SMKGDVYSFGILLLELFTRKRPTDAMFNE 864
            + G++ ++APE    ++    S + DVY+FGI+L EL T + P   + N 
Sbjct: 166 -LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 7e-55
 Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 24/236 (10%)

Query: 634 LSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK-QKGASKSFVAECKALRN 692
           +    D+F   +++G G  G+V+K     +G  +A K+I+L+ +       + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
                ++                 +I  E M  GSL++ L  +        +       +
Sbjct: 61  CNSPYIVGFYGAFYSDGEI-----SICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           +I V   + YL    +  I+H D+KPSN+L++      + DFG++  L +   ++ V   
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 164

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTL 868
                  GT  Y++PE   G   S++ D++S G+ L+E+   + P      + L L
Sbjct: 165 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (462), Expect = 4e-52
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 29/241 (12%)

Query: 630 SYAELSKATDNFSSA---------NKIGEGGSGIVYKGFL---GENGTEVAVKVINLKQ- 676
           ++ + ++A   F+             IG G  G V  G L   G+    VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 677 KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN 736
           +   + F++E   +    H N+I +  V +           I+ EFM+NGSL+ +L  ++
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQND 122

Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL 796
            Q      +VIQ + +   +A+ ++YL        VH DL   N+L++ +LV  VSDFGL
Sbjct: 123 GQF-----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKR 856
           ++FL     DT   T + ++G K  + + APE    R+ +   DV+S+GI++ E+ +   
Sbjct: 175 SRFLE---DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

Query: 857 P 857
            
Sbjct: 232 R 232

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 9e-52
 Identities = 57/237 (24%), Positives = 112/237 (47%), Gaps = 22/237 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           +      ++G G  G V+ G+     T+VAVK +  +   +  +F+AE   ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  V +           I+ E+M+NGSL ++L   +       L++ + L++A  +A 
Sbjct: 71  VRLYAVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + ++        +H DL+ +N+L+   L   ++DFGLA+ + ++             G 
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGA 170

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREF 875
           K  + + APE       ++K DV+SFGILL E+ T  R           + +  R +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-51
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 18/231 (7%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRN 692
           S+A +++     IG G  G   K     +G  +  K ++     +   +  V+E   LR 
Sbjct: 1   SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           ++H N+++       R         IV E+ + G L   +     + +   L     L +
Sbjct: 60  LKHPNIVRYYDRIIDRT---NTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRV 114

Query: 753 AIDVASAIEYLH--HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
              +  A++  H       +++H DLKP+NV LD      + DFGLA+ L++        
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------ 168

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
             S +    GT  Y++PE       + K D++S G LL EL     P  A 
Sbjct: 169 --SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 1e-50
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 633 ELSKATDNFSSAN-KIGEGGSGIVYKGFL--GENGTEVAVKVINLK-QKGASKSFVAECK 688
           +L    DN   A+ ++G G  G V +G     +   +VA+KV+    +K  ++  + E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 689 ALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
            +  + +  ++++I VC            +V E    G L ++L    +++      V  
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEI-----PVSN 110

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
              +   V+  ++YL      + VH DL   NVLL     + +SDFGL+K L   +    
Sbjct: 111 VAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---- 163

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               +     K  + + APE    R+ S + DV+S+G+ + E  +  + 
Sbjct: 164 -SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-50
 Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 22/243 (9%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKII 702
            +IG G    VYKG   E   EVA   +  ++  K   + F  E + L+ ++H N+++  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
                   KG     +V E M +G+L+ +L           + +    +    +   +++
Sbjct: 75  DSWES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQF 127

Query: 763 LHHYCEPSIVHGDLKPSNVLL-DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGT 821
           LH    P I+H DLK  N+ +        + D GLA          ++          GT
Sbjct: 128 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------GT 176

Query: 822 VGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSD 881
             ++APE     +     DVY+FG+ +LE+ T + P     N        +        D
Sbjct: 177 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235

Query: 882 TDC 884
              
Sbjct: 236 KVA 238

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 22/226 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           ++     K+G+G  G V+ G      T VA+K +      + ++F+ E + ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  V S           IV E+M  GSL ++L     +         Q +++A  +AS
Sbjct: 75  VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
            + Y+        VH DL+ +N+L+ ++LV  V+DFGLA+ + ++         +   G 
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGA 174

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
           K  + + APE  +    ++K DV+SFGILL EL T+ R        
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 59/237 (24%), Positives = 109/237 (45%), Gaps = 22/237 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
              +   +IG G  G+V+ G+   N  +VA+K I  +   + + F+ E + +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  VC  +         +V+EFM++G L ++L       +    +    L + +DV  
Sbjct: 63  VQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCE 112

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
               + +  E  ++H DL   N L+ ++ V  VSDFG+ +F+ +          + S G 
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-------YTSSTGT 162

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREF 875
           K  V + +PE       S K DV+SFG+L+ E+F+  +      +    + D S  F
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 7e-48
 Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 26/219 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
                   IG+G  G V  G     G +VAVK I  K    +++F+AE   +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           ++++ V      +      IV E+M  GSL ++L      +    L     L  ++DV  
Sbjct: 63  VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+EYL      + VH DL   NVL+ +D V+ VSDFGL K  S+                
Sbjct: 115 AMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK---------- 161

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              V + APE    ++ S K DV+SFGILL E+++  R 
Sbjct: 162 -LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-47
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 24/217 (11%)

Query: 645 NKIGEGGSGIVYKGFL--GENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIK 700
            ++G G  G V KG+    +    VAVK++  +          +AE   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 701 IITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +I +C    +       +V E  + G L ++L  +        +     + +   V+  +
Sbjct: 73  MIGICEAESW------MLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
           +YL      + VH DL   NVLL     + +SDFGL+K L                  K 
Sbjct: 121 KYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            V + APE     + S K DV+SFG+L+ E F+  + 
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 63/235 (26%), Positives = 116/235 (49%), Gaps = 20/235 (8%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKA 689
           +Y +      + +  +K+G G  G VY+G   +    VAVK +  +     + F+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 690 LRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQR 749
           ++ I+H NL++++ VC+           I+ EFM  G+L ++L   N Q     +S +  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFY-----IITEFMTYGNLLDYLRECNRQ----EVSAVVL 117

Query: 750 LNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIV 809
           L +A  ++SA+EYL    + + +H DL   N L+ ++ +  V+DFGL++ ++        
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 167

Query: 810 ETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
           +T +   G K  + + APE     + S+K DV++FG+LL E+ T         + 
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-47
 Identities = 49/226 (21%), Positives = 93/226 (41%), Gaps = 27/226 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           ++F     +G+G  G VY     ++   +A+KV+    L++ G       E +   ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N++++                ++ E+   G++   L   +           +      +
Sbjct: 66  PNILRLYGYFHDATRV-----YLILEYAPLGTVYRELQKLS------KFDEQRTATYITE 114

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +A+A+ Y H      ++H D+KP N+LL       ++DFG +    +    T+       
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------ 165

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
               GT+ Y+ PE   GR    K D++S G+L  E    K P +A 
Sbjct: 166 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-47
 Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
            IG+G  G V++G     G EVAVK+ +  ++  S    AE      +RH N++  I   
Sbjct: 10  SIGKGRFGEVWRGKW--RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
           +  +        +V ++ ++GSL ++L+         +++V   + +A+  AS + +LH 
Sbjct: 67  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHM 118

Query: 766 YC-----EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
                  +P+I H DLK  N+L+ ++    ++D GLA    +      +          G
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH----RVG 174

Query: 821 TVGYVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFS 872
           T  Y+APE           E+  + D+Y+ G++  E+  R        +  L  +D  
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-47
 Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 22/248 (8%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRN 697
           +++     +GEG  G V           VAVK++++K+     ++   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K        + +      +  E+   G L + +           +           + 
Sbjct: 65  VVKFYGHRREGNIQ-----YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLM 113

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
           + + YLH      I H D+KP N+LLD+     +SDFGLA     +N + ++        
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 164

Query: 818 IKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFF 876
           + GT+ YVAPE    RE  +   DV+S GI+L  +   + P D   +      D+  +  
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224

Query: 877 TRKSDTDC 884
                   
Sbjct: 225 YLNPWKKI 232

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 8e-47
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 22/231 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
            + +   ++G G  G+V  G       +VA+K+I  +   +   F+ E K + N+ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           +++  VC+ +         I+ E+M NG L  +L     +         Q L +  DV  
Sbjct: 62  VQLYGVCTKQRPI-----FIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCE 111

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGI 818
           A+EYL        +H DL   N L++   V  VSDFGL++++ +    +       S+G 
Sbjct: 112 AMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGS 161

Query: 819 KGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLH 869
           K  V +  PE  M  + S K D+++FG+L+ E+++  +     F    T  
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-46
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 26/225 (11%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
            D +    ++G+G  G VYK    E     A KVI+ K +   + ++ E   L +  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++K++           +   I+ EF   G+++  +           L+  Q   +     
Sbjct: 71  IVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTL 120

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A+ YLH   +  I+H DLK  N+L   D    ++DFG++   +                
Sbjct: 121 DALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--------DS 169

Query: 818 IKGTVGYVAPEYGMGREA-----SMKGDVYSFGILLLELFTRKRP 857
             GT  ++APE  M   +       K DV+S GI L+E+   + P
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 2e-46
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 23/220 (10%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN 697
              ++   KIG+G SG VY       G EVA++ +NL+Q+   +  + E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           ++  +           D   +V E++  GSL + +  +            Q   +  +  
Sbjct: 79  IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECL 126

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIG 817
            A+E+LH      ++H D+K  N+LL  D    ++DFG    ++                
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--------ST 175

Query: 818 IKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           + GT  ++APE    +    K D++S GI+ +E+   + P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 6e-46
 Identities = 57/250 (22%), Positives = 92/250 (36%), Gaps = 32/250 (12%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIR 694
              FS   +IG G  G VY      N   VA+K ++   K      +  + E + L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H N I+                 +V E+    + +    H         L  ++   +  
Sbjct: 74  HPNTIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTH 122

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
                + YLH     +++H D+K  N+LL +  +  + DFG A  ++  N          
Sbjct: 123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------- 169

Query: 815 SIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDF 871
                GT  ++APE  +     +   K DV+S GI  +EL  RK P   M       H  
Sbjct: 170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227

Query: 872 SREFFTRKSD 881
             E    +S 
Sbjct: 228 QNESPALQSG 237

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 9e-46
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 22/227 (9%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGEN---GTEVAVKVIN-LKQKGASKSFVAECKAL 690
           S    +F+    IG G  G VY G L +N       AVK +N +   G    F+ E   +
Sbjct: 25  SSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
           ++  H N++ ++ +C     +      +V  +M++G L  ++ +      V        +
Sbjct: 83  KDFSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLI 133

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
              + VA     +        VH DL   N +LD+     V+DFGLA+ +     D   +
Sbjct: 134 GFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFD 186

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +     G K  V ++A E    ++ + K DV+SFG+LL EL TR  P
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (410), Expect = 5e-45
 Identities = 54/252 (21%), Positives = 100/252 (39%), Gaps = 38/252 (15%)

Query: 630 SYAELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLK-QKGASKSF 683
               L    +N      IGEG  G V++         E  T VAVK++  +        F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 684 VAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS 743
             E   +    + N++K++ VC+           +++E+M  G L E+L   +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 744 ------------------LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ 785
                             LS  ++L IA  VA+ + YL        VH DL   N L+ +
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 786 DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFG 845
           ++V  ++DFGL++ + + +                 + ++ PE       + + DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGN------DAIPIRWMPPESIFYNRYTTESDVWAYG 229

Query: 846 ILLLELFTRKRP 857
           ++L E+F+    
Sbjct: 230 VVLWEIFSYGLQ 241

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 50/225 (22%), Positives = 89/225 (39%), Gaps = 23/225 (10%)

Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRN 692
           K  ++F     +GEG    V          E A+K++    + ++        E   +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           + H   +K+       +            + +NG L +++          S         
Sbjct: 65  LDHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
             ++ SA+EYLH      I+H DLKP N+LL++D+   ++DFG AK LS  +      + 
Sbjct: 114 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 169

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                  GT  YV+PE    + A    D+++ G ++ +L     P
Sbjct: 170 -----FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-44
 Identities = 57/285 (20%), Positives = 107/285 (37%), Gaps = 40/285 (14%)

Query: 624 QQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLK-QK 677
           +++  D   E  +  +N      +G G  G V               +VAVK++  K   
Sbjct: 24  REYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81

Query: 678 GASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN 736
              ++ ++E K +  +  H N++ ++  C+           +++E+   G L  +L    
Sbjct: 82  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKR 136

Query: 737 DQL-----------------EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPS 779
           ++                  ++  L+    L  A  VA  +E+L      S VH DL   
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193

Query: 780 NVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKG 839
           NVL+    V  + DFGLA+ + + +   +          +  V ++APE       ++K 
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKS 247

Query: 840 DVYSFGILLLELFTRKRPTDAMFNEGLTLHDFSREFFTRKSDTDC 884
           DV+S+GILL E+F+               +   +  F        
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-44
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 23/231 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL----GENGTEVAVKVINLKQ-KGASKSFVAECKALRNI 693
              +    IG G  G VYKG L    G+    VA+K +     +     F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 694 RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
            H N+I++  V             I+ E+M+NG+L+++L   +        SV+Q + + 
Sbjct: 67  SHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
             +A+ +    +    + VH DL   N+L++ +LV  VSDFGL++ L +    T   +  
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 171

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
              G K  + + APE    R+ +   DV+SFGI++ E+ T         + 
Sbjct: 172 ---GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  160 bits (405), Expect = 8e-44
 Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 24/221 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D++    ++G G  G+V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           + +        F+  +   ++YEFM  G L E +   +++     +S  + +     V  
Sbjct: 86  VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCK 135

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISI 816
            + ++H   E + VH DLKP N++      + +   DFGL   L                
Sbjct: 136 GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---------VK 183

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
              GT  + APE   G+      D++S G+L   L +   P
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 33/265 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQK-GASKSFVAECKALRN 692
           +  S    +G G  G V +         +    VAVK++         ++ ++E K L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 693 I-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQL------------ 739
           +  H N++ ++  C+           ++ E+   G L  +L    D              
Sbjct: 83  LGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 740 EVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
           +  +L +   L+ +  VA  + +L      + +H DL   N+LL    ++ + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTD 859
           + N           +    +  V ++APE       + + DV+S+GI L ELF+      
Sbjct: 195 IKND------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 860 AMFNEGLTLHDFSREFFTRKSDTDC 884
                    +   +E F   S    
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-43
 Identities = 51/233 (21%), Positives = 101/233 (43%), Gaps = 31/233 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNI-R 694
           ++    + IGEG  G V K  + ++G  +   +  +K+   K   + F  E + L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLH----------HSNDQLEVCSL 744
           H N+I ++  C  R +       +  E+  +G+L ++L            +       +L
Sbjct: 70  HPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 745 SVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
           S  Q L+ A DVA     + +  +   +H DL   N+L+ ++ V+ ++DFGL++    + 
Sbjct: 125 SSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 805 PDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             T+          +  V ++A E       +   DV+S+G+LL E+ +    
Sbjct: 182 KKTMG---------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 4e-43
 Identities = 64/252 (25%), Positives = 97/252 (38%), Gaps = 25/252 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL---GENGTEVAVKVIN---LKQKGASKSFVAECKALRN 692
            +     K+G+G  G+V +G           VAVK +    L Q  A   F+ E  A+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           + HRNLI++  V      K      +V E    GSL + L             +      
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-----LLGTLSRY 116

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A+ VA  + YL        +H DL   N+LL    +  + DFGL + L  ++   +++  
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 813 SISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGLTLHDFS 872
                 K    + APE    R  S   D + FG+ L E+FT  +      N    LH   
Sbjct: 174 -----RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228

Query: 873 REFFTRKSDTDC 884
           +E        DC
Sbjct: 229 KEGERLPRPEDC 240

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-43
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 26/227 (11%)

Query: 636 KATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVI-----NLKQKGASKSFVAECKAL 690
           K T+ F     +G G  G VYKG     G +V + V            A+K  + E   +
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 691 RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRL 750
            ++ + ++ +++ +C     +      ++ + M  G L +++    D +          L
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI-----GSQYLL 114

Query: 751 NIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVE 810
           N  + +A  + YL       +VH DL   NVL+       ++DFGLAK L         E
Sbjct: 115 NWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------E 165

Query: 811 TRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               + G K  + ++A E  + R  + + DV+S+G+ + EL T    
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 18/226 (7%)

Query: 635 SKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALR 691
           S  +D +     +G GG   V+         +VAVKV+     +       F  E +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
            + H  ++ +          G     IV E++   +L + +H          ++  + + 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 115

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           +  D   A   L+   +  I+H D+KP+N+++       V DFG+A+ +++         
Sbjct: 116 VIADACQA---LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172

Query: 812 RSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                 + GT  Y++PE   G     + DVYS G +L E+ T + P
Sbjct: 173 A-----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (386), Expect = 3e-41
 Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 24/221 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           D +    ++G G  G+V++      G     K IN        +   E   +  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           I +      +         ++ EF+  G L + +   +       +S  + +N       
Sbjct: 89  INLHDAFEDK-----YEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACE 138

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISI 816
            ++++H   E SIVH D+KP N++ +    S V   DFGLA  L+            I  
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---------EIVK 186

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               T  + APE           D+++ G+L   L +   P
Sbjct: 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 25/230 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL---GENGTEVAVKVI-NLKQKGASKSFVAECKALRNIR 694
           +       IGEG  G V++G           VA+K   N       + F+ E   +R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H +++K+I V +       +   I+ E    G L  +L          SL +   +  A 
Sbjct: 67  HPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAY 115

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
            +++A+ YL        VH D+   NVL+  +    + DFGL++++ +        T   
Sbjct: 116 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYK 165

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
           +   K  + ++APE    R  +   DV+ FG+ + E+             
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-39
 Identities = 44/229 (19%), Positives = 93/229 (40%), Gaps = 24/229 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQ-KGASKSFVAECKALRN 692
           +  + + ++G+G  G+VY+G        E  T VA+K +N          F+ E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLE----VCSLSVIQ 748
               ++++++ V S           ++ E M  G L+ +L      +     +   S+ +
Sbjct: 80  FNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
            + +A ++A     + +      VH DL   N ++ +D    + DFG+ + +   +    
Sbjct: 135 MIQMAGEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---- 187

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
                        V +++PE       +   DV+SFG++L E+ T    
Sbjct: 188 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 2e-38
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 19/222 (8%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           KIG G  G +Y G     G EVA+K+  +K K        E K  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
                   D+  +V E +     + +   S         S+   L +A  + S IEY+H 
Sbjct: 72  ----GAEGDYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIH- 120

Query: 766 YCEPSIVHGDLKPSNVL---LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
               + +H D+KP N L     +  + ++ DFGLAK   +      +  R  +  + GT 
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE-NKNLTGTA 177

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
            Y +    +G E S + D+ S G +L+       P   +   
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-38
 Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 25/230 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
           + +  A  +G G  GIV++     +      K + +K          E   L   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNI 63

Query: 699 IKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVAS 758
           + +        F+  +   +++EF+    + E ++ S  +     L+  + ++    V  
Sbjct: 64  LHLHES-----FESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCE 113

Query: 759 AIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV--SDFGLAKFLSNHNPDTIVETRSISI 816
           A+++LH     +I H D++P N++      S +   +FG A+ L   +   ++       
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL------- 163

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL 866
                  Y APE       S   D++S G L+  L +   P  A  N+ +
Sbjct: 164 --FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (360), Expect = 3e-38
 Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 28/222 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
            +F     +G G  G V+      NG   A+KV+    + +    +    E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             +I++                ++ ++++ G L   L  S       +      +     
Sbjct: 64  PFIIRMWGTFQDAQQI-----FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
                  L +     I++ DLKP N+LLD++    ++DFG AK++ +             
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT--------- 160

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
             + GT  Y+APE    +  +   D +SFGIL+ E+     P
Sbjct: 161 --LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  143 bits (362), Expect = 7e-38
 Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 31/235 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK------QKGASKSFVAECKALRN 692
           ++FS    IG GG G VY     + G   A+K ++ K       +  + +       +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
                ++ +        F   D  + + + M  G L   L       E            
Sbjct: 64  GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFY 112

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETR 812
           A ++   +E++H      +V+ DLKP+N+LLD+     +SD GLA   S   P       
Sbjct: 113 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----- 164

Query: 813 SISIGIKGTVGYVAPEYGM-GREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL 866
                  GT GY+APE    G       D +S G +L +L     P      +  
Sbjct: 165 -----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 9e-38
 Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 27/233 (11%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHR 696
            D +   + +G G    V           VA+K I  K  +G   S   E   L  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++ +  +     ++      ++ + +  G L + +            +      +   V
Sbjct: 68  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQV 116

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLL---DQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
             A++YLH      IVH DLKP N+L    D+D    +SDFGL+K     +  +      
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS------ 167

Query: 814 ISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNEGL 866
                 GT GYVAPE    +  S   D +S G++   L     P     +  L
Sbjct: 168 ---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (354), Expect = 9e-38
 Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 39/235 (16%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---------KGASKSFVAECKA 689
           +N+     +G G S +V +        E AVK+I++           +   ++ + E   
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 690 LRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQ 748
           LR +  H N+I++             F  +V++ M+ G L ++L          +LS  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKV------TLSEKE 111

Query: 749 RLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTI 808
              I   +   I  LH      IVH DLKP N+LLD D+   ++DFG +  L        
Sbjct: 112 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 168

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREA------SMKGDVYSFGILLLELFTRKRP 857
           V          GT  Y+APE               + D++S G+++  L     P
Sbjct: 169 V---------CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-37
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 22/222 (9%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNL 698
            +++    IG G  G+VY+  L ++G  VA+K +   +    +    E + +R + H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 699 IKIITVC-SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +++     S  + K   +  +V +++         H+S  +    +L VI        + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLF 132

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            ++ Y+H      I H D+KP N+LLD D  V  + DFG AK L    P+         +
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------V 180

Query: 817 GIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
               +  Y APE   G    +   DV+S G +L EL   +  
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-37
 Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 26/223 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKAL-RNIR 694
           ++F     +G+G  G V+     +     A+K +    +      +  + E + L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
           H  L  +      ++         V E++  G L   +   +         + +    A 
Sbjct: 62  HPFLTHMFCTFQTKENL-----FFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAA 110

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSI 814
           ++   +++L       IV+ DLK  N+LLD+D    ++DFG+ K     +        + 
Sbjct: 111 EIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AK 159

Query: 815 SIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +    GT  Y+APE  +G++ +   D +SFG+LL E+   + P
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 23/234 (9%)

Query: 634 LSKATDNFSSANKIGEGGSGIVYKGF-LGENGTEVAVKVINLK--QKGASKSFVAECKAL 690
           L +A   +    +IGEG  G V+K   L   G  VA+K + ++  ++G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 691 RNI---RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVI 747
           R++    H N++++  VC+           +V+E +                    +   
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116

Query: 748 QRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDT 807
              ++   +   +++LH +    +VH DLKP N+L+       ++DFGLA+  S     T
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173

Query: 808 IVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM 861
                     +  T+ Y APE  +    +   D++S G +  E+F RK      
Sbjct: 174 ---------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 33/238 (13%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL-------GENGTEVAVKVINLKQ-KGASKSFVAECKAL 690
           D       +GEG  G V                T+VAVK++     +      ++E + +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 691 RNI-RHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS------ 743
           + I +H+N+I ++  C+           ++ E+   G+L E+L          S      
Sbjct: 73  KMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 744 ----LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF 799
               LS    ++ A  VA     + +      +H DL   NVL+ +D V  ++DFGLA+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184

Query: 800 LSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           + +      ++    +   +  V ++APE    R  + + DV+SFG+LL E+FT    
Sbjct: 185 IHH------IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 18/222 (8%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN-LKQKGASKSFVAECKALRNIRHR 696
              +++ + IGEG  G+V   +   N   VA+K I+  + +   +  + E K L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N+I I  +      +      +V   M    L + L   +       LS          +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH-------LSNDHICYFLYQI 118

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              ++Y+H     +++H DLKPSN+LL+      + DFGLA+     +  T   T  +  
Sbjct: 119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-- 173

Query: 817 GIKGTVGYVAPEY-GMGREASMKGDVYSFGILLLELFTRKRP 857
               T  Y APE     +  +   D++S G +L E+ + +  
Sbjct: 174 ---ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-36
 Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 35/242 (14%)

Query: 620 LPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGA 679
           L I++  ++D Y   S+          +G G +G V + F      + A+K++    K  
Sbjct: 2   LQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-- 50

Query: 680 SKSFVAECKAL-RNIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQ 738
                 E +   R  +  ++++I+ V     + G     IV E +  G L   +    DQ
Sbjct: 51  ---ARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ 106

Query: 739 LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSDFG 795
               + +  +   I   +  AI+YLH     +I H D+KP N+L      + +  ++DFG
Sbjct: 107 ----AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK 855
            AK  ++HN  T             T  YVAPE     +     D++S G+++  L    
Sbjct: 160 FAKETTSHNSLTTPCY---------TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210

Query: 856 RP 857
            P
Sbjct: 211 PP 212

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 28/242 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFL-----GENGTEVAVKVINLKQ-KGASKSFVAECKALRN 692
           D       +G G  G V +              VAVK++         ++ ++E K L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCS--------- 743
           I H      +    G   K      ++ EF + G+L  +L    ++              
Sbjct: 73  IGHHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 744 -LSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSN 802
            L++   +  +  VA  +E+L        +H DL   N+LL +  V  + DFGLA+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 803 HNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF 862
                           +  + ++APE    R  +++ DV+SFG+LL E+F+         
Sbjct: 187 D------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 863 NE 864
             
Sbjct: 241 KI 242

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (340), Expect = 8e-36
 Identities = 45/224 (20%), Positives = 87/224 (38%), Gaps = 21/224 (9%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           +IGEG  G++++G    N  +VA+K    +    +     E +  + +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 706 SGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHH 765
                +      +V + +  G   E L     +      SV      A  + + ++ +H 
Sbjct: 70  ----GQEGLHNVLVIDLL--GPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIH- 118

Query: 766 YCEPSIVHGDLKPSNVLLDQDLVSH-----VSDFGLAKFLSNHNPDTIVETRSISIGIKG 820
             E S+V+ D+KP N L+ +    +     V DFG+ KF  +      +  R     + G
Sbjct: 119 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSG 175

Query: 821 TVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE 864
           T  Y++    +GRE S + D+ + G + +       P   +   
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-35
 Identities = 54/225 (24%), Positives = 106/225 (47%), Gaps = 19/225 (8%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHR 696
             +    KIG+G  G V+K    + G +VA+K + ++  ++G   + + E K L+ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 697 NLIKIITVCSGRDFKGADFKA---IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIA 753
           N++ +I +C  +       K    +V++F ++       +     L   +LS I+R+   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQM 125

Query: 754 IDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRS 813
           +     +  L++     I+H D+K +NVL+ +D V  ++DFGLA+  S           +
Sbjct: 126 L-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 814 ISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRP 857
                  T+ Y  PE  +G R+     D++  G ++ E++TR   
Sbjct: 181 ----RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 6e-35
 Identities = 48/229 (20%), Positives = 90/229 (39%), Gaps = 33/229 (14%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGAS------KSFVAECKALRN 692
           D + +  ++G G   +V K      G + A K I  ++  +S      +    E   L+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 693 IRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNI 752
           I+H N+I +  V   +         ++ E +  G L ++L       E  +   ++++  
Sbjct: 70  IQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-- 122

Query: 753 AIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS----HVSDFGLAKFLSNHNPDTI 808
                  +  +++     I H DLKP N++L    V      + DFGLA  +   N    
Sbjct: 123 -------LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 809 VETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
           +          GT  +VAPE        ++ D++S G++   L +   P
Sbjct: 176 I---------FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 24/222 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
           +NF    KIGEG  G+VYK      G  VA+K I L    +G   + + E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K++ V         +   +V+EF+      + L    D   +  + +    +    +
Sbjct: 62  NIVKLLDVIHTE-----NKLYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQL 111

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              + + H +    ++H DLKP N+L++ +    ++DFGLA+                  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--------RTYT 160

Query: 817 GIKGTVGYVAPE-YGMGREASMKGDVYSFGILLLELFTRKRP 857
               T+ Y APE     +  S   D++S G +  E+ TR+  
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-34
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 28/219 (12%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINLK-----QKGASKSFVAECKALRNIRHRNLI 699
           + +GEG    VYK         VA+K I L      + G +++ + E K L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 700 KIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASA 759
            ++     +        ++V++FM+         +S                  +     
Sbjct: 64  GLLDAFGHKSNI-----SLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112

Query: 760 IEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +EYLH +    I+H DLKP+N+LLD++ V  ++DFGLAK                     
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------SPNRAYTHQV 161

Query: 820 GTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRP 857
            T  Y APE   G R   +  D+++ G +L EL  R   
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-34
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 23/221 (10%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
             +    KIGEG  G V+K    E    VA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++++  V             +V+EF      + +   + D       S + +L      
Sbjct: 62  NIVRLHDVLHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------ 110

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
              ++ L      +++H DLKP N+L++++    +++FGLA+             R  S 
Sbjct: 111 ---LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSA 160

Query: 817 GIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            +              +  S   D++S G +  EL    RP
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 6e-34
 Identities = 47/222 (21%), Positives = 81/222 (36%), Gaps = 25/222 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN---LKQKGASKSFVAECKALRNIRH 695
           ++F     +G+G  G V        G   A+K++    +  K      V E + L+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
             L  +       D         V E+   G L   L            +  +      +
Sbjct: 65  PFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRE------RVFTEERARFYGAE 113

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           + SA   L +     +V+ D+K  N++LD+D    ++DFGL K   +             
Sbjct: 114 IVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT------ 164

Query: 816 IGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
               GT  Y+APE     +     D +  G+++ E+   + P
Sbjct: 165 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 2e-32
 Identities = 56/263 (21%), Positives = 99/263 (37%), Gaps = 39/263 (14%)

Query: 612 SARKASNMLPIEQQFLVDSYAELSKAT----------DNFSSANKIGEGGSGIVYKGFLG 661
           +A+K S    +++ FL  +  +  K            D F     +G G  G V      
Sbjct: 5   AAKKGSEQESVKE-FLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63

Query: 662 ENGTEVAVKVINLKQKGASK---SFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI 718
           E+G   A+K+++ ++    K     + E + L+ +    L+K+                +
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY-----M 118

Query: 719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP 778
           V E++  G +   L            S       A  +    EYLH      +++ DLKP
Sbjct: 119 VMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKP 169

Query: 779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMK 838
            N+L+DQ     V+DFG AK +                 + GT   +APE  + +  +  
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-----------LCGTPEALAPEIILSKGYNKA 218

Query: 839 GDVYSFGILLLELFTRKRPTDAM 861
            D ++ G+L+ E+     P  A 
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFAD 241

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)

Query: 639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHR 696
           + +    KIGEG  G+VYK      G   A+K I L++  +G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 697 NLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDV 756
           N++K+  V   +         +V+E +     +              L  +   +  + +
Sbjct: 61  NIVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQL 109

Query: 757 ASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISI 816
            + I Y H   +  ++H DLKP N+L++++    ++DFGLA+           E  ++  
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-- 164

Query: 817 GIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
                  Y AP+  MG +  S   D++S G +  E+      
Sbjct: 165 ------WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 40/222 (18%), Positives = 70/222 (31%), Gaps = 33/222 (14%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLK------QKGASKSFVAECKALRNIR--HRN 697
            +G GG G VY G    +   VA+K +         +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 698 LIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVA 757
           +I+++           D   ++ E  +                  +L      +    V 
Sbjct: 71  VIRLLDWFERP-----DSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120

Query: 758 SAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS-HVSDFGLAKFLSNHNPDTIVETRSISI 816
            A+ +        ++H D+K  N+L+D +     + DFG    L +              
Sbjct: 121 EAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------- 170

Query: 817 GIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRP 857
              GT  Y  PE+            V+S GILL ++     P
Sbjct: 171 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 5e-31
 Identities = 52/263 (19%), Positives = 101/263 (38%), Gaps = 30/263 (11%)

Query: 618 NMLPIEQQFLVDSYAELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK 677
           N     + +  +S+       D++    K+G G    V++     N  +V VK++   +K
Sbjct: 14  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73

Query: 678 GASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSN 736
              K    E K L N+R   N+I +  +      +     A+V+E + N   ++      
Sbjct: 74  ---KKIKREIKILENLRGGPNIITLADIVKDPVSR---TPALVFEHVNNTDFKQLYQ--- 124

Query: 737 DQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD-QDLVSHVSDFG 795
                 +L+         ++  A++Y H      I+H D+KP NV++D +     + D+G
Sbjct: 125 ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175

Query: 796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTR 854
           LA+F        +            +  +  PE  +  +      D++S G +L  +  R
Sbjct: 176 LAEFYHPGQEYNV---------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226

Query: 855 KRPTDAMFNEGLTLHDFSREFFT 877
           K P     +    L   ++   T
Sbjct: 227 KEPFFHGHDNYDQLVRIAKVLGT 249

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 4e-30
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 24/215 (11%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRHRNLIKIIT 703
            IG G  GIV   +       VA+K ++   + +  +K    E   ++ + H+N+I ++ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 704 VCSGRD-FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEY 762
           V + +   +      +V E M     +      + +         +   +   +   I++
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKH 134

Query: 763 LHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTV 822
           LH      I+H DLKPSN+++  D    + DFGLA+        T             T 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------VVTR 182

Query: 823 GYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            Y APE  +G       D++S G ++ E+   K  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 6e-30
 Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 30/233 (12%)

Query: 633 ELSKAT----DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAE 686
           E++K        +     +G G  G V     G  G +VA+K +    + +  +K    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 687 CKALRNIRHRNLIKIITVCSGRD-FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLS 745
            + L+++RH N+I ++ V +  +         +V  FM  G+    L           L 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE------KLG 119

Query: 746 VIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNP 805
             +   +   +   + Y+H        H DLKP N+ +++D    + DFGLA+   +   
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174

Query: 806 DTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRP 857
                      G   T  Y APE  +     +   D++S G ++ E+ T K  
Sbjct: 175 ---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 8e-30
 Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 24/223 (10%)

Query: 638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVIN--LKQKGASKSFVAECKALRNIRH 695
            + + + + +G G  G V   F  + G  VAVK ++   +    +K    E + L++++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 696 RNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAID 755
            N+I ++ V +            +   +    L   +           L+      +   
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQ 129

Query: 756 VASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSIS 815
           +   ++Y+H      I+H DLKPSN+ +++D    + DFGLA+   +             
Sbjct: 130 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---------- 176

Query: 816 IGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRP 857
            G   T  Y APE  +     +   D++S G ++ EL T +  
Sbjct: 177 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 5e-29
 Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 29/228 (12%)

Query: 639 DNFSSANKIGEGGSGIVYKG---FLGENGTEVAVKVIN----LKQKGASKSFVAECKALR 691
           +NF     +G G  G V+        + G   A+KV+     +++   ++    E + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 692 NIRHRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLN 751
           +IR    +    V     F+      ++ +++  G L   L       E           
Sbjct: 84  HIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130

Query: 752 IAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVET 811
           + I V   +  L H  +  I++ D+K  N+LLD +    ++DFGL+K       +     
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE----- 185

Query: 812 RSISIGIKGTVGYVAPEYGMGREA--SMKGDVYSFGILLLELFTRKRP 857
              +    GT+ Y+AP+   G ++      D +S G+L+ EL T   P
Sbjct: 186 --RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 9e-29
 Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 15/218 (6%)

Query: 646 KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVC 705
           K+G G    V+      N T VA+K++    K  +++   E K L+ +   +  K  ++ 
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 706 SGRDFK-----GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAI 760
           +    K            V+  M    L E L     + E   + +I    I+  +   +
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 761 EYLHHYCEPSIVHGDLKPSNVLLDQ-DLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIK 819
           +Y+H  C   I+H D+KP NVL++  D   ++    +A   +                  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------CWYDEHYTNSI 190

Query: 820 GTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRP 857
            T  Y +PE  +G       D++S   L+ EL T    
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  110 bits (276), Expect = 1e-26
 Identities = 84/387 (21%), Positives = 146/387 (37%), Gaps = 29/387 (7%)

Query: 134 NLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSEN 193
            L+      + +  +   + S   L  +T L         +    +  +++L  I+ S N
Sbjct: 20  ALAEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76

Query: 194 RFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVS------LSNASSLEMIEFSKNQFSGG 247
           + T   P+    NL  L ++  N N      P++           + ++ +    +    
Sbjct: 77  QLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 248 VSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVA 307
           ++        +  ++           +  + +  L   + L  L             SV 
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 308 NLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLD 367
              + ++ +    N+IS   P  I    +L+ L+++ NQL       +  LTNL  LDL 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 368 RNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQI 427
            N +    P  L  LT LT LKLG N +    P  L   T L  L ++ N+L    P   
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN 305

Query: 428 LRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNI 487
           L+  T   YL L  N ++   P  V +L  L RL  + NK S    ++L+   N+ +L+ 
Sbjct: 306 LKNLT---YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 488 SGNAFSGSIPLLLDSLQSIKELDFSSN 514
             N  S   P  L +L  I +L  +  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (262), Expect = 7e-25
 Identities = 81/388 (20%), Positives = 158/388 (40%), Gaps = 29/388 (7%)

Query: 110 SLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFN 169
           +L +  +  + + ++T  +  +  +L  +  +      +   ID +  L +LT ++ + N
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSIDGVEYLNNLTQINFSNN 76

Query: 170 QFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLS 229
           Q + + P  + N++ L  I ++ N+     P+    NL  L        +      ++  
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 230 NA-----SSLEMIEFSKNQFSGGVSVDFSRLKNLYWL-NLGINNLGTGAANELDFINLLT 283
           N      +++  I       S       +++ +L  L NL        ++N++  I++L 
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 284 NCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTID 343
             + LE L    N+     P     + + + ++++  N++       + +L +L  L + 
Sbjct: 195 KLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 344 TNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSL 403
            NQ++   P  +  LT L +L L  N +    P  L  LT LT L+L  N LE   P S 
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304

Query: 404 GNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDL 463
            N  NL  L +  N +    P  +  +T L   L   NN ++      + NL N+  L  
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 464 SGNKFSGEIPATLSACANLEYLNISGNA 491
             N+ S   P  L+    +  L ++  A
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 99.3 bits (246), Expect = 7e-23
 Identities = 76/402 (18%), Positives = 143/402 (35%), Gaps = 40/402 (9%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
               +  LG  ++  T+S    +L  +  +     G    I   +  L +L ++  SNN 
Sbjct: 22  AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 77

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
            +   P  L + + L+++  ++N +    P                N     L  +    
Sbjct: 78  LTDITP--LKNLTKLVDILMNNNQIADITPLA-----------NLTNLTGLTLFNNQITD 124

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
                     NRL    +++  + +L+ L+       G     +  +++L  +   +   
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRL 255
                +     L +L  L    N  +   P+     ++L+ +  + NQ     +   + L
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASL 240

Query: 256 KNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQ 315
            NL  L+L  N +          +  L+  +KL  L    N+     P     L+     
Sbjct: 241 TNLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISP-----LAGLTAL 287

Query: 316 IAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSI 375
             +  N         I NL +L +LT+  N ++   P  +  LT LQ+L    N +    
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343

Query: 376 PSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHN 417
            SSL NLT + +L  G N +    P  L N T +  L ++  
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.4 bits (88), Expect = 0.004
 Identities = 10/74 (13%), Positives = 29/74 (39%), Gaps = 4/74 (5%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           +     + ++      ++ RL   N  +       + NL+ + +++   N  +   P  +
Sbjct: 314 LYFNNISDISPVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L 369

Query: 61  GRLISLERLILSNN 74
             L  + +L L++ 
Sbjct: 370 ANLTRITQLGLNDQ 383

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (237), Expect = 2e-22
 Identities = 53/255 (20%), Positives = 82/255 (32%), Gaps = 5/255 (1%)

Query: 288 LERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQL 347
            +R++ + NR       S     +                               D  QL
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 348 TGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCT 407
               P     L  L  L LDR  LQ   P     L  L YL L  N L+     +  +  
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 408 NLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNK 467
           NL  L +  N++     R    + +L   L L  N +    P    +L  LM L L  N 
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLL-LHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL 527
            S      L+    L+YL ++ N +             +++   SS+ +   +P+ L   
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271

Query: 528 SFLEFLNLSYNHFEG 542
                  L+ N  +G
Sbjct: 272 D---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (173), Expect = 4e-14
 Identities = 49/253 (19%), Positives = 80/253 (31%), Gaps = 29/253 (11%)

Query: 345 NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNI----- 399
             L   +P  I      Q++ L  N +     +S      LT L L  N L         
Sbjct: 21  QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 400 --------------------PSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLEL 439
                               P++      L  L++    L    P     +  L     L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL-YL 136

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
            +N L         +L NL  L L GN+ S           +L+ L +  N  +   P  
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIA 559
              L  +  L   +NNL+    E L  L  L++L L+ N +  +   + ++    +F  +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256

Query: 560 GNGKLCGGLDELR 572
            +   C     L 
Sbjct: 257 SSEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.2 bits (170), Expect = 1e-13
 Identities = 53/314 (16%), Positives = 100/314 (31%), Gaps = 39/314 (12%)

Query: 86  SCSNLIELSAD-SNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVR 144
            C N  +++       +  +P  I +    +R+ +  N I+    AS     +L ++ + 
Sbjct: 7   VCYNEPKVTTSCPQQGLQAVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 145 ENRLWGRIDSLGQLKSLTLL-SVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDT 203
            N L     +     +L     ++ N     + P+ F+                      
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH---------------------- 102

Query: 204 GVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNL 263
              L  L  L  +        P      ++L+ +    N         F  L NL  L L
Sbjct: 103 --GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160

Query: 264 GINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRI 323
             N + +                 L+RL  ++NR     PH+  +L   +    +  N +
Sbjct: 161 HGNRISS------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY-LFANNL 213

Query: 324 SGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLT 383
           S      +  L +L +L ++ N               LQ+     + +  S+P  L    
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272

Query: 384 LLTYLKLGLNNLEG 397
           L     L  N+L+G
Sbjct: 273 LKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 5e-13
 Identities = 52/258 (20%), Positives = 89/258 (34%), Gaps = 12/258 (4%)

Query: 55  EIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKL 114
            +P  I    + +R+ L  N  S    A+  +C NL  L   SN L     A    L  L
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 115 ERLSIFQNHITGQL-PASIGNLSSLRVIDV-RENRLWGRIDSLGQLKSLTLLSVAFNQFS 172
           E+L +  N     + PA+   L  L  + + R             L +L  L +  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 173 GMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNAS 232
            +   +  ++ +L  + L  NR +  +P      L SL  L  + N      P +  +  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 233 SLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLY 292
            L  +    N  S   +   + L+ L +L L  N         +         + L++  
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW-------VCDCRARPLWAWLQKFR 254

Query: 293 FNRNRFEGELPHSVANLS 310
            + +     LP  +A   
Sbjct: 255 GSSSEVPCSLPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 8e-12
 Identities = 30/197 (15%), Positives = 63/197 (31%), Gaps = 3/197 (1%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
               +           R+  L L    ++         L+ L+Y+ +  N          
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF 120
             L +L  L L  N  S           +L  L    N +    P     L +L  L +F
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
            N+++     ++  L +L+ + + +N       +      L     + ++    +P    
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ--- 266

Query: 181 NISSLEVISLSENRFTG 197
            ++  ++  L+ N   G
Sbjct: 267 RLAGRDLKRLAANDLQG 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.0 bits (227), Expect = 7e-21
 Identities = 49/236 (20%), Positives = 97/236 (41%), Gaps = 6/236 (2%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
            +L      + +  N+I+     + +NL +L+ L +  N+++   P     L  L++L L
Sbjct: 27  KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
            +N L+         L  L   +  +  +  ++ + L     ++ L  +  K  G     
Sbjct: 87  SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSSGIENGA 145

Query: 427 ILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN 486
              +  LS       N+   ++P   G   +L  L L GNK +    A+L    NL  L 
Sbjct: 146 FQGMKKLSYIRIADTNI--TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201

Query: 487 ISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG 542
           +S N+ S      L +   ++EL  ++N L  ++P  L +  +++ + L  N+   
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.1 bits (222), Expect = 3e-20
 Identities = 41/236 (17%), Positives = 77/236 (32%), Gaps = 7/236 (2%)

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLL 385
            +P ++        L +  N++T     +   L NL  L L  N +    P +   L  L
Sbjct: 24  KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 386 TYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLN 445
             L L  N L+            L        K+  ++   + ++  + L         +
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN--PLKSS 139

Query: 446 GSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQS 505
           G        +K L  + ++    +  IP       +L  L++ GN  +      L  L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 506 IKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           + +L  S N+++      L N   L  L+L+ N                   +  N
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.2 bits (212), Expect = 6e-19
 Identities = 46/218 (21%), Positives = 71/218 (32%), Gaps = 11/218 (5%)

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNL 409
            +P ++    +   LDL  N +         NL  L  L L  N +    P +      L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 410 LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSG--NK 467
             L +S N+L   LP ++ +       L +  N +          L  ++ ++L     K
Sbjct: 82  ERLYLSKNQL-KELPEKMPKTLQ---ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 468 FSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENL 527
            SG           L Y+ I+    +     L  SL    EL    N +       L+ L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGL 194

Query: 528 SFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLC 565
           + L  L LS+N                R     N KL 
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.9 bits (211), Expect = 8e-19
 Identities = 51/296 (17%), Positives = 95/296 (32%), Gaps = 20/296 (6%)

Query: 4   CQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRL 63
           C    V C          DLG + +   L P          +++ +N            L
Sbjct: 10  CHLRVVQCS---------DLGLEKVPKDLPPD------TALLDLQNNKITEIKDGDFKNL 54

Query: 64  ISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNH 123
            +L  LIL NN  S   P   +    L  L    N L         +L +L         
Sbjct: 55  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114

Query: 124 ITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNIS 183
           +   +   +  +  + +             +   +K L+ + +A    +  IP  +    
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--P 171

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           SL  + L  N+ T      +   L +L +L  + N+ +     SL+N   L  +  + N+
Sbjct: 172 SLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFE 299
               V    +  K +  + L  NN+    +N+       T  +    +    N  +
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.1 bits (196), Expect = 7e-17
 Identities = 56/301 (18%), Positives = 101/301 (33%), Gaps = 46/301 (15%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           +P  +       ++ L  N+ T  +      NL +L  L    N  +   P + +    L
Sbjct: 25  VPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           E +  SKNQ           L+ L      I  +     N L+ + ++   +        
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN------- 134

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
                                      + SG      + +  L+++ I    +T TIP  
Sbjct: 135 -------------------------PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNI 414
           +    +L +L LD N +     +SL  L  L  L L  N++      SL N  +L  L++
Sbjct: 169 L--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226

Query: 415 SHNKLIGTLPRQILRITTLSLYLELGNNLLNG------SLPPEVGNLKNLMRLDLSGNKF 468
           ++NKL+   P  +     +   + L NN ++         P       +   + L  N  
Sbjct: 227 NNNKLVKV-PGGLADHKYIQ-VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284

Query: 469 S 469
            
Sbjct: 285 Q 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 1e-15
 Identities = 43/267 (16%), Positives = 92/267 (34%), Gaps = 19/267 (7%)

Query: 159 KSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN 218
               LL +  N+ + +      N+ +L  + L  N+ +   P      L  L  L  + N
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYLSKN 89

Query: 219 NFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDF 278
                          L +    +N+ +      F+ L  +  + LG N L +       F
Sbjct: 90  QLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 279 INLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLN 338
             +     KL  +          +      L  ++ ++ +  N+I+      ++ L +L 
Sbjct: 147 QGM----KKLSYIRIADTN----ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 339 WLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEG- 397
            L +  N ++      +    +L++L L+ N L   +P  L +   +  + L  NN+   
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257

Query: 398 -----NIPSSLGNCTNLLGLNISHNKL 419
                  P       +  G+++  N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 72.4 bits (176), Expect = 3e-14
 Identities = 53/292 (18%), Positives = 106/292 (36%), Gaps = 23/292 (7%)

Query: 127 QLPASIGNLSSLRVIDVRENRLWGRID-SLGQLKSLTLLSVAFNQFSGMIPPSIFNISSL 185
           ++P  +       ++D++ N++    D     LK+L  L +  N+ S + P +   +  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 186 EVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFS 245
           E + LS+N+    LP      L  LR            +   L+    +E+      + S
Sbjct: 82  ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSS 139

Query: 246 GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHS 305
           G  +  F  +K L ++ +   N+ T                 L  L+ + N+       S
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQG---------LPPSLTELHLDGNKITKVDAAS 190

Query: 306 VANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLD 365
           +  L+  + ++ +  N IS      + N   L  L ++ N+L   +P  + +   +Q + 
Sbjct: 191 LKGLN-NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248

Query: 366 LDRNFLQG------SIPSSLGNLTLLTYLKLGLNNLE-GNIPSSLGNCTNLL 410
           L  N +          P         + + L  N ++   I  S   C  + 
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.7 bits (219), Expect = 9e-21
 Identities = 29/170 (17%), Positives = 55/170 (32%), Gaps = 29/170 (17%)

Query: 645 NKIGEGGSGIVYKGFLGENGTEVAVKVINL----------KQKGASKSFVAECKALRNIR 694
             +GEG    V+  +  E   E  VK   +          K+      F           
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 695 HRNLIKIITVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAI 754
            R L K+  +   + +   +  A++ E +    L      + D+             +  
Sbjct: 65  FRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110

Query: 755 DVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHN 804
            +   +   +H     IVHGDL   NVL+ ++ +  + DF  +  +    
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 89.8 bits (221), Expect = 4e-20
 Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 9/267 (3%)

Query: 313 IKQIAMGRNRISG--TIPPEIRNLASLNWLTIDTN-QLTGTIPPEIGELTNLQQLDLDRN 369
           +  + +    +     IP  + NL  LN+L I     L G IPP I +LT L  L +   
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 370 FLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILR 429
            + G+IP  L  +  L  L    N L G +P S+ +  NL+G+    N++ G +P     
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 430 ITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISG 489
            + L   + +  N L G +PP   NL                     S     +      
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 490 NAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGV 549
           +       + L    +  +L   +N + G +P+ L  L FL  LN+S+N+  GE+P  G 
Sbjct: 232 SLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289

Query: 550 FNNKTRFSIAGNGKLCGGLDELRLPSC 576
                  + A N  LCG      LP+C
Sbjct: 290 LQRFDVSAYANNKCLCGS----PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.2 bits (196), Expect = 7e-17
 Identities = 70/275 (25%), Positives = 110/275 (40%), Gaps = 9/275 (3%)

Query: 4   CQWTGVTC--GQRHQRVTRLDLGNQSIRG--TLSPYVGNLSFLRYINIASN-GFNGEIPH 58
             W GV C    +  RV  LDL   ++     +   + NL +L ++ I       G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 59  QIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLS 118
            I +L  L  L +++ + SGAIP  LS    L+ L    N L G +P  I SL  L  ++
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 119 IFQNHITGQLPASIGNLSSLRV-IDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPP 177
              N I+G +P S G+ S L   + +  NRL G+I       +L  + ++ N   G    
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215

Query: 178 SIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMI 237
              +  + + I L++N     L         +  +LR N     G +P  L+    L  +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN--RIYGTLPQGLTQLKFLHSL 273

Query: 238 EFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGA 272
             S N   G +      L+         N    G+
Sbjct: 274 NVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 14/284 (4%)

Query: 73  NNSFSGAIPANLSSCSNLIELSADSNNLVG--EIPADIGSLFKLERLSIFQNH-ITGQLP 129
           N ++ G +    +    +  L     NL     IP+ + +L  L  L I   + + G +P
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 130 ASIGNLSSLRVIDVRENRLWGRIDSLGQ-LKSLTLLSVAFNQFSGMIPPSIFNISSLEVI 188
            +I  L+ L  + +    + G I      +K+L  L  ++N  SG +PPSI ++ +L  I
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 189 SLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGV 248
           +   NR +G++P   G        +  + N  TG IP              +        
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP--------TFANLNLAFVDLSR 206

Query: 249 SVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVAN 308
           ++       L+  +     +     +    +  +     L  L    NR  G LP  +  
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 309 LSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIP 352
           L   +  + +  N + G I P+  NL   +      N+     P
Sbjct: 267 LKF-LHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.3 bits (134), Expect = 5e-09
 Identities = 25/88 (28%), Positives = 36/88 (40%), Gaps = 3/88 (3%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
                   +      + +  LDL N  I GTL   +  L FL  +N++ N   GEIP Q 
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCS 88
           G L   +    +NN      P  L +C+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 53.2 bits (126), Expect = 5e-08
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 1/66 (1%)

Query: 40  SFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNN 99
             L  +++ +N   G +P  + +L  L  L +S N+  G IP    +       +  +N 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 100 LVGEIP 105
            +   P
Sbjct: 303 CLCGSP 308

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.7 bits (161), Expect = 1e-12
 Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 8/211 (3%)

Query: 330 EIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLK 389
           E+  +AS   +  D   LT  +PP++    +   L L  N L     ++L   T LT L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 390 LGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLP 449
             L+  E       G    L  L++SHN+L               L +    N L     
Sbjct: 62  --LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS--FNRLTSLPL 117

Query: 450 PEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKEL 509
             +  L  L  L L GN+     P  L+    LE L+++ N  +     LL+ L+++  L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 510 DFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
               N+L   IP+       L F  L  N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 6e-09
 Identities = 38/205 (18%), Positives = 60/205 (29%), Gaps = 20/205 (9%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
            + S  E+  +  N T  +P  L       ++  S+N               L  LNL  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD- 63

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFE---------------GELPHSVANLS 310
               T    +     L T      +L       +                 LP       
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 311 STIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNF 370
             ++++ +  N +    P  +     L  L++  N LT      +  L NL  L L  N 
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 371 LQGSIPSSLGNLTLLTYLKLGLNNL 395
           L  +IP       LL +  L  N  
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 2e-07
 Identities = 38/209 (18%), Positives = 65/209 (31%), Gaps = 7/209 (3%)

Query: 36  VGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSA 95
           V  ++    +N         +P  + +      L LS N       A L   + L +L  
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL-- 60

Query: 96  DSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSL 155
           + +          G+L  L  L +  N +           +   +           + +L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 156 GQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRT 215
             L  L  L +  N+   + P  +     LE +SL+ N  T  LP      L +L  L  
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLL 179

Query: 216 NANNFTGFIPVSLSNASSLEMIEFSKNQF 244
             N+    IP     +  L       N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 5e-05
 Identities = 35/179 (19%), Positives = 55/179 (30%), Gaps = 5/179 (2%)

Query: 18  VTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFS 77
            T L L    +       +   + L  +N+  +          G L  L  L LS+N   
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 78  GAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSS 137
                   +   L  L    N L       +  L +L+ L +  N +    P  +     
Sbjct: 91  SLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 138 LRVIDVRENRLWGRI-DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
           L  + +  N L       L  L++L  L +  N     IP   F    L    L  N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 35/251 (13%), Positives = 80/251 (31%), Gaps = 13/251 (5%)

Query: 19  TRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSG 78
             LDL  +++   ++  + +   +       +  +  +         ++ + LSN+    
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60

Query: 79  -AIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF--QNHITGQLPASIGNL 135
             +   LS CS L  LS +   L   I   +     L RL++          L   + + 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKS-------LTLLSVAFNQFSGMIPPSIFNISSLEVI 188
           S L  +++     +        +         L L     N     +   +    +L  +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 189 SLSENRFTGSLPVDTGVNLPSLRELR-TNANNFTGFIPVSLSNASSLEMIEFSKNQFSGG 247
            LS++    +        L  L+ L  +   +      + L    +L+ ++       G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 248 VSVDFSRLKNL 258
           + +    L +L
Sbjct: 241 LQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 47/285 (16%), Positives = 91/285 (31%), Gaps = 22/285 (7%)

Query: 261 LNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGR 320
           L+L   NL       L    ++            R+  +  L    +     ++ + +  
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVI-------AFRCPRSFMDQPLAEHFSPFR--VQHMDLSN 55

Query: 321 NRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDR--NFLQGSIPS 377
           + I  +    I    + L  L+++  +L+  I   + + +NL +L+L     F + ++ +
Sbjct: 56  SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115

Query: 378 SLGNLTLLTYLKLGLNNLEG------NIPSSLGNCTNLLGLNISHNKLIGTLPRQILRIT 431
            L + + L  L L              +       T L       N     L   + R  
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175

Query: 432 TLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSG-NKFSGEIPATLSACANLEYLNISGN 490
            L       + +L      E   L  L  L LS       E    L     L+ L + G 
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235

Query: 491 AFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNL 535
              G++ LL ++L     L  + ++        + N    E   +
Sbjct: 236 VPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 3e-07
 Identities = 49/269 (18%), Positives = 80/269 (29%), Gaps = 40/269 (14%)

Query: 328 PPEIRNLASLNWLTIDTNQL-TGTIPPEIGELTNLQQLDLDRNFLQG-SIPSSLGNLTLL 385
           P     L S   +     +        E      +Q +DL  + ++  ++   L   + L
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 386 TYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLY--------- 436
             L L    L   I ++L   +NL+ LN+S          Q L  +   L          
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 437 ----------------------LELGNNLLNGSLPPEVGNLKNLMRLDLSGN-KFSGEIP 473
                                      NL    L   V    NL+ LDLS +     +  
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193

Query: 474 ATLSACANLEYLNISG-NAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEF 532
                   L++L++S          L L  + ++K L       +G +    E L     
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---H 250

Query: 533 LNLSYNHFEGEVPMKGVFNNKTRFSIAGN 561
           L ++ +HF           NK    I G 
Sbjct: 251 LQINCSHFTTIAR--PTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 2/103 (1%)

Query: 384 LLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNL 443
           L   L L   NL  ++   L +   ++      + +   L           + L   + +
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLS-NSVI 58

Query: 444 LNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN 486
              +L   +     L  L L G + S  I  TL+  +NL  LN
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.5 bits (133), Expect = 7e-10
 Identities = 27/127 (21%), Positives = 43/127 (33%), Gaps = 8/127 (6%)

Query: 362 QQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG 421
           + L L    L  ++   L  L L+T+L L  N L    P+ L     L  L  S N  + 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA-LE 56

Query: 422 TLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE---IPATLSA 478
            +           L L   N L   +    + +   L+ L+L GN    E          
Sbjct: 57  NVDGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 479 CANLEYL 485
             ++  +
Sbjct: 116 LPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.7 bits (118), Expect = 8e-08
 Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)

Query: 436 YLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGS 495
            L L +  L  ++   +  L  +  LDLS N+     PA L+A   LE L  S NA    
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 496 IPLLLDSLQSIKELDFSSNNLNG-QIPEYLENLSFLEFLNLSYNHFEGE 543
             +   +L  ++EL   +N L      + L +   L  LNL  N    E
Sbjct: 59  DGV--ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 8e-07
 Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 4/106 (3%)

Query: 117 LSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIP 176
           L +    +T      +  L  +  +D+  NRL     +L  L+ L +L  + N       
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENV 58

Query: 177 PSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTG 222
             + N+  L+ + L  NR   S  +   V+ P L  L    N+   
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 30/127 (23%), Positives = 45/127 (35%), Gaps = 10/127 (7%)

Query: 387 YLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG 446
            L L   +L   +   L     +  L++SHN+L    P     +  L     L  +    
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNAL 55

Query: 447 SLPPEVGNLKNLMRLDLSGNKF-SGEIPATLSACANLEYLNISGNAFS---GSIPLLLDS 502
                V NL  L  L L  N+         L +C  L  LN+ GN+     G    L + 
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 503 LQSIKEL 509
           L S+  +
Sbjct: 116 LPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 19/120 (15%), Positives = 48/120 (40%), Gaps = 6/120 (5%)

Query: 43  RYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVG 102
           R +++A       +   + +L+ +  L LS+N      P  L++   L      +++   
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV--LQASDNAL 55

Query: 103 EIPADIGSLFKLERLSIFQNHITG-QLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSL 161
           E    + +L +L+ L +  N +        + +   L +++++ N L        +L  +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 22/121 (18%), Positives = 43/121 (35%), Gaps = 12/121 (9%)

Query: 274 NELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRN 333
            +L  +  L     +  L  + NR     P     L++      +  +  +      + N
Sbjct: 8   KDLTVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVAN 63

Query: 334 LASLNWLTIDTNQLTGTIPPE-IGELTNLQQLDLDRNFL------QGSIPSSLGNLT-LL 385
           L  L  L +  N+L  +   + +     L  L+L  N L      Q  +   L +++ +L
Sbjct: 64  LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

Query: 386 T 386
           T
Sbjct: 124 T 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 23/127 (18%), Positives = 45/127 (35%), Gaps = 9/127 (7%)

Query: 164 LSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRT-NANNFTG 222
           L +A    +  +   +  +  +  + LS NR     P      L +LR L    A++   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNAL 55

Query: 223 FIPVSLSNASSLEMIEFSKNQFSGGVSVD-FSRLKNLYWLNLGINNLGTGAANELDFINL 281
                ++N   L+ +    N+     ++        L  LNL  N+L      +     +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 282 LTNCSKL 288
           L + S +
Sbjct: 116 LPSVSSI 122

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.5 bits (137), Expect = 3e-09
 Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 9/94 (9%)

Query: 441 NNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLL 500
            N  +  +        +L  L++S NK   E+PA       LE L  S N  +  +P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP--- 320

Query: 501 DSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLN 534
           +  Q++K+L    N L  + P+  E++  L   +
Sbjct: 321 ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 49/326 (15%), Positives = 90/326 (27%), Gaps = 16/326 (4%)

Query: 113 KLERLSIFQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFS 172
           +   L +    ++  LP    +L SL       N L    +    LKSL + +      S
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLTELPELPQSLKSLLVDNNNLKALS 94

Query: 173 GMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNAS 232
            + P   +   S   +         S      V+  SL++L     +       +     
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 233 SLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFI---NLLTNCSKLE 289
             E+            +    +L +L      I           +      L T  +   
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214

Query: 290 RLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTG 349
            L    +        +V +   T                     L+ L       N  + 
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274

Query: 350 TIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNL 409
            I        +L++L++  N L   +P+       L  L    N+L   +P    N    
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQ- 328

Query: 410 LGLNISHNKLIGTLPRQILRITTLSL 435
             L++ +N L    P     +  L +
Sbjct: 329 --LHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 9/91 (9%)

Query: 50  NGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIG 109
           N  + EI        SLE L +SNN     +PA       L  L A  N+L  E+P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHL-AEVPELPQ 324

Query: 110 SLFKLERLSIFQNHITGQLPASIGNLSSLRV 140
           +   L++L +  N +  + P    ++  LR+
Sbjct: 325 N---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 27/94 (28%), Positives = 38/94 (40%), Gaps = 11/94 (11%)

Query: 393 NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           N     I S      +L  LN+S+NKLI  LP    R+  L       N+L    +P   
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIAS---FNHL--AEVPELP 323

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLN 486
            NLK   +L +  N    E P    +  +L  +N
Sbjct: 324 QNLK---QLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 463 LSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE 522
              N  S EI +      +LE LN+S N     +P L   L+    L  S N+L  ++PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPE 321

Query: 523 YLENLSFLEFLNLSYNHFEG 542
             +N   L+ L++ YN    
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 3e-05
 Identities = 52/326 (15%), Positives = 95/326 (29%), Gaps = 19/326 (5%)

Query: 65  SLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSL--FKLERLSIFQN 122
               L L+N   S ++P       +L  L A  N+L  E+P    SL    ++  ++   
Sbjct: 39  QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 123 HITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNI 182
                L   +G  ++                      SL  L         +   +    
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 183 SSLEVISLSENRFTGSLPV-DTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSK 241
              E+ +L       +       +    L      A N        L N   L  I    
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 242 NQFSGGVSVDFSRLKNLYWLNLGINNLGT-GAANELDFINLLTNCSKLERLYFNRNRFEG 300
           N       +  S        N   +      +   LD    + +                
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 301 ELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTN 360
               S+ +L  +++++ +  N++   +P     L  L       N L   +P       N
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ---N 325

Query: 361 LQQLDLDRNFLQG--SIPSSLGNLTL 384
           L+QL ++ N L+    IP S+ +L +
Sbjct: 326 LKQLHVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 2e-04
 Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 14/99 (14%)

Query: 120 FQNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSI 179
           + N  + ++ +      SL  ++V  N+L        +L+ L     +FN  +  +P   
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIA---SFNHLAE-VPEL- 322

Query: 180 FNISSLEVISLSENRFTGSLPVDTGVNLP-SLRELRTNA 217
               +L+ + +  N      P     ++P S+ +LR N+
Sbjct: 323 --PQNLKQLHVEYNPLR-EFP-----DIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 5/66 (7%)

Query: 456 KNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN 515
           +    L+L+    S  +P       +LE L  S N+ +  +P L  SL+S+   + +   
Sbjct: 38  RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 516 LNGQIP 521
           L+   P
Sbjct: 93  LSDLPP 98

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 5/62 (8%)

Query: 479 CANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN 538
                 L ++    S S+P   +    ++ L  S N+L  ++PE  ++L  L   N +  
Sbjct: 37  DRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 539 HF 540
             
Sbjct: 92  AL 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (136), Expect = 5e-09
 Identities = 13/94 (13%), Positives = 28/94 (29%), Gaps = 10/94 (10%)

Query: 457 NLMRLDLSGNKFSGE-IPATLSACANLEYLNISGNAFSG----SIPLLLDSLQSIKELDF 511
           ++  LD+   + S       L      + + +     +      I   L    ++ EL+ 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 512 SSNNLNGQIPEYL-----ENLSFLEFLNLSYNHF 540
            SN L       +          ++ L+L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 2e-08
 Identities = 18/83 (21%), Positives = 36/83 (43%), Gaps = 9/83 (10%)

Query: 454 NLKNLMRLDLSGNKFSGE----IPATLSACANLEYLNISGNAFSGS-IPLLLDSLQS--- 505
               L  L L+    S      + ATL A  +L  L++S N    + I  L++S++    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 506 -IKELDFSSNNLNGQIPEYLENL 527
            +++L       + ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 5e-08
 Identities = 15/68 (22%), Positives = 22/68 (32%), Gaps = 5/68 (7%)

Query: 481 NLEYLNISGNAFSGS-IPLLLDSLQSIKELDFSSNNLNGQ----IPEYLENLSFLEFLNL 535
           +++ L+I     S +    LL  LQ  + +      L       I   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 536 SYNHFEGE 543
             N     
Sbjct: 63  RSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 15/97 (15%), Positives = 27/97 (27%), Gaps = 12/97 (12%)

Query: 428 LRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE----IPATLSACANLE 483
           L I +L +       L +      +  L+    + L     +      I + L     L 
Sbjct: 2   LDIQSLDIQ---CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 484 YLNISGNAFSGSIP-----LLLDSLQSIKELDFSSNN 515
            LN+  N             L      I++L   +  
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 6e-07
 Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 9/82 (10%)

Query: 473 PATLSACANLEYLNISGNAFSG----SIPLLLDSLQSIKELDFSSNNLNGQIPEYL---- 524
                  + L  L ++    S     S+   L +  S++ELD S+N L       L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 525 -ENLSFLEFLNLSYNHFEGEVP 545
            +    LE L L   ++  E+ 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 5e-06
 Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 9/78 (11%)

Query: 436 YLELGNNLLNG----SLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA-----CANLEYLN 486
            L L +  ++     SL   +    +L  LDLS N         L          LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 487 ISGNAFSGSIPLLLDSLQ 504
           +    +S  +   L +L+
Sbjct: 433 LYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 13/90 (14%)

Query: 360 NLQQLDLDRNFLQGS-IPSSLGNLTLLTYLKLGLNNLEG----NIPSSLGNCTNLLGLNI 414
           ++Q LD+    L  +     L  L     ++L    L      +I S+L     L  LN+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 415 SHNKLIGT--------LPRQILRITTLSLY 436
             N+L           L     +I  LSL 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 13/111 (11%)

Query: 44  YINIASNGFNGEIPHQIGRLISLERLILSNNSFSG----AIPANLSSCSNLIELSADSNN 99
              +   G              L  L L++   S     ++ A L +  +L EL   +N 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 100 LVGEIPADIGSLFK-----LERLSIFQNHITGQLPASIGNLS----SLRVI 141
           L       +    +     LE+L ++  + + ++   +  L     SLRVI
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 5/83 (6%)

Query: 42  LRYINIASNGFNGE-IPHQIGRLISLERLILSNNSFSG----AIPANLSSCSNLIELSAD 96
           ++ ++I     +       +  L   + + L +   +      I + L     L EL+  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 97  SNNLVGEIPADIGSLFKLERLSI 119
           SN L       +    +     I
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 24/102 (23%)

Query: 381 NLTLLTYLKLGLNNLEGN----IPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLY 436
             ++L  L L   ++  +    + ++L    +L  L++S+N L              +  
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL------------GDAGI 414

Query: 437 LELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSA 478
           L+L  ++              L +L L    +S E+   L A
Sbjct: 415 LQLVESVRQ--------PGCLLEQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 10/78 (12%), Positives = 21/78 (26%), Gaps = 3/78 (3%)

Query: 233 SLEMIEFSKNQFS-GGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERL 291
            ++ ++    + S    +     L+    + L    L      ++   + L     L  L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60

Query: 292 YFNRNRFEGELPHSVANL 309
               N       H V   
Sbjct: 61  NLRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 13/78 (16%), Positives = 23/78 (29%), Gaps = 9/78 (11%)

Query: 359 TNLQQLDLDRNFLQG----SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLG-----NCTNL 409
           + L+ L L    +      S+ ++L     L  L L  N L       L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 410 LGLNISHNKLIGTLPRQI 427
             L +        +  ++
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 14/81 (17%), Positives = 26/81 (32%), Gaps = 9/81 (11%)

Query: 332 RNLASLNWLTIDTNQLTGTIPPEIGE----LTNLQQLDLDRNFLQGSIPSSLG-----NL 382
           +  + L  L +    ++ +    +        +L++LDL  N L  +    L        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 383 TLLTYLKLGLNNLEGNIPSSL 403
            LL  L L        +   L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 15/86 (17%), Positives = 27/86 (31%), Gaps = 5/86 (5%)

Query: 228 LSNASSLEMIEFSKNQFSGGVSVD----FSRLKNLYWLNLGINNLGTGAANELDFINLLT 283
               S L ++  +    S               +L  L+L  N LG     +L   ++  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423

Query: 284 NCSKLERLYFNRNRFEGELPHSVANL 309
               LE+L      +  E+   +  L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 5/94 (5%)

Query: 310 SSTIKQIAMGRNRISGTIPPEI-RNLASLNWLTIDTNQLTGTIPPEIGE----LTNLQQL 364
           S  I+ + +    +S     E+   L     + +D   LT     +I         L +L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 365 DLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGN 398
           +L  N L       +         K+   +L+  
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 38/217 (17%), Positives = 70/217 (32%), Gaps = 21/217 (9%)

Query: 333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGL 392
            LA+   +    + +T T+     +L  +  L      +       +  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 393 NNLEGNIPSS------LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG 446
           N +    P            +     N+S    + ++    L  T ++    L       
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 447 SLPPEVGNLKNLMRLDL-------SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
            L  ++  + N+  L         S           L+  + L  L    N  S   PL 
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL- 191

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS 536
             SL ++ E+   +N ++   P  L N S L  + L+
Sbjct: 192 -ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 4e-07
 Identities = 38/219 (17%), Positives = 68/219 (31%), Gaps = 22/219 (10%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
             L++ IK IA G++ ++ T+     +L  +  L+     +T      +  L NL  L+L
Sbjct: 16  PALANAIK-IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
             N +    P           L          I       T  L      +         
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 427 ILRITTLSLYLELGNNLL-------------NGSLPPEVGNLKNLMRLDLSGNKFSGEIP 473
           +  +      +   + L                S    + NL  L  L    NK S   P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 474 ATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
             L++  NL  +++  N  S   P  L +  ++  +  +
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 5e-07
 Identities = 32/217 (14%), Positives = 70/217 (32%), Gaps = 16/217 (7%)

Query: 181 NISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFS 240
            +++   I+  ++  T ++      +L  +  L       T      +   ++L  +E  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71

Query: 241 KNQF------SGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
            NQ            +    L      N+                  +T+ + L  L   
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 295 RN-RFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPP 353
           +    +     +++ L+       +       +    + NL+ L  L  D N+++   P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 354 EIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL 390
            +  L NL ++ L  N +    P  L N + L  + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 3e-06
 Identities = 29/218 (13%), Positives = 64/218 (29%), Gaps = 15/218 (6%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGI 265
            L +  ++    +N T    V+ ++   +  +       +         L NL  L L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 266 NNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISG 325
           N +   A  +          S       +       +       +       +       
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 326 TIPPEIRNLASLNWLTI-------DTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSS 378
            +  ++  + +++ L                +    +  L+ L  L  D N +    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 379 LGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
           L +L  L  + L  N +    P  L N +NL  + +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 31/205 (15%), Positives = 65/205 (31%), Gaps = 21/205 (10%)

Query: 358 LTNLQQLDLDRNFLQGSIPSS-LGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH 416
           L N  ++   ++ +  ++  + L  +T L+    G+  +EG     +    NL+GL +  
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72

Query: 417 NKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSG----------- 465
           N++    P + L   T           ++     +     +L    ++            
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 466 --NKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEY 523
                  +I              +S      S    L +L  +  L    N ++   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 524 LENLSFLEFLNLSYNHFEGEVPMKG 548
           L +L  L  ++L  N      P+  
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLAN 215

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 36/228 (15%), Positives = 78/228 (34%), Gaps = 19/228 (8%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
               ++  G  ++  T++    +L  +  ++    G    I   +  L +L  L L +N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74

Query: 76  FSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNL 135
            +   P    +    +ELS +    V  I             +   +       +++  L
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 136 SSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRF 195
                     + L G  +            ++           + N+S L  +   +N+ 
Sbjct: 135 YLDLNQITNISPLAGLTNLQ---------YLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 196 TGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           +   P+    +LP+L E+    N  +   P  L+N S+L ++  + NQ
Sbjct: 186 SDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 49.8 bits (117), Expect = 2e-07
 Identities = 31/179 (17%), Positives = 59/179 (32%), Gaps = 7/179 (3%)

Query: 362 QQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIG 421
             +D     L+  IP  +      T L L  N L       L      L         + 
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 422 TLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACAN 481
            +        +    L+LG N +          L  L  L+L  N+ S  +P +     +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 482 LEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHF 540
           L  LN++ N F+ +   L    + +++   +        P  + ++      +L ++ F
Sbjct: 128 LTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.7 bits (96), Expect = 1e-04
 Identities = 30/174 (17%), Positives = 60/174 (34%), Gaps = 13/174 (7%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           IP  I        + L++N             LP L +L    N  TG  P +   AS +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
           + ++  +N+     +  F  L  L  LNL  N +        +      + + L  L   
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE------HLNSLTSLNLA 134

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLT 348
            N F       +A  +  +++ ++         P ++R+   +    +  ++  
Sbjct: 135 SNPFNCN--CHLAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 4/169 (2%)

Query: 405 NCT-NLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDL 463
            C      ++ +   L   +PR I   TT  L L   N L   S     G L +L++L+L
Sbjct: 5   MCHCEGTTVDCTGRGLK-EIPRDIPLHTT-ELLLN-DNELGRISSDGLFGRLPHLVKLEL 61

Query: 464 SGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEY 523
             N+ +G  P      ++++ L +  N        +   L  +K L+   N ++  +P  
Sbjct: 62  KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121

Query: 524 LENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLCGGLDELR 572
            E+L+ L  LNL+ N F     +        + S+ G    CG   ++R
Sbjct: 122 FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 2e-06
 Identities = 37/197 (18%), Positives = 67/197 (34%), Gaps = 24/197 (12%)

Query: 308 NLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLD 367
             + TIK   + +  ++  +      L S++ +  + + +       I  L N+ +L L+
Sbjct: 22  AFAETIKD-NLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 368 RNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQI 427
            N L    P  L NL  L +L L  N ++             L L  +    I  L    
Sbjct: 77  GNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134

Query: 428 LRITTLSLYLELGNNLLNGSL---------------PPEVGNLKNLMRLDLSGNKFSGEI 472
              +      ++ +  +   L                  +  L  L  L LS N  S ++
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DL 193

Query: 473 PATLSACANLEYLNISG 489
            A L+   NL+ L +  
Sbjct: 194 RA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 42/217 (19%), Positives = 74/217 (34%), Gaps = 23/217 (10%)

Query: 326 TIPPEI------RNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSL 379
           T+P  I         A      +    +T  +     EL ++ Q+  + + ++      +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 380 GNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLEL 439
             L  +T L L  N L    P  L N  NL  L +  NK+      + L+          
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 440 GNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
           G + +NG +         L    ++                 L+ L++  N  S  +P  
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSR-------LTKLDTLSLEDNQISDIVP-- 173

Query: 500 LDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS 536
           L  L  ++ L  S N+++      L  L  L+ L L 
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 28/191 (14%), Positives = 62/191 (32%), Gaps = 21/191 (10%)

Query: 16  QRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNS 75
               + +L  +S+   ++     L+ +  I   ++         I  L ++ +L L+ N 
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79

Query: 76  FSGAIPANLSSCSNLIELSADSN---------------NLVGEIPADIGSLFKLERLSIF 120
            +   P         + L  +                 +L     +DI  L  L +L   
Sbjct: 80  LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139

Query: 121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIF 180
                     ++ +  +       E+     I  L  L  L  L ++ N  S +   ++ 
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALA 197

Query: 181 NISSLEVISLS 191
            + +L+V+ L 
Sbjct: 198 GLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 36/222 (16%), Positives = 75/222 (33%), Gaps = 30/222 (13%)

Query: 175 IPPSIFNISSLEVIS------LSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSL 228
           +P  I  I S +  +      L +   T ++  +    L S+ ++  N ++        +
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG--I 64

Query: 229 SNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKL 288
               ++  +  + N+ +                   + NL       LD   +    S  
Sbjct: 65  QYLPNVTKLFLNGNKLTD---------------IKPLANLKNLGWLFLDENKVKDLSSLK 109

Query: 289 ERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLT 348
           +         E      +  L    +  ++       T    +  L  L+ L+++ NQ++
Sbjct: 110 DLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169

Query: 349 GTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKL 390
             +P  +  LT LQ L L +N +      +L  L  L  L+L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 6e-06
 Identities = 25/146 (17%), Positives = 56/146 (38%), Gaps = 11/146 (7%)

Query: 389 KLGLNNLEGNIPSSLGNCTNL--LGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNG 446
           +L    +E  +   +    +     L++   +         L    + + L   +++   
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSD-----PDLVAQNIDVVLNRRSSMAA- 55

Query: 447 SLPPEVGNLKNLMRLDLSGNKFSG--EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQ 504
           +L     N+  L+ L+LS N+     ++ + +    NL+ LN+SGN       L      
Sbjct: 56  TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115

Query: 505 SIKELDFSSNNLNGQIPEYLENLSFL 530
            ++EL    N+L+    +    +S +
Sbjct: 116 KLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 33/169 (19%), Positives = 56/169 (33%), Gaps = 26/169 (15%)

Query: 351 IPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL 410
           +   + +  +  Q  LD   L+      L    +   L    +++   +     N   LL
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELL 68

Query: 411 GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG 470
            LN+S+N+L                            +   V    NL  L+LSGN+   
Sbjct: 69  SLNLSNNRLYR-----------------------LDDMSSIVQKAPNLKILNLSGNELKS 105

Query: 471 EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQ 519
           E          LE L + GN+ S +       + +I+E       L+G 
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.9 bits (104), Expect = 3e-05
 Identities = 39/332 (11%), Positives = 93/332 (28%), Gaps = 30/332 (9%)

Query: 112 FKLERLSIFQNHITGQ----LPASIGNLSSLRVIDVRENRLWGR--------IDSLGQLK 159
           F +E  S+  + IT +    + A +    S++ I +  N +           I S   L+
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 160 SLTLLSVAFNQFSGMIPPSIFNISSLEV--ISLSENRFTGSLPVDTGVNLPSLRELRTNA 217
                 +   +    IP ++  +    +    L   R + +    T          +   
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELD 277
                     L   +  ++    +       + +   L+++      + N       +  
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 278 FINL---LTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNL 334
             +         +             E       L     Q     +  S  +   +++ 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 335 ASLNWLTIDTNQLTGTIPPEIGE------LTNLQQLDLDRNFLQGSIPSSL-----GNLT 383
            +L  L ++   L+      + +         LQ L L  N ++     +L       + 
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 384 LLTYLKLGLNNL--EGNIPSSLGNCTNLLGLN 413
            L +L+L  N    E ++   +    +  G  
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 2e-04
 Identities = 46/309 (14%), Positives = 90/309 (29%), Gaps = 24/309 (7%)

Query: 224 IPVSLSNASSLEMIEFSKNQFSG----GVSVDFSRLKNLYWLNLGINNL----GTGAANE 275
           +   L    S++ I  S N         +S + +  K+L                     
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 276 LDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIR-NL 334
              +  L  C KL  +  + N F       + +  S    +       +G  P       
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 335 ASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN 394
            +L  L ++           I    N  +    + + +      L +   +    +    
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 395 LEGNIPSSLGNCTNLLGLNISHNKLIG---TLPRQILRITTLSLYLELGNNLLNGSLPPE 451
           +E  +   L  C  L  L++  N       +     L+       L L + LL+      
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262

Query: 452 VGN------LKNLMRLDLSGNKFSGEIPATLSACA-----NLEYLNISGNAFSGSIPLLL 500
           V +         L  L L  N+   +   TL         +L +L ++GN F      ++
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVV 321

Query: 501 DSLQSIKEL 509
           D ++ +   
Sbjct: 322 DEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 15/94 (15%), Positives = 33/94 (35%), Gaps = 4/94 (4%)

Query: 428 LRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGE----IPATLSACANLE 483
             I   SL L+        S+   +    ++  + LSGN    E    +   +++  +LE
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 484 YLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN 517
               S          + ++L+ + +       L+
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 8e-05
 Identities = 24/147 (16%), Positives = 45/147 (30%), Gaps = 5/147 (3%)

Query: 439 LGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPL 498
           L   L+  +   +  N      LDL G K    I    +     + ++ S N        
Sbjct: 3   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG- 58

Query: 499 LLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSI 558
               L+ +K L  ++N +        + L  L  L L+ N       +  + + K+   +
Sbjct: 59  -FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 559 AGNGKLCGGLDELRLPSCQSKGSLTIL 585
                        RL        + +L
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 19/139 (13%), Positives = 37/139 (26%), Gaps = 6/139 (4%)

Query: 329 PEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYL 388
            +  N      L +   ++   I      L     +D   N ++         L  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68

Query: 389 KLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGN---NLLN 445
            +  N +            +L  L +++N L+       L       YL +         
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 446 GSLPPEVGNLKNLMRLDLS 464
                 +  +  +  LD  
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (95), Expect = 1e-04
 Identities = 17/146 (11%), Positives = 33/146 (22%), Gaps = 2/146 (1%)

Query: 86  SCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF-QNHITGQLPASIGNLSSLRVIDVR 144
                  L    +  + +    +     L  L I  Q H+       +  L  LR + + 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 145 ENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTG 204
           ++ L                          +        SL+ + LS N    S  +   
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 205 VNLPSLRELRTNANNFTGFIPVSLSN 230
                                  L++
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAH 150

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 2e-04
 Identities = 24/150 (16%), Positives = 46/150 (30%), Gaps = 3/150 (2%)

Query: 329 PEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS-SLGNLTLLTY 387
           P+       + L    +         +    NL +L ++       +    L  L  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 388 LKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGS 447
           L +  + L    P +      L  LN+S N L  +L  + ++  +L   +  GN L    
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 448 LPPEVGNLKNLMRLDLSGNKFSGEIPATLS 477
               +   +      +   K        L+
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLA 149

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 22/117 (18%), Positives = 35/117 (29%), Gaps = 2/117 (1%)

Query: 450 PEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS-LQSIKE 508
           P+         L  + +    +    L    NL  L I        + L     L  ++ 
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 509 LDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLC 565
           L    + L    P+       L  LNLS+N  E          +     ++GN   C
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 28/144 (19%), Positives = 46/144 (31%), Gaps = 3/144 (2%)

Query: 385 LTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLL 444
            + L+   +    +    L    NL  L I + + +  L  + LR       L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 445 NGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL-LDSL 503
               P        L RL+LS N     +        +L+ L +SGN    S  L  L   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 504 QSIKELDFSSNNLNGQIPEYLENL 527
           +           L       L ++
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHM 151

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 29/227 (12%), Positives = 60/227 (26%), Gaps = 9/227 (3%)

Query: 175 IPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSL 234
           IP  +    +   +     +    +          L ++  + N+    I   + +    
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 235 EMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFN 294
                 +   +       +         L I+N G      L  ++ + +  K+     +
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI---KHLPDVHKIHSLQKVLLDIQD 136

Query: 295 RNRFEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPE 354
                    +S   LS     + + +N I                   D N L       
Sbjct: 137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196

Query: 355 IGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPS 401
               +    LD+ R  +       L NL  L        NL+  +P+
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 38/241 (15%), Positives = 61/241 (25%), Gaps = 10/241 (4%)

Query: 184 SLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQ 243
           S  V    E++ T  +P D      +  ELR            + S    LE IE S+N 
Sbjct: 9   SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

Query: 244 FSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP 303
               +  D                      N   F N     +    L  N         
Sbjct: 65  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN---LPNLQYLLISNTGIKHLPDV 121

Query: 304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQ 363
           H + +L   +  I    N  +      +        L ++ N +              + 
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181

Query: 364 LDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTL 423
              D N L+          +    L +    +       L N   L   +  + K    L
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 238

Query: 424 P 424
           P
Sbjct: 239 P 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 7/47 (14%), Positives = 12/47 (25%), Gaps = 3/47 (6%)

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLL 499
                 + LD+S  +        L     L   +         +P L
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 35/214 (16%), Positives = 67/214 (31%), Gaps = 5/214 (2%)

Query: 326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLL 385
            IP ++    +   L     +L            +L+++++ +N +   I + + +    
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 386 TYLKLGL--NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPR-QILRITTLSLYLELGNN 442
            +       NNL    P +  N  NL  L IS+  +       +I  +  + L ++   N
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 443 LLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDS 502
           +        VG     + L L+ N          +     E      N        +   
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 503 LQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLS 536
                 LD S   ++      LENL  L   +  
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 11/105 (10%), Positives = 22/105 (20%), Gaps = 3/105 (2%)

Query: 1   MNLCQWTGVTCGQRHQRVTRLDLGNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQI 60
           +N+      +          L L    I+   +               +N          
Sbjct: 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF 197

Query: 61  GRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIP 105
                   L +S           L +   L      S   + ++P
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRAR---STYNLKKLP 239

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 34/192 (17%), Positives = 62/192 (32%), Gaps = 20/192 (10%)

Query: 307 ANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDL 366
             L+  +K + +G+  ++ T+     +L  +  L  D   +       +  L NL Q++ 
Sbjct: 15  TALAEKMKTV-LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINF 69

Query: 367 DRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQ 426
             N L    P       +   +          + +        L  N   +         
Sbjct: 70  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 427 ILRITTLSLYLELGNNLL-------------NGSLPPEVGNLKNLMRLDLSGNKFSGEIP 473
           + R+   S  +   + L                +    + NL  L RLD+S NK S    
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--I 187

Query: 474 ATLSACANLEYL 485
           + L+   NLE L
Sbjct: 188 SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 7e-04
 Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 17/201 (8%)

Query: 333 NLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGL 392
            LA      +    +T T+     +L  +  L  DR  ++ SI   +  L  LT +    
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71

Query: 393 NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV 452
           N L    P  L N T      +    +       I  +  L+    L       +    +
Sbjct: 72  NQLTDITP--LKNLT-----KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124

Query: 453 GNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFS 512
            NL NL RL+LS N  S     +     +L+ LN S N  +   P  L +L +++ LD S
Sbjct: 125 KNLTNLNRLELSSNTISDISALS--GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180

Query: 513 SNNLNGQIPEYLENLSFLEFL 533
           SN ++      L  L+ LE L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 29/191 (15%), Positives = 56/191 (29%), Gaps = 15/191 (7%)

Query: 206 NLPSLRELRTNANNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVD-FSRLKNLYWLNLG 264
            L    +      N T    VS ++   +  ++  +       S+D    L NL  +N  
Sbjct: 16  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK---SIDGVEYLNNLTQINFS 70

Query: 265 INNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELPHSVANLSSTIKQIAMGRNRIS 324
            N L      +     +    +  +            L       +       +      
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 325 GTIPPEIRNLASLNWLTIDTNQLTG-------TIPPEIGELTNLQQLDLDRNFLQGSIPS 377
             +      ++ ++ L+  T+           T    +  LT L++LD+  N +     S
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--IS 188

Query: 378 SLGNLTLLTYL 388
            L  LT L  L
Sbjct: 189 VLAKLTNLESL 199

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	884
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.93
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.91
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.91
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.81
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.8
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.76
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.73
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.72
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.68
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.09
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	99.08
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.96
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.45
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.14
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.06
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.71
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.71

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.43  Aligned_cols=201  Identities=25%  Similarity=0.441  Sum_probs=179.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.+++.++||||++++++     +......|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-----YLVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEE-----EEETTEEE
T ss_pred             CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEE-----EEECCEEE
T ss_conf             1053887898128582999999989998999999843017279999999999986799988058577-----98899989


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|+|.+++...       .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        94 ivmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a  163 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEECCCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHH
T ss_conf             999703798089886415-------9999999999999999999999---879722677688868878996864251564


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             1256689986211100110333443110753127988884344320449899876199889956
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      +........        ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       164 ~~~~~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         164 AQITPEQSK--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             EECCSTTCC--------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EEECCCCCC--------CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCC
T ss_conf             132136664--------44444477736826644799880120313729999980488998997

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.58  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=178.2

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226-6506999999999971789974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||+||+|+++.+++.||+|+++... ......+.+|+.+++.++||||+++++++     .+....
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCEE
T ss_conf             568889789712778099999998999699999987540978999999999999867999999499999-----989999


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             2899812899988996106998532468999999999999999999850499-991654989998234899956994243
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCE-PSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg  795 (884)
                      ++||||+++|+|.+++...+      .+++..+..++.|++.|+.|||   + .+|+||||||+|||++.++.+||+|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEECCCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEECCCCCEEEEECC
T ss_conf             99997679986899874249------9999999999999999999999---85999714457799468789989995487


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             4412566899862111001103334431107531279888843443204498998761998899563
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +|+...+...          ...+||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+..
T Consensus       151 la~~~~~~~~----------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         151 VSGQLIDSMA----------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             CCHHHHHHTC-------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCCCCCCCCC----------CCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             7625678862----------11137714119468758998948889989999999998889989988

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.17  Aligned_cols=209  Identities=25%  Similarity=0.381  Sum_probs=179.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226-6506999999999971789974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|+.+++.++||||++++++     +.+....
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~-----~~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEE-----EEETTEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCCCEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654-----0467436


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348999569942434
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  796 (884)
                      |+||||+++|+|.+++...+      .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHH
T ss_conf             79886458980899975379------9999999999999999999999---75983575468997887899879832314


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCC-CCCCCEEEHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             412566899862111001103334431107531279888-8434432044989987619988995633885
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~p~~~~~~~~~  866 (884)
                      |+........      ......+||+.|+|||++.+..+ +.++||||+|+++|||++|+.||....+...
T Consensus       150 a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  214 (271)
T d1nvra_         150 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  214 (271)
T ss_dssp             CEECEETTEE------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred             HEEECCCCCC------CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf             2240468865------3111325574742872861899999710161737999999829978888985999

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.71  Aligned_cols=200  Identities=25%  Similarity=0.411  Sum_probs=178.2

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---665069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+.+.+|+.+++.++||||++++++     +.+..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-----FHDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-----EECSS
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEE-----EEECC
T ss_conf             5376998898517785899999989994999999816885676899999999999985688888859999-----99899


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..++||||+++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+||
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEECCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCCEECCCCCEEECCC
T ss_conf             9899985047985898875048------9999999999999999999999---889465220234414668998711555


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|........          ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       151 G~a~~~~~~~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         151 GWSVHAPSSRR----------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             CSCSCCCCCCC----------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CEEEECCCCCC----------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             63354488852----------3557887634999975899893144046759999983299998889

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=323.61  Aligned_cols=203  Identities=25%  Similarity=0.330  Sum_probs=180.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---665069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++..   .....+.+.+|+.+++.++||||++++++     +++..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCCC
T ss_conf             4742898898317684999999989998999999815654497999999999999986799988778764-----03564


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..|+||||+++|+|.+++...+      .+++..+..++.|++.|++|+|   +++|+||||||+|||++.++.+||+||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCCCCEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEEEEC
T ss_conf             2111000357986055553256------7759999999999965211343---159622464777847658998888205


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             34412566899862111001103334431107531279888843443204498998761998899563
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      |+|+........        ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus       150 G~a~~~~~~~~~--------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         150 GLCKEGISDGAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             TTCBCSCCTTCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCCCCCCCCCC--------CCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf             652003567862--------055100889966665048988833310223067889987899999969

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=324.30  Aligned_cols=203  Identities=22%  Similarity=0.327  Sum_probs=178.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++||||++++++     +++....|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCEEE
T ss_conf             4035998999317782999999989997999999887264679999999999986799798919999-----99899999


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCC
Q ss_conf             8998128999889961069985324689999999999999999998504999916549899982348--99956994243
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD--QDLVSHVSDFG  795 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg  795 (884)
                      +||||+++|+|.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+|||++  .++.+||+|||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEECCCCCHHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCCCCCCEEEEEECC
T ss_conf             99982899808888986389-----9899999999999999999999---779265131445531134678848995256


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             4412566899862111001103334431107531279888843443204498998761998899563
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +|........         .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+..
T Consensus       175 la~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  232 (352)
T d1koba_         175 LATKLNPDEI---------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  232 (352)
T ss_dssp             TCEECCTTSC---------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CCEECCCCCC---------EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             3034378872---------010047645348999747998976333898999999996889989979

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=326.05  Aligned_cols=202  Identities=24%  Similarity=0.401  Sum_probs=178.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.++++++||||++++++     +.+....+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EEETTEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCEEE
T ss_conf             6575898898407681999999889998999999845243169999999999986799799929999-----99899999


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489--9956994243
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ--DLVSHVSDFG  795 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg  795 (884)
                      +||||+++|+|.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+|||++.  ++.+||+|||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECHHHEEECCCCCCEEEEEECC
T ss_conf             99985799889999976237-----8999999999999999999997---569760001546736416889869995452


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             441256689986211100110333443110753127988884344320449899876199889956
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      +|+.......         .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       172 ~a~~~~~~~~---------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         172 LTAHLDPKQS---------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             TCEECCTTSC---------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEECCCCCC---------CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             1044256543---------20006862421889975899872676554659999998598998997

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.38  Aligned_cols=204  Identities=25%  Similarity=0.414  Sum_probs=180.0

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---665069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.++++++||||++++++     +.+..
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSS
T ss_pred             CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----EEECC
T ss_conf             9877898898508790999999989997999999865775577789999999999987688886179999-----99899


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..|+||||+++|+|.+++...+      .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+||
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCCCCCCCCCCCEEEECCC
T ss_conf             8899997048987777653159------9999999999999999997621---650884767741236688853886032


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|+.........      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       153 G~a~~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         153 GTAKVLSPESKQA------RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             TTCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCEECCCCCCCC------CCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC
T ss_conf             1024225677643------335556775525844002689896662304569999980388998995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.83  Aligned_cols=204  Identities=27%  Similarity=0.387  Sum_probs=176.8

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCEE
Q ss_conf             29984680221153179998979999289999941226650699999999997178997421655521587567861028
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      +.|++.+.||+|+||+||+|+++.+++.||||+++.......+.+.+|++++++++||||+++++++     .+....++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-----EECCEEEE
T ss_conf             3759847993077819999999999939999998728999999999999999867999988498898-----00995899


Q ss_pred             EEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99812899988996106998532468999999999999999999850499991654989998234899956994243441
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  798 (884)
                      ||||+++|+|.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+|.
T Consensus        87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEECCCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHHHEEECCCCCEEEEECHHHH
T ss_conf             9962799818899986289-----9999999999999999999999---8898871407003148789998997161230


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCEECCCCCC-----CCCCCCCCCEEEHHHHHHHHHCCCCCCCCCCC
Q ss_conf             256689986211100110333443110753127-----98888434432044989987619988995633
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGM-----GREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~p~~~~~~  863 (884)
                      ......        .......||+.|+|||++.     +..|+.++||||+||++|||++|+.||.+...
T Consensus       159 ~~~~~~--------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~  220 (288)
T d2jfla1         159 KNTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP  220 (288)
T ss_dssp             ECHHHH--------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             CCCCCC--------CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             357786--------41001025626479999832025788888066578789999998208899999899

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=320.70  Aligned_cols=199  Identities=28%  Similarity=0.394  Sum_probs=177.9

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---665069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+++.++||||++++++     +.+..
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSS
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEE-----EEECC
T ss_conf             5470888897207680899999989997999999845775488999999999999986369675330356-----85288


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..|+||||+++|++..++....      .+++..+..++.|++.|+.|||   +++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEECCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHC---CCCEECCCCCCHHEEECCCCCEEEECC
T ss_conf             0056765037863223432222------1110079999999987655412---476770556810503868998898317


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|+......           ...+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.
T Consensus       149 G~a~~~~~~~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         149 GFAKYVPDVT-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             SSCEECSSCB-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCEEECCCC-----------CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf             5216712456-----------4345763435999983899980430465333689997598999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=320.10  Aligned_cols=199  Identities=26%  Similarity=0.353  Sum_probs=177.9

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---665069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++++.||+|+||.||+|+++.+|+.||||++...   .....+.+.+|+.+++.++||||++++++     +....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCC-----CCCCC
T ss_conf             2370898896117680899999989998999999826774588999999999999997487727403444-----43222


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..++||||+.+|++..++...+      .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCCCCCCCCCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHCCCCCCCCEEEEEC
T ss_conf             2232222334662266675158------9899999999999999899998---599861767999936077897886101


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|+......           ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       186 G~a~~~~~~~-----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         186 GFAKRVKGRT-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             TTCEECSSCB-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEECCCCC-----------CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf             0333225666-----------4336763567889971799885331145007899997588998995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=318.63  Aligned_cols=201  Identities=26%  Similarity=0.361  Sum_probs=171.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCCHHHHH---HHHHHHHCCCCCCCCCEEEEECCCCCC
Q ss_conf             429984680221153179998979999289999941226---65069999---999999717899742165552158756
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFV---AECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.   .++.+++.++||||++++++     +.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEE-----EE
T ss_conf             7768510188428890999999999997999999845875426679999999999999850899858899999-----99


Q ss_pred             CCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             78610289981289998899610699853246899999999999999999985049999165498999823489995699
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  791 (884)
                      .....|+||||+++|+|.+++....      .+++..+..++.|++.|+.|||   +++|+||||||+|||++.++.+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEE
T ss_pred             ECCEEEEEEEECCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCEEECCCEEEECCCCCEEE
T ss_conf             8998899999148983899987325------5327899999999999999999---779622044422167858896798


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             42434412566899862111001103334431107531279-888843443204498998761998899563
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       792 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +|||+|+........          ...||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+..
T Consensus       149 ~DFGla~~~~~~~~~----------~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         149 SDLGLACDFSKKKPH----------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             CCCTTCEECSSSCCC----------SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             EEECEEEECCCCCCC----------CCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             220102333788643----------31134554216876038999844104677899999985999888899

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=321.10  Aligned_cols=201  Identities=26%  Similarity=0.372  Sum_probs=176.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226-6506999999999971789974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .+.|++.+.||+|+||+||+|+++.+++.||||++.... ......+.+|+.+++.++||||++++++     +.+....
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSEE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899-----9989988


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348---999569942
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLD---QDLVSHVSD  793 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~D  793 (884)
                      |+||||+++|+|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+||++.   .++.+||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECCCCEEECCCCCCCEEEEEC
T ss_conf             89885268984888653036------7887899999999999987524---13055687046300110468882499831


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             43441256689986211100110333443110753127988884344320449899876199889956
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      ||+|+......         .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCEEEECCCCC---------EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             54358725897---------044003284225918873799980787345159999998597999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.10  Aligned_cols=212  Identities=25%  Similarity=0.366  Sum_probs=177.8

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             4299846802211531799989799992899999412266--50699999999997178997421655521587567861
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+   .....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CCCCE
T ss_conf             333799679830889199999999999799999987465797999999999999997789998248999991---78998


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             0289981289998899610699853246899999999999999999985049--99916549899982348999569942
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC--EPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~D  793 (884)
                      .|+||||+++|+|.+++.....  ....+++..++.++.|++.|+.|||+..  ..+|+||||||+|||++.++.+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             EEEEEECCCCCCHHHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEE
T ss_conf             9999956899938999985154--57899999999999999999999997167788788586765425747888579800


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             434412566899862111001103334431107531279888843443204498998761998899563
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      ||+|+.......        ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+..
T Consensus       158 FG~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~  218 (269)
T d2java1         158 FGLARILNHDTS--------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  218 (269)
T ss_dssp             HHHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCEEECCCCCC--------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC
T ss_conf             100032245777--------5566778823279999839999938988752789999801889989989

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=317.55  Aligned_cols=201  Identities=25%  Similarity=0.412  Sum_probs=171.2

Q ss_pred             CCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             9984680221153179998979999289999941226--65069999999999717899742165552158756786102
Q 002760          640 NFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       640 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .|+..++||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++... ..+...++
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~   88 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred             EEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCCCEEE
T ss_conf             78851697008284999999999995999999851227989999999999999857999850699998403-34588899


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEECC
Q ss_conf             89981289998899610699853246899999999999999999985049999--16549899982348-9995699424
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPS--IVHGDLKPSNVLLD-QDLVSHVSDF  794 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Df  794 (884)
                      +||||+++|+|.+++....      .+++.++..++.|++.|+.|||   +++  |+||||||+|||++ .++.+||+||
T Consensus        89 ivmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEECCCCHHHCEEECCCCCEEEEEC
T ss_conf             9995789894899975135------5469999999999999999999---789979968767435116679998898005


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|+......          ....+||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.
T Consensus       160 Gla~~~~~~~----------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         160 GLATLKRASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             TGGGGCCTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCEECCCCC----------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf             7654236876----------677553813008988478-9998671100799999998788999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=317.91  Aligned_cols=197  Identities=27%  Similarity=0.382  Sum_probs=171.6

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             299846802211531799989799992899999412266---50699999999997178997421655521587567861
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      +.|+..++||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.++++++||||+++++++     .+...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECCE
T ss_conf             8567627970188809999999899939999998444435889999999999999977899982389999-----98998


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             02899812899988996106998532468999999999999999999850499991654989998234899956994243
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  795 (884)
                      .|+||||+++|++..++...+      .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEEECCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCCCEEEECCCCCEEEEECC
T ss_conf             899998069994578997379------9999999999999999999998---6897666788421798799978984436


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC---CCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             4412566899862111001103334431107531279---88884344320449899876199889956
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      +|.......            ...||+.|+|||++.+   ..|+.++||||+||++|||++|+.||.+.
T Consensus       161 ~a~~~~~~~------------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~  217 (309)
T d1u5ra_         161 SASIMAPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (309)
T ss_dssp             TCBSSSSBC------------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCCCCCCC------------CCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             533467787------------313476636889983467888672145455899999998788999997

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=317.15  Aligned_cols=209  Identities=31%  Similarity=0.501  Sum_probs=175.5

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCC---EEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCC
Q ss_conf             4299846802211531799989799992---89999941226-6506999999999971789974216555215875678
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT---EVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.+.||+|+||+||+|+++.+++   .||||.+.... ....+.+.+|+.++++++||||+++++++.     ..
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE-----EC
T ss_conf             0042785698027882999999957997889999999784459899999999999998579988861899996-----28


Q ss_pred             CCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             61028998128999889961069985324689999999999999999998504999916549899982348999569942
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  793 (884)
                      ...++||||+++|+|.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+|
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~D  171 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSD  171 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CEEEEEEEECCCCCCEEEECCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECC
T ss_conf             877999972279853002104567-----9999999999999999889885---27983576150448988999199888


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCC
Q ss_conf             434412566899862111001103334431107531279888843443204498998761-998899563
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~  862 (884)
                      ||+|+..........   .....+..||+.|+|||.+.+..++.++||||+|+++|||+| |+.||.+..
T Consensus       172 FGla~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         172 FGLSRFLEDDTSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             C--------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCCEECCCCCCCCE---EEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
T ss_conf             443157567777653---6502566688300387888369978612144535789999867999999999

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=318.43  Aligned_cols=203  Identities=30%  Similarity=0.507  Sum_probs=175.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+++.++||||+++++++     .+....+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCE-----EECCEEE
T ss_conf             79939865982088808999999999969999997776-10399999999999867999882677527-----4578547


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|++.+++......    .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~----~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             EEEECCCCCCHHHHHHHCCCC----CHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf             876314676067775303554----1579999999999999788898---789305760457689989992898324454


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCC
Q ss_conf             125668998621110011033344311075312798888434432044989987619988995
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~  860 (884)
                      +........       ...+..|++.|+|||++.+..++.++||||+|+++|||++|..||..
T Consensus       163 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         163 RLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             TTCCSSSSE-------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             EECCCCCCE-------EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             653788722-------10355665466692787279998104302178999999867998877

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=316.47  Aligned_cols=203  Identities=33%  Similarity=0.520  Sum_probs=171.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC--CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             42998468022115317999897999928999994122--6650699999999997178997421655521587567861
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+.||+|+||+||+|+++   ..||||+++..  .....+.+.+|+.++++++||||+++++++.      ...
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE------CCE
T ss_conf             451899889830788589999999---98999999734699899999999999998479987864567971------558


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             02899812899988996106998532468999999999999999999850499991654989998234899956994243
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  795 (884)
                      .++||||+++|+|.+++...+.     .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEEECCCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCHHHEEECCCCCEEECCCC
T ss_conf             9999965899888999852357-----8999999999999999988875---0999516147899798189978875002


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC---CCCCCCCCEEEHHHHHHHHHCCCCCCCCCCC
Q ss_conf             4412566899862111001103334431107531279---8888434432044989987619988995633
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG---REASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~p~~~~~~  863 (884)
                      +|+.........      ......||+.|+|||++.+   ..++.++||||+|+++|||+||+.||.+...
T Consensus       150 la~~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         150 LATVKSRWSGSH------QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CEEECCCCCCCC------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             213335567763------12566557431799999505689999531516359999999978899899896

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.41  Aligned_cols=213  Identities=26%  Similarity=0.419  Sum_probs=176.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCC-----EEEEEEEECC-CCCCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCC
Q ss_conf             4299846802211531799989799992-----8999994122-665069999999999717-89974216555215875
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGT-----EVAVKVINLK-QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~-----~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.++||+|+||+||+|++...++     .||+|.+... .......+.+|+.++.++ +||||+++++++     
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----  110 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----  110 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----
T ss_conf             899397019830788199999985788554204999999663358789999999999999715899686877888-----


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf             6786102899812899988996106998-----------------53246899999999999999999985049999165
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ-----------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVH  773 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  773 (884)
                      ......++||||+++|+|.++++..+..                 .....+++..++.++.|++.|++|||   +++|+|
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEE
T ss_conf             62995899997279995999998625777510221000012220012577899999999999999999997---399050


Q ss_pred             CCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC
Q ss_conf             49899982348999569942434412566899862111001103334431107531279888843443204498998761
Q 002760          774 GDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT  853 (884)
Q Consensus       774 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~  853 (884)
                      |||||+||+++.++.+||+|||+|+.........      ......||+.|+|||++.+..++.++||||+|+++|||++
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEE------EECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHH
T ss_conf             5270321443459828985142222045778615------6234357876578388727999963303000399999983


Q ss_pred             -CCCCCCCCCCC
Q ss_conf             -99889956338
Q 002760          854 -RKRPTDAMFNE  864 (884)
Q Consensus       854 -g~~p~~~~~~~  864 (884)
                       |+.||.+...+
T Consensus       262 ~g~~Pf~~~~~~  273 (325)
T d1rjba_         262 LGVNPYPGIPVD  273 (325)
T ss_dssp             TSCCSSTTCCCS
T ss_pred             CCCCCCCCCCHH
T ss_conf             899999998989

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.65  Aligned_cols=203  Identities=24%  Similarity=0.375  Sum_probs=175.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCHHHHHHHHHHHH-CCCCCCCCCEEEEECCCCCCCC
Q ss_conf             42998468022115317999897999928999994122---6650699999999997-1789974216555215875678
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK---QKGASKSFVAECKALR-NIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.++||+|+||+||+|+++.+++.||||+++..   .....+.+..|+.++. .++||||++++++     +.++
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~   75 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTK   75 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECS
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCC
T ss_conf             99718865894087828999999999989999998055533848999999999999984799968789889-----7049


Q ss_pred             CCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             61028998128999889961069985324689999999999999999998504999916549899982348999569942
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  793 (884)
                      ...|+||||+++|+|.+++....      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEECCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCEEECCCCCEECCC
T ss_conf             83167775037980899864047------8999999999999999999998---68934034765404444899630155


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             434412566899862111001103334431107531279888843443204498998761998899563
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      ||+|+........        .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..
T Consensus       147 FG~a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         147 FGMCKENMLGDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             CTTCBCCCCTTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCHHHHCCCCCCC--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             5302323566533--------454578777689999827998832320112278989873889999989

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.61  Aligned_cols=202  Identities=25%  Similarity=0.372  Sum_probs=177.0

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC------CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCC
Q ss_conf             429984680221153179998979999289999941226------65069999999999717899742165552158756
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ------KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|+.++++++||||++++++     +.
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YE   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-----EE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EE
T ss_conf             5677982798117895999999999998999999875663213406899999999999986799899938899-----99


Q ss_pred             CCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----
Q ss_conf             7861028998128999889961069985324689999999999999999998504999916549899982348999----
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL----  787 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----  787 (884)
                      +....|+||||+++|+|.+++...+      .+++..+..++.|++.|++|||   +++|+||||||+||+++.++    
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSC
T ss_pred             ECCEEEEEEECCCCCCCCCHHCCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEEECCCCCCC
T ss_conf             7998999998677864310010356------4215578999999999987666---254221133301279825898666


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             569942434412566899862111001103334431107531279888843443204498998761998899563
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       788 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      .+|++|||+|........         .....|++.|+|||++.+..++.++||||+|+++|||++|+.||.+..
T Consensus       155 ~vkl~DfG~a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  220 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  220 (293)
T ss_dssp             CEEECCCTTCEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEECCHHHHHHCCCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf             469643344210577763---------122477774309999818999976652214099999970889988999

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=310.53  Aligned_cols=201  Identities=30%  Similarity=0.536  Sum_probs=172.0

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||+||+|++. +++.||||+++.. ....+++.+|+.++++++||||+++++++.     .....+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             HHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEC-----CCCCEE
T ss_conf             699588889820888299999988-9999999998788-676899999999999668997565352431-----599337


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|+|.+++.....     .+++..++.++.|++.|+.|+|   +++|+||||||+|||++.++.+||+|||+|
T Consensus        77 lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             EEEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHHEEECCCCCEEECCCCHH
T ss_conf             99983699918997520134-----7889999999999999877653---164310443153266668877686553210


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCC-CCCCCC
Q ss_conf             125668998621110011033344311075312798888434432044989987619-988995
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~p~~~  860 (884)
                      +.........       .....||+.|+|||++.+..++.++||||+|+++|||+++ ++||..
T Consensus       149 ~~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         149 RFVLDDQYTS-------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             -----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EECCCCCCEE-------ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC
T ss_conf             0236887335-------04300176667857860799984033210599999998789888778

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=309.27  Aligned_cols=202  Identities=22%  Similarity=0.313  Sum_probs=176.0

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      -++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++||||++++++     +++...+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-----FESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEE-----EEECCEEE
T ss_conf             010588789831778399999998999699999975786-659999999999985799798909899-----98899889


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489--9956994243
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ--DLVSHVSDFG  795 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg  795 (884)
                      +||||+++|+|.+++...+.     .+++.++..++.|++.|+.|||   +++|+||||||+|||++.  ...+||+|||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEEECCCC
T ss_conf             99953899808899875389-----9999999999999999999998---769975135544434437885189976441


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             4412566899862111001103334431107531279888843443204498998761998899563
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +++......         ......|++.|+|||...+..++.++||||+||++|+|++|+.||.+..
T Consensus       150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~  207 (321)
T d1tkia_         150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             HHHCCCCCC---------CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC
T ss_conf             110034677---------5321223322234021048777840113027999999982899999989

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=309.12  Aligned_cols=205  Identities=27%  Similarity=0.440  Sum_probs=171.4

Q ss_pred             CCCCCCC-EEEECCCEEEEEEEECC--CCCEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             2998468-02211531799989799--99289999941226-65069999999999717899742165552158756786
Q 002760          639 DNFSSAN-KIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       639 ~~y~~~~-~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||+++... ....+++.+|++++++++||||+++++++..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------C
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036------8


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..++||||+++|+|.+++...+.     .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEEEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEECCC
T ss_conf             07999980789968997521256-----9999999999999999878998---688105767646604546885420331


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCC
Q ss_conf             34412566899862111001103334431107531279888843443204498998761-998899563
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~  862 (884)
                      |+|+.........     .......||+.|+|||++.+..++.++||||+|+++|||+| |+.||.+..
T Consensus       154 Gla~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         154 GLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             HHHHCCCCCCCCC-----CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC
T ss_conf             3421155434321-----135621137433586887279999541232201789999938999999979

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=307.36  Aligned_cols=202  Identities=25%  Similarity=0.358  Sum_probs=170.9

Q ss_pred             HCCCCCCC-EEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCCCCCCC
Q ss_conf             42998468-022115317999897999928999994122665069999999999717-8997421655521587567861
Q 002760          638 TDNFSSAN-KIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.+ .||+|+||.||+|++..+++.||||+++.     ...+.+|+.++.++ +||||+++++++... ......
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-CCCCCE
T ss_conf             14879810796545486999999889998999999897-----477999999999866999978298999503-468978


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEE
Q ss_conf             0289981289998899610699853246899999999999999999985049999165498999823489---9956994
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVS  792 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~  792 (884)
                      +|+||||++||+|.+++...+..    .+++.++..++.|++.|++|||   +++|+||||||+|||++.   ++.+||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~----~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCC----CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCCHHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             99999778998499999862787----7579999999999999999999---7698644410022011355556631135


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             243441256689986211100110333443110753127988884344320449899876199889956
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |||+|+........         ....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.
T Consensus       157 DFG~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         157 DFGFAKETTSHNSL---------TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             CCTTCEECCCCCCC---------CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             CCCEEEECCCCCCC---------CCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCC
T ss_conf             45512333688864---------3226775637927774898888888876451677886588998898

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=310.51  Aligned_cols=201  Identities=28%  Similarity=0.525  Sum_probs=170.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.++++++||||+++++++..      ...+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC------CCEE
T ss_conf             899388679810798289999999-9999999998647-6888999999999986799988578731045------9769


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|+|.+++.....    ..+++.+++.++.|++.|+.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEECCCCCHHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEEECCCCEEECCCCCE
T ss_conf             99995789828888751478----98878899999999999999997---489546756422515620244042341014


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCC
Q ss_conf             125668998621110011033344311075312798888434432044989987619988995
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~  860 (884)
                      +...+....       ......|++.|+|||++.+..++.++||||+|+++|||+||..|+..
T Consensus       157 ~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~  212 (272)
T d1qpca_         157 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP  212 (272)
T ss_dssp             EECSSSCEE-------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             EECCCCCCC-------CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             773588644-------20356774444582898379998245645257999999968988888

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=306.37  Aligned_cols=210  Identities=22%  Similarity=0.401  Sum_probs=179.2

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226---65069999999999717899742165552158756786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ---KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  714 (884)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CCCC
T ss_conf             620698689960899299999999999899999985566469899999999999998569998873114354326-8876


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      .+|+||||+++++|.+++...+      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++..+++||
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEEEECCCCCEEHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCEEEHH
T ss_conf             6999997788987101120358------9999999999999999999998---579527634675566575432010034


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             34412566899862111001103334431107531279888843443204498998761998899563
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      |.+..........     .......||+.|+|||++.+..+++++||||+|+++|||++|+.||.+..
T Consensus       156 ~~~~~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         156 GIARAIADSGNSV-----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHCCCCCCC-----CCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC
T ss_conf             4432212354433-----33464257624369999839999966320265289999976979989969

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=304.15  Aligned_cols=205  Identities=26%  Similarity=0.461  Sum_probs=173.9

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCC----EEEEEEEECC-CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCC
Q ss_conf             299846802211531799989799992----8999994122-66506999999999971789974216555215875678
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGT----EVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .+|++.++||+|+||+||+|++..+++    .||+|.++.. .....+.+.+|+.++++++||||+++++++..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------
T ss_conf             99978319820899299999995899889899999996513497999999999999986799888158999961------


Q ss_pred             CCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             61028998128999889961069985324689999999999999999998504999916549899982348999569942
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  793 (884)
                      ...++++|++.+|+|.+++.....     .+++..++.++.|++.|+.|||   +++|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             CCEEEEEEECCCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCHHHCCEECCCCCEEEEC
T ss_conf             983699984268740101113345-----7999999999999999999998---76950476212031167998758602


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             434412566899862111001103334431107531279888843443204498998761-9988995633
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~~  863 (884)
                      ||+|+.........      ......||+.|+|||++.+..++.++||||+|+++|||+| |+.||.+...
T Consensus       155 FGla~~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~  219 (317)
T d1xkka_         155 FGLAKLLGAEEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  219 (317)
T ss_dssp             CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred             CCCCEECCCCCCCC------CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf             55222335444532------236510586446708874699983565440799999999779999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=301.50  Aligned_cols=204  Identities=30%  Similarity=0.513  Sum_probs=176.4

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.++||+|+||+||+|+++ +++.||||+++... ...+.+.+|+.++++++||||+++++++.     .....+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEE-----ECCCEE
T ss_conf             699799689820788399999988-99899999987475-77899999999999668986015889985-----078169


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|++.+++.....     .+++..+++++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+|
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEEECCCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCEEEEECCCCCEEECCCHHH
T ss_conf             99970489938886410246-----7768999999999999999875---468434665413588769984798861442


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             12566899862111001103334431107531279888843443204498998761-9988995633
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~~  863 (884)
                      +.........       .....||+.|+|||.+.+..++.++||||+|+++|||+| |+.||.+...
T Consensus       148 ~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~  207 (258)
T d1k2pa_         148 RYVLDDEYTS-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  207 (258)
T ss_dssp             CBCSSSSCCC-------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             EECCCCCCEE-------ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH
T ss_conf             0235787225-------24657887757807863799885210336432467397559999889999

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=305.26  Aligned_cols=198  Identities=28%  Similarity=0.448  Sum_probs=167.7

Q ss_pred             CEEEECCCEEEEEEEECC--CCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCEEEE
Q ss_conf             802211531799989799--99289999941226--65069999999999717899742165552158756786102899
Q 002760          645 NKIGEGGSGIVYKGFLGE--NGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAIVY  720 (884)
Q Consensus       645 ~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  720 (884)
                      ++||+|+||+||+|.++.  +++.||||+++...  ....+++.+|+.++++++||||+++++++.     . ...++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S-SSEEEEE
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC-----C-CCEEEEE
T ss_conf             783458782999999816973859999998801089899999999999998679989852777750-----5-9779999


Q ss_pred             ECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             81289998899610699853246899999999999999999985049999165498999823489995699424344125
Q 002760          721 EFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKFL  800 (884)
Q Consensus       721 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  800 (884)
                      ||+++|+|.++++...      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+|++|||+|+..
T Consensus        87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ECCCCCCHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHC
T ss_conf             7478896899975225------7899999999999999976687---479556777611310235675123413453313


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCC
Q ss_conf             66899862111001103334431107531279888843443204498998761-998899563
Q 002760          801 SNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMF  862 (884)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~  862 (884)
                      .......     .......||+.|+|||++.+..++.++||||+|+++|||++ |+.||.+..
T Consensus       158 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         158 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             CTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             CCCCCCC-----CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC
T ss_conf             4323443-----224456778420391665379998434430340313289658999999989

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=303.87  Aligned_cols=205  Identities=30%  Similarity=0.475  Sum_probs=171.1

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCC----CEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCC
Q ss_conf             429984680221153179998979999----2899999412266-50699999999997178997421655521587567
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG----TEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  712 (884)
                      ...|+..+.||+|+||.||+|.++.++    ..||||+++.... .....+.+|+.++++++||||+++++++.     .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----C
T ss_conf             89968615981177909999999689987879999999884459689999999999998568987832367783-----3


Q ss_pred             CCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             86102899812899988996106998532468999999999999999999850499991654989998234899956994
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  792 (884)
                      ....++||||+.++++.+++.....     .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+||+
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCCEEEEEEECCCCCCHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEEECCCCEEEEC
T ss_conf             8803899972135740222102345-----4208999999999998541212---1234257656442788899849984


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCC
Q ss_conf             24344125668998621110011033344311075312798888434432044989987619988995
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       793 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~  860 (884)
                      |||+|+.........     ....+..||+.|+|||++.+..++.++||||+|+++|||+++..|+..
T Consensus       153 DFGla~~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         153 DFGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             CCCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCHHHCCCCCCCCC-----EEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf             551030035787652-----674267777343488887049999735563448989999967988655

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=300.38  Aligned_cols=203  Identities=27%  Similarity=0.411  Sum_probs=175.4

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC---------CCHHHHHHHHHHHHCCC-CCCCCCEEEEECC
Q ss_conf             4299846802211531799989799992899999412266---------50699999999997178-9974216555215
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK---------GASKSFVAECKALRNIR-HRNLIKIITVCSG  707 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  707 (884)
                      .++|++.+.||+|+||+||+|++..+++.||||+++....         ...+.+.+|+.++++++ ||||++++++   
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~---   78 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT---   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE---
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE---
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762---


Q ss_pred             CCCCCCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf             87567861028998128999889961069985324689999999999999999998504999916549899982348999
Q 002760          708 RDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  787 (884)
                        +.++...|+||||+++|+|.++++..+      .+++.++..++.|++.|++|||   +++|+||||||+||+++.++
T Consensus        79 --~~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          79 --YETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDM  147 (277)
T ss_dssp             --EECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred             --CCCCCCEEEEEECCCCCHHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCC
T ss_conf             --146760599997689866899998659------9999999999999999999998---75994323462548986899


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC------CCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             569942434412566899862111001103334431107531279------88884344320449899876199889956
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG------REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      .+||+|||+++........         ....||+.|+|||.+.+      ..++.++||||+|+++|+|++|+.||.+.
T Consensus       148 ~~kl~DFG~a~~~~~~~~~---------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGEKL---------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             CEEECCCTTCEECCTTCCB---------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CEEECCCHHEEECCCCCCE---------EEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC
T ss_conf             8387124031672688721---------3452467888988860534456788992331856560231032288898899


Q ss_pred             CC
Q ss_conf             33
Q 002760          862 FN  863 (884)
Q Consensus       862 ~~  863 (884)
                      ..
T Consensus       219 ~~  220 (277)
T d1phka_         219 KQ  220 (277)
T ss_dssp             SH
T ss_pred             CH
T ss_conf             99

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=301.24  Aligned_cols=197  Identities=30%  Similarity=0.395  Sum_probs=166.3

Q ss_pred             CCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-----CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             46802211531799989799992899999412266-----5069999999999717899742165552158756786102
Q 002760          643 SANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK-----GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      ..+.||+|+||+||+|+++.+++.||||+++....     ...+.+.+|+.++++++||||++++++     +......+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~-----~~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE-----ECCTTCCE
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCCCCEE
T ss_conf             5638512728299999999999699999984202124567999999999999986799998689854-----22587402


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+.++++..+.....      .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||.|
T Consensus        77 ivmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             EHHHHHCCHHHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEEECCCCCCCCCCCCCC
T ss_conf             2045534507765541266------7789999999999999998863---163550357762588537784114657610


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             12566899862111001103334431107531279-88884344320449899876199889956
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      +........        ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       148 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         148 KSFGSPNRA--------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             STTTSCCCC--------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCCCCCC--------CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCC
T ss_conf             005787554--------330204733363999726778880564363042899998596999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=298.83  Aligned_cols=202  Identities=27%  Similarity=0.448  Sum_probs=170.7

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             29984680221153179998979999289999941226--6506999999999971789974216555215875678610
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|+.++++++||||++++++     +......
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~-----~~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV-----IHTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEE-----EEETTEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCC-----CCCCCCE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453-----3224320


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348999569942434
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  796 (884)
                      |+||||+.+ ++.+++......    .+++.++..++.|++.|+.|||   +++|+||||||+|||++.++.+|++|||.
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             EEEEEECCC-CHHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCHHEEECCCCCCEECCCCC
T ss_conf             378862377-445554420256----8888999999999999999865---28899213571140113467621035786


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCC-CCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             41256689986211100110333443110753127988-884344320449899876199889956
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+........        .....||+.|+|||+..... ++.++||||+|+++|+|++|+.||.+.
T Consensus       149 a~~~~~~~~~--------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         149 ARAFGVPVRT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             HHHHCCCSBC--------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CEECCCCCCC--------CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCC
T ss_conf             1343688641--------001036521541122136657774221033331342796687998988

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=297.91  Aligned_cols=209  Identities=25%  Similarity=0.387  Sum_probs=171.1

Q ss_pred             HHCCCCCCCEEEECCCEEEEEEEECCC-CCEEEEEEEECCC--CCCHHHHHHHHHHHHCC---CCCCCCCEEEEECCCCC
Q ss_conf             842998468022115317999897999-9289999941226--65069999999999717---89974216555215875
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGEN-GTEVAVKVINLKQ--KGASKSFVAECKALRNI---RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~  710 (884)
                      ..++|++.++||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf             75897988899215586999999988899899999980232451679999999999998742589880236632214666


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf             67861028998128999889961069985324689999999999999999998504999916549899982348999569
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  790 (884)
                      ......+++||+++++.+.........     .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCCEEEEEEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEECCCCCEE
T ss_conf             667469999974058714444430378-----9998999999999999999997---58898357986278985899754


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             942434412566899862111001103334431107531279888843443204498998761998899563
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       791 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      |+|||.+.......         ......||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+..
T Consensus       157 l~dfg~~~~~~~~~---------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         157 LADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             ECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ECCHHHHHHHCCCC---------CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCC
T ss_conf             21000101100234---------5777654851148310017988811100032899999987879989989

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=301.32  Aligned_cols=202  Identities=31%  Similarity=0.522  Sum_probs=170.9

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.++++++|||||++++++..      ...+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC------CCEE
T ss_conf             799798469930798099999999-9999999998804-4888999999999986666788689999823------9759


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|++..++......    .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEECCCCCHHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHH---HHHEECCCCCCEEEEECCCCCEEECCCCHH
T ss_conf             999944799435420000355----3059999999999999999875---411433531230799989992998442555


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             1256689986211100110333443110753127988884344320449899876199889956
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      +.........       .....||+.|+|||++.+..++.++||||+|+++|||++|..|+...
T Consensus       161 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         161 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             HHCCCCCCEE-------ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCC
T ss_conf             4256887335-------24545566545808983799891774132358999998689999988

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=297.40  Aligned_cols=212  Identities=25%  Similarity=0.402  Sum_probs=171.4

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEEECCC-CCCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCC
Q ss_conf             4299846802211531799989799-----99289999941226-65069999999999717-89974216555215875
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQ-KGASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.++||+|+||.||+|++..     +++.||||+++... ....+.+..|...+.++ +|+||+.+++++    .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----T   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE----C
T ss_conf             799798449841678399999986777555783999999860017178999999999988614998499741154----0


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf             6786102899812899988996106998----------532468999999999999999999850499991654989998
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSN  780 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N  780 (884)
                      ......++||||+++|+|.++++..+..          .....+++.++..++.|++.|+.|||   +++|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             CCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCC
T ss_conf             4797579999845899299999853666665322202332146899999999999999999887---3797178677310


Q ss_pred             EEECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCC-CCCCC
Q ss_conf             23489995699424344125668998621110011033344311075312798888434432044989987619-98899
Q 002760          781 VLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTR-KRPTD  859 (884)
Q Consensus       781 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~p~~  859 (884)
                      ||++.++.+||+|||+|+.........      ......||+.|+|||++.+..++.++||||+|+++|||++| ..||.
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSC------CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             EEECCCCCEEECCCCCHHHCCCCCCCC------CCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCC
T ss_conf             657799828984575200113566522------24751667210203686468899663221367899999868899998


Q ss_pred             CCC
Q ss_conf             563
Q 002760          860 AMF  862 (884)
Q Consensus       860 ~~~  862 (884)
                      +..
T Consensus       239 ~~~  241 (299)
T d1ywna1         239 GVK  241 (299)
T ss_dssp             TCC
T ss_pred             CCC
T ss_conf             999

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=294.95  Aligned_cols=208  Identities=25%  Similarity=0.345  Sum_probs=174.1

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226-6506999999999971789974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+++.++|||++++++++....+.....+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348999569942434
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  796 (884)
                      +++ +++.+|+|.+++...       .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        87 ~l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             EEE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEE-EEECCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf             999-962598656644058-------9999999999999999999999---78986777876437887999778754570


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             412566899862111001103334431107531279-88884344320449899876199889956
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |...........     ......|++.|+|||++.. ..++.++||||+|+++|+|++|+.||.+.
T Consensus       156 a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         156 ARVADPDHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             CEECCGGGCBCC-----TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EEECCCCCCCCE-----EECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCC
T ss_conf             565047776410-----1011026520003878604788874101004670133776697997888

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=295.89  Aligned_cols=205  Identities=24%  Similarity=0.375  Sum_probs=172.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCC---CEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCC
Q ss_conf             429984680221153179998979999---289999941226-6506999999999971789974216555215875678
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG---TEVAVKVINLKQ-KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.+.||+|+||.||+|++..++   ..||||.++... ....+.+.+|+.++++++||||+++++++.      .
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE------C
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995------3


Q ss_pred             CCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             61028998128999889961069985324689999999999999999998504999916549899982348999569942
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSD  793 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  793 (884)
                      +..++||||+++|++.+++.....     .+++.++..++.|++.|+.|||   +++++||||||+||+++.++.+||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CEEEEEEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCHHHEEECCCCCEEECC
T ss_conf             747999984069807765422478-----9999999999999987752302---26744141026553206789678765


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             434412566899862111001103334431107531279888843443204498998761-9988995633
Q 002760          794 FGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAMFN  863 (884)
Q Consensus       794 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~~~  863 (884)
                      ||+|+........       ......||+.|+|||++.+..++.++||||+|+++|||++ |..||.+...
T Consensus       152 fG~a~~~~~~~~~-------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~  215 (273)
T d1mp8a_         152 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  215 (273)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             CHHHEECCCCCCE-------ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf             0342133677623-------305400583103266751699887452444247899998269999888999

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=297.45  Aligned_cols=213  Identities=26%  Similarity=0.425  Sum_probs=175.3

Q ss_pred             HHCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCC
Q ss_conf             84299846802211531799989799-----992899999412266-506999999999971789974216555215875
Q 002760          637 ATDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDF  710 (884)
Q Consensus       637 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  710 (884)
                      ..++|++.+.||+|+||+||+|+++.     +++.||||+++.... ...+++.+|+.+++.++||||+++++++.    
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC----
T ss_conf             9889388679820788399999988876577882999999882108579999999999999668997655246660----


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf             6786102899812899988996106998------------------5324689999999999999999998504999916
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ------------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIV  772 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  772 (884)
                       .....++||||+++|+|.+++......                  .....+++.+++.++.|++.|++|||   +++++
T Consensus        87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             -CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCEE
T ss_conf             -59803899981589929999985275542100001110012103467889899999999999999855413---57868


Q ss_pred             ECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHH
Q ss_conf             54989998234899956994243441256689986211100110333443110753127988884344320449899876
Q 002760          773 HGDLKPSNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELF  852 (884)
Q Consensus       773 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell  852 (884)
                      ||||||+|||++.++.+||+|||+|+...+.....      ......|++.|+|||.+.+..++.++||||||+++|||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell  236 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  236 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHH
T ss_conf             54884011689899928983314421136776411------157777676767989972688980563025236299998


Q ss_pred             CCC-CCCCCCCC
Q ss_conf             199-88995633
Q 002760          853 TRK-RPTDAMFN  863 (884)
Q Consensus       853 ~g~-~p~~~~~~  863 (884)
                      +|. .||.+..+
T Consensus       237 ~~~~~p~~~~~~  248 (301)
T d1lufa_         237 SYGLQPYYGMAH  248 (301)
T ss_dssp             TTTCCTTTTSCH
T ss_pred             CCCCCCCCCCCH
T ss_conf             068999999899

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=291.05  Aligned_cols=204  Identities=29%  Similarity=0.494  Sum_probs=169.9

Q ss_pred             CCCEEEECCCEEEEEEEECCCC---CEEEEEEEECC-CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCEE
Q ss_conf             4680221153179998979999---28999994122-6650699999999997178997421655521587567861028
Q 002760          643 SANKIGEGGSGIVYKGFLGENG---TEVAVKVINLK-QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKAI  718 (884)
Q Consensus       643 ~~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  718 (884)
                      ..++||+|+||+||+|++..++   ..||||+++.. .....+++.+|++++++++||||+++++++.    ..++..++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEE
T ss_pred             CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE----ECCCCEEE
T ss_conf             66698136880999999977998799999999884369789999999999998678999867867898----06994389


Q ss_pred             EEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99812899988996106998532468999999999999999999850499991654989998234899956994243441
Q 002760          719 VYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAK  798 (884)
Q Consensus       719 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  798 (884)
                      ||||+++|+|.+++.....     ..++..++.++.|++.|+.|+|   +++|+||||||+|||+++++.+||+|||+++
T Consensus       107 v~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  178 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred             EEEEEECCCHHHHHCCCCC-----CCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHEEECCCCCEEEECCCCHH
T ss_conf             9987406741442101345-----4048999999999887652003---3676257766875767799988991065232


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             2566899862111001103334431107531279888843443204498998761998899563
Q 002760          799 FLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      ...........    ......||+.|+|||...+..++.++||||||+++|||++|..||....
T Consensus       179 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~  238 (311)
T d1r0pa_         179 DMYDKEFDSVH----NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  238 (311)
T ss_dssp             CTTTTTCCCTT----CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred             HCCCCCCCCCE----ECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             25566555310----0256555645567688743799974574661999999997899998889

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=289.20  Aligned_cols=210  Identities=21%  Similarity=0.344  Sum_probs=175.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCC-CCCCCEEEEECCCCCCCCCCC
Q ss_conf             4299846802211531799989799992899999412266506999999999971789-974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRH-RNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ..+|++.++||+|+||+||+|++..+++.||||+++....  ...+.+|++.++.++| ++++.++++.     ......
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEE-----ECCCCC
T ss_conf             9806997998417882999999988997999999750258--299999999999964899987799996-----018811


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEE
Q ss_conf             289981289998899610699853246899999999999999999985049999165498999823489-----995699
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-----DLVSHV  791 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl  791 (884)
                      ++||||+ +++|.+++.....     .++..++..++.|++.|++|||   +++|+||||||+||+++.     ++.+||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEEC-CCCHHHHHHHHCC-----CHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEECCCCCCCCCCEEE
T ss_conf             7999964-8887999975203-----1106899999999999999999---77966266771315234754344795687


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             4243441256689986211100110333443110753127988884344320449899876199889956338
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFNE  864 (884)
Q Consensus       792 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~~~  864 (884)
                      +|||+|+............. .......||+.|+|||++.+..+++++||||+|+++|||++|+.||.+....
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPY-REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCC-CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             CCCCEEEECCCCCCCCCEEE-CCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf             23660577146766541110-2467627751026798964888886999898319999998698767885302

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=293.04  Aligned_cols=207  Identities=26%  Similarity=0.379  Sum_probs=165.4

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHH--HHHHHHCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226650699999--999997178997421655521587567861
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVA--ECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|...+.||+|+||.||+|++  +|+.||||+++...   .+.+..  |+..+..++||||+++++++.... .....
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-CCCEE
T ss_conf             86899988982078819999999--99899999987200---46799999999996279986832688998379-86048


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEE
Q ss_conf             028998128999889961069985324689999999999999999998504-----999916549899982348999569
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHY-----CEPSIVHGDLKPSNVLLDQDLVSH  790 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~k  790 (884)
                      .++||||+++|+|.++++..       .+++.+++.++.|++.|++|+|..     .+++|+||||||+|||++.++.+|
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEEECCCCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEE
T ss_conf             99999646698989998658-------99989999999999999999887665204689866153173135786887768


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCC------CCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             9424344125668998621110011033344311075312798------8884344320449899876199889956
Q 002760          791 VSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR------EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       791 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |+|||+++..........    .......||+.|+|||++.+.      .++.++||||||+++|||+||..||...
T Consensus       149 l~DFGl~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~  221 (303)
T d1vjya_         149 IADLGLAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             ECCCTTCEEEETTTTEEC----C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             EEECCCCCCCCCCCCCEE----CCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             876386623467776200----1355250354767822105654546777675012201599999996289988766

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=290.25  Aligned_cols=211  Identities=23%  Similarity=0.368  Sum_probs=174.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECC--CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCC---CC
Q ss_conf             42998468022115317999897999928999994122--66506999999999971789974216555215875---67
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLK--QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF---KG  712 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  712 (884)
                      .++|++.++||+|+||+||+|++..+++.||||++...  .....+.+.+|+.+++.++|||++++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             86102899812899988996106998532468999999999999999999850499991654989998234899956994
Q 002760          713 ADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVS  792 (884)
Q Consensus       713 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  792 (884)
                      ....++||||++++.+..+.....      .+++..+..++.|++.|+.|||   +++|+||||||+|||++.++.+|++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEECCCCCCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHC---CCCEEECCCCCHHEEECCCCCEEEE
T ss_conf             763899985357874101222034------4330899999999999998852---2998856767222036689968763


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             24344125668998621110011033344311075312798-8884344320449899876199889956
Q 002760          793 DFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       793 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |||++...........    .......||+.|+|||++.+. .+++++||||+|+++|||++|+.||.+.
T Consensus       160 dfg~~~~~~~~~~~~~----~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         160 DFGLARAFSLAKNSQP----NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             CCTTCEECCC-----C----CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ECCEEEECCCCCCCCC----CCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCC
T ss_conf             1350022355444321----13566024978742899707999891787006786466174487998998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=294.67  Aligned_cols=198  Identities=35%  Similarity=0.507  Sum_probs=171.0

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|++  .++.||||+++.  ....+.+.+|++++++++||||+++++++.    ++....+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred             HHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEE----ECCCCEE
T ss_conf             89948857982079808999999--990999999885--777999999999998678989854987887----2389289


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489995699424344
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLA  797 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  797 (884)
                      +||||+++|+|.+++.....    ..+++..++.++.|++.|+.|||   +++|+||||||+||+++.++.+|++|||++
T Consensus        78 lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEECCCCCCHHHHHHHCCC----CCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCHHHHEECCCCCEEECCCCCC
T ss_conf             99963699989999874578----88899999999999985232113---376553666567601468997763245600


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCC
Q ss_conf             12566899862111001103334431107531279888843443204498998761-99889956
Q 002760          798 KFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~  861 (884)
                      +.......           ...++..|+|||+..+..+++++||||||+++|||++ |+.||...
T Consensus       151 ~~~~~~~~-----------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~  204 (262)
T d1byga_         151 KEASSTQD-----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  204 (262)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             EECCCCCC-----------CCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             34478776-----------5566646778178727988858877757999999997899999999

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=289.41  Aligned_cols=230  Identities=23%  Similarity=0.372  Sum_probs=181.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEEC-----CCCCEEEEEEEECCCC-CCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCC
Q ss_conf             429984680221153179998979-----9992899999412266-5069999999999717-89974216555215875
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG-----ENGTEVAVKVINLKQK-GASKSFVAECKALRNI-RHRNLIKIITVCSGRDF  710 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  710 (884)
                      .++|++.++||+|+||.||+|++.     .+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.    
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~----   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE----
T ss_conf             8996985498206882999999806644778869999998742487799999999999876269998878998983----


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             6786102899812899988996106998------------5324689999999999999999998504999916549899
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQ------------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  778 (884)
                       .....++||||+++|+|.++++.....            .....+++..+..++.|++.|++|||   +++++||||||
T Consensus        98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp  173 (311)
T d1t46a_          98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (311)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             -ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCC
T ss_conf             -19978999973799879999985356654444453322233458899999999999999999887---57926662410


Q ss_pred             CCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCC
Q ss_conf             98234899956994243441256689986211100110333443110753127988884344320449899876199889
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPT  858 (884)
Q Consensus       779 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~  858 (884)
                      +||+++.++.++++|||.++.........      ......||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCCCCCCCCCCCCCCCHHEECCCCCCCE------EEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf             21000025752102340102336788615------862013596876778861799997400102589999998589988


Q ss_pred             CCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             95633885287788998324777
Q 002760          859 DAMFNEGLTLHDFSREFFTRKSD  881 (884)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~  881 (884)
                      .........+.+.++.-.....+
T Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~  270 (311)
T d1t46a_         248 YPGMPVDSKFYKMIKEGFRMLSP  270 (311)
T ss_dssp             STTCCSSHHHHHHHHHTCCCCCC
T ss_pred             CCCCCHHHHHHHHHHCCCCCCCC
T ss_conf             77899899999998668988985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=295.72  Aligned_cols=200  Identities=22%  Similarity=0.330  Sum_probs=168.8

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC------CCHHHHHHHHHHHHCCC--CCCCCCEEEEECCCC
Q ss_conf             4299846802211531799989799992899999412266------50699999999997178--997421655521587
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK------GASKSFVAECKALRNIR--HRNLIKIITVCSGRD  709 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  709 (884)
                      .++|++.+.||+|+||+||+|++..+++.||||+++....      ....++.+|+.++++++  ||||++++++     
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~-----   77 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-----   77 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----
T ss_conf             883799679840878399999999999799999985688443345567999999999999743589881279999-----


Q ss_pred             CCCCCCCEEEEECCCC-CCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CC
Q ss_conf             5678610289981289-998899610699853246899999999999999999985049999165498999823489-99
Q 002760          710 FKGADFKAIVYEFMQN-GSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ-DL  787 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~  787 (884)
                      +......++||||+.+ +++.+++....      .+++.++..++.|++.|+.|||   +++|+||||||+|||++. ++
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTT
T ss_pred             EEECCEEEEEEEECCCCCHHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCC
T ss_conf             8309968999983368622899986158------9999999999999999999998---779755667611147744788


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCC-CCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             569942434412566899862111001103334431107531279888-84344320449899876199889956
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREA-SMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       788 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      .+||+|||+|+......          .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...
T Consensus       149 ~vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             EEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EEEECCCCCCEECCCCC----------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC
T ss_conf             48977546535324445----------566565877479999848997886533255403453675688998873

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=289.67  Aligned_cols=202  Identities=25%  Similarity=0.374  Sum_probs=173.3

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCC-CCCCC
Q ss_conf             429984680221153179998979999289999941226--650699999999997178997421655521587-56786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRD-FKGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  714 (884)
                      .++|+++++||+|+||+||+|++..+++.||||+++...  ....+.+.+|+.+++.++||||+++++++...+ .....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..++||||+ +.++..+.+..       .+++..+..++.|++.|+.|||   +++|+||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEECC-CCCHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf             599998405-52189998740-------2269999999999999999987---378764566851111210012211343


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             34412566899862111001103334431107531279-88884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |.|+......           ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus       166 g~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         166 GLARQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             TTCEECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCEECCCCCC-----------CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCC
T ss_conf             1022068763-----------10245533358899817878996501030038999999786998889

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=287.05  Aligned_cols=205  Identities=26%  Similarity=0.364  Sum_probs=165.5

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCC-CCCCCCE
Q ss_conf             299846802211531799989799992899999412266506999999999971789974216555215875-6786102
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDF-KGADFKA  717 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  717 (884)
                      .+|+..++||+|+||+||+|++..+++.||||+++.....    ..+|+.++++++||||+++++++..... .+..+.+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             7767516982176839999999999979999998816068----999999998668989873878997447657731899


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCC
Q ss_conf             8998128999889961069985324689999999999999999998504999916549899982348999-569942434
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL-VSHVSDFGL  796 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~  796 (884)
                      +||||++++.+..+.....   ....+++.++..++.|++.|++|||   +++|+||||||+|||++.++ .+||+|||+
T Consensus        96 lv~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEECCCCCCHHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf             9984168860788886310---3689999999999999999999998---668764578860378735897116733660


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             412566899862111001103334431107531279-888843443204498998761998899563
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +.........         ....|++.|+|||...+ ..++.++||||+||++|||++|+.||....
T Consensus       170 a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         170 AKQLVRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             CEECCTTSCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             HHHCCCCCCC---------CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCC
T ss_conf             5440477653---------200255555682776404688821000246527785502879989879

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=287.16  Aligned_cols=210  Identities=27%  Similarity=0.385  Sum_probs=171.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCCE
Q ss_conf             42998468022115317999897999928999994122665069999999999717899742165552158756786102
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFKA  717 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  717 (884)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  .+++..|+++++.++|++++..+..+    .......+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~   79 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV   79 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEE----EECCCEEE
T ss_conf             8889996898507880999999988998999999721005--88899999999970389960179999----95198778


Q ss_pred             EEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECC
Q ss_conf             89981289998899610699853246899999999999999999985049999165498999823489---995699424
Q 002760          718 IVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQ---DLVSHVSDF  794 (884)
Q Consensus       718 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df  794 (884)
                      +||||+ ++++...+.....     .+++..+..++.|++.|++|||   +++|+||||||+|||++.   +..++++||
T Consensus        80 ivme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEEC-CCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHCCCCCCCCCCEEEEECC
T ss_conf             999873-8713332443068-----8768999999999999999999---799442667876606433577761565046


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCCC
Q ss_conf             344125668998621110011033344311075312798888434432044989987619988995633
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAMFN  863 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~~~  863 (884)
                      |+|+............. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus       151 G~a~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPY-RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             SSCEECBCTTTCCBCCC-CBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             CCCEECCCCCCCCCEEC-CCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCH
T ss_conf             75134255445541000-135776787353299999189989832188617789999849876655305

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=288.68  Aligned_cols=201  Identities=25%  Similarity=0.413  Sum_probs=170.9

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             29984680221153179998979999289999941226--6506999999999971789974216555215875678610
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.++||+|+||+||+|+++ +++.||||+++...  ....+.+.+|+.+++.++||||++++++     +......
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV-----IHTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEE-----EECSSCE
T ss_pred             CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----CCCCCCE
T ss_conf             99634318722778189999968-99999999981232685899999999999986799868766012-----0467731


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348999569942434
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  796 (884)
                      ++++|++.++.+..+....+      .+++.++..++.|++.|++|||   +.+|+||||||+|||++.++.+|++|||.
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEEEHHHHHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHC---CCCEEECCCCCCEEEECCCCCEEECCCCC
T ss_conf             58997400456789986047------7514456899999999999860---57488267877505686899787323664


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             412566899862111001103334431107531279-888843443204498998761998899563
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMG-REASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      |.........        .....|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||.+..
T Consensus       147 a~~~~~~~~~--------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         147 ARAFGIPVRK--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CEECCCCCCC--------CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCC
T ss_conf             3011467654--------1010243110137887178888841002111758999977979989889

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=287.02  Aligned_cols=211  Identities=28%  Similarity=0.416  Sum_probs=175.1

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCC-------CEEEEEEEECCCC-CCHHHHHHHHHHHHCC-CCCCCCCEEEEECCC
Q ss_conf             429984680221153179998979999-------2899999412266-5069999999999717-899742165552158
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENG-------TEVAVKVINLKQK-GASKSFVAECKALRNI-RHRNLIKIITVCSGR  708 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~-------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  708 (884)
                      .++|++.+.||+|+||.||+|+...++       ..||||+++.... .....+.+|...+.++ +||||+++++++.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC--
T ss_conf             899697009851678289999985787555667549999998811286889999999999998139996973465220--


Q ss_pred             CCCCCCCCEEEEECCCCCCHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             756786102899812899988996106998----------5324689999999999999999998504999916549899
Q 002760          709 DFKGADFKAIVYEFMQNGSLEEWLHHSNDQ----------LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKP  778 (884)
Q Consensus       709 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  778 (884)
                         +....++||||+++|+|.+++......          .....+++.+++.++.|++.|+.|||   +++|+||||||
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp  163 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  163 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ---CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECC
T ss_conf             ---188689999736999099999860677643222334574346799999999999999998766---37978630221


Q ss_pred             CCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCC
Q ss_conf             982348999569942434412566899862111001103334431107531279888843443204498998761-9988
Q 002760          779 SNVLLDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRP  857 (884)
Q Consensus       779 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p  857 (884)
                      +|||++.++.+||+|||+++.........      ......|++.|+|||.+.+..|+.++||||||+++|||++ |..|
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTC------CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCEEECCCCCEEECCCHHHCCCCCCCCCC------CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC
T ss_conf             02245478976762211101135555543------146678884663266751798882555477588888740179898


Q ss_pred             CCCCC
Q ss_conf             99563
Q 002760          858 TDAMF  862 (884)
Q Consensus       858 ~~~~~  862 (884)
                      |.+..
T Consensus       238 ~~~~~  242 (299)
T d1fgka_         238 YPGVP  242 (299)
T ss_dssp             STTCC
T ss_pred             CCCCC
T ss_conf             99999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=284.68  Aligned_cols=198  Identities=24%  Similarity=0.349  Sum_probs=168.2

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCCCCEEEEECCCCCCCCCCC
Q ss_conf             429984680221153179998979999289999941226650699999999997178-9974216555215875678610
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      .++|++.++||+|+||+||+|++..+++.||||+++..   ..+.+.+|+.+++.+. ||||+++++++.   .......
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~---~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVK---DPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEE---CTTTCSE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEE---ECCCCCE
T ss_conf             86718978983174819999998899979999998889---99999999999985157998767999998---1687712


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEECCC
Q ss_conf             2899812899988996106998532468999999999999999999850499991654989998234899-956994243
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD-LVSHVSDFG  795 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg  795 (884)
                      ++||||+++++|..+.+         .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+|++|||
T Consensus       108 ~~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EEEEEECCCCCHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEECCCC
T ss_conf             68886317985899746---------8999999999999999998876---43344345644123774899836641565


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHCCCCCCCCCC
Q ss_conf             44125668998621110011033344311075312798-88843443204498998761998899563
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAMF  862 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~p~~~~~  862 (884)
                      +|+........         ....||+.|+|||...+. .++.++||||+|+++|+|++|+.||....
T Consensus       176 ~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         176 LAEFYHPGQEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             GCEECCTTCCC---------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             CCEECCCCCCC---------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             42664688744---------432248642476102688888845232335455587604889998876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=290.37  Aligned_cols=207  Identities=27%  Similarity=0.420  Sum_probs=171.9

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCE--EEEEEEECC-CCCCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCCCCC
Q ss_conf             42998468022115317999897999928--999994122-665069999999999717-89974216555215875678
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTE--VAVKVINLK-QKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  713 (884)
                      .++|++.++||+|+||.||+|+++.++..  ||||+++.. .....+.+.+|+.++.++ +||||+++++++.     ..
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~   83 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR   83 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred             HHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-----CC
T ss_conf             7996887798207882899999989996999999997823385799999999999986228998836788884-----18


Q ss_pred             CCCEEEEECCCCCCHHHHHHCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             610289981289998899610699----------8532468999999999999999999850499991654989998234
Q 002760          714 DFKAIVYEFMQNGSLEEWLHHSND----------QLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLL  783 (884)
Q Consensus       714 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill  783 (884)
                      +..++||||+++|+|.++++....          ......+++.++.+++.|++.|+.|+|   +++++||||||+|||+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV  160 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEE
T ss_conf             7369999802898699998640355555123101234578999999999999999987663---0895455505204898


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCC-CCCCCC
Q ss_conf             899956994243441256689986211100110333443110753127988884344320449899876199-889956
Q 002760          784 DQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK-RPTDAM  861 (884)
Q Consensus       784 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~-~p~~~~  861 (884)
                      +.++.+||+|||+|+........         ....||..|+|||.+.+..++.++||||||+++|||++|. .||.+.
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVKK---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC-------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCCCCEEECCCCCCCCCCCCCCC---------CCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf             68876387434432244422345---------53013775555387526999962215313889999983689999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=291.97  Aligned_cols=205  Identities=28%  Similarity=0.423  Sum_probs=171.7

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCC-C--CEEEEEEEECC---CCCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCC
Q ss_conf             42998468022115317999897999-9--28999994122---665069999999999717899742165552158756
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGEN-G--TEVAVKVINLK---QKGASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~-~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.+.||+|+||.||+|++..+ +  ..||||+++..   ..+..+.+.+|+.++++++||||+++++++.     
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----   81 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----   81 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----
T ss_conf             489199789803888399999998899907999999998355579899999999999998689999878987774-----


Q ss_pred             CCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             78610289981289998899610699853246899999999999999999985049999165498999823489995699
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHV  791 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  791 (884)
                      + ...++||||+++|++.+++.....     .+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.+||
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl  152 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI  152 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEE
T ss_pred             E-CCHHEEEEEECCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECHHHHCCCCCCCEEE
T ss_conf             0-100114654238612544421268-----9999999999999999998752---178752056688815655654332


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHC-CCCCCCCC
Q ss_conf             42434412566899862111001103334431107531279888843443204498998761-99889956
Q 002760          792 SDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFT-RKRPTDAM  861 (884)
Q Consensus       792 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~p~~~~  861 (884)
                      +|||+++.........     .......|+..|+|||++.+..++.++||||||+++|||++ |+.||.+.
T Consensus       153 ~DfGl~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~  218 (273)
T d1u46a_         153 GDFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  218 (273)
T ss_dssp             CCCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCCHHHHHCCCCCCCC-----EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             5611555303588752-----65476325731079999837999942156614899999996899999996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=287.85  Aligned_cols=208  Identities=24%  Similarity=0.346  Sum_probs=174.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEEC---CCCCEEEEEEEECC----CCCCHHHHHHHHHHHHCCCC-CCCCCEEEEECCCC
Q ss_conf             429984680221153179998979---99928999994122----66506999999999971789-97421655521587
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLG---ENGTEVAVKVINLK----QKGASKSFVAECKALRNIRH-RNLIKIITVCSGRD  709 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  709 (884)
                      .++|++.++||+|+||+||+|++.   .+|+.||||+++..    +....+.+.+|+.++++++| |||++++++     
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~-----   97 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----   97 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----
T ss_pred             HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----
T ss_conf             102599989832878399999987658879489999983677210168999999999999864679839996200-----


Q ss_pred             CCCCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             56786102899812899988996106998532468999999999999999999850499991654989998234899956
Q 002760          710 FKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVS  789 (884)
Q Consensus       710 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  789 (884)
                      +.+....++||||+.+|+|.+++...+      .+++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~v  168 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHV  168 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred             ECCCCCEEEEEECCCCCHHHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCCCCEEECCCCCE
T ss_conf             024873001231234117999987304------5437888888999999998851---4998965477320124699988


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCC--CCCCCCCEEEHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99424344125668998621110011033344311075312798--888434432044989987619988995633885
Q 002760          790 HVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR--EASMKGDVYSFGILLLELFTRKRPTDAMFNEGL  866 (884)
Q Consensus       790 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~g~~p~~~~~~~~~  866 (884)
                      ||+|||+|+.........       .....|++.|+|||.+.+.  .++.++||||+||++|+|++|+.||.+....+.
T Consensus       169 kL~DFG~a~~~~~~~~~~-------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~  240 (322)
T d1vzoa_         169 VLTDFGLSKEFVADETER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS  240 (322)
T ss_dssp             EESCSSEEEECCGGGGGG-------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred             EEEECCCHHHHCCCCCCC-------CCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf             874132022203444432-------212223333310687605776887132517777999999768999888877779

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=286.09  Aligned_cols=203  Identities=23%  Similarity=0.356  Sum_probs=172.1

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             4299846802211531799989799992899999412266--50699999999997178997421655521587567861
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK--GASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      .++|++.++||+|+||+||+|++..+++.||||+++....  ...+.+.+|+.+++.++|||++++++++......+...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             CEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             02899812899988996106998532468999999999999999999850499991654989998234899956994243
Q 002760          716 KAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFG  795 (884)
Q Consensus       716 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  795 (884)
                      .+++++++.+|+|.+++...       .+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEEEEECCCCHHHHCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             49999962588623200224-------5309999999999999999997---3887651667763345543220013210


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             44125668998621110011033344311075312798-8884344320449899876199889956
Q 002760          796 LAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGR-EASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       796 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      .|.......           ....|++.|+|||...+. .++.++||||+|+++|+|++|+.||.+.
T Consensus       167 ~a~~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         167 LARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             ---CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HHCCCCCCC-----------CCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf             001257544-----------44345435558355337756785512432058999997688997889

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=281.74  Aligned_cols=200  Identities=24%  Similarity=0.361  Sum_probs=172.5

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             29984680221153179998979999289999941226--6506999999999971789974216555215875678610
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDFKGADFK  716 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  716 (884)
                      ++|++.++||+|+||+||+|++..+++.||||+++...  ......+.+|+.+++.++||||+++++++     .+....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC-----CCCCCE
T ss_conf             997862697128681999999999996999999803217868999999999999856757888213544-----444311


Q ss_pred             EEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             28998128999889961069985324689999999999999999998504999916549899982348999569942434
Q 002760          717 AIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGL  796 (884)
Q Consensus       717 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  796 (884)
                      ++|++++.++++..++...+      .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+|++|||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEECCCCCCCCCCCCCC------CCCHHHHHHHHHHHHHHHHHHH---CCCEEEECCCCCCCCCCCCCCEEEEECCH
T ss_conf             58863023322211212356------5403678999999999987743---39986001467612113378266520460


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCC-CCCCCCEEEHHHHHHHHHCCCCCCCC
Q ss_conf             41256689986211100110333443110753127988-88434432044989987619988995
Q 002760          797 AKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGRE-ASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       797 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~p~~~  860 (884)
                      |+.........        ....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..
T Consensus       148 a~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         148 ARAFGIPVRCY--------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CEECCSCCSCC--------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             HHCCCCCCCCC--------EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC
T ss_conf             11046887510--------0103443101466750698888044402654188998518999988

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=284.21  Aligned_cols=203  Identities=24%  Similarity=0.314  Sum_probs=172.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCC-CCCC
Q ss_conf             429984680221153179998979999289999941226--6506999999999971789974216555215875-6786
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ--KGASKSFVAECKALRNIRHRNLIKIITVCSGRDF-KGAD  714 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  714 (884)
                      .++|++.++||+|+||+||+|++..+|+.||||+++...  .....++.+|+.+++.++||||+++++++..... +...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             CCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             10289981289998899610699853246899999999999999999985049999165498999823489995699424
Q 002760          715 FKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDLVSHVSDF  794 (884)
Q Consensus       715 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  794 (884)
                      ..|+||||+.++ +.+.+..        .+++..+..++.|++.|+.|||   ++||+||||||+|||++.++.++++||
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEECCCHH-HHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCEEEECH
T ss_conf             269998414467-7876503--------8999999999999999998865---221124567763211365443132010


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCC
Q ss_conf             3441256689986211100110333443110753127988884344320449899876199889956
Q 002760          795 GLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDAM  861 (884)
Q Consensus       795 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~~  861 (884)
                      |.++.......         .....||+.|+|||++.+..+++++||||+||++|+|++|+.||.+.
T Consensus       164 ~~~~~~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         164 GLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             CC------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHHCCCCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC
T ss_conf             23211466655---------33221465555813314777787743335662578986598998889

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=288.37  Aligned_cols=210  Identities=22%  Similarity=0.400  Sum_probs=172.6

Q ss_pred             HCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCCCCEEEEECCCCCC
Q ss_conf             4299846802211531799989799-----992899999412266-5069999999999717899742165552158756
Q 002760          638 TDNFSSANKIGEGGSGIVYKGFLGE-----NGTEVAVKVINLKQK-GASKSFVAECKALRNIRHRNLIKIITVCSGRDFK  711 (884)
Q Consensus       638 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  711 (884)
                      .++|++.++||+|+||+||+|.++.     +++.||||+++.... .....+.+|+.++++++||||+++++++.     
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----
T ss_conf             899188359820788189999987864477896899999870128689999999999999769998841254784-----


Q ss_pred             CCCCCEEEEECCCCCCHHHHHHCCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf             786102899812899988996106998----5324689999999999999999998504999916549899982348999
Q 002760          712 GADFKAIVYEFMQNGSLEEWLHHSNDQ----LEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQDL  787 (884)
Q Consensus       712 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  787 (884)
                      .....++||||+++|+|.+++...+..    .....+++.++.+++.|+++|+.|||   +++|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECEECCCCEEECCCC
T ss_conf             288106777604899889998750332113444688799999999999999999876---47965432867754035996


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCC-CCCCCC
Q ss_conf             56994243441256689986211100110333443110753127988884344320449899876199-889956
Q 002760          788 VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRK-RPTDAM  861 (884)
Q Consensus       788 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~-~p~~~~  861 (884)
                      .+||+|||+|+.........      ......|++.|+|||.+.+..++.++||||+|+++|||++|. .||.+.
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~  239 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  239 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             EEEEEECCCCEECCCCCCEE------ECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf             49994245420235776303------1340231632378888736998833344437899999996899999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-43  Score=251.05  Aligned_cols=202  Identities=23%  Similarity=0.309  Sum_probs=159.4

Q ss_pred             CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCC-----------CCCCCCEEEEECC
Q ss_conf             29984680221153179998979999289999941226650699999999997178-----------9974216555215
Q 002760          639 DNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-----------HRNLIKIITVCSG  707 (884)
Q Consensus       639 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  707 (884)
                      .+|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~-   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN-   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE-
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf             85799899750778189999999999799999983431-3368999999999984014555554227676478998763-


Q ss_pred             CCCCCCCCCEEEEECCCCCC-HHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf             87567861028998128999-88996106998532468999999999999999999850499991654989998234899
Q 002760          708 RDFKGADFKAIVYEFMQNGS-LEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVLLDQD  786 (884)
Q Consensus       708 ~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  786 (884)
                        ..+....+.++++...+. ..........    ..+++..+..++.|++.|+.|||+  ..+|+||||||+|||++.+
T Consensus        91 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          91 --HKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             --EEETTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEE
T ss_pred             --ECCCCCEEEEEEECCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECC
T ss_conf             --12565202343200035420000012234----678689999999999999888764--0586465677057056305


Q ss_pred             C------CEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHCCCCCCCC
Q ss_conf             9------5699424344125668998621110011033344311075312798888434432044989987619988995
Q 002760          787 L------VSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLLELFTRKRPTDA  860 (884)
Q Consensus       787 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~p~~~  860 (884)
                      +      .++++|||.|.......           ....|++.|+|||++.+..++.++|+||+|+++++|++|+.||..
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCCCCCCEEEEEECCCCCCCCCCC-----------CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf             765644305675314421234454-----------223665210571321466777643201237899999878899898


Q ss_pred             C
Q ss_conf             6
Q 002760          861 M  861 (884)
Q Consensus       861 ~  861 (884)
                      .
T Consensus       232 ~  232 (362)
T d1q8ya_         232 D  232 (362)
T ss_dssp             -
T ss_pred             C
T ss_conf             7

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.6e-42  Score=244.28  Aligned_cols=240  Identities=30%  Similarity=0.533  Sum_probs=121.6

Q ss_pred             CCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             792226878874999324-8888668923379999999986488799988876676565768973265154227989868
Q 002760          327 IPPEIRNLASLNWLTIDT-NQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGN  405 (884)
Q Consensus       327 ~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  405 (884)
                      +|..+.++++|++|+|++ |.+.+.+|..|.++++|+.|+|++|++.+..+..+..+..|+.+++++|.+....|..+..
T Consensus        68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~  147 (313)
T d1ogqa_          68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCC
T ss_conf             98478467533520202654333002431145420011020356434433222220111001111224555568512206


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             65433211346312376533223211000112037744798999664477766779637997988860332114355412
Q 002760          406 CTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYL  485 (884)
Q Consensus       406 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  485 (884)
                      ++.++.+++++|++.+.+|..+.....+...+.++.|.+++..+..+..+.. ..+++++|...+..+..+..+++++.+
T Consensus       148 l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l  226 (313)
T d1ogqa_         148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKI  226 (313)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEE
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             7400000023553356203121443112323102246435332433222222-233333343322222222222221112


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             23375876125810358666563303576203666523537786661532686171015999865666544102797435
Q 002760          486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNKTRFSIAGNGKLC  565 (884)
Q Consensus       486 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  565 (884)
                      ++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+..+++|+.|++++|.++|.+|..+.+..+....+.+|+++|
T Consensus       227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~  305 (313)
T d1ogqa_         227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC  305 (313)
T ss_dssp             ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred             CCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf             222222222222-2224554444447657066608768847999998979588351668986667998978868895001


Q ss_pred             CCC
Q ss_conf             898
Q 002760          566 GGL  568 (884)
Q Consensus       566 ~~~  568 (884)
                      |.|
T Consensus       306 g~p  308 (313)
T d1ogqa_         306 GSP  308 (313)
T ss_dssp             STT
T ss_pred             CCC
T ss_conf             989

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=1e-38  Score=224.64  Aligned_cols=166  Identities=33%  Similarity=0.393  Sum_probs=93.4

Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             78874999324888866892337999999998648879998887667656576897326515422798986865433211
Q 002760          334 LASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLN  413 (884)
Q Consensus       334 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  413 (884)
                      .++|+.|++++|.+++  ...+..+++|+.+++++|.+++..  .+..+++|+.|++++|.+++..  .+..++.++.+.
T Consensus       218 ~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~  291 (384)
T d2omza2         218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLE  291 (384)
T ss_dssp             CTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred             CCCCCEEECCCCCCCC--CCHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCC
T ss_conf             5778788887777789--613432565341004467447877--5355466877545674457877--323565222233


Q ss_pred             CCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEE
Q ss_conf             34631237653322321100011203774479899966447776677963799798886033211435541223375876
Q 002760          414 ISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS  493 (884)
Q Consensus       414 Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  493 (884)
                      ++.|.+.+                           ...+..+++++.|++++|++++..  .+..+++|+.|++++|+++
T Consensus       292 ~~~n~l~~---------------------------~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~  342 (384)
T d2omza2         292 LNENQLED---------------------------ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS  342 (384)
T ss_dssp             CCSSCCSC---------------------------CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC
T ss_pred             CCCCCCCC---------------------------CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCC
T ss_conf             23233333---------------------------221000024676777788778984--5366898898989899899


Q ss_pred             ECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             125810358666563303576203666523537786661532686
Q 002760          494 GSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYN  538 (884)
Q Consensus       494 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  538 (884)
                      ++ + .+..+++|+.|++++|++++..|  +.++++|+.|++++|
T Consensus       343 ~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         343 DV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC-H-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             97-4-67089999989897995899800--003999999639789

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.4e-39  Score=228.11  Aligned_cols=343  Identities=25%  Similarity=0.311  Sum_probs=177.1

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             99998899744886768578344499998577465766558788233462234411122332489999345798887588
Q 002760           62 RLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVI  141 (884)
Q Consensus        62 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  141 (884)
                      .+.+|++|++++++|+. + ..++.+++|++|++++|+++ .++ .++++++|++|++++|.++.. + .++.+++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~-~l~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEE
T ss_pred             HHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCC
T ss_conf             95787899899989877-6-24245899998968188179-886-334771101030134333222-2-11123343334


Q ss_pred             EECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             82043012323432445443546421233678899544578861199810453235689888988877755735787222
Q 002760          142 DVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFT  221 (884)
Q Consensus       142 ~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~l~  221 (884)
                      +++++.+...+. ......+..+....+.+.......................+. .     +.............+...
T Consensus       116 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~  188 (384)
T d2omza2         116 TLFNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-P-----LANLTTLERLDISSNKVS  188 (384)
T ss_dssp             ECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-G-----GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH-H-----HCCCCCCCCCCCCCCCCC
T ss_conf             433222222222-222222211213466313100232222112222212322011-1-----124542110112224333


Q ss_pred             CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHHHHHHCCCCCCCEEECCCCCCCCC
Q ss_conf             32773462577765002344634457654446555432330532346999997034665312788994998468855678
Q 002760          222 GFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGE  301 (884)
Q Consensus       222 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  301 (884)
                        ....+..+++++.+++++|.+.++.+                                ...++.|+.+++++|.+.. 
T Consensus       189 --~~~~~~~l~~~~~l~l~~n~i~~~~~--------------------------------~~~~~~L~~L~l~~n~l~~-  233 (384)
T d2omza2         189 --DISVLAKLTNLESLIATNNQISDITP--------------------------------LGILTNLDELSLNGNQLKD-  233 (384)
T ss_dssp             --CCGGGGGCTTCSEEECCSSCCCCCGG--------------------------------GGGCTTCCEEECCSSCCCC-
T ss_pred             --CCCCCCCCCCCCEEECCCCCCCCCCC--------------------------------CCCCCCCCEEECCCCCCCC-
T ss_conf             --21100223532333035774478786--------------------------------4445778788887777789-


Q ss_pred             CCCHHHCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             89201100010431102688321137922268788749993248888668923379999999986488799988876676
Q 002760          302 LPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGN  381 (884)
Q Consensus       302 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  381 (884)
                                                .+.+..+++|+.+++++|.+++..  .+..+++|+.|++++|++++..  .+..
T Consensus       234 --------------------------~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~  283 (384)
T d2omza2         234 --------------------------IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAG  283 (384)
T ss_dssp             --------------------------CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTT
T ss_pred             --------------------------CCHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC--CCCC
T ss_conf             --------------------------613432565341004467447877--5355466877545674457877--3235


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             56576897326515422798986865433211346312376533223211000112037744798999664477766779
Q 002760          382 LTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRL  461 (884)
Q Consensus       382 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L  461 (884)
                      ++.++.+.++.|.+++  ...+..+++++.|++++|++.+                          ++ .+..+++|+.|
T Consensus       284 ~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~--------------------------l~-~l~~l~~L~~L  334 (384)
T d2omza2         284 LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--------------------------IS-PVSSLTKLQRL  334 (384)
T ss_dssp             CTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC--------------------------CG-GGGGCTTCCEE
T ss_pred             CCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCC--------------------------CC-CCCCCCCCCEE
T ss_conf             6522223323233333--2210000246767777887789--------------------------84-53668988989


Q ss_pred             ECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCC
Q ss_conf             637997988860332114355412233758761258103586665633035762
Q 002760          462 DLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNN  515 (884)
Q Consensus       462 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  515 (884)
                      ++++|++++ ++ .|..+++|+.|++++|++++..|  +..+++|+.|+|++|.
T Consensus       335 ~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         335 FFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             ECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             ECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf             898998999-74-67089999989897995899800--0039999996397895

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.2e-41  Score=240.72  Aligned_cols=241  Identities=28%  Similarity=0.451  Sum_probs=145.1

Q ss_pred             CCC--EEEEEEECCCC--CEEEEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             872--13756875999--908999928999732--2586766888896888247-8678789968689999889974488
Q 002760            2 NLC--QWTGVTCGQRH--QRVTRLDLGNQSIRG--TLSPYVGNLSFLRYINIAS-NGFNGEIPHQIGRLISLERLILSNN   74 (884)
Q Consensus         2 ~~~--~~~~~~c~~~~--~~v~~l~l~~~~~~~--~~~~~l~~l~~L~~L~l~~-~~i~~~~~~~l~~l~~L~~L~Ls~n   74 (884)
                      |||  +|.||+|+...  +||+.|+|+++.+.+  .+|+++++|++|++|+|++ |.+.+.+|.+|+++++|++|+|++|
T Consensus        32 d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N  111 (313)
T d1ogqa_          32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT  111 (313)
T ss_dssp             CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEE
T ss_pred             CCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf             99889488969748999479889989899888888798478467533520202654333002431145420011020356


Q ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC-CEEEECCCCCCCCC-
Q ss_conf             6768578344499998577465766558788233462234411122332489999345798887-58882043012323-
Q 002760           75 SFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSL-RVIDVRENRLWGRI-  152 (884)
Q Consensus        75 ~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-~~L~l~~n~l~~~~-  152 (884)
                      ++.+..+..+..+.+|+.++++.|.+...+|..+..++.++.+++++|.+.+.+|..+..+..+ +.++++.|++.... 
T Consensus       112 ~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~  191 (313)
T d1ogqa_         112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP  191 (313)
T ss_dssp             CCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECC
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             43443322222011100111122455556851220674000000235533562031214431123231022464353324


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf             43244544354642123367889954457886119981045323568988898887775573578722232773462577
Q 002760          153 DSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNANNFTGFIPVSLSNAS  232 (884)
Q Consensus       153 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~  232 (884)
                      ..+..+.. ..++++.+...+..|..+..+++++.+++++|.+.+.++.  +..+++++.|++++|+++..+|..+.+++
T Consensus       192 ~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~  268 (313)
T d1ogqa_         192 PTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLK  268 (313)
T ss_dssp             GGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--CCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred             CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCEECCCCCHHHHCCC
T ss_conf             33222222-2333333433222222222222211122222222222222--22455444444765706660876884799


Q ss_pred             CCCEECCCCCCCC
Q ss_conf             7650023446344
Q 002760          233 SLEMIEFSKNQFS  245 (884)
Q Consensus       233 ~L~~L~L~~N~l~  245 (884)
                      +|+.|++++|+++
T Consensus       269 ~L~~L~Ls~N~l~  281 (313)
T d1ogqa_         269 FLHSLNVSFNNLC  281 (313)
T ss_dssp             TCCEEECCSSEEE
T ss_pred             CCCEEECCCCCCC
T ss_conf             9998979588351

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=213.11  Aligned_cols=236  Identities=23%  Similarity=0.246  Sum_probs=171.8

Q ss_pred             HHHHHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             04311026883211379222687887499932488886689233799999999864-88799988876676565768973
Q 002760          312 TIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLD-RNFLQGSIPSSLGNLTLLTYLKL  390 (884)
Q Consensus       312 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls-~n~l~~~~~~~~~~l~~L~~L~l  390 (884)
                      .+++|++++|+++...+..|.++++|++|++++|.+..+.+..+.....+..++.+ .|.++...+..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEEC
T ss_conf             98889774881798797786414213000013445433211121222222222222102235446201010102778756


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             26515422798986865433211346312376533223211000112037744798999664477766779637997988
Q 002760          391 GLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSG  470 (884)
Q Consensus       391 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  470 (884)
                      ++|.+....+..+...++|+.+++++|.++                         ...+..|..+++|+.|++++|.++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-------------------------~i~~~~f~~~~~L~~L~l~~N~l~~  167 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------ALPDDTFRDLGNLTHLFLHGNRISS  167 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCCCCCCCCCCCHHCCCCHHHHCCCCCC-------------------------CCCHHHHCCCCCHHHCCCCCCCCCC
T ss_conf             885443201353320001211020014314-------------------------4580574043405022314176566


Q ss_pred             CCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             86033211435541223375876125810358666563303576203666523537786661532686171015999865
Q 002760          471 EIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVF  550 (884)
Q Consensus       471 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~  550 (884)
                      ..+..|.++++|+.+++++|+++++.|..|..+++|+.|++++|.+.+..+..+..+++|+.|++++|+|.|+|+..+..
T Consensus       168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~  247 (284)
T d1ozna_         168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW  247 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHH
T ss_pred             CCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCHHHH
T ss_conf             25666546563413142114346628167665320002333335221000002355465688981199887875646999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             6665441027974358987678
Q 002760          551 NNKTRFSIAGNGKLCGGLDELR  572 (884)
Q Consensus       551 ~~~~~~~~~~n~~~c~~~~~~~  572 (884)
                      .++.......+.-.|..|..++
T Consensus       248 ~~l~~~~~~~~~~~C~~p~~l~  269 (284)
T d1ozna_         248 AWLQKFRGSSSEVPCSLPQRLA  269 (284)
T ss_dssp             HHHHHCCSEECCCBEEESGGGT
T ss_pred             HHHHHCCCCCCCEEECCCHHHC
T ss_conf             9998673888866747966984

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.2e-34  Score=198.15  Aligned_cols=292  Identities=20%  Similarity=0.234  Sum_probs=0.0

Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             75888204301232343244544354642123367889954457886119981045323568988898887775573578
Q 002760          138 LRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNA  217 (884)
Q Consensus       138 L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~  217 (884)
                      .+.++.+++.++.+|..+.  +++++|++++|+++...+.+|.++++|+.|++++|.+. .++...+..+++|+.|++++
T Consensus        12 ~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEECCCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCHHHHHCCCCCCEECCCC
T ss_conf             9999855999885198889--99798978499189869657604656523112344344-52356652798557831568


Q ss_pred             CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHHHHHHCCCCCCCEEECCCCC
Q ss_conf             72223277346257776500234463445765444655543233053234699999703466531278899499846885
Q 002760          218 NNFTGFIPVSLSNASSLEMIEFSKNQFSGGVSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNR  297 (884)
Q Consensus       218 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~  297 (884)
                      |++..+.....   ..+..|++.+|.+..+....+.....+..++...|.........    ..+..+++|+.+++++|.
T Consensus        89 n~l~~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~----~~~~~l~~L~~l~l~~n~  161 (305)
T d1xkua_          89 NQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN----GAFQGMKKLSYIRIADTN  161 (305)
T ss_dssp             SCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT----TGGGGCTTCCEEECCSSC
T ss_pred             CCCCCCCCCHH---HHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCC
T ss_conf             75676764001---11323210246102344445401331100001233333467776----422345656712034677


Q ss_pred             CCCCCCCHHHCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf             56788920110001043110268832113792226878874999324888866892337999999998648879998887
Q 002760          298 FEGELPHSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPS  377 (884)
Q Consensus       298 l~~~~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  377 (884)
                      +.                          .++..+  .++|+.|++++|......+..|..++.++.|++++|.+.+..+.
T Consensus       162 l~--------------------------~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~  213 (305)
T d1xkua_         162 IT--------------------------TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG  213 (305)
T ss_dssp             CC--------------------------SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred             CC--------------------------CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf             45--------------------------167101--77667898978867788826764134133015445533222345


Q ss_pred             CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf             66765657689732651542279898686543321134631237653322321100011203774479899966447776
Q 002760          378 SLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKN  457 (884)
Q Consensus       378 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~  457 (884)
                      .+.++++|++|++++|.++ .+|.+|..+++|+.|++++|+|+......|                   ..+.....+++
T Consensus       214 ~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f-------------------~~~~~~~~~~~  273 (305)
T d1xkua_         214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF-------------------CPPGYNTKKAS  273 (305)
T ss_dssp             TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS-------------------SCSSCCTTSCC
T ss_pred             CCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHC-------------------CCCCHHCCCCC
T ss_conf             4334433224302554002-463110334678989898986576381002-------------------67210021588


Q ss_pred             CCEEECCCCCCC--CCCHHHHHCCCCCCCCCC
Q ss_conf             677963799798--886033211435541223
Q 002760          458 LMRLDLSGNKFS--GEIPATLSACANLEYLNI  487 (884)
Q Consensus       458 L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L  487 (884)
                      |+.|+|++|+++  .+.|..|.-+.....++|
T Consensus       274 L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~~  305 (305)
T d1xkua_         274 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL  305 (305)
T ss_dssp             CSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC
T ss_pred             CCEEECCCCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf             89788989957667689768300245742409

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-32  Score=191.66  Aligned_cols=188  Identities=23%  Similarity=0.252  Sum_probs=133.2

Q ss_pred             CCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             37922268788749993248888668923379999999986488799988876676565768973265154227989868
Q 002760          326 TIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGN  405 (884)
Q Consensus       326 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  405 (884)
                      ..+..|.++++|++|++++|.+....+..+...++|+.+++++|.++++.+..|..+++|+.|++++|.+++..+.+|.+
T Consensus        96 l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~  175 (284)
T d1ozna_          96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG  175 (284)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCC
T ss_conf             46201010102778756885443201353320001211020014314458057404340502231417656625666546


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf             65433211346312376533223211000112037744798999664477766779637997988860332114355412
Q 002760          406 CTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYL  485 (884)
Q Consensus       406 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  485 (884)
                      +++|+.+++++|++.+                         ..|..|..+++|+.|++++|++....+..|..+++|+.|
T Consensus       176 l~~L~~l~l~~N~l~~-------------------------i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L  230 (284)
T d1ozna_         176 LHSLDRLLLHQNRVAH-------------------------VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL  230 (284)
T ss_dssp             CTTCCEEECCSSCCCE-------------------------ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred             CCCCCHHHHHHCCCCC-------------------------CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf             5634131421143466-------------------------281676653200023333352210000023554656889


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             233758761258103586665633035762036665235377866615326861710
Q 002760          486 NISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEG  542 (884)
Q Consensus       486 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  542 (884)
                      ++++|++....+.. .-...++.+....+++....|..+.+.   ...+++.+.++|
T Consensus       231 ~l~~N~l~C~C~~~-~l~~~l~~~~~~~~~~~C~~p~~l~g~---~l~~l~~~~l~g  283 (284)
T d1ozna_         231 RLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGR---DLKRLAANDLQG  283 (284)
T ss_dssp             ECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTTC---BGGGSCGGGSCC
T ss_pred             EECCCCCCCCCCCH-HHHHHHHHCCCCCCCEEECCCHHHCCC---CCCCCCHHHCCC
T ss_conf             81199887875646-999999867388886674796698498---534189888789

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-33  Score=194.39  Aligned_cols=190  Identities=25%  Similarity=0.264  Sum_probs=154.3

Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             88749993248888668923379999999986488799988876676565768973265154227989868654332113
Q 002760          335 ASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNI  414 (884)
Q Consensus       335 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  414 (884)
                      +++++|+|++|.++++.+..|..+++|+.|+|++|+|+. ++ .+..+++|++|++++|+++ ..+..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf             688989884992898597786345655221356654444-31-1111223211111222221-11112122222222222


Q ss_pred             CCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEE
Q ss_conf             46312376533223211000112037744798999664477766779637997988860332114355412233758761
Q 002760          415 SHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSG  494 (884)
Q Consensus       415 s~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  494 (884)
                      ++|++..                         ..+..+..+.+++.|++++|.++...+..+..+++|+.+++++|+++.
T Consensus       108 ~~~~~~~-------------------------~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_         108 SFNRLTS-------------------------LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             CSSCCCC-------------------------CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCCCE-------------------------EECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCC
T ss_conf             2231101-------------------------100112222111122124342102212333221110000000156522


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             25810358666563303576203666523537786661532686171015999865666
Q 002760          495 SIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVPMKGVFNNK  553 (884)
Q Consensus       495 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~  553 (884)
                      ..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|||.|+|...+...++
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl  220 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWL  220 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHH
T ss_pred             CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCCCHHHHHHHH
T ss_conf             37200134212423430139785-56866777888999983699987886437999999

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-31  Score=183.97  Aligned_cols=176  Identities=23%  Similarity=0.212  Sum_probs=78.3

Q ss_pred             HHHHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             43110268832113792226878874999324888866892337999999998648879998887667656576897326
Q 002760          313 IKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGL  392 (884)
Q Consensus       313 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~  392 (884)
                      ++.|++++|.++...+..|.++++|++|+|++|.++.+ + .+..+++|+.|+|++|+++ ..+..+..+++|+.|++++
T Consensus        33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~  109 (266)
T d1p9ag_          33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF  109 (266)
T ss_dssp             CCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred             CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
T ss_conf             89898849928985977863456552213566544443-1-1111223211111222221-1111212222222222222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf             51542279898686543321134631237653322321100011203774479899966447776677963799798886
Q 002760          393 NNLEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEI  472 (884)
Q Consensus       393 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  472 (884)
                      |.+.+..+..+..+.+++.|++++|.+..                         ..+..+..+++++.+++++|+++...
T Consensus       110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~-------------------------l~~~~~~~l~~l~~l~l~~N~l~~~~  164 (266)
T d1p9ag_         110 NRLTSLPLGALRGLGELQELYLKGNELKT-------------------------LPPGLLTPTPKLEKLSLANNNLTELP  164 (266)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCC-------------------------CCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCE-------------------------ECCCCCCCCCCCHHCCCCCCCCCCCC
T ss_conf             31101100112222111122124342102-------------------------21233322111000000015652237


Q ss_pred             HHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             033211435541223375876125810358666563303576203
Q 002760          473 PATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLN  517 (884)
Q Consensus       473 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  517 (884)
                      ++.|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf             200134212423430139785-56866777888999983699987

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.97  E-value=2.3e-27  Score=162.64  Aligned_cols=59  Identities=34%  Similarity=0.443  Sum_probs=27.7

Q ss_pred             CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf             77667796379979888603321143554122337587612581035866656330357620366652
Q 002760          455 LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPE  522 (884)
Q Consensus       455 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  522 (884)
                      +++|++|+|++|+++ .+|.   .+++|+.|+|++|+|+ .+|.   .+++|+.|++++|+|+ .+|.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-SCCC
T ss_pred             CCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCC
T ss_conf             898898979799168-3566---5487998989999687-5453---2288898987699189-7776

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=9.6e-27  Score=159.22  Aligned_cols=137  Identities=28%  Similarity=0.371  Sum_probs=65.6

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf             89688824786787899686899998899744886768578344499998577465766558788233462234411122
Q 002760           41 FLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIF  120 (884)
Q Consensus        41 ~L~~L~l~~~~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  120 (884)
                      ++++|||++++++ .+|+.   +++|++|++++|+++ .+|..+   .+|+.|++++|.++ .++. +.  +.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred             CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-HC--CCCCCCCCC
T ss_conf             9989993799988-78898---789888989999796-336203---32033266551432-0321-02--211111334


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf             3324899993457988875888204301232343244544354642123367889954457886119981045323
Q 002760          121 QNHITGQLPASIGNLSSLRVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFT  196 (884)
Q Consensus       121 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~i~  196 (884)
                      +|.+. .+|. ++.+++|+.|+++++.+...+...   ..+..+.+..+...  ....+..++.++.+++..|.+.
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             CCCCC-CCCC-HHHHCCCEEECCCCCCCCCCCCCC---CCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCC
T ss_conf             55432-2210-011013123113565100132233---33210000122222--3332000122200111233443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-31  Score=186.34  Aligned_cols=166  Identities=22%  Similarity=0.101  Sum_probs=66.5

Q ss_pred             CCCCCCEEEEECCCCCCCC----CCCCCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCCCCCC-
Q ss_conf             8788749993248888668----9233799999999864887999888766-----76565768973265154227989-
Q 002760          333 NLASLNWLTIDTNQLTGTI----PPEIGELTNLQQLDLDRNFLQGSIPSSL-----GNLTLLTYLKLGLNNLEGNIPSS-  402 (884)
Q Consensus       333 ~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~~~-  402 (884)
                      ....++.+++++|.+....    ...+...+.++.+++++|.+.+.....+     .....|+.+++++|.++...... 
T Consensus       253 ~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l  332 (460)
T d1z7xw1         253 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  332 (460)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf             11110000134543321233433221112343334444433322456421110123334443333233341023344321


Q ss_pred             ---CCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCC-CCCCCCCEEECCCCCCCCCC----HH
Q ss_conf             ---86865433211346312376533223211000112037744798999664-47776677963799798886----03
Q 002760          403 ---LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEV-GNLKNLMRLDLSGNKFSGEI----PA  474 (884)
Q Consensus       403 ---~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~----~~  474 (884)
                         +...++|++|+|++|.+.......+..                     .+ ...+.|+.|+|++|.|++..    ..
T Consensus       333 ~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~---------------------~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         333 SSVLAQNRFLLELQISNNRLEDAGVRELCQ---------------------GLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             HHHHHHCSSCCEEECCSSBCHHHHHHHHHH---------------------HHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHEEEECCCCCCCCHHHH---------------------HHHCCCCCCCEEECCCCCCCHHHHHHHHH
T ss_conf             332211011113201210135766400111---------------------22045677788989799797599999999


Q ss_pred             HHHCCCCCCCCCCCCCEEEECCCCCC----C-CCCCCCEEECCCCCCCCC
Q ss_conf             32114355412233758761258103----5-866656330357620366
Q 002760          475 TLSACANLEYLNISGNAFSGSIPLLL----D-SLQSIKELDFSSNNLNGQ  519 (884)
Q Consensus       475 ~~~~l~~L~~L~L~~N~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~  519 (884)
                      .+...++|+.|+|++|+++......+    . ....|+.|++.+|.+...
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             HHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHH
T ss_conf             99629988989899996987999999999974788667898989878989

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.3e-31  Score=185.80  Aligned_cols=191  Identities=21%  Similarity=0.137  Sum_probs=99.6

Q ss_pred             CCCCCCEEEEECCCCCC-----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCCCCCCCCEEECCCCCCCCCCCCC-
Q ss_conf             87887499932488886-----68923379999999986488799988----876676565768973265154227989-
Q 002760          333 NLASLNWLTIDTNQLTG-----TIPPEIGELTNLQQLDLDRNFLQGSI----PSSLGNLTLLTYLKLGLNNLEGNIPSS-  402 (884)
Q Consensus       333 ~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~-  402 (884)
                      ..+.++.+.+.+|.+..     .....+.....++.+++++|.+....    ...+...+.++.+++++|.++...... 
T Consensus       224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l  303 (460)
T d1z7xw1         224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL  303 (460)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             CCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             22221001002112233442011000111111100001345433212334332211123433344444333224564211


Q ss_pred             ----CCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHH--
Q ss_conf             ----86865433211346312376533223211000112037744798999664477766779637997988860332--
Q 002760          403 ----LGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATL--  476 (884)
Q Consensus       403 ----~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--  476 (884)
                          ......|+.+++++|.+.......+.                     ..+...++|++|+|++|++.+.....+  
T Consensus       304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~---------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~  362 (460)
T d1z7xw1         304 CETLLEPGCQLESLWVKSCSFTAACCSHFS---------------------SVLAQNRFLLELQISNNRLEDAGVRELCQ  362 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHHH---------------------HHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred             HCCCCCCCCCCCCCCCCCCCHHHHHHHHCC---------------------CCCCCCCCHHHHHEEEECCCCCCCCHHHH
T ss_conf             101233344433332333410233443213---------------------32211011113201210135766400111


Q ss_pred             --H-CCCCCCCCCCCCCEEEEC----CCCCCCCCCCCCEEECCCCCCCCCCCCCCC-----CCCCCCEEECCCCCCCCCC
Q ss_conf             --1-143554122337587612----581035866656330357620366652353-----7786661532686171015
Q 002760          477 --S-ACANLEYLNISGNAFSGS----IPLLLDSLQSIKELDFSSNNLNGQIPEYLE-----NLSFLEFLNLSYNHFEGEV  544 (884)
Q Consensus       477 --~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~~~~  544 (884)
                        . ....|+.|+|++|.+++.    ....+...++|++|++++|+|++.....+.     ....|+.+++++|.+..+.
T Consensus       363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~  442 (460)
T d1z7xw1         363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM  442 (460)
T ss_dssp             HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred             HHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHH
T ss_conf             22045677788989799797599999999996299889898999969879999999999747886678989898789899

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=7.4e-28  Score=165.29  Aligned_cols=171  Identities=20%  Similarity=0.192  Sum_probs=118.6

Q ss_pred             CCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCC------------------CCHHHHHHHHHHHHCCCCCCCCCEE
Q ss_conf             9846802211531799989799992899999412266------------------5069999999999717899742165
Q 002760          641 FSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQK------------------GASKSFVAECKALRNIRHRNLIKII  702 (884)
Q Consensus       641 y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~  702 (884)
                      +.+.++||+|+||+||+|++. +|+.||||+++....                  ........|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf             022778024856599999979-9999999998604434666556563000888999999778999999981699914499


Q ss_pred             EEECCCCCCCCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf             55215875678610289981289998899610699853246899999999999999999985049999165498999823
Q 002760          703 TVCSGRDFKGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYCEPSIVHGDLKPSNVL  782 (884)
Q Consensus       703 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil  782 (884)
                      ++.         ..+++|||++++...+             ++......++.|++.++.|||   +++|+||||||+|||
T Consensus        81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NIL  135 (191)
T d1zara2          81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  135 (191)
T ss_dssp             EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             EEC---------CCEEEEEEECCCCCCC-------------HHHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHEE
T ss_conf             862---------8889999504565420-------------015789999999999999982---688898368903611


Q ss_pred             ECCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEECCCCCCCCCCCCCCCEEEHHHHHH
Q ss_conf             4899956994243441256689986211100110333443110753127988884344320449899
Q 002760          783 LDQDLVSHVSDFGLAKFLSNHNPDTIVETRSISIGIKGTVGYVAPEYGMGREASMKGDVYSFGILLL  849 (884)
Q Consensus       783 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~  849 (884)
                      ++++ .++++|||.|.....+........         ... .-.+ +-.+.|+.++|+||+.--+.
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~~~l~r---------d~~-~~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWREILER---------DVR-NIIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHHHHHHH---------HHH-HHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             EECC-CEEEEECCCCCCCCCCCCHHHHHH---------HHH-HHHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf             4289-899987788430899870999987---------799-9999-97578998446899999874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.6e-25  Score=148.54  Aligned_cols=99  Identities=17%  Similarity=0.153  Sum_probs=44.8

Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCC-CCCC
Q ss_conf             899973225867668888968882478678789968689999889974488676857-83444999985774657-6655
Q 002760           24 GNQSIRGTLSPYVGNLSFLRYINIASNGFNGEIPHQIGRLISLERLILSNNSFSGAI-PANLSSCSNLIELSADS-NNLV  101 (884)
Q Consensus        24 ~~~~~~~~~~~~l~~l~~L~~L~l~~~~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~-~~~l~~l~~L~~L~L~~-n~l~  101 (884)
                      ++.+++ .+|+.+.  ..+++|++++|.++...+..|.++++|++|++++|.+...+ +..|..+.+++++.+.. |.+.
T Consensus        16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             ECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf             189988-7688889--9889998769918964966861464323211022112420100112222222221111123432


Q ss_pred             CCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             878823346223441112233248
Q 002760          102 GEIPADIGSLFKLERLSIFQNHIT  125 (884)
Q Consensus       102 ~~~p~~~~~l~~L~~L~L~~n~l~  125 (884)
                      ...+..|..+++|+.|++++|.+.
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf             222221222222222234211112

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.91  E-value=2.6e-24  Score=145.90  Aligned_cols=79  Identities=27%  Similarity=0.336  Sum_probs=40.0

Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             44777667796379979888603321143554122337587612581035866656330357620366652353778666
Q 002760          452 VGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLE  531 (884)
Q Consensus       452 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  531 (884)
                      +...++|+.|++++|.+.+..  .|..+++|+.|++++|++.++.+  +..+++|+.|++++|++++..  .+..+++|+
T Consensus       147 ~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~  220 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLF  220 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCC
T ss_pred             HCCCCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCC--CCCCCCCCC
T ss_conf             010211100233333333100--10564633564458884177853--447999998979599689980--203699989


Q ss_pred             EEECC
Q ss_conf             15326
Q 002760          532 FLNLS  536 (884)
Q Consensus       532 ~l~l~  536 (884)
                      .|+++
T Consensus       221 ~L~ls  225 (227)
T d1h6ua2         221 IVTLT  225 (227)
T ss_dssp             EEEEE
T ss_pred             EEEEE
T ss_conf             89712

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.91  E-value=6.6e-25  Score=149.16  Aligned_cols=176  Identities=21%  Similarity=0.262  Sum_probs=86.1

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             499932488886689233799999999864887999-8887667656576897326515422798986865433211346
Q 002760          338 NWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQG-SIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLLGLNISH  416 (884)
Q Consensus       338 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  416 (884)
                      ++++++++.++ .+|..+.  ++++.|+|++|+|+. ..+..|.++++|+.|++++|.+....+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf             99997089967-0298989--78788984898775530200257876272130136322121212221122221010035


Q ss_pred             CCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECC
Q ss_conf             31237653322321100011203774479899966447776677963799798886033211435541223375876125
Q 002760          417 NKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSI  496 (884)
Q Consensus       417 N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  496 (884)
                      |++..                         ..+..|.++++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+....
T Consensus        88 N~l~~-------------------------l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          88 NKIKE-------------------------ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCE-------------------------ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CCCCC-------------------------CCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             53443-------------------------49799807974655245774535359778568753342000364434353


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf             8103586665633035762036665235377866615326861710159
Q 002760          497 PLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSYNHFEGEVP  545 (884)
Q Consensus       497 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  545 (884)
                      ... .-...++.+.+..|.++...|..+.   .++.++++.|.+.|..+
T Consensus       143 ~~~-~~~~~l~~~~l~~~~~~c~~p~~l~---~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         143 HLA-WFAEWLRKKSLNGGAARCGAPSKVR---DVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             GGH-HHHHHHHHHCCSGGGCBBCSSTTTT---TSBGGGSCTTTCCCCCC
T ss_pred             CHH-HHHHHHHHHCCCCCCEEECCCHHHC---CCEEEECCHHHCCCCCC
T ss_conf             027-7764235403568982768984336---98861448755758998

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.90  E-value=3.8e-23  Score=139.58  Aligned_cols=18  Identities=28%  Similarity=0.381  Sum_probs=6.2

Q ss_pred             HHCCCCCCCCCCCCCEEE
Q ss_conf             211435541223375876
Q 002760          476 LSACANLEYLNISGNAFS  493 (884)
Q Consensus       476 ~~~l~~L~~L~L~~N~l~  493 (884)
                      |..+++|+.|++++|+++
T Consensus       191 l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         191 LASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             GGGCTTCCEEECTTSCCC
T ss_pred             HCCCCCCCEEECCCCCCC
T ss_conf             447999998979599689

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=9.6e-24  Score=142.83  Aligned_cols=62  Identities=24%  Similarity=0.329  Sum_probs=20.7

Q ss_pred             CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCC
Q ss_conf             77667796379979888603321143554122337587612581035866656330357620
Q 002760          455 LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNL  516 (884)
Q Consensus       455 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  516 (884)
                      +++|+.|+|++|+|+.+.++.|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|.+
T Consensus        77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~  138 (192)
T d1w8aa_          77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF  138 (192)
T ss_dssp             CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred             CCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf             22221010035534434979980797465524577453535977856875334200036443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=1.2e-22  Score=136.88  Aligned_cols=182  Identities=25%  Similarity=0.344  Sum_probs=119.2

Q ss_pred             HHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             11026883211379222687887499932488886689233799999999864887999888766765657689732651
Q 002760          315 QIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN  394 (884)
Q Consensus       315 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~  394 (884)
                      ...++.+.+++..+  ...+.+|+.|++++|.++...  .+..+++|+.|++++|++++..  .+..+++|++|++++|+
T Consensus        28 ~~~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCC
T ss_conf             99857576577518--879548458978279888744--4764899898769896025860--11358621201433333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHH
Q ss_conf             54227989868654332113463123765332232110001120377447989996644777667796379979888603
Q 002760          395 LEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA  474 (884)
Q Consensus       395 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  474 (884)
                      ++. .+ .+.++++|+.|++++|.+.                           ....+..+++++.+++++|.+++  +.
T Consensus       102 i~~-l~-~l~~l~~L~~L~l~~~~~~---------------------------~~~~l~~l~~l~~l~~~~n~l~~--~~  150 (210)
T d1h6ta2         102 VKD-LS-SLKDLKKLKSLSLEHNGIS---------------------------DINGLVHLPQLESLYLGNNKITD--IT  150 (210)
T ss_dssp             CCC-GG-GGTTCTTCCEEECTTSCCC---------------------------CCGGGGGCTTCCEEECCSSCCCC--CG
T ss_pred             CCC-CC-CCCCCCCCCCCCCCCCCCC---------------------------CCCCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf             212-22-1212221112234565322---------------------------11220111112221122233345--43


Q ss_pred             HHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             321143554122337587612581035866656330357620366652353778666153268
Q 002760          475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFLNLSY  537 (884)
Q Consensus       475 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~  537 (884)
                      .+..+++|+.+++++|++.++.+  +..+++|+.|++++|++++ ++ .+..+++|+.|++++
T Consensus       151 ~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCC
T ss_conf             10001332100134643025645--3678989999897998998-72-116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=5.1e-22  Score=133.39  Aligned_cols=178  Identities=33%  Similarity=0.457  Sum_probs=112.6

Q ss_pred             HHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             11026883211379222687887499932488886689233799999999864887999888766765657689732651
Q 002760          315 QIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNN  394 (884)
Q Consensus       315 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~  394 (884)
                      ...++.+.+++..  ....+.+++.|++++|.++..  +.+..+++|+.|++++|++++..+  +.++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHHCCCCCCCCC--CHHHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf             9996778778855--987946878998999999775--202137886757545655667640--1677522311112222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHH
Q ss_conf             54227989868654332113463123765332232110001120377447989996644777667796379979888603
Q 002760          395 LEGNIPSSLGNCTNLLGLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPA  474 (884)
Q Consensus       395 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  474 (884)
                      +.. .+ .+.++++|+.|++++|.+..                           ...+..+++|+.|++++|++.. . +
T Consensus        96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~---------------------------~~~~~~l~~L~~L~l~~n~l~~-~-~  144 (199)
T d2omxa2          96 IAD-IT-PLANLTNLTGLTLFNNQITD---------------------------IDPLKNLTNLNRLELSSNTISD-I-S  144 (199)
T ss_dssp             CCC-CG-GGTTCTTCSEEECCSSCCCC---------------------------CGGGTTCTTCSEEECCSSCCCC-C-G
T ss_pred             CCC-CC-CCCCCCCCCCCCCCCCCCCC---------------------------CCCCCHHHHHHHHHHHHHHHCC-C-C
T ss_conf             222-21-11112232221112222223---------------------------2100012236776431111002-3-4


Q ss_pred             HHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             32114355412233758761258103586665633035762036665235377866615
Q 002760          475 TLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLENLSFLEFL  533 (884)
Q Consensus       475 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l  533 (884)
                      .+..+++|+.|++++|++++..  .+..+++|+.|++++|++++ ++ .+..+++|++|
T Consensus       145 ~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         145 ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCC
T ss_conf             3332111111223455556770--11679989999787997998-81-01278998949

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=3.8e-21  Score=128.61  Aligned_cols=145  Identities=28%  Similarity=0.347  Sum_probs=60.4

Q ss_pred             CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             26878874999324888866892337999999998648879998887667656576897326515422798986865433
Q 002760          331 IRNLASLNWLTIDTNQLTGTIPPEIGELTNLQQLDLDRNFLQGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTNLL  410 (884)
Q Consensus       331 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  410 (884)
                      +..+++|++|++++|.+++..  .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|.+..  ...+..+++++
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCC
T ss_pred             HHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf             764899898769896025860--11358621201433333212-22-12122211122345653221--12201111122


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf             21134631237653322321100011203774479899966447776677963799798886033211435541223375
Q 002760          411 GLNISHNKLIGTLPRQILRITTLSLYLELGNNLLNGSLPPEVGNLKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGN  490 (884)
Q Consensus       411 ~L~Ls~N~l~~~~p~~~~~~~~~~~~l~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  490 (884)
                      .++++.|.+..                           +..+..+++|+.+++++|++++..  .+..+++|+.|++++|
T Consensus       138 ~l~~~~n~l~~---------------------------~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N  188 (210)
T d1h6ta2         138 SLYLGNNKITD---------------------------ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKN  188 (210)
T ss_dssp             EEECCSSCCCC---------------------------CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             CCCCCCCCCCC---------------------------CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCC
T ss_conf             21122233345---------------------------431000133210013464302564--5367898999989799


Q ss_pred             EEEECCCCCCCCCCCCCEEECC
Q ss_conf             8761258103586665633035
Q 002760          491 AFSGSIPLLLDSLQSIKELDFS  512 (884)
Q Consensus       491 ~l~~~~~~~~~~l~~L~~L~L~  512 (884)
                      +++.+ + .+..+++|+.|+|+
T Consensus       189 ~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         189 HISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CCCBC-G-GGTTCTTCSEEEEE
T ss_pred             CCCCC-H-HHCCCCCCCEEECC
T ss_conf             89987-2-11699998999711

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.81  E-value=4.8e-23  Score=139.00  Aligned_cols=20  Identities=30%  Similarity=0.627  Sum_probs=10.3

Q ss_pred             HHHCCCCCCCEEECCCCCCC
Q ss_conf             53127889949984688556
Q 002760          280 NLLTNCSKLERLYFNRNRFE  299 (884)
Q Consensus       280 ~~l~~l~~L~~L~L~~N~l~  299 (884)
                      ..+...+.|+.|++++|.+.
T Consensus       115 ~~l~~~~~L~~L~l~~n~l~  134 (344)
T d2ca6a1         115 DFLSKHTPLEHLYLHNNGLG  134 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCH
T ss_pred             HHHCCCCCCHHEECCCCCCC
T ss_conf             11002343210000024666

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.80  E-value=6.3e-22  Score=132.89  Aligned_cols=10  Identities=50%  Similarity=0.614  Sum_probs=3.1

Q ss_pred             CCEEECCCCC
Q ss_conf             6615326861
Q 002760          530 LEFLNLSYNH  539 (884)
Q Consensus       530 L~~l~l~~N~  539 (884)
                      |+.|++++|.
T Consensus       304 L~~L~l~~N~  313 (344)
T d2ca6a1         304 LLFLELNGNR  313 (344)
T ss_dssp             CCEEECTTSB
T ss_pred             CCEEECCCCC
T ss_conf             9989787980

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=4.2e-20  Score=122.92  Aligned_cols=262  Identities=14%  Similarity=0.129  Sum_probs=0.0

Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             58882043012323432445443546421233678899544578861199810453235689888988877755735787
Q 002760          139 RVIDVRENRLWGRIDSLGQLKSLTLLSVAFNQFSGMIPPSIFNISSLEVISLSENRFTGSLPVDTGVNLPSLRELRTNAN  218 (884)
Q Consensus       139 ~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n  218 (884)
                      +++|++++.+....-.----..+..+.++...+. ..........+|+.|+++++.+........+...++|++|.+.+|
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHHTTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             CEEECCCCCCCCHHHHHHHHCCCEEEECCCCCCC-CCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf             7797899978814799987455427465233345-522442567878878898984577799999974877651452346


Q ss_pred             CCCCCCCCCCCCCCCCCEECCCC-CCCCCCCCCCC-CCCCCCCEEECCC-CCCCCCCCCHHHHHHHHCCCCCCCEEECCC
Q ss_conf             22232773462577765002344-63445765444-6555432330532-346999997034665312788994998468
Q 002760          219 NFTGFIPVSLSNASSLEMIEFSK-NQFSGGVSVDF-SRLKNLYWLNLGI-NNLGTGAANELDFINLLTNCSKLERLYFNR  295 (884)
Q Consensus       219 ~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~-~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  295 (884)
                      .+.......+..+++|+.|++++ +.+++.....+ ..+++|+.|++++ ..+.....    ........+.|+.|++++
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~----~~~~~~~~~~L~~L~l~~  157 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV----QVAVAHVSETITQLNLSG  157 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH----HHHHHHSCTTCCEEECCS
T ss_pred             CCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCC----HHHHCCCCCCCCHHHHCC
T ss_conf             7986789998518997571510013412355403657887435652245332333220----001000111110122135


Q ss_pred             C--CCCCCCCCHHHCCCHHHHHHCCCCCC-CCCCCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             8--55678892011000104311026883-2113792226878874999324-888866892337999999998648879
Q 002760          296 N--RFEGELPHSVANLSSTIKQIAMGRNR-ISGTIPPEIRNLASLNWLTIDT-NQLTGTIPPEIGELTNLQQLDLDRNFL  371 (884)
Q Consensus       296 N--~l~~~~~~~~~~~~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l  371 (884)
                      +  .+.......+....+.|+.|++++|. +++.....+..+++|++|++++ +.+++.....+..+++|+.|+++++ +
T Consensus       158 ~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~  236 (284)
T d2astb2         158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V  236 (284)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC-C
T ss_conf             542444443434232322212355322347783033332135768779899999787378999726999898964488-8


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             9988876676565768973265154227989868654
Q 002760          372 QGSIPSSLGNLTLLTYLKLGLNNLEGNIPSSLGNCTN  408 (884)
Q Consensus       372 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  408 (884)
                      .+.....+.  ..+..|.+..+.++...+..++....
T Consensus       237 ~d~~l~~l~--~~lp~L~i~~~~ls~~~~~~~~~~~~  271 (284)
T d2astb2         237 PDGTLQLLK--EALPHLQINCSHFTTIARPTIGNKKN  271 (284)
T ss_dssp             CTTCHHHHH--HHSTTSEESCCCSCCTTCSSCSSTTC
T ss_pred             CHHHHHHHH--HHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             989999999--76843661686587777885476664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=4.3e-18  Score=111.92  Aligned_cols=125  Identities=17%  Similarity=0.123  Sum_probs=97.9

Q ss_pred             CCCCCCCCCCCCCEEECCCC-CCCCCCHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf             99966447776677963799-79888603321143554122337587612581035866656330357620366652353
Q 002760          447 SLPPEVGNLKNLMRLDLSGN-KFSGEIPATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIPEYLE  525 (884)
Q Consensus       447 ~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  525 (884)
                      ..|..+..+++|++|++++| .++.+.++.|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|++|+|+...+..+.
T Consensus        22 ~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  101 (156)
T d2ifga3          22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ  101 (156)
T ss_dssp             TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHC
T ss_conf             58600257656574316898664436921225666667216202124774201112455433332267878515745633


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
Q ss_conf             77866615326861710159998656665--441027974358987678
Q 002760          526 NLSFLEFLNLSYNHFEGEVPMKGVFNNKT--RFSIAGNGKLCGGLDELR  572 (884)
Q Consensus       526 ~l~~L~~l~l~~N~l~~~~~~~~~~~~~~--~~~~~~n~~~c~~~~~~~  572 (884)
                      .+ .|+.|++++|+|.|.|...|...+..  ......+...|.+|..+.
T Consensus       102 ~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~  149 (156)
T d2ifga3         102 GL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLA  149 (156)
T ss_dssp             SC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSS
T ss_pred             CC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEECCCHHHC
T ss_conf             53-2124335798633881179999999856576675785779686888

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=2.2e-18  Score=113.56  Aligned_cols=129  Identities=19%  Similarity=0.178  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCC
Q ss_conf             96868999988997448867685783444999985774657665587882334622344111223324899993457988
Q 002760           57 PHQIGRLISLERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLS  136 (884)
Q Consensus        57 ~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~  136 (884)
                      ..++.+...+++|+|++|+|+ .++..+..+.+|+.|++++|++. .+ ..+..+++|+.|++++|+++...+..+..++
T Consensus        11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CC-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             175168574848978899788-65762004145998989799787-64-7744576130643102134577763223345


Q ss_pred             CCCEEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf             87588820430123234--324454435464212336788995----445788611998
Q 002760          137 SLRVIDVRENRLWGRID--SLGQLKSLTLLSVAFNQFSGMIPP----SIFNISSLEVIS  189 (884)
Q Consensus       137 ~L~~L~l~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~----~l~~l~~L~~L~  189 (884)
                      +|++|++++|++..+++  .+..+++|++|++++|++. ..+.    .+..+++|+.||
T Consensus        88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf             34434203000166542110013653206640799634-56106999998789958337

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.68  E-value=4e-19  Score=117.57  Aligned_cols=81  Identities=22%  Similarity=0.215  Sum_probs=33.1

Q ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEEECCC-CCCCCCCCCCEEECCCCCCCCCCCC----------CCC
Q ss_conf             66779637997988860332114355412233758761258-1035866656330357620366652----------353
Q 002760          457 NLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFSGSIP-LLLDSLQSIKELDFSSNNLNGQIPE----------YLE  525 (884)
Q Consensus       457 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----------~~~  525 (884)
                      +|+.|++++|+++..  ..+..+++|+.|++++|+++.... ..+..+++|+.|++++|++....+.          .+.
T Consensus        94 ~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~  171 (198)
T d1m9la_          94 TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK  171 (198)
T ss_dssp             HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHH
T ss_pred             CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf             233333333222222--222222234111234102125542212367776302342798434676322220558999998


Q ss_pred             CCCCCCEEECCCCCCC
Q ss_conf             7786661532686171
Q 002760          526 NLSFLEFLNLSYNHFE  541 (884)
Q Consensus       526 ~l~~L~~l~l~~N~l~  541 (884)
                      .+|+|+.||  +.+++
T Consensus       172 ~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         172 RLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HCSSCCEES--SGGGT
T ss_pred             HCCCCCEEC--CCCCC
T ss_conf             788958769--76689

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.66  E-value=2.2e-16  Score=102.55  Aligned_cols=117  Identities=21%  Similarity=0.227  Sum_probs=0.0

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             89974488676857834449999857746576655878823346223441112233248999934579888758882043
Q 002760           67 ERLILSNNSFSGAIPANLSSCSNLIELSADSNNLVGEIPADIGSLFKLERLSIFQNHITGQLPASIGNLSSLRVIDVREN  146 (884)
Q Consensus        67 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  146 (884)
                      |+|+|++|+++ .++. +..+.+|++|++++|+++ .+|..+..+++|+.|++++|.++ .++. +..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCC
T ss_conf             98986899898-8710-105898898979787168-65215655431354532432112-3574-123355576888898


Q ss_pred             CCCCCC--CCCCCCCCCCEEECCCCCCCCCC---CCCCCCCCCCCEE
Q ss_conf             012323--43244544354642123367889---9544578861199
Q 002760          147 RLWGRI--DSLGQLKSLTLLSVAFNQFSGMI---PPSIFNISSLEVI  188 (884)
Q Consensus       147 ~l~~~~--~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~l~~L~~L  188 (884)
                      ++..++  ..+..+++|+.|++++|+++...   ......+++|+.+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             65888882565379999999897996886826799999989673138

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.09  E-value=6.4e-10  Score=67.25  Aligned_cols=150  Identities=19%  Similarity=0.196  Sum_probs=94.6

Q ss_pred             HHHHHHHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCCCCEEEEECCCCC
Q ss_conf             899998429984680221153179998979999289999941226650699999999997178-9974216555215875
Q 002760          632 AELSKATDNFSSANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIR-HRNLIKIITVCSGRDF  710 (884)
Q Consensus       632 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  710 (884)
                      .++......|++++..+.++.+.||+...  ++..+.+|+...........+.+|...+..+. +--+.+++.+.     
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----   79 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----   79 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEE-----
T ss_conf             99997513527997678998771899990--89869999848876532556999999999876069987289997-----


Q ss_pred             CCCCCCEEEEECCCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------
Q ss_conf             678610289981289998899610699853246899999999999999999985049-----------------------
Q 002760          711 KGADFKAIVYEFMQNGSLEEWLHHSNDQLEVCSLSVIQRLNIAIDVASAIEYLHHYC-----------------------  767 (884)
Q Consensus       711 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------  767 (884)
                      ..++..++||++++|.++.+......        .   ...++.+++..+..||...                       
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~~--------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDEQ--------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTCS--------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             ECCCCEEEEEEECCCCCCCCCCCCCC--------C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf             50896499998604334354334402--------6---999999899999998556842143576446565557789987


Q ss_pred             ---------------------------------CCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             ---------------------------------99916549899982348999569942434412
Q 002760          768 ---------------------------------EPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       768 ---------------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  799 (884)
                                                       ...++|+|+.|.||++++++.+.++||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             76555543033232005799999999844986781789860047642364996599960231441

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=7.1e-12  Score=77.95  Aligned_cols=86  Identities=24%  Similarity=0.274  Sum_probs=48.8

Q ss_pred             CCCCCCCEEECCCCCCCCCC--HHHHHCCCCCCCCCCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCC-------CC
Q ss_conf             47776677963799798886--0332114355412233758761258103586665633035762036665-------23
Q 002760          453 GNLKNLMRLDLSGNKFSGEI--PATLSACANLEYLNISGNAFSGSIPLLLDSLQSIKELDFSSNNLNGQIP-------EY  523 (884)
Q Consensus       453 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-------~~  523 (884)
                      ..+++|+.|+|++|+|+...  +..+..+++|+.|+|++|.++......+....+|+.|++++|++.....       ..
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHH
T ss_conf             74878788637776666773158898658856100043572134234422203310426648997676766615699999


Q ss_pred             CCCCCCCCEEECCCCCC
Q ss_conf             53778666153268617
Q 002760          524 LENLSFLEFLNLSYNHF  540 (884)
Q Consensus       524 ~~~l~~L~~l~l~~N~l  540 (884)
                      +..+|+|+.||  ++++
T Consensus       142 ~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         142 RERFPKLLRLD--GHEL  156 (162)
T ss_dssp             HTTSTTCCEET--TEEC
T ss_pred             HHHCCCCCEEC--CCCC
T ss_conf             99889978799--3888

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.96  E-value=1e-11  Score=77.09  Aligned_cols=39  Identities=36%  Similarity=0.393  Sum_probs=13.8

Q ss_pred             CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCEEE
Q ss_conf             776677963799798886033211435541223375876
Q 002760          455 LKNLMRLDLSGNKFSGEIPATLSACANLEYLNISGNAFS  493 (884)
Q Consensus       455 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  493 (884)
                      +++|+.|+|++|.|+....-.+.+..+|+.|++++|++.
T Consensus        90 l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             STTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf             885610004357213423442220331042664899767

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.70  E-value=1e-07  Score=55.21  Aligned_cols=77  Identities=16%  Similarity=0.146  Sum_probs=50.3

Q ss_pred             CCEEEECCCEEEEEEEECCCCCEEEEEEEECCC-------CCCHHHHHHHHHHHHCC-CC--CCCCCEEEEECCCCCCCC
Q ss_conf             680221153179998979999289999941226-------65069999999999717-89--974216555215875678
Q 002760          644 ANKIGEGGSGIVYKGFLGENGTEVAVKVINLKQ-------KGASKSFVAECKALRNI-RH--RNLIKIITVCSGRDFKGA  713 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l-~h--~niv~~~~~~~~~~~~~~  713 (884)
                      .+.+|.|....||++....+++.+.||.-....       +....+...|...++.+ .+  ..+++++.+.       .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC-------C
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985-------9


Q ss_pred             CCCEEEEECCCCCC
Q ss_conf             61028998128999
Q 002760          714 DFKAIVYEFMQNGS  727 (884)
Q Consensus       714 ~~~~lv~e~~~~g~  727 (884)
                      ...++|||++++..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEECCCCCC
T ss_conf             88779871357765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.45  E-value=2.9e-07  Score=52.74  Aligned_cols=145  Identities=15%  Similarity=0.112  Sum_probs=77.5

Q ss_pred             EEEECCC-EEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCC--CCCEEEEECCCCCCCCCCCEEEEEC
Q ss_conf             0221153-179998979999289999941226650699999999997178997--4216555215875678610289981
Q 002760          646 KIGEGGS-GIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN--LIKIITVCSGRDFKGADFKAIVYEF  722 (884)
Q Consensus       646 ~lg~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~  722 (884)
                      .+..|.. +.||+.... .+..+.+|..+...   ...+..|+..++.+....  +.+++.+.     .+.+..++||++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred             ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEC-----CCCCCEEEEEEE
T ss_conf             76786547758999938-98789999589667---7689999999999986599988613222-----456615999874


Q ss_pred             CCCCCHHH--------------HHHCCCC-CCCCCC--CCHHHHHHHHH--------------------HHHHHHHHHHH
Q ss_conf             28999889--------------9610699-853246--89999999999--------------------99999999850
Q 002760          723 MQNGSLEE--------------WLHHSND-QLEVCS--LSVIQRLNIAI--------------------DVASAIEYLHH  765 (884)
Q Consensus       723 ~~~g~L~~--------------~l~~~~~-~~~~~~--l~~~~~~~i~~--------------------~i~~~l~~LH~  765 (884)
                      ++|.++.+              .+..... ......  ........-..                    .....+..+..
T Consensus        88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             EECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf             41355432212689999999999998736885448875541246889999998754110113401121379999999987


Q ss_pred             ----CCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             ----4999916549899982348999569942434412
Q 002760          766 ----YCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       766 ----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  799 (884)
                          .....++|+|+.|.||+++.+..+.++||+.+..
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             18765795678678887635773796589998533265

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.14  E-value=1.7e-07  Score=54.05  Aligned_cols=119  Identities=14%  Similarity=0.125  Sum_probs=0.0

Q ss_pred             CCCCCCCEECCCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCHHHHHHHHCCCCCCCEEECCCCCCCCCCC
Q ss_conf             2577765002344-634457----65444655543233053234699999703466531278899499846885567889
Q 002760          229 SNASSLEMIEFSK-NQFSGG----VSVDFSRLKNLYWLNLGINNLGTGAANELDFINLLTNCSKLERLYFNRNRFEGELP  303 (884)
Q Consensus       229 ~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  303 (884)
                      .+.++|+.|+|++ +.+...    ....+...+.|+.|++++|.++..+...+.  +.+...+.|+.|++++|.+.....
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la--~~L~~n~~L~~L~L~~n~i~~~g~   89 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLI--ELIETSPSLRVLNVESNFLTPELL   89 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH--HHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHH--HHHHHCCCCCCEEEEHHHCCHHHH
T ss_conf             289998197827999989899999999976377645401201562156798875--310002343300330102145999


Q ss_pred             CHHHCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf             20110001043110268832113792226878874999324888866-------89233799999999864887
Q 002760          304 HSVANLSSTIKQIAMGRNRISGTIPPEIRNLASLNWLTIDTNQLTGT-------IPPEIGELTNLQQLDLDRNF  370 (884)
Q Consensus       304 ~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------~~~~~~~l~~L~~L~Ls~n~  370 (884)
                      ..++.                     ++...+.|+.|++++|.+...       +...+...++|+.|+++.+.
T Consensus        90 ~~l~~---------------------aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          90 ARLLR---------------------STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHH---------------------HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHH---------------------HHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             99999---------------------998489389877887768886579999999999729985386486888

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.13  E-value=1.4e-05  Score=43.63  Aligned_cols=145  Identities=12%  Similarity=0.115  Sum_probs=78.5

Q ss_pred             CCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCC--CCCEEEEECCCCCCCCCCCEEEEECCCCCC
Q ss_conf             153179998979999289999941226650699999999997178997--421655521587567861028998128999
Q 002760          650 GGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN--LIKIITVCSGRDFKGADFKAIVYEFMQNGS  727 (884)
Q Consensus       650 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~  727 (884)
                      +.--.||+++.. +|..+++|+.+... ...+.+..|...+..+...+  ++..+...........+..+.++++++|..
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             CCCCEEEEEECC-CCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf             612026999838-99979999847877-8899999999999999855998787520689805665347999986527768


Q ss_pred             H-----HHH------H---H----CCCCCCCCCCCCH----------------------HHHHHHHHHHHHHHHHH-HHC
Q ss_conf             8-----899------6---1----0699853246899----------------------99999999999999998-504
Q 002760          728 L-----EEW------L---H----HSNDQLEVCSLSV----------------------IQRLNIAIDVASAIEYL-HHY  766 (884)
Q Consensus       728 L-----~~~------l---~----~~~~~~~~~~l~~----------------------~~~~~i~~~i~~~l~~L-H~~  766 (884)
                      +     ..+      +   +    .... ......+.                      ......+.++...+... ...
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~-~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~  189 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLF-IHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  189 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCC-SSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf             8999999999989999998863035786-556778978876656899987476998898999999999999999845456


Q ss_pred             CCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             999916549899982348999569942434412
Q 002760          767 CEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       767 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  799 (884)
                      ...+++|+|+.+.|||++.+  ..++||+.+..
T Consensus       190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             87120247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.06  E-value=2.4e-05  Score=42.25  Aligned_cols=73  Identities=19%  Similarity=0.249  Sum_probs=47.5

Q ss_pred             CCEEEECCCEEEEEEEECC-------CCCEEEEEEEECCCCCCHHHHHHHHHHHHCC-CCCCCCCEEEEECCCCCCCCCC
Q ss_conf             6802211531799989799-------9928999994122665069999999999717-8997421655521587567861
Q 002760          644 ANKIGEGGSGIVYKGFLGE-------NGTEVAVKVINLKQKGASKSFVAECKALRNI-RHRNLIKIITVCSGRDFKGADF  715 (884)
Q Consensus       644 ~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  715 (884)
                      ++.|+.|-.-.+|++....       ..+.|.+++.- . ........+|..+++.+ ++.-.+++++++.     +   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~-----~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS-----G---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECC-----C---
T ss_conf             9991785334348999688775445789817999659-9-6116589999999999975799980899818-----9---


Q ss_pred             CEEEEECCCCCC
Q ss_conf             028998128999
Q 002760          716 KAIVYEFMQNGS  727 (884)
Q Consensus       716 ~~lv~e~~~~g~  727 (884)
                       +.|+||++|.+
T Consensus       117 -g~I~efi~g~~  127 (395)
T d1nw1a_         117 -GRLEEYIPSRP  127 (395)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEECCCC
T ss_conf             -56999734554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.71  E-value=0.00059  Score=34.67  Aligned_cols=166  Identities=11%  Similarity=0.019  Sum_probs=81.3

Q ss_pred             CHHHHHHHHCCCCCCCEE-----EECCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCC--CCCEE
Q ss_conf             488999984299846802-----21153179998979999289999941226650699999999997178997--42165
Q 002760          630 SYAELSKATDNFSSANKI-----GEGGSGIVYKGFLGENGTEVAVKVINLKQKGASKSFVAECKALRNIRHRN--LIKII  702 (884)
Q Consensus       630 ~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~  702 (884)
                      +..++.....+|.+.+..     ..|.--+.|..+..  +..+++|++....  ..+.+..|...+..+...+  ++..+
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             9999999998679998568523788852673899978--9728999807899--98899999999875430255545564


Q ss_pred             EEECCCC-CCCCCCCEEEEECCCCCCHH-----------HH---HHC----CCCCCCCC-----------------CCCH
Q ss_conf             5521587-56786102899812899988-----------99---610----69985324-----------------6899
Q 002760          703 TVCSGRD-FKGADFKAIVYEFMQNGSLE-----------EW---LHH----SNDQLEVC-----------------SLSV  746 (884)
Q Consensus       703 ~~~~~~~-~~~~~~~~lv~e~~~~g~L~-----------~~---l~~----~~~~~~~~-----------------~l~~  746 (884)
                      ....+.. ..-......++.+..+....           ..   ++.    ........                 ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHH-HCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             999999999999999985-04999916549899982348999569942434412
Q 002760          747 IQRLNIAIDVASAIEYLH-HYCEPSIVHGDLKPSNVLLDQDLVSHVSDFGLAKF  799 (884)
Q Consensus       747 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  799 (884)
                      ......+......+...+ .....++||+|+.+.|++++.+...-++||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             127999999987642048554545033378636564020454126742221236

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.71  E-value=1.3e-06  Score=49.12  Aligned_cols=110  Identities=19%  Similarity=0.149  Sum_probs=0.0

Q ss_pred             CCCCCCCEEECCC-CCCC----CCCCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCC----CC
Q ss_conf             8999988997448-8676----8578344499998577465766558----78823346223441112233248----99
Q 002760           61 GRLISLERLILSN-NSFS----GAIPANLSSCSNLIELSADSNNLVG----EIPADIGSLFKLERLSIFQNHIT----GQ  127 (884)
Q Consensus        61 ~~l~~L~~L~Ls~-n~i~----~~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~----~~  127 (884)
                      .+.+.|++|+|++ +.++    ..+..++..+.+|++|++++|.+..    .+-..+...+.++.+++.+|.+.    ..
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf             55999868876899998989999999888419825743015896117789999987752122101210254322014788


Q ss_pred             CCCCCCCCCCCCE--EEECCCCCCC-----CCCCCCCCCCCCEEECCCCC
Q ss_conf             9934579888758--8820430123-----23432445443546421233
Q 002760          128 LPASIGNLSSLRV--IDVRENRLWG-----RIDSLGQLKSLTLLSVAFNQ  170 (884)
Q Consensus       128 ~~~~l~~l~~L~~--L~l~~n~l~~-----~~~~~~~l~~L~~L~l~~n~  170 (884)
                      +...+...++|+.  |++++|.+..     +.+.+...++|+.|++..+.
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             99999848652477321677867679999999999849984788581898